PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Krueger, AB; Drasin, DJ; Lea, WA; Patrick, AN; Patnaik, S; Backos, DS; Matheson, CJ; Hu, X; Barnaeva, E; Holliday, MJ; Blevins, MA; Robin, TP; Eisenmesser, EZ; Ferrer, M; Simeonov, A; Southall, N; Reigan, P; Marugan, J; Ford, HL; Zhao, R				Krueger, Aaron B.; Drasin, David J.; Lea, Wendy A.; Patrick, Aaron N.; Patnaik, Samarjit; Backos, Donald S.; Matheson, Christopher J.; Hu, Xin; Barnaeva, Elena; Holliday, Michael J.; Blevins, Melanie A.; Robin, Tyler P.; Eisenmesser, Elan Z.; Ferrer, Marc; Simeonov, Anton; Southall, Noel; Reigan, Philip; Marugan, Juan; Ford, Heide L.; Zhao, Rui			Allosteric Inhibitors of the Eya2 Phosphatase Are Selective and Inhibit Eya2-mediated Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EYES ABSENT; BRANCHIOOTORENAL SYNDROME; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BREAST-CANCER; BOR SYNDROME; SIX1; IDENTIFICATION; APOPTOSIS	Eya proteins are essential co-activators of the Six family of transcription factors and contain a unique tyrosine phosphatase domain belonging to the haloacid dehalogenase family of phosphatases. The phosphatase activity of Eya is important for the transcription of a subset of Six1-target genes, and also directs cells to the repair rather than apoptosis pathway upon DNA damage. Furthermore, Eya phosphatase activity has been shown to mediate transformation, invasion, migration, and metastasis of breast cancer cells, making it a potential new drug target for breast cancer. We have previously identified a class of N-arylidenebenzohydrazide compounds that specifically inhibit the Eya2 phosphatase. Herein, we demonstrate that these compounds are reversible inhibitors that selectively inhibit the phosphatase activity of Eya2, but not Eya3. Our mutagenesis results suggest that this class of compounds does not bind to the active site and the binding does not require the coordination with Mg2+. Moreover, these compounds likely bind within a site on the opposite face of the active site, and function as allosteric inhibitors. We also demonstrate that this class of compounds inhibits Eya2 phosphatase-mediated cell migration, setting the foundation for these molecules to be developed into chemical probes for understanding the specific function of the Eya2 phosphatase and to serve as a prototype for the development of Eya2 phosphatase specific anti-cancer drugs.	[Krueger, Aaron B.; Holliday, Michael J.; Blevins, Melanie A.; Eisenmesser, Elan Z.; Zhao, Rui] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Drasin, David J.; Patrick, Aaron N.; Robin, Tyler P.; Ford, Heide L.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Lea, Wendy A.; Patnaik, Samarjit; Hu, Xin; Barnaeva, Elena; Ferrer, Marc; Simeonov, Anton; Southall, Noel; Marugan, Juan] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Backos, Donald S.; Matheson, Christopher J.; Reigan, Philip] Univ Colorado, Sch Pharm, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Colorado System; University of Colorado Anschutz Medical Campus	Marugan, J (corresponding author), NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	maruganj@mail.nih.gov; heide.ford@ucdenver.edu; rui.zhao@ucdenver.edu	Backos, Donald/N-5265-2019; Backos, Donald/Q-4791-2018; Southall, Noel T/H-8991-2012	Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210; Southall, Noel T/0000-0003-4500-880X; Robin, Tyler/0000-0002-0211-5552	Structural Biology Shared Resource of the University of Colorado Cancer Center [P30CA046934]; NATIONAL CANCER INSTITUTE [R41CA180347, T32CA082086, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497, T32GM008730, R01GM107262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA030559] Funding Source: NIH RePORTER	Structural Biology Shared Resource of the University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The x-ray and NMR facilities were supported in part by the Structural Biology Shared Resource of the University of Colorado Cancer Center (Grant P30CA046934). We thank Drs. David Jones, Geoffrey Armstrong, Natalie Ahn, and the Ahn laboratory for advice and technical help.	Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Auvergne RM, 2013, CELL REP, V3, P2127, DOI 10.1016/j.celrep.2013.04.035; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; De Munter S, 2013, ACS CHEM BIOL, V8, P36, DOI 10.1021/cb300597g; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Feig M, 2004, CURR OPIN STRUC BIOL, V14, P217, DOI 10.1016/j.sbi.2004.03.009; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Hojo M, 2002, B CHEM SOC JPN, V75, P2629, DOI 10.1246/bcsj.75.2629; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ikeda K, 2007, DEV BIOL, V311, P53, DOI 10.1016/j.ydbio.2007.08.020; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Jung SK, 2010, FASEB J, V24, P560, DOI 10.1096/fj.09-143891; Kanaya S, 1996, J BIOL CHEM, V271, P32729, DOI 10.1074/jbc.271.51.32729; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Krueger AB, 2013, J BIOMOL SCREEN, V18, P85, DOI 10.1177/1087057112453936; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Mattila E, 2011, ANTI-CANCER AGENT ME, V11, P141, DOI 10.2174/187152011794941235; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Park H, 2011, CHEM BIOL DRUG DES, V78, P642, DOI 10.1111/j.1747-0285.2011.01192.x; Patrick AN, 2013, NAT STRUCT MOL BIOL, V20, P447, DOI 10.1038/nsmb.2505; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rebay I, 2005, TRENDS GENET, V21, P163, DOI 10.1016/j.tig.2005.01.005; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Schneider R, 2013, J AM CHEM SOC, V135, P6838, DOI 10.1021/ja4030484; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Tadjuidje E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034806; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Wang QF, 2011, BLOOD, V117, P6895, DOI 10.1182/blood-2010-12-324699; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wu KM, 2013, CANCER RES, V73, P4488, DOI 10.1158/0008-5472.CAN-12-4078; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 2002, DEVELOPMENT, V129, P3033; Zhang L, 2005, CANCER RES, V65, P925; Zhang MM, 2011, ACS CHEM BIOL, V6, P511, DOI 10.1021/cb100357t; Zhang YZ, 2004, JARO-J ASSOC RES OTO, V5, P295, DOI 10.1007/s10162-004-4044-3; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628; Zimmerman JE, 1997, GENOME RES, V7, P128, DOI 10.1101/gr.7.2.128	43	36	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16349	16361		10.1074/jbc.M114.566729	http://dx.doi.org/10.1074/jbc.M114.566729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755226	Green Published, hybrid			2022-12-25	WOS:000337965700038
J	Miyamoto, T; Mochizuki, T; Nakagomi, H; Kira, S; Watanabe, M; Takayama, Y; Suzuki, Y; Koizumi, S; Takeda, M; Tominaga, M				Miyamoto, Tatsuya; Mochizuki, Tsutomu; Nakagomi, Hiroshi; Kira, Satoru; Watanabe, Masaki; Takayama, Yasunori; Suzuki, Yoshiro; Koizumi, Schuichi; Takeda, Masayuki; Tominaga, Makoto			Functional Role for Piezo1 in Stretch-evoked Ca2+ Influx and ATP Release in Urothelial Cell Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR NUCLEOTIDE TRANSPORTER; K+ CHANNELS; ION CHANNELS; OVERACTIVE BLADDER; CATION CHANNELS; SENSORY TRANSDUCTION; ACTIVATED CHANNELS; TRP CHANNELS; FATTY-ACIDS; TRAAK	The urothelium is a sensory structure that contributes to mechanosensation in the urinary bladder. Here, we provide evidence for a critical role for the Piezo1 channel, a newly identified mechanosensory molecule, in the mouse bladder urothelium. We performed a systematic analysis of the molecular and functional expression of Piezo1 channels in the urothelium. Immunofluorescence examination demonstrated abundant expression of Piezo1 in the mouse and human urothelium. Urothelial cells isolated from mice exhibited a Piezo1-dependent increase in cytosolic Ca2+ concentrations in response to mechanical stretch stimuli, leading to potent ATP release; this response was suppressed in Piezo1-knockdown cells. In addition, Piezo1 and TRPV4 distinguished different intensities of mechanical stimulus. Moreover, GsMTx4, an inhibitor of stretch-activated channels, attenuated the Ca2+ influx into urothelial cells and decreased ATP release from them upon stretch stimulation. These results suggest that Piezo1 senses extension of the bladder urothelium, leading to production of an ATP signal. Thus, inhibition of Piezo1 might provide a promising means of treating bladder dysfunction.	[Miyamoto, Tatsuya; Mochizuki, Tsutomu; Nakagomi, Hiroshi; Kira, Satoru; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo, Yamanashi 4093898, Japan; [Watanabe, Masaki; Takayama, Yasunori; Suzuki, Yoshiro; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Suzuki, Yoshiro; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Koizumi, Schuichi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neuropharmacol, Chuo, Yamanashi 4093898, Japan	University of Yamanashi; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; University of Yamanashi	Mochizuki, T (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	tsutomu@yamanashi.ac.jp; tominaga@nips.ac.jp	Koizumi, Schuichi/E-8568-2010; Takayama, Yasunori/AAG-1133-2021	Koizumi, Schuichi/0000-0001-6184-3106; SUZUKI, YOSHIRO/0000-0003-0010-1867	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24791640, 23592361, 23390381, 23249012]; Grants-in-Aid for Scientific Research [24791640] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 24791640 (to T. Miyamoto), 23592361 (to T. Mochizuki), 23390381 (to M. Takeda), and 23249012 (to M. Tominaga) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Araki I, 2008, INT J UROL, V15, P681, DOI 10.1111/j.1442-2042.2008.02052.x; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Chai TC, 2004, NAT CLIN PRACT UROL, V1, P85, DOI 10.1038/ncpuro0057; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; de Groat WC, 2004, UROLOGY, V64, P7, DOI 10.1016/j.urology.2004.08.063; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Du SQ, 2008, UROLOGY, V72, P450, DOI 10.1016/j.urology.2007.11.127; Dunning-Davies BM, 2013, BJU INT, V111, P505, DOI 10.1111/j.1464-410X.2012.11421.x; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Everaerts W, 2008, NEUROUROL URODYNAM, V27, P264, DOI 10.1002/nau.20511; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gottlieb PA, 2012, CHANNELS, V6, P214, DOI 10.4161/chan.21050; Graham Emmanuel, 2006, Curr Urol Rep, V7, P440, DOI 10.1007/s11934-006-0051-8; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Janssen DAW, 2011, J UROLOGY, V186, P1121, DOI 10.1016/j.juro.2011.04.107; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maroto R, 2001, J BIOL CHEM, V276, P23867, DOI 10.1074/jbc.M101500200; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Miyaji T, 2011, J BIOL CHEM, V286, P42881, DOI 10.1074/jbc.M111.277269; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Sharif-Naeini R, 2008, PFLUG ARCH EUR J PHY, V456, P529, DOI 10.1007/s00424-007-0432-y; Shibata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023510; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Sugaya K, 2009, BIOMED RES-TOKYO, V30, P287, DOI 10.2220/biomedres.30.287; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086	60	174	183	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16565	16575		10.1074/jbc.M113.528638	http://dx.doi.org/10.1074/jbc.M113.528638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24759099	Green Published, hybrid			2022-12-25	WOS:000337965700057
J	Reithinger, JH; Yim, C; Kim, S; Lee, H; Kim, H				Reithinger, Johannes H.; Yim, Chewon; Kim, Sungmin; Lee, Hunsang; Kim, Hyun			Structural and Functional Profiling of the Lateral Gate of the Sec61 Translocon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Membrane; Membrane Protein; Protein Translocation; Yeast	SIGNAL SEQUENCE RECOGNITION; POSTTRANSLATIONAL PROTEIN-TRANSPORT; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE SEGMENTS; MEMBRANE-PROTEIN; MOLECULAR CODE; PLUG DOMAIN; CHANNEL; COMPLEX; INTEGRATION	The evolutionarily conserved Sec61 translocon mediates the translocation and membrane insertion of proteins. For the integration of proteins into the membrane, the Sec61 translocon opens laterally to the lipid bilayer. Previous studies suggest that the lateral opening of the channel is mediated by the helices TM2b and TM7 of a pore-forming subunit of the Sec61 translocon. To map key residues in TM2b and TM7 in yeast Sec61 that modulate lateral gating activity, we performed alanine scanning and in vivo site-directed photocross-linking experiments. Alanine scanning identified two groups of critical residues in the lateral gate, one group that leads to defects in the translocation and membrane insertion of proteins and the other group that causes faster translocation and facilitates membrane insertion. Photocross-linking data show that the former group of residues is located at the interface of the lateral gate. Furthermore, different degrees of defects for the membrane insertion of single- and double-spanning membrane proteins were observed depending on whether the mutations were located in TM2b or TM7. These results demonstrate subtle differences in the molecular mechanism of the signal sequence binding/opening of the lateral gate and membrane insertion of a succeeding transmembrane segment in a polytopic membrane protein.	[Yim, Chewon; Kim, Sungmin; Lee, Hunsang; Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Reithinger, Johannes H.] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden	Seoul National University (SNU); Stockholm University	Kim, H (corresponding author), Seoul Natl Univ, Sch Biol Sci, Bldg 504-421, Seoul 151747, South Korea.	joy@snu.ac.kr	Lee, Hunsang/ABC-5697-2020		National Research Foundation of Korea [2013R1A1A2A10010894, 202-2001-1-C00031]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Basic Research Grant 2013R1A1A2A10010894 and Global Research Network Grant 202-2001-1-C00031 from the National Research Foundation of Korea (to H.K.).	Bondar AN, 2010, STRUCTURE, V18, P847, DOI 10.1016/j.str.2010.04.010; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Demirci E, 2013, P NATL ACAD SCI USA, V110, P18856, DOI 10.1073/pnas.1318432110; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hessa T, 2009, J MOL BIOL, V386, P1222, DOI 10.1016/j.jmb.2009.01.027; Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; Junne T, 2007, J BIOL CHEM, V282, P33201, DOI 10.1074/jbc.M707219200; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reithinger JH, 2013, J BIOL CHEM, V288, P18058, DOI 10.1074/jbc.M113.473009; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Trueman SF, 2011, MOL BIOL CELL, V22, P2983, DOI 10.1091/mbc.E11-01-0070; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	48	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15845	15855		10.1074/jbc.M113.533794	http://dx.doi.org/10.1074/jbc.M113.533794			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753257	Green Published, hybrid			2022-12-25	WOS:000337465400063
J	Burkhard, SH; Mair, F; Nussbaum, K; Hasler, S; Becher, B				Burkhard, Sara H.; Mair, Florian; Nussbaum, Kathrin; Hasler, Sabrina; Becher, Burkhard			T Cell Contamination in Flow Cytometry Gating Approaches for Analysis of Innate Lymphoid Cells	PLOS ONE			English	Article							ROR-GAMMA-T; STIMULATION; IMMUNITY; FATE	Innate lymphoid cells (ILCs) differ from T and B cells as they do not express genetically rearranged antigen receptors. The most prominent member of this group, NK cells, can be identified by numerous surface receptors such as natural cytotoxicity receptors (NCRs). However, novel groups of ILCs have recently been described and classified based on fate-determining transcription factors and cytokines being produced, similarly to T helper cells. Due to the lack of exclusive markers, ILCs are primarily defined by the paucity of lineage markers. Using RORc-fate-mapping mice, we found that the common lineage exclusion using CD3 yields an ILC population containing a large proportion of T cells with recombined TCR loci and low expression of CD3. Thus, we suggest adding CD5 as a marker for thorough elimination of T cells to avoid erroneous interpretations of ILC function in immunity.	[Burkhard, Sara H.; Mair, Florian; Nussbaum, Kathrin; Hasler, Sabrina; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Mair, Florian/0000-0001-6732-5449	Swiss National Science Foundation; European Union FP7 project TargetBraIn [279017]; Swiss multiple sclerosis society; Boehringer Ingelheim Fonds (BIF)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union FP7 project TargetBraIn; Swiss multiple sclerosis society; Boehringer Ingelheim Fonds (BIF)(Boehringer Ingelheim)	B.B. is supported by the Swiss National Science Foundation, the European Union FP7 project TargetBraIn (279017) and the Swiss multiple sclerosis society. K.N. is supported by the Boehringer Ingelheim Fonds (BIF), S.B. holds a MD-PhD fellowship from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Dalloul A, 2009, AUTOIMMUN REV, V8, P349, DOI 10.1016/j.autrev.2008.11.007; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017	21	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94196	10.1371/journal.pone.0094196	http://dx.doi.org/10.1371/journal.pone.0094196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759759	Green Published, gold, Green Accepted			2022-12-25	WOS:000335298200012
J	Bind, MA; Coull, B; Suh, H; Wright, R; Baccarelli, A; Vokonas, P; Schwartz, J				Bind, Marie-Abele; Coull, Brent; Suh, Helen; Wright, Robert; Baccarelli, Andrea; Vokonas, Pantel; Schwartz, Joel			A Novel Genetic Score Approach Using Instruments to Investigate Interactions between Pathways and Environment: Application to Air Pollution	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PARTICULATE MATTER; RATE-VARIABILITY; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; ULTRAFINE PARTICLES; ELDERLY-COHORT; INFLAMMATION; ATHEROSCLEROSIS; ASSOCIATION	Air pollution has been associated with increased systemic inflammation markers. We developed a new pathway analysis approach to investigate whether gene variants within relevant pathways (oxidative stress, endothelial function, and metal processing) modified the association between particulate air pollution and fibrinogen, C-reactive protein (CRP), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1). Our study population consisted of 822 elderly participants of the Normative Aging Study (1999-2011). To investigate the role of biological mechanisms and to reduce the number of comparisons in the analysis, we created pathway-specific scores using gene variants related to each pathway. To select the most appropriate gene variants, we used the least absolute shrinkage and selection operator (Lasso) to relate independent outcomes representative of each pathway (8-hydroxydeoxyguanosine for oxidative stress, augmentation index for endothelial function, and patella lead for metal processing) to gene variants. A high genetic score corresponds to a higher allelic risk profile. We fit mixed-effects models to examine modification by the genetic score of the weekly air pollution association with the outcome. Among participants with higher genetic scores within the oxidative stress pathway, we observed significant associations between particle number and fibrinogen, while we did not find any association among participants with lower scores (p(interaction)=0.04). Compared to individuals with low genetic scores of metal processing gene variants, participants with higher scores had greater effects of particle number on fibrinogen (p(interaction)=0.12), CRP (p(interaction)=0.02), and ICAM-1 (p(interaction)=0.08). This two-stage penalization method is easy to implement and can be used for large-scale genetic applications.	[Bind, Marie-Abele; Suh, Helen; Wright, Robert; Baccarelli, Andrea; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Bind, Marie-Abele; Coull, Brent] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Baccarelli, Andrea; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Vokonas, Pantel] Boston Univ, Sch Med, VA Normat Aging Study, Boston, MA 02118 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Bind, MA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	bind@mail.harvard.edu		Suh, Helen/0000-0001-7355-6104; Baccarelli, Andrea/0000-0002-3436-0640; Wright, Robert/0000-0003-1180-6459	U.S. Environmental Protection Agency [EPA RD-827353, RD-832416]; National Institute of Environmental Health Sciences (NIEHS) [RO1-ES015172, ES014663, ES00002, PO1-ES008925]; Clean Air Act (CLARC) [RD83479701]; Cooperative Studies Program/Epidemiology Research and Information Center of the U. S. Department of Veterans Affairs; Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014663, R01ES015172, P30ES000002] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Clean Air Act (CLARC); Cooperative Studies Program/Epidemiology Research and Information Center of the U. S. Department of Veterans Affairs(US Department of Veterans Affairs); Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the U.S. Environmental Protection Agency grants EPA RD-827353 and RD-832416; National Institute of Environmental Health Sciences (NIEHS) grants RO1-ES015172, ES014663, ES00002, PO1-ES008925, and Clean Air Act (CLARC) grant RD83479701. The VA Normative Aging Study (NAS) is supported by the Cooperative Studies Program/Epidemiology Research and Information Center of the U. S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8; Alexeeff SE, 2011, ENVIRON HEALTH PERSP, V119, P481, DOI 10.1289/ehp.1002560; Baja ES, 2010, ENVIRON HEALTH PERSP, V118, P840, DOI 10.1289/ehp.0901396; Bind MA, 2012, EPIDEMIOLOGY, V23, P332, DOI 10.1097/EDE.0b013e31824523f0; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Delfino RJ, 2010, ENVIRON HEALTH PERSP, V118, P756, DOI 10.1289/ehp.0901407; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Ghio AJ, 2005, AM J PHYSIOL-LUNG C, V289, pL460, DOI 10.1152/ajplung.00154.2005; Ghio AJ, 1998, TOXICOL PATHOL, V26, P388, DOI 10.1177/019262339802600313; Hennig B, 2007, NUTR METAB CARDIOVAS, V17, P162, DOI 10.1016/j.numecd.2006.01.003; Hwang SJ, 1997, CIRCULATION, V96, P4219; Kang CM, 2010, J AIR WASTE MANAGE, V60, P1327, DOI 10.3155/1047-3289.60.11.1327; Lee S, 2011, WORLD J CARDIOL, V3, P18, DOI 10.4330/wjc.v3.i1.18; Lim S, 2010, NEUROTOXICOLOGY, V31, P10, DOI 10.1016/j.neuro.2009.10.001; Ljungman P, 2009, ENVIRON HEALTH PERSP, V117, P1373, DOI 10.1289/ehp.0800370; Madrigano J, 2010, OCCUP ENVIRON MED, V67, P312, DOI 10.1136/oem.2009.046193; Mazzoli-Rocha F, 2010, CELL BIOL TOXICOL, V26, P481, DOI 10.1007/s10565-010-9158-2; Miller MR, 2009, ENVIRON HEALTH PERSP, V117, P611, DOI 10.1289/ehp.0800235; Molinelli AR, 2002, INHAL TOXICOL, V14, P1069, DOI 10.1080/08958370290084737; Mordukhovich I, 2009, ENVIRON HEALTH PERSP, V117, P1767, DOI 10.1289/ehp.0900591; Mustafa S, 2008, J VASC SURG, V47, P566, DOI 10.1016/j.jvs.2007.09.060; Nemmar A, 2002, AM J RESP CRIT CARE, V166, P998, DOI 10.1164/rccm.200110-026OC; Park SK, 2005, ENVIRON HEALTH PERSP, V113, P304, DOI 10.1289/ehp.7447; Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197; Peters A, 2009, AM J RESP CRIT CARE, V179, P484, DOI 10.1164/rccm.200805-751OC; Ren C, 2010, J EPIDEMIOL COMMUN H, V64, P49, DOI 10.1136/jech.2008.083295; Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc; Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC; Runge Marschall S, 2010, Trans Am Clin Climatol Assoc, V121, P52; Safran M, 2010, DATABASE-OXFORD, V5, P2010, DOI DOI 10.1093/DATABASE/BAQ020; Sangani RG, 2010, INHAL TOXICOL, V22, P621, DOI 10.3109/08958371003599037; Spanier AJ, 2009, PEDIATR PULM, V44, P812, DOI 10.1002/ppul.21071; Thomson EM, 2007, ENVIRON RES, V105, P224, DOI 10.1016/j.envres.2007.06.005; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Hee VC, 2010, ENVIRON HEALTH PERSP, V118, P962, DOI 10.1289/ehp.0901535; Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	41	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96000	10.1371/journal.pone.0096000	http://dx.doi.org/10.1371/journal.pone.0096000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755831	Green Published, gold			2022-12-25	WOS:000335240300130
J	Juhasz, J; Kertesz-Farkas, A; Szabo, D; Pongor, S				Juhasz, Janos; Kertesz-Farkas, Attila; Szabo, Dora; Pongor, Sandor			Emergence of Collective Territorial Defense in Bacterial Communities: Horizontal Gene Transfer Can Stabilize Microbiomes	PLOS ONE			English	Article							EVOLUTIONARY; COMPETITION; BALANCE	Multispecies bacterial communities such as the microbiota of the gastrointestinal tract can be remarkably stable and resilient even though they consist of cells and species that compete for resources and also produce a large number of antimicrobial agents. Computational modeling suggests that horizontal transfer of resistance genes may greatly contribute to the formation of stable and diverse communities capable of protecting themselves with a battery of antimicrobial agents while preserving a varied metabolic repertoire of the constituent species. In other words horizontal transfer of resistance genes makes a community compatible in terms of exoproducts and capable to maintain a varied and mature metagenome. The same property may allow microbiota to protect a host organism, or if used as a microbial therapy, to purge pathogens and restore a protective environment.	[Juhasz, Janos; Pongor, Sandor] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary; [Kertesz-Farkas, Attila; Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, Grp Prot Struct & Bioinformat, I-34012 Trieste, Italy; [Szabo, Dora] Semmelweis Univ, Inst Med Microbiol, H-1085 Budapest, Hungary	International Center for Genetic Engineering & Biotechnology (ICGEB); Semmelweis University	Pongor, S (corresponding author), Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary.	pongor@icgeb.org		Juhasz, Janos/0000-0002-1307-7387	Nemzeti Innovacios Hivatal (Hungarian: National Innovation Office) NIH [TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, TAMOP-4.2.2/B-10/1-2010-0014]; Orszagos Tudomanyos Kutatasi Alap (Hungarian: National Scientific Research Fund) OTKA [108481]; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy,ICGBE	Nemzeti Innovacios Hivatal (Hungarian: National Innovation Office) NIH; Orszagos Tudomanyos Kutatasi Alap (Hungarian: National Scientific Research Fund) OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); International Centre for Genetic Engineering and Biotechnology, Trieste, Italy,ICGBE	The research at Pazmany Peter Catholic University, Budapest was partially supported by Nemzeti Innovacios Hivatal (Hungarian: National Innovation Office) NIH grants TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, and TAMOP-4.2.2/B-10/1-2010-0014. The work at Semmelweis University was partially supported by Orszagos Tudomanyos Kutatasi Alap (Hungarian: National Scientific Research Fund) OTKA grant 108481. Funding for open access charge and for the services of a scientific writer/editor was provided International Centre for Genetic Engineering and Biotechnology, Trieste, Italy,ICGBE respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIBA T, 1960, Jpn J Microbiol, V4, P219; Brandt LJ, 2013, GASTROINTEST ENDOSC, V78, P240, DOI 10.1016/j.gie.2013.03.1329; Bryskier A., 2005, ANTIMICROBIAL AGENTS, DOI [10.1128/9781555815929, DOI 10.1128/9781555815929]; Bucci V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002497; Chandler JR, 2012, ISME J, V6, P2219, DOI 10.1038/ismej.2012.69; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Francino MP, 2012, HORIZONTAL GENE TRANSFER IN MICROORGANISMS, P1; Gause GF, 1932, J EXP BIOL, V9, P389; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Kellermayer Richard, 2013, World J Gastrointest Pathophysiol, V4, P91, DOI 10.4291/wjgp.v4.i4.91; Kerenyi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057947; Koonin EV, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00119; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Liu L, 2012, GENOMICS, V100, P265, DOI 10.1016/j.ygeno.2012.07.012; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Venturi V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-30; Venturi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009998; Vrieze A, 2013, BEST PRACT RES CL GA, V27, P127, DOI 10.1016/j.bpg.2013.03.003; Wadstrom T, 2009, LACTOBACILLUS MOL BI; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wilson E.O., 1975, P1	31	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95511	10.1371/journal.pone.0095511	http://dx.doi.org/10.1371/journal.pone.0095511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755769	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300049
J	Kuhn, ML; Zemaitaitis, B; Hu, LI; Sahu, A; Sorensen, D; Minasov, G; Lima, BP; Scholle, M; Mrksich, M; Anderson, WF; Gibson, BW; Schilling, B; Wolfe, AJ				Kuhn, Misty L.; Zemaitaitis, Bozena; Hu, Linda I.; Sahu, Alexandria; Sorensen, Dylan; Minasov, George; Lima, Bruno P.; Scholle, Michael; Mrksich, Milan; Anderson, Wayne F.; Gibson, Bradford W.; Schilling, Birgit; Wolfe, Alan J.			Structural, Kinetic and Proteomic Characterization of Acetyl Phosphate-Dependent Bacterial Protein Acetylation	PLOS ONE			English	Article							GCN5-RELATED N-ACETYLTRANSFERASES; SELF-ASSEMBLED MONOLAYERS; MASS-SPECTROMETRY; LYSINE ACETYLATION; CATALYTIC MECHANISM; ESCHERICHIA-COLI; HISTONE ACETYLTRANSFERASE; PEPTIDE ARRAYS; COA SYNTHETASE; TRANSCRIPTION	The emerging view of N-epsilon-lysine acetylation in eukaryotes is of a relatively abundant post-translational modification (PTM) that has a major impact on the function, structure, stability and/or location of thousands of proteins involved in diverse cellular processes. This PTM is typically considered to arise by the donation of the acetyl group from acetyl-coenzyme A (acCoA) to the e-amino group of a lysine residue that is reversibly catalyzed by lysine acetyltransferases and deacetylases. Here, we provide genetic, mass spectrometric, biochemical and structural evidence that N-epsilon-lysine acetylation is an equally abundant and important PTM in bacteria. Applying a recently developed, label-free and global mass spectrometric approach to an isogenic set of mutants, we detected acetylation of thousands of lysine residues on hundreds of Escherichia coli proteins that participate in diverse and often essential cellular processes, including translation, transcription and central metabolism. Many of these acetylations were regulated in an acetyl phosphate (acP)-dependent manner, providing compelling evidence for a recently reported mechanism of bacterial N-epsilon-lysine acetylation. These mass spectrometric data, coupled with observations made by crystallography, biochemistry, and additional mass spectrometry showed that this acP-dependent acetylation is both non-enzymatic and specific, with specificity determined by the accessibility, reactivity and three-dimensional microenvironment of the target lysine. Crystallographic evidence shows acP can bind to proteins in active sites and cofactor binding sites, but also potentially anywhere molecules with a phosphate moiety could bind. Finally, we provide evidence that acP-dependent acetylation can impact the function of critical enzymes, including glyceraldehyde3-phosphate dehydrogenase, triosephosphate isomerase, and RNA polymerase.	[Kuhn, Misty L.; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Zemaitaitis, Bozena; Hu, Linda I.; Lima, Bruno P.; Wolfe, Alan J.] Loyola Univ Chicago, Div Hlth Sci, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Sahu, Alexandria; Sorensen, Dylan; Gibson, Bradford W.; Schilling, Birgit] Buck Inst Res Aging, Novato, CA USA; [Scholle, Michael; Mrksich, Milan] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Scholle, Michael; Mrksich, Milan] Northwestern Univ, Dept Chem, Evanston, IL USA; [Scholle, Michael; Mrksich, Milan] Northwestern Univ, Dept Cell & Mol Biol, Evanston, IL USA; [Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA	Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Buck Institute for Research on Aging; Northwestern University; Northwestern University; Northwestern University; University of California System; University of California San Francisco	Wolfe, AJ (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA.	awolfe@lumc.edu	Mrksich, Milan/G-2469-2011; Lima, Bruno/K-3228-2019	Lima, Bruno/0000-0003-4619-4712; Minasov, George/0000-0001-5460-3462; D'Souza, Alexandria K/0000-0003-2429-3218; Mrksich, Milan/0000-0002-4964-796X	U. S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation and Michigan Technology Tri-Corridor [085P100817]; NIH; NIAID; NIDDK [R24 DK085610]; NIGMS [R01 GM066130]; Department of Health and Human Services [HHSN272200700058C, HHSN272201200026C]; NCI [U54CA151880]; NATIONAL CANCER INSTITUTE [U54CA151880, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066130] Funding Source: NIH RePORTER	U. S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation and Michigan Technology Tri-Corridor; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Health and Human Services; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The use of the Advanced Photon Source, an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U. S. DOE under Contract No. DE-AC02-06CH11357. The use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor (Grant 085P100817). This work was supported by grants from the NIH, NIAID & NIDDK; including R24 DK085610 (NIDDK, to BWG), R01 GM066130 (NIGMS, to AJW), Department of Health and Human Services, Contracts HHSN272200700058C and HHSN272201200026C (NIAID, NIH, Department of Health and Human Services to WFA) and U54CA151880 (NCI, to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brent MM, 2009, J BIOL CHEM, V284, P19412, DOI 10.1074/jbc.M109.014951; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Souza A. K., 2013, P 61 ANN ASMS C MASS; Da Re SS, 1999, FEBS LETT, V457, P323, DOI 10.1016/S0014-5793(99)01057-1; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; Danielson SR, 2009, ANAL CHEM, V81, P7823, DOI 10.1021/ac901176t; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; DISABATO G, 1961, J AM CHEM SOC, V83, P4393, DOI 10.1021/ja01482a024; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOUCAULT G, 1978, EUR J BIOCHEM, V83, P113, DOI 10.1111/j.1432-1033.1978.tb12074.x; Frewen Barbara, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1307s20; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Go MK, 2010, BIOCHEMISTRY-US, V49, P5377, DOI 10.1021/bi100538b; Greiss S, 2009, MOL CELLS, V28, P407, DOI 10.1007/s10059-009-0169-x; Gurard-Levin ZA, 2011, ACS COMB SCI, V13, P347, DOI 10.1021/co2000373; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Gurard-Levin ZA, 2009, CHEMBIOCHEM, V10, P2159, DOI 10.1002/cbic.200900417; Gurard-Levin ZA, 2008, ANNU REV ANAL CHEM, V1, P767, DOI 10.1146/annurev.anchem.1.031207.112903; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hu LDI, 2013, J BACTERIOL, V195, P4174, DOI 10.1128/JB.00383-13; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jencks W. P., 1969, CATALYSIS CHEM ENZYM; Jiang JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036660; Keating DH, 2008, BIOL PROCED ONLINE, V10, P36, DOI 10.1251/bpo141; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; KOSHLAND DE, 1952, J AM CHEM SOC, V74, P2286, DOI 10.1021/ja01129a035; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuhn ML, 2013, PROTEIN SCI, V22, P222, DOI 10.1002/pro.2199; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lawrence SH, 2006, J BACTERIOL, V188, P1143, DOI 10.1128/JB.188.3.1143-1154.2006; Lee DW, 2013, PROTEOMICS, V13, P2278, DOI 10.1002/pmic.201200072; Li R, 2010, MOL MICROBIOL, V76, P1162, DOI 10.1111/j.1365-2958.2010.07125.x; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liarzi O, 2010, MOL MICROBIOL, V76, P932, DOI 10.1111/j.1365-2958.2010.07148.x; Lima BP, 2012, J BIOL CHEM, V287, P32147, DOI 10.1074/jbc.M112.365502; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; Lipmann F, 1944, J BIOL CHEM, V153, P571; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Millard CS, 2003, PROTEIN EXPRES PURIF, V29, P311, DOI 10.1016/S1046-5928(03)00063-9; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mrksich M, 2008, ACS NANO, V2, P7, DOI 10.1021/nn7004156; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PARK JH, 1970, J BIOL CHEM, V245, P2946; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PRUSS BM, 1994, MOL MICROBIOL, V12, P973; RAMPONI G, 1975, BIOCHEMISTRY-US, V14, P2681, DOI 10.1021/bi00683a018; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Schilling B, 2012, QUANTITATION PROTEOM; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schweimer K, 2011, STRUCTURE, V19, P945, DOI 10.1016/j.str.2011.03.024; Sharma V, 2012, PANORAMA PRIVATE REP; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Silhavy T.J., 1984, EXPT GENE FUSIONS; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2003, MOL MICROBIOL, V48, P977, DOI 10.1046/j.1365-2958.2003.03457.x; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Wu X, 2013, J PROTEOMICS, V79, P60, DOI 10.1016/j.jprot.2012.12.001; Xu Qian Steven, 2005, Journal of Structural and Functional Genomics, V6, P269, DOI 10.1007/s10969-005-9001-9; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhao GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070369; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060	100	187	193	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94816	10.1371/journal.pone.0094816	http://dx.doi.org/10.1371/journal.pone.0094816			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756028	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300017
J	Jablonowska, E; Wojcik, K; Szymanska, B; Omulecka, A; Cwiklinska, H; Piekarska, A				Jablonowska, Elzbieta; Wojcik, Kamila; Szymanska, Bozena; Omulecka, Aleksandra; Cwiklinska, Hanna; Piekarska, Anna			Hepatic HMOX1 Expression Positively Correlates with Bach-1 and miR-122 in Patients with HCV Mono and HIV/HCV Coinfection	PLOS ONE			English	Article							C VIRUS-REPLICATION; HEME OXYGENASE-1; LIPID-PEROXIDATION; CORE; MECHANISM; INFECTION	Aim: To analyze the expression of HMOX1 and miR-122 in liver biopsy samples obtained from HCV mono-and HIV/HCV co-infected patients in relation to selected clinical parameters, histological examination and IL-28B polymorphism as well as to determine whether HMOX1 expression is dependent on Bach-1. Materials and Methods: The study group consisted of 90 patients with CHC: 69 with HCV mono and 21 with HIV/HCV co-infection. RT-PCR was used in the analysis of HMOX1, Bach-1 and miR-122 expression in liver biopsy samples and in the assessment of IL-28B single-nucleotide polymorphism C/T (rs12979860) in the blood. Moreover in liver biopsy samples an analysis of HO-1 and Bach-1 protein level by Western Blot was performed. Results: HCV mono-infected patients, with lower grading score (G, 2) and higher HCV viral load (>600000 IU/mL) demonstrated higher expression of HMOX1. In patients with HIV/HCV co-infection, the expression of HMOX1 was lower in patients with lower lymphocyte CD4 count and higher HIV viral load. IL28B polymorphism did not affect the expression of either HMOX1 or miR-122. Higher HMOX1 expression correlated with higher expression of Bach-1 (Spearman's p = 0.586, p = 0.000001) and miR-122 (Spearman's p = 0.270, p = 0.014059). Conclusions: HMOX1 and miR-122 play an important role in the pathogenesis of CHC in HCV mono-and HIV/HCV co-infected patients. Reduced expression of HMOX1 in patients with HIV/HCV co-infection may indicate a worse prognosis in this group. Our results do not support the importance of Bach-1 in repression of HMOX1 in patients with chronic hepatitis C.	[Jablonowska, Elzbieta; Wojcik, Kamila; Piekarska, Anna] Med Univ Lodz, Dept Infect Dis & Hepatol, Lodz, Poland; [Szymanska, Bozena] Med Univ Lodz, Cent Lab, Lodz, Poland; [Omulecka, Aleksandra] Bieganski Prov Specialist Hosp, Dept Pathol, Lodz, Poland; [Cwiklinska, Hanna] Med Univ Lodz, Dept Neurol, Lab Neuroimmunol, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz	Jablonowska, E (corresponding author), Med Univ Lodz, Dept Infect Dis & Hepatol, Lodz, Poland.	elajablonowska@gmail.com	Cwiklinska, Hanna/V-5247-2018	Cwiklinska, Hanna/0000-0002-4556-9431; Jablonowska, Elzbieta/0000-0002-7282-1225				Abdalla MY, 2005, J MED VIROL, V76, P489, DOI 10.1002/jmv.20388; Abdalla MY, 2004, J INFECT DIS, V190, P1109, DOI 10.1086/423488; Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Caballeria L, 2001, AM J GASTROENTEROL, V96, P1160; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; DeMaria N, 1996, FREE RADICAL BIO MED, V21, P291, DOI 10.1016/0891-5849(96)00044-5; Devadas K, 2006, J IMMUNOL, V176, P4252, DOI 10.4049/jimmunol.176.7.4252; Elbirt KK, 1999, P ASSOC AM PHYSICIAN, V111, P438, DOI 10.1111/paa.1999.111.5.438; FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-1; Fillebeen C, 2010, J HEPATOL, V53, P995, DOI 10.1016/j.jhep.2010.04.044; Ghaziani T, 2006, J HEPATOL, V45, P5, DOI 10.1016/j.jhep.2005.12.020; Hou WH, 2009, WORLD J GASTROENTERO, V15, P4499, DOI 10.3748/wjg.15.4499; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jopling CL, 2006, COLD SPRING HARB SYM, V71, P369, DOI 10.1101/sqb.2006.71.022; Kakizaki S, 2000, LIVER, V20, P125, DOI 10.1034/j.1600-0676.2000.020002125.x; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339; MutluTurkoglu U, 1997, RES COMMUN MOL PATH, V96, P357; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Shan Y, 2007, GASTROENTEROLOGY, V133, P1166, DOI 10.1053/j.gastro.2007.08.002; SHIMODA R, 1994, CANCER RES, V54, P3171; Takahashi T, 2007, MINI-REV MED CHEM, V7, P745; Wen Tao, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P618; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491; Zhu ZW, 2010, HEPATOLOGY, V52, P1897, DOI 10.1002/hep.23921	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95564	10.1371/journal.pone.0095564	http://dx.doi.org/10.1371/journal.pone.0095564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752012	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400076
J	Kim, MH; Rebbert, ML; Ro, H; Won, M; Dawid, IB				Kim, Mi Ha; Rebbert, Martha L.; Ro, Hyunju; Won, Minho; Dawid, Igor B.			Cell Adhesion in Zebrafish Embryos Is Modulated by March8	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; E-CADHERIN; CLASS-II; XENOPUS EMBRYOS; DOWN-REGULATION; B-CELLS; C-MIR; EXPRESSION; MOVEMENTS; PROTEIN	March8 is a member of a family of transmembrane E3 ubiquitin ligases that have been studied mostly for their role in the immune system. We find that March8 is expressed in the zebrafish egg and early embryo, suggesting a role in development. Both knock-down and overexpression of March8 leads to abnormal development. The phenotype of zebrafish embryos and Xenopus animal explants overexpressing March8 implicates impairment of cell adhesion as a cause of the effect. In zebrafish embryos and in cultured cells, overexpression of March8 leads to a reduction in the surface levels of E-cadherin, a major cell-cell adhesion molecule. Experiments in cell culture further show that E-cadherin can be ubiquitinated by March8. On the basis of these observations we suggest that March8 functions in the embryo to modulate the strength of cell adhesion by regulating the localization of E-cadherin.	[Kim, Mi Ha; Rebbert, Martha L.; Ro, Hyunju; Won, Minho; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dawid, IB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov		Won, Minho/0000-0002-5873-5216; Ro, Hyunju/0000-0002-0829-9639	National Institute for Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809, ZIAHD001002] Funding Source: NIH RePORTER	National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research has been funded by the intramural research program of the National Institute for Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Babb SG, 2001, DEV DYNAM, V221, P231, DOI 10.1002/dvdy.1132; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; CHOI YS, 1989, J CELL BIOL, V108, P2449, DOI 10.1083/jcb.108.6.2449; CHOI YS, 1990, J CELL BIOL, V110, P1575, DOI 10.1083/jcb.110.5.1575; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Danilova N, 2002, P NATL ACAD SCI USA, V99, P13711, DOI 10.1073/pnas.212515999; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; GINSBERG D, 1991, DEVELOPMENT, V111, P315; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; HEASMAN J, 1994, DEVELOPMENT, V120, P49; Jahnke M, 2013, EUR J IMMUNOL, V43, P1153, DOI 10.1002/eji.201243043; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Jahnke M, 2012, J BIOL CHEM, V287, P7256, DOI 10.1074/jbc.M111.305961; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kaido M, 2009, GENES CELLS, V14, P1067, DOI 10.1111/j.1365-2443.2009.01335.x; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LEVI G, 1991, DEVELOPMENT, V111, P159; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Marrs JA, 1996, INT REV CYTOL, V165, P159, DOI 10.1016/S0074-7696(08)62222-6; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Song SM, 2013, DEV CELL, V24, P486, DOI 10.1016/j.devcel.2013.01.016; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Takeichi M, 2011, DEV CELL, V21, P24, DOI 10.1016/j.devcel.2011.06.002; TOYAMA R, 1995, DEVELOPMENT, V121, P383; van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002; Yogo K, 2012, HISTOCHEM CELL BIOL, V137, P53, DOI 10.1007/s00418-011-0887-y; Zhao BQ, 2013, HISTOCHEM CELL BIOL, V139, P447, DOI 10.1007/s00418-012-1043-z	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94873	10.1371/journal.pone.0094873	http://dx.doi.org/10.1371/journal.pone.0094873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752240	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400020
J	Mayali, X; Weber, PK; Mabery, S; Pett-Ridge, J				Mayali, Xavier; Weber, Peter K.; Mabery, Shalini; Pett-Ridge, Jennifer			Phylogenetic Patterns in the Microbial Response to Resource Availability: Amino Acid Incorporation in San Francisco Bay	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; MARINE-BACTERIA; BACTERIOPLANKTON POPULATIONS; COASTAL WATERS; COMMUNITIES; OCEAN; CALIFORNIA; NITROGEN; DIFFERENTIATION; PHYTOPLANKTON	Aquatic microorganisms are typically identified as either oligotrophic or copiotrophic, representing trophic strategies adapted to low or high nutrient concentrations, respectively. Here, we sought to take steps towards identifying these and additional adaptations to nutrient availability with a quantitative analysis of microbial resource use in mixed communities. We incubated an estuarine microbial community with stable isotope labeled amino acids (AAs) at concentrations spanning three orders of magnitude, followed by taxon-specific quantitation of isotopic incorporation using NanoSIMS analysis of high-density microarrays. The resulting data revealed that trophic response to AA availability falls along a continuum between copiotrophy and oligotrophy, and high and low activity. To illustrate strategies along this continuum more simply, we statistically categorized microbial taxa among three trophic types, based on their incorporation responses to increasing resource concentration. The data indicated that taxa with copiotrophic-like resource use were not necessarily the most active, and taxa with oligotrophic-like resource use were not always the least active. Two of the trophic strategies were not randomly distributed throughout a 16S rDNA phylogeny, suggesting they are under selective pressure in this ecosystem and that a link exists between evolutionary relatedness and substrate affinity. The diversity of strategies to adapt to differences in resource availability highlights the need to expand our understanding of microbial interactions with organic matter in order to better predict microbial responses to a changing environment.	[Mayali, Xavier; Weber, Peter K.; Mabery, Shalini; Pett-Ridge, Jennifer] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Mayali, X (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	mayali1@llnl.gov	Weber, Peter Kilian/AAP-9517-2020; , Jennifer Pett RIdge/AFF-7780-2022; , Jennifer Pett RIdge/AAE-9934-2022	Weber, Peter Kilian/0000-0001-6022-6050; Mayali, Xavier/0000-0002-2170-0773; Pett-Ridge, Jennifer/0000-0002-4439-2398	Lawrence Livermore National Laboratory (LLNL) Laboratory Directed Research and Development (LDRD) [11-ERD-066]; Department of Energy (DOE) Office of Biological and Environmental Research (OBER) Genome Sciences Program [SCW1039]	Lawrence Livermore National Laboratory (LLNL) Laboratory Directed Research and Development (LDRD); Department of Energy (DOE) Office of Biological and Environmental Research (OBER) Genome Sciences Program	This work was supported by Lawrence Livermore National Laboratory (LLNL) Laboratory Directed Research and Development (LDRD) funding (grant # 11-ERD-066) and the Department of Energy (DOE) Office of Biological and Environmental Research (OBER) Genome Sciences Program (grant # SCW1039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2006, APPL ENVIRON MICROB, V72, P2141, DOI 10.1128/AEM.72.3.2141-2147.2006; Alonso-Saez L, 2007, APPL ENVIRON MICROB, V73, P3528, DOI 10.1128/AEM.02627-06; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; COFFIN RB, 1989, LIMNOL OCEANOGR, V34, P531, DOI 10.4319/lo.1989.34.3.0531; Doolittle WF, 2009, GENOME RES, V19, P744, DOI 10.1101/gr.086645.108; Eichinger M, 2011, MICROBIAL CARBON PUM; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; FUHRMAN JA, 1980, APPL ENVIRON MICROB, V39, P1085, DOI 10.1128/AEM.39.6.1085-1095.1980; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Hammes F, 2010, APPL ENVIRON MICROB, V76, P1278, DOI 10.1128/AEM.01914-09; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hollibaugh JT, 2000, AQUAT MICROB ECOL, V21, P103, DOI 10.3354/ame021103; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; JORGENSEN NOG, 1993, MAR ECOL PROG SER, V98, P135, DOI 10.3354/meps098135; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kirchman DL, 1997, MICROBIAL ECOL, V33, P11, DOI 10.1007/s002489900003; Koch AL, 2001, BIOESSAYS, V23, P657, DOI 10.1002/bies.1091; KRANCK K, 1992, J GEOPHYS RES-OCEANS, V97, P11373, DOI 10.1029/92JC00950; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Maddison WP, 2011, MESQUITE MODULAR SYS; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mayali X, 2012, ISME J, V6, P1210, DOI 10.1038/ismej.2011.175; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Mulholland MR, 2003, MAR ECOL PROG SER, V258, P3, DOI 10.3354/meps258003; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; NISSEN H, 1984, MAR ECOL PROG SER, V16, P155, DOI 10.3354/meps016155; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; RATKOWSKY DA, 1982, J BACTERIOL, V149, P1; Salcher MM, 2013, ISME J, V7, P896, DOI 10.1038/ismej.2012.162; Schafer H, 2000, ARCH MICROBIOL, V173, P138, DOI 10.1007/s002039900121; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smith EM, 2003, AQUAT MICROB ECOL, V31, P203, DOI 10.3354/ame031203; Sowell SM, 2011, ISME J, V5, P856, DOI 10.1038/ismej.2010.168; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; SUTTLE CA, 1990, LIMNOL OCEANOGR, V35, P424, DOI 10.4319/lo.1990.35.2.0424; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530	43	29	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95842	10.1371/journal.pone.0095842	http://dx.doi.org/10.1371/journal.pone.0095842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752604	Green Submitted, gold, Green Published			2022-12-25	WOS:000335227400140
J	Spilioti, E; Jaakkola, M; Tolonen, T; Lipponen, M; Virtanen, V; Chinou, I; Kassi, E; Karabournioti, S; Moutsatsou, P				Spilioti, Eliana; Jaakkola, Mari; Tolonen, Tiina; Lipponen, Maija; Virtanen, Vesa; Chinou, Ioanna; Kassi, Eva; Karabournioti, Sofia; Moutsatsou, Paraskevi			Phenolic Acid Composition, Antiatherogenic and Anticancer Potential of Honeys Derived from Various Regions in Greece	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; EXPRESSION; COMPONENTS; EXTRACTS; ADHESION; ASSAY; VIVO	The phenolic acid profile of honey depends greatly on its botanical and geographical origin. In this study, we carried out a quantitative analysis of phenolic acids in the ethyl acetate extract of 12 honeys collected from various regions in Greece. Our findings indicate that protocatechuic acid, p-hydroxybenzoic acid, vanillic acid, caffeic acid and p-coumaric acid are the major phenolic acids of the honeys examined. Conifer tree honey (from pine and fir) contained significantly higher concentrations of protocatechuic and caffeic acid (mean: 6640 and 397 mu g/kg honey respectively) than thyme and citrus honey (mean of protocatechuic and caffeic acid: 437.6 and 116 mu g/kg honey respectively). p-Hydroxybenzoic acid was the dominant compound in thyme honeys (mean: 1252.5 mu g/kg honey). We further examined the antioxidant potential (ORAC assay) of the extracts, their ability to influence viability of prostate cancer (PC-3) and breast cancer (MCF-7) cells as well as their lowering effect on TNF-alpha-induced adhesion molecule expression in endothelial cells (HAEC). ORAC values of Greek honeys ranged from 415 to 2129 mmol Trolox equivalent/kg honey and correlated significantly with their content in protocatechuic acid (p < 0.001), p-hydroxybenzoic acid (p < 0.01), vanillic acid (p < 0.05), caffeic acid (p < 0.01), p-coumaric acid (p < 0.001) and their total phenolic content (p < 0.001). Honey extracts reduced significantly the viability of PC-3 and MCF-7 cells as well as the expression of adhesion molecules in HAEC. Importantly, vanillic acid content correlated significantly with anticancer activity in PC-3 and MCF-7 cells (p < 0.01, p < 0.05 respectively). Protocatechuic acid, vanillic acid and total phenolic content correlated significantly with the inhibition of VCAM-1 expression (p < 0.05, p < 0.05 and p < 0.01 respectively). In conclusion, Greek honeys are rich in phenolic acids, in particular protocatechuic and p-hydroxybenzoic acid and exhibit significant antioxidant, anticancer and antiatherogenic activities which may be attributed, at least in part, to their phenolic acid content.	[Spilioti, Eliana; Kassi, Eva; Karabournioti, Sofia; Moutsatsou, Paraskevi] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece; [Jaakkola, Mari; Tolonen, Tiina; Lipponen, Maija; Virtanen, Vesa] Univ Oulu, Kajaani Univ Consortium, CEMIS Oulu, Sotkamo, Finland; [Chinou, Ioanna] Univ Athens, Dept Pharm, Lab Pharmacognosy & Chem Nat Prod, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; University of Oulu; National & Kapodistrian University of Athens	Moutsatsou, P (corresponding author), Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece.	pmoutsatsou@med.uoa.gr	Kassi, Eva N/G-1278-2011	Kassi, Eva N/0000-0001-7491-2297	Greek Secretariat of Research and Technology, Ministry of Development [ESPA, SMEs 2009]	Greek Secretariat of Research and Technology, Ministry of Development	Greek Secretariat of Research and Technology, Ministry of Development for financial support ( Grant ESPA, SMEs 2009) in cooperation with the company "Attiki'' Alex Pittas SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Al-Mamary M, 2002, NUTR RES, V22, P1041, DOI 10.1016/S0271-5317(02)00406-2; Aljadi AM, 2004, FOOD CHEM, V85, P513, DOI 10.1016/S0308-8146(02)00596-4; Alvarez-Suarez JM, 2010, J AGR FOOD CHEM, V58, P9817, DOI 10.1021/jf1018164; Beretta G, 2007, PLANTA MED, V73, P1182, DOI 10.1055/s-2007-981598; Caccetta RAA, 2000, AM J CLIN NUTR, V71, P67; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Erejuwa OO, 2012, INT J BIOL SCI, V8, P913, DOI 10.7150/ijbs.3697; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; Fernandez-Cabezudo MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055993; Gheldof N, 2002, J AGR FOOD CHEM, V50, P3050, DOI 10.1021/jf0114637; Gheldof N, 2002, J AGR FOOD CHEM, V50, P5870, DOI 10.1021/jf0256135; Haroun M. I., 2012, Journal of Food Technology, V10, P39, DOI 10.3923/jftech.2012.39.45; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Jaganathan SK, 2010, NAT PROD RES, V24, P1295, DOI 10.1080/14786410903184408; Jaganathan SK, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/830616; Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163; Kallio T, 2013, J AGR FOOD CHEM, V61, P10720, DOI 10.1021/jf403208d; Kassim M, 2010, NUTR RES, V30, P650, DOI 10.1016/j.nutres.2010.08.008; Kumar P. P. B. S., 2013, INT J RECENT SCI RES, V3, P1077; Lin CY, 2011, J AGR FOOD CHEM, V59, P5117, DOI 10.1021/jf200103f; Magalhaes LM, 2010, TALANTA, V83, P441, DOI 10.1016/j.talanta.2010.09.042; Molan P C, 2006, Int J Low Extrem Wounds, V5, P40, DOI 10.1177/1534734605286014; Rakha MK, 2008, J MED FOOD, V11, P91, DOI 10.1089/jmf.2006.172; Rocha L., 2012, CANC CLIN ONCOL, V1, P109, DOI DOI 10.5539/CCO.V1N2P109; Rovio S, 2007, ELECTROPHORESIS, V28, P3129, DOI 10.1002/elps.200600783; Samarghandian S, 2011, CLINICS, V66, P1073, DOI 10.1590/S1807-59322011000600026; Stephens JM, 2010, FOOD CHEM, V120, P78, DOI 10.1016/j.foodchem.2009.09.074; Swellam T, 2003, INT J UROL, V10, P213, DOI 10.1046/j.0919-8172.2003.00602.x; Tanaka T., 2011, Journal of Experimental and Clinical Medicine, V3, P27, DOI 10.1016/j.jecm.2010.12.005; Theriault A, 2002, ATHEROSCLEROSIS, V160, P21, DOI 10.1016/S0021-9150(01)00540-8; Tomas-Barberan FA, 2001, J SCI FOOD AGR, V81, P485, DOI 10.1002/jsfa.836; Tsiapara AV, 2009, FOOD CHEM, V116, P702, DOI 10.1016/j.foodchem.2009.03.024; Wang DL, 2010, J AGR FOOD CHEM, V58, P12722, DOI 10.1021/jf103427j; Wang J, 2011, ADV FOOD NUTR RES, V62, P89, DOI 10.1016/B978-0-12-385989-1.00003-X; Weston RJ, 1999, FOOD CHEM, V64, P295, DOI 10.1016/S0308-8146(98)00100-9; Zaghloul AA, 2001, PHARMAZIE, V56, P643; Zhou Z, 2005, EUR J PHARMACOL, V513, P1, DOI 10.1016/j.ejphar.2005.01.059	37	96	101	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94860	10.1371/journal.pone.0094860	http://dx.doi.org/10.1371/journal.pone.0094860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752205	gold, Green Submitted, Green Published			2022-12-25	WOS:000335227400019
J	van Lieshout, E; McNamara, KB; Simmons, LW				van Lieshout, Emile; McNamara, Kathryn B.; Simmons, Leigh W.			Why Do Female Callosobruchus maculatus Kick Their Mates?	PLOS ONE			English	Article							SPERM COMPETITION; BRUCHID BEETLE; COPULATION DURATION; LIFETIME FECUNDITY; GENITAL DAMAGE; EARLY DEATH; COLEOPTERA; RECEPTIVITY; EVOLUTION; MALES	Sexual conflict is now recognised as an important driver of sexual trait evolution. However, due to their variable outcomes and effects on other fitness components, the detection of sexual conflicts on individual traits can be complicated. This difficulty is exemplified in the beetle Callosobruchus maculatus, where longer matings increase the size of nutritious ejaculates but simultaneously reduce female future receptivity. While previous studies show that females gain direct benefits from extended mating duration, females show conspicuous copulatory kicking behaviour, apparently to dislodge mating males prematurely. We explore the potential for sexual conflict by comparing several fitness components and remating propensity in pairs of full sibling females where each female mated with a male from an unrelated pair of full sibling males. For one female, matings were terminated at the onset of kicking, whereas the other's matings remained uninterrupted. While fecundity (number of eggs) was similar between treatments, uninterrupted matings enhanced adult offspring numbers and fractionally also longevity. However, females whose matings were interrupted at the onset of kicking exhibited an increased propensity to remate. Since polyandry can benefit female fitness in this species, we argue that kicking, rather than being maladaptive, may indicate that females prefer remating over increased ejaculate size. It may thus be difficult to assess the presence of sexual conflict over contested traits such as mating duration when females face a trade off between direct benefits gained from one mating and indirect benefits from additional matings.	[van Lieshout, Emile; McNamara, Kathryn B.; Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Crawley, Australia	University of Western Australia	van Lieshout, E (corresponding author), Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Crawley, Australia.	emile.vanlieshout@uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	University of Western Australia; ARC Australian Postdoctoral Fellowship [DP110101163]; ARC Australian Professorial Fellowship [DP110104594]	University of Western Australia; ARC Australian Postdoctoral Fellowship(Australian Research Council); ARC Australian Professorial Fellowship(Australian Research Council)	EVL was funded by a Research Development Award from the University of Western Australia (http://www.research.uwa.edu.au/staff/funding/awards). KBM was funded by an ARC Australian Postdoctoral Fellowship (DP110101163)(http://arc.gov.au/ncgp/). LWS was supported by an ARC Australian Professorial Fellowship (DP110104594)(http://arc.gov.au/ncgp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer MS, 1999, ANIM BEHAV, V58, P669, DOI 10.1006/anbe.1999.1172; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist Goran, 2005, pUnpaginated; Bilde T, 2009, SCIENCE, V324, P1705, DOI 10.1126/science.1171675; Brown EA, 2009, HEREDITY, V103, P340, DOI 10.1038/hdy.2009.80; Cayetano L, 2011, EVOLUTION, V65, P2171, DOI 10.1111/j.1558-5646.2011.01309.x; Cordero C, 2005, J THEOR BIOL, V232, P443, DOI 10.1016/j.jtbi.2004.08.031; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; Eady PE, 2007, P ROY SOC B-BIOL SCI, V274, P247, DOI 10.1098/rspb.2006.3710; Eady PE, 2000, EVOLUTION, V54, P2161, DOI 10.1111/j.0014-3820.2000.tb01259.x; EADY PE, 1991, ECOL ENTOMOL, V16, P45, DOI 10.1111/j.1365-2311.1991.tb00191.x; EADY PE, 1995, BEHAV ECOL SOCIOBIOL, V36, P25, DOI 10.1007/BF00175725; Edvardsson M, 2006, BEHAV ECOL, V17, P430, DOI 10.1093/beheco/arj045; Edvardsson M, 2005, BEHAV ECOL, V16, P788, DOI 10.1093/beheco/ari055; Edvardsson M, 2007, ANIM BEHAV, V74, P183, DOI 10.1016/j.anbehav.2006.07.018; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; FOX CW, 1993, FUNCT ECOL, V7, P203, DOI 10.2307/2389888; Galicia I, 2008, ANN ENTOMOL SOC AM, V101, P786, DOI 10.1603/0013-8746(2008)101[786:OTFOSA]2.0.CO;2; Hotzy C, 2012, CURR BIOL, V22, P2258, DOI 10.1016/j.cub.2012.10.009; Hotzy C, 2009, CURR BIOL, V19, P404, DOI 10.1016/j.cub.2009.01.045; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Lessells CM, 2006, PHILOS T R SOC B, V361, P301, DOI 10.1098/rstb.2005.1795; McNamara KB, 2008, ANIM BEHAV, V76, P771, DOI 10.1016/j.anbehav.2008.04.018; Parker G.A., 1979, P123; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Polak M, 2010, P ROY SOC B-BIOL SCI, V277, P1371, DOI 10.1098/rspb.2009.1720; Ronn JL, 2012, ANIM BEHAV, V83, P75, DOI 10.1016/j.anbehav.2011.10.007; Savalli UM, 1999, FUNCT ECOL, V13, P169, DOI 10.1046/j.1365-2435.1999.00287.x; Simmons L. W., 2001, MG BEH ECOL; van Lieshout E, 2014, EVOLUTION IN PRESS; Wilson N, 1999, J INSECT BEHAV, V12, P295, DOI 10.1023/A:1020883220643; Wilson N, 1997, P ROY SOC B-BIOL SCI, V264, P1491, DOI 10.1098/rspb.1997.0206; Yamane T, 2008, J INSECT PHYSIOL, V54, P1522, DOI 10.1016/j.jinsphys.2008.09.001	33	16	16	0	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95747	10.1371/journal.pone.0095747	http://dx.doi.org/10.1371/journal.pone.0095747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752530	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400114
J	Bellini, A; Girard, PM; Tessier, L; Sage, E; Francesconi, S				Bellini, Angela; Girard, Pierre-Marie; Tessier, Ludovic; Sage, Evelyne; Francesconi, Stefania			Fission Yeast Rad52 Phosphorylation Restrains Error Prone Recombination Pathways	PLOS ONE			English	Article							STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; REPLICATION FORKS; GENOME REARRANGEMENTS; DNA-REPAIR; CHECKPOINT; RHP51; INSTABILITY; RESOLUTION	Rad52 is a key protein in homologous recombination (HR), a DNA repair pathway dedicated to double strand breaks and recovery of blocked or collapsed replication forks. Rad52 allows Rad51 loading on single strand DNA, an event required for strand invasion and D-loop formation. In addition, Rad52 functions also in Rad51 independent pathways because of its ability to promote single strand annealing (SSA) that leads to loss of genetic material and to promote D-loops formation that are cleaved by Mus81 endonuclease. We have previously reported that fission yeast Rad52 is phosphorylated in a Sty1 dependent manner upon oxidative stress and in cells where the early step of HR is impaired because of lack of Rad51. Here we show that Rad52 is also constitutively phosphorylated in mus81 null cells and that Sty1 partially impinges on such phosphorylation. As upon oxidative stress, the Rad52 phosphorylation in rad51 and mus81 null cells appears to be independent of Tel1, Rad3 and Cdc2. Most importantly, we show that mutating serine 365 to glycine (S365G) in Rad52 leads to loss of the constitutive Rad52 phosphorylation observed in cells lacking Rad51 and to partial loss of Rad52 phosphorylation in cells lacking Mus81. Contrariwise, phosphorylation of Rad52-S365G protein is not affected upon oxidative stress. These results indicate that different Rad52 residues are phosphorylated in a Sty1 dependent manner in response to these distinct situations. Analysis of spontaneous HR at direct repeats shows that mutating serine 365 leads to an increase in spontaneous deletion-type recombinants issued from mitotic recombination that are Mus81 dependent. In addition, the recombination rate in the rad52-S365G mutant is further increased by hydroxyurea, a drug to which mutant cells are sensitive.	[Bellini, Angela; Girard, Pierre-Marie; Tessier, Ludovic; Sage, Evelyne; Francesconi, Stefania] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Bellini, Angela; Girard, Pierre-Marie; Tessier, Ludovic; Sage, Evelyne; Francesconi, Stefania] Ctr Univ Orsay, CNRS UMR 3348, F-91405 Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Francesconi, S (corresponding author), Inst Curie, Ctr Rech, F-91405 Orsay, France.	stefania.francseconi@curie.fr	Francesconi, Stefania/J-7910-2016	girard, pierre-marie/0000-0001-9703-4407; francesconi, stefania/0000-0002-9665-349X	Centre National de la Recherche Scientifique; Curie Institute; Association pour la Recherche sur le Cancer	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Curie Institute; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by "Centre National de la Recherche Scientifique'' and Curie Institute. A. Bellini was supported by PhD fellowships from Curie Institute and "Association pour la Recherche sur le Cancer''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Barlow JH, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-7; Bellini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047987; Branzei D, 2007, CELL, V131, P1228, DOI 10.1016/j.cell.2007.12.007; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; Decottignies A, 2007, GENETICS, V176, P1403, DOI 10.1534/genetics.107.071621; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Francesconi S, 2002, GENES CELLS, V7, P663, DOI 10.1046/j.1365-2443.2002.00552.x; Froget B, 2008, MOL BIOL CELL, V19, P445, DOI 10.1091/mbc.E07-07-0728; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Honda M, 2011, EMBO J, V30, P3368, DOI 10.1038/emboj.2011.238; Iraqui I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002976; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Kim WJ, 2002, J BIOL CHEM, V277, P30264, DOI 10.1074/jbc.M202517200; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2012, CURR OPIN GENET DEV; Lambert S, 2013, CHROMOSOMA, V122, P33, DOI 10.1007/s00412-013-0398-9; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murfuni I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003910; Osman F, 2000, CURR GENET, V38, P113, DOI 10.1007/s002940000145; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Smeets MFMA, 2003, GENES CELLS, V8, P573, DOI 10.1046/j.1365-2443.2003.00657.x; Soto T, 2007, MICROBIOL-SGM, V153, P1519, DOI 10.1099/mic.0.2006/004283-0; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Wyatt HDM, 2013, MOL CELL, V52, P234, DOI 10.1016/j.molcel.2013.08.035; Yokoyama M, 2007, DNA REPAIR, V6, P770, DOI 10.1016/j.dnarep.2007.01.005	43	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95788	10.1371/journal.pone.0095788	http://dx.doi.org/10.1371/journal.pone.0095788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748152	gold, Green Submitted, Green Published			2022-12-25	WOS:000335226500145
J	Chani, MTS; Karimov, KS; Asiri, AM; Ahmed, N; Bashir, MM; Khan, SB; Rub, MA; Azum, N				Chani, Muhammad Tariq Saeed; Karimov, Kh. S.; Asiri, Abdullah M.; Ahmed, Nisar; Bashir, Muhammad Mehran; Khan, Sher Bahadar; Rub, Malik Abdul; Azum, Naved			Temperature Gradient Measurements by Using Thermoelectric Effect in CNTs-Silicone Adhesive Composite	PLOS ONE			English	Article								This work presents the fabrication and investigation of thermoelectric cells based on composite of carbon nanotubes (CNT) and silicone adhesive. The composite contains CNT and silicon adhesive 1:1 by weight. The current-voltage characteristics and dependences of voltage, current and Seebeck coefficient on the temperature gradient of cell were studied. It was observed that with increase in temperature gradient the open circuit voltage, short circuit current and the Seebeck coefficient of the cells increase. Approximately 7 times increase in temperature gradient increases the open circuit voltage and short circuit current up to 40 and 5 times, respectively. The simulation of experimental results is also carried out; the simulated results are well matched with experimental results.	[Chani, Muhammad Tariq Saeed; Asiri, Abdullah M.; Khan, Sher Bahadar; Rub, Malik Abdul; Azum, Naved] King Abdulaziz Univ, Ctr Excellence Adv Mat Res CEAMR, Jeddah 21413, Saudi Arabia; [Chani, Muhammad Tariq Saeed; Asiri, Abdullah M.; Khan, Sher Bahadar; Rub, Malik Abdul; Azum, Naved] King Abdulaziz Univ, Dept Chem, Fac Sci, Jeddah 21413, Saudi Arabia; [Karimov, Kh. S.; Ahmed, Nisar; Bashir, Muhammad Mehran] GIK Inst Engn Sci & Technol, Swabi, Khyber Pakhtunk, Pakistan; [Karimov, Kh. S.] Phys Tech Inst Acad Sci, Dushanbe, Tajikistan	King Abdulaziz University; King Abdulaziz University; GIK Institute Engineering Science & Technology; Academy of Sciences of Republic of Tajikistan; S.U. Umarov Physical & Technical Institute	Chani, MTS (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res CEAMR, Jeddah 21413, Saudi Arabia.	tariqchani1@gmail.com	Rub, Malik Abdul/H-6027-2012; Ullah, Sami/AAH-4089-2020; azum, naved/H-6018-2012; Bashir, Muhammad Mehran/A-4398-2016; Khan, Prof. Sher Bahadar/M-7968-2019; Asiri, Abdullah M./C-3458-2009; Chani, Muhammad Tariq Saeed/A-4363-2013; Khan, Sher Bahadar/H-5833-2012	Rub, Malik Abdul/0000-0002-4798-5308; azum, naved/0000-0001-8320-5826; Bashir, Muhammad Mehran/0000-0002-1581-757X; Khan, Prof. Sher Bahadar/0000-0001-9635-7175; Asiri, Abdullah M./0000-0001-7905-3209; Chani, Muhammad Tariq Saeed/0000-0003-1725-1191; Khan, Sher Bahadar/0000-0001-9635-7175	Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah [CEAMR-434-03]	Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah	This project was funded by the Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah, under grant no. CEAMR-434-03. The authors have full rights to publish this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khalfioui M, 2003, SENSOR ACTUAT A-PHYS, V107, P36, DOI 10.1016/S0924-4247(03)00294-2; Alam H, 2013, NANO ENERGY, V2, P190, DOI 10.1016/j.nanoen.2012.10.005; [Anonymous], 2008, J VERTEBR PALEONTOL; Bandaru PR, 2007, J NANOSCI NANOTECHNO, V7, P1239, DOI 10.1166/jnn.2007.307; Bass JC, HIGH EFFICIENT QUANT; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Bottger H., 1985, HOPPING CONDUCTION S; Brabec C.J., 2003, ORGANIC PHOTOVOLTAIC, Vxii; Choi Y, 2011, ORG ELECTRON, V12, P2120, DOI 10.1016/j.orgel.2011.08.025; Croft A., 1992, ENG MATH MODERN FDN; CUTLER M, 1964, PHYS REV, V133, P1153, DOI 10.1103/PhysRev.133.A1153; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Elsheikh MH, 2014, RENEW SUST ENERG REV, V30, P337, DOI 10.1016/j.rser.2013.10.027; Grow RJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1872221; Karimov KS, 1994, ELECTROPHYSICAL PROP; Meng CZ, 2010, ADV MATER, V22, P535, DOI 10.1002/adma.200902221; Minnich AJ, 2009, ENERG ENVIRON SCI, V2, P466, DOI 10.1039/b822664b; Ondersma JW, 2013, COORDIN CHEM REV, V257, P1533, DOI 10.1016/j.ccr.2012.09.010; Panda MK, 2012, COORDIN CHEM REV, V256, P2601, DOI 10.1016/j.ccr.2012.04.041; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Sumino M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3631633; Sun K, 2008, CHARGE TRANSPORT ORG; Tan XJ, 2011, J PHYS CHEM C, V115, P21996, DOI 10.1021/jp205333m; Walia S, 2013, PROG MATER SCI, V58, P1443, DOI 10.1016/j.pmatsci.2013.06.003; Walia S, 2013, J PHYS CHEM C, V117, P9137, DOI 10.1021/jp401731b; Walia S, 2012, CHEM COMMUN, V48, P7462, DOI 10.1039/c2cc33146b; Walia S, 2011, ENERG ENVIRON SCI, V4, P3558, DOI 10.1039/c1ee01370j; Zhan GD, 2005, REV ADV MATER SCI, V10, P185; Zhao WY, 2012, ENERG ENVIRON SCI, V5, P5364, DOI 10.1039/c1ee01931g	29	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95287	10.1371/journal.pone.0095287	http://dx.doi.org/10.1371/journal.pone.0095287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748375	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500076
J	Sun, JR; Zhang, X; Cao, CJ; Mei, XD; Wang, NN; Yan, SL; Zong, SX; Luo, YQ; Yang, HJ; Shen, YB				Sun, Jingru; Zhang, Xiao; Cao, Chuanjian; Mei, Xindi; Wang, Ningning; Yan, Suli; Zong, Shixiang; Luo, Youqing; Yang, Haijun; Shen, Yingbai			Similar Metabolic Changes Induced by HIPVs Exposure as Herbivore in Ammopiptanthus mongolicus	PLOS ONE			English	Article							RAPID CHANGES; NMR METABOLOMICS; BRASSICA-RAPA; PLANT DEFENSE; CARBON; RESPONSES; EXPRESSION; H-1-NMR; LEAVES; GENES	Herbivore-induced plant volatiles (HIPVs) are important compounds to prim neighboring undamaged plants; however, the mechanism for this priming process remains unclear. To reveal metabolic changes in plants exposed to HIPVs, metabolism of leaves and roots of Ammopiptanthus mongolicus seedlings exposed to HIPVs released from conspecific plants infested with larvae of Orgyia ericae were analyzed together with control and infested seedlings using nuclear magnetic resonance (NMR)-based metabolic technology and multi variate data analysis. Results presented showed that HIPVs exposure led to similar but specific metabolic changes compared with those induced by infestation in both leaves and roots. Furthermore, both HIPVs exposure and herbivore attack resulted in metabolic changes involving a series of primary and secondary metabolites in both leaves and roots. Taken together, these results suggested that priming of yet-damaged plants may be achieved by reconfiguring metabolic pathways in leaves and roots to make similar concentrations for all metabolites as those in seedlings infested. Therefore, we propose that improved readiness of defense induction of primed plants toward subsequent herbivore attack may be based on the similar metabolic profiling induced by HIPVs exposure as those caused by herbivore.	[Sun, Jingru; Zhang, Xiao; Mei, Xindi; Wang, Ningning; Yan, Suli; Shen, Yingbai] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Cao, Chuanjian] Forest Pest Control & Quarantine Stn Ningxia, Yinchuan, Peoples R China; [Zong, Shixiang; Luo, Youqing] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Yang, Haijun] Tsinghua Univ, Dept Chem, Beijing Key Lab Microanalyt Methods & Instrumenta, Beijing 100084, Peoples R China	Beijing Forestry University; Beijing Forestry University; Tsinghua University	Shen, YB (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	cyhj@mail.tsinghua.edu.cn; ybshen@bjfu.edu.cn	Yang, Haijun/F-9425-2015	Yang, Haijun/0000-0003-3332-8750	National Nature Science Foundation of China [31270655, 30871727]; Research Fund for the Doctoral Program of Higher Education of China [20090014110014]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work has been supported by National Nature Science Foundation of China (31270655, 30871727) and Research Fund for the Doctoral Program of Higher Education of China (20090014110014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01872; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Babst BA, 2005, NEW PHYTOL, V167, P63, DOI 10.1111/j.1469-8137.2005.01388.x; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Broyart C, 2010, PHYTOCHEM ANALYSIS, V21, P102, DOI 10.1002/pca.1177; Charlton A, 2004, PLANT BIOTECHNOL J, V2, P27, DOI 10.1046/j.1467-7652.2003.00045.x; Chen FF, 2011, J PROTEOME RES, V10, P2273, DOI 10.1021/pr101095t; Choi HK, 2004, PHYTOCHEMISTRY, V65, P857, DOI 10.1016/j.phytochem.2004.01.019; Choi YH, 2006, J NAT PROD, V69, P742, DOI 10.1021/np050535b; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Erb M, 2009, TRENDS PLANT SCI, V14, P653, DOI 10.1016/j.tplants.2009.08.006; Farag MA, 2005, PLANTA, V220, P900, DOI 10.1007/s00425-004-1404-5; Ferrieri AP, 2013, PLANT PHYSIOL, V161, P692, DOI 10.1104/pp.112.208868; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; Gomez S, 2010, NEW PHYTOL, V188, P835, DOI 10.1111/j.1469-8137.2010.03414.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Holland JN, 1996, OECOLOGIA, V107, P87, DOI 10.1007/BF00582238; Howarth JR, 2008, J EXP BOT, V59, P3675, DOI 10.1093/jxb/ern218; Jahangir M, 2008, J PLANT PHYSIOL, V165, P1429, DOI 10.1016/j.jplph.2008.04.011; Jobic C, 2007, PLANTA, V226, P251, DOI 10.1007/s00425-006-0470-2; Kim HK, 2010, PHYTOCHEMISTRY, V71, P773, DOI 10.1016/j.phytochem.2010.02.001; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kim J, 2013, INSECT SCI, V20, P273, DOI 10.1111/j.1744-7917.2012.01584.x; Krishnan P, 2005, J EXP BOT, V56, P255, DOI 10.1093/jxb/eri010; Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131; Leiss KA, 2009, J CHEM ECOL, V35, P219, DOI 10.1007/s10886-008-9586-0; Liu CX, 2010, J PROTEOME RES, V9, P6774, DOI 10.1021/pr100970q; Minorsky PV, 2002, PLANT PHYSIOL, V128, P7, DOI 10.1104/pp.128.1.7; MITHOFER A, 2009, ANN PLANT REV MOL AS, P261; Mohammad M, 2010, PHYTOCHEM ANALYSIS, V21, P110; Mustafa NR, 2009, BIOTECHNOL LETT, V31, P1967, DOI 10.1007/s10529-009-0107-1; Nacoulma AP, 2013, INT J MOL SCI, V14, P12533, DOI 10.3390/ijms140612533; Olsen KM, 2008, J PLANT PHYSIOL, V165, P1491, DOI 10.1016/j.jplph.2007.11.005; Pan TWM, 1996, PROG NUCL MAGN RESON, V28, P161, DOI DOI 10.1016/0079-6565(95)01017-3; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; Lopez-Gresa MP, 2010, PHYTOCHEM ANALYSIS, V21, P89, DOI 10.1002/pca.1179; PROKSA B, 1990, COLLECT CZECH CHEM C, V55, P1257, DOI 10.1135/cccc19901257; R Development Core Team, 2012, R LANG ENV STAT COMP; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Selenge D, 1976, CHEM NAT COMPD, V12, P506; Smith C.M., 2005, PLANT RESISTANCE ART, P65; Sun JR, 2013, PLANT PHYSIOL BIOCH, V69, P101, DOI 10.1016/j.plaphy.2013.04.026; Trygg J, 2002, J CHEMOMETR, V16, P283, DOI 10.1002/cem.724; Uno KT, 2011, P NATL ACAD SCI USA, V108, P6509, DOI 10.1073/pnas.1018435108; Wang YL, 2004, PLANTA MED, V70, P250, DOI [10.1055/s-2004-815543, 10.1055/s.-2004-815543]; Widarto HT, 2006, J CHEM ECOL, V32, P2417, DOI 10.1007/s10886-006-9152-6; Yang SO, 2009, BIOSCI BIOTECH BIOCH, V73, P2032, DOI 10.1271/bbb.90240; Zhang SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035867	50	4	4	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95474	10.1371/journal.pone.0095474	http://dx.doi.org/10.1371/journal.pone.0095474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748156	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500107
J	Zhao, Z; Wang, L; Xu, W				Zhao, Z.; Wang, L.; Xu, W.			IL-13R alpha 2 mediates PNR-induced migration and metastasis in ER alpha-negative breast cancer	ONCOGENE			English	Article							NUCLEAR RECEPTOR NR2E3; S-CONE SYNDROME; IL-13 RECEPTOR; INTERLEUKIN-13 RECEPTOR; PHOTORECEPTOR DEVELOPMENT; ROD PHOTORECEPTORS; MOLECULAR-CLONING; EXPRESSION; IDENTIFICATION; CHAIN	Emerging evidence has linked photoreceptor cell-specific nuclear receptor (PNR/NR2E3), an orphan nuclear hormone receptor, to human breast cancer. PNR was shown to be a transcriptional activator of estrogen receptor-alpha (ER alpha) in ER alpha-positive breast cancer cell lines and high-level expression of PNR correlates with favorable response of ER alpha-positive breast cancer patients to tamoxifen. Interestingly, gene expression microarray study shows that PNR regulates distinct genes from those regulated by ER alpha, suggesting that PNR could have ER alpha-independent functions. Herein, we investigated the function of PNR in ER alpha-negative breast cancer cells. Our results showed that PNR-induced cell migration and metastasis of ER alpha-negative breast cancer cells both in vitro and in vivo, and the effect was attributed to the upregulation of interleukin (IL)-13R alpha 2, a high-affinity receptor for IL-13 that regulates tumor growth, invasion and metastasis of various human cancers. Mechanistically, PNR activated transcription of IL-13R alpha 2 through direct recruitment to IL-13R alpha 2 promoter. Upon stimulation with IL-13, IL-13R alpha 2 increased the extracellular signal-regulated kinases 1 and 2 phosphorylation, which led to breast cancer migration and metastasis. The IL-13 triggered signal cascade was specific to IL-13R alpha 2, as the closely related IL-13R alpha 1 was not regulated by PNR. IL-13R alpha 2 is a novel tumor antigen that is overexpressed in a variety of solid tumor types. This study presents the first evidence that PNR could promote ERa-negative breast cancer metastasis through activation of IL-13R alpha 2-mediated signaling pathway.	[Zhao, Z.; Wang, L.; Xu, W.] Univ Wisconsin, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Xu, W (corresponding author), Univ Wisconsin, Dept Oncol, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	wxu@oncology.wisc.edu			DOD ERA of HOPE Scholar Award [W81XWYH-11-1-0237]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	DOD ERA of HOPE Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by DOD ERA of HOPE Scholar Award (W81XWYH-11-1-0237) to WX.	Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Christofori G, 2007, NATURE, V446, P735, DOI 10.1038/446735a; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Daines MO, 2006, J IMMUNOL, V176, P7495, DOI 10.4049/jimmunol.176.12.7495; David MD, 2003, ONCOGENE, V22, P3386, DOI 10.1038/sj.onc.1206352; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Husain SR, 2003, J NEURO-ONCOL, V65, P37, DOI 10.1023/A:1026242432647; Jezequel P, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas060; Joshi BH, 2009, IMMUNOTHERAPY-UK, V1, P321, DOI 10.2217/IMT.09.8; Kapitskaya M, 2006, ASSAY DRUG DEV TECHN, V4, P253, DOI 10.1089/adt.2006.4.253; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawakami K, 2001, J EXP MED, V194, P1743, DOI 10.1084/jem.194.12.1743; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Mollema NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017494; Murata T, 1997, BIOCHEM BIOPH RES CO, V238, P90, DOI 10.1006/bbrc.1997.7248; Muscat GEO, 2013, MOL ENDOCRINOL, V27, P350, DOI 10.1210/me.2012-1265; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; O'Brien KMB, 2004, INVEST OPHTH VIS SCI, V45, P2807, DOI 10.1167/iovs.03-1317; Obiri NI, 1997, J IMMUNOL, V158, P756; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Olkhanud PB, 2011, J IMMUNOL, V186, P5656, DOI 10.4049/jimmunol.1100463; PANKRATZ MJ, 1992, SCIENCE, V255, P986, DOI 10.1126/science.1546296; Park YY, 2012, EMBO MOL MED, V4, P52, DOI 10.1002/emmm.201100187; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Powell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030993; Puri RK, 1996, BLOOD, V87, P4333, DOI 10.1182/blood.V87.10.4333.bloodjournal87104333; Qin Q, 2013, J OCUL PHARMACOL TH, V29, P298, DOI 10.1089/jop.2012.0135; Ring BZ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-241; Roduit R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007379; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Tan MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074359; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Wang L, 2013, NUCLEIC ACIDS RES, V41, P6870, DOI 10.1093/nar/gkt415; Wang L, 2009, MOL PHARMACOL, V76, P1238, DOI 10.1124/mol.109.059105; Webber AL, 2008, EXP EYE RES, V87, P35, DOI 10.1016/j.exer.2008.04.006; Wolkenberg SE, 2006, BIOORG MED CHEM LETT, V16, P5001, DOI 10.1016/j.bmcl.2006.07.056; Wu AH, 2003, NEURO-ONCOLOGY, V5, P179, DOI 10.1215/S1152851702000510; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]	60	26	27	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1596	1607		10.1038/onc.2014.53	http://dx.doi.org/10.1038/onc.2014.53			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24747967	Green Accepted			2022-12-25	WOS:000351416800012
J	Nadanaka, S; Purunomo, E; Takeda, N; Tamura, J; Kitagawa, H				Nadanaka, Satomi; Purunomo, Eko; Takeda, Naoko; Tamura, Jun-ichi; Kitagawa, Hiroshi			Heparan Sulfate Containing Unsubstituted Glucosamine Residues BIOSYNTHESIS AND HEPARANASE-INHIBITORY ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycobiology; Glycosaminoglycan; Glycosidase; Heparan Sulfate; Heparanase; Proteoglycan; Proteoglycan Synthesis	N-DEACETYLASE/N-SULFOTRANSFERASE; GENE FAMILY; EXPRESSION; GLYPICAN-1; NDST-1; CELLS; ROLES; MICE; GLYCOSAMINOGLYCANS; ACETYLGLUCOSAMINE	Background: The function and biosynthetic mechanism of GlcNH<sub arrange="stack">3<sup arrange="stack">+ in heparan sulfate remain unclear. Results: GlcNH<sub arrange="stack">3<sup arrange="stack">+-containing tetrasaccharides inhibited heparanase activity. Exostosin-like 3 regulated the expression of GlcNH<sub arrange="stack">3<sup arrange="stack">+ structures. Conclusion: GlcNH<sub arrange="stack">3<sup arrange="stack">+-containing tetrasaccharides suppressed cancer cell invasion in vitro. Production of GlcNH<sub arrange="stack">3<sup arrange="stack">+ was controlled by EXTL3 (exostosin-like 3) and NDST-1 (N-deacetylase/N-sulfotransferase-1). Significance: Tumor metastasis might be suppressed by utilizing GlcNH<sub arrange="stack">3<sup arrange="stack">+-containing oligosaccharides. Additionally, a biosynthetic mechanism of GlcNH<sub arrange="stack">3<sup arrange="stack">+-containing heparan sulfates was proposed. Degradation of heparan sulfate (HS) in the extracellular matrix by heparanase is linked to the processes of tumor invasion and metastasis. Thus, a heparanase inhibitor can be a potential anticancer drug. Because HS with unsubstituted glucosamine residues accumulates in heparanase-expressing breast cancer cells, we assumed that these HS structures are resistant to heparanase and can therefore be utilized as a heparanase inhibitor. As expected, chemically synthetic HS-tetrasaccharides containing unsubstituted glucosamine residues, GlcA1-4GlcNH<sub arrange="stack">3<sup arrange="stack">+(6-O-sulfate)1-4GlcA1-4GlcNH<sub arrange="stack">3<sup arrange="stack">+(6-O-sulfate), inhibited heparanase activity and suppressed invasion of breast cancer cells in vitro. Bifunctional NDST-1 (N-deacetylase/N-sulfotransferase-1) catalyzes the modification of N-acetylglucosamine residues within HS chains, and the balance of N-deacetylase and N-sulfotransferase activities of NDST-1 is thought to be a determinant of the generation of unsubstituted glucosamine. We also report here that EXTL3 (exostosin-like 3) controls N-sulfotransferase activity of NDST-1 by forming a complex with NDST-1 and contributes to generation of unsubstituted glucosamine residues.	[Nadanaka, Satomi; Purunomo, Eko; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Takeda, Naoko; Tamura, Jun-ichi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Tamura, Jun-ichi] Tottori Univ, Fac Reg Sci, Dept Reg Environm, Tottori 6808551, Japan	Kobe Pharmaceutical University; Tottori University; Tottori University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079; Purnomo, Eko/0000-0003-2686-4504	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23110003, 25293014, 25460080]; Grants-in-Aid for Scientific Research [13J08319] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas 23110003 (to H. K.) and for Scientific Research (B) 25293014 (to H. K.) and (C) 25460080 (to S. N.) and the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Desai UR, 1998, BIOCHEMISTRY-US, V37, P13033, DOI 10.1021/bi981426h; Ding K, 2001, J BIOL CHEM, V276, P46779, DOI 10.1074/jbc.M105419200; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; Fujii M, 2010, GLYCOCONJUGATE J, V27, P661, DOI 10.1007/s10719-010-9311-4; Gesteira TF, 2011, J BIOL CHEM, V286, P5338, DOI 10.1074/jbc.M110.100719; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Mani K, 2004, GLYCOBIOLOGY, V14, P599, DOI 10.1093/glycob/cwh067; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Murali S, 2011, J BIOL CHEM, V286, P17755, DOI 10.1074/jbc.M110.148874; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Rees MD, 2005, BIOCHEM J, V391, P125, DOI 10.1042/BJ20050630; Saito T, 1998, BIOCHEM BIOPH RES CO, V243, P61, DOI 10.1006/bbrc.1997.8062; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Takeda N, 2012, CARBOHYD RES, V353, P13, DOI 10.1016/j.carres.2012.03.014; Tang P, 2009, DIAGN MOL PATHOL, V18, P125, DOI 10.1097/PDM.0b013e31818d107b; Tiwari V, 2006, J VIROL, V80, P8970, DOI 10.1128/JVI.00296-06; Tsutsumi K, 1998, FEBS LETT, V441, P235, DOI 10.1016/S0014-5793(98)01532-4; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van den Born J, 2003, GLYCOBIOLOGY, V13, P1, DOI 10.1093/glycob/cwg011; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; VLODAVSKY I, 1994, INVAS METAST, V14, P290; Vlodavsky I, 2013, MATRIX BIOL, V32, P220, DOI 10.1016/j.matbio.2013.03.001; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Weyers A, 2012, OMICS, V16, P79, DOI 10.1089/omi.2011.0102; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	46	22	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15231	15243		10.1074/jbc.M113.545343	http://dx.doi.org/10.1074/jbc.M113.545343			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753252	hybrid, Green Published			2022-12-25	WOS:000337465400009
J	Hu, HS; Xuan, YL; Wang, Y; Xue, M; Suo, F; Li, XL; Cheng, WJ; Li, XR; Yin, J; Liu, J; Yan, SH				Hu, Hesheng; Xuan, Yongli; Wang, Ye; Xue, Mei; Suo, Fei; Li, Xiaolu; Cheng, Wenjuan; Li, Xinran; Yin, Jie; Liu, Ju; Yan, Suhua			Targeted NGF siRNA Delivery Attenuates Sympathetic Nerve Sprouting and Deteriorates Cardiac Dysfunction in Rats with Myocardial Infarction	PLOS ONE			English	Article							GROWTH-FACTOR; HEART; INNERVATION; REPAIR; MECHANISMS; MYOCYTES; DEATH; CELLS	Nerve growth factor (NGF) is involved in nerve sprouting, hyper-innervation, angiogenesis, anti-apoptosis, and preservation of cardiac function after myocardial infarction (MI). Positively modulating NGF expression may represent a novel pharmacological strategy to improve post-infarction prognosis. In this study, lentivirus encoding NGF short interfering RNA (siRNA) was prepared, and MI was modeled in the rat using left anterior descending coronary artery ligation. Rats were randomly grouped to receive intramyocardial injection of lentiviral solution containing NGF-siRNA (n = 19, MI-SiNGF group), lentiviral solution containing empty vector (n = 18, MI-GFP group) or 0.9% NaCl solution (n = 18, MI-control group), or to receive thoracotomy and pericardiotomy (n = 17, sham-operated group). At 1, 2, 4, and 8 wk after transduction, rats in the MI-control group had higher levels of NGF mRNA and protein than those in the sham-operated group, rats in the MI-GFP group showed similar levels as the MI-control group, and rats in the MI-SiNGF group had lower levels compared to the MIGFP group, indicating that MI model was successfully established and NGF siRNA effectively inhibited the expression of NGF. At 8 wk, echocardiographic and hemodynamic studies revealed a more severe cardiac dysfunction in the MI-siRNA group compared to the MI-GFP group. Moreover, rats in the MI-siRNA group had lower mRNA and protein expression levels of tyrosine hydroxylase (TH) and growth-associated protein 43-positive nerve fibers (GAP-43) at both the infarcted border and within the non-infarcted left ventricles (LV). NGF silencing also reduced the vascular endothelial growth factor (VEGF) expression and decreased the arteriolar and capillary densities at the infarcted border compared to the MI-GFP group. Histological analysis indicated a large infarcted size in the MI-SiNGF group. These findings suggested that endogenous NGF silencing attenuated sympathetic nerve sprouting and angiogenesis, enlarged the infarct size, aggravated cardiac dysfunction, and potentially contributed to an unfavorable prognosis after MI.	[Hu, Hesheng; Xuan, Yongli; Suo, Fei; Cheng, Wenjuan; Li, Xinran; Yin, Jie] Shandong Univ, Sch Med, Jinan 250100, Peoples R China; [Hu, Hesheng; Wang, Ye; Xue, Mei; Suo, Fei; Li, Xiaolu; Cheng, Wenjuan; Yan, Suhua] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Peoples R China; [Liu, Ju] Shandong Univ, Shandong Prov Qianfoshan Hosp, Med Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Yan, SH (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Peoples R China.	yansuhua5537@163.com	Liu, Ju/Q-6319-2016	Liu, Ju/0000-0001-9932-2613	National Natural Science Foundation of China (NSFC) [81070088]; Science and Technology Development Planning of Shandong Province [2009GG10002049]; Shandong Taishan Scholarship	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning of Shandong Province; Shandong Taishan Scholarship	The study was supported by the National Natural Science Foundation of China (NSFC, 81070088), Science and Technology Development Planning of Shandong Province (2009GG10002049) and the Shandong Taishan Scholarship (Suhua Yan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AM HEART J, V151, P806; Barandon L, 2004, EUR J CARDIO-THORAC, V25, P76, DOI 10.1016/S1010-7940(03)00506-2; Barde Isabelle, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s53; Benabdellah K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023734; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; El-Helou V, 2008, J APPL PHYSIOL, V104, P150, DOI 10.1152/japplphysiol.00663.2007; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Govoni S, 2011, PHARMACOL RES, V63, P266, DOI 10.1016/j.phrs.2010.12.017; Haider HK, 2009, ANTIOXID REDOX SIGN, V11, P1929, DOI [10.1089/ars.2009.2471, 10.1089/ARS.2009.2471]; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Heath BM, 1998, J PHYSIOL-LONDON, V512, P779, DOI 10.1111/j.1469-7793.1998.779bd.x; Huang W, 2010, J MOL CELL CARDIOL, V48, P702, DOI 10.1016/j.yjmcc.2009.10.032; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; Ieda M, 2006, CIRCULATION, V114, P2351, DOI 10.1161/CIRCULATIONAHA.106.627588; Kang CS, 2009, AM J PHYSIOL-HEART C, V296, pH1949, DOI 10.1152/ajpheart.00903.2008; Katz MG, 2011, J MOL CELL CARDIOL, V50, P766, DOI 10.1016/j.yjmcc.2010.09.003; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Minicucci MF, 2011, CLIN CARDIOL, V34, P410, DOI 10.1002/clc.20922; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Swissa M, 2004, J AM COLL CARDIOL, V43, P858, DOI 10.1016/j.jacc.2003.07.053; Thiene G, 2010, CARDIOVASC PATHOL, V19, P1, DOI 10.1016/j.carpath.2009.08.002; Wang Y, 2013, CARDIOLOGY, V126, P50, DOI 10.1159/000351074; Xin P, 2010, EUR J PHARMACOL, V649, P293, DOI 10.1016/j.ejphar.2010.09.036; Yan SH, 2007, INT J CARDIOL, V117, P317, DOI 10.1016/j.ijcard.2006.04.086; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3	33	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95106	10.1371/journal.pone.0095106	http://dx.doi.org/10.1371/journal.pone.0095106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755692	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300028
J	Kolzau, S; Wiedner, C; Rucker, J; Kohler, J; Kohler, A; Dolman, AM				Kolzau, Sebastian; Wiedner, Claudia; Ruecker, Jacqueline; Koehler, Jan; Koehler, Antje; Dolman, Andrew M.			Seasonal Patterns of Nitrogen and Phosphorus Limitation in Four German Lakes and the Predictability of Limitation Status from Ambient Nutrient Concentrations	PLOS ONE			English	Article							FRESH-WATER; LIMITED GROWTH; SHALLOW LAKES; SUPPLY RATIOS; PHYTOPLANKTON; EUTROPHICATION; MARINE; STOICHIOMETRY; PARADIGM; BALANCE	To identify the seasonal pattern of nitrogen (N) and phosphorus (P) limitation of phytoplankton in four different lakes, biweekly experiments were conducted from the end of March to September 2011. Lake water samples were enriched with N, P or both nutrients and incubated under two different light intensities. Chlorophyll a fluorescence (Chla) was measured and a model selection procedure was used to assign bioassay outcomes to different limitation categories. N and P were both limiting at some point. For the shallow lakes there was a trend from P limitation in spring to N or light limitation later in the year, while the deep lake remained predominantly P limited. To determine the ability of in-lake N: P ratios to predict the relative strength of N vs. P limitation, three separate regression models were fit with the log-transformed ratio of Chla of the P and N treatments (Response ratio = RR) as the response variable and those of ambient total phosphorus: total nitrogen (TN:TP), dissolved inorganic nitrogen: soluble reactive phosphorus (DIN:SRP), TN:SRP and DIN:TP mass ratios as predictors. All four N:P ratios had significant positive relationships with RR, such that high N:P ratios were associated with P limitation and low N:P ratios with N limitation. The TN:TP and DIN:TP ratios performed better than the DIN: SRP and TN: SRP in terms of misclassification rate and the DIN:TP ratio had the highest R 2 value. Nitrogen limitation was predictable, frequent and persistent, suggesting that nitrogen reduction could play a role in water quality management. However, there is still uncertainty about the efficacy of N restriction to control populations of N-2 fixing cyanobacteria.	[Kolzau, Sebastian; Wiedner, Claudia; Ruecker, Jacqueline; Dolman, Andrew M.] Brandenburg Univ Technol Cottbus Senftenberg, Dept Freshwater Conservat, Bad Saarow Pieskow, Germany; [Koehler, Jan] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Koehler, Antje] Berlin Senate Dept Urban Dev & Environm, Berlin, Germany	Brandenburg University of Technology Cottbus; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Kolzau, S (corresponding author), Brandenburg Univ Technol Cottbus Senftenberg, Dept Freshwater Conservat, Bad Saarow Pieskow, Germany.	Sebastian.Kolzau@tu-cottbus.de	Rücker, Jacqueline/H-8994-2019; Köhler, Jan/C-2633-2014; Dolman, Andrew/G-2399-2011	Rücker, Jacqueline/0000-0001-6841-7724; Köhler, Jan/0000-0003-1894-2912; Dolman, Andrew/0000-0002-6481-966X	framework program Research for Sustainable Development of the German Federal Ministry of Education and Research [033L041A]; project NITROLIMIT	framework program Research for Sustainable Development of the German Federal Ministry of Education and Research; project NITROLIMIT	This work was performed as part of the research project NITROLIMIT (http://www.Nitrolimit.de) and funded by the framework program Research for Sustainable Development (Grant number: 033L041A) of the German Federal Ministry of Education and Research (http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2007, LIMNOL OCEANOGR-METH, V5, P111, DOI 10.4319/lom.2007.5.111; Bergstrom AK, 2010, AQUAT SCI, V72, P277, DOI 10.1007/s00027-010-0132-0; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butt AJ, 2000, COAST MANAGE, V28, P175, DOI 10.1080/089207500263585; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; DEV, 1960, DTSCH EINH WASS ABW; DILLON PJ, 1974, LIMNOL OCEANOGR, V19, P767, DOI 10.4319/lo.1974.19.5.0767; Dolman AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038757; DOWNING JA, 1992, LIMNOL OCEANOGR, V37, P936, DOI 10.4319/lo.1992.37.5.0936; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; GOTHAM IJ, 1981, J PHYCOL, V17, P309, DOI 10.1111/j.0022-3646.1981.00309.x; GOTHAM IJ, 1981, J PHYCOL, V17, P257, DOI 10.1111/j.1529-8817.1981.tb00848.x; Gruneberg B, 2011, INT REV HYDROBIOL, V96, P599, DOI 10.1002/iroh.201111287; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Hilt S, 2010, J ENVIRON QUAL, V39, P725, DOI 10.2134/jeq2009.0122; HOLMGREN SK, 1984, INT REV GES HYDROBIO, V69, P781, DOI 10.1002/iroh.19840690603; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; JENSEN HS, 1992, LIMNOL OCEANOGR, V37, P577, DOI 10.4319/lo.1992.37.3.0577; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Knosche R, 2006, HYDROBIOLOGIA, V560, P63, DOI 10.1007/s10750-005-0983-x; Kohler J, 2005, FRESHWATER BIOL, V50, P1639, DOI 10.1111/j.1365-2427.2005.01430.x; Levine SN, 1999, CAN J FISH AQUAT SCI, V56, P451, DOI 10.1139/cjfas-56-3-451; Lewis Jr WM, 2011, ENV SCI TECHNOL; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; LIJKLEMA L, 1994, HYDROBIOLOGIA, V275, P335, DOI 10.1007/BF00026724; Maberly SC, 2002, FRESHWATER BIOL, V47, P2136, DOI 10.1046/j.1365-2427.2002.00962.x; MORRIS DP, 1988, FRESHWATER BIOL, V20, P315, DOI 10.1111/j.1365-2427.1988.tb00457.x; Moss B, 2013, HYDROBIOLOGIA, V710, P3, DOI 10.1007/s10750-012-1033-0; Nixdorf B, 1997, HYDROBIOLOGIA, V342, P269, DOI 10.1023/A:1017012012099; Paterson MJ, 2011, LIMNOL OCEANOGR, V56, P1545, DOI 10.4319/lo.2011.56.4.1545; Ptacnik R, 2010, ECOSYSTEMS, V13, P1201, DOI 10.1007/s10021-010-9380-z; Rabotyagov S, 2010, ECOL APPL, V20, P1542, DOI 10.1890/08-0680.1; REDFIELD AC, 1958, AM SCI, V46, P205; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Schauser I, 2009, WATER RES, V43, P1788, DOI 10.1016/j.watres.2009.01.007; Scheffer M., 2004, ECOLOGY SHALLOW LAKE; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; Smith VH, 1999, ARCH HYDROBIOL, V146, P37; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; SOMMER U, 1989, LIMNOL OCEANOGR, V34, P1162, DOI 10.4319/lo.1989.34.7.1162; Spivak AC, 2011, FRESHWATER BIOL, V56, P279, DOI 10.1111/j.1365-2427.2010.02495.x; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; Team RC, 2012, R LANG ENV STAT COMP; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Veraart AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018508; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wiedner C, 2007, OECOLOGIA, V152, P473, DOI 10.1007/s00442-007-0683-5	55	90	92	10	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96065	10.1371/journal.pone.0096065	http://dx.doi.org/10.1371/journal.pone.0096065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755935	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300134
J	Alexander, RE; Williamson, SR; Richey, J; Lopez-Beltran, A; Montironi, R; Davidson, DD; Idrees, MT; Jones, CL; Zhang, SB; Wang, LS; Rao, Q; Pedrosa, JA; Kaimakliotis, HZ; Monn, MF; Koch, MO; Cheng, L				Alexander, Riley E.; Williamson, Sean R.; Richey, Justin; Lopez-Beltran, Antonio; Montironi, Rodolfo; Davidson, Darrell D.; Idrees, Muhammad T.; Jones, Carol L.; Zhang, Shaobo; Wang, Lisha; Rao, Qiu; Pedrosa, Jose A.; Kaimakliotis, Hristos Z.; Monn, M. Francesca; Koch, Michael O.; Cheng, Liang			The Expression Patterns of p53 and p16 and an Analysis of a Possible Role of HPV in Primary Adenocarcinoma of the Urinary Bladder	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; TUMOR-SUPPRESSOR; P16(INK4A); CANCER; OVEREXPRESSION; SENESCENCE; INFECTION; CORRELATE; CERVIX	Background: Primary adenocarcinoma of the urinary bladder is rare. The molecular and cellular events leading to its pathogenesis are not well delineated. The goal of this study was to investigate p53 and p16 expression, as well as HPV status, in a relatively large series of primary bladder adenocarcinomas. Materials and Methods: Thirty six cases of urinary bladder adenocarcinoma were chosen from participating institutions. The diagnosis and available clinical history were reviewed in each case. Immunostains for p53, p16 and HPV and high-risk and low-risk HPV-ISH were performed on all tumors. Results: Patients had an average age of 61 years with a male predominance (1.5: 1 male: female ratio). The average tumor size in cystectomy specimens was 4.3 cm. Of the cases managed by transurethral resection, 40% were pT2 at the time of diagnosis. In cystectomy specimens, 77% were either pT3 or pT4. Strong nuclear p16 expression was seen in 67% of all cases and p53 expression was present in 58% of the cases. Expression of both markers was seen in 33% of cases. Expression of p16 or p53 alone was present in 12 (33%) and 9 (25%) cases, respectively. Neither marker was expressed in only 3 (8%) of the tumors. No significant correlation between clinical variables and any of the markers we studied was identified. No HPV infection was detected in any case. Conclusions: Expression of p53 and/or p16 is very common in urinary bladder adenocarcinoma. These findings implicate a high likelihood that alterations in these cell cycle proteins contribute to the pathogenesis of these tumors. Despite frequent immunohistochemical labeling for p16, no evidence of HPV infection was found.	[Alexander, Riley E.; Richey, Justin; Davidson, Darrell D.; Idrees, Muhammad T.; Jones, Carol L.; Zhang, Shaobo; Cheng, Liang] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Pedrosa, Jose A.; Kaimakliotis, Hristos Z.; Monn, M. Francesca; Koch, Michael O.; Cheng, Liang] Indiana Univ Sch Med, Dept Urol, Indianapolis, IN 46202 USA; [Williamson, Sean R.] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; [Lopez-Beltran, Antonio] Univ Cordoba, Dept Pathol, Cordoba, Spain; [Montironi, Rodolfo] Polytech Univ Marche Reg Ancona, United Hosp, Sch Med, Inst Pathol Anat & Histopathol, Ancona, Italy; [Wang, Lisha] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Rao, Qiu] Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Henry Ford Health System; Henry Ford Hospital; Universidad de Cordoba; Marche Polytechnic University; Fudan University; Nanjing University	Cheng, L (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	liang_cheng@yahoo.com	Monn, Maria/AAY-1222-2020; López-Beltrán, António/AAK-7326-2020; Davidson, Darrell/CAA-4149-2022	Monn, Maria/0000-0001-5521-5250; Davidson, Darrell/0000-0002-6105-274X; Lopez-Beltran, Antonio/0000-0002-0724-1267; Williamson, Sean/0000-0002-3898-1460	Department of Pathology and Laboratory Medicine, Indiana University School of Medicine	Department of Pathology and Laboratory Medicine, Indiana University School of Medicine	The research was supported by internal research funding of the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RE, 2012, MODERN PATHOL, V25, P1526, DOI 10.1038/modpathol.2012.103; Ben Selma W, 2010, PATHOL RES PRACT, V206, P740, DOI 10.1016/j.prp.2010.06.005; Benevolo M, 2006, MODERN PATHOL, V19, P384, DOI 10.1038/modpathol.3800551; Cheng L, 2012, BLADDER PATHOLOGY, Vvii; Dahm P, 2003, EUR UROL, V44, P672, DOI 10.1016/S0302-2838(03)00416-0; Doxtader EE, 2012, HUM PATHOL, V43, P327, DOI 10.1016/j.humpath.2011.05.010; El-Mekresh MM, 1998, BRIT J UROL, V82, P206; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jordan RC, 2012, AM J SURG PATHOL, V36, P945, DOI 10.1097/PAS.0b013e318253a2d1; Kakehi Y, 1998, JPN J CANCER RES, V89, P214, DOI 10.1111/j.1349-7006.1998.tb00551.x; Kapur P, 2011, AM J CLIN PATHOL, V135, P822, DOI 10.1309/AJCP76KUVOTBKQRY; Keating JT, 2001, AM J SURG PATHOL, V25, P884, DOI 10.1097/00000478-200107000-00006; Klaes R, 2002, AM J SURG PATHOL, V26, P1389, DOI 10.1097/00000478-200211000-00001; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Lewis JS, 2012, MODERN PATHOL, V25, P1212, DOI 10.1038/modpathol.2012.79; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pientong C, 2004, DIAGN CYTOPATHOL, V31, P235, DOI 10.1002/dc.20122; Ploeg M, 2010, J UROLOGY, V183, P915, DOI 10.1016/j.juro.2009.11.018; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Rao Q, 2013, MODERN PATHOL, V26, P725, DOI 10.1038/modpathol.2012.229; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Samarawardana P, 2010, CANCER CYTOPATHOL, V118, P146, DOI 10.1002/cncy.20078; Shaker OG, 2013, BIOMED PHARMACOTHER, V67, P183, DOI 10.1016/j.biopha.2012.10.019; Shariat SF, 2004, J CLIN ONCOL, V22, P1014, DOI 10.1200/JCO.2004.03.118; Slaton JW, 2001, UROLOGY, V57, P852, DOI 10.1016/S0090-4295(01)00968-2; Steinestel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065189; Tzai TS, 2004, UROL ONCOL-SEMIN ORI, V22, P112, DOI 10.1016/S1078-1439(03)00176-5; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Westenend PJ, 2001, BJU INT, V88, P198, DOI 10.1046/j.1464-410x.2001.02230.x; Woo SB, 2013, MODERN PATHOL, V26, P1288, DOI 10.1038/modpathol.2013.70; Zaghloul MS, 2006, UROL ONCOL-SEMIN ORI, V24, P13, DOI 10.1016/j.urolonc.2005.05.027; Zhao WQ, 2012, J ONCOL, V2012, DOI 10.1155/2012/957437; zur Hausen H, 1994, Curr Top Microbiol Immunol, V186, P131	37	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95724	10.1371/journal.pone.0095724	http://dx.doi.org/10.1371/journal.pone.0095724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752337	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400109
J	Zeilbeck, LF; Muller, B; Knobloch, V; Tamm, ER; Ohlmann, A				Zeilbeck, Ludwig F.; Mueller, Birgit; Knobloch, Verena; Tamm, Ernst R.; Ohlmann, Andreas			Differential Angiogenic Properties of Lithium Chloride In Vitro and In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3; DIABETIC-RETINOPATHY; VASCULAR DEVELOPMENT; RETINAL VASCULATURE; SIGNALING PATHWAY; BIPOLAR DISORDER; BETA-CATENIN; FACTOR VEGF; NORRIN	Wnt/beta-catenin signaling induced by the Norrin/Frizzled-4 pathway has been shown to improve capillary repair following oxygen induced retinopathy (OIR) in the mouse, a model for retinopathy of prematurity. Here we investigated if treatment with the monovalent cation lithium that has been shown to augment Wnt/beta-catenin signaling in vitro and in vivo has similar effects. In cultured human microvascular endothelial cells, LiCl as well as SB 216763, another small molecule that activates Wnt/beta-catenin signaling, induced proliferation, survival and migration, which are all common parameters for angiogenic properties in vitro. Moreover, treatment with both agents caused an increase in the levels of beta-catenin and their translocation to nuclei while quercetin, an inhibitor of Wnt/b-catenin signaling, completely blocked the effects of LiCl on proliferation. In mice with OIR, intraperitonal or intravitreal treatment with LiCl markedly increased the retinal levels of beta-catenin, but did not improve capillary repair. In contrast, repair was significantly improved following intravitreal treatment with Norrin. The effects of LiCl on HDMEC in vitro have minor relevance for OIR in vivo, and the influence of the Norrin/Frizzled-4 pathway on capillary repair in OIR is not reproducible upon enhancing Wnt/beta-catenin signaling by LiCl treatment strongly indicating the presence of additional and essential mechanisms.	[Zeilbeck, Ludwig F.; Mueller, Birgit; Knobloch, Verena; Tamm, Ernst R.; Ohlmann, Andreas] Univ Regensburg, Inst Human Anat & Embryol, D-93053 Regensburg, Germany	University of Regensburg	Ohlmann, A (corresponding author), Univ Regensburg, Inst Human Anat & Embryol, D-93053 Regensburg, Germany.	andreas.ohlmann@ur.de	Tamm, Ernst/AAB-9772-2019	Tamm, Ernst/0000-0002-6679-8743; Ohlmann, Andreas/0000-0002-7101-9361	Deutsche Forschungsgemeinschaft [FOR 1075, TP7]; PRO RETINA-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); PRO RETINA-Foundation	The study was supported by the Deutsche Forschungsgemeinschaft (Research Unit FOR 1075, TP7; URL: http://www.dfg.de/), and the PRO RETINA-Foundation (URL: http://www.pro-retina-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bressler NM, 2011, NEW ENGL J MED, V365, P1520, DOI 10.1056/NEJMct0908432; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gould TD, 2004, NEUROPSYCHOPHARMACOL, V29, P32, DOI 10.1038/sj.npp.1300283; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guo SZ, 2009, STROKE, V40, P652, DOI 10.1161/STROKEAHA.108.524504; Ho AC, 2012, OPHTHALMOLOGY, V119, P2179, DOI 10.1016/j.ophtha.2012.07.058; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kim YR, 2008, STROKE, V39, P439, DOI 10.1161/STROKEAHA.107.492215; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Marmol F, 2008, PROG NEURO-PSYCHOPH, V32, P1761, DOI 10.1016/j.pnpbp.2008.08.012; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; O'Brien WT, 2004, J NEUROSCI, V24, P6791, DOI 10.1523/JNEUROSCI.4753-03.2004; Ohlmann A, 2005, J NEUROSCI, V25, P1701, DOI 10.1523/JNEUROSCI.4756-04.2005; Ohlmann A, 2012, PROG RETIN EYE RES, V31, P243, DOI 10.1016/j.preteyeres.2012.02.002; Ohlmann A, 2010, J NEUROSCI, V30, P183, DOI 10.1523/JNEUROSCI.3210-09.2010; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Wang H, 2010, BIOCHEM PHARMACOL, V80, P1386, DOI 10.1016/j.bcp.2010.07.034; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Wirostko B, 2008, PROG RETIN EYE RES, V27, P608, DOI 10.1016/j.preteyeres.2008.09.002; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	39	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95546	10.1371/journal.pone.0095546	http://dx.doi.org/10.1371/journal.pone.0095546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751879	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400071
J	Forsgren, MF; Leinhard, OD; Dahlstrom, N; Cedersund, G; Lundberg, P				Forsgren, Mikael Fredrik; Leinhard, Olof Dahlqvist; Dahlstroem, Nils; Cedersund, Gunnar; Lundberg, Peter			Physiologically Realistic and Validated Mathematical Liver Model Revels Hepatobiliary Transfer Rates for Gd-EOB-DTPA Using Human DCE-MRI Data	PLOS ONE			English	Article							CONTRAST AGENT; SYSTEMS BIOLOGY; HEPATIC-UPTAKE; PHARMACOKINETICS; ENHANCEMENT; QUANTIFICATION; TRANSPORT; SAFETY	Objectives: Diffuse liver disease (DLD), such as non-alcoholic fatty liver disease (NASH) and cirrhosis, is a rapidly growing problem throughout the Westernized world. Magnetic resonance imaging (MRI), based on uptake of the hepatocyte-specific contrast agent (CA) Gd-EOB-DTPA, is a promising non-invasive approach for diagnosing DLD. However, to fully utilize the potential of such dynamic measurements for clinical or research purposes, more advanced methods for data analysis are required. Methods: A mathematical model that can be used for such data-analysis was developed. Data was obtained from healthy human subjects using a clinical protocol with high spatial resolution. The model is based on ordinary differential equations and goes beyond local diffusion modeling, taking into account the complete system accessible to the CA. Results: The presented model can describe the data accurately, which was confirmed using chi-square statistics. Furthermore, the model is minimal and identifiable, meaning that all parameters were determined with small degree of uncertainty. The model was also validated using independent data. Conclusions: We have developed a novel approach for determining previously undescribed physiological hepatic parameters in humans, associated with CA transport across the liver. The method has a potential for assessing regional liver function in clinical examinations of patients that are suffering of DLD and compromised hepatic function.	[Forsgren, Mikael Fredrik] Wolfram MathCore AB, Linkoping, Sweden; [Forsgren, Mikael Fredrik; Leinhard, Olof Dahlqvist; Dahlstroem, Nils; Lundberg, Peter] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Forsgren, Mikael Fredrik; Leinhard, Olof Dahlqvist] Linkoping Univ, Dept Radiat Phys, Linkoping, Sweden; [Forsgren, Mikael Fredrik; Leinhard, Olof Dahlqvist; Dahlstroem, Nils; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth Sci, Div Radiol Sci, Linkoping, Sweden; [Dahlstroem, Nils] Linkoping Univ, Dept Radiol, Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Dept Expt Med, Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden; [Lundberg, Peter] Linkoping Univ, Dept Radiol, Dept Radiat Phys, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Forsgren, MF (corresponding author), Wolfram MathCore AB, Linkoping, Sweden.	mikael.f.forsgren@liu.se	Lundberg, Peter/AGD-9679-2022	Forsgren, Mikael/0000-0003-4630-6550	Swedish Research Council (VR/M) [2007-2884]; Medical Research Council of Southeast Sweden (FORSS) [12621]; Linkoping University; Linkoping University Hospital Research Foundations; County Council of Ostergotland	Swedish Research Council (VR/M)(Swedish Research Council); Medical Research Council of Southeast Sweden (FORSS); Linkoping University; Linkoping University Hospital Research Foundations; County Council of Ostergotland	Funding sources: Swedish Research Council (VR/M, 2007-2884, http://www.vr.se/), the Medical Research Council of Southeast Sweden (FORSS, 12621, http://www.fou.nu/is/forss), the Linkoping University, Linkoping University Hospital Research Foundations, County Council of Ostergotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; Belinsky MG, 2005, MOL PHARMACOL, V68, P160, DOI 10.1124/mol.104.010587; BELLENTANI S, 1994, HEPATOLOGY, V20, P1442, DOI 10.1002/hep.1840200611; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Couinaud C, 1957, FOI ETUDES ANATOMIQU; Department of Health and Human Services Center for Disease Control Prevention, VIRAL HEPATITIS; Edda K, 2009, SYSTEMS BIOL TXB; Gomez-Cabrero D, 2011, INTERFACE FOCUS, V1, P438, DOI 10.1098/rsfs.2011.0015; Gschwend S, 2011, INVEST RADIOL, V46, P556, DOI 10.1097/RLI.0b013e31821a218a; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Klipp Edda, 2009, SYSTEMS BIOL TXB; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Leinhard OD, 2012, EUR RADIOL, V22, P642, DOI 10.1007/s00330-011-2302-4; Leonhardt M, 2010, DRUG METAB DISPOS, V38, P1024, DOI 10.1124/dmd.110.032862; Levitt David G, 2003, BMC Clin Pharmacol, V3, P3, DOI 10.1186/1472-6904-3-3; Mahagita C, 2007, AM J PHYSIOL-GASTR L, V293, pG271, DOI 10.1152/ajpgi.00075.2007; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Muhler A., 1993, MAGMA MAGN RESON MAT, V1, P134; Narita M, 2009, J GASTROENTEROL, V44, P793, DOI 10.1007/s00535-009-0056-4; Nilsson H, 2009, J MAGN RESON IMAGING, V29, P1323, DOI 10.1002/jmri.21801; Nishie A, 2011, EUR J RADIOL; NOMURA H, 1988, JPN J MED, V27, P142, DOI 10.2169/internalmedicine1962.27.142; Noren B, 2013, EUR RADIOL, V23, P174, DOI 10.1007/s00330-012-2583-2; Peters AM, 1998, EUR J NUCL MED, V25, P766, DOI 10.1007/s002590050281; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Reimer P, 2004, EUR RADIOL, V14, P559, DOI 10.1007/s00330-004-2236-1; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; SchuhmannGiampieri G, 1997, J CLIN PHARMACOL, V37, P587, DOI 10.1002/j.1552-4604.1997.tb04340.x; SCHUHMANNGIAMPIERI G, 1993, J PHARM SCI-US, V82, P799, DOI 10.1002/jps.2600820809; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59, DOI 10.1148/radiology.183.1.1549695; Shuter B, 1996, MAGN RESON IMAGING, V14, P243, DOI 10.1016/0730-725X(95)02097-D; Sourbron S, 2012, RADIOLOGY, V263, P874, DOI 10.1148/radiol.12110337; Spinazzi A, 1999, ACAD RADIOL, V6, P282, DOI 10.1016/S1076-6332(99)80451-6; Tarmalinggam Y, 2007, ADV PHYSIOL EDUC, V31, P370, DOI 10.1152/advan.00080.2007; Tsuboyama T, 2010, RADIOLOGY, V255, P824, DOI 10.1148/radiol.10091557; Ulloa JL, 2013, NMR BIOMED; Utsunomiya T, 2011, J GASTROENTEROL	42	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95700	10.1371/journal.pone.0095700	http://dx.doi.org/10.1371/journal.pone.0095700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748411	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500139
J	Nagler, M; Bachmann, LM; Schmid, P; Muller, PR; Wuillemin, WA				Nagler, Michael; Bachmann, Lucas M.; Schmid, Pirmin; Mueller, Pascale Raddatz; Wuillemin, Walter A.			Patient Self-Management of Oral Anticoagulation with Vitamin K Antagonists in Everyday Practice: Efficacy and Safety in a Nationwide Long-Term Prospective Cohort Study	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; WARFARIN; TRIAL; THERAPY; CARE; METAANALYSIS; PREVENTION; GUIDELINES; INTENSITY; ACCURACY	Patient self-management (PSM) of oral anticoagulation is under discussion, because evidence from real-life settings is missing. Using data from a nationwide, prospective cohort study in Switzerland, we assessed overall long-term efficacy and safety of PSM and examined subgroups. Data of 1140 patients (5818.9 patient-years) were analysed and no patient were lost to follow-up. Median follow-up was 4.3 years (range 0.2-12.8 years). Median age at the time of training was 54.2 years (range 18.2-85.2) and 34.6% were women. All-cause mortality was 1.4 per 100 patient-years (95% CI 1.1-1.7) with a higher rate in patients with atrial fibrillation (2.5; 1.6-3.7; p<0.001), patients >50 years of age (2.0; 1.6-2.6; p<0.001), and men (1.6; 1.2-2.1; p = 0.036). The rate of thromboembolic events was 0.4 (0.2-0.6) and independent from indications, sex and age. Major bleeding were observed in 1.1 (0.9-1.5) per 100 patient-years. Efficacy was comparable to standard care and new oral anticoagulants in a network meta-analysis. PSM of properly trained patients is effective and safe in a long-term real-life setting and robust across clinical subgroups. Adoption in various clinical settings, including those with limited access to medical care or rural areas is warranted.	[Nagler, Michael; Schmid, Pirmin; Mueller, Pascale Raddatz; Wuillemin, Walter A.] Luzemer Kantonsspital, Div Haematol, CH-6000 Luzern, Switzerland; [Nagler, Michael; Schmid, Pirmin; Mueller, Pascale Raddatz; Wuillemin, Walter A.] Luzemer Kantonsspital, Cent Haematol Lab, CH-6000 Luzern, Switzerland; [Nagler, Michael] Inselspital Univ Hosp, Dept Haematol, Bern, Switzerland; [Nagler, Michael] Inselspital Univ Hosp, Cent Haematol Lab, Bern, Switzerland; [Bachmann, Lucas M.] Medignition Inc, Zug, Switzerland; [Wuillemin, Walter A.] Univ Bern, Bern, Switzerland	Lucerne Cantonal Hospital; Lucerne Cantonal Hospital; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Wuillemin, WA (corresponding author), Luzemer Kantonsspital, Div Haematol, CH-6000 Luzern, Switzerland.	walter.wuillemin@luks.ch	Nagler, Michael/H-6715-2019	Nagler, Michael/0000-0003-4319-2367; Schmid, Pirmin/0000-0002-1171-7643; , Lucas/0000-0002-9868-154X	charitable foundation Coagulation Care; Research Fund Haematology Luzerner Kantonsspital	charitable foundation Coagulation Care; Research Fund Haematology Luzerner Kantonsspital	The study was funded by the charitable foundation Coagulation Care, and Research Fund Haematology Luzerner Kantonsspital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Anaya P, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00009; Ansell J, 2005, INT J CARDIOL, V99, P37, DOI 10.1016/j.ijcard.2003.11.008; Baczek VL, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-5; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Biss TT, 2011, J THROMB HAEMOST, V9, P1090, DOI 10.1111/j.1538-7836.2011.04248.x; Bloomfield HE, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00005; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Christensen TD, 2012, J THROMB HAEMOST, V10, P251, DOI 10.1111/j.1538-7836.2011.04568.x; Christensen TD, 2007, INT J CARDIOL, V118, P54, DOI 10.1016/j.ijcard.2006.06.018; Douketis James D, 2006, Evid Based Cardiovasc Med, V10, P124, DOI 10.1016/j.ebcm.2006.04.021; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Fitzmaurice DA, 2005, BRIT MED J, V331, P1057, DOI 10.1136/bmj.38618.580903.AE; Fitzmaurice DA, 2005, BRIT J HAEMATOL, V131, P156, DOI 10.1111/j.1365-2141.2005.05739.x; Fitzmaurice DA, 2001, BRIT MED J, V323, P985, DOI 10.1136/bmj.323.7319.985; Fritschi J, 2007, SWISS MED WKLY, V137, P252; Garcia-Alamino JM, 2010, COCHRANE DB SYST REV; Gardiner C, 2006, BRIT J HAEMATOL, V132, P598, DOI 10.1111/j.1365-2141.2005.05899.x; Hamad MAS, 2009, EUR J CARDIO-THORAC, V35, P265, DOI 10.1016/j.ejcts.2008.10.020; Heneghan C, 2012, LANCET, V379, P322, DOI 10.1016/S0140-6736(11)61294-4; Hobbs FDR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3653; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kessels A, 2013, OA EPIDEMIOLOGY, V1, P7, DOI DOI 10.13172/2053-079X-1-1-690; Kyrle PA, 2012, LANCET, V379, P292, DOI 10.1016/S0140-6736(11)61748-0; Levi M, 2008, BLOOD, V111, P4471, DOI 10.1182/blood-2007-11-123711; Li Wan Po A, 2012, LANCET, V379, P1789; Lip GYH, 2007, INT J CLIN PRACT, V61, P9, DOI 10.1111/j.1742-1241.2006.01151.x; Mair H, 2012, INTERACT CARDIOV TH, V14, P253, DOI 10.1093/icvts/ivr088; Murray E, 2004, BRIT MED J, V328, P437, DOI 10.1136/bmj.328.7437.437; Nagler M, 2013, J THROMB HAEMOST, V11, P197, DOI 10.1111/jth.12050; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Pisters R, 2009, SEMIN THROMB HEMOST, V35, P554, DOI 10.1055/s-0029-1241048; Po ALW, 2012, LANCET, V379, P1788, DOI 10.1016/S0140-6736(12)60757-0; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; Sawicki PT, 2003, J INTERN MED, V254, P515, DOI 10.1046/j.1365-2796.2003.01215.x; Schulman S, 2012, BLOOD, V119, P3016, DOI 10.1182/blood-2011-10-378950; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Sidhu P, 2001, ANN THORAC SURG, V72, P1523, DOI 10.1016/S0003-4975(01)03049-1; Siebenhofer A, 2011, ANN INTERN MED, V155, P336, DOI 10.7326/0003-4819-155-5-201109060-00018; Siebenhofer A, 2008, THROMB HAEMOSTASIS, V100, P1089, DOI 10.1160/TH08-06-0361; Uhlig K, 2013, ANN INTERN MED, V159, P185, DOI 10.7326/0003-4819-159-3-201308060-00008; van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155	47	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95761	10.1371/journal.pone.0095761	http://dx.doi.org/10.1371/journal.pone.0095761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748062	Green Published, gold			2022-12-25	WOS:000335226500142
J	O'Hara, JK; Kerwin, LJ; Cobbold, SA; Tai, J; Bedell, TA; Reider, PJ; Llinas, M				O'Hara, Jessica K.; Kerwin, Lewis J.; Cobbold, Simon A.; Tai, Jonathan; Bedell, Thomas A.; Reider, Paul J.; Llinas, Manuel			Targeting NAD(+) Metabolism in the Human Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							NICOTINATE MONONUCLEOTIDE ADENYLYLTRANSFERASE; DIPHOSPHOPYRIDINE NUCLEOTIDE; PYRIDINE-NUCLEOTIDES; ANTIGENIC VARIATION; GENOME SEQUENCE; VIRULENCE GENES; HOST-CELL; BIOSYNTHESIS; ACID; INHIBITORS	Nicotinamide adenine dinucleotide (NAD(+)) is an essential metabolite utilized as a redox cofactor and enzyme substrate in numerous cellular processes. Elevated NAD(+) levels have been observed in red blood cells infected with the malaria parasite Plasmodium falciparum, but little is known regarding how the parasite generates NAD(+). Here, we employed a mass spectrometry-based metabolomic approach to confirm that P. falciparum lacks the ability to synthesize NAD(+) de novo and is reliant on the uptake of exogenous niacin. We characterized several enzymes in the NAD(+) pathway and demonstrate cytoplasmic localization for all except the parasite nicotinamidase, which concentrates in the nucleus. One of these enzymes, the P. falciparum nicotinate mononucleotide adenylyltransferase (PfNMNAT), is essential for NAD(+) metabolism and is highly diverged from the human homolog, but genetically similar to bacterial NMNATs. Our results demonstrate the enzymatic activity of PfNMNAT in vitro and demonstrate its ability to genetically complement the closely related Escherichia coli NMNAT. Due to the similarity of PfNMNAT to the bacterial enzyme, we tested a panel of previously identified bacterial NMNAT inhibitors and synthesized and screened twenty new derivatives, which demonstrate a range of potency against live parasite culture. These results highlight the importance of the parasite NAD(+) metabolic pathway and provide both novel therapeutic targets and promising lead antimalarial compounds.	[O'Hara, Jessica K.; Cobbold, Simon A.; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [O'Hara, Jessica K.; Cobbold, Simon A.; Llinas, Manuel] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kerwin, Lewis J.; Bedell, Thomas A.; Reider, Paul J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Tai, Jonathan] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Princeton University; Princeton University; Princeton University; University of Illinois System; University of Illinois Urbana-Champaign	Llinas, M (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	manuel@psu.edu	Bedell, Thomas/AAX-2340-2021	Bedell, Thomas/0000-0001-9866-2050; Cobbold, Simon/0000-0002-9927-8998	Burrough's Wellcome fund (Investigators in Pathogenesis of Infectious Disease Award for Research), an NIH Director's New Innovator Award [1DP2OD001315-01]; Center for Quantitative Biology [P50 GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001315] Funding Source: NIH RePORTER	Burrough's Wellcome fund (Investigators in Pathogenesis of Infectious Disease Award for Research), an NIH Director's New Innovator Award; Center for Quantitative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded through generous support from the Burrough's Wellcome fund (Investigators in Pathogenesis of Infectious Disease Award for Research), an NIH Director's New Innovator Award (1DP2OD001315-01), and with support from the Center for Quantitative Biology (P50 GM071508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Billington RA, 2006, MOL MED, V12, P324, DOI 10.2119/2006-00075.Billington; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; D'Angelo I, 2000, STRUCTURE, V8, P993, DOI 10.1016/S0969-2126(00)00190-8; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; Gazanion E, 2012, INT J PARASITOL, V42, P323, DOI 10.1016/j.ijpara.2012.02.007; Ginsburg H., 2008, MALARIA PARASITE MET; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Harden A., 1906, P ROY SOC LOND B BIO, V78, P369, DOI [DOI 10.1098/RSPB.1906.0070, 10.1098/rspb.1906.0070]; Huang NA, 2010, J MED CHEM, V53, P5229, DOI 10.1021/jm100377f; Jayaram HN, 2011, CURR MED CHEM, V18, P1962; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Klein JR PW, 1942, J BIOL CHEM, V140, P423; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lu SY, 2008, ACTA CRYSTALLOGR F, V64, P893, DOI 10.1107/S1744309108029102; Ma B, 2009, MOL CELL BIOL, V29, P4067, DOI 10.1128/MCB.01461-08; Mancio-Silva L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2539; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519; NAGARAJAN K, 1964, BIOCHIM BIOPHYS ACTA, V93, P176, DOI 10.1016/0304-4165(64)90275-2; Nakamura M, 2012, CIRC RES, V111, P604, DOI 10.1161/CIRCRESAHA.111.247924; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Petrelli R, 2011, CURR MED CHEM, V18, P1973, DOI 10.2174/092986711795590048; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; ROTH E, 1990, BLOOD CELLS, V16, P453; ROTH E, 1990, BLOOD CELLS, V16, P466; ROTH EF, 1982, BIOCHEM BIOPH RES CO, V109, P355, DOI 10.1016/0006-291X(82)91728-4; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; SESTINI S, 1993, ARCH BIOCHEM BIOPHYS, V302, P206, DOI 10.1006/abbi.1993.1200; SHERMAN IW, 1966, AM J TROP MED HYG, V15, P814, DOI 10.4269/ajtmh.1966.15.814; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Sorci L, 2009, CHEM BIOL, V16, P849, DOI 10.1016/j.chembiol.2009.07.006; Stancek Martin, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-16; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; ZEREZ CR, 1990, BLOOD, V75, P1705; Zhang H, 2002, STRUCTURE, V10, P69, DOI 10.1016/S0969-2126(01)00693-1	64	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94061	10.1371/journal.pone.0094061	http://dx.doi.org/10.1371/journal.pone.0094061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747974	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500018
J	Zemp, R; List, R; Gulay, T; Elsig, JP; Naxera, J; Taylor, WR; Lorenzetti, S				Zemp, Roland; List, Renate; Guelay, Turgut; Elsig, Jean Pierre; Naxera, Jaroslav; Taylor, William R.; Lorenzetti, Silvio			Soft Tissue Artefacts of the Human Back: Comparison of the Sagittal Curvature of the Spine Measured Using Skin Markers and an Open Upright MRI	PLOS ONE			English	Article							SEGMENTAL MOVEMENTS; LUMBAR SPINE; FLUOROSCOPIC VIDEO; ANALYSIS SYSTEM; IN-VIVO; MOTION; KINEMATICS; WALKING; PAIN; ROTATION	Soft tissue artefact affects the determination of skeletal kinematics. Thus, it is important to know the accuracy and limitations of kinematic parameters determined and modelled based on skin marker data. Here, the curvature angles, as well as the rotations of the lumbar and thoracic segments, of seven healthy subjects were determined in the sagittal plane using a skin marker set and compared to measurements taken in an open upright MRI scanner in order to understand the influence of soft tissue artefact at the back. The mean STA in the flexed compared to the extended positions were 10.2 +/- 6.1 mm (lumbar)/9.3 +/- 4.2 mm (thoracic) and 10.7 +/- 4.8 mm (lumbar)/9.2 +/- 4.9 mm (thoracic) respectively. A linear regression of the lumbar and thoracic curvatures between the marker-based measurements and MRI-based measurements resulted in coefficients of determination, R-2, of 0.552 and 0.385 respectively. Skin marker measurements therefore allow for the assessment of changes in the lumbar and thoracic curvature angles, but the absolute values suffer from uncertainty. Nevertheless, this marker set appears to be suitable for quantifying lumbar and thoracic spinal changes between quasi-static whole body postural changes.	[Zemp, Roland; List, Renate; Guelay, Turgut; Taylor, William R.; Lorenzetti, Silvio] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Elsig, Jean Pierre] Spine Surg, Kusnacht, Switzerland; [Naxera, Jaroslav] Rontgeninst Zurich Altstetten, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Lorenzetti, S (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	sl@ethz.ch	List, Renate/D-3884-2011; Taylor, William R./F-8692-2010; Lorenzetti, Silvio Rene/B-1188-2009	List, Renate/0000-0003-3292-1915; Taylor, William R./0000-0003-4060-4098; Lorenzetti, Silvio Rene/0000-0002-8339-8960; Zemp, Roland/0000-0003-4335-1217				Akbarshahi M, 2010, J BIOMECH, V43, P1292, DOI 10.1016/j.jbiomech.2010.01.002; AMONOOKUOFI HS, 1992, ACTA ANAT, V145, P373; Bae TS, 2010, CLIN BIOMECH, V25, P628, DOI 10.1016/j.clinbiomech.2010.04.004; Barker S, 2006, MED ENG PHYS, V28, P460, DOI 10.1016/j.medengphy.2005.07.017; Baumgartner D, 2012, SCI WORLD J, DOI 10.1100/2012/184016; Baumgartner W, 2001, 18 C INT SOC BIOM ZU; Bull AMJ, 2000, CLIN BIOMECH, V15, P772, DOI 10.1016/S0268-0033(00)00043-7; Bull Anthony M. J., 2004, Journal of Musculoskeletal Research, V8, P129, DOI 10.1142/S0218957704001296; Cappozzo A, 1996, CLIN BIOMECH, V11, P90, DOI 10.1016/0268-0033(95)00046-1; Consmuller T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050135; Consmuller T, 2012, EUR SPINE J, V21, P2170, DOI 10.1007/s00586-012-2312-1; Consmuller T, 2013, MED ENG PHYS; Crosbie J, 1997, GAIT POSTURE, V5, P13, DOI 10.1016/S0966-6362(96)01068-5; Dettwyler MT, 2005, THESIS ETH ZURICH; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Frigo C, 2003, CLIN BIOMECH, V18, P419, DOI 10.1016/S0268-0033(03)00028-7; Gao B, 2008, J BIOMECH, V41, P3189, DOI 10.1016/j.jbiomech.2008.08.028; Garling EH, 2007, J BIOMECH, V40, pS18, DOI 10.1016/j.jbiomech.2007.03.003; Gulay T, 2011, 29 C INT SOC BIOM SP; Heller MO, 2011, J ORTHOP RES, V29, P1470, DOI 10.1002/jor.21426; Heneghan NR, 2010, MANUAL THER, V15, P599, DOI 10.1016/j.math.2010.05.004; Holden JP, 1997, GAIT POSTURE, V5, P217, DOI 10.1016/S0966-6362(96)01088-0; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Keller Tony S, 2005, Spine J, V5, P297, DOI 10.1016/j.spinee.2004.10.050; Kramers-de Quervain IA, 2001, 18 C INT SOC BIOM ZU; Kratzenstein S, 2012, GAIT POSTURE, V36, P482, DOI 10.1016/j.gaitpost.2012.04.011; KUMAR S, 1990, SPINE, V15, P1311, DOI 10.1097/00007632-199012000-00014; Lee Sai-wing, 2002, Spine (Phila Pa 1976), V27, pE215, DOI 10.1097/00007632-200204150-00022; Leitkam ST, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005400; List R, 2010, 28 INT C BIOM SPORTS, P4; List R, 2012, J STRENGTH COND RES; List R, 2005, THESIS ETH ZURICH; Lorenzetti S, 2012, J STRENGTH COND RES, V26, P2829, DOI 10.1519/JSC.0b013e318267918b; MASLEN BA, 1994, CLIN BIOMECH, V9, P291, DOI 10.1016/0268-0033(94)90041-8; Matsui K, 2006, J ORTHOP SCI, V11, P180, DOI 10.1007/s00776-005-1000-y; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; Morl F, 2006, EUR SPINE J, V15, P742, DOI 10.1007/s00586-005-0960-0; Norton BJ, 2004, J ORTHOP SPORT PHYS, V34, P524, DOI 10.2519/jospt.2004.34.9.524; Pratt V., 1987, COMPUT GRAPHICS-US, V21, P145, DOI [10.1145/37402.37420, DOI 10.1145/37402.37420, DOI 10.1145/37401.37420]; Rozumalski A, 2008, GAIT POSTURE, V28, P378, DOI 10.1016/j.gaitpost.2008.05.005; Ryu JH, 2006, J BIOMECH, V39, P844, DOI 10.1016/j.jbiomech.2005.02.001; Sangeux M, 2006, CLIN BIOMECH, V21, P984, DOI 10.1016/j.clinbiomech.2006.05.006; Stoop M, 2009, THESIS ETH ZURICH; Syczewska M, 1999, CLIN BIOMECH, V14, P384, DOI 10.1016/S0268-0033(99)00003-0; Taylor WR, 2010, MED ENG PHYS, V32, P1080, DOI 10.1016/j.medengphy.2010.07.011; Taylor WR, 2005, J ORTHOP RES, V23, P726, DOI 10.1016/j.orthres.2005.02.006; Telfer S, 2010, GAIT POSTURE, V32, P536, DOI 10.1016/j.gaitpost.2010.07.016; Teyhen DS, 2007, SPINE, V32, pE220, DOI 10.1097/01.brs.0000259206.38946.cb; Teyhen DS, 2005, SPINE, V30, pE406, DOI 10.1097/01.brs.0000170589.47555.c6; Tranberg R, 1998, CLIN BIOMECH, V13, P71, DOI 10.1016/S0268-0033(97)00052-1; Unternahrer S, 2005, THESIS ETH ZURICH; Wojtys EM, 2000, AM J SPORT MED, V28, P490, DOI 10.1177/03635465000280040801; Wu SK, 2007, GAIT POSTURE, V26, P161, DOI 10.1016/j.gaitpost.2006.07.016	54	62	62	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95426	10.1371/journal.pone.0095426	http://dx.doi.org/10.1371/journal.pone.0095426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748013	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500101
J	Douillard, FP; Rasinkangas, P; von Ossowski, I; Reunanen, J; Palva, A; de Vos, WM				Douillard, Francois P.; Rasinkangas, Pia; von Ossowski, Ingemar; Reunanen, Justus; Palva, Airi; de Vos, Willem M.			Functional Identification of Conserved Residues Involved in Lactobacillus rhamnosus Strain GG Sortase Specificity and Pilus Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Electron Microscopy (EM); Protein Motif; Signaling; Site-directed Mutagenesis	COMPLETE GENOME SEQUENCE; GRAM-POSITIVE BACTERIA; ENTEROCOCCUS-FAECIUM ISOLATE; GROUP-B STREPTOCOCCUS; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; CORYNEBACTERIUM-DIPHTHERIAE; BACILLUS-ANTHRACIS; PILIN SUBUNIT; REVEALS PILI	In Gram-positive bacteria, sortase-dependent pili mediate the adhesion of bacteria to host epithelial cells and play a pivotal role in colonization, host signaling, and biofilm formation. Lactobacillus rhamnosus strain GG, a well known probiotic bacterium, also displays on its cell surface mucus-binding pilus structures, along with other LPXTG surface proteins, which are processed by sortases upon specific recognition of a highly conserved LPXTG motif. Bioinformatic analysis of all predicted LPXTG proteins encoded by the L. rhamnosus GG genome revealed a remarkable conservation of glycine residues juxtaposed to the canonical LPXTG motif. Here, we investigated and defined the role of this so-called triple glycine (TG) motif in determining sortase specificity during the pilus assembly and anchoring. Mutagenesis of the TG motif resulted in a lack or an alteration of the L. rhamnosus GG pilus structures, indicating that the TG motif is critical in pilus assembly and that they govern the pilin-specific and housekeeping sortase specificity. This allowed us to propose a regulatory model of the L. rhamnosus GG pilus biogenesis. Remarkably, the TG motif was identified in multiple pilus gene clusters of other Gram-positive bacteria, suggesting that similar signaling mechanisms occur in other, mainly pathogenic, species.	[Douillard, Francois P.; Rasinkangas, Pia; von Ossowski, Ingemar; Reunanen, Justus; Palva, Airi; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki 00790, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6708 PB Wageningen, Netherlands	University of Helsinki; Wageningen University & Research	Douillard, FP (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki 00790, Finland.	francois.douillard@helsinki.fi		von Ossowski, Ingemar Eric/0000-0002-9899-671X	Microbes Inside Program of the European Research Council [ERC 250172]; Center of Excellence in Microbial Food Safety Research of the Academy of Finland [141140]; University of Helsinki; Academy of Finland [252123]	Microbes Inside Program of the European Research Council; Center of Excellence in Microbial Food Safety Research of the Academy of Finland; University of Helsinki; Academy of Finland(Academy of Finland)	This work was supported by Grant ERC 250172 from the Microbes Inside Program of the European Research Council, Grant 141140 from the Center of Excellence in Microbial Food Safety Research of the Academy of Finland, and funds from the University of Helsinki.; Supported by Postdoctoral Research Fellowship Grant 252123 from the Academy of Finland.	Avall-Jaaskelainen S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-165; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bernardeau M, 2006, FEMS MICROBIOL REV, V30, P487, DOI 10.1111/j.1574-6976.2006.00020.x; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cozzi R, 2013, FASEB J, V27, P3144, DOI 10.1096/fj.13-227793; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; de Vos WM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S2; Dieye Y, 2010, APPL ENVIRON MICROB, V76, P7332, DOI 10.1128/AEM.00928-10; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hendrickx APA, 2010, MICROBIOL-SGM, V156, P2649, DOI 10.1099/mic.0.041392-0; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; McGrath S, 2001, APPL ENVIRON MICROB, V67, P608, DOI 10.1128/AEM.67.2.608-616.2001; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Singh D, 2013, ACTA CRYSTALLOGR F, V69, P1182, DOI 10.1107/S1744309113024676; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Swierczynski A, 2006, J BACTERIOL, V188, P6318, DOI 10.1128/JB.00606-06; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; YANAGAWA R, 1968, JPN J VET RES, V16, P31; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	58	19	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15764	15775		10.1074/jbc.M113.542332	http://dx.doi.org/10.1074/jbc.M113.542332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753244	Green Published, hybrid			2022-12-25	WOS:000337465400056
J	Doyle, JM; Katzner, TE; Bloom, PH; Ji, YZ; Wijayawardena, BK; DeWoody, JA				Doyle, Jacqueline M.; Katzner, Todd E.; Bloom, Peter H.; Ji, Yanzhu; Wijayawardena, Bhagya K.; DeWoody, J. Andrew			The Genome Sequence of a Widespread Apex Predator, the Golden Eagle (Aquila chrysaetos)	PLOS ONE			English	Article							MICROSATELLITE MARKERS; TRANSPOSABLE ELEMENTS; COLOR-VISION; HAWK-EAGLE; SIZE; EVOLUTION; CONSERVATION; ACCIPITRIDAE; POPULATION; FALCONIFORMES	Biologists routinely use molecular markers to identify conservation units, to quantify genetic connectivity, to estimate population sizes, and to identify targets of selection. Many imperiled eagle populations require such efforts and would benefit from enhanced genomic resources. We sequenced, assembled, and annotated the first eagle genome using DNA from a male golden eagle (Aquila chrysaetos) captured in western North America. We constructed genomic libraries that were sequenced using Illumina technology and assembled the high-quality data to a depth of similar to 40x coverage. The genome assembly includes 2,552 scaffolds >10 Kb and 415 scaffolds >1.2 Mb. We annotated 16,571 genes that are involved in myriad biological processes, including such disparate traits as beak formation and color vision. We also identified repetitive regions spanning 92 Mb (similar to 6% of the assembly), including LINES, SINES, LTR-RTs and DNA transposons. The mitochondrial genome encompasses 17,332 bp and is similar to 91% identical to the Mountain Hawk-Eagle (Nisaetus nipalensis). Finally, the data reveal that several anonymous microsatellites commonly used for population studies are embedded within protein-coding genes and thus may not have evolved in a neutral fashion. Because the genome sequence includes similar to 800,000 novel polymorphisms, markers can now be chosen based on their proximity to functional genes involved in migration, carnivory, and other biological processes.	[Doyle, Jacqueline M.; Ji, Yanzhu; Wijayawardena, Bhagya K.; DeWoody, J. Andrew] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Wijayawardena, Bhagya K.; DeWoody, J. Andrew] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Katzner, Todd E.] W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA; [Katzner, Todd E.] USDA, Forest Serv, No Res Stn, Parsons, WV USA; [Bloom, Peter H.] Western Fdn Vertebrate Zool, Camarillo, CA USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; West Virginia University; United States Department of Agriculture (USDA); United States Forest Service	Doyle, JM (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	jmdoyle@purdue.edu	DeWoody, James Andrew/C-4909-2008	DeWoody, James Andrew/0000-0002-7315-5631; Katzner, Todd/0000-0003-4503-8435	U.S. Bureau of Land Management [L12AC20102, L11PX02237, L12AC2010]; California Department of Fish and Wildlife [P1182024]; Provost's Office at Purdue University (University Faculty Scholar program)	U.S. Bureau of Land Management; California Department of Fish and Wildlife; Provost's Office at Purdue University (University Faculty Scholar program)	This work was supported by the U.S. Bureau of Land Management (award numbers L12AC20102, L11PX02237, and L12AC2010), the California Department of Fish and Wildlife (Agreement #P1182024), and the Provost's Office at Purdue University (University Faculty Scholar program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2011, CONSERV GENET, V12, P413, DOI 10.1007/s10592-010-0148-y; Andrews CB, 2009, GENOME, V52, P261, DOI 10.1139/G09-003; Backstrom N, 2006, BIOL LETTERS, V2, P435, DOI 10.1098/rsbl.2006.0507; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; Bloom Peter H., 2007, P193; Bourke BP, 2006, MOL ECOL NOTES, V6, P1047, DOI 10.1111/j.1471-8286.2006.01429.x; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Busch JD, 2005, MOL ECOL NOTES, V5, P39, DOI 10.1111/j.1471-8286.2004.00823.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; DeWoody JA, 2013, MOL ECOL RESOUR, V13, P551, DOI 10.1111/1755-0998.12107; Doyle J., 2013, GENOME, V56, P1; Eaton MA, 2007, BIRD STUDY, V54, P212, DOI 10.1080/00063650709461477; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory T. R., 2013, ANIMAL GENOME SIZE D; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hailer F, 2005, MOL ECOL NOTES, V5, P938, DOI 10.1111/j.1471-8286.2005.01122.x; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Harvey CJ, 2012, ESTUAR COAST, V35, P821, DOI 10.1007/s12237-012-9483-1; Heinsohn R, 2007, ANIM BEHAV, V74, P1047, DOI 10.1016/j.anbehav.2007.01.026; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hirai M, 2010, CONSERV GENET RESOUR, V2, P113, DOI 10.1007/s12686-010-9226-1; Hoffman SW, 2003, CONDOR, V105, P397, DOI 10.1650/7146; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Katzner T, 2013, ANIM CONSERV, V16, P367, DOI 10.1111/acv.12067; Kerley LL, 2013, J RAPTOR RES, V47, P328; Kochert MN, 2002, J RAPTOR RES, V36, P32; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krishan A, 2005, CYTOM PART A, V65A, P26, DOI 10.1002/cyto.a.20130; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lerat E, 2010, HEREDITY, V104, P520, DOI 10.1038/hdy.2009.165; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Lewis S.E., 2002, GENOME BIOL, V3, pRESEARCH0082, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lind O, 2013, J EXP BIOL, V216, P1819, DOI 10.1242/jeb.082834; Lohse M, 2013, NUCL ACIDS RES; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Makalowski W, 2012, METHODS MOL BIOL, V855, P337, DOI 10.1007/978-1-61779-582-4_12; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Martinez-Cruz B, 2002, MOL ECOL NOTES, V2, P323, DOI 10.1046/j.1471-8286.2002.00231.x; Mooney N., 1991, Tasforests, V3, P15; MORIN PA, 1993, PRIMATES, V34, P347, DOI 10.1007/BF02382630; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Nadjafzadeh M, 2013, J WILDLIFE MANAGE, V77, P48, DOI 10.1002/jwmg.440; Nekrutenko A, 2000, GENOME RES, V10, P1986, DOI 10.1101/gr.10.12.1986; Nevitt G, 2004, J EXP BIOL, V207, P3537, DOI 10.1242/jeb.01198; Nevitt GA, 2005, BIOL LETT-UK, V1, P303, DOI 10.1098/rsbl.2005.0350; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Oka T, 2001, PRIMATES, V42, P67, DOI 10.1007/BF02640690; Oleksyk TK, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-14; OLENDORFF RR, 1976, AM MIDL NAT, V95, P231, DOI 10.2307/2424254; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Parrish JK, 2001, ECOL APPL, V11, P1858, DOI 10.2307/3061101; Peterson DG, 1994, CHROMOSOME RES, V2, P153, DOI 10.1007/BF01553494; Qin XM, 2013, MITOCHONDR DNA, V24, P255, DOI 10.3109/19401736.2012.752484; Qu YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3071; Rands CM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-95; Rasch E, 1985, ADV MICROSCOPY, P137; Rudnick JA, 2005, MOL ECOL, V14, P2959, DOI 10.1111/j.1365-294X.2005.02641.x; Rudnick JA, 2008, CONSERV GENET, V9, P667, DOI 10.1007/s10592-007-9397-9; Saha S., 2008, Tropical Plant Biology, V1, P85, DOI 10.1007/s12042-007-9007-5; Sambrook J, 2001, MOL CLONING LAB MANU; Seabury CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062415; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smit A., REPEATMASKER OPEN 3; Smit AFA., REPEATMODELER OPEN 1; Smith Jeff P., 2008, P217; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Suryan RM, 2006, PROG OCEANOGR, V68, P303, DOI 10.1016/j.pocean.2006.02.006; Thiel T, 2002, MISA MICROSATELLITE; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; Tingay R., 2010, EAGLE WATCHERS OBSER; VENTURINI G, 1986, COMP BIOCHEM PHYS B, V85, P61, DOI 10.1016/0305-0491(86)90221-X; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Watson J., 2010, GOLDEN EAGLE, V2; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Young Jr. D.P., 2003, COMP AVIAN RESPONSES; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588	89	40	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95599	10.1371/journal.pone.0095599	http://dx.doi.org/10.1371/journal.pone.0095599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759626	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200068
J	Mayzel, B; Aizenberg, J; Ilan, M				Mayzel, Boaz; Aizenberg, Joanna; Ilan, Micha			The Elemental Composition of Demospongiae from the Red Sea, Gulf of Aqaba	PLOS ONE			English	Article							SPONGE MICROCIONA-PROLIFERA; MARINE SPONGE; MEDITERRANEAN SPONGE; TRACE-METALS; BIOLOGICAL PRODUCTION; FLORIDA PANHANDLE; CELL-AGGREGATION; ZINC TOXICITY; HEAVY-METALS; CADMIUM	Trace elements are vital for the growth and development of all organisms. Little is known about the elemental content and trace metal biology of Red Sea demosponges. This study establishes an initial database of sponge elemental content. It provides the necessary foundation for further research of the mechanisms used by sponges to regulate the uptake, accumulation, and storage of metals. The metal content of 16 common sponge species was determined using ICP measurements. A combination of statistical methods was used to determine the correlations between the metals and detect species with significantly high or low concentrations of these metals. Bioaccumulation factors were calculated to compare sponge metal content to local sediment. Theonella swinhoei contained an extremely high concentration of arsenic and barium, much higher (at least 200 times) than all other species and local sediment. Hyrtios erecta had significantly higher concentration of Al, Cr, Fe, Mn, Ti and V than all other species. This is due to sediment accumulation and inclusion in the skeleton fibers of this sponge species. Suberites clavatus was found to contain significantly higher concentration of Cd, Co, Ni and Zn than all other species and local sediment, indicating active accumulation of these metals. It also has the second highest Fe concentration, but without the comparably high concentrations of Al, Mn and Ti that are evident in H. erecta and in local sediment. These differences indicate active uptake and accumulation of Fe in S. clavatus, this was also noted in Niphates rowi. A significantly higher B concentration was found in Crella cyatophora compared to all other species. These results indicate specific roles of trace elements in certain sponge species that deserve further analysis. They also serve as a baseline to monitor the effects of anthropogenic disturbances on Eilat's coral reefs.	[Mayzel, Boaz; Ilan, Micha] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Aizenberg, Joanna] Harvard Univ, Sch Engn & Appl Sci, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Tel Aviv University; Harvard University	Mayzel, B (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel.	bmayzel@gmail.com	Ilan, Micha/ABG-4106-2020	Ilan, Micha/0000-0002-4188-4573	US-Israel Binational Science Foundation [2003340]	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This research was funded by US-Israel Binational Science Foundation grant No. 2003340 (http://www.bsf.org.il/BSFPublic/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUHILAL A, 1993, MAR POLLUT BULL, V26, P85, DOI 10.1016/0025-326X(93)90096-3; Albag O, 2011, THESIS TEL AVIV U; Ali AHAM, 2011, HELGOLAND MAR RES, V65, P67, DOI 10.1007/s10152-010-0202-7; Araujo MF, 2003, X-RAY SPECTROM, V32, P428, DOI 10.1002/xrs.660; Araujo MF, 1999, CHEM SPEC BIOAVAILAB, V11, P25, DOI 10.3184/095422999782775735; Bargagli R, 1996, POLAR BIOL, V16, P513; Bavestrello G, 1998, BIOL BULL, V195, P120, DOI 10.2307/1542819; Bowen VT, 1951, J MAR RES, V10, P1; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; BRULAND KW, 1991, LIMNOL OCEANOGR, V36, P1555, DOI 10.4319/lo.1991.36.8.1555; BRULAND KW, 1980, EARTH PLANET SC LETT, V47, P176, DOI 10.1016/0012-821X(80)90035-7; Burns E, 2003, MAR ECOL PROG SER, V252, P115, DOI 10.3354/meps252115; CAPON RJ, 1993, EXPERIENTIA, V49, P263, DOI 10.1007/BF01923536; Cebrian E, 2006, ENVIRON POLLUT, V141, P452, DOI 10.1016/j.envpol.2005.08.070; Cebrian E, 2003, MAR POLLUT BULL, V46, P1273, DOI 10.1016/S0025-326X(03)00190-5; Cebrian E, 2007, ENVIRON TOXICOL CHEM, V26, P2430, DOI 10.1897/07-292.1; Cerrano Carlo, 2007, V28, P239; Chase Z, 2011, MAR CHEM, V126, P256, DOI 10.1016/j.marchem.2011.06.005; Chen Y, 2008, J GEOPHYS RES, V113; de Cook S.C., 2002, SYSTEMA PORIFERA GUI, P1028, DOI [10.1007/978-1-4615-0747-5, DOI 10.1007/978-1-4615-0747-5]; DEHAIRS F, 1987, BIOGEOCHEMISTRY, V4, P119, DOI 10.1007/BF02180151; Ellwood MJ, 2007, LIMNOL OCEANOGR, V52, P1865, DOI 10.4319/lo.2007.52.5.1865; Ellwood MJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019648; Esteves A, 2006, NICKEL BIOMAGNIFICAT, P115; Fox HM, 1931, P R SOC LOND B-CONTA, V108, P157, DOI 10.1098/rspb.1931.0028; FRANCIS JC, 1988, T AM MICROSC SOC, V107, P67, DOI 10.2307/3226409; FURST MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P1, DOI 10.1016/0016-7037(81)90260-X; Genta-Jouve G, 2012, CHEMOSPHERE, V89, P340, DOI 10.1016/j.chemosphere.2012.04.052; Guan LL, 2001, BIOCHEM BIOPH RES CO, V283, P976, DOI 10.1006/bbrc.2001.4890; Hadas E, 2006, LIMNOL OCEANOGR, V51, P1548, DOI 10.4319/lo.2006.51.3.1548; HANSEN IV, 1995, MAR POLLUT BULL, V31, P133, DOI 10.1016/0025-326X(94)00228-2; Herut B, 2004, PRELIMINARY SCREENIN; Mayzel B, 2012, THESIS TEL AVIV U; Meroz-Fine E, 2005, MAR BIOL, V147, P243, DOI 10.1007/s00227-004-1532-2; Morel F.M.M., 2003, TREATISE GEOCHEMISTR, P113, DOI [10.1016/B0-08-043751-6/06108-9, DOI 10.1016/B0-08-043751-6/06108-9]; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Muller WEG, 2005, FEBS J, V272, P3838, DOI 10.1111/j.1742-4658.2005.04795.x; Muller WEG, 1998, MAR ECOL PROG SER, V167, P127, DOI 10.3354/meps167127; Negri A, 2006, ENVIRON POLLUT, V143, P456, DOI 10.1016/j.envpol.2005.12.005; OLESEN TME, 1994, B ENVIRON CONTAM TOX, V52, P722; OSTROM KM, 1978, DEV BIOL, V64, P332, DOI 10.1016/0012-1606(78)90083-0; Pan K, 2011, MAR POLLUT BULL, V62, P1140, DOI 10.1016/j.marpolbul.2011.02.043; Park M, 2005, CELL CYCLE, V4, P24, DOI 10.4161/cc.4.1.1394; PATEL B, 1985, SCI TOTAL ENVIRON, V41, P143, DOI 10.1016/0048-9697(85)90184-6; PATEL B, 1985, PROC R SOC SER B-BIO, V224, P23, DOI 10.1098/rspb.1985.0019; Pena MMO, 1999, J NUTR; Perez T, 2005, MAR POLLUT BULL, V50, P301, DOI 10.1016/j.marpolbul.2004.11.001; Philp RB, 2003, ARCH ENVIRON CON TOX, V44, P218, DOI 10.1007/s00244-002-2028-z; Philp RB, 1999, COMP BIOCHEM PHYS C, V124, P41, DOI 10.1016/S0742-8413(99)00046-8; Philp RB, 2001, ARCH ENVIRON CON TOX, V41, P282, DOI 10.1007/s002440010250; PRICE NM, 1990, NATURE, V344, P658, DOI 10.1038/344658a0; Rezanka T, 2008, PHYTOCHEMISTRY, V69, P585, DOI 10.1016/j.phytochem.2007.09.018; Schroder HC, 2007, SILICATEINS SILICASE, P581; Shaked Y, 2010, NMP ANN REPORT 2009; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Sunda WG, 1996, LIMNOL OCEANOGR, V41, P373, DOI 10.4319/lo.1996.41.3.0373; Tompkins-MacDonald GJ, 2009, J EXP BIOL, V212, P761, DOI 10.1242/jeb.026971; Turon X, 1997, J EXP ZOOL, V278, P22, DOI 10.1002/(SICI)1097-010X(19970501)278:1<22::AID-JEZ3>3.0.CO;2-8; Vinogradov AP., 1953, ELEMENTARY CHEM COMP; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Wagner C, 1998, MAR BIOL, V131, P411, DOI 10.1007/s002270050334; Webster NS, 2001, ENVIRON MICROBIOL, V3, P19, DOI 10.1046/j.1462-2920.2001.00155.x; Yamaoka Y, 2001, APPL ORGANOMET CHEM, V15, P261, DOI 10.1002/aoc.135; Yamaoka Y, 2006, APPL ORGANOMET CHEM, V20, P545, DOI 10.1002/aoc.1060; Youssef DH, 2011, ENVIRON MONIT ASSESS, V180, P229, DOI 10.1007/s10661-010-1784-x	66	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95775	10.1371/journal.pone.0095775	http://dx.doi.org/10.1371/journal.pone.0095775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759635	Green Published, gold			2022-12-25	WOS:000335298200088
J	Ramachandran, PS; Bhattarai, S; Singh, P; Boudreau, RL; Thompson, S; LaSpada, AR; Drack, AV; Davidson, BL				Ramachandran, Pavitra S.; Bhattarai, Sajag; Singh, Pratibha; Boudreau, Ryan L.; Thompson, Stewart; LaSpada, Albert R.; Drack, Arlene V.; Davidson, Beverly L.			RNA Interference-Based Therapy for Spinocerebellar Ataxia Type 7 Retinal Degeneration	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; CONE-ROD DYSTROPHY; MOUSE MODEL; MUTANT ATAXIN-7; IN-VIVO; PHOTORECEPTOR CELLS; RIBOZYME RESCUE; TRANSGENIC MICE; RAT MODEL; SCA7	Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant neurodegenerative disease characterized by loss of motor coordination and retinal degeneration with no current therapies in the clinic. The causative mutation is an expanded CAG repeat in the ataxin-7 gene whose mutant protein product causes cerebellar and brainstem degeneration and retinal cone-rod dystrophy. Here, we reduced the expression of both mutant and wildtype ataxin-7 in the SCA7 mouse retina by RNA interference and evaluated retinal function 23 weeks post injection. We observed a preservation of normal retinal function and no adverse toxicity with >= 50% reduction of mutant and wildtype ataxin-7 alleles. These studies address an important safety concern regarding non-allele specific silencing of ataxin-7 for SCA7 retinal therapy.	[Ramachandran, Pavitra S.; Davidson, Beverly L.] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Bhattarai, Sajag; Singh, Pratibha; Thompson, Stewart; Drack, Arlene V.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Boudreau, Ryan L.; Davidson, Beverly L.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [LaSpada, Albert R.] Univ Calif San Diego, Dept Pediat, Inst Genom Med, La Jolla, CA 92093 USA; [LaSpada, Albert R.] Univ Calif San Diego, Dept Cellular & Mol Med, Inst Genom Med, La Jolla, CA 92093 USA; [LaSpada, Albert R.] Univ Calif San Diego, Dept Neurosci, Inst Genom Med, La Jolla, CA 92093 USA; [LaSpada, Albert R.] Univ Calif San Diego, Div Biol Sci, Inst Genom Med, La Jolla, CA 92093 USA; [LaSpada, Albert R.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA; [Davidson, Beverly L.] Univ Iowa, Dept Neurol, Iowa City, IA USA; [Davidson, Beverly L.] Univ Iowa, Dept Physiol & Biophys, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Iowa; University of Iowa	Davidson, BL (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	beverly-davidson@uiowa.edu	La Spada, Albert/AAG-8809-2020	Boudreau, Ryan/0000-0002-9800-5349; Davidson, Beverly/0000-0002-3715-6290; Thompson, Stewart/0000-0003-4784-8386; Drack, Arlene/0000-0002-8195-8426	National Ataxia Foundation; Roy J Carver Trust; National Institutes of Health [R01 HD44093, P01 NS50210, R21 NS082112, R01 EY014061]; Foundation Fighting Blindness; Research to Prevent Blindness; Hope for Vision; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044093] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014061] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS082112, P01NS050210] Funding Source: NIH RePORTER	National Ataxia Foundation; Roy J Carver Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hope for Vision; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Ataxia Foundation (BLD and PSR), the Roy J Carver Trust (BLD), the National Institutes of Health (R01 HD44093 and P01 NS50210 to BLD; R21 NS082112 and R01 EY014061 to ARL) and Foundation Fighting Blindness (AVD), Research to Prevent Blindness (AVD), Hope for Vision (AVD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2002, EXP EYE RES, V74, P737, DOI 10.1006/exer.2002.1169; Askou AL, 2012, J GENE MED, V14, P632, DOI 10.1002/jgm.2678; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Boudreau RL, 2012, METHOD ENZYMOL, V507, P275, DOI 10.1016/B978-0-12-386509-0.00014-4; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Busskamp V, 2012, GENE THER, V19, P169, DOI 10.1038/gt.2011.155; Chadderton N, 2009, MOL THER, V17, P593, DOI 10.1038/mt.2008.301; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; DRACK AV, 1992, ARCH OPHTHALMOL-CHIC, V110, P712, DOI 10.1001/archopht.1992.01080170134041; Ehlert EM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-20; Furrer SA, 2013, HUM MOL GENET, V22, P890, DOI 10.1093/hmg/dds495; Furrer SA, 2011, J NEUROSCI, V31, P16269, DOI 10.1523/JNEUROSCI.4000-11.2011; Garg SJ, 2013, CURR OPIN OPHTHALMOL, V24, P407, DOI 10.1097/ICU.0b013e328363829b; Georgiadis A, 2010, GENE THER, V17, P486, DOI 10.1038/gt.2009.162; Hnik Peter, 2009, J Diabetes Sci Technol, V3, P924; Johansson J, 1998, HUM MOL GENET, V7, P171, DOI 10.1093/hmg/7.2.171; Kahle JJ, 2011, HUM MOL GENET, V20, P510, DOI 10.1093/hmg/ddq496; Keiser MS, 2014, MOL THER, V22, P588, DOI 10.1038/mt.2013.279; Keiser MS, 2013, NEUROBIOL DIS, V56, P6, DOI 10.1016/j.nbd.2013.04.003; Khodr CE, 2011, BRAIN RES, V1395, P94, DOI 10.1016/j.brainres.2011.04.036; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; Lennox KA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.46; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Martin JN, 2011, GENE THER, V18, P666, DOI 10.1038/gt.2011.10; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McLoughlin HS, 2012, NEUROSCIENCE, V223, P285, DOI 10.1016/j.neuroscience.2012.08.009; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Robinson GS, 1996, P NATL ACAD SCI USA, V93, P4851, DOI 10.1073/pnas.93.10.4851; Rodriguez-Lebron E, 2013, MOL THER, V21, P1909, DOI 10.1038/mt.2013.152; Tam LCS, 2010, ADV EXP MED BIOL, V664, P559, DOI 10.1007/978-1-4419-1399-9_64; Tang RH, 2012, CLIN EXP OPHTHALMOL, V40, P503, DOI 10.1111/j.1442-9071.2011.02683.x; Thomas BB, 2004, J NEUROSCI METH, V138, P7, DOI 10.1016/j.jneumeth.2004.03.007; Turchinovich A, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-25; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; Wilkinson-Berka JL, 2007, MOL VIS, V13, P1529; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491	42	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95362	10.1371/journal.pone.0095362	http://dx.doi.org/10.1371/journal.pone.0095362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759684	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200049
J	Xu, TF; Zhao, XC; Jiao, YT; Wei, JY; Wang, L; Xu, Y				Xu, Teng-Fei; Zhao, Xiao-Chen; Jiao, Yun-Tong; Wei, Jin-Yu; Wang, Lan; Xu, Yan			A Pathogenesis Related Protein, VpPR-10.1, from Vitis pseudoreticulata: An Insight of Its Mode of Antifungal Activity	PLOS ONE			English	Article							WESTERN WHITE-PINE; BIRCH POLLEN ALLERGEN; BET V 1; PR-10 PROTEIN; PROTEOMIC ANALYSIS; MOLECULAR-CLONING; FROST HARDINESS; MAJOR ALLERGEN; PR PROTEINS; GENE	Previously, VpPR-10.1 was isolated and characterized from a cDNA library of a fungus-resistant accession of Chinese wild grape (Vitis pseudoreticulata). We found that expression of VpPR-10.1 is affected by the fungal pathogen Erysiphe necator. To investigate the biochemical basis of the nuclease activity of VpPR-10.1 and its role in antifungal resistance, we generated recombinant VpPR-10.1 as well as site-directed mutations targeting three conserved amino acid residues among plant PR-10 s: Lys55, Glu149, and Tyr151. We showed that wild-type recombinant VpPR-10.1 exhibits both RNase and DNase activities. Mutant VpPR10.1-Y151H essentially retained all these activities. In contrast, VpPR10.1-K55N, where Lys55 in the P-loop region is mutated to Asn, and VpPR10.1-E149G, where Glu149 is mutated to Gly, lost their nuclease activity, indicating that both residues play a critical role in catalyzing RNA and DNA degradation. Furthermore, VpPR10.1 and VpPR10.1-Y151H inhibited the growth of the cultured fungal pathogen Alternaria alternate. Through transient expression in grapevine, we also demonstrated that VpPR10.1-K55N and VpPR10.1-E149G compromised resistance to E. necator. Finally, we further found that VpPR-10.1 can lead to programmed cell death and DNA degradation when incubated with tobacco BY-2 suspension cells. We show here that Lys55 and Glu149, but not Tyr151, are required for the RNase, DNase and antifungal activities of VpPR-10.1. The strong correlation between the level of VpPR-10.1 nuclease activity and its antifungal property indicates that the former is the biochemical basis for the latter. Taken together, our experiments revealed that VpPR-10.1 is critical in mediating fungal resistance in grape, potentially playing a dual role by degrading pathogen RNA and inducing programmed death of host cells.	[Xu, Teng-Fei; Jiao, Yun-Tong; Wei, Jin-Yu; Wang, Lan; Xu, Yan] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Xu, Teng-Fei; Jiao, Yun-Tong; Wei, Jin-Yu; Wang, Lan; Xu, Yan] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Xu, Teng-Fei; Jiao, Yun-Tong; Wei, Jin-Yu; Wang, Lan; Xu, Yan] Minist Agr, Key Lab Hort Plant Biol & Germplasm Innovat North, Yangling, Shaanxi, Peoples R China; [Zhao, Xiao-Chen] Shandong Seed Grp Co LTD, Jinan, Shandong, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Xu, Y (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	yan.xu@nwsuaf.edu.cn			National Natural Science Foundation of China [31272125]; Program for Young Talents in Northwest AF University [NCET-10-0692, QN2011052]; "948'' Program Ministry of Agriculture, China [2011-G21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Young Talents in Northwest AF University; "948'' Program Ministry of Agriculture, China	This work was supported by the National Natural Science Foundation of China (Grant No. 31272125), the Program for Young Talents in Northwest A&F University to Yan Xu (NCET-10-0692, QN2011052), and the "948'' Program Ministry of Agriculture, China (grant No. 2011-G21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APOLD J, 1981, INT ARCH ALLER A IMM, V64, P439, DOI 10.1159/000232724; Asif MH, 2000, PLANT MOL BIOL REP, V18, P109, DOI 10.1007/BF02824018; Atkinson RG, 1996, NEW ZEAL J CROP HORT, V24, P103, DOI 10.1080/01140671.1996.9513941; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; Biesiadka J, 2002, J MOL BIOL, V319, P1223, DOI 10.1016/S0022-2836(02)00385-6; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; Breda C, 1996, MOL PLANT MICROBE IN, V9, P713, DOI 10.1094/MPMI-9-0713; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733; Castro AJ, 2005, J EXP BOT, V56, P2783, DOI 10.1093/jxb/eri271; CHANG MM, 1993, AM POTATO J, V70, P635, DOI 10.1007/BF02849153; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; CONSTABEL CP, 1995, MOL PLANT MICROBE IN, V8, P104, DOI 10.1094/MPMI-8-0104; DARVILL AG, 1984, ANNU REV PLANT PHYS, V35, P243, DOI 10.1146/annurev.pp.35.060184.001331; DESPRES C, 1995, PLANT CELL, V7, P589, DOI 10.1105/tpc.7.5.589; Dubos C, 2001, J EXP BOT, V52, P1143, DOI 10.1093/jexbot/52.358.1143; EKRAMODDOULLAH AKM, 1995, CAN J FOREST RES, V25, P1137, DOI 10.1139/x95-126; Ekramoddoullah AKM, 1998, CAN J FOREST RES, V28, P412, DOI 10.1139/cjfr-28-3-412; ESNAULT R, 1993, MOL PLANT MICROBE IN, V6, P655, DOI 10.1094/MPMI-6-655; Filipenko E., 2013, RUSSIAN J GENETICS A, V3, P474, DOI 10.1134/S2079059713060026; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Guan X, 2011, PROTOPLASMA, V248, P415, DOI 10.1007/s00709-010-0162-4; He MY, 2013, PROTOPLASMA, V250, P129, DOI 10.1007/s00709-012-0384-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang JC, 1997, PLANT MOL BIOL, V34, P681, DOI 10.1023/A:1005824306560; Jellouli N, 2008, J PLANT PHYSIOL, V165, P471, DOI 10.1016/j.jplph.2007.02.009; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; Kim DH, 2001, EUR J BIOCHEM, V268, P4449, DOI 10.1046/j.1432-1327.2001.02364.x; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Koistinen KM, 2002, NEW PHYTOL, V155, P381, DOI 10.1046/j.1469-8137.2002.00481.x; Koistinen KM, 2000, PLANT CELL ENVIRON, V25, P705; Koukalova B, 1997, FEBS LETT, V414, P289, DOI 10.1016/S0014-5793(97)01008-9; Lebel S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-184; Lin L, 2006, MOL BIOL REP, V33, P197, DOI 10.1007/s11033-006-0008-5; Liu JJ, 2005, PLANTA, V221, P159, DOI 10.1007/s00425-004-1428-x; Liu JJ, 2004, TREE PHYSIOL, V24, P1377, DOI 10.1093/treephys/24.12.1377; Liu JJ, 2003, PHYSIOL PLANTARUM, V119, P544, DOI 10.1046/j.1399-3054.2003.00200.x; Liu JJ, 2003, PLANT MOL BIOL, V52, P103, DOI 10.1023/A:1023930326839; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Lusso M, 1995, PHYSIOL MOL PLANT P, V47, P419, DOI 10.1006/pmpp.1995.1069; Ma WW, 2010, PLANTA, V232, P325, DOI 10.1007/s00425-010-1177-y; Maillot P, 2009, PLANT PHYSIOL BIOCH, V47, P743, DOI 10.1016/j.plaphy.2009.03.016; McGhee JD, 2001, MOL PLANT MICROBE IN, V14, P877, DOI 10.1094/MPMI.2001.14.7.877; Moons A, 1997, PLANT CELL, V9, P2243, DOI 10.1105/tpc.9.12.2243; MYLONA P, 1994, PLANT MOL BIOL, V26, P39, DOI 10.1007/BF00039518; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; PINTO MP, 1995, PLANT PHYSIOL, V109, P1345, DOI 10.1104/pp.109.4.1345; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; Poupard P, 1998, AUST J PLANT PHYSIOL, V25, P459, DOI 10.1071/PP97114; Puhringer H, 2000, PLANT SCI, V152, P35, DOI 10.1016/S0168-9452(99)00222-8; Rakwal R, 2001, PLANT SCI, V161, P469, DOI 10.1016/S0168-9452(01)00433-2; Robert N, 2001, EUR J PLANT PATHOL, V107, P249, DOI 10.1023/A:1011241001383; Santos-Rosa M, 2008, PLANT CELL REP, V27, P1053, DOI 10.1007/s00299-008-0531-z; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sikorski MM, 1999, PLANT SCI, V149, P125, DOI 10.1016/S0168-9452(99)00148-X; SOMSSICH IE, 1988, MOL GEN GENET, V213, P93, DOI 10.1007/BF00333403; Suzuki K, 1995, PLANT PHYSIOL, V119, P1465; SWOBODA I, 1995, J BIOL CHEM, V270, P2607, DOI 10.1074/jbc.270.6.2607; Swoboda I, 1996, PHYSIOL PLANTARUM, V96, P433, DOI 10.1111/j.1399-3054.1996.tb00455.x; Truesdell GM, 1997, PLANT MOL BIOL, V33, P737, DOI 10.1023/A:1005728420374; Ukaji N, 2004, PLANT CELL ENVIRON, V27, P1112, DOI 10.1111/j.1365-3040.2004.01216.x; Utriainen M, 1998, PLANT CELL ENVIRON, V21, P821, DOI 10.1046/j.1365-3040.1998.00326.x; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; WALTER MH, 1990, MOL GEN GENET, V222, P353, DOI 10.1007/BF00633840; Wang CS, 1999, PLANT MOL BIOL, V40, P807, DOI 10.1023/A:1006285028495; Wang YP, 1999, MOL PLANT MICROBE IN, V12, P410, DOI 10.1094/MPMI.1999.12.5.410; WARNER SAJ, 1994, PLANT J, V6, P31, DOI 10.1046/j.1365-313X.1994.6010031.x; WARNER SAJ, 1992, PLANT MOL BIOL, V19, P555, DOI 10.1007/BF00026782; WARNER SAJ, 1993, PLANT J, V3, P191, DOI 10.1046/j.1365-313X.1993.t01-11-00999.x; Wisniewski M, 2004, TREE PHYSIOL, V24, P339, DOI 10.1093/treephys/24.3.339; Xie YR, 2010, J PLANT PHYSIOL, V167, P121, DOI 10.1016/j.jplph.2009.07.004; Xu P, 2003, MOL PLANT MICROBE IN, V16, P467, DOI 10.1094/MPMI.2003.16.6.467; Xu TF, 2013, ACTA PHYSIOL PLANT, V35, P2355, DOI 10.1007/s11738-013-1269-y; Xu WR, 2010, PLANTA, V231, P475, DOI 10.1007/s00425-009-1062-8; Xu Y, 2010, BIOLOGIA, V65, P653, DOI 10.2478/s11756-010-0056-0; Xu YY, 1999, ANTIMICROB AGENTS CH, V43, P2256, DOI 10.1128/AAC.43.9.2256; Yamamoto M, 1997, PLANT CELL PHYSIOL, V38, P1080, DOI 10.1093/oxfordjournals.pcp.a029275; Yan QJ, 2008, PLANT PHYSIOL BIOCH, V46, P93, DOI 10.1016/j.plaphy.2007.10.002; Zhou XJ, 2002, PLANT SCI, V162, P629, DOI 10.1016/S0168-9452(02)00002-X; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	86	23	29	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95102	10.1371/journal.pone.0095102	http://dx.doi.org/10.1371/journal.pone.0095102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759805	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200033
J	Capobianco, E; Mora, A; La Sala, D; Roberti, A; Zaki, N; Badidi, E; Taranta, M; Cinti, C				Capobianco, Enrico; Mora, Antonio; La Sala, Dario; Roberti, Annalisa; Zaki, Nazar; Badidi, Elarbi; Taranta, Monia; Cinti, Caterina			Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line	PLOS ONE			English	Article							INCREASED EXPRESSION; GROWTH; TUMORIGENESIS; METHYLATION; MECHANISMS; CHROMATIN; FACTOR-1; RELAPSE; VIEWS; GENE	Understanding the molecular mechanisms underlying multi-drug resistance (MDR) is one of the major challenges in current cancer research. A phenomenon which is common to both intrinsic and acquired resistance, is the aberrant alteration of gene expression in drug-resistant cancers. Although such dysregulation depends on many possible causes, an epigenetic characterization is considered a main driver. Recent studies have suggested a direct role for epigenetic inactivation of genes in determining tumor chemo-sensitivity. We investigated the effects of the inhibition of DNA methyltransferase (DNMT) and hystone deacethylase (HDAC), considered to reverse the epigenetic aberrations and lead to the re-expression of de novo methylated genes in MDR osteosarcoma (OS) cells. Based on our analysis of the HosDXR150 cell line, we found that in order to reduce cell proliferation, co-treatment of MDR OS cells with DNMT (5-Aza-dC, DAC) and HDAC (Trichostatin A, TSA) inhibitors is more effective than relying on each treatment alone. In re-expressing epigenetically silenced genes induced by treatments, a very specific regulation takes place which suggests that methylation and de-acetylation have occurred either separately or simultaneously to determine MDR OS phenotype. In particular, functional relationships have been reported after measuring differential gene expression, indicating that MDR OS cells acquired growth and survival advantage by simultaneous epigenetic inactivation of both multiple p53-independent apoptotic signals and osteoblast differentiation pathways. Furthermore, co-treatment results more efficient in inducing the re-expression of some main pathways according to the computed enrichment, thus emphasizing its potential towards representing an effective therapeutic option for MDR OS.	[Capobianco, Enrico; Mora, Antonio] CNR, Inst Clin Physiol, Lab Integrat Syst Med, I-56100 Pisa, Italy; [Capobianco, Enrico] Univ Miami, Ctr Computat Sci, Miami, FL USA; [Mora, Antonio; Zaki, Nazar; Badidi, Elarbi] United Arab Emirates Univ, Coll Informat Technol, Al Ain, U Arab Emirates; [La Sala, Dario; Roberti, Annalisa; Taranta, Monia; Cinti, Caterina] CNR, Inst Clin Physiol, Expt Oncol Unit, Siena, Italy; [La Sala, Dario] Policlin Univ, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Roberti, Annalisa] Univ Penn, Perelman Sch Med, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Miami; United Arab Emirates University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Palermo; University of Pennsylvania; Pennsylvania Medicine	Cinti, C (corresponding author), CNR, Inst Clin Physiol, Expt Oncol Unit, Siena, Italy.	ccinti@ifc.cnr.it	Mora, Antonio/ABA-2676-2020; Zaki, Nazar/ABC-1680-2020; Roberti, Annalisa/AAB-4278-2021; Zaki, Nazar M/F-1972-2013	Mora, Antonio/0000-0003-1344-1131; Roberti, Annalisa/0000-0001-8442-7228; Zaki, Nazar M/0000-0002-6259-9843; Cinti, Caterina/0000-0001-8049-0369; Badidi, Elarbi/0000-0001-9121-8766	Consiglio Nazionale delle Ricerche (CNR); Regione Toscana; Bando Unico Ricerca e Sviluppo-Programma Operativo Regionale; Competitivita Regionale e Occupazione; Fondo Europeo di Sviluppo Regionale,; POR CReO	Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Regione Toscana(Regione Toscana); Bando Unico Ricerca e Sviluppo-Programma Operativo Regionale; Competitivita Regionale e Occupazione; Fondo Europeo di Sviluppo Regionale,; POR CReO	This work was supported by funding of Consiglio Nazionale delle Ricerche (CNR) and of Regione Toscana, Bando Unico Ricerca e Sviluppo-Programma Operativo Regionale, Competitivita Regionale e Occupazione, Fondo Europeo di Sviluppo Regionale, POR CReO FESR 2007-2013, Project acronym Title: ACTILA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EK, 2003, EXP CELL RES, V290, P177, DOI 10.1016/S0014-4827(03)00342-2; Batch C, 2004, AM J OBSTET GYNECOL, V191, P1552, DOI 10.1016/j.agoj.2004.05.025; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cain Jason E., 2013, Sarcoma, V2013, P608964, DOI 10.1155/2013/608964; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Cote GM, 2013, CURR TREAT OPTION ON, V14, P454, DOI 10.1007/s11864-013-0239-3; Cui JC, 2011, B CANCER, V98, pE62, DOI 10.1684/bdc.2011.1400; Dario LS, 2008, REV RECENT CLIN TRIA, V3, P192, DOI 10.2174/157488708785700320; Engel MA, 2010, CURR MED CHEM, V17, P3303; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Grimer RJ, 2002, J BONE JOINT SURG BR, V84B, P395, DOI 10.1302/0301-620X.84B3.12019; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Kempf-Bielack B, 2005, J CLIN ONCOL, V23, P559, DOI 10.1200/JCO.2005.04.063; Kresse SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048262; La Sala D, 2003, ONCOGENE, V22, P3518, DOI 10.1038/sj.onc.1206487; Lafleur EA, 2003, IL 12 INHIBITS METAS, P3175; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Luu HH, 2005, CANCER LETT, V229, P135, DOI 10.1016/j.canlet.2005.02.015; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Perissinotto E, 2005, CLIN CANCER RES, V11, P490; Roberti A, 2006, J CELL PHYSIOL, V207, P571, DOI 10.1002/jcp.20515; Scotlandi K, 1996, AM J PATHOL, V149, P1209; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Teodoridis JM, 2004, BIOCHEM SOC T, V32, P916, DOI 10.1042/BST0320916; Terabe M, 2006, CANCER RES, V66, P3869, DOI 10.1158/0008-5472.CAN-05-3421; Thomas D, 2006, J CELL BIOCHEM, V98, P757, DOI 10.1002/jcb.20850; Uchibori M, 2006, INT J ONCOL, V28, P33; Wagner Eric R., 2011, Sarcoma, V2011, P325238, DOI 10.1155/2011/325238; Wilting RH, 2012, DRUG RESIST UPDATE, V15, P21, DOI 10.1016/j.drup.2012.01.008	33	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95596	10.1371/journal.pone.0095596	http://dx.doi.org/10.1371/journal.pone.0095596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756038	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300058
J	Hugerth, LW; Muller, EEL; Hu, YOO; Lebrun, LAM; Roume, H; Lundin, D; Wilmes, P; Andersson, AF				Hugerth, Luisa W.; Muller, Emilie E. L.; Hu, Yue O. O.; Lebrun, Laura A. M.; Roume, Hugo; Lundin, Daniel; Wilmes, Paul; Andersson, Anders F.			Systematic Design of 18S rRNA Gene Primers for Determining Eukaryotic Diversity in Microbial Consortia	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; BACTERIAL COMMUNITIES; IDENTIFICATION; GENERATION; MAGNITUDE; FRAGMENTS; RICHNESS; PROTISTS; DYNAMICS; REVEALS	High-throughput sequencing of ribosomal RNA gene (rDNA) amplicons has opened up the door to large-scale comparative studies of microbial community structures. The short reads currently produced by massively parallel sequencing technologies make the choice of sequencing region crucial for accurate phylogenetic assignments. While for 16S rDNA, relevant regions have been well described, no truly systematic design of 18S rDNA primers aimed at resolving eukaryotic diversity has yet been reported. Here we used 31,862 18S rDNA sequences to design a set of broad-taxonomic range degenerate PCR primers. We simulated the phylogenetic information that each candidate primer pair would retrieve using paired-or single-end reads of various lengths, representing different sequencing technologies. Primer pairs targeting the V4 region performed best, allowing discrimination with paired-end reads as short as 150 bp (with 75% accuracy at genus level). The conditions for PCR amplification were optimised for one of these primer pairs and this was used to amplify 18S rDNA sequences from isolates as well as from a range of environmental samples which were then Illumina sequenced and analysed, revealing good concordance between expected and observed results. In summary, the reported primer sets will allow minimally biased assessment of eukaryotic diversity in different microbial ecosystems.	[Hugerth, Luisa W.; Hu, Yue O. O.; Lundin, Daniel; Andersson, Anders F.] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden; [Muller, Emilie E. L.; Lebrun, Laura A. M.; Roume, Hugo; Wilmes, Paul] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg	Royal Institute of Technology; University of Luxembourg	Wilmes, P (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.	paul.wilmes@uni.lu; anders.andersson@scilifelab.se	Muller, Emilie/J-8727-2019; Wilmes, Paul/B-1707-2017; Hugerth, Luisa W./I-7728-2019; Andersson, Anders/J-9310-2019; Hu, Yue/AHB-2985-2022	Muller, Emilie/0000-0002-3750-2966; Wilmes, Paul/0000-0002-6478-2924; Andersson, Anders/0000-0002-3627-6899; Hu, Yue/0000-0002-2025-2198; Lundin, Daniel/0000-0002-8779-6464	Swedish Research Councils VR [2011-5689]; FORMAS [2009-1174]; Luxemburg National Research fund [ATTRACT/A09/03, CORE/11/BM/1186762, MARP-04, PRD-2011-1/SR]; Chinese Scholarship Council	Swedish Research Councils VR(Swedish Research Council); FORMAS(Swedish Research Council Formas); Luxemburg National Research fund; Chinese Scholarship Council(China Scholarship Council)	This work was funded by the Swedish Research Councils VR [grant 2011-5689], FORMAS [grant 2009-1174] and EC BONUS project BLUEPRINT partially funded by FORMAS through grants to A.F.A, the Luxemburg National Research fund [grants ATTRACT/A09/03 and CORE/11/BM/1186762 to P.W., PHD-MARP-04 to H. R. and PRD-2011-1/SR to E.M.] and the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Aguilera A, 2010, INT MICROBIOL, V13, P21, DOI 10.2436/20.1501.01.108; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Auinger BM, 2008, APPL ENVIRON MICROB, V74, P2505, DOI 10.1128/AEM.01803-07; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Bricheux G, 2013, MICROBIOLOGYOPEN, V2, P402, DOI 10.1002/mbo3.80; Cameron KA, 2012, FEMS MICROBIOL ECOL, V82, P254, DOI 10.1111/j.1574-6941.2011.01277.x; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DEHORITY BA, 1974, J PROTOZOOL, V21, P26, DOI 10.1111/j.1550-7408.1974.tb03612.x; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans TN, 2012, MICROB ECOL, V63, P773, DOI 10.1007/s00248-011-9984-7; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Forsberg AM, 2012, SCAND J GASTROENTERO, V47, P184, DOI 10.3109/00365521.2011.647062; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068278; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Mshvildadze M, 2011, EARLY HUM DEV, V87, P511; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Okamoto N, 2005, PROTIST, V156, P163, DOI 10.1016/j.protis.2004.12.003; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Orsi W, 2011, ISME J, V5, P1357, DOI 10.1038/ismej.2011.7; PACE NR, 1985, ASM NEWS, V51, P4; Paez-Rubio T, 2005, APPL ENVIRON MICROB, V71, P804, DOI 10.1128/AEM.71.2.804-810.2005; Pandey PK, 2012, J BIOSCIENCES, V37, P221, DOI 10.1007/s12038-012-9197-3; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quince C, 2013, GUT, V62, P952, DOI 10.1136/gutjnl-2012-304214; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Roume H, 2013, ISME J, V7, P110, DOI 10.1038/ismej.2012.72; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; SOGIN ML, 1987, ANN NY ACAD SCI, V503, P125, DOI 10.1111/j.1749-6632.1987.tb40603.x; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Weber SD, 1997, APPL ENVIRON MICROB, V73, P6233; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	64	140	141	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							095567	10.1371/journal.pone.0095567	http://dx.doi.org/10.1371/journal.pone.0095567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755918	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300054
J	Stein, ED; Martinez, MC; Stiles, S; Miller, PE; Zakharov, EV				Stein, Eric D.; Martinez, Maria C.; Stiles, Sara; Miller, Peter E.; Zakharov, Evgeny V.			Is DNA Barcoding Actually Cheaper and Faster than Traditional Morphological Methods: Results from a Survey of Freshwater Bioassessment Efforts in the United States?	PLOS ONE			English	Article							BIOTIC INTEGRITY; MACROINVERTEBRATES; BIODIVERSITY; PERFORMANCE; INDEX	Taxonomic identification accounts for a substantial portion of cost associated with bioassessment programs across the United States. New analytical approaches, such as DNA barcoding have been promoted as a way to reduce monitoring costs and improve efficiency, yet this assumption has not been thoroughly evaluated. We address this question by comparing costs for traditional morphology-based bioassessment, the standard Sanger sequencing-based DNA barcoding approach, and emerging next-generation (NGS) molecular methods. Market demand for molecular approaches is also assessed through a survey of the level of freshwater bioassessment effort in the United States across multiple habitat types (lakes, streams, wetlands) and indicators (benthic invertebrates, fish, algae). All state and regional level programs administered by public agencies and reported via agency web sites were included in the survey. Costs were based on surveys of labs and programs willing to provide such information. More than 19,500 sites are sampled annually across the United States, with the majority of effort occurring in streams. Benthic invertebrates are the most commonly used indicator, but algae and fish comprise between 35% and 21% of total sampling effort, respectively. We estimate that between $104 and $193 million is spent annually on routine freshwater bioassessment in the United States. Approximately 30% of the bioassessment costs are comprised of the cost to conduct traditional morphology-based taxonomy. Current barcoding costs using Sanger sequencing are between 1.7 and 3.4 times as expensive as traditional taxonomic approaches, excluding the cost of field sampling (which is common to both approaches). However, the cost of NGS methods are comparable (or slightly less expensive) than traditional methods depending on the indicator. The promise of barcoding as a cheaper alternative to current practices is not yet realized, although molecular methods may provide other benefits, such as a faster sample processing and increased taxonomic resolution.	[Stein, Eric D.; Martinez, Maria C.; Stiles, Sara] Southern Calif Coastal Water Res Project, Costa Mesa, CA 92626 USA; [Miller, Peter E.; Zakharov, Evgeny V.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Southern California Coastal Water Research Project; University of Guelph	Stein, ED (corresponding author), Southern Calif Coastal Water Res Project, Costa Mesa, CA 92626 USA.	erics@sccwrp.org	Stein, Eric D./A-9362-2008; Zakharov, Evgeny/G-9587-2014	Stein, Eric D./0000-0002-4729-809X; Martinez, Maria Cristina/0000-0003-4956-1223	SCCWRP internal agency research funds	SCCWRP internal agency research funds	The work described in this manuscript was funded by SCCWRP internal agency research funds. These internal funds are derived from a combination of state and local agency monies that form SCCWRP's core operating budget. Our joint powers agency provided the funds required to design, implement, and conduct this study. The contributions of our co-authors from University of Guelph were funded through their internal institutional research funds.	Barbour M T, 1999, 841B99002 EPA OFF WA; Birk S, 2012, ECOL INDIC, V18, P31, DOI 10.1016/j.ecolind.2011.10.009; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; Borisenko AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/j.1755-0998.2009.02629.x; Cameron S, 2006, SYST BIOL, V55, P844, DOI 10.1080/10635150600960079; Carter J. L., 2013, 20131129 US GEOL SUR; Carter JL, 2001, J N AM BENTHOL SOC, V20, P658, DOI 10.2307/1468095; Chessman B, 2007, J N AM BENTHOL SOC, V26, P546, DOI 10.1899/06-074.1; De Mattia F, 2012, BOT J LINN SOC, V169, P518, DOI 10.1111/j.1095-8339.2012.01251.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Ode P. R., 2007, STANDARD OPERATING P; Pilgrim EM, 2011, J N AM BENTHOL SOC, V30, P217, DOI 10.1899/10-012.1; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richards AB, 2006, LIST FRESHWATER MACR; Ruaro R, 2013, ECOL INDIC, V29, P105, DOI 10.1016/j.ecolind.2012.12.016; Schoolmaster DR, 2013, ECOL INDIC, V26, P14, DOI 10.1016/j.ecolind.2012.10.016; Stein ED, 2014, FRESHW SCI, V33, P302, DOI 10.1086/674782; Stoeckle MY, 2008, SCI AM, V299, P82; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turak E, 2000, AUSTR WIDE ASSESSMEN; USEPA (United States Environmental Protection Agency), 2007, EPA841B07009 USEPA; USEPA (United States Environmental Protection Agency), 2002, SUMM BIOL ASS PROGR; Zhou X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1	32	84	89	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							095525	10.1371/journal.pone.0095525	http://dx.doi.org/10.1371/journal.pone.0095525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755838	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300051
J	Ding, RS; Kang, SZ; Du, TS; Hao, XM; Zhang, YQ				Ding, Risheng; Kang, Shaozhong; Du, Taisheng; Hao, Xinmei; Zhang, Yanqun			Scaling Up Stomatal Conductance from Leaf to Canopy Using a Dual-Leaf Model for Estimating Crop Evapotranspiration	PLOS ONE			English	Article							IRRIGATED MAIZE FIELD; TRANSPIRATION; PHOTOSYNTHESIS; EVAPORATION; SOIL; RESISTANCE; VEGETATION; CLIMATE; LEAVES	The dual-source Shuttleworth-Wallace model has been widely used to estimate and partition crop evapotranspiration (lambda ET). Canopy stomatal conductance (G(sc)), an essential parameter of the model, is often calculated by scaling up leaf stomatal conductance, considering the canopy as one single leaf in a so-called ''big-leaf'' model. However, G(sc) can be overestimated or underestimated depending on leaf area index level in the big-leaf model, due to a non-linear stomatal response to light. A dual-leaf model, scaling up Gsc from leaf to canopy, was developed in this study. The non-linear stomata-light relationship was incorporated by dividing the canopy into sunlit and shaded fractions and calculating each fraction separately according to absorbed irradiances. The model includes: (1) the absorbed irradiance, determined by separately integrating the sunlit and shaded leaves with consideration of both beam and diffuse radiation; (2) leaf area for the sunlit and shaded fractions; and (3) a leaf conductance model that accounts for the response of stomata to PAR, vapor pressure deficit and available soil water. In contrast to the significant errors of G(sc) in the big-leaf model, the predicted G(sc) using the dual-leaf model had a high degree of data-model agreement; the slope of the linear regression between daytime predictions and measurements was 1.01 (R-2 = 0.98), with RMSE of 0.6120 mm s(-1) 21 for four clear-sky days in different growth stages. The estimates of half-hourly lambda ET using the dual-source dual-leaf model (DSDL) agreed well with measurements and the error was within 5% during two growing seasons of maize with differing hydrometeorological and management strategies. Moreover, the estimates of soil evaporation using the DSDL model closely matched actual measurements. Our results indicate that the DSDL model can produce more accurate estimation of G(sc) and lambda ET, compared to the big-leaf model, and thus is an effective alternative approach for estimating and partitioning lambda ET.	[Ding, Risheng; Kang, Shaozhong; Du, Taisheng; Hao, Xinmei] China Agr Univ, Ctr Agr Water Res China, Beijing 100094, Peoples R China; [Zhang, Yanqun] China Inst Water Resources & Hydropower Res, Natl Ctr Efficient Irrigat Engn & Technol Res Bei, Beijing, Peoples R China	China Agricultural University; China Institute of Water Resources & Hydropower Research	Kang, SZ (corresponding author), China Agr Univ, Ctr Agr Water Res China, Beijing 100094, Peoples R China.	kangsz@cau.edu.cn	kang, Shaozhong/C-5434-2011; Ding, Risheng/AFW-3839-2022; Ding, Risheng/AFP-4581-2022	Ding, Risheng/0000-0001-8565-7623; Ding, Risheng/0000-0001-8565-7623	National Natural Science Foundation of China [51321001, 51309223]; National High-Tech Research and Development Program [2011AA100502, 2013AA102904]; Ph. D. Programs Foundation of Ministry of Education of China [20130008120007]; Introducing Talents of Discipline to Universities [B14002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China); Ph. D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This research was partially supported by the National Natural Science Foundation of China (51321001 and 51309223), the National High-Tech Research and Development Program (2011AA100502 and 2013AA102904) and the Ph. D. Programs Foundation of Ministry of Education of China (20130008120007). The research is also supported by the Program of Introducing Talents of Discipline to Universities (B14002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, 56 FAO, P300; Baldocchi D, 1998, AGR FOREST METEOROL, V90, P1, DOI 10.1016/S0168-1923(97)00072-5; Brutsaert W., 2013, EVAPORATION ATMOSPHE; Campbell GS., 1998, INTRO ENV BIOPHYSICS, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; dePury DGG, 1997, PLANT CELL ENVIRON, V20, P537, DOI 10.1111/j.1365-3040.1997.00094.x; Ding R., 2014, HYDROL PROCESS; Ding RS, 2013, AGR WATER MANAGE, V127, P85, DOI 10.1016/j.agwat.2013.05.018; Ding RS, 2013, AGR FOREST METEOROL, V168, P140, DOI 10.1016/j.agrformet.2012.08.003; Ding RS, 2010, AGR WATER MANAGE, V98, P87, DOI 10.1016/j.agwat.2010.08.001; Er-Raki S, 2010, AGR WATER MANAGE, V97, P1769, DOI 10.1016/j.agwat.2010.06.009; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Hou XY, 2010, AGR FOREST METEOROL, V150, P115, DOI 10.1016/j.agrformet.2009.09.007; Hu ZM, 2009, AGR FOREST METEOROL, V149, P1410, DOI 10.1016/j.agrformet.2009.03.014; Irmak S, 2008, AGR FOREST METEOROL, V148, P1034, DOI 10.1016/j.agrformet.2008.02.001; Irmak S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008484; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Katerji N, 2006, AGR FOREST METEOROL, V138, P142, DOI 10.1016/j.agrformet.2006.04.006; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P1183, DOI 10.1111/j.1365-3040.1995.tb00628.x; Leuning R, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006562; Mauder M., 2004, DOCUMENTATION INSTRU; MEYERS TP, 1987, AGR FOREST METEOROL, V41, P143, DOI 10.1016/0168-1923(87)90075-X; Monteith JL., 2008, PRINCIPLES ENV PHYS, V3, P229; Norman J. M., 1979, Modification of the aerial environment of crops., P249; Pereira LS, 1999, J IRRIG DRAIN ENG, V125, P45, DOI 10.1061/(ASCE)0733-9437(1999)125:2(45); Pieruschka R, 2010, P NATL ACAD SCI USA, V107, P13372, DOI 10.1073/pnas.0913177107; Pyles RD, 2000, Q J ROY METEOR SOC, V126, P2951, DOI 10.1002/qj.49712656917; RAUPACH MR, 1988, AUST J PLANT PHYSIOL, V15, P705, DOI 10.1071/PP9880705; Ross J., 1975, VEGETATION ATMOSPHER, P13; Shuttleworth WJ, 2007, HYDROL EARTH SYST SC, V11, P210, DOI 10.5194/hess-11-210-2007; SHUTTLEWORTH WJ, 1990, Q J ROY METEOR SOC, V116, P497, DOI 10.1256/smsqj.49212; SHUTTLEWORTH WJ, 1985, Q J ROY METEOR SOC, V111, P839, DOI 10.1256/smsqj.46909; SINCLAIR TR, 1976, J APPL ECOL, V13, P813, DOI 10.2307/2402257; STEWART JB, 1988, AGR FOREST METEOROL, V43, P19, DOI 10.1016/0168-1923(88)90003-2; Sun S.F, 1982, MOISTURE HEAT TRANSP; Wang YP, 1998, AGR FOREST METEOROL, V91, P89, DOI 10.1016/S0168-1923(98)00061-6; WEISS A, 1985, AGR FOREST METEOROL, V34, P205, DOI 10.1016/0168-1923(85)90020-6; Whitley R, 2009, J HYDROL, V373, P256, DOI 10.1016/j.jhydrol.2009.04.036; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Zhang BZ, 2008, AGR FOREST METEOROL, V148, P1629, DOI 10.1016/j.agrformet.2008.05.016; Zhang BZ, 2011, AGR FOREST METEOROL, V151, P1086, DOI 10.1016/j.agrformet.2011.03.012; Zhang XY, 2011, AGR WATER MANAGE, V98, P1097, DOI 10.1016/j.agwat.2011.02.003; Zhu GF, 2013, J HYDROL, V476, P42, DOI 10.1016/j.jhydrol.2012.10.006	42	22	24	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95584	10.1371/journal.pone.0095584	http://dx.doi.org/10.1371/journal.pone.0095584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752329	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400082
J	Parganlija, D; Klinkenberg, M; Dominguez-Bautista, J; Hetzel, M; Gispert, S; Chimi, MA; Drose, S; Mai, S; Brandt, U; Auburger, G; Jendrach, M				Parganlija, Dajana; Klinkenberg, Michael; Dominguez-Bautista, Jorge; Hetzel, Miriam; Gispert, Suzana; Chimi, Marthe A.; Droese, Stefan; Mai, Soeren; Brandt, Ulrich; Auburger, Georg; Jendrach, Marina			Loss of PINK1 Impairs Stress-Induced Autophagy and Cell Survival	PLOS ONE			English	Article							PINK1-ASSOCIATED PARKINSONS-DISEASE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; DOPAMINERGIC-NEURONS; QUALITY-CONTROL; CANCER CELLS; APOPTOSIS; MITOPHAGY; PARK6; VULNERABILITY	The mitochondrial kinase PINK1 and the ubiquitin ligase Parkin are participating in quality control after CCCP- or ROS-induced mitochondrial damage, and their dysfunction is associated with the development and progression of Parkinson's disease. Furthermore, PINK1 expression is also induced by starvation indicating an additional role for PINK1 in stress response. Therefore, the effects of PINK1 deficiency on the autophago-lysosomal pathway during stress were investigated. Under trophic deprivation SH-SY5Y cells with stable PINK1 knockdown showed downregulation of key autophagic genes, including Beclin, LC3 and LAMP-2. In good agreement, protein levels of LC3-II and LAMP-2 but not of LAMP-1 were reduced in different cell model systems with PINK1 knockdown or knockout after addition of different stressors. This downregulation of autophagic factors caused increased apoptosis, which could be rescued by overexpression of LC3 or PINK1. Taken together, the PINK1-mediated reduction of autophagic key factors during stress resulted in increased cell death, thus defining an additional pathway that could contribute to the progression of Parkinson's disease in patients with PINK1 mutations.	[Parganlija, Dajana; Klinkenberg, Michael; Dominguez-Bautista, Jorge; Hetzel, Miriam; Gispert, Suzana; Auburger, Georg; Jendrach, Marina] Goethe Univ Frankfurt, Sch Med, Dept Neurol, D-60054 Frankfurt, Germany; [Chimi, Marthe A.; Droese, Stefan; Brandt, Ulrich] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, D-60054 Frankfurt, Germany; [Mai, Soeren] Goethe Univ Frankfurt, Ctr Excellence Frankfurt Macromol Complexes, Inst Cell Biol & Neurosci, Kinemat Cell Res Grp, D-60054 Frankfurt, Germany; [Droese, Stefan] Goethe Univ Hosp, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Jendrach, M (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Neurol, D-60054 Frankfurt, Germany.	jendrach@bio.uni-frankfurt.de	Dröse, Stefan/E-4903-2010; Brandt, Ulrich/C-4406-2008; Klinkenberg, Michael/AAL-5127-2021; Dominguez-Bautista, Jorge Antolio/AAZ-8471-2020; Brandt, Ulrich/GLV-1242-2022	Dröse, Stefan/0000-0002-9361-9034; Brandt, Ulrich/0000-0003-1869-6811; Klinkenberg, Michael/0000-0002-0241-4712; Dominguez-Bautista, Jorge Antolio/0000-0003-4648-0524; Brandt, Ulrich/0000-0003-1869-6811; Hetzel, Miriam/0000-0002-4568-5272	German Federal Ministry of Education (BMBF) [01GS08138]; National Genome Research Network (NGFNplus); GerontoMitoSys network (BMBF) [PTJ 0315584A]	German Federal Ministry of Education (BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network (NGFNplus); GerontoMitoSys network (BMBF)	German Federal Ministry of Education (BMBF 01GS08138), National Genome Research Network (NGFNplus), GerontoMitoSys network (BMBF PTJ 0315584A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025622; Ahmed I, 2012, J NEUROSCI, V32, P16503, DOI 10.1523/JNEUROSCI.0209-12.2012; Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Amir M, 2013, CELL DEATH DIFFER, V20, P878, DOI 10.1038/cdd.2013.21; Berthier A, 2011, HUM PATHOL, V42, P75, DOI 10.1016/j.humpath.2010.05.016; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; Choi I, 2013, GLIA, V61, P800, DOI 10.1002/glia.22475; Cui T, 2011, BRAIN RES, V1394, P1, DOI 10.1016/j.brainres.2011.01.035; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Jendrach M, 2009, J BIOENERG BIOMEMBR, V41, P481, DOI 10.1007/s10863-009-9256-0; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8; Klinkenberg M, 2010, NEUROSCIENCE, V166, P422, DOI 10.1016/j.neuroscience.2009.12.068; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lenzi P, 2012, ARCH ITAL BIOL, V150, P194, DOI 10.4449/aib.v150i2/3.1417; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Mai S, 2012, AUTOPHAGY, V8, P47, DOI 10.4161/auto.8.1.18174; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; SPIELMANN H, 1981, ANAL BIOCHEM, V113, P172, DOI 10.1016/0003-2697(81)90061-0; Strecker V, 2010, MECH AGEING DEV, V131, P48, DOI 10.1016/j.mad.2009.11.005; Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HL, 2011, BBA-MOL BASIS DIS, V1812, P674, DOI 10.1016/j.bbadis.2011.03.007; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Wu GH, 2011, BRAIN RES, V1394, P105, DOI 10.1016/j.brainres.2011.04.013; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	50	34	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95288	10.1371/journal.pone.0095288	http://dx.doi.org/10.1371/journal.pone.0095288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751806	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400049
J	Schilling, MP; Wolf, PG; Duffy, AM; Rai, HS; Rowe, CA; Richardson, BA; Mock, KE				Schilling, Martin P.; Wolf, Paul G.; Duffy, Aaron M.; Rai, Hardeep S.; Rowe, Carol A.; Richardson, Bryce A.; Mock, Karen E.			Genotyping-by-Sequencing for Populus Population Genomics: An Assessment of Genome Sampling Patterns and Filtering Approaches	PLOS ONE			English	Article							GENETIC-VARIATION; BALSAM POPLAR; SNP DISCOVERY; DIVERSITY; CONSERVATION; POLYMORPHISM; PACKAGE; ERRORS	Continuing advances in nucleotide sequencing technology are inspiring a suite of genomic approaches in studies of natural populations. Researchers are faced with data management and analytical scales that are increasing by orders of magnitude. With such dramatic advances comes a need to understand biases and error rates, which can be propagated and magnified in large-scale data acquisition and processing. Here we assess genomic sampling biases and the effects of various population-level data filtering strategies in a genotyping-by-sequencing (GBS) protocol. We focus on data from two species of Populus, because this genus has a relatively small genome and is emerging as a target for population genomic studies. We estimate the proportions and patterns of genomic sampling by examining the Populus trichocarpa genome (Nisqually-1), and demonstrate a pronounced bias towards coding regions when using the methylation-sensitive ApeKI restriction enzyme in this species. Using population-level data from a closely related species (P. tremuloides), we also investigate various approaches for filtering GBS data to retain high-depth, informative SNPs that can be used for population genetic analyses. We find a data filter that includes the designation of ambiguous alleles resulted in metrics of population structure and Hardy-Weinberg equilibrium that were most consistent with previous studies of the same populations based on other genetic markers. Analyses of the filtered data (27,910 SNPs) also resulted in patterns of heterozygosity and population structure similar to a previous study using microsatellites. Our application demonstrates that technically and analytically simple approaches can readily be developed for population genomics of natural populations.	[Schilling, Martin P.; Wolf, Paul G.; Duffy, Aaron M.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Rai, Hardeep S.; Rowe, Carol A.; Mock, Karen E.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Richardson, Bryce A.] USDA Forest Serv, Rocky Mt Res Stn, Provo, UT USA; [Schilling, Martin P.; Wolf, Paul G.; Mock, Karen E.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); United States Forest Service; Utah System of Higher Education; Utah State University	Mock, KE (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	karen.mock@usu.edu	Wolf, Paul/F-7664-2010; Schilling, Martin P/R-4309-2016; Mock, Karen E/C-1418-2011	Wolf, Paul/0000-0002-4317-6976; Schilling, Martin P/0000-0001-8880-4270; Mock, Karen E/0000-0002-8357-4434; Duffy, Aaron/0000-0003-0530-6191	USDA Forest Service Western Forest Transcriptome Survey and National Fire Plan [2012-NFP-GSD-1]	USDA Forest Service Western Forest Transcriptome Survey and National Fire Plan	This research was funded by the USDA Forest Service Western Forest Transcriptome Survey and National Fire Plan (2012-NFP-GSD-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Buerkle CA, 2013, MOL ECOL, V22, P3028, DOI 10.1111/mec.12105; Callahan CM, 2013, J BIOGEOGR, V40, P1780, DOI 10.1111/jbi.12115; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; CHELIAK WM, 1982, CAN J GENET CYTOL, V24, P611, DOI 10.1139/g82-065; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; DiFazio S. P., 2011, Genetics, genomics and breeding of poplar, P1; Ellis JS, 2011, GENETICA, V139, P353, DOI 10.1007/s10709-011-9554-4; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evans LM, 2012, CONSERV GENET, V13, P1601, DOI 10.1007/s10592-012-0409-z; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gompert Z, 2012, MOL ECOL RESOUR, V12, P1168, DOI 10.1111/1755-0998.12009.x; Gompert Z, 2010, MOL ECOL, V19, P2455, DOI 10.1111/j.1365-294X.2010.04666.x; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; JELINSKI DE, 1992, AM J BOT, V79, P728, DOI 10.2307/2444937; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Keller SR, 2011, GENETICS, V188, P941, DOI 10.1534/genetics.111.128041; Little EL, 1971, USDA MISCELLANEOUS P, V1; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; Olson MS, 2013, MOL ECOL, V22, P1214, DOI 10.1111/mec.12067; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Perala D.A., 1990, SILVICS N AM HARDWOO, P555; Phillips T, 2008, NATURE ED, V1, P116; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Rai HS, 2013, TREE GENET GENOMES, V9, P1031, DOI 10.1007/s11295-013-0615-y; Schweitzer JA, 2008, ECOSYSTEMS, V11, P1005, DOI 10.1007/s10021-008-9173-9; Slavov GT, 2010, PLANT GENET GENOMICS, V8, P15, DOI 10.1007/978-1-4419-1541-2_2; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang Y, 2013, GENOME RES, V23, P833, DOI 10.1101/gr.146084.112; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	55	26	27	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95292	10.1371/journal.pone.0095292	http://dx.doi.org/10.1371/journal.pone.0095292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748384	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500078
J	Wang, XL; Yan, Y; Li, YZ; Chu, XQ; Wu, CG; Guo, XQ				Wang, Xiuling; Yan, Yan; Li, Yuzhen; Chu, Xiaoqian; Wu, Changai; Guo, Xingqi			GhWRKY40, a Multiple Stress-Responsive Cotton WRKY Gene, Plays an Important Role in the Wounding Response and Enhances Susceptibility to Ralstonia solanacearum Infection in Transgenic Nicotiana benthamiana	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; DROUGHT TOLERANCE; PLANT-RESPONSES; ABIOTIC STRESS; SALICYLIC-ACID; DEFENSE; JASMONATE; PATHOGEN; ETHYLENE	WRKY transcription factors form one of the largest transcription factor families and function as important components in the complex signaling processes that occur during plant stress responses. However, relative to the research progress in model plants, far less information is available on the function of WRKY proteins in cotton. In the present study, we identified the GhWRKY40 gene in cotton (Gossypium hirsutum) and determined that the GhWRKY40 protein is targeted to the nucleus and is a stress-inducible transcription factor. The GhWRKY40 transcript level was increased upon wounding and infection with the bacterial pathogen Ralstonia solanacearum. The overexpression of GhWRKY40 down-regulated most of the defense-related genes, enhanced the wounding tolerance and increased the susceptibility to R. solanacearum. Consistent with a role in multiple stress responses, we found that the GhWRKY40 transcript level was increased by the stress hormones salicylic acid (SA), methyl jasmonate (MeJA) and ethylene (ET). Moreover, GhWRKY40 interacted with the MAPK kinase GhMPK20, as shown using yeast two-hybrid and bimolecular fluorescence complementation systems. Collectively, these results suggest that GhWRKY40 is regulated by SA, MeJA and ET signaling and coordinates responses to wounding and R. solanacearum attack. These findings highlight the importance of WRKYs in regulating wounding-and pathogen-induced responses.	[Wang, Xiuling; Yan, Yan; Li, Yuzhen; Chu, Xiaoqian; Wu, Changai; Guo, Xingqi] Shandong Agr Univ, State Key Lab Crop Biol, Coll Life Sci, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Guo, XQ (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Coll Life Sci, Tai An, Shandong, Peoples R China.	xqguo@sdau.edu.cn	Wu, Changai/AFF-1493-2022	Wu, Changai/0000-0003-4053-8262; Li, Yuzhen/0000-0003-4068-8316	Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-092B]; National Science Foundation of China [31171837, 30970225]	Genetically Modified Organisms Breeding Major Projects of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Genetically Modified Organisms Breeding Major Projects of China (2009ZX08009-092B) and the National Science Foundation of China (grant no. 31171837; 30970225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Chen LG, 2010, MOL PLANT MICROBE IN, V23, P558, DOI 10.1094/MPMI-23-5-0558; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; HORSCH RB, 1985, COLD SPRING HARB SYM, V50, P433, DOI 10.1101/SQB.1985.050.01.054; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Li YZ, 2013, FEBS J, V280, P5128, DOI 10.1111/febs.12488; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Shen HS, 2012, PLANT MOL BIOL, V80, P241, DOI 10.1007/s11103-012-9941-y; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang XH, 2011, MOL BIOTECHNOL, V48, P165, DOI 10.1007/s12033-010-9357-3; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144; Zhang CQ, 2011, PLANTA, V234, P541, DOI 10.1007/s00425-011-1423-y	43	46	61	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93577	10.1371/journal.pone.0093577	http://dx.doi.org/10.1371/journal.pone.0093577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747610	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500009
J	Sato, T; Goyama, S; Kataoka, K; Nasu, R; Tsuruta-Kishino, T; Kagoya, Y; Nukina, A; Kumagai, K; Kubota, N; Nakagawa, M; Arai, S; Yoshimi, A; Honda, H; Kadowaki, T; Kurokawa, M				Sato, T.; Goyama, S.; Kataoka, K.; Nasu, R.; Tsuruta-Kishino, T.; Kagoya, Y.; Nukina, A.; Kumagai, K.; Kubota, N.; Nakagawa, M.; Arai, S.; Yoshimi, A.; Honda, H.; Kadowaki, T.; Kurokawa, M.			Evil defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia	ONCOGENE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; BLAST CRISIS CML; BCR-ABL; TUMOR-SUPPRESSOR; BONE-MARROW; EXPRESSION; GENE; BETA	Relapse of chronic myeloid leukemia (CML) is triggered by stem cells with a reconstituting capacity similar to that of hematopoietic stem cells (HSCs) and CML stem cells are a source of resistance in drug therapy with tyrosine kinase inhibitors (TKIs). Ecotropic viral integration site 1 (EVI1), a key transcription factor in HSC regulation, is known to predict poor outcomes in myeloid malignancies, however, incapability of prospective isolation of EVI1-high leukemic cells precludes the functional evaluation of intraindividual EVI1-high cells. Introduction of CML into Evi1-internal ribosomal entry site (IRES)-green fluorescent protein (GFP) knock-in mice, a versatile HSC-reporter strain, enables us to separate Evi1-high CML cells from the individual. Evi1-IRES-GFP allele models of CML in chronic phase (CML-CP), by retroviral overexpression of BCR-ABL and by crossing BCR-ABL transgenic mice, revealed that Evi1 is predominantly enriched in the stem cell fraction and associated with an enhanced proliferative as well as a leukemia-initiating capacity and that Evi1-high CML-CP cells exhibit resistance to TKIs. Overexpressing BCR-ABL and NUP98-HOXA9 in Evi1-IRES-GFP knock-in mice to model CML in blast crisis (CML-BC), in which Evi1-high cells turned to be a major population as opposed to a minor population in CML-CP models, showed that Evi1-high CML-BC cells have a greater potential to recapitulate the disease and appear resistant to TKIs. Furthermore, given that Evi1 heterozygosity ameliorates CML-CP and CML-BC development and that the combination of Evi1 and BCR-ABL causes acute myeloid leukemia resembling CML-BC, Evi1 could regulate CML development as a potent driver. In addition, in human CML-CP cases, we show that EVI1 is highly expressed in stem cell-enriched CD34+ CD38-CD90+ fraction at single-cell level. This is the first report to clarify directly that Evi1-high leukemic cells themselves possess the superior potential to Evi1-low cells in oncogenic self-renewal, which highlights the role of Evi1 as a valuable and a functional marker of CML stem cells.	[Sato, T.; Goyama, S.; Kataoka, K.; Nasu, R.; Tsuruta-Kishino, T.; Kagoya, Y.; Nukina, A.; Nakagawa, M.; Arai, S.; Yoshimi, A.; Kurokawa, M.] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan; [Sato, T.] Tokyo Univ Hosp, Dept Transfus Med, Tokyo 113, Japan; [Kumagai, K.; Kubota, N.; Kadowaki, T.] Univ Tokyo, Grad Sch Med, Dept Metab & Diabet Dis, Tokyo 1138655, Japan; [Honda, H.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Hiroshima University	Kurokawa, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp	Kagoya, Yuki/AAD-9870-2019; Kataoka, Keisuke/AAS-2546-2020; Kagoya, Yuki/GQH-4875-2022; Kubota, Naoto/N-7892-2015; Yoshimi, Akihide/I-3792-2019	Kataoka, Keisuke/0000-0002-8263-9902; Yoshimi, Akihide/0000-0002-0664-7281; Sato, Tomohiko/0000-0002-8244-075X; Nakagawa, Masahiro/0000-0002-6420-2555	Japan Society for the Promotion of Science and by Health; Grants-in-Aid for Scientific Research [26860474, 24790962] Funding Source: KAKEN	Japan Society for the Promotion of Science and by Health(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Takuro Nakamura for NUP98-HOXA9; Issay Kitabayashi for MOZ-TIF2; Michael Tomasson for TEL-PDGFR/IRES/AML1-ETO; Novartis for nilotinib. We appreciate expert technical supports by Yoshi Shimamura, Yuko Sawamoto and Rumi Takizawa-Toyama. We express our heartfelt sorrow over Yuko Sawamoto's sudden passing away. This work was carried out at the Joint Usage/Research Center (RIRBM), Hiroshima University, and supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and by Health.	Arai S, 2011, BLOOD, V117, P6304, DOI 10.1182/blood-2009-07-234310; Balgobind BV, 2010, LEUKEMIA, V24, P942, DOI 10.1038/leu.2010.47; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Chitteti BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017498; Chomel JC, 2011, BLOOD, V118, P3657, DOI 10.1182/blood-2011-02-335497; Chu S, 2011, BLOOD, V118, P5565, DOI 10.1182/blood-2010-12-327437; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cuenco GM, 2004, ONCOGENE, V23, P569, DOI 10.1038/sj.onc.1207143; Daghistani M, 2010, BLOOD, V116, P6014, DOI 10.1182/blood-2010-01-264234; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Eguchi-Ishimae M, 2009, INT J HEMATOL, V89, P253, DOI 10.1007/s12185-009-0267-8; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Goyama S, 2004, BLOOD, V104, P3558, DOI 10.1182/blood-2004-04-1535; Goyama S, 2010, LEUKEMIA, V24, P81, DOI 10.1038/leu.2009.202; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Groschel S, 2010, J CLIN ONCOL, V28, P2101, DOI 10.1200/JCO.2009.26.0646; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Honda H, 2000, BLOOD, V95, P1144, DOI 10.1182/blood.V95.4.1144.004k04_1144_1150; Honda H, 1998, BLOOD, V91, P2067, DOI 10.1182/blood.V91.6.2067.2067_2067_2075; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Jones D, 2008, BLOOD, V112, P5190, DOI 10.1182/blood-2008-04-148791; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; MaguerSatta V, 1996, BLOOD, V88, P1796; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Ogawa S, 1996, LEUKEMIA, V10, P788; Paquette RL, 2011, CANCER GENET-NY, V204, P392, DOI 10.1016/j.cancergen.2011.06.002; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Radich JP., 2007, HEMATOL AM SOC HEMAT, V2007, P384, DOI [10.1182/asheducation-2007.1.384, DOI 10.1182/ASHEDUCATION-2007.1.384]; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Roy S, 2012, BRIT J HAEMATOL, V157, P446, DOI 10.1111/j.1365-2141.2012.09078.x; RUSSELL M, 1993, LEUKEMIA, V7, P1654; Sato T, 2008, CANCER SCI, V99, P1407, DOI 10.1111/j.1349-7006.2008.00842.x; Schemionek M, 2010, BLOOD, V115, P3185, DOI 10.1182/blood-2009-04-215376; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Watanabe-Okochi N, 2013, BLOOD, V121, P4142, DOI 10.1182/blood-2011-07-368654; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhang HJ, 2012, NAT GENET, V44, P861, DOI 10.1038/ng.2350; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	60	35	35	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2014	33	42					5028	5038		10.1038/onc.2014.108	http://dx.doi.org/10.1038/onc.2014.108			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OB	24747972	hybrid, Green Published			2022-12-25	WOS:000343768000007
J	Moschner, K; Sundermann, F; Meyer, H; da Graca, AP; Appel, N; Paululat, A; Bakota, L; Brandt, R				Moschner, Katharina; Suendermann, Frederik; Meyer, Heiko; da Graca, Abel Pereira; Appel, Neele; Paululat, Achim; Bakota, Lidia; Brandt, Roland			RNA Protein Granules Modulate tau Isoform Expression and Induce Neuronal Sprouting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA; CORTICAL-NEURONS; STRESS GRANULES; KH DOMAINS; GENE; LOCALIZATION; ASSOCIATION; MEMBRANE; REVEALS	The neuronal microtubule-associated protein Tau is expressed in different variants, and changes in Tau isoform composition occur during development and disease. Here, we investigate a potential role of the multivalent tau mRNA-binding proteins G3BP1 and IMP1 in regulating neuronal tau expression. We demonstrate that G3BP1 and IMP1 expression induces the formation of structures, which qualify as neuronal ribonucleoprotein (RNP) granules and concentrate multivalent proteins and mRNA. We show that RNP granule formation leads to a >30-fold increase in the ratio of high molecular weight to low molecular weight tau mRNA and an similar to 12-fold increase in high molecular weight to low molecular weight Tau protein. We report that RNP granule formation is associated with increased neurite formation and enhanced process growth. G3BP1 deletion constructs that do not induce granule formation are also deficient in inducing neuronal sprouting or changing the expression pattern of tau. The data indicate that granule formation driven by multivalent proteins modulates tau isoform expression and suggest a morphoregulatory function of RNP granules during health and disease.	[Moschner, Katharina; Suendermann, Frederik; da Graca, Abel Pereira; Appel, Neele; Bakota, Lidia; Brandt, Roland] Univ Osnabruck, Dept Neurobiol, D-49076 Osnabruck, Germany; [Meyer, Heiko; Paululat, Achim] Univ Osnabruck, Dept Zool, D-49076 Osnabruck, Germany	University Osnabruck; University Osnabruck	Brandt, R (corresponding author), Univ Osnabruck, Dept Neurobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	brandt@biologie.uni-osnabrueck.de		Paululat, Achim/0000-0002-8845-6859; Harten, Heiko/0000-0002-3304-4523; Brandt, Roland/0000-0003-0101-1257; Bakota, Lidia/0000-0002-8777-5006	Deutsche Forschungsgemeinschaft [SFB 944]; Lichtenberg fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lichtenberg fellowship	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 944, Project P1 (to R. B.), and a Lichtenberg fellowship (to F. S.).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Atlas R, 2007, J NEUROSCI RES, V85, P173, DOI 10.1002/jnr.21099; Bakota L, 2012, MOL GENET GENOMICS, V287, P313, DOI 10.1007/s00438-012-0680-1; Boudreau RL, 2014, NEURON, V81, P294, DOI 10.1016/j.neuron.2013.10.062; BOYNE LJ, 1995, J COMP NEUROL, V358, P279, DOI 10.1002/cne.903580209; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Conrad C, 2007, J NEUROCHEM, V103, P1228, DOI 10.1111/j.1471-4159.2007.04857.x; Dickson JR, 2013, J NEUROCHEM, V127, P739, DOI 10.1111/jnc.12437; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Fath T, 2002, J NEUROSCI, V22, P9733; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hebert S. S., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/406561; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Leschik J, 2007, J NEUROCHEM, V101, P1303, DOI 10.1111/j.1471-4159.2006.04435.x; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Martin S, 2013, J NEUROCHEM, V125, P175, DOI 10.1111/jnc.12189; Mellone M, 2013, J NEUROSCI, V33, P18175, DOI 10.1523/JNEUROSCI.4933-12.2013; Nadezhdina ES, 2010, BBA-MOL CELL RES, V1803, P361, DOI 10.1016/j.bbamcr.2009.12.004; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; SADOT E, 1994, J MOL BIOL, V241, P325, DOI 10.1006/jmbi.1994.1508; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sica R E, 1998, Electromyogr Clin Neurophysiol, V38, P475; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Smith PY, 2011, HUM MOL GENET, V20, P4016, DOI 10.1093/hmg/ddr330; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sohn YK, 1999, J NEUROL SCI, V162, P133, DOI 10.1016/S0022-510X(98)00297-4; Swanger SA, 2011, METHODS MOL BIOL, V714, P103, DOI 10.1007/978-1-61779-005-8_7; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; TENG KK, 1993, J CELL SCI, V106, P611; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wakabayashi K, 2010, ACTA NEUROPATHOL, V120, P1, DOI 10.1007/s00401-010-0706-x; Weissmann C, 2009, TRAFFIC, V10, P1655, DOI 10.1111/j.1600-0854.2009.00977.x; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008	47	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16814	16825		10.1074/jbc.M113.541425	http://dx.doi.org/10.1074/jbc.M113.541425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24755223	hybrid, Green Published			2022-12-25	WOS:000338016200019
J	Takeshita, S; Fumoto, T; Naoe, Y; Ikeda, K				Takeshita, Sunao; Fumoto, Toshio; Naoe, Yoshinori; Ikeda, Kyoji			Age-related Marrow Adipogenesis Is Linked to Increased Expression of RANKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLAST-LIKE CELLS; MURINE BONE-MARROW; SUPPORT DIFFERENTIATION; TRABECULAR BONE; STROMAL CELLS; IN-VITRO; ADIPOCYTES; LIGAND; OSTEOPOROSIS; MOUSE	With advancing age bone marrow is progressively replaced with adipose tissue, accompanied by a concomitant decline in bone mass and strength. The mechanism underlying the increase in marrow fat and bone destruction remains elusive. We found that on the way of adipogenic differentiation of marrow stromal cells, receptor activator for NF-kappa B ligand (Rankl) expression was induced, concomitantly with a down-regulation of osteoprotegerin, which prompted us to hypothesize that cells at a preadipocyte stage express RANKL. This concept was supported by the findings that the early adipogenic transcription factors C/EBP beta and C/EBP delta, but not the late factor peroxisome proliferator-activated receptor gamma, bind to the Rankl promoter and stimulate Rankl gene transcription. In fact, when cells isolated from the bone marrow of aging mice were analyzed by flow cytometry, we found that cells expressing the pre-adipocyte marker Pref-1 were RANKL-positive, and the number of these cells was increased with aging, with concomitant down-regulation of osteoprotegerin, and most importantly, that these RANKL(+)/Pref-1(+) marrow cells were capable of generating osteoclasts from bone marrow macrophages. Thus, the capacity of cells at a pre-adipocyte stage to express RANKL via C/EBP beta and C/EBP delta and to support osteoclastogenesis may account partly for the co-progression of fatty marrow and bone destruction with aging.	[Takeshita, Sunao; Fumoto, Toshio; Ikeda, Kyoji] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Aichi 4748511, Japan; [Naoe, Yoshinori] Natl Ctr Geriatr & Gerontol, Dept Mech Aging, Obu, Aichi 4748511, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology	Ikeda, K (corresponding author), 35 Gengo, Obu, Aichi 4748511, Japan.	sunao@ncgg.go.jp	fumoto, toshio/F-6345-2015	fumoto, toshio/0000-0002-9273-8939	Ministry of Education, Science of Japan [18590359, 22118007]; program Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan [06-31]; Ono Foundation; Daiko Foundation; Tokyo Biochemistry Research Foundation; Grants-in-Aid for Scientific Research [22118007] Funding Source: KAKEN	Ministry of Education, Science of Japan; program Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ono Foundation; Daiko Foundation(Daiko Foundation); Tokyo Biochemistry Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research C mice, to support osteoclastogenesis. 18590359 (to S. T.) and a Grant-in-aid for Scientific Research on Innovative Areas 22118007 (to K. I.) from the Ministry of Education, Science of Japan, a grant from the program Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (06-31) (to K. I.), and grants from Ono Foundation (to S. T.), Daiko Foundation (to K. I.), and Tokyo Biochemistry Research Foundation (to K. I.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; BENAYAHU D, 1994, J CELL BIOCHEM, V56, P374, DOI 10.1002/jcb.240560314; Bethel M, 2013, CURR OSTEOPOROS REP, V11, P99, DOI 10.1007/s11914-013-0135-6; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Chiang BT, 2006, J BIOMED SCI, V13, P621, DOI 10.1007/s11373-006-9101-y; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DEXTER TM, 1977, BIOMED EXPRESS, V27, P344; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Holloway WR, 2002, J BONE MINER RES, V17, P200, DOI 10.1359/jbmr.2002.17.2.200; JEE WSS, 1983, AM J PHYSIOL, V244, pR310, DOI 10.1152/ajpregu.1983.244.3.R310; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Justesen J, 2004, TISSUE ENG, V10, P381, DOI 10.1089/107632704323061744; Kanematsu M, 2000, J BONE MINER RES, V15, P1321, DOI 10.1359/jbmr.2000.15.7.1321; KAWAI K, 1985, J BONE JOINT SURG AM, V67A, P755, DOI 10.2106/00004623-198567050-00010; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2092, DOI 10.1210/en.139.4.2092; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; MARTIN RB, 1991, BONE, V12, P123, DOI 10.1016/8756-3282(91)90011-7; MARTIN RB, 1990, CALCIFIED TISSUE INT, V46, P189, DOI 10.1007/BF02555043; MOORE SG, 1990, RADIOLOGY, V175, P219, DOI 10.1148/radiology.175.1.2315484; Nagase Y, 2009, J BIOL CHEM, V284, P36659, DOI 10.1074/jbc.M109.016915; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; ROZMAN C, 1989, EXP HEMATOL, V17, P34; Sakaguchi K, 2000, PROSTAG LEUKOTR ESS, V62, P319, DOI 10.1054/plef.2000.0161; Shahnazari M, 2012, BONE, V50, P628, DOI 10.1016/j.bone.2011.11.010; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Takeshita S, 2001, BONE, V29, P236, DOI 10.1016/S8756-3282(01)00505-1; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304	42	82	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16699	16710		10.1074/jbc.M114.547919	http://dx.doi.org/10.1074/jbc.M114.547919			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24753250	Green Published, hybrid			2022-12-25	WOS:000338016200010
J	de Assuncao, TM; Lomberk, G; Cao, S; Yaqoob, U; Mathison, A; Simonetto, DA; Huebert, RC; Urrutia, RA; Shah, VH				de Assuncao, Thiago M.; Lomberk, Gwen; Cao, Sheng; Yaqoob, Usman; Mathison, Angela; Simonetto, Douglas A.; Huebert, Robert C.; Urrutia, Raul A.; Shah, Vijay H.			New Role for Kruppel-like Factor 14 as a Transcriptional Activator Involved in the Generation of Signaling Lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Epigenetics; Fibroblast Growth Factor (FGF); Kruppel-like Factor (KLF); Sphingosine-1-phosphate (S1P)	PROTEIN-KINASE-C; EXTRACELLULAR EXPORT; GENE-EXPRESSION; CELL-LINE; GROWTH; SPHINGOSINE-1-PHOSPHATE; ACETYLATION; SPECIFICITY; MECHANISMS; REGULATOR	Sphingosine kinase 1 (SK1) is an FGF-inducible gene responsible for generation of sphingosine-1-phosphate, a critical lipid signaling molecule implicated in diverse endothelial cell functions. In this study, we identified SK1 as a target of the canonical FGF2/FGF receptor 1 activation pathway in endothelial cells and sought to identify novel transcriptional pathways that mediate lipid signaling. Studies using the 1.9-kb SK1 promoter and deletion mutants revealed that basal and FGF2-stimulated promoter activity occurred through two GC-rich regions located within 633 bp of the transcription start site. Screening for GC-rich binding transcription factors that could activate this site demonstrated that KLF14, a gene implicated in obesity and the metabolic syndrome, binds to this region. Congruently, overexpression of KLF14 increased basal and FGF2-stimulated SK1 promoter activity by 3-fold, and this effect was abrogated after mutation of the GC-rich sites. In addition, KLF14 siRNA transfection decreased SK1 mRNA and protein levels by 3-fold. Congruently, SK1 mRNA and protein levels were decreased in livers from KLF14 knock-out mice. Combined, luciferase, gel shift, and chromatin immunoprecipitation assays showed that KLF14 couples to p300 to increase the levels of histone marks associated with transcriptional activation (H4K8ac and H3K14ac), while decreasing repressive marks (H3K9me3 and H3K27me3). Collectively, the results demonstrate a novel mechanism whereby SK1 lipid signaling is regulated by epigenetic modifications conferred by KLF14 and p300. Thus, this is the first description of the activity and mechanisms underlying the function of KLF14 as an activator protein and novel regulator of lipid signaling.	[de Assuncao, Thiago M.; Lomberk, Gwen; Cao, Sheng; Yaqoob, Usman; Mathison, Angela; Simonetto, Douglas A.; Huebert, Robert C.; Urrutia, Raul A.; Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [de Assuncao, Thiago M.; Lomberk, Gwen; Cao, Sheng; Yaqoob, Usman; Mathison, Angela; Simonetto, Douglas A.; Huebert, Robert C.; Urrutia, Raul A.; Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Dept Physiol & Biophys, Rochester, MN 55905 USA; [de Assuncao, Thiago M.; Lomberk, Gwen; Cao, Sheng; Yaqoob, Usman; Mathison, Angela; Simonetto, Douglas A.; Huebert, Robert C.; Urrutia, Raul A.; Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Dept Med, Rochester, MN 55905 USA; [Lomberk, Gwen; Urrutia, Raul A.] Mayo Clin, Epigen Translat Program, Mayo Clin Ctr Individualized Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Urrutia, RA (corresponding author), Mayo Clin, Gastroenterol Res Unit, Guggenheim 10-21,200 First St SW, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu; shah.vijay@mayo.edu		Mathison, Angela/0000-0002-6763-2710; Huebert, Robert/0000-0002-9812-7573	National Institutes of Health [DK59015, AA021171, P30 DL 084567, DK52913, DK100575-01]; Mayo Center for Regenerative Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100575, R01DK059615, R56DK052913, P30DK084567, R01DK052913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA021171, R01AA021171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Center for Regenerative Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59015, AA021171, and P30 DL 084567 (to V. H. S.); DK52913 (to R. U.); and DK100575-01 (to R. C. H.). This work was also supported by funds from the Mayo Center for Regenerative Medicine (to R.C.H.).	Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Belacortu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032004; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Bureau C, 2009, CURR GENOMICS, V10, P353, DOI 10.2174/138920209788921010; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Civelek M, 2011, NAT GENET, V43, P506, DOI 10.1038/ng.842; Daftary GS, 2012, J BIOL CHEM, V287, P7010, DOI 10.1074/jbc.M111.266007; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gonzalez CR, 2013, CYTOKINE, V61, P670, DOI 10.1016/j.cyto.2012.12.009; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Huang KP, 2014, CELL SIGNAL, V26, P629, DOI 10.1016/j.cellsig.2013.12.002; Huebert RC, 2011, AM J PATHOL, V179, P1851, DOI 10.1016/j.ajpath.2011.06.045; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2013, J BIOL CHEM, V288, P17745, DOI 10.1074/jbc.M112.434670; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Panetti TS, 2000, ARTERIOSCL THROM VAS, V20, P1013, DOI 10.1161/01.ATV.20.4.1013; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rigogliuso S, 2010, J ONCOL, V2010, DOI 10.1155/2010/509329; Schwalm S, 2013, BBA-MOL CELL BIOL L, V1831, P239, DOI 10.1016/j.bbalip.2012.07.022; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	35	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15798	15809		10.1074/jbc.M113.544346	http://dx.doi.org/10.1074/jbc.M113.544346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24759103	Green Published, hybrid			2022-12-25	WOS:000337465400059
J	Hamylton, S				Hamylton, Sarah			Will Coral Islands Maintain Their Growth over the Next Century? A Deterministic Model of Sediment Availability at Lady Elliot Island, Great Barrier Reef	PLOS ONE			English	Article							CALCIUM-CARBONATE SATURATION; CALCIFICATION RATE; OCEAN ACIDIFICATION; TEMPERATURE; FUTURE; METABOLISM; FRAMEWORK; SEAWATER; BUDGET; LIGHT	A geomorphic assessment of reef system calcification is conducted for past (3200 Ka to present), present and future (2010-2100) time periods. Reef platform sediment production is estimated at 569 m(3) yr(-1) using rate laws that express gross community carbonate production as a function of seawater aragonite saturation, community composition and rugosity and incorporating estimates of carbonate removal from the reef system. Key carbonate producers including hard coral, crustose coralline algae and Halimeda are mapped accurately (mean R-2 = 0.81). Community net production estimates correspond closely to independent census-based estimates made in-situ (R-2 = 0.86). Reef-scale outputs are compared with historic rates of production generated from (i) radiocarbon evidence of island deposition initiation around 3200 years ago, and (ii) island volume calculated from a high resolution island digital elevation model. Contemporary carbonate production rates appear to be remarkably similar to historical values of 573 m(3) yr(-1). Anticipated future seawater chemistry parameters associated with an RCP8.5 emissions scenario are employed to model rates of net community calcification for the period 2000-2100 on the basis of an inorganic aragonite precipitation law, under the assumption of constant benthic community character. Simulations indicate that carbonate production will decrease linearly to a level of 118 m(3) yr(-1) by 2100 and that by 2150 aragonite saturation levels may no longer support the positive budgetary status necessary to sustain island accretion. Novel aspects of this assessment include the development of rate law parameters to realistically represent the variable composition of coral reef benthic carbonate producers, incorporation of three dimensional rugosity of the entire reef platform and the coupling of model outputs with both historical radiocarbon dating evidence and forward hydrochemical projections to conduct an assessment of island evolution through time. By combining several lines of evidence in a deterministic manner, an assessment of changes in carbonate production is carried out that has tangible geomorphic implications for sediment availability and associated island evolution.	Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW, Australia	University of Wollongong	Hamylton, S (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW, Australia.	shamylto@uow.edu.au		Hamylton, Sarah/0000-0002-6256-3728	University of Wollongong URC Small Grant	University of Wollongong URC Small Grant	This research was funded by a University of Wollongong URC Small Grant (www.uow.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Andrefouet S, 2001, CORAL REEFS, V19, P259; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Bernstein WN, 2008, THESIS U CALIFORNIA; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; CHAPPELL J, 1982, Archaeology in Oceania, V17, P69; Chisholm JRM, 2000, LIMNOL OCEANOGR, V45, P1476, DOI 10.4319/lo.2000.45.7.1476; CHIVAS A, 1986, MAR GEOL, V69, P273, DOI 10.1016/0025-3227(86)90043-5; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Deloitte Access Economics, 2013, EC CONTR GREAT BARR, P195; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; Flood P, 2012, ENCY MODERN CORAL RE, P191; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Gattuso JP, 1999, AM ZOOL, V39, P160; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gourlay M.R., 1988, P 6 INT COR REEF S T, V2, P491; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hale R, 2011, OIKOS, V120, P661, DOI 10.1111/j.1600-0706.2010.19469.x; Hamylton S, 2012, MAR ECOL PROG SER, V460, P35, DOI 10.3354/meps09779; Hamylton SM, 2013, CORAL REEFS, V32, P1025, DOI 10.1007/s00338-013-1074-5; Harney JN, 2003, J SEDIMENT RES, V73, P856, DOI 10.1306/051503730856; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; Hubbard D. K., 1981, P 4 INT COR REEF S, V1, P399; Hubbard DK, 1976, 7CRD U S CAR DEP GEO; Hughes TP, 1999, MAR GEOL, V157, P1, DOI 10.1016/S0025-3227(98)00187-X; Jago OK, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003740; Kench PS, 2005, GEOLOGY, V33, P145, DOI 10.1130/G21066.1; Kench PS, 2006, J COASTAL RES, V22, P209, DOI 10.2112/05A-0016.1; Kinsey D.W., 1979, THESIS U HAWAII; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Leclercq N, 2000, GLOB CHANGE BIOL, V6, P329, DOI 10.1046/j.1365-2486.2000.00315.x; Leclercq N, 2002, LIMNOL OCEANOGR, V47, P558, DOI 10.4319/lo.2002.47.2.0558; Mallela J, 2007, CORAL REEFS, V26, P129, DOI 10.1007/s00338-006-0169-7; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; McCabe RM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006023; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Montaggioni LF, 2009, DEV MARINE GEOL, V5, P1; Morgan K, 2012, P 12 INT COR REEF S; Nellemann C, 1996, ARCTIC, V49, P23; Perry C, 2012, REEFBUDGET METHODOLO; Perry CT, 2012, CORAL REEFS, V31, P853, DOI 10.1007/s00338-012-0901-4; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Perry CT, 2011, GLOBAL CHANGE BIOL, V17, P3679, DOI 10.1111/j.1365-2486.2011.02523.x; Perry CT, 2011, GLOBAL CHANGE BIOL, V17, P76, DOI 10.1111/j.1365-2486.2010.02181.x; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; ROY P, 1991, J COASTAL RES, V7, P1057; Schneider K, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001755; SCOFFIN TP, 1992, CORAL REEFS, V11, P57, DOI 10.1007/BF00357423; Shaw EC, 2012, THESIS U NEW S WALES; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Short A. D., 2009, COAST AUSTR; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Silverman J, 2007, BIOGEOCHEMISTRY, V84, P67, DOI 10.1007/s10533-007-9075-5; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Stoddart D, 1977, BIOL GEOLOGY CORAL R, V2; Storlazzi CD, 2011, CORAL REEFS, V30, P23, DOI 10.1007/s00338-010-0705-3; Stumpf RP, 2003, LIMNOL OCEANOGR, V48, P547, DOI 10.4319/lo.2003.48.1_part_2.0547; Vecsei A, 2001, PALAEOGEOGR PALAEOCL, V175, P185, DOI 10.1016/S0031-0182(01)00371-6	63	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94067	10.1371/journal.pone.0094067	http://dx.doi.org/10.1371/journal.pone.0094067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759700	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200010
J	Buechner, A; Dyballa, KH; Hehrmann, P; Fredelake, S; Lenarz, T				Buechner, Andreas; Dyballa, Karl-Heinz; Hehrmann, Phillipp; Fredelake, Stefan; Lenarz, Thomas			Advanced Beamformers for Cochlear Implant Users: Acute Measurement of Speech Perception in Challenging Listening Conditions	PLOS ONE			English	Article							HEARING-AIDS; DIRECTIONAL-MICROPHONE; BACKGROUND-NOISE; RECOGNITION; RECIPIENTS; INTELLIGIBILITY; PERFORMANCE; STRATEGIES; PROCESSOR; MASKING	Objective: To investigate the performance of monaural and binaural beamforming technology with an additional noise reduction algorithm, in cochlear implant recipients. Method: This experimental study was conducted as a single subject repeated measures design within a large German cochlear implant centre. Twelve experienced users of an Advanced Bionics HiRes90K or CII implant with a Harmony speech processor were enrolled. The cochlear implant processor of each subject was connected to one of two bilaterally placed state-of-the-art hearing aids (Phonak Ambra) providing three alternative directional processing options: an omnidirectional setting, an adaptive monaural beamformer, and a binaural beamformer. A further noise reduction algorithm (ClearVoice) was applied to the signal on the cochlear implant processor itself. The speech signal was presented from 0 degrees and speech shaped noise presented from loudspeakers placed at +/- 70 degrees, +/- 135 degrees and 180 degrees. The Oldenburg sentence test was used to determine the signal-to-noise ratio at which subjects scored 50% correct. Results: Both the adaptive and binaural beamformer were significantly better than the omnidirectional condition (5.3 dB +/- 61.2 dB and 7.1 dB +/- 1.6 dB (p<0.001) respectively). The best score was achieved with the binaural beamformer in combination with the ClearVoice noise reduction algorithm, with a significant improvement in SRT of 7.9 dB +/- 2.4 dB (p<0.001) over the omnidirectional alone condition. Conclusions: The study showed that the binaural beamformer implemented in the Phonak Ambra hearing aid could be used in conjunction with a Harmony speech processor to produce substantial average improvements in SRT of 7.1 dB. The monaural, adaptive beamformer provided an averaged SRT improvement of 5.3 dB.	[Buechner, Andreas; Dyballa, Karl-Heinz; Lenarz, Thomas] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Buechner, Andreas; Lenarz, Thomas] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany; [Hehrmann, Phillipp; Fredelake, Stefan] Adv Bion GmbH, European Res Ctr, Hannover, Germany	Hannover Medical School; Hannover Medical School	Buechner, A (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	buechner@hoerzentrum-hannover.de			EU grant "Europa fordert Niedersachsen''	EU grant "Europa fordert Niedersachsen''	Supported by the EU grant "Europa fordert Niedersachsen'' (http://www.eufoerdert.niedersachsen.de/portal/live.php? navigation_id=5562&article_id=15298&_psmand=18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentler Ruth A, 2005, J Am Acad Audiol, V16, P473, DOI 10.3766/jaaa.16.7.7; Brockmeyer AM, 2011, J AM ACAD AUDIOL, V22, P65, DOI 10.3766/jaaa.22.2.2; Buechner A, 2010, OTOL NEUROTOL, V31, P1386, DOI 10.1097/MAO.0b013e3181f1cdc6; Chung K, 2006, J ACOUST SOC AM, V120, P2216, DOI 10.1121/1.2258500; Dawes P, 2013, J ACOUST SOC AM, V134, P596, DOI 10.1121/1.4807783; Elko G, 1995, IEEE ASSP WORKSH APP, P169, DOI DOI 10.1109/ASPAA.1995.482983; Firszt JB, 2004, EAR HEARING, V25, P375, DOI 10.1097/01.AUD.0000134552.22205.EE; Gifford RH, 2010, J AM ACAD AUDIOL, V21, P441, DOI 10.3766/jaaa.21.7.3; GREENBERG JE, 1992, J ACOUST SOC AM, V91, P1662, DOI 10.1121/1.402446; Hamacher V, 2005, EURASIP J APPL SIG P, V2005, P2915, DOI 10.1155/ASP.2005.2915; Hamacher V, 1997, AM J OTOL, V18, pS46; Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21; James CJ, 2002, EAR HEARING, V23, p49S, DOI 10.1097/00003446-200202001-00006; KATES JM, 1993, J ACOUST SOC AM, V94, P1930, DOI 10.1121/1.407515; Kates JM, 1996, J ACOUST SOC AM, V99, P3138, DOI 10.1121/1.414798; Kokkinakis K, 2012, TRENDS AMPLIF, V16, P102, DOI 10.1177/1084713812456906; Kollmeier B, 1997, J ACOUST SOC AM, V102, P2412, DOI 10.1121/1.419624; Kompis M, 2001, J ACOUST SOC AM, V109, P1134, DOI 10.1121/1.1338558; Latzel M, 2012, BINAURAL VOICESTREAM; Litovsky R, 2006, EAR HEARING, V27, P714, DOI 10.1097/01.aud.0000246816.50820.42; Mackenzie E, 2005, EAR HEARING, V26, P669, DOI 10.1097/01.aud.0000188185.78217.c5; McCreery RW, 2012, AM J AUDIOL, V21, P295, DOI 10.1044/1059-0889(2012/12-0014); Nogueira W, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/531213; Nyffeler M, 2010, STEREOZOOM IMPROVEME; Patrick James F, 2006, Trends Amplif, V10, P175, DOI 10.1177/1084713806296386; PETERSON PM, 1990, ACTA OTO-LARYNGOL, P85; Ricketts T, 1999, Am J Audiol, V8, P117, DOI 10.1044/1059-0889(1999/018); Ricketts T, 2000, EAR HEARING, V21, P45, DOI 10.1097/00003446-200002000-00008; Ricketts T, 2002, INT J AUDIOL, V41, P100, DOI 10.3109/14992020209090400; Ricketts T, 1999, J Am Acad Audiol, V10, P180; Spahr AJ, 2004, ARCH OTOLARYNGOL, V130, P624, DOI 10.1001/archotol.130.5.624; Spriet A, 2007, EAR HEARING, V28, P62, DOI 10.1097/01.aud.0000252470.54246.54; VANHOESEL RJM, 1995, J ACOUST SOC AM, V97, P2498, DOI 10.1121/1.411970; Wagener KC, 2005, INT J AUDIOL, V44, P144, DOI 10.1080/14992020500057517; Wolfe J, 2012, OTOL NEUROTOL, V33, P553, DOI 10.1097/MAO.0b013e31825367a5; Wouters J, 2001, EAR HEARING, V22, P420, DOI 10.1097/00003446-200110000-00006	36	50	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95542	10.1371/journal.pone.0095542	http://dx.doi.org/10.1371/journal.pone.0095542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755864	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300052
J	Lee, JW; Hur, J; Kim, YJ; Lee, HJ; Nam, JE; Kim, HY; Hong, YJ; Ko, SM; Kim, TH; Choi, BW				Lee, Ji Won; Hur, Jin; Kim, Young Jin; Lee, Hye-Jeong; Nam, Ji Eun; Kim, Hee-Yeong; Hong, Yoo Jin; Ko, Seok Min; Kim, Tae Hoon; Choi, Byoung Wook			Aortic Unfolding Determined Using Non-Contrast Cardiac Computed Tomography: Correlations with Age and Coronary Artery Calcium Score	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; LEFT-VENTRICULAR HYPERTROPHY; BODY-SURFACE AREA; CARDIOVASCULAR RISK; SERUM-CREATININE; HEART-RATE; STIFFNESS; DISEASE; HYPERTENSION; DIAMETER	Objective: Aortic unfolding occurs with aging and reflects proximal aortic dilation, aortic arch widening, and decreased curvature. This study 1) evaluated the relationship between aortic unfolding measured using non-contrast cardiac-gated computed tomography (CT) and age, 2) assessed factors influencing aortic unfolding, and 3) determined the association of this measurement with coronary artery calcium (CAC) score. Methods: We reviewed the charts of 219 subjects (142 men, 77 women; mean age 54.26 +/- 9.3 years) who underwent coronary artery calcium scanning during routine health screening from December 2010 to May 2011. Multivariate regression analysis according to cardiovascular risk factors was performed. We also analyzed the relationship between aortic unfolding measurements and CAC score using stepwise multiple linear regression. Results: Mean aortic unfolding was 103.7 +/- 13.9 mm (men, 106.5 +/- 13.5 mm; women, 98.4 +/- 12.9 mm). Age, body surface area, and hypertension were exclusively associated with aortic unfolding. The association between aortic unfolding and CAC score was significant after adjustment for age and gender (beta = 1.89, p = 0.017) and for Framingham risk score (beta = 2.83, p < 0.001). Conclusions: Aortic unfolding defined by measuring aortic width was a reproducible and practical method with non-contrast cardiac CT and associated with age, body surface area, and hypertension. CAC score, a well-established surrogate marker of cardiovascular disease, is positively associated with aortic unfolding. Further study to evaluate aortic unfolding as a potential predictor of cardiovascular risk is warranted.	[Lee, Ji Won] Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Dept Radiol, Pusan, South Korea; [Lee, Ji Won] Med Res Inst, Pusan, South Korea; [Hur, Jin; Kim, Young Jin; Lee, Hye-Jeong; Nam, Ji Eun; Hong, Yoo Jin; Ko, Seok Min; Kim, Tae Hoon; Choi, Byoung Wook] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Dept Cardiovasc Radiol, Seoul, South Korea; [Kim, Hee-Yeong] Kangwon Natl Univ Hosp, Dept Radiol, Chuncheon Si, Gangwon Do, South Korea	Pusan National University; Pusan National University Hospital; Yonsei University; Yonsei University Health System; Kangwon National University; Kangwon National University Hospital	Choi, BW (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Dept Cardiovasc Radiol, Seoul, South Korea.	bchoi@yuhs.ac		Hong, Yoojin/0000-0002-7276-0944; Lee, Hye-Jeong/0000-0003-4349-9174; /0000-0003-3598-2529; Choi, Byoung Wook/0000-0002-8873-5444; Kim, Young Jin/0000-0002-6235-6550; Hur, Jin/0000-0002-8651-6571	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0007812]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0007812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Craiem D, 2013, J HUM HYPERTENS, V27, P504, DOI 10.1038/jhh.2012.69; Craiem D, 2012, ANN BIOMED ENG, V40, P1028, DOI 10.1007/s10439-011-0487-y; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Hamilton PK, 2007, CLIN SCI, V113, P157, DOI 10.1042/CS20070080; Harjai KJ, 1999, ANN INTERN MED, V131, P376, DOI 10.7326/0003-4819-131-5-199909070-00009; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Inoue N, 2009, CIRC J, V73, P549, DOI 10.1253/circj.CJ-08-0492; Johnson CP, 2001, J CLIN PATHOL, V54, P139, DOI 10.1136/jcp.54.2.139; Kurugol S, 2012, IEEE ENG MED BIO, P2343, DOI 10.1109/EMBC.2012.6346433; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Lantelme P, 2002, HYPERTENSION, V39, P1083, DOI 10.1161/01.HYP.0000019132.41066.95; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Mann JFE, 2003, EUR HEART J, V24, P381, DOI 10.1016/S0195-668X(02)00699-1; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Nichols WW, 2005, MCDONALDS BLOOD FLOW, pxii; Nollen GJ, 2004, EUR HEART J, V25, P1146, DOI 10.1016/j.ehj.2004.04.033; O'Rourke MF, 2005, HYPERTENSION, V45, P652, DOI 10.1161/01.HYP.0000153793.84859.b8; O'Rourke M, 2008, JACC-CARDIOVASC IMAG, V1, P749, DOI 10.1016/j.jcmg.2008.08.002; Redheuil A, J AM COLL CARDIOL, V58, P1262; Schillaci G, 2001, ARCH INTERN MED, V161, P886, DOI 10.1001/archinte.161.6.886; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Tomiyama H, 2010, CIRC J, V74, P24, DOI 10.1253/circj.CJ-09-0534; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; Williams B, 2009, J AM COLL CARDIOL, V54, P705, DOI [10.1016/j.jacc.2009.02.088, 10.1016/j.jacc.2009.06.043]; Wolak A, 2008, JACC-CARDIOVASC IMAG, V1, P200, DOI 10.1016/j.jcmg.2007.11.005; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6; Xu CP, 2000, ARTERIOSCL THROM VAS, V20, P2566, DOI 10.1161/01.ATV.20.12.2566	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95887	10.1371/journal.pone.0095887	http://dx.doi.org/10.1371/journal.pone.0095887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755938	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300114
J	Lou, GY; Ma, XX; Fu, XH; Meng, ZP; Zhang, WY; Wang, YD; Van Ness, C; Yu, DN; Xu, RZ; Huang, WD				Lou, Guiyu; Ma, Xiaoxiao; Fu, Xianghui; Meng, Zhipeng; Zhang, Wenyu; Wang, Yan-Dong; Van Ness, Carl; Yu, Donna; Xu, Rongzhen; Huang, Wendong			GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CHOLESTEROL 7-ALPHA-HYDROXYLASE; RECEPTOR TGR5; TARGETED DISRUPTION; ACTIVATION; TRANSCRIPTION; EPAC; MICE; HYDROXYLASE	GPBAR1/TGR5 is a novel plasma membrane-bound G protein-coupled bile acid (BA) receptor. BAs are known to induce the expression of inflammatory cytokines in the liver with unknown mechanism. Here we show that without other external stimuli, TGR5 activation alone induced the expression of interleukin 1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) in murine macrophage cell line RAW264.7 or murine Kupffer cells. The TGR5-mediated increase of pro-inflammatory cytokine expression was suppressed by JNK inhibition. Moreover, the induced pro-inflammatory cytokine expression in mouse liver by 1% cholic acid (CA) diet was blunted in JNK(-/-) mice. TGR5 activation by its ligands enhanced the phosphorylation levels, DNA-binding and trans-activities of c-Jun and ATF2 transcription factors. Finally, the induced pro-inflammatory cytokine expression in Kupffer cells by TGR5 activation correlated with the suppression of Cholesterol 7 alpha-hydroxylase (Cyp7a1) expression in murine hepatocytes. These results suggest that TGR5 mediates the BA-induced pro-inflammatory cytokine production in murine Kupffer cells through JNK-dependent pathway. This novel role of TGR5 may correlate to the suppression of Cyp7a1 expression in hepatocytes and contribute to the delicate BA feedback regulation.	[Lou, Guiyu] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China; [Lou, Guiyu; Ma, Xiaoxiao; Fu, Xianghui; Meng, Zhipeng; Zhang, Wenyu; Wang, Yan-Dong; Van Ness, Carl; Yu, Donna; Huang, Wendong] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Div Mol Diabet Res, Duarte, CA 91010 USA; [Ma, Xiaoxiao; Meng, Zhipeng] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Xu, Rongzhen] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Rongzhen] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China	Army Medical University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; Zhejiang University	Huang, WD (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Div Mol Diabet Res, Duarte, CA 91010 USA.	whuang@coh.org	Ma, Xiaoxiao/AFB-9086-2022; Lou, Guiyu/AAM-2153-2020	Ma, Xiaoxiao/0000-0001-8661-5660; Fu, Xianghui/0000-0001-9808-3892; Wang, Yan-Dong/0000-0003-2293-5854	NCI [1R01-CA139158]; National Natural Science Foundation of P.R. China [81270488]; NATIONAL CANCER INSTITUTE [R01CA139158] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	W.H. is supported by NCI 1R01-CA139158; G.L. is supported by National Natural Science Foundation of P.R. China (No. 81270488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmayr F, 2010, J BIOL CHEM, V285, P3525, DOI 10.1074/jbc.M109.066787; CALMUS Y, 1992, HEPATOLOGY, V16, P719, DOI 10.1002/hep.1840160317; Davies John Q, 2005, Methods Mol Biol, V290, P91; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Feingold KR, 1996, J LIPID RES, V37, P223; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Li TG, 2005, AM J PHYSIOL-GASTR L, V288, pG74, DOI 10.1152/ajpgi.00258.2004; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Liu WM, 2010, PHYTOTHER RES, V24, P369, DOI 10.1002/ptr.2948; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Miyake JH, 2000, J BIOL CHEM, V275, P21805, DOI 10.1074/jbc.C000275200; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Rajagopal S, 2013, AM J PHYSIOL-GASTR L, V304, pG527, DOI 10.1152/ajpgi.00388.2012; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Seimiya H, 1997, J BIOL CHEM, V272, P4631, DOI 10.1074/jbc.272.7.4631; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Stravitz RT, 1996, AM J PHYSIOL-GASTR L, V271, pG293, DOI 10.1152/ajpgi.1996.271.2.G293; Tan KS, 2007, CELL SIGNAL, V19, P251, DOI 10.1016/j.cellsig.2006.06.007; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Wang Xichun, 2013, Curr Pathobiol Rep, V1, P29; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang LS, 2009, MOL ENDOCRINOL, V23, P137, DOI 10.1210/me.2008-0198	31	48	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e93567	10.1371/journal.pone.0093567	http://dx.doi.org/10.1371/journal.pone.0093567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755711	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300008
J	Mauro, A; Martelli, A; Berardinelli, P; Russo, V; Bernabo, N; Di Giacinto, O; Mattioli, M; Barboni, B				Mauro, Annunziata; Martelli, Alessandra; Berardinelli, Paolo; Russo, Valentina; Bernabo, Nicola; Di Giacinto, Oriana; Mattioli, Mauro; Barboni, Barbara			Effect of Antiprogesterone RU486 on VEGF Expression and Blood Vessel Remodeling on Ovarian Follicles before Ovulation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PIG ANTRAL FOLLICLES; FOLLICULAR DEVELOPMENT; PERIOVULATORY PERIOD; ANGIOGENIC FACTORS; EARLY-PREGNANCY; CORPUS-LUTEUM; CELLULAR PROLIFERATION; EXTRACELLULAR-MATRIX; ESTROGEN-RECEPTOR	Background: The success of ovarian follicle growth and ovulation is strictly related to the development of an adequate blood vessel network required to sustain the proliferative and endocrine functions of the follicular cells. Even if the Vascular Endothelial Growth Factor (VEGF) drives angiogenesis before ovulation, the local role exerted by Progesterone (P-4) remains to be clarified, in particular when its concentration rapidly increases before ovulation. Aim: This in vivo study was designed to clarify the effect promoted by a P-4 receptor antagonist, RU486, on VEGF expression and follicular angiogenesis before ovulation, in particular, during the transition from pre to periovulatory follicles induced by human Chorionic Gonadotropins (hCG) administration. Material and Methods: Preovulatory follicle growth and ovulation were pharmacologically induced in prepubertal gilts by combining equine Chorionic Gonadotropins (eCG) and hCG used in the presence or absence of RU486. The effects on VEGF expression were analyzed using biochemical and immunohistochemical studies, either on granulosa or on theca layers of follicles isolated few hours before ovulation. This angiogenic factor was also correlated to follicular morphology and to blood vessels architecture. Results and Conclusions: VEGF production, blood vessel network and follicle remodeling were impaired by RU486 treatment, even if the cause-effect correlation remains to be clarified. The P-4 antagonist strongly down-regulated theca VEGF expression, thus, preventing most of the angiogenic follicle response induced by hCG. RU486-treated follicles displayed a reduced vascular area, a lower rate of endothelial cell proliferation and a reduced recruitment of perivascular mural cells. These data provide important insights on the biological role of RU486 and, indirectly, on steroid hormones during periovulatory follicular phase. In addition, an in vivo model is proposed to evaluate how periovulatory follicular angiogenesis may affect the functionality of the corpus luteum (CL) and the success of pregnancy.	[Mauro, Annunziata; Martelli, Alessandra; Berardinelli, Paolo; Russo, Valentina; Bernabo, Nicola; Di Giacinto, Oriana; Mattioli, Mauro; Barboni, Barbara] Univ Teramo, Fac Vet Med, Teramo, Italy	University of Teramo	Mauro, A (corresponding author), Univ Teramo, Fac Vet Med, Teramo, Italy.	amauro@unite.it	Russo, Valentina/G-8209-2011	Russo, Valentina/0000-0003-4368-2534; MAURO, ANNUNZIATA/0000-0003-3907-0244; Bernabo, Nicola/0000-0001-5140-9656	TERCAS Foundation 2009, Teramo, Italy	TERCAS Foundation 2009, Teramo, Italy	This work was supported by TERCAS Foundation 2009, Teramo, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, STEROIDS, V76, P1116, DOI 10.1016/j.steroids.2011.04.019; Acosta TJ, 2003, REPRODUCTION, V125, P759, DOI 10.1530/rep.0.1250759; Adams GP, 2012, THERIOGENOLOGY, V78, P1733, DOI 10.1016/j.theriogenology.2012.04.010; Ancelin M, 2002, P NATL ACAD SCI USA, V99, P6023, DOI 10.1073/pnas.082110999; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Baerwald AR, 2012, HUM REPROD UPDATE, V18, P73, DOI 10.1093/humupd/dmr039; Bailey DW, 2010, REPRODUCTION, V140, P583, DOI 10.1530/REP-10-0170; Barboni B, 2000, BIOL REPROD, V63, P858, DOI 10.1095/biolreprod63.3.858; Barboni B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063256; BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; Berardinelli P, 2004, ANAT HISTOL EMBRYOL, V33, P23, DOI 10.1111/j.1439-0264.2004.00504.x; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Berisha B, 2008, REPROD FERT DEVELOP, V20, P258, DOI 10.1071/RD07125; Betsholtz C, 2005, EXP SUPPL, V94, P115; Bouchard P, 2011, FERTIL STERIL, V96, P1175, DOI 10.1016/j.fertnstert.2011.08.021; Brown A, 2003, CONTRACEPTION, V68, P203, DOI 10.1016/S0010-7824(03)00146-X; Brown A, 2002, J CLIN ENDOCR METAB, V87, P63, DOI 10.1210/jc.87.1.63; Cadepond F, 1997, ANNU REV MED, V48, P129; Danforth DR, 2003, BIOL REPROD, V68, P1736, DOI 10.1095/biolreprod.101.000679; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Fortune J. E., 2009, Animal Reproduction, V6, P60; Fraser HM, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-18; Fraser HM, 2009, REPROD FERT DEVELOP, V21, P377, DOI 10.1071/RD08272; Fraser HM, 2001, REPRODUCTION, V121, P355, DOI 10.1530/rep.0.1210355; Geva E, 2000, FERTIL STERIL, V74, P429, DOI 10.1016/S0015-0282(00)00670-1; Geva E, 2004, OVARY; Girling JE, 2007, ENDOCRINOLOGY, V148, P5433, DOI 10.1210/en.2007-0856; Girling JE, 2009, REPRODUCTION, V138, P883, DOI 10.1530/REP-09-0147; Gottsch ML, 2002, REPRODUCTION, V124, P347, DOI 10.1530/reprod/124.3.347; Gougeon A., 2004, OVARY, V2nd ed., P25, DOI [DOI 10.1016/B978-012444562-8/50003-3, 10.1016/B978-012444562-8/50003-3]; Greb RR, 1997, HUM REPROD, V12, P1280; Greenwald GS, 1989, BIOL REPROD, V40, P175; Gutman G, 2008, FERTIL STERIL, V89, P922, DOI 10.1016/j.fertnstert.2007.03.097; Hazzard TM, 1999, MOL HUM REPROD, V5, P1115, DOI 10.1093/molehr/5.12.1115; Heikinheimo O, 2003, CONTRACEPTION, V68, P421, DOI 10.1016/S0010-7824(03)00077-5; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hsu SP, 2008, CELL MOL LIFE SCI, V65, P3839, DOI 10.1007/s00018-008-8441-3; Hsu SP, 2011, MOL ENDOCRINOL, V25, P421, DOI 10.1210/me.2010-0424; Hunter MG, 2004, ANIM REPROD SCI, V82-3, P461, DOI 10.1016/j.anireprosci.2004.05.013; Hyder SM, 1999, MOL ENDOCRINOL, V13, P806, DOI 10.1210/me.13.6.806; Ishikawa K, 2003, ENDOCR J, V50, P515, DOI 10.1507/endocrj.50.515; JABLONKASHARIFF A, 1994, BIOL REPROD, V51, P531, DOI 10.1095/biolreprod51.3.531; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kaczmarek MM, 2008, MOL REPROD DEV, V75, P362, DOI 10.1002/mrd.20815; Kaczmarek Monika M, 2005, Reprod Biol, V5, P111; KAWANO T, 1988, J REPROD FERTIL, V83, P279; Liang H, 2011, CONTRACEPTION, V84, P609, DOI 10.1016/j.contraception.2011.03.013; Lopes FL, 2003, BIOL REPROD, V68, P1926, DOI 10.1095/biolreprod.102.013441; Luttgenau J, 2011, THERIOGENOLOGY, V76, P12, DOI 10.1016/j.theriogenology.2010.12.025; Martelli A, 2009, REPRODUCTION, V137, P45, DOI 10.1530/REP-08-0117; Martelli A, 2006, J MOL ENDOCRINOL, V36, P107, DOI 10.1677/jme.1.01921; Martelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-72; Mathew D, 2009, Soc Reprod Fertil Suppl, V66, P333; Mathew DJ, 2011, BIOL REPROD, V84, P130, DOI 10.1095/biolreprod.110.086843; Mattioli M, 2001, BIOL REPROD, V65, P1014, DOI 10.1095/biolreprod65.4.1014; MOOR RM, 1986, J DAIRY SCI, V69, P927, DOI 10.3168/jds.S0022-0302(86)80482-9; Murphy BD, 2001, J REP FER S, P47; Oviedo PJ, 2011, CLIMACTERIC, V14, P41, DOI 10.3109/13697131003602496; Pancarci SM, 2011, ANIM REPROD SCI, V123, P149, DOI 10.1016/j.anireprosci.2011.01.001; Plendl J, 2000, ANAT HISTOL EMBRYOL, V29, P257, DOI 10.1046/j.1439-0264.2000.00265.x; Redmer D A, 1996, Rev Reprod, V1, P182; Ricke WA, 1999, J REPROD FERTIL, V117, P369, DOI 10.1530/jrf.0.1170369; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Robinson CJ, 2001, J CELL SCI, V114, P853; Robinson RS, 2009, REPRODUCTION, V138, P869, DOI 10.1530/REP-09-0283; Sagsoz H, 2011, THERIOGENOLOGY, V75, P1720, DOI 10.1016/j.theriogenology.2011.01.012; Sarkar NN, 2002, EUR J OBSTET GYN R B, V101, P113, DOI 10.1016/S0301-2115(01)00522-X; Shimizu T, 2003, J REPROD DEVELOP, V49, P181; Shimizu T, 2002, BIOL REPROD, V67, P1846, DOI 10.1095/biolreprod.102.006734; Shimizu T, 2007, ANIM REPROD SCI, V102, P228, DOI 10.1016/j.anireprosci.2006.11.012; Singh H, 2009, CELL SIGNAL, V21, P1346, DOI 10.1016/j.cellsig.2009.04.002; Siqueira LC, 2012, THERIOGENOLOGY, V77, P1779, DOI 10.1016/j.theriogenology.2011.12.022; SPITZ IM, 1994, HUM REPROD, V9, P69, DOI 10.1093/humrep/9.suppl_1.69; Stouffer RL, 2001, ARCH MED RES, V32, P567, DOI 10.1016/S0188-4409(01)00323-X; Sugino N, 2002, REPRODUCTION, V123, P379, DOI 10.1530/reprod/123.3.379; TANAKA N, 1993, J REPROD FERTIL, V97, P167, DOI 10.1530/jrf.0.0970167; Toth B, 2008, HISTOCHEM CELL BIOL, V130, P399, DOI 10.1007/s00418-008-0426-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vazquez F, 1999, J BIOL CHEM, V274, P2185, DOI 10.1074/jbc.274.4.2185; Weisberg E, 2011, CONTRACEPTION, V84, P600, DOI 10.1016/j.contraception.2011.04.008; Wulff C, 2002, ENDOCRINOLOGY, V143, P2797, DOI 10.1210/en.143.7.2797; Wulff C, 2001, ENDOCRINOLOGY, V142, P3244, DOI 10.1210/en.142.7.3244; Zeleznik AJ, 2001, BIOL REPROD, V65, P655, DOI 10.1095/biolreprod65.3.655; Zimmermann RC, 2002, ENDOCRINOLOGY, V143, P2496, DOI 10.1210/en.143.7.2496	85	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95910	10.1371/journal.pone.0095910	http://dx.doi.org/10.1371/journal.pone.0095910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756033	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300117
J	Yang, K; Zhang, XJ; Cao, LJ; Liu, XH; Liu, ZH; Wang, XQ; Chen, QJ; Lu, L; Shen, WF; Liu, Y				Yang, Ke; Zhang, Xiao Jie; Cao, Li Juan; Liu, Xin He; Liu, Zhu Hui; Wang, Xiao Qun; Chen, Qiu Jin; Lu, Lin; Shen, Wei Feng; Liu, Yan			Toll-Like Receptor 4 Mediates Inflammatory Cytokine Secretion in Smooth Muscle Cells Induced by Oxidized Low-Density Lipoprotein	PLOS ONE			English	Article							APOE-DEFICIENT MICE; FOAM CELL; PROTEIN-KINASES; ATHEROSCLEROSIS; DISEASE; ACTIVATION; LDL; MACROPHAGES; EXPRESSION; PATHWAY	Oxidized low-density lipoprotein (oxLDL)-regulated secretion of inflammatory cytokines in smooth muscle cells (SMCs) is regarded as an important step in the progression of atherosclerosis; however, its underlying mechanism remains unclear. This study investigated the role of toll-like receptor 4 (TLR4) in oxLDL-induced expression of inflammatory cytokines in SMCs both in vivo and in vitro. We found that the levels of TLR4, interleukin 1-beta (IL1-beta), tumor necrosis factor-alpha (TNF alpha), monocyte chemoattractant protein 1 (MCP-1) and matrix metalloproteinase-2 (MMP-2) expression were increased in the SMCs of atherosclerotic plaques in patients with femoral artery stenosis. In cultured primary arterial SMCs from wild type mice, oxLDL caused dose-and time-dependent increase in the expression levels of TLR4 and cytokines. These effects were significantly weakened in arterial SMCs derived from TLR4 knockout mice (TLR4(-/-)). Moreover, the secretion of inflammatory cytokines was blocked by TLR4-specific antibodies in primary SMCs. Ox-LDL induced activation of p38 and NFkB was also inhibited in TLR4(-/-) primary SMCs or when treated with TLR4-specific antibodies. These results demonstrated that TLR4 is a crucial mediator in oxLDL-induced inflammatory cytokine expression and secretion, and p38 and NFkB activation.	[Zhang, Xiao Jie; Cao, Li Juan; Liu, Xin He; Chen, Qiu Jin; Lu, Lin; Shen, Wei Feng; Liu, Yan] Jiaotong Univ, Sch Med, Rui Jin Hosp, Dept Cardiol, Shanghai, Peoples R China; [Yang, Ke; Liu, Xin He; Liu, Zhu Hui; Wang, Xiao Qun; Lu, Lin; Shen, Wei Feng; Liu, Yan] Jiaotong Univ, Sch Med, Inst Cardiovasc Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, WF (corresponding author), Jiaotong Univ, Sch Med, Rui Jin Hosp, Dept Cardiol, Shanghai, Peoples R China.	rjshenweifeng@gmail.com; liuyan_ivy@126.com		Yang, Ke/0000-0002-1870-1134	National Natural Science Foundation of China [30900521/H0206, 81200204/H0215]; municipal government [10JC1410501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); municipal government	This work was supported by grants from the National Natural Science Foundation of China (30900521/H0206 and 81200204/H0215) and a grant from municipal government (10JC1410501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdian S, 2012, CARDIOVASC RES, V95, P165, DOI 10.1093/cvr/cvs094; Asrih M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/367245; Aviram M, 1998, MOL CELL BIOCHEM, V188, P149, DOI 10.1023/A:1006841011201; Bijani FM, 2012, INT REV IMMUNOL, V31, P379, DOI 10.3109/08830185.2012.706761; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Egashira K, 2002, CIRC J, V66, P529, DOI 10.1253/circj.66.529; Falck-Hansen M, 2013, INT J MOL SCI, V14, P14008, DOI 10.3390/ijms140714008; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; Jing Q, 2000, CIRC RES, V87, P52, DOI 10.1161/01.RES.87.1.52; Jing Q, 1999, CIRC RES, V84, P831; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kiyan Y, 2013, J MOL CELLULAR CARDI; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kuzuya M, 2003, CIRCULATION, V108, P1375, DOI 10.1161/01.CIR.0000086463.15540.3C; Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin YT, 2012, CURR GENOMICS, V13, P633, DOI 10.2174/138920212803759712; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Matsuura E, 2008, AUTOIMMUN REV, V7, P558, DOI 10.1016/j.autrev.2008.04.018; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meng Z, 2013, CELL PHYSIOL BIOCHEM, V31, P842, DOI 10.1159/000350102; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Nakajima K, 2006, CLIN CHIM ACTA, V367, P36, DOI 10.1016/j.cca.2005.12.013; Pasterkamp G, 2004, EUR J CLIN INVEST, V34, P328, DOI 10.1111/j.1365-2362.2004.01338.x; Rice JB, 2003, ARTERIOSCL THROM VAS, V23, P1576, DOI 10.1161/01.ATV.0000081741.38087.F9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sasaki T, 2013, ATHEROSCLEROSIS, V227, P43, DOI 10.1016/j.atherosclerosis.2012.12.008; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Stoll LL, 2004, J IMMUNOL, V173, P1336, DOI 10.4049/jimmunol.173.2.1336; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Viiri LE, 2013, J MOL CELL CARDIOL, V54, P65, DOI 10.1016/j.yjmcc.2012.11.002; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	42	37	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95935	10.1371/journal.pone.0095935	http://dx.doi.org/10.1371/journal.pone.0095935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755612	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300121
J	Kow, RL; Jiang, K; Naydenov, AV; Le, JH; Stella, N; Nathanson, NM				Kow, Rebecca L.; Jiang, Kelly; Naydenov, Alipi V.; Le, Joshua H.; Stella, Nephi; Nathanson, Neil M.			Modulation of Pilocarpine-Induced Seizures by Cannabinoid Receptor 1	PLOS ONE			English	Article							SYSTEM; MODEL; MECHANISMS; M-1; NEUROGENESIS; EXPRESSION; EPILEPSY	Administration of the muscarinic agonist pilocarpine is commonly used to induce seizures in rodents for the study of epilepsy. Activation of muscarinic receptors has been previously shown to increase the production of endocannabinoids in the brain. Endocannabinoids act at the cannabinoid CB1 receptors to reduce neurotransmitter release and the severity of seizures in several models of epilepsy. In this study, we determined the effect of CB1 receptor activity on the induction in mice of seizures by pilocarpine. We found that decreased activation of the CB1 receptor, either through genetic deletion of the receptor or treatment with a CB1 antagonist, increased pilocarpine seizure severity without modifying seizure-induced cell proliferation and cell death. These results indicate that endocannabinoids act at the CB1 receptor to modulate the severity of pilocarpine-induced seizures. Administration of a CB1 agonist produced characteristic CB1-dependent behavioral responses, but did not affect pilocarpine seizure severity. A possible explanation for the lack of effect of CB1 agonist administration on pilocarpine seizures, despite the effects of CB1 antagonist administration and CB1 gene deletion, is that muscarinic receptor-stimulated endocannabinoid production is acting maximally at CB1 receptors to modulate sensitivity to pilocarpine seizures.	[Kow, Rebecca L.; Jiang, Kelly; Naydenov, Alipi V.; Le, Joshua H.; Stella, Nephi; Nathanson, Neil M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nathanson, NM (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nathanso@u.washington.edu	Naderi, Nima/U-5410-2018	Naderi, Nima/0000-0003-4591-8918	National Institutes of Health [R01-ES015594, R01-DA026430];  [T32-GM0108];  [T32-DA033747]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026430, F30DA033747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institutes of Health grants R01-ES015594, and R01-DA026430, and training grants T32-GM0108 and T32-DA033747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado T, 2007, J BIOL CHEM, V282, P23892, DOI 10.1074/jbc.M700678200; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Bubser Michael, 2012, Handb Exp Pharmacol, P121, DOI 10.1007/978-3-642-23274-9_7; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; Digby GJ, 2012, J NEUROSCI, V32, P8532, DOI 10.1523/JNEUROSCI.0337-12.2012; Eglen R. M., 2006, Autonomic & Autacoid Pharmacology, V26, P219, DOI 10.1111/j.1474-8673.2006.00368.x; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Hofmann ME, 2013, EXP NEUROL, V244, P43, DOI 10.1016/j.expneurol.2011.11.047; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Karlocai MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027196; Ledergerber D, 2006, EXP NEUROL, V199, P130, DOI 10.1016/j.expneurol.2006.02.010; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MARTIN BR, 1991, PHARMACOL BIOCHEM BE, V40, P471, DOI 10.1016/0091-3057(91)90349-7; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Nathanson NM, 2000, P NATL ACAD SCI USA, V97, P6245, DOI 10.1073/pnas.97.12.6245; Newman EL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00024; Ohno-Shosaku T, 2003, EUR J NEUROSCI, V18, P109, DOI 10.1046/j.1460-9568.2003.02732.x; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Parent JM, 1997, J NEUROSCI, V17, P3727; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2001, EUR J PHARMACOL, V428, P51, DOI 10.1016/S0014-2999(01)01243-2; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	35	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95922	10.1371/journal.pone.0095922	http://dx.doi.org/10.1371/journal.pone.0095922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752144	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400144
J	Ma, O; Hong, S; Guo, H; Ghiaur, G; Friedman, AD				Ma, Ou; Hong, SunHwa; Guo, Hong; Ghiaur, Gabriel; Friedman, Alan D.			Granulopoiesis Requires Increased C/EBP alpha Compared to Monopoiesis, Correlated with Elevated Cebpa in Immature G-CSF Receptor versus M-CSF Receptor Expressing Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; COLONY-STIMULATING FACTOR; ENHANCER-BINDING-PROTEIN; MONOCYTE LINEAGE COMMITMENT; KAPPA-B P50; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROGENITOR CELLS; DISTAL ENHANCER; CROSS-TALK	C/EBP alpha is required for the formation of granulocyte-monocyte progenitors; however, its role in subsequent myeloid lineage specification remains uncertain. Transduction of murine marrow with either of two Cebpa shRNAs markedly increases monocyte and reduces granulocyte colonies in methylcellulose or the monocyte to neutrophil ratio in liquid culture. Similar findings were found after marrow shRNA transduction and transplantation and with CEBPA knockdown in human marrow CD34(+) cells. These results apparently reflect altered myeloid lineage specification, as similar knockdown allowed nearly complete 32Dcl3 granulocytic maturation. Cebpa knockdown also generated lineage-negative blasts with increased colony replating capacity but unchanged cell cycle parameters, likely reflecting complete differentiation block. The shRNA having the greatest effect on lineage skewing reduced Cebpa 3-fold in differentiating cells but 6-fold in accumulating blasts. Indicating that Cebpa is the relevant shRNA target, shRNA-resistant C/EBP alpha-ER rescued marrow myelopoiesis. Cebpa knockdown in murine marrow cells also increased in vitro erythropoiesis, perhaps reflecting 1.6-fold reduction in PU.1 leading to GATA-1 derepression. Global gene expression analysis of lineage-negative blasts that accumulate after Cebpa knockdown demonstrated reduction in Cebpe and Gfi1, known transcriptional regulators of granulopoiesis, and also reduced Ets1 and Klf5. Populations enriched for immature granulocyte or monocyte progenitor/precursors were isolated by sorting Lin(-)Sca-1(-)c-Kit(+) cells into GCSFR(+)MCSFR(-) or GCSFR(-)MCSFR(+) subsets. Cebpa, Cebpe, Gfi1, Ets1, and Klf5 RNAs were increased in the c-Kit(+)GCSFR(+) and Klf4 and Irf8 in the c-Kit(+)MCSFR(+) populations, with PU.1 levels similar in both. In summary, higher levels of C/EBPa are required for granulocyte and lower levels for monocyte lineage specification, and this myeloid bifurcation may be facilitated by increased Cebpa gene expression in granulocyte compared with monocyte progenitors.	[Ma, Ou; Hong, SunHwa; Guo, Hong; Friedman, Alan D.] Johns Hopkins Univ, Div Pediat Oncol, Baltimore, MD 21218 USA; [Ghiaur, Gabriel] Johns Hopkins Univ, Div Hematol Malignancies, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Friedman, AD (corresponding author), Johns Hopkins Univ, Div Pediat Oncol, Baltimore, MD 21218 USA.	afriedm2@jhmi.edu		Ghiaur, Gabriel/0000-0002-3955-7944	National Institutes of Health [R01 HL089176, U01 HL099775]; Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE [T32CA060441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099775, R01HL089176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants R01 HL089176 and U01 HL099775 and the Giant Food Children's Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberich-Jorda M, 2012, J CLIN INVEST, V122, P4490, DOI 10.1172/JCI65102; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; Cammenga J, 2003, BLOOD, V101, P2206, DOI 10.1182/blood-2002-05-1546; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Diakiw SM, 2012, LEUKEMIA RES, V36, P110, DOI 10.1016/j.leukres.2011.09.013; Futami M, 2011, BLOOD, V118, P1077, DOI 10.1182/blood-2009-12-261636; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hong S, 2011, J LEUKOCYTE BIOL, V90, P643, DOI 10.1189/jlb.0111043; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Huang H, 2012, GENE DEV, V26, P1587, DOI 10.1101/gad.192054.112; Humbert M, 2011, LEUKEMIA RES, V35, P909, DOI 10.1016/j.leukres.2011.03.010; Ishikawa T, 2013, NATURE COMMUNICATION, V4, P1660; Jack GD, 2009, BLOOD, V114, P2172, DOI 10.1182/blood-2008-11-191536; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Koleva RI, 2012, BLOOD, V119, P4878, DOI 10.1182/blood-2011-10-383083; Kummalue T, 2003, J LEUKOCYTE BIOL, V74, P464, DOI 10.1189/jlb.1202622; Lidonnici MR, 2010, CANCER RES, V70, P7949, DOI 10.1158/0008-5472.CAN-10-1667; Pabst T, 2009, CLIN CANCER RES, V15, P5303, DOI 10.1158/1078-0432.CCR-08-2941; Paz-Priel I, 2005, MOL CANCER RES, V3, P585, DOI 10.1158/1541-7786.MCR-05-0111; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; SCOTT LM, 1992, BLOOD, V80, P1725; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Suh HC, 2006, BLOOD, V107, P4308, DOI 10.1182/blood-2005-06-2216; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Valtieri M, 1987, J IMMUNOL, V138, P43; Wang D, 2006, BLOOD, V108, P1223, DOI 10.1182/blood-2005-12-008763; Wang DH, 2009, J IMMUNOL, V182, P5757, DOI 10.4049/jimmunol.0803861; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang L, 2011, BLOOD, V118, P2266, DOI 10.1182/blood-2011-01-331157; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	42	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95784	10.1371/journal.pone.0095784	http://dx.doi.org/10.1371/journal.pone.0095784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752325	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400129
J	Ribeiro, TL; Ribeiro, S; Belchior, H; Caixeta, F; Copelli, M				Ribeiro, Tiago L.; Ribeiro, Sidarta; Belchior, Hindiael; Caixeta, Fabio; Copelli, Mauro			Undersampled Critical Branching Processes on Small-World and Random Networks Fail to Reproduce the Statistics of Spike Avalanches	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; NEURONAL AVALANCHES; CORTICAL NETWORKS; DYNAMIC-RANGE; OSCILLATIONS	The power-law size distributions obtained experimentally for neuronal avalanches are an important evidence of criticality in the brain. This evidence is supported by the fact that a critical branching process exhibits the same exponent tau=3/2. Models at criticality have been employed to mimic avalanche propagation and explain the statistics observed experimentally. However, a crucial aspect of neuronal recordings has been almost completely neglected in the models: undersampling. While in a typical multielectrode array hundreds of neurons are recorded, in the same area of neuronal tissue tens of thousands of neurons can be found. Here we investigate the consequences of undersampling in models with three different topologies (two-dimensional, small-world and random network) and three different dynamical regimes (subcritical, critical and supercritical). We found that undersampling modifies avalanche size distributions, extinguishing the power laws observed in critical systems. Distributions from subcritical systems are also modified, but the shape of the undersampled distributions is more similar to that of a fully sampled system. Undersampled supercritical systems can recover the general characteristics of the fully sampled version, provided that enough neurons are measured. Undersampling in two-dimensional and small-world networks leads to similar effects, while the random network is insensitive to sampling density due to the lack of a well-defined neighborhood. We conjecture that neuronal avalanches recorded from local field potentials avoid undersampling effects due to the nature of this signal, but the same does not hold for spike avalanches. We conclude that undersampled branching-process-like models in these topologies fail to reproduce the statistics of spike avalanches.	[Ribeiro, Tiago L.; Copelli, Mauro] Fed Univ Pernambuco UFPE, Dept Phys, Recife, PE, Brazil; [Ribeiro, Sidarta; Belchior, Hindiael; Caixeta, Fabio] Fed Univ Rio Grande do Norte UFRN, Inst Brain, Natal, RN, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Rio Grande do Norte	Ribeiro, TL (corresponding author), Fed Univ Pernambuco UFPE, Dept Phys, Recife, PE, Brazil.	tiagolinsribeiro@gmail.com	Caixeta, Fabio V/N-9405-2019; Copelli, Mauro/C-6336-2009; Copelli, Mauro/AAG-8110-2020; Caixeta, Fabio V/J-9048-2014; Ribeiro, Sidarta/C-5794-2016	Caixeta, Fabio V/0000-0003-0919-342X; Copelli, Mauro/0000-0001-7441-2858; Caixeta, Fabio V/0000-0003-0919-342X; Ribeiro, Sidarta/0000-0001-9325-9545	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP) [01.06.1092.00]; Pro-Reitoria de Pos-Graduacao da Universidade Federal do Rio Grande do Norte (UFRN); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Ministerio da Ciencia; Tecnologia e Inovacao (MCTI); CNPq [481351/2011-6, 473554/2011-9, 480053/2013-8]; Programa de Apoio a Nucleos Emergentes [PRONEM 003/2011 FAPERN/CNPq, PRONEM 12/2010 FACEPE/CNPq]; Pew Latin American Fellows Program in the Biomedical Sciences; Centro de Pesquisa; Inovacao e Difusao (CEPID-Neuromat)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Pro-Reitoria de Pos-Graduacao da Universidade Federal do Rio Grande do Norte (UFRN); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Ministerio da Ciencia(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Tecnologia e Inovacao (MCTI); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos Emergentes; Pew Latin American Fellows Program in the Biomedical Sciences; Centro de Pesquisa; Inovacao e Difusao (CEPID-Neuromat)	Work supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP) grant 01.06.1092.00, Pro-Reitoria de Pos-Graduacao da Universidade Federal do Rio Grande do Norte (UFRN), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Ministerio da Ciencia, Tecnologia e Inovacao (MCTI), CNPq Universal Grants 481351/2011-6, 473554/2011-9 and 480053/2013-8, Programa de Apoio a Nucleos Emergentes PRONEM 003/2011 FAPERN/CNPq and PRONEM 12/2010 FACEPE/CNPq, Pew Latin American Fellows Program in the Biomedical Sciences, and Centro de Pesquisa, Inovacao e Difusao (CEPID-Neuromat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis VRV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011923; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Beggs JM, 2003, J NEUROSCI, V23, P11167; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Collins CE, 2010, P NATL ACAD SCI USA, V107, P15927, DOI 10.1073/pnas.1010356107; Copelli M, 2007, EUR PHYS J B, V56, P273, DOI 10.1140/epjb/e2007-00114-7; Copelli M, 2005, NEUROCOMPUTING, V65, P691, DOI 10.1016/j.neucom.2004.10.099; Copelli M, 2005, PHYSICA A, V349, P431, DOI 10.1016/j.physa.2004.10.043; Copelli M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.060901; Crist R. E., 2008, P169; de Arcangelis L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028107; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Furtado LS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011907; Girardi-Schappo M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.024701; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; GREENBERG JM, 1978, SIAM J APPL MATH, V34, P515, DOI 10.1137/0134040; Haldeman C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058101; Harris TE, 1989, THEORY BRANCHING PRO; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Larremore DB, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066131; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Levina A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118110; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Moretti P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3521; Munoz MA, 1999, PHYS REV E, V59, P6175, DOI 10.1103/PhysRevE.59.6175; Newman M. E. J., 1992, THEORY CRITICAL PHEN; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Priesemann V, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002985; Priesemann V, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-40; Publio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006970; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Ribeiro TL, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051911; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Tome T, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051921; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; ZAPPERI S, 1995, PHYS REV LETT, V75, P4071, DOI 10.1103/PhysRevLett.75.4071	46	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94992	10.1371/journal.pone.0094992	http://dx.doi.org/10.1371/journal.pone.0094992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751599	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400023
J	Du, WL; Uslar, L; Sevala, S; Shah, K				Du, Wanlu; Uslar, Liubov; Sevala, Sindhura; Shah, Khalid			Targeting c-Met Receptor Overcomes TRAIL-Resistance in Brain Tumors	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; THERAPEUTIC-EFFICACY; CANCER-THERAPY; IN-VIVO; DEATH; APOPTOSIS; GLIOMA; LIGAND; FATE	Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induced apoptosis specifically in tumor cells. However, with approximately half of all known tumor lines being resistant to TRAIL, the identification of TRAIL sensitizers and their mechanism of action become critical to broadly use TRAIL as a therapeutic agent. In this study, we explored whether c-Met protein contributes to TRAIL sensitivity. We found a direct correlation between the c-Met expression level and TRAIL resistance. We show that the knock down c-Met protein, but not inhibition, sensitized brain tumor cells to TRAIL-mediated apoptosis by interrupting the interaction between c-Met and TRAIL cognate death receptor (DR) 5. This interruption greatly induces the formation of death-inducing signaling complex (DISC) and subsequent downstream apoptosis signaling. Using intracranially implanted brain tumor cells and stem cell (SC) lines engineered with different combinations of fluorescent and bioluminescent proteins, we show that SC expressing a potent and secretable TRAIL (S-TRAIL) have a significant anti-tumor effect in mice bearing c-Met knock down of TRAIL-resistant brain tumors. To our best knowledge, this is the first study that demonstrates c-Met contributes to TRAIL sensitivity of brain tumor cells and has implications for developing effective therapies for brain tumor patients.	[Du, Wanlu; Uslar, Liubov; Sevala, Sindhura; Shah, Khalid] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02115 USA; [Du, Wanlu; Uslar, Liubov; Sevala, Sindhura; Shah, Khalid] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Shah, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02115 USA.	kshah@mgh.harvard.edu		Du, Wanlu/0000-0003-2612-7846	James McDonald Foundation [220020245]	James McDonald Foundation	This work was supported by the James McDonald Foundation(KS), grant # 220020245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Abounader R, 2001, FASEB J, V15, P108, DOI 10.1096/fj.01-0421fje; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Bu R, 2012, MOL MED, V18, P167, DOI 10.2119/molmed.2011.00238; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; French LE, 1999, NAT MED, V5, P146, DOI 10.1038/5505; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Gura T, 1997, SCIENCE, V277, P768, DOI 10.1126/science.277.5327.768; Kauer TM, 2012, NAT NEUROSCI, V15, P197, DOI 10.1038/nn.3019; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kock N, 2007, NEOPLASIA, V9, P435, DOI 10.1593/neo.07223; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Landi L, 2013, CURR OPIN ONCOL, V25, P130, DOI 10.1097/CCO.0b013e32835daf37; Li Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-325; Martinez-Quintanilla J, 2013, STEM CELLS, V31, P1706, DOI 10.1002/stem.1355; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Nakada M, 2013, ADV EXP MED BIOL, V986, P143, DOI 10.1007/978-94-007-4719-7_8; Nesterenko I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049219; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Shah K, 2004, CANCER RES, V64, P3236, DOI 10.1158/0008-5472.CAN-03-3516; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Smyth LA, 2005, HYPERTENSION, V46, P100, DOI 10.1161/01.HYP.0000167991.82153.16; Stuckey DW, 2013, TRENDS MOL MED, V19, P685, DOI 10.1016/j.molmed.2013.08.007; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	32	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95490	10.1371/journal.pone.0095490	http://dx.doi.org/10.1371/journal.pone.0095490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748276	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500112
J	Merriman, JA; Nemeth, KA; Schlievert, PM				Merriman, Joseph A.; Nemeth, Kimberly A.; Schlievert, Patrick M.			Novel Antimicrobial Peptides That Inhibit Gram Positive Bacterial Exotoxin Synthesis	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; STAPHYLOCOCCUS-AUREUS; GLYCEROL MONOLAURATE; SUPERANTIGEN; EXPRESSION; GROWTH; PENETRATION; ENTEROTOXIN; ANTIBODIES; FEATURES	Gram-positive bacteria, such as Staphylococcus aureus, cause serious human illnesses through combinations of surface virulence factors and secretion of exotoxins. Our prior studies using the protein synthesis inhibitor clindamycin and signal transduction inhibitors glycerol monolaurate and alpha-globin and beta-globin chains of hemoglobin indicate that their abilities to inhibit exotoxin production by S. aureus are separable from abilities to inhibit growth of the organism. Additionally, our previous studies suggest that inhibition of exotoxin production, in absence of ability to kill S. aureus and normal flora lactobacilli, will prevent colonization by pathogenic S. aureus, while not interfering with lactobacilli colonization. These disparate activities may be important in development of novel anti-infective agents that do not alter normal flora. We initiated studies to explore the exotoxin-synthesis-inhibition activity of hemoglobin peptides further to develop potential agents to prevent S. aureus infections. We tested synthesized alpha-globin chain peptides, synthetic variants of alpha-globin chain peptides, and two human defensins for ability to inhibit exotoxin production without significantly inhibiting S. aureus growth. All of these peptides were weakly or not inhibitory to bacterial growth. However, the peptides were inhibitory to exotoxin production with increasing activity dependent on increasing numbers of positively-charged amino acids. Additionally, the peptides could be immobilized on agarose beads or have amino acid sequences scrambled and still retain exotoxin-synthesis-inhibition. The peptides are not toxic to human vaginal epithelial cells and do not inhibit growth of normal flora L. crispatus. These peptides may interfere with plasma membrane signal transduction in S. aureus due to their positive charges.	[Merriman, Joseph A.; Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Nemeth, Kimberly A.] Procter & Gamble Co, Cincinnati, OH USA	University of Iowa; Procter & Gamble	Schlievert, PM (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	Patrick-schlievert@uiowa.edu		Schlievert, Patrick/0000-0001-8314-9369	Procter Gamble Company; USPHS [R01 AI074283, U54 AI57153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI074283] Funding Source: NIH RePORTER	Procter Gamble Company(Procter & Gamble); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from The Procter & Gamble Company, and USPHS Grants R01 AI074283, and U54 AI57153. PMS is a member of the Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases. The funders, other than author KAN, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGDOLL MS, 1984, LANCET, V2, P691; BERGDOLL MS, 1981, LANCET, V1, P1017; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Brosnahan AJ, 2008, BIOCHEMISTRY-US, V47, P12995, DOI 10.1021/bi801468w; Davis CC, 2003, AM J OBSTET GYNECOL, V189, P1785, DOI 10.1016/S0002-9378(03)00873-1; DAVIS JP, 1980, NEW ENGL J MED, V303, P1429, DOI 10.1056/NEJM198012183032501; Ganzle MG, 2003, APPL ENVIRON MICROB, V69, P1305, DOI 10.1128/AEM.69.2.1305-1307.2003; Kansal R, 2007, J CLIN IMMUNOL, V27, P327, DOI 10.1007/s10875-007-9072-4; Khodaverdian V, 2013, ANTIMICROB AGENTS CH, V57, P3645, DOI 10.1128/AAC.00269-13; Komatsuzawa H, 2006, J PATHOL, V208, P249, DOI 10.1002/path.1898; Laughton JM, 2006, MICROBIOL-SGM, V152, P1155, DOI 10.1099/mic.0.28654-0; Lee JH, 2012, CURR MICROBIOL, V65, P726, DOI 10.1007/s00284-012-0229-x; Li JR, 2011, P NATL ACAD SCI USA, V108, P3360, DOI 10.1073/pnas.1017431108; Lin YC, 2011, BIOCHEMISTRY-US, V50, P7157, DOI 10.1021/bi200435n; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mak P, 2004, PEPTIDES, V25, P1839, DOI 10.1016/j.peptides.2004.06.015; Mak P, 2000, ANTON LEEUW INT J G, V77, P197, DOI 10.1023/A:1002081605784; Mansson M, 2011, MAR DRUGS, V9, P2537, DOI 10.3390/md9122537; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; MURRAY DL, 1994, J IMMUNOL, V152, P87; Parsonnet J, 2005, J CLIN MICROBIOL, V43, P4628, DOI 10.1128/JCM.43.9.4628-4634.2005; Pechous R, 2004, ANTIMICROB AGENTS CH, V48, P3057, DOI 10.1128/AAC.48.8.3057-3063.2004; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Schlievert PM, 2007, ANTIMICROB AGENTS CH, V51, P3056, DOI 10.1128/AAC.01295-06; Schlievert PM, 2013, ANTIMICROB AGENTS CH, V57, P5432, DOI 10.1128/AAC.01279-13; SCHLIEVERT PM, 1984, J INFECT DIS, V149, P471, DOI 10.1093/infdis/149.3.471; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; SCHLIEVERT PM, 1983, J INFECT DIS, V147, P236, DOI 10.1093/infdis/147.2.236; SCHLIEVERT PM, 1986, LANCET, V1, P1149; Schlievert PM, 2004, J CLIN MICROBIOL, V42, P2875, DOI 10.1128/JCM.42.6.2875-2876.2004; SHANDS KN, 1980, NEW ENGL J MED, V303, P1436, DOI 10.1056/NEJM198012183032502; Spaulding A. R, 2014, J INFECT DIS; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Strandberg KL, 2009, CLIN INFECT DIS, V49, P1711, DOI 10.1086/644614; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Yarwood JM, 2000, J CLIN MICROBIOL, V38, P1797, DOI 10.1128/JCM.38.5.1797-1803.2000	46	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95661	10.1371/journal.pone.0095661	http://dx.doi.org/10.1371/journal.pone.0095661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748386	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500135
J	Akbari-Birgani, S; Hosseinkhani, S; Mollamohamadi, S; Baharvand, H				Akbari-Birgani, Shiva; Hosseinkhani, Saman; Mollamohamadi, Sepideh; Baharvand, Hossein			Delay in Apoptosome Formation Attenuates Apoptosis in Mouse Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; TERMINAL DIFFERENTIATION; CASPASE ACTIVATION; COMPLEX I; MITOCHONDRIAL; DEATH; ATP; LYMPHOCYTES; DEFICIENCY; COMMITMENT	Differentiation is an inseparable process of development in multicellular organisms. Mouse embryonic stem cells (mESCs) represent a valuable research tool to conduct in vitro studies of cell differentiation. Apoptosis as a well known cell death mechanism shows some common features with cell differentiation, which has caused a number of ambiguities in the field. The research question here is how cells could differentiate these two processes from each other. We have investigated the role of the mitochondrial apoptotic pathway and cell energy level during differentiation of mESCs into the cardiomyocytes and their apoptosis. p53 expression, cytochrome c release, apoptosome formation, and caspase-3/7 activation are observed upon induction of both apoptosis and differentiation. However, remarkable differences are detected in time of cytochrome c appearance, apoptosome formation, and caspase activity upon induction of both processes. In apoptosis, apoptosome formation and caspase activity were observed rapidly following the cytochrome c release. Unlike apoptosis, the release of cytochrome c upon differentiation took more time, and the maximum caspase activity was also postponed for 24 h. This delay suggests that there is a regulatory mechanism during differentiation of mESCs into cardiomyocytes. The highest ATP content of cells was observed immediately after cytochrome c release 6 h after apoptosis induction and then decreased, but it was gradually increased up to 48 h after differentiation. These observations suggest that a delay in the release of cytochrome c or delay in ATP increase attenuate apoptosome formation, and caspase activation thereby discriminates apoptosis from differentiation in mESCs.	[Akbari-Birgani, Shiva; Hosseinkhani, Saman] Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran; [Mollamohamadi, Sepideh; Baharvand, Hossein] Iranian Acad Ctr Educ Culture & Res ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, ACECR, Tehran, Iran	Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Hosseinkhani, S (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran.	saman_h@modares.ac.ir; Baharvand@RoyanInstitute.org	Akbari-Birgani, Shiva/X-8696-2019	Akbari-Birgani, Shiva/0000-0001-8826-4083; Hosseinkhani, Saman/0000-0002-0345-7909				Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; Eguchi Y, 1997, CANCER RES, V57, P1835; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Ghiasi P, 2012, NEUROL RES, V34, P297, DOI 10.1179/1743132812Y.0000000012; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Hassani SN, 2012, STEM CELL REV REP, V8, P472, DOI 10.1007/s12015-011-9306-y; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim J, 2003, BREAST CANCER RES TR, V79, P321, DOI 10.1023/A:1024043302583; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mohammadi S, 2011, PHOTOCHEM PHOTOBIOL, V87, P1338, DOI 10.1111/j.1751-1097.2011.00973.x; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Nazari M, 2011, PHOTOCH PHOTOBIO SCI, V10, P1203, DOI 10.1039/c1pp05012e; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Sanders EJ, 2002, J ANAT, V201, P121, DOI 10.1046/j.1469-7580.2002.00081.x; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Torkzadeh-Mahani M, 2012, BIOSENS BIOELECTRON, V38, P362, DOI 10.1016/j.bios.2012.06.034; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	37	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16905	16913		10.1074/jbc.M113.536730	http://dx.doi.org/10.1074/jbc.M113.536730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24755221	Green Published, hybrid			2022-12-25	WOS:000338016200026
J	Baker, B; Maitra, U; Geng, S; Li, LW				Baker, Bianca; Maitra, Urmila; Geng, Shuo; Li, Liwu			Molecular and Cellular Mechanisms Responsible for Cellular Stress and Low-grade Inflammation Induced by a Super-low Dose of Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; INSULIN-RESISTANCE; INNATE IMMUNITY; KAPPA-B; NECROPTOSIS; MACROPHAGES; APOPTOSIS; NECROSIS; LIPOPOLYSACCHARIDE; OBESITY	Super-low-dose endotoxemia in experimental animals and humans is linked to low-grade chronic inflammatory diseases. However, the underlying molecular and cellular mechanisms are not well understood. In this study, we examined the effects of a super-low dose of LPS on low-grade inflammation in macrophages as well as underlying mechanisms. We observed that a super-low dose of LPS induces mitochondrial fission and cell necroptosis in primary murine macrophages, dependent upon interleukin 1 receptor-associated kinase (IRAK-1). Mechanistically, our study reveals that a super-low dose of LPS causes protein ubiquitination and degradation of mitofusin 1 (Mfn1), a molecule required for maintaining proper mitochondrial fusion. A super-low dose of LPS also leads to dephosphorylation and activation of Drp1, a molecule responsible for mitochondrial fission and cell necroptosis. Furthermore, we demonstrated that a super-low dose of LPS activates receptor interacting protein 3 kinase (RIP3), a key molecule critical for the assembly of the necrosome complex, the initiation of Drp1 dephosphorylation, and necroptosis. The effects of a super-low dose of LPS are abolished in macrophages harvested from IRAK-1-deficient mice. Taken together, our study identified a novel molecular pathway that leads to cellular stress and necroptosis in macrophages challenged with a super-low dose of endotoxin. This may reconcile low-grade inflammation often associated with low-grade endotoxemia.	[Baker, Bianca; Maitra, Urmila; Geng, Shuo; Li, Liwu] Virginia Tech, Dept Biol Sci, Lab Inflammat Biol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Tech, Dept Biol, Life Sci 1 Bldg,Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu	Geng, Shuo/J-3735-2013	Li, Liwu/0000-0001-8870-5299	National Institutes of Health [R01HL115835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL115835.	Bao LP, 2006, J BIOL CHEM, V281, P33635, DOI 10.1074/jbc.M606339200; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang S., 2011, J MED SCI, V31, P191; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Ferrari LF, 2011, J NEUROSCI, V31, P11404, DOI 10.1523/JNEUROSCI.2223-11.2011; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ishikawa J, 2007, STROKE, V38, P911, DOI 10.1161/01.STR.0000258115.46765.f1; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kim SJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.238; Koshinuma S, 2014, J ANESTH, V28, P235, DOI 10.1007/s00540-013-1716-3; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Li LW, 2003, J ENDOTOXIN RES, V9, P39, DOI 10.1179/096805103125001324; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Lira FS, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-82; Liu G, 2007, J IMMUNOL, V179, P4125, DOI 10.4049/jimmunol.179.6.4125; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Maitra U, 2013, ARTERIOSCL THROM VAS, V33, P24, DOI 10.1161/ATVBAHA.112.300049; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Maitra U, 2009, J BIOL CHEM, V284, P35403, DOI 10.1074/jbc.M109.059501; Maitra U, 2009, MOL CELL BIOL, V29, P5989, DOI 10.1128/MCB.00541-09; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P240, DOI 10.1038/ijo.2009.242; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Shnyra A, 1998, J IMMUNOL, V160, P3729; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhou ZR, 2012, PROTEIN CELL, V3, P811, DOI 10.1007/s13238-012-2083-9	50	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16262	16269		10.1074/jbc.M114.569210	http://dx.doi.org/10.1074/jbc.M114.569210			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24759105	hybrid, Green Published			2022-12-25	WOS:000337965700030
J	Hislop, JN; Islam, TA; Eleftheriadou, I; Carpentier, DCJ; Trabalza, A; Parkinson, M; Schiavo, G; Mazarakis, ND				Hislop, James N.; Islam, Tarin A.; Eleftheriadou, Ioanna; Carpentier, David C. J.; Trabalza, Antonio; Parkinson, Michael; Schiavo, Giampietro; Mazarakis, Nicholas D.			Rabies Virus Envelope Glycoprotein Targets Lentiviral Vectors to the Axonal Retrograde Pathway in Motor Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; NEUROTROPHIN RECEPTOR P75(NTR); CELL-ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; TETANUS TOXIN; OVERLAP EXTENSION; ENDOCYTIC PATHWAY; MEMBRANE-FUSION; EARLY ENDOSOMES; LIVE CELLS	Rabies pseudotyped lentiviral vectors have great potential in gene therapy, not least because of their ability to transduce neurons following their distal axonal application. However, very little is known about the molecular processes that underlie their retrograde transport and cell transduction. Using multiple labeling techniques and confocal microscopy, we demonstrated that pseudotyping with rabies virus envelope glycoprotein (RV-G) enabled the axonal retrograde transport of two distinct subtypes of lentiviral vector in motor neuron cultures. Analysis of this process revealed that these vectors trafficked through Rab5-positive endosomes and accumulated within a non-acidic Rab7 compartment. RV-G pseudotyped vectors were co-transported with both the tetanus neurotoxin-binding fragment and the membrane proteins thought to mediate rabies virus endocytosis (neural cell adhesion molecule, nicotinic acetylcholine receptor, and p75 neurotrophin receptor), thus demonstrating that pseudotyping with RV-G targets lentiviral vectors for transport along the same pathway exploited by several toxins and viruses. Using motor neurons cultured in compartmentalized chambers, we demonstrated that axonal retrograde transport of these vectors was rapid and efficient; however, it was not able to transduce the targeted neurons efficiently, suggesting that impairment in processes occurring after arrival of the viral vector in the soma is responsible for the low transduction efficiency seen in vivo, which suggests a novel area for improvement of gene therapy vectors.	[Hislop, James N.; Islam, Tarin A.; Eleftheriadou, Ioanna; Carpentier, David C. J.; Trabalza, Antonio; Mazarakis, Nicholas D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, London W12 0NN, England; [Parkinson, Michael; Schiavo, Giampietro] Canc Res UK London Res Inst, Mol NeuroPathoBiol Lab, Lincolns Inn Fields Labs, London WC2A 3LY, England; [Schiavo, Giampietro] UCL, UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England	Imperial College London; Cancer Research UK; University of London; University College London	Mazarakis, ND (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, Du Cane Rd, London W12 0NN, England.	n.mazarakis@imperial.ac.uk		Schiavo, Giampietro/0000-0002-4319-8745; Trabalza, Antonio/0000-0003-3018-9820; Islam, Tarin/0000-0002-7602-3175; Carpentier, David/0000-0002-8172-9121	European Research Council [23314]; Imperial College funds; Cancer Research UK	European Research Council(European Research Council (ERC)European Commission); Imperial College funds; Cancer Research UK(Cancer Research UK)	This work was supported by Seventh Framework Programme European Research Council Advanced Investigators Grant 23314 (to N. D. M. supporting J. N. H., T. A. I., I. E., A. T., and D. C. J. C.), Imperial College funds (to N. D. M.), and Cancer Research UK (to M. P., K. B., and G. S.).	Adams S, 2002, FORBES, V169, P124; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bercsenyi K, 2013, CURR TOP MICROBIOL, V364, P91, DOI 10.1007/978-3-642-33570-9_5; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Butowt R, 2003, EUR J NEUROSCI, V17, P673, DOI 10.1046/j.1460-9568.2003.02497.x; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Carpentier DCJ, 2012, GENE THER, V19, P761, DOI 10.1038/gt.2011.124; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Colpitts TM, 2007, VIROLOGY, V369, P78, DOI 10.1016/j.virol.2007.07.012; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Deinhardt K, 2007, TRAFFIC, V8, P1736, DOI 10.1111/j.1600-0854.2007.00645.x; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Eleftheriadou I, 2014, MOL THER, V22, P1285, DOI 10.1038/mt.2014.49; Gaudin Y, 1999, MOL MEMBR BIOL, V16, P21, DOI 10.1080/096876899294724; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Klingen Y, 2008, J VIROL, V82, P237, DOI 10.1128/JVI.01342-07; Kovalevich J, 2012, FUTURE VIROL, V7, P687, DOI 10.2217/FVL.12.57; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; Lei Yuning, 2009, J Biol Eng, V3, P8, DOI 10.1186/1754-1611-3-8; LENTZ TL, 1983, YALE J BIOL MED, V56, P315; Liu YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067400; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mentis GZ, 2006, J NEUROSCI METH, V157, P208, DOI 10.1016/j.jneumeth.2006.04.011; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Oksayan Sibil, 2012, Infectious Disorders - Drug Targets, V12, P38; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rasalingam P, 2005, VIRUS RES, V111, P55, DOI 10.1016/j.virusres.2005.03.010; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Restani L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003087; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Schenkwein D, 2010, HUM GENE THER, V21, P589, DOI 10.1089/hum.2009.051; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056; St Pierre CA, 2011, EXP MOL PATHOL, V91, P723, DOI 10.1016/j.yexmp.2011.05.011; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Trabalza A, 2013, GENE THER, V20, P723, DOI 10.1038/gt.2012.85; Trabalza A, 2014, J VIROL, V88, P2877, DOI 10.1128/JVI.03376-13; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; Verhoeyen E, 2004, J GENE MED, V6, pS83, DOI 10.1002/jgm.494; Wade A, 2012, J NEUROCHEM, V121, P575, DOI 10.1111/j.1471-4159.2012.07658.x; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wong LF, 2006, HUM GENE THER, V17, P1, DOI 10.1089/hum.2006.17.1; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	61	25	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16148	16163		10.1074/jbc.M114.549980	http://dx.doi.org/10.1074/jbc.M114.549980			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24753246	Green Published, hybrid			2022-12-25	WOS:000337965700021
J	Bos, MP; Grijpstra, J; Boxtel, RTV; Tommassen, J				Bos, Martine P.; Grijpstra, Jan; Boxtel, Ria Tommassen-van; Tommassen, Jan			Involvement of Neisseria meningitidis Lipoprotein GNA2091 in the Assembly of a Subset of Outer Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Membrane Biogenesis; Membrane Protein; Microbiology; Vaccine; BAM Complex; Neisseria meningitidis; YraP	SEROGROUP-B; LIPOPOLYSACCHARIDE TRANSPORT; IDENTIFICATION; BIOGENESIS; COMPLEX; VACCINE; CHAPERONE; BACTERIA; DOMAIN; BAM	GNA2091 of Neisseria meningitidis is a lipoprotein of unknown function that is included in the novel 4CMenB vaccine. Here, we investigated the biological function and the subcellular localization of the protein. We demonstrate that GNA2091 functions in the assembly of outer membrane proteins (OMPs) because its absence resulted in the accumulation of misassembled OMPs. Cell fractionation and protease accessibility experiments showed that the protein is localized at the periplasmic side of the outer membrane. Pulldown experiments revealed that it is not stably associated with the -barrel assembly machinery, the previously identified complex for OMP assembly. Thus, GNA2091 constitutes a novel outer membrane-based lipoprotein required for OMP assembly. Furthermore, its location at the inner side of the outer membrane indicates that protective immunity elicited by this antigen cannot be due to bactericidal or opsonic activity of antibodies.	[Bos, Martine P.; Grijpstra, Jan; Boxtel, Ria Tommassen-van; Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University	Bos, MP (corresponding author), Univ Utrecht, Dept Mol Microbiol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	m.bos@uu.nl	Tommassen, Jan/I-1690-2016	Tommassen, Jan/0000-0001-7633-4945				Anwari K, 2012, MOL MICROBIOL, V84, P832, DOI 10.1111/j.1365-2958.2012.08059.x; Anwari K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008619; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2011, J BIOL CHEM, V286, P28688, DOI 10.1074/jbc.M111.239673; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Pan JY, 2010, J PROTEOME RES, V9, P3730, DOI 10.1021/pr100301f; Pannekoek Y, 2009, FEMS MICROBIOL LETT, V294, P216, DOI 10.1111/j.1574-6968.2009.01568.x; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Steeghs L, 2002, CELL MICROBIOL, V4, P599, DOI 10.1046/j.1462-5822.2002.00214.x; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Teriete P, 2010, BIOCHEMISTRY-US, V49, P2768, DOI 10.1021/bi100158s; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; Veld RAGHI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029002; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yeats C, 2003, TRENDS BIOCHEM SCI, V28, P352, DOI 10.1016/S0968-0004(03)00115-4	39	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15602	15610		10.1074/jbc.M113.539510	http://dx.doi.org/10.1074/jbc.M113.539510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24755216	Green Published, hybrid			2022-12-25	WOS:000337465400042
J	van Schalkwyk, C; Variava, E; Shapiro, AE; Rakgokong, M; Masonoke, K; Lebina, L; Welte, A; Martinson, N				van Schalkwyk, Cari; Variava, Ebrahim; Shapiro, Adrienne E.; Rakgokong, Modiehi; Masonoke, Katlego; Lebina, Limakatso; Welte, Alex; Martinson, Neil			Incidence of TB and HIV in Prospectively Followed Household Contacts of TB Index Patients in South Africa	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; DISCORDANT COUPLES; RANDOMIZED TRIAL; SEXUAL-BEHAVIOR; BURDEN	Objective: To report the incidence rates of TB and HIV in household contacts of index patients diagnosed with TB. Design: A prospective cohort study in the Matlosana sub-district of North West Province, South Africa. Methods: Contacts of index TB patients received TB and HIV testing after counseling at their first household visit and were then followed up a year later, in 2010. TB or HIV diagnoses that occurred during the period were determined. Results: For 2,377 household contacts, the overall observed TB incidence rate was 1.3 per 100 person years (95% CI 0.9-1.9/100py) and TB incidence for individuals who were HIV-infected and HIV seronegative at baseline was 5.4/100py (95% CI 2.9-9.0/100py) and 0.7/100py ( 95% CI 0.3-1.4/100py), respectively. The overall HIV incidence rate was 2.2/100py (95% CI 1.3-8.4/100py). Conclusions: In the year following a household case finding visit when household contacts were tested for TB and HIV, the incidence rate of both active TB and HIV infection was found to be extremely high. Clearly, implementing proven strategies to prevent HIV acquisition and preventing TB transmission and progression to disease remains a priority in settings such as South Africa.	[van Schalkwyk, Cari; Welte, Alex] Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn DST NRF, Ctr Excellence Epidemiol Modelling & Anal SACEMA, ZA-7600 Stellenbosch, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp Complex, North West Dept Hlth, Klerksdorp, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Johannesburg, South Africa; [Shapiro, Adrienne E.] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Rakgokong, Modiehi; Masonoke, Katlego; Lebina, Limakatso; Martinson, Neil] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	Stellenbosch University; University of Witwatersrand; University of California System; University of California San Francisco; University of Witwatersrand; Johns Hopkins University	van Schalkwyk, C (corresponding author), Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn DST NRF, Ctr Excellence Epidemiol Modelling & Anal SACEMA, ZA-7600 Stellenbosch, South Africa.	carivs@sun.ac.za	Variava, Ebrahim/AAO-5717-2020; Shapiro, Adrienne E/GQZ-4527-2022	Variava, Ebrahim/0000-0003-2888-789X; Shapiro, Adrienne E/0000-0002-3106-1258; van Schalkwyk, Cari/0000-0001-5154-1390; Motlhaoleng, Katlego/0000-0001-7644-1038	USAID; Canadian International Development Agency [A033749]; Fogarty ICORTHA grant [5 U2RTW00730/3]; NIH MSTP training grant [T32GM007309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	USAID(United States Agency for International Development (USAID)); Canadian International Development Agency; Fogarty ICORTHA grant; NIH MSTP training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	USAID funded household visits, the Canadian International Development Agency (Project A033749) funded laboratory testing and the North West Department of Health supplied HIV test kits. EV, LL and MR received research training support through a Fogarty ICORTHA grant (5 U2RTW00730/3). AES received funding support through NIH MSTP training grant (T32GM007309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1; Claassens MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076272; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hoffmann CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062211; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Kritski AL, 1996, AM J RESP CRIT CARE, V153, P331, DOI 10.1164/ajrccm.153.1.8542139; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Vella V, 2011, INT J TUBERC LUNG D, V15, P1170, DOI 10.5588/ijtld.10.0781; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; World Health Organization, 2019, 10 HLTH ISS WHO WILL, DOI DOI 10.1016/S2213-2600(19)30418-7	19	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95372	10.1371/journal.pone.0095372	http://dx.doi.org/10.1371/journal.pone.0095372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759741	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200051
J	Nesti, A; Beykirch, KA; MacNeilage, PR; Barnett-Cowan, M; Bulthoff, HH				Nesti, Alessandro; Beykirch, Karl A.; MacNeilage, Paul R.; Barnett-Cowan, Michael; Buelthoff, Heinrich H.			The Importance of Stimulus Noise Analysis for Self-Motion Studies	PLOS ONE			English	Article							DETECTION THRESHOLDS; HUMAN DISCRIMINATION	Motion simulators are widely employed in basic and applied research to study the neural mechanisms of perception and action during inertial stimulation. In these studies, uncontrolled simulator-introduced noise inevitably leads to a disparity between the reproduced motion and the trajectories meticulously designed by the experimenter, possibly resulting in undesired motion cues to the investigated system. Understanding actual simulator responses to different motion commands is therefore a crucial yet often underestimated step towards the interpretation of experimental results. In this work, we developed analysis methods based on signal processing techniques to quantify the noise in the actual motion, and its deterministic and stochastic components. Our methods allow comparisons between commanded and actual motion as well as between different actual motion profiles. A specific practical example from one of our studies is used to illustrate the methodologies and their relevance, but this does not detract from its general applicability. Analyses of the simulator's inertial recordings show direction-dependent noise and nonlinearity related to the command amplitude. The Signal-toNoise Ratio is one order of magnitude higher for the larger motion amplitudes we tested, compared to the smaller motion amplitudes. Simulator-introduced noise is found to be primarily of deterministic nature, particularly for the stronger motion intensities. The effect of simulator noise on quantification of animal/human motion sensitivity is discussed. We conclude that accurate recording and characterization of executed simulator motion are a crucial prerequisite for the investigation of uncertainty in self-motion perception.	[Nesti, Alessandro; Beykirch, Karl A.; Barnett-Cowan, Michael; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [MacNeilage, Paul R.] Univ Munich, Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Barnett-Cowan, Michael] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; University of Munich; University of Waterloo; Korea University	Nesti, A (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	alessandro.nesti@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012	Bülthoff, Heinrich H/0000-0003-2568-0607	Max Planck Society; German Federal Ministry of Education and Research [01 EO 0901]; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	AN, MBC and KAB were supported by funds from the Max Planck Society. PRM was supported by the German Federal Ministry of Education and Research under the Grant code 01 EO 0901. This work was also supported by the Brain Korea 21 PLUS Program through the National Research Foundation of Korea funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARD WG, 1979, 144 AGARD WG NATO; Ahn HS, 2007, IEEE T SYST MAN CY C, V37, P1099, DOI 10.1109/TSMCC.2007.905759; Baloh RW, 2011, BALOH HONRUBIAS CLIN; Barany R, 1907, MONATSSCHR OHRENHEIL, P41477; Barnett-Cowan M, 2012, JOVE-J VIS EXP, DOI 10.3791/3436; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; Bertolini G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036763; Ellis G, 2012, CONTROL SYSTEM DESIGN GUIDE: USING YOUR COMPUTER TO UNDERSTAND AND DIAGNOSE FEEDBACK CONTROLLERS, 4TH EDITION, P1; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P996, DOI 10.1152/jn.1976.39.5.996; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; Gong WS, 2002, IEEE T BIO-MED ENG, V49, P175, DOI 10.1109/10.979358; Grant P, 2001, MOTION CHARACTERISTI, V2001, P1; Grant PR, 2007, AIAA MODELING SIMULA; Grant W, 1991, J VESTIBUL RES-EQUIL, V1, P139; Greig GL, 1988, MASKING MOTION CUES; HALVORSEN WG, 1977, SOUND VIB, V11, P8; Hosman R, 1978, LR265 TU DELFT; Lopez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048293; LOWENSTEIN O, 1955, J PHYSIOL-LONDON, V127, P104, DOI 10.1113/jphysiol.1955.sp005241; Mach E., 1875, GRUNDLINIEN LEHRE BE; MacNeilage PR, 2010, J NEUROPHYSIOL, V104, P765, DOI 10.1152/jn.01067.2009; Mallery RM, 2010, EXP BRAIN RES, V204, P11, DOI 10.1007/s00221-010-2288-1; McConnell K.G., 1995, VIBRATION TESTING TH; Meares D, 1998, REPORT MPEG 2 AAC ST; Mouchnino L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055081; Naseri AR, 2012, EXP BRAIN RES, V218, P455, DOI 10.1007/s00221-012-3035-6; Nesti A, 2014, EXP BRAIN RES, V232, P303, DOI 10.1007/s00221-013-3741-8; Richerson SJ, 2003, GAIT POSTURE, V18, P11, DOI 10.1016/S0966-6362(02)00189-3; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; Seidman SH, 2008, EXP BRAIN RES, V184, P13, DOI 10.1007/s00221-007-1072-3; Tahboub K, 2007, INTEGR COMPUT-AID E, V14, P15; Teufel H.J., 2007, AIAA MOD SIM TECHN C, V1, P1; Van Drongelen W, 2008, SIGNAL PROCESSING NE; Widrow B, 1975, P IEEE, V63, P105; Yu XJ, 2012, J NEUROSCI, V32, P8306, DOI 10.1523/JNEUROSCI.1067-12.2012; Zaichik LE, 1999, AIAA MODELING AND SIMULATION TECHNOLOGIES CONFERENCE, P512	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94570	10.1371/journal.pone.0094570	http://dx.doi.org/10.1371/journal.pone.0094570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755871	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300012
J	Scholtz, RV; Overman, AR				Scholtz, Richard V., III; Overman, Allen R.			Estimating Seasonal Nitrogen Removal and Biomass Yield by Annuals with the Extended Logistic Model	PLOS ONE			English	Article							FORAGE GRASS RESPONSE; CORN RESPONSE; BAHIAGRASS RESPONSE; BERMUDAGRASS	The Extended Logistic Model (ELM) has been previously shown to adequately describe seasonal biomass production and N removal with respect to applied N for several types of annuals and perennials. In this analysis, data from a corn (Zea mays L.) study with variable applied N were analyzed to test hypotheses that certain parameters in the ELM are invariant with respect to site specific attributes, like environmental conditions and soil type. Invariance to environmental conditions suggests such parameters may be functions of the crop characteristics and certain other management practices alone (like plant population, planting date, harvest date). The first parameter analyzed was Delta b, the difference between the N uptake shifting parameter and the biomass shifting parameter. The second parameter tested was N-cm, the maximum N concentration. Both parameters were shown to be statistically invariant, despite soil and site differences. This was determined using analysis of variance with normalized nonlinear regression of the ELM on the data from the study. This analysis lends further evidence that there are common parameters involved in the ELM that do not rely on site-specific or situation-specific factors. More insight into the derivation of, definition of, and logic behind the various parameters involved in the model are also given in this paper.	[Scholtz, Richard V., III; Overman, Allen R.] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Scholtz, RV (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32610 USA.	rscholtz@ufl.edu		Scholtz, Richard/0000-0001-8989-0131	Florida Experiment Station	Florida Experiment Station	The funding of this analysis was provided by the Florida Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferris T., 1989, COMING AGE MILKY WAY; France J., 1984, MATH MODELS AGR; Kamprath E. J., 1986, TECHNICAL B N CAROLI, V282; Monteith JL, 1996, AGRON J, V88, P695, DOI 10.2134/agronj1996.00021962008800050003x; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; Overman AR, 2012, J PLANT NUTR, V35, P2118, DOI 10.1080/01904167.2012.724137; Overman A.R., 2002, MATH MODELS CROP GRO; Overman AR, 2006, COMMUN SOIL SCI PLAN, V37, P1157, DOI 10.1080/00103620600623350; OVERMAN AR, 1994, AGRON J, V86, P617, DOI 10.2134/agronj1994.00021962008600040007x; Overman AR, 2004, COMMUN SOIL SCI PLAN, V35, P2485, DOI [10.1081/CSS-200030343, 10.1081/LCSS-200030343]; Overman AR, 2004, J PLANT NUTR, V27, P1747, DOI 10.1081/PLN-200026411; Overman AR, 2004, J PLANT NUTR, V27, P1757, DOI 10.1081/PLN-200026416; Overman AR, 2003, T ASAE, V46, P1375, DOI 10.13031/2013.15448; Overman AR, 2003, COMMUN SOIL SCI PLAN, V34, P2177, DOI 10.1081/CSS-120024056; Overman AR, 2003, COMMUN SOIL SCI PLAN, V34, P2163, DOI 10.1081/CSS-120024055; Overman AR, 2003, COMMUN SOIL SCI PLAN, V34, P1303, DOI 10.1081/CSS-120020446; Overman AR, 2002, COMMUN SOIL SCI PLAN, V33, P3609, DOI 10.1081/CSS-120015910; OVERMAN AR, 1995, T ASAE, V38, P103, DOI 10.13031/2013.27817; OVERMAN AR, 1990, COMMUN SOIL SCI PLAN, V21, P595, DOI 10.1080/00103629009368255; Overman AR, 1999, J PLANT NUTR, V22, P81, DOI 10.1080/01904169909365608; Overman AR, 1998, COMMUN SOIL SCI PLAN, V29, P237, DOI 10.1080/00103629809369941; OVERMAN AR, 1994, AGRON J, V86, P1012, DOI 10.2134/agronj1994.00021962008600060015x; Overman AR, 2012, MEMOIR MODEL YIELD P; Reck WR, 1996, J PLANT NUTR, V19, P201, DOI 10.1080/01904169609365117; Scholtz RV, 2002, THESIS U FLORIDA GAI; Smith, 1998, APPL REGRESSION ANAL, V3	26	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95934	10.1371/journal.pone.0095934	http://dx.doi.org/10.1371/journal.pone.0095934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755574	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300120
J	Singh, S; Mondal, P; Trigun, SK				Singh, Santosh; Mondal, Papia; Trigun, Surendra K.			Acute Liver Failure in Rats Activates Glutamine-Glutamate Cycle but Declines Antioxidant Enzymes to Induce Oxidative Stress in Cerebral Cortex and Cerebellum	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; PORTACAVAL ANASTOMOSIS; BRAIN-SLICES; ENCEPHALOPATHY; HYPERAMMONEMIA; GLUTATHIONE; SYNTHETASE; CIRRHOSIS; AMMONIA; MECHANISMS	Background and Purpose: Liver dysfunction led hyperammonemia (HA) causes a nervous system disorder; hepatic encephalopathy (HE). In the brain, ammonia induced glutamate-excitotoxicity and oxidative stress are considered to play important roles in the pathogenesis of HE. The brain ammonia metabolism and antioxidant enzymes constitute the main components of this mechanism; however, need to be defined in a suitable animal model. This study was aimed to examine this aspect in the rats with acute liver failure (ALF). Methods: ALF in the rats was induced by intraperitoneal administration of 300 mg thioacetamide/Kg. b.w up to 2 days. Glutamine synthetase (GS) and glutaminase (GA), the two brain ammonia metabolizing enzymes vis a vis ammonia and glutamate levels and profiles of all the antioxidant enzymes vis a vis oxidative stress markers were measured in the cerebral cortex and cerebellum of the control and the ALF rats. Results: The ALF rats showed significantly increased levels of ammonia in the blood (HA) but little changes in the cortex and cerebellum. This was consistent with the activation of the GS-GA cycle and static levels of glutamate in these brain regions. However, significantly increased levels of lipid peroxidation and protein carbonyl contents were consistent with the reduced levels of all the antioxidant enzymes in both the brain regions of these ALF rats. Conclusion: ALF activates the GS-GA cycle to metabolize excess ammonia and thereby, maintains static levels of ammonia and glutamate in the cerebral cortex and cerebellum. Moreover, ALF induces oxidative stress by reducing the levels of all the antioxidant enzymes which is likely to play important role, independent of glutamate levels, in the pathogenesis of acute HE.	[Singh, Santosh] Guru Ghasidas Vishwavidyalaya, Dept Zool, Bilaspur, Chhattisgarh, India; [Mondal, Papia; Trigun, Surendra K.] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India	Guru Ghasidas Vishwavidyalaya; Banaras Hindu University (BHU)	Trigun, SK (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	sktrigun@sify.com	Singh, Santosh/AAI-4521-2020	SINGH, SANTOSH/0000-0003-2308-1483	DAE: BRNS Govt. of India [P-29/64]	DAE: BRNS Govt. of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	This work was financially supported by a DAE: BRNS Govt. of India project sanctioned to SKT (BHU;P-29/64). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2010, BIOCHEM PHARMACOL, V80, P1303, DOI 10.1016/j.bcp.2010.07.024; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; [Anonymous], 1998, HEPATOLOGY, V35, P716; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Butterworth RE, 2000, J HEPATOL, V32, P171, DOI 10.1016/S0168-8278(00)80424-9; Butterworth RF, 2009, LIVER INT, V29, P783, DOI 10.1111/j.1478-3231.2009.02034.x; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Dingledine Raymond, 1999, P315; Felipo, 2009, HDB NEUROCHEMISTRY M, P43, DOI [10.1007/978-0-387-30375-8_3, DOI 10.1007/978-0-387-30375-8_3]; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Gorg B, 2010, HEPATOLOGY, V52, P256, DOI 10.1002/hep.23656; Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176; Haussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hou WC, 2004, ELECTROPHORESIS, V25, P2926, DOI 10.1002/elps.200406041; Jeon JM, 2009, AFR J MICROBIOL RES, V3, P605; KATO M, 1992, HEPATOLOGY, V15, P1060, DOI 10.1002/hep.1840150615; Koiri RK, 2009, INVEST NEW DRUG, V27, P503, DOI 10.1007/s10637-008-9202-8; MAGISTRETTI PJ, 2003, FUNDAMENTAL NEUROSCI, P339; Marquez J, 2009, NEUROCHEM INT, V55, P64, DOI 10.1016/j.neuint.2009.02.022; Mates JM, 2009, MINI-REV MED CHEM, V9, P1202, DOI 10.2174/138955709789055180; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Mehrotra A, 2013, MOL CELL BIOCHEM, V381, P157, DOI 10.1007/s11010-013-1698-3; Mehrotra A, 2012, NEUROCHEM RES, V37, P171, DOI 10.1007/s11064-011-0596-x; Murthy CRK, 2000, NEUROCHEM INT, V37, P255, DOI 10.1016/S0197-0186(00)00028-0; Prakash R, 2010, NAT REV GASTRO HEPAT, V7, P515, DOI 10.1038/nrgastro.2010.116; RAO VLR, 1995, J NEUROCHEM, V65, P677; Rodrigo R, 2006, NEUROCHEM INT, V48, P472, DOI 10.1016/j.neuint.2005.10.014; Romero-Gomez M, 2006, WORLD J GASTROENTERO, V12, P2406, DOI 10.3748/wjg.v12.i15.2406; Sathyasaikumar KV, 2007, NEUROCHEM RES, V32, P517, DOI 10.1007/s11064-006-9265-x; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SHANKAR RA, 1985, ARCH BIOCHEM BIOPHYS, V239, P248, DOI 10.1016/0003-9861(85)90833-1; Shapiro H, 2006, J GASTROEN HEPATOL, V21, P358, DOI 10.1111/j.1440-1746.2005.03984.x; Singh S, 2008, NEUROCHEM RES, V33, P103, DOI 10.1007/s11064-007-9422-x; Singh S, 2010, CEREBELLUM, V9, P384, DOI 10.1007/s12311-010-0172-y; Siqueira IR, 2005, INT J DEV NEUROSCI, V23, P663, DOI 10.1016/j.ijdevneu.2005.03.001; Skowronska M, 2012, NEUROTOX RES, V21, P236, DOI 10.1007/s12640-011-9269-4; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5	38	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95855	10.1371/journal.pone.0095855	http://dx.doi.org/10.1371/journal.pone.0095855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755687	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300106
J	Skrnjug, I; Rueckert, C; Libanova, R; Lienenklaus, S; Weiss, S; Guzman, CA				Skrnjug, Ivana; Rueckert, Christine; Libanova, Rimma; Lienenklaus, Stefan; Weiss, Siegfried; Guzman, Carlos A.			The Mucosal Adjuvant Cyclic di-AMP Exerts Immune Stimulatory Effects on Dendritic Cells and Macrophages	PLOS ONE			English	Article							INNATE IMMUNITY; III INTERFERON; DNA SENSOR; GMP-AMP; 2ND-MESSENGER; EXPRESSION; DINUCLEOTIDE; MODULATION; RESPONSES; REVEALS	The cyclic di-nucleotide bis-(3',5')-cyclic dimeric adenosine monophosphate (c-di-AMP) is a candidate mucosal adjuvant with proven efficacy in preclinical models. It was shown to promote specific humoral and cellular immune responses following mucosal administration. To date, there is only fragmentary knowledge on the cellular and molecular mode of action of c-di-AMP. Here, we report on the identification of dendritic cells and macrophages as target cells of c-di-AMP. We show that c-di-AMP induces the cell surface up-regulation of T cell co-stimulatory molecules as well as the production of interferon-beta. Those responses were characterized by in vitro experiments with murine and human immune cells and in vivo studies in mice. Analyses of dendritic cell subsets revealed conventional dendritic cells as principal responders to stimulation by c-di-AMP. We discuss the impact of the reported antigen presenting cell activation on the previously observed adjuvant effects of c-di-AMP in mouse immunization studies.	[Skrnjug, Ivana; Rueckert, Christine; Libanova, Rimma; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Lienenklaus, Stefan; Weiss, Siegfried] Helmholtz Ctr Infect Res, Dept Mol Immunol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Rueckert, C (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	christine.rueckert@helmholtz-hzi.de	Lienenklaus, Stefan/HIK-0899-2022	Lienenklaus, Stefan/0000-0003-4790-3445	EU (PANFLUVAC); BMBF in the context of the programs Gerontosys 2 (Gerontoshield); EuroNanoMed (HCVAX); ERANetRUS (HCRUS); Helmholtz Association (IG-SCID)	EU (PANFLUVAC); BMBF in the context of the programs Gerontosys 2 (Gerontoshield)(Federal Ministry of Education & Research (BMBF)); EuroNanoMed (HCVAX); ERANetRUS (HCRUS); Helmholtz Association (IG-SCID)	This work was supported in part by grants from the EU (PANFLUVAC); BMBF in the context of the programs Gerontosys 2 (Gerontoshield), EuroNanoMed (HCVAX) and ERANetRUS (HCRUS), and the Helmholtz Association (IG-SCID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Blaauboer SM, 2014, J IMMUNOL, V192, P492, DOI 10.4049/jimmunol.1301812; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Ciabattini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019346; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dresing P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015567; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hu DL, 2009, VACCINE, V27, P4867, DOI 10.1016/j.vaccine.2009.04.053; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kassianos AJ, 2010, METHODS MOL BIOL, V595, P45, DOI 10.1007/978-1-60761-421-0_3; Ko SY, 2007, EUR J IMMUNOL, V37, P2127, DOI 10.1002/eji.200636909; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Libanova R, 2012, MICROB BIOTECHNOL, V5, P168, DOI 10.1111/j.1751-7915.2011.00306.x; Libanova R, 2010, VACCINE, V28, P2249, DOI 10.1016/j.vaccine.2009.12.045; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Ogunniyi AD, 2008, VACCINE, V26, P4676, DOI 10.1016/j.vaccine.2008.06.099; Olive C, 2012, EXPERT REV VACCINES, V11, P237, DOI [10.1586/erv.11.189, 10.1586/ERV.11.189]; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Rueckert C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003001; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Solodova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018543; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; Vendetti S, 2009, METHODS, V49, P334, DOI 10.1016/j.ymeth.2009.04.018; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wegmann F, 2012, NAT BIOTECHNOL, V30, P883, DOI 10.1038/nbt.2344; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11	45	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95728	10.1371/journal.pone.0095728	http://dx.doi.org/10.1371/journal.pone.0095728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755640	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300082
J	Solheim, M; La Rosa, SL; Mathisen, T; Snipen, LG; Nes, IF; Brede, DA				Solheim, Margrete; La Rosa, Sabina Leanti; Mathisen, Thomas; Snipen, Lars G.; Nes, Ingolf F.; Brede, Dag Anders			Transcriptomic and Functional Analysis of NaCl-Induced Stress in Enterococcus faecalis	PLOS ONE			English	Article							BIOSYNTHESIS-ACTIVATING PHEROMONE; ALKYL HYDROPEROXIDE REDUCTASE; LACTIS SUBSP CREMORIS; ESCHERICHIA-COLI; GENE-EXPRESSION; SERINE-PROTEASE; REPORTER SYSTEM; OSMOTIC-STRESS; SALT STRESS; GELATINASE	The robust physiology of Enterococcus faecalis facilitates tolerance to various stresses. We here report the transcriptional response of E. faecalis V583 to growth in the presence of 6.5% NaCl. Among the early responses observed was an immediate down-regulation of mscL, accompanied by an up-regulation of genes predicted to be involved in uptake of extracellular potassium and glycine betaine. The high NaCl concentration also induced expression of chaperons and cell envelope related traits, such as the enterococcal polysaccharide antigen (epa) locus. Functional genetic analysis revealed reduced salt stress resistance in both epaB and epaE mutants. The reduced salt resistance phenotype associated with the epaB mutant was restored by complementation, hence demonstrating a role of Epa in the physiological robustness of E. faecalis. Furthermore, we demonstrate that Epa confers increased resistance towards multiple cell envelope stress-inducing factors. Accordingly, these findings delineate a potential link between the robust nature of E. faecalis and its ability to perform as a human pathogen, and provide a new perspective on the mechanisms by which Epa contributes to virulence. Notably, the high NaCl concentration also resulted in strict repression of the gelE-sprE operon and impaired gelatinase activity. We demonstrate that NaCl antagonize the GBAP-pheromone dependent induction in a concentration dependent manner.	[Solheim, Margrete; La Rosa, Sabina Leanti; Mathisen, Thomas; Nes, Ingolf F.; Brede, Dag Anders] Norwegian Univ Life Sci, Lab Microbial Gene Technol & Food Microbiol, As, Norway; [Snipen, Lars G.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, Biostat Sect, As, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Solheim, M (corresponding author), Norwegian Univ Life Sci, Lab Microbial Gene Technol & Food Microbiol, As, Norway.	margrete.solheim@nmbu.no	La Rosa, Sabina Leanti/L-4785-2019	La Rosa, Sabina Leanti/0000-0003-3527-8101	European Union 6th Framework Programme [LSHE-CT-2007-037410]; Norwegian research council [191452]	European Union 6th Framework Programme(European Commission); Norwegian research council(Research Council of NorwayEuropean Commission)	This work was financially supported by the European Union 6th Framework Programme "Approaches to Control multi-resistant Enterococci: Studies on molecular ecology, horizontal gene transfer, fitness and prevention'' ( LSHE-CT-2007-037410). SLLR and DAB were financially supported by Norwegian research council project no. 191452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEZAGA MR, 1995, MICROBIOL-UK, V141, P41; Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; ARMSTRONGBUISSERET L, 1995, MICROBIOL-SGM, V141, P1655, DOI 10.1099/13500872-141-7-1655; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; Bron PA, 2006, APPL ENVIRON MICROB, V72, P2876, DOI 10.1128/AEM.72.4.2876-2884.2006; Connil N, 2002, APPL ENVIRON MICROB, V68, P3537, DOI 10.1128/AEM.68.7.3537-3544.2002; Coyette J, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P177; Del Papa MF, 2011, J BACTERIOL, V193, P1527, DOI 10.1128/JB.01522-10; Diep DB, 2000, MICROBIOL-SGM, V146, P2155, DOI 10.1099/00221287-146-9-2155; Engelbert M, 2004, INFECT IMMUN, V72, P3628, DOI 10.1128/IAI.72.6.3628-3633.2004; Gardini F, 2001, INT J FOOD MICROBIOL, V64, P105, DOI 10.1016/S0168-1605(00)00445-1; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; HEEFNER DL, 1982, P NATL ACAD SCI-BIOL, V79, P2798, DOI 10.1073/pnas.79.9.2798; HOLO H, 1991, J BACTERIOL, V173, P3879, DOI 10.1128/JB.173.12.3879-3887.1991; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; Huycke MM, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P133; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; KUNIN CM, 1991, J LAB CLIN MED, V118, P217; La Rosa SL, 2012, APPL ENVIRON MICROB, V78, P7003, DOI 10.1128/AEM.02018-12; MEASURES JC, 1975, NATURE, V257, P398, DOI 10.1038/257398a0; Mikami K, 2003, PROG LIPID RES, V42, P527, DOI 10.1016/S0163-7827(03)00036-5; Mishra Y, 2009, BIOCHEM BIOPH RES CO, V381, P606, DOI 10.1016/j.bbrc.2009.02.100; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nakayama J, 2007, J BACTERIOL, V189, P1358, DOI 10.1128/JB.00969-06; Nakayama J, 2006, J BACTERIOL, V188, P8321, DOI 10.1128/JB.00865-06; Nakayama J, 2013, ACS CHEM BIOL, V8, P804, DOI 10.1021/cb300717f; Nakayama J, 2009, ANTIMICROB AGENTS CH, V53, P580, DOI 10.1128/AAC.00995-08; Nilsen T, 1998, J BACTERIOL, V180, P1848, DOI 10.1128/JB.180.7.1848-1854.1998; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piuri M, 2005, J APPL MICROBIOL, V98, P84, DOI 10.1111/j.1365-2672.2004.02428.x; POLAREK JW, 1992, J BACTERIOL, V174, P2145, DOI 10.1128/JB.174.7.2145-2151.1992; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rigottier-Gois L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029023; Rud I, 2006, MICROBIOL-SGM, V152, P1011, DOI 10.1099/mic.0.28599-0; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sava IG, 2010, CLIN MICROBIOL INFEC, DOI [10.1111/j.1198-743X.2010.03213.x, DOI 10.1111/J.1198-743X.2010.03213.X]; Schniederberend M, 2010, BBA-BIOMEMBRANES, V1798, P32, DOI 10.1016/j.bbamem.2009.10.002; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Singh KV, 2009, J INFECT DIS, V200, P417, DOI 10.1086/600124; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Solheim M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-194; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; Thurlow LR, 2010, INFECT IMMUN, V78, P4936, DOI 10.1128/IAI.01118-09; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000	59	32	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94571	10.1371/journal.pone.0094571	http://dx.doi.org/10.1371/journal.pone.0094571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755907	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300013
J	Chen, RX; Lu, WM; Zhu, LP; Lu, MP; Wang, ML; Wang, YL; Chen, XY; Zhu, XJ; Yin, M; Zhang, ZD; Cheng, L				Chen, Ruo-Xi; Lu, Wen-Min; Zhu, Lu-Ping; Lu, Mei-Ping; Wang, Mei-Lin; Wang, Yun-Li; Chen, Xin-Yuan; Zhu, Xin-Jie; Yin, Min; Zhang, Zheng-Dong; Cheng, Lei			Association Study on ADAM33 Polymorphisms in Mite-Sensitized Persistent Allergic Rhinitis in a Chinese Population	PLOS ONE			English	Article							GENE POLYMORPHISMS; LUNG-FUNCTION; BRONCHIAL HYPERRESPONSIVENESS; INCREASED EXPRESSION; METALLOPROTEASE 33; PEDIATRIC ASTHMA; HAN POPULATION; DISINTEGRIN; DISEASE; SUSCEPTIBILITY	Background: The ADAM33 gene has been identified as a potentially important asthma candidate gene and polymorphisms in this gene have been shown to be associated with asthma and seasonal allergic rhinitis. Objective: To assess whether the ADAM33 polymorphisms are associated with persistent allergic rhinitis (PER) due to house dust mites in a Chinese population. Methods: In a hospital-based case-control study of 515 patients with mite-sensitized PER and 495 healthy controls, we genotyped seven single nucleotide polymorphisms (SNPs) in ADAM33. Serum levels of eosinophil cationic protein, total IgE and allergen-specific IgE against Dermatophagoides pteronyssinus and Dermatophagoides farinae were measured by the ImmunoCAP assays. Results: In the single-locus analysis, three polymorphisms, rs3918392 (F1), rs528557 (S2) and rs2787093, were significantly associated with mite-sensitized PER. SNP S2 was associated with significantly increased risk both of asthmatic and nonasthmatic mite-sensitized PER. In the combined genotypes analysis, individuals with 2-4 risk alleles had a significantly higher risk of mite-sensitized PER (adjusted OR = 1.99, 95% CI = 1.50-2.62) than those with 0-1 risk alleles. Haplotype-based association analysis revealed that the ACAGCCT haplotype might have potential to protect against mite-sensitized PER (adjusted OR = 0.67; 95% CI = 0.49-0.90). Conclusions: Polymorphisms in the ADAM33 gene may contribute to susceptibility of mite-sensitized PER in this Chinese population.	[Chen, Ruo-Xi; Lu, Wen-Min; Zhu, Lu-Ping; Lu, Mei-Ping; Wang, Yun-Li; Chen, Xin-Yuan; Zhu, Xin-Jie; Yin, Min; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Wang, Mei-Lin; Zhang, Zheng-Dong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Yin, Min; Cheng, Lei] Nanjing Med Univ, Int Ctr Allergy Res, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Cheng, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China.	jspent@126.com	zhang, zheng/HCH-9684-2022; Lu, Wen-Min/K-9831-2019; Cheng, Lei/AAT-2690-2021	Lu, Wen-Min/0000-0003-2410-8502; Cheng, Lei/0000-0001-6541-7702	Jiangsu Higher Education Institutions; Health Promotion Project [XK200719, RC2007065, RC2011071]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education, People's Republic of China [ROCS 2008-890]; Ministry of Education; People's Republic of China	Jiangsu Higher Education Institutions; Health Promotion Project; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education, People's Republic of China; Ministry of Education; People's Republic of China	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Health Promotion Project (XK200719, RC2007065 and RC2011071) of Jiangsu Province, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS 2008-890), Ministry of Education, the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes KC, 2000, J ALLERGY CLIN IMMUN, V106, pS192; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bijanzadeh M, 2010, LUNG, V188, P415, DOI 10.1007/s00408-010-9247-2; Blakey J, 2005, THORAX, V60, P274, DOI 10.1136/thx.2004.027227; Blakey JD, 2009, THORAX, V64, P381, DOI 10.1136/thx.2008.102053; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet PJ, 2007, ALLERGY, V62, P367, DOI 10.1111/j.1398-9995.2006.01276.x; Bugiani M, 2005, ALLERGY, V60, P165, DOI 10.1111/j.1398-9995.2005.00659.x; Cakebread JA, 2004, SPRINGER SEMIN IMMUN, V25, P361, DOI 10.1007/s00281-003-0153-z; Cheng L, 2004, CLIN EXP ALLERGY, V34, P1192, DOI 10.1111/j.1365-2222.2004.02008.x; de Faria ICJ, 2008, J PEDIAT-BRAZIL, V84, P203, DOI [10.2223/JPED.1783, 10.1590/S0021-75572008000300004]; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P863, DOI 10.1016/j.jaci.2006.12.665; Gelfand Erwin W, 2009, Proc Am Thorac Soc, V6, P278, DOI 10.1513/pats.200808-090RM; Godava M, 2012, BIOMED PAP, V156, P236, DOI 10.5507/bp.2012.009; Grossman J, 1997, CHEST, V111, pS11, DOI 10.1378/chest.111.2_Supplement.11S; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Hirota T, 2006, CLIN EXP ALLERGY, V36, P884, DOI 10.1111/j.1365-2222.2006.02522.x; Holgate ST, 2006, PULM PHARMACOL THER, V19, P3, DOI 10.1016/j.pupt.2005.02.008; Holgate ST, 2010, DRUG NEWS PERSPECT, V23, P381, DOI 10.1358/dnp.2010.23.6.1437242; Holloway JW, 2004, CHEM IMMUNOL, V84, P1, DOI 10.1146/annurev.immunol.22.012703.104727; Howard TD, 2003, J ALLERGY CLIN IMMUN, V112, P717, DOI 10.1016/S0091-6749(03)01939-0; Ito I, 2007, J ALLERGY CLIN IMMUN, V119, P89, DOI 10.1016/j.jaci.2006.08.038; Jongepier H, 2004, CLIN EXP ALLERGY, V34, P757, DOI 10.1111/j.1365-2222.2004.1938.x; Kedda MA, 2006, EUR J HUM GENET, V14, P1027, DOI 10.1038/sj.ejhg.5201662; Lee JH, 2004, CLIN EXP ALLERGY, V34, P860, DOI 10.1111/j.1365-2222.2004.01977.x; Lee YH, 2012, INFLAMM RES, V61, P1355, DOI 10.1007/s00011-012-0536-5; Leynaert Benedicte, 2000, Journal of Allergy and Clinical Immunology, V106, pS201; Liang SQ, 2013, HUM IMMUNOL, V74, P648, DOI 10.1016/j.humimm.2013.01.025; Lind DL, 2003, AM J RESP CRIT CARE, V168, P1312, DOI 10.1164/rccm.200306-877OC; Linneberg A, 2002, ALLERGY, V57, P1048, DOI 10.1034/j.1398-9995.2002.23664.x; Pino-Yanes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073157; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Reijmerink NE, 2009, ALLERGY, V64, P898, DOI 10.1111/j.1398-9995.2009.01939.x; Schedel M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-91; Song GG, 2013, GENE, V524, P72, DOI 10.1016/j.gene.2013.04.023; Su DJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-82; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V127, P102, DOI 10.1016/j.jaci.2010.11.018; Tripathi P, 2013, INDIAN J MED RES, V137, P507; Umland SP, 2003, AM J RESP CELL MOL, V29, P571, DOI 10.1165/rcmb.2003-0028OC; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vergara CI, 2010, INT ARCH ALLERGY IMM, V152, P32, DOI 10.1159/000260081; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Wang P, 2006, INT J IMMUNOGENET, V33, P303, DOI 10.1111/j.1744-313X.2006.00617.x; Xue WL, 2013, MOL MED REP, V8, P1795, DOI 10.3892/mmr.2013.1733; Yoshinaka T, 2002, GENE, V282, P227, DOI 10.1016/S0378-1119(01)00818-6; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306; Zhang XM, 2009, MOL BIOL REP, V36, P1505, DOI 10.1007/s11033-008-9343-z; Zihlif M, 2013, GENE, V531, P462, DOI 10.1016/j.gene.2013.08.085	49	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95033	10.1371/journal.pone.0095033	http://dx.doi.org/10.1371/journal.pone.0095033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751681	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400025
J	Goeldner, I; Skare, TL; Utiyama, SR; Nisihara, RM; Tong, HV; Messias-Reason, IJT; Velavan, TP				Goeldner, Isabela; Skare, Thelma L.; Utiyama, Shirley R.; Nisihara, Renato M.; Hoang Van Tong; Messias-Reason, Iara J. T.; Velavan, Thirumalaisamy P.			Mannose Binding Lectin and Susceptibility to Rheumatoid Arthritis in Brazilian Patients and Their Relatives	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPLEMENT-SYSTEM; GENE POLYMORPHISMS; SYNOVIAL-FLUID; ASSOCIATION; PROTEIN; DISEASES; VARIANTS; REVEALS; PATHWAY	Introduction: Rheumatoid arthritis (RA) is a commonly occurring systemic inflammatory auto immune disease and is believed to be associated with genetic factors. The innate immune complement protein Mannose binding lectin (MBL) and their MBL2 genetic variants are associated with different infectious and autoimmune diseases. Methods: In a Brazilian cohort, we aim to associate the functional role of circulating MBL serum levels and MBL2 variants in clinically classified patients (n = 196) with rheumatoid arthritis including their relatives (n = 200) and ethnicity matched healthy controls (n = 200). MBL serum levels were measured by ELISA and functional MBL2 variants were genotyped by direct sequencing. Results: The exon1+ 54 MBL2* B variant was significantly associated with an increased risk and the reconstructed haplotype MBL2* LYPB was associated with RA susceptibility. Circulating serum MBL levels were observed significantly lower in RA patients compared to their relatives and controls. No significant contribution of MBL levels were observed with respect to functional class, age at disease onset, disease duration and/or other clinical parameters such as nodules, secondary Sjogren syndrome, anti-CCP and rheumatoid factor. Differential distribution of serum MBL levels with functional MBL2 variants was observed in respective RA patients and their relatives. Conclusions: Our results suggest MBL levels as a possible marker for RA susceptibility in a Brazilian population.	[Goeldner, Isabela; Utiyama, Shirley R.; Nisihara, Renato M.; Messias-Reason, Iara J. T.] Univ Fed Parana, Dept Med Pathol, BR-80060000 Curitiba, Parana, Brazil; [Goeldner, Isabela; Hoang Van Tong; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Skare, Thelma L.] Evangel Hosp, Rheumatol Unit, Curitiba, Parana, Brazil; [Velavan, Thirumalaisamy P.] Fdn Congolaise Rech Med, Brazzaville, Rep Congo	Universidade Federal do Parana; Eberhard Karls University of Tubingen	Messias-Reason, IJT (corresponding author), Univ Fed Parana, Dept Med Pathol, BR-80060000 Curitiba, Parana, Brazil.	iarareason@hc.ufpr.br; velavan@medizin.uni-tuebingen.de	Nisihara, Renato RN/I-9654-2016; Velavan, Thirumalaisamy P/C-1223-2010; van Tong, Hoang/E-9448-2011; Eibofner, Isabela/D-1884-2014	Nisihara, Renato RN/0000-0002-1234-8093; Velavan, Thirumalaisamy P/0000-0002-9809-9883; van Tong, Hoang/0000-0002-7170-8810; Eibofner, Isabela/0000-0002-9850-6231; Jose de Messias Reason, Iara/0000-0002-5573-260X	Araucaria' Foundation [412/2009]; Coordination for the Improvement of Higher Level Personnel (CAPES).; Open Access Publishing Fund of Tuebingen University	Araucaria' Foundation; Coordination for the Improvement of Higher Level Personnel (CAPES).(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Open Access Publishing Fund of Tuebingen University	This work was partially supported by grants from the Araucaria' Foundation (No. 412/2009, protocol 5103), as well as by fellowship from the Coordination for the Improvement of Higher Level Personnel (CAPES). The authors acknowledge the partial support by the Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Ammitzboll CG, 2012, RHEUMATOL INT, V32, P1457, DOI 10.1007/s00296-011-1879-x; Antony JS, 2013, J INFECT DIS, V207, P1675, DOI 10.1093/infdis/jit081; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Assaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034113; Ballanti E, 2011, AUTOIMMUN REV, V10, P617, DOI 10.1016/j.autrev.2011.04.012; Bansback Nick, 2009, Best Pract Res Clin Rheumatol, V23, P83, DOI 10.1016/j.berh.2008.11.005; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Boldt ABW, 2012, ADV CLIN CHEM, V56, P105, DOI 10.1016/B978-0-12-394317-0.00012-1; Boldt ABW, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-38; Boldt ABW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-97; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carroll MV, 2011, ADV DRUG DELIVER REV, V63, P965, DOI 10.1016/j.addr.2011.06.005; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; Cruyssen BV, 2007, RHEUMATOLOGY, V46, P1792, DOI 10.1093/rheumatology/kem266; Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Di Muzio G, 2011, INT J IMMUNOPATH PH, V24, P357, DOI 10.1177/039463201102400209; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Glesse N, 2011, CLIN EXP RHEUMATOL, V29, P983; Goeldner I, 2011, CLIN RHEUMATOL, V30, P975, DOI 10.1007/s10067-011-1711-8; Goeldner I, 2010, RHEUMATOLOGY, V49, P1590, DOI 10.1093/rheumatology/keq134; Graudal N, 2004, SCAND J RHEUMATOL, V33, P1, DOI 10.1080/03009740310004847; Graudal NA, 2000, ARTHRITIS RHEUM, V43, P515, DOI 10.1002/1529-0131(200003)43:3<515::AID-ANR6>3.0.CO;2-T; Graudal NA, 1998, J RHEUMATOL, V25, P629; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Hemminki K, 2009, ARTHRITIS RHEUM, V60, P2845, DOI 10.1002/art.24749; Hinks A, 2007, ANN RHEUM DIS, V66, P683, DOI 10.1136/ard.2006.060459; Im CH, 2012, RHEUMATOL INT, V32, P2251, DOI 10.1007/s00296-011-1939-2; Ip WK, 2000, ARTHRITIS RHEUM, V43, P1679, DOI 10.1002/1529-0131(200008)43:8<1679::AID-ANR3>3.3.CO;2-4; Jha AN, 2014, INFECT IMMUN, V82, P52, DOI 10.1128/IAI.01041-13; JOSE PJ, 1990, ANN RHEUM DIS, V49, P747, DOI 10.1136/ard.49.10.747; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Luz PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060237; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Maffei G, 2005, J PERIODONTOL, V76, P1881, DOI 10.1902/jop.2005.76.11.1881; Magorivska I, 2014, ANN RHEUM DIS, V73, pA25, DOI 10.1136/annrheumdis-2013-205124.57; Martiny FL, 2012, J RHEUMATOL, V39, P6, DOI 10.3899/jrheum.110052; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Ojurongbe O, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-37; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Saevarsdottir S, 2007, J RHEUMATOL, V34, P1692; Saevarsdottir S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3321; Sandrin-Garcia P, 2011, HUM IMMUNOL, V72, P516, DOI 10.1016/j.humimm.2011.03.007; Sato R, 1997, Fukushima J Med Sci, V43, P99; SWAAK AJG, 1987, CLIN RHEUMATOL, V6, P350, DOI 10.1007/BF02206833; Tong HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028113; Troelsen LN, 2012, J RHEUMATOL, V39, P463, DOI 10.3899/jrheum.110584; Troelsen LN, 2010, J RHEUMATOL, V37, P536, DOI 10.3899/jrheum.090812; Troelsen LN, 2010, MOL IMMUNOL, V47, P713, DOI 10.1016/j.molimm.2009.10.021; van de Geijn FE, 2008, RHEUMATOLOGY, V47, P1168, DOI 10.1093/rheumatology/ken226; Velavan TP, 2010, SCAND J GASTROENTERO, V45, P1129, DOI 10.3109/00365521.2010.485324; Verdu P, 2006, HUM MOL GENET, V15, P2650, DOI 10.1093/hmg/ddl193; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; Xie Q, 2012, HUM IMMUNOL, V73, P966, DOI 10.1016/j.humimm.2012.07.043	62	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95519	10.1371/journal.pone.0095519	http://dx.doi.org/10.1371/journal.pone.0095519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751721	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400068
J	Jackson, WS; Krost, C; Borkowski, AW; Kaczmarczyk, L				Jackson, Walker S.; Krost, Clemens; Borkowski, Andrew W.; Kaczmarczyk, Lech			Translation of the Prion Protein mRNA Is Robust in Astrocytes but Does Not Amplify during Reactive Astrocytosis in the Mouse Brain	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; STRAUSSLER-SCHEINKER DISEASE; TYPICAL CLINICAL-FEATURES; PRP GENE; ALZHEIMERS-DISEASE; REPORTER GENE; A-BETA; EXPRESSION; MICE; SCRAPIE	Prion diseases induce neurodegeneration in specific brain areas for undetermined reasons. A thorough understanding of the localization of the disease-causing molecule, the prion protein (PrP), could inform on this issue but previous studies have generated conflicting conclusions. One of the more intriguing disagreements is whether PrP is synthesized by astrocytes. We developed a knock-in reporter mouse line in which the coding sequence of the PrP expressing gene (Prnp), was replaced with that for green fluorescent protein (GFP). Native GFP fluorescence intensity varied between and within brain regions. GFP was present in astrocytes but did not increase during reactive gliosis induced by scrapie prion infection. Therefore, reactive gliosis associated with prion diseases does not cause an acceleration of local PrP production. In addition to aiding in Prnp gene activity studies, this reporter mouse line will likely prove useful for analysis of chimeric animals produced by stem cell and tissue transplantation experiments.	[Jackson, Walker S.; Krost, Clemens; Kaczmarczyk, Lech] German Ctr Neurodegenerat Dis, Bonn, Germany; [Jackson, Walker S.; Borkowski, Andrew W.] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Massachusetts Institute of Technology (MIT); Whitehead Institute	Jackson, WS (corresponding author), German Ctr Neurodegenerat Dis, Bonn, Germany.	walker.jackson@dzne.de	Kaczmarczyk, Lech/AAK-2892-2020	Kaczmarczyk, Lech/0000-0003-2747-3134; Jackson, Walker/0000-0002-3003-5509	United States Department of Defense [DAMD 17-03-1-0413]; DZNE	United States Department of Defense(United States Department of Defense); DZNE(Helmholtz Association)	This work was supported by United States Department of Defense grant DAMD 17-03-1-0413 and by internal funds of the DZNE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Barmada SJ, 2005, J NEUROSCI, V25, P5824, DOI 10.1523/JNEUROSCI.1192-05.2005; Bian JF, 2006, BIOCHEM BIOPH RES CO, V340, P894, DOI 10.1016/j.bbrc.2005.12.085; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUGIANI O, 1993, J NEUROPATH EXP NEUR, V52, P64, DOI 10.1097/00005072-199301000-00008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Faas H, 2010, NEUROIMAGE, V49, P2607, DOI 10.1016/j.neuroimage.2009.10.009; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; GHETTI B, 1989, NEUROLOGY, V39, P1453, DOI 10.1212/WNL.39.11.1453; GHETTI B, 1994, MOL NEUROBIOL, V8, P41, DOI 10.1007/BF02778006; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Haeberle AM, 2000, MICROSC RES TECHNIQ, V50, P66, DOI 10.1002/1097-0029(20000701)50:1<66::AID-JEMT10>3.0.CO;2-3; Haigh C L, 2006, Int J Biomed Sci, V2, P315; Hainfellner JA, 1998, ACTA NEUROPATHOL, V96, P116, DOI 10.1007/s004010050870; Haraguchi T, 2009, NEUROPATHOLOGY, V29, P454, DOI 10.1111/j.1440-1789.2008.00964.x; Heikenwalder M, 2008, IMMUNITY, V29, P998, DOI 10.1016/j.immuni.2008.10.014; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Jackson WS, 2014, DIS MODEL MECH, V7, P21, DOI 10.1242/dmm.012146; Jackson WS, 2013, P NATL ACAD SCI USA, V110, P14759, DOI 10.1073/pnas.1312006110; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; Jackson WS, 2003, HUM MOL GENET, V12, P1621, DOI 10.1093/hmg/ddg163; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Kleene R, 2007, J NEUROSCI, V27, P12331, DOI 10.1523/JNEUROSCI.1358-07.2007; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Laine J, 2001, EUR J NEUROSCI, V14, P47, DOI 10.1046/j.0953-816x.2001.01621.x; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Le Pichon CE, 2008, J COMP NEUROL, V508, P487, DOI 10.1002/cne.21698; Lemaire-Vieille C, 2000, P NATL ACAD SCI USA, V97, P5422, DOI 10.1073/pnas.080081197; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Mathiason CK, 2013, J VIROL, V87, P1947, DOI 10.1128/JVI.02592-12; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; MURAMOTO T, 1992, ACTA NEUROPATHOL, V84, P686; PARRY HB, 1962, HEREDITY, V17, P75, DOI 10.1038/hdy.1962.4; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Reiniger L, 2011, ACTA NEUROPATHOL, V121, P5, DOI 10.1007/s00401-010-0691-0; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Seo JS, 2012, NEUROBIOL AGING, V33, P1110, DOI 10.1016/j.neurobiolaging.2010.09.019; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; STICHEL CC, 1991, J NEUROCYTOL, V20, P97, DOI 10.1007/BF01279614; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tsuchiya K, 2004, NEUROPATHOLOGY, V24, P46, DOI 10.1111/j.1440-1789.2003.00513.x; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Yap YHY, 2012, CELL BIOL INT, V36, P273, DOI 10.1042/CBI20110088; Ye X, 1999, HISTOL HISTOPATHOL, V14, P673, DOI 10.14670/HH-14.673; Yoshida H, 2010, NEUROPATHOLOGY, V30, P159, DOI 10.1111/j.1440-1789.2009.01048.x; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	69	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95958	10.1371/journal.pone.0095958	http://dx.doi.org/10.1371/journal.pone.0095958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752288	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400147
J	Koffman, J; Ho, YK; Davies, J; Gao, W; Higginson, IJ				Koffman, Jonathan; Ho, Yuen King; Davies, Joanna; Gao, Wei; Higginson, Irene J.			Does Ethnicity Affect Where People with Cancer Die ? A Population-Based 10 Year Study	PLOS ONE			English	Article							SPECIALIST PALLIATIVE CARE; HEALTH-CARE; UNITED-STATES; DEATH; PLACE; HOSPICE; LIFE; END; INEQUALITIES; MINORITY	Background: Ageing is a growing issue for people from UK black, Asian and minority ethnic (BAME) groups. The health experiences of these groups are recognised as a 'tracer' to measure success in end of life patient-preferred outcomes that includes place of death (PoD). Aim: To examine patterns in PoD among BAME groups who died of cancer. Material and Methods: Mortality data for 93,375 cancer deaths of those aged >= 65 years in London from 2001-2010 were obtained from the UK Office for National Statistics (ONS). Decedent's country of birth was used as a proxy for ethnicity. Linear regression examined trends in place of death across the eight ethnic groups and Poisson regression examined the association between country of birth and place of death. Results: 76% decedents were born in the UK, followed by Ireland (5.9%), Europe(5.4%) and Caribbean(4.3%). Most deaths(52.5%) occurred in hospital, followed by home(18.7%). During the study period, deaths in hospital declined with an increase in home deaths; trend for time analysis for those born in UK(0.50%/yr[0.36-0.64%] p < 0.001), Europe (1.00%/yr[0.64-1.30%] p < 0.001), Asia(1.09%/yr[0.94-1.20%] p < 0.001) and Caribbean(1.03%/yr[0.72-1.30%] p < 0.001). However, time consistent gaps across the geographical groups remained. Following adjustment hospital deaths were more likely for those born in Asia(Proportion ratio(PR) 1.12[95% CI1.08-1.15] p < 0.001) and Africa(PR 1.11[95% CI1.07-1.16] p < 0.001). Hospice deaths were less likely for those born in Asia(PR 0.73 [0.68-0.80] p < 0.001), Africa (PR 0.83[95% CI0.74-0.93] p < 0.001), and 'other' geographical regions (PR0.90[95% 0.82-0.98] p < 0.001). Home deaths were less likely for those born in the Caribbean(PR0.91[95% CI 0.85-0.98] p < 0.001). Conclusions: Location of death varies by country of birth. BAME groups are more likely to die in a hospital and less likely to die at home or in a hospice. Further investigation is needed to determine whether these differences result from patient-centred preferences, or other environment or service-related factors. This knowledge will enable strategies to be developed to improve access to relevant palliative care and related services, where necessary.	[Koffman, Jonathan; Ho, Yuen King; Davies, Joanna; Gao, Wei; Higginson, Irene J.] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England	University of London; King's College London	Koffman, J (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.	jonathan.koffman@kcl.ac.uk	Gao, Wei/G-8653-2011; Higginson, Irene Julie/C-7309-2012	Gao, Wei/0000-0001-8298-3415; Higginson, Irene Julie/0000-0002-3687-1313; Koffman, Jonathan/0000-0001-8513-5681	National Institute for Health Research Health Services and Delivery Research (NIHR HS DR) [09/2000/58]; National Institute for Health Research [09/2000/58] Funding Source: researchfish	National Institute for Health Research Health Services and Delivery Research (NIHR HS DR); National Institute for Health Research(National Institute for Health Research (NIHR))	The GUIDE Care project was funded by the National Institute for Health Research Health Services and Delivery Research (NIHR HS& DR) programme (Project number 09/2000/58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affairs UNDoEaS, 2006, WORLD MIGR STOCK 200; Ahmad WIU, 2007, SOCIOL HEALTH ILL, V29, P795, DOI 10.1111/j.1467-9566.2007.01051.x; Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Arora S., 2001, RACISM MED AGENDA CH, P141; Aspinall PJ, 1999, J PUBLIC HEALTH MED, V21, P125, DOI 10.1093/pubmed/21.2.125; Barratt H, 2001, BRIT MED J, V323, P240; Bhopal RS, 2012, J PUBLIC HEALTH-UK, V34, P167, DOI 10.1093/pubmed/fds004; Bruera E, 2003, J PAIN SYMPTOM MANAG, V26, P637, DOI 10.1016/S0885-3924(03)00204-5; Calazani N, 2013, PALLIATIVE END LIFE; Centre NI, 2009, GOOD IS HES ETHN COD; Cohen LL, 2008, J PALLIAT MED, V11, P763, DOI 10.1089/jpm.2007.0216; Connor SR, 2008, PALLIATIVE MED, V22, P205, DOI 10.1177/0269216308089305; Coupland VH, 2011, PALLIATIVE MED, V25, P314, DOI 10.1177/0269216310395986; Decker SL, 2007, EUR J PUBLIC HEALTH, V17, P285, DOI 10.1093/eurpub/ckl243; Enguidanos S, 2005, J AM GERIATR SOC, V53, P1411, DOI 10.1111/j.1532-5415.2005.53410.x; Europe WROf, 2010, HLTH SYST CAN ADDR H; Fischbacher CM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-142; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gastrell Julie, 2004, Health Stat Q, P7; Goddard M, 2001, SOC SCI MED, V53, P1149, DOI 10.1016/S0277-9536(00)00415-9; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Haas JS, 2007, J GEN INTERN MED, V22, P396, DOI 10.1007/s11606-006-0034-y; Health Do, 2008, END LIF CAR STRAT PR; Health SAf, 2013, HACKNEY COMPASSIONAT; Higginson IJ, 2005, CLIN GERIATR MED, V21, P45, DOI 10.1016/j.cger.2004.08.003; Hopp FP, 2000, J AM GERIATR SOC, V48, P658, DOI 10.1111/j.1532-5415.2000.tb04724.x; Hospices Ht, 2012, EXCELLENCE HOSPICE C; Iwashyna TJ, 2002, J AM GERIATR SOC, V50, P1113, DOI 10.1046/j.1532-5415.2002.50269.x; Jack RH, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-281; Karim K, 2000, PALLIATIVE MED, V14, P471, DOI 10.1191/026921600701536390; Karlsen S, 2010, ETHNIC HEALTH, V15, P549, DOI 10.1080/13557858.2010.497204; Kirkup J., 2012, TELEGRAPH; Koffman J, 2000, J PUBLIC HEALTH MED, V22, P245, DOI 10.1093/pubmed/22.2.245; Koffman J, 2001, PALLIATIVE MED, V15, P337, DOI 10.1191/026921601678320322; Koffman J, 2008, OXFORD TXB PALLIATIV, P141; Koffman J, 2011, PSYCHO-ONCOLOGY, DOI [10.1002/pon.1912: 4-400, DOI 10.1002/PON.1912:4-400]; Koffman J., 2006, EUR J PALLIAT CARE, V11, P18; Koffman J, 2007, PALLIATIVE MED, V21, P145, DOI 10.1177/0269216306074639; Koffman Jonathan, 2004, J Palliat Med, V7, P628, DOI 10.1089/jpm.2004.7.628; Lock A, 2005, BMC PALLIAT CARE, V4, DOI [10.1186/1472-1684X-1184-1186, DOI 10.1186/1472-1684X-1184-1186]; Lorant V, 2011, EUR J PUBLIC HEALTH, V21, P235, DOI 10.1093/eurpub/ckq061; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Martins T, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-197; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McLennan D., 2011, ENGLISH INDICES DEPR; R Mathur, 2013, J PUBLIC HLTH, V36, P19; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Simpson L., 2007, H OFFICIAL STAT, V23, P185; Sleeman KE, 2013, PALLIATIVE MED, V27, P840, DOI 10.1177/0269216313490436; Smaje C, 1997, DEATH GENDER ETHNICI, P142; Statistics OfN, 2012, ETHN NAT ID ENGL WAL; Statistics OfN, 2013, 2011 CENS AN COMP RU; Statistics OfN, 2012, 2011 CENS KEY STAT E; Stronks K, 2009, ETHN HLTH, V14, P1; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; United Nations General Assembly, 1949, UN DECL HUM RIGHTS, V3381; Velikova G, 2004, BRIT J CANCER, V90, P1926, DOI 10.1038/sj.bjc.6601795; Wei G, 2013, PLOS MED, V10; Wood DJ, 2004, PALLIATIVE MED, V18, P543, DOI 10.1191/0269216304pm892oa; Worth A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b183	63	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95052	10.1371/journal.pone.0095052	http://dx.doi.org/10.1371/journal.pone.0095052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2DX	24751724	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400028
J	Lefevre, M; Felmlee, DJ; Parnot, M; Baumert, TF; Schuster, C				Lefevre, Mathieu; Felmlee, Daniel J.; Parnot, Marie; Baumert, Thomas F.; Schuster, Catherine			Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CELL ENTRY; RECEPTOR; BINDING; ATTACHMENT; INFECTION; PROTEIN; NEUTRALIZATION; PROTEOGLYCANS; LIPOPROTEINS	Hepatitis C virus (HCV) is a major cause of liver disease worldwide and HCV infection represents a major health problem. HCV associates with host lipoproteins forming host/viral hybrid complexes termed lipoviral particles. Apolipoprotein E (apoE) is a lipoprotein component that interacts with heparan sulfate proteoglycans (HSPG) to mediate hepatic lipoprotein uptake, and may likewise mediate HCV entry. We sought to define the functional regions of apoE with an aim to identify critical apoE binding partners involved in HCV infection. Using adenoviral vectors and siRNA to modulate apoE expression we show a direct correlation of apoE expression and HCV infectivity, whereas no correlation exists with viral protein expression. Mutating the HSPG binding domain (HSPG-BD) of apoE revealed key residues that are critical for mediating HCV infection. Furthermore, a novel synthetic peptide that mimics apoE's HSPG-BD directly and competitively inhibits HCV infection. Genetic knockdown of the HSPG proteins syndecan (SDC) 1 and 4 revealed that SDC4 principally mediates HCV entry. Our data demonstrate that HCV uses apoE-SDC4 interactions to enter hepatoma cells and establish infection. Targeting apoE-SDC interactions could be an alternative strategy for blocking HCV entry, a critical step in maintaining chronic HCV infection.	[Lefevre, Mathieu; Felmlee, Daniel J.; Parnot, Marie; Baumert, Thomas F.; Schuster, Catherine] INSERM, U1110, Res Inst Viral & Hepat Dis, Strasbourg, France; [Lefevre, Mathieu; Felmlee, Daniel J.; Parnot, Marie; Baumert, Thomas F.; Schuster, Catherine] Univ Strasbourg, Strasbourg, France; [Baumert, Thomas F.] Hop Univ Strasbourg, Pole Hepatodigestif, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schuster, C (corresponding author), INSERM, U1110, Res Inst Viral & Hepat Dis, Strasbourg, France.	catherine.schuster@unistra.fr	Schuster, Catherine/H-9355-2016; Baumert, Thomas/ABF-4718-2020	Schuster, Catherine/0000-0001-7281-4511; Baumert, Thomas/0000-0002-8864-2168; Felmlee, Daniel/0000-0001-8350-122X	Agence Nationale de Recherches sur le SIDA (ANRS) [2010-307/2011-415]; European Union [ERC-2008-AdG-233130-HEPCENT]; French National "Investissement d'Avenir'' LabEx HEPSYS [ANR-10-LABX-28]; European Association for Study of the Liver (EASL); ANRS; fellowship of the French Ministry for Research and Education (MESR)	Agence Nationale de Recherches sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); European Union(European Commission); French National "Investissement d'Avenir'' LabEx HEPSYS(French National Research Agency (ANR)); European Association for Study of the Liver (EASL); ANRS(ANRSFrench National Research Agency (ANR)); fellowship of the French Ministry for Research and Education (MESR)	C. Schuster acknowledges funding by Agence Nationale de Recherches sur le SIDA (ANRS) (2010-307/2011-415). T. F. Baumert acknowledges funding by the European Union (ERC-2008-AdG-233130-HEPCENT) and the French National "Investissement d'Avenir'' LabEx HEPSYS (ANR-10-LABX-28). D. J. Felmlee acknowledges fellowships from European Association for Study of the Liver (EASL) and ANRS. M. Lefevre was supported by a fellowship of the French Ministry for Research and Education (MESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Bhattacharjee PS, 2009, CURR EYE RES, V34, P99, DOI 10.1080/02713680802647662; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chung Raymond T, 2012, Gastroenterology, V143, pe1, DOI 10.1053/j.gastro.2012.07.011; Deng YP, 2012, HEPATOLOGY, V55, P277, DOI 10.1002/hep.24626; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Felmlee DJ, 2013, VIRUSES-BASEL, V5, P1292, DOI 10.3390/v5051292; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Gonzales JC, 2013, J CLIN INVEST, V123, P2742, DOI 10.1172/JCI67398; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krepstakies M, 2012, J INFECT DIS, V205, P1654, DOI 10.1093/infdis/jis273; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Libeu CP, 2001, J BIOL CHEM, V276, P39138, DOI 10.1074/jbc.M104746200; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Morikawa K, 2007, J MED VIROL, V79, P714, DOI 10.1002/jmv.20842; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Sandrin V, 2005, J GEN VIROL, V86, P3189, DOI 10.1099/vir.0.81428-0; Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015; Shi Q, 2013, J VIROL, V87, P6866, DOI 10.1128/JVI.03475-12; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Wolf M, 2008, NUCLEIC ACIDS RES, V36, P3054, DOI 10.1093/nar/gkn111; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeisel MB, 2009, FRONT BIOSCI-LANDMRK, V14, P3274, DOI 10.2741/3450; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006	43	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95550	10.1371/journal.pone.0095550	http://dx.doi.org/10.1371/journal.pone.0095550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751902	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400072
J	Li, JS; Doyle, MA; Saeed, I; Wong, SQ; Mar, V; Goode, DL; Caramia, F; Doig, K; Ryland, GL; Thompson, ER; Hunter, SM; Halgamuge, SK; Ellul, J; Dobrovic, A; Campbell, IG; Papenfuss, AT; McArthur, GA; Tothill, RW				Li, Jason; Doyle, Maria A.; Saeed, Isaam; Wong, Stephen Q.; Mar, Victoria; Goode, David L.; Caramia, Franco; Doig, Ken; Ryland, Georgina L.; Thompson, Ella R.; Hunter, Sally M.; Halgamuge, Saman K.; Ellul, Jason; Dobrovic, Alexander; Campbell, Ian G.; Papenfuss, Anthony T.; McArthur, Grant A.; Tothill, Richard W.			Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment	PLOS ONE			English	Article							READ ALIGNMENT; MUTATIONS; VARIANTS; DATABASE; TOOL	Targeted resequencing by massively parallel sequencing has become an effective and affordable way to survey small to large portions of the genome for genetic variation. Despite the rapid development in open source software for analysis of such data, the practical implementation of these tools through construction of sequencing analysis pipelines still remains a challenging and laborious activity, and a major hurdle for many small research and clinical laboratories. We developed TREVA (Targeted REsequencing Virtual Appliance), making pre-built pipelines immediately available as a virtual appliance. Based on virtual machine technologies, TREVA is a solution for rapid and efficient deployment of complex bioinformatics pipelines to laboratories of all sizes, enabling reproducible results. The analyses that are supported in TREVA include: somatic and germline single-nucleotide and insertion/deletion variant calling, copy number analysis, and cohort-based analyses such as pathway and significantly mutated genes analyses. TREVA is flexible and easy to use, and can be customised by Linux-based extensions if required. TREVA can also be deployed on the cloud (cloud computing), enabling instant access without investment overheads for additional hardware. TREVA is available at http://bioinformatics. petermac. org/treva/.	[Li, Jason; Doyle, Maria A.; Caramia, Franco; Doig, Ken; Ellul, Jason] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Li, Jason; Saeed, Isaam; Halgamuge, Saman K.] Univ Melbourne, Dept Mech Engn, Parkville, Vic 3052, Australia; [Saeed, Isaam] YourGene Biosci Australia, Southbank, Vic, Australia; [Wong, Stephen Q.; Dobrovic, Alexander] Peter MacCallum Canc Ctr, Mol Pathol Res & Dev Lab, East Melbourne, Vic, Australia; [Mar, Victoria] Alfred Hosp, Victorian Melanoma Serv, Prahran, Vic 3181, Australia; [Mar, Victoria] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia; [Goode, David L.] Peter MacCallum Canc Ctr, Sarcoma Genet & Genom Lab, East Melbourne, Vic, Australia; [Ryland, Georgina L.; Thompson, Ella R.; Hunter, Sally M.; Campbell, Ian G.] Peter MacCallum Canc Ctr, Canc Genet Lab, East Melbourne, Vic, Australia; [Papenfuss, Anthony T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Goode, David L.; Campbell, Ian G.; Papenfuss, Anthony T.; McArthur, Grant A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Mar, Victoria; McArthur, Grant A.] Peter MacCallum Canc Ctr, Oncogen Signaling & Growth Control Program, Mol Oncol Lab, East Melbourne, Vic, Australia; [McArthur, Grant A.; Tothill, Richard W.] Peter MacCallum Canc Ctr, Translat Res Lab, Canc Therapeut Program, East Melbourne, Vic, Australia; [McArthur, Grant A.] St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [McArthur, Grant A.; Tothill, Richard W.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Goode, David L.; Papenfuss, Anthony T.] Peter MacCallum Canc Ctr, Bioinformat & Canc Genom Lab, East Melbourne, Vic, Australia; [Dobrovic, Alexander] Ludwig Inst Canc Res, Translat Genom & Epigen Lab, Heidelberg, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Florey Institute of Neuroscience & Mental Health; Monash University; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; Ludwig Institute for Cancer Research	Li, JS (corresponding author), Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia.	Jason.Li@petermac.org	campbell, Ian G/F-6006-2011; Ryland, Georgina L/AAD-9273-2022; Papenfuss, Anthony T/C-6297-2008; Halgamuge, Saman/A-8154-2008; SAEED, ISAAM/F-4492-2016	Ryland, Georgina L/0000-0002-4990-0961; Papenfuss, Anthony T/0000-0002-1102-8506; Halgamuge, Saman/0000-0002-2536-4930; Ellul, Jason/0000-0002-6046-5139; Wong, Stephen Q./0000-0002-7335-2168; Goode, David/0000-0002-3277-6562; McArthur, Grant/0000-0001-8908-6071; Doyle, Maria/0000-0003-4847-8436; Tothill, Richard William/0000-0003-4522-1184; SAEED, ISAAM/0000-0002-9360-414X; Li, Jason/0000-0002-1150-3549; Campbell, Ian/0000-0002-7773-4155; Mar, Victoria/0000-0001-9423-3435; Dobrovic, Alexander/0000-0003-3414-112X; Thompson, Ella/0000-0001-5206-5111	NeCTAR (Australia's National eResearch Collaboration Tools and Resources); Yourgene Bioscience, Taiwan	NeCTAR (Australia's National eResearch Collaboration Tools and Resources); Yourgene Bioscience, Taiwan	NeCTAR (Australia's National eResearch Collaboration Tools and Resources) and Yourgene Bioscience, Taiwan, supported the project with cloud expertise, storage and bandwidth.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], DROP REF; Asmann YW, 2012, BIOINFORMATICS, V28, P277, DOI 10.1093/bioinformatics/btr612; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; D'Antonio M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S11; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Forbes SA, NUCL ACIDS RES, V39, pD945; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goodstadt L, 2010, BIOINFORMATICS, V26, P2778, DOI 10.1093/bioinformatics/btq524; Hashimoto M., 2013, VAGRANT RUNNING; Hashimoto M, 2014, VAGRANT; Ji HP, 2012, GENOME MED, V4, DOI 10.1186/gm306; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li JW, 2012, NUCLEIC ACIDS RES, V40, pD1313, DOI 10.1093/nar/gkr1058; Mar VJ, 2013, CLIN CANC RES; Martin M, 2011, EMBNETJOURNAL; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nocq J, 2013, BIOINFORMATICS, V29, P2075, DOI 10.1093/bioinformatics/btt352; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; Pabinger S., 2013, BRIEF BIOINFORM; Planet E, 2012, BIOINFORMATICS, V28, P589, DOI 10.1093/bioinformatics/btr700; Richter BG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000369; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Sherry ST, 1999, GENOME RES, V9, P677; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; Tothill RW, 2013, J PATHOL, V231, P413, DOI 10.1002/path.4251; Walsh T, 2010, P NATL ACAD SCI; Wong SQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03494	40	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95217	10.1371/journal.pone.0095217	http://dx.doi.org/10.1371/journal.pone.0095217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752294	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400041
J	McCarthy, CA; Vinh, A; Miller, AA; Hallberg, A; Alterman, M; Callaway, JK; Widdop, RE				McCarthy, Claudia A.; Vinh, Antony; Miller, Alyson A.; Hallberg, Anders; Alterman, Mathias; Callaway, Jennifer K.; Widdop, Robert E.			Direct Angiotensin AT2 Receptor Stimulation Using a Novel AT2 Receptor Agonist, Compound 21, Evokes Neuroprotection in Conscious Hypertensive Rats	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; AT(2) RECEPTORS; CHRONIC PRETREATMENT; STROKE; MICROGLIA; CANDESARTAN; MODEL; MACROPHAGES; SYSTEM	Background: In this study, the neuroprotective effect of a novel nonpeptide AT2R agonist, C21, was examined in a conscious model of stroke to verify a class effect of AT2R agonists as neuroprotective agents. Methods and Results: Spontaneously hypertensive rats (SHR) were pre-treated for 5 days prior to stroke with C21 alone or in combination with the AT2R antagonist PD123319. In a separate series of experiments C21 was administered in a series of 4 doses commencing 6 hours after stroke. A focal reperfusion model of ischemia was induced in conscious SHR by administering endothelin-1 to the middle cerebral artery (MCA). Motor coordination was assessed at 1 and 3 days after stroke and post mortem analyses of infarct volumes, microglia activation and neuronal survival were performed at 72 hours post MCA occlusion. When given prior to stroke, C21 dose dependently decreased infarct volume, which is consistent with the behavioural findings illustrating an improvement in motor deficit. During the pre-treatment protocol C21 was shown to enhance microglia activation, which are likely to be evoking protection by releasing brain derived neurotrophic factor. When drug administration was delayed until 6 hours after stroke, C21 still reduced brain injury. Conclusion: These results indicate that centrally administered C21 confers neuroprotection against stroke damage. This benefit is likely to involve various mechanisms, including microglial activation of endogenous repair and enhanced cerebroperfusion. Thus, we have confirmed the neuroprotective effect of AT2R stimulation using a nonpeptide compound which highlights the clinical potential of the AT2R agonists for future development.	[McCarthy, Claudia A.; Vinh, Antony; Widdop, Robert E.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Miller, Alyson A.] RMIT Univ, Dept Med Sci, Bundoora, Vic, Australia; [Hallberg, Anders; Alterman, Mathias] Uppsala Univ, Dept Med Chem, Uppsala, Sweden; [Callaway, Jennifer K.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	Monash University; Royal Melbourne Institute of Technology (RMIT); Uppsala University; University of Melbourne	McCarthy, CA (corresponding author), Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia.	claudia.mccarthy@monash.edu	Vinh, Antony/I-1563-2014	Vinh, Antony/0000-0001-8367-6134; Widdop, Robert/0000-0002-6515-0435	National Health and Medical Research Council of Australia [APP1007986]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council of Australia (APP1007986) to REW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhusban A, 2013, J PHARMACOL EXP THER, V344, P348, DOI 10.1124/jpet.112.197483; Arnold JMO, 2003, CIRCULATION, V107, P1284, DOI 10.1161/01.CIR.0000054165.93055.42; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosnyak S, 2010, BRIT J PHARMACOL, V159, P709, DOI 10.1111/j.1476-5381.2009.00575.x; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Callaway JK, 2000, J NEUROSCI METH, V102, P53, DOI 10.1016/S0165-0270(00)00278-8; Chapman N, 2004, STROKE, V35, P116, DOI 10.1161/01.STR.0000106480.76217.6F; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Faure S, 2008, J HYPERTENS, V26, P2008, DOI 10.1097/HJH.0b013e32830dd5ee; Gelosa P, 2009, J HYPERTENS, V27, P2444, DOI 10.1097/HJH.0b013e3283311ba1; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Ito T, 2002, STROKE, V33, P2297, DOI 10.1161/01.STR.0000027274.03779.F3; Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; Kaschina E, 2008, CIRCULATION, V118, P2523, DOI 10.1161/CIRCULATIONAHA.108.784868; Krikov M, 2008, J HYPERTENS, V26, P544, DOI 10.1097/HJH.0b013e3282f2dac9; Lee Seyoung, 2012, Exp Transl Stroke Med, V4, P16, DOI 10.1186/2040-7378-4-16; Li J, 2005, FASEB J, V10; Lu Q, 2005, NEUROREPORT, V16, P1963, DOI 10.1097/01.wnr.0000187636.13147.cd; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; McCarthy CA, 2012, HYPERTENSION, V60, P1531, DOI 10.1161/HYPERTENSIONAHA.112.199646; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Namsolleck P, 2013, NEUROBIOL DIS, V51, P177, DOI 10.1016/j.nbd.2012.11.008; Schroeter M, 1997, STROKE, V28, P328; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Wan YQ, 2004, J MED CHEM, V47, P5995, DOI 10.1021/jm049715t; Zhu MY, 2000, J NEUROPHYSIOL, V84, P2494, DOI 10.1152/jn.2000.84.5.2494	33	61	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95762	10.1371/journal.pone.0095762	http://dx.doi.org/10.1371/journal.pone.0095762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752645	Green Published, Green Accepted, gold			2022-12-25	WOS:000335227400121
J	Mullen, MP; Hanrahan, JP				Mullen, Michael P.; Hanrahan, James P.			Direct Evidence on the Contribution of a Missense Mutation in GDF9 to Variation in Ovulation Rate of Finnsheep	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; BONE MORPHOGENETIC PROTEIN-15; BMP15 GENE; SHEEP; STERILITY; OOCYTE; IDENTIFICATION; PROLIFICACY; SECRETION; VARIANTS	The Finnish Landrace (Finnsheep) is a well known high-prolificacy sheep breed and has been used in many countries as a source of genetic material to increase fecundity of local breeds. Analyses to date have indicated that mutations with a large effect on ovulation rate are not responsible for the exceptional prolificacy of Finnsheep. The objectives of this study were to ascertain if: 1) any of 12 known mutations with large effects on ovulation rate in sheep, or 2) any other DNA sequence variants within the candidate genes GDF9 and BMP15 are implicated in the high prolificacy of the Finnish Landrace breed; using material from lines developed by divergent selection on ovulation rate. Genotyping results showed that none of 12 known mutations (FecB(B), FecX(B), FecX(G), FecX(GR), FecX(H), FecX(I), FecX(L), FecX(O), FecX(R), FecG(E), FecG(H), or FecG(T)) were present in a sample of 108 Finnsheep and, thus, do not contribute to the exceptional prolificacy of the breed. However, DNA sequence analysis of GDF9 identified a previously known mutation, V371M, whose frequency differed significantly (P < 0.001) between High and Low ovulation rate lines. While analysis of ovulation rate data for Finnsheep failed to establish a significant association between this trait and V371M, analysis of data on Belclare sheep revealed a significant association between V371M and ovulation rate (P < 0.01). Ewes that were heterozygous for V371M exhibited increased ovulation rate (+ 0.17, s.e. 0.080; P < 0.05) compared to wild type and the effect was non-additive (ovulation rate of heterozygotes was significantly lower (P < 0.01) than the mean of the homozygotes). This finding brings to 13 the number of mutations that have large effects on ovulation rate in sheep and to 5, including FecB(B), FecG(E), FecX(O) and FecX(GR), the number of mutations within the TGF beta superfamily with a positive effect on prolificacy in the homozygous state.	[Mullen, Michael P.; Hanrahan, James P.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Athenry, Co Galway, Ireland	Teagasc	Mullen, MP (corresponding author), TEAGASC, Anim & Grassland Res & Innovat Ctr, Mellows Campus, Athenry, Co Galway, Ireland.	michael.mullen@teagasc.ie		Mullen, Michael/0000-0003-1185-4389	Teagasc Walsh Fellowship Scheme	Teagasc Walsh Fellowship Scheme	Financial support through the Teagasc Walsh Fellowship Scheme is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], [No title captured]; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Davis GH, 2006, ANIM REPROD SCI, V92, P87, DOI 10.1016/j.anireprosci.2005.06.001; Demars J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003482; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Drouilhet L, 2010, BIOL REPROD, V82, P815, DOI 10.1095/biolreprod.109.082065; Eikje LS, 2008, ANIMAL, V2, P167, DOI 10.1017/S1751731107001176; Fabre S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-20; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Hanrahan J. P., 1985, Genetics of reproduction in sheep., P193; Hanrahan J. P., 1982, 2nd World Congress on Genetics applied to Livestock Production, 4th-8th October 1982. 5. Plenary sessions, P294; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Hanrahan JP, 1990, RES REPORT, P139; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LAND RB, 1978, ANIM REPROD SCI, V1, P109, DOI 10.1016/0378-4320(78)90020-9; Lecerf F, 2002, P 7 WORLD C GEN APP, P753; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; Maijala K., 1996, PROLIFIC SHEEP, P10; Martinez-Royo A, 2008, ANIM GENET, V39, P294, DOI 10.1111/j.1365-2052.2008.01707.x; McNatty KP, 2005, GENET SEL EVOL, V37, pS25, DOI 10.1051/gse:2004029; McNatty KP, 2004, REPRODUCTION, V128, P379, DOI 10.1530/rep.1.00280; Mullen MP, 2009, IRISH J AGR FOOD RES, V48, P109; Mullen MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053172; Nicol L, 2009, REPRODUCTION, V138, P921, DOI 10.1530/REP-09-0193; Piper L. R., 1982, The Booroola Merino. Proceedings of a workshop held at Armidale, N.S.W. 24 August 1980, P9; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Silva BDM, 2011, ANIM GENET, V42, P89, DOI 10.1111/j.1365-2052.2010.02078.x; Steine T., 1985, Genetics of reproduction in sheep., P47; Teixeira FL, 2002, J CLIN ENDOCR METAB, V87, P1337, DOI 10.1210/jc.87.3.1337; Vage DI, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-1; Vitt UA, 2000, BIOL REPROD, V62, P370, DOI 10.1095/biolreprod62.2.370; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Zhang Z., 2012, COMPUT MATH METHOD M, V2012, P15	40	24	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95251	10.1371/journal.pone.0095251	http://dx.doi.org/10.1371/journal.pone.0095251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751660	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400044
J	Nguyen, HL; Ha, DA; Phan, DT; Nguyen, QN; Nguyen, VL; Nguyen, NH; Nguyen, H; Goldberg, RJ				Nguyen, Hoa L.; Duc Anh Ha; Dat Tuan Phan; Quang Ngoc Nguyen; Viet Lan Nguyen; Nguyen Hanh Nguyen; Ha Nguyen; Goldberg, Robert J.			Sex Differences in Clinical Characteristics, Hospital Management Practices, and In-Hospital Outcomes in Patients Hospitalized in a Vietnamese Hospital with a First Acute Myocardial Infarction	PLOS ONE			English	Article							ACUTE-CORONARY-SYNDROME; GENDER-DIFFERENCES; EARLY MORTALITY; HEART-DISEASE; ST ELEVATION; WOMEN; REGISTRY; MEN; SURVIVAL; TRENDS	Background: Cardiovascular disease is one of the leading causes of morbidity and mortality in Vietnam. We conducted a pilot study of Hanoi residents hospitalized with acute myocardial infarction (AMI) at the Vietnam National Heart Institute in Hanoi. The objectives of this observational study were to examine sex differences in clinical characteristics, hospital management, in-hospital clinical complications, and mortality in patients hospitalized with an initial AMI. Methods: The study population consisted of 302 Hanoi residents hospitalized with a first AMI at the largest tertiary care medical center in Hanoi in 2010. Results: The average age of study patients was 66 years and one third were women. Women were older (70 vs. 64 years) and were more likely than men to have had hyperlipidemia previously diagnosed (10% vs. 2%). During hospitalization, women were less likely to have undergone percutaneous coronary intervention (PCI) compared with men (57% vs. 74%), and women were more likely to have developed heart failure compared with men (19% vs. 10%). Women experienced higher in-hospital case-fatality rates (CFRs) than men (13% vs. 4%) and these differences were attenuated after adjustment for age and history of hyperlipidemia (OR: 2.64; 95% CI: 1.01, 6.89), and receipt of PCI during hospitalization (OR: 2.09; 95% CI: 0.77, 5.09). Conclusions: Our pilot data suggest that among patients hospitalized with a first AMI in Hanoi, women experienced higher in-hospital CFRs than men. Full-scale surveillance of all Hanoi residents hospitalized with AMI at all Hanoi medical centers is needed to confirm these findings. More targeted and timely educational and treatment approaches for women appear warranted.	[Nguyen, Hoa L.; Nguyen Hanh Nguyen; Ha Nguyen] Inst Populat Hlth & Dev, Hanoi, Vietnam; [Nguyen, Hoa L.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Duc Anh Ha] Minist Hlth, Hanoi, Vietnam; [Dat Tuan Phan; Quang Ngoc Nguyen; Viet Lan Nguyen] Viet Nam Natl Heart Inst, Hanoi, Vietnam; [Goldberg, Robert J.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA	University of Oxford; University of Massachusetts System; University of Massachusetts Worcester	Nguyen, HL (corresponding author), Inst Populat Hlth & Dev, Hanoi, Vietnam.	hoanguyen@phad.org	Nguyen, Hoa/AAA-5685-2020	Nguyen, Hoa/0000-0002-4998-8510	Global Health Office, University of Massachusetts Medical School, Worcester, MA, USA	Global Health Office, University of Massachusetts Medical School, Worcester, MA, USA	This study was funded by the Global Health Office, University of Massachusetts Medical School, Worcester, MA, USA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, HLTH STAT YB 2006; [Anonymous], 2001, HLTH STAT YB 2000; Bowker TJ, 2000, EUR HEART J, V21, P1458, DOI 10.1053/euhj.2000.2237; Butala NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025904; DEMIROVIC J, 1995, AM J CARDIOL, V75, P1096, DOI 10.1016/S0002-9149(99)80737-1; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377; El-Menyar A, 2009, AM J CARDIOL, V104, P1018, DOI 10.1016/j.amjcard.2009.06.003; Goldberg RJ, 2009, AM J CARDIOL, V103, P598, DOI 10.1016/j.amjcard.2008.10.038; Heer T, 2002, AM J CARDIOL, V89, P511, DOI 10.1016/S0002-9149(01)02289-5; Hoang Van Minh, 2006, Prev Chronic Dis, V3, pA89; Jamison DT, 2006, DIS CONTROL PRIORITI; Jiang SL, 2006, AM J CARDIOL, V98, P1000, DOI 10.1016/j.amjcard.2006.05.015; MacIntyre K, 2001, J AM COLL CARDIOL, V38, P729, DOI 10.1016/S0735-1097(01)01465-6; Marrugat J, 1998, JAMA-J AM MED ASSOC, V280, P1405, DOI 10.1001/jama.280.16.1405; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Ministry of Health, 2010, HLTH STAT YB 2009; Nguyen HL, 2010, CIRC-CARDIOVASC QUAL, V3, P82, DOI 10.1161/CIRCOUTCOMES.109.884361; Pagidipati NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062061; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosengren A, 2001, EUR HEART J, V22, P314, DOI 10.1053/euhj.2000.2368; Song XT, 2007, CHINESE MED J-PEKING, V120, P1063, DOI 10.1097/00029330-200706020-00007; Srichaiveth Boonchu, 2007, Journal of the Medical Association of Thailand, V90, P65; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Wang XL, 2013, J INT MED RES, V41, P231, DOI 10.1177/0300060512474567; Wenger N, 2008, CLIN PHARMACOL THER, V83, P37, DOI 10.1038/sj.clpt.6100447	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95631	10.1371/journal.pone.0095631	http://dx.doi.org/10.1371/journal.pone.0095631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752383	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400093
J	Popov, S; Takemori, H; Tokudome, T; Mao, YJ; Otani, K; Mochizuki, N; Pires, N; Pinho, MJ; Franco-Cereceda, A; Torielli, L; Ferrandi, M; Hamsten, A; Soares-da-Silva, P; Eriksson, P; Bertorello, AM; Brion, L				Popov, Sergej; Takemori, Hiroshi; Tokudome, Takeshi; Mao, Yuanjie; Otani, Kentaro; Mochizuki, Naoki; Pires, Nuno; Pinho, Maria Joao; Franco-Cereceda, Anders; Torielli, Lucia; Ferrandi, Mara; Hamsten, Anders; Soares-da-Silva, Patricio; Eriksson, Per; Bertorello, Alejandro M.; Brion, Laura			Lack of Salt-Inducible Kinase 2 (SIK2) Prevents the Development of Cardiac Hypertrophy in Response to Chronic High-Salt Intake	PLOS ONE			English	Article							HYPERTENSION-LINKED MUTATION; LEFT-VENTRICULAR MASS; INTRACELLULAR SODIUM; BLOOD-PRESSURE; GENETIC-HYPERTENSION; SIGNALING PATHWAYS; ARTERIAL-PRESSURE; PROTEIN-KINASES; CELL-LINE; 1 NETWORK	Cardiac left ventricle hypertrophy (LVH) constitutes a major risk factor for heart failure. Although LVH is most commonly caused by chronic elevation in arterial blood pressure, reduction of blood pressure to normal levels does not always result in regression of LVH, suggesting that additional factors contribute to the development of this pathology. We tested whether genetic preconditions associated with the imbalance in sodium homeostasis could trigger the development of LVH without concomitant increases in blood pressure. The results showed that the presence of a hypertensive variant of alpha-adducin gene in Milan rats (before they become hypertensive) resulted in elevated expression of genes associated with LVH, and of salt-inducible kinase 2 (SIK2) in the left ventricle (LV). Moreover, the mRNA expression levels of SIK2, alpha-adducin, and several markers of cardiac hypertrophy were positively correlated in tissue biopsies obtained from human hearts. In addition, we found in cardiac myocytes that a-adducin regulates the expression of SIK2, which in turn mediates the effects of adducin on hypertrophy markers gene activation. Furthermore, evidence that SIK2 is critical for the development of LVH in response to chronic high salt diet (HS) was obtained in mice with ablation of the sik2 gene. Increases in the expression of genes associated with LVH, as well as increases in LV wall thickness upon HS, occurred only in sik2(+/+) but not in sik2(-/-) mice. Thus LVH triggered by HS or the presence of a genetic variant of alpha-adducin requires SIK2 and is independent of elevated blood pressure. Inhibitors of SIK2 may constitute part of a novel therapeutic regimen aimed at prevention/regression of LVH.	[Popov, Sergej; Bertorello, Alejandro M.; Brion, Laura] Karolinska Univ Hosp Solna, Karolinska Inst, CMM, Dept Med,Membrane Signaling Network, Stockholm, Sweden; [Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, Osaka, Japan; [Tokudome, Takeshi; Mao, Yuanjie] Natl Cerebral & Cardiovasc Res Inst, Dept Biochem, Osaka, Japan; [Otani, Kentaro; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Res Inst, Osaka, Japan; [Pires, Nuno; Soares-da-Silva, Patricio] BIAL Portela & Ca SA, S Mamede Do Coronado, Portugal; [Pinho, Maria Joao; Soares-da-Silva, Patricio] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, P-4100 Oporto, Portugal; [Franco-Cereceda, Anders] Karolinska Inst, Dept Mol Med & Surg, Cardiothorac Surg Unit, Stockholm, Sweden; [Torielli, Lucia; Ferrandi, Mara] Prassis Sigma Tau Res Inst, Milan, Italy; [Hamsten, Anders; Eriksson, Per] Karolinska Univ Hosp Solna, Karolinska Inst, CMM, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; National Institute of Health Sciences - Japan; Bial Group; Universidade do Porto; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Brion, L (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, CMM, Dept Med,Membrane Signaling Network, Stockholm, Sweden.	laura.brion@ki.se	Soares-da-Silva, Patricio/A-6704-2015; Mao, Yuanjie/G-2020-2015	Soares-da-Silva, Patricio/0000-0002-2446-5078; Mao, Yuanjie/0000-0002-4196-7133; Pires, Nuno/0000-0001-5244-8550; Popov, Sergej/0000-0003-0940-9585; Otani, Kentaro/0000-0001-7607-8056; Eriksson, Per/0000-0002-5635-2692	Swedish Research Council [10860, 12660]; Swedish Heart and Lung Foundation [20120227]; AFA Insurance Sweden; Swedish Heart and Lung Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); AFA Insurance Sweden; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	The study was supported by grants to Dr.Alejandro M.Bertorello from the Swedish Research Council (10860), the Swedish Heart and Lung Foundation (20120227) and AFA Insurance Sweden (http://www.afaforsakring.se/Andra-sprak/Engelska/).The Swedish research Council (12660), the Swedish Heart and Lung Foundation and a donation from Fredrik Lundberg supported the human study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bianchi G, 2005, AM J PHYSIOL-REG I, V289, pR1536, DOI 10.1152/ajpregu.00441.2005; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Capasso G, 2005, AM J PHYSIOL-RENAL, V288, pF1173, DOI 10.1152/ajprenal.00228.2004; Carlson SH, 2000, HYPERTENSION, V35, pE1, DOI 10.1161/01.HYP.35.2.e1; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; de Wardener HE, 2004, KIDNEY INT, V66, P2454, DOI 10.1111/j.1523-1755.2004.66018.x; DUCAILAR G, 1992, AM J PHYSIOL, V263, pH177, DOI 10.1152/ajpheart.1992.263.1.H177; Efendiev R, 2004, CIRC RES, V95, P1100, DOI 10.1161/01.RES.0000149570.20845.89; Ferrandi M, 1996, HYPERTENSION, V28, P1018, DOI 10.1161/01.HYP.28.6.1018; Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; Folkersen L, 2011, MOL MED, V17, P1365, DOI 10.2119/molmed.2011.00286; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frohlich ED, 2004, NAT CLIN PRACT CARD, V1, P24, DOI 10.1038/ncpcardio0025; Hamlyn JM, 2011, CURR HYPERTENS REP, V13, P14, DOI 10.1007/s11906-010-0161-z; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Jaitovich A, 2010, BBA-MOL BASIS DIS, V1802, P1140, DOI 10.1016/j.bbadis.2010.03.009; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Manunta P, 1999, HYPERTENSION, V34, P450, DOI 10.1161/01.HYP.34.3.450; Marian AJ, 2003, J AM COLL CARDIOL, V41, P994, DOI 10.1016/S0735-1097(02)03003-6; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Popov S, 2012, AM J PHYSIOL-HEART C, V303, pH57, DOI 10.1152/ajpheart.00512.2011; Popov S, 2011, J HYPERTENS, V29, P2395, DOI 10.1097/HJH.0b013e32834d3d55; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; RUIZ JC, 1994, MECH DEVELOP, V48, P153, DOI 10.1016/0925-4773(94)90056-6; Shin HM, 1999, MOL IMMUNOL, V36, P1209, DOI 10.1016/S0161-5890(99)00140-6; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Stenstrom K, 2009, J HYPERTENS, V27, P2452, DOI 10.1097/HJH.0b013e328330cf15; Stephenson A, 2004, GENOMICS, V83, P1105, DOI 10.1016/j.ygeno.2003.12.007; Takemori H, 2007, MOL CELL ENDOCRINOL, V265, P196, DOI 10.1016/j.mce.2006.12.020; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Xiao JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035779; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744	41	12	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95771	10.1371/journal.pone.0095771	http://dx.doi.org/10.1371/journal.pone.0095771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752134	gold, Green Submitted, Green Published			2022-12-25	WOS:000335227400124
J	Wu, T; Li, YY; Huang, DL; Han, F; Zhang, YY; Zhang, DW; Han, JH				Wu, Ting; Li, Yuanyue; Huang, Deli; Han, Felicia; Zhang, Ying-Ying; Zhang, Duan-Wu; Han, Jiahuai			Regulator of G-Protein Signaling 19 (RGS19) and Its Partner G alpha-Inhibiting Activity Polypeptide 3 (GNAI3) Are Required for zVAD-Induced Autophagy and Cell Death in L929 Cells	PLOS ONE			English	Article							PROGRAMMED NECROSIS; INTERACTING PROTEIN; HT-29 CELLS; TNF-ALPHA; APOPTOSIS; PATHWAY; ACTIVATION; G(I3); GAIP	Autophagy has diverse biological functions and is involved in many biological processes. The L929 cell death induced by the pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-(OMe)-fluoromethyl ketone (zVAD) was shown to be an autophagy-mediated death for which RIP1 and RIP3 were both required. It was also reported that zVAD can induce a small amount of TNF production, which was shown to be required for zVAD-induced L929 cell death, arguing for the contribution of autophagy in the zVAD-induced L929 cell death. In an effort to study RIP3 mediated cell death, we identified regulator of G-protein signaling 19 (RGS19) as a RIP3 interacting protein. We showed that RGS19 and its partner G alpha-inhibiting activity polypeptide 3 (GNAI3) are involved in zVAD-, but not TNF-, induced cell death. The role of RGS19 and GNAI3 in zVAD-induced cell death is that they are involved in zVAD-induced autophagy. By the use of small hairpin RNAs and chemical inhibitors, we further demonstrated that zVAD-induced autophagy requires not only RIP1, RIP3, PI3KC3 and Beclin-1, but also RGS19 and GNAI3, and this autophagy is required for zVAD-induced TNF production. Collectively, our data suggest that zVAD-induced L929 cell death is a synergistic result of autophagy, caspase inhibition and autocrine effect of TNF.	[Wu, Ting] Xiamen Univ, Sch Life Sci, Canc Res Ctr, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Wu, Ting; Li, Yuanyue; Huang, Deli; Han, Felicia; Zhang, Ying-Ying; Zhang, Duan-Wu; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Zhang, DW (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	duanwu.zhang@utsouthwestern.edu; jhan@xmu.edu.cn	Han, J/G-4671-2010; Zhang, Duanwu/AAH-1627-2020; Zhang, Yingying/G-5244-2017; 黄, 德力/GWU-7847-2022	Zhang, Duanwu/0000-0003-2946-846X; 黄, 德力/0000-0002-6989-639X; Li, Yuanyue/0000-0001-5971-0355	Fundamental Research Funds for the Central Universities [2010121105]; Natural Science Foundation of Fujian Province of China [2011J05100]; National Basic Research Program of China (973 Program) [2013CB944903, 2014CB541804]; National Natural Science Foundation of China [31330047, 91029304, 81061160512, 31221065]; Hi-Tech Research and Development Program of China (863 program) [2012AA02A201]; 111 Project [B12001]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2012KF003]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); 111 Project(Ministry of Education, China - 111 Project); Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University	This work was supported by the Fundamental Research Funds for the Central Universities (2010121105), the Natural Science Foundation of Fujian Province of China (2011J05100), the National Basic Research Program of China (973 Program 2013CB944903, 2014CB541804), the National Natural Science Foundation of China (31330047, 91029304, 81061160512, 31221065), the Hi-Tech Research and Development Program of China (863 program; 2012AA02A201), the 111 Project (B12001), and the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University (SKLCSB2012KF003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Chen SY, 2011, AUTOPHAGY, V7, P217, DOI 10.4161/auto.7.2.14212; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Nyfeler B, 2011, MOL CELL BIOL, V31, P2867, DOI 10.1128/MCB.05430-11; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Tan SH, 2014, AUTOPHAGY, V10, P226, DOI 10.4161/auto.27003; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Wu YT, 2009, AUTOPHAGY, V5, P824, DOI 10.4161/auto.9099; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2011, CELL RES, V21, P368, DOI 10.1038/cr.2011.3; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	25	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94634	10.1371/journal.pone.0094634	http://dx.doi.org/10.1371/journal.pone.0094634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751948	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400015
J	Alemu, K; Worku, A; Berhane, Y; Kumie, A				Alemu, Kassahun; Worku, Alemayehu; Berhane, Yemane; Kumie, Abera			Men Traveling Away from Home Are More Likely to Bring Malaria into High Altitude Villages, Northwest Ethiopia	PLOS ONE			English	Article							BUTAJIRA AREA; RISK-FACTORS; TRANSMISSION; PREVENTION; PREVALENCE; INFECTION; LEVEL	Background: Information about malaria risk factors at high altitudes is scanty. Understanding the risk factors that determine the risk of malaria transmission at high altitude villages is important to facilitate implementing sustainable malaria control and prevention programs. Methods: An unmatched case control study was conducted among patients seeking treatment at health centers in high altitude areas. Either microscopy or rapid diagnostic tests were used to confirm the presence of plasmodium species. A generalized linear model was used to identify the predictors of malaria transmission in high altitude villages. Results: Males (AOR = 3.11, 95%CI: 2.28, 4.23), and those who traveled away from the home in the previous month (AOR = 2.01, 95% CI: 1.56, 2.58) were strongly associated with presence of malaria in high altitude villages. Other significant factors, including agriculture in occupation (AOR = 1.41, 95% CI: 1.05, 1.93), plants used for fencing (AOR = 1.70, 95% CI: 1.18, 2.52) and forests near the house (AOR = 1.60, 95% CI: 1.15, 2.47), were found predictors for malaria in high altitude villages. Conclusion: Travel outside of their home was an important risk of malaria infections acquisition. Targeting males who frequently travel to malarious areas can reduce malaria transmission risks in high altitude areas.	[Alemu, Kassahun] Univ Gondar, Dept Environm & Occupat Hlth & Safety, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Addis Ababa, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Kumie, Abera] Univ Addis Ababa, Dept Hlth Management Environm Hlth & Behav Sci, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia	University of Gondar; Addis Ababa University; Addis Continental Institute of Public Health; Addis Ababa University	Alemu, K (corresponding author), Univ Gondar, Dept Environm & Occupat Hlth & Safety, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	alemukass@yahoo.com	Kumie, Abera/AAC-8537-2022; Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	University of Gondar	University of Gondar	University of Gondar is the source of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; [Anonymous], 2012, ETHIOPIA NATL MALARI; [Anonymous], 2009, MAL RAP DIAGN TEST P; [Anonymous], EP INF VERS 3 5 1; Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Cheung W, 2008, INT J CLIMATOL, V10, P1002, DOI DOI 10.1002/J0C.1623; FMoH, 2013, PRES MAL IN; FMOH (Federal ministry of Health of Ethiopia), 2012, NAT MAL GUID; Franco-Paredes C, 2006, LANCET INFECT DIS, V6, P139, DOI 10.1016/S1473-3099(06)70410-8; GORDIS L, 2009, EPIDEMIOLOGY, P247; Graves PM, 2009, T ROYAL SOC TROPICAL; Hoffmann J.P., 2004, GEN LINEAR MODELS AP; Jager KJ, 2008, KIDNEY INT, V73, P256, DOI 10.1038/sj.ki.5002650; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Loha E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047354; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Peterson I, 2009, AM J TROP MED HYG, V80, P103, DOI 10.4269/ajtmh.2009.80.103; Shanks GD, 2004, J TRAVEL MED, V11, P354; Shanks GD, 2005, EMERGING INFECT DIS, V11; StataCorp, 2013, STAT STAT SOFTW REL; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-44; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2009, PAR CONF MAL DIAGN R; Woyessa A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-273; Woyessa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-84; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5; Yukich JO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-33	27	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95341	10.1371/journal.pone.0095341	http://dx.doi.org/10.1371/journal.pone.0095341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748159	gold, Green Submitted, Green Published			2022-12-25	WOS:000335226500088
J	Corsetti, F				Corsetti, Fabiano			Performance Analysis of Electronic Structure Codes on HPC Systems: A Case Study of SIESTA	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; ATOMS; WATER; VASP	We report on scaling and timing tests of the SIESTA electronic structure code for ab initio molecular dynamics simulations using density-functional theory. The tests are performed on six large-scale supercomputers belonging to the PRACE Tier-0 network with four different architectures: Cray XE6, IBM BlueGene/Q, BullX, and IBM iDataPlex. We employ a systematic strategy for simultaneously testing weak and strong scaling, and propose a measure which is independent of the range of number of cores on which the tests are performed to quantify strong scaling efficiency as a function of simulation size. We find an increase in efficiency with simulation size for all machines, with a qualitatively different curve depending on the supercomputer topology, and discuss the connection of this functional form with weak scaling behaviour. We also analyze the absolute timings obtained in our tests, showing the range of system sizes and cores favourable for different machines. Our results can be employed as a guide both for running SIESTA on parallel architectures, and for executing similar scaling tests of other electronic structure codes.	CIC nanoGUNE, Donostia San Sebastian, Spain		Corsetti, F (corresponding author), CIC nanoGUNE, Donostia San Sebastian, Spain.	f.corsetti@nanogune.eu		Corsetti, Fabiano/0000-0002-2275-436X; nanoGUNE, CIC/0000-0001-7874-5254	CIC nanoGUNE; PRACE	CIC nanoGUNE; PRACE	This work was supported by CIC nanoGUNE (www.nanogune.eu) and PRACE (www.prace-ri.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMDAHL GM, 1967, P AFIPS SPRING JOINT, V30, P483, DOI DOI 10.1145/1465482.1465560; Antonelli D, 2005, UCBCSD051399 EECS DE; Auckenthaler T, 2011, PARALLEL COMPUT, V37, P783, DOI 10.1016/j.parco.2011.05.002; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blackford L. S., 1997, SCALAPACK USERS GUID; Blum V, 2009, COMPUT PHYS COMMUN, V180, P2175, DOI 10.1016/j.cpc.2009.06.022; Bottin F, 2008, COMP MATER SCI, V42, P329, DOI 10.1016/j.commatsci.2007.07.019; Bowler DR, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/3/036503; Bowler DR, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/7/074207; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Corsetti F, 2014, COMPUT PHYS COMMUN, V185, P873, DOI 10.1016/j.cpc.2013.12.008; Corsetti F, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/43/435504; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Enkovaara J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/25/253202; Genovese L, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2949547; Genovese L, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3166140; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gonze X, 2009, COMPUT PHYS COMMUN, V180, P2582, DOI 10.1016/j.cpc.2009.07.007; GUSTAFSON JL, 1988, COMMUN ACM, V31, P532, DOI 10.1145/42411.42415; Gygi F, 2008, IBM J RES DEV, V52, P137, DOI 10.1147/rd.521.0137; Gygi F., 2006, LARGE SCALE ELECT ST; Hacene M, 2012, J COMPUT CHEM, V33, P2581, DOI 10.1002/jcc.23096; Hafner J, 2006, MRS BULL, V31, P659, DOI 10.1557/mrs2006.174; Hakala S, 2013, LECT NOTES COMPUT SC, V7782, P63, DOI 10.1007/978-3-642-36803-5_4; Hine NDM, 2009, COMPUT PHYS COMMUN, V180, P1041, DOI 10.1016/j.cpc.2008.12.023; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohn W, 1996, PHYS REV LETT, V76, P3168, DOI 10.1103/PhysRevLett.76.3168; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Lin L, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/29/295501; Maniopoulou A, 2012, COMPUT PHYS COMMUN, V183, P1696, DOI 10.1016/j.cpc.2012.03.009; Marzari N, 2006, MRS BULL, V31, P681, DOI 10.1557/mrs2006.177; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Plummer M, 2006, J MATER CHEM, V16, P1885, DOI 10.1039/b600182n; Sanz-Navarro CF, 2011, THEOR CHEM ACC, V128, P825, DOI 10.1007/s00214-010-0816-5; Skylaris CK, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839852; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; VandeVondele J, 2012, J CHEM THEORY COMPUT, V8, P3565, DOI 10.1021/ct200897x; Varini N, 2013, COMPUT PHYS COMMUN, V184, P1827, DOI 10.1016/j.cpc.2013.03.003; Wagner W, 2002, J PHYS CHEM REF DATA, V31, P387, DOI 10.1063/1.1461829; Wang J, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3521268	44	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95390	10.1371/journal.pone.0095390	http://dx.doi.org/10.1371/journal.pone.0095390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748385	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500096
J	Gilbert, MK; Kim, HJ; Tang, YH; Naoumkina, M; Fang, DD				Gilbert, Matthew K.; Kim, Hee Jin; Tang, Yuhong; Naoumkina, Marina; Fang, David D.			Comparative Transcriptome Analysis of Short Fiber Mutants Ligon-Lintless 1 And 2 Reveals Common Mechanisms Pertinent to Fiber Elongation in Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							PECTIN METHYL ESTERASE; GENE-EXPRESSION; DOWN-REGULATION; GLYOXAL OXIDASE; LI-1 MUTANT; CELL-WALL; IN-VITRO; GROWTH; INITIATION; PATHWAYS	Understanding the molecular processes affecting cotton (Gossypium hirsutum) fiber development is important for developing tools aimed at improving fiber quality. Short fiber cotton mutants Ligon-lintless 1 (Li-1) and Ligon-lintless 2 (Li-2) are naturally occurring, monogenic mutations residing on different chromosomes. Both mutations cause early cessation in fiber elongation. These two mutants serve as excellent model systems to elucidate molecular mechanisms relevant to fiber length development. Previous studies of these mutants using transcriptome analysis by our laboratory and others had been limited by the fact that very large numbers of genes showed altered expression patterns in the mutants, making a targeted analysis difficult or impossible. In this research, a comparative microarray analysis was conducted using these two short fiber mutants and their near isogenic wild type (WT) grown under both field and greenhouse environments in order to identify key genes or metabolic pathways common to fiber elongation. Analyses of three transcriptome profiles obtained from different growth conditions and mutant types showed that most differentially expressed genes (DEGs) were affected by growth conditions. Under field conditions, short fiber mutants commanded higher expression of genes related to energy production, manifested by the increasing of mitochondrial electron transport activity or responding to reactive oxygen species when compared to the WT. Eighty-eight DEGs were identified to have altered expression patterns common to both short fiber mutants regardless of growth conditions. Enrichment, pathway and expression analyses suggested that these 88 genes were likely involved in fiber elongation without being affected by growth conditions.	[Gilbert, Matthew K.; Kim, Hee Jin; Naoumkina, Marina; Fang, David D.] USDA ARS, Cotton Fiber Biosci Res Unit, So Reg Res Ctr, New Orleans, LA 70124 USA; [Tang, Yuhong] Samuel Roberts Noble Fdn Inc, Genom Core Facil, Ardmore, OK USA	United States Department of Agriculture (USDA); Noble Research Institute	Fang, DD (corresponding author), USDA ARS, Cotton Fiber Biosci Res Unit, So Reg Res Ctr, New Orleans, LA 70124 USA.	david.fang@ars.usda.gov	FANG, DAVID/AAV-5774-2020; Kim, Heejin/HII-8568-2022	FANG, DAVID/0000-0003-0036-5459; Tang, Yuhong/0000-0003-2967-778X	USDA-ARS CRIS [6435-21000-017D]; ARS [ARS-0424867] Funding Source: Federal RePORTER	USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research was funded by the USDA-ARS CRIS project 6435-21000-017D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine RC, 2008, PLANT J, V54, P863, DOI 10.1111/j.1365-313X.2008.03451.x; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bolton JJ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/659301; Bowling AJ, 2011, PROTOPLASMA, V248, P579, DOI 10.1007/s00709-010-0212-y; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai CP, 2013, THEOR APPL GENET, V126, P963, DOI 10.1007/s00122-012-2029-x; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; Chaudhary B, 2008, EVOL DEV, V10, P567, DOI 10.1111/j.1525-142X.2008.00272.x; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davidonis GH, 2004, AGRON J, V96, P42, DOI 10.2134/agronj2004.0042; Ding MQ, 2014, GENE, V535, P273, DOI 10.1016/j.gene.2013.11.017; Dong CH, 2001, PLANT CELL, V13, P1333, DOI 10.1105/tpc.13.6.1333; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gilbert MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075268; Gilbert MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-403; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hinchliffe DJ, 2011, CROP SCI, V51, P1683, DOI 10.2135/cropsci2010.10.0569; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hong JK, 2008, PLANTA, V227, P539, DOI 10.1007/s00425-007-0637-5; Huang GQ, 2013, PLANT PHYSIOL, V161, P1278, DOI 10.1104/pp.112.203760; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Jiang YY, 2012, PLANT OMICS, V5, P351; Karaca M, 2002, J HERED, V93, P221, DOI 10.1093/jhered/93.3.221; KERSTEN PJ, 1990, P NATL ACAD SCI USA, V87, P2936, DOI 10.1073/pnas.87.8.2936; KERSTEN PJ, 1993, P NATL ACAD SCI USA, V90, P7411, DOI 10.1073/pnas.90.15.7411; Kiba T, 2005, PLANT CELL PHYSIOL, V46, P339, DOI 10.1093/pcp/pci033; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; KOHEL RJ, 1992, CROP SCI, V32, P733, DOI 10.2135/cropsci1992.0011183X003200030031x; KOHEL RJ, 1972, CROP SCI, V12, P66, DOI 10.2135/cropsci1972.0011183X001200010022x; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Liakatas A, 1998, J AGR SCI-CAMBRIDGE, V130, P463, DOI 10.1017/S0021859698005413; Liu K, 2012, GENOMICS, V100, P42, DOI 10.1016/j.ygeno.2012.04.007; Liu QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065131; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Naoumkina M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-155; NARBUTH EV, 1990, J HERED, V81, P131; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pilling J, 2000, PLANTA, V210, P391, DOI 10.1007/PL00008147; Pomar F, 2002, FEBS LETT, V529, P198, DOI 10.1016/S0014-5793(02)03339-2; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Reboul R, 2011, J BIOL CHEM, V286, P39982, DOI 10.1074/jbc.M111.255695; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; Roussopoulos D, 1998, J AGR SCI, V130, P451, DOI 10.1017/S0021859698005401; Ruan YL, 2005, SEED SCI RES, V15, P269, DOI 10.1079/SSR2005217; SCHUBERT AM, 1976, CROP SCI, V16, P539, DOI 10.2135/cropsci1976.0011183X001600040026x; SEAGULL RW, 1986, CAN J BOT, V64, P1373, DOI 10.1139/b86-188; Shi HY, 2012, ACTA BIOCH BIOPH SIN, V44, P555, DOI 10.1093/abbs/gms035; Siedlecka A, 2008, PLANT PHYSIOL, V146, P554, DOI 10.1104/pp.107.111963; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; TIWARI SC, 1995, CAN J BOT, V73, P746, DOI 10.1139/b95-081; Turley RB, 2007, DEESTERFIED PECTINS; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaughn KC, 1999, PROTOPLASMA, V209, P226, DOI 10.1007/BF01453451; Vidali L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005744; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Wang HY, 2009, PLANT BIOTECHNOL J, V7, P13, DOI 10.1111/j.1467-7652.2008.00367.x; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; WILLISON JHM, 1977, PROTOPLASMA, V92, P21, DOI 10.1007/BF01280198; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228	69	26	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95554	10.1371/journal.pone.0095554	http://dx.doi.org/10.1371/journal.pone.0095554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748059	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500123
J	Heiser, D; Tan, YS; Kaplan, I; Godsey, B; Morisot, S; Cheng, WC; Small, D; Civin, CI				Heiser, Diane; Tan, Yee Sun; Kaplan, Ian; Godsey, Brian; Morisot, Sebastien; Cheng, Wen-Chih; Small, Donald; Civin, Curt I.			Correlated miR-mRNA Expression Signatures of Mouse Hematopoietic Stem and Progenitor Cell Subsets Predict "Stemness" and "Myeloid" Interaction Networks	PLOS ONE			English	Article							MICRORNA; DIFFERENTIATION; DELETION	Several individual miRNAs (miRs) have been implicated as potent regulators of important processes during normal and malignant hematopoiesis. In addition, many miRs have been shown to fine-tune intricate molecular networks, in concert with other regulatory elements. In order to study hematopoietic networks as a whole, we first created a map of global miR expression during early murine hematopoiesis. Next, we determined the copy number per cell for each miR in each of the examined stem and progenitor cell types. As data is emerging indicating that miRs function robustly mainly when they are expressed above a certain threshold (similar to 100 copies per cell), our database provides a resource for determining which miRs are expressed at a potentially functional level in each cell type. Finally, we combine our miR expression map with matched mRNA expression data and external prediction algorithms, using a Bayesian modeling approach to create a global landscape of predicted miR-mRNA interactions within each of these hematopoietic stem and progenitor cell subsets. This approach implicates several interaction networks comprising a "stemness" signature in the most primitive hematopoietic stem cell (HSC) populations, as well as "myeloid" patterns associated with two branches of myeloid development.	[Heiser, Diane; Tan, Yee Sun; Kaplan, Ian; Godsey, Brian; Morisot, Sebastien; Cheng, Wen-Chih; Civin, Curt I.] Univ Maryland, Sch Med, Dept Pediat, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Heiser, Diane; Tan, Yee Sun; Kaplan, Ian; Godsey, Brian; Morisot, Sebastien; Cheng, Wen-Chih; Civin, Curt I.] Univ Maryland, Sch Med, Dept Physiol, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Heiser, Diane; Small, Donald] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine	Civin, CI (corresponding author), Univ Maryland, Sch Med, Dept Pediat, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA.	CCivin@som.umaryland.edu			National Foundation for Cancer Research; National Institutes of Health [PO1CA70970]; Maryland Stem Cell Research Foundation/TEDCO [2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065-00]; Kyle Haydock Professorship; NATIONAL CANCER INSTITUTE [R01CA090668] Funding Source: NIH RePORTER	National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation/TEDCO; Kyle Haydock Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Foundation for Cancer Research, the National Institutes of Health (PO1CA70970) and the Maryland Stem Cell Research Foundation/TEDCO (2007-MSCRFII-0114, 2008-MSCRF-303524 and 2010-MSCRFII-0065-00). Dr. Small is also supported by the Kyle Haydock Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Godsey B, 2012, PLOS ONE IN PRESS; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Leon CMMP, 2011, J CELL PHYSIOL, V226, P1780, DOI 10.1002/jcp.22507; Lo Celso C, 2007, J VIS EXP; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Petriv OI, 2010, P NATL ACAD SCI USA, V107, P15443, DOI 10.1073/pnas.1009320107; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Team RC, 2012, R LANG ENV STAT COMP; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Yasudo H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024995	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94852	10.1371/journal.pone.0094852	http://dx.doi.org/10.1371/journal.pone.0094852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747944	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500038
J	Hopkins, GR; Brodie, ED; French, SS				Hopkins, Gareth R.; Brodie, Edmund D., Jr.; French, Susannah S.			Developmental and Evolutionary History Affect Survival in Stressful Environments	PLOS ONE			English	Article							SEA-LEVEL RISE; LARVAL AMBYSTOMA-GRACILE; WATER-QUALITY EVENTS; ROAD DEICING SALT; CHASMAGNATHUS-GRANULATA; SALINITY TOLERANCE; CARRY-OVER; INCUBATION-TEMPERATURE; HYDROMINERAL BALANCE; SODIUM-CHLORIDE	The world is increasingly impacted by a variety of stressors that have the potential to differentially influence life history stages of organisms. Organisms have evolved to cope with some stressors, while with others they have little capacity. It is thus important to understand the effects of both developmental and evolutionary history on survival in stressful environments. We present evidence of the effects of both developmental and evolutionary history on survival of a freshwater vertebrate, the rough-skinned newt (Taricha granulosa) in an osmotically stressful environment. We compared the survival of larvae in either NaCl or MgCl2 that were exposed to salinity either as larvae only or as embryos as well. Embryonic exposure to salinity led to greater mortality of newt larvae than larval exposure alone, and this reduced survival probability was strongly linked to the carry-over effect of stunted embryonic growth in salts. Larval survival was also dependent on the type of salt (NaCl or MgCl2) the larvae were exposed to, and was lowest in MgCl2, a widely-used chemical deicer that, unlike NaCl, amphibian larvae do not have an evolutionary history of regulating at high levels. Both developmental and evolutionary history are critical factors in determining survival in this stressful environment, a pattern that may have widespread implications for the survival of animals increasingly impacted by substances with which they have little evolutionary history.	[Hopkins, Gareth R.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Hopkins, GR (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	gareth.r.hopkins@gmail.com			Utah State University (USU) Department of Biology and the Ecology Center; Natural Sciences and Engineering Research Council of Canada (NSERC)	Utah State University (USU) Department of Biology and the Ecology Center; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported financially by the Utah State University (USU) Department of Biology and the Ecology Center. The USU Merril-Cazier Library's Open Access Funding Initiative and the USU Ecology Center kindly assisted with publication costs. The Natural Sciences and Engineering Research Council of Canada (NSERC) provided additional financial support to GRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLE KW, 1988, COPEIA, P345, DOI 10.2307/1445874; Alexander LG, 2012, COPEIA, P106, DOI 10.1643/CP-09-206; ALVARADO RH, 1970, COMP BIOCHEM PHYSIOL, V33, P93, DOI 10.1016/0010-406X(70)90486-X; ALVARADO RH, 1970, COMP BIOCHEM PHYSIOL, V33, P85, DOI 10.1016/0010-406X(70)90485-8; ALVARADO RH, 1970, AM J PHYSIOL, V218, P1510, DOI 10.1152/ajplegacy.1970.218.5.1510; ALVARADO RH, 1985, J EXP ZOOL, V236, P127, DOI 10.1002/jez.1402360203; Armstrong J, 1989, DEV BIOL AXOLOTL, P220; ASHRAF M, 1989, NEW PHYTOL, V112, P245, DOI 10.1111/j.1469-8137.1989.tb02380.x; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BEEBEE TJC, 1986, HERPETOL J, V1, P78; BEEBEE TJC, 1985, HERPETOL J, V1, P14; Bernabo I, 2013, AQUAT TOXICOL, V132, P119, DOI [10.1016/j.aquatox.2013.01.019, 10.1016/j.aquatox.2013.01]; Boone MD, 2002, COPEIA, P511, DOI 10.1643/0045-8511(2002)002[0511:EOHTFL]2.0.CO;2; Borst M, 2014, J AM WATER RESOUR AS, V50, P29, DOI 10.1111/jawr.12132; Brand AB, 2010, ARCH ENVIRON CON TOX, V58, P325, DOI 10.1007/s00244-009-9373-0; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; CALOW P, 1991, COMP BIOCHEM PHYS C, V100, P3, DOI 10.1016/0742-8413(91)90110-F; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Charmantier G, 1998, INVERTEBR REPROD DEV, V33, P177, DOI 10.1080/07924259.1998.9652630; Charmantier G, 2002, MAR ECOL PROG SER, V229, P185, DOI 10.3354/meps229185; Chinathamby K, 2006, AUST J ZOOL, V54, P97, DOI 10.1071/ZO06006; Christy MT, 2002, AMPHIBIA-REPTILIA, V23, P1, DOI 10.1163/156853802320877582; Collins SJ, 2009, ENVIRON POLLUT, V157, P320, DOI 10.1016/j.envpol.2008.06.032; COOKE AS, 1979, B ENVIRON CONTAM TOX, V21, P837, DOI 10.1007/BF01685514; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dougherty Christopher K., 2006, Applied Herpetology, V3, P87, DOI 10.1163/157075406776984266; Drever J.I., 1997, GEOCHEMISTRY NATURAL; DUNSON WA, 1977, COPEIA, P375; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; DuRant SE, 2012, FUNCT ECOL, V26, P416, DOI 10.1111/j.1365-2435.2011.01945.x; DuRant SE, 2012, BIOL LETTERS, V8, P108, DOI 10.1098/rsbl.2011.0735; Egea-Serrano A, 2012, ECOL EVOL, V2, P1382, DOI 10.1002/ece3.249; Ehlinger GS, 2004, BIOL BULL-US, V206, P87, DOI 10.2307/1543539; Environment Canada, 2001, PRIOR SUBST LIST ASS, P283; Gall BG, 2011, TOXICON, V57, P978, DOI 10.1016/j.toxicon.2011.03.020; Gimenez L, 2002, J EXP MAR BIOL ECOL, V270, P93, DOI 10.1016/S0022-0981(02)00012-6; Gimenez L, 2003, MAR ECOL PROG SER, V249, P251, DOI 10.3354/meps249251; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; GORDON MS, 1961, J EXP BIOL, V38, P659; Gorman HE, 2004, P ROY SOC B-BIOL SCI, V271, P1923, DOI 10.1098/rspb.2004.2799; GORNITZ V, 1995, EARTH SURF PROC LAND, V20, P7, DOI 10.1002/esp.3290200103; GOSNER KL, 1957, ECOLOGY, V38, P256, DOI 10.2307/1931684; Greulich K, 2003, AQUAT TOXICOL, V65, P329, DOI 10.1016/S0166-445X(03)00153-X; Griffis-Kyle KL, 2005, ENVIRON TOXICOL CHEM, V24, P1523, DOI 10.1897/04-452R.1; Hallsworth JE, 2007, ENVIRON MICROBIOL, V9, P801, DOI 10.1111/j.1462-2920.2006.01212.x; Harless ML, 2011, ENVIRON TOXICOL CHEM, V30, P1637, DOI 10.1002/etc.544; Harrison R.G, 1969, ORG DEV EMBRYO, V1, P44; HOFFMAN RW, 1981, WATER RESOUR BULL, V17, P280; Hopkins GR, 2013, EVOL APPL, V6, P384, DOI 10.1111/eva.12016; Hua J, 2013, COPEIA, P562, DOI 10.1643/OT-12-126; Karraker NE, 2008, ECOL APPL, V18, P724, DOI 10.1890/07-1644.1; Karraker NE, 2011, ENVIRON POLLUT, V159, P833, DOI 10.1016/j.envpol.2010.11.019; Karraker NE, 2009, ENVIRON RES, V109, P40, DOI 10.1016/j.envres.2008.09.001; Kaushal SS, 2005, P NATL ACAD SCI USA, V102, P13517, DOI 10.1073/pnas.0506414102; Kearney BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043427; Kusch RC, 2008, ENVIRON TOXICOL CHEM, V27, P705, DOI 10.1897/07-273.1; Langhans M, 2009, J FRESHWATER ECOL, V24, P335, DOI 10.1080/02705060.2009.9664301; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Mandrillon AL, 2007, CHEMOECOLOGY, V17, P169, DOI 10.1007/s00049-007-0376-x; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; MCKNIGHT CM, 1993, COPEIA, P475, DOI 10.2307/1447148; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moran AL, 2001, ECOLOGY, V82, P1597, DOI 10.2307/2679803; National Transportation Research Board, 2007, 577 NAT TRANSP RES B; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Orizaola G, 2010, OIKOS, V119, P980, DOI 10.1111/j.1600-0706.2009.17956.x; PADHYE AD, 1992, HERPETOL J, V2, P18; Pahkala M, 2001, P ROY SOC B-BIOL SCI, V268, P1699, DOI 10.1098/rspb.2001.1725; Pechenik JA, 1998, BIOSCIENCE, V48, P901, DOI 10.2307/1313294; Petranka JW, 2010, AQUAT ECOL, V44, P155, DOI 10.1007/s10452-009-9286-z; Purcell KM, 2008, EVOL APPL, V1, P155, DOI 10.1111/j.1752-4571.2007.00001.x; Qiu JW, 1999, MAR ECOL PROG SER, V188, P123, DOI 10.3354/meps188123; Rasanen K, 2002, FRESHWATER BIOL, V47, P19, DOI 10.1046/j.1365-2427.2002.00777.x; Rohr JR, 2006, ENVIRON HEALTH PERSP, V114, P46, DOI 10.1289/ehp.8405; Rohr JR, 2005, ENVIRON TOXICOL CHEM, V24, P1253, DOI 10.1897/04-448R.1; SHOEMAKER VH, 1977, ANNU REV PHYSIOL, V39, P449, DOI 10.1146/annurev.ph.39.030177.002313; Smith Geoffrey R, 2000, Conserv Biol, V14, P1903, DOI 10.1111/j.1523-1739.2000.99364.x; Snodgrass JW, 2008, ENVIRON POLLUT, V154, P291, DOI 10.1016/j.envpol.2007.10.003; Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V290, P133, DOI 10.1016/S0022-0981(03)00071-6; Thunqvist EL, 2004, SCI TOTAL ENVIRON, V325, P29, DOI 10.1016/j.scitotenv.2003.11.020; Touchon JC, 2013, ECOLOGY, V94, P850, DOI 10.1890/12-0194.1; Touchon JC, 2010, FUNCT ECOL, V24, P566, DOI 10.1111/j.1365-2435.2009.01650.x; Vernberg FJ, 2001, COASTAL ZONE PRESENT; Viertel B, 1999, AMPHIBIA-REPTILIA, V20, P161, DOI 10.1163/156853899X00178; Vonesh JR, 2002, OECOLOGIA, V133, P325, DOI 10.1007/s00442-002-1039-9; Warkentin KM, 1999, BIOL J LINN SOC, V68, P443, DOI 10.1006/bijl.1999.0325; WARKENTIN KM, 1995, P NATL ACAD SCI USA, V92, P3507, DOI 10.1073/pnas.92.8.3507; Watkins TB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P140, DOI 10.1086/498182; WEBB GJW, 1989, AM ZOOL, V29, P953; Whitfield PH, 1996, WATER SCI TECHNOL, V33, P151, DOI 10.1016/0273-1223(96)00197-7; WHITFIELD PH, 1992, WATER RESOUR BULL, V28, P703; Williams WD, 2001, HYDROBIOLOGIA, V466, P329, DOI 10.1023/A:1014598509028; Wu CS, 2014, J EXP ZOOL PART A, V321, P57, DOI 10.1002/jez.1837; WU L, 1981, NEW PHYTOL, V89, P471, DOI 10.1111/j.1469-8137.1981.tb02328.x	97	15	15	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95174	10.1371/journal.pone.0095174	http://dx.doi.org/10.1371/journal.pone.0095174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748021	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500064
J	Jungqvist, G; Oni, SK; Teutschbein, C; Futter, MN				Jungqvist, Gunnar; Oni, Stephen K.; Teutschbein, Claudia; Futter, Martyn N.			Effect of Climate Change on Soil Temperature in Swedish Boreal Forests	PLOS ONE			English	Article							INTEGRATED CATCHMENTS MODEL; CHANGE IMPACT; LAKE SIMCOE; RUNOFF DYNAMICS; BIAS CORRECTION; CARBON BALANCE; SNOW COVER; FROST; WATER; NITROGEN	Complex non-linear relationships exist between air and soil temperature responses to climate change. Despite its influence on hydrological and biogeochemical processes, soil temperature has received less attention in climate impact studies. Here we present and apply an empirical soil temperature model to four forest sites along a climatic gradient of Sweden. Future air and soil temperature were projected using an ensemble of regional climate models. Annual average air and soil temperatures were projected to increase, but complex dynamics were projected on a seasonal scale. Future changes in winter soil temperature were strongly dependent on projected snow cover. At the northernmost site, winter soil temperatures changed very little due to insulating effects of snow cover but southern sites with little or no snow cover showed the largest projected winter soil warming. Projected soil warming was greatest in the spring (up to 4 degrees C) in the north, suggesting earlier snowmelt, extension of growing season length and possible northward shifts in the boreal biome. This showed that the projected effects of climate change on soil temperature in snow dominated regions are complex and general assumptions of future soil temperature responses to climate change based on air temperature alone are inadequate and should be avoided in boreal regions.	[Jungqvist, Gunnar; Teutschbein, Claudia] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden; [Oni, Stephen K.; Futter, Martyn N.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Oni, SK (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	stephen.oni@slu.se	Teutschbein, Claudia/P-5504-2014; Futter, Martyn N/G-6238-2011	Teutschbein, Claudia/0000-0002-3344-2468; Futter, Martyn N/0000-0002-9789-7138	Swedish science council; Formas; SKB; Kempe foundation; Mistra; SLU; EU FP6 Integrated Project ENSEMBLES [505539]; ECCO project; DomQua project	Swedish science council; Formas(Swedish Research Council Formas); SKB; Kempe foundation; Mistra; SLU; EU FP6 Integrated Project ENSEMBLES(European Commission); ECCO project; DomQua project	This study was funded by Swedish science council, Formas, SKB, Kempe foundation, Mistra and SLU. This study is part of larger forest water programs; ForWater and Future Forest, studying the effect of climate and forest managements on forest water quality. The ENSEMBLES data used in this work was funded by the EU FP6 Integrated Project ENSEMBLES (Contract 505539) whose support is gratefully acknowledged. MNF was supported by the ECCO and DomQua projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson J, 2004, AMBIO, V33, P228, DOI 10.1579/0044-7447-33.4.228; Arkhangelskaya TA, 2014, GEODERMA, V213, P608, DOI 10.1016/j.geoderma.2013.04.001; Austin JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029021; Bergh J, 1999, GLOB CHANGE BIOL, V5, P245, DOI 10.1046/j.1365-2486.1999.00205.x; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; Brooks PD, 2011, GEOGR COMPASS, V5, DOI 10.1111/j.1749-8198.2011.00420.x; Brown PJ, 2011, AGR FOREST METEOROL, V151, P947, DOI 10.1016/j.agrformet.2011.02.014; Brown RD, 2000, J CLIMATE, V13, P2339, DOI 10.1175/1520-0442(2000)013<2339:NHSCVA>2.0.CO;2; Campbell JL, 2010, HYDROL PROCESS, V24, P2465, DOI 10.1002/hyp.7666; Christensen JH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035694; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Crossman J, 2013, J GREAT LAKES RES, V39, P19, DOI 10.1016/j.jglr.2012.11.003; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Domisch T, 2001, TREE PHYSIOL, V21, P465, DOI 10.1093/treephys/21.7.465; Euskirchen ES, 2006, GLOBAL CHANGE BIOL, V12, P731, DOI 10.1111/j.1365-2486.2006.01113.x; Fitzhugh RD, 2001, BIOGEOCHEMISTRY, V56, P215, DOI 10.1023/A:1013076609950; Futter MN, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR004960; Futter MN, 2011, AMBIO, V40, P906, DOI 10.1007/s13280-011-0203-z; Gislason SR, 2009, EARTH PLANET SC LETT, V277, P213, DOI 10.1016/j.epsl.2008.10.018; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P135, DOI 10.1023/A:1013039830323; Haei M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024017; Haei M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042821; Henry HAL, 2008, CLIMATIC CHANGE, V87, P421, DOI 10.1007/s10584-007-9322-8; Houle D, 2012, J CLIMATE, V25, P7690, DOI 10.1175/JCLI-D-11-00440.1; Karvonen T, 1988, MODEL PREDICTING EFF, P215; Kellomaki S, 2010, SILVA FENN, V44, P213, DOI 10.14214/sf.455; Koca D, 2006, CLIMATIC CHANGE, V78, P381, DOI 10.1007/s10584-005-9030-1; Kreyling J, 2013, CAN J SOIL SCI, V93, P427, DOI [10.4141/CJSS2012-025, 10.4141/cjss2012-025]; Laudon H, 2013, WATER RESOUR RES, V49, P7154, DOI 10.1002/wrcr.20520; Lindroth A, 1998, GLOBAL CHANGE BIOL, V4, P443, DOI 10.1046/j.1365-2486.1998.00165.x; Lofgren S, 2011, AMBIO, V40, P836, DOI 10.1007/s13280-011-0207-8; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Mellander PE, 2007, CLIMATIC CHANGE, V85, P179, DOI 10.1007/s10584-007-9254-3; Nabuurs GJ, 2013, NAT CLIM CHANGE, V3, P792, DOI [10.1038/NCLIMATE1853, 10.1038/nclimate1853]; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; Nyberg L, 2001, HYDROL PROCESS, V15, P909, DOI 10.1002/hyp.256; Oni SK, 2013, BIOGEOSCIENCES, V10, P2315, DOI 10.5194/bg-10-2315-2013; Oni SK, 2012, SCI TOTAL ENVIRON, V414, P387, DOI 10.1016/j.scitotenv.2011.10.025; Oni SK, 2014, CLIM DYNAM, V42, P2305, DOI 10.1007/s00382-014-2124-6; Oni SK, 2011, J GREAT LAKES RES, V37, P160, DOI 10.1016/j.jglr.2010.05.003; Oquist MG, 2008, GLOBAL CHANGE BIOL, V14, P2839, DOI 10.1111/j.1365-2486.2008.01669.x; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Oztas T, 2003, CATENA, V52, P1, DOI 10.1016/S0341-8162(02)00177-7; Rankinen K, 2004, HYDROL EARTH SYST SC, V8, P695, DOI 10.5194/hess-8-695-2004; Rankinen K, 2004, HYDROL EARTH SYST SC, V8, P706, DOI 10.5194/hess-8-706-2004; Refsgaard JC, 2007, ENVIRON MODELL SOFTW, V22, P1543, DOI 10.1016/j.envsoft.2007.02.004; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Solomon S., 2007, CLIMATE CHANGE, V2007, P996; Stahli M, 2001, HYDROL PROCESS, V15, P927, DOI 10.1002/hyp.232; Stieglitz M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017337; Stone RS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000286; Stromgren M, 2002, GLOBAL CHANGE BIOL, V8, P1195, DOI 10.1046/j.1365-2486.2002.00546.x; Teutschbein C, 2013, HYDROL EARTH SYST SC, V17, P5061, DOI 10.5194/hess-17-5061-2013; Teutschbein C, 2012, J HYDROL, V456, P12, DOI 10.1016/j.jhydrol.2012.05.052; Tierney GL, 2001, BIOGEOCHEMISTRY, V56, P175, DOI 10.1023/A:1013072519889; Van der Linden P, 2009, ENSEMBLE CLIMATE CHA; Vincent LA, 2006, ATMOS OCEAN, V44, P177, DOI 10.3137/ao.440205; Wade AJ, 2002, HYDROL EARTH SYST SC, V6, P583, DOI 10.5194/hess-6-583-2002; Winterdahl M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010235; Zhang Y, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004910	61	72	72	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93957	10.1371/journal.pone.0093957	http://dx.doi.org/10.1371/journal.pone.0093957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747938	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500017
J	Klarica, M; Rados, M; Erceg, G; Petosic, A; Jurjevic, I; Oreskovic, D				Klarica, Marijan; Rados, Milan; Erceg, Gorislav; Petosic, Antonio; Jurjevic, Ivana; Oreskovic, Darko			The Influence of Body Position on Cerebrospinal Fluid Pressure Gradient and Movement in Cats with Normal and Impaired Craniospinal Communication	PLOS ONE			English	Article							INTRACRANIAL-PRESSURE; SPINAL-CORD; POSTURE; HYDRODYNAMICS; HYDROCEPHALUS; DYNAMICS; SHUNTS; DURA; MRI; LYMPHATICS	Intracranial hypertension is a severe therapeutic problem, as there is insufficient knowledge about the physiology of cerebrospinal fluid (CSF) pressure. In this paper a new CSF pressure regulation hypothesis is proposed. According to this hypothesis, the CSF pressure depends on the laws of fluid mechanics and on the anatomical characteristics inside the cranial and spinal space, and not, as is today generally believed, on CSF secretion, circulation and absorption. The volume and pressure changes in the newly developed CSF model, which by its anatomical dimensions and basic biophysical features imitates the craniospinal system in cats, are compared to those obtained on cats with and without the blockade of craniospinal communication in different body positions. During verticalization, a long-lasting occurrence of negative CSF pressure inside the cranium in animals with normal cranio-spinal communication was observed. CSF pressure gradients change depending on the body position, but those gradients do not enable unidirectional CSF circulation from the hypothetical site of secretion to the site of absorption in any of them. Thus, our results indicate the existence of new physiological/pathophysiological correlations between intracranial fluids, which opens up the possibility of new therapeutic approaches to intracranial hypertension.	[Klarica, Marijan; Rados, Milan; Erceg, Gorislav; Jurjevic, Ivana] Univ Zagreb, Sch Med, Dept Pharmacol, Zagreb 41001, Croatia; [Klarica, Marijan; Rados, Milan; Erceg, Gorislav; Jurjevic, Ivana] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Zagreb 41001, Croatia; [Petosic, Antonio] Univ Zagreb, Dept Electroacoust, Fac Elect Engn & Comp, Zagreb 41000, Croatia; [Oreskovic, Darko] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia	University of Zagreb; University of Zagreb; University of Zagreb; Rudjer Boskovic Institute	Klarica, M (corresponding author), Univ Zagreb, Sch Med, Dept Pharmacol, Zagreb 41001, Croatia.	mklarica@mef.hr	Jurjevic, Ivana/AAB-4609-2020; Petošić, Antonio/AAC-8843-2019	Petošić, Antonio/0000-0003-2069-2764	Ministry of Science, Education and Sport of the Republic of Croatia [098-1080231-2328, 108-1080231-0023]	Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	This work has been supported by the Ministry of Science, Education and Sport of the Republic of Croatia (Projects: 1. Hydrodynamics of cerebrospinal fluid. No. 098-1080231-2328; and 2. Pathophysiology of cerebrospinal fluid and intracranial pressure. No. 108-1080231-0023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 2005, ACT NEUR S, V95, P177; Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; BRADBURY M, 1981, TRENDS NEUROSCI, V4, P100, DOI 10.1016/0166-2236(81)90032-1; BRADLEY KC, 1970, J NEUROL NEUROSUR PS, V33, P387, DOI 10.1136/jnnp.33.3.387; BRIERLEY JB, 1948, J ANAT, V82, P153; Bulat M, 2008, COLLEGIUM ANTROPOL, V32, P43; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; CUTLER RWP, 1968, BRAIN, V91, P707, DOI 10.1093/brain/91.4.707; Dandy WE, 1929, J AMER MED ASSOC, V92, P2012, DOI 10.1001/jama.1929.02700500024008; Davson H., 1987, PHYS PATHO PHYS CERE, V24, P106; Fishman RA, 1991, CEREBROSPINAL FLUID; FOX JL, 1973, J NEUROL NEUROSUR PS, V36, P302, DOI 10.1136/jnnp.36.2.302; Grashey H, 1892, FESTSCHRIFT MED; Igarashi H, 2014, NEUROREPORT, V25, P39, DOI 10.1097/WNR.0000000000000042; Johnston M, 2005, NEUROPATH APPL NEURO, V31, P632, DOI 10.1111/j.1365-2990.2005.00679.x; Jurjevic I, 2011, COLLEGIUM ANTROPOL, V35, P51; Klarica M, 2005, ACT NEUR S, V95, P407; Klarica M, 2006, CROAT MED J, V47, P233; Klarica M, 2013, NEUROSCIENCE, V248, P278, DOI 10.1016/j.neuroscience.2013.06.022; Klarica M, 2009, NEUROSCIENCE, V158, P1397, DOI 10.1016/j.neuroscience.2008.11.041; Kuzman Tomislav, 2012, Acta Neurochir Suppl, V114, P357, DOI 10.1007/978-3-7091-0956-4_69; Levine DN, 2001, J NEUROL SCI, V192, P1, DOI 10.1016/S0022-510X(01)00601-3; Loman J, 1935, ARCH NEURO PSYCHIATR, V33, P1279, DOI 10.1001/archneurpsyc.1935.02250180138007; Loman J, 1934, ARCH NEUROL PSYCHIAT, V31, P679; MAGNAES B, 1978, SURG NEUROL, V10, P45; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARTINS AN, 1972, J NEUROL NEUROSUR PS, V35, P468, DOI 10.1136/jnnp.35.4.468; Masserman JH, 1934, ARCH NEURO PSYCHIATR, V32, P523, DOI 10.1001/archneurpsyc.1934.02250090060006; MCCULLOUGH DC, 1974, J NEUROSURG, V40, P372, DOI 10.3171/jns.1974.40.3.0372; Michael H, 2013, 15 INT C INTR PRESS, P48; O'Connell JEA, 1943, BRAIN, V66, P204, DOI 10.1093/brain/66.3.204; Oreskovic D, 2011, PROG NEUROBIOL, V94, P238, DOI 10.1016/j.pneurobio.2011.05.005; Oreskovic D, 2002, NEUROSCI LETT, V327, P103, DOI 10.1016/S0304-3940(02)00395-6; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Poca MA, 2006, NEUROSURGERY, V58, P899, DOI 10.1227/01.NEU.0000209915.16235.6D; Pollay M, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-9; Pollock LJ, 1936, ARCH NEURO PSYCHIATR, V36, P931, DOI 10.1001/archneurpsyc.1936.02260110016005; PORTNOY HD, 1973, J NEUROSURG, V38, P729, DOI 10.3171/jns.1973.38.6.0729; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Tschan CA, 2010, 14 INT C INTR PRESS, P105; TUNTURI AR, 1977, J NEUROSURG, V47, P391, DOI 10.3171/jns.1977.47.3.0391; TUNTURI AR, 1978, J NEUROSURG, V48, P975, DOI 10.3171/jns.1978.48.6.0975; von Storch TJC, 1937, ARCH NEURO PSYCHIATR, V38, P1158, DOI 10.1001/archneurpsyc.1937.02260240038003; WEED LEWIS H., 1929, ARCH SURG, V18, P1049; Weed LH, 1933, PHYSIOL REV, V13, P0080; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; WIIG H, 1983, AM J PHYSIOL, V244, pH239, DOI 10.1152/ajpheart.1983.244.2.H239; Zarzur E, 1996, ARQ NEURO-PSIQUIAT, V54, P455, DOI 10.1590/S0004-282X1996000300015	51	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95229	10.1371/journal.pone.0095229	http://dx.doi.org/10.1371/journal.pone.0095229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748150	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000335226500068
J	Li, J; Zheng, X; Guo, XP; Qi, L; Dong, XZ				Li, Jie; Zheng, Xin; Guo, Xiaopeng; Qi, Lei; Dong, Xiuzhu			Characterization of an Archaeal Two-Component System That Regulates Methanogenesis in Methanosaeta harundinacea	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; DIVERSITY; CLASSIFICATION; TRANSCRIPTION; PROTEINS; RESOURCE; NETWORK; MODEL	Two-component signal transduction systems (TCSs) are a major mechanism used by bacteria in response to environmental changes. Although many sequenced archaeal genomes encode TCSs, they remain poorly understood. Previously, we reported that a methanogenic archaeon, Methanosaeta harundinacea, encodes Fill, which synthesizes carboxyl-acyl homoserine lactones, to regulate transitions of cellular morphology and carbon metabolic fluxes. Here, we report that fill, the cotranscribed filR2, and the adjacent filR1 constitute an archaeal TCS. Fill possesses a cytoplasmic kinase domain (histidine kinase A and histidine kinase-like ATPase) and its cognate response regulator. FilR1 carries a receiver (REC) domain coupled with an ArsR-related domain with potential DNA-binding ability, while FilR2 carries only a REC domain. In a phosphorelay assay, Fill was autophosphorylated and specifically transferred the phosphoryl group to FilR1 and FilR2, confirming that the three formed a cognate TCS. Through chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR) using an anti-FilR1 antibody, FilR1 was shown to form in vivo associations with its own promoter and the promoter of the fill-filR2 operon, demonstrating a regulatory pattern common among TCSs. ChIP-qPCR also detected FilR1 associations with key genes involved in acetoclastic methanogenesis, acs4 and acs1. Electrophoretic mobility shift assays confirmed the in vitro tight binding of FilR1 to its own promoter and those of fill-filR2, acs4, and mtrABC. This also proves the DNA-binding ability of the ArsR-related domain, which is found primarily in Archaea. The archaeal promoters of acs4, fill, acs1, and mtrABC also initiated FilR1-modulated expression in an Escherichia coli lux reporter system, suggesting that FilR1 can up-regulate both archaeal and bacterial transcription. In conclusion, this work identifies an archaeal Fill/FilRs TCS that regulates the methanogenesis of M. harundinacea.	[Li, Jie; Zheng, Xin; Guo, Xiaopeng; Qi, Lei; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Zheng, Xin; Guo, Xiaopeng; Qi, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dong, XZ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	dongxz@im.ac.cn	Dong, Xiuzhu/EBF-2196-2022	Dong, Xiuzhu/0000-0002-6926-5459; li, jie/0000-0002-2773-6806	National Natural Science Foundation of China [31100035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31100035). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby Mark K., 2006, Archaea, V2, P11, DOI 10.1155/2006/562404; Barakat M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-315; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Decker KB, 2013, ANN REV MICROBIOL; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Hellingwerf KJ, 2005, TRENDS MICROBIOL, V13, P152, DOI 10.1016/j.tim.2005.02.001; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jenal U, 2009, CURR OPIN MICROBIOL, V12, P152, DOI 10.1016/j.mib.2009.01.010; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leigh JA, 2011, FEMS MICROBIOL REV, V35, P577, DOI 10.1111/j.1574-6976.2011.00265.x; Ma K, 2006, INT J SYST EVOL MICR, V56, P127, DOI 10.1099/ijs.0.63887-0; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; SPROTT GD, 1979, CAN J MICROBIOL, V25, P730, DOI 10.1139/m79-106; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Varughese KI, 2005, J BACTERIOL, V187, P8221, DOI 10.1128/JB.187.24.8221-8227.2005; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Zhu JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036756	35	4	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95502	10.1371/journal.pone.0095502	http://dx.doi.org/10.1371/journal.pone.0095502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748383	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500116
J	Milto, K; Michailova, K; Smirnovas, V				Milto, Katazyna; Michailova, Ksenija; Smirnovas, Vytautas			Elongation of Mouse Prion Protein Amyloid-Like Fibrils: Effect of Temperature and Denaturant Concentration	PLOS ONE			English	Article							MAMMALIAN PRIONS; HYDROGEN/DEUTERIUM EXCHANGE; NEURODEGENERATIVE DISEASES; PARALLEL; DOMAIN; CORE	Prion protein is known to have the ability to adopt a pathogenic conformation, which seems to be the basis for protein-only infectivity. The infectivity is based on self-replication of this pathogenic prion structure. One of possible mechanisms for such replication is the elongation of amyloid-like fibrils. We measured elongation kinetics and thermodynamics of mouse prion amyloid-like fibrils at different guanidine hydrochloride (GuHCl) concentrations. Our data show that both increases in temperature and GuHCl concentration help unfold monomeric protein and thus accelerate elongation. Once the monomers are unfolded, further increases in temperature raise the rate of elongation, whereas the addition of GuHCl decreases it. We demonstrated a possible way to determine different activation energies of amyloid-like fibril elongation by using folded and unfolded protein molecules. This approach separates thermodynamic data for fibril-assisted monomer unfolding and for refolding and formation of amyloid-like structure.	[Milto, Katazyna; Michailova, Ksenija; Smirnovas, Vytautas] Vilnius State Univ, Dept Biothermodynam & Drug Design, Inst Biotechnol, Vilnius, Lithuania	Vilnius University	Smirnovas, V (corresponding author), Vilnius State Univ, Dept Biothermodynam & Drug Design, Inst Biotechnol, Vilnius, Lithuania.	vytautas.smirnovas@bti.vu.lt	Smirnovas, Vytautas/O-6270-2018	Smirnovas, Vytautas/0000-0002-1829-5455	Research Council of Lithuania [MIP-030/2012]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This research was funded by a grant (No. MIP-030/2012) from the Research Council of Lithuania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buell AK, 2012, ANGEW CHEM INT EDIT, V51, P5247, DOI 10.1002/anie.201108040; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Huang YY, 2009, ADV MATER, V21, P3945, DOI 10.1002/adma.200900498; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Klug GMJA, 2013, J NEUROL NEUROSUR PS, V84, P1372, DOI 10.1136/jnnp-2012-304820; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Milto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068684; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004	31	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94469	10.1371/journal.pone.0094469	http://dx.doi.org/10.1371/journal.pone.0094469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747600	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500030
J	Moua, T; Zand, L; Hartman, RP; Hartman, TE; Qin, DX; Peikert, T; Qian, Q				Moua, Teng; Zand, Ladan; Hartman, Robert P.; Hartman, Thomas E.; Qin, Dingxin; Peikert, Tobias; Qian, Qi			Radiologic and Clinical Bronchiectasis Associated with Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							CIGARETTE-SMOKE EXPOSURE; COMPUTED-TOMOGRAPHY; STANDARDIZATION; PREVALENCE; CILIA; CT	Background: Polycystin 1 and 2, the protein abnormalities associated with autosomal dominant polycystic kidney disease (ADPKD), are also found in airway cilia and smooth muscle cells. There is evidence of increased radiologic bronchiectasis associated with ADPKD, though the clinical and functional implications of this association are unknown. We hypothesized an increased prevalence of both radiologic and clinical bronchiectasis is associated with APDKD as compared to non-ADPKD chronic kidney disease (CKD) controls. Materials and Methods: A retrospective case-control study was performed at our institution involving consecutive ADPKD and non-ADPKD chronic kidney disease (CKD) patients seen over a 13 year period with both chest CT and PFT. CTs were independently reviewed by two blinded thoracic radiologists. Manually collected clinical data included symptoms, smoker status, transplant history, and PFT findings. Results: Ninety-two ADPKD and 95 non-ADPKD CKD control patients were compared. Increased prevalence of radiologic bronchiectasis, predominantly mild lower lobe disease, was found in ADPKD patients compared to CKD control (19 vs. 9%, P = 0.032, OR 2.49 (CI 1.1-5.8)). After adjustment for covariates, ADPKD was associated with increased risk of radiologic bronchiectasis (OR 2.78 (CI 1.16-7.12)). Symptomatic bronchiectasis occurred in approximately a third of ADPKD patients with radiologic disease. Smoking was associated with increased radiologic bronchiectasis in ADPKD patients (OR 3.59, CI 1.23-12.1). Conclusions: Radiological bronchiectasis is increased in patients with ADPKD particularly those with smoking history as compared to non-ADPKD CKD controls. A third of such patients have symptomatic disease. Bronchiectasis should be considered in the differential in ADPKD patients with respiratory symptoms and smoking history.	[Moua, Teng; Peikert, Tobias] Mayo Clin, Div Pulm Crit Care, Rochester, MN 55905 USA; [Zand, Ladan; Qin, Dingxin; Qian, Qi] Mayo Clin, Div Nephrol, Rochester, MN USA; [Hartman, Robert P.; Hartman, Thomas E.] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Moua, T (corresponding author), Mayo Clin, Div Pulm Crit Care, Rochester, MN 55905 USA.	moua.teng@mayo.edu	Moua, Teng/AAG-7445-2019		NCI NIH HHS [K23 CA159391] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K23CA159391] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Bhalal L, 2005, ADV ANAT PATHOL, V12, P126, DOI 10.1097/01.pap.0000163959.29032.1f; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Barua M, 2010, SEMIN NEPHROL, V30, P356, DOI 10.1016/j.semnephrol.2010.06.002; Bhatta N, 2008, Kathmandu Univ Med J (KUMJ), V6, P195; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Driscoll JA, 2008, CHEST, V133, P1181, DOI 10.1378/chest.07-2147; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Jain Raksha, 2012, Front Biosci (Schol Ed), V4, P1088; Kim JS, 1997, AM J ROENTGENOL, V168, P751, DOI 10.2214/ajr.168.3.9057529; Kumar S, 2006, NEPHROL DIAL TRANSPL, V21, P3576, DOI 10.1093/ndt/gfl405; Kwak HJ, 2010, TOHOKU J EXP MED, V222, P237, DOI 10.1620/tjem.222.237; Leopold PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008157; Maestrelli P, 2001, AM J RESP CRIT CARE, V164, pS76, DOI 10.1164/ajrccm.164.supplement_2.2106067; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1984, AM J ROENTGENOL, V143, P971, DOI 10.2214/ajr.143.5.971; NAIDICH DP, 1982, J COMPUT ASSIST TOMO, V6, P437, DOI 10.1097/00004728-198206000-00001; O'Donnell AE, 2008, CHEST, V134, P815, DOI 10.1378/chest.08-0776; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Qian Q, 2007, NEPHROL DIAL TRANSPL, V22, P1769, DOI 10.1093/ndt/gfm034; Qian Q, 2007, CLIN J AM SOC NEPHRO, V2, P1223, DOI 10.2215/CJN.01920507; Seitz AE, 2012, CHEST, V142, P432, DOI 10.1378/chest.11-2209; Simet SM, 2010, AM J RESP CELL MOL, V43, P635, DOI 10.1165/rcmb.2009-0297OC; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed; Wu J, 2009, CHEST, V136, P561, DOI 10.1378/chest.08-1549	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93674	10.1371/journal.pone.0093674	http://dx.doi.org/10.1371/journal.pone.0093674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747723	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500012
J	Szabova, L; Bupp, S; Kamal, M; Householder, DB; Hernandez, L; Schlomer, JJ; Baran, ML; Yi, M; Stephens, RM; Annunziata, CM; Martin, PL; Van Dyke, TA; Ohler, ZW; Difilippantonio, S				Szabova, Ludmila; Bupp, Sujata; Kamal, Muhaymin; Householder, Deborah B.; Hernandez, Lidia; Schlomer, Jerome J.; Baran, Maureen L.; Yi, Ming; Stephens, Robert M.; Annunziata, Christina M.; Martin, Philip L.; Van Dyke, Terry A.; Ohler, Zoe Weaver; Difilippantonio, Simone			Pathway-Specific Engineered Mouse Allograft Models Functionally Recapitulate Human Serous Epithelial Ovarian Cancer	PLOS ONE			English	Article							ADP-RIBOSE POLYMERASE; MAMMARY-TUMORS; POLY(ADP-RIBOSE); CHEMOTHERAPY; BRCA1; INHIBITOR; MUTATIONS; INDUCTION; OLAPARIB; THERAPY	The high mortality rate from ovarian cancers can be attributed to late-stage diagnosis and lack of effective treatment. Despite enormous effort to develop better targeted therapies, platinum-based chemotherapy still remains the standard of care for ovarian cancer patients, and resistance occurs at a high rate. One of the rate limiting factors for translation of new drug discoveries into clinical treatments has been the lack of suitable preclinical cancer models with high predictive value. We previously generated genetically engineered mouse (GEM) models based on perturbation of Tp53 and Rb with or without Brca1 or Brca2 that develop serous epithelial ovarian cancer (SEOC) closely resembling the human disease on histologic and molecular levels. Here, we describe an adaptation of these GEM models to orthotopic allografts that uniformly develop tumors with short latency and are ideally suited for routine preclinical studies. Ovarian tumors deficient in Brca1 respond to treatment with cisplatin and olaparib, a PARP inhibitor, whereas Brca1-wild type tumors are non-responsive to treatment, recapitulating the relative sensitivities observed in patients. These mouse models provide the opportunity for evaluation of effective therapeutics, including prediction of differential responses in Brca1-wild type and Brca1-deficient tumors and development of relevant biomarkers.	[Szabova, Ludmila; Bupp, Sujata; Kamal, Muhaymin; Householder, Deborah B.; Schlomer, Jerome J.; Baran, Maureen L.; Martin, Philip L.; Van Dyke, Terry A.; Ohler, Zoe Weaver; Difilippantonio, Simone] Leidos Biomedical Res Inc, Frederick Natl Lab Canc Res, Ctr Adv Preclin Res, Frederick, MD USA; [Hernandez, Lidia; Annunziata, Christina M.] NCI, Med Oncol Branch, Bethesda, MD 20892 USA; [Yi, Ming; Stephens, Robert M.] Leidos Biomedical Res Inc, Frederick Natl Lab Canc Res, Adv Biomed Comp Ctr, Frederick, MD USA; [Van Dyke, Terry A.] Frederick Natl Lab Canc Res, Mouse Canc Genet Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Szabova, L (corresponding author), Leidos Biomedical Res Inc, Frederick Natl Lab Canc Res, Ctr Adv Preclin Res, Frederick, MD USA.	lszabova@mail.nih.gov	Annunziata, Christina/L-3219-2016	Annunziata, Christina/0000-0003-2033-6532; Yi, Ming/0000-0001-9098-1364; Weaver Ohler, Zoe/0000-0002-6287-2504	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011353] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole with federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG; Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Borst P, 2008, CELL CYCLE, V7, P1353, DOI 10.4161/cc.7.10.5930; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; BUICK RN, 1985, CANCER RES, V45, P3668; Carser JE, 2011, GYNECOL ONCOL, V123, P492, DOI 10.1016/j.ygyno.2011.08.017; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chernikova SB, 2012, CANCER BIOL THER, V13, P61, DOI [10.4161.cbt.13.2.18872, 10.4161/cbt.13.2.18872]; Connolly DC, 2003, CANCER RES, V63, P1389; Dann RB, 2012, GYNECOL ONCOL, V125, P677, DOI 10.1016/j.ygyno.2012.03.006; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Fojo T, 2005, CRIT REV ONCOL HEMAT, V53, P25, DOI 10.1016/j.critrevonc.2004.09.008; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gallagher DJ, 2011, ANN ONCOL, V22, P1127, DOI 10.1093/annonc/mdq577; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Hay T, 2009, CANCER RES, V69, P3850, DOI 10.1158/0008-5472.CAN-08-2388; Helleman J, 2006, CANCER BIOL THER, V5, P943, DOI 10.4161/cbt.5.8.2876; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Khan OA, 2011, BRIT J CANCER, V104, P750, DOI 10.1038/bjc.2011.8; Kim WY, 2012, CURR TOP MICROBIOL, V355, P19, DOI 10.1007/82_2011_160; Ledermann J., 2013, J CLIN ONC ABSTR, V31, P5505; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; Markman M, 2000, Oncologist, V5, P26, DOI 10.1634/theoncologist.5-1-26; McGuire WP, 2003, BRIT J CANCER, V89, pS3, DOI 10.1038/sj.bjc.6601494; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Plummer ER, 2006, CURR OPIN PHARMACOL, V6, P364, DOI 10.1016/j.coph.2006.02.004; Quinn BA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-24; Quinn JE, 2009, GYNECOL ONCOL, V113, P134, DOI 10.1016/j.ygyno.2008.12.015; Ratner ES, 2012, CURR OPIN ONCOL, V24, P564, DOI 10.1097/CCO.0b013e3283564230; Rigakos G, 2012, ONCOLOGIST, V17, P956, DOI 10.1634/theoncologist.2012-0028; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Stordal B, 2013, MOL ONCOL, V7, P567, DOI 10.1016/j.molonc.2012.12.007; Swisher EM, 2008, CANCER RES, V68, P2581, DOI 10.1158/0008-5472.CAN-08-0088; Szabova L, 2012, CANCER RES, V72, P4141, DOI 10.1158/0008-5472.CAN-11-3834; Xing DY, 2006, CANCER RES, V66, P8949, DOI 10.1158/0008-5472.CAN-06-1495; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583	47	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95649	10.1371/journal.pone.0095649	http://dx.doi.org/10.1371/journal.pone.0095649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748377	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500133
J	Yeh, YC; Tang, MJ; Parekh, AB				Yeh, Yi-Chun; Tang, Ming-Jer; Parekh, Anant B.			Caveolin-1 Alters the Pattern of Cytoplasmic Ca2+ Oscillations and Ca2+-dependent Gene Expression by Enhancing Leukotriene Receptor Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CALCIUM CURRENT; ENDOTHELIAL-CELLS; CYSLT(1) RECEPTOR; G-PROTEINS; H-RAS; IDENTIFICATION; GROWTH; INACTIVATION; NEURONS	Cytoplasmic Ca2+ oscillations constitute a widespread signaling mode and are often generated in response to stimulation of G protein-coupled receptors that activate phospholipase C. In mast cells, repetitive Ca2+ oscillations can be evoked by modest activation of cysteinyl leukotriene type I receptors by the physiological trigger, leukotriene C-4. The Ca2+ oscillations arise from regenerative Ca2+ release from inositol 1,4,5-trisphosphate-sensitive stores followed by Ca2+ entry through store-operated Ca2+ channels, and the latter selectively activate the Ca2+-dependent transcription factor NFAT. The cysteinyl leukotriene type I receptors desensitize through negative feedback by protein kinase C, which terminates the oscillatory Ca2+ response. Here, we show that the scaffolding protein caveolin-1 has a profound effect on receptor-driven Ca2+ signals and downstream gene expression. Overexpression of caveolin-1 increased receptor-phospholipase C coupling, resulting in initially larger Ca2+ release transients of longer duration but which then ran down quickly. NFAT-activated gene expression, triggered in response to the Ca2+ signal, was also reduced by caveolin-1. Mutagenesis studies revealed that these effects required a functional scaffolding domain within caveolin-1. Mechanistically, the increase in Ca2+ release in the presence of caveolin-1 activated protein kinase C, which accelerated homologous desensitization of the leukotriene receptor and thereby terminated the oscillatory Ca2+ response. Our results reveal that caveolin-1 is a bimodal regulator of receptor-dependent Ca2+ signaling, which fine-tunes the spatial and temporal profile of the Ca2+ rise and thereby its ability to activate the NFAT pathway.	[Yeh, Yi-Chun; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Tang, Ming-Jer] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Tang, Ming-Jer] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan	University of Oxford; National Cheng Kung University; Tunghai University	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk		Yeh, Yi-Chun/0000-0002-2807-9369; Tang, Ming-Jer/0000-0002-0883-4363	Medical Research Council; National Science Council Fellowship from Taiwan [100-2911-I-006-036]; MRC [G1000813] Funding Source: UKRI; Medical Research Council [G1000813] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Science Council Fellowship from Taiwan; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council grant (to A. B. P.).; Y-C.Y. was a recipient of National Science Council Fellowship 100-2911-I-006-036 from Taiwan.	Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Dawe GB, 2013, NAT STRUCT MOL BIOL, V20, P1054, DOI 10.1038/nsmb.2654; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kar P, 2012, P NATL ACAD SCI USA, V109, P6969, DOI 10.1073/pnas.1201204109; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Kiss AL, 2000, EUR J CELL BIOL, V79, P343, DOI 10.1078/S0171-9335(04)70038-2; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li WP, 2001, J CELL SCI, V114, P1397; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2002, J BIOL CHEM, V277, P20820, DOI 10.1074/jbc.M203163200; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Nash MS, 2001, BIOCHEM J, V356, P137, DOI 10.1042/0264-6021:3560137; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Schwartz EA, 2005, BIOCHEM J, V390, P199, DOI 10.1042/BJ20041182; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Sjostrom M, 2001, EUR J BIOCHEM, V268, P2578, DOI 10.1046/j.1432-1327.2001.02142.x; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	34	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17843	17853		10.1074/jbc.M114.553453	http://dx.doi.org/10.1074/jbc.M114.553453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24755228	Green Published, hybrid			2022-12-25	WOS:000338018100046
J	Waight, JD; Banik, D; Griffiths, EA; Nemeth, MJ; Abrams, SI				Waight, Jeremy D.; Banik, Debarati; Griffiths, Elizabeth A.; Nemeth, Michael J.; Abrams, Scott I.			Regulation of the Interferon regulatory factor-8 (IRF-8) Tumor Suppressor Gene by the Signal Transducer and Activator of Transcription 5 (STAT5) Transcription Factor in Chronic Myeloid Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Cell Death; Leukemia; STAT Transcription Factor; Tumor Suppressor Gene	CHRONIC MYELOGENOUS LEUKEMIA; SEQUENCE BINDING-PROTEIN; PERIPHERAL T-CELLS; CONSTITUTIVE ACTIVATION; HEMATOPOIETIC PROGENITORS; TYROSINE PHOSPHORYLATION; ICSBP DEFICIENCY; WILMS-TUMOR; EXPRESSION; ABL	Tyrosine kinase inhibitors such as imatinib can effectively target the BCR-ABL oncoprotein in a majority of patients with chronic myeloid leukemia (CML). Unfortunately, some patients are resistant primarily to imatinib and others develop drug resistance, prompting interest in the discovery of new drug targets. Although much of this resistance can be explained by the presence of mutations within the tyrosine kinase domain of BCR-ABL, such mutations are not universally identified. Interferon regulatory factor-8 (IRF-8) is a transcription factor that is essential for myelopoiesis. Depressed IRF-8 levels are observed in a majority of CML patients and Irf-8(-/-) mice exhibit a CML-like disease. The underlying mechanisms of IRF-8 loss in CML are unknown. We hypothesized that BCR-ABL suppresses transcription of IRF-8 through STAT5, a proximal BCR-ABL target. Treatment of primary cells from newly diagnosed CML patients in chronic phase as well as BCR-ABL(+) cell lines with imatinib increased IRF-8 transcription. Furthermore, IRF-8 expression in cell line models was necessary for imatinib-induced antitumor responses. We have demonstrated that IRF-8 is a direct target of STAT5 and that silencing of STAT5 induced IRF-8 expression. Conversely, activating STAT5 suppressed IRF-8 transcription. Finally, we showed that STAT5 blockade using a recently discovered antagonist increased IRF-8 expression in patient samples. These data reveal a previously unrecognized BCR-ABL-STAT5-IRF-8 network, which widens the repertoire of potentially new anti-CML targets.	[Waight, Jeremy D.; Banik, Debarati; Nemeth, Michael J.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Griffiths, Elizabeth A.; Abrams, Scott I.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Griffiths, Elizabeth A.; Nemeth, Michael J.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Nemeth, MJ (corresponding author), Roswell Pk Canc Inst, Dept Med, Elm & Carlton St, Buffalo, NY 14263 USA.	Michael.Nemeth@RoswellPark.org; Scott.Abrams@RoswellPark.org			NCI, National Institutes of Health [R01CA140622]; National Institutes of Health [T32CA085183]; NCI, National Institutes of Health Cancer Center [CA016056]; Roswell Park Alliance Foundation; NATIONAL CANCER INSTITUTE [P30CA016056, T32CA085183, R01CA140622] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health Cancer Center; Roswell Park Alliance Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01CA140622 (to S. I. A.), National Institutes of Health Training Grant T32CA085183 (to J. D. W.), and NCI, National Institutes of Health Cancer Center Support Grant CA016056. This work was also supported by an Alliance Developmental Award from the Roswell Park Alliance Foundation (to S. I. A. and M. J. N.).	Banik D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045422; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; Koenigsmann J, 2009, BLOOD, V113, P4690, DOI 10.1182/blood-2008-05-158485; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Li G, 2010, LEUKEMIA, V24, P1397, DOI 10.1038/leu.2010.131; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; ODA T, 1994, J BIOL CHEM, V269, P22925; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Rong Y, 2006, CANCER RES, V66, P8049, DOI 10.1158/0008-5472.CAN-06-1172; Schmidt M, 2004, BLOOD, V103, P4142, DOI 10.1182/blood-2003-01-0285; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Seo JH, 2010, CANCER RES, V70, P7325, DOI 10.1158/0008-5472.CAN-10-0607; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Shuai K, 1996, ONCOGENE, V13, P247; Tamura T, 2003, BLOOD, V102, P4547, DOI 10.1182/blood-2003-01-0291; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TENHOEVE J, 1994, BLOOD, V84, P1731; Vidovic K, 2010, LEUKEMIA, V24, P992, DOI 10.1038/leu.2010.33; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; WeberNordt RM, 1996, BLOOD, V88, P809; Yang DF, 2007, CANCER RES, V67, P3301, DOI 10.1158/0008-5472.CAN-06-4068; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	46	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15642	15652		10.1074/jbc.M113.544320	http://dx.doi.org/10.1074/jbc.M113.544320			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753251	Green Published, hybrid			2022-12-25	WOS:000337465400046
J	Kam, YW; Lee, WWL; Simarmata, D; Le Grand, R; Tolou, H; Merits, A; Roques, P; Ng, LFP				Kam, Yiu-Wing; Lee, Wendy W. L.; Simarmata, Diane; Le Grand, Roger; Tolou, Hugues; Merits, Andres; Roques, Pierre; Ng, Lisa F. P.			Unique Epitopes Recognized by Antibodies Induced in Chikungunya Virus-Infected Non-Human Primates: Implications for the Study of Immunopathology and Vaccine Development	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; E2 GLYCOPROTEIN; REUNION ISLAND; I-TASSER; PROTEIN; REPLICATION; REEMERGENCE; DESIGN; CELLS; MODEL	Chikungunya virus (CHIKV) is an Alphavirus that causes chronic and incapacitating arthralgia in humans. Although patient cohort studies have shown the production of CHIKV specific antibodies, the fine specificity of the antibody response against CHIKV is not completely defined. The macaque model of CHIKV infection was established due to limitations of clinical specimens. More importantly, its close relation to humans will allow the study of chronic infection and further identify important CHIKV targets. In this study, serum samples from CHIKV-infected macaques collected at different time-points post infection were used to characterize the antibody production pattern and kinetics. Results revealed that anti-CHIKV antibodies were neutralizing and the E2 glycoprotein, Capsid, nsP1, nsP3 and nsP4 proteins were targets of the anti-CHIKV antibody response in macaques. Furthermore, linear B-cell epitopes recognized by these anti-CHIKV antibodies were identified, and mapped to their structural localization. This characterizes the specificity of anti-CHIKV antibody response in macaques and further demonstrates the importance of the different regions in CHIKV-encoded proteins in the adaptive immune response. Information from this study provides critical knowledge that will aid in the understanding of CHIKV infection and immunity, vaccine design, and pre-clinical efficacy studies.	[Kam, Yiu-Wing; Lee, Wendy W. L.; Simarmata, Diane; Ng, Lisa F. P.] Biopolis, Agcy Sci Technol & Res A STAR, Singapore Immunol Network, Singapore, Singapore; [Lee, Wendy W. L.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Le Grand, Roger; Roques, Pierre] CEA, Div ImmunoVirol SIV, Inst Emerging Dis & Innovat Therapies IMETI, Fontenay Aux Roses, France; [Le Grand, Roger; Roques, Pierre] Univ Paris 11, UMR E1, Orsay, France; [Tolou, Hugues] Grp Etude Preventol, Villenave Dornon, France; [Merits, Andres] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Tartu; National University of Singapore	Roques, P (corresponding author), CEA, Div ImmunoVirol SIV, Inst Emerging Dis & Innovat Therapies IMETI, Fontenay Aux Roses, France.	pierre.roques@cea.fr; lisa_ng@immunol.a-star.edu.sg	Merits, Andres/H-3125-2015; Kam, Yiu/AAI-4148-2021; Roques, Pierre/M-2212-2013	Merits, Andres/0000-0001-8193-0071; Kam, Yiu/0000-0002-8360-9537; Ng, Lisa/0000-0003-4071-5222; Roques, Pierre/0000-0003-1825-1054	Biomedical Research Council (BMRC); Joint Council Office (JCO); European Union [261202]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Joint Council Office (JCO); European Union(European Commission)	This work was supported by the Biomedical Research Council (BMRC) and a research grant by the Joint Council Office (JCO), A*STAR. Part of this work was also supported by the European Union project: Integration of Chikungunya RESearch "ICRES'' grant number 261202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn A, 1999, J VIROL, V73, P10029, DOI 10.1128/JVI.73.12.10029-10039.1999; Akahata W, 2012, J VIROL, V86, P8879, DOI 10.1128/JVI.00370-12; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Ansumana R, 2013, EMERG INFECT DIS, V19, P1108, DOI 10.3201/eid1907.121563; Bessaud M, 2006, EMERG INFECT DIS, V12, P1604, DOI 10.3201/eid1210.060596; Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086; Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028; Chen CI, 2010, AM J TROP MED HYG, V83, P1249, DOI 10.4269/ajtmh.2010.10-0290; Chen KC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-169; Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059; Chua CL, 2014, J VIROL METHODS, V195, P126, DOI 10.1016/j.jviromet.2013.10.015; Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; Davies JM, 2000, VIROLOGY, V275, P67, DOI 10.1006/viro.2000.0474; Duong V, 2012, EMERG INFECT DIS, V18, P2066, DOI 10.3201/eid1812.120471; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-108; Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Hernandez R, 2008, J VIROL, V82, P5750, DOI 10.1128/JVI.02673-07; Kam YW, 2007, VACCINE, V25, P729, DOI 10.1016/j.vaccine.2006.08.011; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213; Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033; Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928; Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343; Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124; Munasinghe D R, 1966, Ceylon Med J, V11, P129; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Parrott MM, 2009, J VIROL, V83, P2584, DOI 10.1128/JVI.02158-08; PAVRI K, 1986, T ROY SOC TROP MED H, V80, P491, DOI 10.1016/0035-9203(86)90358-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Renault P, 2007, AM J TROP MED HYG, V77, P727; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun EC, 2013, APPL MICROBIOL BIOT, V97, P6359, DOI 10.1007/s00253-013-4819-8; Teng TS, 2011, FUTURE VIROL, V6, P975, DOI 10.2217/FVL.11.67; Tretyakova I, 2014, J INFECT DI IN PRESS; Verma P, 2014, CLIN CHEM LAB MED, V52, P297, DOI 10.1515/cclm-2013-0363; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; WUST CJ, 1989, VIRUS RES, V13, P101, DOI 10.1016/0168-1702(89)90009-9; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	54	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95647	10.1371/journal.pone.0095647	http://dx.doi.org/10.1371/journal.pone.0095647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755730	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300067
J	Wang, WJ; Chang, CH; Sun, MF; Hsu, SF; Weng, CS				Wang, Wei-Jie; Chang, Chen-Hung; Sun, Mao-Feng; Hsu, Sheng-Feng; Weng, Ching-Sung			DPP-4 Inhibitor Attenuates Toxic Effects of Indoxyl Sulfate on Kidney Tubular Cells	PLOS ONE			English	Article							NF-KAPPA-B; REGULATES RENAL EXPRESSION; OXIDATIVE STRESS; MESENCHYMAL TRANSITION; DISEASE; ACTIVATION; EFFICACY; FAILURE; SAFETY; RATS	Diabetic nephropathy is a common causative factor of chronic kidney disease (CKD). DPP-4 inhibitor has the ability to improve kidney function and renal microvasculature. In the present study, we investigate the deleterious effects of IS on proximal tubular cells and the protective role of DPP-4 inhibitor. Human kidney 2 (HK-2) cells were exposed to IS in the presence or absence of DPP-4 inhibitor. Effects of DPP-4 inhibitor on viability of HK-2 cells were determined by MTT assay. Reactive oxygen species (ROS) production was examined using fluorescent microscopy. Levels of cleaved caspase-3, transforming growth factor-beta (TGF-beta), alpha-smooth muscle actin (alpha-SMA) and NF-kappaB p65 and phosphorylation of AKT and extracellular signal-regulated kinase (ERK) were detected by immunoblotting. Production of ROS and level of cleaved caspase-3 were increased by IS in a dose-dependent manner. The phosphorylation of AKT and ERK p65 were decreased alongside activation of NF-kappa B. Expression of TGF-beta and alpha-SMA, were upregulated in IS-treated HK-2 cells. Treatment with DPP-4 inhibitor resulted in a significant increase in cell viability and a decrease of ROS production in IS-treated HK-2 cells. DPP-4 inhibitor restored IS-induced deactivations of AKT and ERK and inhibited activation of NF-kappa B in IS-treated HK-2 cells. Moreover, DPP-4 inhibitor could also attenuate IS-induced up-regulation of TGF-beta and alpha-SMA expression. These findings suggest that DPP-4 inhibitor possesses anti-apoptotic activity to ameliorate the IS-induced renal damage, which may be partly attributed to regulating ROS/p38MAPK/ERK and P13K-AKT pathways as well as downstream NF-kappa B signaling pathway.	[Wang, Wei-Jie; Weng, Ching-Sung] Chung Yuan Christian Univ, Dept Biomed Engn, Chungli, Taiwan; [Wang, Wei-Jie] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Internal Med, Div Nephrol, Taoyuan, Taiwan; [Chang, Chen-Hung] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Pharm, Taoyuan, Taiwan; [Sun, Mao-Feng] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Sun, Mao-Feng] China Med Univ Hosp, Dept Acupuncture, Taichung, Taiwan; [Hsu, Sheng-Feng; Weng, Ching-Sung] China Med Univ, Coll Chinese Med, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Hsu, Sheng-Feng] China Med Univ Hosp, Taipei Branch, Dept Acupuncture, Taichung, Taiwan	Chung Yuan Christian University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hsu, SF (corresponding author), China Med Univ, Coll Chinese Med, Grad Inst Acupuncture Sci, Taichung, Taiwan.	hsusf@mail.cmu.edu.tw; jasonheartyman@yahoo.com.tw						Adelibieke Y, 2013, CIRC J, V77, P1326, DOI 10.1253/circj.CJ-12-0884; Atoh K, 2009, DIABETES RES CLIN PR, V83, P220, DOI 10.1016/j.diabres.2008.09.053; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Davidson MH, 2011, AM J CARDIOL, V108, p33B, DOI 10.1016/j.amjcard.2011.03.046; Dummer CD, 2008, J NEPHROL, V21, P900; Eberhardt W, 2002, KIDNEY INT, V61, P20, DOI 10.1046/j.1523-1755.2002.00087.x; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Fujigaki Y, 2005, VIRCHOWS ARCH, V446, P164, DOI 10.1007/s00428-004-1155-5; Fukami K, 2008, CURR PHARM DESIGN, V14, P946, DOI 10.2174/138161208784139710; Glorie LLF, 2012, AM J PHYSIOL-RENAL, V303, pF681, DOI 10.1152/ajprenal.00075.2012; Joo K.W., 2013, BMC KIDNEY NEPHROL, V27, P14; Kadowaki D, 2012, LIFE SCI, V91, P1304, DOI 10.1016/j.lfs.2012.09.018; Kim SH, 2012, LAB INVEST, V92, P488, DOI 10.1038/labinvest.2011.194; Kothny W, 2012, DIABETES OBES METAB, V14, P1032, DOI 10.1111/j.1463-1326.2012.01634.x; Lukashevich V, 2011, DIABETES OBES METAB, V13, P947, DOI 10.1111/j.1463-1326.2011.01467.x; Mar PK, 2001, EXP EYE RES, V72, P455, DOI 10.1006/exer.2000.0967; Miyazaki T, 1997, KIDNEY INT S, V62, pS15; Nakagawa N, 2006, AM J NEPHROL, V26, P455, DOI 10.1159/000096423; Neumiller JJ, 2012, ANN PHARMACOTHER, V46, P358, DOI 10.1345/aph.1Q522; Pechkovsky DV, 2010, AM J RESP CELL MOL, V43, P641, DOI 10.1165/rcmb.2009-0318OC; Read PA, 2010, CIRC-CARDIOVASC IMAG, V3, P195, DOI 10.1161/CIRCIMAGING.109.899377; Shimizu H, 2013, AM J NEPHROL, V37, P97, DOI 10.1159/000346420; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Shimizu H, 2012, LIFE SCI, V90, P525, DOI 10.1016/j.lfs.2012.01.013; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Taki K, 2006, J RENAL NUTR, V16, P199, DOI 10.1053/j.jrn.2006.04.020; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Valcz G, 2012, PATHOL ONCOL RES, V18, P371, DOI 10.1007/s12253-011-9454-z; Verzola D, 2004, J AM SOC NEPHROL, V15, pS85, DOI 10.1097/01.ASN.0000093370.20008.BC; Wu VC, 2013, ANGIOGENESIS, V16, P609, DOI 10.1007/s10456-013-9339-8; Yang K, 2012, TOXICOL LETT, V215, P77, DOI 10.1016/j.toxlet.2012.10.004	33	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e93447	10.1371/journal.pone.0093447	http://dx.doi.org/10.1371/journal.pone.0093447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755682	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300007
J	Wei, SG; Li, L; Chen, ZC; Lian, JY; Lin, GJ; Huang, ZL; Yin, ZY				Wei, Shi Guang; Li, Lin; Chen, Zhen Cheng; Lian, Ju Yu; Lin, Guo Jun; Huang, Zhong Liang; Yin, Zuo Yun			Which Models Are Appropriate for Six Subtropical Forests: Species-Area and Species-Abundance Models	PLOS ONE			English	Article							RICHNESS ESTIMATORS; SCALE-DEPENDENCE; DIVERSITY; PATTERNS; CURVES; DEFORESTATION; BIODIVERSITY; COMMUNITIES; PERFORMANCE; EXTINCTION	The species-area relationship is one of the most important topic in the study of species diversity, conservation biology and landscape ecology. The species-area relationship curves describe the increase of species number with increasing area, and have been modeled by various equations. In this paper, we used detailed data from six 1-ha subtropical forest communities to fit three species-area relationship models. The coefficient of determination and F ratio of ANOVA showed all the three models fitted well to the species-area relationship data in the subtropical communities, with the logarithm model performing better than the other two models. We also used the three species-abundance distributions, namely the lognormal, logcauchy and logseries model, to fit them to the species-abundance data of six communities. In this case, the logcauchy model had the better fit based on the coefficient of determination. Our research reveals that the rare species always exist in the six communities, corroborating the neutral theory of Hubbell. Furthermore, we explained why all species-abundance figures appeared to be left-side truncated. This was due to subtropical forests have high diversity, and their large species number includes many rare species.	[Wei, Shi Guang; Li, Lin; Chen, Zhen Cheng] Guilin Univ Elect Technol, Guilin 541004, Peoples R China; [Lian, Ju Yu; Huang, Zhong Liang] Chinese Acad Sci, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Lin, Guo Jun] Changjiang Water Resources Protect Inst, Wuhan 430051, Peoples R China; [Yin, Zuo Yun] Guangdong Forest Res Inst, Guangzhou 510520, Guangdong, Peoples R China	Guilin University of Electronic Technology; Chinese Academy of Sciences; South China Botanical Garden, CAS; Yangtze River Water Resources Protection Bureau	Li, L (corresponding author), Guilin Univ Elect Technol, Guilin 541004, Peoples R China.	lilinwsg@163.com; huangzl@scbg.ac.cn		Wei, ShiGuang/0000-0002-0273-4978	National Natural Science Foundation of China (NSFC) [31200412, 31200326]; Knowledge Innovation Project of Chinese Academy of Sciences [KSCX2-EW-Z]; Project of Scientific Research and Technological Development of Guilin [20130105-8]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Project of Scientific Research and Technological Development of Guilin	The authors thank the National Natural Science Foundation of China(NSFC grant no. 31200412,31200326), and the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-Z), the Project of Scientific Research and Technological Development of Guilin(20130105-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ECOLOGY EXPT ANAL DI; ARCHIBALD EEA, 1949, J ECOL, V37, P274, DOI 10.2307/2256609; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; BARKMAN JJ, 1989, VEGETATIO, V85, P89, DOI 10.1007/BF00042259; Batista JLF, 1998, FOREST ECOL MANAG, V110, P293, DOI 10.1016/S0378-1127(98)00296-5; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; BOECKLEN WJ, 1984, BIOL CONSERV, V29, P63, DOI 10.1016/0006-3207(84)90014-4; Brooks T, 1999, ANIM CONSERV, V2, P211, DOI 10.1111/j.1469-1795.1999.tb00067.x; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; BUYS MH, 1994, J VEG SCI, V5, P63, DOI 10.2307/3235638; COHEN JE, 1968, AM NAT, V102, P165, DOI 10.1086/282533; COLEMAN BD, 1981, MATH BIOSCI, V54, P191, DOI 10.1016/0025-5564(81)90086-9; Colwell RK, 2009, ESTIMATES STAT ESTIM; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Gleason HA, 1925, ECOLOGY, V6, P66, DOI 10.2307/1929241; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Guo QF, 2002, J VEG SCI, V13, P575, DOI 10.1111/j.1654-1103.2002.tb02084.x; He FL, 2005, ECOL LETT, V8, P386, DOI 10.1111/j.1461-0248.2005.00729.x; He FL, 1996, J BIOGEOGR, V23, P57, DOI 10.1046/j.1365-2699.1996.00976.x; He FL, 1996, AM NAT, V148, P719, DOI 10.1086/285950; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; HOPKINS B, 1957, J ECOL, V45, P441, DOI 10.2307/2256927; Hubbell S.P., 1983, DIVERSITY CANOPY TRE; HUBBELL SP, 1995, PROG BIOMET, V9, P171; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; Hubbell Stephen P., 2001, V32, pi; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Jaccard P, 1902, B SOC VAUD SCI NAT, V38, P69, DOI [10.5169/seals-266762, DOI 10.5169/SEALS-266762]; Jackson CR, 2001, ECOLOGY, V81, P555; KELLY BJ, 1989, J ECOL, V77, P1021, DOI 10.2307/2260820; KEMPTON RA, 1974, J ANIM ECOL, V43, P381, DOI 10.2307/3371; Kochy M, 1997, NORD J BOT, V17, P215, DOI 10.1111/j.1756-1051.1997.tb00311.x; KOHN DD, 1994, J ECOL, V82, P367, DOI 10.2307/2261304; Krauss J, 2004, BIODIVERS CONSERV, V13, P1427, DOI 10.1023/B:BIOC.0000021323.18165.58; Lande R, 2000, OIKOS, V89, P601, DOI 10.1034/j.1600-0706.2000.890320.x; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Liu CR, 1999, ACTA PHYTOECOLOGICA, V23, P490; LOEHLE C, 1990, LANDSCAPE ECOL, V5, P39, DOI 10.1007/BF00153802; LOMOLINO MV, 1989, AM NAT, V133, P277, DOI 10.1086/284917; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; Lu X-T, 2010, FOREST ECOL MANAG, V260; Lu XT, 2010, J TROP FOR SCI, V22, P260; MAC ARTHUR ROBERT H., 1967; May R.M., 1975, P81; Molles M., 1999, ECOLOGY CONCEPTS APP; OBESO JR, 1992, J VEG SCI, V3, P129, DOI 10.2307/3236008; Ovaskainen O, 2003, ECOL LETT, V6, P903, DOI 10.1046/j.1461-0248.2003.00517.x; PALMER MW, 1990, ECOLOGY, V71, P1195, DOI 10.2307/1937387; PALMER MW, 1994, AM NAT, V144, P717, DOI 10.1086/285704; PIELOU E C, 1969, P286; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Plotkin JB, 2002, ECOLOGY, V83, P3344, DOI 10.1890/0012-9658(2002)083[3344:STSCOA]2.0.CO;2; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Ricklefs RE, 1999, OIKOS, V86, P369, DOI 10.2307/3546454; Ricklefs RE, 2004, ECOGRAPHY, V27, P129; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 1999, ECOGRAPHY, V22, P614, DOI 10.1111/j.1600-0587.1999.tb00510.x; Schoener T. W., 1976, P 16 INT ORNITHOLOGI, P629, DOI DOI 10.1111/J.1474-919X.1905.TB07792.X; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Sizling AL, 2004, ECOL LETT, V7, P60, DOI 10.1046/j.1461-0248.2003.00549.x; Stohlgren Thomas J., 2001, Biological Invasions, V3, P37, DOI 10.1023/A:1011451417418; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Turner WR, 2005, ECOGRAPHY, V28, P721, DOI 10.1111/j.2005.0906-7590.04273.x; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; WALTHER BA, 1995, PARASITOL TODAY, V11, P306, DOI 10.1016/0169-4758(95)80047-6; Wang XG, 2011, J ECOL, V99, P1382, DOI 10.1111/j.1365-2745.2011.01857.x; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Wei SG, 2010, ECOL RES, V25, P93, DOI 10.1007/s11284-009-0633-2; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Williams C. B., 1964, PATTERNS BALANCE NAT; Williamson M. H., 1981, ISLAND POPULATIONS; Yin ZY, 2005, ECOL MODEL, V184, P329, DOI 10.1016/j.ecolmodel.2004.10.011	78	2	2	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95890	10.1371/journal.pone.0095890	http://dx.doi.org/10.1371/journal.pone.0095890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755956	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300115
J	Hao, LH; Lindenbach, B; Wang, XF; Dye, B; Kushner, D; He, QL; Newton, M; Ahlquist, P				Hao, Linhui; Lindenbach, Brett; Wang, Xiaofeng; Dye, Billy; Kushner, David; He, Qiuling; Newton, Michael; Ahlquist, Paul			Genome-Wide Analysis of Host Factors in Nodavirus RNA Replication	PLOS ONE			English	Article							GENES AFFECTING REPLICATION; SACCHAROMYCES-CEREVISIAE; VIRUS-REPLICATION; SCREEN REVEALS; INSECT VIRUS; PROTEIN; IDENTIFICATION; EXPRESSION; TRANSLATION; PARALLELS	Flock House virus (FHV), the best studied of the animal nodaviruses, has been used as a model for positive-strand RNA virus research. As one approach to identify host genes that affect FHV RNA replication, we performed a genome wide analysis using a yeast single gene deletion library and a modified, reporter genes expressing FHV derivative. A total of 4,491 yeast deletion mutants were tested for their ability to support FHV replication. Candidates for host genes modulating FHV replication were selected based on the initial genome-wide reporter gene assay and validated in repeated Northern blot assays for their ability to support wild type FHV RNA1 replication. Overall, 65 deletion strains were confirmed to show significant changes in the replication of both FHV genomic RNA1 and sub-genomic RNA3 with a false discovery rate of 5%. Among them, eight genes support FHV replication, since their deletion significantly reduced viral RNA accumulation, while 57 genes limit FHV replication, since their deletion increased FHV RNA accumulation. Of the gene products implicated in affecting FHV replication, three are localized to mitochondria, where FHV RNA replication occurs, 16 normally reside in the nucleus and may have indirect roles in FHV replication, and the remaining 46 are in the cytoplasm, with functions enriched in translation, RNA processing and trafficking.	[Hao, Linhui; Lindenbach, Brett; Wang, Xiaofeng; Dye, Billy; Kushner, David; Ahlquist, Paul] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Hao, Linhui; Ahlquist, Paul] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [He, Qiuling; Newton, Michael] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Newton, Michael] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; [Ahlquist, Paul] Univ Wisconsin, Morgridge Inst Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Ahlquist, P (corresponding author), Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA.	ahlquist@wisc.edu	Wang, Xiaofeng/E-9940-2016	Wang, Xiaofeng/0000-0002-3850-3274; Kushner, David B/0000-0002-6260-5094	National Institutes of Health [GM35072, HG6568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035072, R37GM035072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM35072 to PA and HG6568 to MAN. PA is an investigator of the Howard Hughes Medical Institute and the Morgridge Institute for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; BALL LA, 1995, J VIROL, V69, P2722, DOI 10.1128/JVI.69.4.2722-2722.1995; Bonetti D, 2013, EMBO J, V32, P275, DOI 10.1038/emboj.2012.327; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burchett SA, 2001, J BIOL CHEM, V276, P26472, DOI 10.1074/jbc.M103436200; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Dasgupta R, 2003, J GEN VIROL, V84, P1789, DOI 10.1099/vir.0.18938-0; Dasgupta R, 2001, P NATL ACAD SCI USA, V98, P4910, DOI 10.1073/pnas.081288198; Dye BT, 2005, J VIROL, V79, P8909, DOI 10.1128/JVI.79.14.8909-8919.2005; Dye BT, 2005, BIOTECHNIQUES, V38, P868, DOI 10.2144/05386BM04; Gancarz BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023988; George R, 1998, P NATL ACAD SCI USA, V95, P2296, DOI 10.1073/pnas.95.5.2296; Gimenez-Barcons M, 2013, J VIROL, V87, P6192, DOI 10.1128/JVI.03327-12; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hao LH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003235; Huang SG, 2006, J COMPUT BIOL, V13, P786, DOI 10.1089/cmb.2006.13.786; Johnson KL, 1997, J VIROL, V71, P3323, DOI 10.1128/JVI.71.4.3323-3327.1997; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Lindenbach BD, 2002, J VIROL, V76, P3905, DOI 10.1128/JVI.76.8.3905-3919.2002; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Miller DJ, 2001, J VIROL, V75, P11664, DOI 10.1128/JVI.75.23.11664-11676.2001; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Noueiry AO, 2003, MOL CELL BIOL, V23, P4094, DOI 10.1128/MCB.23.12.4094-4106.2003; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Price BD, 2000, J VIROL, V74, P11724, DOI 10.1128/JVI.74.24.11724-11733.2000; Rutter J, 2002, CELL, V111, P17, DOI 10.1016/S0092-8674(02)00974-1; Saha D, 2012, BIOCHEM BIOPH RES CO, V424, P579, DOI 10.1016/j.bbrc.2012.06.156; Sanford W., 1985, APPL LINEAR REGRESSI; Sanyal K, 1998, MOL GEN GENET, V260, P242, DOI 10.1007/s004380050892; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; SELLING BH, 1990, P NATL ACAD SCI USA, V87, P434, DOI 10.1073/pnas.87.1.434; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Stertz S, 2011, MICROBES INFECT, V13, P516, DOI 10.1016/j.micinf.2011.01.012; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Takeuchi H, 2008, MICROBIOL IMMUNOL, V52, P318, DOI 10.1111/j.1348-0421.2008.00040.x; Van Wynsberghe PA, 2007, J VIROL, V81, P4633, DOI 10.1128/JVI.02267-06; White KA, 2004, PROG NUCLEIC ACID RE, V78, P187, DOI 10.1016/S0079-6603(04)78005-8; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95799	10.1371/journal.pone.0095799	http://dx.doi.org/10.1371/journal.pone.0095799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752411	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400132
J	Jabbour, F; Cossard, G; Le Guilloux, M; Sannier, J; Nadot, S; Damerval, C				Jabbour, Florian; Cossard, Guillaume; Le Guilloux, Martine; Sannier, Julie; Nadot, Sophie; Damerval, Catherine			Specific Duplication and Dorsoventrally Asymmetric Expression Patterns of Cycloidea-Like Genes in Zygomorphic Species of Ranunculaceae	PLOS ONE			English	Article							FLORAL SYMMETRY GENES; CYC-LIKE GENES; PHYLOGENETIC ANALYSIS; COROLLA MONOSYMMETRY; POSITIVE SELECTION; TCP DOMAIN; EVOLUTION; FLOWER; DIVERSIFICATION; PERIANTH	Floral bilateral symmetry (zygomorphy) has evolved several times independently in angiosperms from radially symmetrical (actinomorphic) ancestral states. Homologs of the Antirrhinum majus CYCLOIDEA gene (CYC) have been shown to control floral symmetry in diverse groups in core eudicots. In the basal eudicot family Ranunculaceae, there is a single evolutionary transition from actinomorphy to zygomorphy in the stem lineage of the tribe Delphinieae. We characterized CYC homologs in 18 genera of Ranunculaceae, including the four genera of Delphinieae, in a sampling that represents the floral morphological diversity of this tribe, and reconstructed the evolutionary history of this gene family in Ranunculaceae. Within each of the two RANACYL (Ranunculaceae CYCLOIDEA-like) lineages previously identified, an additional duplication possibly predating the emergence of the Delphinieae was found, resulting in up to four gene copies in zygomorphic species. Expression analyses indicate that the RANACYL paralogs are expressed early in floral buds and that the duration of their expression varies between species and paralog class. At most one RANACYL paralog was expressed during the late stages of floral development in the actinomorphic species studied whereas all paralogs from the zygomorphic species were expressed, composing a species-specific identity code for perianth organs. The contrasted asymmetric patterns of expression observed in the two zygomorphic species is discussed in relation to their distinct perianth architecture.	[Jabbour, Florian] Univ Paris 11, UMR 0320, UMR 8120, Gif Sur Yvette, France; [Jabbour, Florian; Cossard, Guillaume; Sannier, Julie; Nadot, Sophie] Univ Paris 11, CNRS, UMR 8079, AgroParisTech, F-91405 Orsay, France; [Jabbour, Florian] Univ Munich LMU, Munich, Germany; [Jabbour, Florian] Museum Natl Hist Nat, UMR ISYEB MNHN CNRS UPMC EPHE 7205, Inst Systemat, F-75231 Paris, France; [Cossard, Guillaume] Univ Lausanne, Dept Ecol & Evolut, Biophore, Lausanne, Switzerland; [Le Guilloux, Martine; Damerval, Catherine] CNRS, UMR 0320, UMR 8120, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Munich; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech	Damerval, C (corresponding author), Univ Paris 11, UMR 0320, UMR 8120, Gif Sur Yvette, France.	damerval@moulon.inra.fr		Jabbour, Florian/0000-0002-7729-1067	Ministere de l'Enseignement Superieur et de la Recherche, France; Munich, Germany; German Science Foundation (DFG) [RE 603/12-1]; 'La Plante et son Environnement'; Agence Nationale de la Recherche [ANR-07-BLAN-0112]	Ministere de l'Enseignement Superieur et de la Recherche, France; Munich, Germany; German Science Foundation (DFG)(German Research Foundation (DFG)); 'La Plante et son Environnement'; Agence Nationale de la Recherche(French National Research Agency (ANR))	FJ was supported by a PhD fellowship from the Ministere de l'Enseignement Superieur et de la Recherche, France. FJ's postdoc lab work in Munich, Germany, was supported by the German Science Foundation (DFG) grant No. RE 603/12-1. This work was supported in 2007 by a grant from IFR 87 'La Plante et son Environnement', and the Agence Nationale de la Recherche through the ANR-07-BLAN-0112 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett ME, 2011, AM J BOT, V98, P227, DOI 10.3732/ajb.1000246; Beentje H., 2010, KEW PLANT GLOSSARY I; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Busch A, 2007, P NATL ACAD SCI USA, V104, P16714, DOI 10.1073/pnas.0705338104; Busch A, 2012, MOL BIOL EVOL, V29, P1241, DOI 10.1093/molbev/msr297; Carlson SE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-325; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Citerne H, 2010, ADV BOT RES, V54, P85, DOI 10.1016/S0065-2296(10)54003-5; Citerne HL, 2006, P NATL ACAD SCI USA, V103, P12017, DOI 10.1073/pnas.0600986103; Citerne HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074803; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Cubas P, 2001, CURR BIOL, V11, P1050, DOI 10.1016/S0960-9822(01)00295-0; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Damerval C, 2007, ANN BOT-LONDON, V100, P631, DOI 10.1093/aob/mcm041; Damerval C, 2007, PLANT PHYSIOL, V143, P759, DOI 10.1104/pp.106.090324; Damerval C, 2013, AM J BOT, V100, P391, DOI 10.3732/ajb.1200376; Endress PK, 1999, INT J PLANT SCI, V160, pS3, DOI 10.1086/314211; Erbar C, 1999, FLORA, V194, P317; Feng XZ, 2006, P NATL ACAD SCI USA, V103, P4970, DOI 10.1073/pnas.0600681103; Force A, 1999, GENETICS, V151, P1531; Fukuda Yoko, 2001, Plant Species Biology, V16, P151, DOI 10.1046/j.1442-1984.2001.00059.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hileman LC, 2003, MOL BIOL EVOL, V20, P591, DOI 10.1093/molbev/msg063; Hileman LC, 2014, CURR OPIN PLANT BIOL, V17, P146, DOI 10.1016/j.pbi.2013.12.002; Howarth DG, 2005, INT J PLANT SCI, V166, P357, DOI 10.1086/428634; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; Howarth DG, 2011, ANN BOT-LONDON, V107, P1521, DOI 10.1093/aob/mcr049; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jabbour F, 2012, INT J PLANT SCI, V173, P1036, DOI 10.1086/667613; Jabbour Florian, 2011, PhytoKeys, V7, P21, DOI 10.3897/phytokeys.7.2010; Jabbour F, 2012, MOL PHYLOGENET EVOL, V62, P928, DOI 10.1016/j.ympev.2011.12.005; Jabbour F, 2009, ANN BOT-LONDON, V104, P809, DOI 10.1093/aob/mcp162; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim M, 2008, SCIENCE, V322, P1116, DOI 10.1126/science.1164371; Kolsch A, 2006, PLANT BIOLOGY, V8, P680, DOI 10.1055/s-2006-924286; KOSUGE K, 1989, Journal of Japanese Botany, V64, P65; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Mondragon-Palomino M, 2011, ANN BOT-LONDON, V107, P1533, DOI 10.1093/aob/mcr059; Navaud O, 2007, J MOL EVOL, V65, P23, DOI 10.1007/s00239-006-0174-z; Ohno S., 1970, EVOLUTION GENE DUPLI; Pang HB, 2010, J SYST EVOL, V48, P309, DOI 10.1111/j.1759-6831.2010.00091.x; Preston JC, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-6; Preston JC, 2011, P NATL ACAD SCI USA, V108, P2343, DOI 10.1073/pnas.1011361108; Reardon W, 2009, PLANT MOL BIOL, V71, P241, DOI 10.1007/s11103-009-9520-z; Ree RH, 2004, MOL BIOL EVOL, V21, P321, DOI 10.1093/molbev/msh022; Rudall PJ, 2004, NEW PHYTOL, V162, P25, DOI 10.1111/j.1469-8137.2004.01032.x; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tahtiharju S, 2012, MOL BIOL EVOL, V29, P1155, DOI 10.1093/molbev/msr283; Tucker SC, 2005, INT J PLANT SCI, V166, P557, DOI 10.1086/429848; Wang W, 2013, TAXON, V62, P713, DOI 10.12705/624.10; Wang Z, 2008, P NATL ACAD SCI USA, V105, P10414, DOI 10.1073/pnas.0803291105; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan Z, 2009, PLANT PHYSIOL, V149, P235, DOI 10.1104/pp.108.128231; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang W, 2013, FRONT PLANT SCI, V4, P1; Zhang WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036033; Zhang WH, 2010, P NATL ACAD SCI USA, V107, P6388, DOI 10.1073/pnas.0910155107; Zhou XR, 2008, NEW PHYTOL, V178, P532, DOI 10.1111/j.1469-8137.2008.02384.x	65	23	25	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95727	10.1371/journal.pone.0095727	http://dx.doi.org/10.1371/journal.pone.0095727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752428	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400111
J	Yu, XZ; Strub, MP; Barnard, TJ; Noinaj, N; Piszczek, G; Buchanan, SK; Taraska, JW				Yu, Xiaozhen; Strub, Marie-Paule; Barnard, Travis J.; Noinaj, Nicholas; Piszczek, Grzegorz; Buchanan, Susan K.; Taraska, Justin W.			An Engineered Palette of Metal Ion Quenchable Fluorescent Proteins	PLOS ONE			English	Article							BINDING PROTEINS; STRUCTURAL BASIS; ENERGY-TRANSFER; ZINC; PREDICTION; CHEMISTRY; SITES; GFP; NEUROBIOLOGY; SENSORS	Many fluorescent proteins have been created to act as genetically encoded biosensors. With these sensors, changes in fluorescence report on chemical states in living cells. Transition metal ions such as copper, nickel, and zinc are crucial in many physiological and pathophysiological pathways. Here, we engineered a spectral series of optimized transition metal ion-binding fluorescent proteins that respond to metals with large changes in fluorescence intensity. These proteins can act as metal biosensors or imaging probes whose fluorescence can be tuned by metals. Each protein is uniquely modulated by four different metals (Cu2+, Ni2+, Co2+, and Zn2+). Crystallography revealed the geometry and location of metal binding to the engineered sites. When attached to the extracellular terminal of a membrane protein VAMP2, dimeric pairs of the sensors could be used in cells as ratiometric probes for transition metal ions. Thus, these engineered fluorescent proteins act as sensitive transition metal ion-responsive genetically encoded probes that span the visible spectrum.	[Yu, Xiaozhen; Strub, Marie-Paule; Taraska, Justin W.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Barnard, Travis J.; Noinaj, Nicholas; Buchanan, Susan K.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Taraska, JW (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	justin.taraska@nih.gov	Piszczek, Grzegorz/GYU-2029-2022; Taraska, Justin/H-8876-2016	Taraska, Justin/0000-0001-5355-9535	National Heart Lung and Blood Institute; National Institute Diabetes and Digestive and Kidney Diseases; National Cancer Institute [Y1-CO1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE- AC02- 06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338, ZIAHL006098, ZIAHL006099] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute Diabetes and Digestive and Kidney Diseases; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	J.W.T. is supported by the intramural research program of the National Heart Lung and Blood Institute, and S.K.B. is supported by the National Institute Diabetes and Digestive and Kidney Diseases. GM/CA at the APS has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Basic Energy Sciences, Office of Science, under contract DE- AC02- 06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; ARNOLD FH, 1991, SCIENCE, V252, P1796, DOI 10.1126/science.1648261; Arpino JAJ, 2012, J AM CHEM SOC, V134, P13632, DOI 10.1021/ja301987h; Barondeau DP, 2002, J AM CHEM SOC, V124, P3522, DOI 10.1021/ja0176954; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Chen Z, 2013, MOL BIOSYST, V9, P2213, DOI 10.1039/c3mb70100j; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evers TH, 2007, J MOL BIOL, V374, P411, DOI 10.1016/j.jmb.2007.09.021; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Ibraheem A, 2010, CURR OPIN CHEM BIOL, V14, P30, DOI 10.1016/j.cbpa.2009.09.033; Isarankura-Na-Ayudhya C, 2010, BIOL TRACE ELEM RES, V134, P352, DOI 10.1007/s12011-009-8476-9; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mizuno T, 2007, J AM CHEM SOC, V129, P11378, DOI 10.1021/ja0685102; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; Richmond TA, 2000, BIOCHEM BIOPH RES CO, V268, P462, DOI 10.1006/bbrc.1999.1244; Royant A, 2011, J STRUCT BIOL, V174, P385, DOI 10.1016/j.jsb.2011.02.004; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sochacki KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2158; SUH SS, 1991, PROTEIN ENG, V4, P301, DOI 10.1093/protein/4.3.301; Taraska JW, 2009, P NATL ACAD SCI USA, V106, P16227, DOI 10.1073/pnas.0905207106; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; VERSIECK J, 1974, CLIN CHEM, V20, P1141; Vinkenborg JL, 2010, CURR OPIN CHEM BIOL, V14, P231, DOI 10.1016/j.cbpa.2009.11.022; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Wang C, 2010, PROTEIN SCI, V19, P494, DOI 10.1002/pro.327; Yu XZ, 2013, STRUCTURE, V21, P9, DOI 10.1016/j.str.2012.11.013	51	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95808	10.1371/journal.pone.0095808	http://dx.doi.org/10.1371/journal.pone.0095808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752441	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400133
J	Bessmeltseva, M; Viiard, E; Simm, J; Paalme, T; Sarand, I				Bessmeltseva, Marianna; Viiard, Ene; Simm, Jaak; Paalme, Toomas; Sarand, Inga			Evolution of Bacterial Consortia in Spontaneously Started Rye Sourdoughs during Two Months of Daily Propagation	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ARTISAN BAKERY; WHEAT; IDENTIFICATION; DYNAMICS; YEAST; FERMENTATION; PARAMETERS; DIVERSITY; COMMUNITY	The evolution of bacterial consortia was studied in six semi-solid rye sourdoughs during long-term backslopping at different temperatures. Each rye sourdough was started spontaneously in a laboratory (dough yield 200), propagated at either 20 degrees C or 30 degrees C, and renewed daily at an inoculation rate of 1:10 for 56 days. The changes in bacterial diversity over time were followed by both DGGE coupled with partial 16S rRNA gene sequencing and pyrosequencing of bar-coded 16S rRNA gene amplicons. Four species from the genus Lactobacillus (brevis, crustorum, plantarum, and paralimentarius) were detected in different combinations in all sourdoughs after 56 propagation cycles. Facultative heterofermentative lactic acid bacteria dominated in sourdoughs fermented at 30 degrees C, while both obligate and facultative heterofermentative LAB were found to dominate in sourdoughs fermented at 20 degrees C. After 56 propagation cycles, Kazachstania unispora (formerly Saccharomyces unisporus) was identified as the only yeast species that dominated in sourdoughs fermented at 20 degrees C, while different combinations of strains from four yeast species (Kazachstania unispora, Saccharomyces cerevisiae, Candida krusei and Candida glabrata) were detected in sourdoughs propagated at 30 degrees C. The evolution of bacterial communities in sourdoughs fermented at the same temperature did not follow the same time course and changes in the composition of dominant and subdominant bacterial communities occurred even after six weeks of backslopping.	[Bessmeltseva, Marianna; Viiard, Ene; Paalme, Toomas; Sarand, Inga] Competence Ctr Food & Fermentat Technol, Tallinn, Estonia; [Bessmeltseva, Marianna; Viiard, Ene; Paalme, Toomas; Sarand, Inga] Tallinn Univ Technol, Food Proc Dept, EE-19086 Tallinn, Estonia; [Simm, Jaak] Tallinn Univ Technol, Ctr Biol Integrated Syst, EE-19086 Tallinn, Estonia; [Sarand, Inga] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	Tallinn University of Technology; Tallinn University of Technology; Tallinn University of Technology	Viiard, E (corresponding author), Competence Ctr Food & Fermentat Technol, Tallinn, Estonia.	ene@tftak.eu	Sarand, Inga/AAK-1871-2020	Sarand, Inga/0000-0002-9517-8965	European Regional Development Fund [EU29994]; Estonian Ministry of Education and Research [SF140090s08]; Estonian Science Foundation [ETF9417]; European Social Fund's Doctoral Studies and Internationalization programme DoRa	European Regional Development Fund(European Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; European Social Fund's Doctoral Studies and Internationalization programme DoRa	The financial support for this research was provided by the European Regional Development Fund project EU29994, Estonian Ministry of Education and Research grant SF140090s08, Estonian Science Foundation grant ETF9417 and by European Social Fund's Doctoral Studies and Internationalization programme DoRa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrighetto C, 2000, LETT APPL MICROBIOL, V30, P5, DOI [10.1046/j.1472-765x.2000.00589.x, 10.1046/j.1472-765X.2000.00589.x]; Bhattacharya I, 2013, COMPR REV FOOD SCI F, V12, P353, DOI 10.1111/1541-4337.12016; Boekhorst J, 2009, MICROBIOLOGY, V150, P3601; Callon C, 2006, SYST APPL MICROBIOL, V29, P172, DOI 10.1016/j.syapm.2005.07.008; Cocolin L, 2013, INT J FOOD MICROBIOL; Daniel HM, 2011, ANTON LEEUW INT J G, V99, P63, DOI 10.1007/s10482-010-9517-2; De Vuyst L, 2005, TRENDS FOOD SCI TECH, V16, P43, DOI 10.1016/j.tifs.2004.02.012; Delgado S, 2013, FOOD MICROBIOL, V36, P103, DOI 10.1016/j.fm.2013.04.015; DIOWKSZ A, 2006, BAKERY PRODUCTS SCI, P365; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P7827, DOI 10.1128/AEM.02955-13; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gobbetti M, 1995, FOOD MICROBIOL, V12, P497, DOI 10.1006/fmic.1995.0065; Gobbetti M, 1998, TRENDS FOOD SCI TECH, V9, P267, DOI 10.1016/S0924-2244(98)00053-3; Hammes W. P., 1996, Advances in Food Sciences, V18, P176; Hammes W.P., 1998, MICROBIOLOGY FERMENT, V1, P199, DOI [10.1007/978-1-4613-0309-1_8, DOI 10.1007/978-1-4613-0309-1_8]; Hansen AS, 2004, HDB FOOD BEVERAGE FE, P840; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huys G, 2013, HDB SOURDOUGH TECHNO; Londero A, 2012, J DAIRY RES, V79, P262, DOI 10.1017/S0022029912000179; Lonner C, 1988, THESIS LUND U SWEDEN; Balcazar JL, 2007, COMP IMMUNOL MICROB, V30, P111, DOI 10.1016/j.cimid.2006.12.001; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P475, DOI 10.1128/AEM.69.1.475-482.2003; Minervini F, 2014, INT J FOOD MICROBIOL, V171, P136, DOI 10.1016/j.ijfoodmicro.2013.11.021; Minervini F, 2012, APPL ENVIRON MICROB, V78, P5328, DOI 10.1128/AEM.00572-12; Minervini F, 2010, FOOD MICROBIOL, V27, P897, DOI 10.1016/j.fm.2010.05.021; Moroni AV, 2011, FOOD MICROBIOL, V28, P497, DOI 10.1016/j.fm.2010.10.016; Mu ZS, 2012, FOOD MICROBIOL, V31, P301, DOI 10.1016/j.fm.2012.04.004; Muller MRA, 2001, FOOD MICROBIOL, V18, P217, DOI 10.1006/fmic.2000.0394; Pang H, 2012, INT J SYST EVOL MICR, V62, P2383, DOI 10.1099/ijs.0.035329-0; Plumed-Ferrer C, 2008, APPL ENVIRON MICROB, V74, P5349, DOI 10.1128/AEM.00324-08; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rosenquist H, 2000, FOOD MICROBIOL, V17, P241, DOI 10.1006/fmic.1999.0313; Salovaara H, 1984, ACTA ALIMENTARIA POL, V10, P242; Savard T, 2002, J FOOD PROTECT, V65, P828, DOI 10.4315/0362-028X-65.5.828; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siti Hajar M. D., 2012, International Food Research Journal, V19, P775; Temmerman R, 2004, TRENDS FOOD SCI TECH, V15, P348, DOI 10.1016/j.tifs.2003.12.007; Van der Meulen R, 2007, APPL ENVIRON MICROB, V73, P4741, DOI 10.1128/AEM.00315-07; Vera A, 2009, FOOD MICROBIOL, V26, P728, DOI 10.1016/j.fm.2009.07.010; Viiard E, 2013, J APPL MICROBIOL, V114, P404, DOI 10.1111/jam.12045; Vogelmann SA, 2009, INT J FOOD MICROBIOL, V130, P205, DOI 10.1016/j.ijfoodmicro.2009.01.020; Vrancken G, 2011, APPL ENVIRON MICROB, V77, P3406, DOI 10.1128/AEM.02668-10; Vrancken G, 2011, APPL ENVIRON MICROB, V77, P2716, DOI 10.1128/AEM.02470-10; Vrancken G, 2010, FEMS YEAST RES, V10, P471, DOI 10.1111/j.1567-1364.2010.00621.x; Weckx S, 2010, FOOD MICROBIOL, V27, P1000, DOI 10.1016/j.fm.2010.06.005; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wick M, 2003, ACTA BIOTECHNOL, V23, P51, DOI 10.1002/abio.200390008	49	44	47	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95449	10.1371/journal.pone.0095449	http://dx.doi.org/10.1371/journal.pone.0095449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748058	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500103
J	Biswas, A; Mandal, S; Sau, S				Biswas, Anindya; Mandal, Sukhendu; Sau, Subrata			The N-Terminal Domain of the Repressor of Staphylococcus aureus Phage Phi 11 Possesses an Unusual Dimerization Ability and DNA Binding Affinity	PLOS ONE			English	Article							P22 C2 REPRESSOR; LAMBDA-REPRESSOR; CRYSTAL-STRUCTURE; CIRCULAR-DICHROISM; OPERATOR COMPLEX; CI REPRESSOR; PROTEIN; PURIFICATION; RECOGNITION; REGULATOR	Bacteriophage Phi 11 uses Staphylococcus aureus as its host and, like lambdoid phages, harbors three homologous operators in between its two divergently oriented repressor genes. None of the repressors of Phi 11, however, showed binding to all three operators, even at high concentrations. To understand why the DNA binding mechanism of Phi 11 repressors does not match that of lambdoid phage repressors, we studied the N-terminal domain of the Phi 11 lysogenic repressor, as it harbors a putative helix-turn-helix motif. Our data revealed that the secondary and tertiary structures of the N-terminal domain were different from those of the full-length repressor. Nonetheless, the N-terminal domain was able to dimerize and bind to the operators similar to the intact repressor. In addition, the operator base specificity, binding stoichiometry, and binding mechanism of this domain were nearly identical to those of the whole repressor. The binding affinities of the repressor and its N-terminal domain were reduced to a similar extent when the temperature was increased to 42 degrees C. Both proteins also adequately dislodged a RNA polymerase from a Phi 11 DNA fragment carrying two operators and a promoter. Unlike the intact repressor, the binding of the N-terminal domain to two adjacent operator sites was not cooperative in nature. Taken together, we suggest that the dimerization and DNA binding abilities of the N-terminal domain of the Phi 11 repressor are distinct from those of the DNA binding domains of other phage repressors.	[Biswas, Anindya; Mandal, Sukhendu; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, W Bengal, India.	subratasau@gmail.com		Biswas, Anindya/0000-0003-1645-2856	Bose Institute	Bose Institute(Department of Science & Technology (India))	The work was supported by an intramural grant from Bose Institute to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; Ausubel FM, 1998, CURRENT PROTOCOLS MO; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Bell CE, 2001, J MOL BIOL, V314, P1127, DOI 10.1006/jmbi.2000.5196; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL A, 1994, ANNU REV MICROBIOL, V48, P193, DOI 10.1146/annurev.micro.48.1.193; CARLSON PA, 1994, J BACTERIOL, V176, P6907, DOI 10.1128/JB.176.22.6907-6914.1994; Creighton T.E., 1997, PROTEIN STRUCTURE PR; Das M, 2007, J BIOCHEM MOL BIOL, V40, P740; Das M, 2009, BMB REP, V42, P160, DOI 10.5483/BMBRep.2009.42.3.160; DEANDA J, 1983, J BIOL CHEM, V258, P536; Frandsen KH, 2013, BIOCHEMISTRY-US, V52, P6892, DOI 10.1021/bi400439y; Ganguly T, 2009, FEBS J, V276, P1975, DOI 10.1111/j.1742-4658.2009.06924.x; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; HECHT MH, 1984, P NATL ACAD SCI-BIOL, V81, P5685, DOI 10.1073/pnas.81.18.5685; HEINRICH J, 1995, FEMS MICROBIOL REV, V17, P121; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; Jensen SO, 2010, PLASMID, V64, P135, DOI 10.1016/j.plasmid.2010.06.001; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kiely PD, 2008, MICROBIOL-SGM, V154, P2209, DOI 10.1099/mic.0.2007/015032-0; Li Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027246; Maxam A M, 1980, Methods Enzymol, V65, P499; McCallum N, 2010, J BACTERIOL, V192, P5151, DOI 10.1128/JB.00491-10; Mondal R, 2010, BMB REP, V43, P176, DOI 10.5483/BMBRep.2010.43.3.176; MONDRAGON A, 1989, J MOL BIOL, V205, P189, DOI 10.1016/0022-2836(89)90375-6; MONINI P, 1991, J VIROL, V65, P2124, DOI 10.1128/JVI.65.4.2124-2130.1991; NERI D, 1992, J MOL BIOL, V223, P743, DOI 10.1016/0022-2836(92)90987-U; Newman JA, 2013, J BIOL CHEM, V288, P10766, DOI 10.1074/jbc.M113.455592; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; PABO CO, 1979, P NATL ACAD SCI USA, V76, P1608, DOI 10.1073/pnas.76.4.1608; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; Pedersen M, 2008, J MOL BIOL, V376, P983, DOI 10.1016/j.jmb.2007.12.022; Pinkett HW, 2006, MOL CELL, V21, P605, DOI 10.1016/j.molcel.2006.01.019; Ruiz-Sanz J, 1999, EUR J BIOCHEM, V263, P246, DOI 10.1046/j.1432-1327.1999.00491.x; Salinas RK, 2009, PROTEINS, V75, P518, DOI 10.1002/prot.22344; Sambrook J, 2001, MOL CLONING LAB MANU; SEVILLASIERRA P, 1994, J MOL BIOL, V235, P1003, DOI 10.1006/jmbi.1994.1053; Shearwin KE, 2002, J BIOL CHEM, V277, P3186, DOI 10.1074/jbc.M107740200; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f	45	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95012	10.1371/journal.pone.0095012	http://dx.doi.org/10.1371/journal.pone.0095012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747758	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500052
J	Han, JH; Kim, IS; Jung, SH; Lee, SG; Son, HY; Myung, CS				Han, Joo-Hui; Kim, In-Su; Jung, Sang-Hyuk; Lee, Sang-Gil; Son, Hwa-Young; Myung, Chang-Seon			The Effects of Propionate and Valerate on Insulin Responsiveness for Glucose Uptake in 3T3-L1 Adipocytes and C2C12 Myotubes via G Protein-Coupled Receptor 41	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CHAIN FATTY-ACIDS; GLUCAGON-LIKE PEPTIDE-1; ERK1/2 ACTIVATION; GLYCEMIC CONTROL; DOWN-REGULATION; MUSCLE-CELLS; IN-VITRO; RESISTANCE; FAMILY	Since insulin resistance can lead to hyperglycemia, improving glucose uptake into target tissues is critical for regulating blood glucose levels. Among the free fatty acid receptor (FFAR) family of G protein-coupled receptors, GPR41 is known to be the G alpha(i/o)-coupled receptor for short-chain fatty acids (SCFAs) such as propionic acid (C3) and valeric acid (C5). This study aimed to investigate the role of GPR41 in modulating basal and insulin-stimulated glucose uptake in insulin-sensitive cells including adipocytes and skeletal muscle cells. Expression of GPR41 mRNA and protein was increased with maximal expression at differentiation day 8 for 3T3-L1 adipocytes and day 6 for C2C12 myotubes. GPR41 protein was also expressed in adipose tissues and skeletal muscle. After analyzing dose-response relationship, 300 mu M propionic acid or 500 mM valeric acid for 30 min incubation was used for the measurement of glucose uptake. Both propionic acid and valeric acid increased insulin-stimulated glucose uptake in 3T3-L1 adipocyte, which did not occur in cells transfected with siRNA for GPR41 (siGPR41). In C2C12 myotubes, these SCFAs increased basal glucose uptake, but did not potentiate insulin-stimulated glucose uptake, and siGPR41 treatment reduced valerate-stimulated basal glucose uptake. Therefore, these findings indicate that GPR41 plays a role in insulin responsiveness enhanced by both propionic and valeric acids on glucose uptake in 3T3-L1 adipocytes and C2C12 myotubes, and in valerate-induced increase in basal glucose uptake in C2C12 myotubes.	[Han, Joo-Hui; Kim, In-Su; Jung, Sang-Hyuk; Lee, Sang-Gil; Myung, Chang-Seon] Chungnam Natl Univ, Dept Pharmacol, Coll Pharm, Taejon, South Korea; [Son, Hwa-Young] Chungnam Natl Univ, Dept Vet Pathol, Coll Vet Med, Taejon, South Korea; [Myung, Chang-Seon] Chungnam Natl Univ, Inst Drug Res & Dev, Taejon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University	Myung, CS (corresponding author), Chungnam Natl Univ, Dept Pharmacol, Coll Pharm, Taejon, South Korea.	cm8r@cnu.ac.kr	Han, Joo-Hui/AAW-8958-2021	Son, Hwa-Young/0000-0003-4388-0952; Han, Joo-Hui/0000-0002-3638-0581; Myung, Chang-Seon/0000-0002-6292-2911	National Research Foundation of Korea (NRF) [2010-0014839]; Priority Research Centers Program [2009-0093815]; Ministry of Education, Science, and Technology (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Priority Research Centers Program; Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant (No. 2010-0014839) and the Priority Research Centers Program (No. 2009-0093815), funded by the Ministry of Education, Science, and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen S, 2009, CELL SIGNAL, V21, P1984, DOI 10.1016/j.cellsig.2009.09.009; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Covington DK, 2006, BIOCHEM SOC T, V34, P770, DOI 10.1042/BST0340770; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Goldstein BJ, 2002, AM J CARDIOL, V90, p3G; Green A, 1997, AM J PHYSIOL-ENDOC M, V273, pE254, DOI 10.1152/ajpendo.1997.273.2.E254; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Izawa Y, 2005, EXP CELL RES, V308, P291, DOI 10.1016/j.yexcr.2005.04.028; Kim KY, 2007, MOL PHARMACOL, V71, P1554, DOI 10.1124/mol.106.031948; KIRKHAM DM, 1992, BIOCHEM J, V284, P301, DOI 10.1042/bj2840301; Lanner JT, 2008, CURR OPIN PHARMACOL, V8, P339, DOI 10.1016/j.coph.2008.01.006; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; MUECKLER M, 1990, DIABETES, V39, P6, DOI 10.2337/diabetes.39.1.6; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Parker JC, 2002, ADV DRUG DELIVER REV, V54, P1173, DOI 10.1016/S0169-409X(02)00093-5; Perez-Matute P, 2012, J INFECT CHEMOTHER, V18, P485, DOI 10.1007/s10156-011-0361-8; Pu J, 2011, J LIPID RES, V52, P1319, DOI 10.1194/jlr.M011254; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seljeset S, 2012, J RECEPT SIG TRANSD, V32, P196, DOI 10.3109/10799893.2012.692118; Sellin JH, 1999, NEWS PHYSIOL SCI, V14, P58; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Wolever TMS, 1997, METABOLISM, V46, P805, DOI 10.1016/S0026-0495(97)90127-X; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Zhang WY, 2012, J AGR FOOD CHEM, V60, P7652, DOI 10.1021/jf300601z	37	33	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95268	10.1371/journal.pone.0095268	http://dx.doi.org/10.1371/journal.pone.0095268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748202	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500072
J	Panda, S; El Khader, I; Casellas, F; Vivancos, JL; Cors, MG; Santiago, A; Cuenca, S; Guarner, F; Manichanh, C				Panda, Suchita; El Khader, Ismail; Casellas, Francesc; Lopez Vivancos, Josefa; Garcia Cors, Montserrat; Santiago, Alba; Cuenca, Silvia; Guarner, Francisco; Manichanh, Chaysavanh			Short-Term Effect of Antibiotics on Human Gut Microbiota	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; FLUOROQUINOLONES; LEVOFLOXACIN; INFECTIONS; DIVERSITY; BACTERIA; IMPACTS; DISEASE; MICE	From birth onwards, the human gut microbiota rapidly increases in diversity and reaches an adult-like stage at three years of age. After this age, the composition may fluctuate in response to external factors such as antibiotics. Previous studies have shown that resilience is not complete months after cessation of the antibiotic intake. However, little is known about the short-term effects of antibiotic intake on the gut microbial community. Here we examined the load and composition of the fecal microbiota immediately after treatment in 21 patients, who received broad-spectrum antibiotics such as fluoroquinolones and beta-lactams. A fecal sample was collected from all participants before treatment and one week after for microbial load and community composition analyses by quantitative PCR and pyrosequencing of the 16S rRNA gene, respectively. Fluoroquinolones and beta-lactams significantly decreased microbial diversity by 25% and reduced the core phylogenetic microbiota from 29 to 12 taxa. However, at the phylum level, these antibiotics increased the Bacteroidetes/Firmicutes ratio (p = 0.0007, FDR = 0.002). At the species level, our findings unexpectedly revealed that both antibiotic types increased the proportion of several unknown taxa belonging to the Bacteroides genus, a Gram-negative group of bacteria (p = 0.0003, FDR, 0.016). Furthermore, the average microbial load was affected by the treatment. Indeed, the beta-lactams increased it significantly by two-fold (p = 0.04). The maintenance of or possible increase detected in microbial load and the selection of Gram-negative over Gram-positive bacteria breaks the idea generally held about the effect of broad-spectrum antibiotics on gut microbiota.	[Panda, Suchita; El Khader, Ismail; Casellas, Francesc; Santiago, Alba; Cuenca, Silvia; Guarner, Francisco; Manichanh, Chaysavanh] Vall dHebron Res Inst, Digest Syst Res Unit, Barcelona, Spain; [Casellas, Francesc; Guarner, Francisco; Manichanh, Chaysavanh] Inst Salud Carlos III, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Madrid, Spain; [Lopez Vivancos, Josefa; Garcia Cors, Montserrat] Univ Int Catalunya, Capio Hosp Gen Catalunya, Dept Internal Med, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Universitat Internacional de Catalunya (UIC)	Manichanh, C (corresponding author), Vall dHebron Res Inst, Digest Syst Res Unit, Barcelona, Spain.	cmanicha@gmail.com	Casellas, Francesc/AAT-1018-2021; Guarner, Francisco/ABF-1192-2020	Casellas, Francesc/0000-0003-3196-039X; Guarner, Francisco/0000-0002-4051-0836; Santiago, Alba/0000-0002-3773-8020; Chaysavanh, Manichanh/0000-0002-2287-4003	Fondo de Investigacion Sanitaria, Ministerio de Ciencia e Innovacion, Spain [PI10/00902]; HENUFOOD [CEN-20101016]; Instituto de Salud Carlos III	Fondo de Investigacion Sanitaria, Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentInstituto de Salud Carlos III); HENUFOOD; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was funded in part by the Fondo de Investigacion Sanitaria, Ministerio de Ciencia e Innovacion, Spain (PI10/00902 grant) and in part by HENUFOOD (CEN-20101016). Ciberehd is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blandino G, 2007, J CHEMOTHERAPY, V19, P495, DOI 10.1179/joc.2007.19.5.495; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; CHAO A, 1984, SCAND J STAT, V11, P265; Croom KF, 2003, DRUGS, V63, P2769, DOI 10.2165/00003495-200363240-00008; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Esty W, 1986, ANN STAT, V14, P781; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Holten KB, 2000, AM FAM PHYSICIAN, V62, P611; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mandell GL, 1996, GOODMAN GILMANS PHAR, P1073; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; McNulty CAM, 2012, J ANTIMICROB CHEMOTH, V67, P2543, DOI 10.1093/jac/dks358; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Perez-Cobas AE, 2012, GUT; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schaumann R., 2007, Anti-Infective Agents in Medicinal Chemistry, V6, P49; Solomkin JS, 2010, SURG INFECT, V11, P79, DOI 10.1089/sur.2009.9930; Stein GE, 2008, ANAEROBE, V14, P8, DOI 10.1016/j.anaerobe.2007.09.005; Stein GE, 2006, CLIN INFECT DIS, V42, P1598, DOI 10.1086/503907; SUTO MJ, 1992, J MED CHEM, V35, P4745, DOI 10.1021/jm00103a013; Umenai T, 2010, EUR J CLIN MICROBIOL, V29, P633, DOI 10.1007/s10096-010-0905-3; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; White AR, 2004, J ANTIMICROB CHEMOTH, V53, pI3, DOI 10.1093/jac/dkh050; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536	38	193	202	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95476	10.1371/journal.pone.0095476	http://dx.doi.org/10.1371/journal.pone.0095476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748167	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500108
J	Duan, RB; Zhang, L; Chen, DF; Yang, F; Yang, JS; Yang, WJ				Duan, Ru-Bing; Zhang, Li; Chen, Dian-Fu; Yang, Fan; Yang, Jin-Shu; Yang, Wei-Jun			Two p90 Ribosomal S6 Kinase Isoforms Are Involved in the Regulation of Mitotic and Meiotic Arrest in Artemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BOX-BINDING PROTEIN-1; BRINE SHRIMP; CYTOSTATIC FACTOR; METAPHASE ARREST; MAPK PATHWAY; DOCKING SITE; CELL-CYCLE; MEIOSIS I; RSK	There are multiple isoforms of p90 ribosomal S6 kinase (RSK), which regulate diverse cellular functions such as cell growth, proliferation, maturation, and motility. However, the relationship between the structures and functions of RSK isoforms remains undetermined. Artemia is a useful model in which to study cell cycle arrest because these animals undergo prolonged diapauses, a state of obligate dormancy. A novel RSK isoform was identified in Artemia, which was termed Ar-Rsk2. This isoform was compared with an RSK isoform that we previously identified in Artemia, termed Ar-Rsk1. Ar-Rsk2 has an ERK-docking motif, whereas Ar-Rsk1 does not. Western blot analysis revealed that Ar-Rsk1 was activated by phosphorylation, which blocked meiosis in oocytes. Knockdown of Ar-Rsk1 reduced the level of phosphorylated cdc2 and thereby suppressed cytostatic factor activity. This indicates that Ar-Rsk1 regulates the cytostatic factor in meiosis. Expression of Ar-Rsk2 was down-regulated in Artemia cysts in which mitosis was arrested. Knockdown of Ar-Rsk2 resulted in decreased levels of cyclin D3 and phosphorylated histone H3, and the production of pseudo-diapause cysts. This indicates that Ar-Rsk2 regulates mitotic arrest. PLK and ERK RNAi showed that Ar-Rsk2, but not Ar-Rsk1, could be activated by PLK-ERK in Artemia. This is the first study to report that RSK isoforms with and without an ERK-docking motif regulate mitosis and meiosis, respectively. This study provides insight into the relationship between the structures and functions of RSK isoforms.	[Yang, Wei-Jun] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, WJ (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830; Yang, Jin-Shu/0000-0001-6680-7737	National Natural Science Foundation of China [31270424]; National Basic Research Program of China 973 Program [2012CB944903]; National Basic Research Program of China 863 Program [2012AA10A401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); National Basic Research Program of China 863 Program(National Basic Research Program of ChinaNational High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 31270424, National Basic Research Program of China 973 Program Grant 2012CB944903, and National Basic Research Program of China 863 Program Grant 2012AA10A401.	ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; Arul N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00201; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Chen S, 2011, BIOL REPROD, V85, P31, DOI 10.1095/biolreprod.110.090340; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Clark DE, 2005, CANCER RES, V65, P3108; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; CLEGG JS, 1978, J CELL PHYSIOL, V94, P123, DOI 10.1002/jcp.1040940202; Clegg JS, 1997, J EXP BIOL, V200, P467; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai ZM, 2011, BIOSCIENCE REP, V31, P17, DOI 10.1042/BSR20090141; Feng CZ, 2007, COMP BIOCHEM PHYS B, V147, P191, DOI 10.1016/j.cbpb.2007.01.024; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Imada K, 2013, CLIN CANCER RES, V19, P4638, DOI 10.1158/1078-0432.CCR-12-3705; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Ivanovska I, 2004, CURR BIOL, V14, P75, DOI 10.1016/j.cyb.2003.12.031; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Ruiz EJ, 2010, CURR BIOL, V20, P717, DOI 10.1016/j.cub.2010.02.050; Kondoh E, 2006, DEV BIOL, V293, P228, DOI 10.1016/j.ydbio.2006.02.005; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Li R, 2012, J BIOL CHEM, V287, P15923, DOI 10.1074/jbc.M111.312413; Liu J, 2007, ONCOGENE, V26, P1286, DOI 10.1038/sj.onc.1210203; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; Lopez-Vicente L, 2009, CLIN CANCER RES, V15, P4546, DOI 10.1158/1078-0432.CCR-08-3159; Ma WM, 2013, BIOCHEM J, V449, P285, DOI 10.1042/BJ20121259; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Moriwaki K, 2013, ZOOL SCI, V30, P975, DOI 10.2108/zsj.30.975; Myers AP, 2004, MOL CELL BIOL, V24, P4255, DOI 10.1128/MCB.24.10.4255-4266.2004; Nambu Z, 2004, J EXP ZOOL PART A, V301A, P542, DOI 10.1002/jez.a.80; Neise D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.386; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Rath A, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-6; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmitt A, 2002, J CELL SCI, V115, P2457; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Stratford AL, 2012, STEM CELLS, V30, P1338, DOI 10.1002/stem.1128; Sulzmaier FJ, 2013, CANCER RES, V73, P6099, DOI 10.1158/0008-5472.CAN-13-1087; Thakur A, 2008, CLIN CANCER RES, V14, P4427, DOI 10.1158/1078-0432.CCR-08-0458; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Tunquist BJ, 2002, CURR BIOL, V12, P1027, DOI 10.1016/S0960-9822(02)00894-1; Yamamoto DS, 2008, MECH DEVELOP, V125, P996, DOI 10.1016/j.mod.2008.08.004; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068374; Zhu XJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-21	52	10	10	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16006	16015		10.1074/jbc.M114.553370	http://dx.doi.org/10.1074/jbc.M114.553370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755224	Green Published, hybrid			2022-12-25	WOS:000337965700011
J	Kato, M; Lin, SJ				Kato, Michiko; Lin, Su-Ju			YCL047C/POF1 Is a Novel Nicotinamide Mononucleotide Adenylyltransferase (NMNAT) in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Metabolism; Metabolic Regulation; NAD Biosynthesis; Yeast Genetics; Yeast Metabolism; Nicotinamide Mononucleotide Adenylyltransferase; Nicotinamide Riboside Salvage	LIFE-SPAN EXTENSION; CALORIE RESTRICTION; SALVAGE PATHWAY; NADR PROTEIN; DIPHOSPHOPYRIDINE NUCLEOTIDE; ENZYMATIC-PROPERTIES; NAD(+) BIOSYNTHESIS; GENE DELETION; IDENTIFICATION; REGULATOR	NAD(+) is an essential metabolic cofactor involved in various cellular biochemical processes. Nicotinamide riboside (NR) is an endogenously produced key pyridine metabolite that plays important roles in the maintenance of NAD(+) pool. Using a NR-specific cell-based screen, we identified mutants that exhibit altered NR release phenotype. Yeast cells lacking the ORF YCL047C/POF1 release considerably more NR compared with wild type, suggesting that POF1 plays an important role in NR/NAD(+) metabolism. The amino acid sequence of Pof1 indicates that it is a putative nicotinamide mononucleotide adenylyltransferase (NMNAT). Unlike other yeast NMNATs, Pof1 exhibits NMN-specific adenylyltransferase activity. Deletion of POF1 significantly lowers NAD(+) levels and decreases the efficiency of NR utilization, resistance to oxidative stress, and NR-induced life span extension. We also show that NR is constantly produced by multiple nucleotidases and that the intracellular NR pools are likely to be compartmentalized, which contributes to the regulation of NAD(+) homeostasis. Our findings may contribute to the understanding of the molecular basis and regulation of NAD(+) metabolism in higher eukaryotes.	[Kato, Michiko; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol & Mol Genet, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			National Institutes of Health [GM102297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102297.	AbdelRaheim SR, 2001, ARCH BIOCHEM BIOPHYS, V388, P18, DOI 10.1006/abbi.2000.2268; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Brachmann CB, 1998, YEAST, V14, P115; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Costa IM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-268; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Emanuelli M, 2003, PROTEIN EXPRES PURIF, V27, P357, DOI 10.1016/S1046-5928(02)00645-9; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Grose JH, 2005, J BACTERIOL, V187, P2774, DOI 10.1128/JB.187.8.2774-2782.2005; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; KANEKO Y, 1985, MOL CELL BIOL, V5, P248, DOI 10.1128/MCB.5.1.248; Kurnasov OV, 2002, J BACTERIOL, V184, P6906, DOI 10.1128/JB.184.24.6906-6917.2002; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Magni G, 2004, CURR MED CHEM, V11, P873, DOI 10.2174/0929867043455666; NATALINI P, 1986, BIOCHEMISTRY-US, V25, P3725, DOI 10.1021/bi00360a037; Ocampo A, 2013, HUM MOL GENET, V22, P1699, DOI 10.1093/hmg/ddt016; Ohashi K, 2013, EUKARYOT CELL, V12, P648, DOI 10.1128/EC.00339-12; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Raffaelli N, 1999, J BACTERIOL, V181, P5509, DOI 10.1128/JB.181.17.5509-5511.1999; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/nchembio.1352, 10.1038/NCHEMBIO.1352]; Sies H., 1982, METABOLIC COMPARTMEN, P205; Singh SK, 2002, J BIOL CHEM, V277, P33291, DOI 10.1074/jbc.M204368200; Sporty J, 2009, YEAST, V26, P363, DOI 10.1002/yea.1671; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu YF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.21; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721	50	18	22	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15577	15587		10.1074/jbc.M114.558643	http://dx.doi.org/10.1074/jbc.M114.558643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24759102	Green Published, hybrid			2022-12-25	WOS:000337465400040
J	Miryeganeh, M; Takayama, K; Tateishi, Y; Kajita, T				Miryeganeh, Matin; Takayama, Koji; Tateishi, Yoichi; Kajita, Tadashi			Long-Distance Dispersal by Sea-Drifted Seeds Has Maintained the Global Distribution of Ipomoea pes-caprae subsp brasiliensis (Convolvulaceae)	PLOS ONE			English	Article							POPULATION-STRUCTURE; HIBISCUS-TILIACEUS; PANTROPICAL PLANT; GENETIC-STRUCTURE; NUCLEAR; CHLOROPLAST; POLYMORPHISM; DIVERGENCE; LIKELIHOOD; SOFTWARE	Ipomoea pes-caprae (Convolvulaceae), a pantropical plant with sea-drifted seeds, is found globally in the littoral areas of tropical and subtropical regions. Unusual long-distance seed dispersal has been believed to be responsible for its extraordinarily wide distribution; however, the actual level of inter-population migration has never been studied. To clarify the level of migration among populations of I. pes-caprae across its range, we investigated nucleotide sequence variations by using seven low-copy nuclear markers and 272 samples collected from 34 populations that cover the range of the species. We applied coalescent-based approaches using Bayesian and maximum likelihood methods to assess migration rates, direction of migration, and genetic diversity among five regional populations. Our results showed a high number of migrants among the regional populations of I. pes-caprae subsp. brasiliensis, which suggests that migration among distant populations was maintained by long-distance seed dispersal across its global range. These results also provide strong evidence for recent trans-oceanic seed dispersal by ocean currents in all three oceanic regions. We also found migration crossing the American continents. Although this is an apparent land barrier for sea-dispersal, migration between populations of the East Pacific and West Atlantic regions was high, perhaps because of trans-isthmus migration via pollen dispersal. Therefore, the migration and gene flow among populations across the vast range of I. pes-caprae is maintained not only by seed dispersal by sea-drifted seeds, but also by pollen flow over the American continents. On the other hand, populations of subsp. pes-caprae that are restricted to only the northern part of the Indian Ocean region were highly differentiated from subsp. brasiliensis. Cryptic barriers that prevented migration by sea dispersal between the ranges of the two subspecies and/or historical differentiation that caused local adaptation to different environmental factors in each region could explain the genetic differentiation between the subspecies.	[Miryeganeh, Matin; Kajita, Tadashi] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba, Japan; [Takayama, Koji] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 113, Japan; [Tateishi, Yoichi] Univ Ryukyus, Fac Educ, Nishihara, Okinawa 90301, Japan	Chiba University; University of Tokyo; University of the Ryukyus	Kajita, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, 1-33 Yayoi, Chiba, Japan.	tkaji@faculty.chiba-u.jp	Kajita, Tadashi/ABB-2784-2020		JSPS KAKENHI [25290080, 22405005, 19370032, 16370043, 11740467, 14405015, 12575011]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI 25290080, 22405005, 19370032, 16370043 and 11740467 to TK JSPS KAKENHI 14405015 and 12575011 to YT (http://www. jsps.go.jp) grant for aid by Yamada Science Foundation 2005 to TK (http://www. yamadazaidan. jp/); Fujiwara Natural History Foundation 1999 to TK (http://fujiwara-nh.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2011, PLOS ONE, V7; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DEVALL MS, 1989, AM J BOT, V76, P1821, DOI 10.2307/2444480; DURBIN ML, 1995, P NATL ACAD SCI USA, V92, P3338, DOI 10.1073/pnas.92.8.3338; Edwards SV, 2000, EVOLUTION, V54, P1839; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FU YX, 1993, GENETICS, V133, P693; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harwell MC, 2002, ECOLOGY, V83, P3319, DOI 10.2307/3072082; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; KIMURA M, 1971, GENET RES, V18, P125, DOI 10.1017/S0016672300012520; KIMURA M, 1964, GENETICS, V49, P561; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Kuhner MK, 2007, GENETICS, V175, P155, DOI 10.1534/genetics.106.056457; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martins TR, 2005, SYST BOT, V30, P435, DOI 10.1600/0363644054223675; Miller RE, 1999, SYST BOT, V24, P209, DOI 10.2307/2419549; Minobe S, 2010, CONSERV GENET, V11, P301, DOI 10.1007/s10592-009-9806-3; Miryeganeh M, 2014, J JPN BOT IN PRESS; NAKANISHI H, 1988, Ecological Research, V3, P163, DOI 10.1007/BF02346937; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nettel A, 2007, EVOLUTION, V61, P958, DOI 10.1111/j.1558-5646.2007.00070.x; Ooststroom van SJ, 1953, FLORA MALESIANA, V4, P439; Rajapakse S, 2004, MOL PHYLOGENET EVOL, V30, P623, DOI 10.1016/S1055-7903(03)00249-5; Rambaut A, 2007, TRACER 1 4; St John H., 1970, BOT JAHREBUCHER, V89, P563; Steele PR, 2008, MOL PHYLOGENET EVOL, V48, P1013, DOI 10.1016/j.ympev.2008.05.017; Strand AE, 1997, MOL ECOL, V6, P113, DOI 10.1046/j.1365-294X.1997.00153.x; TAJIMA F, 1989, GENETICS, V123, P585; Takayama K, 2008, MOL ECOL, V17, P2730, DOI 10.1111/j.1365-294X.2008.03799.x; Takayama K, 2006, MOL ECOL, V15, P2871, DOI 10.1111/j.1365-294X.2006.02963.x; Takayama K, 2013, AM J BOT, V100, P1191, DOI 10.3732/ajb.1200567; Toleno DM, 2010, PLANT SPEC BIOL, V25, P30, DOI 10.1111/j.1442-1984.2009.00256.x; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Triest L, 2008, AQUAT BOT, V89, P138, DOI 10.1016/j.aquabot.2007.12.013; Vatanparast Mohammad, 2011, Journal of Japanese Botany, V86, P15; Wall JD, 2003, GENETICS, V163, P395; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	45	30	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e91836	10.1371/journal.pone.0091836	http://dx.doi.org/10.1371/journal.pone.0091836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755614	gold, Green Submitted, Green Published			2022-12-25	WOS:000335240300002
J	Cameron, A; Gaynor, EC				Cameron, Andrew; Gaynor, Erin C.			Hygromycin B and Apramycin Antibiotic Resistance Cassettes for Use in Campylobacter jejuni	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSPOSON MUTAGENESIS; GENE-EXPRESSION; VECTORS; CLONING; SYSTEM; CONSTRUCTION; PATHOGENESIS; MECHANISM; SEQUENCE	Campylobacter jejuni genetic manipulation is restricted by the limited number of antibiotic resistance cassettes available for use in this diarrheal pathogen. In this study, two antibiotic resistance cassettes were developed, encoding for hygromycin B and apramycin resistance, for use in mutagenesis or for selection of gene expression and complementation constructs in C. jejuni. First, the marker genes were successfully modified to allow for insertional mutagenesis or deletion of a gene-of-interest, and were bracketed with restriction sites for the facilitation of site-specific cloning. These hygromycin B and apramycin markers are encoded by plasmids pAC1H and pAC1A, respectively. We also modified an insertional gene-delivery vector to create pRRH and pRRA, containing the hygromycin B and apramycin resistance genes, and 3 unique restriction sites for the directional introduction of genes into the conserved multi-copy rRNA gene clusters of the C. jejuni chromosome. We determined the effective antibiotic concentrations required for selection, and established that no harmful effects or fitness costs were associated with carrying hygromycin B or apramycin resistance under standard C. jejuni laboratory conditions. Using these markers, the arylsulfatase reporter gene astA was deleted, and the ability to genetically complement the astA deletion using pRRH and pRRA for astA gene insertion was demonstrated. Furthermore, the relative levels of expression from the endogenous astA promoter were compared to that of polycistronic mRNA expression from the constitutive promoter upstream of the resistance gene. The development of additional antibiotic resistance cassettes for use in Campylobacter will enable multiple gene deletion and expression combinations as well as more in-depth study of multi-gene systems important for the survival and pathogenesis of this important bacterium.	[Cameron, Andrew; Gaynor, Erin C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Gaynor, EC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	egaynor@mail.ubc.ca			Canadian Institutes of Health Research (CIHR); Canada Research Chair award; Burroughs Wellcome Fund Career Development Award in the Biomedical Sciences; CIHR [MOP-68981]; Natural Sciences and Engineering Research Council of Canada [F11-05378]; BWF	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Burroughs Wellcome Fund Career Development Award in the Biomedical Sciences(Burroughs Wellcome Fund); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); BWF	A. Cameron is supported by CGS-M and CGS-D traineeships from the Canadian Institutes of Health Research (CIHR; http://www.cihr-irsc.gc.ca). EC Gaynor is supported by a Canada Research Chair award (http://www.chairs-chaires.gc.ca) and a Burroughs Wellcome Fund Career Development Award in the Biomedical Sciences (BWF; http://www.bwfund.org/). This work was funded by CIHR grant MOP-68981, Natural Sciences and Engineering Research Council of Canada grant F11-05378 (http://www.nserc-crsng.gc.ca), and the BWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Burian J, 2012, J BIOL CHEM, V287, P299, DOI 10.1074/jbc.M111.302588; Cameron A, 2012, J BACTERIOL, V194, P6116, DOI 10.1128/JB.01409-12; Colegio OR, 2001, J BACTERIOL, V183, P2384, DOI 10.1128/JB.183.7.2384-2388.2001; Davis L, 2005, CURRENT PROTOCOLS MI; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Golden NJ, 2000, INFECT IMMUN, V68, P5450, DOI 10.1128/IAI.68.9.5450-5453.2000; Grabowska AD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-166; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x; Hendrixson DR, 2001, MOL MICROBIOL, V40, P214, DOI 10.1046/j.1365-2958.2001.02376.x; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; LABIGNEROUSSEL A, 1988, J BACTERIOL, V170, P1704, DOI 10.1128/jb.170.4.1704-1708.1988; LABIGNEROUSSEL A, 1987, J BACTERIOL, V169, P5320, DOI 10.1128/jb.169.11.5320-5323.1987; Lin AE, 2009, INFECT IMMUN, V77, P4912, DOI 10.1128/IAI.00571-08; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; Magalhaes MLB, 2005, BIOCHEMISTRY-US, V44, P16275, DOI 10.1021/bi051777d; MENARD R, 1993, J BACTERIOL, V175, P5899; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Paget E, 1996, J BACTERIOL, V178, P6357, DOI 10.1128/jb.178.21.6357-6360.1996; PARDO JM, 1985, J GEN MICROBIOL, V131, P1289; SALAUZE D, 1990, ANTIMICROB AGENTS CH, V34, P1915, DOI 10.1128/AAC.34.10.1915; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; WALTON JR, 1978, J ANTIMICROB CHEMOTH, V4, P309, DOI 10.1093/jac/4.4.309; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Watanabe M, 1999, APPL ENVIRON MICROB, V65, P1036; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Yao RJ, 1996, J BACTERIOL, V178, P3335, DOI 10.1128/jb.178.11.3335-3338.1996; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	31	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95084	10.1371/journal.pone.0095084	http://dx.doi.org/10.1371/journal.pone.0095084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751825	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400030
J	Hess, BJM; Thomassen, JS				Hess, Bernhard J. M.; Thomassen, Jakob S.			Kinematics of Visually-Guided Eye Movements	PLOS ONE			English	Article							SUPERIOR COLLICULUS; SEARCH COIL; 3-DIMENSIONAL KINEMATICS; LISTINGS LAW; POSITION; PURSUIT; MONKEY; VELOCITY; MUSCLE; STABILIZATION	One of the hallmarks of an eye movement that follows Listing's law is the half-angle rule that says that the angular velocity of the eye tilts by half the angle of eccentricity of the line of sight relative to primary eye position. Since all visually-guided eye movements in the regime of far viewing follow Listing's law (with the head still and upright), the question about its origin is of considerable importance. Here, we provide theoretical and experimental evidence that Listing's law results from a unique motor strategy that allows minimizing ocular torsion while smoothly tracking objects of interest along any path in visual space. The strategy consists in compounding conventional ocular rotations in meridian planes, that is in horizontal, vertical and oblique directions (which are all torsion-free) with small linear displacements of the eye in the frontal plane. Such compound rotation-displacements of the eye can explain the kinematic paradox that the fixation point may rotate in one plane while the eye rotates in other planes. Its unique signature is the half-angle law in the position domain, which means that the rotation plane of the eye tilts by half-the angle of gaze eccentricity. We show that this law does not readily generalize to the velocity domain of visually-guided eye movements because the angular eye velocity is the sum of two terms, one associated with rotations in meridian planes and one associated with displacements of the eye in the frontal plane. While the first term does not depend on eye position the second term does depend on eye position. We show that compounded rotation - displacements perfectly predict the average smooth kinematics of the eye during steady-state pursuit in both the position and velocity domain.	[Hess, Bernhard J. M.; Thomassen, Jakob S.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Hess, BJM (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	bhess@neurol.uzh.ch			Swiss National Science Foundation; Betty and David Koetser Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Betty and David Koetser Foundation	This work was supported by the Swiss National Science Foundation and the Betty and David Koetser Foundation for Brain Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo B, 2005, J NEUROPHYSIOL, V93, P1710, DOI 10.1152/jn.01020.2004; Angelaki DE, 2003, J NEUROPHYSIOL, V89, P2685, DOI 10.1152/jn.01137.2002; Angelaki DE, 2003, J NEUROSCI, V23, P1104, DOI 10.1523/JNEUROSCI.23-04-01104.2003; Blohm G, 2010, J NEUROPHYSIOL, V104, P2103, DOI 10.1152/jn.00728.2009; Cullen KE, 2004, J NEUROPHYSIOL, V91, P1919, DOI 10.1152/jn.00988.2003; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125; Demer JL, 2000, INVEST OPHTH VIS SCI, V41, P1280; Demer JL, 1997, INVEST OPHTH VIS SCI, V38, P1774; Donders F. C., 1848, HOLLANDISCHE BEITRAG, V1, P105; Ghasia FF, 2008, J NEUROSCI, V28, P5082, DOI 10.1523/JNEUROSCI.0513-08.2008; Gibson JJ, 1950, PERCEPTION VISUAL WO; HASLWANTER T, 1991, EXP BRAIN RES, V87, P470; HAUSTEIN W, 1989, BIOL CYBERN, V60, P411, DOI 10.1007/BF00204696; Helmholtz HV, 1867, HDB PHYSL OPTIK; HEPP K, 1993, J NEUROPHYSIOL, V69, P965, DOI 10.1152/jn.1993.69.3.965; HEPP K, 1990, COMMUN MATH PHYS, V132, P285, DOI 10.1007/BF02278012; HEPP K, 1995, VISION RES, V35, P3237, DOI 10.1016/0042-6989(95)00104-M; Hepp K., 1997, 3 DIMENSIONAL KINEMA, P33; Hepp K, 2009, J STAT PHYS, V134, P1033, DOI 10.1007/s10955-009-9719-z; Hess BJM, 2011, J NEUROPHYSIOL, V106, P2151, DOI 10.1152/jn.00194.2011; HESS BJM, 1990, VISION RES, V30, P597, DOI 10.1016/0042-6989(90)90070-2; HESS BJM, 1992, VISION RES, V32, P1647, DOI 10.1016/0042-6989(92)90157-E; Hess BJM, 2003, J NEUROPHYSIOL, V90, P1340, DOI 10.1152/jn.00167.2003; HESTENES D, 1994, NEURAL NETWORKS, V7, P65, DOI 10.1016/0893-6080(94)90056-6; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P2179; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; MINKEN AWH, 1993, EXP BRAIN RES, V93, P521, DOI 10.1007/BF00229367; Nakayama K., 1983, VERGENCE EYE MOVEMEN, P543; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Roy JE, 2003, J NEUROPHYSIOL, V90, P271, DOI 10.1152/jn.01074.2002; Sandor PS, 2001, VISION RES, V41, P2245, DOI 10.1016/S0042-6989(01)00111-0; Scheck F, 2007, MECH NEWTONS LAWS DE; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; Tchelidze T, 2008, J NEUROPHYSIOL, V99, P96, DOI 10.1152/jn.00804.2007; Thurtell MJ, 2012, VISION RES, V60, P7, DOI 10.1016/j.visres.2012.02.012; Thurtell MJ, 2011, ANN NY ACAD SCI, V1233, P34, DOI 10.1111/j.1749-6632.2011.06129.x; TWEED D, 1992, VISION RES, V32, P1225, DOI 10.1016/0042-6989(92)90217-7; TWEED D, 1990, VISION RES, V30, P111, DOI 10.1016/0042-6989(90)90131-4; TWEED D, 1990, VISION RES, V30, P97, DOI 10.1016/0042-6989(90)90130-D; Tweed D, 1998, SCIENCE, V281, P1363, DOI 10.1126/science.281.5381.1363; Tweed D, 1997, J NEUROPHYSIOL, V77, P654, DOI 10.1152/jn.1997.77.2.654; VANOPSTAL AJ, 1991, SCIENCE, V252, P1313, DOI 10.1126/science.1925545; VanOpstal J, 1996, J NEUROSCI, V16, P7284; WURTZ RH, 1972, J NEUROPHYSIOL, V35, P575, DOI 10.1152/jn.1972.35.4.575; [No title captured]	47	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95234	10.1371/journal.pone.0095234	http://dx.doi.org/10.1371/journal.pone.0095234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751602	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400043
J	Munster, M; Fremder, E; Miller, V; Ben-Tsedek, N; Davidi, S; Scherer, SJ; Shaked, Y				Munster, Michal; Fremder, Ella; Miller, Valeria; Ben-Tsedek, Neta; Davidi, Shiri; Scherer, Stefan J.; Shaked, Yuval			Anti-VEGF-A Affects the Angiogenic Properties of Tumor-Derived Microparticles	PLOS ONE			English	Article							CELLS; CANCER; EXOSOMES; PROCOAGULANT; PLATELETS; THERAPY; INHIBIT; GROWTH	Tumor derived microparticles (TMPs) have recently been shown to contribute to tumor re-growth partially by inducing the mobilization and tumor homing of specific bone marrow derived pro-angiogenic cells (BMDCs). Since antiangiogenic drugs block proangiogenic BMDC mobilization and tumor homing, we asked whether TMPs from cells exposed to an antiangiogenic drug may affect BMDC activity and trafficking. Here we show that the level of VEGF-A is reduced in TMPs from EMT/6 breast carcinoma cells exposed to the anti-VEGF-A antibody, B20. Consequently, these TMPs exhibit reduced angiogenic potential as evaluated by a Matrigel plug and Boyden chamber assays. Consistently, BMDC mobilization, tumor angiogenesis, microvessel density and BMDC-colonization in growing tumors are reduced in mice inoculated with TMPs from B20-exposed cells as compared to mice inoculated with control TMPs. Collectively, our results suggest that the neutralization of VEGF-A in cultured tumor cells can block TMP-induced BMDC mobilization and colonization of tumors and hence provide another mechanism of action by which antiangiogenic drugs act to inhibit tumor growth and angiogenesis.	[Munster, Michal; Fremder, Ella; Miller, Valeria; Ben-Tsedek, Neta; Davidi, Shiri; Shaked, Yuval] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Pharmacol, Haifa, Israel; [Scherer, Stefan J.] Hoffmann La Roche AG, Basel, Switzerland	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Roche Holding	Shaked, Y (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Pharmacol, Haifa, Israel.	yshaked@tx.technion.ac.il			Israel Cancer Research Fund; European Research Council under FP7 program	Israel Cancer Research Fund; European Research Council under FP7 program	This work was supported by research grants from the Israel Cancer Research Fund, European Research Council under FP7 program, and a sponsored research agreement with Hoffmann La Roche. The funder, Roche, provided support in the form of a salary for author SJS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adini A, 2009, J IMMUNOL METHODS, V342, P78, DOI 10.1016/j.jim.2008.11.016; Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baran J, 2010, CANCER IMMUNOL IMMUN, V59, P841, DOI 10.1007/s00262-009-0808-2; Benayoun L, 2012, STEM CELLS, V30, P1831, DOI 10.1002/stem.1170; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Bertolini F, 2010, BBA-REV CANCER, V1806, P131, DOI 10.1016/j.bbcan.2010.05.004; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; CAHAN MA, 1994, CANCER CHEMOTH PHARM, V33, P441, DOI 10.1007/s002800050079; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Fremder E, 2013, INT J CANC; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Gingis-Velitski S, 2011, CANCER RES, V71, P6986, DOI 10.1158/0008-5472.CAN-11-0629; Hajrasouliha AR, 2013, J BIOL CHEM, V288, P28058, DOI 10.1074/jbc.M113.470765; Horrevoets AJG, 2009, AM J PATHOL, V174, P1594, DOI 10.2353/ajpath.2009.090198; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Mostefai HA, 2008, PHYSIOL RES, V57, P311, DOI 10.33549/physiolres.931533; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shaked Y, 2007, CANCER RES, V67, P7055, DOI 10.1158/0008-5472.CAN-07-0905; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shaked Y, 2009, CANCER RES, V69, P7524, DOI 10.1158/0008-5472.CAN-09-0381; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Toth B, 2008, THROMB HAEMOSTASIS, V100, P663, DOI 10.1160/TH07-10-0602; Toth B, 2007, AM J REPROD IMMUNOL, V58, P389, DOI 10.1111/j.1600-0897.2007.00532.x; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; Verheu HMW, 2007, CLIN CANCER RES, V13, P5341, DOI 10.1158/1078-0432.CCR-07-0847; Videira PA, 2011, UROL INT, V86, P95, DOI 10.1159/000321905; Voloshin T, 2013, EXPT CELL RES; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562	41	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95983	10.1371/journal.pone.0095983	http://dx.doi.org/10.1371/journal.pone.0095983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752333	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400149
J	Gong, KR; Kung, LH; Magni, G; Bhargava, A; Jasmin, L				Gong, Kerui; Kung, Ling-Hsuan; Magni, Giulia; Bhargava, Aditi; Jasmin, Luc			Increased Response to Glutamate in Small Diameter Dorsal Root Ganglion Neurons after Sciatic Nerve Injury	PLOS ONE			English	Article							SATELLITE GLIAL-CELLS; METHYL-D-ASPARTATE; PRIMARY SENSORY NEURONS; KAINATE RECEPTORS; NEUROPATHIC PAIN; PERIPHERAL SENSITIZATION; INDUCED EXCITATION; NMDA RECEPTORS; RAT; AMPA	Glutamate in the peripheral nervous system is involved in neuropathic pain, yet we know little how nerve injury alters responses to this neurotransmitter in primary sensory neurons. We recorded neuronal responses from the ex-vivo preparations of the dorsal root ganglia (DRG) one week following a chronic constriction injury (CCI) of the sciatic nerve in adult rats. We found that small diameter DRG neurons (<30 mu m) exhibited increased excitability that was associated with decreased membrane threshold and rheobase, whereas responses in large diameter neurons (>30 mu m) were unaffected. Puff application of either glutamate, or the selective ionotropic glutamate receptor agonists alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) and kainic acid (KA), or the group I metabotropic receptor (mGluR) agonist (S)-3,5-dihydroxyphenylglycine (DHPG), induced larger inward currents in CCI DRGs compared to those from uninjured rats. N-methyl-D-aspartate (NMDA)-induced currents were unchanged. In addition to larger inward currents following CCI, a greater number of neurons responded to glutamate, AMPA, NMDA, and DHPG, but not to KA. Western blot analysis of the DRGs revealed that CCI resulted in a 35% increase in GluA1 and a 60% decrease in GluA2, the AMPA receptor subunits, compared to uninjured controls. mGluR1 receptor expression increased by 60% in the membrane fraction, whereas mGluR5 receptor subunit expression remained unchanged after CCI. These results show that following nerve injury, small diameter DRG neurons, many of which are nociceptive, have increased excitability and an increased response to glutamate that is associated with changes in receptor expression at the neuronal membrane. Our findings provide further evidence that glutamatergic transmission in the periphery plays a role in nociception.	[Gong, Kerui; Jasmin, Luc] Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, San Francisco, CA USA; [Gong, Kerui; Kung, Ling-Hsuan; Magni, Giulia; Jasmin, Luc] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Magni, Giulia; Bhargava, Aditi] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Bhargava, Aditi] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bhargava, A (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	aditi.bhargava@ucsfmedctr.org; ljasmin@gmail.com	Magni, Giulia/AAH-9366-2020	Magni, Giulia/0000-0003-0995-8947	NIH [NS061241, NS079897]; Painless Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061241, R21NS079897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Painless Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by NIH NS061241 and NS079897 grants to LJ and unrestricted grant by the Painless Research Foundation to AB. http://www.painlessresearch.org/index.html. The foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2010, J NEUROSCI RES, V88, P992, DOI 10.1002/jnr.22275; BASBAUM AI, 1991, PAIN, V47, P359, DOI 10.1016/0304-3959(91)90229-Q; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Carlton SM, 1999, BRAIN RES, V820, P63, DOI 10.1016/S0006-8993(98)01328-6; Carlton SM, 2001, NEUROSCIENCE, V105, P957, DOI 10.1016/S0306-4522(01)00238-X; CARLTON SM, 1995, NEUROSCI LETT, V197, P25, DOI 10.1016/0304-3940(95)11889-5; CARLTON SM, 1991, NEUROSCI LETT, V131, P88, DOI 10.1016/0304-3940(91)90343-R; Carlton SM, 2007, J COMP NEUROL, V501, P780, DOI 10.1002/cne.21285; Casimiro TM, 2011, MOL CELL NEUROSCI, V48, P161, DOI 10.1016/j.mcn.2011.07.007; Chen HS, 2010, J PAIN, V11, P321, DOI 10.1016/j.jpain.2009.07.013; Christoph T, 2005, BRAIN RES, V1048, P218, DOI 10.1016/j.brainres.2005.04.081; Coggeshall RE, 1998, J COMP NEUROL, V391, P78; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; de Groot J, 2000, NEUROREPORT, V11, P497, DOI 10.1097/00001756-200002280-00014; DEVOR M, 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P1; Dogrul A, 2000, NEUROSCI LETT, V292, P115, DOI 10.1016/S0304-3940(00)01458-0; Du J, 2008, NEUROSCIENCE, V154, P754, DOI 10.1016/j.neuroscience.2008.03.084; Du J, 2006, NEUROSCIENCE, V137, P999, DOI 10.1016/j.neuroscience.2005.10.008; Du J, 2003, NEUROSCIENCE, V118, P547, DOI 10.1016/S0306-4522(03)00009-5; Hanani M, 2010, NEURON GLIA BIOL, V6, P85, DOI 10.1017/S1740925X10000025; Hasdemir B, 2012, MOL ENDOCRINOL, V26, P681, DOI 10.1210/me.2011-1361; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jang JH, 2004, NEUROSCIENCE, V128, P169, DOI 10.1016/j.neuroscience.2004.06.040; Jasmin L, 2010, NEURON GLIA BIOL, V6, P63, DOI 10.1017/S1740925X10000098; Jensen TS, 2009, EUR J PAIN SUPP, P33, DOI 10.1016/j.eujps.2009.07.012; Jin YH, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/915706; Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036; KAJANDER KC, 1992, NEUROSCI LETT, V138, P225, DOI 10.1016/0304-3940(92)90920-3; Keast JR, 2000, J COMP NEUROL, V424, P577; Kerchner GA, 2002, J NEUROSCI, V22, P8010; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; Kopach O, 2011, PAIN, V152, P912, DOI 10.1016/j.pain.2011.01.016; Kral MG, 1999, PAIN, V81, P15, DOI 10.1016/S0304-3959(98)00264-4; Kung LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068312; Lam DK, 2009, BRAIN RES, V1253, P48, DOI 10.1016/j.brainres.2008.11.056; Laursen JC, 2014, NEUROSCIENCE, V256, P23, DOI 10.1016/j.neuroscience.2013.10.009; Lee CJ, 2002, NEURON, V35, P135, DOI 10.1016/S0896-6273(02)00729-8; Lee CJ, 2001, J NEUROSCI, V21, P4572, DOI 10.1523/JNEUROSCI.21-13-04572.2001; Lee J, 2007, NEUROSCI LETT, V421, P91, DOI 10.1016/j.neulet.2007.05.031; Lesage A, 2010, EUR J PHARMACOL, V639, P2, DOI 10.1016/j.ejphar.2009.12.043; Liu HT, 1997, NATURE, V386, P721, DOI 10.1038/386721a0; Liu XJ, 2002, J NEUROCHEM, V80, P562, DOI 10.1046/j.0022-3042.2001.00721.x; Ma QP, 2000, NEUROSCIENCE, V101, P699, DOI 10.1016/S0306-4522(00)00419-X; McRoberts JA, 2011, NEUROSCIENCE, V172, P474, DOI 10.1016/j.neuroscience.2010.10.045; Netzeband JG, 1997, J NEUROPHYSIOL, V78, P63, DOI 10.1152/jn.1997.78.1.63; Neugebauer V, 2001, TRENDS NEUROSCI, V24, P550, DOI 10.1016/S0166-2236(00)02007-5; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Rojas A, 2013, MOL PHARMACOL, V83, P106, DOI 10.1124/mol.112.081802; Rozas JL, 2011, ADV EXP MED BIOL, V717, P69, DOI 10.1007/978-1-4419-9557-5_7; Ruscheweyh R, 2002, BRAIN RES REV, V40, P215, DOI 10.1016/S0165-0173(02)00203-5; SATO K, 1993, NEUROREPORT, V4, P1263, DOI 10.1097/00001756-199309000-00013; Stefani MR, 2010, EUR J PHARMACOL, V639, P26, DOI 10.1016/j.ejphar.2010.01.028; Thakor DK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-14; Vikman KS, 2008, J PHYSIOL-LONDON, V586, P515, DOI 10.1113/jphysiol.2007.145581; Wang LN, 2006, BRAIN RES, V1120, P46, DOI 10.1016/j.brainres.2006.08.077; Willcockson H, 2008, CELL TISSUE RES, V334, P17, DOI 10.1007/s00441-008-0662-0; Wu LJ, 2007, CURR PHARM DESIGN, V13, P1597, DOI 10.2174/138161207780765864; Zhang GH, 2003, NEUROSCI LETT, V351, P177, DOI 10.1016/j.neulet.2003.08.009; Zhang JM, 1997, J NEUROPHYSIOL, V78, P2790, DOI 10.1152/jn.1997.78.5.2790; Zhang JM, 1997, PAIN, V72, P51, DOI 10.1016/S0304-3959(97)00013-4; Zhang JM, 1999, J NEUROPHYSIOL, V82, P3359, DOI 10.1152/jn.1999.82.6.3359; Zheng JH, 2007, J NEUROPHYSIOL, V97, P15, DOI 10.1152/jn.00559.2006; Zhou ST, 2001, BRAIN RES, V913, P18, DOI 10.1016/S0006-8993(01)02747-0	67	30	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95491	10.1371/journal.pone.0095491	http://dx.doi.org/10.1371/journal.pone.0095491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748330	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500113
J	Realpe, T; Correa, N; Rozo, JC; Ferro, BE; Gomez, V; Zapata, E; Ribon, W; Puerto, G; Castro, C; Nieto, LM; Diaz, ML; Rivera, O; Couvin, D; Rastogi, N; Arbelaez, MP; Robledo, J				Realpe, Teresa; Correa, Nidia; Carlos Rozo, Juan; Elena Ferro, Beatriz; Gomez, Veronica; Zapata, Elsa; Ribon, Wellman; Puerto, Gloria; Castro, Claudio; Maria Nieto, Luisa; Lilia Diaz, Maria; Rivera, Oriana; Couvin, David; Rastogi, Nalin; Patricia Arbelaez, Maria; Robledo, Jaime			Population Structure among Mycobacterium tuberculosis Isolates from Pulmonary Tuberculosis Patients in Colombia	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; BEIJING GENOTYPE; 1ST INSIGHT; COMPLEX; CLASSIFICATION; POLYMORPHISMS; SPOLIGOTYPES; ASSOCIATION	Background: Phylogeographic composition of M. tuberculosis populations reveals associations between lineages and human populations that might have implications for the development of strategies to control the disease. In Latin America, lineage 4 or the Euro-American, is predominant with considerable variations among and within countries. In Colombia, although few studies from specific localities have revealed differences in M. tuberculosis populations, there are still areas of the country where this information is lacking, as is a comparison of Colombian isolates with those from the rest of the world. Principal Findings: A total of 414 M. tuberculosis isolates from adult pulmonary tuberculosis cases from three Colombian states were studied. Isolates were genotyped using IS6110-restriction fragment length polymorphism (RFLP), spoligotyping, and 24-locus Mycobacterial interspersed repetitive units variable number tandem repeats (MIRU-VNTRs). SIT42 (LAM9) and SIT62 (H1) represented 53.3% of isolates, followed by 8.21% SIT50 (H3), 5.07% SIT53 (T1), and 3.14% SIT727 (H1). Composite spoligotyping and 24-locus MIRU-VNTR minimum spanning tree analysis suggest a recent expansion of SIT42 and SIT62 evolved originally from SIT53 (T1). The proportion of Haarlem sublineage (44.3%) was significantly higher than that in neighboring countries. Associations were found between M. tuberculosis MDR and SIT45 (H1), as well as HIV-positive serology with SIT727 (H1) and SIT53 (T1). Conclusions: This study showed the population structure of M. tuberculosis in several regions from Colombia with a dominance of the LAM and Haarlem sublineages, particularly in two major urban settings (Medellin and Cali). Dominant spoligotypes were LAM((SIT 42) and Haarlem (SIT62). The proportion of the Haarlem sublineage was higher in Colombia compared to that in neighboring countries, suggesting particular conditions of co-evolution with the corresponding human population that favor the success of this sublineage.	[Realpe, Teresa; Correa, Nidia; Gomez, Veronica; Zapata, Elsa; Robledo, Jaime] CIB, Corp Invest Biol, Medellin, Colombia; [Realpe, Teresa; Correa, Nidia; Robledo, Jaime] Univ Pontificia Bolivariana, Medellin, Colombia; [Carlos Rozo, Juan; Elena Ferro, Beatriz; Maria Nieto, Luisa] CIDEIM, Ctr Int Entrenamiento & Invest Med, Cali, Colombia; [Carlos Rozo, Juan; Ribon, Wellman; Puerto, Gloria; Castro, Claudio] Inst Nacl Salud, Bogota, Colombia; [Lilia Diaz, Maria; Rivera, Oriana] Univ Cauca, Popayan, Colombia; [Patricia Arbelaez, Maria] Univ Antioquia, Medellin, Colombia; [Realpe, Teresa; Correa, Nidia; Carlos Rozo, Juan; Elena Ferro, Beatriz; Ribon, Wellman; Puerto, Gloria; Castro, Claudio; Maria Nieto, Luisa; Lilia Diaz, Maria; Rivera, Oriana; Patricia Arbelaez, Maria; Robledo, Jaime] CCITB, Medellin, Colombia; [Ribon, Wellman] Univ Ind Santander, Bucaramanga, Colombia; [Couvin, David; Rastogi, Nalin] WHO Supranatl TB Reference Lab, TB & Mycobacteria Unit, Inst Pasteur Guadeloupe, Abymes Guadeloupe, France	Universidad Pontificia Bolivariana; Instituto Nacional de Salud (Colombia); Universidad del Cauca; Universidad de Antioquia; Universidad Industrial de Santander	Robledo, J (corresponding author), CIB, Corp Invest Biol, Medellin, Colombia.	jrobledo@cib.org.co	RIVERA-LOZADA, ORIANA/C-7121-2019; RASTOGI, NALIN/AAP-1958-2020; LM, Nieto/N-4646-2013; Ferro, Beatriz Eugenia/F-7144-2016	RIVERA-LOZADA, ORIANA/0000-0002-6546-3570; RASTOGI, NALIN/0000-0002-7199-7747; LM, Nieto/0000-0003-1566-5876; Ferro, Beatriz Eugenia/0000-0001-6045-1610; Couvin, David/0000-0002-7897-9023; Castro Osorio, Claudia Marcela/0000-0002-8792-2002; Arbelaez Montoya, Maria Patricia/0000-0003-2435-4658; RIVERA, ORIANA/0000-0002-6401-3201	Colciencias [431-2004]; Corporacion para Investigaciones Biologicas; Universidad de Antioquia; Centro Internacional de Investigaciones Medicas; Instituto Nacional de Salud; Universidad del Cauca; Colombian Public Health Institution: Direccion Seccional de Salud de Antioquia; Colombian Public Health Institution: Secretaria Departamental de Salud del Valle; Colombian Public Health Institution: Secretaria Departamental de Salud del Cauca	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Corporacion para Investigaciones Biologicas; Universidad de Antioquia; Centro Internacional de Investigaciones Medicas; Instituto Nacional de Salud; Universidad del Cauca; Colombian Public Health Institution: Direccion Seccional de Salud de Antioquia; Colombian Public Health Institution: Secretaria Departamental de Salud del Valle; Colombian Public Health Institution: Secretaria Departamental de Salud del Cauca	This work was supported by Colciencias grant No. 431-2004 for the Colombian Center for Tuberculosis Research, CCITB. Additional funding was provided by participating institutions: Corporacion para Investigaciones Biologicas, Universidad de Antioquia, Centro Internacional de Investigaciones Medicas, Instituto Nacional de Salud and Universidad del Cauca. This work was also supported by the following Colombian Public Health Institutions: Direccion Seccional de Salud de Antioquia, Secretaria Departamental de Salud del Valle and Secretaria Departamental de Salud del Cauca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; de Beer JL, 2012, J CLIN MICROBIOL, V50, P662, DOI 10.1128/JCM.00607-11; de Miranda SS, 2011, MEM I OSWALDO CRUZ, V106, P267, DOI 10.1590/S0074-02762011000300003; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Ferdinand S, 2004, RES MICROBIOL, V155, P647, DOI 10.1016/j.resmic.2004.04.013; Ferro BE, 2011, EMERG INFECT DIS, V17, P1259, DOI 10.3201/eid1707.101797; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Ghosh S, 2012, INFECT GENET EVOL, V12, P782, DOI 10.1016/j.meegid.2011.10.013; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Gonzalo X, 2011, EMERG INFECT DIS, V17, P528, DOI 10.3201/eid1703.100394; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Imperiale BR, 2013, INT J TUBERC LUNG D, V17, P1088, DOI 10.5588/ijtld.12.0949; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Laserson KF, 2000, INT J TUBERC LUNG D, V4, P673; Nieto LM, 2012, J CLIN MICROBIOL, V50, P4185, DOI 10.1128/JCM.01946-12; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mathema B, 2012, J INFECT DIS, V205, P964, DOI 10.1093/infdis/jir876; Murcia MI, 2010, INFECT GENET EVOL, V10, P678, DOI 10.1016/j.meegid.2010.03.010; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Ritacco V, 2012, EMERG INFECT DIS, V18, P1802, DOI 10.3201/eid1811.120126; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; [No title captured]	45	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93848	10.1371/journal.pone.0093848	http://dx.doi.org/10.1371/journal.pone.0093848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747767	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500013
J	Ruan, XY; Liu, HF; Boardman, L; Kocher, JPA				Ruan, Xiaoyang; Liu, Hongfang; Boardman, Lisa; Kocher, Jean-Pierre A.			Genome-Wide Analysis of Loss of Heterozygosity in Breast Infiltrating Ductal Carcinoma Distant Normal Tissue Highlights Arm Specific Enrichment and Expansion across Tumor Stages	PLOS ONE			English	Article							GENETIC ALTERATIONS; HOMOLOGOUS RECOMBINATION; SUBSTRATE LENGTH; SUPPRESSOR GENE; STROMAL CELLS; CANCER; TUMORIGENESIS; INSTABILITY; PROGRESSION; DEPENDENCE	Studies have shown concurrent loss of heterozygosity (LOH) in breast infiltrating ductal carcinoma (IDC) and adjacent or distant normal tissue. However, the overall extent of LOH in normal tissue and their significance to tumorigenesis remain unknown, as existing studies are largely based on selected microsatellite markers. Here we present the first autosome-wide study of LOH in IDC and distant normal tissue using informative loci deduced from SNP array-based and sequencing-based techniques. We show a consistently high LOH concurrence rate in IDC (mean = 24%) and distant normal tissue (m = 54%), suggesting for most patients (31/33) histologically normal tissue contains genomic instability that can be a potential marker of increased IDC risk. Concurrent LOH is more frequent in fragile site related genes like WWOX (9/31), NTRK2 (10/31), and FHIT (7/31) than traditional genetic markers like BRCA1 (0/23), BRCA2 (2/29) and TP53 (1/13). Analysis at arm level shows distant normal tissue has low level but non-random enrichment of LOH (topped by 8p and 16q) significantly correlated with matched IDC (Pearson r = 0.66, p = 3.5E-6) (topped by 8p, 11q, 13q, 16q, 17p, and 17q). The arm-specific LOH enrichment was independently observed in tumor samples from 548 IDC patients when stratified by tumor size based T stages. Fine LOH structure from sequencing data indicates LOH in low order tissues non-randomly overlap (similar to 67%) with LOH that usually has longer tract length (the length of genomic region affected by LOH) in high order tissues. The consistent observations from multiple datasets suggest progressive LOH in the development of IDC potentially through arm-specific pile up effect with discernible signature in normal tissue. Our finding also suggests that LOH detected in IDC by comparing to paired adjacent or distant normal tissue are more likely underestimated.	[Ruan, Xiaoyang; Liu, Hongfang; Kocher, Jean-Pierre A.] Mayo Clin, Dept Hlth Sci Res, Coll Med, Rochester, MN USA; [Boardman, Lisa] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Kocher, JPA (corresponding author), Mayo Clin, Dept Hlth Sci Res, Coll Med, Rochester, MN USA.	kocher.jeanpierre@mayo.edu			Center for Individualized Medicine of Mayo Clinic; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER	Center for Individualized Medicine of Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Center for Individualized Medicine of Mayo Clinic for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; [Anonymous], 1996, ENV HLTH PERSPECT, V104, P818; Barnes RL, 2007, NUCLEIC ACIDS RES, V35, P3478, DOI 10.1093/nar/gkm249; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Cavalli LR, 2004, CANCER GENET CYTOGEN, V149, P38, DOI 10.1016/S0165-4608(03)00282-6; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Fukino K, 2007, JAMA-J AM MED ASSOC, V297, P2103, DOI 10.1001/jama.297.19.2103; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Lakhani SR, 1999, J PATHOL, V189, P496, DOI 10.1002/(SICI)1096-9896(199912)189:4&lt;496::AID-PATH485&gt;3.0.CO;2-D; Matei D, 2006, ONCOGENE, V25, P2060, DOI 10.1038/sj.onc.1209232; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Moinfar F, 2000, CANCER RES, V60, P2562; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Reis JS, 2003, BREAST CANCER RES, V5, P313, DOI 10.1186/bcr650; Ruan XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031628; Schmitt MW, 2012, ANN NY ACAD SCI, V1267, P110, DOI 10.1111/j.1749-6632.2012.06590.x; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; SHEN P, 1986, GENETICS, V112, P441; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Wang M, 2007, CANCER RES, V67, P93, DOI 10.1158/0008-5472.CAN-06-2723; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090	29	3	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95783	10.1371/journal.pone.0095783	http://dx.doi.org/10.1371/journal.pone.0095783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748104	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500143
J	Xia, Y; Lei, L; Brabham, C; Stork, J; Strickland, J; Ladak, A; Gu, Y; Wallace, I; DeBolt, S				Xia, Ye; Lei, Lei; Brabham, Chad; Stork, Jozsef; Strickland, James; Ladak, Adam; Gu, Ying; Wallace, Ian; DeBolt, Seth			Acetobixan, an Inhibitor of Cellulose Synthesis Identified by Microbial Bioprospecting	PLOS ONE			English	Article							SYNTHASE COMPLEXES; PLASMA-MEMBRANE; BACTERIAL IDENTIFICATION; FUNCTIONAL ASSOCIATION; GENETIC-EVIDENCE; ARABIDOPSIS; RESISTANCE; THAXTOMIN; BIOSYNTHESIS; MICROTUBULES	In plants, cellulose biosynthesis is an essential process for anisotropic growth and therefore is an ideal target for inhibition. Based on the documented utility of small-molecule inhibitors to dissect complex cellular processes we identified a cellulose biosynthesis inhibitor (CBI), named acetobixan, by bio-prospecting among compounds secreted by endophytic microorganisms. Acetobixan was identified using a drug-gene interaction screen to sift through hundreds of endophytic microbial secretions for one that caused synergistic reduction in root expansion of the leaky AtcesA6(prc1-1) mutant. We then mined this microbial secretion for compounds that were differentially abundant compared with Bacilli that failed to mimic CBI action to isolate a lead pharmacophore. Analogs of this lead compound were screened for CBI activity, and the most potent analog was named acetobixan. In living Arabidopsis cells visualized by confocal microscopy, acetobixan treatment caused CESA particles localized at the plasma membrane (PM) to rapidly re-localize to cytoplasmic vesicles. Acetobixan inhibited C-14-Glc uptake into crystalline cellulose. Moreover, cortical microtubule dynamics were not disrupted by acetobixan, suggesting specific activity towards cellulose synthesis. Previous CBI resistant mutants such as ixr1-2, ixr2-1 or aegeus were not cross resistant to acetobixan indicating that acetobixan targets a different aspect of cellulose biosynthesis.	[Xia, Ye; Brabham, Chad; Stork, Jozsef; DeBolt, Seth] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA; [Lei, Lei; Gu, Ying] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA USA; [Strickland, James] ARS, USDA, Forage Anim Prod Res Unit, Lexington, KY USA; [Ladak, Adam] Waters Waters Corp, Milford, MA USA; [Wallace, Ian] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA	University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; United States Department of Agriculture (USDA); Waters Corporation; Nevada System of Higher Education (NSHE); University of Nevada Reno	DeBolt, S (corresponding author), Univ Kentucky, Dept Hort, Lexington, KY 40546 USA.	sdebo2@uky.edu	Xia, Ye/B-8217-2016; Lei, Lei/P-4623-2017	Gu, Ying/0000-0001-8415-4768; Lei, Lei/0000-0003-4803-4763	National Science Foundation [NSF-IOS-0922947]; Department of Energy [DOE-FOA10-0000368]; NSF-MCB [1121375]; Direct For Biological Sciences [1256029] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1121375] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); NSF-MCB(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by a grant from the National Science Foundation grants NSF-IOS-0922947 and Department of Energy DOE-FOA10-0000368 (SD) and NSF-MCB 1121375 (YG). The authors thank William Underwood critical reading of the manuscript and Chris Somerville for the financial support of IW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Armstrong JI, 2004, P NATL ACAD SCI USA, V101, P14978, DOI 10.1073/pnas.0404312101; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bischoff V, 2009, J EXP BOT, V60, P955, DOI 10.1093/jxb/ern344; Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; Brabham C, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00309; Bringmann M, 2012, PLANT CELL, V24, P163, DOI 10.1105/tpc.111.093575; Brown RM, 1986, J MACROMOLECULE SCI, V33, P1345; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Devulder G, 2003, J CLIN MICROBIOL, V41, P1785, DOI 10.1128/JCM.41.4.1785-1787.2003; Doumbou CL, 1998, APPL ENVIRON MICROB, V64, P4313; Drakakaki G, 2011, P NATL ACAD SCI USA, V108, P17850, DOI 10.1073/pnas.1108581108; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Fagard M, 1999, THESIS PARIS SUD ORS; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; HEIM DR, 1989, PLANT PHYSIOL, V90, P146, DOI 10.1104/pp.90.1.146; HEIM DR, 1990, PLANT PHYSIOL, V93, P695, DOI 10.1104/pp.93.2.695; Jarvis MC, 2013, PLANT PHYSIOL, V163, P1485, DOI 10.1104/pp.113.231092; Ki JS, 2009, J MICROBIOL METH, V77, P48, DOI 10.1016/j.mimet.2009.01.003; Kinkel LL, 1998, CAN J MICROBIOL, V44, P768, DOI 10.1139/cjm-44-8-768; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Lei L, 2012, PLANT SIGNAL BEHAV, V7, P714, DOI 10.4161/psb.20338; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; MONTEZINOS D, 1980, PLANTA, V148, P305, DOI 10.1007/BF00388116; Moreno-Hagelsieb G, 2012, NUCLEIC ACIDS RES, V40, P7104, DOI 10.1093/nar/gks443; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Olivares FL, 1996, BIOL FERT SOILS, V21, P197, DOI 10.1007/BF00335935; Paredez AR, 2008, PLANT PHYSIOL, V147, P1723, DOI 10.1104/pp.108.120196; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peng L, 2001, PLANTA, V217, P922; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pillay VK, 1997, CAN J MICROBIOL, V43, P354, DOI 10.1139/m97-049; Reddy GSN, 2000, INT J SYST EVOL MICR, V50, P1553, DOI 10.1099/00207713-50-4-1553; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabba RP, 1999, WEED SCI, V47, P757, DOI 10.1017/S004317450009144X; Sampathkumar A, 2013, PLANT PHYSIOL, V162, P675, DOI 10.1104/pp.113.215277; Sansinenea E, 2011, BIOTECHNOL LETT, V33, P1523, DOI 10.1007/s10529-011-0617-5; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Sessitsch A, 2004, CAN J MICROBIOL, V50, P239, DOI 10.1139/W03-118; Sethaphong L, 2013, P NATL ACAD SCI USA, V110, P7512, DOI 10.1073/pnas.1301027110; Siciliano SD, 1999, FEMS MICROBIOL ECOL, V29, P263, DOI 10.1111/j.1574-6941.1999.tb00617.x; Sturz AV, 2000, CRIT REV PLANT SCI, V19, P1, DOI 10.1016/S0735-2689(01)80001-0; Surpin M, 2005, P NATL ACAD SCI USA, V102, P4902, DOI 10.1073/pnas.0500222102; Toth R, 2010, TRENDS PLANT SCI, V15, P81, DOI 10.1016/j.tplants.2009.11.005; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Xia Y., 2013, GCB BIOENERGY, V5, P674, DOI [10.1111/j.1757-1707.2012.01208.x, DOI 10.1111/J.1757-1707.2012.01208.X]; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029496; Zouhar J, 2004, P NATL ACAD SCI USA, V101, P9497, DOI 10.1073/pnas.0402121101	70	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95245	10.1371/journal.pone.0095245	http://dx.doi.org/10.1371/journal.pone.0095245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748166	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500070
J	Bengtsson, SBK; Barklund, P; von Bromssen, C; Stenlid, J				Bengtsson, Stina Barbro Katrin; Barklund, Pia; von Bromssen, Claudia; Stenlid, Jan			Seasonal Pattern of Lesion Development in Diseased Fraxinus excelsior Infected by Hymenoscyphus pseudoalbidus	PLOS ONE			English	Article							CHALARA-FRAXINEA; SPECIAL EMPHASIS; ASH; DIEBACK; RESISTANCE; SYMPTOMS; GROWTH; STANDS; FUNGI; STEMS	Ash dieback is a recent widespread disease on ash (Fraxinus sp.) that is causing important economic and ecological losses throughout Europe. The disease is initiated by the ascomycetous fungus Hymenoscyphus pseudoalbidus (anamorph Chalara fraxinea). The main aim of this study was to investigate seasonal pattern of lesion development associated with ash dieback. We present data on the spread of 324 natural lesions in ash shoots, branches and stems surveyed over a 32 month period. Most lesions were active and showed the greatest rate of growth during the summer; however, lesions were active throughout the year. Tree mortality was high, with more than a third of the surveyed trees dying during the study. Although many lesions permanently ceased to develop, the rate at which new lesions emerged was greater than the rate at which lesions entered a resting phase. The most common cause for a lesion going into a permanent state of rest was that it had encountered a branch-base. Genotype analysis showed that multiple infections can occur in a single tree given that different genotypes were identified in different lesions as well as in single lesions. A weak positive correlation was noted between tree health and tree size and a weak negative correlation was noted between tree overall health and lesion activity. The lower limit for H. pseudoalbidus growth in culture was between 4.0 degrees C and 0.5 degrees C.	[Bengtsson, Stina Barbro Katrin; Barklund, Pia; Stenlid, Jan] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden; [von Bromssen, Claudia] Swedish Univ Agr Sci, Dept Econ, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Bengtsson, SBK (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden.	Stina.Bengtsson@slu.se	von Brömssen, Claudia/AAX-6300-2020; Stenlid, Jan/K-5909-2019	von Brömssen, Claudia/0000-0002-1452-8696; Stenlid, Jan/0000-0002-5344-2094	FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning) [229-2010-1344]; Swedish University of Agricultural Sciences	FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas); Swedish University of Agricultural Sciences	The project was financed by FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, http://www.formas.se/), grant number 229-2010-1344, and a personal grant to Jan Stenlid from the Swedish University of Agricultural Sciences (http://www.slu.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson PF, 2010, FOREST PATHOL, V40, P43, DOI 10.1111/j.1439-0329.2009.00605.x; Bakys R, 2009, PLANT PATHOL, V58, P284, DOI 10.1111/j.1365-3059.2008.01977.x; Bakys R, 2010, SCANDINAVIAN J FORES, V26, P128; Bakys R, 2011, SCAND J FOREST RES, V26, P128, DOI 10.1080/02827581.2010.536569; Bengtsson SBK, 2012, FUNGAL ECOL, V5, P147, DOI 10.1016/j.funeco.2011.10.004; Cech T. L., 2008, Forstschutz Aktuell, P24; Cleary MR, 2013, PLANT PATHOL, V62, P1294, DOI 10.1111/ppa.12048; Dmyterko E., 2003, Sylwan, V147, P9; European and Mediterranean Plant Protection Organization, 2012, EPPO AL LIST; Gardenfors U., 2010, RED LIST SWEDISH SPE; Grad B, 2009, PHYTOPATHOLOGIA, V54, P61; Gross A, 2012, FUNGAL GENET BIOL, V49, P977, DOI 10.1016/j.fgb.2012.08.008; Gross A, 2012, FOREST PATHOL, V42, P252, DOI 10.1111/j.1439-0329.2011.00751.x; Husson C, 2012, PLANT PATHOL, V61, P889, DOI 10.1111/j.1365-3059.2011.02578.x; Johansson SBK, 2010, FOREST PATHOL, V40, P111, DOI 10.1111/j.1439-0329.2009.00614.x; Jonsson MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045701; Kenigsvalde K., 2010, MEZZINATNE, V21, P110; Kirisits T., 2012, J AGR EXTENSION RURA, V4, P184, DOI DOI 10.5897/JAERD12.046; Kowalski T, 2009, FOREST PATHOL, V39, P1, DOI 10.1111/j.1439-0329.2008.00565.x; Kowalski Tadeusz, 2010, Acta Agrobotanica, V63, P99; Lygis V, 2005, SCAND J FOREST RES, V20, P337, DOI 10.1080/02827580510036238; McKinney LV, 2012, FOREST PATHOL, V42, P69, DOI 10.1111/j.1439-0329.2011.00725.x; McKinney LV, 2011, HEREDITY, V106, P788, DOI 10.1038/hdy.2010.119; Nejad P, 2004, FOREST PATHOL, V34, P369, DOI 10.1111/j.1439-0329.2004.00378.x; Pliura A, 2011, BALT FOR, V17, P17; Przybyl K, 2002, FOREST PATHOL, V32, P387, DOI 10.1046/j.1439-0329.2002.00301.x; Schumacher J, 2010, FOREST PATHOL, V40, P419, DOI 10.1111/j.1439-0329.2009.00615.x; Skovsgaard JP, 2010, FOREST PATHOL, V40, P7, DOI 10.1111/j.1439-0329.2009.00599.x; Stener LG, 2012, SCANDINAVIAN J FORES, V1, P1; Talgo V, 2009, PLANT DIS, V93, P548, DOI 10.1094/PDIS-93-5-0548A; Timmermann V., 2011, Bulletin OEPP, V41, P14, DOI 10.1111/j.1365-2338.2010.02429.x; Wulff S., 2013, NATIONELL RIKTAD SKA; Zhao YJ, 2012, MYCOTAXON, V122, P25, DOI 10.5248/122.25	33	26	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e76429	10.1371/journal.pone.0076429	http://dx.doi.org/10.1371/journal.pone.0076429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759550	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200001
J	Stamp, R; Schembri, A; Fenlon, J; Rentelis, R; Woll, B; Cormier, K				Stamp, Rose; Schembri, Adam; Fenlon, Jordan; Rentelis, Ramas; Woll, Bencie; Cormier, Kearsy			Lexical Variation and Change in British Sign Language	PLOS ONE			English	Article							HAND	This paper presents results from a corpus-based study investigating lexical variation in BSL. An earlier study investigating variation in BSL numeral signs found that younger signers were using a decreasing variety of regionally distinct variants, suggesting that levelling may be taking place. Here, we report findings from a larger investigation looking at regional lexical variants for colours, countries, numbers and UK placenames elicited as part of the BSL Corpus Project. Age, school location and language background were significant predictors of lexical variation, with younger signers using a more levelled variety. This change appears to be happening faster in particular sub- groups of the deaf community (e.g., signers from hearing families). Also, we find that for the names of some UK cities, signers from outside the region use a different sign than those who live in the region.	[Stamp, Rose; Fenlon, Jordan; Rentelis, Ramas; Woll, Bencie; Cormier, Kearsy] UCL, Deafness Cognit & Language Res Ctr DCAL, London, England; [Schembri, Adam] La Trobe Univ, Linguist Program, Melbourne, Vic, Australia; [Schembri, Adam] La Trobe Univ, Ctr Res Language Div, Melbourne, Vic, Australia	University of London; University College London; La Trobe University; La Trobe University	Stamp, R (corresponding author), UCL, Deafness Cognit & Language Res Ctr DCAL, London, England.	rose_stamp@hotmail.com	Cormier, Kearsy/C-2327-2009; Woll, Bencie/C-2040-2008; Schembri, Adam Charles/ABE-6139-2020	Woll, Bencie/0000-0002-3300-4775; Schembri, Adam Charles/0000-0002-8814-5911; Fenlon, Jordan/0000-0003-1127-2637; Stamp, Rose/0000-0002-1993-559X	Economic and Social Research Council (ESRC) [RES-062-23-0825]; Economic and Social Research Council of Great Britain [RES-620-28-6001, RES-620-28-0002]; ESRC [RES-620-28-6001, ES/I03479X/1, ES/F017251/1] Funding Source: UKRI; Economic and Social Research Council [ES/F017251/1, RES-620-28-6001, ES/I03479X/1] Funding Source: researchfish	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council of Great Britain(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The data for this study were collected as part of the British Sign Language Corpus Project, supported by the Economic and Social Research Council (ESRC) (Grant RES-062-23-0825 and postgraduate award, Stamp, 2013). Additional work was supported by the Economic and Social Research Council of Great Britain grants RES-620-28-6001 and RES-620-28-0002: Deafness Cognition and Language Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG NIGEL, 2001, SOCIAL STYLISTIC VAR; Ash Sharon, 2002, HDB LANGUAGE VARIATI, P402; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bayard D., 1989, REO J LINGUISTIC SOC, V32, P17; Bayley R, 2002, HDB LANGUAGE VARIATI, P312; Bonvillian RJ, 1993, PSYCHOL PERSPECTIVES, P229; Brien David, 1992, DICT BRIT SIGN LANGU; Chambers J. K., 2004, LEGACIES COLONIAL EN, P224; CHAMBERS JACK K., 2000, ENGL WORLD-WIDE, V21, P1; Chambers JK, 1999, VARIATION LINGUISTIC, V8, P117; Cheshire Jenny., 2002, HDB LANGUAGE VARIATI, P423, DOI DOI 10.1002/9780470756591.CH17; Coates J., 2001, J SOCIOLING, V5, P507, DOI [10.1111/1467-9481.00162, DOI 10.1111/1467-9481.00162]; Cormier K, 2011, P C LANG DOC LING TH; Cormier K, 2012, P 5 WORKSH REPR PROC, P7; Cormier K, 2008, SIGN LANG LINGUIST, V11, P3, DOI 10.1075/sl&l.11.1.03cor; Crasborn O., 2008, P LREC 2008 6 INT C; Eckert P., 1997, HDB SOCIOLINGUISTICS, P151, DOI DOI 10.1002/9781405166256.CH9; Elton F, 2008, BRIT SIGN LANGUAGE L; Elton F, 2010, CHANGING WAY WE SIGN; Fenlon J, 2013, LANG COMMUN, V33, P69, DOI 10.1016/j.langcom.2012.09.001; Foran C, 1995, CONTACT VOICE IRISH, V23; Francis W. N., 1983, DIALECTOLOGY INTRO; Giles Howard., 1997, SOCIOLINGUISTICS REA, P232, DOI DOI 10.1007/978-1-349-25582-5_19; Hiddinga A, 2011, LANG SOC, V40, P483, DOI 10.1017/S0047404511000480; Hoyer K, 2007, SOCIOLINGUIST DEAF, V13, P195; Jackson Peter, 1990, BRITAINS DEAF HERITA; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Johnson DE, 2009, LANG LINGUIST COMPAS, V3, P359, DOI 10.1111/j.1749-818x.2008.00108.x; Johnston T., 2003, CROSS LINGUISTIC PER, P47; Johnston T., 2007, AUSTR SIGN LANGUAGE; Johnston T, 2010, INT J CORPUS LINGUIS, V15, P106, DOI 10.1075/ijcl.15.1.05joh; Katseff S, 2004, THEOR ISS SIGN LANG; Kyle J, 1993, LANGUAGE SIGN DEV DE; Kyle Jim, 1988, SIGN LANGUAGE STUDY, DOI Cambridge; Labov W., 1972, SOCIOLINGUISTIC PATT; Ladd P, 2003, UNDERSTANDING; Lane H., 1992, MASK BENEVOLENCE DIS; LeMaster Barbara, 1991, SIGN LANGUAGE STUDIE, V73, P361, DOI DOI 10.1353/SLS.1991.0034; Lodge R. A., 2004, SOCIOLINGUISTIC HIST; Lucas C., 2001, SOCIOLINGUISTIC VARI; Marschark M., 2018, RAISING ED DEAF CHIL; Matthews PA, 1996, IRISH DEAF COMMUNITY; McKee R, 2011, SIGN LANG STUD, V11, P485, DOI 10.1353/sls.2011.0012; Mickelburgh R, 2004, TELEGRAPH; Mitchell R. E., 2004, SIGN LANG STUD, V4, P138, DOI DOI 10.1353/SLS.2004.0005; Nagy N, 2011, J SOCIOLING, V15, P366, DOI 10.1111/j.1467-9841.2011.00488.x; Office for National Statistics UK, 2011, 2011 CENS QUICK STAT; Quinn G, 2010, SIGN LANG STUD, V10, P476, DOI 10.1353/sls.0.0056; Rand David., 1991, GOLDVARB 2 1 VARIABL; Sankoff David, 1988, LINGUISTICS CAMBRIDG, P140, DOI DOI 10.1017/CBO9780511620577.009; Schembri A, 2008, C CONSTR EXPL SIGN L; Schembri A, 2011, BRIT SIGN LANGUAGE C; Schembri A., 2010, LANGUAGE DOCUMENTATI, VVII, P105; Schembri A, 2009, BRIT SIGN LANGUAGE B; Schembri A, 2013, LANG DOC CONSERV, V7, P136; Schembri A, 2009, LANG VAR CHANGE, V21, P193, DOI 10.1017/S0954394509990081; Schembri Adam., 2010, SIGN LANGUAGES, P476, DOI [10.1017/CBO9780511712203.022, DOI 10.1017/CBO9780511712203.022]; Schembri Adam, 1999, SIGN LANGUAGE LINGUI, V2, P115, DOI [DOI 10.1075/SLL.2.2.03JOH, 10.1075/sll.2.2.03joh]; Stamp R, J SOCIOLINGUISTICS; Sutton-Spence R., 1990, LANG VAR CHANGE, V2, P313, DOI [10.1017/S0954394500000399, DOI 10.1017/S0954394500000399]; Sutton-Spence R., 1994, THESIS U BRISTOL; Sutton-Spence Rachel, 1999, LINGUISTICS BRIT SIG; Tagliamonte SA, 2007, LANG VAR CHANGE, V19, P199, DOI 10.1017/S095439450707007X; The Sun Newspaper, 2004, SUN             0322, P8; The Warnock Report, 1978, REP COMM ENQ ED HAND; The World Federation of the Deaf, 2003, COUNTR NAM SIGN BOOK; Trudgill Peter, 1986, DIALECTS CONTACT; Uus K, 2006, PEDIATRICS, V117, pE887, DOI 10.1542/peds.2005-1064; Valli C., 2005, LINGUISTICS AM SIGN; Watt D., 2002, J SOCIOLING, V6, P44, DOI DOI 10.1111/1467-9481.00176; Weinreich U., 1968, EMPIRICAL FDN THEORY; Williams Ann, 1999, URBAN VOICES ACCENT, P141; Woll B., 1991, VARIATION RECENT CHA; Woll B, 1994, PERSPECTIVES SIGN LA, V2, P293; Woll B., 2001, SOCIOLINGUISTICS SIG, P8, DOI DOI 10.1017/CBO9780511612824.004; Woll Bencie., 1987, SIGN SCH, P12; Woll Bencie., 1990, CURRENT TRENDS EUROP, P61	77	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94053	10.1371/journal.pone.0094053	http://dx.doi.org/10.1371/journal.pone.0094053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3EI	24759673	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200009
J	Mazei-Robison, MS; Appasani, R; Edwards, S; Wee, S; Taylor, SR; Picciotto, MR; Koob, GF; Nestler, EJ				Mazei-Robison, Michelle S.; Appasani, Raghu; Edwards, Scott; Wee, Sunmee; Taylor, Seth R.; Picciotto, Marina R.; Koob, George F.; Nestler, Eric J.			Self-Administration of Ethanol, Cocaine, or Nicotine Does Not Decrease the Soma Size of Ventral Tegmental Area Dopamine Neurons	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; CELL-SIZE; MORPHOLOGY; RATS; AMPHETAMINE; RECEPTORS; BEHAVIOR; SYSTEM; ALTERS; MANIA	Our previous observations show that chronic opiate administration, including self-administration, decrease the soma size of dopamine (DA) neurons in the ventral tegmental area (VTA) of rodents and humans, a morphological change correlated with increased firing rate and reward tolerance. Given that a general hallmark of drugs of abuse is to increase activity of the mesolimbic DA circuit, we sought to determine whether additional drug classes produced a similar morphological change. Sections containing VTA were obtained from rats that self-administered cocaine or ethanol and from mice that consumed nicotine. In contrast to opiates, we found no change in VTA DA soma size induced by any of these other drugs. These data suggest that VTA morphological changes are induced in a drug-specific manner and reinforce recent findings that some changes in mesolimbic signaling and neuroplasticity are drug-class dependent.	[Mazei-Robison, Michelle S.; Appasani, Raghu; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Mazei-Robison, Michelle S.; Appasani, Raghu; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Mazei-Robison, Michelle S.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Mazei-Robison, Michelle S.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Edwards, Scott; Wee, Sunmee; Koob, George F.] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA; [Edwards, Scott] Louisiana State Univ, Sch Med, Dept Physiol, New Orleans, LA USA; [Wee, Sunmee] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Taylor, Seth R.; Picciotto, Marina R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Michigan State University; Michigan State University; Scripps Research Institute; Louisiana State University System; Scripps Research Institute; Yale University	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Mazei-Robison, Michelle/I-4304-2017; Picciotto, Marina R./F-8747-2012	Mazei-Robison, Michelle/0000-0002-2372-1420; Picciotto, Marina R./0000-0002-4404-1280	National Institutes of Health [DA14241, DA14133, DA025381]; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA025381, R01DA014133, R01DA014241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health: DA14241 (MRP and SRT), DA14133 (EJN), and DA025381 (MMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chu NN, 2007, BRAIN RES, V1182, P90, DOI 10.1016/j.brainres.2007.08.086; Coque L, 2011, NEUROPSYCHOPHARMACOL, V36, P1478, DOI 10.1038/npp.2011.33; Edwards S, 2012, ADDICT BIOL, V17, P76, DOI 10.1111/j.1369-1600.2010.00291.x; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; King SL, 2004, NEUROPHARMACOLOGY, V47, P132, DOI 10.1016/j.neuropharm.2004.06.024; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; Mueller D, 2006, NEUROSCIENCE, V137, P727, DOI 10.1016/j.neuroscience.2005.09.038; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 1999, SYNAPSE, V33, P160; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Sarti F, 2007, EUR J NEUROSCI, V26, P749, DOI 10.1111/j.1460-9568.2007.05689.x; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; Spiga S, 2003, EUR J NEUROSCI, V17, P605, DOI 10.1046/j.1460-9568.2003.02435.x; Spiga S, 2010, ADDICT BIOL, V15, P266, DOI 10.1111/j.1369-1600.2010.00218.x; van Diepen MT, 2009, NAT CELL BIOL, V11, P1191, DOI 10.1038/ncb1961; Wee S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003948	19	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95962	10.1371/journal.pone.0095962	http://dx.doi.org/10.1371/journal.pone.0095962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755634	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300123
J	Shah, NJ; Herzog, H; Weirich, C; Tellmann, L; Kaffanke, J; Caldeira, L; Kops, ER; Qaim, SM; Coenen, HH; Iida, H				Shah, N. Jon; Herzog, Hans; Weirich, Christoph; Tellmann, Lutz; Kaffanke, Joachim; Caldeira, Liliana; Kops, Elena Rota; Qaim, Syed M.; Coenen, Heinz H.; Iida, Hidehiro			Effects of Magnetic Fields of up to 9.4 T on Resolution and Contrast of PET Images as Measured with an MR-BrainPET	PLOS ONE			English	Article							POSITRON RANGE; SIMULATION; DETECTOR; SCANNER	Simultaneous, hybrid MR-PET is expected to improve PET image resolution in the plane perpendicular to the static magnetic field of the scanner. Previous papers have reported this either by simulation or experiment with simple sources and detector arrangements. Here, we extend those studies using a realistic brain phantom in a recently installed MR-PET system comprising a 9.4 T MRI-scanner and an APD-based BrainPET insert in the magnet bore. Point and line sources and a 3D brain phantom were filled with F-18 (low-energy positron emitter), Ga-68 (medium energy positron emitter) or I-120, a non-standard positron emitter (high positron energies of up to 4.6 MeV). Using the BrainPET insert, emission scans of the phantoms were recorded at different positions inside and outside the magnet bore such that the magnetic field was 0 T, 3 T, 7 T or 9.4 T. Brain phantom images, with the 'grey matter' compartment filled with F-18, showed no obvious resolution improvement with increasing field. This is confirmed by practically unchanged transaxial FWHM and 'grey/white matter' ratio values between at 0T and 9.4T. Field-dependent improvements in the resolution and contrast of transaxial PET images were clearly evident when the brain phantom was filled with Ga-68 or I-120. The grey/white matter ratio increased by 7.3% and 16.3%, respectively. The greater reduction of the FWTM compared to FWHM in Ga-68 or I-120 line-spread images was in agreement with the improved contrast of Ga-68 or I-120 images. Notwithstanding elongations seen in the z-direction of Ga-68 or I-120 point source images acquired in foam, brain phantom images show no comparable extension. Our experimental study confirms that integrated MR-PET delivers improved PET image resolution and contrast for medium- and high-energy positron emitters even though the positron range is reduced only in directions perpendicular to the magnetic field.	[Shah, N. Jon; Herzog, Hans; Weirich, Christoph; Tellmann, Lutz; Kaffanke, Joachim; Caldeira, Liliana; Kops, Elena Rota] Forschungszentrum Julich, Inst Neurosci & Med, INM Med Imaging Phys 4, D-52425 Julich, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, JARA, Fac Med, Dept Neurol, Aachen, Germany; [Qaim, Syed M.; Coenen, Heinz H.] Forschungszentrum Julich, Inst Neurosci & Med, INM Nucl Chem 5, D-52425 Julich, Germany; [Iida, Hidehiro] Natl Cardiovasc Ctr, Res Inst, Dept Investigat Radiol, Osaka, Japan	Helmholtz Association; Research Center Julich; RWTH Aachen University; Helmholtz Association; Research Center Julich; National Cerebral & Cardiovascular Center - Japan	Shah, NJ (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med, INM Med Imaging Phys 4, D-52425 Julich, Germany.	n.j.shah@fz-juelich.de	Shah, N. Jon/H-5849-2013; Iida, Hidehiro/D-4582-2011; Caldeira, Liliana/M-8902-2016; Iida, Hidehiro/D-5159-2011	Shah, N. Jon/0000-0002-8151-6169; Caldeira, Liliana/0000-0002-9530-5899; Tellmann, Lutz/0000-0002-1154-2847; Iida, Hidehiro/0000-0002-7914-3068	Bundesministerium fur Bildung and Forschung [13N9121]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; EU FP7 project TRIMAGE [602621]	Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; EU FP7 project TRIMAGE	Funding from the Bundesministerium fur Bildung and Forschung (Grant No.: 13N9121) and generous support from Siemens Healthcare for construction of the 9.4 T MR-PET scanner are gratefully acknowledged. This work was funded in part by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. N. Jon Shah is also funded in part through the EU FP7 project TRIMAGE (Grant no. 602621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio A, 2008, IEEE NSS MIC; Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773; Catana C, 2006, J NUCL MED, V47, P1968; Catana C, 2010, J NUCL MED, V51, P1431, DOI 10.2967/jnumed.109.069112; Champion C, 2007, PHYS MED BIOL, V52, P6605, DOI 10.1088/0031-9155/52/22/004; Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726; DERENZO SE, 1986, IEEE T NUCL SCI, V33, P565, DOI 10.1109/TNS.1986.4337166; FOWLER JF, 1959, AMER J ROENTGENOL RA, V81, P312; HAMMER BE, 1994, MED PHYS, V21, P1917, DOI 10.1118/1.597178; Heiss WD, 2009, EUR J NUCL MED MOL I, V36, P105, DOI 10.1007/s00259-008-0962-3; Herzog H, 2006, EUR J NUCL MED MOL I, V33, P1249, DOI 10.1007/s00259-006-0176-5; Herzog H, 2011, NUKLEARMED-NUCL MED, V50, P74, DOI 10.3413/Nukmed-0347-10-09; Herzog H, 2010, FUTUR NEUROL, V5, P807, DOI 10.2217/FNL.10.59; HOFFMAN EJ, 1990, IEEE T NUCL SCI, V37, P616, DOI 10.1109/23.106686; Hohn A, 2000, RADIOCHIM ACTA, V88, P139, DOI 10.1524/ract.2000.88.3-4.139; Hong IK, 2007, IEEE T MED IMAGING, V26, P789, DOI 10.1109/TMI.2007.892644; IIDA H, 1986, IEEE T NUCL SCI, V33, P597, DOI 10.1109/TNS.1986.4337173; Iida H, 2013, ANN NUCL MED, V27, P25, DOI 10.1007/s12149-012-0655-7; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Judenhofer MS, 2007, RADIOLOGY, V244, P807, DOI 10.1148/radiol.2443061756; Kolb A, 2012, EUR RADIOL, V22, P1776, DOI 10.1007/s00330-012-2415-4; Kraus R, 2012, IEEE T NUCL SCI, V59, P1900, DOI 10.1109/TNS.2012.2207436; Lehnert W, 2011, PHYS MED BIOL, V56, P3313, DOI 10.1088/0031-9155/56/11/009; Levin CS, 1999, PHYS MED BIOL, V44, P781, DOI 10.1088/0031-9155/44/3/019; Lubberink M, 2011, EUR J NUCL MED MOL I, V38, P10, DOI 10.1007/s00259-011-1768-2; Neuner I, 2012, EUR RADIOL, V22, P2568, DOI 10.1007/s00330-012-2543-x; Palmer MR, 2004, IEEE NUCL SCI CONF R, P2682; Peng H, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/N101; Pichler BJ, 2006, J NUCL MED, V47, P639; Qaim SM, 2003, APPL RADIAT ISOTOPES, V58, P69, DOI 10.1016/S0969-8043(02)00226-9; Raylman RR, 1996, IEEE T NUCL SCI, V43, P2406, DOI 10.1109/23.531789; Sanchez-Crespo A, 2004, EUR J NUCL MED MOL I, V31, P44, DOI 10.1007/s00259-003-1330-y; Schlemmer HPW, 2008, RADIOLOGY, V248, P1028, DOI 10.1148/radiol.2483071927; Schmand M, 2007, J NUCL MED S2; Thielemans K, 2006, IEEE NUCL SCI CONF R, P2174, DOI 10.1109/NSSMIC.2006.354345; Wirrwar A, 1997, IEEE T NUCL SCI, V44, P184, DOI 10.1109/23.568801; Zaidi H, 2011, PHYS MED BIOL, V56, P3091, DOI 10.1088/0031-9155/56/10/013	37	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95250	10.1371/journal.pone.0095250	http://dx.doi.org/10.1371/journal.pone.0095250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755872	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300033
J	Sun, QJ; Xing, Y; Qiu, C; Xiong, L				Sun, Qingjie; Xing, Yan; Qiu, Chao; Xiong, Liu			The Pasting and Gel Textural Properties of Corn Starch in Glucose, Fructose and Maltose Syrup	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; GELLING PROPERTIES; GELATINIZATION; SUCROSE; WHEAT	The pasting and gel textural properties of corn starch in syrup at different concentrations were investigated by Rapid Visco Analyzer (RVA) and Texture profile analysis (TPA) tests. The results showed that the pasting temperatures of corn starch greatly increased, especially at higher sugar concentration. Increasing concentration of syrup caused an increase in peak, trough and final viscosity of corn starch. Peak viscosity and the disintegration rate of starch increased in the following order: fructose syrup > maltose syrup > glucose syrup. Increasing syrup concentration to 13%, 25% and 50% resulted in a lower retrogradation rate than the control. When the maltose syrup concentration increased to 50%, the retrogradation rate decreased to 14.30% from 33.38%. The highest hardness was observed when the syrup concentration was 25%. There was a particular low hardness when the concentration of syrup was 50%. The springiness of starch gels in syrup was similar at different concentrations.	[Sun, Qingjie; Qiu, Chao; Xiong, Liu] Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Shandong, Peoples R China; [Xing, Yan] Lishui Bur Commerce, Dept Grain Reserve & Control, Nanjing, Jiangsu, Peoples R China	Qingdao Agricultural University	Sun, QJ (corresponding author), Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Shandong, Peoples R China.	phdsun@163.com	Qiu, Chao/GZH-2155-2022	Qiu, Chao/0000-0002-6427-6124				Ahmad FB, 1999, BIOPOLYMERS, V50, P401, DOI 10.1002/(SICI)1097-0282(19991005)50:4&lt;401::AID-BIP6&gt;3.0.CO;2-V; Gunaratne A, 2007, CARBOHYD POLYM, V70, P112, DOI 10.1016/j.carbpol.2007.03.011; Kaur M, 2010, FOOD RES INT, V43, P263, DOI 10.1016/j.foodres.2009.09.027; Kim Y, 2012, J KOREAN SOC APPL BI, V55, P413, DOI 10.1007/s13765-012-2002-z; Maaruf AG, 2001, CARBOHYD POLYM, V46, P331, DOI 10.1016/S0144-8617(00)00272-1; Mantzari G, 2010, CARBOHYD POLYM, V79, P154, DOI 10.1016/j.carbpol.2009.07.043; Marfil PHM, 2012, FOOD BIOPHYS, V7, P236, DOI 10.1007/s11483-012-9262-3; Mezreb K, 2006, CARBOHYD POLYM, V64, P1, DOI 10.1016/j.carbpol.2005.09.007; Perry PA, 2002, CARBOHYD POLYM, V49, P155, DOI 10.1016/S0144-8617(01)00324-1; Richardson G, 2003, STARCH-STARKE, V55, P150, DOI 10.1002/star.200390029; Saleem Q, 2005, J FOOD ENG, V68, P19, DOI 10.1016/j.jfoodeng.2004.05.020; Sandhu KS, 2007, FOOD CHEM, V101, P1499, DOI 10.1016/j.foodchem.2006.01.060; Secchi N, 2011, LWT-FOOD SCI TECHNOL, V44, P1073, DOI 10.1016/j.lwt.2010.09.018; Seetharaman K, 2001, CEREAL CHEM, V78, P379, DOI 10.1094/CCHEM.2001.78.4.379; Sharma R, 2009, J FOOD PROCESS PRES, V33, P401, DOI 10.1111/j.1745-4549.2008.00283.x; Singh N, 2003, FOOD CHEM, V81, P219, DOI 10.1016/S0308-8146(02)00416-8; Winter SS, 1985, J COLLOID SCI, V13, P576; Zhou HY, 2011, STARCH-STARKE, V63, P323, DOI 10.1002/star.201000129; Zhu F, 2009, FOOD CHEM, V112, P919, DOI 10.1016/j.foodchem.2008.06.079	19	28	28	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95862	10.1371/journal.pone.0095862	http://dx.doi.org/10.1371/journal.pone.0095862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755772	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300109
J	Veldhuizen, EJA; Schneider, VAF; Agustiandari, H; van Dijk, A; Tjeerdsma-van Bokhoven, JLM; Bikker, FJ; Haagsman, HP				Veldhuizen, Edwin J. A.; Schneider, Viktoria A. F.; Agustiandari, Herfita; van Dijk, Albert; Tjeerdsma-van Bokhoven, Johanna L. M.; Bikker, Floris J.; Haagsman, Henk P.			Antimicrobial and Immunomodulatory Activities of PR-39 Derived Peptides	PLOS ONE			English	Article							RICH ANTIBACTERIAL PEPTIDE; HOST-DEFENSE PEPTIDES; ESCHERICHIA-COLI; PIG INTESTINE; IN-VITRO; INHIBITS APOPTOSIS; SEQUENCE; MECHANISMS; EXPRESSION; RESISTANCE	The porcine cathelicidin PR-39 is a host defence peptide that plays a pivotal role in the innate immune defence of the pig against infections. Besides direct antimicrobial activity, it is involved in immunomodulation, wound healing and several other biological processes. In this study, the antimicrobial-and immunomodulatory activity of PR-39, and N- and C-terminal derivatives of PR-39 were tested. PR-39 exhibited an unexpected broad antimicrobial spectrum including several Gram positive strains such as Bacillus globigii and Enterococcus faecalis. Of organisms tested, only Staphylococcus aureus was insensitive to PR-39. Truncation of PR-39 down to 15 (N-terminal) amino acids did not lead to major loss of activity, while peptides corresponding to the C-terminal part of PR-39 were hampered in their antimicrobial activity. However, shorter peptides were all much more sensitive to inhibition by salt. Active peptides induced ATP leakage and loss of membrane potential in Bacillus globigii and Escherichia coli, indicating a lytic mechanism of action for these peptides. Finally, only the mature peptide was able to induce IL-8 production in porcine macrophages, but some shorter peptides also had an effect on TNF-alpha production showing differential regulation of cytokine induction by PR-39 derived peptides. None of the active peptides showed high cytotoxicity highlighting the potential of these peptides for use as an alternative to antibiotics.	[Veldhuizen, Edwin J. A.; Schneider, Viktoria A. F.; Agustiandari, Herfita; van Dijk, Albert; Tjeerdsma-van Bokhoven, Johanna L. M.; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Mol Host Def, Utrecht, Netherlands; [Bikker, Floris J.] Vrije Univ Amsterdam, Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, Amsterdam, Netherlands	Utrecht University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Veldhuizen, EJA (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Mol Host Def, Utrecht, Netherlands.	E.J.A.Veldhuizen@uu.nl	Haagsman, Henk P/F-8919-2010; Bikker, Floris/B-1187-2012; Bikker, Floris/R-1941-2019	Bikker, Floris/0000-0002-9453-4630	ALTANT program of the Dutch Ministry of Economic Affairs, Agriculture and Innovation and Immuno Valley	ALTANT program of the Dutch Ministry of Economic Affairs, Agriculture and Innovation and Immuno Valley	This work was supported by the ALTANT program of the Dutch Ministry of Economic Affairs, Agriculture and Innovation and Immuno Valley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Bikker FJ, 2006, CHEM BIOL DRUG DES, V68, P148, DOI 10.1111/j.1747-0285.2006.00424.x; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; Catrina SB, 2009, J PEPT SCI, V15, P842, DOI 10.1002/psc.1185; Chan YR, 2001, J INVEST DERMATOL, V116, P230, DOI 10.1046/j.1523-1747.2001.01231.x; Chan YR, 1998, J BIOL CHEM, V273, P28978, DOI 10.1074/jbc.273.44.28978; COCIANCICH S, 1994, BIOCHEM J, V300, P567, DOI 10.1042/bj3000567; Delfino D, 2004, MICROBIOLOGICA, V27, P369; Fan F, 2010, PROTEIN EXPRES PURIF, V73, P147, DOI 10.1016/j.pep.2010.05.012; Fritsche S, 2012, J PEPT SCI, V18, P599, DOI 10.1002/psc.2440; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; GUDMUNDSSON GH, 1995, P NATL ACAD SCI USA, V92, P7085, DOI 10.1073/pnas.92.15.7085; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Huang HJ, 1997, J LEUKOCYTE BIOL, V61, P624, DOI 10.1002/jlb.61.5.624; Jusko M, 2014, J INNATE IMMUN, V6, P31, DOI 10.1159/000351458; Knappe D, 2011, CHEMBIOCHEM, V12, P874, DOI 10.1002/cbic.201000792; Lee PHA, 2005, P NATL ACAD SCI USA, V102, P3750, DOI 10.1073/pnas.0500268102; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Linde CMA, 2001, J ANTIMICROB CHEMOTH, V47, P575, DOI 10.1093/jac/47.5.575; Mattiuzzo M, 2007, MOL MICROBIOL, V66, P151, DOI 10.1111/j.1365-2958.2007.05903.x; Mattiuzzo M, 2014, J MICROBIOL BIOTECHN, V24, P160, DOI 10.4014/jmb.1310.10015; Otvos L, 2000, BIOCHEMISTRY-US, V39, P14150, DOI 10.1021/bi0012843; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Pranting M, 2008, ANTIMICROB AGENTS CH, V52, P2734, DOI 10.1128/AAC.00205-08; Ramanathan B, 2004, DEV COMP IMMUNOL, V28, P163, DOI 10.1016/S0145-305X(03)00135-6; Ramanathan B, 2002, MICROBES INFECT, V4, P361, DOI 10.1016/S1286-4579(02)01549-6; Sang YM, 2009, DEV COMP IMMUNOL, V33, P334, DOI 10.1016/j.dci.2008.05.006; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Shi JH, 1996, ANTIMICROB AGENTS CH, V40, P115, DOI 10.1128/AAC.40.1.115; SHI JS, 1994, J LEUKOCYTE BIOL, V56, P807, DOI 10.1002/jlb.56.6.807; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; STORICI P, 1993, BIOCHEM BIOPH RES CO, V196, P1058, DOI 10.1006/bbrc.1993.2358; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Vunnam S, 1997, J PEPT RES, V49, P59; Wessely-Szponder J, 2010, J MICROBIOL METH, V83, P8, DOI 10.1016/j.mimet.2010.07.010; Wu JP, 2004, CIRCULATION, V109, P1660, DOI 10.1161/01.CIR.0000124067.35915.E0	40	70	74	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95939	10.1371/journal.pone.0095939	http://dx.doi.org/10.1371/journal.pone.0095939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755622	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300122
J	Furlanetto, T; Gallace, A; Ansuini, C; Becchio, C				Furlanetto, Tiziano; Gallace, Alberto; Ansuini, Caterina; Becchio, Cristina			Effects of Arm Crossing on Spatial Perspective-Taking	PLOS ONE			English	Article							SPACE; CONGRUENCY; HANDEDNESS; COMPATIBILITY; IMAGERY; ONESELF; HANDS; TOUCH	Human social interactions often require people to take a different perspective than their own. Although much research has been done on egocentric spatial representation in a solo context, little is known about how space is mapped in relation to other bodies. Here we used a spatial perspective-taking paradigm to investigate whether observing a person holding his arms crossed over the body midline has an impact on the encoding of left/right and front/back spatial relations from that person's perspective. In three experiments, we compared performance in a task in which spatial judgments were made from the perspective of the participant or from that of a co-experimenter. Depending on the experimental condition, the participant's and the co-experimenter's arms were either crossed or not crossed over the midline. Our results showed that crossing the arms had a specific effect on spatial judgments based on a first-person perspective. More specifically, the responses corresponding to the dominant hand side were slower in the crossed than in the uncrossed arms condition. Crucially, a similar effect was also found when the participants adopted the perspective of a person holding his arms crossed, but not when the other person's arms were held in an unusual but uncrossed posture. Taken together these findings indicate that egocentric space and altercentric space are similarly coded in neurocognitive maps structured with respect to specific body segments.	[Furlanetto, Tiziano; Becchio, Cristina] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Gallace, Alberto] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Ansuini, Caterina; Becchio, Cristina] Fdn Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy	University of Turin; University of Milano-Bicocca; Istituto Italiano di Tecnologia - IIT; University of Genoa	Becchio, C (corresponding author), Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy.	cristina.becchio@unito.it	Gallace, Alberto/L-7276-2015	GALLACE, ALBERTO/0000-0002-4561-8926	Regione Piemonte; bando Scienze Umane e Sociali [L.R. n.4/2006]	Regione Piemonte(Regione Piemonte); bando Scienze Umane e Sociali	This work was supported by a grant from the Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n.4/2006 to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1999, J COGNITIVE NEUROSCI, V11, P67, DOI 10.1162/089892999563256; Becchio C, 2013, SOC COGN AFFECT NEUR, V8, P165, DOI 10.1093/scan/nsr083; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Campbell J, 1993, SPATIAL REPRESENTATI, P65; Casasanto D, 2011, PSYCHOL SCI, V22, P419, DOI 10.1177/0956797611401755; CASSAM Quassim, 1995, BODY SELF, P311; FRANKLIN N, 1990, J EXP PSYCHOL GEN, V119, P63, DOI 10.1037/0096-3445.119.1.63; Furlanetto T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00455; Furlanetto T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00071; Gallace A, 2011, PAIN, V152, P1418, DOI 10.1016/j.pain.2011.02.029; Gallace A, 2014, TOUCH FUTURE FUTURE, P181; Gardner MR, 2011, ACTA PSYCHOL, V137, P371, DOI 10.1016/j.actpsy.2011.04.006; Gardner MR, 2010, BRAIN COGNITION, V73, P35, DOI 10.1016/j.bandc.2010.02.002; Gardner MR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00457; Haggard P., 2005, HIGHER ORDER MOTOR D, P261; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Holmes NP, 2006, BRAIN RES, V1077, P108, DOI 10.1016/j.brainres.2005.11.010; Kessler K, 2010, FRONT PSYCHOL, V1, DOI [10.3389/fpsyg.2010.00213, 10.3389/fphys.2010.00213]; Kessler K, 2010, COGNITION, V114, P72, DOI 10.1016/j.cognition.2009.08.015; Kominsky JF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00266; Legrand D, 2007, CONSCIOUS COGN, V16, P687, DOI 10.1016/j.concog.2007.06.003; Lin ZC, 2014, J EXP PSYCHOL HUMAN, V40, P968, DOI 10.1037/a0035005; Lin ZC, 2012, J VISION, V12, DOI 10.1167/12.11.24; Lloyd DM, 2003, PERCEPT PSYCHOPHYS, V65, P901, DOI 10.3758/BF03194823; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Mainwaring S, 2003, SPAT COGN COMPUT, V3, P3, DOI [DOI 10.1207/S15427633SCC0301_2, DOI 10.1207/S15427633SCC0301_]; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Maravita A, 2000, NEUROREPORT, V11, P3521, DOI 10.1097/00001756-200011090-00024; Mohr C, 2013, J APPL SOC PSYCHOL, V43, P1369, DOI 10.1111/jasp.12093; Mohr C, 2010, BRIT J PSYCHOL, V101, P277, DOI 10.1348/000712609X457450; NICOLETTI R, 1984, ACTA PSYCHOL, V57, P133, DOI 10.1016/0001-6918(84)90039-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OLSON GM, 1973, J EXP PSYCHOL, V100, P284, DOI 10.1037/h0035453; Pezzulo G, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum2013.00800, DOI 10.3389/FNHUM2013.00800]; Pierce SJ, 1996, BRAIN COGNITION, V32, P307; Rubichi S, 2006, PERCEPT PSYCHOPHYS, V68, P1059, DOI 10.3758/BF03193709; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Surtees A, 2013, COGNITION, V129, P426, DOI 10.1016/j.cognition.2013.06.008; Theodoridou A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00197; Thirioux B, 2010, J NEUROSCI, V30, P7202, DOI 10.1523/JNEUROSCI.3403-09.2010; Torta DM, 2013, J PAIN, V14, P957, DOI 10.1016/j.jpain.2013.03.009; Tversky B, 2003, ENVIRON BEHAV, V35, P66, DOI 10.1177/0013916502238865; Tversky B, 2009, COGNITION, V110, P124, DOI 10.1016/j.cognition.2008.10.008; van Elk M, 2013, CONSCIOUS COGN, V22, P545, DOI 10.1016/j.concog.2013.02.006; Viaud-Delmon I, 2007, ANN NEUROL, V62, P418, DOI 10.1002/ana.21176; Zacks Jeffrey M, 2005, Behav Cogn Neurosci Rev, V4, P96, DOI 10.1177/1534582305281085	48	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95748	10.1371/journal.pone.0095748	http://dx.doi.org/10.1371/journal.pone.0095748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2DX	24752571	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400115
J	Galkina, EI; Shin, A; Coser, KR; Shioda, T; Kohane, IS; Seong, IS; Wheeler, VC; Gusella, JF; MacDonald, ME; Lee, JM				Galkina, Ekaterina I.; Shin, Aram; Coser, Kathryn R.; Shioda, Toshi; Kohane, Isaac S.; Seong, Ihn Sik; Wheeler, Vanessa C.; Gusella, James F.; MacDonald, Marcy E.; Lee, Jong-Min			HD CAGnome: A Search Tool for Huntingtin CAG Repeat Length-Correlated Genes	PLOS ONE			English	Article							EXPRESSION CHANGES; DISEASE; POLYGLUTAMINE; BIOMARKERS; EXPANSION; ONSET; BRAIN; AGE	Background: The length of the huntingtin (HTT) CAG repeat is strongly correlated with both age at onset of Huntington's disease (HD) symptoms and age at death of HD patients. Dichotomous analysis comparing HD to controls is widely used to study the effects of HTT CAG repeat expansion. However, a potentially more powerful approach is a continuous analysis strategy that takes advantage of all of the different CAG lengths, to capture effects that are expected to be critical to HD pathogenesis. Methodology/Principal Findings: We used continuous and dichotomous approaches to analyze microarray gene expression data from 107 human control and HD lymphoblastoid cell lines. Of all probes found to be significant in a continuous analysis by CAG length, only 21.4% were so identified by a dichotomous comparison of HD versus controls. Moreover, of probes significant by dichotomous analysis, only 33.2% were also significant in the continuous analysis. Simulations revealed that the dichotomous approach would require substantially more than 107 samples to either detect 80% of the CAG-length correlated changes revealed by continuous analysis or to reduce the rate of significant differences that are not CAG length-correlated to 20% (n = 133 or n = 206, respectively). Given the superior power of the continuous approach, we calculated the correlation structure between HTT CAG repeat lengths and gene expression levels and created a freely available searchable website, "HD CAGnome,'' that allows users to examine continuous relationships between HTT CAG and expression levels of similar to 20,000 human genes. Conclusions/Significance: Our results reveal limitations of dichotomous approaches compared to the power of continuous analysis to study a disease where human genotype-phenotype relationships strongly support a role for a continuum of CAG length-dependent changes. The compendium of HTT CAG length-gene expression level relationships found at the HD CAGnome now provides convenient routes for discovery of candidates influenced by the HD mutation.	[Galkina, Ekaterina I.; Shin, Aram; Seong, Ihn Sik; Wheeler, Vanessa C.; Gusella, James F.; MacDonald, Marcy E.; Lee, Jong-Min] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Coser, Kathryn R.; Shioda, Toshi] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Kohane, Isaac S.] Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Kohane, Isaac S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Kohane, Isaac S.] I2b2 Natl Ctr Biomed Comp, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Lee, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	jlee51@mgh.harvard.edu			CHDI Foundation, Inc.; National Institutes of Health (NINDS Massachusetts HD Center Without Walls) [NS16367, NS32765, NS049206, LM008748 NLM i2b2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049206, R01NS032765, P50NS016367, P01NS016367] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	CHDI Foundation, Inc.; National Institutes of Health (NINDS Massachusetts HD Center Without Walls); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants from CHDI Foundation, Inc. and the National Institutes of Health (NS16367, NINDS Massachusetts HD Center Without Walls (J.F.G. & M.E.M.), NS32765 (M.E.M.), NS049206 (V.C.W .), and LM008748 NLM i2b2 (I.S.K.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2013, HUM MOL GENET, V22, P3227, DOI 10.1093/hmg/ddt176; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Perlis RH, 2010, AM J PSYCHIAT, V167, P574, DOI 10.1176/appi.ajp.2009.09070973; Persichetti F, 1994, Neurobiol Dis, V1, P159, DOI 10.1006/nbdi.1994.0019; Runne H, 2007, P NATL ACAD SCI USA, V104, P14424, DOI 10.1073/pnas.0703652104; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007	18	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95556	10.1371/journal.pone.0095556	http://dx.doi.org/10.1371/journal.pone.0095556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751919	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400073
J	Kim, MA; Kim, YR; Sagong, B; Cho, HJ; Bae, JW; Kim, J; Lee, J; Park, HJ; Choi, JY; Lee, KY; Kim, UK				Kim, Min-A; Kim, Ye-Ri; Sagong, Borum; Cho, Hyun-Ju; Bae, Jae Woong; Kim, Jeongho; Lee, Jinwook; Park, Hong-Joon; Choi, Jae Young; Lee, Kyu-Yup; Kim, Un-Kyung			Genetic Analysis of Genes Related to Tight Junction Function in the Korean Population with Non-Syndromic Hearing Loss	PLOS ONE			English	Article							RECESSIVE DEAFNESS; MOLECULAR-STRUCTURE; MUTATIONS; PROTEINS	Tight junctions (TJs) are essential components of eukaryotic cells, and serve as paracellular barriers and zippers between adjacent tissues. TJs are critical for normal functioning of the organ of Corti, a part of the inner ear that causes loss of sensorineural hearing when damaged. To investigate the relation between genes involved in TJ function and hereditary loss of sensorineural hearing in the Korean population, we selected the TJP2 and CLDN14 genes as candidates for gene screening of 135 Korean individuals. The TJP2 gene, mutation of which causes autosomal dominant non-syndromic hearing loss (ADNSHL), lies at the DFNA51 locus on chromosome 9. The CLDN14 gene, mutation of which causes autosomal recessive non-syndromic hearing loss (ARNSHL), lies at the DFNB29 locus on chromosome 21. In the present study, we conducted genetic analyses of the TJP2 and CLDN14 genes in 87 unrelated patients with ADNSHL and 48 unrelated patients with either ARNSHL or potentially sporadic hearing loss. We identified two pathogenic variations, c. 334G > A (p.A112T) and c.3562A > G (p.T1188A), and ten single nucleotide polymorphisms (SNPs) in the TJP2 gene. We found eight non-pathogenic variations in the CLDN14 gene. These findings indicate that, whereas mutation of the TJP2 gene might cause ADNSHL, CLDN14 is not a major causative gene for ARNSHL in the Korean population studied. Our findings may improve the understanding of the genetic cause of non-syndromic hearing loss in the Korean population.	[Kim, Min-A; Kim, Ye-Ri; Sagong, Borum; Cho, Hyun-Ju; Bae, Jae Woong; Kim, Jeongho; Lee, Jinwook; Kim, Un-Kyung] Kyungpook Natl Univ, Dept Biol, Coll Nat Sci, Taegu, South Korea; [Kim, Min-A; Kim, Ye-Ri; Sagong, Borum; Kim, Jeongho; Lee, Jinwook; Kim, Un-Kyung] Kyungpook Natl Univ, Sch Life Sci, KNU Creat BioRes Grp, Plus Project BK21, Taegu, South Korea; [Park, Hong-Joon] Soree Ear Clin, Seoul, South Korea; [Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Kyu-Yup] Kyungpook Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Yonsei University; Yonsei University Health System; Kyungpook National University	Lee, KY (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Taegu, South Korea.	kylee@knu.ac.kr; kimuk@knu.ac.kr			Korea Health Technology RD Project; Ministry of Health and Welfare; Republic of Korea [A111774]	Korea Health Technology RD Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Republic of Korea	This work was supported by a grant of the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A111774). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; Batissoco AC, 2009, BRAZ J MED BIOL RES, V42, P168, DOI 10.1590/S0100-879X2009000200004; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Carlton VEH, 2003, NAT GENET, V34, P91, DOI 10.1038/ng1147; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; Kohler K, 2005, BIOL CELL, V97, P659; Lee K, 2012, AM J MED GENET A, V158A, P315, DOI 10.1002/ajmg.a.34407; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P1, DOI 10.1111/j.1749-6632.2009.04925.x; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Tapia R, 2009, MOL BIOL CELL, V20, P1102, DOI 10.1091/mbc.E08-03-0277; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Walsh T, 2010, AM J HUM GENET, V87, P101, DOI 10.1016/j.ajhg.2010.05.011; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wattenhofer M, 2005, HUM MUTAT, V25, P543, DOI 10.1002/humu.20172; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7	22	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95646	10.1371/journal.pone.0095646	http://dx.doi.org/10.1371/journal.pone.0095646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752540	gold, Green Submitted, Green Published			2022-12-25	WOS:000335227400097
J	Mortl, A; Lorenz, T; Hirche, S				Moertl, Alexander; Lorenz, Tamara; Hirche, Sandra			Rhythm Patterns Interaction - Synchronization Behavior for Human-Robot Joint Action	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; PHASE-TRANSITIONS; COORDINATION; DYNAMICS; ADAPTATION; MOVEMENTS; DISCRETE; MODEL; TIME; ENTRAINMENT	Interactive behavior among humans is governed by the dynamics of movement synchronization in a variety of repetitive tasks. This requires the interaction partners to perform for example rhythmic limb swinging or even goal-directed arm movements. Inspired by that essential feature of human interaction, we present a novel concept and design methodology to synthesize goal-directed synchronization behavior for robotic agents in repetitive joint action tasks. The agents' tasks are described by closed movement trajectories and interpreted as limit cycles, for which instantaneous phase variables are derived based on oscillator theory. Events segmenting the trajectories into multiple primitives are introduced as anchoring points for enhanced synchronization modes. Utilizing both continuous phases and discrete events in a unifying view, we design a continuous dynamical process synchronizing the derived modes. Inverse to the derivation of phases, we also address the generation of goal-directed movements from the behavioral dynamics. The developed concept is implemented to an anthropomorphic robot. For evaluation of the concept an experiment is designed and conducted in which the robot performs a prototypical pick-and-place task jointly with human partners. The effectiveness of the designed behavior is successfully evidenced by objective measures of phase and event synchronization. Feedback gathered from the participants of our exploratory study suggests a subjectively pleasant sense of interaction created by the interactive behavior. The results highlight potential applications of the synchronization concept both in motor coordination among robotic agents and in enhanced social interaction between humanoid agents and humans.	[Moertl, Alexander; Lorenz, Tamara; Hirche, Sandra] Tech Univ Munich, Inst Informat Oriented Control, D-80290 Munich, Germany; [Lorenz, Tamara] Univ Munich, Munich, Germany	Technical University of Munich; University of Munich	Mortl, A (corresponding author), Tech Univ Munich, Inst Informat Oriented Control, D-80290 Munich, Germany.	moertl@tum.de		Lorenz, Tamara/0000-0002-8567-3559	European Union Seventh Framework Programme within the ERC Starting Grant "Control based on Human Models (con-humo)" [337654]; German Research Foundation (DFG) within the excellence initiative research cluster "Cognition for Technical Systems"; Collaborative Research Centre on "High-Fidelity Telepresence and Teleaction'' [SFB453]	European Union Seventh Framework Programme within the ERC Starting Grant "Control based on Human Models (con-humo)"; German Research Foundation (DFG) within the excellence initiative research cluster "Cognition for Technical Systems"(German Research Foundation (DFG)); Collaborative Research Centre on "High-Fidelity Telepresence and Teleaction''	The research leading to these results has received funding from the European Union Seventh Framework Programme within the ERC Starting Grant "Control based on Human Models (con-humo)" under grant agreement no337654 and from the German Research Foundation (DFG) within the excellence initiative research cluster "Cognition for Technical Systems" and the Collaborative Research Centre SFB453 on "High-Fidelity Telepresence and Teleaction''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JJ, 1996, HUM MOVEMENT SCI, V15, P1, DOI 10.1016/0167-9457(95)00041-0; Althoff D, 2009, COGN SYST MONOGR, V6, P43; Billard A., 2008, SPRINGER HDB ROBOTIC, P1371, DOI DOI 10.1007/978-3-540-30301-5_60; Buchli J, 2006, BIOL CYBERN, V95, P645, DOI 10.1007/s00422-006-0128-y; Chaminade T, 2011, INT C SKILLS 2011, V1, P00014; Chyon Hae Kim, 2009, 2009 9th IEEE-RAS International Conference on Humanoid Robots (Humanoids 2009), P148, DOI 10.1109/ICHR.2009.5379585; Degallier S, 2006, IEEE-RAS INT C HUMAN, P512, DOI 10.1109/ICHR.2006.321321; Delignieres D, 2011, J MOTOR BEHAV, V43, P311, DOI 10.1080/00222895.2011.588274; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fuchs A, 1996, BIOL CYBERN, V74, P21, DOI 10.1007/BF00199134; Gams A, 2009, AUTON ROBOT, V27, P3, DOI 10.1007/s10514-009-9118-y; Goetz J, 2003, RO-MAN 2003: 12TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P55; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hogan N, 2007, EXP BRAIN RES, V181, P13, DOI 10.1007/s00221-007-0899-y; Hsieh GC, 1996, IEEE T IND ELECTRON, V43, P609, DOI 10.1109/41.544547; Huber Markus, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P639, DOI 10.1109/ROMAN.2009.5326233; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; Kasuga T, 2005, IEEE INT CONF ROBOT, P3802; Kelso JAS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005749; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Kreuz T, 2007, PHYSICA D, V225, P29, DOI 10.1016/j.physd.2006.09.039; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lopresti-Goodman SM, 2008, J MOTOR BEHAV, V40, P3, DOI 10.3200/JMBR.40.1.3-10; Lorenz T., 2011, 2011 RO-MAN: The 20th IEEE International Symposium on Robot and Human Interactive Communication, P198, DOI 10.1109/ROMAN.2011.6005253; Maeda Y, 2003, ADV ROBOTICS, V17, P67, DOI 10.1163/156855303321125631; Marin L, 2009, INTERACT STUD, V10, P479, DOI 10.1075/is.10.3.09mar; MATSUOKA K, 1985, BIOL CYBERN, V52, P367, DOI 10.1007/BF00449593; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Mortl A, 2012, BIOL CYBERN, V106, P241, DOI 10.1007/s00422-012-0492-8; Okada M, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P1410, DOI 10.1109/ROBOT.2002.1014741; Petric T, 2011, INT J ROBOT RES, V30, P1775, DOI 10.1177/0278364911421511; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Pongas D., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P2911; Quiroga RQ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041904; Rand RH, 1988, NEURAL CONTROL RYTHM; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Repp BH, 2010, J MOTOR BEHAV, V42, P111, DOI 10.1080/00222890903566418; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; Rosenblum MG, 2004, FLUCT NOISE LETT, V4, pL53, DOI 10.1142/S0219477504001653; Sato T, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P652; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; SCHMIDT RC, 1993, J EXP PSYCHOL HUMAN, V19, P397, DOI 10.1037/0096-1523.19.2.397; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Stanczyk B., 2004, 2004 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) (IEEE Cat. No.04CH37566), P2532; Studenka BE, 2011, ACTA PSYCHOL, V136, P432, DOI 10.1016/j.actpsy.2011.01.011; Torre K, 2009, EXP BRAIN RES, V199, P157, DOI 10.1007/s00221-009-1991-2; Ubukata T, 2009, J ROBOT MECHATRON, V21, P342, DOI 10.20965/jrm.2009.p0342; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Varlet M, 2011, J BIOMECH, V44, P1200, DOI 10.1016/j.jbiomech.2011.02.001; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Zhang Z, 2009, PROCEEDINGS OF 2009 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS TECHNOLOGY AND APPLICATIONS, P659, DOI 10.1109/ICCOMTA.2009.5349119	60	25	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95195	10.1371/journal.pone.0095195	http://dx.doi.org/10.1371/journal.pone.0095195			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2DX	24752212	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400039
J	Ruger-Herreros, C; Gil-Sanchez, MD; Sancar, G; Brunner, M; Corrochano, LM				Ruger-Herreros, Carmen; del Mar Gil-Sanchez, Maria; Sancar, Gencer; Brunner, Michael; Corrochano, Luis M.			Alteration of Light-Dependent Gene Regulation by the Absence of the RCO-1/RCM-1 Repressor Complex in the Fungus Neurospora crassa	PLOS ONE			English	Article							WHITE-COLLAR COMPLEX; BLUE-LIGHT; CIRCADIAN CLOCK; TRANSCRIPTIONAL REPRESSION; FEEDBACK LOOP; FLUFFY GENE; EXPRESSION; RESPONSES; PHOTORECEPTOR; CONIDIATION	The activation of transcription by light in the fungus Neurospora crassa requires the White Collar Complex (WCC), a photoreceptor and transcription factor complex. After light reception two WCCs interact and bind the promoters of light-regulated genes to activate transcription. This process is regulated by VVD, a small photoreceptor that disrupts the interaction between WCCs and leads to a reduction in transcription after long exposures to light. The N. crassa RCO-1/RCM-1 repressor complex is the homolog of the Tup1-Ssn6 repressor complex in yeast, and its absence modifies photoadaptation. We show that the absence of the RCO-1/RCM-1 repressor complex leads to several alterations in transcription that are gene-specific: an increase in the accumulation of mRNAs in the dark, a repression of transcription, and a derepression of transcription after long exposures to light. The absence of the RCO-1/RCM-1 repressor complex leads to lower VVD levels that are available for the regulation of the activity of the WCC. The reduction in the amount of VVD results in increased WCC binding to the promoters of light-regulated genes in the dark and after long exposures to light, leading to the modification of photoadaptation that has been observed in rco-1 and rcm-1 mutants. Our results show that the photoadaptation phenotype of mutants in the RCO-1/RCM-1 repressor complex is, at least in part, an indirect consequence of the reduction of vvd transcription, and the resulting modification in the regulation of transcription by the WCC.	[Ruger-Herreros, Carmen; del Mar Gil-Sanchez, Maria; Corrochano, Luis M.] Univ Seville, Dept Genet, Seville, Spain; [Sancar, Gencer; Brunner, Michael] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany	University of Sevilla; Ruprecht Karls University Heidelberg	Corrochano, LM (corresponding author), Univ Seville, Dept Genet, Seville, Spain.	corrochano@us.es	Ruger-Herreros, Carmen/AAB-2098-2020; Corrochano, Luis M/F-5720-2010	Ruger-Herreros, Carmen/0000-0002-3982-9962; Corrochano, Luis M/0000-0002-6282-6567; GIL SANCHEZ, MARIA DEL MAR/0000-0001-8314-2685; Brunner, Michael/0000-0001-9798-3047	European funds (European Regional Development Fund, ERDF); Spanish Ministerio de Educacion y Ciencia [BIO2012-38520]; Regional Government (Junta de Andalucia) [P09-CVI-5027]; EMBO short-term fellowship; Regional Government (Junta de Andalucia); DFG [BR 1375-1, SFB 638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	European funds (European Regional Development Fund, ERDF); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Regional Government (Junta de Andalucia)(Junta de Andalucia); EMBO short-term fellowship(European Molecular Biology Organization (EMBO)); Regional Government (Junta de Andalucia)(Junta de Andalucia); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by European funds (European Regional Development Fund, ERDF), the Spanish Ministerio de Educacion y Ciencia (BIO2012-38520), and the Regional Government (Junta de Andalucia, P09-CVI-5027). CRH was supported by an EMBO short-term fellowship, and a PhD fellowship and a visiting fellowship from the Regional Government (Junta de Andalucia). The work was supported by DFG grants BR 1375-1 and SFB 638. MB is a member of CellNetworks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARPAIA G, 1995, DEV BIOL, V170, P626, DOI 10.1006/dbio.1995.1242; Bailey LA, 1998, GENETICS, V148, P1813; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; BAUM JA, 1985, J MOL BIOL, V182, P79, DOI 10.1016/0022-2836(85)90029-4; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Chen CH, 2010, FUNGAL GENET BIOL, V47, P922, DOI 10.1016/j.fgb.2010.07.005; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Chen CH, 2009, EMBO J, V28, P1029, DOI 10.1038/emboj.2009.54; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2003, J BIOL CHEM, V278, P3801, DOI 10.1074/jbc.M209592200; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; CORROCHANO LM, 1995, DEV BIOL, V167, P190, DOI 10.1006/dbio.1995.1016; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Franchi L, 2005, MOL MICROBIOL, V56, P334, DOI 10.1111/j.1365-2958.2005.04545.x; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gligoris T, 2007, MOL CELL BIOL, V27, P4198, DOI 10.1128/MCB.00238-07; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hunt SM, 2010, P NATL ACAD SCI USA, V107, P16709, DOI 10.1073/pnas.1009474107; LAUTER FR, 1993, P NATL ACAD SCI USA, V90, P8249, DOI 10.1073/pnas.90.17.8249; Lee K, 2003, GENETICS, V163, P103; LI CG, 1995, DEV BIOL, V169, P90, DOI 10.1006/dbio.1995.1129; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Mochizuki T, 2004, FEBS LETT, V571, P26, DOI 10.1016/j.febslet.2004.06.052; Navarro-Sampedro L, 2008, GENETICS, V178, P171, DOI 10.1534/genetics.107.079582; Neiss A, 2008, EMBO REP, V9, P788, DOI 10.1038/embor.2008.113; Olmedo M, 2010, FUNGAL GENET BIOL, V47, P939, DOI 10.1016/j.fgb.2010.08.001; Olmedo M, 2010, GENETICS, V184, P651, DOI 10.1534/genetics.109.109975; Olmedo M, 2010, FUNGAL GENET BIOL, V47, P352, DOI 10.1016/j.fgb.2009.11.004; Rizzo JM, 2011, NUCLEIC ACIDS RES, V39, P8803, DOI 10.1093/nar/gkr557; Rodriguez-Romero J, 2006, MOL MICROBIOL, V61, P1049, DOI 10.1111/j.1365-2958.2006.05293.x; Ruger-Herreros C, 2011, GENETICS, V188, P809, DOI 10.1534/genetics.111.130096; SACHS MS, 1991, DEV BIOL, V148, P117, DOI 10.1016/0012-1606(91)90322-T; Saelices L, 2007, MOL GENET GENOMICS, V278, P527, DOI 10.1007/s00438-007-0269-2; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Schwerdtfeger C, 2000, EUR J BIOCHEM, V267, P414, DOI 10.1046/j.1432-1327.2000.01016.x; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; ZALOKAR M, 1954, ARCH BIOCHEM BIOPHYS, V50, P71, DOI 10.1016/0003-9861(54)90010-7; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200; Zhou ZP, 2013, P NATL ACAD SCI USA, V110, pE4867, DOI 10.1073/pnas.1315133110	50	10	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95069	10.1371/journal.pone.0095069	http://dx.doi.org/10.1371/journal.pone.0095069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747913	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500055
J	Shu, Q; Hu, ZL; Huang, C; Yu, XW; Fan, H; Yang, JW; Fang, P; Ni, L; Chen, JG; Wang, F				Shu, Qing; Hu, Zhuang-Li; Huang, Chao; Yu, Xiao-Wei; Fan, Hua; Yang, Jing-Wen; Fang, Peng; Ni, Lan; Chen, Jian-Guo; Wang, Fang			Orexin-A Promotes Cell Migration in Cultured Rat Astrocytes via Ca2+-Dependent PKC alpha and ERK1/2 Signals	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE-9 EXPRESSION; OREXIN/HYPOCRETIN NEURONS; REGULATED KINASE; PHOSPHOLIPASE-C; AMPA RECEPTORS; NEUROPEPTIDE-Y; DEPENDENT ERK; CA2+ INFLUX; ACTIVATION; PROTEIN	Orexin-A is an important neuropeptide involved in the regulation of feeding, arousal, energy consuming, and reward seeking in the body. The effects of orexin-A have widely studied in neurons but not in astrocytes. Here, we report that OX1R and OX2R are expressed in cultured rat astrocytes. Orexin-A stimulated the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), and then induced the migration of astrocytes via its receptor OX1R but not OX2R. Orexin-A-induced ERK1/2 phosphorylation and astrocytes migration are Ca2+-dependent, since they could be inhibited by either chelating the extracellular Ca2+ or blocking the pathway of store-operated calcium entry (SOCE). Furthermore, both non-selective protein kinase C (PKC) inhibitor and PKC alpha selective inhibitor, but not PKC delta inhibitor, prevented the increase in ERK1/2 phosphorylation and the migration of astrocytes, indicating that the Ca2+-dependent PKC alpha acts as the downstream of the OX1R activation and mediates the orexin-A-induced increase in ERK1/2 phosphorylation and cell migration. In conclusion, these results suggest that orexin-A can stimulate ERK1/2 phosphorylation and then facilitate the migration of astrocytes via PLC-PKC alpha signal pathway, providing new knowledge about the functions of the OX1R in astrocytes.	[Shu, Qing; Hu, Zhuang-Li; Huang, Chao; Yu, Xiao-Wei; Fan, Hua; Yang, Jing-Wen; Fang, Peng; Ni, Lan; Chen, Jian-Guo; Wang, Fang] Huazhong Univ Sci & Technol, Dept Pharmacol, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Hu, Zhuang-Li; Ni, Lan; Chen, Jian-Guo; Wang, Fang] Minist Educ China, Key Lab Neurol Dis HUST, Wuhan, Hubei, Peoples R China; [Hu, Zhuang-Li; Ni, Lan; Chen, Jian-Guo; Wang, Fang] Key Lab Drug Target Res & Pharmacodynam Evaluat H, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Ministry of Education, China	Wang, F (corresponding author), Huazhong Univ Sci & Technol, Dept Pharmacol, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	wangfangtj0322@163.com	wang, fang/GYD-4295-2022		National Basic Research Program of China (973 Program) [2013CB531303]; National Natural Science Foundation of China (NSFC) [30930104]; NSFC [81222048, 81173071]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program, No. 2013CB531303) and the National Natural Science Foundation of China (NSFC, Key Project, No. 30930104) to Dr. J.G. Chen. It was also supported by NSFC grants to Dr. F. Wang (No. 81222048) and to Z.L. Hu (No. 81173071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires V, 2007, MOL PHARMACOL, V72, P1545, DOI 10.1124/mol.107.039792; Albert AP, 2007, J PHYSIOL-LONDON, V583, P25, DOI 10.1113/jphysiol.2007.137802; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Ammoun S, 2006, MOL ENDOCRINOL, V20, P80, DOI 10.1210/me.2004-0389; Blom T, 2005, CELL SIGNAL, V17, P827, DOI 10.1016/j.cellsig.2004.11.022; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Duguay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026430; Ekholm ME, 2007, BIOCH BIOPHYS; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Girault EM, 2012, PROG BRAIN RES, V198, P47, DOI 10.1016/B978-0-444-59489-1.00005-7; Hsieh HL, 2004, CELL SIGNAL, V16, P1163, DOI 10.1016/j.cellsig.2004.03.021; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Hu LC, 2013, TUMOR BIOL, V34, P2573, DOI 10.1007/s13277-013-0803-2; Huang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049954; Huang C, 2010, GLIA, V58, P1415, DOI 10.1002/glia.21017; Ikeda Y, 2006, BASIC RES CARDIOL, V101, P418, DOI 10.1007/s00395-006-0595-2; Johansson L, 2007, BRIT J PHARMACOL, V150, P97, DOI 10.1038/sj.bjp.0706959; Kane JK, 2000, BIOCHEM BIOPH RES CO, V272, P959, DOI 10.1006/bbrc.2000.2880; Kim MK, 2010, BIOCHEM BIOPH RES CO, V403, P59, DOI 10.1016/j.bbrc.2010.10.115; Mikrouli E, 2011, NEUROPEPTIDES, V45, P401, DOI 10.1016/j.npep.2011.07.010; Ramanjaneya M, 2009, J ENDOCRINOL, V202, P249, DOI 10.1677/JOE-08-0536; Rychkov GY, 2005, CELL CALCIUM, V37, P183, DOI 10.1016/j.ceca.2004.09.001; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shin HS, 2009, BIOCHEM BIOPH RES CO, V378, P409, DOI 10.1016/j.bbrc.2008.11.051; Skrzypski M, 2012, FEBS LETT, V586, P4157, DOI 10.1016/j.febslet.2012.10.013; Smart D, 1999, BRIT J PHARMACOL, V128, P1, DOI 10.1038/sj.bjp.0702780; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Tsai HW, 2008, J NEUROPATH EXP NEUR, V67, P516; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Tsunematsu T, 2013, BEHAV BRAIN RES, V255, P64, DOI 10.1016/j.bbr.2013.05.021; Woldan-Tambor A, 2011, PHARMACOL REP, V63, P717, DOI 10.1016/S1734-1140(11)70583-7; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003; Zhou JR, 2013, J NEUROIMMUNOL, V260, P55, DOI 10.1016/j.jneuroim.2013.04.005	36	21	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95259	10.1371/journal.pone.0095259	http://dx.doi.org/10.1371/journal.pone.0095259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748172	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500071
J	Norouzitallab, P; Baruah, K; Vandegehuchte, M; Van Stappen, G; Catania, F; Vanden Bussche, J; Vanhaecke, L; Sorgeloos, P; Bossier, P				Norouzitallab, Parisa; Baruah, Kartik; Vandegehuchte, Michiel; Van Stappen, Gilbert; Catania, Francesco; Vanden Bussche, Julie; Vanhaecke, Lynn; Sorgeloos, Patrick; Bossier, Peter			Environmental heat stress induces epigenetic transgenerational inheritance of robustness in parthenogenetic Artemia model	FASEB JOURNAL			English	Article						heat shock protein 70; DNA methylation; histone modification; stress resistance; heritability	SHOCK-PROTEIN 70S; HISTONE MODIFICATIONS; GENOME INSTABILITY; DNA METHYLATION; HSP70 GENE; FRANCISCANA; TEMPERATURE; ACETYLATION; ARABIDOPSIS; RESISTANCE	The notion that phenotypic traits emerging from environmental experiences are heritable remains under debate. However, the recent report of nonmendelian transgenerational epigenetic inheritance, i.e., the inheritance of traits not determined by the DNA sequence, might make such a phenomenon plausible. In our study, by carrying out common garden experiments, we could provide clear evidences that, on exposure to nonlethal heat shocks, a parental population of parthenogenetic (all female) Artemia (originating from one single female) experiences an increase in levels of Hsp70 production, tolerance toward lethal heat stress, and resistance against pathogenic Vibrio campbellii. Interestingly, these acquired phenotypic traits were transmitted to three successive generations, none of which were exposed to the parental stressor. This transgenerational inheritance of the acquired traits was associated with altered levels of global DNA methylation and acetylated histones H3 and H4 in the heat-shocked group compared to the control group, where both the parental and successive generations were reared at standard temperature. These results indicated that epigenetic mechanisms, such as global DNA methylation and histones H3 and H4 acetylation, have particular dynamics that are crucial in the heritability of the acquired adaptive phenotypic traits across generations.	[Norouzitallab, Parisa; Baruah, Kartik; Van Stappen, Gilbert; Sorgeloos, Patrick; Bossier, Peter] Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium; [Norouzitallab, Parisa; Baruah, Kartik; Van Stappen, Gilbert; Sorgeloos, Patrick; Bossier, Peter] Univ Ghent, Artemia Reference Ctr, B-9000 Ghent, Belgium; [Vandegehuchte, Michiel] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium; [Catania, Francesco] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Vanden Bussche, Julie; Vanhaecke, Lynn] Univ Ghent, Chem Anal Lab, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University; University of Munster; Ghent University	Bossier, P (corresponding author), Univ Ghent, Lab Aquaculture, Rozier 44, B-9000 Ghent, Belgium.	peter.bossier@ugent.be	catania, francesco/AAW-1190-2020; Baruah, Kartik/ABG-1532-2020; Vanden Bussche, Julie/K-5134-2014; Bossier, Peter GM/A-8118-2008; Vanhaecke, Lynn/N-1061-2017	Baruah, Kartik/0000-0002-2060-4982; Vanden Bussche, Julie/0000-0002-3831-6663; Bossier, Peter GM/0000-0002-6165-9111; Catania, Francesco/0000-0002-2652-9397; Vandegehuchte, Michiel/0000-0002-3915-4416; Vanhaecke, Lynn/0000-0003-0400-2188; Norouzitallab, Parisa/0000-0002-1740-0444	Ghent University (BOF-PhD grant) [BOF10/DOS/031]; Belgian Science Policy Office (Belspo) AquaStress project [IUAPVII/64]; Special Research Fund of Ghent University [BOF12/BAS/042]	Ghent University (BOF-PhD grant); Belgian Science Policy Office (Belspo) AquaStress project; Special Research Fund of Ghent University(Ghent University)	This study was supported by Ghent University (BOF-PhD grant to P.N.; BOF10/DOS/031) and the Belgian Science Policy Office (Belspo) AquaStress project (IUAPVII/64/Sorgeloos). K. B. is a postdoctoral fellow of Research Foundation Flanders (FWO; Brussels, Belgium). The authors highly acknowledge the Special Research Fund of Ghent University (BOF12/BAS/042) for procuring the chemiluminescence detection system. The authors highly thank the technical staffs of the Laboratory of Aquaculture and the Artemia Reference Center at Ghent University, in particular Christ Mahieu, Anita De Haese, Brigitte Van Moffaert, and Tom Baelemans, for their assistance in rearing the animals.	Abatzopoulos TJ, 2003, HYDROBIOLOGIA, V492, P191, DOI 10.1023/A:1024826702830; Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baruah K, 2013, FISH SHELLFISH IMMUN, V34, P183, DOI 10.1016/j.fsi.2012.10.025; Baruah K, 2012, AQUACULTURE, V334, P152, DOI 10.1016/j.aquaculture.2011.12.015; Baruah K, 2011, FISH SHELLFISH IMMUN, V31, P134, DOI 10.1016/j.fsi.2011.04.008; Baruah K, 2010, FISH SHELLFISH IMMUN, V29, P733, DOI 10.1016/j.fsi.2010.07.011; Baxevanis Athanasios D., 2004, Journal of Biological Research (Thessaloniki), V1, P107; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briski E, 2008, AQUACULTURE, V282, P19, DOI 10.1016/j.aquaculture.2008.06.034; Cannuyer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058743; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen T, 2002, ARCH BIOCHEM BIOPHYS, V408, P171, DOI 10.1016/S0003-9861(02)00564-7; Clegg JS, 2000, J EXP MAR BIOL ECOL, V252, P85, DOI 10.1016/S0022-0981(00)00239-2; Correia B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053543; Crow JF, 2002, EVOLUTION, V56, P1313; De Block M, 2011, CURR OPIN PLANT BIOL, V14, P275, DOI 10.1016/j.pbi.2011.02.007; Drinkwater L.E., 1991, EXPT BIOL CYST DIAPA, P93; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Fritah S, 2009, MOL BIOL CELL, V20, P4976, DOI 10.1091/mbc.E09-04-0295; Gan JK, 2013, GENET MOL RES, V12, P809, DOI 10.4238/2013.March.15.1; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Ismaeil I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054306; Iwama GK, 1998, REV FISH BIOL FISHER, V8, P35, DOI 10.1023/A:1008812500650; Jablonka E, 2002, ANN NY ACAD SCI, V981, P82; Jablonka E, 2013, PROG BIOPHYS MOL BIO, V111, P99, DOI 10.1016/j.pbiomolbio.2012.08.014; Jensen LT, 2008, CELL STRESS CHAPERON, V13, P177, DOI 10.1007/s12192-008-0020-x; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Koturbash I, 2006, INT J RADIAT ONCOL, V66, P327, DOI 10.1016/j.ijrobp.2006.06.012; Kultz D, 2003, J EXP BIOL, V206, P3119, DOI 10.1242/jeb.00549; Lim Unhee, 2012, Methods Mol Biol, V863, P359, DOI 10.1007/978-1-61779-612-8_23; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Myers FA, 2001, J BIOL CHEM, V276, P20197, DOI 10.1074/jbc.M009472200; Nambu Z, 2008, J EXP ZOOL PART A, V309A, P17, DOI 10.1002/jez.428; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pecinka A, 2012, PLANT CELL PHYSIOL, V53, P801, DOI 10.1093/pcp/pcs044; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Shankar S, 2013, PHARMACOL THERAPEUT, V138, P1, DOI 10.1016/j.pharmthera.2012.11.002; Sorgeloos P., 1980, USE BRINE SHRIMP ART, V3, P25; Sung YY, 2012, J FISH DIS, V35, P563, DOI 10.1111/j.1365-2761.2012.01397.x; Sung YY, 2007, FISH SHELLFISH IMMUN, V22, P318, DOI 10.1016/j.fsi.2006.05.008; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060364; Tetievsky A, 2010, J APPL PHYSIOL, V109, P1552, DOI 10.1152/japplphysiol.00469.2010; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Van Stappen G., 1996, INTRO BIOL ECOLOGY A, P101; Vandegehuchte MB, 2014, MUTAT RES-GEN TOX EN, V764, P36, DOI 10.1016/j.mrgentox.2013.08.008; Vandegehuchte MB, 2010, COMP BIOCHEM PHYS C, V151, P278, DOI 10.1016/j.cbpc.2009.11.007; Vanschoenwinkel B, 2010, AQUAT ECOL, V44, P771, DOI 10.1007/s10452-010-9315-y; Verhoeven KJF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038605; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; Zhao YM, 2006, CELL RES, V16, P566, DOI 10.1038/sj.cr.7310074; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	71	77	80	1	74	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3552	3563		10.1096/fj.14-252049	http://dx.doi.org/10.1096/fj.14-252049			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24755740				2022-12-25	WOS:000340265400024
J	Cai, Q; Fu, LJ; Wang, Z; Gan, NQ; Dai, XX; Wang, YS				Cai, Qian; Fu, Lijuan; Wang, Zi; Gan, Nanqin; Dai, Xiaoxia; Wang, Yinsheng			alpha-N-Methylation of Damaged DNA-binding Protein 2 (DDB2) and Its Function in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; MASS-SPECTROMETRY; H2B VARIANTS; HISTONE H2B; IDENTIFICATION; TRIMETHYLALANINE; RESIDUE; LYSINE; YEAST; RCC1	DDB2 exhibits a high affinity toward UV-damaged DNA, and it is involved in the initial steps of global genome nucleotide excision repair. Mutations in the DDB2 gene cause the genetic complementation group E of xeroderma pigmentosum, an autosomal recessive disease manifested clinically by hypersensitivity to sunlight exposure and an increased predisposition to skin cancer. Here we found that, in human cells, the initiating methionine residue in DDB2 was removed and that the N-terminal alanine could be methylated on its alpha-amino group in human cells, with trimethylation being the major form. We also demonstrated that the alpha-N-methylation of DDB2 is catalyzed by the N-terminal RCC1 methyltransferase. In addition, a methylation-defective mutant of DDB2 displayed diminished nuclear localization and was recruited at a reduced efficiency to UV-induced cyclobutane pyrimidine dimer foci. Moreover, loss of this methylation conferred compromised ATM (ataxia telangiectasia mutated) activation, decreased efficiency in cyclobutane pyrimidine dimer repair, and elevated sensitivity of cells toward UV light exposure. Our study provides new knowledge about the posttranslational regulation of DDB2 and expands the biological functions of protein alpha-N-methylation to DNA repair.	[Cai, Qian; Fu, Lijuan; Wang, Zi; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Gan, Nanqin; Dai, Xiaoxia; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	yinsheng.wang@ucr.edu	CAI, QIAN/E-2352-2017	CAI, QIAN/0000-0002-7865-5993; Dai, Xiaoxia/0000-0002-3514-5061	National Institutes of Health [R01 ES019873]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 ES019873.	Bailey AO, 2013, P NATL ACAD SCI USA, V110, P11827, DOI 10.1073/pnas.1300325110; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Cong F, 2002, J BIOL CHEM, V277, P34870, DOI 10.1074/jbc.M204416200; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DESROSIERS R, 1988, J BIOL CHEM, V263, P4686; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; HENRY GD, 1982, FEBS LETT, V144, P11, DOI 10.1016/0014-5793(82)80558-9; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KEENEY S, 1993, J BIOL CHEM, V268, P21293; MARTINAGE A, 1985, EUR J BIOCHEM, V147, P351, DOI 10.1111/j.1432-1033.1985.tb08757.x; Matsuda N, 2005, DNA REPAIR, V4, P537, DOI 10.1016/j.dnarep.2004.12.012; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Meng FY, 2004, ANAL CHEM, V76, P2852, DOI 10.1021/ac0354903; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; NOMOTO M, 1982, J BIOCHEM-TOKYO, V92, P1675, DOI 10.1093/oxfordjournals.jbchem.a134096; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Petkowski JJ, 2012, BIOCHEMISTRY-US, V51, P5942, DOI 10.1021/bi300278f; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Ray A, 2013, DNA REPAIR, V12, P273, DOI 10.1016/j.dnarep.2013.01.003; Rouget R, 2008, J BIOL CHEM, V283, P5533, DOI 10.1074/jbc.M706257200; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; SMITH GM, 1980, EUR J BIOCHEM, V110, P123, DOI 10.1111/j.1432-1033.1980.tb04847.x; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sun Nian-Kang, 2002, Chang Gung Med J, V25, P723; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Xiong L, 2010, BIOCHEMISTRY-US, V49, P5236, DOI 10.1021/bi1001322; Xiong L, 2009, J AM SOC MASS SPECTR, V20, P1172, DOI 10.1016/j.jasms.2009.02.014; Zhang F, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016915; Zhao Q, 2008, J BIOL CHEM, V283, P32553, DOI 10.1074/jbc.M803963200; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	39	36	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16046	16056		10.1074/jbc.M114.558510	http://dx.doi.org/10.1074/jbc.M114.558510			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24753253	hybrid, Green Published			2022-12-25	WOS:000337965700014
J	Moore, AJ; Moore, WL; Baldwin, BG				Moore, Abigail J.; Moore, William L.; Baldwin, Bruce G.			Genetic and Ecotypic Differentiation in a Californian Plant Polyploid Complex (Grindelia, Asteraceae)	PLOS ONE			English	Article							POPULATION-STRUCTURE; ADAPTIVE DIVERGENCE; REPRODUCTIVE ISOLATION; PARALLEL EVOLUTION; DIVERSIFICATION; ORIGIN; BIOGEOGRAPHY; STICKLEBACK; PHYLOGENY; INFERENCE	Studies of ecotypic differentiation in the California Floristic Province have contributed greatly to plant evolutionary biology since the pioneering work of Clausen, Keck, and Hiesey. The extent of gene flow and genetic differentiation across interfertile ecotypes that span major habitats in the California Floristic Province is understudied, however, and is important for understanding the prospects for local adaptation to evolve or persist in the face of potential gene flow across populations in different ecological settings. We used microsatellite data to examine local differentiation in one of these lineages, the Pacific Coast polyploid complex of the plant genus Grindelia (Asteraceae). We examined 439 individuals in 10 different populations. The plants grouped broadly into a coastal and an inland set of populations. The coastal group contained plants from salt marshes and coastal bluffs, as well as a population growing in a serpentine grassland close to the coast, while the inland group contained grassland plants. No evidence for hybridization was found at the single location where adjacent populations of the two groups were sampled. In addition to differentiation along ecotypic lines, there was also a strong signal of local differentiation, with the plants grouping strongly by population. The strength of local differentiation is consistent with the extensive morphological variation observed across populations and the history of taxonomic confusion in the group. The Pacific Clade of Grindelia and other young Californian plant groups warrant additional analysis of evolutionary divergence along the steep coast-to-inland climatic gradient, which has been associated with local adaptation and ecotype formation since the classic studies of Clausen, Keck, and Hiesey.	[Moore, Abigail J.] Johannes Gutenberg Univ Mainz, Inst Spezielle Bot & Bot Garten, D-55122 Mainz, Germany; [Moore, Abigail J.; Baldwin, Bruce G.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Moore, Abigail J.; Baldwin, Bruce G.] Univ Calif Berkeley, Jepson Herbarium, Berkeley, CA 94720 USA; [Moore, William L.] Univ Utah, David Eccles Sch Business, Salt Lake City, UT USA	Johannes Gutenberg University of Mainz; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Utah System of Higher Education; University of Utah	Moore, AJ (corresponding author), Johannes Gutenberg Univ Mainz, Inst Spezielle Bot & Bot Garten, D-55122 Mainz, Germany.	abigail_moore@brown.edu			Lawrence R. Heckard Endowment Fund of the Jepson Herbarium; Department of Integrative Biology at the University of California, Berkeley	Lawrence R. Heckard Endowment Fund of the Jepson Herbarium; Department of Integrative Biology at the University of California, Berkeley	Funding was provided by the Lawrence R. Heckard Endowment Fund of the Jepson Herbarium (ucjeps.berkeley.edu) and Department of Integrative Biology at the University of California, Berkeley (ib.berkeley.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2007, NEW PHYTOL, V175, P197, DOI 10.1111/j.1469-8137.2007.02127.x; Almany GR, 2009, MOL ECOL RESOUR, V9, P1460, DOI 10.1111/j.1755-0998.2009.02759.x; [Anonymous], 2010, R LANG ENV STAT COMP; Baldwin BG, 2005, EVOLUTION, V59, P2473; Baldwin BG, 2006, ANN MO BOT GARD, V93, P64, DOI 10.3417/0026-6493(2006)93[64:CPAPOE]2.0.CO;2; Baldwin BG, 2011, AM J BOT, V98, P731, DOI 10.3732/ajb.1000346; Bruneaux M, 2013, MOL ECOL, V22, P565, DOI 10.1111/j.1365-294X.2012.05749.x; Calsbeek R, 2003, MOL ECOL, V12, P1021, DOI 10.1046/j.1365-294X.2003.01794.x; Clausen J., 1948, CARNEGIE I WASHINGTO, V581, p[i, 1]; Clausen J., 1951, STAGES EVOLUTION PLA; Clausen J., 1940, CARNEGIE I WASHINGTO, V520, P1, DOI DOI 10.1098/rspb.2012.2146; Clausen J., 1945, CARNEGIE INST WASH P, V564, p[i, 1]; Cronquist A, 1955, VASCULAR PLANTS PACI, V5, P1; Davis EB, 2008, MOL ECOL, V17, P120, DOI 10.1111/j.1365-294X.2007.03469.x; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUNFORD MP, 1970, AM J BOT, V57, P623, DOI 10.2307/2441285; DUNFORD MP, 1964, AM J BOT, V51, P49, DOI 10.2307/2440063; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Foster SA, 2007, NEW PHYTOL, V175, P370, DOI 10.1111/j.1469-8137.2007.02077.x; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Glenn TC, 2006, TOUCHDOWN PCR PROTOC; GRANT V, 1966, AM NAT, V100, P99, DOI 10.1086/282404; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hendry AP, 2002, EVOLUTION, V56, P1199; HOBBS GA, 1954, ECOLOGY, V35, P453, DOI 10.2307/1931035; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Karrenberg S, 2007, AM NAT, V169, P725, DOI 10.1086/516758; Keck DD, 1959, CALIFORNIA FLORA, P1163; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Kraft NJB, 2010, DIVERS DISTRIB, V16, P403, DOI 10.1111/j.1472-4642.2010.00640.x; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; Lane MA, 1993, JEPSON MANUAL HIGHER, P271; LEWIS H, 1973, AM NAT, V107, P161, DOI 10.1086/282824; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; Lowry DB, 2012, BIOL J LINN SOC, V106, P241, DOI 10.1111/j.1095-8312.2012.01867.x; Lowry DB, 2009, NEW PHYTOL, V183, P776, DOI 10.1111/j.1469-8137.2009.02901.x; MCLAUGHLIN SP, 1986, AM J BOT, V73, P1748, DOI 10.2307/2444241; MCNEILLY T, 1968, HEREDITY, V23, P205, DOI 10.1038/hdy.1968.29; Moore AJ, 2012, TAXON, V61, P211, DOI 10.1002/tax.611015; Moore AJ, 2012, JEPSON MANUAL VASCUL, P336; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Nosil P, 2012, P ROY SOC B-BIOL SCI, V279, P5058, DOI 10.1098/rspb.2012.0813; O'Dell RE, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P97; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2009, DOCUMENTATION STRUCT; Ramsey J, 2008, EVOLUTION, V62, P639, DOI 10.1111/j.1558-5646.2007.00264.x; Raven PH., 1978, U CALIF PUBL BOT, V72, P1, DOI DOI 10.2307/1929235; Roda F, 2013, MOL ECOL, V22, P2941, DOI 10.1111/mec.12311; Ronfort JL, 1998, GENETICS, V150, P921; Schultheis Lisa M., 2010, Madrono, V57, P20, DOI 10.3120/0024-9637-57.1.20; Severns PM, 2010, BIODIVERS CONSERV, V19, P3605, DOI 10.1007/s10531-010-9897-7; STEYERMARK JULIAN A., 1934, ARM MISSOURI BOT GARD, V21, P433, DOI 10.2307/2394201; STROTHER J. L, 2006, FLORA N AM N MEXICO, V20, P424; Turesson G, 1922, HEREDITAS, V3, P211, DOI 10.1111/j.1601-5223.1922.tb02734.x; Vickery RK, 1952, THESIS STANFORD U PA; Wu CA, 2010, OECOLOGIA, V162, P23, DOI 10.1007/s00442-009-1448-0	60	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95656	10.1371/journal.pone.0095656	http://dx.doi.org/10.1371/journal.pone.0095656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755840	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300070
J	Pons-Salort, M; Serra-Cobo, J; Jay, F; Lopez-Roig, M; Lavenir, R; Guillemot, D; Letort, V; Bourhy, H; Opatowski, L				Pons-Salort, Margarita; Serra-Cobo, Jordi; Jay, Flora; Lopez-Roig, Marc; Lavenir, Rachel; Guillemot, Didier; Letort, Veronique; Bourhy, Herve; Opatowski, Lulla			Insights into Persistence Mechanisms of a Zoonotic Virus in Bat Colonies Using a Multispecies Metapopulation Model	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; NATURAL COLONIES; MYOTIS-MYOTIS; RABIES; LYSSAVIRUSES; INFECTION; DYNAMICS; TRANSMISSION; EVOLUTION; RECORD	Rabies is a worldwide zoonosis resulting from Lyssavirus infection. In Europe, Eptesicus serotinus is the most frequently reported bat species infected with Lyssavirus, and thus considered to be the reservoir of European bat Lyssavirus type 1 (EBLV-1). To date, the role of other bat species in EBLV-1 epidemiology and persistence remains unknown. Here, we built an EBLV-12transmission model based on local observations of a three-cave and four-bat species (Myotis capaccinii, Myotis myotis, Miniopterus schreibersii, Rhinolophus ferrumequinum) system in the Balearic Islands, for which a 1995-2011 serological dataset indicated the continuous presence of EBLV-1. Eptesicus serotinus was never observed in the system during the 16-year follow-up and therefore was not included in the model. We used the model to explore virus persistence mechanisms and to assess the importance of each bat species in the transmission dynamics. We found that EBLV-1 could not be sustained if transmission between M. schreibersii and other bat species was eliminated, suggesting that this species serves as a regional reservoir. Global sensitivity analysis using Sobol's method revealed that following the rate of autumn-winter infectious contacts, M. schreibersii's incubation-and immune-period durations, but not the infectious period length, were the most relevant factors driving virus persistence.	[Pons-Salort, Margarita; Guillemot, Didier; Opatowski, Lulla] Inst Pasteur, Unite Pharmacoepidemiol & Malad Infect, Paris, France; [Pons-Salort, Margarita; Guillemot, Didier; Opatowski, Lulla] INSERM, U657, Paris, France; [Pons-Salort, Margarita; Guillemot, Didier; Opatowski, Lulla] Univ Versailles St Quentin En Yvelines, EA 4499, Fac Med Paris Ile de France Ouest, Garches, France; [Serra-Cobo, Jordi; Lopez-Roig, Marc] Ctr Recerca Infecc Viriques Illes Balears, Palma De Mallorca, Spain; [Serra-Cobo, Jordi] Univ Barcelona, Dept Biol Anim, Inst Recerca Biodiversitat, Barcelona, Spain; [Jay, Flora] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Lavenir, Rachel; Bourhy, Herve] WHO Collaborat Ctr Reference & Res Rabies, Natl Reference Ctr Rabies, Inst Pasteur, Unite Dynam Lyssavirus & Adaptat Hote, Paris, France; [Guillemot, Didier] Hop Raymond Poincare, AP HP, Garches, France; [Letort, Veronique] Ecole Cent Paris, Lab Math Appl Syst, Chatenay Malabry, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Barcelona; University of California System; University of California Berkeley; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Pons-Salort, M (corresponding author), Inst Pasteur, Unite Pharmacoepidemiol & Malad Infect, Paris, France.	margapons@gmail.com	Guillemot, Didier/AAN-3051-2020; Serra-Cobo, Jordi/G-4673-2016; Opatowski, Lulla/I-3143-2015	Opatowski, Lulla/0000-0001-8348-700X; Pons-Salort, Margarita/0000-0001-5597-9285; Guillemot, Didier/0000-0002-8497-1765; jay, flora/0000-0001-5884-4730	PREDEMICS UE [278433]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [ANR- 10-LABX-62-IBEID]	PREDEMICS UE; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''(French National Research Agency (ANR))	This work was funded by the PREDEMICS UE project No. 278433, and the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (grant n degrees ANR- 10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual B, 2008, DEV BIOLOGICALS, V131, P547; Amengual B, 1997, J GEN VIROL, V78, P2319, DOI 10.1099/0022-1317-78-9-2319; Amengual B, 2005, EVOLUCIO PODER PATOG; Amengual B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000566; Amengual B, 2007, ACTA CHIROPTEROL, V9, P319, DOI 10.3161/1733-5329(2007)9[319:FROSOS]2.0.CO;2; AUBERT MFA, 1991, ANN RECH VET, V22, P77; Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Davis PL, 2005, J VIROL, V79, P10487, DOI 10.1128/JVI.79.16.10487-10497.2005; Fooks AR, 2003, EPIDEMIOL INFECT, V131, P1029, DOI 10.1017/S0950268803001481; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Hayman DTS, 2012, EPIDEMIOL INFECT, V140, P2163, DOI 10.1017/S0950268812000167; Hutterer R., 2005, BAT MIGRATIONS EUROP; Jackson FR, 2008, J WILDLIFE DIS, V44, P612, DOI 10.7589/0090-3558-44.3.612; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; PEREZJORDA JL, 1995, J WILDLIFE DIS, V31, P372, DOI 10.7589/0090-3558-31.3.372; Restif O, 2012, ECOL LETT, V15, P1083, DOI 10.1111/j.1461-0248.2012.01836.x; Saltelli A, 2000, STAT SCI, V15, P377, DOI 10.1214/ss/1009213004; Serra-Cobo J, 2002, EMERG INFECT DIS, V8, P413, DOI 10.3201/eid0804.010263; Serra-Cobo J, 2009, RATPENATS CIENCIA MI; Serra-Cobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064467; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018	26	13	13	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95610	10.1371/journal.pone.0095610	http://dx.doi.org/10.1371/journal.pone.0095610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755619	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300061
J	Uemura, H; Katsuura-Kamano, S; Yamaguchi, M; Sawachika, F; Arisawa, K				Uemura, Hirokazu; Katsuura-Kamano, Sakurako; Yamaguchi, Miwa; Sawachika, Fusakazu; Arisawa, Kokichi			Serum Hepatic Enzyme Activity and Alcohol Drinking Status in Relation to the Prevalence of Metabolic Syndrome in the General Japanese Population	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; FATTY LIVER-DISEASE; AMINOTRANSFERASE LEVELS; CARDIOVASCULAR-DISEASE; RISK; MEN; PREDICTOR; ADULTS; CONSUMPTION; MARKERS	Background: Studies on the combined associations of elevated serum hepatic enzyme activity and alcohol drinking with metabolic syndrome are rare. Our objectives were to evaluate the associations of elevated serum hepatic enzyme activity with the prevalence of metabolic syndrome in the general Japanese population and whether alcohol drinking had a modifying effect on these associations. Methods: We conducted a cross-sectional study with 1,027 men and 1,152 women throughout Japan during 2002-2010. Biochemical factors including alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) were determined in overnight fasting blood, and a survey on lifestyle was conducted by questionnaire. Serum ALT and GGT levels were divided into tertiles in men and women, and their associations with the prevalence of metabolic syndrome were evaluated by logistic regressions. Results: Elevated serum ALT and GGT, even within the reference range, were independently associated with increased metabolic syndrome prevalence and were associated with most of its components in both sexes, except for the association between GGT and low high-density lipoprotein (HDL) cholesterol in men. Stratified analyses by alcohol drinking status revealed that within the same tertile category of serum ALT and GGT, subjects classified as alcohol abstainers showed higher adjusted odds ratios for metabolic syndrome prevalence than those classified as regular alcohol drinkers in both sexes. The interaction effects of serum GGT with alcohol drinking status on metabolic syndrome prevalence were significant in both sexes. Conclusions: These results suggest that elevated serum ALT and GGT, even within the reference range, are independently associated with increased metabolic syndrome prevalence, especially in alcohol abstainers, in Japanese men and women.	[Uemura, Hirokazu; Katsuura-Kamano, Sakurako; Yamaguchi, Miwa; Sawachika, Fusakazu; Arisawa, Kokichi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Med, Tokushima 770, Japan	Tokushima University	Uemura, H (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Med, Tokushima 770, Japan.	uemura@basic.med.tokushima-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [24590749]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Number 24590749) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	Alkerwi A, 2009, ATHEROSCLEROSIS, V204, P624, DOI 10.1016/j.atherosclerosis.2008.10.036; Angelico F, 2005, J CLIN ENDOCR METAB, V90, P1578, DOI 10.1210/jc.2004-1024; Angelico F, 2003, J GASTROEN HEPATOL, V18, P588, DOI 10.1046/j.1440-1746.2003.02958.x; [Anonymous], J AM BOARD FAM MED, V24, P407; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; CUSHMAN P, 1984, ALCOHOL CLIN EXP RES, V8, P253, DOI 10.1111/j.1530-0277.1984.tb05506.x; Dong MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014254; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Kim BJ, 2012, CIRC J, V76, P2363, DOI 10.1253/circj.CJ-12-0315; Kim MY, 2012, KOREAN J FAM MED, V33, P211, DOI 10.4082/kjfm.2012.33.4.211; Lauria MW, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-74; Lee DH, 2005, ATHEROSCLEROSIS, V178, P327, DOI 10.1016/j.atherosclerosis.2004.08.027; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Lee MY, 2008, DIABETIC MED, V25, P469, DOI 10.1111/j.1464-5491.2008.02415.x; Li M, 2009, OBESITY, V17, P809, DOI 10.1038/oby.2008.617; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; Nakamoto M, 2013, INT ARCH OCC ENV HEA, V86, P849, DOI 10.1007/s00420-012-0819-8; Nakanishi N, 2003, ANGIOLOGY, V54, P551, DOI 10.1177/000331970305400504; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Stoutenberg M, 2013, BR J NUTR, P1; Tahan V, 2008, HEPATO-GASTROENTEROL, V55, P1433; Uemura H, 2009, ENVIRON HEALTH PERSP, V117, P568, DOI 10.1289/ehp.0800012; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	34	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95981	10.1371/journal.pone.0095981	http://dx.doi.org/10.1371/journal.pone.0095981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755715	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300127
J	Wu, TT; Shi, Z; Baumgart, T				Wu, Tingting; Shi, Zheng; Baumgart, Tobias			Mutations in BIN1 Associated with Centronuclear Myopathy Disrupt Membrane Remodeling by Affecting Protein Density and Oligomerization	PLOS ONE			English	Article							N-BAR DOMAIN; T-TUBULE BIOGENESIS; AMPHIPATHIC HELICES; CURVATURE GENERATION; AMPHIPHYSIN-2 BIN1; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; MECHANISM; DEFECTS; INVAGINATION	The regulation of membrane shapes is central to many cellular phenomena. Bin/Amphiphysin/Rvs (BAR) domain-containing proteins are key players for membrane remodeling during endocytosis, cell migration, and endosomal sorting. BIN1, which contains an N-BAR domain, is assumed to be essential for biogenesis of plasma membrane invaginations (T-tubules) in muscle tissues. Three mutations, K35N, D151N and R154Q, have been discovered so far in the BAR domain of BIN1 in patients with centronuclear myopathy (CNM), where impaired organization of T-tubules has been reported. However, molecular mechanisms behind this malfunction have remained elusive. None of the BIN1 disease mutants displayed a significantly compromised curvature sensing ability. However, two mutants showed impaired membrane tubulation both in vivo and in vitro, and displayed characteristically different behaviors. R154Q generated smaller membrane curvature compared to WT N-BAR. Quantification of protein density on membranes revealed a lower membrane-bound density for R154Q compared to WT and the other mutants, which appeared to be the primary reason for the observation of impaired deformation capacity. The D151N mutant was unable to tubulate liposomes under certain experimental conditions. At medium protein concentrations we found 'budding' structures on liposomes that we hypothesized to be intermediates during the tubulation process except for the D151N mutant. Chemical crosslinking assays suggested that the D151N mutation impaired protein oligomerization upon membrane binding. Although we found an insignificant difference between WT and K35N N-BAR in in vitro assays, depolymerizing actin in live cells allowed tubulation of plasma membranes through the K35N mutant. Our results provide insights into the membrane-involved pathophysiological mechanisms leading to human disease.	[Wu, Tingting; Shi, Zheng; Baumgart, Tobias] Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Baumgart, T (corresponding author), Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA.	baumgart@sas.upenn.edu		Shi, Zheng/0000-0002-5214-1871	National Institutes of Health [R01-GM-097552-A01]; National Science Foundation [MCB-0718569]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the National Institutes of Health grant R01-GM-097552-A01 (PI: Tobias Baumgart) and National Science Foundation grant MCB-0718569 (PI: Tobias Baumgart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025529; Al-Qusairi L, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-26; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Boehm J, 2010, ORPHANET J RARE DIS, V5; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Claeys KG, 2010, NEUROLOGY, V74, P519, DOI 10.1212/WNL.0b013e3181cef7f9; Cui HS, 2013, BIOPHYS J, V104, P404, DOI 10.1016/j.bpj.2012.12.006; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; De Carlo S, 2010, METHOD ENZYMOL, V481, P127, DOI 10.1016/S0076-6879(10)81006-7; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SM, 2010, DEV CELL, V18, P332, DOI 10.1016/j.devcel.2010.02.003; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Fujimura-Kiyono C, 2008, NEUROL INDIA, V56, P325; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Gilli P, 2009, ACCOUNTS CHEM RES, V42, P33, DOI 10.1021/ar800001k; Gortat A, 2012, J BIOL CHEM, V287, P4232, DOI 10.1074/jbc.M111.325837; Heinrich MC, 2010, J PHYS CHEM LETT, V1, P3401, DOI 10.1021/jz101403q; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jung AG, 2010, PLOS ONE, V5; Jungbluth H, 2008, ORPHANET J RARE DIS, V3; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Levental I, 2009, BIOCHEMISTRY-US, V48, P8241, DOI 10.1021/bi9007879; Low C, 2008, BIOPHYS J, V95, P4315, DOI 10.1529/biophysj.108.134155; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mejaddam A Y, 2009, Acta Myol, V28, P91; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Pan K, 2012, MOL MED, V18, P507, DOI 10.2119/molmed.2011.00319; Prendergast GC, 2009, BBA-REV CANCER, V1795, P25, DOI 10.1016/j.bbcan.2008.09.001; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Rao YJ, 2011, CELL MOL LIFE SCI, V68, P3983, DOI 10.1007/s00018-011-0768-5; Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014; Royer B, 2013, EMBO REP, V14, P907, DOI 10.1038/embor.2013.119; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sander B, 2011, MICROSC RES TECHNIQ, V74, P642, DOI 10.1002/jemt.20963; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Simunovic M, 2013, P NATL ACAD SCI USA, V110, P20396, DOI 10.1073/pnas.1309819110; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Su YC, 2010, BIOCHEMISTRY-US, V49, P6009, DOI 10.1021/bi100642n; Tang M, 2009, BBA-BIOMEMBRANES, V1788, P514, DOI 10.1016/j.bbamem.2008.10.027; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Tian AW, 2009, BIOPHYS J, V97, P1636, DOI 10.1016/j.bpj.2009.07.012; Tjondrokoesoemo A, 2011, PLOS ONE, V6; TONER M, 1988, BIOCHEMISTRY-US, V27, P7435, DOI 10.1021/bi00419a039; Toussaint A, 2010, NEUROMUSCULAR DISORD, V20, P611, DOI 10.1016/j.nmd.2010.07.050; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; Traub LM, 2010, NATURE, V465, P556, DOI 10.1038/465556a; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Vamparys L, 2013, BIOPHYS J, V104, P585, DOI 10.1016/j.bpj.2012.11.3836; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Yoon YD, 2012, J BIOL CHEM, V287, P34078, DOI 10.1074/jbc.M112.372789; Yu H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002892; Zhu C, 2012, BIOPHYS J, V102, P1837, DOI 10.1016/j.bpj.2012.03.039	74	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e93060	10.1371/journal.pone.0093060	http://dx.doi.org/10.1371/journal.pone.0093060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755653	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300005
J	Yu, CH; Zhu, XL; Fan, ZH				Yu, Chang Ho; Zhu, Xianlei; Fan, Zhi-hua			Spatial/Temporal Variations and Source Apportionment of VOCs Monitored at Community Scale in an Urban Area	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; POSITIVE MATRIX FACTORIZATION; AIR-POLLUTION; SOURCE IDENTIFICATION; SPATIAL VARIABILITY; ATLANTA AEROSOL; UNITED-STATES; AMBIENT AIR; HOT-SPOT; CHILDREN	This study aimed to characterize spatial/ temporal variations of ambient volatile organic compounds (VOCs) using a community-scale monitoring approach and identify the main sources of concern in Paterson, NJ, an urban area with mixed sources of VOCs. VOC samples were simultaneously collected from three local source-dominated (i.e., commercial, industrial, and mobile) sites in Paterson and one background site in Chester, NJ (located similar to 58 km southwest of Paterson). Samples were collected using the EPA TO-15 method from midnight to midnight, one in every sixth day over one year. Among the 60 analyzed VOCs, ten VOCs (acetylene, benzene, dichloromethane, ethylbenzene, methyl ethyl ketone, styrene, toluene, m, p-xylene, o-xylene, and p-dichlorobenzene) were selected to examine their spatial/temporal variations. All of the 10 VOCs in Paterson were significantly higher than the background site (p < 0.01). Ethylbenzene, m, p-xylene, o-xylene, and pdichlorobenzene measured at the commercial site were significantly higher than the industrial/mobile sites (p < 0.01). Seven VOCs (acetylene, benzene, dichloromethane, methyl ethyl ketone, styrene, toluene, and p-dichlorobenzene) were significantly different by season (p < 0.05), that is, higher in cold seasons than in warm seasons. In addition, dichloromethane, methyl ethyl ketone, and toluene were significantly higher on weekdays than weekend days (p < 0.05). These results are consistent with literature data, indicating the impact of anthropogenic VOC sources on air pollution in Paterson. Positive Matrix Factorization (PMF) analysis was applied for 24-hour integrated VOC measurements in Paterson over one year and identified six contributing factors, including motor vehicle exhausts (20%), solvents uses (19%), industrial emissions (16%), mobile+ stationery sources (12%), small shop emissions (11%), and others (22%). Additional locational analysis confirmed the identified sources were well matched with point sources located upwind in Paterson. The study demonstrated the community-scale monitoring approach can capture spatial variation of VOCs in an urban community with mixed VOC sources. It also provided robust data to identify major sources of concern in the community.	[Yu, Chang Ho; Fan, Zhi-hua] Rutgers State Univ, Environm & Occupat Hlth Sci, Div Exposure Sci, Piscataway, NJ 08854 USA; [Zhu, Xianlei] China Univ Petr, Coll Geosci, Beijing, Peoples R China	Rutgers State University New Brunswick; China University of Petroleum	Fan, ZH (corresponding author), Rutgers State Univ, Environm & Occupat Hlth Sci, Div Exposure Sci, Piscataway, NJ 08854 USA.	zfan@eohsi.rutgers.edu			U.S. Environmental Protection Agency through New Jersey Department of Environmental Protection [SR05-035]; National Institute of Environmental Health Sciences (NIEHS); Rutgers University Center for Environmental Exposures and Disease [NIEHS P30ES005022]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency through New Jersey Department of Environmental Protection; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Rutgers University Center for Environmental Exposures and Disease; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the U.S. Environmental Protection Agency (subcontract through New Jersey Department of Environmental Protection Grant # SR05-035). Dr.Fan is supported in part by the National Institute of Environmental Health Sciences (NIEHS) sponsored Rutgers University Center for Environmental Exposures and Disease, Grant # NIEHS P30ES005022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SG, 2007, ATMOS ENVIRON, V41, P227, DOI 10.1016/j.atmosenv.2006.08.021; Buzcu B, 2006, ATMOS ENVIRON, V40, P2385, DOI 10.1016/j.atmosenv.2005.12.020; Cheng L, 1997, ATMOS ENVIRON, V31, P239, DOI 10.1016/1352-2310(96)00170-7; Choi YJ, 2004, ATMOS ENVIRON, V38, P775, DOI 10.1016/j.atmosenv.2003.10.004; Delfino RJ, 2003, ENVIRON HEALTH PERSP, V111, P647, DOI 10.1289/ehp.5992; FUJITA EM, 1998, ANAL DATA 1995 NARST, V3; Gustafson P, 2007, J ENVIRON MONITOR, V9, P23, DOI [10.1039/b614142k, 10.1039/B614142K]; Jia C, 2008, ATMOS ENVIRON, V42, P2101, DOI 10.1016/j.atmosenv.2007.11.047; Kim E, 2003, J AIR WASTE MANAGE, V53, P731, DOI 10.1080/10473289.2003.10466209; Kim E, 2005, ENVIRON SCI TECHNOL, V39, P4172, DOI 10.1021/es049824x; Kim E, 2003, ATMOS ENVIRON, V37, P5009, DOI 10.1016/j.atmosenv.2003.08.035; Kim E, 2007, ATMOS ENVIRON, V41, P567, DOI 10.1016/j.atmosenv.2006.08.023; Lin L, 2011, J AIR WASTE MANAGE, V61, P631, DOI 10.3155/1047-3289.61.6.631; Miller L, 2010, ATMOS ENVIRON, V44, P1162, DOI 10.1016/j.atmosenv.2009.12.030; Mohamed MF, 2002, CHEMOSPHERE, V47, P863, DOI 10.1016/S0045-6535(02)00107-8; Na K, 2001, ATMOS ENVIRON, V35, P2603, DOI 10.1016/S1352-2310(00)00464-7; New Jersey Department of Environmental Protection, 2010, URB COMM AIR TOX MON; Paatero P, 2003, ANAL CHIM ACTA, V490, P277, DOI 10.1016/S0003-2670(02)01643-4; Paatero P, 1997, CHEMOMETR INTELL LAB, V37, P23, DOI 10.1016/S0169-7439(96)00044-5; Pankow JF, 2003, ATMOS ENVIRON, V37, P5023, DOI 10.1016/j.atmosenv.2003.08.006; Parrish DD, 2006, ATMOS ENVIRON, V40, P2288, DOI 10.1016/j.atmosenv.2005.11.033; Polissar AV, 1998, J GEOPHYS RES-ATMOS, V103, P19045, DOI 10.1029/98JD01212; Rumchev K, 2004, THORAX, V59, P746, DOI 10.1136/thx.2003.013680; Smith LA, 2007, ENVIRON MONIT ASSESS, V128, P369, DOI 10.1007/s10661-006-9320-8; Swift J, 2006, NAT ENV MON C NEMC W; Touma JS, 2006, J AIR WASTE MANAGE, V56, P1716, DOI 10.1080/10473289.2006.10464576; U.S. Environmental Protection Agency, 1999, DET VOL ORG COMP VOC; U.S. Environmental Protection Agency, 2011, SPECIATE DAT BROWS; U.S. Environmental Protection Agency, 2009, NAT SCAL AIR TOX ASS; United States Environmental Protection Agency, 2008, EPA POS MATR FACT PM; US Census Bureau, 2012, CENS DAT PAT CIT; Watson JG, 2001, ATMOS ENVIRON, V35, P1567, DOI 10.1016/S1352-2310(00)00461-1; Wichmann FA, 2009, J ALLERGY CLIN IMMUN, V123, P632, DOI 10.1016/j.jaci.2008.09.052; Wu XM, 2012, ATMOS ENVIRON, V57, P72, DOI 10.1016/j.atmosenv.2012.04.029; Yu CH, 2011, J AIR WASTE MANAGE, V61, P673, DOI 10.3155/1047-3289.61.6.673; Zhu XL, 2008, ATMOS ENVIRON, V42, P7329, DOI 10.1016/j.atmosenv.2008.07.039	36	6	6	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95734	10.1371/journal.pone.0095734	http://dx.doi.org/10.1371/journal.pone.0095734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755686	gold, Green Submitted, Green Published			2022-12-25	WOS:000335240300085
J	Cai, CY; Chen, YC; Zhong, SP; Ji, B; Wang, JZ; Bai, XT; Shi, GG				Cai, Congyi; Chen, Yicun; Zhong, Shuping; Ji, Bin; Wang, Jinzhi; Bai, Xueting; Shi, Ganggang			Anti-Inflammatory Activity of N-Butanol Extract from Ipomoea stolonifera In Vivo and In Vitro	PLOS ONE			English	Article							ADJUVANT-INDUCED ARTHRITIS; COASTAL MEDICINAL-PLANTS; OIL EAR TEST; NATURAL-PRODUCTS; RAT; EDEMA; ACID; INFLAMMATION; ANTIOXIDANT; DIVERSITY	Ipomoea stolonifera (I. stolonifera) has been used for the treatment of inflammatory diseases including rheumatism and rheumatoid arthritis in Chinese traditional medicine. However, the anti-inflammatory activity of I. stolonifera has not been elucidated. For this reason, the anti-inflammatory activity of n-butanol extract of I. stolonifera (BE-IS) was evaluated in vivo by using acute models (croton oil-induced mouse ear edema, carrageenan-induced rat paw edema, and carrageenan-induced rat pleurisy) and chronic models (cotton pellet-induced rat granuloma, and complete Freund's adjuvant (CFA)induced rat arthritis). Results indicated that oral administration of BE-IS significantly attenuated croton oil-induced ear edema, decreased carrageenan-induced paw edema, reduced carrageenan-induced exudates and cellular migration, inhibited cotton pellet-induced granuloma formation and improved CFA-induced arthritis. Preliminary mechanism studies demonstrated that BE-IS decreased the levels of myeloperoxidase (MPO) and malondialdehyde (MDA), increased the activity of anti-oxidant enzyme superoxide dismutase (SOD) in vivo, and reduced the production of nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta and IL-6 in lipopolysaccharide-activated RAW264.7 macrophages in vitro. Results obtained in vivo and in vitro demonstrate that BE-IS has considerable anti-inflammatory potential, which provided experimental evidences for the traditional application of Ipomoea stolonifera in inflammatory diseases.	[Cai, Congyi; Chen, Yicun; Ji, Bin; Bai, Xueting; Shi, Ganggang] Shantou Univ, Coll Med, Dept Pharmacol, Shantou, Peoples R China; [Cai, Congyi] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Pharm, Shantou, Peoples R China; [Zhong, Shuping] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Wang, Jinzhi] Shantou Univ, Coll Med, Dept Chem, Shantou, Peoples R China; [Shi, Ganggang] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Cardiovasc Dis, Shantou, Peoples R China	Shantou University; Shantou University; University of Southern California; Shantou University; Shantou University	Shi, GG (corresponding author), Shantou Univ, Coll Med, Dept Pharmacol, Shantou, Peoples R China.	ggshi@stu.edu.cn			National Natural Science Foundation of China [30973922]; Guangdong Natural Science Foundation [9351503102000001]; central government special funds the development of local colleges and universities; Administration of Traditional Chinese Medicine of Guangdong Province, China [2010408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); central government special funds the development of local colleges and universities; Administration of Traditional Chinese Medicine of Guangdong Province, China	This study was undertaken and supported within a grant from the National Natural Science Foundation of China (No. 30973922), the teamwork projects funded by the Guangdong Natural Science Foundation (No. 9351503102000001), the central government special funds supporting the development of local colleges and universities, and Administration of Traditional Chinese Medicine of Guangdong Province, China (No. 2010408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SF, 2006, PHARMACOL RES, V53, P233, DOI 10.1016/j.phrs.2005.11.005; [Anonymous], 2002, OECD GUID DOC ACUT O; Antonisamy P, 2011, J PHARM PHARMACOL, V63, P1070, DOI 10.1111/j.2042-7158.2011.01300.x; Barbour SE, 1998, MOL IMMUNOL, V35, P977, DOI 10.1016/S0161-5890(98)00070-4; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Cabrini DA, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq026; Costantino V, 2004, CURR MED CHEM, V11, P1671, DOI 10.2174/0929867043364973; de Souza MM, 2000, J ETHNOPHARMACOL, V69, P85, DOI 10.1016/S0378-8741(99)00142-7; DEYOUNG LM, 1989, AGENTS ACTIONS, V26, P335; Eddouks M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/142087; Glauser MP, 1996, DRUGS, V52, P9, DOI 10.2165/00003495-199600522-00004; Hou Y, 2010, CURR MED CHEM, V17, P1191, DOI 10.2174/092986710790827834; Huang MH, 2011, J ETHNOPHARMACOL, V135, P545, DOI 10.1016/j.jep.2011.03.057; IALENTI A, 1993, BRIT J PHARMACOL, V110, P701, DOI 10.1111/j.1476-5381.1993.tb13868.x; Inbaneson Samuel Jacob, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P364, DOI 10.1016/S2221-1691(12)60057-4; Kang M, 2010, J ETHNOPHARMACOL, V131, P485, DOI 10.1016/j.jep.2010.07.025; Kim HW, 2003, CARCINOGENESIS, V24, P235, DOI 10.1093/carcin/24.2.235; Krogh R, 1999, PHARMAZIE, V54, P464; Mannel DN, 2000, CHEM IMMUNOL, V74, P141; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matallana G, 2005, AM J BOT, V92, P1513, DOI 10.3732/ajb.92.9.1513; MATSUDA R, 1992, FOLIA PHARMACOL JPN, V99, P363, DOI 10.1254/fpj.99.363; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MIKAMI T, 1983, EUR J PHARMACOL, V95, P1, DOI 10.1016/0014-2999(83)90261-3; MOLLOY RG, 1993, BRIT J SURG, V80, P289, DOI 10.1002/bjs.1800800308; Mondol MAM, 2013, MAR DRUGS, V11, P2846, DOI 10.3390/md11082846; Morteza-Semnani K, 2004, FITOTERAPIA, V75, P123, DOI 10.1016/j.fitote.2003.12.007; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAGATOMI H, 1984, ARZNEIMITTELFORSCH, V34-1, P599; Nasri R, 2013, CURR PROTEIN PEPT SC, V14, P199; Odum W E, 1977, Science, V197, P1071, DOI 10.1126/science.197.4308.1071-a; OECD Guidelines, 2000, OECD ENV HLTH SAF PU, V19; Park HH, 2013, INT IMMUNOPHARMACOL, V15, P296, DOI 10.1016/j.intimp.2012.12.005; PONGPRAYOON U, 1991, PLANTA MED, V57, P515, DOI 10.1055/s-2006-960196; Qiu H, 1995, GUIHAIA, V15, P7; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; Rasool M, 2007, FUND CLIN PHARMACOL, V21, P157, DOI 10.1111/j.1472-8206.2006.00461.x; Ravikumar S, 2005, J ENVIRON BIOL, V26, P383; Roth SH, 2012, DRUGS, V72, P873, DOI 10.2165/11633740-000000000-00000; SELYE H, 1953, JAMA-J AM MED ASSOC, V152, P1207, DOI 10.1001/jama.1953.63690130001006; Simon RA, 2003, CLIN REV ALLERG IMMU, V24, P189, DOI 10.1385/CRIAI:24:2:189; TUBARO A, 1986, AGENTS ACTIONS, V19, P371, DOI 10.1007/BF01971259; TUBARO A, 1986, AGENTS ACTIONS, V17, P347, DOI 10.1007/BF01982641; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; VINEGAR R, 1982, FED PROC, V41, P2588; WEST MA, 1995, J TRAUMA, V39, P404; Williams A, 2010, ENVIRON MANAGE, V46, P738, DOI 10.1007/s00267-010-9558-3; WINTER CA, 1957, J AM PHARM ASSOC, V46, P515, DOI 10.1002/jps.3030460902; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544	51	33	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95931	10.1371/journal.pone.0095931	http://dx.doi.org/10.1371/journal.pone.0095931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752203	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400145
J	Forment, JV; Flipphi, M; Ventura, L; Gonzalez, R; Ramon, D; MacCabe, AP				Forment, Josep V.; Flipphi, Michel; Ventura, Luisa; Gonzalez, Ramon; Ramon, Daniel; MacCabe, Andrew P.			High-Affinity Glucose Transport in Aspergillus nidulans Is Mediated by the Products of Two Related but Differentially Expressed Genes	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; MULTIPLE SEQUENCE ALIGNMENT; BEST-FIT MODELS; SUGAR-TRANSPORT; NEUROSPORA-CRASSA; HEXOSE; SYSTEMS; CLONING; CREA; INVOLVEMENT	Independent systems of high and low affinity effect glucose uptake in the filamentous fungus Aspergillus nidulans. Low-affinity uptake is known to be mediated by the product of the mstE gene. In the current work two genes, mstA and mstC, have been identified that encode high-affinity glucose transporter proteins. These proteins' primary structures share over 90% similarity, indicating that the corresponding genes share a common origin. Whilst the function of the paralogous proteins is little changed, they differ notably in their patterns of expression. The mstC gene is expressed during the early phases of germination and is subject to CreA-mediated carbon catabolite repression whereas mstA is expressed as a culture tends toward carbon starvation. In addition, various pieces of genetic evidence strongly support allelism of mstC and the previously described locus sorA. Overall, our data define MstC/SorA as a high-affinity glucose transporter expressed in germinating conidia, and MstA as a high-affinity glucose transporter that operates in vegetative hyphae under conditions of carbon limitation.	[Forment, Josep V.; Flipphi, Michel; Ventura, Luisa; Gonzalez, Ramon; Ramon, Daniel; MacCabe, Andrew P.] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain; [Forment, Josep V.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Flipphi, Michel] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Gonzalez, Ramon] Univ La Rioja, Gobierno La Rioja, CSIC, Inst Ciencias Vid & Vino, Logrono, Spain; [Ramon, Daniel] Biopolis SL, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Cambridge; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja	MacCabe, AP (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, Jaime Roig 11, E-46010 Valencia, Spain.	andrew@iata.csic.es	Gonzalez, Ramon/Y-5961-2019; González, Ramón/G-9281-2011; Forment, Josep/J-3678-2015; MacCabe, Andrew P/H-4522-2012	Gonzalez, Ramon/0000-0001-7388-1660; González, Ramón/0000-0001-7388-1660; Forment, Josep/0000-0002-7797-2583; MacCabe, Andrew P/0000-0003-4918-7761	Ministerio de Educacion y Ciencia [AP2001-2163]; Ramon y Cajal postdoctoral fellowship [RYC-2004-003005]; European Union [QLK3-CT99-00729]; Spanish Government [BIO2008-00228, AGL2011-29925]	Ministerio de Educacion y Ciencia(Spanish Government); Ramon y Cajal postdoctoral fellowship(Spanish Government); European Union(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	J.V.F. was the recipient of a pre-doctoral grant from the Ministerio de Educacion y Ciencia (AP2001-2163). M.F. was the recipient of a Ramon y Cajal postdoctoral fellowship (RYC-2004-003005). Work in the authors' laboratory has been supported by the European Union (QLK3-CT99-00729) and grants from the Spanish Government BIO2008-00228 and AGL2011-29925. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; BUXTON FP, 1983, MOL GEN GENET, V190, P403, DOI 10.1007/BF00331067; Clutterbuck A.J, 1974, HDB GENETICS, V1, P447; Clutterbuck AJ, 1997, FUNGAL GENET BIOL, V21, P267, DOI 10.1006/fgbi.1997.0984; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; dEnfert C, 1997, FUNGAL GENET BIOL, V21, P163, DOI 10.1006/fgbi.1997.0975; dos Reis TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081412; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELORZA MV, 1971, MOL GEN GENET, V111, P185, DOI 10.1007/BF00267792; Fantes P A, 1973, J Gen Microbiol, V77, P417; Flipphi M, 2003, J BIOL CHEM, V278, P11849, DOI 10.1074/jbc.M209443200; Forment JV, 2006, J BIOL CHEM, V281, P8339, DOI 10.1074/jbc.M508198200; FUHRMANN GF, 1993, BIOCHIM BIOPHYS ACTA, V1145, P180, DOI 10.1016/0005-2736(93)90396-H; GAJEWSKI W, 1972, MOL GEN GENET, V116, P99, DOI 10.1007/BF00582220; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HERRIN DL, 1988, BIOTECHNIQUES, V6, P196; Heytler P G, 1979, Methods Enzymol, V55, P462; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; KLINGMULLER W, 1970, MOL GEN GENET, V109, P27, DOI 10.1007/BF00334044; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; MacCabe AP, 2003, MICROBIOL-SGM, V149, P2129, DOI 10.1099/mic.0.26349-0; MARK CG, 1971, BIOCHIM BIOPHYS ACTA, V249, P216, DOI 10.1016/0005-2736(71)90098-8; Mathieu M, 2000, MOL MICROBIOL, V36, P123, DOI 10.1046/j.1365-2958.2000.01833.x; OAKLEY CE, 1987, GENE, V53, P293, DOI 10.1016/0378-1119(87)90019-9; OESTREICHER N, 1993, GENE, V132, P185, DOI 10.1016/0378-1119(93)90194-8; Orejas M, 1999, MOL MICROBIOL, V31, P177, DOI 10.1046/j.1365-2958.1999.01157.x; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Palma M, 2007, J MOL MICROB BIOTECH, V12, P241, DOI 10.1159/000099645; Panozzo C, 1998, J BIOL CHEM, V273, P6367, DOI 10.1074/jbc.273.11.6367; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Payne GA, 2006, MED MYCOL, V44, pS9, DOI 10.1080/13693780600835716; RAND JB, 1980, J BACTERIOL, V141, P707, DOI 10.1128/JB.141.2.707-714.1980; RAND JB, 1980, J BACTERIOL, V142, P763, DOI 10.1128/JB.142.3.763-767.1980; SCARBOROUGH GA, 1970, J BIOL CHEM, V245, P3985; SCHNEIDER RP, 1971, J BACTERIOL, V106, P487, DOI 10.1128/JB.106.2.487-492.1971; SCHNEIDER RP, 1971, J BACTERIOL, V106, P479, DOI 10.1128/JB.106.2.479-486.1971; SCHULTE TH, 1975, J BACTERIOL, V122, P1076, DOI 10.1128/JB.122.3.1076-1080.1975; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATUM EL, 1949, SCIENCE, V109, P509, DOI 10.1126/science.109.2838.509; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; Wei HJ, 2004, FUNGAL GENET BIOL, V41, P148, DOI 10.1016/j.fgb.2003.10.006; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	51	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94662	10.1371/journal.pone.0094662	http://dx.doi.org/10.1371/journal.pone.0094662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751997	Green Submitted, gold, Green Published			2022-12-25	WOS:000335227400016
J	Ha, IH; Lee, J; Kim, MR; Kim, H; Shin, JS				Ha, In-Hyuk; Lee, Jinho; Kim, Me-riong; Kim, Hyejin; Shin, Joon-Shik			The Association between the History of Cardiovascular Diseases and Chronic Low Back Pain in South Koreans: A Cross-Sectional Study	PLOS ONE			English	Article							LUMBAR INTERVERTEBRAL DISKS; CORONARY-HEART-DISEASE; NORD-TRONDELAG-HEALTH; C-REACTIVE PROTEIN; RISK-FACTORS; FOLLOW-UP; SERUM-LIPIDS; PREVALENCE; FRAMINGHAM; DIFFUSION	Background: Cardiovascular disease and related risk factors have been suggested as a mechanism leading to atherosclerosis of the lumbar vessels and consequent lumbar pain or sciatica. But there is continued controversy concerning its generalization. This study examined whether cardiovascular disease or its risk factors were associated with chronic low back pain (cLBP) in Koreans. Methods: Health surveys and examinations were conducted on a nationally representative sample (n = 23,632) of Koreans. A total of 13,841 eligible participants (aged 20 to 89 years) were examined to determine the association between cardiovascular disease, the Framingham risk score, major cardiovascular risk factors (blood pressure, diabetes, cholesterol, and smoking habits) and chronic LBP. Results: The total prevalence of cLBP was 16.6% (men: 10.8%, women: 21.1%) and that in patients with a history of cardiovascular diseases was 36.6% (men: 26.5%, women: 47.1%). The results showed that patients' medical history of cardiovascular disease was significantly associated with cLBP in both men and women when adjusted for covariates (men: OR 2.16; 95% CI 1.34 similar to 3.49; women: OR 2.26; 95% CI 1.51 similar to 3.38). No association was observed between cLBP and the Framingham risk score, medication for hyperlipemia, hypertension, diabetes, and major cardiovascular risk factors (systolic blood pressure, total cholesterol, high density lipoprotein cholesterol, triglycerides, glucose and smoking habits) in either men or women. Conclusions: The prevalence of cLBP is correlated to a history of cardiovascular disease, but not to the major cardiovascular risk factors from the Framingham study. Further studies on whether these results were affected by psychological factors in patients with a history of cardiovascular diseases or whether new potential risk factors from the artery atherosclerosis hypothesis applying to Koreans exist are needed.	[Ha, In-Hyuk; Lee, Jinho; Kim, Me-riong; Kim, Hyejin; Shin, Joon-Shik] Jaseng Hosp Korean Med, Jaseng Med Fdn, Seoul, South Korea; [Ha, In-Hyuk] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Ha, In-Hyuk] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Lee, Jinho] Kyung Hee Univ, Grad Sch Korean Med, Dept Herbol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University	Ha, IH (corresponding author), Jaseng Hosp Korean Med, Jaseng Med Fdn, Seoul, South Korea.	hanihata@gmail.com		Kim, Me-riong/0000-0002-5245-6187; Shin, Joon-Shik/0000-0001-5488-3273; HA, IN-HYUK/0000-0002-5020-6723				Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Briggs MS, 2013, ARCH PHYS MED REHAB, V94, P745, DOI 10.1016/j.apmr.2012.11.026; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Goldberg MS, 2000, SPINE, V25, P995, DOI 10.1097/00007632-200004150-00016; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hagen K, 2005, ARCH INTERN MED, V165, P916, DOI 10.1001/archinte.165.8.916; Hemingway H, 1999, J EPIDEMIOL COMMUN H, V53, P197, DOI 10.1136/jech.53.4.197; Hestbaek L, 2003, J MANIP PHYSIOL THER, V26, P243, DOI 10.1016/S0161-4754(03)00003-4; Heuch I, 2013, SPINE, V38, P133, DOI 10.1097/BRS.0b013e3182647af2; Heuch I, 2010, EPIDEMIOLOGY, V21, P837, DOI 10.1097/EDE.0b013e3181f20808; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jhawar Balraj S, 2006, Spine J, V6, P684, DOI 10.1016/j.spinee.2006.04.016; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; Kauppila LI, 2004, SPINE, V29, P2147, DOI 10.1097/01.brs.0000141168.77393.b8; KAUPPILA LI, 1993, J SPINAL DISORD, V6, P124; Keyserling WM, 2000, AM IND HYG ASSOC J, V61, P39, DOI 10.1080/15298660008984513; Kurunlahti M, 2001, RADIOLOGY, V221, P779, DOI 10.1148/radiol.2213010134; Leboeuf-Yde C, 2000, SPINE, V25, P226, DOI 10.1097/00007632-200001150-00015; Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08; Leino-Arjas P, 2006, SCAND J WORK ENV HEA, V32, P12, DOI 10.5271/sjweh.971; Leino-Arjas P, 2008, ATHEROSCLEROSIS, V197, P43, DOI 10.1016/j.atherosclerosis.2007.07.035; Pearson TA, 2002, CIRCULATION, V105, P886, DOI 10.1161/hc0702.103727; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Shiri R, 2007, EUR SPINE J, V16, P2043, DOI 10.1007/s00586-007-0362-6; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Sumner AE, 2009, J PEDIAT, V155; Sumner AE, 2008, ATHEROSCLEROSIS, V196, P696, DOI 10.1016/j.atherosclerosis.2006.12.018; SVENSSON HO, 1983, SPINE, V8, P277, DOI 10.1097/00007632-198304000-00008; Takeyachi Y, 2006, SURG NEUROL, V66, P172, DOI 10.1016/j.surneu.2006.02.038; Tokuda O, 2007, J MAGN RESON IMAGING, V25, P185, DOI 10.1002/jmri.20785; Turgut Ahmet Tuncay, 2008, Pathophysiology, V15, P31, DOI 10.1016/j.pathophys.2007.12.001; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	37	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e93671	10.1371/journal.pone.0093671	http://dx.doi.org/10.1371/journal.pone.0093671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751659	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400005
J	Yasui, T; Morii, E; Yamamoto, Y; Yoshii, T; Takenaka, Y; Nakahara, S; Todo, T; Inohara, H				Yasui, Toshimichi; Morii, Eiichi; Yamamoto, Yoshifumi; Yoshii, Tadashi; Takenaka, Yukinori; Nakahara, Susumu; Todo, Takeshi; Inohara, Hidenori			Human Papillomavirus and Cystic Node Metastasis in Oropharyngeal Cancer and Cancer of Unknown Primary Origin	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CERVICAL LYMPH-NODES; TUMOR-ORIGIN; NECK-CANCER; HEAD; DNA; INFECTION; SITE; PCR	The clinical significance of human papillomavirus (HPV) in neck node metastasis from cancer of unknown primary (CUP) is not well established. We aimed to address the relationship of HPV status between node metastasis and the primary tumor, and also the relevance of HPV status regarding radiographically detected cystic node metastasis in head and neck squamous cell carcinoma (HNSCC) and CUP. HPV DNA was examined in 68 matched pairs of node metastasis and primary tumor, and in node metastasis from 27 CUPs. In surgically treated CUPs, p16 was examined immunohistochemically. When tonsillectomy proved occult tonsillar cancer in CUP, HPV DNA and p16 were also examined in the occult primary. Cystic node metastasis on contrast-enhanced computed tomography scans was correlated with the primary site and HPV status in another series of 255 HNSCCs and CUPs with known HPV status. Node metastasis was HPV-positive in 19/37 (51%) oropharyngeal SCCs (OPSCCs) and 10/27 (37%) CUPs, but not in non-OPSCCs. Fluid was collected from cystic node metastasis using fine needle aspiration in two OPSCCs and one CUP, and all fluid collections were HPV-positive. HPV status, including the presence of HPV DNA, genotype, and physical status, as well as the expression pattern of p16 were consistent between node metastasis and primary or occult primary tumor. Occult tonsillar cancer was found more frequently in p16-positive CUP than in p16-negative CUP (odds ratio (OR), 39.0; 95% confidence interval (CI), 1.4-377.8; P = 0.02). Radiographically, cystic node metastasis was specific to OPSCC and CUP, and was associated with HPV positivity relative to necrotic or solid node metastasis (OR, 6.2; 95% CI, 1.2-45.7; P = 0.03). In conclusion, HPV status remains unchanged after metastasis. The occult primary of HPV-positive CUP is most probably localized in the oropharynx. HPV status determined from fine needle aspirates facilitates the diagnosis of cystic node metastasis.	[Yasui, Toshimichi; Yamamoto, Yoshifumi; Yoshii, Tadashi; Takenaka, Yukinori; Nakahara, Susumu; Inohara, Hidenori] Osaka Univ, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan; [Morii, Eiichi] Osaka Univ, Fac Med, Dept Pathol, Suita, Osaka, Japan; [Todo, Takeshi] Osaka Univ, Fac Med, Dept Radiat Biol & Med Genet, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Inohara, H (corresponding author), Osaka Univ, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan.	hinohara@ent.med.osaka-u.ac.jp	Takenaka, Yukinori/I-3516-2019	Takenaka, Yukinori/0000-0002-3135-5635	Grants-in-Aid for Scientific Research [23241023] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Allen CT, 2010, LARYNGOSCOPE, V120, P1756, DOI 10.1002/lary.20936; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Barwad A, 2012, DIAGN CYTOPATHOL, V40, P893, DOI 10.1002/dc.21667; Begum S, 2003, CLIN CANCER RES, V9, P6469; Begum S, 2007, CLIN CANCER RES, V13, P1186, DOI 10.1158/1078-0432.CCR-06-1690; Cianchetti M, 2009, LARYNGOSCOPE, V119, P2348, DOI 10.1002/lary.20638; El-Mofty SK, 2008, HEAD NECK PATHOL, V2, P163, DOI 10.1007/s12105-008-0066-1; Glombitza F, 2010, PATHOL RES PRACT, V206, P229, DOI 10.1016/j.prp.2009.11.007; Goldenberg D, 2008, HEAD NECK-J SCI SPEC, V30, P898, DOI 10.1002/hed.20796; Gourin CG, 2000, LARYNGOSCOPE, V110, P1637, DOI 10.1097/00005537-200010000-00012; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Maruyama H, 2014, CANC SCI IN PRESS; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Park GC, 2012, ORAL ONCOL, V48, P1250, DOI 10.1016/j.oraloncology.2012.05.026; Pisharodi LR, 1997, DIAGN CYTOPATHOL, V17, P70, DOI 10.1002/(SICI)1097-0339(199707)17:1<70::AID-DC16>3.0.CO;2-7; Regauer S, 1999, BRIT J CANCER, V79, P1437, DOI 10.1038/sj.bjc.6690229; Strojan P, 2013, HEAD NECK-J SCI SPEC, V35, P123, DOI 10.1002/hed.21898; Thompson LDR, 1998, CANCER, V82, P944, DOI 10.1002/(SICI)1097-0142(19980301)82:5<944::AID-CNCR21>3.0.CO;2-#; Ueda Y, 2004, AM J CLIN PATHOL, V122, P266, DOI 10.1309/65MKPQT3E2BDM67E; Weiss D, 2011, HEAD NECK-J SCI SPEC, V33, P856, DOI 10.1002/hed.21548	21	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95364	10.1371/journal.pone.0095364	http://dx.doi.org/10.1371/journal.pone.0095364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752007	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400055
J	Zhu, XD; Shao, ZH; Li, CQ; Li, J; Zhong, Q; Learoyd, J; Meliton, A; Meliton, L; Leff, AR; Vanden Hoek, TL				Zhu, Xiangdong; Shao, Zuo-Hui; Li, Changqing; Li, Jing; Zhong, Qiang; Learoyd, Jonathan; Meliton, Angelo; Meliton, Lucille; Leff, Alan R.; Vanden Hoek, Terry L.			TAT-Protein Blockade during Ischemia/Reperfusion Reveals Critical Role for p85 PI3K-PTEN Interaction in Cardiomyocyte Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; KINASE-INDEPENDENT PATHWAY; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; HYPOTHERMIA CARDIOPROTECTION; POSITIVE REGULATION; PHOSPHOLIPASE A(2); HUMAN EOSINOPHILS; PTEN INHIBITORS; TENSIN HOMOLOG	Recent work shows that cooling protection after mouse cardiac arrest and cardiomyocyte ischemia is mediated by Akt activation. The PI3K p85 subunit can either augment or inhibit Akt activation depending on its binding to p110 or PTEN respectively. To further clarify the role of PI3K p85 in cardioprotection, we studied novel TAT-p85 fusion proteins that selectively inhibit PI3K p85 binding. We hypothesized that TAT fused p85 lacking the PTEN binding site (TAT-Delta PTEN p85) would enhance Akt phosphorylation to afford cardioprotection. Conversely, TAT fused p85 lacking the p110 binding site (TAT-Delta p110p85) would decrease Akt phosphorylation and abrogate cardioprotection. Microscopy and Western blot analysis demonstrated that TAT fusion protein was transduced into cardiomyocytes within 5 min and remained more than 2 h. Inhibition of PI3K/Akt by TAT-Delta p110 p85 significantly increased cell death from 44.6 +/- 2.7% to 92.5 +/- 3.4% after simulated ischemia and reperfusion. By contrast, PTEN inhibition using TAT-Delta PTEN p85 decreased cell death to 11.9 +/- 5.3%, a similar level of cardioprotection seen with past cooling studies. Additional studies with the small molecule PTEN inhibitor VO-OHpic confirmed that PTEN inhibition was highly protective against cell death induced by ischemia and reperfusion. We conclude that blockade of p85-PTEN interaction and PTEN inhibition may be promising strategies for rescuing the heart from ischemia and reperfusion injury.	[Zhu, Xiangdong; Shao, Zuo-Hui; Li, Changqing; Li, Jing; Zhong, Qiang; Vanden Hoek, Terry L.] Univ Illinois Hosp & Hlth Sci Syst, Cardiovasc Res Ctr, Program Adv Resuscitat Med, Chicago, IL 60612 USA; [Zhu, Xiangdong; Shao, Zuo-Hui; Li, Changqing; Li, Jing; Zhong, Qiang; Vanden Hoek, Terry L.] Univ Illinois Hosp & Hlth Sci Syst, Dept Emergency Med, Chicago, IL USA; [Learoyd, Jonathan; Meliton, Angelo; Meliton, Lucille; Leff, Alan R.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	University of Chicago	Vanden Hoek, TL (corresponding author), Univ Illinois Hosp & Hlth Sci Syst, Cardiovasc Res Ctr, Program Adv Resuscitat Med, Chicago, IL 60612 USA.	tvh@uic.edu		zhu, xiangdong/0000-0002-5627-8082	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The co-author Dr. Alan Leff has received research grant support from GlaxoSmithKline. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdillahi M, 2012, AM J PHYSIOL-HEART C, V303, pH297, DOI 10.1152/ajpheart.00999.2011; Anderson DH, 2010, CELL CYCLE, V9, P2055, DOI 10.4161/cc.9.11.11926; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Baines CP, 1999, BASIC RES CARDIOL, V94, P188, DOI 10.1007/s003950050142; Ban K, 2008, CIRC RES, V103, P643, DOI 10.1161/CIRCRESAHA.108.175018; Barber Domingo F, 2006, Sci STKE, V2006, ppe49, DOI 10.1126/stke.3622006pe49; Beiser DG, 2010, AM J PHYSIOL-HEART C, V298, pH1761, DOI 10.1152/ajpheart.00187.2010; BONSER RW, 1991, BRIT J PHARMACOL, V103, P1237, DOI 10.1111/j.1476-5381.1991.tb12330.x; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chang WT, 2007, EUR J PHARMACOL, V566, P58, DOI 10.1016/j.ejphar.2007.03.037; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; Dal Ponte C, 2011, LIVER TRANSPLANT, V17, P474, DOI 10.1002/lt.22256; Drescher C, 2011, EUR J CARDIO-THORAC, V40, P352, DOI 10.1016/j.ejcts.2010.12.006; Gao XP, 2007, J BIOL CHEM, V282, P6116, DOI 10.1074/jbc.M610248200; Haubner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009350; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hua F, 2007, J IMMUNOL, V178, P7317, DOI 10.4049/jimmunol.178.11.7317; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Li DY, 2009, J CEREBR BLOOD F MET, V29, P1903, DOI 10.1038/jcbfm.2009.102; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Mak Lok Hang, 2010, J Chem Biol, V3, P157, DOI 10.1007/s12154-010-0041-7; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Myou S, 2003, J IMMUNOL, V171, P4399, DOI 10.4049/jimmunol.171.8.4399; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Qian JQ, 2012, AM J PHYSIOL-HEART C, V302, pH1806, DOI 10.1152/ajpheart.00929.2011; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Ruan HM, 2009, J MOL CELL CARDIOL, V46, P193, DOI 10.1016/j.yjmcc.2008.10.021; Sano M, 2005, AM J RESP CELL MOL, V33, P65, DOI 10.1165/rcmb.2005-0076OC; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Schwartzbauer G, 2001, J BIOL CHEM, V276, P35786, DOI 10.1074/jbc.M102479200; Shao ZH, 2010, AM J PHYSIOL-HEART C, V298, pH2164, DOI 10.1152/ajpheart.00994.2009; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shugg RPP, 2013, J BIOL CHEM, V288, P35346, DOI 10.1074/jbc.M113.507525; Siddall HK, 2008, BASIC RES CARDIOL, V103, P560, DOI 10.1007/s00395-008-0735-y; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Zhu XD, 2008, AM J RESP CELL MOL, V39, P263, DOI 10.1165/rcmb.2008-0047OC; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	42	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95622	10.1371/journal.pone.0095622	http://dx.doi.org/10.1371/journal.pone.0095622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752319	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400090
J	Ziegler, JC; Lahmers, KK; Barrington, GM; Parish, SM; Kilzer, K; Baker, K; Besser, TE				Ziegler, Jessie C.; Lahmers, Kevin K.; Barrington, George M.; Parish, Steven M.; Kilzer, Katherine; Baker, Katherine; Besser, Thomas E.			Safety and Immunogenicity of a Mycoplasma ovipneumoniae Bacterin for Domestic Sheep (Ovis aries)	PLOS ONE			English	Article							PASTEURELLA-HAEMOLYTICA VACCINE; SYSTEMIC IMMUNE-RESPONSES; BIGHORN SHEEP; MANNHEIMIA-HAEMOLYTICA; RESPIRATORY-DISEASE; FATAL PNEUMONIA; CANADENSIS; TRANSMISSION; ASSOCIATION; PROTECTION	Background: Mortality from epizootic pneumonia is hindering re-establishment of bighorn sheep populations in western North America. Mycoplasma ovipneumoniae, a primary agent of this disease, is frequently carried asymptomatically by the domestic sheep and goats that constitute the reservoir of this agent for transmission to bighorn sheep. Our long-term objective is to reduce the risk of M. ovipneumoniae infection of bighorn sheep; one approach to this objective is to control the pathogen in its reservoir hosts. Methods: The safety and immunogenicity of M. ovipneumoniae for domestic sheep was evaluated in three experimental immunization protocols: 1) live M. ovipneumoniae (50 ug protein); 2) killed M. ovipneumoniae (50 ug whole cell protein) in oil adjuvant; and 3) killed M. ovipneumoniae (250 ug whole cell protein) in oil adjuvant. Immunogenicity was assessed by two serum antibody measures: competitive enzyme-linked immunosorbent assay (cELISA) (experiments 1-3) and serum growth inhibition (Experiment 3). Passive immunogenicity was also assessed in the third experiment using the same assays applied to blood samples obtained from the lambs of immunized ewes. Results and Conclusions: Adverse reactions to immunization were generally minor, but local reactions were regularly observed at immunization sites with bacterins in oil adjuvants. No evidence of M. ovipneumoniae specific antibody responses were observed in the first or second experiments and no resistance to colonization was observed in the first experiment. However, the ewes in the third experiment developed strong cELISA serum antibody responses and significant serum M. ovipneumoniae inhibition activity, and these responses were passively transferred to their lambs. The results of these trials indicate that immunization with relatively large antigenic mass combined with an adjuvant is capable of inducing strong active antibody responses in ewes and passively immunizing lambs.	[Ziegler, Jessie C.; Barrington, George M.; Parish, Steven M.] Washington State Univ, Dept Vet Clin Med, Pullman, WA 99164 USA; [Lahmers, Kevin K.; Kilzer, Katherine; Baker, Katherine; Besser, Thomas E.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University; Washington State University	Ziegler, JC (corresponding author), Washington State Univ, Dept Vet Clin Med, Pullman, WA 99164 USA.	jcziegler@vetmed.wsu.edu	Lahmers, Kevin/E-8272-2017; Ziegler, Johannes/C-2234-2008	Lahmers, Kevin/0000-0002-5290-3426; Ziegler, Johannes/0000-0002-2061-5729	Federal Aid to Wildlife Restoration Project administered through the Idaho Department of Fish and Game [W-160-R]	Federal Aid to Wildlife Restoration Project administered through the Idaho Department of Fish and Game	This project was funded by a grant from Federal Aid to Wildlife Restoration Project W-160-R administered through the Idaho Department of Fish and Game. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley M R, 1975, N Z Vet J, V23, P137, DOI 10.1080/00480169.1975.34214; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Besser TE, 2012, J WILDLIFE DIS, V48, P168, DOI 10.7589/0090-3558-48.1.168; BLACK SR, 1988, J WILDLIFE DIS, V24, P627, DOI 10.7589/0090-3558-24.4.627; BROGDEN KA, 1988, AM J VET RES, V49, P1669; Cassirer EF, 2013, J ANIM ECOL, V82, P518, DOI 10.1111/1365-2656.12031; Cassirer EF, 2001, J WILDLIFE DIS, V37, P49, DOI 10.7589/0090-3558-37.1.49; Dassanayake RP, 2010, VET MICROBIOL, V145, P354, DOI 10.1016/j.vetmic.2010.04.011; Foreyt B, 1998, EVALUATION MULTIVALE, P18; Foreyt W.J., 1994, P BIENN S NO WILD SH, V9, P7; Foreyt WJ, 2009, J WILDLIFE DIS, V45, P272, DOI 10.7589/0090-3558-45.2.272; FOREYT WJ, 1989, AM J VET RES, V50, P341; FOREYT WJ, 1982, J WILDLIFE DIS, V18, P163, DOI 10.7589/0090-3558-18.2.163; Foreyt WJ, 1996, J WILDLIFE DIS, V32, P594, DOI 10.7589/0090-3558-32.4.594; FOREYT WJ, 1994, J WILDLIFE DIS, V30, P137, DOI 10.7589/0090-3558-30.2.137; Foreyt WJ, 1996, J WILDLIFE DIS, V32, P315, DOI 10.7589/0090-3558-32.2.315; Foreyt WJ, 1992, FAILURE EXPT PASTEUR, P155; Gourlay RN, 1983, METHODS MYCOPLASMOLO, VII, P81; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; Kraabel BJ, 1998, J WILDLIFE DIS, V34, P325, DOI 10.7589/0090-3558-34.2.325; Lawrence PK, 2010, J WILDLIFE DIS, V46, P706, DOI 10.7589/0090-3558-46.3.706; Lyman Ott R., 2010, INTRO STAT METHODS D, V6th; Marchioro SB, 2013, VACCINE, V31, P1305, DOI 10.1016/j.vaccine.2012.12.068; Miller MW, 1997, J WILDLIFE DIS, V33, P738, DOI 10.7589/0090-3558-33.4.738; National Research Council Committee for the Update of the Guide for the C. U. o. L., 2011, DRUG DISCOVERY EVALU; NEWTON LG, 1992, AUST VET J, V69, P306, DOI 10.1111/j.1751-0813.1992.tb09912.x; Nicholas R, 2010, METHODS MOL BIOL MYC, P105; Nicholas R, 2008, MYCOPLASMA DISEASES OF RUMINANTS, P169, DOI 10.1079/9780851990125.0169; Nicholas R, 2008, MYCOPLASMA DISEASES OF RUMINANTS, P69, DOI 10.1079/9780851990125.0069; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Sirochman MA, 2012, J WILDLIFE DIS, V48, P781, DOI 10.7589/0090-3558-48.3.781; Subramaniam R, 2011, CLIN VACCINE IMMUNOL, V18, P1689, DOI 10.1128/CVI.05276-11; Thacker EL, 2000, AM J VET RES, V61, P1384, DOI 10.2460/ajvr.2000.61.1384	35	25	31	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95698	10.1371/journal.pone.0095698	http://dx.doi.org/10.1371/journal.pone.0095698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752006	gold, Green Submitted, Green Published			2022-12-25	WOS:000335227400103
J	Ma, LP; Shen, YQ; Khatri, HP; Schachner, M				Ma, Liping; Shen, Yan-Qin; Khatri, Harsh P.; Schachner, Melitta			The Asparaginyl Endopeptidase Legumain Is Essential for Functional Recovery after Spinal Cord Injury in Adult Zebrafish	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PROMOTES LOCOMOTOR RECOVERY; GENE-EXPRESSION ANALYSIS; CENTRAL-NERVOUS-SYSTEM; MAMMALIAN LEGUMAIN; CELL-SURFACE; CYSTATIN E/M; REGENERATION; ACTIVATION; CANCER	Unlike mammals, adult zebrafish are capable of regenerating severed axons and regaining locomotor function after spinal cord injury. A key factor for this regenerative capacity is the innate ability of neurons to re-express growth-associated genes and regrow their axons after injury in a permissive environment. By microarray analysis, we have previously shown that the expression of legumain (also known as asparaginyl endopeptidase) is upregulated after complete transection of the spinal cord. In situ hybridization showed upregulation of legumain expression in neurons of regenerative nuclei during the phase of axon regrowth/sprouting after spinal cord injury. Upregulation of Legumain protein expression was confirmed by immunohistochemistry. Interestingly, upregulation of legumain expression was also observed in macrophages/microglia and neurons in the spinal cord caudal to the lesion site after injury. The role of legumain in locomotor function after spinal cord injury was tested by reducing Legumain expression by application of anti-sense morpholino oligonucleotides. Using two independent anti-sense morpholinos, locomotor recovery and axonal regrowth were impaired when compared with a standard control morpholino. We conclude that upregulation of legumain expression after spinal cord injury in the adult zebrafish is an essential component of the capacity of injured neurons to regrow their axons. Another feature contributing to functional recovery implicates upregulation of legumain expression in the spinal cord caudal to the injury site. In conclusion, we established for the first time a function for an unusual protease, the asparaginyl endopeptidase, in the nervous system. This study is also the first to demonstrate the importance of legumain for repair of an injured adult central nervous system of a spontaneously regenerating vertebrate and is expected to yield insights into its potential in nervous system regeneration in mammals.	[Ma, Liping; Khatri, Harsh P.; Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08901 USA; [Ma, Liping; Khatri, Harsh P.; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Shen, Yan-Qin; Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Guangdong, Peoples R China; [Shen, Yan-Qin] Jiangnan Univ, Sch Med, Dept Basic Med, Wuxi, Jiangsu, Peoples R China	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Shantou University; Jiangnan University	Schachner, M (corresponding author), Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08901 USA.	schachner@stu.edu.cn			New Jersey Commission on Spinal Cord Research [05-3048-SCR-E-0, 08-3079-SCR-E-0]	New Jersey Commission on Spinal Cord Research	This work was supported by grants from the New Jersey Commission on Spinal Cord Research (05-3048-SCR-E-0 and 08-3079-SCR-E-0, http://www.state.nj.us/health/spinalcord/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade V, 2011, J HEPATOL, V55, P626, DOI 10.1016/j.jhep.2010.12.022; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 1998, J NEUROSCI, V18, P5789; Becker T, 2001, J COMP NEUROL, V433, P131, DOI 10.1002/cne.1131; Briggs JJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-17; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chen JM, 1998, BIOCHEM J, V335, P111, DOI 10.1042/bj3350111; Choi SJ, 1999, J BIOL CHEM, V274, P27747, DOI 10.1074/jbc.274.39.27747; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dias TB, 2012, J NEUROSCI, V32, P3245, DOI 10.1523/JNEUROSCI.6398-11.2012; Edgington LE, 2013, J AM CHEM SOC, V135, P174, DOI 10.1021/ja307083b; Goff LA, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-76; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Haugen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052980; Huang WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066613; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lecaille F, 2004, BIOL CHEM, V385, P511, DOI 10.1515/BC.2004.060; Lieberoth Bettina C., 2003, Methods in Cell Science, V25, P65, DOI 10.1023/B:MICS.0000006848.57869.4c; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lin JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052376; Lin YY, 2013, CANCER SCI, V104, P1217, DOI 10.1111/cas.12202; Liu C, 2003, CANCER RES, V63, P2957; Liu Y, 2012, MOL PHARMACEUT, V9, P168, DOI 10.1021/mp200434n; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Ma LP, 2006, EUR J NEUROSCI, V23, P2265, DOI 10.1111/j.1460-9568.2006.04782.x; Ma LP, 2012, EUR J NEUROSCI, V35, P353, DOI 10.1111/j.1460-9568.2011.07958.x; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Ohno Y, 2013, WORLD J UROL, V31, P359, DOI 10.1007/s00345-012-0977-z; Pan HC, 2013, EUR J NEUROSCI, V37, P203, DOI 10.1111/ejn.12038; Reimer MM, 2009, J NEUROSCI, V29, P15073, DOI 10.1523/JNEUROSCI.4748-09.2009; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Smith R, 2012, BIOCHIMIE, V94, P2590, DOI 10.1016/j.biochi.2012.07.026; Van Hove I, 2012, J NEUROCHEM, V123, P203, DOI 10.1111/j.1471-4159.2012.07900.x; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Wang LN, 2012, J CELL BIOCHEM, V113, P2679, DOI 10.1002/jcb.24143; Wu BH, 2010, J BIOL CHEM, V285, P1790, DOI 10.1074/jbc.M109.049064; Wu WY, 2006, CANCER RES, V66, P970, DOI 10.1158/0008-5472.CAN-05-2591; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Yamane T, 2002, BBA-PROTEIN STRUCT M, V1596, P108, DOI 10.1016/S0167-4838(02)00209-1; Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043; Yu Y, 2013, EUR J NEUROSCI, V38, P2280, DOI 10.1111/ejn.12222; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	52	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95098	10.1371/journal.pone.0095098	http://dx.doi.org/10.1371/journal.pone.0095098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747977	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500056
J	Negishi, M; Wongpalee, SP; Sarkar, S; Park, J; Lee, KY; Shibata, Y; Reon, BJ; Abounader, R; Suzuki, Y; Sugano, S; Dutta, A				Negishi, Masamitsu; Wongpalee, Somsakul P.; Sarkar, Sukumar; Park, Jonghoon; Lee, Kyung Yong; Shibata, Yoshiyuki; Reon, Brian J.; Abounader, Roger; Suzuki, Yutaka; Sugano, Sumio; Dutta, Anindya			A New lncRNA, APTR, Associates with and Represses the CDKN1A/p21 Promoter by Recruiting Polycomb Proteins	PLOS ONE			English	Article							NONCODING RNAS; GLIOBLASTOMA-MULTIFORME; DNA-DAMAGE; ALU-RNA; CELLS; P21; CHROMATIN; CANCER; P53; PROLIFERATION	Long noncoding RNAs (lncRNAs) have emerged as a major regulator of cell physiology, but many of which have no known function. CDKN1A/p21 is an important inhibitor of the cell-cycle, regulator of the DNA damage response and effector of the tumor suppressor p53, playing a crucial role in tumor development and prevention. In order to identify a regulator for tumor progression, we performed an siRNA screen of human lncRNAs required for cell proliferation, and identified a novel lncRNA, APTR, that acts in trans to repress the CDKN1A/p21 promoter independent of p53 to promote cell proliferation. APTR associates with the promoter of CDKN1A/p21 and this association requires a complementary-Alu sequence encoded in APTR. A different module of APTR associates with and recruits the Polycomb repressive complex 2 (PRC2) to epigenetically repress the p21 promoter. A decrease in APTR is necessary for the induction of p21 after heat stress and DNA damage by doxorubicin, and the levels of APTR and p21 are anti-correlated in human glioblastomas. Our data identify a new regulator of the cell-cycle inhibitor CDKN1A/p21 that acts as a proliferative factor in cancer cell lines and in glioblastomas and demonstrate that Alu elements present in lncRNAs can contribute to targeting regulatory lncRNAs to promoters.	[Negishi, Masamitsu; Wongpalee, Somsakul P.; Sarkar, Sukumar; Park, Jonghoon; Lee, Kyung Yong; Shibata, Yoshiyuki; Reon, Brian J.; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Abounader, Roger] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Inst Med Sci, Tokyo, Japan	University of Virginia; University of Virginia; University of Tokyo	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073; Wongpalee, Somsakul/0000-0002-3169-5509	UVA Cancer Center through the Farrow Fellowship Fund; NCI [P30 CA44579];  [P01 CA104106];  [R01 GM 084465]; NATIONAL CANCER INSTITUTE [P30CA044579, P01CA104106, T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, R01GM084465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045209] Funding Source: NIH RePORTER	UVA Cancer Center through the Farrow Fellowship Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MN was partly supported by the UVA Cancer Center through the Farrow Fellowship Fund and the NCI Cancer Center Support Grant, P30 CA44579. The work was supported by P01 CA104106 and R01 GM 084465 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P2374, DOI 10.1093/nar/gkl246; HSU K, 1995, J BIOL CHEM, V270, P10179, DOI 10.1074/jbc.270.17.10179; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim J, 2014, CANC RES CANC R 0114; Kraus A, 2000, J NEUROSURG, V93, P863, DOI 10.3171/jns.2000.93.5.0863; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee KY, 2012, J BIOL CHEM, V287, P11891, DOI 10.1074/jbc.M111.338467; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lukyanov DV, 2000, EUR J BIOCHEM, V267, P2362, DOI 10.1046/j.1432-1327.2000.01248.x; Machida YJ, 2006, MOL BIOL CELL, V17, P4837, DOI 10.1091/mbc.E06-04-0340; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Negishi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012373; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	38	63	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95216	10.1371/journal.pone.0095216	http://dx.doi.org/10.1371/journal.pone.0095216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748121	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500067
J	Sebastian, J; Wong, MK; Tang, E; Dinneny, JR				Sebastian, Jose; Wong, Mandy Ka; Tang, Evan; Dinneny, Jose R.			Methods to Promote Germination of Dormant Setaria viridis Seeds	PLOS ONE			English	Article							ABSCISIC-ACID; GENOME SEQUENCE; FOXTAIL MILLET; GREEN FOXTAIL; SMOKE; MODEL; L.; GIBBERELLINS; ITALICA; BEAUV	Setaria viridis has recently emerged as a promising genetic model system to study diverse aspects of monocot biology. While the post-germination life cycle of S. viridis is approximately 8 weeks long, the prolonged dormancy of freshly harvested seeds can more than double the total time required between successive generations. Here we describe methods that promote seed germination in S. viridis. Our results demonstrate that treating S. viridis seeds with liquid smoke or a GA(3) and KNO3 solution improves germination rates to 90% or higher even in seeds that are 6 days post-harvest with similar results obtained whether seeds are planted in soil or on gel-based media. Importantly, we show that these treatments have no significant effect on the growth of the adult plant. We have tested these treatments on diverse S. viridis accessions and show variation in their response. The methods described here will help advance research using this model grass species by increasing the pace at which successive generations of plants can be analyzed.	[Sebastian, Jose; Wong, Mandy Ka; Tang, Evan; Dinneny, Jose R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Dinneny, JR (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	jdinneny@carnegiescience.edu		wong, ka man/0000-0002-6284-4271; Dinneny, Jose/0000-0002-3998-724X	Department of Energy Biological and Environmental Research program [DE-SC0008769]	Department of Energy Biological and Environmental Research program	Funding is provided by a grant from the Department of Energy Biological and Environmental Research program (#DE-SC0008769) to J.R.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchison B, 2001, THESIS IOWA STATE U; BANTING JD, 1973, CAN J PLANT SCI, V53, P369, DOI 10.4141/cjps73-071; BARTELS PG, 1978, WEED SCI, V26, P198, DOI 10.1017/S0043174500049675; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Born VWH, 1971, CAN J PLANT SCI, V51, P53; BRADBEER JW, 1967, NEW PHYTOL, V66, P515, DOI 10.1111/j.1469-8137.1967.tb05423.x; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Chen SY, 2008, TREE PHYSIOL, V28, P1431, DOI 10.1093/treephys/28.9.1431; Defelice MS, 2002, WEED TECHNOL, V16, P253, DOI 10.1614/0890-037X(2002)016[0253:GFSVLP]2.0.CO;2; Dekker J, 2003, WEED SCI, V51, P641, DOI 10.1614/P2002-IR; Dekker J, 2002, AM J BOT, V89, P410, DOI 10.3732/ajb.89.3.410; DOUGLAS BJ, 1985, CAN J PLANT SCI, V65, P669, DOI 10.4141/cjps85-089; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; Gashi B, 2012, J BIOTECHNOL, V11, P4537; Graeber K, 2012, PLANT CELL ENVIRON, V35, P1769, DOI 10.1111/j.1365-3040.2012.02542.x; Hanley ME, 2009, APPL VEG SCI, V12, P385, DOI 10.1111/j.1654-109X.2009.01038.x; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Javid A., 2001, PAKISTAN J BIOL SCI, V4, P1108; Jiang H, 2013, JOVE-J VIS EXP, DOI 10.3791/50527; KAHN A, 1957, SCIENCE, V125, P645, DOI 10.1126/science.125.3249.645; KEELEY JE, 1987, ECOLOGY, V68, P434, DOI 10.2307/1939275; Kepczynski J, 2010, PLANT GROWTH REGUL, V62, P85, DOI 10.1007/s10725-010-9493-6; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Naredo MEB, 1998, SEED SCI TECHNOL, V26, P675; Nelson DC, 2012, ANNU REV PLANT BIOL, V63, P107, DOI 10.1146/annurev-arplant-042811-105545; Nelson DC, 2009, PLANT PHYSIOL, V149, P863, DOI 10.1104/pp.108.131516; Perez-Fernandez MA, 2003, J CHEM ECOL, V29, P237, DOI 10.1023/A:1021997118146; SAINI HS, 1985, PLANT PHYSIOL, V77, P940, DOI 10.1104/pp.77.4.940; Seo M, 2009, PLANT MOL BIOL, V69, P463, DOI 10.1007/s11103-008-9429-y; Steinbach HS, 1997, PLANT PHYSIOL, V113, P149, DOI 10.1104/pp.113.1.149; Todorovic S, 2005, PLANT GROWTH REGUL, V47, P141, DOI 10.1007/s10725-005-3253-z; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	39	27	28	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95109	10.1371/journal.pone.0095109	http://dx.doi.org/10.1371/journal.pone.0095109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748008	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500058
J	Song, WG; Liu, YZ; Liu, Y; Zhang, C; Yuan, B; Zhang, LB; Sun, SL				Song, Wengang; Liu, Yongzhe; Liu, Ying; Zhang, Cong; Yuan, Bao; Zhang, Lianbo; Sun, Shilong			Increased P16 DNA Methylation in Mouse Thymic Lymphoma Induced by Irradiation	PLOS ONE			English	Article							EPIGENETIC REGULATION; GENE-EXPRESSION; CPG ISLANDS; HYPERMETHYLATION; P16(INK4A); PROGRESSION	DNA methylation is an important part of epigenetics. In this study, we examined the methylation state of two CpG islands in the promoter of the p16 gene in radiation-induced thymic lymphoma samples. The mRNA and protein levels of P16 were significantly reduced in radiation-induced thymic lymphoma tissue samples. Twenty-three CpG sites of the CpG islands in the p16 promoter region were detected, and the methylation percentages of -71, -63, -239, -29, -38, -40, -23, 46 CpG sites were significantly higher in radiation-induced thymic lymphoma tissue samples than those in matched non-irradiated thymus tissue samples. This study provides new evidence for the methylation state of p16 in the radiation-induced thymic lymphoma samples, which suggests that the methylation of these CpG sites in the p16 promoter may reduce its expression in the thymic lymphoma after irradiation.	[Song, Wengang] Beihua Univ, Jinlin, Peoples R China; [Liu, Yongzhe] Tianjin Med Univ, Dept Toxicol, Sch Publ Hlth, Tianjin, Peoples R China; [Liu, Ying] Jilin Univ, Dept Toxicol, Sch Publ Hlth, Changchun 130023, Peoples R China; [Zhang, Cong; Sun, Shilong] Jilin Univ, Minist Hlth, Key Lab Radiobiol, Changchun 130023, Peoples R China; [Zhang, Cong; Sun, Shilong] Tsinghua Univ, Natl Lab Med Mol Biol, Beijing 100084, Peoples R China; [Yuan, Bao] Jilin Univ, Coll Anim Sci, Changchun 130023, Peoples R China; [Zhang, Lianbo] Jilin Univ, China Japan Union Hosp, Dept Plast & Reconstruct Surg, Changchun 130023, Peoples R China	Beihua University; Tianjin Medical University; Jilin University; Jilin University; Tsinghua University; Jilin University; Jilin University	Zhang, LB (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Plast & Reconstruct Surg, Changchun 130023, Peoples R China.	doctorzhanglianbo@163.com			National Science Foundation of China [81372068]; Science and Technology research projects of the Education Department of Jilin province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology research projects of the Education Department of Jilin province	This paper is supported by a grant from the National Science Foundation of China (No. 81372068) and the Science and Technology research projects of the Education Department of Jilin province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Attaleb M, 2009, ONCOL RES, V18, P185, DOI 10.3727/096504009790217416; Bai H, 2003, MUTAT RES-GEN TOX EN, V535, P73, DOI 10.1016/S1383-5718(02)00288-7; Cao J, 2009, CLIN CANCER RES, V15, P5178, DOI 10.1158/1078-0432.CCR-09-0580; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Deng DJ, 2010, CHINESE J CANCER RES, V22, P245, DOI 10.1007/s11670-010-0245-y; Feng ZQ, 2011, EXP MOL PATHOL, V91, P569, DOI 10.1016/j.yexmp.2011.06.004; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goetz W, 2011, RADIAT RES, V175, P575, DOI 10.1667/RR2390.1; Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251; HIRAMA T, 1995, BLOOD, V86, P841; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KAPLAN HS, 1953, CANCER RES, V13, P677; Kaup S, 2006, MUTAT RES-FUND MOL M, V597, P87, DOI 10.1016/j.mrfmmm.2005.06.032; Koturbash I, 2005, BIOCHEM BIOPH RES CO, V337, P526, DOI 10.1016/j.bbrc.2005.09.084; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Krakowczyk L, 2010, MED SCI MONITOR, V16, pCR469; Kumar A, 2011, INT J RADIAT BIOL, V87, P1086, DOI 10.3109/09553002.2011.605417; Li QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013732; Lu ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035928; Michelotti GA, 2007, FASEB J, V21, P1979, DOI 10.1096/fj.06-7118com; Mosesso P, 2010, MUTAT RES-GEN TOX EN, V701, P86, DOI 10.1016/j.mrgentox.2010.03.005; Nielsen DA, 2009, NEUROPSYCHOPHARMACOL, V34, P867, DOI 10.1038/npp.2008.108; PATTENGALE P, 1986, CURR TOP MICROBIOL, V132, P9; PATTENGALE PK, 1983, J NATL CANCER I, V70, P169; Rother J, 2009, CURR GENOMICS, V10, P231, DOI 10.2174/138920209788488526; Salam I, 2009, MOL CELL BIOCHEM, V332, P51, DOI 10.1007/s11010-009-0173-7; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharma G, 2007, LIFE SCI, V80, P1873, DOI 10.1016/j.lfs.2007.02.026; Shim YH, 2003, CANCER LETT, V190, P213, DOI 10.1016/S0304-3835(02)00613-4; Silva SD, 2012, BRAZ J MED BIOL RES, V45, P1327, DOI 10.1590/S0100-879X2012007500140; Smith Elaine M, 2010, Infect Agent Cancer, V5, P4, DOI 10.1186/1750-9378-5-4; Vidaurreta M, 2008, UROL ONCOL-SEMIN ORI, V26, P239, DOI 10.1016/j.urolonc.2007.01.018; Voso MT, 2010, CHEM-BIOL INTERACT, V184, P46, DOI 10.1016/j.cbi.2009.10.013	34	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93850	10.1371/journal.pone.0093850	http://dx.doi.org/10.1371/journal.pone.0093850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747802	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500014
J	Macha, MA; Rachagani, S; Pai, P; Gupta, S; Lydiatt, WM; Smith, RB; Johansson, SL; Lele, SM; Kakar, SS; Lee, JH; Meza, J; Ganti, AK; Jain, M; Batra, SK				Macha, M. A.; Rachagani, S.; Pai, P.; Gupta, S.; Lydiatt, W. M.; Smith, R. B.; Johansson, S. L.; Lele, S. M.; Kakar, S. S.; Lee, J. H.; Meza, J.; Ganti, A. K.; Jain, M.; Batra, S. K.			MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway	ONCOGENE			English	Article							PANCREATIC-CANCER; HUMAN-PAPILLOMAVIRUS; MUCINS MUC1; EXPRESSION; GROWTH; PROLIFERATION; METASTASIS; OVEREXPRESSION; SURVIVAL; BIOLOGY	The limited effectiveness of therapy for patients with advanced stage head and neck squamous cell carcinoma (HNSCC) or recurrent disease is a reflection of an incomplete understanding of the molecular basis of HNSCC pathogenesis. MUC4, a high molecular weight glycoprotein, is differentially overexpressed in many human cancers and implicated in cancer progression and resistance to several chemotherapies. However, its clinical relevance and the molecular mechanisms through which it mediates HNSCC progression are not well understood. This study revealed a significant upregulation of MUC4 in 78% (68/87) of HNSCC tissues compared with 10% positivity (1/10) in benign samples (P = 0.006, odds ratio (95% confidence interval) = 10.74 (2.0-57.56). MUC4 knockdown (KD) in SCC1 and SCC10B HNSCC cell lines resulted in significant inhibition of growth in vitro and in vivo, increased senescence as indicated by an increase in the number of flat, enlarged and senescence-associated beta-galactosidase (SA-beta-Gal)positive cells. Decreased cellular proliferation was associated with G(0)/G(1) cell cycle arrest and decrease expression of cell cycle regulatory proteins like cyclin E, cyclin D1 and decrease in BrdU incorporation. Mechanistic studies revealed upregulation of p16, pRb dephosphorylation and its interaction with histone deacetylase 1/2. This resulted in decreased histone acetylation (H3K9) at cyclin E promoter leading to its downregulation. Orthotopic implantation of MUC4 KD SCC1 cells into the floor of the mouth in nude mice resulted in the formation of significantly smaller tumors (170 +/- 18.30 mg) compared to those (375 +/- 17.29 mg) formed by control cells (P = 0.00007). In conclusion, our findings showed that MUC4 overexpression has a critical role by regulating proliferation and cellular senescence of HNSCC cells. Downregulation of MUC4 may be a promising therapeutic approach for treating HNSCC patients.	[Macha, M. A.; Rachagani, S.; Pai, P.; Gupta, S.; Jain, M.; Batra, S. K.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Lydiatt, W. M.; Smith, R. B.] Univ Nebraska, Med Ctr, Dept Otolaryngol, Omaha, NE 68198 USA; [Johansson, S. L.; Lele, S. M.] Univ Nebraska, Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Kakar, S. S.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA; [Lee, J. H.] Sanford Canc Res Ctr, Sanford ENT Head & Neck Surg, Sioux Falls, SD USA; [Meza, J.] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE 68198 USA; [Ganti, A. K.] VA Nebraska Western Iowa Hlth Care Syst, Dept Internal Med, Omaha, NE USA; [Ganti, A. K.] Univ Nebraska, Med Ctr, Omaha, NE 68198 USA; [Jain, M.; Batra, S. K.] Buffett Canc Ctr, Omaha, NE USA; [Batra, S. K.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Louisville; Sanford Health; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Jain, M (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	mjain@unmc.edu; sbatra@unmc.edu	Ganti, Apar Kishor/D-5498-2015; MACHA, MUZAFAR AHMAD/AAN-5735-2020	Ganti, Apar Kishor/0000-0003-3724-2671; MACHA, MUZAFAR AHMAD/0000-0003-4468-4435	National Institutes of Health [RO1 CA133774, U54 CA163120, UO1 CA111294, P50 CA 127297, R21 CA156037, P20 RR021937]; NATIONAL CANCER INSTITUTE [R21CA156037, R01CA133774, P50CA127297, U54CA163120, U01CA111294] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the invaluable technical support from Ms Kavita Mallya and Hanan I Farghaly. We also thank Janice A Taylor and James R Talaska of the confocal laser scanning microscope core facility at UNMC for their support. This work was supported, in part, by the grants from National Institutes of Health (RO1 CA133774, U54 CA163120, UO1 CA111294, P50 CA 127297, R21 CA156037 and P20 RR021937).	Alos L, 2005, AM J SURG PATHOL, V29, P806, DOI 10.1097/01.pas.0000155856.84553.c9; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bafna S, 2008, CANCER RES, V68, P9231, DOI 10.1158/0008-5472.CAN-08-3135; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Cai Yang, 2007, Chinese Journal of Pathology, V36, P375; Califano J, 1996, CANCER RES, V56, P2488; Cammarano MS, 2005, MOL CELL BIOL, V25, P9532, DOI 10.1128/MCB.25.21.9532-9542.2005; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chakraborty Subhankar, 2008, Expert Opin Med Diagn, V2, P891, DOI 10.1517/17530059.2.8.891; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Chung IS, 2008, ORAL ONCOL, V44, P1118, DOI 10.1016/j.oraloncology.2008.01.017; Dey P, 2012, CLIN CANCER RES, V18, P6188, DOI 10.1158/1078-0432.CCR-12-1789; DIMRI GP, 1994, COLD SPRING HARB SYM, V59, P67, DOI 10.1101/SQB.1994.059.01.010; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Gil Z, 2009, ISR MED ASSOC J, V11, P296; Hamada T, 2012, INT J CANCER, V130, P1768, DOI 10.1002/ijc.26187; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kitazono I, 2013, PANCREAS, V42, P1120, DOI 10.1097/MPA.0b013e3182965915; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Liggett WH, 1996, CANCER RES, V56, P4119; LLeonart ME, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-3; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Macha MA, CANC LETT, V341, P166; Majhi PD, 2013, J THORAC ONCOL, V8, P398, DOI 10.1097/JTO.0b013e3182829e06; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Mukhopadhyay P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054455; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nichols Anthony C, 2012, ISRN Oncol, V2012, P809370, DOI 10.5402/2012/809370; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Ponnusamy MP, 2008, BRIT J CANCER, V99, P520, DOI 10.1038/sj.bjc.6604517; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Ponnusamy MP, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-4; Rabassa ME, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-253; Rachagani S, 2012, CARCINOGENESIS, V33, P1953, DOI 10.1093/carcin/bgs225; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sano D, 2011, CLIN CANCER RES, V17, P6658, DOI 10.1158/1078-0432.CCR-11-0046; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027922; Tang AL, 2012, HEAD NECK-J SCI SPEC, V34, P1480, DOI 10.1002/hed.21962; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; Weed DT, 2001, OTOLARYNG HEAD NECK, V124, P127, DOI 10.1067/mhn.2001.112575; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06	56	23	24	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1698	1708		10.1038/onc.2014.102	http://dx.doi.org/10.1038/onc.2014.102			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24747969	Green Accepted			2022-12-25	WOS:000351848400010
J	Calero, R; Morchon, E; Johnsen, JI; Serrano, R				Calero, Raul; Morchon, Esther; Johnsen, John Inge; Serrano, Rosario			Sunitinib Suppress Neuroblastoma Growth through Degradation of MYCN and Inhibition of Angiogenesis	PLOS ONE			English	Article							N-MYC; FACTOR-I; TUMOR-CELLS; RECEPTOR; PROTEIN; ANTITUMOR; AMPLIFICATION; PROGRESSION; ACTIVATION; EXPRESSION	Neuroblastoma, a tumor of the peripheral sympathetic nervous system, is the most common and deadly extracranial tumor of childhood. The majority of high-risk neuroblastoma exhibit amplification of the MYCN proto-oncogene and increased neoangiogenesis. Both MYCN protein stabilization and angiogenesis are regulated by signaling through receptor tyrosine kinases (RTKs). Therefore, inhibitors of RTKs have a potential as a treatment option for high-risk neuroblastoma. We used receptor tyrosine kinase antibody arrays to profile the activity of membrane-bound RTKs in neuroblastoma and found the multi-RTK inhibitor sunitinib to tailor the activation of RTKs in neuroblastoma cells. Sunitinib inhibited several RTKs and demonstrated potent antitumor activity on neuroblastoma cells, through induction of apoptosis and cell cycle arrest. Treatment with sunitinib decreased MYCN protein levels by inhibition of PI3K/AKT signaling and GSK3 beta. This effect correlates with a decrease in VEGF secretion in neuroblastoma cells with MYCN amplification. Sunitinib significantly inhibited the growth of established, subcutaneous MYCN-amplified neuroblastoma xenografts in nude mice and demonstrated an anti-angiogenic effect in vivo with a reduction of tumor vasculature and a decrease of MYCN expression. These results suggest that sunitinib should be tested as a treatment option for high risk neuroblastoma patients.	[Calero, Raul; Morchon, Esther; Serrano, Rosario] Albacete Univ Hosp, AECC CHUA Canc Res Unit, Albacete, Spain; [Calero, Raul; Johnsen, John Inge] Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Serrano, Rosario] Univ Castilla La Mancha, Toledo, Spain	Karolinska Institutet; Universidad de Castilla-La Mancha	Serrano, R (corresponding author), Albacete Univ Hosp, AECC CHUA Canc Res Unit, Albacete, Spain.	rosario.serrano@uclm.es	Serrano, Rosario/F-3906-2016; Calero, Raul/F-7867-2016	Serrano, Rosario/0000-0002-0853-597X; Calero, Raul/0000-0003-1525-1921; Johnsen, John Inge/0000-0003-1277-812X	scientific foundation of Spanish Association against Cancer (AECC); Castilla La Mancha University; Castilla La Mancha Foundation for Health Research; Castilla La Mancha Health Service	scientific foundation of Spanish Association against Cancer (AECC); Castilla La Mancha University; Castilla La Mancha Foundation for Health Research; Castilla La Mancha Health Service	This work was supported by the scientific foundation of Spanish Association against Cancer (AECC), the Castilla La Mancha University, and the Castilla La Mancha Foundation for Health Research and Castilla La Mancha Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2011, MOL CANCER THER, V10, P697, DOI 10.1158/1535-7163.MCT-10-0695; Beaudry P, 2008, MOL CANCER THER, V7, P418, DOI 10.1158/1535-7163.MCT-07-0568; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chanthery YH, 2012, SCI TRANSL MED, V4; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; de Bouard S, 2007, NEURO-ONCOLOGY, V9, P412, DOI 10.1215/15228517-2007-024; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Fakhari M, 2002, J PEDIATR SURG, V37, P582, DOI 10.1053/jpsu.2002.31614; Galderisi U, 1999, J CELL BIOCHEM, V74, P313, DOI 10.1002/(SICI)1097-4644(19990901)74:3<313::AID-JCB1>3.3.CO;2-Q; Grimmer MR, 2006, CURR OPIN PEDIATR, V18, P634, DOI 10.1097/MOP.0b013e32801080fe; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; Ho R, 2002, CANCER RES, V62, P6462; Ikezoe T, 2006, CANCER SCI, V97, P945, DOI 10.1111/j.1349-7006.2006.00263.x; Jaboin J, 2002, CANCER RES, V62, P6756; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Johnsen J, 2009, APOPTOSIS, V14, P424, DOI 10.1007/s10495-009-0325-y; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Khanna C, 2002, IN VIVO, V16, P77; Kim B, 2004, ONCOGENE, V23, P130, DOI 10.1038/sj.onc.1206924; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; Michaelis M, 2008, CLIN CANCER RES, V14, P6531, DOI 10.1158/1078-0432.CCR-08-0821; Misawa A, 2000, CANCER RES, V60, P64; Nilsson MB, 2010, ONCOGENE; Ocana A, 2009, CURR DRUG TARGETS, V10, P575, DOI 10.2174/138945009788488378; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Ribatti D, 2002, INT J CANCER, V102, P351, DOI 10.1002/ijc.10742; Richardson DS, 2006, ONCOGENE, V25, P3206, DOI 10.1038/sj.onc.1209349; Rossler J, 2009, ANTICANCER RES, V29, P1327; Schwab TS, 2005, APOPTOSIS, V10, P831, DOI 10.1007/s10495-005-0429-y; Segerstrom L, 2011, INT J CANCER, V129, P2958, DOI 10.1002/ijc.26268; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Weber A, 2003, CLIN CANCER RES, V9, P5683; Zhang LB, 2009, NEOPLASIA, V11, P426, DOI 10.1593/neo.09166	40	24	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95628	10.1371/journal.pone.0095628	http://dx.doi.org/10.1371/journal.pone.0095628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759734	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200071
J	Chuang, TD; Khorram, O				Chuang, Tsai-Der; Khorram, Omid			miR-200c Regulates IL8 Expression by Targeting IKBKB: A Potential Mediator of Inflammation in Leiomyoma Pathogenesis	PLOS ONE			English	Article							NF-KAPPA-B; MESSENGER-RNA; BREAST-CANCER; IKK-BETA; CELLS; MICRORNAS; IL-8; GENE; PHOSPHORYLATION; ANGIOGENESIS	We have previously reported that leiomyoma expressed lower levels of miR-200c and elevated IL8 as compared to paired myometrium. Here we addressed the regulatory functions of miR-200c on the expression of inflammatory mediators and cellular viability using leiomyomas and paired myometrium and their isolated primary smooth muscle cells. Our results indicated that gain-of function or knockdown of miR-200c in leiomyoma smooth muscle cells (LSMC) regulated IL8 mRNA and protein expression through direct targeting of IKBKB and alteration of NF-kB activity. Additionally, leiomyoma expressed higher levels of phosphorylated IKBKB with no significant difference in the level of IKBKB mRNA and protein as compared to matched myometrium. Gain-of function of miR-200c in LSMC resulted in decreased IkBaphosphorylation and p65 nuclear translocation, which led to decreased p65 transcriptional activity of IL8 promoter, and increased caspase 3/7 activity which was not reversible following IL8 restoration. Collectively, our results suggest that NF-kB signaling pathway is a target of miR200c regulatory function, and low level of miR-200c expression in leiomyoma by transcriptional regulation of inflammatory mediators such as IL8, in part account for development of leiomyomas.	[Chuang, Tsai-Der; Khorram, Omid] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Khorram, O (corresponding author), Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA.	okhorram@obgyn.humc.edu			department of OB/GYN at Harbor-UCLA Medical Center; LA Biomed at Harbor-UCLA Medical Center	department of OB/GYN at Harbor-UCLA Medical Center; LA Biomed at Harbor-UCLA Medical Center	Funding support is from the department of OB/GYN and LA Biomed at Harbor-UCLA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Brandl M, 2010, J CELL SCI, V123, P4231, DOI 10.1242/jcs.071100; Chegini N, 2002, MOL HUM REPROD, V8, P1071, DOI 10.1093/molehr/8.12.1071; Chegini N, 2010, SEMIN REPROD MED, V28, P179, DOI 10.1055/s-0030-1251476; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chuang TD, 2007, KIDNEY INT, V71, P867, DOI 10.1038/sj.ki.5002155; Chuang TD, 2012, ENDOCR-RELAT CANCER, V19, P541, DOI 10.1530/ERC-12-0007; Chuang TD, 2012, MOL ENDOCRINOL, V26, P1028, DOI 10.1210/me.2012-1075; Dai L, 2012, MOL HUM REPROD, V18, P136, DOI 10.1093/molehr/gar066; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107; Fujimoto J, 2002, ANN ONCOL, V13, P430, DOI 10.1093/annonc/mdf078; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Malik M, 2009, FERTIL STERIL, V91, P2177, DOI 10.1016/j.fertnstert.2008.03.045; Panda H, 2012, REPROD SCI, V19, P786, DOI 10.1177/1933719112438448; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Reddy MA, 2012, ARTERIOSCL THROM VAS, V32, P721, DOI 10.1161/ATVBAHA.111.241109; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Selam B, 2002, J CLIN ENDOCR METAB, V87, P3921, DOI 10.1210/jc.87.8.3921; Senturk LM, 2001, AM J OBSTET GYNECOL, V184, P559, DOI 10.1067/mob.2001.111160; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Syssoev KA, 2008, B EXP BIOL MED+, V145, P84, DOI 10.1007/s10517-008-0038-1; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wilson C, 2008, MOL CANCER THER, V7, P2649, DOI 10.1158/1535-7163.MCT-08-0148; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107	47	52	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95370	10.1371/journal.pone.0095370	http://dx.doi.org/10.1371/journal.pone.0095370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755559	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300039
J	Ma, XY; Wang, XX; Cao, J; Geng, ZR; Wang, ZL				Ma, Xiaoyan; Wang, Xiaoxin; Cao, Jing; Geng, Zhirong; Wang, Zhilin			Effect of Proline Analogues on Activity of Human Prolyl Hydroxylase and the Regulation of HIF Signal Transduction Pathway	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; ENDOTHELIAL GROWTH-FACTOR; CANCER CELL-LINES; FACTOR-I; GENE-EXPRESSION; GLYCOLYTIC-ENZYMES; MAMMALIAN-CELLS; ALPHA-ENOLASE; INHIBITORS; OXYGEN	Hypoxia inducible factor 1 (HIF-1) plays a pivotal role in cellular responses to hypoxia. Prolyl hydroxylase 3 (PHD3) degrades HIF-1 alpha under normoxic conditions through the hydroxylation of HIF-1a for proteolysis. Inhibiting PHD3 activity is crucial for up-regulating HIF-1 alpha, thereby acting as a potential target for treating hypoxia-related diseases. In this study, two proline analogues (PA1 and PA2) were screened as PHD3 inhibitors with apparent EC50 values of 1.53 and 3.17 mu M respectively, indicating good inhibition potency. Nine proteins, significantly regulated by PA1, were identified using 2-DE coupled with MALDI-TOF/TOF MS. Pyruvate kinase isozymes M1/M2 (PKM) and alpha-enolase 1 (ENO1), which are key modulators of glycolysis, are directly regulated by HIF-1 alpha. Moreover, VEGF, a signal protein stimulating angiogenesis, was strongly promoted by PA1. Our findings suggest that PA1 stabilized HIF-1 alpha as well as up-regulated glycolysis and angiogenesis proteins. Herein, for the first time, we systematically studied proline analogue PA1 as a PHD3 inhibitor, which provides innovative evidence for the treatment of HIF-related diseases.	[Ma, Xiaoyan; Wang, Xiaoxin; Cao, Jing; Geng, Zhirong; Wang, Zhilin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Geng, ZR (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China.	gengzr@nju.edu.cn; wangzl@nju.edu.cn	Geng, Zhirong/HGC-1447-2022	Geng, Zhirong/0000-0003-3766-9034	National Basic Research Program of China [2013CB922102]; National Natural Science Foundation of China [21075064, 21027013, 21021062, 21275072, 21201101]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Basic Research Program of China (2013CB922102) and the National Natural Science Foundation of China (21075064, 21027013, 21021062, 21275072 and 21201101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON RM, 1995, J BIOL CHEM, V270, P27752, DOI 10.1074/jbc.270.46.27752; Agis H, 2012, J PERIODONTAL RES, V47, P165, DOI 10.1111/j.1600-0765.2011.01415.x; Asikainen TM, 2005, P NATL ACAD SCI USA, V102, P10212, DOI 10.1073/pnas.0504520102; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; BERGER A, 1954, J AM CHEM SOC, V76, P5552, DOI 10.1021/ja01650a082; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cao J, 2013, MEDCHEMCOMM, V4, P1222, DOI 10.1039/c3md00117b; Cao J, 2012, ORG BIOMOL CHEM, V10, P3913, DOI 10.1039/c2ob07076f; CARNEY DN, 1985, CANCER RES, V45, P2913; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Davidson TL, 2006, MOL CARCINOGEN, V45, P479, DOI 10.1002/mc.20176; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Geng ZR, 2011, J INORG BIOCHEM, V105, P391, DOI 10.1016/j.jinorgbio.2010.12.001; GIALLONGO A, 1990, EUR J BIOCHEM, V190, P567, DOI 10.1111/j.1432-1033.1990.tb15611.x; Gorres KL, 2008, BIOCHEMISTRY-US, V47, P9447, DOI 10.1021/bi8009373; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jones SM, 2013, NEUROSCIENCE, V252, P420, DOI 10.1016/j.neuroscience.2013.07.060; Kulkarni AC, 2007, ANTIOXID REDOX SIGN, V9, P1717, DOI 10.1089/ars.2007.1724; Kwon HS, 2011, BIOORG MED CHEM LETT, V21, P4325, DOI 10.1016/j.bmcl.2011.05.050; Lai JCK, 2003, NEUROCHEM RES, V28, P933, DOI 10.1023/A:1023235712524; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Liedtke AJ, 1999, AM J PHYSIOL-HEART C, V277, pH1435, DOI 10.1152/ajpheart.1999.277.4.H1435; Lienard BM, 2008, CHEM COMMUN, P6393, DOI 10.1039/b814440k; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Marrif H, 1999, J NEUROSCI RES, V57, P255; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; McNeill LA, 2005, ANAL BIOCHEM, V336, P125, DOI 10.1016/j.ab.2004.09.019; Mecinovic J, 2009, BIOORG MED CHEM LETT, V19, P6192, DOI 10.1016/j.bmcl.2009.09.005; Melnikova I, 2006, NAT REV DRUG DISCOV, V5, P627, DOI 10.1038/nrd2113; Metzen E, 2004, BIOL CHEM, V385, P223, DOI 10.1515/BC.2004.016; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Mizukami Y, 2004, J BIOL CHEM, V279, P50120, DOI 10.1074/jbc.M402299200; Mole DR, 2010, ANTIOXID REDOX SIGN, V12, P445, DOI 10.1089/ars.2009.2790; Mole DR, 2003, BIOORG MED CHEM LETT, V13, P2677, DOI 10.1016/S0960-894X(03)00539-0; Muhling J, 2003, J CHROMATOGR B, V789, P383, DOI 10.1016/S1570-0232(03)00163-6; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; Okuda T, 2006, ALIMENT PHARM THER, V24, P182, DOI 10.1111/j.1365-2036-2006.00043.x; Ong SG, 2012, PHARMACOL THERAPEUT, V136, P69, DOI 10.1016/j.pharmthera.2012.07.005; Paul SAM, 2004, J CELL PHYSIOL, V200, P20, DOI 10.1002/jcp.10479; Perez AS, 2010, J BIOL CHEM, V285, P18217; PROCKOP DJ, 1969, J BIOL CHEM, V244, P4838; PTASHNE KA, 1985, BIOCHIM BIOPHYS ACTA, V844, P19, DOI 10.1016/0167-4889(85)90228-9; Ratan RR, 2004, STROKE, V35, P2687, DOI 10.1161/01.STR.0000143216.85349.9e; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; ROBIN ED, 1984, J CELL PHYSIOL, V118, P287, DOI 10.1002/jcp.1041180311; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Tegley CM, 2008, BIOORG MED CHEM LETT, V18, P3925, DOI 10.1016/j.bmcl.2008.06.031; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weeks CL, 2002, J CHEM SOC DALTON, P931, DOI 10.1039/b107378h; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wu YC, 2010, NEUROCHEM INT, V57, P198, DOI 10.1016/j.neuint.2010.05.008; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu XF, 2012, NEPHROLOGY, V17, P58, DOI 10.1111/j.1440-1797.2011.01498.x	70	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95692	10.1371/journal.pone.0095692	http://dx.doi.org/10.1371/journal.pone.0095692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755992	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300074
J	Shanahan, M; Ritter, A				Shanahan, Marian; Ritter, Alison			Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; MARIJUANA USE; CONTINGENT VALUATION; ADDICTION TREATMENT; DRUG-USE; PROHIBITION; PREVALENCE; CIGARETTES; AUSTRALIA; OUTCOMES	Aims: To date there has been limited analysis of the economic costs and benefits associated with cannabis legalisation. This study redresses this gap. A cost benefit analysis of two cannabis policy options the status quo (where cannabis use is illegal) and a legalised-regulated option was conducted. Method: A cost benefit analysis was used to value the costs and benefits of the two policies in monetary terms. Costs and benefits of each policy option were classified into five categories (direct intervention costs, costs or cost savings to other agencies, benefits or lost benefits to the individual or the family, other impacts on third parties, and adverse or spill over events). The results are expressed as a net social benefit (NSB). Findings: The mean NSB per annum from Monte Carlo simulations (with the 5 and 95 percentiles) for the status quo was $294.6 million AUD ($201.1 to $392.7 million) not substantially different from the $234.2 million AUD ($136.4 to $331.1 million) for the legalised-regulated model which excludes government revenue as a benefit. When government revenue is included, the NSB for legalised-regulated is higher than for status quo. Sensitivity analyses demonstrate the significant impact of educational attainment and wellbeing as drivers for the NSB result. Conclusion: Examining the percentiles around the two policy options, there appears to be no difference between the NSB for these two policy options. Economic analyses are essential for good public policy, providing information about the extent to which one policy is substantially economically favourable over another. In cannabis policy, for these two options this does not appear to be the case.	[Shanahan, Marian; Ritter, Alison] UNSW Australia, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Shanahan, M (corresponding author), UNSW Australia, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia.	M.Shanahan@unsw.edu.au		Ritter, Alison/0000-0001-9540-1920; Shanahan, Marian/0000-0001-9873-3576	Australian Research Council [DP0880066]; Colonial Foundation Trust; National Drug and Alcohol Research Centre; Commonwealth Government of Australia; NHMRC Senior Research Fellowship	Australian Research Council(Australian Research Council); Colonial Foundation Trust; National Drug and Alcohol Research Centre; Commonwealth Government of Australia(Australian Government); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant from the Australian Research Council [DP0880066]. This work forms part of the Drug Policy Modelling Program, a program funded by the Colonial Foundation Trust and auspiced by the National Drug and Alcohol Research Centre, which receives core funding from the Commonwealth Government of Australia. Professor Ritter is funded through an NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ableson P, 2000, PUBLIC EC PRINCIPLES; Access Economics, 2008, HLTH NAT VAL STAT LI; Australian Bureau of Statistics, 2020, AV WEEKL EARN AUSTR; Australian Competition and Consumer Commission, 2008, REP ACCC INQ COMP RE; Australian Government Productivity Commission, 2007, REP GOV SERV 2006 CO; Australian Institute of Health and Welfare, 2008, 2007 NAT DRUG STRAT; Australian Institute of Health and Welfare (AIHW), 2008, 2007 NAT DRUG STRAT; Babor TF, 2003, ALCOHOL NO ORDINARY; Boys A, 2001, HEALTH EDUC RES, V16, P457, DOI 10.1093/her/16.4.457; Bureau of Crime Statistics and Research, 2006, COURT STAT; Burns L, 2006, ADDICTION, V101, P873, DOI 10.1111/j.1360-0443.2006.01444.x; California Department of Public Health, 2010, MED MAR PROGR FEES; Callard C, 2005, TOB CONTROL, V14, P278, DOI 10.1136/tc.2005.011353; Cameron L, 2001, ECON REC, V77, P19, DOI 10.1111/1475-4932.00002; Cancer Council Victoria, 2010, TOB AUSTR FACTS ISS; Carr VJ, 2003, AUST NZ J PSYCHIAT, V37, P31, DOI 10.1046/j.1440-1614.2003.01092.x; Caulkins JP, 2011, ADDICTION, V106, P1886, DOI 10.1111/j.1360-0443.2011.03461.x; Communities Office of Liquor Gaming and Racing, 2010, UND DRINK OFF; Crancer A, 2010, INVOLVEMENT MARIJUAN; Department of Justice, 2009, BEC POPP GROW; Donnelly N., 1999, EFFECTS CANNABIS EXP; Drummer OH, 2004, ACCIDENT ANAL PREV, V36, P239, DOI 10.1016/S0001-4575(02)00153-7; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Englesman E, 2003, INT J DRUG POLICY, V14, P217; English DR, 1997, ADDICTION, V92, P1553; European Legal Database on Drugs, 2007, ADDICTION; Fergusson DM, 2002, BJOG-INT J OBSTET GY, V109, P21, DOI 10.1016/S1470-0328(02)01020-0; Fergusson DM, 2001, ACCIDENT ANAL PREV, V33, P703, DOI 10.1016/S0001-4575(00)00082-8; Freeman B, 2008, ADDICTION, V103, P580, DOI 10.1111/j.1360-0443.2008.02145.x; French MT, 2002, HEALTH SERV RES, V37, P433, DOI 10.1111/1475-6773.031; Geis G, 2005, CHOP CHOP ILLEGAL CI; Godfrey C, 2006, ECONOMIST-NETHERLAND, V154, P563, DOI 10.1007/s10645-006-9030-1; Haden M., 2004, International Journal of Drug Policy, V15, P225, DOI 10.1016/j.drugpo.2004.03.006; Hall W, 2003, CANNABIS USE DEPENDE; Hall W, 2009, CURR OPIN PSYCHIATR, V22, P258, DOI 10.1097/YCO.0b013e3283298f36; Hickman M, 2009, ADDICTION, V104, P1856, DOI 10.1111/j.1360-0443.2009.02736.x; Horwood LJ, 2010, DRUG ALCOHOL DEPEN, V110, P247, DOI 10.1016/j.drugalcdep.2010.03.008; Hughes C., 2007, EFFECTS DECRIMINALIZ; Kilmer B., 2010, ALTERED STATE ASSESS, DOI DOI 10.1089/jpm.2015.0051; King County Bar Association, 2005, EFF DRUG CONTR NEW L; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Leigh A, 2008, ECON EDUC REV, V27, P149, DOI 10.1016/j.econedurev.2006.09.004; Limb M, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/:bmj.e3936, DOI 10.1136/:BMJ.E3936]; MacCoun R, 2001, DRUG WAR HERISIES LE; MacCoun R.J., 2010, ESTIMATING NONPRICE; Mann RE, 2008, CANNABIS USE DRIVING; Mann RE, 2007, J SAFETY RES, V38, P669, DOI 10.1016/j.jsr.2007.09.004; Martire K, 2009, PRINCIPAL DRUG ANAL; May T, 2007, POLICING CANNABIS CL; May T, 2002, TIMES THEY ARE CHANG; McCaffrey DF, 2010, HEALTH ECON, V19, P1281, DOI 10.1002/hec.1561; McDonald D, 1994, CANBERRA COMMONWEALT; McIntosh E, 2010, APPL METHODS COST BE; McLaren J, 2006, CANNABIS AUSTR USE S; Ministerial Council on Drug Strategy, 2005, AUSTR NAT TOB STRAT; Miron J, 2005, BUDGETARY IMPLICATIO; Mishan EJQE, 2007, COST BENEFIT ANAL; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; NADELMANN EA, 1989, SCIENCE, V245, P939, DOI 10.1126/science.2772647; Ngui R, 2010, CANNABIS USE DISORDE; NSW Industrial Relations, 2008, NSW PUBL SECT AW AGR; NSW Police Force, 2009, THIN BLUE LIN INF SE; NSW Police Force, 2007, CANN CAUT SCHEM; Pacula R.L., 2010, EXAMINING IMPACT MAR; Passey M, 2003, EVALUATION LISMORE M; Phillips B, 2008, NSW DRUG TRENDS 2008; Pudney S., 2006, MEASURING DIFFERENT; Pudney S, 2010, ECON POLICY, P165; Rhodes W, 1997, WHAT AM USERS SPEND; Roads and Traffic Authority, 2010, LIC; Rolles Stephen, 2009, WAR DRUGS BLUEPRINT; Room R., 2008, CANNABIS POLICY MOVI; Shanahan M., 2011, ASSESSING EC CONSEQU; Shanahan M, 2014, J EXP CRIMINOL, V10, P59, DOI 10.1007/s11292-013-9176-1; Sindelar JL, 2004, DRUG ALCOHOL DEPEN, V73, P41, DOI 10.1016/j.drugalcdep.2003.09.002; Teesson M, 2012, AUST NZ J PSYCHIAT, V46, P1182, DOI 10.1177/0004867412460591; Tolkien II Team, 2006, TOLK 2 NEEDS BAS COS; TRUMBULL WN, 1990, J POLICY ANAL MANAG, V9, P201, DOI 10.2307/3325412; Tsuchiya A, 2001, EC EVALUATION HLTH C; UNODC United Nations Office on Drugs and Crime Vienna, 2010, WORLD DRUG REP 2010; van Ours JC, 2009, J HEALTH ECON, V28, P132, DOI 10.1016/j.jhealeco.2008.09.001; Vining A, 2010, J BENEFIT-COST ANAL, V1, DOI 10.2202/2152-2812.1013; Weatherburn D, 2003, AUST NZ J CRIMINOL, V36, P77, DOI 10.1375/acri.36.1.77; Weimer DL, 2009, HEALTH ECON, V18, P181, DOI 10.1002/hec.1365; WHITTINGTON D, 1986, J POLICY ANAL MANAG, V5, P665, DOI 10.2307/3324877; Williams J, 2004, HEALTH ECON, V13, P825, DOI 10.1002/hec.859; Williams J, 2004, HEALTH ECON, V13, P123, DOI 10.1002/hec.796; Wilson J, 1991, CRIME JUSTICE, V13; WILSON JQ, 1990, COMMENTARY, V89, P21; Wodak A, 2002, BRIT MED J, V324, P105, DOI 10.1136/bmj.324.7329.105; Wood E, 2010, TOOLS DEBATE US FEDE; World Health Organization (WHO), 2005, WHO FRAM CONV TOB CO; Zarkin GA, 2000, J SUBST ABUSE TREAT, V18, P149, DOI 10.1016/S0740-5472(99)00030-6	93	19	19	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							095569	10.1371/journal.pone.0095569	http://dx.doi.org/10.1371/journal.pone.0095569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2IS	24755942	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300055
J	Sharif-Askari, FS; Sulaiman, SAS; Sharif-Askari, NS; Hussain, AA				Sharif-Askari, Fatemeh Saheb; Sulaiman, Syed Azhar Syed; Sharif-Askari, Narjes Saheb; Hussain, Ali Al Sayed			Development of an Adverse Drug Reaction Risk Assessment Score among Hospitalized Patients with Chronic Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ELDERLY-PATIENTS; CLINICAL-TRIALS; EVENTS; ASSOCIATION; VALIDATION; FAILURE; MODELS	Background: Adverse drug reactions (ADRs) represent a major burden on the healthcare system. Chronic kidney disease (CKD) patients are particularly vulnerable to ADRs because they are usually on multiple drug regimens, have multiple comorbidities, and because of alteration in their pharmacokinetics and pharmacodynamic parameters. Therefore, one step towards reducing this burden is to identify patients who are at increased risk of an ADR. Objective: To develop a method of identifying CKD patients who are at increased risk for experiencing ADRs during hospitalisation. Materials and Methods: Factors associated with ADRs were identified by using demographic, clinical and laboratory variables of patients with CKD stages 3 to 5 (estimated glomerular filtration rate, 10-59 ml/min/1.73 m(2)) who were admitted between January 1, 2012, and December 31, 2012, to the renal unit of Dubai Hospital. An ADR risk score was developed by constructing a series of logistic regression models. The overall model performance for sequential models was evaluated using Akaike Information Criterion for goodness of fit. Odd ratios of the variables retained in the best model were used to compute the risk scores. Results: Of 512 patients (mean [SD] age, 60 [16] years), 62 (12.1%) experienced an ADR during their hospitalisation. An ADR risk score included age 65 years or more, female sex, conservatively managed end-stage renal disease, vascular disease, serum level of C-reactive protein more than 10 mg/L, serum level of albumin less than 3.5 g/dL, and the use of 8 medications or more during hospitalization. The C statistic, which assesses the ability of the risk score to predict ADRs, was 0.838; 95% CI, 0.784-0.892). Conclusion: A score using routinely available patient data can be used to identify CKD patients who are at increased risk of ADRs.	[Sharif-Askari, Fatemeh Saheb; Sulaiman, Syed Azhar Syed; Sharif-Askari, Narjes Saheb] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Hussain, Ali Al Sayed] Dubai Hlth Author, Dept Pharm, Dubai, U Arab Emirates	Universiti Sains Malaysia	Sharif-Askari, FS (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	dr.fatemeh.askari@gmail.com	Sharif-Askari, Narjes Saheb/I-1743-2019	Sharif-Askari, Narjes Saheb/0000-0003-0482-6777; Syed Sulaiman, Syed Azhar/0000-0002-0775-859X				Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; British Medical Association, 2012, BRIT NATL FORMULARY; Catananti C, 2009, CLIN PHARMACOL THER, V86, P307, DOI 10.1038/clpt.2009.89; Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934; Corsonello A, 2005, ARCH INTERN MED, V165, P790, DOI 10.1001/archinte.165.7.790; Corsonello A, 2005, J GERONTOL A-BIOL, V60, P1147, DOI 10.1093/gerona/60.9.1147; Corsonello A, 2011, DRUG AGING, V28, P379, DOI 10.2165/11588280-000000000-00000; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Efron B., 1994, INTRO BOOTSTRAP; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Gurwitz JH, 2002, ARCH INTERN MED, V162, P1670, DOI 10.1001/archinte.162.15.1670; Hellden A, 2009, DRUG AGING, V26, P595, DOI 10.2165/11315790-000000000-00000; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Johnston PE, 2006, AM J HEALTH-SYST PH, V63, P2218, DOI 10.2146/ajhp050405; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Manley HJ, 2003, AM J KIDNEY DIS, V41, P386, DOI 10.1053/ajkd.2003.50048; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Onder G, 2002, PHARMACOEPIDEM DR S, V11, P385, DOI 10.1002/pds.721; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rozich JD, 2003, QUAL SAF HEALTH CARE, V12, P194, DOI 10.1136/qhc.12.3.194; Steel K, 2004, QUAL SAF HEALTH CARE, V13, P76, DOI 10.1136/qshc.2002.003830; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Verbeeck RK, 2009, EUR J CLIN PHARMACOL, V65, P757, DOI 10.1007/s00228-009-0678-8; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wester K, 2008, BRIT J CLIN PHARMACO, V65, P573, DOI 10.1111/j.1365-2125.2007.03064.x; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423; World Health Organization, 2004, INT CLASSIFICATION D, Vsecond	40	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95991	10.1371/journal.pone.0095991	http://dx.doi.org/10.1371/journal.pone.0095991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755778	Green Published, gold			2022-12-25	WOS:000335240300129
J	Ford, ES; Mannino, DM; Wheaton, AG; Presley-Cantrell, L; Liu, Y; Giles, WH; Croft, JB				Ford, Earl S.; Mannino, David M.; Wheaton, Anne G.; Presley-Cantrell, Letitia; Liu, Yong; Giles, Wayne H.; Croft, Janet B.			Trends in the Use, Sociodemographic Correlates, and Undertreatment of Prescription Medications for Chronic Obstructive Pulmonary Disease among Adults with Chronic Obstructive Pulmonary Disease in the United States from 1999 to 2010	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; AMERICAN-COLLEGE; COPD; CARE; MANAGEMENT; PHYSICIANS; ADHERENCE; DIAGNOSIS; BARRIERS; AWARENESS	Background: The extent to which patients with COPD are receiving indicated treatment with medications to improve lung function and recent trends in the use of these medications is not well documented in the United States. The objective of this study was to examine trends in prescription medications for COPD among adults in the United States from 1999 to 2010. Methods: We performed a trend analysis using data from up to 1426 participants aged >= 20 years with self-reported COPD from six national surveys (National Health and Nutrition Examination Survey 1999-2010). Results: During 2009-2010, the age-adjusted percentage of participants who used any kind of medication was 44.2%. Also during 2009-2010, the most commonly used medications were short-acting agents (36.0%), inhaled corticosteroids (ICS) (18.3%), and LABAs (16.7%). The use of long-acting beta-2 agonists (LABAs) (p for trend <0.001), ICS (p for trend = 0.013) increased significantly over the 12-year period. Furthermore, the use of tiotropium increased rapidly during this period (p for trend <0.001). For the years 2005-2010, the use of LABAs, ICS and tiotropium increased with age. Compared with whites, Mexican Americans were less likely to use short-acting agents, LABAs, ICS, tiotropium, and any kind of COPD medication. Among participants aged 20-79 years with spirometry measurements during 2007-2010, the use of any medication was reported by 19.0% of those with a moderate/severe obstructive impairment and by 72.6% of those with self-reported COPD and any obstructive impairment. Conclusion: The percentages of adults with COPD who reported having various classes of prescription medications that improve airflow limitations changed markedly from 1999-2000 to 2009-2010. However, many adults with COPD did not report having recommended prescription medications.	[Ford, Earl S.; Wheaton, Anne G.; Presley-Cantrell, Letitia; Liu, Yong; Giles, Wayne H.; Croft, Janet B.] Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Mannino, David M.] Univ Kentucky, Coll Publ Hlth, Dept Prevent Med & Environm Hlth, Lexington, KY USA	Centers for Disease Control & Prevention - USA; University of Kentucky	Ford, ES (corresponding author), Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	eford@cdc.gov		Wheaton, Anne/0000-0002-3181-9612; Mannino, David/0000-0003-3646-7828				Barr R Graham, 2005, Am J Med, V118, P1415; Brehm JM, 2008, AM J RESP CRIT CARE, V177, P473, DOI 10.1164/rccm.200708-1274PP; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CDC National Centre for Chronic Disease Prevention & Health Promotion; Division of adult and community health, 2011, PUBL HLTH STRAT FRAM; Centers for Disease Control and Prevention, 2011, SPIR 1 TEST 2 TEST B; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Colorado COPD Coalition American Lung Association of Colorado, 2007, STRAT PLAN ADDR CHRO; Decramer M, 2013, ACTA CLIN BELG, V68, P325, DOI 10.2143/ACB.3403; Foster Jill A, 2007, MedGenMed, V9, P24; Fromer L, 2011, INT J CHRONIC OBSTR, V6, P605, DOI 10.2147/COPD.S24692; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Halpin DMG, 2007, RESP MED, V101, P2378, DOI 10.1016/j.rmed.2007.06.010; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Ingebrigtsen TS, 2013, CHEST, V144, P1811, DOI 10.1378/chest.13-0453; Jones R, 2011, PRIM CARE RESP J, V20, P33, DOI 10.4104/pcrj.2010.00069; Make B, 2012, INT J CHRONIC OBSTR, V7, P1, DOI 10.2147/COPD.S27032; Nair KV, 2011, PATIENT PREFER ADHER, V5, P195, DOI 10.2147/PPA.S18481; National Heart Lung and Blood Institute, 2012, COPD LEARN MOR BREAT; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Perez X, 2012, RESP MED, V106, P374, DOI 10.1016/j.rmed.2011.09.010; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rabe KF, 2011, LANCET, V378, P1038, DOI 10.1016/S0140-6736(11)61295-6; Salinas GD, 2011, INT J CHRONIC OBSTR, V6, P171, DOI 10.2147/COPD.S16396; Sarc I, 2011, J EVAL CLIN PRACT, V17, P737, DOI 10.1111/j.1365-2753.2010.01617.x; Suh DC, 2008, RESP CARE, V53, P1461; Takahashi TU, 2003, RESPIROLOGY, V8, P504, DOI 10.1046/j.1440-1843.2003.00501.x; Toy EL, 2011, RESP MED, V105, P435, DOI 10.1016/j.rmed.2010.09.006; U.S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Center for Health Statistics, 1994, VITAL HLTH STAT, V1; Voelkel NF, 2000, CHEST, V117, p372S, DOI 10.1378/chest.117.5_suppl_2.372S; Zielinski J, 2006, EUR RESPIR J, V27, P833, DOI 10.1183/09031936.06.00025905	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95305	10.1371/journal.pone.0095305	http://dx.doi.org/10.1371/journal.pone.0095305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751857	Green Published, gold			2022-12-25	WOS:000335227400050
J	Franceschi, V; Stellari, FF; Mangia, C; Jacca, S; Lavrentiadou, S; Cavirani, S; Heikenwalder, M; Donofrio, G				Franceschi, Valentina; Stellari, Fabio Franco; Mangia, Carlo; Jacca, Sarah; Lavrentiadou, Sophia; Cavirani, Sandro; Heikenwalder, Mathias; Donofrio, Gaetano			In Vivo Image Analysis of BoHV-4-Based Vector in Mice	PLOS ONE			English	Article							BOVINE HERPESVIRUS-4; PERSISTENT INFECTION; CELL-LINES; LIVER; VIRUS; SEQUESTRATION; ADENOVIRUS; DELIVERY; HEPATOCYTES; EXPRESSION	Due to its biological characteristics bovine herpesvirus 4 (BoHV-4) has been considered as an appropriate gene delivery vector. Its genomic clone, modified as a bacterial artificial chromosome (BAC), is better genetically manipulable and can be used as an efficient gene delivery and vaccine vector. Although a large amount of data have been accumulated in vitro on this specific aspect, the same cannot be asserted for the in vivo condition. Therefore, here we investigated the fate of a recombinant BoHV-4 strain expressing luciferase (BoHV-4-A-CMVluc Delta TK) after intraperitoneal or intravenous inoculation in mice, by generating a novel recombinant BoHV-4 expressing luciferase (BoHV-4-A-CMVluc Delta TK) and by following the virus replication through in vivo imaging analysis. BoHV-4-A-CMVluc Delta TK was first characterized in vitro where it was shown, on one hand that its replication properties are identical to those of the parental virus, and on the other that the transduced/ infected cells strongly express luciferase. When BoHV-4-A-CMVlucDTK was inoculated in mice, either intraperitoneally or intravenously, BoHV-4-A-CMVluc Delta TK infection/transduction was exclusively localized to the liver, as detected by in vivo image analysis, and in particular almost exclusively in the hepatocytes, as determined by immuno-histochemistry. These data, that add a new insight on the biology of BoHV-4 in vivo, provide the first indication for the potential use of a BoHV-4-based vector in gene-transfer in the liver.	[Franceschi, Valentina; Stellari, Fabio Franco; Mangia, Carlo; Jacca, Sarah; Lavrentiadou, Sophia; Cavirani, Sandro; Donofrio, Gaetano] Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-80290 Munich, Germany	University of Parma; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Donofrio, G (corresponding author), Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy.	gaetano.donofrio@unipr.it	Heikenwalder, Mathias/AAA-2269-2020; franceschi, valentina/AAR-5566-2020	Cavirani, Sandro/0000-0002-1014-2307; franceschi, valentina/0000-0003-3945-2285; Mangia, Carlo/0000-0002-4533-9062; Donofrio, Gaetano/0000-0002-8984-0377; Lavrentiadou, Sophia/0000-0002-4062-2336	Italian Minister of the Education, University and Research [PRIN 2010LLXR94_004]	Italian Minister of the Education, University and Research	The authors would like to thank the Italian Minister of the Education, University and Research for the financial support (PRIN 2010LLXR94_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Arii S, 2000, J Hepatobiliary Pancreat Surg, V7, P40, DOI 10.1007/s005340050152; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; CRANDELL RA, 1978, J CLIN MICROBIOL, V7, P214; Di Paolo NC, 2009, MOL THER, V17, P675, DOI 10.1038/mt.2008.307; Donofrio G, 2008, VACCINE, V26, P6031, DOI 10.1016/j.vaccine.2008.09.023; Donofrio G, 2002, J VIROL METHODS, V101, P49, DOI 10.1016/S0166-0934(01)00419-0; Donofrio G, 2006, CLIN VACCINE IMMUNOL, V13, P1246, DOI 10.1128/CVI.00200-06; Donofrio G, 2006, J VIROL METHODS, V136, P126, DOI 10.1016/j.jviromet.2006.04.008; Donofrio G, 2006, MICROBES INFECT, V8, P898, DOI 10.1016/j.micinf.2005.10.016; Donofrio G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052758; Donofrio G, 2011, VACCINE, V29, P867, DOI 10.1016/j.vaccine.2010.11.048; Donofrio G, 2009, CLIN VACCINE IMMUNOL, V16, P1675, DOI 10.1128/CVI.00224-09; Donofrio G, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-68; Gillet L, 2005, CANCER RES, V65, P9463, DOI 10.1158/0008-5472.CAN-05-1076; Gillet L, 2004, J VIROL, V78, P2336, DOI 10.1128/JVI.78.5.2336-2347.2004; Haisma HJ, 2008, J GEN VIROL, V89, P1097, DOI 10.1099/vir.0.83495-0; MIMS CA, 1959, BRIT J EXP PATHOL, V40, P543; OSORIO FA, 1985, J GEN VIROL, V66, P1941, DOI 10.1099/0022-1317-66-9-1941; OSORIO FA, 1983, AM J VET RES, V44, P975; PETERSON RB, 1988, COMP IMMUNOL MICROB, V11, P93, DOI 10.1016/0147-9571(88)90023-9; Redaelli M, 2012, NEURO-ONCOLOGY, V14, P288, DOI 10.1093/neuonc/nor219; Redaelli M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-298; Redaelli Marco, 2008, Genet Vaccines Ther, V6, P6, DOI 10.1186/1479-0556-6-6; SASSE D, 1992, ENZYME, V46, P8, DOI 10.1159/000468776; SHIRATORI Y, 1993, SEMIN LIVER DIS, V13, P39, DOI 10.1055/s-2007-1007336; Snoeys J, 2006, MOL THER, V13, P98, DOI 10.1016/j.ymthe.2005.06.477; Stone D, 2007, MOL THER, V15, P2146, DOI 10.1038/sj.mt.6300319; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Zhang LQ, 2002, J VIROL, V76, P5271, DOI 10.1128/JVI.76.10.5271-5273.2002; Zimmermann W, 2001, J VIROL, V75, P1186, DOI 10.1128/JVI.75.3.1186-1194.2001	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95779	10.1371/journal.pone.0095779	http://dx.doi.org/10.1371/journal.pone.0095779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752229	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400126
J	Gandhi, JA; Ekhar, VV; Asplund, MB; Abdulkareem, AF; Ahmadi, M; Coelho, C; Martinez, LR				Gandhi, Jay A.; Ekhar, Vaibhav V.; Asplund, Melissa B.; Abdulkareem, Asan F.; Ahmadi, Mohammed; Coelho, Carolina; Martinez, Luis R.			Alcohol Enhances Acinetobacter baumannii-Associated Pneumonia and Systemic Dissemination by Impairing Neutrophil Antimicrobial Activity in a Murine Model of Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; ALVEOLAR MACROPHAGES; ETHANOL INGESTION; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL PNEUMONIA; MESSENGER-RNA; RATS; DISEASE; CELLS	Acinetobacter baumannii (Ab) is a common cause of community-acquired pneumonia (CAP) in chronic alcoholics in tropical and sub-tropical climates and associated with a >50% mortality rate. Using a murine model of alcohol (EtOH) administration, we demonstrated that EtOH enhances Ab-mediated pneumonia leading to systemic infection. Although EtOH did not affect neutrophil recruitment to the lungs of treated mice, it decreased phagocytosis and killing of bacteria by these leukocytes leading to increased microbial burden and severity of disease. Moreover, we determined that mice that received EtOH prior to Ab infection were immunologically impaired, which was reflected in increased pulmonary inflammation, sequential dissemination to the liver and kidneys, and decreased survival. Furthermore, immunosuppression by EtOH was associated with deregulation of cytokine production in the organs of infected mice. This study establishes that EtOH impairs immunity in vivo exacerbating Ab infection and disease progression. The ability of Ab to cause disease in alcoholics warrants the study of its virulence mechanisms and host interactions.	[Gandhi, Jay A.; Ekhar, Vaibhav V.; Asplund, Melissa B.; Abdulkareem, Asan F.; Ahmadi, Mohammed; Martinez, Luis R.] Long Isl Univ Post, Dept Biomed Sci, Brookville, NY 11548 USA; [Ahmadi, Mohammed] Adelphi Univ, Dept Biol, Garden City, NY USA; [Coelho, Carolina; Martinez, Luis R.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Martinez, Luis R.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA; [Coelho, Carolina] Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol Coimbra, PhD Program Expt Biol & Biomed, Coimbra, Portugal; [Coelho, Carolina] Univ Coimbra, Fac Med, Inst Microbiol, Coimbra, Portugal	Adelphi University; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Universidade de Coimbra; Universidade de Coimbra	Martinez, LR (corresponding author), Long Isl Univ Post, Dept Biomed Sci, Brookville, NY 11548 USA.	luis.martinez-torres@liu.edu		Coelho, Carolina/0000-0002-7523-3031	Long Island University-Post Faculty Research Committee Award; Fundacao Ciencia e Tecnologia [SFRH/BD/33471/2008]	Long Island University-Post Faculty Research Committee Award; Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	LRM is supported by the Long Island University-Post Faculty Research Committee Award. CC was supported by PhD grant SFRH/BD/33471/2008 by Fundacao Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Asplund MB, 2013, VIRULENCE, V4, P467, DOI 10.4161/viru.25641; BIRD GLA, 1990, ANN INTERN MED, V112, P917, DOI 10.7326/0003-4819-112-12-917; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Chen Chang-Wen, 1992, Journal of the Formosan Medical Association, V91, P754; Cheung ATW, 1999, NUTR RES, V19, P1763, DOI 10.1016/S0271-5317(99)00116-5; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; CORTESE MM, 1992, ARCH INTERN MED, V152, P2277, DOI 10.1001/archinte.152.11.2277; Einsiedel LJ, 2010, MED J AUSTRALIA, V192, P567, DOI 10.5694/j.1326-5377.2010.tb03638.x; Falagas ME, 2007, EUR J CLIN MICROBIOL, V26, P857, DOI 10.1007/s10096-007-0365-6; Falagas ME, 2006, J MED MICROBIOL, V55, P1619, DOI 10.1099/jmm.0.46747-0; FELVER ME, 1990, ALCOHOL CLIN EXP RES, V14, P255, DOI 10.1111/j.1530-0277.1990.tb00482.x; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; GALLUCCI RM, 1994, ALCOHOL CLIN EXP RES, V18, P625, DOI 10.1111/j.1530-0277.1994.tb00921.x; GREENBERG S, 1995, ALCOHOL CLIN EXP RES, V19, P394, DOI 10.1111/j.1530-0277.1995.tb01521.x; GREENBERG SS, 1995, P SOC EXP BIOL MED, V209, P46; Iwase M, 2006, J SURG RES, V134, P114, DOI 10.1016/j.jss.2005.10.013; Jareo PW, 1996, ALCOHOL CLIN EXP RES, V20, P1646, DOI 10.1111/j.1530-0277.1996.tb01711.x; JAREO PW, 1995, ALCOHOL ALCOHOLISM, V30, P311; KUO CH, 1991, LIVER, V11, P334; Leung AS, 2006, CHEST, V129, P102, DOI 10.1378/chest.129.1.102; LISTER PD, 1993, J INFECT DIS, V167, P1131, DOI 10.1093/infdis/167.5.1131; LISTER PD, 1993, J INFECT DIS, V168, P922, DOI 10.1093/infdis/168.4.922; MacGregor R R, 1997, Curr Clin Top Infect Dis, V17, P291; Mihu MR, 2011, VIRULENCE, V2, P97, DOI 10.4161/viru.2.2.15061; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Murdoch EL, 2011, SHOCK, V35, P403, DOI 10.1097/SHK.0b013e31820217c9; NELSON S, 1991, J INFECT DIS, V164, P901, DOI 10.1093/infdis/164.5.901; Nwugo CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051936; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Rosa H, 2000, AM J GASTROENTEROL, V95, P1290, DOI 10.1111/j.1572-0241.2000.02026.x; ROSELLE GA, 1984, ALCOHOL CLIN EXP RES, V8, P62; Rubins JB, 1996, J INFECT DIS, V174, P507, DOI 10.1093/infdis/174.3.507; SCHAFER C, 1995, Z GASTROENTEROL, V33, P503; SCHENKER S, 1995, ALCOHOL CLIN EXP RES, V19, P1364, DOI 10.1111/j.1530-0277.1995.tb01626.x; Smith MG, 2004, MOL CELL BIOL, V24, P3874, DOI 10.1128/MCB.24.9.3874-3884.2004; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Standiford TJ, 1997, ALCOHOL CLIN EXP RES, V21, P1212, DOI 10.1111/j.1530-0277.1997.tb04440.x; SZABO G, 1993, J LEUKOCYTE BIOL, V54, P534, DOI 10.1002/jlb.54.6.534; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; VILA J, 1993, ANTIMICROB AGENTS CH, V37, P138, DOI 10.1128/AAC.37.1.138; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997	47	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95707	10.1371/journal.pone.0095707	http://dx.doi.org/10.1371/journal.pone.0095707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752133	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400104
J	Jin, F; Feng, DZ				Jin, Feng; Feng, Dazheng			Image Registration Algorithm Using Mexican Hat Function-Based Operator and Grouped Feature Matching Strategy	PLOS ONE			English	Article								Feature detection and matching are crucial for robust and reliable image registration. Although many methods have been developed, they commonly focus on only one class of image features. The methods that combine two or more classes of features are still novel and significant. In this work, methods for feature detection and matching are proposed. A Mexican hat function-based operator is used for image feature detection, including the local area detection and the feature point detection. For the local area detection, we use the Mexican hat operator for image filtering, and then the zero-crossing points are extracted and merged into the area borders. For the feature point detection, the Mexican hat operator is performed in scale space to get the key points. After the feature detection, an image registration is achieved by using the two classes of image features. The feature points are grouped according to a standardized region that contains correspondence to the local area, precise registration is achieved eventually by the grouped points. An image transformation matrix is estimated by the feature points in a region and then the best one is chosen through competition of a set of the transformation matrices. This strategy has been named the Grouped Sample Consensus (GCS). The GCS has also ability for removing the outliers effectively. The experimental results show that the proposed algorithm has high registration accuracy and small computational volume.	[Jin, Feng] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Jin, Feng; Feng, Dazheng] Xidian Univ, Natl Key Lab Sci & Technol Radar Signal Proc, Xian, Peoples R China	Xidian University; Xidian University	Jin, F (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	xdjinfeng@163.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Cui CH, 2011, IEEE T IMAGE PROCESS, V20, P1627, DOI 10.1109/TIP.2010.2103948; Dai XL, 1999, IEEE T GEOSCI REMOTE, V37, P2351, DOI 10.1109/36.789634; Daubechies I, 1992, SOC IND APPL MATH; Fitzgibbon AW, 2001, P BMVC, P43; Kadir T., 2004, P 8 EUR C COMP VIS P, P345; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Manjunath BS, 1996, PATTERN RECOGN, V29, P627, DOI 10.1016/0031-3203(95)00115-8; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Matas J., 2002, Electronic Proceedings of the 13th British Machine Vision Conference, P384; Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Padmavathi G, 2010, P 3 INT C IM SIGN PR; Tuytelaars T, 2000, P 11 BRIT MACH VIS C; Wang J., 2012, ADV IMAGE VIDEO TECH, P393; Yang K, 2004, P IEEE C COMP VIS PA; Yasein MS, 2008, IEEE INT SYMP CIRC S, P3558, DOI 10.1109/ISCAS.2008.4542228; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	19	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95576	10.1371/journal.pone.0095576	http://dx.doi.org/10.1371/journal.pone.0095576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752223	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400079
J	Latzman, RD; Hopkins, WD; Keebaugh, AC; Young, LJ				Latzman, Robert D.; Hopkins, William D.; Keebaugh, Alaine C.; Young, Larry J.			Personality in Chimpanzees (Pan troglodytes): Exploring the Hierarchical Structure and Associations with the Vasopressin V1A Receptor Gene	PLOS ONE			English	Article							HIGHER-ORDER FACTORS; ZOOLOGICAL PARKS; FLANKING REGION; 5-FACTOR MODEL; BEHAVIOR; MICROSATELLITE; TEMPERAMENT; CHILDHOOD; DOMINANCE; NUMBER	One of the major contributions of recent personality psychology is the finding that traits are related to each other in an organized hierarchy. To date, however, researchers have yet to investigate this hierarchy in nonhuman primates. Such investigations are critical in confirming the cross-species nature of trait personality helping to illuminate personality as neurobiologically-based and evolutionarily-derived dimensions of primate disposition. Investigations of potential genetic polymorphisms associated with hierarchical models of personality among nonhuman primates represent a critical first step. The current study examined the hierarchical structure of chimpanzee personality as well as sex-specific associations with a polymorphism in the promoter region of the vasopressin V1a receptor gene (AVPR1A), a gene associated with dispositional traits, among 174 chimpanzees. Results confirmed a hierarchical structure of personality across species and, despite differences in early rearing experiences, suggest a sexually dimorphic role of AVPR1A polymorphisms on hierarchical personality profiles at a higher-order level.	[Latzman, Robert D.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Hopkins, William D.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA; [Hopkins, William D.] Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA; [Keebaugh, Alaine C.; Young, Larry J.] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Div Behav Neurosci & Psychiat Disorders,Ctr Trans, Atlanta, GA USA; [Keebaugh, Alaine C.; Young, Larry J.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University; Emory University	Latzman, RD (corresponding author), Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA.	rlatzman@gsu.edu	Young, Larry/HGE-5031-2022		National Institutes of Health [NS-42867, HD-38051, HD-56232]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure [P51OD11132]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038051, R01HD056232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042867] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by National Institutes of Health grants NS-42867, HD-38051, and HD-56232. Additional support was provided by the National Center for Research Resources P51RR165 to YNPRC, which is currently supported by the Office of Research Infrastructure Programs/OD P51OD11132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2012, BEHAV GENET, V42, P675, DOI 10.1007/s10519-012-9537-y; American Psychological Association, 2012, GUID ETH COND CAR US; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bard K.A, 1994, EARLY DEV PARENTING, V3, P19, DOI 10.1002/edp.2430030104; BARD KA, 1992, INFANT BEHAV DEV, V15, P43, DOI 10.1016/0163-6383(92)90005-Q; Barrett CE, 2013, HORM BEHAV, V63, P518, DOI 10.1016/j.yhbeh.2013.01.005; Bennett AJP, 2010, NONHUMAN PRIMATE RES; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Clark LA, 2005, J ABNORM PSYCHOL, V114, P505, DOI 10.1037/0021-843X.114.4.505; Clark LA, 2008, TEMPERAMENT ORGANIZI; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; De Vries GJ, 2012, ANN AM ACAD SCI, V652, P387; DeYoung CG, 2006, J PERS SOC PSYCHOL, V91, P1138, DOI 10.1037/0022-3514.91.6.1138; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Donaldson ZR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-180; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Goldberg LR, 2006, J RES PERS, V40, P347, DOI 10.1016/j.jrp.2006.01.001; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hong KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022144; Hopkins WD, 2012, GENES BRAIN BEHAV, V11, P552, DOI 10.1111/j.1601-183X.2012.00799.x; Hopwood CJ, 2011, J RES PERS, V45, P468, DOI 10.1016/j.jrp.2011.06.002; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; King JE, 2005, J PERS, V73, P389, DOI 10.1111/j.1467-6494.2005.00313.x; King JE, 1997, J RES PERS, V31, P257, DOI 10.1006/jrpe.1997.2179; Markon KE, 2005, J PERS SOC PSYCHOL, V88, P139, DOI 10.1037/0022-3514.88.1.139; Markon KE, 2009, SOC PERSONAL PSYCHOL, V3, P812, DOI 10.1111/j.1751-9004.2009.00213.x; Martin JE, 2005, APPL ANIM BEHAV SCI, V90, P167, DOI 10.1016/j.applanim.2004.08.019; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Revelle W, 2013, J RES PERS, V47, P493, DOI 10.1016/j.jrp.2013.04.012; Rushton JP, 2008, PERS INDIV DIFFER, V45, P679, DOI 10.1016/j.paid.2008.07.015; Sackett GP, 2006, DEV PRIMATOL; Stockard Charles R., 1931, PHYS BASIS PERSONALI; Tackett JL, 2012, J PERS, V80, P847, DOI 10.1111/j.1467-6494.2011.00748.x; Tackett JL, 2008, J RES PERS, V42, P1456, DOI 10.1016/j.jrp.2008.06.005; Tellegen A, 1985, ANXIETY ANXIETY DISO, P681; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wassink TH, 2004, MENT RETARD DEV D R, V10, P272, DOI 10.1002/mrdd.20041; Weinstein TA, 2008, HDB PERSONALITY THEO, P328; Weiss A, 2002, J PERS SOC PSYCHOL, V83, P1141, DOI 10.1037//0022-3514.83.5.1141; Weiss A, 2000, BEHAV GENET, V30, P213, DOI 10.1023/A:1001966224914; Weiss A, 2009, AM J PRIMATOL, V71, P283, DOI 10.1002/ajp.20649; Weiss A, 2007, AM J PRIMATOL, V69, P1264, DOI 10.1002/ajp.20428; Weiss A, 2012, ANIM BEHAV, V83, P1355, DOI 10.1016/j.anbehav.2012.02.024; Weiss A, 2011, J RES PERS, V45, P393, DOI 10.1016/j.jrp.2011.04.006; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Yirmiya N, 2006, MOL PSYCHIATR, V11, P488, DOI 10.1038/sj.mp.4001812; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	53	25	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95741	10.1371/journal.pone.0095741	http://dx.doi.org/10.1371/journal.pone.0095741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752497	Green Published, gold			2022-12-25	WOS:000335227400113
J	Michalk, I; Feldmann, A; Koristka, S; Arndt, C; Cartellieri, M; Ehninger, A; Ehninger, G; Bachmann, MP				Michalk, Irene; Feldmann, Anja; Koristka, Stefanie; Arndt, Claudia; Cartellieri, Marc; Ehninger, Armin; Ehninger, Gerhard; Bachmann, Michael P.			Characterization of a Novel Single-Chain Bispecific Antibody for Retargeting of T Cells to Tumor Cells via the TCR Co-Receptor CD8	PLOS ONE			English	Article							CANCER-IMMUNOTHERAPY; EFFECTOR-CELLS; PROSTATE	There is currently growing interest in retargeting of effector T cells to tumor cells via bispecific antibodies (bsAbs). Usually, bsAbs are directed on the one hand to the CD3 complex of T cells and on the other hand to a molecule expressed on the surface of the target cell. A bsAb-mediated cross-linkage via CD3 leads to an activation of CD8+ T cells and consequently to killing of the target cells. In parallel, CD4+ T cells including TH1, TH2, TH17 cells and even regulatory T cells (Tregs) will be activated as well. Cytokines produced by CD4+ T cells can contribute to severe side effects e. g. life-threatening cytokine storms and, thinking of the immunosupressive function of Tregs, can even be counterproductive. Therefore, we asked whether or not it is feasible to limit retargeting to CD8+ T cells e. g. via targeting of the co-receptor CD8 instead of CD3. In order to test for proof of concept, a novel bsAb with specificity for CD8 and a tumor-associated surface antigen was constructed. Interestingly, we found that pre-activated (but not freshly isolated) CD8+ T cells can be retargeted via CD8-engaging bsAbs leading to an efficient lysis of target cells.	[Michalk, Irene; Feldmann, Anja; Koristka, Stefanie; Arndt, Claudia; Cartellieri, Marc; Ehninger, Armin; Bachmann, Michael P.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany; [Feldmann, Anja; Cartellieri, Marc; Bachmann, Michael P.] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Radioimmunol, Dresden, Germany; [Ehninger, Armin; Ehninger, Gerhard] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Clin & Polyclin 1, Dresden, Germany; [Bachmann, Michael P.] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Bachmann, MP (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany.	michael.bachmann@tu-dresden.de	Bachmann, Michael/AAA-5153-2020; Cartellieri, Marc/M-3281-2013; Arndt, Claudia/F-1648-2019; Bachmann, Michael P/E-8850-2010; Cartellieri, Marc/AAL-8197-2020; Feldmann, Anja/AAI-1809-2020	Bachmann, Michael/0000-0002-8029-5755; Cartellieri, Marc/0000-0002-4672-3963; Arndt, Claudia/0000-0002-1285-5052; Bachmann, Michael P/0000-0002-8029-5755; Feldmann, Anja/0000-0001-5099-2448	Center for Regenerative Therapies Dresden (CRTD); TU Dresden; Dresden; Robert Pfleger Stiftung	Center for Regenerative Therapies Dresden (CRTD); TU Dresden(European Commission); Dresden; Robert Pfleger Stiftung	This study was supported by grants given to MB by the Center for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany and the Robert Pfleger Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt C, 2014, LEUKEMIA, V28, P59, DOI 10.1038/leu.2013.243; Arndt C, 2013, LEUKEMIA, V27, P964, DOI 10.1038/leu.2013.18; Arndt Claudia, 2012, Methods Mol Biol, V869, P465, DOI 10.1007/978-1-61779-821-4_40; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bartsch H, 2009, METHODS MOL BIOL, V536, P293, DOI 10.1007/978-1-59745-542-8_31; Bippes CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016315; Byrne H, 2013, TRENDS BIOTECHNOL, V31, P621, DOI 10.1016/j.tibtech.2013.08.007; Chelius D, 2010, MABS-AUSTIN, V2, P309, DOI 10.4161/mabs.2.3.11791; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; Dreier T, 2003, J IMMUNOL, V170, P4397, DOI 10.4049/jimmunol.170.8.4397; Feldmann A, 2012, J IMMUNOL, V189, P3249, DOI 10.4049/jimmunol.1200341; Feldmann A, 2011, PROSTATE, V71, P998, DOI 10.1002/pros.21315; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Kharfan-Dabaja MA, 2013, BRIT J HAEMATOL, V163, P315, DOI 10.1111/bjh.12528; Koristka S, 2013, J AUTOIMMUN, V42, P105, DOI 10.1016/j.jaut.2013.01.002; Morgenroth A, 2007, PROSTATE, V67, P1121, DOI 10.1002/pros.20608; Muller D, 2010, BIODRUGS, V24, P89, DOI 10.2165/11530960-000000000-00000; Nagorsen D, 2012, PHARMACOL THERAPEUT, V136, P334, DOI 10.1016/j.pharmthera.2012.07.013; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; Pickhard A, 2014, NUCL MED BIOL, V41, P68, DOI 10.1016/j.nucmedbio.2013.09.010; Portner LM, 2012, CANCER IMMUNOL IMMUN, V61, P1869, DOI 10.1007/s00262-012-1339-9; Stamova S, 2011, LEUKEMIA, V25, P1053, DOI 10.1038/leu.2011.42; Stamova S, 2012, ANTIBODIES, V1, P172, DOI 10.3390/antib1020172; Stamova S, 2012, ANAL BIOCHEM, V423, P261, DOI 10.1016/j.ab.2011.12.042	25	11	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95517	10.1371/journal.pone.0095517	http://dx.doi.org/10.1371/journal.pone.0095517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751697	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400066
J	Mizoguchi, K; Kanno, H; Ikarashi, Y; Kase, Y				Mizoguchi, Kazushige; Kanno, Hitomi; Ikarashi, Yasushi; Kase, Yoshio			Specific Binding and Characteristics of 18 beta-Glycyrrhetinic Acid in Rat Brain	PLOS ONE			English	Article							TRADITIONAL JAPANESE MEDICINE; PSYCHOLOGICAL SYMPTOMS; GLYCYRRHETINIC ACID; GLUTAMATE RELEASE; OXIDATIVE STRESS; GENE-EXPRESSION; YOKUKANSAN; DEMENTIA; DEHYDROGENASE; GLYCYRRHIZIN	18 beta-Glycyrrhetinic acid (GA) is the aglycone of glycyrrhizin that is a component of Glycyrrhiza, and has several pharmacological actions in the central nervous system. Recently, GA has been demonstrated to reach the brain by crossing the blood-brain barrier in rats after oral administration of a Glycyrrhiza-containing traditional Japanese medicine, yokukansan. These findings suggest that there are specific binding sites for GA in the brain. Here we show evidence that [H-3] GA binds specifically to several brain areas by quantitative autoradiography; the density was higher in the hippocampus, moderate in the caudate putamen, nucleus accumbens, amygdala, olfactory bulb, cerebral cortex, thalamus, and mid brain, and lower in the brain stem and cerebellum. Several kinds of steroids, gap junction-blocking reagents, glutamate transporter-recognized compounds, and glutamate receptor agonists did not inhibit the [H-3] GA binding. Microautoradiography showed that the [H-3] GA signals in the hippocampus were distributed in small non-neuronal cells similar to astrocytes. Immunohistochemical analysis revealed that immunoreactivity of 11 beta-hydroxysteroid dehydrogenase type-1 (11 beta-HSD1), a defined molecule recognized by GA, was detected mainly in neurons, moderately in astrocytes, and very slightly in microglial cells, of the hippocampus. These results demonstrate that specific binding sites for GA exist in rat brain tissue, and suggest that the pharmacological actions of GA may be related to 11 beta-HSD1 in astrocytes. This finding provides important information to understand the pharmacology of GA in the brain.	[Mizoguchi, Kazushige; Kanno, Hitomi; Ikarashi, Yasushi; Kase, Yoshio] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ami, Ibaraki, Japan	Tsumura & Company	Mizoguchi, K (corresponding author), Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ami, Ibaraki, Japan.	mizoguchi_kazushige@mail.tsumura.co.jp			Tsumura Co.	Tsumura Co.(Tsumura & Company)	This study was funded by Tsumura & Co. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.''	Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162; DAVIDSON JS, 1986, BIOCHEM BIOPH RES CO, V134, P29, DOI 10.1016/0006-291X(86)90522-X; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Fujiwara H, 2011, NEUROSCIENCE, V180, P305, DOI 10.1016/j.neuroscience.2011.01.064; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Furuta A, 1997, J NEUROSCI, V17, P8363; Goudriaan A, 2013, SCHIZOPHR B IN PRESS; Hayakawa N, 2007, MECH AGEING DEV, V128, P311, DOI 10.1016/j.mad.2007.01.005; Hayashi Y, 2010, PROG NEURO-PSYCHOPH, V34, P541, DOI 10.1016/j.pnpbp.2010.02.016; HERMAN JP, 1989, MOL ENDOCRINOL, V3, P1886, DOI 10.1210/mend-3-11-1886; Hughes SW, 2004, NEURON, V42, P253, DOI 10.1016/S0896-6273(04)00191-6; Ikarashi Y, 2009, BIOL PHARM BULL, V32, P1701, DOI 10.1248/bpb.32.1701; IRIE A, 1992, BIOCHIM BIOPHYS ACTA, V1160, P229, DOI 10.1016/0167-4838(92)90012-3; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248, DOI 10.4088/JCP.v66n0214; Jin SJ, 2009, TOHOKU J EXP MED, V217, P87, DOI 10.1620/tjem.217.87; Kawakami Z, 2011, CELL MOL NEUROBIOL, V31, P1203, DOI 10.1007/s10571-011-9722-1; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; KINDY MS, 1992, MOL BRAIN RES, V13, P199, DOI 10.1016/0169-328X(92)90027-9; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Lecanu L, 2006, PHARMACOLOGY, V76, P19, DOI 10.1159/000088929; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leuba G, 2009, BRAIN RES BULL, V80, P196, DOI 10.1016/j.brainresbull.2009.06.009; Liu D, 2007, BIOORGAN MED CHEM, V15, P5432, DOI 10.1016/j.bmc.2007.05.057; Matsuda Y, 2013, HUM PSYCHOPHARM CLIN, V28, P80, DOI 10.1002/hup.2286; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mizoguchi K, 2011, NEUROSCIENCE, V177, P127, DOI 10.1016/j.neuroscience.2010.12.045; Monji A, 2009, PROG NEURO-PSYCHOPH, V33, P308, DOI 10.1016/j.pnpbp.2008.12.008; NEGISHI M, 1991, BIOCHIM BIOPHYS ACTA, V1066, P77, DOI 10.1016/0005-2736(91)90253-5; Nishi A, 2012, NEUROSCIENCE, V207, P124, DOI 10.1016/j.neuroscience.2012.01.037; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Proulx E, 2006, EUR J NEUROSCI, V23, P489, DOI 10.1111/j.1460-9568.2005.04558.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Seckl JR, 1997, FRONT NEUROENDOCRIN, V18, P49, DOI 10.1006/frne.1996.0143; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x; Takeda A, 2008, NUTR NEUROSCI, V11, P41, DOI 10.1179/147683008X301414; Takeda S, 1996, J PHARM PHARMACOL, V48, P902, DOI 10.1111/j.2042-7158.1996.tb05998.x; Takeuchi H, 2008, EXP NEUROL, V214, P144, DOI 10.1016/j.expneurol.2008.08.001; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; ULMANN A, 1975, ENDOCRINOLOGY, V97, P46, DOI 10.1210/endo-97-1-46; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100	46	12	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95760	10.1371/journal.pone.0095760	http://dx.doi.org/10.1371/journal.pone.0095760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752617	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400120
J	Takahashi, T; Hanazawa, K; Inoue, T; Sato, K; Sedohara, A; Okahara, J; Suemizu, H; Yagihashi, C; Yamamoto, M; Eto, T; Konno, Y; Okano, H; Suematsu, M; Sasaki, E				Takahashi, Tsukasa; Hanazawa, Kisaburo; Inoue, Takashi; Sato, Kenya; Sedohara, Ayako; Okahara, Junko; Suemizu, Hiroshi; Yagihashi, Chie; Yamamoto, Masafumi; Eto, Tomoo; Konno, Yusuke; Okano, Hideyuki; Suematsu, Makoto; Sasaki, Erika			Birth of Healthy Offspring following ICSI in In Vitro-Matured Common Marmoset (Callithrix jacchus) Oocytes	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; METAPHASE-II ARREST; DEVELOPMENTAL COMPETENCE; GERMLINE TRANSMISSION; LENTIVIRAL VECTORS; EMBRYO DEVELOPMENT; TRANSGENIC CATTLE; BOVINE OOCYTES; MOUSE OOCYTES; GENE-TRANSFER	Intracytoplasmic sperm injection (ICSI), an important method used to treat male subfertility, is applied in the transgenic technology of sperm-mediated gene transfer. However, no study has described successful generation of offspring using ICSI in the common marmoset, a small non-human primate used as a model for biomedical translational research. In this study, we investigated blastocyst development and the subsequent live offspring stages of marmoset oocytes matured in vitro and fertilized by ICSI. To investigate the optimal timing of performing ICSI, corrected immature oocytes were matured in vitro and ICSI was performed at various time points (1-2 h, 2-4 h, 4-6 h, 6-8 h, and 8-10 h after extrusion of the first polar body (PB)). Matured oocytes were then divided randomly into two groups: one was used for in vitro fertilization (IVF) and the other for ICSI. To investigate in vivo development of embryos followed by ICSI, 6-cell-to 8-cell-stage embryos and blastocysts were nonsurgically transferred into recipient marmosets. Although no significant differences were observed in the fertilization rate of blastocysts among ICSI timing after the first PB extrusion, the blastocyst rate at 1-2 h was lowest among groups at 2-4 h, 4-6 h, 6-8 h, and 8-10 h. Comparing ICSI to IVF, the fertilization rates obtained in ICSI were higher than in IVF (p>0.05). No significant difference was noted in the cleaved blastocyst rate between ICSI and IVF. Following the transfer of 37 ICSI blastocysts, 4 of 20 recipients became pregnant, while with the transfer of 21 6-cell-to 8-cell-stage ICSI embryos, 3 of 8 recipients became pregnant. Four healthy offspring were produced and grew normally. These are the first marmoset offspring produced by ICSI, making it an effective fertilization method for marmosets.	[Takahashi, Tsukasa; Sato, Kenya; Sedohara, Ayako; Okahara, Junko; Eto, Tomoo; Sasaki, Erika] Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Takahashi, Tsukasa; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo, Japan; [Hanazawa, Kisaburo] Juntendo Univ, Dept Oncol, Nerima Hosp, Nerima Ku, Tokyo, Japan; [Inoue, Takashi] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Suemizu, Hiroshi; Yagihashi, Chie; Yamamoto, Masafumi] Cent Inst Expt Anim, Dept Biomed Res, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Konno, Yusuke] Altair Corp, Kohoku Ku, Yokohama, Kanagawa, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Sasaki, Erika] Keio Univ, Keio Adv Res Ctr, Shinjuku Ku, Tokyo, Japan	Keio University; Juntendo University; Keio University; Keio University	Sasaki, E (corresponding author), Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki Ku, Kawasaki, Kanagawa, Japan.	esasaki@ciea.or.jp	Suematsu, Makoto/I-8135-2013; Okano, Hideyuki/I-7584-2019; Suematsu, Makoto/O-5762-2018	Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Inoue, Takashi/0000-0003-4691-7255; Suemizu, Hiroshi/0000-0002-3706-2454	Strategic Research Program for Brain Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; PRESTO of the Japan Science and Technology Agency; World-Leading Innovative R&D on Science and Technology (FIRST) program "Strategic Exploitation of Neuro-Genetics for Emergence of the Mind'' from the Cabinet Office; government of Japan; Global COE Program for Education and Research Center for Metabolomic Systems Biology from the MEXT	Strategic Research Program for Brain Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO of the Japan Science and Technology Agency; World-Leading Innovative R&D on Science and Technology (FIRST) program "Strategic Exploitation of Neuro-Genetics for Emergence of the Mind'' from the Cabinet Office; government of Japan; Global COE Program for Education and Research Center for Metabolomic Systems Biology from the MEXT	A part of this study was the result of "Highly Creative Animal Model Development for Brain Sciences'' and "Construction of System for Spread of Primate Model Animals'' supported by the Strategic Research Program for Brain Science, Grant-in-Aid for Scientific Research A from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; http://www.mext.go.jp/english/), Japan, PRESTO of the Japan Science and Technology Agency to E.S., Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program "Strategic Exploitation of Neuro-Genetics for Emergence of the Mind'' from the Cabinet Office (http://www.brain.riken.jp/first-okano/en/index.html), government of Japan to E. S. and H.O., and the Global COE Program for Education and Research Center for Metabolomic Systems Biology from the MEXT to M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini David F, 2003, Reprod Biomed Online, V6, P410; Balakier H, 2004, HUM REPROD, V19, P982, DOI 10.1093/humrep/deh158; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Chan AWS, 1998, P NATL ACAD SCI USA, V95, P14028, DOI 10.1073/pnas.95.24.14028; Deng MQ, 2001, MOL REPROD DEV, V59, P38, DOI 10.1002/mrd.1005; Dominko T, 1997, MOL REPROD DEV, V47, P456, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;456::AID-MRD13&gt;3.0.CO;2-U; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Gilchrist RB, 1997, BIOL REPROD, V56, P238, DOI 10.1095/biolreprod56.1.238; GOTO K, 1990, VET REC, V127, P517; Grupen CG, 2007, THERIOGENOLOGY, V68, P861, DOI 10.1016/j.theriogenology.2007.07.009; Hamano K, 1999, BIOL REPROD, V60, P1194, DOI 10.1095/biolreprod60.5.1194; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Hofmann A, 2004, BIOL REPROD, V71, P405, DOI 10.1095/biolreprod.104.028472; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Hyun CS, 2007, HUM REPROD, V22, P1991, DOI 10.1093/humrep/dem124; KEEFER CL, 1989, GAMETE RES, V22, P59, DOI 10.1002/mrd.1120220107; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; KUBIAK JZ, 1989, DEV BIOL, V136, P537, DOI 10.1016/0012-1606(89)90279-0; Kuederling I, 2000, AM J PRIMATOL, V52, P149, DOI 10.1002/1098-2345(200011)52:3<149::AID-AJP4>3.0.CO;2-B; Liu H, 2001, BIOL REPROD, V65, P1794, DOI 10.1095/biolreprod65.6.1794; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marshall VS, 1997, J MED PRIMATOL, V26, P241, DOI 10.1111/j.1600-0684.1997.tb00218.x; Moor RM, 1998, HUM REPROD UPDATE, V4, P223, DOI 10.1093/humupd/4.3.223; Nubbemeyer R, 1997, J MED PRIMATOL, V26, P139, DOI 10.1111/j.1600-0684.1997.tb00045.x; Oikawa T, 2005, ANIM REPROD SCI, V86, P187, DOI 10.1016/j.anireprosci.2004.07.003; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Shinohara ET, 2007, TRANSGENIC RES, V16, P333, DOI 10.1007/s11248-007-9077-z; Suganuma R, 2005, BIOL REPROD, V73, P1157, DOI 10.1095/biolreprod.105.044669; SUMMERS PM, 1987, J REPROD FERTIL, V79, P241; Tian JH, 2006, THERIOGENOLOGY, V66, P439, DOI 10.1016/j.theriogenology.2005.10.026; Tkachenko OY, 2010, HUM REPROD, V25, P2047, DOI 10.1093/humrep/deq148; Tomioka I, 2012, THERIOGENOLOGY, V78, P1487, DOI 10.1016/j.theriogenology.2012.06.024; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; VANSTEIRTEGHEM AC, 1993, HUM REPROD, V8, P1061, DOI 10.1093/oxfordjournals.humrep.a138192; Walls M, 2012, REPROD BIOMED ONLINE, V25, P603, DOI 10.1016/j.rbmo.2012.08.001	38	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95560	10.1371/journal.pone.0095560	http://dx.doi.org/10.1371/journal.pone.0095560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751978	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400075
J	Suzuki, J; Imai, Y; Aoki, M; Fujita, D; Aoyama, N; Tada, Y; Wakayama, K; Akazawa, H; Izumi, Y; Isobe, M; Komuro, I; Nagai, R; Hirata, Y				Suzuki, Jun-ichi; Imai, Yasushi; Aoki, Mieko; Fujita, Daishi; Aoyama, Norio; Tada, Yuko; Wakayama, Kouji; Akazawa, Hiroshi; Izumi, Yuichi; Isobe, Mitsuaki; Komuro, Issei; Nagai, Ryozo; Hirata, Yasunobu			Periodontitis in Cardiovascular Disease Patients with or without Marfan Syndrome -A Possible Role of Prevotella intermedia-	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-INDUCED PRODUCTION; ABDOMINAL AORTIC-ANEURYSMS; MURINE MACROPHAGES; ACTIVATOR	Background: Although periodontitis is a risk factor for cardiovascular disease (CVD), the influence of periodontitis on Marfan syndrome (MFS) with CVD is unclear. The aim of this study was to assess the relationship between periodontal bacterial burden and MSF with CVD. Methods and Results: The subjects were patients with MFS with CVD (n = 47); age and gender matched non-MFS CVD patients (n = 48) were employed as controls. Full-mouth clinical measurements, including number of teeth, probing of pocket depth (PD), bleeding on probing (BOP) and community periodontal index (CPI) were recorded. We also evaluated the existence of three periodontal pathogens, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Prevotella intermedia using polymerase chain reaction assays. Serum antibody titers against the pathogens were also measured. We revealed that MFS with CVD patients had periodontitis more frequently than the age and gender matched non-MFS CVD control subjects. MFS with CVD patients had significantly severer periodontitis, fewer remaining teeth and deeper PD compared to the non-MFS CVD controls. Furthermore, the serum antibody titer level against Prevotella intermedia was significantly lower in MFS plus CVD patients compared to the non-MFS CVD patients. Conclusion: Periodontitis may influence the pathophysiology of cardiovascular complications in MFS patients. A specific periodontal pathogen might be a crucial therapeutic target to prevent CVD development.	[Suzuki, Jun-ichi; Tada, Yuko; Wakayama, Kouji; Akazawa, Hiroshi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, Tokyo, Japan; [Aoki, Mieko; Fujita, Daishi; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan; [Aoyama, Norio; Izumi, Yuichi] Tokyo Med & Dent Univ, Dept Periodontol, Bunkyo Ku, Tokyo, Japan; [Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan; [Imai, Yasushi; Nagai, Ryozo] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Chiyoda Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Jichi Medical University	Suzuki, J (corresponding author), Univ Tokyo, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, Tokyo, Japan.	junichisuzuki-circ@umin.ac.jp	Tada, Yuko/M-6513-2015	Tada, Yuko/0000-0003-1410-9894; Akazawa, Hiroshi/0000-0002-3574-9607	Medical Survey and Research Foundation; Mitsui Life Insurance Research Foundation; Mitsui Sumitomo Marine Welfare Research Foundation; Geriatric Dental Research Foundation; Human Health Future Research Foundation; St. Luke's Hospital Research Foundation; Health Labor Science's Research Grants from the Japanese Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research [25461084] Funding Source: KAKEN	Medical Survey and Research Foundation; Mitsui Life Insurance Research Foundation; Mitsui Sumitomo Marine Welfare Research Foundation; Geriatric Dental Research Foundation; Human Health Future Research Foundation; St. Luke's Hospital Research Foundation; Health Labor Science's Research Grants from the Japanese Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the grants from the Medical Survey and Research Foundation, Mitsui Life Insurance Research Foundation, Mitsui Sumitomo Marine Welfare Research Foundation, Mitsui Sumitomo Marine Welfare Research Foundation, Geriatric Dental Research Foundation, Human Health Future Research Foundation, St. Luke's Hospital Research Foundation and the Health Labor Science's Research Grants from the Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama N, 2012, J PERIODONTAL RES, V47, P463, DOI 10.1111/j.1600-0765.2011.01454.x; Aoyama N, 2013, CIRC J, V77, P1565, DOI 10.1253/circj.CJ-12-1191; Choi IS, 2013, J PERIODONTOL, V84, P545, DOI 10.1902/jop.2012.120180; De Coster PJA, 2002, ORAL SURG ORAL MED O, V93, P564, DOI 10.1067/moe.2002.121430; Gonzales EA, 2009, J AM ACAD NURSE PRAC, V21, P663, DOI 10.1111/j.1745-7599.2009.00461.x; Guan SM, 2011, FEMS IMMUNOL MED MIC, V62, P91, DOI 10.1111/j.1574-695X.2011.00789.x; Hosomi N, 2012, CEREBROVASC DIS, V34, P385, DOI 10.1159/000343659; Jin JY, 2013, J PERIODONTAL RES, V48, P687, DOI 10.1111/jre.12054; Judge DP, 2008, ANNU REV MED, V59, P43, DOI 10.1146/annurev.med.59.103106.103801; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Moreno G, 2013, J AM GERIATR SOC, V61, P2027, DOI 10.1111/jgs.12513; Suda N, 2009, J EXP ZOOL PART B, V312B, P503, DOI 10.1002/jez.b.21278; Takata M, 2013, HEART VESSELS	14	52	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95521	10.1371/journal.pone.0095521	http://dx.doi.org/10.1371/journal.pone.0095521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748407	gold, Green Submitted, Green Published			2022-12-25	WOS:000335226500119
J	Morone, S; Augeri, S; Cuccioloni, M; Mozzicafreddo, M; Angeletti, M; Lo Buono, N; Giacomino, A; Ortolan, E; Funaro, A				Morone, Simona; Augeri, Stefania; Cuccioloni, Massimiliano; Mozzicafreddo, Matteo; Angeletti, Mauro; Lo Buono, Nicola; Giacomino, Alice; Ortolan, Erika; Funaro, Ada			Binding of CD157 Protein to Fibronectin Regulates Cell Adhesion and Spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Surface Receptor; Extracellular Matrix; Fibronectin; Membrane Protein; BST-1; CD157; Heparin-binding Domain	ADP-RIBOSYL CYCLASE; EXTRACELLULAR-MATRIX; SURFACE-MOLECULE; ECTOENZYMES; KINASE; CD38; BST-1/CD157; PHYSIOLOGY; RECEPTOR; COMPLEX	CD157/BST-1 behaves both as an ectoenzyme and signaling receptor and is an important regulator of leukocyte trafficking and ovarian cancer progression. However, the molecular interactions underpinning the role of CD157 in these processes remain obscure. The biological functions of CD157 and its partnership with members of the integrin family prompted us to assume the existence of a direct interaction between CD157 and an unknown component of the extracellular matrix. Using solid-phase binding assays and surface plasmon resonance analysis, we demonstrated that CD157 binds fibronectin with high affinity within its heparin-binding domains 1 and 2. Furthermore, we found that CD157 binds to other extracellular matrix proteins containing heparin-binding domains. Finally, we proved that the CD157-fibronectin interaction occurs with living cells, where it elicits CD157-mediated cell responses. Indeed, knockdown of CD157 in Met-5A mesothelial cells changed their morphology and cytoskeleton organization and attenuated the activation of intracellular signaling pathways triggered by fibronectin. This led to impaired cell spreading and adhesion to selected extracellular matrix proteins. Collectively, these findings indicate a central role of CD157 in cell-extracellular matrix interactions and make CD157 an attractive therapeutic target in inflammation and cancer.	[Morone, Simona; Augeri, Stefania; Lo Buono, Nicola; Giacomino, Alice; Ortolan, Erika; Funaro, Ada] Univ Turin, Dept Med Sci, Immunogenet Lab, I-10126 Turin, Italy; [Cuccioloni, Massimiliano; Mozzicafreddo, Matteo; Angeletti, Mauro] Univ Camerino, Sch Biosci & Vet Med, I-62032 Camerino, Italy	University of Turin; University of Camerino	Funaro, A (corresponding author), Univ Turin, Dept Med Sci, 10126 Via Santena 19, Turin, Italy.	ada.funaro@unito.it	Angeletti, Mauro/AAC-5597-2019; Cuccioloni, Massimiliano/X-7188-2019; Mozzicafreddo, M./AAW-2816-2021; Funaro, Ada/AAC-3203-2019; Lo Buono, Nicola/F-4817-2013	Angeletti, Mauro/0000-0001-6719-5517; Mozzicafreddo, M./0000-0001-9835-8446; Funaro, Ada/0000-0001-6341-1817; Lo Buono, Nicola/0000-0001-5538-6869; ORTOLAN, Erika/0000-0003-2287-9020; Cuccioloni, Massimiliano/0000-0002-6025-1990	Italian Association for Cancer Research [IG 11602]; Italian Ministry for University and Scientific Research; International Foundation for Research in Experimental Medicine; Fondazione Umberto Veronesi	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); International Foundation for Research in Experimental Medicine; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This work was supported by Italian Association for Cancer Research Grant IG 11602 (to E. O.), Italian Ministry for University and Scientific Research 60% Projects (to A. F.), and The International Foundation for Research in Experimental Medicine.; Supported by a fellowship from the Fondazione Umberto Veronesi.	BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Funaro A, 2004, BLOOD, V104, P4269, DOI 10.1182/blood-2004-06-2129; Funaro A, 2009, FRONT BIOSCI-LANDMRK, V14, P929, DOI 10.2741/3287; Goding JW, 2000, J LEUKOCYTE BIOL, V67, P285, DOI 10.1002/jlb.67.3.285; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; Hussain AMM, 1999, CELL SIGNAL, V11, P891, DOI 10.1016/S0898-6568(99)00057-1; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; KAISHO T, 1994, P NATL ACAD SCI USA, V91, P5325, DOI 10.1073/pnas.91.12.5325; Lavagno L, 2007, J BIOL REG HOMEOS AG, V21, P5; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Liang F, 2001, FEBS LETT, V506, P207, DOI 10.1016/S0014-5793(01)02912-X; Lo Buono N, 2011, J BIOL CHEM, V286, P18681, DOI 10.1074/jbc.M111.227876; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Malavasi F, 2006, MOL MED, V12, P334, DOI 10.2119/2006-00094.Malavasi; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Morone S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043649; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Okuyama Y, 1996, BIOCHEM BIOPH RES CO, V228, P838, DOI 10.1006/bbrc.1996.1741; Ortolan E, 2002, CELL BIOCHEM FUNCT, V20, P309, DOI 10.1002/cbf.978; Ortolan E, 2006, BLOOD, V108, P4214, DOI 10.1182/blood-2006-04-017160; Ortolan E, 2010, JNCI-J NATL CANCER I, V102, P1160, DOI 10.1093/jnci/djq256; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pirazzoli V, 2013, BLOOD, V121, P2316, DOI 10.1182/blood-2012-08-451187; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; Quarona V, 2013, CYTOM PART B-CLIN CY, V84B, P207, DOI 10.1002/cyto.b.21092; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Salmi M, 2012, EUR J IMMUNOL, V42, P284, DOI 10.1002/eji.201142223; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Todd 3rd R.F., 1995, LEUKOCYTE TYPING, P991; TODD RF, 1985, BLOOD, V65, P964; Yamamoto-Katayama S, 2001, BIOCHEM J, V357, P385, DOI 10.1042/0264-6021:3570385; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386	41	20	21	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15588	15601		10.1074/jbc.M113.535070	http://dx.doi.org/10.1074/jbc.M113.535070			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753259	Green Published, hybrid			2022-12-25	WOS:000337465400041
J	Hoeijmakers, L; Harbich, D; Schmid, B; Lucassen, PJ; Wagner, KV; Schmidt, MV; Hartmann, J				Hoeijmakers, Lianne; Harbich, Daniela; Schmid, Bianca; Lucassen, Paul J.; Wagner, Klaus V.; Schmidt, Mathias V.; Hartmann, Jakob			Depletion of FKBP51 in Female Mice Shapes HPA Axis Activity	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; DNA METHYLATION; SEX-DIFFERENCES; STRESS; POLYMORPHISMS; EXPRESSION; DEPRESSION; PROTEIN; RISK; ASSOCIATION	Psychiatric disorders such as depressive disorders and posttraumatic stress disorder are a major disease burden worldwide and have a higher incidence in women than in men. However, the underlying mechanism responsible for the sex-dependent differences is not fully understood. Besides environmental factors such as traumatic life events or chronic stress, genetic variants contribute to the development of such diseases. For instance, variations in the gene encoding the FK506 binding protein 51 (FKBP51) have been repeatedly associated with mood and anxiety. FKBP51 is a negative regulator of the glucocorticoid receptor and thereby of the hypothalamic-pituitary-adrenal axis that also interacts with other steroid hormone receptors such as the progesterone and androgen receptors. Thus, the predisposition of women to psychiatric disorders and the interaction of female hormones with FKBP51 and the glucocorticoid receptor implicate a possible difference in the regulation of the hypothalamic-pituitary-adrenal axis in female FKBP51 knockout (51KO) mice. Therefore, we investigated neuroendocrine, behavioural and physiological alterations relevant to mood disorders in female 51KO mice. Female 51KOs and wild type littermates were subjected to various behavioural tests, including the open field, elevated plus maze and forced swim test. The neuroendocrine profile was investigated under basal conditions and in response to an acute stressor. Furthermore, we analysed the mRNA expression levels of the glucocorticoid receptor and corticotrophin release hormone in different brain regions. Overall, female 51KO mice did not display any overt behavioural phenotype under basal conditions, but showed a reduced basal hypothalamic-pituitary-adrenal axis activity, a blunted response to, and an enhanced recovery from, acute stress. These characteristics strongly overlap with previous studies in male 51KO mice indicating that FKBP51 shapes the behavioural and neuroendocrine phenotype independent of the sex of the individual.	[Hoeijmakers, Lianne; Harbich, Daniela; Schmid, Bianca; Wagner, Klaus V.; Schmidt, Mathias V.; Hartmann, Jakob] Max Planck Inst Psychiat, Munich, Bavaria, Germany; [Hoeijmakers, Lianne; Lucassen, Paul J.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands	Max Planck Society; University of Amsterdam	Hartmann, J (corresponding author), Max Planck Inst Psychiat, Munich, Bavaria, Germany.	jhartmann@mpipsykl.mpg.de	Hartmann, Jakob/GPF-5919-2022; Lucassen, Paul/ABA-3113-2020	Hartmann, Jakob/0000-0002-1960-8177; Lucassen, Paul/0000-0001-9708-9133; Schmidt, Mathias/0000-0002-3788-2268	Max Planck Society; Hersenstichting Nederland; ISAO	Max Planck Society(Max Planck Society); Hersenstichting Nederland; ISAO	The present study was funded by the Max Planck Society. PJL is supported by the Hersenstichting Nederland (https://www.hersenstichting.nl) and ISAO (https://www.alzheimer.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu S, 2013, J SLEEP RES IN PRESS; Bangasser DA, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-2; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bourke CH, 2013, PSYCHONEUROENDOCRINO, V38, P84, DOI 10.1016/j.psyneuen.2012.05.001; Breslau Naomi, 2002, J Gend Specif Med, V5, P34; Cheung-Flynn J, 2007, CELL STRESS PROTEINS, P281; de Kloet ER, 2009, BRAIN RES, V1293, P129, DOI 10.1016/j.brainres.2009.03.039; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Febbo PG, 2005, J UROLOGY, V173, P1772, DOI 10.1097/01.ju.0000155845.44729.ba; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Guidotti G, 2012, NEUROPSYCHOPHARMACOL, V1, P1; Hartmann J, 2012, NEUROPHARMACOLOGY, V62, P332, DOI 10.1016/j.neuropharm.2011.07.041; Heim C, 2009, CNS SPECTRUMS, V14, P13; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Kirchheiner J, 2008, PHARMACOGENOMICS, V9, P841, DOI 10.2217/14622416.9.7.841; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; Lee RS, 2011, PSYCHOPHARMACOLOGY, V218, P303, DOI 10.1007/s00213-011-2307-3; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; Lekman M, 2008, BIOL PSYCHIAT, V63, P1103, DOI 10.1016/j.biopsych.2007.10.026; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; McCormick CM, 2007, PHARMACOL BIOCHEM BE, V86, P220, DOI 10.1016/j.pbb.2006.07.012; Menke A, 2013, GENES BRAIN BEHAV, V12, P289, DOI 10.1111/gbb.12026; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Pazirandeh A, 2005, ENDOCRINOLOGY, V146, P2501, DOI 10.1210/en.2004-0943; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; REBUFFESCRIVE M, 1992, PHYSIOL BEHAV, V52, P583, DOI 10.1016/0031-9384(92)90351-2; Sarapas C, 2011, DIS MARKERS, V30, P101, DOI [10.1155/2011/328054, 10.3233/DMA-2011-0764]; Scharf SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016883; Schmidt MV, 2009, POSTNATAL GLUCOCORTI; Solhaug HI, 2012, INCREASED PREVALENCE; Solomon MB, 2009, PHYSIOL BEHAV, V97, P250, DOI 10.1016/j.physbeh.2009.02.033; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; van den Brandt J, 2007, AM J PATHOL, V170, P1041, DOI 10.2353/ajpath.2007.060804; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; Wagner KV, 2012, NEUROPSYCHOPHARMACOL, V37, P2797, DOI 10.1038/npp.2012.150; Wagner KV, 2011, PSYCHONEUROENDOCRINO, V36, P579, DOI 10.1016/j.psyneuen.2010.09.007; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; Wang Q, 2012, NEUROPHARMACOLOGY, V62, P527, DOI 10.1016/j.neuropharm.2011.09.014; Wang XD, 2011, J NEUROSCI, V31, P13625, DOI 10.1523/JNEUROSCI.2259-11.2011; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Westberry JM, 2006, J STEROID BIOCHEM, V100, P34, DOI 10.1016/j.jsbmb.2006.03.004; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Yang XJ, 2012, BIOCHEM BIOPH RES CO, V420, P570, DOI 10.1016/j.bbrc.2012.03.035	55	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95796	10.1371/journal.pone.0095796	http://dx.doi.org/10.1371/journal.pone.0095796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759731	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200090
J	Abubakr, A; Alimon, AR; Yaakub, H; Abdullah, N; Ivan, M				Abubakr, Abdelrahim; Alimon, Abdul Razak; Yaakub, Halimatun; Abdullah, Norhani; Ivan, Michael			Effect of Feeding Palm Oil By-Products Based Diets on Total Bacteria, Cellulolytic Bacteria and Methanogenic Archaea in the Rumen of Goats	PLOS ONE			English	Article							REAL-TIME PCR; CHAIN FATTY-ACIDS; BUTYRIVIBRIO-FIBRISOLVENS; METHANE SUPPRESSION; RUMINAL BACTERIA; LINOLEIC-ACID; COCONUT OIL; IN-VITRO; FERMENTATION; SHEEP	Rumen microorganisms are responsible for digestion and utilization of dietary feeds by host ruminants. Unconventional feed resources could be used as alternatives in tropical areas where feed resources are insufficient in terms of quality and quantity. The objective of the present experiment was to evaluate the effect of diets based on palm oil (PO), decanter cake (DC) or palm kernel cake (PKC) on rumen total bacteria, selected cellulolytic bacteria, and methanogenic archaea. Four diets: control diet (CD), decanter cake diet (DCD), palm kernel cake diet (PKCD) and CD plus 5% PO diet (CPOD) were fed to rumen cannulated goats and rumen samples were collected at the start of the experimental diets (day 0) and on days 4, 6, 8, 12, 18, 24 and 30 post dietary treatments. Feeding DCD and PKCD resulted in significantly higher (P<0.05) DNA copy number of total bacteria, Fibrobacter succinogenes, Ruminococcus flavefeciens, and Ruminococcus albus. Rumen methanogenic archaea was significantly lower (P<0.05) in goats fed PKCD and CPOD and the trend showed a severe reduction on days 4 and 6 post experimental diets. In conclusion, results indicated that feeding DCD and PKC increased the populations of cellulolytic bacteria and decreased the density of methanogenic archaea in the rumen of goats.	[Abubakr, Abdelrahim; Alimon, Abdul Razak; Yaakub, Halimatun] Univ Putra Malaysia, Dept Anim Sci, Serdang 43400, Selangor, Malaysia; [Alimon, Abdul Razak; Abdullah, Norhani; Ivan, Michael] Univ Putra Malaysia, Inst Trop Agr, Serdang 43400, Selangor, Malaysia; [Abdullah, Norhani] Univ Putra Malaysia, Dept Biochem, Serdang 43400, Selangor, Malaysia; [Abubakr, Abdelrahim] Univ Bahri, Fac Anim Prod, Dept Anim Nutr, Khartoum, Sudan	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Alimon, AR (corresponding author), Univ Putra Malaysia, Dept Anim Sci, Serdang 43400, Selangor, Malaysia.	ralimon@upm.edu.my	Abubakr, Abdelrahim/B-1592-2009	Yaakub, Halimatun/0000-0003-2691-6984				ABDULLAH N, 1988, ANIM FEED SCI TECH, V20, P79, DOI 10.1016/0377-8401(88)90129-0; Abubakr A. R., 2013, Journal of the Saudi Society of Agricultural Sciences, V12, P147, DOI 10.1016/j.jssas.2012.11.002; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AOAC, 2000, OFFICIAL METHODS ANA; Chanjula P, 2010, SONGKLANAKARIN J SCI, V36, P527; Chen JQ, 2001, MICROBIOL-UK, V147, P21, DOI 10.1099/00221287-147-1-21; DEHORITY BA, 1989, APPL ENVIRON MICROB, V55, P2789, DOI 10.1128/AEM.55.11.2789-2792.1989; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Dohme F, 1999, LETT APPL MICROBIOL, V29, P187, DOI 10.1046/j.1365-2672.1999.00614.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forster RJ, 1997, APPL ENVIRON MICROB, V63, P1256, DOI 10.1128/AEM.63.4.1256-1260.1997; GIRARD V, 1978, BIOCHIM BIOPHYS ACTA, V528, P17, DOI 10.1016/0005-2760(78)90048-6; Harfoot C, 1997, RUMEN MICROBIAL ECOS, P382; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; Ivan M, 2001, SMALL RUMINANT RES, V41, P215, DOI 10.1016/S0921-4488(01)00220-6; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kudo H, 1987, CAN J MICROBIOL, V33, P241; Liu SJ, 2012, J ANIM PHYSIOL AN N, V96, P9, DOI 10.1111/j.1439-0396.2010.01113.x; Machmuller A, 1999, CAN J ANIM SCI, V79, P65, DOI 10.4141/A98-079; Machmuller A, 2006, AGR ECOSYST ENVIRON, V112, P107, DOI 10.1016/j.agee.2005.08.010; MACZULAK AE, 1981, APPL ENVIRON MICROB, V42, P856, DOI 10.1128/AEM.42.5.856-862.1981; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Maia MRG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-52; McSweeney CS, 2007, J APPL MICROBIOL, V103, P1757, DOI 10.1111/j.1365-2672.2007.03408.x; Mosoni P, 2011, J ANIM SCI, V89, P783, DOI 10.2527/jas.2010-2947; Newbold C.J., 1988, NUTR SOC, V47, p154A, DOI [10.5713/ajas.2014.14216, DOI 10.5713/AJAS.2014.14216]; Ozutsumi Y, 2006, CURR MICROBIOL, V52, P158, DOI 10.1007/s00284-005-0266-9; Paillard D, 2007, ANTON LEEUW INT J G, V91, P417, DOI 10.1007/s10482-006-9121-7; Potu RB, 2011, J MICROBIOL, V49, P216, DOI 10.1007/s12275-011-0365-1; RAJION MA, 1985, AUST J BIOL SCI, V38, P33, DOI 10.1071/BI9850033; Romero-Huelva M, 2012, J DAIRY SCI, V95, P6015, DOI 10.3168/jds.2012-5573; SAS, 2003, SAS US GUID STAT 9 1; Shinkai T, 2007, APPL ENVIRON MICROB, V73, P1646, DOI 10.1128/AEM.01896-06; Skillman LC, 2006, APPL ENVIRON MICROB, V72, P200, DOI 10.1128/AEM.72.1.200-206.2006; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; VWintzingerode F., 1997, FEMS MICROBIOL REV, V21, P213, DOI DOI 10.1111/J.1574-6976.1997.TB00351.X; Wallace RJ, 2002, ASIAN AUSTRAL J ANIM, V15, P1458, DOI 10.5713/ajas.2002.1458; Wanapat M, 2009, CURR MICROBIOL, V58, P294, DOI 10.1007/s00284-008-9322-6; Williams A.G., 1992, RUMEN PROTOZOA; Wright ADG, 2004, APPL ENVIRON MICROB, V70, P1263, DOI 10.1128/AEM.70.3.1263-1270.2004; Yabuuchi Y, 2006, ANIM SCI J, V77, P300, DOI 10.1111/j.1740-0929.2006.00352.x; Yang SL, 2009, ANIMAL, V3, P1562, DOI 10.1017/S1751731109990462; Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005; Zhang CM, 2008, ANIM FEED SCI TECH, V146, P259, DOI 10.1016/j.anifeedsci.2008.01.005	45	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95713	10.1371/journal.pone.0095713	http://dx.doi.org/10.1371/journal.pone.0095713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756125	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000335240300078
J	Chatterjee, A; Chattopadhyay, D; Chakrabarti, G				Chatterjee, Abhisek; Chattopadhyay, Dhrubajyoti; Chakrabarti, Gopal			miR-17-5p Downregulation Contributes to Paclitaxel Resistance of Lung Cancer Cells through Altering Beclin1 Expression	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; BREAST-CANCER; PERMEABILITY TRANSITION; AUTOPHAGY INHIBITION; INDUCED APOPTOSIS; CYTOCHROME-C; TAXOL; MICRORNAS; SENSITIVITY; MECHANISM	Non-small-cell lung cancer (NSCLC) is one of the most leading causes of cancer-related deaths worldwide. Paclitaxel based combination therapies have long been used as a standard treatment in aggressive NSCLCs. But paclitaxel resistance has emerged as a major clinical problem in combating non-small-cell lung cancer and autophagy is one of the important mechanisms involved in this phenomenon. In this study, we used microRNA (miRNA) arrays to screen differentially expressed miRNAs between paclitaxel sensitive lung cancer cells A549 and its paclitaxel-resistant cell variant (A549-T24). We identified miR-17-5p was one of most significantly downregulated miRNAs in paclitaxel-resistant lung cancer cells compared to paclitaxel sensitive parental cells. We found that overexpression of miR-17-5p sensitized paclitaxel resistant lung cancer cells to paclitaxel induced apoptotic cell death. Moreover, in this report we demonstrated that miR-17-5p directly binds to the 39-UTR of beclin 1 gene, one of the most important autophagy modulator. Overexpression of miR-17-5p into paclitaxel resistant lung cancer cells reduced beclin1 expression and a concordant decease in cellular autophagy. We also observed similar results in another paclitaxel resistant lung adenosquamous carcinoma cells (H596-TxR). Our results indicated that paclitaxel resistance of lung cancer is associated with downregulation of miR-17-5p expression which might cause upregulation of BECN1 expression.	[Chakrabarti, Gopal] Univ Calcutta, Dept Biotechnol, Kolkata, WB, India; Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, WB, India	University of Calcutta; University of Calcutta	Chakrabarti, G (corresponding author), Univ Calcutta, Dept Biotechnol, Kolkata, WB, India.	gcbcg@caluniv.ac.in			Department of Biotechnology, Govt. of India [BT/PR12889/AGR/36/624/2009]; DST-PURSE programme, University of Calcutta	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); DST-PURSE programme, University of Calcutta	The work was supported by a grant from the Department of Biotechnology, Govt. of India (No. BT/PR12889/AGR/36/624/2009) to GC. AC was supported by a fellowship from the same grant, and subsequently, a fellowship from DST-PURSE programme, University of Calcutta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BR, 2009, BIOCHEMISTRY-US, V48, P6963, DOI 10.1021/bi900152k; Ajabnoor GMA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.139; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; [Anonymous], MOL CANC THER, V8, P1055; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chi Eun Young, 2013, Obstet Gynecol Sci, V56, P84, DOI 10.5468/OGS.2013.56.2.84; Comincini S, 2013, CANCER BIOL THER, V14, P574, DOI 10.4161/cbt.24597; Dumontet Charles, 2005, Bull Cancer, V92, pE25; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; GREENBERGER LM, 1988, P NATL ACAD SCI USA, V85, P3762, DOI 10.1073/pnas.85.11.3762; Holleman A, 2011, ONCOGENE, V30, P4386, DOI 10.1038/onc.2011.148; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Kaminskyy VO, 2012, AUTOPHAGY, V8, P1032, DOI 10.4161/auto.20123; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Li J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-215; Liang ZX, 2007, BIOCHEM BIOPH RES CO, V363, P542, DOI 10.1016/j.bbrc.2007.09.007; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Munafo DB, 2001, J CELL SCI, V114, P3619; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Oguri T, 2008, MOL CANCER THER, V7, P1150, DOI 10.1158/1535-7163.MCT-07-2088; Pan XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056679; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; ROY SN, 1985, CANCER RES, V45, P3856; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Varbiro G, 2001, FREE RADICAL BIO MED, V31, P548, DOI 10.1016/S0891-5849(01)00616-5; Villeneuve DJ, 2006, BREAST CANCER RES TR, V96, P17, DOI 10.1007/s10549-005-9026-6; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	45	114	120	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95716	10.1371/journal.pone.0095716	http://dx.doi.org/10.1371/journal.pone.0095716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755562	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300079
J	Clark, CG; Chong, PM; McCorrister, SJ; Mabon, P; Walker, M; Westmacott, GR				Clark, Clifford G.; Chong, Patrick M.; McCorrister, Stuart J.; Mabon, Philip; Walker, Matthew; Westmacott, Garrett R.			DNA Sequence Heterogeneity of Campylobacter jejuni CJIE4 Prophages and Expression of Prophage Genes	PLOS ONE			English	Article							NATURAL TRANSFORMATION; STRAINS; WALKERTON; OUTBREAK; REVEALS; MAZF	Campylobacter jejuni carry temperate bacteriophages that can affect the biology or virulence of the host bacterium. Known effects include genomic rearrangements and resistance to DNA transformation. C. jejuni prophage CJIE1 shows sequence variability and variability in the content of morons. Homologs of the CJIE1 prophage enhance both adherence and invasion to cells in culture and increase the expression of a specific subset of bacterial genes. Other C. jejuni temperate phages have so far not been well characterized. In this study we describe investigations into the DNA sequence variability and protein expression in a second prophage, CJIE4. CJIE4 sequences were obtained de novo from DNA sequencing of five C. jejuni isolates, as well as from whole genome sequences submitted to GenBank by other research groups. These CJIE4 DNA sequences were heterogenous, with several different insertions/deletions (indels) in different parts of the prophage genome. Two variants of a 3-4 kb region inserted within CJIE4 had different gene content that distinguished two major conserved CJIE4 prophage families. Additional indels were detected throughout the prophage. Detection of proteins in the five isolates characterized in our laboratory in isobaric Tags for Relative and Absolute Quantitation (iTRAQ) experiments indicated that prophage proteins within each of the two large indel variants were expressed during growth of the bacteria on Mueller Hinton agar plates. These proteins included the extracellular DNase associated with resistance to DNA transformation and prophage repressor proteins. Other proteins associated with known or suspected roles in prophage biology were also expressed from CJIE4, including capsid protein, the phage integrase, and MazF, a type II toxin-antitoxin system protein. Together with the results previously obtained for the CJIE1 prophage these results demonstrate that sequence variability and expression of moron genes are both general properties of temperate bacteriophages in C. jejuni.	[Clark, Clifford G.; Walker, Matthew] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Chong, Patrick M.; McCorrister, Stuart J.; Westmacott, Garrett R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Mass Spectrometry & Prote Core Facil, Winnipeg, MB, Canada; [Mabon, Philip] Publ Hlth Agcy Canada, Natl Microbiol Lab, Bioinformat Core Facil, Winnipeg, MB, Canada	Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada	Clark, CG (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Clifford.Clark@phac-aspc.gc.ca			Government of Canada A-base (program)	Government of Canada A-base (program)	This study was funded by Government of Canada A-base (program) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r30; Barton C, 2007, J CLIN MICROBIOL, V45, P386, DOI 10.1128/JCM.01513-06; Boyd E Fidelma, 2012, Bacteriophage, V2, P139; Clark CG, 2005, J CLIN MICROBIOL, V43, P2080, DOI 10.1128/JCM.43.5.2080-2091.2005; Clark CG, 2003, EMERG INFECT DIS, V9, P1232; Clark C, 2012, NY TIMES BK REV, P12; Clark CG, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-70; Clark CG, 2011, CAN J MICROBIOL, V57, P795, DOI [10.1139/W11-069, 10.1139/w11-069]; Clark CG, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-49; Cooper KK, 2011, J BACTERIOL, V193, P1491, DOI 10.1128/JB.01475-10; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gaasbeek EJ, 2010, J BACTERIOL, V192, P936, DOI 10.1128/JB.00867-09; Gaasbeek EJ, 2009, J BACTERIOL, V191, P2296, DOI 10.1128/JB.01430-08; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Pittenger LG, 2012, FOODBORNE PATHOG DIS, V9, P473, DOI 10.1089/fpd.2011.1048; Pohlhaus JR, 2008, J BACTERIOL, V190, P5239, DOI 10.1128/JB.00173-08; SALAMA S, 1989, LETT APPL MICROBIOL, V8, P5, DOI 10.1111/j.1472-765X.1989.tb00211.x; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Stefan A, 2003, FEBS LETT, V546, P295, DOI 10.1016/S0014-5793(03)00604-5; Sutton MD, 2001, J BACTERIOL, V183, P1085, DOI 10.1128/JB.183.3.1085-1089.2001; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhou YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070241	32	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95349	10.1371/journal.pone.0095349	http://dx.doi.org/10.1371/journal.pone.0095349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756024	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300038
J	Gong, YY; Huang, L; Cheng, WF; Li, XL; Lu, J; Lin, L; Si, XM				Gong, Yaoyao; Huang, Lei; Cheng, Wenfang; Li, Xueliang; Lu, Jia; Lin, Lin; Si, Xinmin			Roles of Interleukin-9 in the Growth and Cholecystokinin-Induced Intracellular Calcium Signaling of Cultured Interstitial Cells of Cajalle	PLOS ONE			English	Article							SMALL-INTESTINE; CROHNS-DISEASE; MURINE STOMACH; MAST-CELLS; IL-9; ICC; PROGENITORS; RECEPTOR; STIMULATION; DYSFUNCTION	Interstitial cells of Cajal (ICC) are pacemaker cells in the gastrointestinal (GI) tract and loss of ICC is associated with many GI motility disorders. Previous studies have shown that ICC have the capacity to regenerate or restore, and several growth factors are critical to their growth, maintenance or regeneration. The present study aimed to investigate the roles of interleukin-9 (IL-9) in the growth, maintenance and pacemaker functions of cultured ICC. Here, we report that IL-9 promotes proliferation of ICC, and culturing ICC with IL-9 enhances cholecystokinin-8-induced Ca2+ transients, which is probably caused by facilitating maintenance of ICC functions under culture condition. We also show co-localizations of cholecystokinin-1 receptor and IL-9 receptor with c-kit by double-immunohistochemical labeling. In conclusion, IL-9 can promote ICC growth and help maintain ICC functions; IL-9 probably performs its functions via IL-9 receptors on ICC.	[Gong, Yaoyao; Cheng, Wenfang; Li, Xueliang; Lu, Jia; Lin, Lin; Si, Xinmin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Huang, Lei] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Pediat Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Lin, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	lin9100@aliyun.com; sixinmin@126.com		Gong, Yaoyao/0000-0001-8135-5310	National Natural Science Foundation of China [30900666]; Programs of Department of Health of Jiangsu Province [H201061]; Graduate Innovation Project Foundation of Jiangsu Province [CXZZ12_ 0570]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programs of Department of Health of Jiangsu Province; Graduate Innovation Project Foundation of Jiangsu Province	This study was supported by operating grants from the National Natural Science Foundation of China (Grant No. 30900666, http://www.nsfc.gov.cn), the Programs of Department of Health of Jiangsu Province (Grant No. H201061, http://www.jswst.gov.cn) and the Graduate Innovation Project Foundation of Jiangsu Province (Grant No. CXZZ12_ 0570, http://www.ec.js.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelilah SG, 2001, J IMMUNOL, V166, P2768, DOI 10.4049/jimmunol.166.4.2768; Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P4453, DOI 10.1113/jphysiol.2010.196824; Beckett EAH, 2003, J PHYSIOL-LONDON, V553, P545, DOI 10.1113/jphysiol.2003.050419; Bernardini N, 2012, J CELL MOL MED, V16, P318, DOI 10.1111/j.1582-4934.2011.01298.x; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Dickens EJ, 2001, J PHYSIOL-LONDON, V531, P827, DOI 10.1111/j.1469-7793.2001.0827h.x; Gong YY, 2012, WORLD J GASTROENTERO, V18, P7184, DOI 10.3748/wjg.v18.i48.7184; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Gounni AS, 2004, J IMMUNOL, V173, P2771, DOI 10.4049/jimmunol.173.4.2771; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Horvath VJ, 2005, DIABETES, V54, P1528, DOI 10.2337/diabetes.54.5.1528; Izbeki F, 2010, J PHYSIOL-LONDON, V588, P3101, DOI 10.1113/jphysiol.2010.191023; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kim TW, 2003, J PHYSIOL-LONDON, V546, P415, DOI 10.1113/jphysiol.2002.028977; Liu HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024928; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Lowie BJ, 2011, AM J PHYSIOL-GASTR L, V301, pG835, DOI 10.1152/ajpgi.00077.2011; Matsuzawa S, 2003, J IMMUNOL, V170, P3461, DOI 10.4049/jimmunol.170.7.3461; Mei F, 2006, VIRCHOWS ARCH, V449, P348, DOI 10.1007/s00428-006-0258-6; Ordog T, 2004, AM J PHYSIOL-CELL PH, V286, pC448, DOI 10.1152/ajpcell.00273.2003; Porcher C, 2002, AM J GASTROENTEROL, V97, P118; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Tete S, 2012, J BIOL REG HOMEOS AG, V26, P319; Wang XY, 2007, NEUROGASTROENT MOTIL, V19, P349, DOI 10.1111/j.1365-2982.2006.00894.x; Wang ZY, 2010, J MEMBRANE BIOL, V234, P217, DOI 10.1007/s00232-010-9248-3; Wright GWJ, 2012, NEUROGASTROENT MOTIL, V24, pe221, DOI 10.1111/j.1365-2982.2012.01881.x; Ye J, 2006, J CELL MOL MED, V10, P687, DOI 10.1111/j.1582-4934.2006.tb00428.x	32	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95898	10.1371/journal.pone.0095898	http://dx.doi.org/10.1371/journal.pone.0095898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755995	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300116
J	Jia, J; Wang, WZ; Meng, W; Ding, MJ; Ma, SL; Wang, XJ				Jia, Jing; Wang, Wenzhe; Meng, Wen; Ding, Mingjian; Ma, Shenglin; Wang, Xiaoju			Development of a Multiplex Autoantibody Test for Detection of Lung Cancer	PLOS ONE			English	Article							SEROLOGICAL BIOMARKER; EARLY-DIAGNOSIS; TUMOR-ANTIGEN; ANTIBODIES; IDENTIFICATION; SERA; IMMUNOASSAY; SENSITIVITY; SURVIVAL; PROTEIN	Lung cancer is the leading cause of cancer-related deaths for both men and women. Early diagnosis of lung cancer has a 5-year survival rate of 48.8%, however, nearly 35% of stage I patients relapses after surgical resection, thus portending a poor prognosis. Therefore, detecting lung cancer in early stage and further identifying the high-risk patients would allow the opportunity to provide adjuvant therapy and possibly increase survival. There is considerable evidence that the immune system produces an autoantibody response to neoplastic cells. The detection of such autoantibodies has been shown to have diagnostic and prognostic value. Here we took advantage of the high-throughput Luminex technique to multiplex a total of 14 tumor-associated autoantigens to detect the autoantibody from the patients sera. The 14 antigens were expressed by in vitro transcription/translation system with HaloTag at N-terminus. The fusion proteins were then covalently immobilized onto the Luminex microspheres conjugated by the halo-link ligand, thus eliminating the protein purification procedure. Sera samples from cancer patients and healthy controls were interacted with the microsphere-antigen complex to measure the autoantibodies. We have developed a quick multiplex detection system for measuring autoantibody signature from patient sera with minimal cross-reaction. A panel of seven autoantibody biomarkers has generated an AUC. 80% in distinguishing the lung cancers from healthy controls. This study is the first report by combining Luminex platform and HaloTag technology to detect humoral immune response in cancer patients. Due to the flexibility of the Luminex technology, this approach can be applied to others conditions such as infectious, neurological, and metabolic diseases. One can envision that this multiplex Luminex system as well as the panel of seven biomarkers could be used to screen the highrisk population with subsequent CT test based on the blood test result.	[Jia, Jing; Wang, Wenzhe; Ding, Mingjian; Wang, Xiaoju] Zhejiang Acad Med Sci, Ctr Mol Med, Hangzhou, Zhejiang, Peoples R China; [Ma, Shenglin; Wang, Xiaoju] Zhejiang Acad Med Sci, Inst Lung Canc, Hangzhou, Zhejiang, Peoples R China; [Meng, Wen; Ma, Shenglin] Hangzhou First Peoples Hosp, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Medical Sciences; Zhejiang Academy of Medical Sciences	Ma, SL (corresponding author), Zhejiang Acad Med Sci, Inst Lung Canc, Hangzhou, Zhejiang, Peoples R China.	mashenglin@medmail.com.cn; wangxj@zjams.com.cn	jia, jing/T-6990-2019; Wang, Wenzhe/T-1427-2017	Wang, Wenzhe/0000-0001-6797-0878	National Natural Science Foundation [81172072]; Science Foundation for Distinguished Young Scholars [R2101405]; Infrastructure and Facility Development Program of Science and Technology Department of Zhejiang Province [2011F10015]; Major Science and Technology Innovation Project of Hangzhou, China [20112313A01]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Infrastructure and Facility Development Program of Science and Technology Department of Zhejiang Province; Major Science and Technology Innovation Project of Hangzhou, China	This study was supported by the National Natural Science Foundation (81172072), the Science Foundation for Distinguished Young Scholars (R2101405), the Infrastructure and Facility Development Program of Science and Technology Department of Zhejiang Province (2011F10015), Major Science and Technology Innovation Project of Hangzhou (20112313A01), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baykul T, 2010, J INT MED RES, V38, P737, DOI 10.1177/147323001003800302; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Bradley CJ, 2001, CANCER, V91, P178, DOI 10.1002/1097-0142(20010101)91:1<178::AID-CNCR23>3.0.CO;2-S; Brower V, 2009, J NATL CANCER I, V101, P11, DOI 10.1093/jnci/djn483; Casiano CA, 2006, MOL CELL PROTEOMICS, V5, P1745, DOI 10.1074/mcp.R600010-MCP200; Chang JW, 2005, FEBS LETT, V579, P2873, DOI 10.1016/j.febslet.2005.04.028; Chapman CJ, 2008, THORAX, V63, P228, DOI 10.1136/thx.2007.083592; Chen GA, 2007, CANCER RES, V67, P3461, DOI 10.1158/0008-5472.CAN-06-4475; Chen JS, 2011, CLIN CHIM ACTA, V412, P1417, DOI 10.1016/j.cca.2011.04.020; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Farlow EC, 2010, CLIN CANCER RES, V16, P3452, DOI 10.1158/1078-0432.CCR-09-3192; Fu Q, 2010, CLIN CHEM, V56, P314, DOI 10.1373/clinchem.2009.135087; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Kaur S, 2012, BIOMARK MED, V6, P597, DOI [10.2217/BMM.12.69, 10.2217/bmm.12.69]; Kovalenko Elena I, 2011, BMC Res Notes, V4, P340, DOI 10.1186/1756-0500-4-340; Leidinger P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-18; Liu WH, 2011, AUTOIMMUN REV, V10, P331, DOI 10.1016/j.autrev.2010.12.002; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Ma Li, 2010, Zhongguo Fei Ai Za Zhi, V13, P706, DOI 10.3779/j.issn.1009-3419.2010.07.09; Mack U, 2000, ONCOL REP, V7, P669; Nesterova M, 2006, BBA-MOL BASIS DIS, V1762, P398, DOI 10.1016/j.bbadis.2005.12.010; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Pereira-Faca SR, 2007, CANCER RES, V67, P12000, DOI 10.1158/0008-5472.CAN-07-2913; Pickering JW, 2002, AM J CLIN PATHOL, V117, P589; Qiu J, 2008, J CLIN ONCOL, V26, P5060, DOI 10.1200/JCO.2008.16.2388; Rom WN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-234; Sangrajrang S, 2003, LUNG CANCER-J IASLC, V39, P297, DOI 10.1016/S0169-5002(02)00509-3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tan EM, 2001, J CLIN INVEST, V108, P1411, DOI 10.1172/JCI200114451; Tureci O, 2006, CANCER LETT, V236, P64, DOI 10.1016/j.canlet.2005.05.008; Yagihashi A, 2005, LUNG CANCER, V48, P217, DOI 10.1016/j.lungcan.2004.11.002; Yao XA, 2010, BIOMARKERS, V15, P128, DOI 10.3109/13547500903325662; Yao YB, 2012, BIOCHEM BIOPH RES CO, V423, P613, DOI 10.1016/j.bbrc.2012.06.050; Zhang Y, 2013, INT J ONCOL, V42, P93, DOI 10.3892/ijo.2012.1699; Zhong L, 2006, J THORAC ONCOL, V1, P513, DOI 10.1097/01243894-200607000-00003	37	25	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95444	10.1371/journal.pone.0095444	http://dx.doi.org/10.1371/journal.pone.0095444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755629	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300042
J	Malik, A; Lee, J; Lee, J				Malik, Adeel; Lee, Juyong; Lee, Jooyoung			Community-Based Network Study of Protein-Carbohydrate Interactions in Plant Lectins Using Glycan Array Data	PLOS ONE			English	Article							CONCANAVALIN-A; N-ACETYLGLUCOSAMINE; STRUCTURAL BASIS; BINDING-SITES; CRYSTAL-STRUCTURE; AGGLUTININ; SPECIFICITY; RECOGNITION; PREDICTION; MICROARRAYS	Lectins play major roles in biological processes such as immune recognition and regulation, inflammatory responses, cytokine signaling, and cell adhesion. Recently, glycan microarrays have shown to play key roles in understanding glycobiology, allowing us to study the relationship between the specificities of glycan binding proteins and their natural ligands at the omics scale. However, one of the drawbacks in utilizing glycan microarray data is the lack of systematic analysis tools to extract information. In this work, we attempt to group various lectins and their interacting carbohydrates by using community-based analysis of a lectin-carbohydrate network. The network consists of 1119 nodes and 16769 edges and we have identified 3 lectins having large degrees of connectivity playing the roles of hubs. The community based network analysis provides an easy way to obtain a general picture of the lectin-glycan interaction and many statistically significant functional groups.	[Malik, Adeel; Lee, Juyong; Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Ctr In Silico Prot Sci, Seoul, South Korea	Korea Institute for Advanced Study (KIAS)	Lee, J (corresponding author), Korea Inst Adv Study, Sch Computat Sci, Ctr In Silico Prot Sci, Seoul, South Korea.	jlee@kias.re.kr	Malik, Adeel/ABD-4831-2020; Lee, Juyong/A-7869-2013	Malik, Adeel/0000-0002-3453-6001; Lee, Juyong/0000-0003-1174-4358	National Research Foundation of Korea (NRF) - Korea government (MEST) [2008-0061987]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2008-0061987). The authors thank Korea Institute for Advanced Study for providing computing resources (KIAS Center for Advanced Computation Linux Cluster) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024039; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; [Anonymous], INT J INFORM TECHNOL; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; Botos I, 2003, CELL MOL LIFE SCI, V60, P277, DOI 10.1007/s000180300023; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Cartellieri S, 2001, ANAL BIOCHEM, V295, P66, DOI 10.1006/abio.2001.5177; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; DARVILL A, 1992, GLYCOBIOLOGY, V2, P181, DOI 10.1093/glycob/2.3.181; Duverger E, 2003, BIOCHIMIE, V85, P167, DOI 10.1016/S0300-9084(03)00060-9; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P637, DOI 10.1016/j.sbi.2003.09.002; Fiore M, 2013, ORG BIOMOL CHEM, V11, P7113, DOI 10.1039/c3ob41203b; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; GOLDSTEIN IJ, 1965, BIOCHEMISTRY-US, V4, P876, DOI 10.1021/bi00881a013; GOLDSTEIN IJ, 1974, ANN NY ACAD SCI, V234, P283, DOI 10.1111/j.1749-6632.1974.tb53040.x; Gupta D, 1997, J BIOL CHEM, V272, P6388, DOI 10.1074/jbc.272.10.6388; HARDMAN KD, 1972, BIOCHEMISTRY-US, V11, P4910, DOI 10.1021/bi00776a006; Higurashi M, 2008, PROTEIN SCI, V17, P72, DOI 10.1110/ps.073196308; Houseman BT, 2002, CHEM BIOL, V9, P443, DOI 10.1016/S1074-5521(02)00124-2; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; IGLESIAS JL, 1982, EUR J BIOCHEM, V123, P247, DOI 10.1111/j.1432-1033.1982.tb19760.x; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Itakura Y, 2007, J BIOCHEM, V142, P459, DOI 10.1093/jb/mvm153; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; KAKU H, 1990, ARCH BIOCHEM BIOPHYS, V277, P255, DOI 10.1016/0003-9861(90)90576-K; Kawaguchi T, 1999, J COLLOID INTERF SCI, V210, P290, DOI 10.1006/jcis.1998.5976; Kletter Doron, 2013, Curr Protoc Chem Biol, V5, P157, DOI 10.1002/9780470559277.ch130028; Koh GCKW, 2012, J PROTEOME RES, V11, P2014, DOI 10.1021/pr201211w; Kulharia M, 2009, J MOL GRAPH MODEL, V28, P297, DOI 10.1016/j.jmgm.2009.08.009; Lee JG, 2013, SCI REP-UK, V3, DOI [10.1038/srep01034, 10.1038/srep02197]; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060372; Lee J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056702; LERNER DR, 1992, J BIOL CHEM, V267, P11085; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; Malik Adeel, 2010, Advances in Bioinformatics, V2010, P436036, DOI 10.1155/2010/436036; Masaka R, 2010, BIOORGAN MED CHEM, V18, P621, DOI 10.1016/j.bmc.2009.12.006; Maupin KA, 2012, GLYCOBIOLOGY, V22, P160, DOI 10.1093/glycob/cwr128; MCCOY JP, 1983, ANAL BIOCHEM, V130, P437, DOI 10.1016/0003-2697(83)90613-9; Miyagawa S, 2013, SURG TODAY, V43, P1439, DOI 10.1007/s00595-013-0569-6; Moothoo DN, 1999, ACTA CRYSTALLOGR D, V55, P353, DOI 10.1107/S0907444998008919; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Naismith JH, 1996, J BIOL CHEM, V271, P972, DOI 10.1074/jbc.271.2.972; Nassif H, 2009, PROTEINS, V77, P121, DOI 10.1002/prot.22424; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Park SJ, 2002, ANGEW CHEM INT EDIT, V41, P3180, DOI 10.1002/1521-3773(20020902)41:17<3180::AID-ANIE3180>3.0.CO;2-S; Park S, 2007, NAT PROTOC, V2, P2747, DOI 10.1038/nprot.2007.373; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; PORETZ RD, 1970, BIOCHEMISTRY-US, V9, P2890, DOI 10.1021/bi00816a021; Porter A, 2010, GLYCOBIOLOGY, V20, P369, DOI 10.1093/glycob/cwp187; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.pp.44.060193.003111; REEKE GN, 1975, J BIOL CHEM, V250, P1525; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Sathisha GJ, 2008, AMINO ACIDS, V35, P309, DOI 10.1007/s00726-007-0624-y; Shahidi-Noghabi S, 2010, J INSECT PHYSIOL, V56, P1101, DOI 10.1016/j.jinsphys.2010.03.012; SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Shionyu-Mitsuyama C, 2003, PROTEIN ENG, V16, P467, DOI 10.1093/protein/gzg065; Shriver Z, 2004, NAT REV DRUG DISCOV, V3, P863, DOI 10.1038/nrd1521; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Taroni C, 2000, PROTEIN ENG, V13, P89, DOI 10.1093/protein/13.2.89; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Turton K, 2004, GLYCOBIOLOGY, V14, P923, DOI 10.1093/glycob/cwh114; van Dongen S, 2000, THESIS; van Dongen S, 2000, MCL ALGORITHM CLUSTE; VanDamme EJM, 1996, EUR J BIOCHEM, V235, P128, DOI 10.1111/j.1432-1033.1996.00128.x; Varki A., 1999, ESSENTIALS GLYCOBIOL; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Wang YF, 2011, FEBS LETT, V585, P3927, DOI 10.1016/j.febslet.2011.10.035; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Wright CS, 1996, STRUCTURE, V4, P1339, DOI 10.1016/S0969-2126(96)00141-4; WRIGHT CS, 1992, J BIOL CHEM, V267, P14345; Wu AM, 2006, MOL IMMUNOL, V43, P1700, DOI 10.1016/j.molimm.2005.09.008; Wu AM, 1997, GLYCOBIOLOGY, V7, P1061, DOI 10.1093/glycob/7.8.1061; Zhu KY, 1996, PLANT PHYSIOL, V110, P195, DOI 10.1104/pp.110.1.195	82	11	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95480	10.1371/journal.pone.0095480	http://dx.doi.org/10.1371/journal.pone.0095480			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755681	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300046
J	Nawaz, R; Ayub, M; Javaid, A				Nawaz, Rab; Ayub, Muhammad; Javaid, Akmal			Plane Wave Diffraction by a Finite Plate with Impedance Boundary Conditions	PLOS ONE			English	Article							MOVING FLUID; HALF-PLANE; ACOUSTIC DIFFRACTION; STRIP; FLOW	In this study we have examined a plane wave diffraction problem by a finite plate having different impedance boundaries. The Fourier transforms were used to reduce the governing problem into simultaneous Wiener-Hopf equations which are then solved using the standard Wiener-Hopf procedure. Afterwards the separated and interacted fields were developed asymptotically by using inverse Fourier transform and the modified stationary phase method. Detailed graphical analysis was also made for various physical parameters we were interested in.	[Nawaz, Rab; Javaid, Akmal] COMSATS Inst Informat Technol, Dept Math, Wah Cantt, Pakistan; [Nawaz, Rab; Ayub, Muhammad] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Quaid I Azam University	Nawaz, R (corresponding author), COMSATS Inst Informat Technol, Dept Math, Wah Cantt, Pakistan.	rabnawaz@ciitwah.edu.pk	Nawaz, Rab/A-3495-2015	Nawaz, Rab/0000-0002-9707-0608	COMSATS Institute of Information Technology (CIIT) Wah Cantt Pakistan	COMSATS Institute of Information Technology (CIIT) Wah Cantt Pakistan	In case of acceptance of this article my institute COMSATS Institute of Information Technology (CIIT) Wah Cantt Pakistan will release the required funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2006, J MATH ANAL APPL, V321, P609, DOI 10.1016/j.jmaa.2005.08.047; ASGHAR S, 1991, IMA J APPL MATH, V46, P217, DOI 10.1093/imamat/46.3.217; Ayub M, 2009, J MATH ANAL APPL, V349, P245, DOI 10.1016/j.jmaa.2008.08.044; Castro LP, 2008, J MATH ANAL APPL, V337, P1031, DOI 10.1016/j.jmaa.2007.04.037; Chakrabarti A., 1977, Indian Journal of Pure and Applied Mathematics, V8, P702; Copson ET, 1967, ASYMPTOTIC EXPANSION; Herman IM, 1987, RADIO SCI, V22, P335; Imran A, 2007, PROG ELECTROMAGN RES, V75, P303, DOI 10.2528/PIER07053104; Imran A, 2009, OPT COMMUN, V282, P443, DOI 10.1016/j.optcom.2008.10.046; Jeon W, 2008, AIAA J, V46, P2977, DOI 10.2514/1.32424; Jones D.S., 1896, THEORY ELECTROMAGNET; Keller JB, 1962, J OPT SOC AM, V5; Lawrie JB, 2007, J ENG MATH, V59, P351, DOI 10.1007/s10665-007-9195-x; Morse PM, 1961, ENCY PHYS ACOUSTICS, VI; MYERS MK, 1980, J SOUND VIB, V71, P429, DOI 10.1016/0022-460X(80)90424-1; Nawaz R, 2012, INDIAN J PURE AP MAT, V43, P571, DOI 10.1007/s13226-012-0034-z; Noble B, 1958, METHODS BASED WEINER; Pelosi P, 1996, IEEE T ANT PROPAG MA; Poincare H., 1892, ACTA MATH, V16, P297; RAWLINS AD, 1975, PROC R SOC LON SER-A, V346, P469, DOI 10.1098/rspa.1975.0186; RAWLINS AD, 1975, P ROY SOC EDINB A, V72, P337, DOI 10.1017/S0080454100009717; RAWLINS AD, 1977, INT J ENG SCI, V15, P569, DOI 10.1016/0020-7225(77)90053-2; Rawlins AD, 1984, J ENG MATH, P18; Senior T. B. A., 1995, APPROXIMATE BOUNDARY; SENIOR TBA, 1979, IEEE T ANTENN PROPAG, V27, P808, DOI 10.1109/TAP.1979.1142189; Serbest AH, 1993, ANAL NUMERICAL METHO; Sommers G.A., 1992, P I ELECTR ENG, V139, P297	28	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e92566	10.1371/journal.pone.0092566	http://dx.doi.org/10.1371/journal.pone.0092566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755624	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300003
J	Sun, Y; Zhang, YC; Liu, YC; Xue, SX; Geng, XY; Hao, T; Sun, JS				Sun, Yan; Zhang, Yichen; Liu, Yichen; Xue, Shuxia; Geng, Xuyun; Hao, Tong; Sun, Jinsheng			Changes in the Organics Metabolism in the Hepatopancreas Induced by Eyestalk Ablation of the Chinese Mitten Crab Eriocheir sinensis Determined via Transcriptome and DGE Analysis	PLOS ONE			English	Article							CRUSTACEAN HYPERGLYCEMIC HORMONE; CARBOHYDRATE-METABOLISM; KURUMA PRAWN; EXPRESSION; TOOL; CHH; SHRIMP	Background: To understand the regulation mechanism of eyestalk ablation on the activities of hepatopancreas, Illumina RNA-Seq and digital gene expression (DGE) analyses were performed to investigate the transcriptome of the eyestalk, Y-organ, and hepatopancreas of E. sinensis and to identify the genes associated with the hepatopancreas metabolism that are differentially expressed under eyestalk ablation conditions. Results: A total of 58,582 unigenes were constructed from 157,168 contigs with SOAPdenovo. A BlastX search against the NCBI Nr database identified 21,678 unigenes with an E-value higher than 10(-5). Using the BLAST2Go and BlastAll software programs, 6,883 unigenes (11.75% of the total) were annotated to the Gene Ontology (GO) database, 7,386 (12.6%) unigenes were classified into 25 Clusters of Orthologous Groups of Proteins (COGs), 16,200 (27.7%) unigenes were assigned to 242 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and 1,846 unigenes were matched to "metabolism pathways". The DGE analysis revealed that 1,416 unigenes were significantly differentially expressed in the hepatopancreas, of which 890 unigenes were up-regulated and 526 unigenes were down-regulated. Of the differentially expressed genes, 382 unigenes were annotated and 63 were classified into metabolism pathways. The results of the real-time polymerase chain reaction (PCR) analysis of four unigenes related to carbohydrate metabolism were consistent with those obtained from the DGE analysis, which demonstrates that the sequencing data were satisfactory for further gene expression analyses. Conclusion: This paper reported the transcriptom of the eyestalk, Y-organ, and hepatopancreas from E. sinensis. DGE analysis provided the different expressed genes of the metabolism processes in hepatopancreas that are affected by eyestalk ablation. These findings will facilitate further investigations on the mechanisms of the metabolism of organic substances during development and reproduction in crustaceans.	[Zhang, Yichen; Liu, Yichen; Hao, Tong; Sun, Jinsheng] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Sun, Yan; Xue, Shuxia; Geng, Xuyun; Sun, Jinsheng] Tianjin Ctr Control & Prevent Aquat Anim Infect D, Tianjin, Peoples R China	Tianjin Normal University; Tianjin Center for Disease Control & Prevention	Sun, JS (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	jinshsun@163.com	liu, yang/HHY-8583-2022; liu, yichen/GVT-6262-2022		National High-Tech Research and Development Program of China [2012A A10A401, 2012AA092205]; National Key technology RD Program [2012BAD26B04]; Major State Basic Research Development Program of China [2012CB114405]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Key technology RD Program(National Key Technology R&D Program); Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was financially supported by grants from the National High-Tech Research and Development Program of China (863 programs, 2012A A10A401 and 2012AA092205); the National Key technology R&D Program (2012BAD26B04); the program from key laboratory of freshwater aquatic genetic resources certificated by ministry of agriculture and the Major State Basic Research Development Program of China (973 programs, 2012CB114405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIYODI KG, 1970, BIOL REV, V45, P121, DOI 10.1111/j.1469-185X.1970.tb01627.x; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Cheng Yong-Xu, 1998, Acta Zoologica Sinica, V44, P420; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Gaxiola G, 2005, COMP BIOCHEM PHYS A, V140, P29, DOI 10.1016/j.cbpb.2004.10.018; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; KUMMER G, 1993, PEPTIDES, V14, P103, DOI 10.1016/0196-9781(93)90016-A; Lemos D, 2003, COMP BIOCHEM PHYS B, V135, P707, DOI 10.1016/S1096-4959(03)00166-0; Li C, 2011, PLOS ONE, V7; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Manfrin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065176; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Munday KA, 1971, RESP ENERGY METABOLI; Murugesan R., 2008, Journal of Fisheries and Aquatic Sciences, V3, P82; Nagai C, 2011, GEN COMP ENDOCR, V172, P293, DOI 10.1016/j.ygcen.2011.03.019; Nagai C, 2009, PEPTIDES, V30, P507, DOI 10.1016/j.peptides.2008.07.017; Reddy PS, 2001, BIOL BULL, V201, P17, DOI 10.2307/1543521; REDDY PS, 1992, ARCH INT PHYSIOL BIO, V100, P281, DOI 10.3109/13813459208998115; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Santos EA, 1997, PHYSIOL ZOOL, V70, P415, DOI 10.1086/515846; SEDLMEIER D, 1987, COMP BIOCHEM PHYS A, V87, P423, DOI 10.1016/0300-9629(87)90146-0; Sonanez-Organis JG, 2011, COMP BIOCHEM PHYS B, V158, P242, DOI 10.1016/j.cbpb.2010.12.006; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tseng DY, 2001, COMP BIOCHEM PHYS A, V129, P909, DOI 10.1016/S1095-6433(01)00355-5; Venkitraman P. R., 2004, Indian Journal of Experimental Biology, V42, P403; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	34	20	22	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95827	10.1371/journal.pone.0095827	http://dx.doi.org/10.1371/journal.pone.0095827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755618	gold, Green Submitted, Green Published			2022-12-25	WOS:000335240300101
J	Ulrich, R; Puff, C; Wewetzer, K; Kalkuhl, A; Deschl, U; Baumgartner, W				Ulrich, Reiner; Puff, Christina; Wewetzer, Konstantin; Kalkuhl, Arno; Deschl, Ulrich; Baumgaertner, Wolfgang			Transcriptional Changes in Canine Distemper Virus-Induced Demyelinating Leukoencephalitis Favor a Biphasic Mode of Demyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GNOTOBIOTIC DOGS; UP-REGULATION; ANIMAL-MODEL; EXPRESSION; ENCEPHALOMYELITIS; INFECTION; BRAIN; ENCEPHALITIS; PATHOGENESIS	Canine distemper virus (CDV)-induced demyelinating leukoencephalitis in dogs (Canis familiaris) is suggested to represent a naturally occurring translational model for subacute sclerosing panencephalitis and multiple sclerosis in humans. The aim of this study was a hypothesis-free microarray analysis of the transcriptional changes within cerebellar specimens of five cases of acute, six cases of subacute demyelinating, and three cases of chronic demyelinating and inflammatory CDV leukoencephalitis as compared to twelve non-infected control dogs. Frozen cerebellar specimens were used for analysis of histopathological changes including demyelination, transcriptional changes employing microarrays, and presence of CDV nucleoprotein RNA and protein using microarrays, RT-qPCR and immunohistochemistry. Microarray analysis revealed 780 differentially expressed probe sets. The dominating change was an up-regulation of genes related to the innate and the humoral immune response, and less distinct the cytotoxic T-cell-mediated immune response in all subtypes of CDV leukoencephalitis as compared to controls. Multiple myelin genes including myelin basic protein and proteolipid protein displayed a selective down-regulation in subacute CDV leukoencephalitis, suggestive of an oligodendrocyte dystrophy. In contrast, a marked up-regulation of multiple immunoglobulin-like expressed sequence tags and the delta polypeptide of the CD3 antigen was observed in chronic CDV leukoencephalitis, in agreement with the hypothesis of an immune-mediated demyelination in the late inflammatory phase of the disease. Analysis of pathways intimately linked to demyelination as determined by morphometry employing correlation-based Gene Set Enrichment Analysis highlighted the pathomechanistic importance of up-regulated genes comprised by the gene ontology terms "viral replication'' and "humoral immune response'' as well as down-regulated genes functionally related to "metabolite and energy generation''.	[Ulrich, Reiner; Puff, Christina; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Wewetzer, Konstantin] Hannover Med Sch, Dept Funct & Appl Anat, Hannover, Germany; [Kalkuhl, Arno; Deschl, Ulrich] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Nonclin Drug Safety, Biberach, Riss, Germany; [Ulrich, Reiner; Wewetzer, Konstantin; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; Boehringer Ingelheim	Ulrich, R (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Germany.	reiner.ulrich@tiho-hannover.de			German Research Foundation (DFG) [BA 815/9-1]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony	German Research Foundation (DFG)(German Research Foundation (DFG)); Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony	This work is in part supported by research grants from the German Research Foundation (DFG, grant number: BA 815/9-1), and the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldinger S, 1996, ACTA NEUROPATHOL, V92, P273, DOI 10.1007/s004010050518; Alldinger S, 2000, ACTA NEUROPATHOL, V99, P138, DOI 10.1007/PL00007417; APPEL MJ, 1987, VIRUS INFECT CARNIVO; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Baumgaertner Wolfgang, 2005, P871, DOI 10.1007/0-387-25518-4_51; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; Bennett JL, 2003, J NEUROVIROL, V9, P623, DOI 10.1080/714044484; Briggs JW, 2011, TLS-TIMES LIT SUPPL, P6; CERRUTISOLA S, 1983, J NEUROIMMUNOL, V4, P77, DOI 10.1016/0165-5728(83)90013-9; CORNWELL HJ, 1965, J COMP PATHOL THERAP, V75, P3, DOI 10.1016/0021-9975(65)90043-5; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; DeMonbreun WA, 1937, AM J PATHOL, V13, P187; DUNKIN G. W., 1926, JOUR COMP PATH & THERAP, V39, P213; GLAUS T, 1990, ACTA NEUROPATHOL, V80, P59, DOI 10.1007/BF00294222; GRABER HU, 1995, ACTA NEUROPATHOL, V90, P312, DOI 10.1007/BF00296516; GRIOT C, 1989, ACTA NEUROPATHOL, V78, P396, DOI 10.1007/BF00688176; Grone A, 2000, J NEUROIMMUNOL, V110, P20, DOI 10.1016/S0165-5728(00)00332-5; HIGGINS RJ, 1982, ACTA NEUROPATHOL, V58, P1, DOI 10.1007/BF00692691; HIGGINS RJ, 1989, ACTA NEUROPATHOL, V77, P441, DOI 10.1007/BF00687381; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; KOESTNER A, 1975, AM J PATHOL, V78, P361; KRAKOWKA S, 1976, J INFECT DIS, V134, P629, DOI 10.1093/infdis/134.6.629; KRAKOWKA S, 1973, INFECT IMMUN, V8, P819, DOI 10.1128/IAI.8.5.819-827.1973; KRAKOWKA S, 1975, J INFECT DIS, V132, P384, DOI 10.1093/infdis/132.4.384; LAUDER I. M., 1954, Veterinary Record, V66, P623; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Miao Q, 2003, ACTA NEUROPATHOL, V106, P486, DOI 10.1007/s00401-003-0754-6; Nesseler A, 1999, VET MICROBIOL, V69, P23, DOI 10.1016/S0378-1135(99)00083-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schobesberger M, 1999, ACTA NEUROPATHOL, V97, P279, DOI 10.1007/s004010050986; Schobesberger M, 2002, ACTA NEUROPATHOL, V103, P11, DOI 10.1007/s004010100427; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sips GJ, 2007, REV MED VIROL, V17, P223, DOI 10.1002/rmv.526; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; So EY, 2006, GLIA, V53, P858, DOI 10.1002/glia.20346; Stein VM, 2011, VET IMMUNOL IMMUNOP, V144, P17, DOI 10.1016/j.vetimm.2011.06.029; Stein VM, 2004, J NEUROIMMUNOL, V153, P122, DOI 10.1016/j.jneuroim.2004.05.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUMMERS BA, 1979, ACTA NEUROPATHOL, V46, P1, DOI 10.1007/BF00684797; SUMMERS BA, 1987, J NEUROCYTOL, V16, P871; SUMMERS BA, 1984, J COMP PATHOL, V94, P65, DOI 10.1016/0021-9975(84)90009-4; Tipold A, 1999, ACTA NEUROPATHOL, V97, P45, DOI 10.1007/s004010050954; Tizard I. R., 2009, VET IMMUNOLOGY INTRO; Tripathi S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt054; Tsunoda I, 2003, AM J PATHOL, V162, P1259, DOI 10.1016/S0002-9440(10)63922-3; Ulrich R, 2010, J CELL MOL MED, V14, P434, DOI 10.1111/j.1582-4934.2008.00646.x; VANDEVELDE M, 1981, ACTA NEUROPATHOL, V54, P31, DOI 10.1007/BF00691330; VANDEVELDE M, 1980, VET PATHOL, V17, P17, DOI 10.1177/030098588001700102; VANDEVELDE M, 1986, J NEUROIMMUNOL, V11, P41, DOI 10.1016/0165-5728(86)90073-1; VANDEVELDE M, 1982, ACTA NEUROPATHOL, V56, P285, DOI 10.1007/BF00691260; VANDEVELDE M, 1983, ACTA NEUROPATHOL, V59, P269, DOI 10.1007/BF00691492; VANDEVELDE M, 1985, ACTA NEUROPATHOL, V67, P211, DOI 10.1007/BF00687803; Vandevelde M, 2012, VET NEUROPATHOLOGY E, P61; Wunschmann A, 1999, VET IMMUNOL IMMUNOP, V67, P101, DOI 10.1016/S0165-2427(98)00216-5	60	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95917	10.1371/journal.pone.0095917	http://dx.doi.org/10.1371/journal.pone.0095917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755553	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300119
J	Gomez, EV; Gonzalez, AT; Bertot, LC; Garcia, AY; Rodriguez, YS; Perez, YM				Vilar Gomez, Eduardo; Torres Gonzalez, Ana; Calzadilla Bertot, Luis; Yasells Garcia, Ali; Sanchez Rodriguez, Yoan; Martinez Perez, Yadina			Arterial Blood Pressure Is Closely Related to Ascites Development in Compensated HCV-Related Cirrhosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SUSTAINED VIROLOGICAL RESPONSE; NATURAL-HISTORY; PORTAL-HYPERTENSION; LIVER-DISEASE; BETA-BLOCKERS; LONG-TERM; GASTROESOPHAGEAL VARICES; HEMODYNAMIC-RESPONSE; HEPATORENAL-SYNDROME	Background: Arterial blood pressure (BP) is a reliable marker of circulatory dysfunction in cirrhotic patients. There are no prospective studies evaluating the association between different levels of arterial BP and ascites development in compensated cirrhotic patients.Therefore, we evaluated the relationship between arterial BP and ascites development in compensated cirrhotic patients. Materials and Methods: A total of 402 patients with compensated HCV- related cirrhosis were prospectively followed during 6 years to identify ascites development. At baseline, patients underwent systolic, diastolic and mean arterial pressure (MAP) measurements. Any history of arterial hypertension was also recorded. The occurrence of events such as bleeding, hepatocellular carcinoma, death and liver transplantation prior to ascites development were considered as competing risk events. Results: Over a median of 156 weeks, ascites occurred in 54 patients (13%). At baseline, MAP was significantly lower in patients with ascites development (75.9 mm/Hg [95% CI, 70.3-84.3]) than those without ascites (93.6 mm/Hg [95% CI: 86.6-102.3]). After adjusting for covariates, the 6-year cumulative incidence of ascites was 40% (95% CI, 34%-48%) for patients with MAP, 83.32 mm/Hg. In contrast, cumulative incidences of ascites were almost similar among patients with MAP values between 83.32 mm/Hg and 93.32 mm/Hg (7% [95% CI: 4%-12%]), between 93.32 mm/Hg and 100.31 mm/Hg (5% [95% CI: 4%-11%]) or higher than 100.31 mm/Hg (3% [95% CI: 1%-6%]). The MAP was an independent predictor of ascites development. Conclusions: The MAP is closely related to the development of ascites in compensated HCV- related cirrhosis. The risk of ascites development increases in 4.4 fold for subjects with MAP values < 83.32 mm/Hg.	[Vilar Gomez, Eduardo] Natl Inst Gastroenterol, Dept Res & Clin Experimentat, Havana, Cuba; [Torres Gonzalez, Ana; Calzadilla Bertot, Luis; Yasells Garcia, Ali; Sanchez Rodriguez, Yoan; Martinez Perez, Yadina] Natl Inst Gastroenterol, Dept Hepatol, Havana, Cuba		Gomez, EV (corresponding author), Natl Inst Gastroenterol, Dept Res & Clin Experimentat, Havana, Cuba.	eduardovilar2000@yahoo.com	Vilar, Eduardo/H-8556-2019; Bertot, Luis Calzadilla/I-5813-2019; Calzadilla Bertot, Luis/ABB-2257-2021	Vilar, Eduardo/0000-0003-1435-4013; Calzadilla Bertot, Luis/0000-0001-9221-0272				Abraldes JG, 2003, HEPATOLOGY, V37, P902, DOI 10.1053/jhep.2003.50133; [Anonymous], CANC INVEST, V27, P235; Arroyo V, 2003, J HEPATOL, V38, pS69, DOI 10.1016/S0168-8278(03)00007-2; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruno S, 2010, HEPATOLOGY, V51, P2069, DOI 10.1002/hep.23528; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009; Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; FERNANDEZSEARA J, 1989, GASTROENTEROLOGY, V97, P1304, DOI 10.1016/0016-5085(89)91704-6; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Ghany MG, 2010, GASTROENTEROLOGY, V138, P136, DOI 10.1053/j.gastro.2009.09.007; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Groszmann RJ, 2005, NEW ENGL J MED, V353, P2254, DOI 10.1056/NEJMoa044456; Henriksen JH, 2006, GUT, V55, P380, DOI 10.1136/gut.2005.064329; Hernandez-Gea V, 2012, AM J GASTROENTEROL, V107, P418, DOI 10.1038/ajg.2011.456; Iacobellis A, 2011, CLIN GASTROENTEROL H, V9, P249, DOI 10.1016/j.cgh.2010.10.036; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Krag A, 2010, GUT, V59, P105, DOI 10.1136/gut.2009.180570; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; LOYKE HF, 1962, ARCH INTERN MED, V110, P45, DOI 10.1001/archinte.1962.03620190047006; LOYKE HF, 1955, AM J MED SCI, V230, P627, DOI 10.1097/00000441-195523060-00004; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Merli M, 2003, J HEPATOL, V38, P266, DOI 10.1016/S0168-8278(02)00420-8; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Ruiz-del-Arbol L, 2005, HEPATOLOGY, V42, P439, DOI 10.1002/hep.20766; Ruiz-del-Arbol W, 2003, HEPATOLOGY, V38, P1210, DOI 10.1053/jhep.2003.50447; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Gomez EV, 2013, J HEPATOL, V58, P434, DOI 10.1016/j.jhep.2012.10.023; Gomez EV, 2009, WORLD J GASTROENTERO, V15, P2768, DOI 10.3748/wjg.15.2768; Villanueva C, 2009, GASTROENTEROLOGY, V137, P119, DOI 10.1053/j.gastro.2009.03.048; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95736	10.1371/journal.pone.0095736	http://dx.doi.org/10.1371/journal.pone.0095736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755710	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300086
J	Firat, YH; Simanski, M; Rademacher, F; Schroder, L; Brasch, J; Harder, J				Firat, Yasemin Helene; Simanski, Maren; Rademacher, Franziska; Schroeder, Lena; Brasch, Jochen; Harder, Juergen			Infection of Keratinocytes with Trichophytum rubrum Induces Epidermal Growth Factor-Dependent RNase 7 and Human Beta-Defensin-3 Expression	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; SKIN; DECTIN-2	Human keratinocytes are able to express various antimicrobial peptides (AMP) to protect the skin from exaggerated microbial colonization and infection. Recently, in vitro growth-inhibiting activity of the skin-derived AMP psoriasin, RNase 7 and human beta-defensin (hBD)-2 against dermatophytes such as Trichophyton (T.) rubrum have been reported. To evaluate whether keratinocytes are able to respond to T. rubrum infection by an induced expression of AMP we exposed primary keratinocytes to living conidia of T. rubrum. This led to conidia germination and mycelial growth which was paralleled by a strong gene induction of the skin-derived AMP RNase 7 and hBD-3. Gene expression of the AMP psoriasin (S100A7) and hBD-2 were only slightly induced. The T. rubrum-mediated RNase 7 gene induction was accompanied by increased secretion of RNase 7. Parallel treatment of the keratinocytes with T. rubrum and the cytokine combination IL-17A/IFN-gamma resulted in synergistic induction of RNase 7 and hBD-3 expression. Since patients receiving therapy by inhibition of the epidermal growth factor receptor (EGFR) more often suffer from dermatophytoses we investigated whether EGFR may be involved in the T. rubrum-mediated RNase 7 and hBD-3 induction. Primary keratinocytes incubated with an EGFR blocking antibody as well as with the EGFR antagonist AG1478 showed a significantly diminished RNase 7 and hBD-3 induction upon exposure of the keratinocytes to T. rubrum indicating that EGFR is involved in the T. rubrum-mediated induction of RNase 7 and hBD-3. The growth of T. rubrum in vitro was inhibited by hBD-3 in a dose-dependent manner suggesting that hBD-3 may contribute to cutaneous innate defense against T. rubrum. Taken together our data indicate that keratinocytes are able to initiate a fast defense response towards T. rubrum by the increased expression of AMP active against T. rubrum. A dysregulation of AMP may contribute to chronic and recurring dermatophytoses.	[Firat, Yasemin Helene; Simanski, Maren; Rademacher, Franziska; Schroeder, Lena; Brasch, Jochen; Harder, Juergen] Univ Med Ctr Schleswig Holstein, Dept Dermatol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Harder, J (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Dermatol, Campus Kiel, Kiel, Germany.	jharder@dermatology.uni-kiel.de	Harder, Jürgen/B-3162-2010	Harder, Jurgen/0000-0002-4075-4603	Deutsche Forschungsgemeinschaft [HA 3386/3 -2, HA 3386/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants of the Deutsche Forschungsgemeinschaft (HA 3386/3 -2 and 6-1) given to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batbayar S, 2012, BIOMOL THER, V20, P433, DOI 10.4062/biomolther.2012.20.5.433; Brasch J, 2013, MYCOSES; Brasch J, 2010, J DTSCH DERMATOL GES, V8, P780, DOI 10.1111/j.1610-0387.2010.07481.x; De Hoog G. S., 2000, ATLAS CLIN FUNGI; Eilers RE, 2010, JNCI-J NATL CANCER I, V102, P47, DOI 10.1093/jnci/djp439; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fritz P, 2012, MED MYCOL, V50, P579, DOI 10.3109/13693786.2012.660203; Gil ML, 2006, MICROBES INFECT, V8, P2299, DOI 10.1016/j.micinf.2006.03.014; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Harder J, 2013, EXP DERMATOL, V22, P1, DOI 10.1111/exd.12046; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Koten B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006424; Li M, 2011, J DERMATOL SCI, V61, P72, DOI 10.1016/j.jdermsci.2010.11.009; Lichtenberger BM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005886; Roth SA, 2014, J INVEST DERMATOL, V134, P374, DOI 10.1038/jid.2013.313; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schroeder Jens-M., 2011, Allergology International, V60, P17, DOI 10.2332/allergolint.10-RAI-0292; Seebacher C, 2008, MYCOPATHOLOGIA, V166, P335, DOI 10.1007/s11046-008-9100-9; Simanski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059531; Smijs TGM, 2011, PHOTOCHEM PHOTOBIOL, V87, P2, DOI 10.1111/j.1751-1097.2010.00848.x; Villamon E, 2004, MICROBES INFECT, V6, P1, DOI 10.1016/j.micinf.2003.09.020; WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240, DOI 10.1128/CMR.8.2.240	24	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93941	10.1371/journal.pone.0093941	http://dx.doi.org/10.1371/journal.pone.0093941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747887	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500016
J	Giantin, M; Granato, A; Baratto, C; Marconato, L; Vascellari, M; Morello, EM; Vercelli, A; Mutinelli, F; Dacasto, M				Giantin, Mery; Granato, Anna; Baratto, Chiara; Marconato, Laura; Vascellari, Marta; Morello, Emanuela M.; Vercelli, Antonella; Mutinelli, Franco; Dacasto, Mauro			Global Gene Expression Analysis of Canine Cutaneous Mast Cell Tumor: Could Molecular Profiling Be Useful for Subtype Classification and Prognostication?	PLOS ONE			English	Article							POOR-PROGNOSIS; BREAST-CANCER; PROTEIN EXPRESSION; IDENTIFICATION; SURVIVAL; CDC20; OVEREXPRESSION; GELSOLIN; MARKERS; PATHOLOGISTS	Prognosis and therapeutic management of dogs with cutaneous mast cell tumors (MCTs) depend on clinical stage and histological grade. However, the prognostic value of this latter is still questionable. In the present study, MCT transcriptome was analyzed to identify a set of candidate genes potentially useful for predicting the biological behavior of MCTs. Fifty-one canine MCT biopsies were analyzed. Isolated and purified total RNAs were individually hybridized to the Agilent Canine V2 4x44k DNA microarray. The comparison of reference differentiated and undifferentiated MCT transcriptome revealed a total of 597 differentially expressed genes (147 down-regulated and 450 up-regulated). The functional analysis of this set of genes provided evidence that they were mainly involved in cell cycle, DNA replication, p53 signaling pathway, nucleotide excision repair and pyrimidine metabolism. Class prediction analysis identified 13 transcripts providing the greatest accuracy of class prediction and divided samples into two categories (differentiated and undifferentiated), harboring a different prognosis. The Principal Component Analysis of all samples, made by using the selected 13 markers, confirmed MCT classification. The first three components accounted for 99.924% of the total variance. This molecular classification significantly correlated with survival time (p = 0.0026). Furthermore, among all marker genes, a significant association was found between mRNA expression and MCT-related mortality for FOXM1, GSN, FEN1 and KPNA2 (p<0.05). Finally, marker genes mRNA expression was evaluated in a cohort of 22 independent samples. Data obtained enabled to identify MCT cases with different prognosis. Overall, the molecular characterization of canine MCT transcriptome allowed the identification of a set of 13 transcripts that clearly separated differentiated from undifferentiated MCTs, thus predicting outcome regardless of the histological grade. These results may have clinical relevance and warrant future validation in a prospective study.	[Giantin, Mery; Dacasto, Mauro] Univ Padua, Dipartimento Biomed Comparata & Alimentaz, Padua, Italy; [Granato, Anna; Baratto, Chiara; Vascellari, Marta; Mutinelli, Franco] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy; [Marconato, Laura] Ctr Oncol Vet, Bologna, Italy; [Morello, Emanuela M.] Univ Turin, Dipartimento Sci Vet, Turin, Italy; [Vercelli, Antonella] Ambulatorio Vet Assoc, Turin, Italy	University of Padua; IZS delle Venezie; University of Turin	Giantin, M (corresponding author), Univ Padua, Dipartimento Biomed Comparata & Alimentaz, Padua, Italy.	mery.giantin@unipd.it	MUTINELLI, FRANCO/K-7525-2018; Marconato, Laura/AAD-7263-2020; Giantin, Mery/AAX-3235-2020; Vercelli, Alessandro/A-1926-2012	MUTINELLI, FRANCO/0000-0003-2903-9390; Marconato, Laura/0000-0002-7843-615X; Vascellari, Marta/0000-0002-4537-4386; MORELLO, Emanuela Maria/0000-0002-9801-6646; Vercelli, Alessandro/0000-0002-5909-2128	Istituto Zooprofilattico Sperimentale delle Venezie [RC IZSVE 4/10]	Istituto Zooprofilattico Sperimentale delle Venezie	This work was supported by grants from Istituto Zooprofilattico Sperimentale delle Venezie (RC IZSVE 4/10: Caratterizzazione biomolecolare del mastocitoma di cane mediante microarray) to Anna Granato, Marta Vascellari and Mauro Dacasto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2011, BIOCHEM BIOPH RES CO, V412, P44, DOI 10.1016/j.bbrc.2011.07.034; Baig RM, 2013, DIS MARKERS, V34, P71, DOI [10.3233/DMA-120952, 10.1155/2013/795410]; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Bergkvist A, 2010, METHODS, V50, P323, DOI 10.1016/j.ymeth.2010.01.009; Blackwood L, 2012, VET COMP ONCOL, V10, pe1, DOI 10.1111/j.1476-5829.2012.00341.x; Boerkamp KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071094; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Chang DZ, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-15; Chen YD, 2013, J NEURO-ONCOL, V111, P145, DOI 10.1007/s11060-012-1007-0; Choi JW, 2013, VIRCHOWS ARCH, V463, P681, DOI 10.1007/s00428-013-1473-6; Christiansen A, 2013, CANCER LETT, V331, P18, DOI 10.1016/j.canlet.2012.12.013; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; da Costa A, 2012, J COMP PATHOL, V146, P143, DOI 10.1016/j.jcpa.2011.06.004; Dai BB, 2013, J BIOL CHEM, V288, P1634, DOI 10.1074/jbc.M112.379362; De Martino I, 2009, CANCER RES, V69, P1844, DOI 10.1158/0008-5472.CAN-08-4133; Dhawan D, 2012, UROL ONCOL, V31, P1761; Fong V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028714; Fowles JS, 2015, VET COMP ONCOL, V13, P288, DOI 10.1111/vco.12044; Frantz AM, 2013, VET PATHOL, V50, P693, DOI 10.1177/0300985812465325; Fry AM, 2013, BIOESSAYS, V35, P762, DOI 10.1002/bies.201300053; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Giantin M, 2012, J VET DIAGN INVEST, V24, P116, DOI 10.1177/1040638711425945; Goldschmidt MH, 2002, TUMORS DOMESTIC ANIM, V4, P105; Gulzar ZG, 2013, ONCOGENE, V32, P70, DOI 10.1038/onc.2012.27; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; He WL, 2013, EJSO-EUR J SURG ONC, V39, P141, DOI 10.1016/j.ejso.2012.08.023; Horny HP, 2007, PATHOBIOLOGY, V74, P121, DOI 10.1159/000101711; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin S, 2012, CHINESE MED J-PEKING, V125, P262, DOI 10.3760/cma.j.issn.0366-6999.2012.02.019; Ju W, 2009, ONCOL RES, V18, P47, DOI 10.3727/096504009789954672; Kalia M, 2013, METABOLISM, V62, pS11, DOI 10.1016/j.metabol.2012.08.016; Kaneko N, 2009, BIOCHEM BIOPH RES CO, V390, P1235, DOI 10.1016/j.bbrc.2009.10.127; Kato T, 2012, J SURG ONCOL, V106, P423, DOI 10.1002/jso.23109; Kiupel M, 2011, VET PATHOL, V48, P147, DOI 10.1177/0300985810386469; Klopfleisch R, 2011, VET J, V190, P236, DOI 10.1016/j.tvjl.2011.04.010; Klopfleisch R, 2010, VET PATHOL, V47, P98, DOI 10.1177/0300985809353310; Klopfleisch R, 2009, VET PATHOL, V46, P416, DOI 10.1354/vp.08-VP-0212-K-FL; Klopfleisch R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-618; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Li C, 2013, TUMOR BIOL, V34, P1021, DOI 10.1007/s13277-012-0641-7; Liu ZY, 2013, MOL NEUROBIOL, V47, P325, DOI 10.1007/s12035-012-8367-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London CA, 2003, VET CLIN N AM-SMALL, V33, P473, DOI 10.1016/S0195-5616(03)00003-2; Espinosa AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055975; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Mi YJ, 2013, DIS ESOPHAGUS, V26, P636, DOI 10.1111/dote.12002; Mo ML, 2010, INT J BIOL MARKER, V25, P236, DOI 10.5301/JBM.2010.6088; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Northrup NC, 2005, J VET DIAGN INVEST, V17, P561, DOI 10.1177/104063870501700606; Northrup NC, 2005, J VET DIAGN INVEST, V17, P245, DOI 10.1177/104063870501700305; O'Donoghue LE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-506; PATNAIK AK, 1984, VET PATHOL, V21, P469, DOI 10.1177/030098588402100503; Qiu JJ, 2013, TUMOR BIOL, V34, P2971, DOI 10.1007/s13277-013-0860-6; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sazawa A, 2002, J UROLOGY, V168, P1182, DOI 10.1016/S0022-5347(05)64622-8; Schlieben P, 2012, VET J, V194, P210, DOI 10.1016/j.tvjl.2012.04.002; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Selvarajah GT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-72; Sethi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047086; Shubbar E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-1; Singh P, 2008, MOL CANCER RES, V6, P1710, DOI 10.1158/1541-7786.MCR-08-0269; Song G, 2013, J RHEUMATOL, V40, P461, DOI 10.3899/jrheum.120264; Stuart JE, 2011, J NEUROPATH EXP NEUR, V70, P1, DOI 10.1097/NEN.0b013e3182018f1c; Su YH, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-2; Tamburini BA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-619; THAMM DH, 2007, WITHROW MACEWENS SMA, P402, DOI DOI 10.1016/B978-072160558-6.50022-8; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Wang Z, 2012, CURR PHARM DESIGN, V9, P3210; Weng Mei-ying, 2012, Cancer Biology Medicine, V9, P192, DOI 10.7497/j.issn.2095-3941.2012.03.007; Wu WJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-142; Xu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013696; Yun HJ, 2008, EXP MOL MED, V40, P345, DOI 10.3858/emm.2008.40.3.345; Zheng M, 2010, PLOS ONE, V7	77	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95481	10.1371/journal.pone.0095481	http://dx.doi.org/10.1371/journal.pone.0095481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748173	Green Published, gold			2022-12-25	WOS:000335226500109
J	Peng, J; Dan, L; Huang, M				Peng, Jing; Dan, Li; Huang, Mei			Sensitivity of Global and Regional Terrestrial Carbon Storage to the Direct CO2 Effect and Climate Change Based on the CMIP5 Model Intercomparison	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; CYCLE FEEDBACK; SYSTEM; BIOSPHERE; UNCERTAINTIES; SIMULATIONS; DROUGHT; GROWTH; 20TH-CENTURY; TEMPERATURE	Global and regional land carbon storage has been significantly affected by increasing atmospheric CO2 concentration and climate change. Based on fully coupled climate-carbon-cycle simulations from the Coupled Model Intercomparison Project Phase 5 (CMIP5), we investigate sensitivities of land carbon storage to rising atmospheric CO2 concentration and climate change over the world and 21 regions during the 130 years. Overall, the simulations suggest that consistently spatial positive effects of the increasing CO2 concentrations on land carbon storage are expressed with a multi-model averaged value of 1.04PgC per ppm. The stronger positive values are mainly located in the broad areas of temperate and tropical forest, especially in Amazon basin and western Africa. However, large heterogeneity distributed for sensitivities of land carbon storage to climate change. Climate change causes decrease in land carbon storage in most tropics and the Southern Hemisphere. In these regions, decrease in soil moisture (MRSO) and enhanced drought somewhat contribute to such a decrease accompanied with rising temperature. Conversely, an increase in land carbon storage has been observed in high latitude and altitude regions (e. g., northern Asia and Tibet). The model simulations also suggest that global negative impacts of climate change on land carbon storage are predominantly attributed to decrease in land carbon storage in tropics. Although current warming can lead to an increase in land storage of high latitudes of Northern Hemisphere due to elevated vegetation growth, a risk of exacerbated future climate change may be induced due to release of carbon from tropics.	[Peng, Jing; Dan, Li] Chinese Acad Sci, Inst Atmospher Phys, START Temperate East Asia Reg Ctr, Beijing, Peoples R China; [Peng, Jing; Dan, Li] Chinese Acad Sci, Inst Atmospher Phys, Key Lab Reg Climate Environm Temperate East Asia, Beijing, Peoples R China; [Huang, Mei] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Dan, L (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, START Temperate East Asia Reg Ctr, Beijing, Peoples R China.	danli@tea.ac.cn		peng, jing/0000-0003-2834-6698	National Natural Science Foundation of China [41275082, 41305070]; CAS Strategic Priority Research Program [XDA05110103]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-QN208, 7-122158]; National Basic Research Program of China [2010CB950500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Strategic Priority Research Program; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the project of National Natural Science Foundation of China (grant no. 41275082 and 41305070), the CAS Strategic Priority Research Program (grant no. XDA05110103), the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-QN208 and 7-122158), the National Basic Research Program of China (grant no. 2010CB950500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz-Segura D, 2010, GLOBAL CHANGE BIOL, V16, P760, DOI 10.1111/j.1365-2486.2009.01956.x; Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Arora VK, 2009, J CLIMATE, V22, P6066, DOI 10.1175/2009JCLI3037.1; Arora VK, 2013, J CLIMATE, V26, P5289, DOI 10.1175/JCLI-D-12-00494.1; Arora VK, 2005, GLOBAL CHANGE BIOL, V11, P39, DOI 10.1111/j.1365-2486.2004.00890.x; Berthelot M, 2005, GLOBAL CHANGE BIOL, V11, P959, DOI 10.1111/j.1365-2486.2005.00957.x; Boer GJ, 2013, J CLIMATE, V26, P3326, DOI 10.1175/JCLI-D-12-00365.1; Boer GJ, 2010, J CLIMATE, V23, P775, DOI 10.1175/2009JCLI3161.1; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Brovkin V, 2013, J CLIMATE, V26, P6859, DOI 10.1175/JCLI-D-12-00623.1; Christian JR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000920; Christidis N, 2007, J CLIMATE, V20, P5441, DOI 10.1175/2007JCLI1568.1; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dan L, 2005, GLOBAL PLANET CHANGE, V47, P153, DOI 10.1016/j.gloplacha.2004.10.019; Dan L, 2007, TELLUS B, V59, P425, DOI 10.1111/j.1600-0889.2007.00274.x; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Fisher JB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0376; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gao QZ, 2009, CLIMATIC CHANGE, V97, P515, DOI 10.1007/s10584-009-9617-z; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Giorgi F, 2000, CLIM DYNAM, V16, P169, DOI 10.1007/PL00013733; Girardin MP, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001287; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hemming D, 2013, AGR FOREST METEOROL, V170, P79, DOI 10.1016/j.agrformet.2011.10.016; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Ito A, 2005, CLIM DYNAM, V24, P435, DOI 10.1007/s00382-004-0489-7; Ji JJ, 1995, J BIOGEOGR, V22, P445, DOI 10.2307/2845941; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad D., 2004, Global Change Biology, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; Peng J, 2014, GLOBAL PLANET CHANGE, V112, P64, DOI 10.1016/j.gloplacha.2013.11.007; Peng J, 2013, THEOR APPL CLIMATOL, V111, P483, DOI 10.1007/s00704-012-0673-3; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Piao SL, 2011, AGR FOREST METEOROL, V151, P1599, DOI 10.1016/j.agrformet.2011.06.016; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Post WM, 1997, GLOBAL BIOGEOCHEM CY, V11, P99, DOI 10.1029/96GB03942; Qian HF, 2010, GLOBAL CHANGE BIOL, V16, P641, DOI 10.1111/j.1365-2486.2009.01989.x; Raddatz TJ, 2007, CLIM DYNAM, V29, P565, DOI 10.1007/s00382-007-0247-8; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Roeckner E, 2011, CLIMATIC CHANGE, V105, P91, DOI 10.1007/S10584-010-9886-6; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Tuomi M, 2008, ECOL MODEL, V211, P182, DOI 10.1016/j.ecolmodel.2007.09.003; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Wu TW, 2013, J GEOPHYS RES-ATMOS, V118, P4326, DOI 10.1002/jgrd.50320; Yi CX, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034007; Zak DR, 2011, ECOL LETT, V14, P1220, DOI 10.1111/j.1461-0248.2011.01692.x; Zeng N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020904; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x; Zickfeld K, 2011, J CLIMATE, V24, P4255, DOI 10.1175/2011JCLI3898.1	67	13	13	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95282	10.1371/journal.pone.0095282	http://dx.doi.org/10.1371/journal.pone.0095282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748331	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500075
J	Eden, CJ; Ju, B; Murugesan, M; Phoenix, TN; Nimmervoll, B; Tong, Y; Ellison, DW; Finkelstein, D; Wright, K; Boulos, N; Dapper, J; Thiruvenkatam, R; Lessman, CA; Taylor, MR; Gilbertson, RJ				Eden, C. J.; Ju, B.; Murugesan, M.; Phoenix, T. N.; Nimmervoll, B.; Tong, Y.; Ellison, D. W.; Finkelstein, D.; Wright, K.; Boulos, N.; Dapper, J.; Thiruvenkatam, R.; Lessman, C. A.; Taylor, M. R.; Gilbertson, R. J.			Orthotopic models of pediatric brain tumors in zebrafish	ONCOGENE			English	Article							NEURAL CREST; CANCER; MEDULLOBLASTOMA	High-throughput screens (HTS) of compound toxicity against cancer cells can identify thousands of potential new drug-leads. But only limited numbers of these compounds can progress to expensive and labor-intensive efficacy studies in mice, creating a 'bottle neck' in the drug development pipeline. Approaches that triage drug-leads for further study are greatly needed. Here we provide an intermediary platform between HTS and mice by adapting mouse models of pediatric brain tumors to grow as orthotopic xenografts in the brains of zebrafish. Freshly isolated mouse ependymoma, glioma and choroid plexus carcinoma cells expressing red fluorescence protein were conditioned to grow at 34 degrees C. Conditioned tumor cells were then transplanted orthotopically into the brains of zebrafish acclimatized to ambient temperatures of 34 degrees C. Live in vivo fluorescence imaging identified robust, quantifiable and reproducible brain tumor growth as well as spinal metastasis in zebrafish. All tumor xenografts in zebrafish retained the histological characteristics of the corresponding parent mouse tumor and efficiently recruited fish endothelial cells to form a tumor vasculature. Finally, by treating zebrafish harboring ERBB2-driven gliomas with an appropriate cytotoxic chemotherapy (5-fluorouracil) or tyrosine kinase inhibitor (erlotinib), we show that these models can effectively assess drug efficacy. Our data demonstrate, for the first time, that mouse brain tumors can grow orthotopically in fish and serve as a platform to study drug efficacy. As large cohorts of brain tumor-bearing zebrafish can be generated rapidly and inexpensively, these models may serve as a powerful tool to triage drug-leads from HTS for formal efficacy testing in mice.	[Eden, C. J.; Murugesan, M.; Phoenix, T. N.; Nimmervoll, B.; Tong, Y.; Boulos, N.; Dapper, J.; Thiruvenkatam, R.; Gilbertson, R. J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Ju, B.; Taylor, M. R.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Ellison, D. W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Finkelstein, D.] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Wright, K.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Lessman, C. A.] St Jude Childrens Res Hosp, Dept Biol Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Taylor, MR (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Michael.Taylor@stjude.org; Richard.Gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021	Gilbertson, Richard James/0000-0001-7539-9472; Nimmervoll, Birgit/0000-0002-3324-092X; KM, Mohankumar/0000-0001-9407-1800	National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); ALSAC; NATIONAL CANCER INSTITUTE [P01CA096832, R01CA129541, P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765, RJG), the Collaborative Ependymoma Research Network (CERN) and by ALSAC. We are grateful to the staff of the Hartwell Center for Bioinformatics and Biotechnology, and Flow Cytometry & Cell Sorting Shared Resource at St Jude Children's Research Hospital for technical assistance.	Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Caponigro G, 2011, NAT REV DRUG DISCOV, V10, P179, DOI 10.1038/nrd3385; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Collymore C, 2013, JOVE-J VIS EXP, DOI 10.3791/50691; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HERBERT J, 1990, AM J PATHOL, V136, P1317; Hernan R, 2003, CANCER RES, V63, P140; Hong SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002029; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Lacy J, 2012, HEMATOL ONCOL CLIN N, V26, P779, DOI 10.1016/j.hoc.2012.04.007; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lin NU, 2013, LANCET ONCOL, V14, pE407, DOI 10.1016/S1470-2045(13)70308-5; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pounds S, 2011, BIOINFORMATICS, V27, P2098, DOI 10.1093/bioinformatics/btr362; Prados MD, 2006, NEURO-ONCOLOGY, V8, P67, DOI 10.1215/S1522851705000451; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Stoletov K, 2008, ONCOGENE, V27, P4509, DOI 10.1038/onc.2008.95; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Walbert T, 2011, J NEURO-ONCOL, V102, P273, DOI 10.1007/s11060-010-0313-7; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762	30	38	38	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1736	1742		10.1038/onc.2014.107	http://dx.doi.org/10.1038/onc.2014.107			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24747973	Green Accepted			2022-12-25	WOS:000351848400014
J	Yokoo, T; Saito, H; Yoshitake, Y; Xu, Q; Asami, T; Tsukiyama, T; Teraishi, M; Okumoto, Y; Tanisaka, T				Yokoo, Takayuki; Saito, Hiroki; Yoshitake, Yoshihiro; Xu, Quan; Asami, Takehito; Tsukiyama, Takuji; Teraishi, Masayoshi; Okumoto, Yutaka; Tanisaka, Takatoshi			Se14, Encoding a JmjC Domain-Containing Protein, Plays Key Roles in Long-Day Suppression of Rice Flowering through the Demethylation of H3K4me3 of RFT1	PLOS ONE			English	Article							CRITICAL DAY LENGTH; H3 LYSINE 4; GENE-EXPRESSION; CHROMATIN MODIFICATIONS; HISTONE DEMETHYLATION; ARABIDOPSIS-THALIANA; LOCUS; TIME; HD3A; TRIMETHYLATION	Floral transition from the vegetative to the reproductive growth phase is a major change in the plant life cycle and a key factor in reproductive success. In rice (Oryza sativa L.), a facultative short-day plant, numerous flowering time and flower formation genes that control floral transition have been identified and their physiological effects and biochemical functions have been clarified. In the present study, we used a Se14-deficient mutant line (HS112) and other flowering mutant lines to investigate the photoperiodic response, chromosomal location and function in the photoperiod sensitivity of the Se14 gene. We also studied the interactive effects of this locus with other crucial flowering time genes. We found that Se14 is independent of the known photoperiod-sensitive genes, such as Hd1 and Ghd7, and is identical to Os03g0151300, which encodes a Jumonji C (JmjC) domain-containing protein. Expression analysis revealed that the expressions of RFT1, a floral initiator known as a "florigen-like gene", and Ehd1 were up-regulated in HS112, whereas this up-regulation was not observed in the original variety of 'Gimbozu'. ChIP assays of the methylation states of histone H3 at lysine 4 (H3K4) revealed that the trimethylated H3K4 in the promoter region of the RFT1 chromatin was significantly increased in HS112. We conclude that Se14 is a novel photoperiod-sensitivity gene that has a suppressive effect on floral transition (flowering time) under long day-length conditions through the modification of chromatin structure by H3K4me3 demethylation in the promoter region of RFT1.	[Yokoo, Takayuki; Saito, Hiroki; Yoshitake, Yoshihiro; Xu, Quan; Asami, Takehito; Tsukiyama, Takuji; Teraishi, Masayoshi; Okumoto, Yutaka; Tanisaka, Takatoshi] Kyoto Univ, Grad Sch Agr, Kyoto, Japan	Kyoto University	Saito, H (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	sh6117@kais.kyoto-u.ac.jp	Teraishi, Masayoshi/D-8602-2018; Teraishi, Masayoshi/AAC-1055-2021	Teraishi, Masayoshi/0000-0002-6768-8052; Teraishi, Masayoshi/0000-0002-6768-8052	Jointed research with Riken; "Plant Breeding with heavy-ion beams for rice and soybean''	Jointed research with Riken; "Plant Breeding with heavy-ion beams for rice and soybean''	This work was supported by the Jointed research with Riken; "Plant Breeding with heavy-ion beams for rice and soybean''. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 2009, J CROP RES, V54, P85; Chardon F, 2005, J MOL EVOL, V61, P579, DOI 10.1007/s00239-004-0179-4; Chen QF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003239; Chen XS, 2011, BBA-GENE REGUL MECH, V1809, P421, DOI 10.1016/j.bbagrm.2011.03.004; Cui XK, 2013, P NATL ACAD SCI USA, V110, P1953, DOI 10.1073/pnas.1217020110; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Hagiwara WE, 2009, MOL ECOL, V18, P1537, DOI 10.1111/j.1365-294X.2009.04119.x; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Ishikawa R, 2011, MOL GENET GENOMICS, V285, P461, DOI 10.1007/s00438-011-0621-4; Itoh H, 2013, MOL PLANT, V6, P635, DOI 10.1093/mp/sst022; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jang IC, 2011, PLANT CELL, V23, P459, DOI 10.1105/tpc.110.080481; Jarillo JA, 2011, PLANT SCI, V181, P364, DOI 10.1016/j.plantsci.2011.06.011; Jeong JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008033; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Ko JH, 2010, EMBO J, V29, P3208, DOI 10.1038/emboj.2010.198; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee SY, 2004, PLANT J, V38, P754, DOI 10.1111/j.1365-313X.2004.02082.x; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Monden Y, 2009, DNA RES, V16, P131, DOI 10.1093/dnares/dsp004; Nishida H, 2002, CROP SCI, V42, P348, DOI 10.2135/cropsci2002.0348; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Pien S, 2008, PLANT CELL, V20, P580, DOI 10.1105/tpc.108.058172; Saito H, 2011, THEOR APPL GENET, V122, P109, DOI 10.1007/s00122-010-1426-2; Saito H, 2009, THEOR APPL GENET, V119, P315, DOI 10.1007/s00122-009-1040-3; Sun QW, 2008, P NATL ACAD SCI USA, V105, P13679, DOI 10.1073/pnas.0805901105; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamagata H., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P351, DOI 10.1142/9789812814265_0031; Yang HC, 2012, PLANT CELL REP, V31, P1297, DOI 10.1007/s00299-012-1249-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yano M, 2002, NIAS ANN REP, P27; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62	44	30	36	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96064	10.1371/journal.pone.0096064	http://dx.doi.org/10.1371/journal.pone.0096064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759811	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200131
J	Allan, AM; Goggin, SL; Caldwell, KK				Allan, Andrea M.; Goggin, Samantha L.; Caldwell, Kevin K.			Prenatal Alcohol Exposure Modifies Glucocorticoid Receptor Subcellular Distribution in the Medial Prefrontal Cortex and Impairs Frontal Cortex-Dependent Learning	PLOS ONE			English	Article							PITUITARY-ADRENAL RESPONSES; MINERALOCORTICOID RECEPTOR; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; PHOSPHORYLATION; DYNEIN; BRAIN; DOMAIN; ACTIVATION; TRANSPORT	Prenatal alcohol exposure (PAE) has been shown to impair learning, memory and executive functioning in children. Perseveration, or the failure to respond adaptively to changing contingencies, is a hallmark on neurobehavioral assessment tasks for human fetal alcohol spectrum disorder (FASD). Adaptive responding is predominantly a product of the medial prefrontal cortex (mPFC) and is regulated by corticosteroids. In our mouse model of PAE we recently reported deficits in hippocampal formation-dependent learning and memory and a dysregulation of hippocampal formation glucocorticoid receptor (GR) subcellular distribution. Here, we examined the effect of PAE on frontal cortical-dependent behavior, as well as mPFC GR subcellular distribution and the levels of regulators of intracellular GR transport. PAE mice displayed significantly reduced response flexibility in a Y-maze reversal learning task. While the levels of total nuclear GR were reduced in PAE mPFC, levels of GR phosphorylated at serines 203, 211 and 226 were not significantly changed. Cytosolic, but not nuclear, MR levels were elevated in the PAE mPFC. The levels of critical GR trafficking proteins, FKBP51, Hsp90, cyclophilin 40, dynamitin and dynein intermediate chain, were altered in PAE mice, in favor of the exclusion of GR from the nucleus, indicating dysregulation of GR trafficking. Our findings suggest that there may be a link between a deficit in GR nuclear localization and frontal cortical learning deficits in prenatal alcohol-exposed mice.	[Allan, Andrea M.; Goggin, Samantha L.; Caldwell, Kevin K.] Univ New Mexico, Sch Med, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Allan, AM (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	AAllan@salud.unm.edu	Allan, Andrea M/L-8919-2015	Allan, Andrea/0000-0002-6745-4352	National Institutes of Health [1R01AA017449, P20AA017068, R03AA020101]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017449, R03AA020101, P20AA017068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by National Institutes of Health grant #1R01AA017449 (AMA), P20AA017068 (KKC, AMA) and R03AA020101 (KKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzic M, 2009, J ENDOCRINOL, V202, P87, DOI 10.1677/JOE-08-0509; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Banerjee A, 2008, BIOCHEMISTRY-US, V47, P10471, DOI 10.1021/bi8011862; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; Brady ML, 2012, ALCOHOL CLIN EXP RES, V36, P457, DOI 10.1111/j.1530-0277.2011.01644.x; Buckley CT, 2003, ANAL BIOCHEM, V320, P193, DOI 10.1016/S0003-2697(03)00394-4; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; Caldwell KK, 2013, ALCOHOLISM CLIN EXPT; Carrigan A, 2007, J BIOL CHEM, V282, P10963, DOI 10.1074/jbc.M602931200; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; DIORIO D, 1993, J NEUROSCI, V13, P3839; Dursun I, 2006, PHARMACOL BIOCHEM BE, V85, P345, DOI 10.1016/j.pbb.2006.09.001; Faresse N, 2012, FASEB J, V26, P4373, DOI 10.1096/fj.12-209924; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Galigniana MD, 2004, J BIOL CHEM, V279, P55754, DOI 10.1074/jbc.M406259200; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Gourley SL, 2012, P NATL ACAD SCI USA, V109, P20714, DOI 10.1073/pnas.1208342109; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Harrell JM, 2004, J BIOL CHEM, V279, P54647, DOI 10.1074/jbc.M406863200; Harris AP, 2013, PSYCHONEUROENDOCRINO, V38, P648, DOI 10.1016/j.psyneuen.2012.08.007; Hayward MD, 2004, PHARMACOL BIOCHEM BE, V79, P171, DOI 10.1016/j.pbb.2004.07.002; Hirayama M, 2013, MOL CELL PROTEOMICS, V12, P1377, DOI 10.1074/mcp.M112.024802; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Joels M, 2012, PHARMACOL REV, V64, P901, DOI 10.1124/pr.112.005892; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; Kodituwakku PW, 2009, DEV DISABIL RES REV, V15, P218, DOI 10.1002/ddrr.73; Kumar R, 2012, MOL CELL ENDOCRINOL, V348, P450, DOI 10.1016/j.mce.2011.03.024; Le Moellic C, 2004, J AM SOC NEPHROL, V15, P1145; Maddox Stephanie A, 2013, Front Psychiatry, V4, P62, DOI 10.3389/fpsyt.2013.00062; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; Meaney MJ, 2013, BEHAV NEUROSCI, V127, P637, DOI 10.1037/a0034187; O'Connor MJ, 2006, J PEDIATR PSYCHOL, V31, P50, DOI 10.1093/jpepsy/jsj021; Ouyang J, 2012, INT IMMUNOPHARMACOL, V14, P334, DOI 10.1016/j.intimp.2012.08.012; Ponomarev I, 2013, ALCOHOL RES-CURR REV, V35, P69; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Radley JJ, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00007; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Uban KA, 2013, PSYCHONEUROENDOCRINO, V38, P1953, DOI 10.1016/j.psyneuen.2013.02.017; Vandevyver S, 2012, TRAFFIC, V13, P364, DOI 10.1111/j.1600-0854.2011.01288.x; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Zhou FC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-124	51	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96200	10.1371/journal.pone.0096200	http://dx.doi.org/10.1371/journal.pone.0096200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755652	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300144
J	Boenigk, J; Beisser, D; Zimmermann, S; Bock, C; Jakobi, J; Grabner, D; Grossmann, L; Rahmann, S; Barcikowski, S; Sures, B				Boenigk, Jens; Beisser, Daniela; Zimmermann, Sonja; Bock, Christina; Jakobi, Jurij; Grabner, Daniel; Grossmann, Lars; Rahmann, Sven; Barcikowski, Stephan; Sures, Bernd			Effects of Silver Nitrate and Silver Nanoparticles on a Planktonic Community: General Trends after Short-Term Exposure	PLOS ONE			English	Article							2 GREEN-ALGAE; ION RELEASE; PSEUDOKIRCHNERIELLA-SUBCAPITATA; ENGINEERED NANOPARTICLES; RNA-SEQ; IN-VIVO; TOXICITY; ANTIBACTERIAL; NANOSILVER; PHOTOSYNTHESIS	Among metal pollutants silver ions are one of the most toxic forms, and have thus been assigned to the highest toxicity class. Its toxicity to a wide range of microorganisms combined with its low toxicity to humans lead to the development of a wealth of silver-based products in many bactericidal applications accounting to more than 1000 nano-technology-based consumer products. Accordingly, silver is a widely distributed metal in the environment originating from its different forms of application as metal, salt and nanoparticle. A realistic assessment of silver nanoparticle toxicity in natural waters is, however, problematic and needs to be linked to experimental approaches. Here we apply metatranscriptome sequencing allowing for elucidating reactions of whole communities present in a water sample to stressors. We compared the toxicity of ionic silver and ligand-free silver nanoparticles by short term exposure on a natural community of aquatic microorganisms. We analyzed the effects of the treatments on metabolic pathways and species composition on the eukaryote metatranscriptome level in order to describe immediate molecular responses of organisms using a community approach. We found significant differences between the samples treated with 5 mg/L AgNO3 compared to the controls, but no significant differences in the samples treated with AgNP compared to the control samples. Statistical analysis yielded 126 genes (KO-IDs) with significant differential expression with a false discovery rate (FDR)< 0.05 between the control (KO) and AgNO3 (NO3) groups. A KEGG pathway enrichment analysis showed significant results with a FDR below 0.05 for pathways related to photosynthesis. Our study therefore supports the view that ionic silver rather than silver nanoparticles are responsible for silver toxicity. Nevertheless, our results highlight the strength of metatranscriptome approaches for assessing metal toxicity on aquatic communities.	[Boenigk, Jens; Zimmermann, Sonja; Bock, Christina; Jakobi, Jurij; Grabner, Daniel; Grossmann, Lars; Barcikowski, Stephan; Sures, Bernd] Univ Duisburg Essen, Essen, Germany; [Boenigk, Jens; Bock, Christina; Grossmann, Lars] Univ Duisburg Essen, Ctr Water & Environm Res, Essen, Germany; [Beisser, Daniela; Rahmann, Sven] Univ Duisburg Essen, Fac Med, Inst Human Genet, Essen, Germany; [Zimmermann, Sonja; Grabner, Daniel; Sures, Bernd] Univ Duisburg Essen, Ctr Water & Environm Res, Essen, Germany; [Jakobi, Jurij; Barcikowski, Stephan] Ctr Nanointegrat Duisburg Essen CENIDE, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Boenigk, J (corresponding author), Univ Duisburg Essen, Essen, Germany.	Jens.Boenigk@uni-due.de	Barcikowski, Stephan/I-4754-2012; Sures, Bernd/B-6652-2013; Beisser, Daniela/AAR-8642-2020; Bock, Christina/S-5649-2017	Barcikowski, Stephan/0000-0002-9739-7272; Beisser, Daniela/0000-0002-0679-6631; Bock, Christina/0000-0002-6509-3768; Grabner, Daniel/0000-0002-1251-7096; Sures, Bernd/0000-0001-6865-6186	Centre for Water and Environmental Research (ZWU); University of Duisburg-Essen; DFG project [BO3245/3-1]	Centre for Water and Environmental Research (ZWU); University of Duisburg-Essen; DFG project(German Research Foundation (DFG))	Funding of the study by the Centre for Water and Environmental Research (ZWU), University of Duisburg-Essen and DFG project BO3245/3-1 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auinger BM, 2008, APPL ENVIRON MICROB, V74, P2505, DOI 10.1128/AEM.01803-07; Barcikowski S, 2013, PHYS CHEM CHEM PHYS, V15, P3022, DOI 10.1039/c2cp90132c; Batley GE, 2013, ACCOUNTS CHEM RES, V46, P854, DOI 10.1021/ar2003368; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923; Chunquan L, 2012, ISUBPATHWAYMINER PAC; Cleveland D, 2012, SCI TOTAL ENVIRON, V421, P267, DOI 10.1016/j.scitotenv.2012.01.025; Deutsches Institut fur Normung, 1985, 3841216198512 DIN; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Grade S, 2014, GOLD BULL, V47, P83, DOI 10.1007/s13404-013-0125-6; Grade S, 2012, RSC ADV, V2, P7190, DOI 10.1039/c2ra20546g; Hahn A, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-011-0686-3; Hahn A, 2011, J MATER CHEM, V21, P10287, DOI 10.1039/c0jm04480f; Hund-Rinke K, 2008, 4308 UBA; Jost S, 2010, J PHYCOL, V46, P901, DOI 10.1111/j.1529-8817.2010.00871.x; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p; Kumar R, 2005, J BIOMED MATER RES B, V75B, P311, DOI 10.1002/jbm.b.30306; Kupper H, 2002, J PHYCOL, V38, P429, DOI 10.1046/j.1529-8817.2002.01148.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lapresta-Fernandez A, 2012, TRAC-TREND ANAL CHEM, V32, P40, DOI 10.1016/j.trac.2011.09.007; Lee DY, 2005, AQUAT TOXICOL, V75, P127, DOI 10.1016/j.aquatox.2005.06.011; Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Menendez-Manjon A, 2013, APPL PHYS A-MATER, V110, P343, DOI 10.1007/s00339-012-7264-0; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Osborn HL, 2013, AQUAT TOXICOL, V138, P12, DOI 10.1016/j.aquatox.2013.04.002; Oukarroum A, 2012, ECOTOX ENVIRON SAFE, V78, P80, DOI 10.1016/j.ecoenv.2011.11.012; Piccapietra F, 2012, ENVIRON SCI TECHNOL, V46, P7390, DOI 10.1021/es300734m; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rehbock C, 2013, PHYS CHEM CHEM PHYS, V15, P3057, DOI 10.1039/c2cp42641b; Ribeiro F, 2014, SCI TOTAL ENVIRON, V466, P232, DOI 10.1016/j.scitotenv.2013.06.101; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scotter MJ, 2005, FOOD ADDIT CONTAM, V22, P1163, DOI 10.1080/02652030500306885; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Shi JP, 2012, ENVIRON TOXICOL CHEM, V31, P1630, DOI 10.1002/etc.1864; Simon DF, 2013, APPL ENVIRON MICROB, V79, P4774, DOI 10.1128/AEM.00998-13; Tiedemann D, 2014, ANALYST, V139, P931, DOI 10.1039/c3an01463k; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wang Z, 2012, ENVIRON TOXICOL CHEM, V31, P2408, DOI 10.1002/etc.1964; WATANABE T, 1988, NIPPON KAGAKU KAISHI, P383, DOI 10.1246/nikkashi.1988.383; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Zeng HB, 2012, ADV FUNCT MATER, V22, P1333, DOI 10.1002/adfm.201102295; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	54	35	36	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95340	10.1371/journal.pone.0095340	http://dx.doi.org/10.1371/journal.pone.0095340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755991	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300037
J	Chabot-Couture, G; Nigmatulina, K; Eckhoff, P				Chabot-Couture, Guillaume; Nigmatulina, Karima; Eckhoff, Philip			An Environmental Data Set for Vector-Borne Disease Modeling and Epidemiology	PLOS ONE			English	Article							URBAN MALARIA CONTROL; DAR-ES-SALAAM; PLASMODIUM-FALCIPARUM; SPATIAL INTERPOLATION; ANOPHELES-ARABIENSIS; SURFACE TEMPERATURE; SATELLITE IMAGERY; SOIL-MOISTURE; DRIVEN MODEL; WEST-AFRICA	Understanding the environmental conditions of disease transmission is important in the study of vector-borne diseases. Low-and middle-income countries bear a significant portion of the disease burden; but data about weather conditions in those countries can be sparse and difficult to reconstruct. Here, we describe methods to assemble high-resolution gridded time series data sets of air temperature, relative humidity, land temperature, and rainfall for such areas; and we test these methods on the island of Madagascar. Air temperature and relative humidity were constructed using statistical interpolation of weather station measurements; the resulting median 95 th percentile absolute errors were 2.75 degrees C and 16.6%. Missing pixels from the MODIS11 remote sensing land temperature product were estimated using Fourier decomposition and time-series analysis; thus providing an alternative to the 8-day and 30-day aggregated products. The RFE 2.0 remote sensing rainfall estimator was characterized by comparing it with multiple interpolated rainfall products, and we observed significant differences in temporal and spatial heterogeneity relevant to vector-borne disease modeling.	[Chabot-Couture, Guillaume; Nigmatulina, Karima; Eckhoff, Philip] Intellectual Ventures, Inst Dis Modeling, Bellevue, WA 98005 USA	Intellectual Ventures	Chabot-Couture, G (corresponding author), Intellectual Ventures, Inst Dis Modeling, Bellevue, WA 98005 USA.	gcouture@intven.com	NIGMATULINA, KARIMA/AAO-6812-2020		Intellectual Ventures Laboratory	Intellectual Ventures Laboratory	Intellectual Ventures Laboratory funded this study. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; ARKIN PA, 1987, MON WEATHER REV, V115, P51, DOI 10.1175/1520-0493(1987)115<0051:TRBLSC>2.0.CO;2; Benali A, 2012, REMOTE SENS ENVIRON, V124, P108, DOI 10.1016/j.rse.2012.04.024; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Brown Molly E, 2008, FAMINE EARLY WARNING; Ceccato P, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/595948; Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295; Chiang G.L., 1991, J TROP MED PUBL HLTH, V22, P643; Colombi A., 2007, EARSeL eProceedings, V6, P38; COZ J, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P41; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Curran PJ, 2000, ADV PARASIT, V47, P37, DOI 10.1016/S0065-308X(00)47006-5; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; Dee DP, 2003, MON WEATHER REV, V131, P155, DOI 10.1175/1520-0493(2003)131<0155:TCOVFA>2.0.CO;2; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; DODD AV, 1965, MON WEA REV, V93, P113, DOI DOI 10.1175/1520-0493(1965)093<LESSTHAN>0113:DPDITC<GREATERTHAN>2.3.CO;2; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Elnaiem DEA, 2003, AM J TROP MED HYG, V68, P10, DOI 10.4269/ajtmh.2003.68.1.0680010; Ferraro RR, 1996, B AM METEOROL SOC, V77, P891, DOI 10.1175/1520-0477(1996)077<0891:AEYTSO>2.0.CO;2; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Flores F, 2010, CHIL J AGR RES, V70, P436, DOI 10.4067/S0718-58392010000300011; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; Goetz SJ, 2000, ADV PARASIT, V47, P289, DOI 10.1016/S0065-308X(00)47012-0; Grover-Kopec E, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-6; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; HANSEN J, 1987, J GEOPHYS RES-ATMOS, V92, P13345, DOI 10.1029/JD092iD11p13345; Hart QJ, 2009, CIV ENG ENVIRON SYST, V26, P19, DOI 10.1080/10286600802003500; Hartkamp AD, 1999, GIS SERIES, V99-01; Hassan QK, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2740040; Hay SI, 1999, TROP MED INT HEALTH, V4, P58, DOI 10.1046/j.1365-3156.1999.00355.x; Hay SI, 1997, INT J REMOTE SENS, V18, P2899, DOI 10.1080/014311697217125; Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hengl T, 2011, THEOR APPL CLIMATOL, P311; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hunter RD, 2005, J APPL METEOROL, V44, P1501, DOI 10.1175/JAM2295.1; Hutchinson M.F., 1998, J GEOGR INF DECIS AN, V2, P152; HUTCHINSON MF, 1995, AGR FOREST METEOROL, V73, P237, DOI 10.1016/0168-1923(94)05077-J; Jacob BG, 2007, AM J TROP MED HYG, V76, P73, DOI 10.4269/ajtmh.2007.76.73; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Jones AE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-162; Justice C, 2008, P 33 INT S REM SENS; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6; Kaya S, 2002, INT GEOSC REM SENS S, P3; Kim K. S., 2008, New Zealand Plant Protection, V61, P292; Kimball JS, 1997, AGR FOREST METEOROL, V85, P87, DOI 10.1016/S0168-1923(96)02366-0; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Krefis AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017905; Kristan M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-231; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Love T. B, 2004, C APPL CLIM, VP5; Ma XL, 2002, APPL OPTICS, V41, P909, DOI 10.1364/AO.41.000909; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; McKenzie FE, 2001, ECOLOGY, V82, P2673, DOI 10.1890/0012-9658(2001)082[2673:SPDALE]2.0.CO;2; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Nishida K, 2003, IEEE T GEOSCI REMOTE, V41, P493, DOI 10.1109/TGRS.2003.811744; Njoku EG, 2003, IEEE T GEOSCI REMOTE, V41, P215, DOI 10.1109/TGRS.2002.808243; Novella N, 2010, VALIDATION SATELLITE; Oldeman L. R., 1990, AGROCLIMATIC CHARACT; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Patz JA, 1998, TROP MED INT HEALTH, V3, P818, DOI 10.1046/j.1365-3156.1998.00309.x; Peng GX, 2006, CHINESE GEOGR SCI, V16, P260, DOI 10.1007/s11769-006-0260-6; Phillips DL, 1996, ECOL MODEL, V91, P213, DOI 10.1016/0304-3800(95)00191-3; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Rogers DJ, 1996, ANN TROP MED PARASIT, V90, P225, DOI 10.1080/00034983.1996.11813049; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rudolf B, 2004, CALCULATION GRIDDED, P231; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Seemann SW, 2003, J APPL METEOROL, V42, P1072, DOI 10.1175/1520-0450(2003)042<1072:OROATM>2.0.CO;2; Shaman J, 2006, ECOL MODEL, V194, P395, DOI 10.1016/j.ecolmodel.2005.10.037; Singh D, 2007, CURR SCI INDIA, V93, P1281; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Susskind J, 2006, ADV MICROWAVE SOUNDI, P111; Tatem Andrew J, 2004, Int J Appl Earth Obs Geoinf, V6, P33, DOI 10.1016/j.jag.2004.07.001; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Tsuda Y, 1999, J MED ENTOMOL, V36, P601, DOI 10.1093/jmedent/36.5.601; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; Verdin J, 2005, PHILOS T R SOC B, V360, P2155, DOI 10.1098/rstb.2005.1754; Wan Z, 2004, INT J REMOTE SENS, V25, P261, DOI 10.1080/0143116031000116417; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Xie PP, 1996, J CLIMATE, V9, P840, DOI 10.1175/1520-0442(1996)009<0840:AOGMPU>2.0.CO;2; Ye Y, 2009, GLOB HLTH ACTION, V2, P1; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Zhang K, 2010, CONTINUOUS SATELLITE, V46; Zhou XD, 2009, INT J ORAL SCI, V1, P1	103	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94741	10.1371/journal.pone.0094741	http://dx.doi.org/10.1371/journal.pone.0094741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755954	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300015
J	Ciuffreda, MC; Tolva, V; Casana, R; Gnecchi, M; Vanoli, E; Spazzolini, C; Roughan, J; Calvillo, L				Ciuffreda, Maria Chiara; Tolva, Valerio; Casana, Renato; Gnecchi, Massimiliano; Vanoli, Emilio; Spazzolini, Carla; Roughan, John; Calvillo, Laura			Rat Experimental Model of Myocardial Ischemia/Reperfusion Injury: An Ethical Approach to Set up the Analgesic Management of Acute Post-Surgical Pain	PLOS ONE			English	Article							INFARCT SIZE; TRAMADOL; RESPONSES; CARPROFEN; ISCHEMIA	Rationale: During the past 30 years, myocardial ischemia/reperfusion injury in rodents became one of the most commonly used model in cardiovascular research. Appropriate pain-prevention appears critical since it may influence the outcome and the results obtained with this model. However, there are no proper guidelines for pain management in rats undergoing thoracic surgery. Accordingly, we evaluated three analgesic regimens in cardiac ischemia/reperfusion injury. This study was strongly focused on 3R's ethic principles, in particular the principle of Reduction. Methods: Rats undergoing surgery were treated with pre-surgical tramadol (45 mg/kg intra-peritoneal), or carprofen (5 mg/kg sub-cutaneous), or with pre-surgical administration of carprofen followed by 2 post-surgery tramadol injections (multi-modal group). We assessed behavioral signs of pain and made a subjective evaluation of stress and suffering one and two hours after surgery. Results: Multi-modal treatment significantly reduced the number of signs of pain compared to carprofen alone at both the first hour (61 +/- 42 vs 123 +/- 47; p < 0.05) and the second hour (43 +/- 21 vs 74 +/- 24; p < 0.05) post-surgery. Tramadol alone appeared as effective as multi-modal treatment during the first hour, but signs of pain significantly increased one hour later (from 66 +/- 72 to 151 +/- 86, p < 0.05). Carprofen alone was more effective at the second hour post-surgery when signs of pain reduced to 74 +/- 24 from 113 +/- 40 in the first hour (p < 0.05). Stress behaviors during the second hour were observed in only 20% of rats in the multi-modal group compared to 75% and 86% in the carprofen and tramadol groups, respectively (p < 0.05). Conclusions: Multi-modal treatment with carprofen and tramadol was more effective in preventing pain during the second hour after surgery compared with both tramadol or carprofen. Our results suggest that the combination of carprofen and tramadol represent the best therapy to prevent animal pain after myocardial ischemia/reperfusion. We obtained our results accordingly with the ethical principle of Reduction.	[Ciuffreda, Maria Chiara; Gnecchi, Massimiliano] Fdn IRCCS, Policlin San Matteo, IRCCS Inst Treatment & Res, Dept Cardiothorac & Vasc Sci,Coronary Care Unit, I-27100 Pavia, Italy; [Ciuffreda, Maria Chiara; Gnecchi, Massimiliano] Fdn IRCCS, Policlin San Matteo, IRCCS Inst Treatment & Res, Lab Clin & Expt Cardiol, I-27100 Pavia, Italy; [Ciuffreda, Maria Chiara; Gnecchi, Massimiliano] Fdn IRCCS Policlin San Matteo, Lab Expt Cardiol Cell & Mol Therapy, I-27100 Pavia, Italy; [Tolva, Valerio; Casana, Renato] IRCCS Ist Auxol Italiano, Dept Surg, Milan, Italy; [Gnecchi, Massimiliano] Univ Pavia, Dept Mol Med, Unit Cardiol, I-27100 Pavia, Italy; [Gnecchi, Massimiliano] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Vanoli, Emilio] IRCCS Multimedia, Dept Cardiol, Milan, Italy; [Spazzolini, Carla] IRCCS Ist Auxol Italiano, Ctr Cardiac Arrhythmias Genet Base, Milan, Italy; [Roughan, John] Univ Newcastle, Comparat Biol Ctr, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Calvillo, Laura] IRCCS Ist Auxol Italiano, Lab Cardiac Arrhythmias Genet Base, Milan, Italy	IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Istituto Auxologico Italiano; University of Pavia; University of Cape Town; IRCCS Multimedica; IRCCS Istituto Auxologico Italiano; Newcastle University - UK; IRCCS Istituto Auxologico Italiano	Calvillo, L (corresponding author), IRCCS Ist Auxol Italiano, Lab Cardiac Arrhythmias Genet Base, Milan, Italy.	l.calvillo@auxologico.it	tolva, valerio stefano/FHS-3400-2022; calvillo, laura/K-1901-2019; Gnecchi, Massimiliano/J-8609-2018; Spazzolini, Carla/AAA-5023-2020; Casana, Renato/AAA-2364-2020; Tolva, Valerio/AAG-9168-2021; Roughan, John Vincent/AAF-3586-2021; tolva, valerio/AAY-1802-2020; Gnecchi, Massimiliano/X-7095-2019	calvillo, laura/0000-0002-5151-8243; Gnecchi, Massimiliano/0000-0001-7435-4328; Spazzolini, Carla/0000-0003-1209-0157; Casana, Renato/0000-0002-1049-9656; Roughan, John Vincent/0000-0002-0031-3918; tolva, valerio/0000-0002-4642-0727; Gnecchi, Massimiliano/0000-0001-7435-4328; VANOLI, EMILIO/0000-0001-9068-9099; Ciuffreda, Maria Chiara/0000-0003-1673-313X	UK NC3Rs; Ministero Italiano della Sanita [GR-2008-1142871, GR-2010-2320533]; Fondazione Cariplo [2007-5984]; Ministero Italiano degli Affari Esteri [ZA11GR2]; National Centre for the Replacement [G0900763/1] Funding Source: researchfish	UK NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Ministero Italiano della Sanita(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo); Ministero Italiano degli Affari Esteri; National Centre for the Replacement	Dr. Roughan is funded by the UK NC3Rs (http://www.nc3rs.org.uk/). This work was supported by the Ministero Italiano della Sanita (GR-2008-1142871; GR-2010-2320533)(http://www.salute.gov.it/), the Fondazione Cariplo (2007-5984)(http://www.fondazionecariplo.it/it/index.html) and the Ministero Italiano degli Affari Esteri (ZA11GR2)(http://www.esteri. it/MAE/IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvillo L, 2003, CARDIOVASC DRUG THER, V17, P199, DOI 10.1023/A:1026182404805; Calvillo L, 2011, J CARDIOVASC PHARM, V58, P500, DOI 10.1097/FJC.0b013e31822b7204; Cannon CZ, 2011, LAB ANIMAL, V40, P85, DOI 10.1038/laban0311-85; Cannon CZ, 2010, LAB ANIMAL, V39, P342, DOI 10.1038/laban1110-342; Ceyhan A, 2005, J VET MED A, V52, P249, DOI 10.1111/j.1439-0442.2005.00719.x; Gaspani L, 2002, J NEUROIMMUNOL, V129, P18, DOI 10.1016/S0165-5728(02)00165-0; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kongara K, 2012, NEW ZEAL VET J, V60, P129, DOI 10.1080/00480169.2011.641156; Liu YM, 2008, J ZHEJIANG UNIV-SC B, V9, P895, DOI 10.1631/jzus.B0820039; McIntyre AR, 2007, J AM ASSOC LAB ANIM, V46, P65; Michael LH, 1999, AM J PHYSIOL-HEART C, V277, pH660, DOI 10.1152/ajpheart.1999.277.2.H660; Roughan JV, 2004, LAB ANIM-UK, V38, P286, DOI 10.1258/002367704323133673; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; SELYE H., 1960, ANGIOLOGY, V11, P398, DOI 10.1177/000331976001100505; Valtchanova-Matchouganska A, 2004, LIFE SCI, V75, P901, DOI 10.1016/j.lfs.2003.12.029; Wright-Williams S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075948; Zhang LZ, 2009, EUR J ANAESTH, V26, P1048, DOI 10.1097/EJA.0b013e32832c785d	18	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e5913	10.1371/journal.pone.0095913	http://dx.doi.org/10.1371/journal.pone.0095913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756074	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300118
J	Hsieh, WJ; Lin, FM; Huang, HD; Wang, HY				Hsieh, Wan J.; Lin, Feng-Mao; Huang, Hsien-Da; Wang, Hsiuying			Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling	PLOS ONE			English	Article							WEB SERVER; IDENTIFICATION; GROWTH; MACROPHAGES; INSTABILITY; MICROARRAY; DATABASE; BINDING; TGFBR2; RNAS	Recent studies have revealed that a small non-coding RNA, microRNA (miRNA) down-regulates its mRNA targets. This effect is regarded as an important role in various biological processes. Many studies have been devoted to predicting miRNA-target interactions. These studies indicate that the interactions may only be functional in some specific tissues, which depend on the characteristics of an miRNA. No systematic methods have been established in the literature to investigate the correlation between miRNA-target interactions and tissue specificity through microarray data. In this study, we propose a method to investigate miRNA-target interaction-supported tissues, which is based on experimentally validated miRNA-target interactions. The tissue specificity results by our method are in accordance with the experimental results in the literature.	[Hsieh, Wan J.; Wang, Hsiuying] Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan; [Lin, Feng-Mao; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, HD (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Dept Biol Sci & Technol, Hsinchu, Taiwan.	bryan@mail.nctu.edu.tw; wang@stat.nctu.edu.tw	Huang, Hsien-Da/AAA-7376-2019; Wang, Hsiuying/AAB-7115-2021; Wang, Hsiuying/CAJ-3855-2022	Wang, Hsiuying/0000-0002-5863-0756; 	National Science Council of the Republic of China [NSC 98-2311-B-009-004-MY3, NSC 99-2627-B-009-003, NSC 101-2311-B-009-003-MY3, NSC 100-2627-B-009-002, NSC 101-2118-M-009-006-MY2, NSC 101-2811-M-009-064, NSC 102-2911-I-009-101]; Taiwan National Science Council I-RiCE Program [NSC 101-2911-I-009-101]; Veterans General Hospitals and University System of Taiwan (VGHUST) [VGHUST101-G5-1-1, VGHUST103-G5-1-2]; MOE ATU; National Center for Theoretical Sciences; UST-UCSD International Center of Excellence in Advanced Bio-engineering	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Taiwan National Science Council I-RiCE Program; Veterans General Hospitals and University System of Taiwan (VGHUST); MOE ATU(Ministry of Education, Taiwan); National Center for Theoretical Sciences; UST-UCSD International Center of Excellence in Advanced Bio-engineering	The authors would like to thank the National Science Council of the Republic of China for financially supporting this research under Contract No. NSC 98-2311-B-009-004-MY3, NSC 99-2627-B-009-003, NSC 101-2311-B-009-003-MY3, NSC 100-2627-B-009-002, NSC 101-2118-M-009-006-MY2, NSC 101-2811-M-009-064 and NSC 102-2911-I-009-101. This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC 101-2911-I-009-101, and Veterans General Hospitals and University System of Taiwan (VGHUST) Joint Research Program under Grant Number: VGHUST101-G5-1-1 and VGHUST103-G5-1-2. This work was also partially supported by MOE ATU and National Center for Theoretical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartonicek N, 2010, BIOINFORMATICS, V26, P2900, DOI 10.1093/bioinformatics/btq545; Biswas S, 2008, GENE CHROMOSOME CANC, V47, P95, DOI 10.1002/gcc.20511; Enright AJ, 2004, GENOME BIOL, V5; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hsieh WJ, 2013, J THEOR BIOL, V337, P54, DOI 10.1016/j.jtbi.2013.08.002; Hsieh WJ, 2011, J THEOR BIOL, V286, P79, DOI 10.1016/j.jtbi.2011.06.022; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Le Brigand K, 2010, BIOINFORMATICS, V26, P3131, DOI 10.1093/bioinformatics/btq589; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Z, 2011, NUCLEIC ACIDS RES, V39, pW139, DOI 10.1093/nar/gkr351; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Ogino S, 2007, HUM PATHOL, V38, P614, DOI 10.1016/j.humpath.2006.10.005; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Plaisier CL, 2011, NUCLEIC ACIDS RES, V39, pW125, DOI 10.1093/nar/gkr374; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025062; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wang HY, 2009, J THEOR BIOL, V259, P793, DOI 10.1016/j.jtbi.2009.05.007; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-29; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wei X, 2010, P NATL ACAD SCI; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014681; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851	47	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95697	10.1371/journal.pone.0095697	http://dx.doi.org/10.1371/journal.pone.0095697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756070	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300076
J	Ryndak, MB; Singh, KK; Peng, Z; Zolla-Pazner, S; Li, HL; Meng, L; Laal, S				Ryndak, Michelle B.; Singh, Krishna K.; Peng, Zhengyu; Zolla-Pazner, Susan; Li, Hualin; Meng, Lu; Laal, Suman			Transcriptional Profiling of Mycobacterium tuberculosis Replicating Ex vivo in Blood from HIV- and HIV plus Subjects	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; PULMONARY TUBERCULOSIS; MICROARRAY ANALYSIS; EXTRAPULMONARY TUBERCULOSIS; MOLECULAR CHAPERONES; VIRULENCE FACTORS; CALMETTE-GUERIN; UP-REGULATION	Hematogenous dissemination of Mycobacterium tuberculosis (M. tb) occurs during both primary and reactivated tuberculosis (TB). Although hematogenous dissemination occurs in non-HIV TBpatients, in similar to 80% of these patients, TB manifests exclusively as pulmonary disease. In contrast, extrapulmonary, disseminated, and/or miliary TB is seen in 60-70% of HIVinfected TB patients, suggesting that hematogenous dissemination is likely more common in HIV+ patients. To understand M. tb adaptation to the blood environment during bacteremia, we have studied the transcriptome of M. tb replicating in human whole blood. To investigate if M. tb discriminates between the hematogenous environments of immunocompetent and immunodeficient individuals, we compared the M. tb transcriptional profiles during replication in blood from HIV-and HIV+ donors. Our results demonstrate that M. tb survives and replicates in blood from both HIV-and HIV+ donors and enhances its virulence/pathogenic potential in the hematogenous environment. The M. tb blood-specific transcriptome reflects suppression of dormancy, induction of cell-wall remodeling, alteration in mode of iron acquisition, potential evasion of immune surveillance, and enhanced expression of important virulence factors that drive active M. tb infection and dissemination. These changes are accentuated during bacterial replication in blood from HIV+ patients. Furthermore, the expression of ESAT-6, which participates in dissemination of M. tb from the lungs, is upregulated in M. tb growing in blood, especially during growth in blood from HIV+ patients. Preliminary experiments also demonstrate that ESAT-6 promotes HIV replication in U1 cells. These studies provide evidence, for the first time, that during bacteremia, M. tb can adapt to the blood environment by modifying its transcriptome in a manner indicative of an enhanced-virulence phenotype that favors active infection. Additionally, transcriptional modifications in HIV+ blood may further accentuate M. tb virulence and drive both M. tb and HIV infection.	[Ryndak, Michelle B.; Singh, Krishna K.; Zolla-Pazner, Susan; Laal, Suman] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Peng, Zhengyu; Meng, Lu] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zolla-Pazner, Susan; Laal, Suman] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10013 USA; [Li, Hualin] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA	New York University; NYU Langone Medical Center; Fudan University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Laal, S (corresponding author), Vet Affairs New York Harbor Healthcare Syst, New York, NY 10013 USA.	Suman.Laal@nyumc.org	Zolla-Pazner, Susan/S-1864-2019; Meng, Lu/GXN-0092-2022	Zolla-Pazner, Susan/0000-0002-0750-2666; 	Center for AIDS Research (CFAR) [P30 AI027742]; Veterans Affairs Research Career Scientist Award; National Institutes of Health (NIH)/Fogarty International Center training grant [D43 TW001409]; Department of Veterans Affairs; Veterans Health Administration; Office of Research and Development; FOGARTY INTERNATIONAL CENTER [D43TW001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027742] Funding Source: NIH RePORTER	Center for AIDS Research (CFAR); Veterans Affairs Research Career Scientist Award(US Department of Veterans Affairs); National Institutes of Health (NIH)/Fogarty International Center training grant; Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Center for AIDS Research (CFAR) grant (P30 AI027742) awarded to K. K. S., and the Veterans Affairs Research Career Scientist Award and the National Institutes of Health (NIH)/Fogarty International Center training grant (D43 TW001409) both awarded to S. L. This material is also based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development with salary support to Research Microbiologist and Research Career Scientist, S. L. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Arora P, 2013, ADV EXP MED BIOL, V783, P199, DOI 10.1007/978-1-4614-6111-1_11; Badri M, 2001, INT J TUBERC LUNG D, V5, P225; BARBER TW, 1990, MEDICINE, V69, P375, DOI 10.1097/00005792-199011000-00005; Barrios-Payan JA, 2012, J INFECT DI IN PRESS; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; BOUZA E, 1993, ARCH INTERN MED, V153, P496, DOI 10.1001/archinte.153.4.496; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Bretl DJ, 2012, INFECT IMMUN, V80, P3018, DOI 10.1128/IAI.00520-12; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Cappelli G, 2006, RES MICROBIOL, V157, P445, DOI 10.1016/j.resmic.2005.10.007; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chen TA, 2010, MICROB PATHOGENESIS, V49, P311, DOI 10.1016/j.micpath.2010.07.004; Cheon SH, 2002, CLIN DIAGN LAB IMMUN, V9, P901, DOI 10.1128/CDLI.9.4.901-907.2002; Chiu YS, 2007, J FORMOS MED ASSOC, V106, P355, DOI 10.1016/S0929-6646(09)60320-X; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; CLARK RA, 1991, REV INFECT DIS, V13, P1089; Clough MC, 1917, B J HOPKINS HOSP; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Devi U, 2003, BRIT J NUTR, V90, P541, DOI 10.1079/BJN2003936; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; Doherty TM, 2012, IMMUNOTHERAPY-UK, V4, P629, DOI [10.2217/IMT.12.52, 10.2217/imt.12.52]; Dubnau E, 2002, INFECT IMMUN, V70, P2787, DOI 10.1128/IAI.70.6.2787-2795.2002; Dudoit D, 2000, 578 U CAL DEP STAT; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Esteban J, 2001, INT J TUBERC LUNG D, V5, P763; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; Gennaro ML, 2007, INT J TUBERC LUNG D, V11, P624; Gobin J, 1996, J EXP MED, V183, P1527, DOI 10.1084/jem.183.4.1527; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; Goletti D, 1996, J IMMUNOL, V157, P1271; Gopinath K, 2008, EUR J CLIN MICROBIOL, V27, P423, DOI 10.1007/s10096-007-0450-x; GORNY MK, 1989, P NATL ACAD SCI USA, V86, P1624, DOI 10.1073/pnas.86.5.1624; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; HANSON DL, 1995, ARCH INTERN MED, V155, P1537, DOI 10.1001/archinte.155.14.1537; Harris TG, 2010, CLIN INFECT DIS, V50, P1524, DOI 10.1086/652654; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HO RS, 1978, J INFECT DIS, V138, P237, DOI 10.1093/infdis/138.2.237; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jacob ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070305; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kinhikar AG, 2006, MOL MICROBIOL, V60, P999, DOI 10.1111/j.1365-2958.2006.05151.x; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Kumar A, 2011, EXPERT REV MOL MED, V13; Kumar NP, 2013, CLIN VACCINE IMMUNOL, V20, P704, DOI 10.1128/CVI.00038-13; Laal S, 1997, CLIN DIAGN LAB IMMUN, V4, P49, DOI 10.1128/CDLI.4.1.49-56.1997; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; LEDERMAN MM, 1994, J ACQ IMMUN DEF SYND, V7, P727; Lee SW, 2006, J KOREAN MED SCI, V21, P1028, DOI 10.3346/jkms.2006.21.6.1028; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Lewis DK, 2002, INT J TUBERC LUNG D, V6, P1067; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lillebaek T, 2002, APMIS, V110, P625, DOI 10.1034/j.1600-0463.2002.1100905.x; Lincoln EM, 1935, AM J DIS CHILD, V50, P84; Lopez-Gatell H, 2007, AM J EPIDEMIOL, V165, P1134, DOI 10.1093/aje/kwk116; Majumdar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035847; Mariotti S, 2013, J IMMUNOL, V191, P274, DOI 10.4049/jimmunol.1202900; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Meraviglia S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/587315; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; Mert A, 2007, RESPIROLOGY, V12, P311, DOI 10.1111/j.1440-1843.2006.01011.x; Mihret A, 2012, VIRULENCE, V3, P654, DOI 10.4161/viru.22586; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; Naing C, 2013, LUNG, V191, P27, DOI 10.1007/s00408-012-9440-6; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; Narang S, 2012, J PEDIAT HEMATOL ONC, V34, P13, DOI 10.1097/MPH.0b013e318240d50d; Narberhaus F, 1999, MOL MICROBIOL, V31, P1, DOI 10.1046/j.1365-2958.1999.01166.x; Newton S, 2011, JOVE-J VIS EXP, DOI 10.3791/3332; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; Nyambi PN, 1998, J VIROL, V72, P9384, DOI 10.1128/JVI.72.11.9384-9391.1998; Ong CK, 2008, INT E J SCI MED ED, V2, P17; ONORATO IM, 1992, J INFECT DIS, V165, P87, DOI 10.1093/infdis/165.1.87; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Ridruechai C, 2011, SE ASIAN J TROP MED, V42, P876; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Safe IP, 2013, BRAZ J INFECT DIS, V17, P110, DOI 10.1016/j.bjid.2012.04.004; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sartain MJ, 2006, MOL CELL PROTEOMICS, V5, P2102, DOI 10.1074/mcp.M600089-MCP200; Sawant KV, 2007, INFECT IMMUN, V75, P1870, DOI 10.1128/IAI.00858-06; Sawant KV, 2010, MICROBES INFECT, V12, P828, DOI 10.1016/j.micinf.2010.05.009; Schlingemann J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni029; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SHAFER RW, 1989, AM REV RESPIR DIS, V140, P1611, DOI 10.1164/ajrccm/140.6.1611; SHAFER RW, 1991, MEDICINE, V70, P384, DOI 10.1097/00005792-199111000-00004; Shapiro L., 1932, AM REV TUBERCUL, V26, P418; Shen GM, 2009, CLIN VACCINE IMMUNOL, V16, P49, DOI 10.1128/CVI.00334-08; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Silva CL, 1999, MICROBES INFECT, V1, P429, DOI 10.1016/S1286-4579(99)80046-X; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Sonnenberg MG, 1997, INFECT IMMUN, V65, P4515, DOI 10.1128/IAI.65.11.4515-4524.1997; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tan CK, 2010, CLIN MICROBIOL INFEC, V16, P627, DOI 10.1111/j.1469-0691.2009.02939.x; Tan W, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012924, 10.1371/journal.pone.0013356]; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; TOOSSI Z, 1993, J EXP MED, V177, P1511, DOI 10.1084/jem.177.5.1511; Trivedi A, 2012, ADV MICROB PHYSIOL, V60, P263, DOI 10.1016/B978-0-12-398264-3.00004-8; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Waddell SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-94; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Wayne L. G., 1998, Tubercle and Lung Disease, V79, P127, DOI 10.1054/tuld.1998.0015; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, TB HIV FACTS; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; YOUNG D, 1993, PHILOS T ROY SOC B, V339, P363, DOI 10.1098/rstb.1993.0035; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	148	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94939	10.1371/journal.pone.0094939	http://dx.doi.org/10.1371/journal.pone.0094939			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755630	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300023
J	Badenes-Perez, FR; Gershenzon, J; Heckel, DG				Badenes-Perez, Francisco R.; Gershenzon, Jonathan; Heckel, David G.			Insect Attraction versus Plant Defense: Young Leaves High in Glucosinolates Stimulate Oviposition by a Specialist Herbivore despite Poor Larval Survival due to High Saponin Content	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; PLUTELLA-XYLOSTELLA LEPIDOPTERA; BARBAREA-VULGARIS; HOST PLANTS; FEEDING-DETERRENT; LEAF BEETLE; TRAP CROPS; MANAGEMENT; RESISTANCE; ECOLOGY	Glucosinolates are plant secondary metabolites used in plant defense. For insects specialized on Brassicaceae, such as the diamondback moth, Plutella xylostella L. (Lepidoptera: Plutellidae), glucosinolates act as "fingerprints" that are essential in host plant recognition. Some plants in the genus Barbarea (Brassicaceae) contain, besides glucosinolates, saponins that act as feeding deterrents for P. xylostella larvae, preventing their survival on the plant. Two-choice oviposition tests were conducted to study the preference of P. xylostella among Barbarea leaves of different size within the same plant. P. xylostella laid more eggs per leaf area on younger leaves compared to older ones. Higher concentrations of glucosinolates and saponins were found in younger leaves than in older ones. In 4-week-old plants, saponins were present in true leaves, while cotyledons contained little or no saponins. When analyzing the whole foliage of the plant, the content of glucosinolates and saponins also varied significantly in comparisons among plants that were 4, 8, and 12 weeks old. In Barbarea plants and leaves of different ages, there was a positive correlation between glucosinolate and saponin levels. This research shows that, in Barbarea plants, ontogenetical changes in glucosinolate and saponin content affect both attraction and resistance to P. xylostella. Co-occurrence of a high content of glucosinolates and saponins in the Barbarea leaves that are most valuable for the plant, but are also the most attractive to P. xylostella, provides protection against this specialist herbivore, which oviposition behavior on Barbarea seems to be an evolutionary mistake.	[Badenes-Perez, Francisco R.; Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Badenes-Perez, Francisco R.] CSIC, Inst Ciencias Agr, Madrid, Spain; [Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA); Max Planck Society	Badenes-Perez, FR (corresponding author), Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany.	frbadenes@ica.csic.es	Gershenzon, Jonathan/K-1331-2013; Heckel, David G/K-2138-2013; Badenes-Perez, Francisco Ruben/K-9722-2014	Gershenzon, Jonathan/0000-0002-1812-1551; Heckel, David G/0000-0001-8991-2150; Badenes-Perez, Francisco Ruben/0000-0002-8954-7920	Max Planck Society; Spanish Ministry of Science and Innovation [AGL201018151]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the Max Planck Society (http://www.mpg.de/en) and the Spanish Ministry of Science and Innovation (grant# AGL201018151) (http://www.idi.mineco.gob.es/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel MM, 2000, J CHEM ECOL, V26, P1065, DOI 10.1023/A:1005445217004; Agerbirk N, 2003, J CHEM ECOL, V29, P1417, DOI 10.1023/A:1024217504445; Agerbirk N, 2001, PHYTOCHEMISTRY, V58, P91, DOI 10.1016/S0031-9422(01)00151-0; Badenes-Perez FR, 2005, J ECON ENTOMOL, V98, P836, DOI 10.1603/0022-0493-98.3.836; Badenes-Perez FR, 2004, J ECON ENTOMOL, V97, P1365, DOI 10.1603/0022-0493-97.4.1365; Badenes-Perez FR, 2006, ENTOMOL EXP APPL, V120, P23, DOI 10.1111/j.1570-7458.2006.00416.x; Badenes-Perez FR, 2014, PHYTOCHEMISTRY, V98, P137, DOI 10.1016/j.phytochem.2013.11.009; Badenes-Perez FR, 2010, PEST MANAG SCI, V66, P832, DOI 10.1002/ps.1949; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; De Geyter E, 2012, PEST MANAG SCI, V68, P1199, DOI 10.1002/ps.3284; FEENY P, 1977, ANN MO BOT GARD, V64, P221, DOI 10.2307/2395334; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gutbrodt B, 2012, CHEMOECOLOGY, V22, P101, DOI 10.1007/s00049-012-0102-1; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; HARPER JL, 1989, OECOLOGIA, V80, P53, DOI 10.1007/BF00789931; Heisswolf A, 2005, ECOL ENTOMOL, V30, P299, DOI 10.1111/j.0307-6946.2005.00706.x; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Idris AB, 1996, ENVIRON ENTOMOL, V25, P825, DOI 10.1093/ee/25.4.825; JAIN DC, 1991, PHYTOTHER RES, V5, P139, DOI 10.1002/ptr.2650050311; Janz N, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P349; KARBAN R, 1990, OIKOS, V59, P27, DOI 10.2307/3545118; Kause A, 1999, OECOLOGIA, V120, P102, DOI 10.1007/s004420050838; King BH, 1998, J INSECT BEHAV, V11, P23, DOI 10.1023/A:1020810415249; Lambdon PW, 2003, AGR ECOSYST ENVIRON, V97, P205, DOI 10.1016/S0167-8809(03)00036-7; LARSSON S, 1995, OIKOS, V72, P155, DOI 10.2307/3546051; Lu JH, 2004, B ENTOMOL RES, V94, P509, DOI 10.1079/BER2004328; Matsuda K, 1998, APPL ENTOMOL ZOOL, V33, P255, DOI 10.1303/aez.33.255; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Nielsen JK, 2010, J CHEM ECOL, V36, P277, DOI 10.1007/s10886-010-9758-6; Nielsen JK, 2005, ENTOMOL EXP APPL, V115, P265, DOI 10.1111/j.1570-7458.2005.00293.x; Nielsen NJ, 2010, J AGR FOOD CHEM, V58, P5509, DOI 10.1021/jf903988f; Osbourn A, 1996, TRENDS PLANT SCI, V1, P4, DOI 10.1016/S1360-1385(96)80016-1; Pecetti L, 2010, J SCI FOOD AGR, V90, P2405, DOI 10.1002/jsfa.4099; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; PIVNICK KA, 1990, ENVIRON ENTOMOL, V19, P587, DOI 10.1093/ee/19.3.587; POTTER DA, 1989, OECOLOGIA, V78, P322, DOI 10.1007/BF00379105; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Raupp M.J., 1983, P91; RAUPP MJ, 1988, ENVIRON ENTOMOL, V17, P316, DOI 10.1093/ee/17.2.316; Renwick JAA, 2006, J CHEM ECOL, V32, P755, DOI 10.1007/s10886-006-9036-9; RENWICK JAA, 1989, EXPERIENTIA, V45, P223, DOI 10.1007/BF01951807; Rhoades D.F., 1979, HERBIVORES THEIR INT; ROOT RB, 1969, ANN ENTOMOL SOC AM, V62, P852, DOI 10.1093/aesa/62.4.852; Badenes-Perez FR, 2011, NEW PHYTOL, V189, P549, DOI 10.1111/j.1469-8137.2010.03486.x; Shelton AL, 2005, J CHEM ECOL, V31, P1711, DOI 10.1007/s10886-005-5922-9; Shelton AM, 2004, CROP PROT, V23, P497, DOI 10.1016/j.cropro.2003.10.005; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Shinoda T, 2002, J CHEM ECOL, V28, P587, DOI 10.1023/A:1014500330510; Spangler SM, 2000, ENVIRON ENTOMOL, V29, P1226, DOI 10.1603/0046-225X-29.6.1226; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Spencer JL, 1999, J INSECT BEHAV, V12, P483, DOI 10.1023/A:1020914723562; Stadler E, 2002, ACTA ZOOL ACAD SCI H, V48, P265; Szakiel A, 2011, PHYTOCHEM REV, V10, P471, DOI 10.1007/s11101-010-9177-x; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Teng HM, 2009, J INTEGR PLANT BIOL, V51, P529, DOI 10.1111/j.1744-7909.2009.00830.x; Thompson JN, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P7; Uematsu H, 1996, JPN J APPL ENTOMOL Z, V40, P35, DOI 10.1303/jjaez.40.35; van Leur H, 2006, PHYTOCHEMISTRY, V67, P1214, DOI 10.1016/j.phytochem.2006.04.021; van Loon JJA, 2002, ENTOMOL EXP APPL, V104, P27, DOI 10.1046/j.1570-7458.2002.00987.x; VanDam NM, 1996, FUNCT ECOL, V10, P128, DOI 10.2307/2390271; Wallace SK, 2002, J CHEM ECOL, V28, P243, DOI 10.1023/A:1017973005994; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Zhang PJ, 2012, J PEST SCI, V85, P247, DOI 10.1007/s10340-012-0425-2	66	60	62	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95766	10.1371/journal.pone.0095766	http://dx.doi.org/10.1371/journal.pone.0095766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752069	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400123
J	do Prado, RS; Alves, RJ; de Oliveira, CMA; Kato, L; da Silva, RA; Quintino, GO; Cunha, SD; Soares, CMD; Pereira, M				do Prado, Renata Silva; Alves, Ricardo Justino; Alves de Oliveira, Cecilia Maria; Kato, Lucilia; da Silva, Roosevelt Alves; Quintino, Guilherme Oliveira; Cunha, Silvio do Desterro; de Almeida Soares, Celia Maria; Pereira, Maristela			Inhibition of Paracoccidioides lutzii Pb01 Isocitrate Lyase by the Natural Compound Argentilactone and Its Semi-Synthetic Derivatives	PLOS ONE			English	Article							BRASILIENSIS YEAST-PHASE; GLYOXYLATE CYCLE; MYCOBACTERIUM-TUBERCULOSIS; CANDIDA-ALBICANS; MAMMALIAN HOST; PROTEIN; FUNGUS; PATHOGENICITY; MYCELIUM; GROWTH	The dimorphic fungus Paracoccidioides spp. is responsible for paracoccidioidomycosis, the most prevalent systemic mycosis in Latin America, causing serious public health problems. Adequate treatment of mycotic infections is difficult, since fungi are eukaryotic organisms with a structure and metabolism similar to those of eukaryotic hosts. In this way, specific fungus targets have become important to search of new antifungal compound. The role of the glyoxylate cycle and its enzymes in microbial virulence has been reported in many fungal pathogens, including Paracoccidioides spp. Here, we show the action of argentilactone and its semi-synthetic derivative reduced argentilactone on recombinant and native isocitrate lyase from Paracoccidioides lutzii Pb01 (PbICL) in the presence of different carbon sources, acetate and glucose. Additionally, argentilactone and its semi-synthetic derivative reduced argentilactone exhibited relevant inhibitory activity against P. lutzii Pb01 yeast cells and dose-dependently influenced the transition from the mycelium to yeast phase. The other oxygenated derivatives tested, epoxy argentilactone and diol argentilactone-, did not show inhibitory action on the fungus. The results were supported by in silico experiments.	[do Prado, Renata Silva; de Almeida Soares, Celia Maria; Pereira, Maristela] Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil; [Alves, Ricardo Justino; Alves de Oliveira, Cecilia Maria; Kato, Lucilia] Univ Fed Goias, Inst Quim, Lab Prod Nat, Goiania, Go, Brazil; [da Silva, Roosevelt Alves; Quintino, Guilherme Oliveira] Univ Fed Goias, Nucleo Colaborat BioSistemas, Goiania, Go, Brazil; [Cunha, Silvio do Desterro] Univ Fed Bahia, Dept Quim Organ, Inst Quim, Salvador, BA, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal da Bahia	Pereira, M (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil.	maristelaufg@gmail.com	da Silva, Roosevelt Alves/AAF-1577-2019; de Oliveira, Cecilia M A/C-5830-2013; Kato, Lucilia/P-1292-2019; Cunha, Silvio/AAX-2081-2020; Soares, Celia/N-6395-2014; Pereira, Maristela/AAT-5765-2021	da Silva, Roosevelt Alves/0000-0001-5624-4790; de Oliveira, Cecilia M A/0000-0003-3339-5363; 	MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FINEP (Financiadora de Estudos e Projetos); INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica); CAPES and GOQ; CNPq	MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP (Financiadora de Estudos e Projetos)(Financiadora de Inovacao e Pesquisa (Finep)); INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica); CAPES and GOQ(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work performed at Universidade Federal de Goias was supported by MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; http://www.mct.gov.br/; http://www.cnpq.br/), FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico; http://www.mct.gov.br/), FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias; http://www.fapeg.go.gov.br/), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; http://www.capes.gov.br/), FINEP (Financiadora de Estudos e Projetos; http://www.finep.gov.br/), and INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica; http://www.inct-if.com.br/portal/). Additionally, RSP and RJA were supported by fellowship from CAPES and GOQ by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Zapatero C, 2007, EXPERT OPIN DRUG DIS, V2, P469, DOI 10.1517/17460441.2.4.469; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves RJ, 2013, J MOL STRUCT, V1035, P448, DOI 10.1016/j.molstruc.2012.11.056; [Anonymous], GROMACS V4 0; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Bastos KP, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-29; Bellissimo-Rodrigues F, 2010, MEM I OSWALDO CRUZ, V105, P904, DOI 10.1590/S0074-02762010000700011; Benard G, 2008, MYCOPATHOLOGIA, V165, P209, DOI 10.1007/s11046-007-9065-0; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cooney NM, 2008, CURR OPIN MICROBIOL, V11, P511, DOI 10.1016/j.mib.2008.09.018; Costa M, 2007, MICROBIOL-SGM, V153, P4194, DOI 10.1099/mic.0.2007/009332-0; Santana LAD, 2012, MEM I OSWALDO CRUZ, V107, P310, DOI 10.1590/S0074-02762012000300004; Cruz AHD, 2011, FEBS J, V278, P2318, DOI 10.1111/j.1742-4658.2011.08150.x; Neto BRD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-272; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; de Oliveira CMA, 2004, J BRAZIL CHEM SOC, V15, P756, DOI 10.1590/S0103-50532004000500023; Derengowski LS, 2008, MED MYCOL, V46, P125, DOI 10.1080/13693780701670509; Eastmond PJ, 2000, P NATL ACAD SCI USA, V97, P5669, DOI 10.1073/pnas.97.10.5669; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Fava-Netto C, 1861, REV INST MED TROP, V4, P161; Felipe MSS, 2005, J BIOL CHEM, V280, P24706, DOI 10.1074/jbc.M500625200; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; GMG R, 2012, PLOS NEGL TROP DIS, V6, P1; Goldstein AL, 2001, GENETICS, V159, P499; Grossklaus DD, 2013, MICROBES INFECT, V15, P347, DOI 10.1016/j.micinf.2012.12.002; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; Idnurm A, 2002, EUKARYOT CELL, V1, P719, DOI 10.1128/EC.1.5.719-724.2002; Johann S, 2012, REV IBEROAM MICOL, V29, P205, DOI 10.1016/j.riam.2012.02.002; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim DG, 2012, J NAT PROD, V75, P959, DOI 10.1021/np3001915; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Lee D, 2008, BIOORG MED CHEM LETT, V18, P5377, DOI 10.1016/j.bmcl.2008.09.059; Lee HS, 2007, J AGR FOOD CHEM, V55, P6923, DOI 10.1021/jf071125r; Lee HS, 2009, BIOORG MED CHEM LETT, V19, P1051, DOI 10.1016/j.bmcl.2009.01.017; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MAIOROV VN, 1995, PROTEINS, V22, P273, DOI 10.1002/prot.340220308; MCFADDEN BA, 1977, J BACTERIOL, V131, P136, DOI 10.1128/JB.131.1.136-144.1977; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; National Committee for Clinical Laboratory Standards, 2002, REF METH BROTH DIL A, pM27; Nunura J, 2010, REV CHIL INFECTOL, V27, P551, DOI /S0716-10182010000700011; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Pereira M, 2010, BBA-MOL CELL BIOL L, V1801, P1163, DOI 10.1016/j.bbalip.2010.06.007; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; Restrepo A, 2001, MED MYCOL, V39, P233, DOI 10.1080/714031028; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; Sakkiah S, 2012, J MOL MODEL, V18, P3267, DOI 10.1007/s00894-011-1247-5; Sakkiah S, 2012, CHEM BIOL DRUG DES, V80, P64, DOI 10.1111/j.1747-0285.2012.01339.x; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shin DS, 2007, FEMS MICROBIOL LETT, V272, P43, DOI 10.1111/j.1574-6968.2007.00733.x; Sriram D, 2011, BIOORG MED CHEM LETT, V21, P5149, DOI 10.1016/j.bmcl.2011.07.062; Srivastava M, 2010, FUNGAL GENET BIOL, V47, P800, DOI 10.1016/j.fgb.2010.06.014; Sundriyal S, 2006, CURR MED CHEM, V13, P1321, DOI 10.2174/092986706776873023; Tomazett PK, 2011, FUNGAL BIOL-UK, V115, P62, DOI 10.1016/j.funbio.2010.10.005; Tomazett PK, 2010, FUNGAL BIOL-UK, V114, P809, DOI 10.1016/j.funbio.2010.07.007; Vereecke D, 2002, J BACTERIOL, V184, P1112, DOI 10.1128/jb.184.4.1112-1120.2002; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Yasuda MAS, 2005, EXPERT OPIN PHARMACO, V6, P385, DOI 10.1517/14656566.6.3.385; Zambuzzi-Carvalho PF, 2009, MED MYCOL, V47, P734, DOI 10.3109/13693780802609620	70	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94832	10.1371/journal.pone.0094832	http://dx.doi.org/10.1371/journal.pone.0094832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752170	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400018
J	Hu, YL; Wan, R; Yu, G; Shen, J; Ni, JB; Yin, GJ; Xing, M; Chen, CY; Fan, YT; Xiao, WQ; Xu, G; Wang, XP; Hu, GY				Hu, Yanling; Wan, Rong; Yu, Ge; Shen, Jie; Ni, Jianbo; Yin, Guojian; Xing, Miao; Chen, Congying; Fan, Yuting; Xiao, Wenqin; Xu, Gang; Wang, Xingpeng; Hu, Guoyong			Imbalance of Wnt/Dkk Negative Feedback Promotes Persistent Activation of Pancreatic Stellate Cells in Chronic Pancreatitis	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; EPIGENETIC INACTIVATION; HUMAN DICKKOPF-1; EXPRESSION; GENE; ANTAGONISTS; FIBROSIS; CANCER; ROLES; DKK1	The role of persistent activation of pancreatic stellate cells (PSCs) in the fibrosis associated with chronic pancreatitis (CP) is increasingly being recognized. Recent studies have shown that Wnt signaling is involved in the development of fibrosis in multiple organs, however, the role of specific Wnts in pancreatic fibrosis remains unknown. We investigated the role of Wnt signaling during PSC activation in CP and the effect of beta-catenin inhibition and Dickkopf-related protein 1 (Dkk1) restoration on the phenotype of PSCs. CP was induced in mice by repetitive caerulein injection and mouse PSCs were isolated and activated in vitro. The expression of Wnts, beta-catenin, secreted frizzled-related proteins (sFRPs) and Dkks was analyzed by quantitative RT-PCR and western blotting. The canonical Wnt signaling pathway was examined by immunofluorescence and western blot detection of nuclear beta-catenin expression. The effect of recombinant mouse Dkk-1 (rmDkk-1) on cell proliferation and apoptosis was assessed by flow cytometry, immunofluorescence, immunocytochemistry and Cell Counting Kit-8 (CCK-8) analysis. The expression of beta-catenin, collagen1 alpha 1, TGF beta RII, PDGFR beta and alpha-SMA in PSCs treated with different concentrations of rmDkk-1 or siRNA against beta-catenin was determined by quantitative RT-PCR and western blotting. Wnt2 was the only Wnt whose expression was significantly upregulated in response to PSC activation, and Wnt2 and beta-catenin protein levels were significantly increased in the pancreas of CP mice, whereas Dkk-1 expression was evidently decreased. Nuclear beta-catenin levels were markedly increased in activated PSCs, and rmDkk-1 suppressed the nuclear translocation of beta-catenin and the proliferation and extracellular matrix production of PSCs through the downregulation of PDGFR beta and TGF beta RII. Upregulation of Dkk-1 expression increased apoptosis in cultured PSCs. These results indicate that Wnt signaling may mediate the profibrotic effect of PSC activation, and Wnt2/Dkk-1 could be potential therapeutic targets for CP.	[Hu, Yanling; Yu, Ge; Yin, Guojian; Xing, Miao; Fan, Yuting; Xiao, Wenqin; Wang, Xingpeng; Hu, Guoyong] Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200092, Peoples R China; [Wan, Rong; Shen, Jie; Ni, Jianbo; Chen, Congying; Xu, Gang; Wang, Xingpeng; Hu, Guoyong] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China	Tongji University; Shanghai Jiao Tong University	Wang, XP (corresponding author), Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200092, Peoples R China.	wangxingpeng@hotmail.com; huguoyongsh@sina.com			National Natural Science Foundation of China [81370568, 81100317, 81270543]; Foundation for Shanghai Science and Technology Committee [12QA1402600, 114119a6800, 12411950600, 11411950601]; outstanding Young Scholars Program of Shanghai Health System [XYQ2011004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Shanghai Science and Technology Committee; outstanding Young Scholars Program of Shanghai Health System	This work was supported in part by National Natural Science Foundation of China (No. 81370568, No. 81100317 and No. 81270543), Foundation for Shanghai Science and Technology Committee (No. 12QA1402600, No. 114119a6800, No. 12411950600 and No. 11411950601) and outstanding Young Scholars Program of Shanghai Health System (No. XYQ2011004). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bayle J, 2008, J INVEST DERMATOL, V128, P871, DOI 10.1038/sj.jid.5701101; Buchholz M, 2005, J MOL MED, V83, P795, DOI 10.1007/s00109-005-0680-2; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi HJ, 2012, IUBMB LIFE, V64, P724, DOI 10.1002/iub.1062; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Haniu M, 2011, PROTEIN SCI, V20, P1802, DOI 10.1002/pro.705; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; McCarroll JA, 2006, GUT, V55, P79, DOI 10.1136/gut.2005.064543; Millar JBA, 2002, GENOME BIOL, V3; Myung SJ, 2007, FEBS LETT, V581, P2954, DOI 10.1016/j.febslet.2007.05.050; Nagashio Y, 2004, LAB INVEST, V84, P1610, DOI 10.1038/labinvest.3700191; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Rawson JB, 2011, CARCINOGENESIS, V32, P741, DOI 10.1093/carcin/bgr020; Shen J, 2012, PANCREATOLOGY, V12, P91, DOI 10.1016/j.pan.2012.02.008; Shimizu K, 2008, J GASTROEN HEPATOL, V23, pS119, DOI 10.1111/j.1440-1746.2007.05296.x; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Wang JB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007963; Whyte JL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008078; Wirths O, 2003, LAB INVEST, V83, P429, DOI 10.1097/01.LAB.0000059926.66359.BD; Yang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031807; Ye B, 2013, CARDIOVASC PATHOL, V22, P54, DOI 10.1016/j.carpath.2012.03.004	41	18	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95145	10.1371/journal.pone.0095145	http://dx.doi.org/10.1371/journal.pone.0095145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747916	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500061
J	Pfeil, J; Borrmann, S; Tozan, Y				Pfeil, Johannes; Borrmann, Steffen; Tozan, Yesim			Dihydroartemisinin-Piperaquine vs. Artemether-Lumefantrine for First-Line Treatment of Uncomplicated Malaria in African Children: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; COMBINATION THERAPY; NON-INFERIORITY; ARTESUNATE; EFFICACY; BURDEN	Background: Recent multi-centre trials showed that dihydroartemisinin-piperaquine (DP) was as efficacious and safe as artemether-lumefantrine (AL) for treatment of young children with uncomplicated P. falciparum malaria across diverse transmission settings in Africa. Longitudinal follow-up of patients in these trials supported previous findings that DP had a longer post-treatment prophylactic effect than AL, reducing the risk of reinfection and conferring additional health benefits to patients, particularly in areas with moderate to high malaria transmission. Methods: We developed a Markov model to assess the cost-effectiveness of DP versus AL for first-line treatment of uncomplicated malaria in young children from the provider perspective, taking into consideration the post-treatment prophylactic effects of the drugs as reported by a recent multi-centre trial in Africa and using the maximum manufacturer drug prices for artemisinin-based combination therapies set by the Global Fund in 2013. We estimated the price per course of treatment threshold above which DP would cease to be a cost-saving alternative to AL as a first-line antimalarial drug. Results: First-line treatment with DP compared to AL averted 0.03 DALYs (95% CI: 0.006-0.07) and 0.001 deaths (95% CI: 0.00-0.002) and saved $0.96 (95% CI: 0.33-2.46) per child over one year. The results of the threshold analysis showed that DP remained cost-saving over AL for any DP cost below $1.23 per course of treatment. Conclusions: DP is superior to AL from both the clinical and economic perspectives for treatment of uncomplicated P. falciparum malaria in young children. A paediatric dispersible formulation of DP is under development and should facilitate a targeted deployment of this antimalarial drug. The use of DP as first-line antimalarial drug in paediatric malaria patients in moderate to high transmission areas of Africa merits serious consideration by health policymakers.	[Pfeil, Johannes] Univ Hosp, Ctr Childhood & Adolescent Med, Heidelberg, Germany; [Pfeil, Johannes] Univ Hosp, Dept Infect Dis, Heidelberg, Germany; [Pfeil, Johannes] German Ctr Infect Res DZIF, Heidelberg, Germany; [Borrmann, Steffen] Kenyan Med Res Inst KEMRI, Kilifi, Kenya; [Borrmann, Steffen] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Tozan, Yesim] NYU, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA; [Tozan, Yesim] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; German Center for Infection Research; Kenya Medical Research Institute; Eberhard Karls University of Tubingen; New York University; Ruprecht Karls University Heidelberg	Tozan, Y (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA.	tozan@nyu.edu	; Borrmann, Steffen/G-1838-2013	Pfeil, Johannes/0000-0003-0104-8375; Borrmann, Steffen/0000-0001-9189-4393	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	The authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUID TREATM MAL; Arinaitwe E, 2009, CLIN INFECT DIS, V49, P1629, DOI 10.1086/647946; Awab GR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-105; Ayieko Philip, 2009, Cost Eff Resour Alloc, V7, P3, DOI 10.1186/1478-7547-7-3; Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Creek DJ, 2013, J INFECT DIS, V207, P1646, DOI 10.1093/infdis/jit078; Davis WA, 2011, B WORLD HEALTH ORGAN, V89, P211, DOI 10.2471/BLT.10.084103; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Goodman C, 2000, EC ANAL MALARIA CONT; Hasugian AR, 2007, CLIN INFECT DIS, V44, P1067, DOI 10.1086/512677; Lopez ADAO, 2001, 40 GPE WHO; Lubell Y, 2011, B WORLD HEALTH ORGAN, V89, P504, DOI 10.2471/BLT.11.085878; Malmberg M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-103; Moon S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000106; Mulligan JA, 2006, TROP MED INT HEALTH, V11, P452, DOI 10.1111/j.1365-3156.2006.01590.x; Murray C, 1993, WORLD DEV REP INV HL, P19; Nambozi M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-50; Roca-Feltrer A, 2008, TROP MED INT HEALTH, V13, P771, DOI 10.1111/j.1365-3156.2008.02076.x; Shaukat Ayesha M, 2012, Malar J, V11, P207, DOI 10.1186/1475-2875-11-207; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Stepniewska K, 2008, ANTIMICROB AGENTS CH, V52, P1589, DOI 10.1128/AAC.00903-07; The Four Artemisinin-Based Combinations Study Group, 2011, PLOS MED, V8; The Global Fund website, ACT PRIC AFF MED FAC; Ubben D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-211; US Department of Labor Bureau of Labor Statistics, CPI INFL CALC; White L, 2012, MAL C 2012; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; World Bank, 1993, WORLD DEV REP INV HL	30	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95681	10.1371/journal.pone.0095681	http://dx.doi.org/10.1371/journal.pone.0095681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748395	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500137
J	Sato, D; Itami, N; Tasaki, H; Takeo, S; Kuwayama, T; Iwata, H				Sato, Daichi; Itami, Nobuhiko; Tasaki, Hidetaka; Takeo, Shun; Kuwayama, Takehito; Iwata, Hisataka			Relationship between mitochondrial DNA Copy Number and SIRT1 Expression in Porcine Oocytes	PLOS ONE			English	Article							GENE-EXPRESSION; RESVERATROL; BIOGENESIS; MATURATION; AUTOPHAGY; ACTIVATION; PROTEASOME; MITOPHAGY; ABUNDANCE; PROTECTS	The present study assessed the effect of resveratrol on the expression of SIRT1 and mitochondrial quality and quantity in porcine oocytes. Supplementing the maturation medium with 20 mu M resveratrol increased the expression of SIRT1, and enhanced mitochondrial functions, as observed from the increased ATP content and mitochondrial membrane potential. Addition of resveratrol also improved the ability of oocytes to develop into the blastocyst stage following activation. The effects of resveratrol on mitochondrial number were examined by comparing the mitochondrial DNA copy number (Mt number) between group of oocytes collected from the same donor gilt ovaries. Supplementing the maturation medium with only resveratrol did not affect the Mt number in the oocytes. However, supplementing the maturation medium with 10 mu M MG132, a proteasome inhibitor, significantly increased the amount of ubiquitinated proteins and Mt number by 12 and 14%, respectively. In addition, when resveratrol was added to the medium containing MG132, the Mt number increased significantly by 39%, this effect was diminished by the addition of the SIRT1 inhibitor EX527. Furthermore, supplementing the medium with MG132 and EX527 did not affect Mt number. The mean SIRT1 expression in 20 oocytes was significantly and positively correlated with the Mt number in oocytes collected from the same donor. This study suggests that the expression of SIRT1 is associated with the Mt number in oocytes. In addition, activation of SIRT1 by resveratrol enhances the biosynthesis and degradation of mitochondria in oocytes, thereby replenishing and improving mitochondrial function and the developmental ability of oocytes.	[Sato, Daichi; Itami, Nobuhiko; Tasaki, Hidetaka; Takeo, Shun; Kuwayama, Takehito; Iwata, Hisataka] Tokyo Univ Agr, Atugi City, Japan	Tokyo University of Agriculture	Iwata, H (corresponding author), Tokyo Univ Agr, Atugi City, Japan.	h1iwata@nodai.ac.jp	ITAMI, Nobuhiko/ABA-6806-2020; TASAKI, Hidetaka/ABD-6421-2021; TASAKI, Hidetaka/ABC-1547-2020	TASAKI, Hidetaka/0000-0001-9828-9786	KAKENHI [25450400]; Grants-in-Aid for Scientific Research [25450400] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientic Research C (KAKENHI, grant number: 25450400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Biala A, 2010, BLOOD PRESSURE, V19, P196, DOI 10.3109/08037051.2010.481808; Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI 10.1016/j.mito.2013.04.002; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cotterill M, 2013, MOL HUM REPROD, V19, P444, DOI 10.1093/molehr/gat013; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Endo M, 2012, ZYGOTE, V12, P1, DOI DOI 10.1017/S0967199412000603; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529; Greiss S, 2009, MOL CELLS, V28, P407, DOI 10.1007/s10059-009-0169-x; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Iwata H, 2011, REPROD FERT DEVELOP, V23, P424, DOI 10.1071/RD10133; Jiao F, 2007, MOL REPROD DEV, V74, P1278, DOI 10.1002/mrd.20698; Kushnir VA, 2012, J ASSIST REPROD GEN, V29, P637, DOI 10.1007/s10815-012-9771-5; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Li YG, 2013, BIOCHEM BIOPH RES CO, V438, P270, DOI 10.1016/j.bbrc.2013.07.042; Liu Meilian, 2011, Commun Integr Biol, V4, P382, DOI 10.4161/cib.4.4.15309; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; PETTERS RM, 1993, J REPROD FERTIL, P61; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shang LS, 2009, J CELL MOL MED, V13, P4176, DOI 10.1111/j.1582-4934.2008.00468.x; Simsek-Duran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064955; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Takeo S, 2013, MOL REPROD DEV, V80, P508, DOI 10.1002/mrd.22187; Takeo S, 2014, J REPROD DEVELOP, V60, P92, DOI 10.1262/jrd.2013-102; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka H, 2014, REPROD DOMEST ANIM, V49, P101, DOI 10.1111/rda.12235; Wang F, 2014, FERTIL STERIL, V101, P577, DOI 10.1016/j.fertnstert.2013.10.041; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	40	71	78	10	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94488	10.1371/journal.pone.0094488	http://dx.doi.org/10.1371/journal.pone.0094488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747689	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500031
J	Shah, PP; Lockwood, WW; Saurabh, K; Kurlawala, Z; Shannon, SP; Waigel, S; Zacharias, W; Beverly, LJ				Shah, P. P.; Lockwood, W. W.; Saurabh, K.; Kurlawala, Z.; Shannon, S. P.; Waigel, S.; Zacharias, W.; Beverly, L. J.			Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells	ONCOGENE			English	Article							PROTEIN; METASTASIS; EXPRESSION; REVEALS; STRESS; ZEB1; GENE	Ubiquilin1 (UBQLN1) is a ubiquitin-like domain and a ubiquitin-associated domain containing protein that has been reported to be involved in shuttling proteins to the proteasome, especially during endoplasmic reticulum-associated protein degradation. Thus, UBQLN1 function has been shown to be critical for combating a number of neurological disorders caused by protein aggregation, such as amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's disease. A role for UBQLN1 in regulating processes involved in tumorigenesis has not been demonstrated. Herein, we show that loss of UBQLN1 causes increased cell migration and invasion, actin cytoskeleton reorganization and induction of epithelial-to-mesenchymal transition (EMT). Loss of UBQLN1 results in a significant decrease in the expression of epithelial markers including E-cadherin and claudin1, whereas expression of mesenchymal markers including Vimentin, Snail and ZEB1 are significantly elevated. Interestingly, we found that ZEB1 is required for induction of mesenchymal-like properties following loss of UBQLN1 and ZEB1 is capable of repressing expression of UBQLN1, suggesting a physiological, reciprocal regulation of EMT by UBQLN1 and ZEB1. Further, we find evidence for a role for UBQLN2 in also regulating EMT and cell migration. These observations have potential clinical relevance because the UBQLN1 gene is lost and underexpressed in a large percentage of human cancer cell lines, and primary human lung cancer samples and recurrent mutations in all five UBQLN family members have been identified in human lung cancers. Taken together, our results suggest for the first time a role for UBQLN family members in cancer biology.	[Shah, P. P.; Saurabh, K.; Kurlawala, Z.; Shannon, S. P.; Waigel, S.; Zacharias, W.; Beverly, L. J.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Lockwood, W. W.] NHGRI, Canc Biol & Genet Sect, Canc Genet Branch, NIH, Bethesda, MD USA; [Saurabh, K.; Zacharias, W.; Beverly, L. J.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; [Zacharias, W.; Beverly, L. J.] Univ Louisville, Dept Med, Div Hematol & Oncol, Louisville, KY 40202 USA	University of Louisville; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Louisville; University of Louisville	Beverly, LJ (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Sch Med, Dept Med,Div Hematol & Oncol, 505 South Hancock St,CTRB Room 204, Louisville, KY 40202 USA.	Levi.Beverly@Louisville.edu	Kurlawala, Zimple/AAK-8303-2020	Kurlawala, Zimple/0000-0003-3925-9290	James Graham Brown Cancer Center, University of Louisville; Molecular Targets COBRE from NIH [8P20GM103482-10]; Lung Cancer Research Foundation; Rounsavall Foundation; Wendy Will Case Cancer Fund; National Cancer Institute [R25-CA-134283]; NIH/NIGMS Phase III COBRE [1P30 GM106396-01]; James Graham Brown Foundation; Kosair Pediatric Cancer Program; NIH/NIGMS KY-INBRE [P20GM103436]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA134283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396, P20GM103482, P20GM103436] Funding Source: NIH RePORTER	James Graham Brown Cancer Center, University of Louisville; Molecular Targets COBRE from NIH; Lung Cancer Research Foundation; Rounsavall Foundation; Wendy Will Case Cancer Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIGMS Phase III COBRE; James Graham Brown Foundation; Kosair Pediatric Cancer Program; NIH/NIGMS KY-INBRE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lavona Casson and current members of the Beverly lab for technical assistance and Dr Mohammad T Malik for valuable comments, discussion and technical advice. We would like to thank Douglas Darling for the gift of the ZEB1 antibody. The work was supported by the start-up funds from James Graham Brown Cancer Center, University of Louisville and Kosair Pediatric Cancer Program and Molecular Targets COBRE 8P20GM103482-10 from NIH, an award from the Lung Cancer Research Foundation to LJB, an award from the Rounsavall Foundation to LJB, an award from the Wendy Will Case Cancer Fund to LJB, R25-CA-134283 from the National Cancer Institute to SPS. Part of this work was performed with assistance of the UofL Genomics Facility, which is supported by NIH/NIGMS Phase III COBRE 1P30 GM106396-01, NIH/NIGMS KY-INBRE P20GM103436, the James Graham Brown Foundation, and user fees.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Arias-Vasquez A, 2007, NEUROSCI LETT, V424, P1, DOI 10.1016/j.neulet.2007.07.015; Beverly LJ, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1119167109; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Chen GA, 2007, CANCER RES, V67, P3461, DOI 10.1158/0008-5472.CAN-06-4475; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamiya T, 2011, FREE RADICAL RES, V45, P692, DOI 10.3109/10715762.2011.567985; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lu A, 2009, J MOL NEUROSCI, V38, P19, DOI 10.1007/s12031-008-9155-6; Nurwidya F, 2012, CANCER RES TREAT, V44, P151, DOI 10.4143/crt.2012.44.3.151; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Oyanagi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053209; Rutherford NJ, 2013, BRAIN RES, V1524, P62, DOI 10.1016/j.brainres.2013.06.006; Shah PP, 2012, ONCOGENE, V31, P3124, DOI 10.1038/onc.2011.488; Soetandyo N, 2010, J CELL SCI, V123, P1031, DOI 10.1242/jcs.059758; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang GJ, 2013, ONCOL LETT, V5, P564, DOI 10.3892/ol.2012.1026	31	38	41	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1709	1717		10.1038/onc.2014.97	http://dx.doi.org/10.1038/onc.2014.97			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24747970	Green Accepted			2022-12-25	WOS:000351848400011
J	Liu, YC; Chen, ZJ; Neller, MA; Miles, JJ; Purcell, AW; McCluskey, J; Burrows, SR; Rossjohn, J; Gras, S				Liu, Yu Chih; Chen, Zhenjun; Neller, Michelle A.; Miles, John J.; Purcell, Anthony W.; McCluskey, James; Burrows, Scott R.; Rossjohn, Jamie; Gras, Stephanie			A Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen Micropolymorphism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; MHC CLASS-I; SEQUENCE VARIATION; PERIPHERAL-BLOOD; NUCLEAR ANTIGEN; RECEPTOR; POLYMORPHISM; VARIANTS; FEATURES; IMPACT	Mutations within T cell epitopes represent a common mechanism of viral escape from the host protective immune response. The diverse T cell repertoire and the extensive human leukocyte antigen (HLA) polymorphism across populations is the evolutionary response to viral mutation. However, the molecular basis underpinning the interplay between HLA polymorphism, the T cell repertoire, and viral escape is unclear. Here we investigate the T cell response to a HLA-B*35:01- and HLA-B*35:08-restricted (407)HPVGEADYFEY(417) epitope from Epstein-Barr virus and naturally occurring variants at positions 4 and 5 thereof. Each viral variant differently impacted on the epitope's flexibility and conformation when bound to HLA-B*35:08 or HLA-B*35:01. We provide a molecular basis for understanding how the single residue polymorphism that discriminates between HLA-B*35:01/08 profoundly impacts on T cell receptor recognition. Surprisingly, one viral variant (P5-Glu to P5-Asp) effectively changed restriction preference from HLA-B*35:01 to HLA-B*35:08. Collectively, our study portrays the interplay between the T cell response, viral escape, and HLA polymorphism, whereby HLA polymorphism enables altered presentation of epitopes from different strains of Epstein-Barr virus.	[Liu, Yu Chih; Purcell, Anthony W.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Chen, Zhenjun; McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Neller, Michelle A.; Miles, John J.; Burrows, Scott R.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Neller, Michelle A.; Miles, John J.; Burrows, Scott R.] QIMR Berghofer Ctr Immunotherapy & Vaccine Dev, Brisbane, Qld 4006, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia	Monash University; University of Melbourne; QIMR Berghofer Medical Research Institute; Cardiff University; Monash University	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	jamie.rossjohn@monash.edu; stephanie.gras@monash.edu	Burrows, Scott/G-2050-2011; McCluskey, James/A-1291-2007; Purcell, Anthony/AAH-1942-2019; Miles, John J/ABC-1105-2020; Rossjohn, Jamie/F-9032-2013	Burrows, Scott/0000-0002-1430-0472; McCluskey, James/0000-0002-8597-815X; Purcell, Anthony/0000-0003-0532-8331; Miles, John J/0000-0001-5506-6304; Rossjohn, Jamie/0000-0002-2020-7522; gras, stephanie/0000-0001-7416-038X; Neller, Michelle/0000-0002-2457-1508	Australian Research Council; National Health and Medical Research Council of Australia [APP1067374, APP1021620]; National Health and Medical Research Council of Australia Career Development Fellowship; National Health and Medical Research Council of Australia Senior Research Fellowship; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and National Health and Medical Research Council of Australia Grants APP1067374 and APP1021620.; Supported by a National Health and Medical Research Council of Australia Career Development Fellowship.; Supported by a National Health and Medical Research Council of Australia Senior Research Fellowship.; Supported by an Australia Fellowship from the National Health and Medical Research Council. To whom correspondence may be addressed: Dept. of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Vic 3800 Australia. Tel.: 613-99029236; Fax: 613-9902500; E-mail: jamie.rossjohn@monash.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell MJ, 2008, J INFECT DIS, V197, P1594, DOI 10.1086/587848; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Burrows JM, 2007, EUR J IMMUNOL, V37, P946, DOI 10.1002/eji.200636588; DAMBAUGH T, 1984, P NATL ACAD SCI-BIOL, V81, P7632, DOI 10.1073/pnas.81.23.7632; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALK K, 1993, IMMUNOGENETICS, V38, P161, DOI 10.1007/BF00190906; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Parham P, 1996, NATURE, V384, P109, DOI 10.1038/384109a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Sitki-Green D, 2002, J VIROL, V76, P9645, DOI 10.1128/JVI.76.19.9645-9656.2002; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; SNUDDEN DK, 1995, ONCOGENE, V10, P1545; Stewart-Jones GB, 2012, P NATL ACAD SCI USA, V109, pE3483, DOI 10.1073/pnas.1207896109; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Varro Rudolf, 2007, Methods Mol Biol, V378, P125, DOI 10.1007/978-1-59745-323-3_9; Wang JT, 2003, J MED VIROL, V69, P417, DOI 10.1002/jmv.10305; Wang WY, 2002, CLIN CANCER RES, V8, P2586; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; Zhang XS, 2004, CANCER LETT, V211, P11, DOI 10.1016/j.canlet.2004.01.035	42	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16688	16698		10.1074/jbc.M114.563502	http://dx.doi.org/10.1074/jbc.M114.563502			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24759101	Green Published, hybrid			2022-12-25	WOS:000338016200009
J	Budzik, JM; Jarlsberg, LG; Higashi, J; Grinsdale, J; Hopewell, PC; Kato-Maeda, M; Nahid, P				Budzik, Jonathan M.; Jarlsberg, Leah G.; Higashi, Julie; Grinsdale, Jennifer; Hopewell, Phil C.; Kato-Maeda, Midori; Nahid, Payam			Pyrazinamide Resistance, Mycobacterium tuberculosis Lineage and Treatment Outcomes in San Francisco, California	PLOS ONE			English	Article							UNITED-STATES; BOVIS; PULMONARY	Background: Pyrazinamide (PZA) is a first line agent for the treatment of active tuberculosis. PZA is also considered a potent companion drug for newer regimens under development. There are limited data on the demographic, clinical, and pathogen characteristics of PZA resistant tuberculosis. Methods: Using a retrospective cohort study design, we evaluated all PZA resistant M. tuberculosis (M.tb) and M. bovis cases reported in San Francisco from 1991 to 2011. Demographic, clinical, and molecular data were analyzed. M.tb lineage was determined for all PZA resistant strains and compared to PZA susceptible strains. Results: PZA resistance was identified in 1.8% (50 of 2,842) of mycobacterial isolates tested, corresponding to a case rate of 0.3 per 100,000 in the population. Monoresistant PZA infection was associated with the Hispanic population ([OR], 6.3; 95% [Cl], 1.97-20.16) and 48% of cases were due to M. bovis. Infection with monoresistant PZA was also associated with extrapulmonary disease ([OR], 6.0; 95% [Cl], 2.70-13.26). There was no statistically significant difference between treatment failure and mortality rates in patients infected with PZA monoresistance compared to pansusceptible controls (4% vs. 8%, p=0.51), or those with PZA and MDR resistance (PZA-MDR) compared to MDR controls (18% vs. 29%, p=0.40). PZA resistance was not associated with M.tb lineage. Conclusions: Across two decades of comprehensive epidemiologic data on tuberculosis in San Francisco County, PZA resistance was uncommon. PZA resistance caused predominantly extrapulmonary disease and was more common in Hispanics compared to other ethnicities, with nearly half the cases attributed to M. bovis. No association was found between PZA monoresistance and M.tb lineage. Treatment outcomes were not adversely influenced by the presence of PZA resistance.	[Budzik, Jonathan M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Higashi, Julie; Grinsdale, Jennifer] San Francisco Dept Publ Hlth, TB Control Unit, San Francisco, CA USA; [Jarlsberg, Leah G.; Hopewell, Phil C.; Kato-Maeda, Midori; Nahid, Payam] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Curry Int TB Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Budzik, JM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	jonathan.budzik2@ucsf.edu		Nahid, Payam/0000-0003-2811-1311; Jarlsberg, Leah/0000-0001-6548-6337	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007185] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2013, REP TUB US; [Anonymous], 2003, MMWR RECOMM REP; Conde MB, 2011, DRUG DEVELOP RES, V72, P501, DOI 10.1002/ddr.20456; de Jong BC, 2005, J CLIN MICROBIOL, V43, P3530, DOI 10.1128/JCM.43.7.3530-3532.2005; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gonzalez OY, 2003, CLIN INFECT DIS, V36, P140, DOI 10.1086/344908; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Kurbatova EV, 2013, CLIN INFECT DIS, V57, P1081, DOI 10.1093/cid/cit452; Niemann S, 2000, J CLIN MICROBIOL, V38, P152; Rhee JT, 2000, INT J TUBERC LUNG D, V4, P1111; Stoffels K, 2012, ANTIMICROB AGENTS CH, V56, P5186, DOI 10.1128/AAC.05385-11; van Deutekom H, 2004, AM J RESP CRIT CARE, V169, P806, DOI 10.1164/rccm.200306-856OC; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Yee DP, 2012, INT J TUBERC LUNG D, V16, P604, DOI 10.5588/ijtld.11.0376	17	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95645	10.1371/journal.pone.0095645	http://dx.doi.org/10.1371/journal.pone.0095645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759760	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200072
J	Petrlova, J; Dalla-Riva, J; Morgelin, M; Lindahl, M; Krupinska, E; Stenkula, KG; Voss, JC; Lagerstedt, JO				Petrlova, Jitka; Dalla-Riva, Jonathan; Morgelin, Matthias; Lindahl, Maria; Krupinska, Ewa; Stenkula, Karin G.; Voss, John C.; Lagerstedt, Jens O.			Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; DENSITY LIPOPROTEIN CHOLESTEROL; RANDOMIZED CONTROLLED-TRIAL; CORONARY ATHEROSCLEROSIS; MICE; COMPONENTS; TRANSPORT; MUTATION; CARRIERS; FIBRILS	Apolipoprotein A-I (apoA-I) is the main protein of high-density lipoprotein (HDL) and a principal mediator of the reverse cholesterol transfer pathway. Variants of apoA-I have been shown to be associated with hereditary amyloidosis. We previously characterized the G26R and L178H variants that both possess decreased stability and increased fibril formation propensity. Here we investigate the Milano variant of apoAI (R173C; apoAI-M), which despite association with low plasma levels of HDL leads to low prevalence of cardiovascular disease in carriers of this mutation. The R173C substitution is located to a region (residues 170 to 178) that contains several fibrillogenic apoA-I variants, including the L178H variant, and therefore we investigated a potential fibrillogenic property of the apoAI-M protein. Despite the fact that apoAI-M shared several features with the L178H variant regarding increased helical content and low degree of ThT binding during prolonged incubation in physiological buffer, our electron microscopy analysis revealed no formation of fibrils. These results suggest that mutations inducing secondary structural changes may be beneficial in cases where fibril formation does not occur.	[Petrlova, Jitka; Dalla-Riva, Jonathan; Lindahl, Maria; Krupinska, Ewa; Stenkula, Karin G.; Lagerstedt, Jens O.] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Infect Med, Lund, Sweden; [Voss, John C.] Univ Calif Davis, Sch Med, Davis, CA 95616 USA	Lund University; Lund University; University of California System; University of California Davis	Lagerstedt, JO (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	jens.lagerstedt@med.lu.se	Lagerstedt, Jens/AAF-9567-2021	Lagerstedt, Jens/0000-0002-4313-2666; Stenkula, Karin/0000-0002-0739-1150; Voss, John/0000-0001-9279-209X	Swedish Research council [522-2008-3724, 7480]; NIH [HL77268]; Wenner-Gren foundations; Crafoord foundation; Petrus and Augusta Hedlund foundation; Greta and Johan Kocks foundation; Gyllenstierna Krapperup's foundation; Magnus Bergwall foundation; Ake Wiberg foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077268] Funding Source: NIH RePORTER	Swedish Research council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren foundations; Crafoord foundation; Petrus and Augusta Hedlund foundation; Greta and Johan Kocks foundation; Gyllenstierna Krapperup's foundation; Magnus Bergwall foundation; Ake Wiberg foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Swedish Research council (522-2008-3724, 7480), NIH (HL77268), the Wenner-Gren foundations, the Crafoord foundation, the Petrus and Augusta Hedlund foundation, the Greta and Johan Kocks foundation, the Gyllenstierna Krapperup's foundation, the Magnus Bergwall foundation and the Ake Wiberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ET, 2009, J LIPID RES, V50, P1409, DOI 10.1194/jlr.M800578-JLR200; Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Cho KH, 2006, EUR J CLIN INVEST, V36, P875, DOI 10.1111/j.1365-2362.2006.01737.x; de Sousa MM, 2000, AM J PATHOL, V156, P1911, DOI 10.1016/S0002-9440(10)65064-X; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Favari E, 2007, J BIOL CHEM, V282, P5125, DOI 10.1074/jbc.M609336200; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gomaraschi M, 2007, CIRCULATION, V116, P2165, DOI 10.1161/CIRCULATIONAHA.107.705657; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Ibanez B, 2012, ATHEROSCLEROSIS, V220, P72, DOI 10.1016/j.atherosclerosis.2011.10.006; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kaul S, 2004, J AM COLL CARDIOL, V44, P1311, DOI 10.1016/j.jacc.2004.06.028; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lee-Rueckert M, 2006, ATHEROSCLEROSIS, V189, P8, DOI 10.1016/j.atherosclerosis.2006.02.014; Moore RE, 2005, CIRC RES, V97, P763, DOI 10.1161/01.RES.0000185320.82962.F7; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Shah PK, 1998, CIRCULATION, V97, P780, DOI 10.1161/01.CIR.97.8.780; Sirtori CR, 2001, CIRCULATION, V103, P1949; Sriram R, 2011, NMR BIOMED, V24, P916, DOI 10.1002/nbm.1650; Suurkuusk M, 1999, EUR J BIOCHEM, V265, P346, DOI 10.1046/j.1432-1327.1999.00739.x; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2508; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zehender F, 2012, BIOCHEMISTRY-US, V51, P1269, DOI 10.1021/bi2013799	31	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96150	10.1371/journal.pone.0096150	http://dx.doi.org/10.1371/journal.pone.0096150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755625	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300142
J	Tian, JW; Cheng, JC; Zhang, JZ; Ye, L; Zhang, FX; Dong, QJ; Wang, HB; Fu, FH				Tian, Jingwei; Cheng, Jucan; Zhang, Jianzhao; Ye, Liang; Zhang, Fangxi; Dong, Qiuju; Wang, Hongbo; Fu, Fenghua			Protection of Pyruvate against Glutamate Excitotoxicity Is Mediated by Regulating DAPK1 Protein Complex	PLOS ONE			English	Article							BCL-X-L; CYTOCHROME-C RELEASE; BECLIN 1; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; CASPASE ACTIVATION; SIGNALING PATHWAY; NMDA RECEPTOR; BRAIN-DAMAGE; AUTOPHAGY	The neuroprotective activity of pyruvate has been confirmed in previous in vivo and in vitro studies. Here, we report a novel mechanism that pyruvate prevents SH-SY5Y cells from glutamate excitotoxicity by regulating death-associated protein kinase 1 (DAPK1) protein complex. Our results showed pyruvate regulated DAPK1 protein complex to protect cells by two ways. First, pyruvate induced the dissociation of DAPK1 with NMDA receptors. The disruption of the DAPK1-NMDA receptors complex resulted in a decrease in NMDA receptors phosphorylation. Then the glutamate-stimulated Ca2+ influx was inhibited and intracellular Ca2+ overload was alleviated, which blocked the release of cytochrome c and cell death. In addition, increased Bcl-xL induced by pyruvate regulated Bax/Bak dependent death by inhibiting the release of cytochrome c from the mitochondrial inter-membrane space into the cytosol. As a result, the cytochrome c-initiated caspase cascade, including caspase-3 and caspase-9, was inhibited. Second, pyruvate promoted the association between DAPK1 and Beclin-1, which resulted in autophagy activation. The autophagy inhibitor 3-methyladenine reversed the protection afforded by pyruvate. Furthermore, the attenuation of mitochondrial damage induced by pyruvate was partly reduced by 3-methyladenine. This suggested autophagy mediated pyruvate protection by preventing mitochondrial damage. Taken together, pyruvate protects cells from glutamate excitotoxicity by regulating DAPK1 complexes, both through dissociation of DAPK1 from NMDA receptors and association of DAPK1 with Beclin-1. They go forward to protect cells by attenuating Ca2+ overload and activating autophagy. Finally, a convergence of the two ways protects mitochondria from glutamate excitotoxicity, which leads to cell survival.	[Tian, Jingwei; Cheng, Jucan; Zhang, Jianzhao; Ye, Liang; Zhang, Fangxi; Dong, Qiuju; Wang, Hongbo; Fu, Fenghua] Yantai Univ, Sch Pharm, Minist Educ China, Key Lab Mol Pharmacol & Drug Evaluat, Yantai, Peoples R China	Ministry of Education, China; Yantai University	Zhang, JZ (corresponding author), Yantai Univ, Sch Pharm, Minist Educ China, Key Lab Mol Pharmacol & Drug Evaluat, Yantai, Peoples R China.	zhangjianzhao@live.cn	Tian, Jingwei/GPJ-9819-2022; 王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339	"Major New Drugs'' special projects of Ministry of Science and Technology of PR China [2013ZX09102-017, 2013ZX09402201]; National Basic Research Program of China [2012CB724003]; Taishan Scholar Project	"Major New Drugs'' special projects of Ministry of Science and Technology of PR China; National Basic Research Program of China(National Basic Research Program of China); Taishan Scholar Project	This work was supported by the "Major New Drugs'' special projects of Ministry of Science and Technology of PR China (NO. 2013ZX09102-017 and 2013ZX09402201), Taishan Scholar Project and the National Basic Research Program of China (No. 2012CB724003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENVENISTE H, 1988, ACTA NEUROL SCAND, V78, P529, DOI 10.1111/j.1600-0404.1988.tb03697.x; Blandini F, 1996, FUNCT NEUROL, V11, P3; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Desagher S, 1997, J NEUROSCI, V17, P9060; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Fernandez-Gomez FJ, 2006, NEUROBIOL DIS, V24, P296, DOI 10.1016/j.nbd.2006.07.005; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Ha JS, 2010, BRAIN RES, V1359, P291, DOI 10.1016/j.brainres.2010.08.086; Hu Y, 2012, J BIOMED BIOTECHNOL, V1, P5; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu SB, 2012, J NEUROSCI, V32, P4887, DOI 10.1523/JNEUROSCI.5828-11.2012; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LLOYD B, 1978, CLIN CHEM, V24, P1724; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Makhinson M, 1999, J NEUROSCI, V19, P2500; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Nair S, 2013, INT J MOL SCI, V14, P13858, DOI 10.3390/ijms140713858; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Peng TI, 1998, MOL PHARMACOL, V53, P974; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Rothman Steven M., 1995, Trends in Neurosciences, V18, P57, DOI 10.1016/0166-2236(95)93869-Y; Ryou MG, 2012, STROKE, V43, P1101, DOI 10.1161/STROKEAHA.111.620088; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; van Leyen K, 2005, J NEUROCHEM, V92, P824, DOI 10.1111/j.1471-4159.2004.02915.x; Wang Q, 2009, NEUROBIOL DIS, V36, P223, DOI 10.1016/j.nbd.2009.07.018; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Wang XN, 2012, J ALZHEIMERS DIS, V30, P665, DOI 10.3233/JAD-2012-101869; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WILLEMS JL, 1978, FEBS LETT, V86, P42, DOI 10.1016/0014-5793(78)80094-5; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024036; Yamauchi M, 1998, BRAIN RES, V780, P253, DOI 10.1016/S0006-8993(97)01201-8; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhang J., 2012, CHINESE J IMMUNOLOGY, V1, P7; Zhao SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073665; Zhu YS, 2010, PROTEIN CELL, V1, P468, DOI 10.1007/s13238-010-0048-4	55	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95777	10.1371/journal.pone.0095777	http://dx.doi.org/10.1371/journal.pone.0095777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755839	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300090
J	Masoumy, M; Yu, J; Liu, JY; Yanasak, N; Middleton, C; Lamoke, F; Mozaffari, MS; Baban, B				Masoumy, Mohamad; Yu, Jack; Liu, Jun Yao; Yanasak, Nathan; Middleton, Christopher; Lamoke, Folami; Mozaffari, Mahmood S.; Baban, Babak			The Role of Indoleamine 2,3 Dioxygenase in Beneficial Effects of Stem Cells in Hind Limb Ischemia Reperfusion Injury	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; MESENCHYMAL STROMAL CELLS; TOXOPLASMA-GONDII; 2,3-DIOXYGENASE; PROLIFERATION; MECHANISM; ACTIVATION; EXPRESSION; BLOCKS; GROWTH	Ischemia-Reperfusion (IR) injury of limb remains a significant clinical problem causing secondary complications and restricting clinical recovery, despite rapid restoration of blood flow and successful surgery. In an attempt to further improve post ischemic tissue repair, we investigated the effect of a local administration of bone marrow derived stem cells (BMDSCs) in the presence or absence of immune-regulatory enzyme, IDO, in a murine model. A whole limb warm ischemia-reperfusion model was developed using IDO sufficient (WT) and deficient (KO) mice with C57/BL6 background. Twenty-four hours after injury, 5 Chi 10(5) cells (5 Chi 10(5) cells/200 mu L of PBS solution) BMDSCs (Sca1 + cells) were injected intramuscularly while the control group received just the vehicle buffer (PBS). Forty-eight to seventy-two hours after limb BMDSC injection, recovery status including the ratio of intrinsic paw function between affected and normal paws, general mobility, and inflammatory responses were measured using video micrometery, flow cytometry, and immunohistochemistry techniques. Additionally, MRI/MRA studies were performed to further study the inflammatory response between groups and to confirm reconstitution of blood flow after ischemia. For the first time, our data, showed that IDO may potentially represent a partial role in triggering the beneficial effects of BMDSCs in faster recovery and protection against structural changes and cellular damage in a hind limb IR injury setting (P=0.00058).	[Masoumy, Mohamad; Yu, Jack; Baban, Babak] Georgia Regents Univ, Dept Surg, Augusta, GA 30904 USA; [Liu, Jun Yao; Mozaffari, Mahmood S.; Baban, Babak] Georgia Regents Univ, Dept Oral Biol, Augusta, GA USA; [Yanasak, Nathan] Georgia Regents Univ, Dept Radiol & Imaging, Augusta, GA USA; [Middleton, Christopher] Georgia Regents Univ, Ctr Canc, Augusta, GA USA; [Lamoke, Folami] Georgia Regents Univ, Dept Ophthalmol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Baban, B (corresponding author), Georgia Regents Univ, Dept Surg, Augusta, GA 30904 USA.	bbaban@gru.edu	Yanasak, Nathan/CAG-5116-2022		institutional funds; Milford B. Hatcher Endowment	institutional funds; Milford B. Hatcher Endowment	This study was supported by institutional funds (provided to BB) and the Milford B. Hatcher Endowment (provided to JY). The authors are grateful to Mrs. Michelle Barnes for her administrative support.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Baban B, 2012, AM J PHYSIOL-REG I, V303, pR1136, DOI 10.1152/ajpregu.00315.2012; Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Casado FL, 2011, MOL PHARMACOL, V80, P673, DOI 10.1124/mol.111.071381; Castillo M, 2007, INT J BIOMED SCI, V3, P76; Cogle CR, 2003, MAYO CLIN PROC, V78, P993; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Daubener W, 2001, INFECT IMMUN, V69, P6527, DOI 10.1128/IAI.69.10.6527-6531.2001; Dazzi F, 2012, IMMUNOLOGY, V137, P206, DOI 10.1111/j.1365-2567.2012.03621.x; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Harizi H, 2006, CELL MOL IMMUNOL, V3, P271; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Lee JY, 2013, PLAST RECONSTR SURG, V132, P1173, DOI 10.1097/PRS.0b013e3182a3bfeb; Li Ming, 2013, J BONE MARROW RES, V1, P4; Matysiak M, 2008, J NEUROIMMUNOL, V193, P12, DOI 10.1016/j.jneuroim.2007.07.025; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Mellor AL, 2003, ADV EXP MED BIOL, V527, P27; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Milwid JM, 2012, STEM CELLS INT, V2012; Munn DH, 2006, CURR OPIN IMMUNOL, V18, P220, DOI 10.1016/j.coi.2006.01.002; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang HY, 2012, CELL IMMUNOL, V272, P112, DOI 10.1016/j.cellimm.2011.10.010; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95720	10.1371/journal.pone.0095720	http://dx.doi.org/10.1371/journal.pone.0095720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752324	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400108
J	Palacios-Ortega, S; Varela-Guruceaga, M; Milagro, FI; Martinez, JA; de Miguel, C				Palacios-Ortega, Sara; Varela-Guruceaga, Maider; Ignacio Milagro, Fermin; Alfredo Martinez, Jose; de Miguel, Carlos			Expression of Caveolin 1 Is Enhanced by DNA Demethylation during Adipocyte Differentiation. Status of Insulin Signaling	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; WHITE ADIPOSE-TISSUE; HIGH-FAT DIET; GENE-EXPRESSION; CAVEOLIN-1-DEFICIENT MICE; TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; GLUCOSE-UPTAKE; PPAR-GAMMA; METHYLATION	Caveolin 1 (Cav-1) is an essential constituent of adipocyte caveolae which binds the beta subunit of the insulin receptor (IR) and is implicated in the regulation of insulin signaling. We have found that, during adipocyte differentiation of 3T3-L1 cells the promoter, exon 1 and first intron of the Cav-1 gene undergo a demethylation process that is accompanied by a strong induction of Cav-1 expression, indicating that epigenetic mechanisms must have a pivotal role in this differentiation process. Furthermore, IR, PKB-Akt and Glut-4 expression are also increased during the differentiation process suggesting a coordinated regulation with Cav-1. Activation of Cav-1 protein by phosphorylation arises during the differentiation process, yet in fully mature adipocytes insulin is no longer able to significantly increase Cav-1 phosphorylation. However, these long-term differentiated cells are still able to respond adequately to insulin, increasing IR and PKB-Akt phosphorylation and glucose uptake. The activation of Cav-1 during the adipocyte differentiation process could facilitate the maintenance of insulin sensitivity by these fully mature adipocytes isolated from additional external stimuli. However, under the influence of physiological conditions associated to obesity, such as chronic inflammation and hypoxia, insulin sensitivity would finally be compromised.	[Palacios-Ortega, Sara; Varela-Guruceaga, Maider; de Miguel, Carlos] Univ Navarra, Dept Biochem & Genet, E-31080 Pamplona, Spain; [Ignacio Milagro, Fermin; Alfredo Martinez, Jose] Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain; [Ignacio Milagro, Fermin; Alfredo Martinez, Jose; de Miguel, Carlos] Carlos III Hlth Res Inst, Physiopathol Obes & Nutr CIBERobn, Madrid, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	de Miguel, C (corresponding author), Univ Navarra, Dept Biochem & Genet, E-31080 Pamplona, Spain.	cdmiguel@unav.es	de Miguel, Carlos/H-2153-2011; Milagro, Fermin/F-2315-2015; Martinez Hernandez, J Alfredo/K-8709-2014	de Miguel, Carlos/0000-0003-4655-5856; Milagro, Fermin/0000-0002-3228-9916; Martinez Hernandez, J Alfredo/0000-0001-5218-6941; Palacios Ortega, Sara/0000-0002-7112-5009	UNAV through Linea Especial "Nutricion, Obesidad, Salud'' [LE/97]; Asociacion de Amigos de la Universidad de Navarra	UNAV through Linea Especial "Nutricion, Obesidad, Salud''; Asociacion de Amigos de la Universidad de Navarra	This study received support from UNAV through Linea Especial "Nutricion, Obesidad, Salud'' (LE/97). SPO and MVG were recipients of a predoctoral grant from the Asociacion de Amigos de la Universidad de Navarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Gomez-Ruiz A, 2010, J CELL PHYSIOL, V225, P206, DOI 10.1002/jcp.22241; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; Kimura A, 2002, J BIOL CHEM, V277, P30153, DOI 10.1074/jbc.M203375200; Kotokorpi P, 2007, MOL PHARMACOL, V72, P947, DOI 10.1124/mol.107.037358; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lomba A, 2010, MOL GENET METAB, V101, P273, DOI 10.1016/j.ymgme.2010.07.017; Lopez IP, 2004, BIOCHEM BIOPH RES CO, V318, P234, DOI 10.1016/j.bbrc.2004.04.018; Lopez IP, 2005, MOL CELL BIOCHEM, V275, P109, DOI 10.1007/s11010-005-1082-z; Moest H, 2013, BBA-MOL CELL BIOL L, V1831, P1208, DOI 10.1016/j.bbalip.2013.04.001; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Okamura M, 2010, ORGANOGENESIS, V6, P24, DOI 10.4161/org.6.1.11121; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pettersson AML, 2013, DIABETOLOGIA, V56, P2044, DOI 10.1007/s00125-013-2954-5; Pitulis N, 2009, ANTICANCER RES, V29, P2331; Plagemann A, 2010, J PERINAT MED, V38, P393, DOI [10.1515/JPM.2010.051, 10.1515/jpm.2010.051]; Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Singh P, 2012, CIRC RES, V111, P599, DOI [10.1161/circresaha.112.273656, 10.1161/CIRCRESAHA.112.273656]; Smith RM, 1998, CELL SIGNAL, V10, P355, DOI 10.1016/S0898-6568(97)00170-8; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; Stralfors P, 2012, ADV EXP MED BIOL, V729, P111, DOI 10.1007/978-1-4614-1222-9_8; Syeed N, 2012, ASIAN PAC J CANCER P, V13, P371, DOI 10.7314/APJCP.2012.13.1.371; Tong Q, 2001, Rev Endocr Metab Disord, V2, P349, DOI 10.1023/A:1011863414321; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Tsuji Y, 2006, INT J MOL MED, V18, P489; WEILAND M, 1990, BIOCHEM J, V270, P331, DOI 10.1042/bj2700331; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xu E, 2013, REV ENDOCRINE METABO; Yang J, 2012, OBESITY, V20, P932, DOI 10.1038/oby.2011.371; Yuan T, 2007, CELL RES, V17, P772, DOI 10.1038/cr.2007.73; Zhu JG, 2012, CELL BIOCHEM BIOPHYS, V63, P1, DOI 10.1007/s12013-012-9336-3; Zschocke J, 2002, J BIOL CHEM, V277, P38772, DOI 10.1074/jbc.M205664200	49	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95100	10.1371/journal.pone.0095100	http://dx.doi.org/10.1371/journal.pone.0095100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751908	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400032
J	Smolinska, A; Klaassen, EMM; Dallinga, JW; van de Kant, KDG; Jobsis, Q; Moonen, EJC; van Schayck, OCP; Dompeling, E; van Schooten, FJ				Smolinska, Agnieszka; Klaassen, Ester M. M.; Dallinga, Jan W.; van de Kant, Kim D. G.; Jobsis, Quirijn; Moonen, Edwin J. C.; van Schayck, Onno C. P.; Dompeling, Edward; van Schooten, Frederik J.			Profiling of Volatile Organic Compounds in Exhaled Breath As a Strategy to Find Early Predictive Signatures of Asthma in Children	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; LUNG-CANCER; AGED 3; METABOLOMICS; DIAGNOSIS; CLASSIFICATION; VALIDATION; BIOMARKERS; SYMPTOMS; INFANTS	Wheezing is one of the most common respiratory symptoms in preschool children under six years old. Currently, no tests are available that predict at early stage who will develop asthma and who will be a transient wheezer. Diagnostic tests of asthma are reliable in adults but the same tests are difficult to use in children, because they are invasive and require active cooperation of the patient. A non-invasive alternative is needed for children. Volatile Organic Compounds (VOCs) excreted in breath could yield such non-invasive and patient-friendly diagnostic. The aim of this study was to identify VOCs in the breath of preschool children (inclusion at age 2-4 years) that indicate preclinical asthma. For that purpose we analyzed the total array of exhaled VOCs with Gas Chromatography time of flight Mass Spectrometry of 252 children between 2 and 6 years of age. Breath samples were collected at multiple time points of each child. Each breath-o-gram contained between 300 and 500 VOCs; in total 3256 different compounds were identified across all samples. Using two multivariate methods, Random Forests and dissimilarity Partial Least Squares Discriminant Analysis, we were able to select a set of 17 VOCs which discriminated preschool asthmatic children from transient wheezing children. The correct prediction rate was equal to 80% in an independent test set. These VOCs are related to oxidative stress caused by inflammation in the lungs and consequently lipid peroxidation. In conclusion, we showed that VOCs in the exhaled breath predict the subsequent development of asthma which might guide early treatment.	[Smolinska, Agnieszka; Dallinga, Jan W.; Moonen, Edwin J. C.; van Schooten, Frederik J.] Maastricht Univ, Dept Toxicol, Nutr & Toxicol Res Inst Maastricht NUTRIM, Maastricht, Netherlands; [Smolinska, Agnieszka] Top Inst Food & Nutr, Wageningen, Netherlands; [Klaassen, Ester M. M.; van de Kant, Kim D. G.; Jobsis, Quirijn; Dompeling, Edward] Maastricht Univ Med Ctr, Dept Pediat Pulmonol, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands; [van Schayck, Onno C. P.] Maastricht Univ Med Ctr, Dept Gen Practice, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands	Maastricht University; Top Institute Food & Nutrition; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Smolinska, A (corresponding author), Maastricht Univ, Dept Toxicol, Nutr & Toxicol Res Inst Maastricht NUTRIM, Maastricht, Netherlands.	A.Smolinska@maastrichtuniversity.nl			Top Institute Food and Nutrition [GH001]	Top Institute Food and Nutrition	This study was supported by grants from the Top Institute Food and Nutrition (TiFN GH001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler W, 2011, COMPUTATION STAT, V26, P355, DOI 10.1007/s00180-011-0249-1; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P287, DOI 10.1016/j.jaci.2012.04.025; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Boots AW, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027108; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buszewski B, 2007, BIOMED CHROMATOGR, V21, P553, DOI 10.1002/bmc.835; Caldeira M, 2012, J CHROMATOGR A, V1254, P87, DOI 10.1016/j.chroma.2012.07.023; Caldeira M, 2011, J CHROMATOGR A, V1218, P3771, DOI 10.1016/j.chroma.2011.04.026; Carraro S, 2007, AM J RESP CRIT CARE, V175, P986, DOI 10.1164/rccm.200606-769OC; Caudri D, 2010, THORAX, V65, P801, DOI 10.1136/thx.2009.126912; Crenesse D, 2001, PEDIATR PULM, V32, P56, DOI 10.1002/ppul.1089; Cristescu SM, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046009; Dallinga JW, 2010, CLIN EXP ALLERGY, V40, P68, DOI 10.1111/j.1365-2222.2009.03343.x; Daszykowski M, 2007, CHEMOMETR INTELL LAB, V85, P269, DOI 10.1016/j.chemolab.2006.03.006; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Esbensen KH, 2010, J CHEMOMETR, V24, P168, DOI 10.1002/cem.1310; Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC; Ibrahim B, 2011, THORAX, V66, P804, DOI 10.1136/thx.2010.156695; KANENGISER S, 1994, PEDIATR PULM, V18, P144, DOI 10.1002/ppul.1950180305; Karpievitch YV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007087; Kim YH, 2012, ANAL CHEM, V84, P8284, DOI 10.1021/ac301792x; Klaassen E, 2012, ALLERGY, V67, P27; KOKOSZKA J, 1993, DIS COLON RECTUM, V36, P597, DOI 10.1007/BF02049868; Malley JD, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-12; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; Miekisch W, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/3/036007; Nielsen NPV, 1998, J CHROMATOGR A, V805, P17, DOI 10.1016/S0021-9673(98)00021-1; Phillips M, 2005, J CLIN ONCOL, V23, p839S; Robroeks CMHHT, 2010, PEDIATR RES, V68, P75, DOI 10.1203/00006450-201011001-00143; Romoli R, 2011, J MASS SPECTROM, V46, P1051, DOI 10.1002/jms.1987; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Schubert JK, 2004, EXPERT REV MOL DIAGN, V4, P619, DOI 10.1586/14737159.4.5.619; Smolinska A, 2012, ANAL CHIM ACTA, V750, P82, DOI 10.1016/j.aca.2012.05.049; Smolinska A, 2012, ANAL BIOANAL CHEM, V403, P947, DOI 10.1007/s00216-012-5871-4; SNEE RD, 1977, TECHNOMETRICS, V19, P415, DOI 10.2307/1267881; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Van Berkel JJBN, 2008, J CHROMATOGR B, V861, P101, DOI 10.1016/j.jchromb.2007.11.008; Van Berkel JJBN, 2010, RESP MED, V104, P557, DOI 10.1016/j.rmed.2009.10.018; van de Kant KDG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-210; Verdam FJ, 2013, J HEPATOL, V58, P543, DOI 10.1016/j.jhep.2012.10.030; Walczak B, 2000, WAVELETS CHEM; Watson J. T., 2007, INTRO MASS SPECTROME; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; Zar HJ, 2000, ARCH DIS CHILD, V82, P305, DOI 10.1136/adc.82.4.305; Zerzucha P, 2012, CHEMOMETR INTELL LAB, V110, P156, DOI 10.1016/j.chemolab.2011.11.005	50	90	92	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95668	10.1371/journal.pone.0095668	http://dx.doi.org/10.1371/journal.pone.0095668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752575	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400098
J	Alban, C; Tardif, M; Mininno, M; Brugiere, S; Gilgen, A; Ma, S; Mazzoleni, M; Gigarel, O; Martin-Laffon, J; Ferro, M; Ravanel, S				Alban, Claude; Tardif, Marianne; Mininno, Morgane; Brugiere, Sabine; Gilgen, Annabelle; Ma, Sheng; Mazzoleni, Meryl; Gigarel, Oceane; Martin-Laffon, Jacqueline; Ferro, Myriam; Ravanel, Stephane			Uncovering the Protein Lysine and Arginine Methylation Network in Arabidopsis Chloroplasts	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; SUBCELLULAR LOCATION; HISTONE METHYLATION; LARGE SUBUNIT; AT-CHLORO; IDENTIFICATION; METHYLTRANSFERASE	Post-translational modification of proteins by the addition of methyl groups to the side chains of Lys and Arg residues is proposed to play important roles in many cellular processes. In plants, identification of non-histone methylproteins at a cellular or subcellular scale is still missing. To gain insights into the extent of this modification in chloroplasts we used a bioinformatics approach to identify protein methyltransferases targeted to plastids and set up a workflow to specifically identify Lys and Arg methylated proteins from proteomic data used to produce the Arabidopsis chloroplast proteome. With this approach we could identify 31 high-confidence Lys and Arg methylation sites from 23 chloroplastic proteins, of which only two were previously known to be methylated. These methylproteins are split between the stroma, thylakoids and envelope sub-compartments. They belong to essential metabolic processes, including photosynthesis, and to the chloroplast biogenesis and maintenance machinery (translation, protein import, division). Also, the in silico identification of nine protein methyltransferases that are known or predicted to be targeted to plastids provided a foundation to build the enzymes/substrates relationships that govern methylation in chloroplasts. Thereby, using in vitro methylation assays with chloroplast stroma as a source of methyltransferases we confirmed the methylation sites of two targets, plastid ribosomal protein L11 and the beta-subunit of ATP synthase. Furthermore, a biochemical screening of recombinant chloroplastic protein Lys methyltransferases allowed us to identify the enzymes involved in the modification of these substrates. The present study provides a useful resource to build the methyltransferases/methylproteins network and to elucidate the role of protein methylation in chloroplast biology.	[Alban, Claude; Mininno, Morgane; Gilgen, Annabelle; Ma, Sheng; Mazzoleni, Meryl; Gigarel, Oceane; Martin-Laffon, Jacqueline; Ravanel, Stephane] Univ Grenoble Alpes, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Alban, Claude; Mininno, Morgane; Gilgen, Annabelle; Ma, Sheng; Mazzoleni, Meryl; Gigarel, Oceane; Martin-Laffon, Jacqueline; Ravanel, Stephane] CNRS, UMR5168, Grenoble, France; [Alban, Claude; Mininno, Morgane; Gilgen, Annabelle; Ma, Sheng; Mazzoleni, Meryl; Gigarel, Oceane; Martin-Laffon, Jacqueline; Ravanel, Stephane] CEA, Lab Physiol Cellulaire & Vegetale, iRTSV, Grenoble, France; [Alban, Claude; Mininno, Morgane; Gilgen, Annabelle; Ma, Sheng; Mazzoleni, Meryl; Gigarel, Oceane; Martin-Laffon, Jacqueline; Ravanel, Stephane] INRA, USC1359, Grenoble, France; [Tardif, Marianne; Brugiere, Sabine; Ferro, Myriam] Univ Grenoble Alpes, Grenoble, France; [Tardif, Marianne; Brugiere, Sabine; Ferro, Myriam] CEA, iRTSV, Grenoble, France; [Tardif, Marianne; Brugiere, Sabine; Ferro, Myriam] INSERM, U1038, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ravanel, S (corresponding author), Univ Grenoble Alpes, Lab Physiol Cellulaire & Vegetale, Grenoble, France.	stephane.ravanel@cea.fr	FERRO, Myriam/O-6588-2014; MARTIN-LAFFON, Jacqueline/P-3062-2016; Alban, Claude/ABG-2296-2021; Tardif, Marianne/AAA-5357-2019	FERRO, Myriam/0000-0002-4222-6847; Tardif, Marianne/0000-0003-4438-8281; Ravanel, Stephane/0000-0001-9475-4222; Sabine, BRUGIERE/0000-0002-0757-0968; MARTIN-LAFFON, Jacqueline/0000-0002-0593-8626; Alban, Claude/0000-0003-3587-6339	Department of Plant Biology INRA; Cluster 9 of the Region Rhone-Alpes; French National Research Agency [ANR-2010-BLAN-1610-01 Chloro-Pro]; Proteomics French Infrastructure (ProFI) [ANR-10-INBS-08-01]; French Ministry of Higher Education and Research	Department of Plant Biology INRA; Cluster 9 of the Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); French National Research Agency(French National Research Agency (ANR)); Proteomics French Infrastructure (ProFI); French Ministry of Higher Education and Research	This study received financial support from the Department of Plant Biology INRA, the Cluster 9 of the Region Rhone-Alpes, the French National Research Agency (ANR-2010-BLAN-1610-01 Chloro-Pro), and the Proteomics French Infrastructure (ProFI; ANR-10-INBS-08-01). This work was supported by a PhD fellowship (to M. Mininno) funded by the French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, J GENET GENOMICS, V39, P195, DOI 10.1016/j.jgg.2012.04.001; Baginsky S, 2009, MOL PLANT, V2, P1141, DOI 10.1093/mp/ssp058; Banerjee J, 2013, PLANT CELL, V25, P4493, DOI 10.1105/tpc.113.119115; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BLACK MT, 1987, J BIOL CHEM, V262, P9803; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; Bruley C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00205; Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006; Chen H, 2006, NUCLEIC ACIDS RES, V34, pW249, DOI 10.1093/nar/gkl233; CHEN ZG, 1992, FEBS LETT, V298, P69, DOI 10.1016/0014-5793(92)80024-B; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; DECOTTIGNIES P, 1995, ARCH BIOCHEM BIOPHYS, V316, P249, DOI 10.1006/abbi.1995.1035; Dirk LMA, 2006, ENZYMES, V24, P179, DOI 10.1016/S1874-6047(06)80009-0; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Egorova KS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P535, DOI 10.1134/S0006297910050019; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Erales J, 2008, FEBS J, V275, P1248, DOI 10.1111/j.1742-4658.2008.06284.x; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Grimm R, 1997, FEBS LETT, V408, P350, DOI 10.1016/S0014-5793(97)00462-6; HOUTZ RL, 1992, PLANT PHYSIOL, V98, P1170, DOI 10.1104/pp.98.3.1170; HOUTZ RL, 1989, P NATL ACAD SCI USA, V86, P1855, DOI 10.1073/pnas.86.6.1855; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; KAMP RM, 1987, BIOCHEMISTRY-US, V26, P5866, DOI 10.1021/bi00392a043; Kaundal R, 2010, PLANT PHYSIOL, V154, P36, DOI 10.1104/pp.110.156851; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Li KK, 2012, MED RES REV, V32, P815, DOI 10.1002/mrr.20228; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Lopez-Valenzuela JA, 2003, PLANT PHYSIOL, V133, P1285, DOI 10.1104/pp.103.027854; Lott K, 2013, J PROTEOMICS, V91, P210, DOI 10.1016/j.jprot.2013.07.010; Low JKK, 2013, J PROTEOME RES, V12, P3884, DOI 10.1021/pr400556c; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Mininno M, 2012, J BIOL CHEM, V287, P21034, DOI 10.1074/jbc.M112.359976; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; NIEMI KJ, 1990, PLANT PHYSIOL, V93, P1235, DOI 10.1104/pp.93.3.1235; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; Salvi Daniel, 2008, V432, P19, DOI 10.1007/978-1-59745-028-7_2; Schwartz D, 2012, ESSAYS BIOCHEM, V52, P165, DOI [10.1042/bse0520165, 10.1042/BSE0520165]; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Shi SP, 2012, MOL BIOSYST, V8, P1520, DOI 10.1039/c2mb05502c; Shi SP, 2012, PLOS ONE, V7; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; Steiner S, 2011, PLANT PHYSIOL, V157, P1043, DOI 10.1104/pp.111.184515; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; van Wijk KJ, 2011, PLANT PHYSIOL, V155, P1578, DOI 10.1104/pp.111.172932; VANET A, 1994, MOL MICROBIOL, V14, P947, DOI 10.1111/j.1365-2958.1994.tb01330.x; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200; Zaffagnini M, 2012, PLANT SCI, V185, P86, DOI 10.1016/j.plantsci.2012.01.005; Zhang LS, 2012, NEW PHYTOL, V195, P248, DOI 10.1111/j.1469-8137.2012.04143.x; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	70	32	32	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95512	10.1371/journal.pone.0095512	http://dx.doi.org/10.1371/journal.pone.0095512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748391	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500117
J	Friebe, D; Yang, T; Schmidt, T; Borg, N; Steckel, B; Ding, ZP; Schrader, J				Friebe, Daniela; Yang, Tao; Schmidt, Timo; Borg, Nadine; Steckel, Bodo; Ding, Zhaoping; Schrader, Juergen			Purinergic Signaling on Leukocytes Infiltrating the LPS-Injured Lung	PLOS ONE			English	Article							T-CELL-ACTIVATION; ATP RELEASE; ADENOSINE RECEPTORS; P2X(7) RECEPTORS; ADP-RIBOSYLATION; SURFACE-PROTEINS; MECHANISMS; CD73; INFLAMMATION; NEUTROPHILS	Extracellular nucleotides and nucleosides have been implicated as important signaling molecules in the pathogenesis of acute lung injury (ALI). While adenosine is known to inhibit T cell activation, little information is available as to ATP and NAD degrading enzymes, the expression of ATP and adenosine receptors/transporters in different T cell subsets. ALI was induced by challenging mice with intra-tracheal instillation of 60 mu l (3 mu g/g) LPS. After 3 d and 7 d blood, lung tissue and bronchoalveolar lavage was collected and immune cells were analyzed using flow cytometry. The transcriptional phenotype of T helper cells, cytotoxic and regulatory T cells sorted by FACS was assessed by measuring the expression profile of 28 genes related to purinergic signaling using TaqMan Array Micro Fluidic Cards. Catabolism of ATP, NAD and cAMP by activated CD4(+) T cells was evaluated by HPLC. CD73 was found to be highly abundant on lymphoid cells with little abundance on myeloid cells, while the opposite was true for CD39. After ALI, the abundance of CD39 and CD73 significantly increased on all T cell subsets derived from lung tissue and bronchoalveolar space. Expression analysis in T cell subsets of the lung revealed ATP (Cd39, Cd73) and NAD (Cd38, Cd157, Cd296, Pc-1) degrading enzymes. However, only transcription of Cd38, Cd39, Cd73, Ent1 and A2a receptor was significantly upregulated after ALI in T helper cells. CD4(+) T cells from injured lung rapidly metabolized extracellular ATP to AMP and adenosine but not NAD or cAMP. These findings show that lung T cells - the dominant cell fraction in the later phase of ALI - exhibit a unique expression pattern of purinergic signaling molecules. Adenosine is formed by T cells at an enhanced rate from ATP but not from NAD and together with upregulated A2a receptor is likely to modulate the healing process after acute lung injury.	[Friebe, Daniela; Yang, Tao; Schmidt, Timo; Borg, Nadine; Steckel, Bodo; Ding, Zhaoping; Schrader, Juergen] Univ Dusseldorf, Dept Mol Cardiol, Dusseldorf, Germany; [Yang, Tao] Second Mil Med Univ, Dept Anesthesiol & Intens Care Med, Changhai Hosp, Shanghai, Peoples R China	Heinrich Heine University Dusseldorf; Naval Medical University	Schrader, J (corresponding author), Univ Dusseldorf, Dept Mol Cardiol, Dusseldorf, Germany.	schrader@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft [SFB612]; National Natural Science Foundation of China [81101443]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Deutsche Forschungsgemeinschaft SFB612 (http://www.uni-duesseldorf.de/home/Fakultaeten/Medizin/SFB) and Dr. Tao Yang was financially supported by the National Natural Science Foundation of China (Grant No. 81101443, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apasov SG, 1999, INT IMMUNOL, V11, P179, DOI 10.1093/intimm/11.2.179; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Bernier LP, 2013, GLIA, V61, P2038, DOI 10.1002/glia.22574; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bonner F, 2013, CIRC RES, V113, P301, DOI 10.1161/CIRCRESAHA.113.300180; Bonner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034730; Chiavegatti T, 2008, BRIT J PHARMACOL, V153, P1331, DOI 10.1038/sj.bjp.0707648; Cunningham ML, 2002, TOXICOL SCI, V70, P157, DOI 10.1093/toxsci/70.2.157; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Ehrentraut H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032416; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Geiser T, 2004, ANESTH ANALG, V98, P281, DOI 10.1213/01.ANE.0000108960.44348.E8; Giannattasio G, 2011, J IMMUNOL, V187, P1486, DOI 10.4049/jimmunol.1003669; Haag F, 2007, PURINERG SIGNAL, V3, P71, DOI 10.1007/s11302-006-9038-7; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Horenstein AL, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26246; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Krebs C, 2005, J IMMUNOL, V174, P3298, DOI 10.4049/jimmunol.174.6.3298; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Manohar M, 2012, J LEUKOCYTE BIOL, V92, P787, DOI 10.1189/jlb.0312121; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Shenkar R, 1999, J IMMUNOL, V163, P954; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thiel M, 2003, MICROBES INFECT, V5, P515, DOI 10.1016/S1286-4579(03)00068-6; Tschernig T, 1999, EUR RESPIR J, V13, P66; Tsukimoto M, 2009, BIOCHEM BIOPH RES CO, V384, P512, DOI 10.1016/j.bbrc.2009.05.011; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yegutkin GG, 2011, EUR J IMMUNOL, V41, P1231, DOI 10.1002/eji.201041292; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	50	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95382	10.1371/journal.pone.0095382	http://dx.doi.org/10.1371/journal.pone.0095382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748324	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500093
J	Liu, GZ; Wang, L; Wang, Q; Zhou, GM; Wang, Y; Jiang, Q				Liu, Guanzheng; Wang, Lei; Wang, Qian; Zhou, GuangMin; Wang, Ying; Jiang, Qing			A New Approach to Detect Congestive Heart Failure Using Short-Term Heart Rate Variability Measures	PLOS ONE			English	Article							PROGRESSION; MORTALITY; POWER	Heart rate variability (HRV) analysis has quantified the functioning of the autonomic regulation of the heart and heart's ability to respond. However, majority of studies on HRV report several differences between patients with congestive heart failure (CHF) and healthy subjects, such as time-domain, frequency domain and nonlinear HRV measures. In the paper, we mainly presented a new approach to detect congestive heart failure (CHF) based on combination support vector machine (SVM) and three nonstandard heart rate variability (HRV) measures (e. g. SUM_TD, SUM_FD and SUM_IE). The CHF classification model was presented by using SVM classifier with the combination SUM_TD and SUM_FD. In the analysis performed, we found that the CHF classification algorithm could obtain the best performance with the CHF classification accuracy, sensitivity and specificity of 100%, 100%, 100%, respectively.	[Liu, Guanzheng; Wang, Qian; Zhou, GuangMin; Wang, Ying; Jiang, Qing] Sun Yat Sen Univ, Sch Engn, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Lei] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Jiang, Q (corresponding author), Sun Yat Sen Univ, Sch Engn, Guangzhou 510275, Guangdong, Peoples R China.	jqing@mail.sysu.edu.cn	Zhou, guangmin/J-6020-2013; Zhou, Guangmin/ABE-6563-2020; Wang, Lei/F-2792-2012	Zhou, Guangmin/0000-0002-3629-5686; Wang, Lei/0000-0002-7033-9806				Aksoy S, 2001, PATTERN RECOGN LETT, V22, P563, DOI 10.1016/S0167-8655(00)00112-4; Al-Angari HM, 2007, IEEE T BIO-MED ENG, V54, P1900, DOI 10.1109/TBME.2006.889772; Asyali MH, 2003, P ANN INT IEEE EMBS, V25, P200, DOI 10.1109/IEMBS.2003.1279568; Bilchick KC, 2006, J CARDIOVASC ELECTR, V17, P691, DOI 10.1111/j.1540-8167.2006.00501.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Chang CI, 2006, IEEE T GEOSCI REMOTE, V44, P1575, DOI 10.1109/TGRS.2006.864389; Dorgin M, 1994, NOMENCLATURE CRITERI; Garcia-Gonzalez MA, 2009, IEEE T BIO-MED ENG, V56, P345, DOI 10.1109/TBME.2008.2005951; GUZZETTI S, 1995, EUR HEART J, V16, P1100, DOI 10.1093/oxfordjournals.eurheartj.a061053; Guzzetti S, 2000, AUTON NEUROSCI-BASIC, V86, P114, DOI 10.1016/S1566-0702(00)00239-3; Guzzetti S, 2001, AUTON NEUROSCI-BASIC, V90, P102, DOI 10.1016/S1566-0702(01)00274-0; Hu J, 2010, ANN BIOMED ENG, V38, P854, DOI 10.1007/s10439-009-9863-2; Isler Y, 2007, COMPUT BIOL MED, V37, P1502, DOI 10.1016/j.compbiomed.2007.01.012; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Liu GZ, 2011, TELEMED E-HEALTH, V17, P705, DOI 10.1089/tmj.2011.0022; Liu GZ, 2011, TELEMED E-HEALTH, V17, P348, DOI 10.1089/tmj.2010.0182; Moore RKG, 2004, HEART, V90, pA6; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Pecchia L, 2011, IEEE T INF TECHNOL B, V15, P40, DOI 10.1109/TITB.2010.2091647; Provost F, 1998, MACH LEARN, V30, P127, DOI 10.1023/A:1007442505281; Xue H, 2011, IEEE T NEURAL NETWOR, V22, P573, DOI 10.1109/TNN.2011.2108315	22	53	58	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93399	10.1371/journal.pone.0093399	http://dx.doi.org/10.1371/journal.pone.0093399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747432	gold, Green Submitted, Green Published			2022-12-25	WOS:000335226500006
J	Tunon, J; Cristobal, C; Tarin, N; Acena, A; Gonzalez-Casaus, ML; Huelmos, A; Alonso, J; Lorenzo, O; Gonzalez-Parra, E; Mahillo-Fernandez, I; Pello, AM; Carda, R; Farre, J; Rodriguez-Artalejo, F; Lopez-Bescos, L; Egido, J				Tunon, Jose; Cristobal, Carmen; Tarin, Nieves; Acena, Alvaro; Luisa Gonzalez-Casaus, Maria; Huelmos, Ana; Alonso, Joaquin; Lorenzo, Oscar; Gonzalez-Parra, Emilio; Mahillo-Fernandez, Ignacio; Maria Pello, Ana; Carda, Rocio; Farre, Jeronimo; Rodriguez-Artalejo, Fernando; Lopez-Bescos, Lorenzo; Egido, Jesus			Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MYOCARDIAL-INFARCTION; 25-HYDROXYVITAMIN D; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK; FGF23; COMMUNITY; CALCIFICATION; MORTALITY	Objective: Vitamin D and fibroblast growth factor-23 (FGF-23) are related with cardiovascular disorders. We have investigated the relationship of calcidiol (vitamin D metabolite) and FGF-23 plasma levels with the incidence of adverse outcomes in patients with coronary artery disease. Methods: Prospective follow-up study of 704 outpatients, attending the departments of Cardiology of four hospitals in Spain, 6-12 months after an acute coronary event. Baseline calcidiol, FGF-23, parathormone, and phosphate plasma levels were assessed. The outcome was the development of acute ischemic events (any acute coronary syndrome, stroke, or transient ischemic attack), heart failure, or death. Cox regression adjusted for the main confounders was performed. Results: Calcidiol levels showed a moderate-severe decrease in 57.3% of cases. Parathormone, FGF-23, and phosphate levels were increased in 30.0%, 11.5% and 0.9% of patients, respectively. Only 22.4% of patients had glomerular filtration rate, 60 ml/min1.73 m(2). After a mean follow-up was 2.15 +/- 0.99 years, 77 patients developed the outcome. Calcidiol (hazard ratio [HR] = 0.67; 95% confidence interval [CI] = 0.48-0.94; p = 0.021) and FGF-23 (HR = 1.13; 95% CI = 1.04-1.23; p = 0.005) plasma levels predicted independently the outcome. There was a significant interaction between calcidiol and FGF-23 levels (p = 0.025). When the population was divided according to FGF-23 levels, calcidiol still predicted the outcome independently in patients with FGF-23 levels higher than the median (HR = 0.50; 95% CI = 0.31-0.80; p = 0.003) but not in those with FGF-23 levels below this value (HR = 1.03; 95% CI = 0.62-1.71; p = 0.904). Conclusions: Abnormalities in mineral metabolism are frequent in patients with stable coronary artery disease. In this population, low calcidiol plasma levels predict an adverse prognosis in the presence of high FGF-23 levels.	[Tunon, Jose; Acena, Alvaro; Maria Pello, Ana; Carda, Rocio; Farre, Jeronimo] IIS Fdn Jimenez Diaz, Dept Cardiol, Madrid, Spain; [Tunon, Jose; Lorenzo, Oscar; Egido, Jesus] IIS Fdn Jimenez Diaz, Lab Vasc Pathol, Madrid, Spain; [Tunon, Jose; Lorenzo, Oscar; Gonzalez-Parra, Emilio; Farre, Jeronimo; Egido, Jesus] Univ Autonoma Madrid, Madrid, Spain; [Cristobal, Carmen; Alonso, Joaquin] Hosp Fuenlabrada, Dept Cardiol, Fuenlabrada, Spain; [Cristobal, Carmen; Alonso, Joaquin; Lopez-Bescos, Lorenzo] Rey Juan Carlos Univ, Alcorcon, Spain; [Tarin, Nieves] Hosp Univ Mostoles, Dept Cardiol, Madrid, Spain; [Luisa Gonzalez-Casaus, Maria] Hosp Gomez Ulla, Lab Nephrol & Mineral Metab, Madrid, Spain; [Huelmos, Ana] Hosp Univ Fdn Alcorcon, Dept Cardiol, Madrid, Spain; [Gonzalez-Parra, Emilio; Egido, Jesus] IIS Fdn Jimenez Diaz, Dept Nephrol, Madrid, Spain; [Mahillo-Fernandez, Ignacio] IIS Fdn Jimenez Diaz, Dept Epidemiol, Madrid, Spain; [Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid IdiPaz, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Rodriguez-Artalejo, Fernando] CIBERESP, Madrid, Spain; [Egido, Jesus] CIBERDEM, Madrid, Spain	Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; Autonomous University of Madrid; Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos; Alcorcon Foundation University Hospital; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Tunon, J (corresponding author), IIS Fdn Jimenez Diaz, Dept Cardiol, Madrid, Spain.	jtunon@secardiologia.es	Acena, Alvaro/AAG-4539-2021; Tunon, Jose/ABA-8847-2020; Lorenzo, Oscar/L-2526-2013; Tarín-Vicente, Nieves/O-2300-2019; Tarin-Vicente, Nieves/O-6345-2015; Tuñón, José L/R-3037-2016; Mahillo-Fernandez, Ignacio/T-2042-2018	Lorenzo, Oscar/0000-0001-5515-6078; Tarín-Vicente, Nieves/0000-0002-7335-418X; Tarin-Vicente, Nieves/0000-0002-7335-418X; Tuñón, José L/0000-0003-2220-180X; Tunon, Jose/0000-0002-1373-0999; Alonso, Joaquin J/0000-0003-4360-5897; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541; GONZALEZ CASAUS, MARIA LUISA/0000-0002-1268-7191	Fondo de Investigaciones Sanitarias [PI05/0451, PI05/1497, PI05/52475, PI05/1043, PS09/01405, PI10/00072]; Spanish Society of Cardiology; Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA [RD06/0014/0035]; Fundacion Lilly; Instituto de Salud Carlos III FEDER [RD09/0076/00101]; AbbVie Laboratories	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spanish Society of Cardiology; Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA; Fundacion Lilly; Instituto de Salud Carlos III FEDER(Instituto de Salud Carlos IIIEuropean Commission); AbbVie Laboratories(AbbVie)	This work was supported by grants from the following: Fondo de Investigaciones Sanitarias (PI05/0451, PI05/1497, PI05/52475, PI05/1043, PS09/01405, and PI10/00072): http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/convocatorias-ayudas-accion-estrategica-salud.shtml; Spanish Society of Cardiology; Spanish Heart Foundation. http://www.secardiologia.es/; Spanish Society of Arteriosclerosis. www.searteriosclerosis.org; RECAVA (RD06/0014/0035); www.recava.com; Fundacion Lilly. https://www.lilly.es/nuestra-compania/fundacion-lilly-folder; Instituto de Salud Carlos III FEDER (FJD biobank: RD09/0076/00101); http://www.isciii.es/; and AbbVie Laboratories. http://www.abbvie.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2013, KIDNEY INT, V83, P160, DOI 10.1038/ki.2012.327; Bittner V, 2012, AM HEART J, V164, P387, DOI 10.1016/j.ahj.2012.06.016; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; Brondum-Jacobsen P, 2012, ARTERIOSCL THROM VAS, V32, P2794, DOI 10.1161/ATVBAHA.112.248039; Chen WR, 2014, HEART LUNG CIRC, V23, P314, DOI 10.1016/j.hlc.2013.08.012; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Gonzalez-Parra E, 2012, NEPHROL DIAL TRANSPL, V27, piv17, DOI 10.1093/ndt/gfs534; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Heart Protection Study, 2011, LANCET, V377, P469, DOI 10.1016/S0140-6736(10)62174-5; Holick MF, 2008, CLIN J AM SOC NEPHRO, V3, P1548, DOI 10.2215/CJN.01350308; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Karakas M, 2013, J CLIN ENDOCR METAB, V98, P272, DOI 10.1210/jc.2012-2368; Kendrick J, 2012, AM J KIDNEY DIS, V60, P567, DOI 10.1053/j.ajkd.2012.04.014; Ketteler M, 2013, EUR HEART J, V34, P1099, DOI 10.1093/eurheartj/ehs247; Lavie CJ, 2011, J AM COLL CARDIOL, V58, P1547, DOI 10.1016/j.jacc.2011.07.008; Masai H, 2013, ATHEROSCLEROSIS, V226, P228, DOI 10.1016/j.atherosclerosis.2012.10.045; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Nakano C, 2012, CLIN J AM SOC NEPHRO, V7, P810, DOI 10.2215/CJN.08680811; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Scialla JJ, 2013, KIDNEY INT, V83, P1159, DOI 10.1038/ki.2013.3; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Siasos G, 2013, INT J CARDIOL, V168, P4445, DOI 10.1016/j.ijcard.2013.06.151; Syal SK, 2012, J INVASIVE CARDIOL, V24, P385; Tang WJ, 2010, CALCIFIED TISSUE INT, V86, P404, DOI 10.1007/s00223-010-9355-2; Taylor EN, 2011, AM HEART J, V161, P956, DOI 10.1016/j.ahj.2011.02.012; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Wu JM, 1996, J CLIN INVEST, V97, P1577, DOI 10.1172/JCI118582	36	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95402	10.1371/journal.pone.0095402	http://dx.doi.org/10.1371/journal.pone.0095402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748388	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500097
J	Zimmermann, B; Kohler, A				Zimmermann, Boris; Kohler, Achim			Infrared Spectroscopy of Pollen Identifies Plant Species and Genus as Well as Environmental Conditions	PLOS ONE			English	Article							PINUS-SYLVESTRIS; GERMINATION; PATTERNS; CLASSIFICATION; HYBRIDIZATION; CONSEQUENCES; POLLINATION; DISPERSAL	Background: It is imperative to have reliable and timely methodologies for analysis and monitoring of seed plants in order to determine climate-related plant processes. Moreover, impact of environment on plant fitness is predominantly based on studies of female functions, while the contribution of male gametophytes is mostly ignored due to missing data on pollen quality. We explored the use of infrared spectroscopy of pollen for an inexpensive and rapid characterization of plants. Methodology: The study was based on measurement of pollen samples by two Fourier transform infrared techniques: single reflectance attenuated total reflectance and transmission measurement of sample pellets. The experimental set, with a total of 813 samples, included five pollination seasons and 300 different plant species belonging to all principal spermatophyte clades (conifers, monocotyledons, eudicots, and magnoliids). Results: The spectroscopic-based methodology enables detection of phylogenetic variations, including the separation of confamiliar and congeneric species. Furthermore, the methodology enables measurement of phenotypic plasticity by the detection of inter-annual variations within the populations. The spectral differences related to environment and taxonomy are interpreted biochemically, specifically variations of pollen lipids, proteins, carbohydrates, and sporopollenins. The study shows large variations of absolute content of nutrients for congenital species pollinating in the same environmental conditions. Moreover, clear correlation between carbohydrate-to-protein ratio and pollination strategy has been detected. Infrared spectral database with respect to biochemical variation among the range of species, climate and biogeography will significantly improve comprehension of plant-environment interactions, including impact of global climate change on plant communities.	[Zimmermann, Boris; Kohler, Achim] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway	Norwegian University of Life Sciences	Zimmermann, B (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway.	boris.zimmermann@nmbu.no	Zimmermann, Boris/N-8297-2014; Zimmermann, Boris/GVS-6235-2022	Zimmermann, Boris/0000-0001-5046-520X; Zimmermann, Boris/0000-0001-5046-520X; Kohler, Achim/0000-0001-5759-1989	Ministry of Education, Sciences and Sports of the Republic of Croatia [098-0982904-2927]; Unity Through Knowledge Fund [92/11]; Norwegian Food Research Foundation; Research Council of Norway [199581/I10, 173321/I10]	Ministry of Education, Sciences and Sports of the Republic of Croatia; Unity Through Knowledge Fund; Norwegian Food Research Foundation; Research Council of Norway(Research Council of Norway)	The research was supported by the Ministry of Education, Sciences and Sports of the Republic of Croatia ((grant 098-0982904-2927, the Unity Through Knowledge Fund (grant 92/11), the Norwegian Food Research Foundation and the Research Council of Norway (grants 199581/I10 and 173321/I10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Benton M.J., 2009, INTRO PALEOBIOLOGY F; Blackmore S, 2007, PLANT SYST EVOL, V263, P3, DOI 10.1007/s00606-006-0464-3; Curtu AL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-218; Dell'Anna R, 2009, ANAL BIOANAL CHEM, V394, P1443, DOI 10.1007/s00216-009-2794-9; Dinis AM, 2009, PROTOPLASMA, V238, P35, DOI 10.1007/s00709-009-0071-6; Giovanetti M, 2011, B INSECTOL, V64, P77; Godoy O, 2009, ANN BOT-LONDON, V103, P485, DOI 10.1093/aob/mcn232; Gottardini E, 2007, AEROBIOLOGIA, V23, P211, DOI 10.1007/s10453-007-9065-z; Hedhly A, 2009, TRENDS PLANT SCI, V14, P30, DOI 10.1016/j.tplants.2008.11.001; Hesse M., 2009, POLLEN TERMINOLOGY; Honys D, 2003, PLANT PHYSIOL, V153, P980; ILARI JL, 1988, APPL SPECTROSC, V42, P722, DOI 10.1366/0003702884429058; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Koti S, 2005, J EXP BOT, V56, P725, DOI 10.1093/jxb/eri044; MARTENS H, 1991, J PHARMACEUT BIOMED, V9, P625, DOI 10.1016/0731-7085(91)80188-F; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Molina RT, 1996, GRANA, V35, P38, DOI 10.1080/00173139609430499; Moran EV, 2012, AM J BOT, V99, P92, DOI 10.3732/ajb.1100023; MULCAHY DL, 1979, SCIENCE, V206, P20, DOI 10.1126/science.206.4414.20; Pacini E, 1997, ANN BOT-LONDON, V80, P83, DOI 10.1006/anbo.1997.0421; Pacini E, 1996, SEX PLANT REPROD, V9, P362, DOI 10.1007/BF02441957; Pappas CS, 2003, APPL SPECTROSC, V57, P23, DOI 10.1366/000370203321165160; Piffanelli P, 1997, PLANT J, V11, P549, DOI 10.1046/j.1365-313X.1997.11030549.x; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; Rodriguez-Garcia MI, 2003, PROTOPLASMA, V221, P237, DOI 10.1007/s00709-002-0076-x; Savolainen O, 2004, FOREST ECOL MANAG, V197, P79, DOI 10.1016/j.foreco.2004.05.006; Schaeffer RN, 2013, ECOL LETT, V16, P399, DOI 10.1111/ele.12044; Schulte F, 2010, J BIOPHOTONICS, V3, P542, DOI 10.1002/jbio.201000031; Schulte F, 2009, ANAL CHEM, V81, P8426, DOI 10.1021/ac901389p; Schulte F, 2008, ANAL CHEM, V80, P9551, DOI 10.1021/ac801791a; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zimmermann B, 2010, APPL SPECTROSC, V64, P1364, DOI 10.1366/000370210793561664	42	60	63	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95417	10.1371/journal.pone.0095417	http://dx.doi.org/10.1371/journal.pone.0095417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748390	Green Published, Green Accepted, gold			2022-12-25	WOS:000335226500099
J	Greenall, SA; Donoghue, JF; Gottardo, NG; Johns, TG; Adams, TE				Greenall, S. A.; Donoghue, J. F.; Gottardo, N. G.; Johns, T. G.; Adams, T. E.			Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo	ONCOGENE			English	Article							GROWTH-FACTOR-RECEPTOR; EXTRACELLULAR DOMAIN; TARGETED THERAPIES; TYROSINE KINASES; ERYTHROPOIETIN RECEPTOR; DISULFIDE BOND; ACTIVATION; GLIOBLASTOMA; CELLS; CANCER	A feature of many gliomas is the amplification of the epidermal growth factor receptor (EGFR), resulting in its overexpression. Missense mutations or deletions within the extracellular domain are associated with this amplification and can lead to constitutive activation of the receptor, with the Domain I/II deletion, EGFRvIII, being the most common. These changes have also been associated with increased sensitivity to EGFR inhibition using small molecule inhibitors. We have expressed, in human glioma cells, EGFR containing four glioma-specific EGFR missense mutations within Domain IV (C620Y, C624F, C628Y and C636Y) to analyze their biological properties and sensitivity to EGFR inhibition. One of these mutants, C620Y, exhibited an enhanced basal phosphorylation, which was partially dependent on an EGFR-ligand autocrine loop. All Domain IV mutants responded equally as well as wildtype EGFR (wtEGFR) to ligand stimulation. Biochemical analysis revealed that a pre-formed, disulfide-bonded dimer associated with these mutations was underglycosylated, inactive and cytoplasmically retained. Ligand stimulation resulted in the formation of a tyrosine-phosphorylated, disulfide-bonded dimer for all Domain IV mutants but not for wtEGFR. Following treatment with the next-generation, irreversible pan-ErbB inhibitor dacomitinib, the C620Y, C624F and EGFRvIII mutants were inactivated, covalently dimerized and were retained in the cytoplasm, resulting in cell-surface receptor loss and, for C620Y and C624F, decreased binding of EGF. Dacomitinib treatment significantly reduced the in vivo growth of human glioma xenografts bearing C620Y, but not wtEGFR. Collectively, these data indicate that the unique biochemical traits of Domain IV EGFR cysteine mutants can be exploited for enhanced sensitivity to EGFR small molecule inhibitors, with potential clinical applications.	[Greenall, S. A.; Adams, T. E.] CSIRO, Div Mat Sci & Engn, Parkville, Vic 3052, Australia; [Donoghue, J. F.; Johns, T. G.] Monash Inst Med Res, Oncogen Signaling Lab & Brain Canc Discovery Coll, Clayton, Vic, Australia; [Gottardo, N. G.] Telethon Inst Child Hlth Res & Brain Canc Discove, Ctr Child Hlth Res, Subiaco, WA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; University of Western Australia	Greenall, SA (corresponding author), CSIRO, Div Mat Sci & Engn, 343 Royal Parade, Parkville, Vic 3052, Australia.	sameer.greenall@csiro.au	Adams, Timothy E/I-6231-2012; Johns, Terrance/C-2441-2008	Adams, Timothy E/0000-0003-3436-0066; Johns, Terrance/0000-0002-8874-4543; Donoghue, Jacqueline/0000-0003-1370-2469; Gottardo, Nicholas/0000-0002-1082-6776; Greenall, Sameer/0000-0002-1461-7111	CSIRO OCE Postdoctoral Fellowship; Cure Cancer Australia Foundation Postdoctoral Fellowship; NHMRC project [1028552, 1012020]; Victorian Government's Operational Infrastructure Support Program; Cure for Life Foundation	CSIRO OCE Postdoctoral Fellowship; Cure Cancer Australia Foundation Postdoctoral Fellowship; NHMRC project(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Cure for Life Foundation	We would like to thank Professor Antony Burgess from the Walter and Eliza Hall Institute, Melbourne, Victoria for his critical review of the manuscript. SAG is supported by a CSIRO OCE Postdoctoral Fellowship. JFD is funded by a Cure Cancer Australia Foundation Postdoctoral Fellowship. TGJ was supported by NH&MRC project grants (1028552 and 1012020), the Victorian Government's Operational Infrastructure Support Program and Cure for Life Foundation.	Abe Y, 1998, J BIOL CHEM, V273, P11150, DOI 10.1074/jbc.273.18.11150; Adams TE, 2009, GROWTH FACTORS, V27, P141, DOI 10.1080/08977190902843565; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Cvrljevic AN, 2011, J CELL SCI, V124, P2938, DOI 10.1242/jcs.083295; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Frederick L, 2000, CANCER RES, V60, P1383; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Greenall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034658; He LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00854; Idbaih A, 2009, NEUROPATH APPL NEURO, V35, P208, DOI 10.1111/j.1365-2990.2008.00977.x; Johns TG, 2005, FASEB J, V19, P780, DOI 10.1096/fj.04-1766fje; Johns TG, 2002, INT J CANCER, V98, P398, DOI 10.1002/ijc.10189; Laisney JAGC, 2013, ONCOGENE, V32, P2403, DOI 10.1038/onc.2012.267; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Li L, 2014, ONCOGENE, V33, P4253, DOI 10.1038/onc.2013.400; Lichtner RB, 2001, CANCER RES, V61, P5790; Macdonald J, 2006, BBA-MOL CELL RES, V1763, P870, DOI 10.1016/j.bbamcr.2006.05.002; Mangasarian K, 1997, J CELL PHYSIOL, V172, P117, DOI 10.1002/(SICI)1097-4652(199707)172:1<117::AID-JCP13>3.3.CO;2-S; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pillay V, 2009, NEOPLASIA, V11, P448, DOI 10.1593/neo.09230; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Ymer Susie I, 2011, Cancers (Basel), V3, P2032, DOI 10.3390/cancers3022032; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411	39	17	18	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1658	1666		10.1038/onc.2014.106	http://dx.doi.org/10.1038/onc.2014.106			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24747966				2022-12-25	WOS:000351848400006
J	Bamford, RA; Zhao, ZY; Hotchin, NA; Styles, IB; Nash, GB; Tucker, JHR; Bicknell, R				Bamford, Rosemary A.; Zhao, Zheng-yun; Hotchin, Neil A.; Styles, Iain B.; Nash, Gerard B.; Tucker, James H. R.; Bicknell, Roy			Electroporation and Microinjection Successfully Deliver Single-Stranded and Duplex DNA into Live Cells as Detected by FRET Measurements	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; NUCLEIC-ACID HYBRIDIZATION; MOLECULAR BEACONS; LIVING CELLS; INTRACELLULAR DELIVERY; MESSENGER-RNA; IN-VIVO; FLUORESCENCE; PROBES; ANTISENSE	Forster resonance energy transfer (FRET) technology relies on the close proximity of two compatible fluorophores for energy transfer. Tagged (Cy3 and Cy5) complementary DNA strands forming a stable duplex and a doubly-tagged single strand were shown to demonstrate FRET outside of a cellular environment. FRET was also observed after transfecting these DNA strands into fixed and live cells using methods such as microinjection and electroporation, but not when using lipid based transfection reagents, unless in the presence of the endosomal acidification inhibitor bafilomycin. Avoiding the endocytosis pathway is essential for efficient delivery of intact DNA probes into cells.	[Bamford, Rosemary A.] Univ Birmingham, PSIBS Doctoral Training Ctr, Birmingham B15 2TT, W Midlands, England; [Zhao, Zheng-yun; Tucker, James H. R.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England; [Hotchin, Neil A.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Styles, Iain B.] Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England; [Nash, Gerard B.] Univ Birmingham, Sch Clin & Expt Med, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Bicknell, Roy] Univ Birmingham, Inst Biomed Res, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Tucker, JHR (corresponding author), Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England.	j.tucker@bham.ac.uk; r.bicknell@bham.ac.uk	Tucker, James/F-8641-2018; Nash, Gerard B/E-4182-2010	Tucker, James/0000-0001-7645-0815; Nash, Gerard B/0000-0002-5935-2831; Styles, Iain/0000-0002-6755-0299; Hotchin, Neil/0000-0002-1844-7607; Bicknell, Roy/0000-0002-0941-8919	EPSRC Leadership Fellowship [EP/G007578/1]; EPSRC PSIBS Doctoral Centre [EP/F50053X/1]; EPSRC [EP/G007578/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G007578/1, 965052] Funding Source: researchfish	EPSRC Leadership Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC PSIBS Doctoral Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EPSRC Leadership Fellowship [grant number EP/G007578/1 to JHRT] and EPSRC PSIBS Doctoral Centre [grant number EP/F50053X/1 to RAB]. (EPSRC http://www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Bao G, 2009, ANNU REV BIOMED ENG, V11, P25, DOI 10.1146/annurev-bioeng-061008-124920; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; CARDULLO RA, 1988, P NATL ACAD SCI USA, V85, P8790, DOI 10.1073/pnas.85.23.8790; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chesnoy S, 2000, ANNU REV BIOPH BIOM, V29, P27, DOI 10.1146/annurev.biophys.29.1.27; CLEGG RM, 1993, P NATL ACAD SCI USA, V90, P2994, DOI 10.1073/pnas.90.7.2994; Dahan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072389; DIACUMAKOS EG, 1973, P NATL ACAD SCI USA, V70, P3382, DOI 10.1073/pnas.70.12.3382; Dokka S, 2000, ADV DRUG DELIVER REV, V44, P35, DOI 10.1016/S0169-409X(00)00082-X; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Emig M, 1999, LEUKEMIA, V13, P1825, DOI 10.1038/sj.leu.2401566; Endoh T, 2009, ADV DRUG DELIVER REV, V61, P704, DOI 10.1016/j.addr.2009.04.005; FISHER TL, 1993, NUCLEIC ACIDS RES, V21, P3857, DOI 10.1093/nar/21.16.3857; FORSTER T, 1946, NATURWISSENSCHAFTEN, V33, P166, DOI 10.1007/BF00585226; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; Jothikumar P, 2009, BIOTECHNIQUES, V46, P519, DOI 10.2144/000113127; Karadag A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh059; Lakowicz J, 2006, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]; LEONETTI JP, 1991, P NATL ACAD SCI USA, V88, P2702, DOI 10.1073/pnas.88.7.2702; Manchester J, 2012, J AM CHEM SOC, V134, P10791, DOI 10.1021/ja304205m; Masuko M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e34; MERGNY JL, 1994, NUCLEIC ACIDS RES, V22, P920, DOI 10.1093/nar/22.6.920; Mhlanga MM, 2001, METHODS, V25, P463, DOI 10.1006/meth.2001.1269; MORRISON LE, 1989, ANAL BIOCHEM, V183, P231, DOI 10.1016/0003-2697(89)90473-9; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nitin N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh063; Okabe K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1196; Paillasson S, 1997, EXP CELL RES, V231, P226, DOI 10.1006/excr.1996.3464; PASTAN IH, 1981, SCIENCE, V214, P504, DOI 10.1126/science.6170111; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Price N., 1999, FUNDAMENTALS ENZYMOL; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Sapsford KE, 2006, ANGEW CHEM INT EDIT, V45, P4562, DOI 10.1002/anie.200503873; SIXOU S, 1994, NUCLEIC ACIDS RES, V22, P662, DOI 10.1093/nar/22.4.662; Sokol DL, 1998, P NATL ACAD SCI USA, V95, P11538, DOI 10.1073/pnas.95.20.11538; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Tsuji A, 2000, BIOPHYS J, V78, P3260, DOI 10.1016/S0006-3495(00)76862-7; Tsuji A, 2001, BIOPHYS J, V81, P501, DOI 10.1016/S0006-3495(01)75717-7; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Uchiyama H, 1996, J BIOL CHEM, V271, P380, DOI 10.1074/jbc.271.1.380; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280; Zhang Y, 2008, BIOESSAYS, V30, P606, DOI 10.1002/bies.20759	49	10	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95097	10.1371/journal.pone.0095097	http://dx.doi.org/10.1371/journal.pone.0095097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755680	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300027
J	Lambert, AA; Drummond, MB; Mehta, SH; Brown, TT; Lucas, GM; Kirk, GD; Estrella, MM				Lambert, Allison A.; Drummond, M. Bradley; Mehta, Shruti H.; Brown, Todd T.; Lucas, Gregory M.; Kirk, Gregory D.; Estrella, Michelle M.			Risk Factors for Vitamin D Deficiency among HIV-Infected and Uninfected Injection Drug Users	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; BONE-MINERAL DENSITY; D SUPPLEMENTATION; CALCIUM SUPPLEMENTATION; SEASONAL-VARIATION; CUTANEOUS SYNTHESIS; CONTROLLED-TRIAL; BINDING-PROTEIN; MUSCLE STRENGTH; HIGH PREVALENCE	Introduction: Vitamin D deficiency is highly prevalent and is associated with bone disease, cardiovascular disease, metabolic syndrome and malignancy. Injection drug users (IDUs), with or without HIV infection, are at risk for these conditions; however, limited data on vitamin D deficiency exist in this population. We determined the prevalence and correlates of vitamin D deficiency among urban IDUs in the AIDS Linked to the IntraVenous Experience (ALIVE) Study cohort. Methods: For this cross-sectional sub-study, vitamin D deficiency was defined as a serum 25(OH)-vitamin D level <20 ng/mL. Multivariable logistic regression was used to identify factors independently associated with vitamin D deficiency. Results: Of 950 individuals analyzed, 29% were HIV-infected. The median age was 49 years; 65% were male, and 91% were black. The median vitamin D level was 13.5 ng/mL (IQR, 9.0-20.3); 74% were deficient (68% in HIV-infected vs. 76% in HIV-uninfected, p = 0.01). Non-black race, fall/winter season, multivitamin intake, higher serum albumin, HCV seropositivity and HIV-infection were associated with significantly lower odds of vitamin D deficiency. Conclusions: Vitamin D deficiency is prevalent among IDUs. Notably, HIV-infected IDUs were less likely to be vitamin D deficient. Higher vitamin D levels were associated with multivitamin intake and with higher albumin levels, suggesting that nutritional status contributes substantially to deficiency. The association between HCV serostatus and vitamin D level remains unclear. Further investigation is needed to define the clinical implications of the heavy burden of vitamin D deficiency in this high-risk, aging population with significant co-morbidities.	[Lambert, Allison A.; Drummond, M. Bradley] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21218 USA; [Mehta, Shruti H.; Kirk, Gregory D.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Brown, Todd T.] Johns Hopkins Univ, Dept Med, Div Endocrinol & Metab, Baltimore, MD USA; [Lucas, Gregory M.; Kirk, Gregory D.] Johns Hopkins Univ, Dept Med, Div Infect Dis, Baltimore, MD USA; [Estrella, Michelle M.] Johns Hopkins Univ, Dept Med, Div Nephrol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lambert, AA (corresponding author), Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21218 USA.	alamber5@jhmi.edu		Drummond, Michael/0000-0002-6968-4610	National Institutes of Health, National Institute on Drug Abuse (NIDA) [R01-DA-04334, R01-DA-12568]; Tufts University Nutrition Collaborative; Center for Drug Abuse and AIDS Research; NIDA [P30 DA13868, P30 AI094189, K24 DA035684, R01-DA-026770]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL103192, U01HL121814, T32HL007534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012568, K24DA035684, R01DA004334, U01DA036297, R01DA026770, P30DA013868] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Tufts University Nutrition Collaborative; Center for Drug Abuse and AIDS Research; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institutes of Health, National Institute on Drug Abuse (NIDA) Grants R01-DA-04334 and R01-DA-12568 and also by NIDA Grant P30 DA13868, P30 AI094189 and K24 DA035684, the Tufts University Nutrition Collaborative and the Center for Drug Abuse and AIDS Research. GML is supported by NIDA Grant R01-DA-026770. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi OM, 2011, JAIDS-J ACQ IMM DEF, V57, P197, DOI 10.1097/QAI.0b013e31821ae418; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Annweiler C, 2009, J NUTR HEALTH AGING, V13, P893, DOI 10.1007/s12603-009-0248-x; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Bailey BA, 2012, J RURAL HEALTH, V28, P356, DOI 10.1111/j.1748-0361.2012.00407.x; Binswanger IA, 2000, CLIN INFECT DIS, V30, P579, DOI 10.1086/313703; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; BOUILLON R, 1984, J CLIN ENDOCR METAB, V59, P86, DOI 10.1210/jcem-59-1-86; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; CHERUBIN CE, 1993, ANN INTERN MED, V119, P1017, DOI 10.7326/0003-4819-119-10-199311150-00009; CLEMENS TL, 1982, LANCET, V1, P74; Compher CW, 2008, OBES SURG, V18, P220, DOI 10.1007/s11695-007-9289-6; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Daly RM, 2006, J BONE MINER RES, V21, P397, DOI 10.1359/JBMR.051206; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Ebright JR, 2002, INFECT DIS CLIN N AM, V16, P697, DOI 10.1016/S0891-5520(02)00017-X; Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Gallagher JC, 2013, J CLIN ENDOCR METAB, V98, P1137, DOI 10.1210/jc.2012-3106; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; GRAHAM NMH, 1992, JAMA-J AM MED ASSOC, V267, P369, DOI 10.1001/jama.267.3.369; HIND CRK, 1990, THORAX, V45, P957, DOI 10.1136/thx.45.12.957; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kahn LS, 2011, J NATL MED ASSOC, V103, P407, DOI 10.1016/S0027-9684(15)30337-0; Kaysen GA, 2001, KIDNEY INT, V60, P333, DOI 10.1046/j.1523-1755.2001.00804.x; Klein RS, 2005, CLIN INFECT DIS, V41, P1794, DOI 10.1086/498311; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; McComsey GA, 2007, AIDS, V21, P2473, DOI 10.1097/QAD.0b013e3282ef961d; MCLAUGHLIN M, 1974, LANCET, V1, P536; Meier C, 2004, J BONE MINER RES, V19, P1221, DOI 10.1359/JBMR.040511; MELLER Y, 1986, ISRAEL J MED SCI, V22, P8; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; Ormesher B, 2011, AIDS, V25, P1237, DOI 10.1097/QAD.0b013e3283474ef9; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Rao J, 2009, J CLIN GASTROENTEROL, V43, P94, DOI 10.1097/MCG.0b013e3180cabc14; REICHMAN LB, 1979, ARCH INTERN MED, V139, P337, DOI 10.1001/archinte.139.3.337; Rodriguez M, 2009, AIDS RES HUM RETROV, V25, P9, DOI 10.1089/aid.2008.0183; STAMP TCB, 1974, NATURE, V247, P563, DOI 10.1038/247563a0; Stata Corp, 2012, STAT STAT SOFTW REL; Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4; VANDERSCHUEREN D, 1991, CALCIFIED TISSUE INT, V49, P84, DOI 10.1007/BF02565126; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Vlahov D, 1991, NIDA Res Monogr, V109, P75; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wasserman P, 2010, AIDS PATIENT CARE ST, V24, P223, DOI 10.1089/apc.2009.0241; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S; Zadshir Ashraf, 2005, Ethn Dis, V15, pS5; Zhu K, 2010, J AM GERIATR SOC, V58, P2063, DOI 10.1111/j.1532-5415.2010.03142.x	68	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95802	10.1371/journal.pone.0095802	http://dx.doi.org/10.1371/journal.pone.0095802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756000	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300096
J	Sui, X; Wang, XR; Huang, HH; Peng, GT; Wang, SB; Fan, ZQ				Sui, Xin; Wang, Xiangrong; Huang, Honghui; Peng, Guotao; Wang, Shoubing; Fan, Zhengqiu			A Novel Photocatalytic Material for Removing Microcystin-LR under Visible Light Irradiation: Degradation Characteristics and Mechanisms	PLOS ONE			English	Article							TIO2; DECOMPOSITION; DESTRUCTION; OXIDATION; RR	Background and Purpose: Microcystin-LR (MC-LR), a common toxic species in contaminated aquatic systems, persists for long periods because of its cyclic structure. Ag3PO4 is an environment-friendly photocatalyst with relatively good degradation capacity for hazardous organic pollutants. This study aimed to investigate the degradation capacity of Ag3PO4 for MC-LR under visible light. Methods: An Ag3PO4 photocatalyst was synthesized by the ion-exchange method and characterized by X-ray diffraction, field-emission scanning electron microscope, and UV-Vis spectrophotometer. MC-LR was quantified in each sample through high-performance liquid chromatograph. The degradation efficiency of MC-LR was affected by initial pH, initial Ag3PO4 concentration, initial MC-LR concentration, and recycle experiments. The degradation intermediates of MC-LR were examined by liquid chromatography-mass spectrometry (LC/MS). Results: The degradation process can be well fitted with the pseudo-first-order kinetic model. The maximum MC-LR degradation rate of 99.98% can be obtained within 5 h under the following optimum conditions: pH of 5.01, Ag3PO4 concentration of 26.67 g/L, and MC-LR concentration of 9.06 mg/L. Nine intermediates were detected and analyzed by LC/MS. Three main degradation pathways were proposed based on the molecular weight of the intermediates and the reaction mechanism: (1) hydroxylation on the aromatic ring of Adda, (2) hydroxylation on the diene bonds of Adda, and (3) internal interactions on the cyclic structure of MC-LR. Conclusion: Ag3PO4 is a highly efficient catalyst for MC-LR degradation in aqueous solutions.	[Sui, Xin; Wang, Xiangrong; Peng, Guotao; Wang, Shoubing; Fan, Zhengqiu] Fudan Univ, Dept Environm Sci & Engn, Shanghai 200433, Peoples R China; [Huang, Honghui] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China	Fudan University; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS	Fan, ZQ (corresponding author), Fudan Univ, Dept Environm Sci & Engn, Shanghai 200433, Peoples R China.	zhqfan@fudan.edu.cn	Peng, Guotao/P-2016-2018; Fan, zhengqiu/AAF-8705-2021	Peng, Guotao/0000-0001-7169-9961; huang, hong hui/0000-0001-9207-1583	Country China Scholarship Council; Key Laboratory of Fishery Ecology and Environment, Guangdong Province, China	Country China Scholarship Council; Key Laboratory of Fishery Ecology and Environment, Guangdong Province, China	The project was supported by Country China Scholarship Council and Key Laboratory of Fishery Ecology and Environment, Guangdong Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou MG, 2008, TOXICON, V51, P1103, DOI 10.1016/j.toxicon.2008.01.018; Antoniou MG, 2009, APPL CATAL B-ENVIRON, V91, P165, DOI 10.1016/j.apcatb.2009.05.020; Antoniou MG, 2008, ENVIRON SCI TECHNOL, V42, P8877, DOI 10.1021/es801637z; Bi YP, 2011, PHYS CHEM CHEM PHYS, V13, P10071, DOI 10.1039/c1cp20488b; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Chen P, 2012, ENVIRON SCI TECHNOL, V46, P2345, DOI 10.1021/es2036338; Choi H, 2007, ENVIRON SCI TECHNOL, V41, P7530, DOI 10.1021/es0709122; Dai GF, 2012, WATER RES, V46, P1482, DOI 10.1016/j.watres.2011.11.010; Diehnelt CW, 2006, ANAL CHEM, V78, P501, DOI 10.1021/ac051556d; Ge M, 2012, IND ENG CHEM RES, V51, P5167, DOI 10.1021/ie202864n; Jacobs LCV, 2013, CHEMOSPHERE, V90, P1552, DOI 10.1016/j.chemosphere.2012.09.004; Jiang JQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055729, 10.1371/journal.pone.0068482]; Khan SB, 2014, PLOS ONE, V9; Lawton LA, 2003, J CATAL, V213, P109, DOI 10.1016/S0021-9517(02)00049-0; Liu I, 2003, ENVIRON SCI TECHNOL, V37, P3214, DOI 10.1021/es0201855; Liu W, 2013, MATER RES BULL, V48, P106, DOI 10.1016/j.materresbull.2012.10.015; Ma QW, 2012, J HAZARD MATER, V215, P75, DOI 10.1016/j.jhazmat.2012.02.033; Ma QW, 2011, FRESEN ENVIRON BULL, V20, P1007; PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104; Qiao RP, 2005, TOXICON, V45, P745, DOI 10.1016/j.toxicon.2005.01.012; Rawal SB, 2012, CATAL COMMUN, V17, P131, DOI 10.1016/j.catcom.2011.10.034; Teng W, 2012, APPL CATAL B-ENVIRON, V125, P538, DOI 10.1016/j.apcatb.2012.05.043; Thomas M, 2002, MATER LETT, V56, P386, DOI 10.1016/S0167-577X(02)00496-2; Vachet RW, 1996, J AM CHEM SOC, V118, P6252, DOI 10.1021/ja9531034; Wang WG, 2012, CHEM-ASIAN J, V7, P1902, DOI 10.1002/asia.201200197; Yi ZG, 2010, NAT MATER, V9, P559, DOI [10.1038/NMAT2780, 10.1038/nmat2780]; Zhou D, 2013, PLOS ONE, V8, DOI 10.1371/journal; Ziegmann M, 2010, WATER RES, V44, P195, DOI 10.1016/j.watres.2009.09.035	28	11	12	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95798	10.1371/journal.pone.0095798	http://dx.doi.org/10.1371/journal.pone.0095798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755986	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300095
J	Ao, HS; Wang, XQ; Xu, F; Zheng, Z; Chen, M; Li, L; Wu, CQ; Wang, Q; Hu, SS				Ao, Hushan; Wang, Xianqiang; Xu, Fei; Zheng, Zhe; Chen, Ming; Li, Lei; Wu, Chaoqun; Wang, Qian; Hu, Shengshou			The Impact of Body Mass Index on Short-and Long-Term Outcomes in Patients Undergoing Coronary Artery Graft Bypass	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; CARDIAC-SURGERY; EXTREME OBESITY; RISK-FACTORS; FOLLOW-UP; MORBIDITY; WEIGHT; REVASCULARIZATION; PREDICTORS; SOCIETY	Objective: This study was designed to investigate the impact of body mass index (BMI) on short-and long-term outcomes after initial revascularization with coronary artery bypass graft (CABG) surgery. Methods: 4916 Chinese who consecutively underwent isolated, primary CABG at the Cardiovascular Institute of Fuwai Hospital from January 1, 1999 to December 31, 2005 were included in this study. They were classified based on BMI as follows: underweight: < 18.5 kg/m(2), normal weight: 18.5 to 23.9 kg/m(2), overweight: 24 to 27.9 kg/m(2), obesity: 28 to 32 kg/m(2), and severe obesity. > 32 kg/m(2). Short (in-hospital) and long-term (5-years) major post-operative complications and mortalities were compared among various BMI groups after initial revascularization. Results: Multiple regression analysis of five years follow-up of clinical end points indicated that various BMI groups were not associated with significant differences in 5 years mortality and MACCE, however, old age, smoking, hypertension, myocardial infarction and heart failure were the risk factor for the mortality. Conclusions: In this large-scale study with long term follow-up after primary CABG in an exclusively ethnic Chinese population, we found that different BMI groups were not significantly associated with 5-years mortality and MACCE, however, old age, smoking, hypertension, myocardial infarction and heart failure were the risk factors of post-operative mortality, and old age, hypertension and heart failure increased the rate of MACCE.	[Ao, Hushan] Chinese Acad Med Sci, Peking Union Med Coll, Dept Anesthesiol, State Key Lab Translat Cardiovasc Med,Fuwai Hosp, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Peking Union Med Coll, Cardiovasc Inst, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ao, HS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Dept Anesthesiol, State Key Lab Translat Cardiovasc Med,Fuwai Hosp, Beijing 100730, Peoples R China.	aohushan@sina.com						Baslaim G, 2008, ANN THORAC CARDIOVAS, V14, P369; Birkmeyer NJO, 1998, CIRCULATION, V97, P1689, DOI 10.1161/01.CIR.97.17.1689; Bouillanne O, 2009, AM J CLIN NUTR, V90, P505, DOI 10.3945/ajcn.2009.27819; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cao LH, 2012, ANN SURG, V255, P399, DOI 10.1097/SLA.0b013e318234313b; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; CRUSE PJE, 1973, ARCH SURG-CHICAGO, V107, P206, DOI 10.1001/archsurg.1973.01350200078018; Engel AM, 2009, ANN THORAC SURG, V88, P1793, DOI 10.1016/j.athoracsur.2009.07.077; FASOL R, 1992, THORAC CARDIOV SURG, V40, P126, DOI 10.1055/s-2007-1020129; Fukui T, 2010, CIRC J, V74, P2103, DOI 10.1253/circj.CJ-10-0275; Gurm HS, 2002, J AM COLL CARDIOL, V39, P834, DOI 10.1016/S0735-1097(02)01687-X; Hamman BL, 2006, AM J CARDIOL, V98, P734, DOI 10.1016/j.amjcard.2006.04.008; HARRIS T, 1988, JAMA-J AM MED ASSOC, V259, P1520; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Jin RY, 2005, CIRCULATION, V111, P3359, DOI 10.1161/CIRCULATIONAHA.104.489880; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kim J, 2003, AM HEART J, V146, P555, DOI 10.1016/S0002-8703(03)00185-6; Kuduvalli M, 2003, EUR J CARDIO-THORAC, V23, P368, DOI 10.1016/S1010-7940(02)00827-8; Kuduvalli M, 2002, EUR J CARDIO-THORAC, V22, P787, DOI 10.1016/S1010-7940(02)00448-7; Kunadian B, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-51; Lavie CJ, 2008, NAT CLIN PRACT CARD, V5, P428, DOI 10.1038/ncpcardio1257; Lavie CJ, 2003, J AM COLL CARDIOL, V42, P677, DOI 10.1016/S0735-1097(03)00784-8; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Lindhout AH, 2004, EUR J CARDIO-THORAC, V26, P535, DOI 10.1016/j.ejcts.2004.05.034; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Nalysnyk L, 2003, HEART, V89, P767, DOI 10.1136/heart.89.7.767; Oreopoulos A, 2008, OBESITY, V16, P442, DOI 10.1038/oby.2007.36; Orhan G, 2004, EUR J CARDIO-THORAC, V25, P212, DOI 10.1016/j.ejcts.2003.11.003; Pan W, 2006, ANESTHESIOLOGY, V104, P441, DOI 10.1097/00000542-200603000-00010; PARSONNET V, 1989, CIRCULATION, V79, P3; Perrotta S, 2007, J CARDIOVASC SURG, V48, P239; Prabhakar G, 2002, ANN THORAC SURG, V74, P1125, DOI 10.1016/S0003-4975(02)03899-7; Prapas SN, 2007, EUR J CARDIO-THORAC, V32, P488, DOI 10.1016/j.ejcts.2007.05.025; PRASAD US, 1991, EUR J CARDIO-THORAC, V5, P67, DOI 10.1016/1010-7940(91)90003-3; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Syrakas CA, 2007, THORAC CARDIOV SURG, V55, P491, DOI 10.1055/s-2007-965599; Todd Miller M, 2008, J Cardiometab Syndr, V3, P162, DOI 10.1111/j.1559-4572.2008.00004.x; Uva Miguel Sousa, 2002, Rev Port Cardiol, V21, P255; Uva MS, 2002, REV PORT CARDIOL, V21, P267; Vassiliades TA, 2003, HEART SURG FORUM, V6, P99; Wang XQ, 2010, ANN THORAC SURG, V89, P1489, DOI 10.1016/j.athoracsur.2010.02.006; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	46	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95223	10.1371/journal.pone.0095223	http://dx.doi.org/10.1371/journal.pone.0095223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752323	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400042
J	Fletcher, R; Gribben, C; Ma, XQ; Burchfield, JG; Thomas, KC; Krycer, JR; James, DE; Fazakerley, DJ				Fletcher, Rachael; Gribben, Christopher; Ma, Xuiquan; Burchfield, James G.; Thomas, Kristen C.; Krycer, James R.; James, David E.; Fazakerley, Daniel J.			The Role of the Niemann-Pick Disease, Type C1 Protein in Adipocyte Insulin Action	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLUCOSE TRANSPORTERS; SUSCEPTIBILITY LOCI; CHOLESTEROL TRAFFICKING; GLUT4 GENE; RECEPTOR; LOCALIZATION; METABOLISM; ACTIVATION; EXPRESSION	The Niemann-Pick disease, type C1 (NPC1) gene encodes a transmembrane protein involved in cholesterol efflux from the lysosome. SNPs within NPC1 have been associated with obesity and type 2 diabetes, and mice heterozygous or null for NPC1 are insulin resistant. However, the molecular mechanism underpinning this association is currently undefined. This study aimed to investigate the effects of inhibiting NPC1 function on insulin action in adipocytes. Both pharmacological and genetic inhibition of NPC1 impaired insulin action. This impairment was evident at the level of insulin signalling and insulin-mediated glucose transport in the short term and decreased GLUT4 expression due to reduced liver X receptor (LXR) transcriptional activity in the long-term. These data show that cholesterol homeostasis through NPC1 plays a crucial role in maintaining insulin action at multiple levels in adipocytes.	[Fletcher, Rachael; Gribben, Christopher; Ma, Xuiquan; Burchfield, James G.; Thomas, Kristen C.; Krycer, James R.; James, David E.; Fazakerley, Daniel J.] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW, Australia; [Krycer, James R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [James, David E.] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney	Fazakerley, DJ (corresponding author), Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW, Australia.	d.fazakerley@garvan.org.au	Burchfield, James/C-1779-2019; Fazakerley, Daniel/J-2652-2019; Ma, Hugh/S-4266-2019	Burchfield, James/0000-0002-6609-6151; Fazakerley, Daniel/0000-0001-8241-2903; Ma, Hugh/0000-0001-7227-1289; Cooke, Kristen/0000-0002-3534-1660; Krycer, James/0000-0003-1536-7270; James, David/0000-0001-5946-5257	NHMRC program grant	NHMRC program grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an NHMRC program grant (D.E.J.). D.E.J. is an NHMRC Senior Principal Research Fellow. D.J.F. is a Sir Henry Wellcome Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chen J, 2008, J CELL PHYSIOL, V217, P281, DOI 10.1002/jcp.21498; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; COUGHLIN SR, 1989, SCIENCE, V243, P1191; DAHL NK, 1992, J BIOL CHEM, V267, P4889; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Jelinek D, 2013, GENE, V527, P65, DOI 10.1016/j.gene.2013.05.080; Jelinek D, 2011, HUM MOL GENET, V20, P312, DOI 10.1093/hmg/ddq466; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nishimura T, 2013, MOL BIOL CELL; Ong QR, 2012, BIOCHEM BIOPH RES CO, V424, P482, DOI 10.1016/j.bbrc.2012.06.139; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; PEDERSEN O, 1991, ENDOCRINOLOGY, V129, P771, DOI 10.1210/endo-129-2-771; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Reverter M, 2011, MOL BIOL CELL, V22, P4108, DOI 10.1091/mbc.E11-04-0332; Rigamonti E, 2005, CIRC RES, V97, P682, DOI 10.1161/01.RES.0000184678.43488.9f; Robiou-du-Pont S, 2013, INT J OBESITY, V37, P980, DOI 10.1038/ijo.2012.175; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Rossetti L, 1997, J CLIN INVEST, V100, P1831, DOI 10.1172/JCI119711; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	53	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95598	10.1371/journal.pone.0095598	http://dx.doi.org/10.1371/journal.pone.0095598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752197	gold, Green Published			2022-12-25	WOS:000335227400087
J	Henry, SC; Schmidt, EA; Fessler, MB; Taylor, GA				Henry, Stanley C.; Schmidt, Elyse A.; Fessler, Michael B.; Taylor, Gregory A.			Palmitoylation of the Immunity Related GTPase, Irgm1: Impact on Membrane Localization and Ability to Promote Mitochondrial Fission	PLOS ONE			English	Article							CELL-AUTONOMOUS IMMUNITY; PROTEIN PALMITOYLATION; RESISTANCE MECHANISM; TOXOPLASMA-GONDII; HOST-RESISTANCE; LRG-47; MOUSE; AUTOPHAGY; MICE; TUBERCULOSIS	The Immunity-Related GTPases (IRG) are a family of large GTPases that mediate innate immune responses. Irgm1 is particularly critical for immunity to bacteria and protozoa, and for inflammatory homeostasis in the intestine. Although precise functions for Irgm1 have not been identified, prior studies have suggested roles in autophagy/mitophagy, phagosome remodeling, cell motility, and regulating the activity of other IRG proteins. These functions ostensibly hinge on the ability of Irgm1 to localize to intracellular membranes, such as those of the Golgi apparatus and mitochondria. Previously, it has been shown that an amphipathic helix, the alpha K helix, in the C-terminal portion of the protein partially mediates membrane binding. However, in absence of alpha K, there is still substantial binding of Irgm1 to cellular membranes, suggesting the presence of other membrane binding motifs. In the current work, an additional membrane localization motif was found in the form of palmitoylation at a cluster of cysteines near the alpha K. An Irgm1 mutant possessing alanine to cysteine substitutions at these amino acids demonstrated little residual palmitoylation, yet it displayed only a small decrease in localization to the Golgi and mitochondria. In contrast, a mutant containing the palmitoylation mutations in combination with mutations disrupting the amphipathic character of the alpha K displayed a complete loss of apparent localization to the Golgi and mitochondria, as well as an overall loss of association with cellular membranes in general. Additionally, Irgm1 was found to promote mitochondrial fission, and this function was undermined in Irgm1 mutants lacking the palmitoylation domain, and to a greater extent in those lacking the alpha K, or the alpha K and palmitoylation domains combined. Our data suggest that palmitoylation together with the alpha K helix firmly anchor Irgm1 in the Golgi and mitochondria, thus facilitating function of the protein.	[Henry, Stanley C.; Taylor, Gregory A.] VA Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC 27705 USA; [Schmidt, Elyse A.; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Schmidt, Elyse A.; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Schmidt, Elyse A.; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Immunol, Div Geriatr, Durham, NC USA; [Schmidt, Elyse A.; Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Fessler, Michael B.] NIEHS, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA	Geriatric Research Education & Clinical Center; Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Taylor, GA (corresponding author), VA Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC 27705 USA.	gregory.taylor@duke.edu	Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613	National Institutes of Health [AI57831]; VA Merit Review grant; National Institute of Environmental Health Sciences, NIH [Z01 ES102005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102005, ZIAES102005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review grant(US Department of Veterans Affairs); National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grant AI57831 (GAT), a VA Merit Review grant (GAT), and by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH, Z01 ES102005 (MBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Blanc M, 2013, BIOCHEM SOC T, V41, P84, DOI 10.1042/BST20120337; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Chang CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028323; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Henry SC, 2010, J LEUKOCYTE BIOL, V87, P333, DOI 10.1189/jlb.0509299; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; King KY, 2011, BLOOD, V118, P1525, DOI 10.1182/blood-2011-01-328682; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Liesenfeld O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020568; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Liu B, 2013, AM J PHYSIOL-GASTR L, V305, pG573, DOI 10.1152/ajpgi.00071.2013; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Merrick BA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006007; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Springer HM, 2013, J IMMUNOL, V191, P1765, DOI 10.4049/jimmunol.1300641; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhao YO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008648; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	44	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95021	10.1371/journal.pone.0095021	http://dx.doi.org/10.1371/journal.pone.0095021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751652	Green Submitted, gold, Green Published			2022-12-25	WOS:000335227400024
J	Li, FJ; Wu, NQ; Rousseau, DD; Dong, YJ; Zhang, D; Pei, YP				Li, Fengjiang; Wu, Naiqin; Rousseau, Denis-Didier; Dong, Yajie; Zhang, Dan; Pei, Yunpeng			Late Miocene-Pliocene Paleoclimatic Evolution Documented by Terrestrial Mollusk Populations in the Western Chinese Loess Plateau	PLOS ONE			English	Article							ASIAN WINTER MONSOON; RED CLAY DEPOSITS; LATE CENOZOIC UPLIFT; TIBETAN PLATEAU; SUMMER MONSOON; FOSSIL MAMMALS; GRAIN-SIZE; EAST-ASIA; MAGNETIC-SUSCEPTIBILITY; VEGETATION EVOLUTION	The Neogene eolian deposits in the Chinese Loess Plateau (CLP) are one of the most useful continental deposits for understanding climatic changes. To decipher Late Neogene paleoclimatic changes in the CLP, we present a terrestrial mollusk record spanning the time interval between 7.1 and 3.5 Ma from the western CLP. The results indicate four stages of paleoclimatic evolution: From 7.1 to 6.2 Ma, cold and dry climatic conditions prevailed as evidenced by high values of the total number of cold-aridiphilous (CA) mollusk species and by low values of all of the thermo-humidiphilous (TH) mollusk indices. From 6.2 to 5.4 Ma, the climate remained cold and dry but was not quite as dry as during the preceding phase, as indicated by the dominance of CA mollusks and more TH species and individuals. From 5.4 to 4.4 Ma, a warm and moist climate prevailed, as indicated by high values of the TH species and individuals and by the sparsity of CA species and individuals. From 4.4 to 3.5 Ma, all of the CA indices increased significantly and maintained high values; all of the TH indices exhibit high values from 4.4 to 4.0 Ma, an abrupt decrease from 4.0 Ma and a further increase from 3.7 Ma. The CA species of Cathaica pulveraticula, Cathaica schensiensis, and Pupopsis retrodens are only identified in this stage, indicating that the CA species were diversified and that the climate was becoming drier. Moreover, the CA mollusk group exhibits considerable diversity from 7.1 to 5.4 Ma when a cold, dry climate prevailed; whereas the diversity of the TH group was high during the relatively warm, wet interval from 5.4 to 4.4 Ma. This indicates that variations in the diversity of the CA and TH mollusk groups were closely related to climatic changes during the Late Miocene to Pliocene.	[Li, Fengjiang; Wu, Naiqin; Dong, Yajie; Zhang, Dan] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Rousseau, Denis-Didier] Ecole Normale Super, Meteorol Dynam Lab, UMR INSU CNRS 8539, F-75231 Paris, France; [Rousseau, Denis-Didier] Ecole Normale Super, CERES ERTI, F-75231 Paris, France; [Rousseau, Denis-Didier] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Pei, Yunpeng] China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Columbia University; China University of Geosciences	Li, FJ (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China.	fengjiangli@mail.iggcas.ac.cn	Rousseau, Denis-Didier/I-6892-2012	Rousseau, Denis-Didier/0000-0003-2475-3405; Dong, Yajie/0000-0003-3913-2812; Li, Fengjiang/0000-0003-3748-8305	Chinese Academy of Sciences [KZCX2-EW-QN107]; National Basic Research Program of China [2010CB950204]; Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues [XDA05120203]; National Natural Science Foundation of China [41072130, 41272205, 41230104]; CNRS-NSFC; Lamont-Doherty Earth Observatory [7763]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CNRS-NSFC; Lamont-Doherty Earth Observatory	This study is supported by the Chinese Academy of Sciences (KZCX2-EW-QN107), the National Basic Research Program of China (No. 2010CB950204), the Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues (XDA05120203), the National Natural Science Foundation of China (Projects 41072130, 41272205, and 41230104), and part of the work was achieved during a stay in Paris through a CNRS-NSFC grant. This is Lamont-Doherty Earth Observatory contribution 7763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Z.S., 1990, QUATERN INT, V7, P91, DOI DOI 10.1016/1040-6182(90)90042-3; An ZH, 2005, GEOLOGY, V33, P705, DOI 10.1130/G21423.1; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chaisson WP, 2000, PALEOCEANOGRAPHY, V15, P497, DOI 10.1029/1999PA000442; Chen J, 2006, GEOCHIM COSMOCHIM AC, V70, P1471, DOI 10.1016/j.gca.2005.11.029; Chen MH, 2003, MAR GEOL, V201, P169, DOI 10.1016/S0025-3227(03)00215-9; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; DEMENOCAL P, 1993, JOIDES J, V19, P29; DING ZL, 1995, QUATERNARY RES, V44, P149, DOI 10.1006/qres.1995.1059; Ding ZL, 1999, PALAEOGEOGR PALAEOCL, V152, P49, DOI 10.1016/S0031-0182(99)00034-6; Ding ZL, 2000, PALAEOGEOGR PALAEOCL, V160, P291, DOI 10.1016/S0031-0182(00)00076-6; Ding ZL, 1998, GEOPHYS RES LETT, V25, P1225, DOI 10.1029/98GL00836; Ding ZL, 2001, EARTH PLANET SC LETT, V185, P99, DOI 10.1016/S0012-821X(00)00366-6; DOWSETT HJ, 1992, SCIENCE, V258, P1133, DOI 10.1126/science.258.5085.1133; Eronen JT, 2014, ANN ZOOL FENN, V51, P227, DOI 10.5735/086.051.0222; Fan MJ, 2006, EARTH PLANET SC LETT, V248, P186, DOI 10.1016/j.epsl.2006.05.025; Fang XM, 2005, GEOL SOC AM BULL, V117, P1208, DOI 10.1130/B25727.1; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fortelius M, 2002, EVOL ECOL RES, V4, P1005; Guo ZT, 2004, GLOBAL PLANET CHANGE, V41, P135, DOI 10.1016/j.gloplacha.2004.01.002; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hao QZ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031162; Hao QZ, 2012, NATURE, V490, P393, DOI 10.1038/nature11493; Hao QZ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019392; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Haywood AM, 2009, PHILOS T R SOC A, V367, P3, DOI 10.1098/rsta.2008.0205; Haywood AM, 2004, EARTH PLANET SC LETT, V218, P363, DOI 10.1016/S0012-821X(03)00685-X; HOU HY, 1983, ANN MO BOT GARD, V70, P509, DOI 10.2307/2992085; HOVAN SA, 1989, NATURE, V340, P296, DOI 10.1038/340296a0; Jacques FMB, 2013, B GEOSCI, V88, P175, DOI 10.3140/bull.geosci.1359; JANSEN E, 1991, NATURE, V349, P600, DOI 10.1038/349600a0; Jia GD, 2003, GEOLOGY, V31, P1093, DOI 10.1130/G19992.1; Jiang WY, 2002, CHINESE SCI BULL, V47, P687, DOI 10.1360/02tb9156; Kaakinen A, 2006, PALAEOGEOGR PALAEOCL, V237, P359, DOI 10.1016/j.palaeo.2005.12.011; Kaakinen Anu, 2013, P203; KUKLA G, 1990, T ROY SOC EDIN-EARTH, V81, P263, DOI 10.1017/S0263593300020794; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P18393, DOI 10.1029/JD094iD15p18393; Li BH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001016; Li FJ, 2006, SCI CHINA SER D, V49, P724, DOI 10.1007/s11430-006-0724-7; Li FJ, 2008, EARTH PLANET SC LETT, V274, P439, DOI 10.1016/j.epsl.2008.07.038; Li FJ, 2006, GEOLOGY, V34, P405, DOI 10.1130/G22232.1; Liu LP, 2009, PALAEOGEOGR PALAEOCL, V279, P201, DOI 10.1016/j.palaeo.2009.05.014; Liu TS., 1985, LOESS ENV; Liu XD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017510; Liu XD, 2002, PALAEOGEOGR PALAEOCL, V183, P223, DOI 10.1016/S0031-0182(01)00488-6; Liu YS, 2011, PALAEOGEOGR PALAEOCL, V304, P308, DOI 10.1016/j.palaeo.2010.07.004; Maier-Reimer E, 1990, PALEOCEANOGRAPHY, V5, P349, DOI 10.1029/PA005i003p00349; Mikolajewicz U, 1997, PALEOCEANOGRAPHY, V12, P429, DOI 10.1029/96PA03542; MIKOLAJEWICZ U, 1993, PALEOCEANOGRAPHY, V8, P409, DOI 10.1029/93PA00893; Molnar P, 2005, PALAEONTOL ELECTRON, V8; Passey BH, 2009, EARTH PLANET SC LETT, V277, P443, DOI 10.1016/j.epsl.2008.11.008; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Puissegur JJ, 1976, RAPPORTS AVEC AUTRES, V3, P241; Qiang XK, 2011, SCI CHINA EARTH SCI, V54, P136, DOI 10.1007/s11430-010-4126-5; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; Ravelo AC, 2000, GEOPHYS RES LETT, V27, P1001, DOI 10.1029/1999GL007000; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Raymo ME, 1992, EOS T AM GEOPHYS UN, V73, P95; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; RIND D, 1991, J GEOPHYS RES-ATMOS, V96, P7437, DOI 10.1029/91JD00009; Rousseau DD, 1997, GEOLOGY, V25, P275, DOI 10.1130/0091-7613(1997)025<0275:ANMROT>2.3.CO;2; ROUSSEAU DD, 1992, BOREAS, V21, P105; Rousseau DD, 1999, QUATERNARY RES, V52, P286, DOI 10.1006/qres.1999.2078; ROUSSEAU DD, 1994, QUATERNARY RES, V42, P176, DOI 10.1006/qres.1994.1067; ROUSSEAU DD, 1993, QUATERNARY RES, V40, P237, DOI 10.1006/qres.1993.1075; Rousseau DD, 2000, GLOBAL PLANET CHANGE, V26, P199, DOI 10.1016/S0921-8181(00)00086-2; RUDDIMAN WF, 1990, T ROY SOC EDIN-EARTH, V81, P301, DOI 10.1017/S0263593300020812; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; St John KEK, 2002, BOREAS, V31, P28; Steinke S, 2010, PALAEOGEOGR PALAEOCL, V289, P33, DOI 10.1016/j.palaeo.2010.02.007; Sun DH, 1998, GEOPHYS RES LETT, V25, P85, DOI 10.1029/97GL03353; Sun DH, 2011, GLOBAL PLANET CHANGE, V76, P106, DOI 10.1016/j.gloplacha.2010.12.006; Sun JM, 2009, GEOLOGY, V37, P159, DOI 10.1130/G25338A.1; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Tang H, 2011, CLIM PAST, V7, P847, DOI 10.5194/cp-7-847-2011; Thiede J, 1998, QUATERNARY SCI REV, V17, P185, DOI 10.1016/S0277-3791(97)00076-0; Vandenberghe J, 2004, PALAEOGEOGR PALAEOCL, V204, P239, DOI 10.1016/S0031-0182(03)00729-6; Wan SM, 2006, PALAEOGEOGR PALAEOCL, V241, P139, DOI 10.1016/j.palaeo.2006.06.013; Wang L, 2006, PALAEOGEOGR PALAEOCL, V241, P118, DOI 10.1016/j.palaeo.2006.06.012; Wang PX, 2005, QUATERNARY SCI REV, V24, P595, DOI 10.1016/j.quascirev.2004.10.002; Wang Y, 2005, EARTH PLANET SC LETT, V236, P322, DOI 10.1016/j.epsl.2005.05.006; Wang YX, 2007, PALAEOGEOGR PALAEOCL, V249, P351, DOI 10.1016/j.palaeo.2007.02.010; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Wei G, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001300; Wen LJ, 2005, SCI CHINA SER D, V48, P1452, DOI 10.1360/01yd0558; Wolf-Welling Thomas C.W., 1996, Proceedings of the Ocean Drilling Program Scientific Results, V151, P515; Wu NQ, 2007, QUATERNARY SCI REV, V26, P1884, DOI 10.1016/j.quascirev.2007.04.006; Wu NQ, 1996, SCI CHINA SER D, V39, P494; Wu NQ, 2000, CHINESE SCI BULL, V45, P1617, DOI 10.1007/BF02886225; Wu NQ, 2006, PALAEOGEOGR PALAEOCL, V233, P287, DOI 10.1016/j.palaeo.2005.10.006; Wu NQ, 2002, BOREAS, V31, P20, DOI 10.1080/03009480210648; Wu NQ, 2001, J GEOPHYS RES-ATMOS, V106, P20045, DOI 10.1029/2001JD900224; Wu YS, 2001, ACTA BOT SIN, V43, P750; Xu Y, 2009, PALAEOGEOGR PALAEOCL, V284, P383, DOI 10.1016/j.palaeo.2009.10.023; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang CF, 2009, EARTH PLANET SC LETT, V287, P311, DOI 10.1016/j.epsl.2009.08.025; Zhang Zhao-Qun, 2002, Vertebrata Palasiatica, V40, P165; Zheng HB, 2004, GLOBAL PLANET CHANGE, V41, P147, DOI 10.1016/j.gloplacha.2004.01.003; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2; Zhu YM, 2008, PALAEOGEOGR PALAEOCL, V268, P47, DOI 10.1016/j.palaeo.2008.08.001; Zoller L, 2001, EARTH-SCI REV, V54, P19, DOI 10.1016/S0012-8252(01)00039-3	107	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95154	10.1371/journal.pone.0095754	http://dx.doi.org/10.1371/journal.pone.0095754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752586	Green Published, gold			2022-12-25	WOS:000335227400117
J	Li, H; Fitchett, C; Kozdon, K; Jayaram, H; Rose, GE; Bailly, M; Ezra, DG				Li, He; Fitchett, Caroline; Kozdon, Katarzyna; Jayaram, Hari; Rose, Geoffrey E.; Bailly, Maryse; Ezra, Daniel G.			Independent Adipogenic and Contractile Properties of Fibroblasts in Graves' Orbitopathy: An In Vitro Model for the Evaluation of Treatments	PLOS ONE			English	Article							ORBITAL FIBROBLASTS; OXIDATIVE STRESS; HYALURONIC-ACID; MOUSE MODEL; TISSUE; RECEPTOR; DISEASE; THY-1; EXPRESSION; PHOSPHORYLATION	Graves' orbitopathy (GO) is a disfiguring and sometimes blinding disease, characterised by inflammation and swelling of orbital tissues, with fibrosis and adipogenesis being predominant features. Little is known about the disease aetiology and the molecular mechanisms driving the phenotypic changes in orbital fibroblasts are unknown. Using fibroblasts isolated from the orbital fat of undiseased individuals or GO patients, we have established a novel in vitro model to evaluate the dual profile of GO cells in a three-dimensional collagen matrix; this pseudo-physiological 3D environment allows measurement of their contractile and adipogenic properties. GO cells contracted collagen matrices more efficiently than control cells following serum or TGF beta 1 stimulation, and showed a slightly increased ability to proliferate in the 3D matrix, in accordance with a fibro-proliferative phenotype. GO cells, unlike controls, also spontaneously differentiated into adipocytes in 3D cultures-confirming an intrinsic adipogenic profile. However, both control and GO cells underwent adipogenesis when cultured under pathological pressure levels. We further demonstrate that a Thy-1-low population of GO cells underlies the adipogenic -but (not) under bar the contractile-phenotype and, using inhibitors, confirm that the contractile and adipogenic phenotypes are regulated by separate pathways. In view of the current lack of suitable treatment for GO, we propose that this new model testing the duality of the GO phenotype could be useful as a preclinical evaluation for the efficacy of potential treatments.	[Li, He; Fitchett, Caroline; Kozdon, Katarzyna; Rose, Geoffrey E.; Bailly, Maryse; Ezra, Daniel G.] UCL Inst Ophthalmol, Dept Cell Biol, London, England; [Jayaram, Hari] UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England; [Rose, Geoffrey E.; Ezra, Daniel G.] Moorfields Eye Hosp NHS Fdn Trust, Moorfields Eye Hosp, London, England; [Rose, Geoffrey E.; Ezra, Daniel G.] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Rose, Geoffrey E.; Ezra, Daniel G.] UCL Inst Ophthalmol, UCL Partners AHSC, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Bailly, M (corresponding author), UCL Inst Ophthalmol, Dept Cell Biol, London, England.	m.bailly@ucl.ac.uk	Jayaram, Hari/H-7016-2019; Bailly, Maryse/C-1663-2008	Jayaram, Hari/0000-0003-1998-0670; Kozdon, Katarzyna/0000-0002-8006-8982; Bailly, Maryse/0000-0002-0593-6356	Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology; Academy of Medical Sciences (AMS) [AMS-SGCL4-Ezra] Funding Source: researchfish; Medical Research Council [G0801049, G0500927] Funding Source: researchfish; National Institute for Health Research [CL-2011-18-008] Funding Source: researchfish; MRC [G0801049, G0500927] Funding Source: UKRI	Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was sponsored by the Academy of Medical Sciences (Fellowship to Dr. Daniel Ezra) and by Fight for Sight (Ref 1985). Dr. Hari Jayaram is a recipient of the UCL/ Medical Research Council Centenary Award. This study was partly funded by the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baker B. M., 2012, J CELL SCI; Bartalena L, 2003, BIOFACTORS, V19, P155, DOI 10.1002/biof.5520190308; Berthout A, 2010, J FR OPHTALMOL, V33, P623, DOI 10.1016/j.jfo.2010.08.004; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Chen WLK, 2011, ADV DRUG DELIVER REV, V63, P269, DOI 10.1016/j.addr.2011.01.004; Crisp M, 2000, INVEST OPHTH VIS SCI, V41, P3249; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Ezra DG, 2009, EXPERT REV OPHTHALMO, V4, P47, DOI 10.1586/17469899.4.1.47; Ezra DG, 2010, INVEST OPHTH VIS SCI, V51, P3853, DOI 10.1167/iovs.09-4724; Garrity JA, 2006, AM J OPHTHALMOL, V142, P147, DOI 10.1016/j.ajo.2006.02.047; Hoa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034173; Hondur A, 2008, CURR EYE RES, V33, P421, DOI 10.1080/02713680802123532; Huang CY, 2012, CONNECT TISSUE RES, V53, P187, DOI 10.3109/03008207.2011.642035; Kang SM, 2013, MOL CELL TOXICOL, V9, P195, DOI 10.1007/s13273-013-0024-1; Khoo TK, 2008, THYROID, V18, P1291, DOI 10.1089/thy.2008.0255; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; Koumas L, 2002, EUR J IMMUNOL, V32, P477, DOI 10.1002/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U; Kumar S, 2004, J CLIN ENDOCR METAB, V89, P930, DOI 10.1210/jc.2003-031427; Kumar S, 2012, J CLIN ENDOCR METAB, V97, P1681, DOI 10.1210/jc.2011-2890; Martin-Martin B, 2011, EUR J CELL BIOL, V90, P26, DOI 10.1016/j.ejcb.2010.09.008; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McGee KM, 2011, EMBO REP, V12, P963, DOI 10.1038/embor.2011.141; Moshkelgosha S, 2013, ENDOCRINOLOGY, V154, P3008, DOI 10.1210/en.2013-1576; Naik VM, 2010, SURV OPHTHALMOL, V55, P215, DOI 10.1016/j.survophthal.2009.06.009; Oh SR, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/794984, 10.1155/2013/203681]; Pei Y, 2004, EXP EYE RES, V79, P705, DOI 10.1016/j.exer.2004.08.002; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pritchard J, 2003, J IMMUNOL, V170, P6348, DOI 10.4049/jimmunol.170.12.6348; Rege TA, 2006, EXP CELL RES, V312, P3752, DOI 10.1016/j.yexcr.2006.07.029; Riemann CD, 1999, OPHTHALMIC PLAST REC, V15, P121, DOI 10.1097/00002341-199903000-00010; SISSON JC, 1970, EXP EYE RES, V10, P201, DOI 10.1016/S0014-4835(70)80028-8; Smith TJ, 2010, CLIN EXP IMMUNOL, V162, P24, DOI 10.1111/j.1365-2249.2010.04219.x; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; Smith TJ, 2003, AUTOIMMUNITY, V36, P409, DOI 10.1080/08916930310001603000; Smith TJ, 2002, J CLIN ENDOCR METAB, V87, P385, DOI 10.1210/jc.87.1.385; Stacey DH, 2009, TISSUE ENG PT A, V15, P3389, DOI [10.1089/ten.tea.2008.0293, 10.1089/ten.TEA.2008.0293]; Sun YT, 2005, BIOCHEMISTRY-US, V44, P14455, DOI 10.1021/bi0509090; Tovell VE, 2012, INVEST OPHTH VIS SCI, V53, P4682, DOI 10.1167/iovs.11-8577; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; van Steensel L, 2010, INVEST OPHTH VIS SCI, V51, P1002, DOI 10.1167/iovs.09-4338; van Steensel L, 2009, INVEST OPHTH VIS SCI, V50, P3091, DOI 10.1167/iovs.08-2443; Zarkovic M, 2012, J THROID RES, V2012, DOI 10.1155/2012/302537; Zhang L, 2012, J CLIN ENDOCR METAB, V97, P653, DOI 10.1210/jc.2011-1299; Zhao SX, 2011, J ENDOCRINOL, V210, P369, DOI 10.1530/JOE-11-0162	46	17	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95586	10.1371/journal.pone.0095586	http://dx.doi.org/10.1371/journal.pone.0095586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751986	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400084
J	Tada, M; Ishii-Watabe, A; Suzuki, T; Kawasaki, N				Tada, Minoru; Ishii-Watabe, Akiko; Suzuki, Takuo; Kawasaki, Nana			Development of a Cell-Based Assay Measuring the Activation of Fc gamma RIIa for the Characterization of Therapeutic Monoclonal Antibodies	PLOS ONE			English	Article							HUMAN IGG1; METHIONINE OXIDATION; EFFECTOR FUNCTION; CYTOKINE-RELEASE; BINDING; RECEPTORS; AFFINITY; ADCC; POLYMORPHISMS; VARIANT	Antibody-dependent cellular cytotoxicity (ADCC) is one of the important mechanisms of action of the targeting of tumor cells by therapeutic monoclonal antibodies (mAbs). Among the human Fcc receptors (Fc gamma Rs), Fc gamma RIIIa is well known as the only receptor expressed in natural killer (NK) cells, and it plays a pivotal role in ADCC by IgG1-subclass mAbs. In addition, the contributions of Fc gamma RIIa to mAb-mediated cytotoxicity have been reported. Fc gamma RIIa is expressed in myeloid effector cells including neutrophils and macrophages, and it is involved in the activation of these effector cells. However, the measurement of the cytotoxicity via Fc gamma RIIa-expressing effector cells is complicated and inconvenient for the characterization of therapeutic mAbs. Here we report the development of a cell-based assay using a human Fc gamma RIIa-expressing reporter cell line. The Fc gamma RIIa reporter cell assay was able to estimate the activation of Fc gamma RIIa by antigen-bound mAbs by a very simple method in vitro. The usefulness of this assay for evaluating the activity of mAbs with different abilities to activate Fc gamma RIIa was confirmed by the examples including the comparison of the activity of the anti-CD20 mAb rituximab and its Fc-engineered variants, and two anti-EGFR mAbs with different IgG subclasses, cetuximab (IgG1) and panitumumab (IgG2). We also applied this assay to the characterization of a force-oxidized mAb, and we observed that oxidation significantly decreased the Fc gamma RIIa activation by EGFR-bound cetuximab. These results suggest that our Fc gamma RIIa reporter assay is a promising tool for the characterization of therapeutic mAbs, including Fc-engineered mAbs, IgG2-subclass mAbs, and their product-related variants.	[Tada, Minoru; Ishii-Watabe, Akiko; Suzuki, Takuo; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo, Japan	National Institute of Health Sciences - Japan	Ishii-Watabe, A (corresponding author), Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo, Japan.	watabe@nihs.go.jp	Tada, Minoru/AHB-5933-2022	Tada, Minoru/0000-0003-4739-1259	Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan; KAKENHI from the Japan Society for the Promotion of Science (JSPS)	Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan; KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), by the Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan, and by KAKENHI from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Bertolotti-Ciarlet A, 2009, MOL IMMUNOL, V46, P1878, DOI 10.1016/j.molimm.2009.02.002; Brennan FR, 2010, MABS-AUSTIN, V2, P233, DOI 10.4161/mabs.2.3.11782; Bretaudeau Laurent, 2011, BMC Proc, V5 Suppl 8, pP63, DOI 10.1186/1753-6561-5-S8-P63; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Bugelski PJ, 2009, EXPERT REV CLIN IMMU, V5, P499, DOI [10.1586/eci.09.31, 10.1586/ECI.09.31]; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307; Davies J, 2001, BIOTECHNOL BIOENG, V74, P288, DOI 10.1002/bit.1119.abs; Derer S, 2014, MABS, V6, P10; Desjarlais JR, 2007, DRUG DISCOV TODAY, V12, P898, DOI 10.1016/j.drudis.2007.08.009; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Heider KH, 2011, BLOOD, V118, P4159, DOI 10.1182/blood-2011-04-351932; Jonsson F, 2012, BLOOD, V119, P2533, DOI 10.1182/blood-2011-07-367334; Kawakami T, 2012, BLOOD, V119, P2432, DOI 10.1182/blood-2012-01-397786; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Liu D, 2008, BIOCHEMISTRY-US, V47, P5088, DOI 10.1021/bi702238b; Miller AS, 2012, J IMMUNOL METHODS, V385, P45, DOI 10.1016/j.jim.2012.08.004; Mimoto F, 2013, MABS-AUSTIN, V5, P229, DOI 10.4161/mabs.23452; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nagarajan S, 2000, BLOOD, V95, P1069, DOI 10.1182/blood.V95.3.1069.003k14_1069_1077; Nelson DA, 2001, AEROSPACE AM, V39, P7; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Pan H, 2009, PROTEIN SCI, V18, P424, DOI 10.1002/pro.45; Parekh BS, 2012, MABS-AUSTIN, V4, P310, DOI 10.4161/mabs.19873; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Schnueriger A, 2011, MOL IMMUNOL, V48, P1512, DOI 10.1016/j.molimm.2011.04.010; Scott Andrew M, 2012, Cancer Immun, V12, P14; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; Subramaniam JM, 2012, DRUGS, V72, P1293, DOI 10.2165/11631090-000000000-00000; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Tada M, 2012, IMMUNOGENETICS, V64, P869, DOI 10.1007/s00251-012-0646-9; Tax WJM, 1997, TRANSPLANTATION, V63, P106, DOI 10.1097/00007890-199701150-00020; Traynor K, 2013, AM J HEALTH-SYST PH, V70, P2162, DOI 10.2146/news130080; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; Vlasak J, 2008, CURR PHARM BIOTECHNO, V9, P468, DOI 10.2174/138920108786786402; Wang WR, 2011, MOL IMMUNOL, V48, P860, DOI 10.1016/j.molimm.2010.12.009; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Wilde MI, 1996, DRUGS, V51, P865, DOI 10.2165/00003495-199651050-00010; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598	49	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95787	10.1371/journal.pone.0095787	http://dx.doi.org/10.1371/journal.pone.0095787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752341	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400130
J	Taylor, MD; van der Meulen, DE; Ives, MC; Walsh, CT; Reinfelds, IV; Gray, CA				Taylor, Matthew D.; van der Meulen, Dylan E.; Ives, Matthew C.; Walsh, Chris T.; Reinfelds, Ivars V.; Gray, Charles A.			Shock, Stress or Signal ? Implications of Freshwater Flows for a Top-Level Estuarine Predator	PLOS ONE			English	Article							ARGYROSOMUS-JAPONICUS SCIAENIDAE; SOUTH-EASTERN; MARINE NURSERIES; FISH; VARIABILITY; MULLOWAY; RIVER; MOVEMENT; HABITAT; GROWTH	Physicochemical variability in estuarine systems plays an important role in estuarine processes and in the lifecycles of estuarine organisms. In particular, seasonality of freshwater inflow to estuaries may be important in various aspects of fish lifecycles. This study aimed to further understand these relationships by studying the movements of a top-level estuarine predator in response to physicochemical variability in a large, temperate south-east Australian estuary (Shoalhaven River). Mulloway (Argyrosomus japonicus, 47-89 cm total length) were surgically implanted with acoustic transmitters, and their movements and migrations monitored over two years via fixed-position VR2W acoustic receivers configured in a linear array along the length of the estuary. The study period included a high degree of abiotic variability, with multiple pulses (exponentially high flows over a short period of time) in fresh water to the estuary, as well as broader seasonal variation in flow, temperature and conductivity. The relative deviation of fish from their modal location in the estuary was affected primarily by changes in conductivity, and smaller fish (n = 4) tended to deviate much further downstream from their modal position in the estuary than larger fish (n = 8). High-flow events which coincided with warmer temperatures tended to drive mature fish down the estuary and potentially provided a spawning signal to stimulate aggregation of adults near the estuary mouth; however, this relationship requires further investigation. These findings indicate that pulse and press effects of freshwater inflow and associated physicochemical variability play a role in the movements of mulloway, and that seasonality of large freshwater flows may be important in spawning. The possible implications of river regulation and the extraction of freshwater for consumptive uses on estuarine fishes are discussed.	[Taylor, Matthew D.] Port Stephens Fisheries Inst, NSW Dept Primary Ind, Nelson Bay, NSW, Australia; [Taylor, Matthew D.; van der Meulen, Dylan E.; Gray, Charles A.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Ives, Matthew C.] Univ Oxford, Environm Change Inst, Ctr Environm, Oxford OX1 2JD, England; [van der Meulen, Dylan E.; Walsh, Chris T.] Batemans Bay Fisheries Ctr, NSW Dept Primary Ind, Sunshine Bay, NSW, Australia; [Reinfelds, Ivars V.] NSW Off Water, Wollongong, NSW, Australia; [Gray, Charles A.] WildFish Res, Sydney, NSW, Australia	NSW Department of Primary Industries; University of New South Wales Sydney; University of Oxford; NSW Department of Primary Industries	Taylor, MD (corresponding author), Port Stephens Fisheries Inst, NSW Dept Primary Ind, Nelson Bay, NSW, Australia.	matt.taylor@dpi.nsw.gov.au	Ives, Matthew/H-7647-2019; van der Meulen, Dylan E/A-8449-2017	van der Meulen, Dylan E/0000-0002-9777-7670; Ives, Matthew/0000-0002-3536-2787; Gray, Charles/0000-0001-9939-9995	NSW Recreational Fishing Saltwater Trust; Australian Research Council	NSW Recreational Fishing Saltwater Trust; Australian Research Council(Australian Research Council)	The funding sources for this study included the Caring for Country program, the NSW Recreational Fishing Saltwater Trust, and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 1999, MAR FRESHWATER RES, V50, P57, DOI 10.1071/MF98045; BARKER D, 2009, GUIDE ACCEPTABLE PRO; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Braverman MS, 2009, ESTUAR COAST SHELF S, V82, P557, DOI 10.1016/j.ecss.2009.02.018; Childs AR, 2011, MAR FRESHWATER RES, V62, P432, DOI 10.1071/MF10219; CLOERN JE, 1985, HYDROBIOLOGIA, V129, P229, DOI 10.1007/BF00048697; Cowley PD, 2008, AFR J MAR SCI, V30, P247, DOI 10.2989/AJMS.2008.30.2.5.555; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; David V, 2005, ESTUAR COAST SHELF S, V64, P171, DOI 10.1016/j.ecss.2005.01.014; Deegan LA, 1997, MAR ECOL PROG SER, V147, P31, DOI 10.3354/meps147031; Ferguson GJ, 2008, AQUAT LIVING RESOUR, V21, P145, DOI 10.1051/alr:2008034; Fielder DS., 2011, HATCHERY MANUAL PROD; Gillanders BM, 2002, OCEANOGR MAR BIOL, V40, P233; Gillson J, 2011, REV FISH SCI, V19, P168, DOI 10.1080/10641262.2011.560690; Grabemann I, 1997, ESTUAR COAST SHELF S, V45, P235, DOI 10.1006/ecss.1996.0178; GRAY CA, 1993, AUST J MAR FRESH RES, V44, P401; Griffiths MH, 1997, S AFR J MARINE SCI, V18, P249; Griffiths MH, 1997, S AFR J MARINE SCI, V18, P137; Griffiths MH, 1996, S AFR J MARINE SCI, V17, P135; Hall D., 1986, ASSESSMENT MULLOWAY; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Hindell JS, 2008, MAR ECOL PROG SER, V366, P219, DOI 10.3354/meps07519; HOCH MP, 1993, MAR ECOL PROG SER, V98, P283, DOI 10.3354/meps098283; Hoffman JC, 2010, ESTUAR COAST, V33, P1391, DOI 10.1007/s12237-010-9295-0; Hull D., 1984, SAFIC (South Australian Fishing Industry Council), V8, P3; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Kleijnen JPC, 1997, J STAT COMPUT SIM, V57, P111, DOI 10.1080/00949659708811805; Kurup GR, 1998, ESTUAR COAST SHELF S, V47, P191, DOI 10.1006/ecss.1998.0346; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Lewis S., 2010, TERRESTRIAL RUNOFF G; MALLIN MA, 1993, MAR ECOL PROG SER, V93, P199, DOI 10.3354/meps093199; Marchand Jocelyne, 1993, Netherlands Journal of Aquatic Ecology, V27, P427, DOI 10.1007/BF02334804; McKinley AC, 2011, AQUAT CONSERV, V21, P636, DOI 10.1002/aqc.1223; McKinley AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026353; McKinley AC, 2011, ENVIRON POLLUT, V159, P1499, DOI 10.1016/j.envpol.2011.03.008; Meynecke JO, 2006, ESTUAR COAST SHELF S, V69, P491, DOI 10.1016/j.ecss.2006.05.011; Naesje TF, 2012, MAR ECOL PROG SER, V460, P221, DOI 10.3354/meps09780; North EW, 2006, FISH OCEANOGR, V15, P429, DOI 10.1111/j.1365-2419.2005.00389.x; Pease B, 1981, 23B BBS STAT POLL CO; Potter IC, 1999, AUST J ECOL, V24, P395, DOI 10.1046/j.1442-9993.1999.00980.x; Pursche AR, 2013, FISHERIES MANAG ECOL, V20, P445, DOI 10.1111/fme.12031; R Development Core Team, 2012, R LANG ENV STAT COMP; Reinfelds IV, 2013, RIVER RES APPL, V29, P512, DOI 10.1002/rra.1611; Robins JB, 2005, MAR FRESHWATER RES, V56, P343, DOI 10.1071/MF04087; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Sarkar D., 2019, NLME LINEAR NONLINEA; Secor DH, 2000, FISH RES, V46, P359, DOI 10.1016/S0165-7836(00)00159-4; Silberschneider V, 2009, FISH RES, V95, P220, DOI 10.1016/j.fishres.2008.09.002; Silberschneider V., 2005, NSW DPI FISHERIES FI, V82; Simons RD, 2006, LIMNOL OCEANOGR, V51, P2621, DOI 10.4319/lo.2006.51.6.2621; Staunton-Smith J, 2004, MAR FRESHWATER RES, V55, P787, DOI 10.1071/MF03198; Taylor MD, 2009, FISHERIES MANAG ECOL, V16, P478, DOI 10.1111/j.1365-2400.2009.00700.x; Taylor MD, 2006, MAR ECOL PROG SER, V328, P237, DOI 10.3354/meps328237; Taylor MD, 2006, ESTUAR COAST, V29, P785, DOI 10.1007/BF02786529; Taylor MD, 2010, MAR FRESHWATER RES, V61, P302, DOI 10.1071/MF09014; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Walsh CT, 2013, ESTUAR COAST SHELF S, V118, P60, DOI 10.1016/j.ecss.2012.12.009; Walsh CT, 2012, AM FISH S S, V76, P251; Walsh CT, 2012, ECOL FRESHW FISH, V21, P145, DOI 10.1111/j.1600-0633.2011.00534.x; West R.J., 1992, AUSTR ANGLERS FISHIN, P84; Whitfield AK, 2010, J FISH BIOL, V76, P2067, DOI 10.1111/j.1095-8649.2010.02641.x; WHITFIELD AK, 1994, S AFR J ZOOL, V29, P175; Winkler G, 2004, J EXP MAR BIOL ECOL, V308, P127, DOI 10.1016/j.jembe.2004.02.017; Winkler G, 2003, MAR ECOL PROG SER, V251, P59, DOI 10.3354/meps251059; Winkler G, 2007, MAR ECOL PROG SER, V332, P171, DOI 10.3354/meps332171; WONG KC, 1994, J GEOPHYS RES-OCEANS, V99, P14209, DOI 10.1029/94JC00861; Yagi Y, 2011, ENVIRON BIOL FISH, V91, P337, DOI 10.1007/s10641-011-9790-6; Zieman JC, 1999, ESTUARIES, V22, P460, DOI 10.2307/1353211; Zuur Alain F., 2009, P1	70	34	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95680	10.1371/journal.pone.0095680	http://dx.doi.org/10.1371/journal.pone.0095680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752585	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400100
J	Tyler, CL; Kowalewski, M				Tyler, Carrie L.; Kowalewski, Michal			Utility of Marine Benthic Associations as a Multivariate Proxy of Paleobathymetry: A Direct Test from Recent Coastal Ecosystems of North Carolina	PLOS ONE			English	Article							FAUNAL GRADIENT ANALYSIS; CONTINENTAL-SHELF; UPPER ORDOVICIAN; TIME; SEA; ASSEMBLAGES; ORDINATION; BIOFACIES; PATTERNS; PROXIMITIES	Benthic marine fossil associations have been used in paleontological studies as multivariate environmental proxies, with particular focus on their utility as water depth estimators. To test this approach directly, we evaluated modern marine invertebrate communities along an onshore-offshore gradient to determine the relationship between community composition and bathymetry, compare the performance of various ordination techniques, and assess whether restricting community datasets to preservable taxa (a proxy for paleontological data) and finer spatial scales diminishes the applicability of multivariate community data as an environmental proxy. Different indirect (unconstrained) ordination techniques (PCoA, CA, DCA, and NMDS) yielded consistent outcomes: locality Axis 1 scores correlated with actual locality depths, and taxon Axis 1 scores correlated with actual preferred taxon depths, indicating that changes in faunal associations primarily reflect bathymetry, or its environmental correlatives. For datasets restricted to taxa with preservable hard parts, heavily biomineralized mollusks, open ocean habitats, and a single onshore-offshore gradient, the significant correlation between water depth and Axis 1 was still observed. However, for these restricted datasets, the correlation between Axis 1 and bathymetry was reduced and, in most cases, notably weaker than estimates produced by subsampling models. Consistent with multiple paleontological studies, the direct tests carried out here for a modern habitat using known bathymetry suggests that multivariate proxies derived from marine benthic associations may serve as a viable proxy of water depth. The general applicability of multivariate paleocommunity data as an indirect proxy of bathymetry is dependent on habitat type, intrinsic ecological characteristics of dominant faunas, taxonomic scope, and spatial and temporal scales of analysis, highlighting the need for continued testing in present-day depositional settings.	[Tyler, Carrie L.; Kowalewski, Michal] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Tyler, CL (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	ctyler@flmnh.ufl.edu	Tyler, Carrie L./X-2700-2019; Kowalewski, Michal/B-4263-2008	Tyler, Carrie L./0000-0003-0168-2093; Kowalewski, Michal/0000-0002-8575-4711	National Science Foundation [EAR- 1243484]	National Science Foundation(National Science Foundation (NSF))	This research was funded by the National Science Foundation (EAR- 1243484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati L, 2006, PALAIOS, V21, P516, DOI 10.2110/palo.2006.p06-069; [Anonymous], 1988, ADV ECOL RES; Bandy O. L., 1960, AAPG BULL, V44, p1921 ; BILYARD GR, 1979, MAR BIOL, V54, P329, DOI 10.1007/BF00395439; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DAY JH, 1971, J ANIM ECOL, V40, P93, DOI 10.2307/3333; FEDER HM, 1994, MAR ECOL PROG SER, V111, P171, DOI 10.3354/meps111171; FLESSA KW, 1993, PALEOBIOLOGY, V19, P266, DOI 10.1017/S0094837300015918; FRANZ DR, 1981, BIOL BULL-US, V160, P394, DOI 10.2307/1540848; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Hatheway WH, 1971, STAT ECOLOGY; Hendy AJW, 2013, PALAIOS, V28, P210, DOI 10.2110/palo.2012.p12-024r; HILL MO, 1973, J ECOL, V61, P237, DOI 10.2307/2258931; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Holland SM, 2005, PALAIOS, V20, P573, DOI 10.2110/palo.2004.p04-28; Holland SM, 2001, PALAIOS, V16, P205, DOI 10.2307/3515600; Holland SM, 2007, PALAIOS, V22, P392, DOI 10.2110/palo.2006.p06-066r; Holmes NJ, 1997, MAR ECOL PROG SER, V155, P103, DOI 10.3354/meps155103; Jorgensen LL, 1999, POLAR BIOL, V22, P395, DOI 10.1007/s003000050435; KENKEL NC, 1981, VEGETATIO, V45, P147, DOI 10.1007/BF00054669; Kidwell S.M., 1991, Topics in Geobiology, V9, P115; Kidwell SM, 1997, GEOBIOS-LYON, V30, P977, DOI 10.1016/S0016-6995(97)80219-7; Kidwell SM, 2013, ANN REV ECOLOGY EVOL, V44; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Kowalewski M, 1996, J GEOL, V104, P317, DOI 10.1086/629827; Kowalewski M, 2002, GEOL SOC AM BULL, V114, P239, DOI 10.1130/0016-7606(2002)114<0239:MHAOMM>2.0.CO;2; Kowalewski Michal, 2003, Topics in Geobiology, V21, P1; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Leliaert F, 2000, BOT MAR, V43, P359, DOI 10.1515/BOT.2000.036; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McKinney FK, 2006, GEOLOGY, V34, P881, DOI 10.1130/G22707.1; Menzel D, 1993, OCEAN PROCESSES US S; Miller AI, 2001, J GEOL, V109, P603, DOI 10.1086/321965; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Olabarria C, 2006, BIODIVERS CONSERV, V15, P3685, DOI 10.1007/s10531-005-1344-9; Olszewski T, 1999, PALEOBIOLOGY, V25, P226, DOI 10.1017/S009483730002652X; Olszewski TD, 2001, PALAIOS, V16, P444, DOI 10.2307/3515562; Olszewski TD, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/05059.1; Patzkowsky ME, 2012, STRATIGRAPHIC PALEOB; Redman CM, 2007, PALAIOS, V22, P630, DOI 10.2110/palo.2006.p06-044r; Scarponi D, 2004, GEOLOGY, V32, P989, DOI 10.1130/G20808.1; Scarponi Daniele, 2008, GeoActa, V7, P1; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; Smale DA, 2008, POLAR BIOL, V31, P189, DOI 10.1007/s00300-007-0346-3; Sokal RR, 1995, BIOMETRY; SPRINGER DA, 1985, LETHAIA, V18, P181, DOI 10.1111/j.1502-3931.1985.tb00697.x; Tomasovych A, 2009, PALEOBIOLOGY, V35, P94, DOI 10.1666/08024.1; Vanderklift MA, 1996, MAR ECOL PROG SER, V136, P137, DOI 10.3354/meps136137; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; WALTON WR, 1955, J PALEONTOL, V29, P952; WARTENBERG D, 1987, AM NAT, V129, P434, DOI 10.1086/284647; Webber AJ, 2002, PALAIOS, V17, P545, DOI 10.1669/0883-1351(2002)017<0545:HRFGAA>2.0.CO;2; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; WILLIAMSON MH, 1978, J ECOL, V66, P911, DOI 10.2307/2259303; ZIEGLER AM, 1968, LETHAIA, V1, P1, DOI 10.1111/j.1502-3931.1968.tb01724.x	60	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95711	10.1371/journal.pone.0095711	http://dx.doi.org/10.1371/journal.pone.0095711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752221	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400106
J	Uriarte-Arcia, AV; Lopez-Yanez, I; Yanez-Marquez, C				Valeria Uriarte-Arcia, Abril; Lopez-Yanez, Itzama; Yanez-Marquez, Cornelio			One-Hot Vector Hybrid Associative Classifier for Medical Data Classification	PLOS ONE			English	Article								Pattern recognition and classification are two of the key topics in computer science. In this paper a novel method for the task of pattern classification is presented. The proposed method combines a hybrid associative classifier (Clasificador Hibrido Asociativo con Traslacion, CHAT, in Spanish), a coding technique for output patterns called one-hot vector and majority voting during the classification step. The method is termed as CHAT One-Hot Majority (CHAT-OHM). The performance of the method is validated by comparing the accuracy of CHAT-OHM with other well-known classification algorithms. During the experimental phase, the classifier was applied to four datasets related to the medical field. The results also show that the proposed method outperforms the original CHAT classification accuracy.	[Valeria Uriarte-Arcia, Abril; Yanez-Marquez, Cornelio] Inst Politecn Nacl, Ctr Invest Computac, Alpha Beta Grp, Neural Networks & Unconvent Computating Lab, Mexico City, DF, Mexico; [Lopez-Yanez, Itzama] Inst Politecn Nacl, Ctr Innovac & Desarrollo Tecnol Computo, Alpha Beta Grp, Intelligent Comp Lab, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Uriarte-Arcia, AV (corresponding author), Inst Politecn Nacl, Ctr Invest Computac, Alpha Beta Grp, Neural Networks & Unconvent Computating Lab, Mexico City, DF, Mexico.	auriarteb10@sagitario.cic.ipn.mx	Uriarte-Arcia, Abril Valeria/N-6031-2017; Yáñez, Itzamá López/B-1523-2008; Yáñez-Márquez, Cornelio/A-1411-2008	Uriarte-Arcia, Abril Valeria/0000-0003-2222-303X; Yáñez, Itzamá López/0000-0001-6007-4464; Yáñez-Márquez, Cornelio/0000-0002-6250-4728	Instituto Politecnico Nacional; Secretaria Academica; COFAA; SIP; CIC; CIDETEC; CONACyT; SNI	Instituto Politecnico Nacional; Secretaria Academica; COFAA; SIP; CIC; CIDETEC; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SNI	The authors would like to thank the Instituto Politecnico Nacional (Secretaria Academica, COFAA, SIP, CIC, and CIDETEC), the CONACyT, and SNI for their economical support to develop this work.	Amari SI, 1972, SYSTEM COMPUTING CON, V3, P15; ANDERSON J A, 1972, Mathematical Biosciences, V14, P197, DOI 10.1016/0025-5564(72)90075-2; Bache K, 2013, UCI MACHINE LEARNING; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chartier S, 2002, INT C PATT RECOG, P431, DOI 10.1109/ICPR.2002.1047940; Christofides N., 1975, COMPUTER SCI APPL MA; DUDA RO, 2001, PATTERN CLASSIFICATI; Guzman E, 2006, LECT NOTES COMPUT SC, V4225, P519, DOI 10.1007/11892755_54; Hall M, 2010, WEKA 3 DATA MINING S; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Kohavi R, 1995, LECT NOTES ARTIF INT, V912, P174; Kohavi R., 1995, INT JOINT C ART INT, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; KOHONEN T, 1972, IEEE T COMPUT, VC 21, P353, DOI 10.1109/TC.1972.5008975; KOSKO B, 1988, IEEE T SYST MAN CYB, V18, P49, DOI 10.1109/21.87054; Lopez-Yanez I, 2011, INT J COMPUT INT SYS, V4, P680; Mathai G., 1989, IJCNN: International Joint Conference on Neural Networks (Cat. No.89CH2765-6), P33, DOI 10.1109/IJCNN.1989.118556; NAKANO K, 1972, IEEE T SYST MAN CYB, VSMC2, P380, DOI 10.1109/TSMC.1972.4309133; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Rennie J., 2003, P 20 INT C MACH LEAR, ppp; Ritter GX, 1998, IEEE T NEURAL NETWOR, V9, P281, DOI 10.1109/72.661123; Santiago-Montero R, 2003, THESIS CIC MEXICO; Schapire R., 1996, P 13 INT C MACH LEAR, V13, P148, DOI DOI 10.5555/3091696.3091715; STEINBUCH K, 1961, KYBERNETIK, V1, P36, DOI 10.1007/BF00293853; Webb GI, 2000, MACH LEARN, V40, P159, DOI 10.1023/A:1007659514849; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; WILSON DL, 1972, IEEE T SYST MAN CYB, VSMC2, P408, DOI 10.1109/TSMC.1972.4309137; Witten IH, 2011, MOR KAUF D, P1; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Yanez-Marquez C, 2001, LINEAR ASS ANDERSON, V50; Yanez-Marquez C, 2001, LERNMATRIX STEINBUCH, V48	31	38	41	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95715	10.1371/journal.pone.0095715	http://dx.doi.org/10.1371/journal.pone.0095715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752287	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400107
J	Wu, HS; Zhang, YH; Liu, P; Xie, JQ; He, YY; Deng, CS; De Clercq, P; Pang, H				Wu, Hongsheng; Zhang, Yuhong; Liu, Ping; Xie, Jiaqin; He, Yunyu; Deng, Congshuang; De Clercq, Patrick; Pang, Hong			Effects of Transgenic Cry1Ac+CpTI Cotton on Non-Target Mealybug Pest Ferrisia virgata and Its Predator Cryptolaemus montrouzieri	PLOS ONE			English	Article							PROPYLAEA-JAPONICA COLEOPTERA; BT-MAIZE; COTESIA-MARGINIVENTRIS; BIOLOGICAL PARAMETERS; ARTHROPOD PREDATORS; BEETLE COLEOPTERA; NATURAL ENEMIES; CRY1AB PROTEIN; LIFE-HISTORY; CORN POLLEN	Recently, several invasive mealybugs (Hemiptera: Pseudococcidae) have rapidly spread to Asia and have become a serious threat to the production of cotton including transgenic cotton. Thus far, studies have mainly focused on the effects of mealybugs on non-transgenic cotton, without fully considering their effects on transgenic cotton and trophic interactions. Therefore, investigating the potential effects of mealybugs on transgenic cotton and their key natural enemies is vitally important. A first study on the effects of transgenic cotton on a non-target mealybug, Ferrisia virgata (Cockerell) (Hemiptera: Pseudococcidae) was performed by comparing its development, survival and body weight on transgenic cotton leaves expressing Cry1Ac (Bt toxin) + CpTI (Cowpea Trypsin Inhibitor) with those on its near-isogenic non-transgenic line. Furthermore, the development, survival, body weight, fecundity, adult longevity and feeding preference of the mealybug predator Cryptolaemus montrouzieri Mulsant (Coleoptera: Coccinellidae) was assessed when fed F. virgata maintained on transgenic cotton. In order to investigate potential transfer of Cry1Ac and CpTI proteins via the food chain, protein levels in cotton leaves, mealybugs and ladybirds were quantified. Experimental results showed that F. virgata could infest this bivalent transgenic cotton. No significant differences were observed in the physiological parameters of the predator C. montrouzieri offered F. virgata reared on transgenic cotton or its near-isogenic line. Cry1Ac and CpTI proteins were detected in transgenic cotton leaves, but no detectable levels of both proteins were present in the mealybug or its predator when reared on transgenic cotton leaves. Our bioassays indicated that transgenic cotton poses a negligible risk to the predatory coccinellid C. montrouzieri via its prey, the mealybug F.virgata.	[Wu, Hongsheng; Zhang, Yuhong; Liu, Ping; Xie, Jiaqin; He, Yunyu; Deng, Congshuang; Pang, Hong] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Hongsheng; De Clercq, Patrick] Univ Ghent, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium	Sun Yat Sen University; Ghent University	De Clercq, P (corresponding author), Univ Ghent, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium.	patrick.declercq@ugent.be; lsshpang@mail.sysu.edu.cn	Pang, Hong/J-8710-2014; De Clercq, Patrick/B-5721-2015; Pang, Hong/AAL-7785-2020	De Clercq, Patrick/0000-0003-0664-1602; Pang, Hong/0000-0002-0585-3577; Xie, Jiaqin/0000-0002-6864-1467	National Basic Research Program of China [2013CB127605]; National Natural Science Foundation of China [31171899]; Youth Scientific Research Foundation of Guangdong Academy of Sciences [qnjj201206]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Scientific Research Foundation of Guangdong Academy of Sciences	This research was supported by grants from National Basic Research Program of China (973) (2013CB127605), National Natural Science Foundation of China (Grant No.31171899) and the Youth Scientific Research Foundation of Guangdong Academy of Sciences (No.qnjj201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare KG, 2008, ENVIRON ENTOMOL, V37, P630, DOI 10.1603/0046-225X(2008)37[630:LHOPMH]2.0.CO;2; da Silva-Torres CSA, 2013, PHYTOPARASITICA, V41, P31, DOI 10.1007/s12600-012-0261-1; Ashouri A, 2001, ENVIRON ENTOMOL, V30, P524, DOI 10.1603/0046-225X-30.3.524; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; BARTLETT BR, 1974, ENVIRON ENTOMOL, V3, P553, DOI 10.1093/ee/3.3.553; Beltra A., 2010, Entomologia Hellenica, V19, P137; Chen LZ, 2011, J PEST SCI, V84, P9, DOI 10.1007/s10340-010-0319-0; Chong JH, 2008, ENVIRON ENTOMOL, V37, P323, DOI 10.1603/0046-225X(2008)37[323:LHOTMM]2.0.CO;2; Cui Jinjie, 2000, Acta Phytophylacica Sinica, V27, P141; Cui JJ, 2003, THESIS CHINESE ACAD; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2010, ECOTOXICOLOGY, V19, P1183, DOI 10.1007/s10646-010-0502-3; Dhillon MK, 2013, J ENVIRON BIOL, V34, P67; Dogan EB, 1996, J ECON ENTOMOL, V89, P1105, DOI 10.1093/jee/89.5.1105; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutt U., 2007, MEALY BUG INFESTATIO; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; Faria CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000600; Ferry N, 2006, TRANSGENIC RES, V15, P13, DOI 10.1007/s11248-005-4803-x; GEDEN CJ, 1992, ANN ENTOMOL SOC AM, V85, P179, DOI 10.1093/aesa/85.2.179; Geng JH, 2006, ENVIRON ENTOMOL, V35, P1661, DOI 10.1603/0046-225X(2006)35[1661:EOPORC]2.0.CO;2; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Han P, 2010, ECOTOXICOLOGY, V19, P1452, DOI 10.1007/s10646-010-0530-z; Hanchinal S, 2011, KARNATAKA J AGR SCI, V24; Hanchinal S.G., 2010, Karnataka Journal of Agricultural Sciences, V23, P137; Harwood JD, 2005, MOL ECOL, V14, P2815, DOI 10.1111/j.1365-294X.2005.02611.x; Head G, 2001, ENTOMOL EXP APPL, V99, P37, DOI 10.1023/A:1018913429026; Hilder VA, 1999, CROP PROT, V18, P177, DOI 10.1016/S0261-2194(99)00028-9; Hodgson C, 2008, ZOOTAXA, P1; Jiang Rui-Xing, 2009, Huanjing Kunchong Xuebao, V31, P238; Joyce AL, 2010, BIOCONTROL, V55, P573, DOI 10.1007/s10526-010-9278-x; Kaur H, 2012, PHYTOPARASITICA, V40, P131, DOI 10.1007/s12600-011-0211-3; Khan IA, 2012, J INSECT SCI, V12, DOI [10.1673/031.012.7801, 10.1673/031.012.14701]; Khuhro S. N., 2012, Sarhad Journal of Agriculture, V28, P259; Kolliker-Ott UM, 2003, ENTOMOL EXP APPL, V109, P197, DOI 10.1046/j.0013-8703.2003.00104.x; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Lawo NC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004804; Lawrence PK, 2002, ELECTRON J BIOTECHN, V5, DOI 10.2225/vol5-issue1-fulltext-3; Li FuGuang, 2000, Scientia Agricultura Sinica, V33, P46; Li Liying, 1993, Natural Enemies of Insects, V15, P142; Li Y., 2011, P IEEE INT S ASS MAN, V1, P1, DOI DOI 10.1080/21573727.2011.601453; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; Liu BA, 2009, ECOTOX ENVIRON SAFE, V72, P1163, DOI 10.1016/j.ecoenv.2009.02.002; Liu XD, 2005, ECOL ENTOMOL, V30, P307, DOI 10.1111/j.0307-6946.2005.00690.x; Liu Xiao-Xia, 2005, Insect Science, V12, P101, DOI 10.1111/j.1744-7917.2005.00012.x; Lu Y, 2011, ACTA AGR BOREALI SIN, V26, P163; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lumbierres B, 2004, ECOL ENTOMOL, V29, P309, DOI 10.1111/j.0307-6946.2004.00597.x; Lumbierres B, 2011, BIOCONTROL, V56, P133, DOI 10.1007/s10526-010-9317-7; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; Lundgren JG, 2009, CROP PROT, V28, P1017, DOI 10.1016/j.cropro.2009.06.001; Mani M., 2008, Journal of Biological Control, V22, P169; MANI M, 1990, INSECT SCI APPL, V11, P167, DOI 10.1017/S1742758400010535; McCullagh P, 1989, GEN LINEAR MODELS; Nagrare VS., 2011, COMPENDIUM COTTON ME; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Poppy GM, 2004, PHYSIOL ENTOMOL, V29, P257, DOI 10.1111/j.0307-6962.2004.00382.x; Porcar M, 2010, B ENTOMOL RES, V100, P297, DOI 10.1017/S0007485309990290; Porcar M, 2009, APPL ENVIRON MICROB, V75, P4897, DOI 10.1128/AEM.00686-09; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Ramirez-Romero R, 2008, PESTIC BIOCHEM PHYS, V91, P110, DOI 10.1016/j.pestbp.2008.01.010; Ramirez-Romero R, 2007, CROP PROT, V26, P953, DOI 10.1016/j.cropro.2006.09.001; Raps A, 2001, MOL ECOL, V10, P525, DOI 10.1046/j.1365-294x.2001.01236.x; Renard S, 1998, J INSECT BEHAV, V11, P429, DOI 10.1023/A:1020911016042; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Rui YuKui, 2004, Scientia Agricultura Sinica, V37, P1575; Schmidt JEU, 2009, ARCH ENVIRON CON TOX, V56, P221, DOI 10.1007/s00244-008-9191-9; Schreiner I, 2000, STRIPED MEALYBUG FER; Sharma HC, 2007, BIOCONTROL, V52, P469, DOI 10.1007/s10526-006-9032-6; Sharma HC, 2000, CURR SCI INDIA, V79, P421; Solangi G.S., 2008, Journal of Entomology, V5, P31; Tan GY, 2013, FOOD ANAL METHOD, V6, P614, DOI 10.1007/s12161-012-9459-6; Torres JB, 2006, AGR FOREST ENTOMOL, V8, P191, DOI 10.1111/j.1461-9563.2006.00298.x; Wang YP, 2010, AGR FOREST ENTOMOL, V12, P403, DOI 10.1111/j.1461-9563.2010.00490.x; Xu Y, 2012, J INTEGR AGR, V11, P1493, DOI 10.1016/S2095-3119(12)60149-X; Zhang GF, 2006, ENVIRON ENTOMOL, V35, P143, DOI 10.1603/0046-225X-35.1.143; Zhang GF, 2006, CROP PROT, V25, P527, DOI 10.1016/j.cropro.2005.08.008; Zhao XinNing, 2012, Cotton Science, V24, P496; Zhou FC, 2005, ENTOMOL J E CHINA, V14, P132; Zhu SR, 2006, ZOOL STUD, V45, P98; Zwahlen Claudia, 2005, Environmental Biosafety Research, V4, P113, DOI 10.1051/ebr:2005014	85	7	8	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95537	10.1371/journal.pone.0095537	http://dx.doi.org/10.1371/journal.pone.0095537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751821	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400070
J	de Oliveira, DC; Magalhaes, TA; Ferreira, BG; Teixeira, CT; Formiga, AT; Fernandes, GW; Isaias, RMD				de Oliveira, Denis Coelho; Magalhaes, Thiago Alves; Ferreira, Bruno Garcia; Teixeira, Cristiane Trindade; Formiga, Anete Teixeira; Fernandes, Geraldo Wilson; dos Santos Isaias, Rosy Mary			Variation in the Degree of Pectin Methylesterification during the Development of Baccharis dracunculifolia Kidney-Shaped Gall	PLOS ONE			English	Article							CELL-WALLS; ARABINOGALACTAN PROTEINS; SPATIAL REGULATION; INSECT; PEA; POLYSACCHARIDES; GLYCOPROTEINS; ANTIBODIES; ROLES	Insect galls may be study models to test the distribution of pectins and arabinogalactan-proteins (AGPs) and their related functions during plant cell cycles. These molecules are herein histochemically and immunocitochemically investigated in the kidney-shaped gall induced by Baccharopelma dracunculifoliae (Psyllidae) on leaves of Baccharis dracunculifolia DC. (Asteraceae) on developmental basis. The homogalacturonans (HGAs) (labeled by JIM5) and the arabinans (labeled by LM6) were detected either in non-galled leaves or in young galls, and indicated stiffening of epidermal cell walls, which is an important step for cell redifferentiation. The labeling of HGAs by JIM7 changed from young to senescent stage, with an increase in the rigidity of cell walls, which is important for the acquaintance of the final gall shape and for the mechanical opening of the gall. The variation on the degree of HGAs during gall development indicated differential PMEs activity during gall development. The epitopes recognized by LM2 (AGP glycan) and LM5 (1-4-beta-D-galactans) had poor alterations from non-galled leaves towards gall maturation and senescence. Moreover, the dynamics of pectin and AGPs on two comparable mature kidney-shaped galls on B. dracunculifolia and on B. reticularia revealed specific peculiarities. Our results indicate that similar gall morphotypes in cogeneric host species may present distinct cell responses in the subcelular level, and also corroborate the functions proposed in literature for HGAs.	[de Oliveira, Denis Coelho] Univ Fed Uberlandia, Inst Biol INBIO, BR-38400 Uberlandia, MG, Brazil; [Magalhaes, Thiago Alves; Ferreira, Bruno Garcia; Teixeira, Cristiane Trindade; Formiga, Anete Teixeira; dos Santos Isaias, Rosy Mary] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bot, Belo Horizonte, MG, Brazil; [Fernandes, Geraldo Wilson] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Isaias, RMD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bot, Belo Horizonte, MG, Brazil.	rosy@icb.ufmg.br	Ferreira, Bruno G./F-9428-2013; de Oliveira, Denis Coelho/AAU-8139-2020; Fernandes, Geraldo/AAN-5602-2021; MAGALHÃES, THIAGO/H-4271-2016; Isaias, Rosy MS/C-3736-2013; Oliveira, Denis/A-4923-2013	Ferreira, Bruno G./0000-0003-2156-2988; de Oliveira, Denis Coelho/0000-0002-6386-918X; Fernandes, Geraldo/0000-0003-1559-6049; MAGALHÃES, THIAGO/0000-0001-9566-6398; Isaias, Rosy MS/0000-0001-8500-3320; 	FAPEMIG [APQ-01801-09, CRA-30058/12]; CNPq [307007/2012-0, 403733/2012]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the FAPEMIG (APQ-01801-09 and CRA-30058/12) and CNPq (307007/2012-0 and 403733/2012) for financial support and research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Arduin M., 2005, Braz. J. Biol., V65, P559, DOI 10.1590/S1519-69842005000400002; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; de Oliveira DC, 2011, PROTOPLASMA, V248, P829, DOI 10.1007/s00709-010-0258-x; de Oliveira DC, 2010, PLANT SCI, V178, P350, DOI 10.1016/j.plantsci.2010.02.002; Isaias RMD, 2011, BOTANY, V89, P581, DOI [10.1139/B11-048, 10.1139/b11-048]; FERNANDES GW, 1990, ENVIRON ENTOMOL, V19, P1173, DOI 10.1093/ee/19.5.1173; Formiga AT, 2013, PROTOPLASMA, V250, P899, DOI 10.1007/s00709-012-0473-8; Foster TJ, 1996, BIOPOLYMERS, V39, P51, DOI 10.1002/(SICI)1097-0282(199607)39:1<51::AID-BIP6>3.3.CO;2-7; Gao MG, 1999, PLANT J, V19, P321, DOI 10.1046/j.1365-313X.1999.00544.x; HERMAN EM, 1992, PLANT PHYSIOL, V98, P264, DOI 10.1104/pp.98.1.264; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Isaias RMS, 2013, NEOTROP ENTOMOL, V42, P230, DOI 10.1007/s13744-013-0115-7; JENSEN W. A, 1962, BOT HISTOCHEMISTRY; Jiang LX, 2005, PLANT CELL, V17, P584, DOI 10.1105/tpc.104.027631; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Knox JP, 1997, INT REV CYTOL, V171, P79; KNOX JP, 1992, PLANT J, V2, P137, DOI 10.1111/j.1365-313X.1992.00137.x; Lev-Yadun S., 2003, Current Topics in Plant Biology, Volume 4, P93; Liu QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065131; Magalhaes TA, 2014, PROTOPLASMA, V251, P747, DOI 10.1007/s00709-013-0574-z; Majewska-Sawka A, 2000, PLANT PHYSIOL, V122, P3, DOI 10.1104/pp.122.1.3; Mani M.S., 1964, ECOLOGY PLANT GALLS, DOI 10.1007/978-94-017-6230-4; Mastroberti AA, 2008, PROTOPLASMA, V232, P233, DOI 10.1007/s00709-007-0274-7; McCartney L, 2002, J EXP BOT, V53, P707, DOI 10.1093/jexbot/53.369.707; McCartney L, 2000, PLANT J, V22, P105, DOI 10.1046/j.1365-313x.2000.00719.x; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Oliveira DC, 2010, PROTOPLASMA, V242, P81, DOI 10.1007/s00709-010-0128-6; Orfila C, 2000, PLANT PHYSIOL, V122, P775, DOI 10.1104/pp.122.3.775; PENNELL RI, 1990, NATURE, V344, P547, DOI 10.1038/344547a0; PENNELL RI, 1989, J CELL BIOL, V108, P1967, DOI 10.1083/jcb.108.5.1967; Perez S, 2003, BIOCHIMIE, V85, P109, DOI 10.1016/S0300-9084(03)00053-1; Raman A, 2007, CURR SCI INDIA, V92, P748; Redfern M, 1992, PLANT GALLS; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Rohfritsch O., 1992, P60; Roland JC, 1991, ELECT MICROSCOPY PLA, P2; Rose J.K.C., 2003, PLANT CELL WALL; Sabba RP, 2005, J AM SOC HORTIC SCI, V130, P936, DOI 10.21273/JASHS.130.6.936; Sala K, 2013, BIOL PLANTARUM, V57, P410, DOI 10.1007/s10535-013-0304-6; SCHINDLER TM, 1995, PROTOPLASMA, V188, P213, DOI 10.1007/BF01280373; Shorthouse JD, 2005, BASIC APPL ECOL, V6, P407, DOI 10.1016/j.baae.2005.07.001; STERLING C, 1970, AM J BOT, V57, P172, DOI 10.2307/2440510; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; WEIS KG, 1988, J HISTOCHEM CYTOCHEM, V36, P1037, DOI 10.1177/36.8.3392393; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Wolf S, 2012, PROTOPLASMA, V249, P169, DOI 10.1007/s00709-011-0371-5	50	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94588	10.1371/journal.pone.0094588	http://dx.doi.org/10.1371/journal.pone.0094588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747777	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500034
J	Grabmaier, U; Theiss, HD; Keithahn, A; Kreiner, J; Brenner, C; Huber, B; von der Helm, C; Gross, L; Klingel, K; Franz, WM; Brunner, S				Grabmaier, Ulrich; Theiss, Hans D.; Keithahn, Alexandra; Kreiner, Julia; Brenner, Christoph; Huber, Bruno; von der Helm, Christine; Gross, Lisa; Klingel, Karin; Franz, Wolfgang-M.; Brunner, Stefan			The Role of 1.5 Tesla MRI and Anesthetic Regimen Concerning Cardiac Analysis in Mice with Cardiomyopathy	PLOS ONE			English	Article							MYOCARDITIS; VIRUS; PERSISTENCE; INHIBITION; THERAPY; MODELS	Accurate assessment of left ventricular function in rodent models is essential for the evaluation of new therapeutic approaches for cardiac diseases. In our study, we provide new insights regarding the role of a 1.5 Tesla (T) magnetic resonance imaging (MRI) device and different anesthetic regimens on data validity. As dedicated small animal MRI and echocardiographic devices are not broadly available, we evaluated whether monitoring cardiac function in small rodents with a clinical 1.5 T MRI device is feasible. On a clinical electrocardiogram (ECG) synchronized 1.5 T MRI scanner we therefore studied cardiac function parameters of mice with chronic virus-induced cardiomyopathy. Thus, reduced left ventricular ejection fraction (LVEF) could be verified compared to healthy controls. However, our results showed a high variability. First, anesthesia with medetomidine, midazolam and fentanyl (MMF) led to depressed cardiac function parameters and more variability than isoflurane gas inhalation anesthesia, especially at high concentrations. Furthermore, calculation of an average ejection fraction value from sequenced scans significantly reduced the variance of the results. To sum up, we introduce the clinical 1.5 T MRI device as a new tool for effective analysis of left ventricular function in mice with cardiomyopathy. Besides, we suggest isoflurane gas inhalation anesthesia at high concentrations for variance reduction and recommend calculation of an average ejection fraction value from multiple sequenced MRI scans to provide valid data and a solid basis for further clinical testing.	[Grabmaier, Ulrich; Theiss, Hans D.; Kreiner, Julia; Brenner, Christoph; Huber, Bruno; Gross, Lisa; Franz, Wolfgang-M.; Brunner, Stefan] Univ Munich, Dept Internal Med 1, Munich, Germany; [Keithahn, Alexandra] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-80290 Munich, Germany; [Klingel, Karin] Univ Tubingen, Dept Mol Pathol, Tubingen, Germany; [von der Helm, Christine] Klinikum Augsburg, Dept Dermatol, Augsburg, Germany	University of Munich; Technical University of Munich; University of Munich; Eberhard Karls University of Tubingen; Klinikum Augsburg	Grabmaier, U (corresponding author), Univ Munich, Dept Internal Med 1, Campus Grosshadern, Munich, Germany.	Ulrich.Grabmaier@med.uni-muenchen.de		Huber, Bruno/0000-0002-1032-7686	Else-Kroner-Fresenius-Stiftung	Else-Kroner-Fresenius-Stiftung	Financial support was provided by the Else-Kroner-Fresenius-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006; Brunner S, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-43; Cochet H, 2012, EUR RADIOL; Frustaci A, 2009, EUR HEART J, V30, P1995, DOI 10.1093/eurheartj/ehp249; Gilson WD, 2007, METHODS, V43, P35, DOI 10.1016/j.ymeth.2007.03.012; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Heymans S, 2006, CIRCULATION, V114, P565, DOI 10.1161/CIRCULATIONAHA.105.591032; KANDOLF R, 1985, P NATL ACAD SCI USA, V82, P4818, DOI 10.1073/pnas.82.14.4818; Kania G, 2008, CARDIOVASC RES, V80, P236, DOI 10.1093/cvr/cvn190; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kober F, 2005, MAGNET RESON MED, V53, P601, DOI 10.1002/mrm.20373; Kreissl MC, 2006, J NUCL MED, V47, P974; Kuhl U, 2003, CIRCULATION, V107, P2793, DOI 10.1161/01.CIR.0000072766.67150.51; Nakamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041736; Nindl V, 2012, EUR J IMMUNOL, V42, P2311, DOI 10.1002/eji.201142209; Pinkert S, 2009, CIRCULATION, V120, P2358, DOI 10.1161/CIRCULATIONAHA.108.845339; Protti A, 2012, AM J PHYSIOL-HEART C, V303, pH309, DOI 10.1152/ajpheart.00208.2012; Reil GH, 2012, EUR HEART J; Rutschow S, 2010, EUR J PHARMACOL, V630, P145, DOI 10.1016/j.ejphar.2009.12.019; Schultheiss HP, 2011, EUR HEART J, V32, P2616, DOI 10.1093/eurheartj/ehr165; Schumacher A, 2008, PERFUSION-UK, V23, P291, DOI 10.1177/0267659109102485; Stuckey DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028569; Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109; Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003; Voelkl JGJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/185683; Wagenhaus B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042383; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463	29	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94615	10.1371/journal.pone.0094615	http://dx.doi.org/10.1371/journal.pone.0094615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747816	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500035
J	Sabatini, FM; Burrascano, S; Tuomisto, H; Blasi, C				Sabatini, Francesco Maria; Burrascano, Sabina; Tuomisto, Hanna; Blasi, Carlo			Ground Layer Plant Species Turnover and Beta Diversity in Southern-European Old-Growth Forests	PLOS ONE			English	Article							FAGUS-ABIES FOREST; FLORISTIC VARIATION; CONSISTENT TERMINOLOGY; SPATIAL PROCESSES; TEMPERATE; PATTERNS; DISPERSAL; DYNAMICS; PTERIDOPHYTES; BIODIVERSITY	Different assembly processes may simultaneously affect local-scale variation of species composition in temperate old-growth forests. Ground layer species diversity reflects chance colonization and persistence of low-dispersal species, as well as fine-scale environmental heterogeneity. The latter depends on both purely abiotic factors, such as soil properties and topography, and factors primarily determined by overstorey structure, such as light availability. Understanding the degree to which plant diversity in old-growth forests is associated with structural heterogeneity and/or to dispersal limitation will help assessing the effectiveness of silvicultural practices that recreate old-growth patterns and structures for the conservation or restoration of plant diversity. We used a nested sampling design to assess fine-scale species turnover, i.e. the proportion of species composition that changes among sampling units, across 11 beech-dominated old-growth forests in Southern Europe. For each stand, we also measured a wide range of environmental and structural variables that might explain ground layer species turnover. Our aim was to quantify the relative importance of dispersal limitation in comparison to that of stand structural heterogeneity while controlling for other sources of environmental heterogeneity. For this purpose, we used multiple regression on distance matrices at the within-stand extent, and mixed effect models at the extent of the whole dataset. Species turnover was best predicted by structural and environmental heterogeneity, especially by differences in light availability and in topsoil nutrient concentration and texture. Spatial distances were significant only in four out of eleven stands with a relatively low explanatory power. This suggests that structural heterogeneity is a more important driver of local-scale ground layer species turnover than dispersal limitation in southern European old-growth beech forests.	[Sabatini, Francesco Maria; Burrascano, Sabina; Blasi, Carlo] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy; [Tuomisto, Hanna] Univ Turku, Dept Biol, SF-20500 Turku, Finland	Sapienza University Rome; University of Turku	Sabatini, FM (corresponding author), Univ Roma La Sapienza, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	francescomaria.sabatini@uniroma1.it	Tuomisto, Hanna/G-6483-2012; Biosystems, Plant/GYU-1538-2022; Sabatini, Francesco/H-3290-2019	Tuomisto, Hanna/0000-0003-1640-490X; Sabatini, Francesco/0000-0002-7202-7697; Burrascano, Sabina/0000-0002-6537-3313; BLASI, Carlo/0000-0003-3016-0091	Sapienza, University of Rome [C26N12ESSE, C26A128K4A]	Sapienza, University of Rome	The original project was funded by two grants of Sapienza, University of Rome: 1. grant number C26N12ESSE - F.M. Sabatini (PI); 2. grant number C26A128K4A - C. Blasi (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre O, 2003, FOREST ECOL MANAG, V183, P137, DOI 10.1016/S0378-1127(03)00102-6; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Bauhus J, 2009, FOREST ECOL MANAG, V258, P525, DOI 10.1016/j.foreco.2009.01.053; Bianchi L, 2011, IFOREST, V4, P136, DOI 10.3832/ifor0564-004; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bruelheide H, 2005, FOREST ECOL MANAG, V210, P205, DOI 10.1016/j.foreco.2005.02.050; Burrascano S, 2011, PLANT ECOL, V212, P829, DOI 10.1007/s11258-010-9866-y; Burrascano S, 2009, PLANT BIOSYST, V143, P190, DOI 10.1080/11263500802709699; Burrascano S, 2008, PLANT BIOSYST, V142, P313, DOI 10.1080/11263500802150613; Burrascano S, 2013, APPL VEG SCI, V16, P404, DOI 10.1111/avsc.12021; Burrascano S, 2013, FOREST ECOL MANAG, V291, P458, DOI 10.1016/j.foreco.2012.11.020; Burton JI, 2011, J ECOL, V99, P764, DOI 10.1111/j.1365-2745.2011.01807.x; Calamini G., 2011, Italia Forestale e Montana, V66, P365; Capotorti G, 2012, PLANT BIOSYST, V146, P258, DOI 10.1080/11263504.2012.695298; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Curovic M, 2011, ARCH BIOL SCI, V63, P429, DOI 10.2298/ABS1102429C; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Gueze M, 2013, J VEG SCI, V24, P284, DOI 10.1111/j.1654-1103.2012.01461.x; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hubbell Stephen P., 2001, V32, pi; Hunter Jr M. L., 1990, WILDLIFE FORESTS FOR; Jones MM, 2013, J ECOL, V101, P506, DOI 10.1111/1365-2745.12053; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Karst J, 2005, ECOLOGY, V86, P2473, DOI 10.1890/04-1420; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; LARSEN JB, 1995, FOREST ECOL MANAG, V73, P85, DOI 10.1016/0378-1127(94)03501-M; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Lombardi F., 2010, Italia Forestale e Montana, V65, P481, DOI 10.4129/ifm.2010.5.02; Lopez-Martinez JO, 2013, J VEG SCI, V24, P33, DOI 10.1111/j.1654-1103.2012.01446.x; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Motta R, PLANT BIOSYST; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Nagel TA, 2010, PLANT ECOL, V208, P307, DOI 10.1007/s11258-009-9707-z; Nagel TA, 2008, CAN J FOREST RES, V38, P2728, DOI 10.1139/X08-110; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Norden B, 2001, BIODIVERS CONSERV, V10, P779, DOI 10.1023/A:1016675103935; PEET RK, 1978, VEGETATIO, V37, P65, DOI 10.1007/BF00126830; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Piovesan G, 2005, J VEG SCI, V16, P13, DOI 10.1111/j.1654-1103.2005.tb02334.x; Poulsen AD, 2006, BIOTROPICA, V38, P468, DOI 10.1111/j.1744-7429.2006.00168.x; PRIETO JAF, 1992, VEGETATIO, V102, P33, DOI 10.1007/BF00031702; R Core Team, 2016, R FDN STAT COMP; Rivas-Martinez S., 2009, WORLDWIDE BIOCLIMATI; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Rugani T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052641; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K, 2007, J TROP ECOL, V23, P13, DOI 10.1017/S0266467406003889; Sabatini F. M., 2010, Italia Forestale e Montana, V65, P621, DOI 10.4129/ifm.2010.5.10; Sabatini FM, COMMUNITY E IN PRESS; Sabatini FM, 2014, APPL VEG SCI, V17, P398, DOI 10.1111/avsc.12083; Saitta A, 2011, PLANT BIOSYST, V145, P958, DOI 10.1080/11263504.2011.633114; Travaglini D, 2012, PLANT BIOSYST, V146, P175, DOI 10.1080/11263504.2011.650731; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; Tuomisto H, 2011, OECOLOGIA, V167, P903, DOI 10.1007/s00442-011-2128-4; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; WHITTAKER J, 1984, J R STAT SOC C-APPL, V33, P52; Wilson EO, 1967, THEORY ISLAND BIOGEO; Winter S, 2008, FOREST ECOL MANAG, V255, P1251, DOI 10.1016/j.foreco.2007.10.029; Zuur AF, 2009, STAT BIOL HLTH, P269	70	28	28	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95244	10.1371/journal.pone.0095244	http://dx.doi.org/10.1371/journal.pone.0095244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748155	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500069
J	Satoh-Kuriwada, S; Kawai, M; Iikubo, M; Sekine-Hayakawa, Y; Shoji, N; Uneyama, H; Sasano, T				Satoh-Kuriwada, Shizuko; Kawai, Misako; Iikubo, Masahiro; Sekine-Hayakawa, Yuki; Shoji, Noriaki; Uneyama, Hisayuki; Sasano, Takashi			Development of an Umami Taste Sensitivity Test and Its Clinical Use	PLOS ONE			English	Article							CIRCUMVALLATE PAPILLAE; GUSTATORY FUNCTION; RECEPTOR; BUDS; THRESHOLDS; PERCEPTION; FUNGIFORM; AGREEMENT; VARIANT; SCALE	There is a close relationship between perception of umami, which has become recognized as the fifth taste, and the human physical condition. We have developed a clinical test for umami taste sensitivity using a filter paper disc with a range of six monosodium glutamate (MSG) concentrations. We recruited 28 patients with taste disorders (45-78 years) and 184 controls with no taste disorders (102 young [18-25 years] and 82 older [65-89 years] participants). Filter paper discs (5 mm dia.) were soaked in aqueous MSG solutions (1, 5, 10, 50, 100 and 200 mM), then placed on three oral sites innervated by different taste nerves. The lowest concentration participants correctly identified was defined as the recognition threshold (RT) for MSG. This test showed good reproducibility for inter-and intra-observer variability. We concluded that: (1) The RT of healthy controls differed at measurement sites innervated by different taste nerves; that is, the RT of the anterior tongue was higher than that of either the posterior tongue or the soft palate in both young and older individuals. (2) No significant difference in RT was found between young adults and older individuals at any measurement site. (3) The RT of patients with taste disorders was higher before treatment than that of the healthy controls at any measurement site. (4) The RT after treatment in these patients improved to the same level as that of the healthy controls. (5) The cutoff values of RT, showing the highest diagnostic accuracy (true positives + true negatives), were 200 mM MSG for AT and 50 mM MSG for PT and SP. The diagnostic accuracy at these cutoff values was 0.92, 0.87 and 0.86 for AT, PT and SP, respectively. Consequently, this umami taste sensitivity test is useful for discriminating between normal and abnormal umami taste sensations.	[Satoh-Kuriwada, Shizuko; Iikubo, Masahiro; Shoji, Noriaki; Sasano, Takashi] Tohoku Univ, Div Oral Diag, Dept Oral Med & Surg, Grad Sch Dent,Aoba Ku, Sendai, Miyagi 980, Japan; [Kawai, Misako; Sekine-Hayakawa, Yuki; Uneyama, Hisayuki] Ajinomoto Co Inc, Inst Innovat, Kawasaki Ku, Kawasaki, Kanagawa, Japan	Tohoku University; Ajinomoto Co Inc	Satoh-Kuriwada, S (corresponding author), Tohoku Univ, Div Oral Diag, Dept Oral Med & Surg, Grad Sch Dent,Aoba Ku, Sendai, Miyagi 980, Japan.	kuri-shu@dent.tohoku.ac.jp; shoji_noriaki@dent.tohoku.ac.jp			Ministry of Education, Japan [24659931, 24590780, 25305039]; Grants-in-Aid for Scientific Research [25305039, 24590780] Funding Source: KAKEN	Ministry of Education, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Japan (No. 24659931, 24590780, 25305039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arey LB, 1935, ANAT REC, V64, P9, DOI 10.1002/ar.1090640103; ARVIDSON K, 1979, SCAND J DENT RES, V87, P435; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Chaudhari N, 1996, J NEUROSCI, V16, P3817; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Conger AD, 1969, RADIAT RES, V37, P3149; Fleiss J. L., 1981, STAT METHODS RATES P, V2; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Fujibayashi Takashi, 2004, Mod Rheumatol, V14, P425, DOI 10.3109/s10165-004-0338-x; Halpern B. P., 1987, Umami: a basic taste. Physiology, biochemistry, nutrition, food science, P327; HENKIN RI, 1963, J CLIN INVEST, V42, P727, DOI 10.1172/JCI104765; Henkin RI, 2008, SIG 15 PERSPECTIVES, V13, P20; Ikeda K, 2002, CHEM SENSES, V27, P847, DOI 10.1093/chemse/27.9.847; Jyotaki M, 2009, J HEALTH SCI, V55, P674, DOI 10.1248/jhs.55.674; Kiesow F., 1984, PHILOS STUD, V10, P329; Landis BN, 2005, LARYNGOSCOPE, V115, P1124, DOI 10.1097/01.MLG.0000163750.72441.C3; Lewandowski KE, 2009, ANN ACAD MED SINGAP, V38, P383; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; MISTRETTA CM, 1984, J ANAT, V138, P323; Mojet J, 2005, FOOD QUAL PREFER, V16, P413, DOI 10.1016/j.foodqual.2004.08.001; Mueller C, 2003, RHINOLOGY, V41, P2; Mueller CA, 2011, ANN OTO RHINOL LARYN, V120, P358, DOI 10.1177/000348941112000602; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; Nishimoto K, 1996, ORL J OTO-RHINO-LARY, V58, P258, DOI 10.1159/000276849; San Gabriel A, 2005, CHEM SENSES, V30, pI25, DOI 10.1093/chemse/bjh095; Satoh-Kuriwada S, 2009, J HEALTH SCI, V55, P689, DOI 10.1248/jhs.55.689; Schiffman SS, 2000, EUR J CLIN NUTR, V54, pS54, DOI 10.1038/sj.ejcn.1601026; SCHIFFMAN SS, 1990, CHEM SENSES, V15, P671, DOI 10.1093/chemse/15.6.671; SCHIFFMAN SS, 1991, PHYSIOL BEHAV, V49, P843, DOI 10.1016/0031-9384(91)90193-R; Schiffman SS., 1991, TASTE SMELL PERCEPTI, P61; TAYLOR JA, 1953, J ABNORM SOC PSYCH, V48, P285, DOI 10.1037/h0056264; Tomita H, 1986, Auris Nasus Larynx, V13 Suppl 1, pS1; Toyono T, 2003, CELL TISSUE RES, V313, P29, DOI 10.1007/s00441-003-0740-2; Yamaguchi S, 1998, FOOD REV INT, V14, P139, DOI 10.1080/87559129809541156; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	38	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95177	10.1371/journal.pone.0095177	http://dx.doi.org/10.1371/journal.pone.0095177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748056	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500065
J	Tapia-Lewin, S; Pardo, LM				Tapia-Lewin, Sebastian; Pardo, Luis Miguel			Field Assessment of the Predation Risk - Food Availability Trade-Off in Crab Megalopae Settlement	PLOS ONE			English	Article							VALDIVIA RIVER ESTUARY; CALLINECTES-SAPIDUS; CHEMICAL CUES; BLUE-CRAB; RELATIVE IMPORTANCE; HABITAT SELECTION; HEMIGRAPSUS-SANGUINEUS; DELAYED METAMORPHOSIS; MARINE-INVERTEBRATES; CARCINUS-MAENAS	Settlement is a key process for meroplanktonic organisms as it determines distribution of adult populations. Starvation and predation are two of the main mortality causes during this period; therefore, settlement tends to be optimized in microhabitats with high food availability and low predator density. Furthermore, brachyuran megalopae actively select favorable habitats for settlement, via chemical, visual and/or tactile cues. The main objective in this study was to assess the settlement of Metacarcinus edwardsii and Cancer plebejus under different combinations of food availability levels and predator presence. We determined, in the field, which factor is of greater relative importance when choosing a suitable microhabitat for settling. Passive larval collectors were deployed, crossing different scenarios of food availability and predator presence. We also explore if megalopae actively choose predator-free substrates in response to visual and/or chemical cues. We tested the response to combined visual and chemical cues and to each individually. Data was tested using a two-way factorial design ANOVA. In both species, food did not cause significant effect on settlement success, but predator presence did, therefore there was not trade-off in this case and megalopae respond strongly to predation risk by active aversion. Larvae of M. edwardsii responded to chemical and visual cues simultaneously, but there was no response to either cue by itself. Statistically, C. plebejus did not exhibit a differential response to cues, but reacted with a strong similar tendency as M. edwardsii. We concluded that crab megalopae actively select predator-free microhabitat, independently of food availability, using chemical and visual cues combined. The findings in this study highlight the great relevance of predation on the settlement process and recruitment of marine invertebrates with complex life cycles.	[Tapia-Lewin, Sebastian; Pardo, Luis Miguel] Univ Austral Chile, Fac Ciencias, Lab Costero Calfuco, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile	Pardo, LM (corresponding author), Univ Austral Chile, Fac Ciencias, Lab Costero Calfuco, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	luispardo@uach.cl	Pardo, L M/A-3178-2008	Pardo, L M/0000-0003-2005-4922; Tapia, Sebastian/0000-0001-5791-7977; Pardo, Luis Miguel/0000-0002-8179-5057	FONDECYT [11070024]; DID UACh	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DID UACh	LMP acknowledges funding from FONDECYT project 11070024 and DID UACh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2007, J EXP MAR BIOL ECOL, V347, P77, DOI 10.1016/j.jembe.2007.03.010; Almeida MJ, 2011, J EXP MAR BIOL ECOL, V410, P72, DOI 10.1016/j.jembe.2011.10.011; Anger K, 2006, INVERTEBR REPROD DEV, V49, P175, DOI 10.1080/07924259.2006.9652207; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Berteness M., MARINE COMMUNITY ECO, P183; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Casariego AM, 2011, J SEA RES, V66, P87, DOI 10.1016/j.seares.2011.05.001; Casariego AM, 2009, J MAR BIOL ASSOC UK, V89, P781, DOI 10.1017/S0025315408002324; Chiussi R, 2001, J CRUSTACEAN BIOL, V21, P593, DOI 10.1651/0278-0372(2001)021[0593:OOTHCC]2.0.CO;2; Diaz H, 1999, J EXP MAR BIOL ECOL, V233, P25, DOI 10.1016/S0022-0981(98)00121-X; Diaz H, 2001, J EXP MAR BIOL ECOL, V266, P1, DOI 10.1016/S0022-0981(01)00330-6; Diele K, 2007, J EXP MAR BIOL ECOL, V348, P174, DOI 10.1016/j.jembe.2007.04.008; Dittel A, 1996, J EXP MAR BIOL ECOL, V198, P191, DOI 10.1016/0022-0981(96)00003-2; FERNANDEZ M, 1993, MAR ECOL PROG SER, V92, P171, DOI 10.3354/meps092171; Forward RB, 2003, MAR BIOL, V142, P747, DOI 10.1007/s00227-002-0966-7; Forward RB, 2001, AM ZOOL, V41, P1108, DOI 10.1668/0003-1569(2001)041[1108:CFMOBC]2.0.CO;2; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Garces-Vargas J, 2013, LAT AM J AQUAT RES, V41, P113, DOI 10.3856/vol41-issue1-fulltext-9; Gebauer P, 2003, REV CHIL HIST NAT, V76, P169; Gebauer P, 1998, J EXP MAR BIOL ECOL, V223, P185, DOI 10.1016/S0022-0981(97)00159-7; Hazlett BA, 2005, ANIM BEHAV, V69, P967, DOI 10.1016/j.anbehav.2004.06.028; Ismail TGE-K., 2012, JOBAZ, V65, P95, DOI [10.1016/j.jobaz.2012.02.004, DOI 10.1016/J.JOBAZ.2012.02.004]; Januario SM, 2013, J EXP MAR BIOL ECOL, V446, P36, DOI 10.1016/j.jembe.2013.04.017; JENSEN GC, 1989, J EXP MAR BIOL ECOL, V131, P223, DOI 10.1016/0022-0981(89)90114-7; JENSEN GC, 1991, J EXP MAR BIOL ECOL, V153, P49, DOI 10.1016/S0022-0981(05)80005-X; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; Krediet CJ, 2009, J EXP MAR BIOL ECOL, V373, P133, DOI 10.1016/j.jembe.2009.04.001; Krimsky LS, 2008, J EXP MAR BIOL ECOL, V358, P178, DOI 10.1016/j.jembe.2008.02.010; Lecchini D, 2011, CR BIOL, V334, P911, DOI 10.1016/j.crvi.2011.08.003; Lindsey EL, 2006, MAR ECOL PROG SER, V306, P223, DOI 10.3354/meps306223; Luppi TA, 2001, J EXP MAR BIOL ECOL, V265, P29, DOI 10.1016/S0022-0981(01)00322-7; Matamala TB, 2011, THESIS U AUSTRAL CHI, P71; Pardo LM, 2012, HELGOLAND MAR RES, V66, P253, DOI 10.1007/s10152-011-0267-y; Pardo LM, 2012, LAT AM J AQUAT RES, V40, P142, DOI 10.3856/vol40-issue1-fulltext-14; Pardo LM, 2009, J MAR BIOL ASSOC UK, V89, P481, DOI 10.1017/S0025315409003233; Moksnes PO, 2006, MAR ECOL PROG SER, V308, P165, DOI 10.3354/meps308165; Moksnes PO, 2003, MAR ECOL PROG SER, V250, P215, DOI 10.3354/meps250215; Moksnes PO, 2002, J EXP MAR BIOL ECOL, V271, P41, DOI 10.1016/S0022-0981(02)00041-2; O'Connor NJ, 2007, MAR ECOL PROG SER, V352, P1, DOI 10.3354/meps07315; Pardo LM, 2007, J EXP MAR BIOL ECOL, V344, P10, DOI 10.1016/j.jembe.2006.12.024; Pardo LM, 2010, J EXP MAR BIOL ECOL, V393, P100, DOI 10.1016/j.jembe.2010.07.008; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; Sotelano MP, 2012, J EXP MAR BIOL ECOL, V411, P52, DOI 10.1016/j.jembe.2011.10.029; PECHENIK JA, 1990, OPHELIA, V32, P63, DOI 10.1080/00785236.1990.10422025; PINO M, 1994, ESTUAR COAST SHELF S, V38, P491; Pirtle JL, 2010, J EXP MAR BIOL ECOL, V393, P130, DOI 10.1016/j.jembe.2010.07.012; RITTSCHOF D, 1992, J CHEM ECOL, V18, P959, DOI 10.1007/BF00980056; Rodriguez RA, 2000, MAR ECOL PROG SER, V195, P221, DOI 10.3354/meps195221; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Schram FR, 2012, J CRUSTACEAN BIOL, V32, P665, DOI 10.1163/193724012X640650; Steinberg MK, 2008, ESTUAR COAST, V31, P738, DOI 10.1007/s12237-008-9063-6; Stevens BG, 2003, J EXP MAR BIOL ECOL, V283, P63, DOI 10.1016/S0022-0981(02)00471-9; STONER DS, 1990, ECOLOGY, V71, P1682, DOI 10.2307/1937577; Thiel M, 2003, J ZOOL, V261, P353, DOI 10.1017/S0952836903004333; Underwood AJ, 2004, MAR ECOL PROG SER, V268, P173, DOI 10.3354/meps268173; Welch JM, 1997, MAR ECOL PROG SER, V154, P143, DOI 10.3354/meps154143; Williamson JE, 2012, J EXP MAR BIOL ECOL, V414, P38, DOI 10.1016/j.jembe.2012.01.009; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; WOLCOTT DL, 1994, MAR ECOL PROG SER, V109, P157, DOI 10.3354/meps109157; Zar JH, 1999, BIOSTATISTICAL ANAL	60	16	16	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95335	10.1371/journal.pone.0095335	http://dx.doi.org/10.1371/journal.pone.0095335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748151	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500087
J	Saino, H; Shimizu, T; Hiratake, J; Nakatsu, T; Kato, H; Sakata, K; Mizutani, M				Saino, Hiromichi; Shimizu, Tetsuya; Hiratake, Jun; Nakatsu, Toru; Kato, Hiroaki; Sakata, Kanzo; Mizutani, Masaharu			Crystal Structures of beta-Primeverosidase in Complex with Disaccharide Amidine Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE AGLYCONE SPECIFICITY; OOLONG TEA; FURCATIN HYDROLASE; PLANT VOLATILES; AROMA FORMATION; KEY ENZYME; GLUCOSIDASE; GLYCOSIDASE; EXPRESSION; GLYCOSYLAMIDINES	beta-Primeverosidase (PD) is a disaccharide-specific beta-glycosidase in tea leaves. This enzyme is involved in aroma formation during the manufacturing process of oolong tea and black tea. PD hydrolyzes beta-primeveroside (6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside) at the beta-glycosidic bond of primeverose to aglycone, and releases aromatic alcoholic volatiles of aglycones. PD only accepts primeverose as the glycone substrate, but broadly accepts various aglycones, including 2-phenylethanol, benzyl alcohol, linalool, and geraniol. We determined the crystal structure of PD complexes using highly specific disaccharide amidine inhibitors, N-beta-primeverosylamidines, and revealed the architecture of the active site responsible for substrate specificity. We identified three subsites in the active site: subsite -2 specific for 6-O-beta-Dxylopyranosyl, subsite -1 well conserved among beta-glucosidases and specific for beta-D-glucopyranosyl, and wide subsite +1 for hydrophobic aglycone. Glu-470, Ser-473, and Gln-477 act as the specific hydrogen bond donors for 6-O-beta-D-xylopyranosyl in subsite -2. On the other hand, subsite +1 was a large hydrophobic cavity that accommodates various aromatic aglycones. Compared with aglycone-specific beta-glucosidases of the glycoside hydrolase family 1, PD lacks the Trp crucial for aglycone recognition, and the resultant large cavity accepts aglycone and 6-O-beta-D-xylopyranosyl together. PD recognizes the beta-primeverosides in subsites -1 and -2 by hydrogen bonds, whereas the large subsite +1 loosely accommodates various aglycones. The glycone-specific activity of PD for broad aglycone substrates results in selective and multiple release of temporally stored alcoholic volatile aglycones of beta-primeveroside.	[Saino, Hiromichi] Aoyama Gakuin Univ, Coll Sci & Engn, Sagamihara, Kanagawa 2525258, Japan; [Shimizu, Tetsuya] Okayama Univ, Fac Sci, Okayama 7008530, Japan; [Hiratake, Jun; Sakata, Kanzo] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Nakatsu, Toru; Kato, Hiroaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Mizutani, Masaharu] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan	Aoyama Gakuin University; Okayama University; Kyoto University; Kyoto University; Kobe University	Saino, H (corresponding author), Aoyama Gakuin Univ, Coll Sci & Engn, Sagamihara, Kanagawa 2525258, Japan.	saino@chem.aoyama.ac.jp		Nakatsu, Toru/0000-0002-9582-4023; Kato, Hiroaki/0000-0002-5993-4532; Mizutani, Masaharu/0000-0002-4321-0644	Ministry of Education, Culture, Sports, Science, and Technology of Japan [13460049, 16380079]; MEXT (Ministry of Education, Culture, Sports, Science and Technology)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants-in-Aids 13460049 and 16380079 and the MEXT (Ministry of Education, Culture, Sports, Science and Technology)-supported Program for the Strategic Research Foundation at Private Universities (2013-2017).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn YO, 2004, J BIOL CHEM, V279, P23405, DOI 10.1074/jbc.M311379200; Ahn YO, 2007, PLANT CELL PHYSIOL, V48, P938, DOI 10.1093/pcp/pcm065; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Barleben L, 2007, PLANT CELL, V19, P2886, DOI 10.1105/tpc.106.045682; BERRAH G, 1962, J BACTERIOL, V83, P738, DOI 10.1128/JB.83.4.738-744.1962; BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cho JY, 2007, BIOSCI BIOTECH BIOCH, V71, P1476, DOI 10.1271/bbb.60708; Chuankhayan P, 2007, ARCH BIOCHEM BIOPHYS, V468, P205, DOI 10.1016/j.abb.2007.09.015; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Daiyasu H, 2008, J BIOCHEM, V144, P467, DOI 10.1093/jb/mvn095; DeLano W. L., 2002, CCP4 NEWSLETT PROTEI, V40, P44; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Griffin SG, 1999, FLAVOUR FRAG J, V14, P322, DOI [10.1002/(SICI)1099-1026(199909/10)14:5<322::AID-FFJ837>3.3.CO;2-W, 10.1002/(SICI)1099-1026(199909/10)14:5&lt;322::AID-FFJ837&gt;3.0.CO;2-4]; GUO WF, 1995, BIOSCI BIOTECH BIOCH, V59, P962, DOI 10.1271/bbb.59.962; GUO WF, 1993, PHYTOCHEMISTRY, V33, P1373, DOI 10.1016/0031-9422(93)85093-7; GUO WF, 1994, BIOSCI BIOTECH BIOCH, V58, P1532, DOI 10.1271/bbb.58.1532; Guo WF, 2001, BIOORG MED CHEM LETT, V11, P467, DOI 10.1016/S0960-894X(00)00706-X; Hancock SM, 2005, CHEMBIOCHEM, V6, P866, DOI 10.1002/cbic.200400341; Himeno N, 2013, BIOSCI BIOTECH BIOCH, V77, P934, DOI 10.1271/bbb.120889; Hiratake J, 2003, METHOD ENZYMOL, V363, P421; Hua YL, 2013, ARCH BIOCHEM BIOPHYS, V537, P39, DOI 10.1016/j.abb.2013.06.005; Inoue K, 2003, CARBOHYD RES, V338, P1477, DOI 10.1016/S0008-6215(03)00201-5; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; KIM JM, 1995, J AGR FOOD CHEM, V43, P2839, DOI 10.1021/jf00059a013; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma SJ, 2001, BIOSCI BIOTECH BIOCH, V65, P2719, DOI 10.1271/bbb.65.2719; Meyer BK, 2007, J PHARM SCI-US, V96, P3155, DOI 10.1002/jps.20976; Mizutani M, 2002, PLANT PHYSIOL, V130, P2164, DOI 10.1104/pp.102.011023; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Saino H, 2008, BIOSCI BIOTECH BIOCH, V72, P376, DOI 10.1271/bbb.70447; Sakata K, 2003, METHOD ENZYMOL, V363, P444; Sue M, 2011, PLANT SCI, V180, P268, DOI 10.1016/j.plantsci.2010.09.001; Tribolo S, 2007, J MOL BIOL, V370, P964, DOI 10.1016/j.jmb.2007.05.034; Utama IMS, 2002, J AGR FOOD CHEM, V50, P6371, DOI 10.1021/jf020484d; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verdoucq L, 2004, J BIOL CHEM, V279, P31796, DOI 10.1074/jbc.M402918200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xia LQ, 2012, ACS CHEM BIOL, V7, P226, DOI 10.1021/cb200267w; Zhu YJ, 2011, FOOD CHEM, V124, P298, DOI 10.1016/j.foodchem.2010.06.036	47	14	15	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16826	16834		10.1074/jbc.M114.553271	http://dx.doi.org/10.1074/jbc.M114.553271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24753293	Green Published, hybrid			2022-12-25	WOS:000338016200020
J	Nonaka, M; Fukuda, MN; Gao, C; Li, Z; Zhang, HT; Greene, MI; Peehl, DM; Ten, FZ; Fukuda, M				Nonaka, Motohiro; Fukuda, Michiko N.; Gao, Chao; Li, Zhen; Zhang, Hongtao; Greene, Mark I.; Peehl, Donna M.; Ten Feizi; Fukuda, Minoru			Determination of Carbohydrate Structure Recognized by Prostate-specific F77 Monoclonal Antibody through Expression Analysis of Glycosyltransferase Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE GENE; O-GLYCANS; CORE 2; CANCER; GLYCOSYLATION; CARCINOMA; HYPOXIA; CELLS; RITUXIMAB; LYMPHOMA	This study reports the determination of the carbohydrate epitope of monoclonal antibody F77 previously raised against human prostate cancer PC-3 cells (Zhang, G., Zhang, H., Wang, Q., Lal, P., Carroll, A. M., de la Llera-Moya, M., Xu, X., and Greene, M. I. (2010) Proc. Natl. Acad. Sci. U. S. A. 107, 732-737). We performed a series of co-transfections using mammalian expression vectors encoding specific glycosyltransferases. We thereby identified branching enzymes and FUT1 (required for Fuc alpha 1 -> 2Gal linkage) as being essential for F77 antigen formation. When immortalized normal prostate 267B1 cells were transfected with FUT1 alone, cells showed weak expression of F77 antigen. By contrast, cells co-transfected with FUT1 plus either GCNT1, GCNT2, or GCNT3(an enzyme required to form GlcNAc beta -> 6Gal/GalNAc) showed robust F77 antigen expression, suggesting that F77 specifically binds to Fuc alpha 1 -> 2-Gal beta -> GlcNAc beta 1 -> 6Gal/GalNAc. RT-PCR for FUT1, GCNT1, GCNT2, and GCNT3 showed that F77-positive cell lines indeed express transcripts encoding FUT1 plus one GCNT. F77-positive prostate cancer cells transfected with siRNAs targeting FUT1, GCNT2, and GCNT3 showed significantly reduced F77 antigen, confirming the requirement of these enzymes for epitope synthesis. We also found that hypoxia induces F77 epitope expression in immortalized prostate RWPE1 cells, which express F77 antigen moderately under normoxia but at an elevated level under hypoxia. Quantitative RT-PCR demonstrated up-regulation of FUT1, GCNT2, and GCNT3 transcripts in RWPE1 cells under hypoxia, suggesting that hypoxia up-regulates glycosyltransferase expression required for F77 antigen synthesis. These results define the F77 epitope and provide a potential mechanism for F77 antigen synthesis in malignant prostate cancer.	[Nonaka, Motohiro; Fukuda, Michiko N.; Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, La Jolla, CA 92037 USA; [Zhang, Hongtao; Greene, Mark I.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Peehl, Donna M.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; [Gao, Chao; Li, Zhen; Ten Feizi] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England	Sanford Burnham Prebys Medical Discovery Institute; University of Pennsylvania; Stanford University; Imperial College London	Fukuda, M (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	minoru@sanfordburnham.org		Li, Zhen/0000-0002-8853-4941; Feizi, Ten/0000-0001-6495-0329; Gao, Chao/0000-0003-3489-3989; Zhang, Hongtao/0000-0001-9173-0049	National Institutes of Health [GM62116, GM098791]; Engineering and Physical Sciences Research Council [EP/G037604/1, GR/S79268/02] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016520, P01CA071932, U01CA168925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791, U54GM062116] Funding Source: NIH RePORTER; EPSRC [EP/G037604/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Dr. Elise Lamar for editing the manuscript. Synthetic oligosaccharides were provided as core D by the Consortium for Functional Glycomics supported by National Institutes of Health Grants GM62116 and GM098791.	ABE K, 1983, J BIOL CHEM, V258, P1793; Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Alvarez-Rueda N, 2007, CLIN CANCER RES, V13, p5613S, DOI 10.1158/1078-0432.CCR-07-1057; Bakovic MP, 2013, J PROTEOME RES, V12, P821, DOI 10.1021/pr300887z; BIERHUIZEN MFA, 1993, GENE DEV, V7, P468, DOI 10.1101/gad.7.3.468; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Carrington SD, 2012, METHODS MOL BIOL, V842, P191, DOI 10.1007/978-1-61779-513-8_11; CARROLL AM, 1984, CLIN IMMUNOL IMMUNOP, V33, P268, DOI 10.1016/0090-1229(84)90081-3; Feizi T, 2000, GLYCOCONJUGATE J, V17, P553, DOI 10.1023/A:1011022509500; Feizi T, 2013, ANN NY ACAD SCI, V1292, P33, DOI 10.1111/nyas.12210; Gao C, 2014, J BIOL CHEM, V289, P16462, DOI 10.1074/jbc.M114.558932; Gornik O, 2012, BBA-GEN SUBJECTS, V1820, P1318, DOI 10.1016/j.bbagen.2011.12.004; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HELLSTROM I, 1990, CANCER RES, V50, P2183; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; Huang XM, 2004, PROSTATE, V61, P1, DOI 10.1002/pros.20074; Kannagi R, 2000, METHOD ENZYMOL, V312, P160; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Lauc G, 2014, BBA-GEN SUBJECTS, V1840, P65, DOI 10.1016/j.bbagen.2013.08.017; Lauc G, 2010, MOL BIOSYST, V6, P329, DOI 10.1039/b910377e; Liu L, 2013, GLYCOCONJUGATE J, V30, P791, DOI 10.1007/s10719-013-9483-9; Maeda T, 2001, INT J HEMATOL, V74, P70, DOI 10.1007/BF02982552; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; Nakamori S, 1997, J CLIN ONCOL, V15, P816, DOI 10.1200/JCO.1997.15.2.816; Nozawa S, 2004, CLIN CANCER RES, V10, P7071, DOI 10.1158/1078-0432.CCR-04-0802; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Shibata TK, 2012, J BIOL CHEM, V287, P6592, DOI 10.1074/jbc.M111.305334; Shimodaira K, 1997, CANCER RES, V57, P5201; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stanley P, 1996, GLYCOBIOLOGY, V6, P695, DOI 10.1093/glycob/6.7.695; Talwar GP, 2001, PROSTATE, V46, P207; Tobinai K, 2001, CANCER CHEMOTH PHARM, V48, pS85, DOI 10.1007/s002800100313; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wada Y, 2010, MOL CELL PROTEOMICS, V9, P719, DOI 10.1074/mcp.M900450-MCP200; WATTENBERG BW, 1990, J CELL BIOL, V111, P421, DOI 10.1083/jcb.111.2.421; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Zhang G, 2010, P NATL ACAD SCI USA, V107, P732, DOI 10.1073/pnas.0911397107; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414; Zitzmann N, 2005, ADV EXP MED BIOL, V564, P1; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	43	23	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16478	16486		10.1074/jbc.M114.559047	http://dx.doi.org/10.1074/jbc.M114.559047			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24753248	Green Published, hybrid			2022-12-25	WOS:000337965700049
J	Guinotte, JM; Davies, AJ				Guinotte, John M.; Davies, Andrew J.			Predicted Deep-Sea Coral Habitat Suitability for the US West Coast	PLOS ONE			English	Article							VULNERABLE MARINE ECOSYSTEMS; LOPHELIA-PERTUSA; SPECIES DISTRIBUTIONS; WATER CORAL; OCEAN ACIDIFICATION; DISTRIBUTION MODELS; SUITABLE HABITAT; ATLANTIC; CONSERVATION; SLOPE	Regional scale habitat suitability models provide finer scale resolution and more focused predictions of where organisms may occur. Previous modelling approaches have focused primarily on local and/or global scales, while regional scale models have been relatively few. In this study, regional scale predictive habitat models are presented for deep-sea corals for the U.S. West Coast (California, Oregon and Washington). Model results are intended to aid in future research or mapping efforts and to assess potential coral habitat suitability both within and outside existing bottom trawl closures (i.e. Essential Fish Habitat (EFH)) and identify suitable habitat within U.S. National Marine Sanctuaries (NMS). Deep-sea coral habitat suitability was modelled at 500 mx500 m spatial resolution using a range of physical, chemical and environmental variables known or thought to influence the distribution of deep-sea corals. Using a spatial partitioning cross-validation approach, maximum entropy models identified slope, temperature, salinity and depth as important predictors for most deep-sea coral taxa. Large areas of highly suitable deep-sea coral habitat were predicted both within and outside of existing bottom trawl closures and NMS boundaries. Predicted habitat suitability over regional scales are not currently able to identify coral areas with pin point accuracy and probably overpredict actual coral distribution due to model limitations and unincorporated variables (i.e. data on distribution of hard substrate) that are known to limit their distribution. Predicted habitat results should be used in conjunction with multibeam bathymetry, geological mapping and other tools to guide future research efforts to areas with the highest probability of harboring deep-sea corals. Field validation of predicted habitat is needed to quantify model accuracy, particularly in areas that have not been sampled.	[Guinotte, John M.] Marine Conservat Inst, Seattle, WA 98103 USA; [Davies, Andrew J.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Gwynedd, Wales	Bangor University	Guinotte, JM (corresponding author), Marine Conservat Inst, Seattle, WA 98103 USA.	john.guinotte@marine-conservation.org	Davies, Andrew/A-4222-2008	Davies, Andrew/0000-0002-2087-0885	NOAA's Deep Sea Coral Research and Technology Program	NOAA's Deep Sea Coral Research and Technology Program	This project was supported by funding from NOAA's Deep Sea Coral Research and Technology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellman MA, 2005, CAN J FISH AQUAT SCI, V62, P2886, DOI 10.1139/F05-180; Boyer T, 2005, INT J CLIMATOL, V25, P931, DOI 10.1002/joc.1173; Boyer T.P., 2009, NOAA ATLAS NESDIS; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Caress D.W, 2006, MB SYSTEM MAPPING SE; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Etnoyer P, 2007, MAR ECOL PROG SER, V339, P311, DOI 10.3354/meps339311; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; Garcia H. E., 2006, NOAA ATLAS NESDIS, V3; Garcia H. E., 2006, NOAA ATLAS NESDIS, V4; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Groundfish Essential Fish Habitat Review Committee, 2012, 1 EFHRC; Guinan J, 2009, ECOL INFORM, V4, P83, DOI 10.1016/j.ecoinf.2009.01.004; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Jones KH, 1998, COMPUT GEOSCI, V24, P315, DOI 10.1016/S0098-3004(98)00032-6; Kampstra P, 2008, J STAT SOFTWARE, V28; Leverette TL, 2005, ERLANGEN EARTH C SER, P467, DOI 10.1007/3-540-27673-4_23; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; National Marine Fisheries Service, 2013, GROUNDF ESS FISH HAB; NGDC, 2011, MAR GEOPH TRACKL DAT; NGDC, 2011, NOS HYDR SURV DAT; NGDC, 2011, US COAST REL MOD DEV; NGDC, 2011, MULT BATH; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Penney AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082273; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Rengstorf AM, 2013, J BIOGEOGR, V40, P1702, DOI 10.1111/jbi.12123; Rengstorf AM, 2012, MAR GEOD, V35, P343, DOI 10.1080/01490419.2012.699020; Ross RE, 2013, DIVERS DISTRIB, V19, P433, DOI 10.1111/ddi.12010; Smith W. H. F., 1997, Science, V277, P1956, DOI 10.1126/science.277.5334.1956; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Thresher RE, 2011, MAR ECOL PROG SER, V442, P87, DOI 10.3354/meps09400; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Troupin C, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005512; Vierod ADT, 2014, DEEP-SEA RES PT II, V99, P6, DOI 10.1016/j.dsr2.2013.06.010; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; White M, 2007, GEO-MAR LETT, V27, P391, DOI 10.1007/s00367-007-0060-8; White M, 2007, INT J EARTH SCI, V96, P1, DOI 10.1007/s00531-006-0099-1; Whitmire CE, 2012, BOTTOM TRAWL FISHING; Whitmire CE, 2007, STATE DEEP CORAL ECO, P109; WILSON JB, 1979, J MAR BIOL ASSOC UK, V59, P165, DOI 10.1017/S0025315400046257; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	56	38	40	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e93918	10.1371/journal.pone.0093918	http://dx.doi.org/10.1371/journal.pone.0093918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759613	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200008
J	Bloch, DB; Li, PC; Bloch, EG; Berenson, DF; Galdos, RL; Arora, P; Malhotra, R; Wu, CN; Yang, WH				Bloch, Donald B.; Li, Pingcheng; Bloch, Emily G.; Berenson, Daniel F.; Galdos, Rita L.; Arora, Pankaj; Malhotra, Rajeev; Wu, Connie; Yang, Weihong			LMKB/MARF1 Localizes to mRNA Processing Bodies, Interacts with Ge-1, and Regulates IFI44L Gene Expression	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; P-BODIES; STRESS GRANULES; BODY; AUTOANTIGEN; COMPONENT; CONTAIN; OOCYTES; MARF1	The mRNA processing body (P-body) is a cellular structure that regulates the stability of cytoplasmic mRNA. MARF1 is a murine oocyte RNA-binding protein that is associated with maintenance of mRNA homeostasis and genomic stability. In this study, autoantibodies were used to identify Limkain B (LMKB), the human orthologue of MARF1, as a P-body component. Indirect immunofluorescence demonstrated that Ge-1 (a central component of the mammalian core-decapping complex) co-localized with LMKB in P-bodies. Two-hybrid and co-immunoprecipitation assays were used to demonstrate interaction between Ge-1 and LMKB. The C-terminal 120 amino acids of LMKB mediated interaction with Ge-1 and the N-terminal 1094 amino acids of Ge-1 were required for interaction with LMKB. LMKB is the first protein identified to date that interacts with this portion of Ge-1. LMKB was expressed in human B and T lymphocyte cell lines; depletion of LMKB increased expression of IFI44L, a gene that has been implicated in the cellular response to Type I interferons. The interaction between LMKB/MARF1, a protein that contains RNA-binding domains, and Ge-1, which interacts with core-decapping proteins, suggests that LMKB has a role in the regulation of mRNA stability. LMKB appears to have different functions in different cell types: maintenance of genomic stability in developing oocytes and possible dampening of the inflammatory response in B and T cells.	[Bloch, Donald B.; Berenson, Daniel F.; Galdos, Rita L.; Yang, Weihong] Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Bloch, Donald B.; Li, Pingcheng; Bloch, Emily G.; Berenson, Daniel F.; Galdos, Rita L.; Arora, Pankaj; Malhotra, Rajeev; Wu, Connie; Yang, Weihong] Harvard Univ, Sch Med, Boston, MA USA; [Bloch, Donald B.; Li, Pingcheng; Bloch, Emily G.; Wu, Connie] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA; [Arora, Pankaj] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Arora, Pankaj; Malhotra, Rajeev] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Bloch, DB (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.	dbloch@partners.org	Yang, Wei/HIA-0360-2022; Arora, Pankaj/F-3437-2011; Yang, Wei/GWV-4107-2022	Arora, Pankaj/0000-0003-2420-3550; Malhotra, Rajeev/0000-0003-0120-4630; Berenson, Daniel/0000-0001-6396-6935; Bloch, Donald/0000-0002-6828-4754	Massachusetts General Hospital; American Heart Association [11FTF7290032]; National Heart, Lung, and Blood Institute [K08HL111210]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL111210, T32HL007208] Funding Source: NIH RePORTER	Massachusetts General Hospital(General Electric); American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from the Massachusetts General Hospital and from the American Heart Association (11FTF7290032) and the National Heart, Lung, and Blood Institute (K08HL111210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-13; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Beliakova-Bethell N, 2006, RNA, V12, P94, DOI 10.1261/rna.2264806; BLOCH DB, 1994, CLIN IMMUNOL IMMUNOP, V72, P380, DOI 10.1006/clin.1994.1156; Bloch DB, 2005, J RHEUMATOL, V32, P477; Bloch DB, 2011, EXP CELL RES, V317, P2183, DOI 10.1016/j.yexcr.2011.05.027; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Dunster K, 2005, CLIN EXP IMMUNOL, V140, P556, DOI 10.1111/j.1365-2249.2005.02774.x; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Hillebrand Jens, 2007, ScientificWorldJournal, V7, P178; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jakymiw A, 2007, J CELL SCI, V120, P1317, DOI 10.1242/jcs.03429; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Metcalf JV, 1996, LANCET, V348, P1399, DOI 10.1016/S0140-6736(96)04410-8; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Su YQ, 2012, P NATL ACAD SCI USA, V109, P18653, DOI 10.1073/pnas.1216904109; Su YQ, 2012, SCIENCE, V335, P1496, DOI 10.1126/science.1214680; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907; Yang WH, 2004, CLIN GASTROENTEROL H, V2, P1116, DOI 10.1016/S1542-3565(04)00465-3; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405	33	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94784	10.1371/journal.pone.0094784	http://dx.doi.org/10.1371/journal.pone.0094784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755989	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300016
J	Sedda, L; Mweempwa, C; Ducheyne, E; De Pus, C; Hendrickx, G; Rogers, DJ				Sedda, Luigi; Mweempwa, Cornelius; Ducheyne, Els; De Pus, Claudia; Hendrickx, Guy; Rogers, David J.			A Bayesian Geostatistical Moran Curve Model for Estimating Net Changes of Tsetse Populations in Zambia	PLOS ONE			English	Article							GLOSSINA-MORSITANS-MORSITANS; ROBINEAU-DESVOIDY DIPTERA; LOCAL VARIATION; DYNAMICS; VARIABILITY; CONVERGENCE; UNCERTAINTY; FLIES; MCMC; FLY	For the first time a Bayesian geostatistical version of the Moran Curve, a logarithmic form of the Ricker stock recruitment curve, is proposed that is able to give an estimate of net change in population demographic rates considering components such as fertility and density dependent and density independent mortalities. The method is applied to spatio-temporally referenced count data of tsetse flies obtained from fly-rounds. The model is a linear regression with three components: population rate of change estimated from the Moran curve, an explicit spatio-temporal covariance, and the observation error optimised within a Bayesian framework. The model was applied to the three main climate seasons of Zambia (rainy January to April, cold-dry-May to August, and hot-dry-September to December) taking into account land surface temperature and (seasonally changing) cattle distribution. The model shows a maximum positive net change during the hot-dry season and a minimum between the rainy and cold-dry seasons. Density independent losses are correlated positively with day-time land surface temperature and negatively with night-time land surface temperature and cattle distribution. The inclusion of density dependent mortality increases considerably the goodness of fit of the model. Cross validation with an independent dataset taken from the same area resulted in a very accurate estimate of tsetse catches. In general, the overall framework provides an important tool for vector control and eradication by identifying vector population concentrations and local vector demographic rates. It can also be applied to the case of sustainable harvesting of natural populations.	[Sedda, Luigi; Rogers, David J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Mweempwa, Cornelius] Minist Agr & Cooperat, Dept Vet & Livestock Dev, Lusaka, Zambia; [Ducheyne, Els; Hendrickx, Guy] Avia GIS, Zoersel, Belgium; [De Pus, Claudia] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium	University of Oxford; Institute of Tropical Medicine (ITM)	Sedda, L (corresponding author), Univ Southampton, Southampton, Hants, England.	L.Sedda@soton.ac.uk	Sedda, Luigi/ABD-8784-2020	Sedda, Luigi/0000-0002-9271-6596	European Union [HEALTH-F3-2010-261504]; WELLCOME TRUST [075824,]	European Union(European Commission); WELLCOME TRUST(Wellcome TrustEuropean Commission)	LS, DJR, and GH are supported by the European Union grant HEALTH-F3-2010-261504 EDENext; this paper is catalogued by the EDEN Steering Committee as EDENext 216 (http://www. edenext. eu). The contents are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. CM, CDP and ED were supported by the research funding from WELLCOME TRUST project 075824, "Fragfly''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Calder C, 2003, ECOLOGY, V84, P1395, DOI 10.1890/0012-9658(2003)084[1395:IMSOSI]2.0.CO;2; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Cressie N, 1999, J AM STAT ASSOC, V94, P1330, DOI 10.2307/2669946; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; DRANSFIELD RD, 1990, B ENTOMOL RES, V80, P265, DOI 10.1017/S000748530005046X; FORD J., 1959, BULL ENT RES, V50, P275, DOI 10.1017/S0007485300054584; Hanski I., 1999, METAPOPULATION ECOLO; Hargrove JW, 2005, TRYPANOSOMIASES, P113; Hargrove JW, 2001, B ENTOMOL RES, V91, P79; Hargrove JW, 2001, B ENTOMOL RES, V91, P25; HARGROVE JW, 1994, PHYSIOL ENTOMOL, V19, P307, DOI 10.1111/j.1365-3032.1994.tb01057.x; Kass RE, 2006, BAYESIAN ANAL, V1, P535, DOI 10.1214/06-BA117B; Mwape L, 2012, INT J TECHNOL ASSESS, V28, P294, DOI 10.1017/S0266462312000347; Natarajan R, 2000, J AM STAT ASSOC, V95, P227, DOI 10.2307/2669540; RANDOLPH SE, 1984, B ENTOMOL RES, V74, P425, DOI 10.1017/S0007485300015686; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROGERS D, 1979, J ANIM ECOL, V48, P825, DOI 10.2307/4197; ROGERS DJ, 1984, B ENTOMOL RES, V74, P403, DOI 10.1017/S0007485300015674; Smith BJ, 2007, J STAT SOFTW, V21, P1; Van den Bossche P, 2002, MED VET ENTOMOL, V16, P170, DOI 10.1046/j.1365-2915.2002.00360.x; Varley G. C., 1974, INSECT POPULATION EC, V43; Varley GC, 1962, INTERPRETATION INSEC, P142; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; West M., 2006, BAYESIAN FORECASTING; Yan J, 2007, STAT COMPUT, V17, P323, DOI 10.1007/s11222-007-9022-2	27	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96002	10.1371/journal.pone.0096002	http://dx.doi.org/10.1371/journal.pone.0096002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755848	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000335240300131
J	Shi, JH; Gao, LD; Zhu, Y; Chen, T; Liu, YZ; Dong, LB; Liu, FQ; Yang, H; Cai, YH; Yu, MD; Yao, Y; Xu, CL; Xiao, XM; Shu, YL				Shi, Jinghong; Gao, Lidong; Zhu, Yun; Chen, Tao; Liu, Yunzhi; Dong, Libo; Liu, Fuqiang; Yang, Hao; Cai, Yahui; Yu, Mingdong; Yao, Yi; Xu, Cuilin; Xiao, Xiangming; Shu, Yuelong			Investigation of Avian Influenza Infections in Wild Birds, Poultry and Humans in Eastern Dongting Lake, China	PLOS ONE			English	Article							HONG-KONG; VIRUSES; WETLAND; PROVINCE; DUCKS	We investigated avian influenza infections in wild birds, poultry, and humans at Eastern Dongting Lake, China. We analyzed 6,621 environmental samples, including fresh fecal and water samples, from wild birds and domestic ducks that were collected from the Eastern Dongting Lake area from November 2011 to April 2012. We also conducted two cross-sectional serological studies in November 2011 and April 2012, with 1,050 serum samples collected from people exposed to wild birds and/or domestic ducks. Environmental samples were tested for the presence of avian influenza virus (AIV) using quantitative PCR assays and virus isolation techniques. Hemagglutination inhibition assays were used to detect antibodies against AIV H5N1, and microneutralization assays were used to confirm these results. Among the environmental samples from wild birds and domestic ducks, AIV prevalence was 5.19 and 5.32%, respectively. We isolated 39 and 5 AIVs from the fecal samples of wild birds and domestic ducks, respectively. Our analysis indicated 12 subtypes of AIV were present, suggesting that wild birds in the Eastern Dongting Lake area carried a diverse array of AIVs with low pathogenicity. We were unable to detect any antibodies against AIV H5N1 in humans, suggesting that human infection with H5N1 was rare in this region.	[Shi, Jinghong; Zhu, Yun; Chen, Tao; Dong, Libo; Xu, Cuilin; Shu, Yuelong] Natl Hlth Family Plan Commiss, Key Lab Med Virol, Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Gao, Lidong; Liu, Yunzhi; Liu, Fuqiang; Yang, Hao] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Cai, Yahui; Yu, Mingdong] Yueyang City Ctr Dis Control & Prevent, Yueyang, Peoples R China; [Yao, Yi] Hunan East Dongting Lake Natl Nat Reserve, Yueyang, Peoples R China; [Xiao, Xiangming] Univ Oklahoma, Norman, OK 73019 USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Oklahoma System; University of Oklahoma - Norman	Shu, YL (corresponding author), Natl Hlth Family Plan Commiss, Key Lab Med Virol, Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	yshu@cnic.org.cn	xiao, xiang/GWU-6035-2022	Xiao, Xiangming/0000-0003-0956-7428	Collaborative project from United States Center for Disease Control [5U51IP000334-03]; China-US Collaborative Program on Emerging and Re-emerging Infectious Disease; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101028] Funding Source: NIH RePORTER	Collaborative project from United States Center for Disease Control; China-US Collaborative Program on Emerging and Re-emerging Infectious Disease; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a Collaborative project (5U51IP000334-03) from United States Center for Disease Control, and China-US Collaborative Program on Emerging and Re-emerging Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; [曹小玉 Cao Xiaoyu], 2010, [西北林学院学报, Journal of Northwest Forestry College], V25, P221; Cui P, 2011, VECTOR-BORNE ZOONOT, V11, P567, DOI 10.1089/vbz.2009.0240; Duan LA, 2011, INFLUENZA OTHER RESP, V5, P65; Fereidouni SR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-43; Globig A, 2009, EMERG INFECT DIS, V15, P1633, DOI 10.3201/eid1510.090439; Gray GC, 2011, J CLIN VIROL, V51, P132, DOI 10.1016/j.jcv.2011.03.011; Hunan Province Rural Social and Economic Investigation Team, 2008, RUR STAT YB HUN; Li JW, 2008, VIRUS GENES, V37, P88, DOI 10.1007/s11262-008-0245-x; Li LiPing, 2007, Journal of Economic Animal, V11, P224; Lu EnJie, 2007, Journal of Tropical Medicine (Guangzhou), V7, P923; Montalvo-Corral M, 2011, TRANSBOUND EMERG DIS, V58, P63, DOI 10.1111/j.1865-1682.2010.01182.x; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Perez-Ramirez E, 2010, VET MICROBIOL, V146, P200, DOI 10.1016/j.vetmic.2010.05.008; Prosser DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017622; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang B, 2012, J VIROL, V86, P11939, DOI 10.1128/JVI.02042-12; *WHO DEP COMM DIS, WHO MAN AN INFL DIAG; WHO/GIP, 2003, CUM NUMB CONF HUM CA; Xie J, 2006, HUNAN J ANIMAL SCI V, V4, P26; Yuan J, 2011, CHINA TROPICAL MED, V5, P573; Zhang D, 2002, WORLD REGIONAL STUDI, V11, P107; Zhang HB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-42; Zhang HB, 2011, ARCH VIROL, V156, P95, DOI 10.1007/s00705-010-0836-4; Zhong Fu-sheng, 2007, Shengtaixue Zazhi, V26, P1959; Zhou L, 2012, CHIN PREV MED, V13, P11879	31	14	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95685	10.1371/journal.pone.0095685	http://dx.doi.org/10.1371/journal.pone.0095685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755911	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300072
J	Demyanets, S; Speidl, WS; Tentzeris, I; Jarai, R; Katsaros, KM; Farhan, S; Krychtiuk, KA; Wonnerth, A; Weiss, TW; Huber, K; Wojta, J				Demyanets, Svitlana; Speidl, Walter S.; Tentzeris, Ioannis; Jarai, Rudolf; Katsaros, Katharina M.; Farhan, Serdar; Krychtiuk, Konstantin A.; Wonnerth, Anna; Weiss, Thomas W.; Huber, Kurt; Wojta, Johann			Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RECEPTOR FAMILY-MEMBER; RISK STRATIFICATION; IL-33; CELLS; EXPRESSION; ACTIVATION; BIOMARKERS; MORTALITY; RESPONSES	Objectives: ST2 is a receptor for interleukin (IL)-33. We investigated an association of soluble ST2 (sST2) and IL-33 serum levels with different clinical stages of coronary artery disease. We assessed the predictive value of sST2 and IL-33 in patients with stable angina, non-ST elevation myocardial infarction (NSTEMI) and ST elevation myocardial infarction (STEMI). Methods: We included 373 patients of whom 178 had stable angina, 97 had NSTEMI, and 98 had STEMI. Patients were followed for a mean of 43 months. The control group consisted of 65 individuals without significant stenosis on coronary angiography. Serum levels of sST2 and IL-33 were measured by ELISAs. Results: sST2 levels were significantly increased in patients with STEMI as compared to patients with NSTEMI and stable angina as well as with controls. IL-33 levels did not differ between the four groups. During follow-up, 37 (10%) patients died and the combined endpoint (all cause death, MI and rehospitalisation for cardiac causes) occurred in 66 (17.6%) patients. sST2 serum levels significantly predicted mortality in the total cohort. When patients were stratified according to their clinical presentation, the highest quintile of sST2 significantly predicted mortality in patients with STEMI, but not with NSTEMI or stable coronary artery disease. sST2 was a significant predictor for the combined endpoint in STEMI patients and in patients with stable angina. Serum levels of IL-33 were not associated with clinical outcome in the total cohort, but the highest quintile of IL-33 predicted mortality in patients with STEMI. Conclusions: Serum levels of sST2 are increased in patients with acute coronary syndromes as compared to levels in patients with stable coronary artery disease and in individuals without coronary artery disease. sST2 and IL-33 were associated with mortality in patients with STEMI but not in patients with NSTEMI or stable angina.	[Demyanets, Svitlana; Speidl, Walter S.; Katsaros, Katharina M.; Krychtiuk, Konstantin A.; Wonnerth, Anna; Wojta, Johann] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Demyanets, Svitlana] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Tentzeris, Ioannis; Jarai, Rudolf; Farhan, Serdar; Weiss, Thomas W.; Huber, Kurt] Wilhelminenhosp, Med Dept Cardiol & Emergency Med 3, Vienna, Austria; [Wojta, Johann] Med Univ Vienna, Core Facil, Vienna, Austria; [Katsaros, Katharina M.; Krychtiuk, Konstantin A.; Wonnerth, Anna; Wojta, Johann] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Wilhelminenspital; Medical University of Vienna; Ludwig Boltzmann Institute	Wojta, J (corresponding author), Med Univ Vienna, Dept Internal Med 2, Vienna, Austria.	johann.wojta@meduniwien.ac.at	Wojta, Johann/AAC-8433-2020; Speidl, Walter S./AAU-8830-2020	Wojta, Johann/0000-0002-1282-9276; Speidl, Walter S./0000-0002-7267-3138; Krychtiuk, Konstantin/0000-0001-7792-2837	Austrian Science Fund (FWF) [T445-B11 to SD]; Ludwig Boltzmann Cluster for Cardiovascular Research (Vienna, Austria); Promotion of Research in Arteriosclerosis; Thrombosis and Vascular Biology (Vienna, Austria)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Ludwig Boltzmann Cluster for Cardiovascular Research (Vienna, Austria); Promotion of Research in Arteriosclerosis; Thrombosis and Vascular Biology (Vienna, Austria)	This work was supported by the Austrian Science Fund (FWF-Project number T445-B11 to SD), Ludwig Boltzmann Cluster for Cardiovascular Research (Vienna, Austria), and Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology (Vienna, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abston ED, 2012, CIRC-HEART FAIL, V5, P366, DOI 10.1161/CIRCHEARTFAILURE.111.963769; Bartunek J, 2008, J AM COLL CARDIOL, V52, P2166, DOI 10.1016/j.jacc.2008.09.027; Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001; Coglianese EE, 2012, CLIN CHEM, V58, P1673, DOI 10.1373/clinchem.2012.192153; Demyanets S, 2014, CYTOKINE; Demyanets S, 2013, J MOL CELL CARDIOL, V60, P16, DOI 10.1016/j.yjmcc.2013.03.020; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Dhillon OS, 2013, INT J CARDIOL, V167, P2182, DOI 10.1016/j.ijcard.2012.05.073; Dhillon OS, 2011, AM HEART J, V161, P1163, DOI 10.1016/j.ahj.2011.03.025; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Eggers KM, 2010, AM HEART J, V159, P788, DOI 10.1016/j.ahj.2010.02.022; Iwahana H, 1999, EUR J BIOCHEM, V264, P397, DOI 10.1046/j.1432-1327.1999.00615.x; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kohli P, 2012, CLIN CHEM, V58, P257, DOI 10.1373/clinchem.2011.173369; Mildner M, 2010, CARDIOVASC RES, V87, P769, DOI 10.1093/cvr/cvq104; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047830; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Rui T, 2012, CARDIOVASC RES, V94, P370, DOI 10.1093/cvr/cvs015; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Tsapaki A, 2010, J THROMB THROMBOLYS, V30, P365, DOI 10.1007/s11239-010-0496-y; Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Weir RAP, 2010, J AM COLL CARDIOL, V55, P243, DOI 10.1016/j.jacc.2009.08.047; Yndestad A, 2010, INT J BIOCHEM CELL B, V42, P263, DOI 10.1016/j.biocel.2009.10.021; Zhang K, 2013, CHINESE MED J-PEKING, V126, P3628, DOI 10.3760/cma.j.issn.0366-6999.20130145	33	63	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95055	10.1371/journal.pone.0095055	http://dx.doi.org/10.1371/journal.pone.0095055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751794	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400029
J	Geherin, SA; Wilson, RP; Jennrich, S; Debes, GF				Geherin, Skye A.; Wilson, R. Paul; Jennrich, Silke; Debes, Gudrun F.			CXCR4 Is Dispensable for T Cell Egress from Chronically Inflamed Skin via the Afferent Lymph	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; DENDRITIC CELLS; IFN-GAMMA; B-CELLS; PERIPHERAL-TISSUES; CUTTING EDGE; FACTOR-I; CCR7; MIGRATION; EXPRESSION	T cell recirculation through extralymphoid tissues is essential to immune surveillance, host defense and inflammation. In this process, T cells enter the tissue from the blood and subsequently leave via the afferent lymph. In the absence of inflammation, T cells require CCR7 expression to egress from the skin or lung, which is consistent with the constitutive expression of the CCR7 ligand CCL21 on lymphatic endothelium. However, during chronic inflammation alternative chemoattractants come into play, allowing Ccr7-deficient (Ccr7(-/-)) T cells to egress efficiently from affected skin. As T cell egress from inflamed sites is a potential control point of the inflammatory response, we aimed to determine alternative T cell exit receptors using a mouse and a sheep model. We show that CCR7(+) and CCR7(-) T cells exiting from the chronically inflamed skin were highly responsive to the CXCR4 ligand CXCL12, which was induced in the lymphatics in the inflamed site. Based on these findings, we hypothesized that CXCR4 mediates T cell egress from inflamed skin. However, pharmacological inhibition of CXCR4 did not affect the tissue egress of wildtype or Ccr7(-/-) CD4 and CD8 T cells after adoptive transfer into chronically inflamed skin. Similarly, adoptively transferred Cxcr4(-/-) Ccr7(-/-) and Ccr7(-/-) T cells egressed from the inflamed skin equally well. Based on these data, we conclude that, while CXCR4 might play an essential role for other cell types that enter the afferent lymphatics, it is dispensable for T cell egress from the chronically inflamed skin.	[Geherin, Skye A.; Wilson, R. Paul; Jennrich, Silke; Debes, Gudrun F.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Debes, GF (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	gdebes@vet.upenn.edu		Debes, Gudrun/0000-0003-4208-7362	National Institutes of Health [R01-AR056730, F32-AR062451]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056730, F32AR062451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R01-AR056730 (to GFD) and F32-AR062451 (to RPW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avniel S, 2006, J INVEST DERMATOL, V126, P468, DOI 10.1038/sj.jid.5700069; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bai ZB, 2009, J IMMUNOL, V182, P1287, DOI 10.4049/jimmunol.182.3.1287; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Berahovich RD, 2010, J IMMUNOL, V185, P5130, DOI 10.4049/jimmunol.1001660; BIRKELAND ML, 1989, P NATL ACAD SCI USA, V86, P6734, DOI 10.1073/pnas.86.17.6734; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Brown MN, 2010, J IMMUNOL, V185, P4873, DOI 10.4049/jimmunol.1000676; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Burman A, 2005, J IMMUNOL, V174, P1693, DOI 10.4049/jimmunol.174.3.1693; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Debes GF, 2006, J IMMUNOL, V176, P557, DOI 10.4049/jimmunol.176.1.557; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Eberhard Yanina, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-7; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geherin SA, 2013, VET IMMUNOL IMMUNOP, V155, P87, DOI 10.1016/j.vetimm.2013.06.008; Geherin SA, 2012, J IMMUNOL, V188, P6027, DOI 10.4049/jimmunol.1102639; Griffith JW, 2013, EUR J IMMUNOL, V43, P1430, DOI 10.1002/eji.201243183; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Hopken UE, 2007, BLOOD, V109, P886, DOI 10.1182/blood-2006-03-013532; Hopken UE, 2010, J LEUKOCYTE BIOL, V87, P671, DOI 10.1189/jlb.0709505; Humpert ML, 2012, PROTEOMICS, V12, P1938, DOI 10.1002/pmic.201100581; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Jennrich S, 2012, J VIROL, V86, P3436, DOI 10.1128/JVI.07025-11; Johnson LA, 2013, J CELL SCI, V126, P5259, DOI 10.1242/jcs.135343; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; LASCELLES A, 1961, Q J EXP PHYSIOL CMS, V46, P199, DOI 10.1113/expphysiol.1961.sp001536; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Ouwehand K, 2008, EUR J IMMUNOL, V38, P3050, DOI 10.1002/eji.200838384; Saeki H, 1999, J IMMUNOL, V162, P2472; Scimone ML, 2004, J EXP MED, V199, P1113, DOI 10.1084/jem.20031645; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Vrieling M, 2012, J IMMUNOL, V188, P578, DOI 10.4049/jimmunol.1101972; YOUNG AJ, 1997, MANUAL IMMUNOLOGICAL, P2039; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95626	10.1371/journal.pone.0095626	http://dx.doi.org/10.1371/journal.pone.0095626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752354	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400092
J	Chai, C; Cheng, HZ; Ge, W; Ma, D; Shi, YX				Chai, Chao; Cheng, Hongzhen; Ge, Wei; Ma, Dong; Shi, Yanxi			Phthalic Acid Esters in Soils from Vegetable Greenhouses in Shandong Peninsula, East China	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; ORGANIC CONTAMINANTS; AGRICULTURAL SOILS; SURFACE-WATER; PAES; DEGRADATION; POLLUTANTS; GUANGZHOU; SEDIMENT; EXCHANGE	Soils at depths of 0 cm to 10 cm, 10 cm to 20 cm, and 20 cm to 40 cm from 37 vegetable greenhouses in Shandong Peninsula, East China, were collected, and 16 phthalic acid esters (PAEs) were detected using gas chromatography-mass spectrometry (GC-MS). All 16 PAEs could be detected in soils from vegetable greenhouses. The total of 16 PAEs (Sigma(16)PAEs) ranged from 1.939 mg/kg to 35.442 mg/kg, with an average of 6.748 mg/kg. Among four areas, including Qingdao, Weihai, Weifang, and Yantai, the average and maximum concentrations of Sigma(16)PAEs in soils at depths of 0 cm to 10 cm appeared in Weifang, which has a long history of vegetable production and is famous for extensive greenhouse cultivation. Despite the different concentrations of Sigma(16)PAEs, the PAE compositions were comparable. Among the 16 PAEs, di(2-ethylhexyl) phthalate (DEHP), di-n-octyl phthalate (DnOP), di-n-butyl phthalate (DnBP), and diisobutyl phthalate (DiBP) were the most abundant. Compared with the results on agricultural soils in China, soils that are being used or were used for vegetable greenhouses had higher PAE concentrations. Among PAEs, dimethyl phthalate (DMP), diethyl phthalate (DEP) and DnBP exceeded soil allowable concentrations (in US) in more than 90% of the samples, and DnOP in more than 20%. Shandong Peninsula has the highest PAE contents, which suggests that this area is severely contaminated by PAEs.	[Chai, Chao; Cheng, Hongzhen; Ma, Dong; Shi, Yanxi] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Peoples R China; [Ge, Wei] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University	Shi, YX (corresponding author), Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Peoples R China.	yanxiyy@126.com		Ge, Wei/0000-0002-4610-7933	Science and Technology Plan Projects of Qingdao [12-1-3-64-nsh]; Two Districts'' Foundation of Shandong Province, China [2011-Yellow-19]; Talent Foundation of Qingdao Agricultural University [630642]	Science and Technology Plan Projects of Qingdao; Two Districts'' Foundation of Shandong Province, China; Talent Foundation of Qingdao Agricultural University	This work was supported by the "Science and Technology Plan Projects of Qingdao (No. 12-1-3-64-nsh), the Two Districts'' Foundation of Shandong Province, China (No. 2011-Yellow-19) and the Talent Foundation of Qingdao Agricultural University (No. 630642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amellal N, 2001, APPL GEOCHEM, V16, P1611, DOI 10.1016/S0883-2927(01)00034-8; Amir S, 2005, PROCESS BIOCHEM, V40, P2183, DOI 10.1016/j.procbio.2004.08.012; BASCOMB CL, 1964, J SCI FOOD AGR, V15, P821, DOI 10.1002/jsfa.2740151201; Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6; Benlahcen KT, 1997, MAR POLLUT BULL, V34, P298, DOI 10.1016/S0025-326X(96)00098-7; Biscardi D, 2003, SCI TOTAL ENVIRON, V302, P101, DOI 10.1016/S0048-9697(02)00349-2; Buszka PM, 2009, B ENVIRON CONTAM TOX, V82, P653, DOI 10.1007/s00128-009-9702-z; Cai QY, 2007, J CHROMATOGR A, V1143, P207, DOI 10.1016/j.chroma.2007.01.007; [蔡全英 Cai Quanying], 2005, [生态学报, Acta Ecologica Sinica], V25, P283; [陈静 Chen Jing], 2005, [环境科学研究, Research of Environmental Sciences], V18, P79; Chen YongShan, 2011, Acta Pedologica Sinica, V48, P516; Chiou CT, 2001, ENVIRON SCI TECHNOL, V35, P1437, DOI 10.1021/es0017561; Chou K, 2006, J MED TOXICOL, V2, P126, DOI 10.1007/BF03161027; Costa JM., 2004, FRUIT VEGETABLE TECH, V4, P8; Cousins IT, 1999, CHEMOSPHERE, V39, P2507, DOI 10.1016/S0045-6535(99)00164-2; Dan Zhang, 2009, Frontiers of Earth Science in China, V3, P73, DOI 10.1007/s11707-009-0017-5; Department of Environmental Conservation, 1994, DET SOIL CLEAN OBJ C; Ejlertsson J, 1996, BIODEGRADATION, V7, P345, DOI 10.1007/BF00115748; EPA U. S, 2006, EL COD FED REG T 423; EVANS KM, 1990, WATER AIR SOIL POLL, V51, P13, DOI 10.1007/BF00211500; FLOWERS TH, 1991, COMMUN SOIL SCI PLAN, V22, P1409, DOI 10.1080/00103629109368501; Gjessing E.T., 1976, PHYS CHEM CHARACTERI; Gomez-Hens A, 2003, TRAC-TREND ANAL CHEM, V22, P847, DOI 10.1016/S0165-9936(03)01201-9; [关卉 GUAN Hui], 2007, [农业环境科学学报, Journal of Agro-environment Science], V26, P622; He W, 2013, SCI TOTAL ENVIRON, V461, P672, DOI [10.1016/j.scitotenv2013.05.049, 10.1016/j.scitotenv.2013.05.049]; HITCH RK, 1992, B ENVIRON CONTAM TOX, V48, P259, DOI 10.1007/BF00194381; Jiang YF, 2009, THESIS SHANDONG U; JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016; Katsoyiannis A, 2006, CHEMOSPHERE, V65, P1551, DOI 10.1016/j.chemosphere.2006.04.004; Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017; Li Z., 2012, CHINESE AGR MECH, V1, P7; Lin C, 2009, J HAZARD MATER, V161, P270, DOI 10.1016/j.jhazmat.2008.03.082; Liu H, 2010, CHEMOSPHERE, V78, P382, DOI 10.1016/j.chemosphere.2009.11.009; Liu ZhaoHui, 2008, Acta Pedologica Sinica, V45, P296; Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004; Mo CH, 2008, J HAZARD MATER, V152, P1208, DOI 10.1016/j.jhazmat.2007.07.105; SCHWARTZ V, 1995, FRESEN J ANAL CHEM, V351, P629, DOI 10.1007/BF00323339; SHANKER R, 1985, ENVIRON POLLUT A, V39, P1, DOI 10.1016/0143-1471(85)90057-1; Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610; SHELTON DR, 1984, ENVIRON SCI TECHNOL, V18, P93, DOI 10.1021/es00120a008; Soil Survey Division Staff. Soil Survey Manual, 1993, AGR HDB, V18; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Tan Z, 2012, ENV SCI MANAGEMENT, V37, P120; [万甜甜 Wan Tiantian], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2795; Wang Cheng, 2009, Environmental Science & Technology (China), V32, P118; Wang J, 2013, ENVIRON POLLUT, V180, P265, DOI 10.1016/j.envpol.2013.05.036; Wang LJ., 2013, THESIS DALIAN MARITI; Wang ML, 2007, THESIS SHANDONG AGR; Wang P, 2008, CHEMOSPHERE, V72, P1567, DOI 10.1016/j.chemosphere.2008.04.032; Xie ZY, 2007, ENVIRON SCI TECHNOL, V41, P4555, DOI 10.1021/es0630240; [熊鹏翔 Xiong Pengxiang], 2008, [化学通报, Chemistry], V71, P636; Zeng F, 2010, ATMOS ENVIRON, V44, P834, DOI 10.1016/j.atmosenv.2009.11.029; Zeng F, 2008, ENVIRON POLLUT, V156, P425, DOI 10.1016/j.envpol.2008.01.045; Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029; Zhang LF, 2012, J ENVIRON SCI-CHINA, V24, P335, DOI 10.1016/S1001-0742(11)60782-1; Zou ZR, 2002, FACILITY HORTICULTUR	57	47	64	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95701	10.1371/journal.pone.0095701	http://dx.doi.org/10.1371/journal.pone.0095701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747982	gold, Green Submitted, Green Published			2022-12-25	WOS:000335226500140
J	Ishida, K; Sekizuka, T; Hayashida, K; Matsuo, J; Takeuchi, F; Kuroda, M; Nakamura, S; Yamazaki, T; Yoshida, M; Takahashi, K; Nagai, H; Sugimoto, C; Yamaguchi, H				Ishida, Kasumi; Sekizuka, Tsuyoshi; Hayashida, Kyoko; Matsuo, Junji; Takeuchi, Fumihiko; Kuroda, Makoto; Nakamura, Shinji; Yamazaki, Tomohiro; Yoshida, Mitsutaka; Takahashi, Kaori; Nagai, Hiroki; Sugimoto, Chihiro; Yamaguchi, Hiroyuki			Amoebal Endosymbiont Neochlamydia Genome Sequence Illuminates the Bacterial Role in the Defense of the Host Amoebae against Legionella pneumophila	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; LEUCINE-RICH REPEAT; III SECRETION; CHLAMYDIAE; GENES; EVOLUTION; SYMBIONTS; MECHANISM; EFFECTOR; BIOFILMS	Previous work has shown that the obligate intracellular amoebal endosymbiont Neochlamydia S13, an environmental chlamydia strain, has an amoebal infection rate of 100%, but does not cause amoebal lysis and lacks transferability to other host amoebae. The underlying mechanism for these observations remains unknown. In this study, we found that the host amoeba could completely evade Legionella infection. The draft genome sequence of Neochlamydia S13 revealed several defects in essential metabolic pathways, as well as unique molecules with leucine-rich repeats (LRRs) and ankyrin domains, responsible for protein-protein interaction. Neochlamydia S13 lacked an intact tricarboxylic acid cycle and had an incomplete respiratory chain. ADP/ATP translocases, ATP-binding cassette transporters, and secretion systems (types II and III) were well conserved, but no type IV secretion system was found. The number of outer membrane proteins (OmcB, PomS, 76-kDa protein, and OmpW) was limited. Interestingly, genes predicting unique proteins with LRRs (30 genes) or ankyrin domains (one gene) were identified. Furthermore, 33 transposases were found, possibly explaining the drastic genome modification. Taken together, the genomic features of Neochlamydia S13 explain the intimate interaction with the host amoeba to compensate for bacterial metabolic defects, and illuminate the role of the endosymbiont in the defense of the host amoebae against Legionella infection.	[Ishida, Kasumi; Matsuo, Junji; Yamazaki, Tomohiro; Yamaguchi, Hiroyuki] Hokkaido Univ, Dept Med Lab Sci, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Sekizuka, Tsuyoshi; Takeuchi, Fumihiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Hayashida, Kyoko; Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Nakamura, Shinji] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Tokyo, Japan; [Yoshida, Mitsutaka; Takahashi, Kaori] Juntendo Univ, Grad Sch Med, Div Ultrastruct Res, Tokyo, Japan; [Nagai, Hiroki] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Hokkaido University; National Institute of Infectious Diseases (NIID); Hokkaido University; Juntendo University; Juntendo University; Osaka University	Yamaguchi, H (corresponding author), Hokkaido Univ, Dept Med Lab Sci, Fac Hlth Sci, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp	Nagai, Hiroki/G-4113-2015; Nagai, Hiroki/GXZ-7815-2022; Sugimoto, Chihiro/F-6583-2012; HAYASHIDA, Kyouko/ABH-6260-2020	Nagai, Hiroki/0000-0003-1659-2197; Sugimoto, Chihiro/0000-0002-8708-0140; HAYASHIDA, Kyouko/0000-0001-9266-5162; Sekizuka, Tsuyoshi/0000-0002-1302-5472	KAKENHI [21590474, 24659194, 24117501]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants-in-aid for scientific research from KAKENHI, grant numbers 21590474, 24659194, and 24117501, "Innovation Areas (Matryoshika-type evolution)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistleitner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055010; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Arlehamn CSL, 2011, CELL MICROBIOL, V13, P388, DOI 10.1111/j.1462-5822.2010.01541.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Becker B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-203; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Dugan J, 2007, MICROBIOL-SGM, V153, P71, DOI 10.1099/mic.0.29253-0; Erkens GB, 2012, BIOCHEMISTRY-US, V51, P4390, DOI 10.1021/bi300504v; Eugster M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-231; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Harada T, 2012, BIOL PHARM BULL, V35, P1460, DOI 10.1248/bpb.b11-00011; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Heinz E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-634; Hinz A, 2012, BIOCHEMISTRY-US, V51, P4981, DOI 10.1021/bi300128f; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Jules M, 2007, FEBS LETT, V581, P2829, DOI 10.1016/j.febslet.2007.05.026; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Luo ZQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00036; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08; Matsuo J, 2010, RES MICROBIOL, V161, P711, DOI [10.1016/J.resmic.2010.07.004, 10.1016/j.resmic.2010.07.004]; Matsuo J, 2010, ENV MICROBIOL REP, V2, P524, DOI 10.1111/j.1758-2229.2009.00094.x; Moraes TF, 2012, BBA-BIOMEMBRANES, V1818, P2687, DOI 10.1016/j.bbamem.2012.06.007; Moustafa A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002205; Nunes A, 2013, INFECT GENET EVOL, V16, P392, DOI 10.1016/j.meegid.2013.03.018; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Okude M, 2012, MICROBES ENVIRON, V27, P423, DOI 10.1264/jsme2.ME11353; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Peterson MW, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-7; Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771; Purushothaman S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016850; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Sekizuka T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-72; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; Singer AU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003121; Sixt BS, 2011, PROTEOMICS, V11, P1868, DOI 10.1002/pmic.201000510; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8; Zhou JM, 2008, CURR OPIN MICROBIOL, V11, P179, DOI 10.1016/j.mib.2008.02.004; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	56	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95166	10.1371/journal.pone.0095166	http://dx.doi.org/10.1371/journal.pone.0095166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747986	Green Published, gold			2022-12-25	WOS:000335226500063
J	Jallouk, AP; Moley, KH; Omurtag, K; Hu, G; Lanza, GM; Wickline, SA; Hood, JL				Jallouk, Andrew P.; Moley, Kelle H.; Omurtag, Kenan; Hu, Grace; Lanza, Gregory M.; Wickline, Samuel A.; Hood, Joshua L.			Nanoparticle Incorporation of Melittin Reduces Sperm and Vaginal Epithelium Cytotoxicity	PLOS ONE			English	Article							HIV PREVENTION; MICROBICIDES; CELLS	Melittin is a cytolytic peptide component of bee venom which rapidly integrates into lipid bilayers and forms pores resulting in osmotic lysis. While the therapeutic utility of free melittin is limited by its cytotoxicity, incorporation of melittin into the lipid shell of a perfluorocarbon nanoparticle has been shown to reduce its toxicity in vivo. Our group has previously demonstrated that perfluorocarbon nanoparticles containing melittin at concentrations,10 mu M inhibit HIV infectivity in vitro. In the current study, we assessed the impact of blank and melittin-containing perfluorocarbon nanoparticles on sperm motility and the viability of both sperm and vaginal epithelial cells. We found that free melittin was toxic to sperm and vaginal epithelium at concentrations greater than 2 mM (p<0.001). However, melittin nanoparticles were not cytotoxic to sperm (p = 0.42) or vaginal epithelium (p = 0.48) at an equivalent melittin concentration of 10 mM. Thus, nanoparticle formulation of melittin reduced melittin cytotoxicity fivefold and prevented melittin toxicity at concentrations previously shown to inhibit HIV infectivity. Melittin nanoparticles were toxic to vaginal epithelium at equivalent melittin concentrations >= 20 mu M (p<0.001) and were toxic to sperm at equivalent melittin concentrations >= 40 mu M (p<0.001). Sperm cytotoxicity was enhanced by targeting of the nanoparticles to the sperm surface antigen sperm adhesion molecule 1. While further testing is needed to determine the extent of cytotoxicity in a more physiologically relevant model system, these results suggest that melittin-containing nanoparticles could form the basis of a virucide that is not toxic to sperm and vaginal epithelium. This virucide would be beneficial for HIV serodiscordant couples seeking to achieve natural pregnancy.	[Jallouk, Andrew P.; Hu, Grace; Lanza, Gregory M.; Wickline, Samuel A.; Hood, Joshua L.] Washington Univ, Sch Med, Dept Med,Div Cardiol, Consortium Translat Res Adv Imaging & Nanomed, St Louis, MO 63110 USA; [Moley, Kelle H.; Omurtag, Kenan] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hood, JL (corresponding author), Washington Univ, Sch Med, Dept Med,Div Cardiol, Consortium Translat Res Adv Imaging & Nanomed, St Louis, MO 63110 USA.	jhood@dom.wustl.edu	Hood, Joshua L./I-9797-2019	Hood, Joshua L./0000-0003-3998-4118	Bill & Melinda Gates Foundation [OPP1024642]; Campbell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073646] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Campbell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Bill & Melinda Gates Foundation Grand Challenges Explorations Grant Number OPP1024642 (http://www. grandchallenges.org/Explorations) and The Campbell Foundation (http://www. campbellfoundation.net). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Cardona-Maya W, 2011, J REPROD IMMUNOL, V92, P1, DOI 10.1016/j.jri.2011.09.002; Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579; das Neves J, 2011, WIRES NANOMED NANOBI, V3, P389, DOI 10.1002/wnan.144; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; Eke AC, 1996, COCHRANE DATABASE SY; Hood JL, 2013, ANTIVIR THER, V18, P95, DOI 10.3851/IMP2346; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Klein DH, 2009, PARTICLE SIZE DISTRI; Kunz G, 1996, HUM REPROD, V11, P627, DOI 10.1093/HUMREP/11.3.627; Mallipeddi R, 2010, EXPERT OPIN DRUG DEL, V7, P37, DOI 10.1517/17425240903338055; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Palekar RU, 2013, MOL PHARMACEUT, V10, P4168, DOI 10.1021/mp400210q; Pertoft H, 2000, J BIOCHEM BIOPH METH, V44, P1, DOI 10.1016/S0165-022X(00)00066-X; Sabeur K, 1997, J ANDROL, V18, P151; Soman NR, 2008, NANO LETT, V8, P1131, DOI 10.1021/nl073290r; Soman NR, 2009, J CLIN INVEST, V119, P2830, DOI 10.1172/JCI38842; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Suri A, 2004, REPROD BIOL ENDOCRIN, V2, P1; Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95	22	22	22	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95411	10.1371/journal.pone.0095411	http://dx.doi.org/10.1371/journal.pone.0095411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748389	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500098
J	Shimizu, S; Miyamoto, N; Matsuura, T; Fujii, Y; Umezawa, M; Umegaki, K; Hiramoto, K; Shirato, H				Shimizu, Shinichi; Miyamoto, Naoki; Matsuura, Taeko; Fujii, Yusuke; Umezawa, Masumi; Umegaki, Kikuo; Hiramoto, Kazuo; Shirato, Hiroki			A Proton Beam Therapy System Dedicated to Spot-Scanning Increases Accuracy with Moving Tumors by Real-Time Imaging and Gating and Reduces Equipment Size	PLOS ONE			English	Article							RESPIRATORY-GATED DELIVERY; MOTION; RADIOTHERAPY; LUNG	Purpose: A proton beam therapy (PBT) system has been designed which dedicates to spot-scanning and has a gating function employing the fluoroscopy-based real-time-imaging of internal fiducial markers near tumors. The dose distribution and treatment time of the newly designed real-time-image gated, spot-scanning proton beam therapy (RGPT) were compared with free-breathing spot-scanning proton beam therapy (FBPT) in a simulation. Materials and Methods: In-house simulation tools and treatment planning system VQA (Hitachi, Ltd., Japan) were used for estimating the dose distribution and treatment time. Simulations were performed for 48 motion parameters (including 8 respiratory patterns and 6 initial breathing timings) on CT data from two patients, A and B, with hepatocellular carcinoma and with clinical target volumes 14.6 cc and 63.1 cc. The respiratory patterns were derived from the actual trajectory of internal fiducial markers taken in X-ray real-time tumor-tracking radiotherapy (RTRT). Results: With FBPT, 9/48 motion parameters achieved the criteria of successful delivery for patient A and 0/48 for B. With RGPT 48/48 and 42/48 achieved the criteria. Compared with FBPT, the mean liver dose was smaller with RGPT with statistical significance (p<0.001); it decreased from 27% to 13% and 28% to 23% of the prescribed doses for patients A and B, respectively. The relative lengthening of treatment time to administer 3 Gy (RBE) was estimated to be 1.22 (RGPT/FBPT: 138 s/113 s) and 1.72 (207 s/120 s) for patients A and B, respectively. Conclusions: This simulation study demonstrated that the RGPT was able to improve the dose distribution markedly for moving tumors without very large treatment time extension. The proton beam therapy system dedicated to spot-scanning with a gating function for real-time imaging increases accuracy with moving tumors and reduces the physical size, and subsequently the cost of the equipment as well as of the building housing the equipment.	[Shimizu, Shinichi; Shirato, Hiroki] Hokkaido Univ, Dept Radiat Oncol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Miyamoto, Naoki] Hokkaido Univ, Grad Sch Med, Dept Med Phys, Sapporo, Hokkaido, Japan; [Matsuura, Taeko] Hokkaido Univ, Sect Med Phys, Hosp Proton Beam Therapy Ctr, Sapporo, Hokkaido, Japan; [Fujii, Yusuke; Umezawa, Masumi] Hitachi Ltd, Hitachi Res Lab, Omika, Ibaraki, Japan; [Umegaki, Kikuo] Hokkaido Univ, Div Quantum Sci & Engn, Grad Sch Engn, Sapporo, Hokkaido, Japan; [Hiramoto, Kazuo] Hitachi Ltd, Res & Dev Grp, Omika, Ibaraki, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hitachi Limited; Hokkaido University; Hitachi Limited	Matsuura, T (corresponding author), Hokkaido Univ, Sect Med Phys, Hosp Proton Beam Therapy Ctr, Sapporo, Hokkaido, Japan.	matsuura@med.hokudai.ac.jp	Shirato, Hiroki/A-7068-2010; Shimizu, Shinichi/G-4477-2010	Shimizu, Shinichi/0000-0003-3143-0479	Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Grants-in-Aid for Scientific Research [25861049] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, 62 ICRU; Gillin MT, 2010, MED PHYS, V37, P154, DOI 10.1118/1.3259742; Hall EJ, 2006, INT J RADIAT ONCOL, V65, P1, DOI 10.1016/j.ijrobp.2006.01.027; Jaffray DA, 2012, NAT REV CLIN ONCOL, V9, P688, DOI 10.1038/nrclinonc.2012.194; Kawachi K, 1983, Acta Radiol Suppl, V364, P81; Matsuura T, 2013, MED PHYS, V40, DOI 10.1118/1.4810966; Matsuura T, 2012, MED PHYS, V39, P5584, DOI 10.1118/1.4745558; Rietzel E, 2010, MED PHYS, V37, P449, DOI 10.1118/1.3250856; Schatti A, 2013, PHYS MED BIOL, V58, P8555, DOI 10.1088/0031-9155/58/23/8555; Seppenwoolde Y, 2002, INT J RADIAT ONCOL, V53, P822, DOI 10.1016/S0360-3016(02)02803-1; Shirato H, 2006, INT J RADIAT ONCOL, V64, P1229, DOI 10.1016/j.ijrobp.2005.11.016; Shirato H, 1999, LANCET, V353, P1331, DOI 10.1016/S0140-6736(99)00700-X; Shirato H, 2012, CANCER SCI, V103, P1, DOI 10.1111/j.1349-7006.2011.02114.x; Smith A, 2009, MED PHYS, V36, P4068, DOI 10.1118/1.3187229; Toramatsu C, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-48; Tsunashima Y, 2008, PHYS MED BIOL, V53, P1947, DOI 10.1088/0031-9155/53/7/010; Tsunashima Y, 2010, PHYS MED BIOL, V55, P7633, DOI 10.1088/0031-9155/55/24/016; Umezawa M, 2013, AIP CONF PROC, V1525, P360, DOI 10.1063/1.4802351	18	51	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94971	10.1371/journal.pone.0094971	http://dx.doi.org/10.1371/journal.pone.0094971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747601	gold, Green Published			2022-12-25	WOS:000335226500048
J	Sochat, V; Supekar, K; Bustillo, J; Calhoun, V; Turner, JA; Rubin, DL				Sochat, Vanessa; Supekar, Kaustubh; Bustillo, Juan; Calhoun, Vince; Turner, Jessica A.; Rubin, Daniel L.			A Robust Classifier to Distinguish Noise from fMRI Independent Components	PLOS ONE			English	Article							RESTING-STATE NETWORKS; BRAIN NETWORKS; ARTIFACT REMOVAL; FUNCTIONAL MRI; CONNECTIVITY; REGULARIZATION; IDENTIFICATION; SELECTION; ICA	Analyzing Functional Magnetic Resonance Imaging (fMRI) of resting brains to determine the spatial location and activity of intrinsic brain networks-a novel and burgeoning research field-is limited by the lack of ground truth and the tendency of analyses to overfit the data. Independent Component Analysis (ICA) is commonly used to separate the data into signal and Gaussian noise components, and then map these components on to spatial networks. Identifying noise from this data, however, is a tedious process that has proven hard to automate, particularly when data from different institutions, subjects, and scanners is used. Here we present an automated method to delineate noisy independent components in ICA using a data-driven infrastructure that queries a database of 246 spatial and temporal features to discover a computational signature of different types of noise. We evaluated the performance of our method to detect noisy components from healthy control fMRI (sensitivity = 0.91, specificity = 0.82, cross validation accuracy (CVA) = 0.87, area under the curve (AUC) = 0.93), and demonstrate its generalizability by showing equivalent performance on (1) an age-and scanner-matched cohort of schizophrenia patients from the same institution (sensitivity = 0.89, specificity = 0.83, CVA = 0.86), (2) an age-matched cohort on an equivalent scanner from a different institution (sensitivity = 0.88, specificity = 0.88, CVA = 0.88), and (3) an age-matched cohort on a different scanner from a different institution (sensitivity = 0.72, specificity = 0.92, CVA = 0.79). We additionally compare our approach with a recently published method [1]. Our results suggest that our method is robust to noise variations due to population as well as scanner differences, thereby making it well suited to the goal of automatically distinguishing noise from functional networks to enable investigation of human brain function.	[Sochat, Vanessa] Stanford Univ, Sch Med, Grad Program Biomed Informat, Stanford, CA 94305 USA; [Supekar, Kaustubh] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Rubin, Daniel L.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Bustillo, Juan; Calhoun, Vince; Turner, Jessica A.] Mind Res Network, Albuquerque, NM USA; [Bustillo, Juan] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Turner, Jessica A.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Turner, Jessica A.] Inst Neurosci, Atlanta, GA USA	Stanford University; Stanford University; Stanford University; Lovelace Respiratory Research Institute; University of New Mexico; University System of Georgia; Georgia State University	Sochat, V (corresponding author), Stanford Univ, Sch Med, Grad Program Biomed Informat, Stanford, CA 94305 USA.	vsochat@stanford.edu	Turner, Jessica A/H-7282-2015; Turner, Jessica A/N-2228-2017; Calhoun, Vince D./ACN-9399-2022; Sochat, Vanessa/C-6893-2015	Turner, Jessica A/0000-0003-0076-8434; Turner, Jessica A/0000-0003-0076-8434; Calhoun, Vince D./0000-0001-9058-0747; Sochat, Vanessa/0000-0002-4387-3819	National Cancer Institute, National Institutes of Health, National Institute of General Medical Sciences [U01-CA-142555]; NIMH [R01-MH-084898]; COBRE NIGMS [P20-GM-103472]; Stanford Graduate Fellowship; National Science Foundation; NATIONAL CANCER INSTITUTE [U01CA142555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084898] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, National Institute of General Medical Sciences; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); COBRE NIGMS; Stanford Graduate Fellowship(Stanford University); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Cancer Institute, National Institutes of Health, National Institute of General Medical Sciences, grant number U01-CA-142555, NIMH R01-MH-084898, and COBRE NIGMS P20-GM-103472. V. Sochat is supported by a Stanford Graduate Fellowship and a National Science Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2013, P NATL ACAD IN PRESS; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bhaganagarapu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00343; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; De Mol C, 2009, J COMPLEXITY, V25, P201, DOI 10.1016/j.jco.2009.01.002; Di Martino A., 2013, MOL PSYCHIAT; Forster BB, 1998, CAN ASSOC RADIOL J, V49, P320; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; GadElkarim JJ, 2013, HUMAN BRAIN MAPPING; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Greicius MD, 2003, CURR OPIN NEUROL, V16, P143, DOI 10.1097/00019052-200304000-00004; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hall D, 2012, NEUROINFORMATICS, V10, P331, DOI 10.1007/s12021-012-9151-4; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 1999, FAST ALGORITHM ESTIM, V892, P894; Hyvarinen A., 2002, WHAT IS INDEPENDENT, P145, DOI [10.1002/0471221317.ch7, DOI 10.1002/0471221317.CH7]; Jones DT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039731, 10.1371/journal.pone.0044294]; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kemp F, 2003, J ROYAL STAT SOC D, V52, P412; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Lund TE, 2006, NEUROIMAGE, V29, P54, DOI 10.1016/j.neuroimage.2005.07.005; McKeown M. J., 1997, ANAL FMRI DATA BLIND; McKeown MJ, 2003, CURR OPIN NEUROBIOL, V13, P620, DOI 10.1016/j.conb.2003.09.012; Milham MP, 2012, FRONTIERS SYSTEMS NE, V6; Perlbarg V, 2007, MAGN RESON IMAGING, V25, P35, DOI 10.1016/j.mri.2006.09.042; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rummel C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00214; Salimi-Khorshidi G, 2013, NEUROIMAGE; Segall JM, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00010; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spadone S, 2012, NEUROIMAGE, V62, P1912, DOI 10.1016/j.neuroimage.2012.05.051; Storti SF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00072; Sui J, 2009, NEUROIMAGE, V46, P73, DOI 10.1016/j.neuroimage.2009.01.026; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Thomas CG, 2002, NEUROIMAGE, V17, P1521, DOI 10.1006/nimg.2002.1200; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Turner JA, 2012, TWIN RES HUM GENET, V15, P324, DOI 10.1017/thg.2012.1; Turner JA, 2012, PSYCHIAT RES-NEUROIM, V201, P253, DOI 10.1016/j.pscychresns.2011.09.012; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2013, JAMA PSYCHIAT, V70, P869, DOI 10.1001/jamapsychiatry.2013.104; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Wolf RC, 2011, J PSYCHIATR NEUROSCI, V36, P402, DOI 10.1503/jpn.100150; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	60	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95493	10.1371/journal.pone.0095493	http://dx.doi.org/10.1371/journal.pone.0095493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748378	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500115
J	Yildirim, F; Ji, SB; Kronenberg, G; Barco, A; Olivares, R; Benito, E; Dirnagl, U; Gertz, K; Endres, M; Harms, C; Meisel, A				Yildirim, Ferah; Ji, Shengbo; Kronenberg, Golo; Barco, Angel; Olivares, Roman; Benito, Eva; Dirnagl, Ulrich; Gertz, Karen; Endres, Matthias; Harms, Christoph; Meisel, Andreas			Histone Acetylation and CREB Binding Protein Are Required for Neuronal Resistance against Ischemic Injury	PLOS ONE			English	Article							RUBINSTEIN-TAYBI-SYNDROME; SUBEROYLANILIDE HYDROXAMIC ACID; LONG-TERM-MEMORY; CEREBRAL-ISCHEMIA; MEDIATED NEUROPROTECTION; DEACETYLASE INHIBITION; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; BRAIN-INJURY; CBP	Epigenetic transcriptional regulation by histone acetylation depends on the balance between histone acetyltransferase (HAT) and deacetylase activities (HDAC). Inhibition of HDAC activity provides neuroprotection, indicating that the outcome of cerebral ischemia depends crucially on the acetylation status of histones. In the present study, we characterized the changes in histone acetylation levels in ischemia models of focal cerebral ischemia and identified cAMP-response element binding protein (CREB)-binding protein (CBP) as a crucial factor in the susceptibility of neurons to ischemic stress. Both neuron-specific RNA interference and neurons derived from CBP heterozygous knockout mice showed increased damage after oxygen-glucose deprivation (OGD) in vitro. Furthermore, we demonstrated that ischemic preconditioning by a short (5 min) subthreshold occlusion of the middle cerebral artery (MCA), followed 24 h afterwards by a 30 min occlusion of the MCA, increased histone acetylation levels in vivo. Ischemic preconditioning enhanced CBP recruitment and histone acetylation at the promoter of the neuroprotective gene gelsolin leading to increased gelsolin expression in neurons. Inhibition of CBP's HAT activity attenuated neuronal ischemic preconditioning. Taken together, our findings suggest that the levels of CBP and histone acetylation determine stroke outcome and are crucially associated with the induction of an ischemia-resistant state in neurons.	[Yildirim, Ferah; Ji, Shengbo; Kronenberg, Golo; Dirnagl, Ulrich; Gertz, Karen; Endres, Matthias; Harms, Christoph; Meisel, Andreas] Charite, Dept Expt Neurol, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [Yildirim, Ferah; Ji, Shengbo; Kronenberg, Golo; Dirnagl, Ulrich; Gertz, Karen; Endres, Matthias; Harms, Christoph; Meisel, Andreas] Charite, Klin & Hsch Ambulanz Neurol, D-13353 Berlin, Germany; [Barco, Angel; Olivares, Roman; Benito, Eva] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Kronenberg, Golo] Charite, Psychiat Klin & Poliklin, D-13353 Berlin, Germany; [Dirnagl, Ulrich; Gertz, Karen; Endres, Matthias; Meisel, Andreas] Charite, ExcellenceCluster NeuroCure, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Harms, C (corresponding author), Charite, Dept Expt Neurol, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany.	christoph.harms@charite.de	Barco, Angel/ABF-1864-2021; Harms, Christoph/HIK-2989-2022; Benito, Eva/AAN-9604-2020; Kronenberg, Golo/F-8772-2010; Harms, Christoph/AAD-7895-2021; Barco, Angel/C-3062-2008; Gertz, Karen/J-1603-2015	Barco, Angel/0000-0002-0653-3751; Harms, Christoph/0000-0002-2063-2860; Barco, Angel/0000-0002-0653-3751; Gertz, Karen/0000-0002-1203-641X; Benito, Eva/0000-0003-0094-0257; Kronenberg, Golo/0000-0002-5310-9849; Meisel, Andreas/0000-0001-7233-5342; Yildirim, Ferah/0000-0003-2979-6623; Endres, Matthias/0000-0001-6520-3720; Dirnagl, Ulrich/0000-0003-0755-6119	German Research Foundation [Exc 257]; Federal Ministry of Education and Research [01 EO 08 01]; Helmholtz Association [SO-022NG]; European Community [201024]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); European Community(European Commission)	This work was supported by the German Research Foundation (Exc 257), the Federal Ministry of Education and Research (01 EO 08 01), the Helmholtz Association (SO-022NG) and has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 201024 (all given to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Belayev L, 1996, NEUROREPORT, V8, P55, DOI 10.1097/00001756-199612200-00012; Chen GQ, 2010, J NEUROSCI, V30, P13066, DOI 10.1523/JNEUROSCI.2378-10.2010; Cong SY, 2005, MOL CELL NEUROSCI, V30, P12, DOI 10.1016/j.mcn.2005.05.003; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Hara T, 2003, J NEUROCHEM, V86, P805, DOI 10.1046/j.1471-4159.2003.01847.x; Harms C, 2004, MOL CELL NEUROSCI, V25, P69, DOI 10.1016/j.mcn.2003.09.012; Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Meisel A, 2006, J NEUROCHEM, V98, P1019, DOI 10.1111/j.1471-4159.2006.04016.x; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Mergenthaler P, 2011, J PHYSIOL-LONDON, V589, P4147, DOI 10.1113/jphysiol.2011.209718; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Rouaux C, 2004, BIOCHEM PHARMACOL, V68, P1157, DOI 10.1016/j.bcp.2004.05.035; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Takahashi J, 2002, BRAIN, V125, P1534, DOI 10.1093/brain/awf154; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Valor LM, 2011, J NEUROSCI, V31, P1652, DOI 10.1523/JNEUROSCI.4737-10.2011; Yildirim F, 2008, EXP NEUROL, V210, P531, DOI 10.1016/j.expneurol.2007.11.031	42	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95465	10.1371/journal.pone.0095465	http://dx.doi.org/10.1371/journal.pone.0095465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748101	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500104
J	Don-Doncow, N; Escobar, Z; Johansson, M; Kjellstrom, S; Garcia, V; Munoz, E; Sterner, O; Bjartell, A; Hellsten, R				Don-Doncow, Nicholas; Escobar, Zilma; Johansson, Martin; Kjellstrom, Sven; Garcia, Victor; Munoz, Eduardo; Sterner, Olov; Bjartell, Anders; Hellsten, Rebecka			Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING STAT3; PATHWAY; ACTIVATION; PROTEINS; TRANSDUCER; EXPRESSION; MUTATIONS	The transcription factor STAT3 is constitutively active in several malignancies including castration-resistant prostate cancer and has been identified as a promising therapeutic target. The fungal metabolite galiellalactone, a STAT3 signaling inhibitor, inhibits the growth, both in vitro and in vivo, of prostate cancer cells expressing active STAT3 and induces apoptosis of prostate cancer stem cell-like cells expressing phosphorylated STAT3 (pSTAT3). However, the molecular mechanism of this STAT3-inhibiting effect by galiellalactone has not been clarified. A biotinylated analogue of galiellalactone (GL-biot) was synthesized to be used for identification of galiellalactone target proteins. By adding streptavidin-Sepharose beads to GL-biot-treated DU145 cell lysates, STAT3 was isolated and identified as a target protein. Confocal microscopy revealed GL-biot in both the cytoplasm and the nucleus of DU145 cells treated with GL-biot, appearing to co-localize with STAT3 in the nucleus. Galiellalactone inhibited STAT3 binding to DNA in DU145 cell lysates without affecting phosphorylation status of STAT3. Mass spectrometry analysis of recombinant STAT3 protein pretreated with galiellalactone revealed three modified cysteines (Cys-367, Cys-468, and Cys-542). Here we demonstrate with chemical and molecular pharmacological methods that galiellalactone is a cysteine reactive inhibitor that covalently binds to one or more cysteines in STAT3 and that this leads to inhibition of STAT3 binding to DNA and thus blocks STAT3 signaling without affecting phosphorylation. This further validates galiellalactone as a promising direct STAT3 inhibitor for treatment of castration-resistant prostate cancer.	[Don-Doncow, Nicholas; Johansson, Martin; Bjartell, Anders; Hellsten, Rebecka] Lund Univ, Div Urol Canc, SE-20502 Malmo, Sweden; [Escobar, Zilma; Sterner, Olov] Lund Univ, Div Organ Chem, SE-22100 Lund, Sweden; [Kjellstrom, Sven] Lund Univ, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Garcia, Victor; Munoz, Eduardo] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Inst Res Biomed Cordoba, E-14004 Cordoba, Spain	Lund University; Lund University; Lund University; Universidad de Cordoba	Hellsten, R (corresponding author), Lund Univ, CMP, Div Urol Canc, Malmo Univ Hosp, Jan Waldenstroms Gata 59, SE-20502 Malmo, Sweden.	rebecka.hellsten@med.lu.se	Munoz, Eduardo/I-5225-2012; Don-Doncow, Nicholas/ABB-7450-2020	Munoz, Eduardo/0000-0001-8478-5842; Kjellstrom, Sven/0000-0003-4646-5279	Swedish Cancer Society; Swedish Research Council Medicine; National Health Service, Lund University (Sweden); Lund University (BioCare); Goteborg University (BioCare); Percy Falk Foundation; Gunnar Nilsson Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine(Swedish Research Council); National Health Service, Lund University (Sweden); Lund University (BioCare); Goteborg University (BioCare); Percy Falk Foundation; Gunnar Nilsson Cancer Foundation	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council Medicine, government funding of clinical research within the National Health Service, Lund University (Sweden), governmental strategic funding for cancer research at Lund and Goteborg Universities (BioCare), the Percy Falk Foundation, and the Gunnar Nilsson Cancer Foundation.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Barre B, 2007, TRENDS MOL MED, V13, P4, DOI 10.1016/j.molmed.2006.11.001; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Buettner R, 2011, ACS CHEM BIOL, V6, P432, DOI 10.1021/cb100253e; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Heidelberger S, 2013, BIOORG MED CHEM LETT, V23, P4719, DOI 10.1016/j.bmcl.2013.05.066; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hellsten R, 2008, PROSTATE, V68, P269, DOI 10.1002/pros.20699; Hellsten R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022118; Horinaga M, 2005, UROLOGY, V66, P671, DOI 10.1016/j.urology.2005.03.066; Johansson M, 2001, ORG LETT, V3, P2843, DOI 10.1021/ol016286+; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kroon P, 2013, CANCER RES, V73, P5288, DOI 10.1158/0008-5472.CAN-13-0874; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Mohler JL, 2012, J NATL COMPR CANC NE, V10, P1081, DOI 10.6004/jnccn.2012.0114; Mora LB, 2002, CANCER RES, V62, P6659; Perez M, 2014, CHEM-BIOL INTERACT, V214, P69, DOI 10.1016/j.cbi.2014.02.012; Peyser ND, 2013, ONCOTARGETS THER, V6, P999, DOI 10.2147/OTT.S47903; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Quintas-Cardama A., 2013, CLIN CANCER RES, V19, P1933; Rudolph K, 2013, CYTOKINE, V61, P285, DOI 10.1016/j.cyto.2012.10.011; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sellier H., 2013, JAK STAT, V2; Shodeinde AL, 2012, ONCOTARGETS THER, V5, P119, DOI 10.2147/OTT.S32559; Sridhar SS, 2014, EUR UROL, V65, P289, DOI 10.1016/j.eururo.2013.08.008; Tam L, 2007, BRIT J CANCER, V97, P378, DOI 10.1038/sj.bjc.6603871; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; von Nussbaum F, 2004, EUR J ORG CHEM, V2004, P2783, DOI 10.1002/ejoc.200400137; Weidler M, 2000, FEBS LETT, V484, P1, DOI 10.1016/S0014-5793(00)02115-3; Yang J, 2005, CANCER RES, V65, P939; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zgheib C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043313	36	69	74	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15969	15978		10.1074/jbc.M114.564252	http://dx.doi.org/10.1074/jbc.M114.564252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755219	hybrid, Green Published			2022-12-25	WOS:000337965700008
J	Chen, DN; Ma, YT; Liu, H; Zhou, QY; Li, JD				Chen, Dan-Na; Ma, Yan-Tao; Liu, Huadie; Zhou, Qun-Yong; Li, Jia-Da			Functional Rescue of Kallmann Syndrome-associated Prokineticin Receptor 2 (PKR2) Mutants Deficient in Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptor (GPCR); Molecular Chaperone; Protein Misfolding; Signal Transduction; Trafficking; PKR2; Kallmann Syndrome	PHARMACOLOGICAL CHAPERONES; QUALITY-CONTROL; INTRACELLULAR LOOP; COMPLEX GENETICS; OLFACTORY-BULB; PROTEIN; MUTATIONS; PROKR2; EXPRESSION; TRANSPORT	Mutations in the G protein-coupled prokineticin receptor 2 (PKR2) are known to cause Kallmann syndrome and idiopathic hypogonadotropic hypogonadism manifesting with delayed puberty and infertility. Some of the mutant receptors are not routed to the cell surface; instead, they are trapped in the cellular secretory pathway. The cell-permeant agonists/antagonists have been used to rescue some membrane receptors that are not targeted onto the cell membrane. Here, we chose three disease-associated mutations (W178S, G234D, and P290S), which all resulted in retention of PKR2 intracellularly. We show that a small molecule PKR2 antagonist (A457) dramatically increased cell surface expression and rescued the function of P290S PKR2, but had no effect on W178S and G234D PKR2. Furthermore, we also tested chemical chaperone glycerol on the cell surface expression and function of PKR2 mutants. Treatment with 10% glycerol significantly increased the cell surface expression and signaling of P290S and W178S PKR2. These data demonstrate that some Kallmann syndrome-associated, intracellularly retained mutant PKR2 receptors can be functionally rescued, suggesting a potential treatment strategy for patients bearing such mutations.	[Chen, Dan-Na; Ma, Yan-Tao; Liu, Huadie; Li, Jia-Da] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Chen, Dan-Na] Changsha Med Univ, Dept Basic Med Sci, Changsha 410219, Hunan, Peoples R China; [Li, Jia-Da] Hubei Univ Sci & Technol, Dept Pharmacol, Xianning 437100, Hubei, Peoples R China; [Zhou, Qun-Yong] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA	Central South University; Changsha Medical University; Hubei University of Science & Technology; University of California System; University of California Irvine	Li, JD (corresponding author), Cent S Univ, State Key Lab Med Genet, 110 Xiangya St, Changsha 410078, Hunan, Peoples R China.	lijiada@sklmg.edu.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Li, Jia-Da/0000-0002-4236-3518	National Basic Research Program of China [2012CB517904]; National Natural Science Foundation of China [31371187, 30970958, 81070481]; Graduate Research and Innovation Projects of Hunan Province [CX2013B090]; Fundamental Research Fund for the Central Universities of Central South University [2013zzts270]; Ministry of Education of China; Lotus Scholar Professorship Funds from Hunan Province Government; Central South University of China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Research and Innovation Projects of Hunan Province; Fundamental Research Fund for the Central Universities of Central South University; Ministry of Education of China(Ministry of Education, China); Lotus Scholar Professorship Funds from Hunan Province Government; Central South University of China	This work was supported by National Basic Research Program of China Grant 2012CB517904, National Natural Science Foundation of China Grants 31371187, 30970958, and 81070481, Graduate Research and Innovation Projects of Hunan Province Grant CX2013B090, Fundamental Research Fund for the Central Universities of Central South University Grant 2013zzts270, grants from the Ministry of Education of China, the Lotus Scholar Professorship Funds from Hunan Province Government, and a research grant provided by the Central South University of China.	Abreu AP, 2008, J CLIN ENDOCR METAB, V93, P4113, DOI 10.1210/jc.2008-0958; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bomberger JM, 2012, ADV EXP MED BIOL, V744, P25, DOI 10.1007/978-1-4614-2364-5_3; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Chevrier L, 2011, MOL CELL ENDOCRINOL, V346, P21, DOI 10.1016/j.mce.2011.04.018; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; Conn PM, 2010, TRENDS ENDOCRIN MET, V21, P190, DOI 10.1016/j.tem.2009.11.003; Conn PM, 2009, TRENDS PHARMACOL SCI, V30, P228, DOI 10.1016/j.tips.2009.02.002; Curtis VF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054916; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Dode C, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00019; Dode C, 2009, EUR J HUM GENET, V17, P139, DOI 10.1038/ejhg.2008.206; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Hardelin JP, 2008, SEX DEV, V2, P181, DOI 10.1159/000152034; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Janovick JA, 2013, P NATL ACAD SCI USA, V110, P21030, DOI 10.1073/pnas.1315194110; Kallmann FJ, 1944, AM J MENT DEF, V48, P203; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Layman LC, 2013, J CLIN ENDOCR METAB, V98, P1860, DOI 10.1210/jc.2013-1624; Li JD, 2012, PROG BRAIN RES, V199, P119, DOI 10.1016/B978-0-444-59427-3.00028-9; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; NAFTOLIN F, 1971, NATURE, V232, P496, DOI 10.1038/232496a0; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Peng Z, 2011, J BIOL CHEM, V286, P16615, DOI 10.1074/jbc.M111.223784; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2010, FRONT HORM RES, V39, P142, DOI 10.1159/000312700; Raibekas AA, 1997, J BIOL CHEM, V272, P22248, DOI 10.1074/jbc.272.35.22248; Rajan RS, 2011, CURR MED CHEM, V18, P1; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020263; Sarfati J, 2013, EUR J ENDOCRINOL, V169, P805, DOI 10.1530/EJE-13-0419; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Zhou QY, 2005, FEBS J, V272, P5703, DOI 10.1111/j.1742-4658.2005.04984.x; Zhou XT, 2013, BIOCHEM BIOPH RES CO, V439, P12, DOI 10.1016/j.bbrc.2013.08.039	46	15	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15518	15526		10.1074/jbc.M114.556381	http://dx.doi.org/10.1074/jbc.M114.556381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753254	hybrid, Green Published			2022-12-25	WOS:000337465400034
J	Coey, CT; Fitzgerald, ME; Maiti, A; Reiter, KH; Guzzo, CM; Matunis, MJ; Drohat, AC				Coey, Christopher T.; Fitzgerald, Megan E.; Maiti, Atanu; Reiter, Katherine H.; Guzzo, Catherine M.; Matunis, Michael J.; Drohat, Alexander C.			E2-mediated Small Ubiquitin-like Modifier (SUMO) Modification of Thymine DNA Glycosylase Is Efficient but Not Selective for the Enzyme-Product Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair (BER); DNA Methylation; DNA Repair; Enzyme Turnover; Post-translational Modification (PTM); Small Ubiquitin-like Modifier (SUMO); Sumoylation; Ubiquitin-conjugating Enzyme (E2 Enzyme)	CONJUGATING ENZYME; PROTEIN MODIFICATION; CRYSTAL-STRUCTURE; BINDING; 5-FORMYLCYTOSINE; EXCISION; TDG; SUMOYLATION; 5-CARBOXYLCYTOSINE; PURIFICATION	Thymine DNA glycosylase (TDG) initiates the repair of GT mismatches that arise by deamination of 5-methylcytosine (mC), and it excises 5-formylcytosine and 5-carboxylcytosine, oxidized forms of mC. TDG functions in active DNA demethylation and is essential for embryonic development. TDG forms a tight enzyme-product complex with abasic DNA, which severely impedes enzymatic turnover. Modification of TDG by small ubiquitin-like modifier (SUMO) proteins weakens its binding to abasic DNA. It was proposed that sumoylation of product-bound TDG regulates product release, with SUMO conjugation and deconjugation needed for each catalytic cycle, but this model remains unsubstantiated. We examined the efficiency and specificity of TDG sumoylation using in vitro assays with purified E1 and E2 enzymes, finding that TDG is modified efficiently by SUMO-1 and SUMO-2. Remarkably, we observed similar modification rates for free TDG and TDG bound to abasic or undamaged DNA. To examine the conjugation step directly, we determined modification rates (k(obs)) using preformed E2 approximate to SUMO-1 thioester. The hyperbolic dependence of k(obs) on TDG concentration gives k(max) = 1.6 min(-1) and K-1/2 = 0.55 m, suggesting that E2 approximate to SUMO-1 has higher affinity for TDG than for the SUMO targets RanGAP1 and p53 (peptide). Whereas sumoylation substantially weakens TDG binding to DNA, TDG approximate to SUMO-1 still binds relatively tightly to AP-DNA (K-d approximate to 50 nm). Although E2 approximate to SUMO-1 exhibits no specificity for product-bound TDG, the relatively high conjugation efficiency raises the possibility that E2-mediated sumoylation could stimulate product release in vivo. This and other implications for the biological role and mechanism of TDG sumoylation are discussed.	[Coey, Christopher T.; Fitzgerald, Megan E.; Maiti, Atanu; Drohat, Alexander C.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Reiter, Katherine H.; Guzzo, Catherine M.; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Drohat, AC (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA.	adrohat@som.umaryland.edu		Maiti, Atanu/0000-0002-9080-1025; Matunis, Michael/0000-0002-9350-6611; Drohat, Alex/0000-0002-7458-8770	National Institutes of Health [S10-OD011969]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711, R01GM060980] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Prof. F. Melchior (University of Heidelberg) for expression plasmids for Ubc9 and SUMO-1 (mature form), Prof. M. Shirakawa (Kyoto University) for a plasmid for the co-expression of human SUMO-1 and the E1 and E2 enzymes, and Dr. Bor-Jang Hwang and Dr. Aparna Kishor for assistance with immunoblotting. Support for procuring the imaging system (GE Typhoon FLA 9500) used in these studies was provided by the National Institutes of Health Grant S10-OD011969 (to A.L. Lu).	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Choi SJ, 2006, J BIOL CHEM, V281, P30669, DOI 10.1074/jbc.M604033200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim EJ, 2008, BIOCHEM BIOPH RES CO, V377, P838, DOI 10.1016/j.bbrc.2008.10.058; Liu XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063680; Lucey MJ, 2005, NUCLEIC ACIDS RES, V33, P6393, DOI 10.1093/nar/gki940; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Maiti A, 2013, J AM CHEM SOC, V135, P15813, DOI 10.1021/ja406444x; Maiti A, 2012, P NATL ACAD SCI USA, V109, P8091, DOI 10.1073/pnas.1201010109; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Maiti A, 2011, DNA REPAIR, V10, P545, DOI 10.1016/j.dnarep.2011.03.004; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Mohideen F, 2009, NAT STRUCT MOL BIOL, V16, P945, DOI 10.1038/nsmb.1648; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pilla E, 2012, J BIOL CHEM, V287, P44320, DOI 10.1074/jbc.M112.397224; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Scharer OD, 1997, P NATL ACAD SCI USA, V94, P4878, DOI 10.1073/pnas.94.10.4878; Scharer OD, 1998, J BIOL CHEM, V273, P8592, DOI 10.1074/jbc.273.15.8592; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Sjolund AB, 2013, MUTAT RES-FUND MOL M, V743, P12, DOI 10.1016/j.mrfmmm.2012.11.001; Smet-Nocca C, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-4; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Stindt Maren H, 2011, Cell Cycle, V10, P3176; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; Xu XH, 2014, J BIOL CHEM, V289, P8881, DOI 10.1074/jbc.M113.538835; Yunus AA, 2005, METHOD ENZYMOL, V398, P74, DOI 10.1016/S0076-6879(05)98008-7; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200; Zilio N, 2013, DNA REPAIR, V12, P761, DOI 10.1016/j.dnarep.2013.07.001	65	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15810	15819		10.1074/jbc.M114.572081	http://dx.doi.org/10.1074/jbc.M114.572081			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753249	Green Published, hybrid			2022-12-25	WOS:000337465400060
J	Harris, DP; Bandyopadhyay, S; Maxwell, TJ; Willard, B; DiCorleto, PE				Harris, Daniel P.; Bandyopadhyay, Smarajit; Maxwell, Tyler J.; Willard, Belinda; DiCorleto, Paul E.			Tumor Necrosis Factor (TNF)-alpha Induction of CXCL10 in Endothelial Cells Requires Protein Arginine Methyltransferase 5 (PRMT5)-mediated Nuclear Factor (NF)-kappa B p65 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Gene Expression; NF-Kappa B (NF-KB); Post-Translational Modification (PTM); Protein Methylation; Tumor Necrosis Factor (TNF)	NF-KAPPA-B; INTERFERON-INDUCIBLE PROTEIN-10; CORONARY-ARTERY-DISEASE; IFN-GAMMA; INFLAMMATORY RESPONSE; GENE-EXPRESSION; CHEMOKINE; PRMT5; TRANSCRIPTION; IP-10	Background: NF-B post-translational modifications contribute to gene-specific transcriptional activation. Results: Symmetrical dimethylation of NF-B p65 by PRMT5 enhances CXCL10 induction in response to TNF-. Conclusion: Arginine methylation of p65 is a novel mechanism regulating inflammatory chemokine induction. Significance: Methylation of specific NF-B arginine residues contributes to promoter targeting and transcriptional activation. The chemokine CXCL10/IP-10 facilitates recruitment of Th1-type leukocytes to inflammatory sites. In this study, we show that the arginine methyltransferase PRMT5 is critical for CXCL10 transcription in TNF--activated human endothelial cells (EC). We found that depletion of PRMT5 results in significantly reduced levels of CXCL10 mRNA, demonstrating a positive role for PRMT5 in CXCL10 induction. Chromatin immunoprecipitation experiments revealed the presence of the symmetrical dimethylarginine modification catalyzed by PRMT5 associated with the CXCL10 promoter in response to TNF-. However, symmetrical dimethylarginine-modified proteins were not detected at the promoter in the absence of PRMT5, indicating that PRMT5 is essential for methylation to occur. Furthermore, NF-B p65, a critical driver of TNF--mediated CXCL10 induction, was determined to be methylated at arginine residues. Crucially, RNAi-mediated PRMT5 depletion abrogated p65 methylation and CXCL10 promoter binding. Mass spectrometric analysis in EC identified five dimethylated arginine residues in p65, four of which are uncharacterized in the literature. Expression of Arg-to-Lys point mutants of p65 demonstrated that both Arg-30 and Arg-35 must be dimethylated to achieve full CXCL10 expression. In conclusion, we have identified previously uncharacterized p65 post-translational modifications critical for CXCL10 induction.	[Harris, Daniel P.; Bandyopadhyay, Smarajit; Maxwell, Tyler J.; Willard, Belinda; DiCorleto, Paul E.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Harris, Daniel P.; DiCorleto, Paul E.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	DiCorleto, PE (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	dicorlp@ccf.org		Harris, Daniel/0000-0002-1852-0683	National Center for Advancing Translational Sciences component of the NIH [UL1TR000439]; NIH Roadmap for Medical Research; National Institutes of Health [1S10RR031537-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences component of the NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Lisa Dechert, Chad Braley, and Emily Tillmaand for cell culture assistance. We thank Unni Chandrasekharan, Matthew Waitkus, and Joel Boerckel for helpful comments during manuscript preparation. Human umbilical vein endothelial cells were harvested from human umbilical cords collected from the Birthing Services Department at the Cleveland Clinic (Hillcrest Hospital) and the Perinatal Clinical Research Center (PCRC) at the Cleveland MetroHealth Hospital. The PCRC has been supported by a grant (UL1TR000439) awarded to the Clinical and Translational Science Collaborative of Cleveland by the National Center for Advancing Translational Sciences component of the NIH and the NIH Roadmap for Medical Research. The Orbitrap Elite instrument was purchased via a National Institutes of Health shared instrument grant (1S10RR031537-01).	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Bandyopadhyay S, 2007, MOL CELL BIOL, V27, P4207, DOI 10.1128/MCB.00052-07; Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Boisvert FM, 2004, MOL CELL, V15, P492, DOI 10.1016/j.molcel.2004.08.011; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Fernandes JL, 2004, CYTOKINE, V26, P131, DOI 10.1016/j.cyto.2004.01.007; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guo ZG, 2010, NAT CHEM BIOL, V6, P766, DOI [10.1038/NCHEMBIO.422, 10.1038/nchembio.422]; Hamilton TA, 2007, J LEUKOCYTE BIOL, V82, P213, DOI 10.1189/jlb.1206754; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kawamura A, 2003, CIRC J, V67, P851, DOI 10.1253/circj.67.851; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Majumder S, 1998, J IMMUNOL, V161, P4736; Marx N, 2000, J IMMUNOL, V164, P6503, DOI 10.4049/jimmunol.164.12.6503; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Molina-Serrano D, 2013, BIOCHEM SOC T, V41, P751, DOI 10.1042/BST20130003; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Scarpati EM, 1996, J BIOL CHEM, V271, P3025, DOI 10.1074/jbc.271.6.3025; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Tweedie-Cullen RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036980; Wang XK, 1996, J BIOL CHEM, V271, P24286, DOI 10.1074/jbc.271.39.24286; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	41	51	53	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15328	15339		10.1074/jbc.M114.547349	http://dx.doi.org/10.1074/jbc.M114.547349			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753255	Green Published, hybrid			2022-12-25	WOS:000337465400017
J	Ma, YH; Ha, CS; Hwang, SW; Lee, HJ; Kim, GC; Lee, KW; Song, K				Ma, Yonghao; Ha, Chang Seung; Hwang, Seok Won; Lee, Hae June; Kim, Gyoo Cheon; Lee, Kyo-Won; Song, Kiwon			Non-Thermal Atmospheric Pressure Plasma Preferentially Induces Apoptosis in p53-Mutated Cancer Cells by Activating ROS Stress-Response Pathways	PLOS ONE			English	Article							DNA-DAMAGE; P53 STABILIZATION; DIFFERENTIATION; RESISTANCE; MECHANISM; ARREST; GROWTH; REPAIR; CYCLE	Non-thermal atmospheric pressure plasma (NTAPP) is an ionized gas at room temperature and has potential as a new apoptosis-promoting cancer therapy that acts by generating reactive oxygen species (ROS). However, it is imperative to determine its selectivity and standardize the components and composition of NTAPP. Here, we designed an NTAPP-generating apparatus combined with a He gas feeding system and demonstrated its high selectivity toward p53-mutated cancer cells. We first determined the proper conditions for NTAPP exposure to selectively induce apoptosis in cancer cells. The apoptotic effect of NTAPP was greater for p53-mutated cancer cells; artificial p53 expression in p53-negative HT29 cells decreased the pro-apoptotic effect of NTAPP. We also examined extra-and intracellular ROS levels in NTAPP-treated cells to deduce the mechanism of NTAPP action. While NTAPP-mediated increases in extracellular nitric oxide (NO) did not affect cell viability, intracellular ROS increased under NTAPP exposure and induced apoptotic cell death. This effect was dose-dependently reduced following treatment with ROS scavengers. NTAPP induced apoptosis even in doxorubicin-resistant cancer cell lines, demonstrating the feasibility of NTAPP as a potent cancer therapy. Collectively, these results strongly support the potential of NTAPP as a selective anticancer treatment, especially for p53-mutated cancer cells.	[Ma, Yonghao; Song, Kiwon] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Ha, Chang Seung; Hwang, Seok Won; Lee, Hae June] Pusan Natl Univ, Dept Elect Engn, Pusan 609735, South Korea; [Kim, Gyoo Cheon] Pusan Natl Univ, Sch Dent, Dept Oral Anat, Yangsan, South Korea; [Lee, Kyo-Won] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Obstet & Gynecol, Seoul, South Korea	Yonsei University; Pusan National University; Pusan National University; Pusan National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Song, K (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	bc5012@yonsei.ac.kr			KRICT [SI-1304]; Ministry of Knowledge Economy, Korea	KRICT; Ministry of Knowledge Economy, Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This research was supported by a grant from KRICT (SI-1304) and the Ministry of Knowledge Economy, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Cardaci S, 2008, MOL PHARMACOL, V74, P1234, DOI 10.1124/mol.108.048975; Choi SU, 1999, ANTICANCER RES, V19, P2035; Downs I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038051; Duval A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083001; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Endo S, 2003, NEUROSCI LETT, V350, P122, DOI 10.1016/S0304-3940(03)00856-5; Fang Shih-Yuan, 2006, Acta Anaesthesiol Taiwan, V44, P141; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Giustarini D, 2008, METHOD ENZYMOL, V440, P361, DOI 10.1016/S0076-6879(07)00823-3; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Gweon B, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3352316; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Jang ER, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.070466; Ji ZY, 2012, J INVEST DERMATOL, V132, P356, DOI 10.1038/jid.2011.313; Joh HM, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4742742; Johnson CL, 2002, MOL CANCER THER, V1, P861; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kim J, 2010, BIOCHEM BIOPH RES CO, V400, P739, DOI 10.1016/j.bbrc.2010.08.140; Kim W, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013001; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Lee HW, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/5/053001; Lee HR, 2008, MOL CELL BIOCHEM, V318, P23, DOI 10.1007/s11010-008-9853-y; Liu DX, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/2/025018; Mishra OP, 2004, NEUROSCIENCE, V123, P179, DOI 10.1016/j.neuroscience.2003.08.008; Moreno CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000441; Morfill GE, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115011; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Park GY, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/043001; Park SR, 2010, YONSEI MED J, V51, P708, DOI 10.3349/ymj.2010.51.5.708; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sakiyama Y, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/42/425201; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Tang RY, 2011, CHEM COMMUN, V47, P12867, DOI 10.1039/c1cc15397h; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Wang X, 2011, FREE RADICAL BIO MED, V51, P539, DOI 10.1016/j.freeradbiomed.2011.04.019; Wesolowska O, 2005, ANTICANCER RES, V25, P383; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3	60	123	129	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e91947	10.1371/journal.pone.0091947	http://dx.doi.org/10.1371/journal.pone.0091947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759730	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200005
J	Dong, LB; Bo, H; Bai, T; Gao, RB; Dong, J; Zhang, Y; Guo, JF; Zou, SM; Zhou, JF; Zhu, Y; Xin, L; Li, XD; Xu, CL; Wang, DY; Shu, YL				Dong, Libo; Bo, Hong; Bai, Tian; Gao, Rongbao; Dong, Jie; Zhang, Ye; Guo, Junfeng; Zou, Shumei; Zhou, Jianfang; Zhu, Yun; Xin, Li; Li, Xiaodan; Xu, Cuiling; Wang, Dayan; Shu, Yuelong			A Combination of Serological Assays to Detect Human Antibodies to the Avian Influenza A H7N9 Virus	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; ERYTHROCYTES; INFECTION	Human infection with avian influenza A H7N9 virus was first identified in March 2013 and represents an ongoing threat to public health. There is a need to optimize serological methods for this new influenza virus. Here, we compared the sensitivity and specificity of the hemagglutinin inhibition (HI), microneutralization (MN), and Western blot (WB) assays for the detection of human antibodies against avian influenza A (H7N9) virus. HI with horse erythrocytes (hRBCs) and a modified MN assay possessed greater sensitivity than turkey erythrocytes and the standard MN assay, respectively. Using these assays, 80% of tested sera from confirmed H7N9 cases developed detectable antibody to H7N9 after 21 days. To balance sensitivity and specificity, we found serum titers of >= 20 (MN) or 160 (HI) samples were most effective in determining seropositive to H7N9 virus. Single serum with HI titers of 20-80 or MN titer of 10 could be validated by each other or WB assay. Unlike serum collected from adult or elderly populations, the antibody response in children with mild disease was low or undetectable. These combinations of assays will be useful in case diagnosis and serologic investigation of human cases.	[Dong, Libo; Bo, Hong; Bai, Tian; Gao, Rongbao; Dong, Jie; Zhang, Ye; Guo, Junfeng; Zou, Shumei; Zhou, Jianfang; Zhu, Yun; Xin, Li; Li, Xiaodan; Xu, Cuiling; Wang, Dayan; Shu, Yuelong] Natl Hlth & Family Planning Commiss, Key Lab Med Virol, China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Shu, YL (corresponding author), Natl Hlth & Family Planning Commiss, Key Lab Med Virol, China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	yshu@cnic.org.cn			National Basic Research Program (973) of China [2011CB504704]; Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology [KJYJ-2013-01-01]; National Mega-projects for Infectious Diseases [2012ZX10004501-004-002]	National Basic Research Program (973) of China(National Basic Research Program of China); Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology; National Mega-projects for Infectious Diseases	This study was supported by the National Basic Research Program (973) of China (2011CB504704, to Dr. Shu); the Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology (No. KJYJ-2013-01-01 to Dr. Shu); and National Mega-projects for Infectious Diseases (2012ZX10004501-004-002 to Dr. Dong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, 2013, MOD HEM INH HI ASS U; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; Kendal AP, 1982, CONCEPTS PROCEDURES; Meijer A, 2006, J VIROL METHODS, V132, P113, DOI 10.1016/j.jviromet.2005.10.001; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; WHO/GIP, 2014, NUMB CONF HUM CAS AV; Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2; Yang S, 2013, J INFECT DIS; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	13	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95612	10.1371/journal.pone.0095612	http://dx.doi.org/10.1371/journal.pone.0095612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755627	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300062
J	Hikihara, Y; Tanaka, C; Oshima, Y; Ohkawara, K; Ishikawa-Takata, K; Tanaka, S				Hikihara, Yuki; Tanaka, Chiaki; Oshima, Yoshitake; Ohkawara, Kazunori; Ishikawa-Takata, Kazuko; Tanaka, Shigeho			Prediction Models Discriminating between Nonlocomotive and Locomotive Activities in Children Using a Triaxial Accelerometer with a Gravity-removal Physical Activity Classification Algorithm	PLOS ONE			English	Article							ENERGY-EXPENDITURE; VALIDATION; VALIDITY; CALIBRATION; INTENSITY; COMPENDIUM	The aims of our study were to examine whether a gravity-removal physical activity classification algorithm (GRPACA) is applicable for discrimination between nonlocomotive and locomotive activities for various physical activities (PAs) of children and to prove that this approach improves the estimation accuracy of a prediction model for children using an accelerometer. Japanese children (42 boys and 26 girls) attending primary school were invited to participate in this study. We used a triaxial accelerometer with a sampling interval of 32 Hz and within a measurement range of 66 G. Participants were asked to perform 6 nonlocomotive and 5 locomotive activities. We measured raw synthetic acceleration with the triaxial accelerometer and monitored oxygen consumption and carbon dioxide production during each activity with the Douglas bag method. In addition, the resting metabolic rate (RMR) was measured with the subject sitting on a chair to calculate metabolic equivalents (METs). When the ratio of unfiltered synthetic acceleration (USA) and filtered synthetic acceleration (FSA) was 1.12, the rate of correct discrimination between nonlocomotive and locomotive activities was excellent, at 99.1% on average. As a result, a strong linear relationship was found for both nonlocomotive (METs = 0.013 x synthetic acceleration + 1.220, R-2 = 0.772) and locomotive (METs = 0.0056 x synthetic acceleration + 0.944, R-2 = 0.880) activities, except for climbing down and up. The mean differences between the values predicted by our model and measured METs were 20.50 to 0.23 for moderate to vigorous intensity (< 3.5 METs) PAs like running, ball throwing and washing the floor, which were regarded as unpredictable PAs. In addition, the difference was within 0.25 METs for sedentary to mild moderate PAs (< 3.5 METs). Our specific calibration model that discriminates between nonlocomotive and locomotive activities for children can be useful to evaluate the sedentary to vigorous PAs intensity of both nonlocomotive and locomotive activities.	[Hikihara, Yuki] Chiba Inst Technol, Fac Engn, Chiba, Japan; [Tanaka, Chiaki] JF Oberlin Univ, Div Integrated Sci, Tokyo, Japan; [Oshima, Yoshitake] Univ Mkt & Distribut Sci, Fac Serv Ind, Kobe, Hyogo, Japan; [Ohkawara, Kazunori] Univ Electrocommun, Fac Informat & Engn, Tokyo, Japan; [Ishikawa-Takata, Kazuko] Natl Inst Hlth & Nutr, Dept Nutr Educ, Tokyo 162, Japan; [Tanaka, Shigeho] Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo 162, Japan	Chiba Institute of Technology; University of Electro-Communications - Japan; National Institute of Health & Nutrition - Japan; National Institute of Health & Nutrition - Japan	Hikihara, Y (corresponding author), Chiba Inst Technol, Fac Engn, Chiba, Japan.	hikihara.yuki@it-chiba.ac.jp	Tanaka, Chiaki/AGN-2367-2022	Tanaka, Chiaki/0000-0001-9113-436X	Ministry of Education, Culture, Sports, Science and Technology [KAKENHI: 21700700]; Grant of Kozuki Foundation for Sports and Education; Grants-in-Aid for Scientific Research [24700759] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant of Kozuki Foundation for Sports and Education; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in-Aid for Scientific Research (KAKENHI: 21700700) for The Ministry of Education, Culture, Sports, Science and Technology and the Grant of Kozuki Foundation for Sports and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alhassan S, 2012, ACCURACY ACCELEROMET; Allor KM, 2000, J APPL PHYSIOL, V89, P512, DOI 10.1152/jappl.2000.89.2.512; Amorim PRS, 2007, INT J PEDIATR OBES, V2, P249, DOI 10.1080/17477160701453466; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bratteby LE, 1997, EUR J CLIN NUTR, V51, P585, DOI 10.1038/sj.ejcn.1600449; Chu EYW, 2007, MED SCI SPORT EXER, V39, P2085, DOI 10.1249/mss.0b013e318148436c; Crouter SE, 2013, MED SCI SPORT EXER, V45, P1403, DOI 10.1249/MSS.0b013e318285f03b; Crouter SE, 2012, MED SCI SPORT EXER, V44, P1177, DOI 10.1249/MSS.0b013e3182447825; de Graauw SM, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/489304; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Eston RG, 1998, J APPL PHYSIOL, V84, P362, DOI 10.1152/jappl.1998.84.1.362; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Heil DP, 2006, RES Q EXERCISE SPORT, V77, P64, DOI 10.5641/027013606X13080769703920; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hikihara Y, 2012, J PHYS ACT HEALTH, V9, P935, DOI 10.1123/jpah.9.7.935; Janssen I, 2007, APPL PHYSIOL NUTR ME, V32, pS109, DOI 10.1139/H07-109; JANZ KF, 1994, MED SCI SPORT EXER, V26, P369; Midorikawa T, 2007, OBESITY, V15, P3031, DOI 10.1038/oby.2007.361; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Ogawa T, 2005, EUR J APPL PHYSIOL, V94, P254, DOI 10.1007/s00421-005-1322-7; Ohkawara K., 2011, BR J NUTR, P1; Oshima Y, 2010, GAIT POSTURE, V31, P370, DOI 10.1016/j.gaitpost.2010.01.005; Pate RR, 2000, OBESITY SILVER SPRIN, V14, P2000; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Rowlands AV, 2004, MED SCI SPORT EXER, V36, P518, DOI 10.1249/01.MSS.0000117158.14542.E7; Schmitz KH, 2005, MED SCI SPORT EXER, V37, P155, DOI 10.1249/01.MSS.0000150084.97823.F7; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tanaka C, 2007, OBESITY, V15, P1233, DOI 10.1038/oby.2007.145; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2	37	34	34	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94940	10.1371/journal.pone.0094940	http://dx.doi.org/10.1371/journal.pone.0094940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755646	gold, Green Submitted, Green Published			2022-12-25	WOS:000335240300024
J	Ni, HW; Zhao, WZ; Kong, XT; Li, HT; Ouyang, J				Ni, Haiwen; Zhao, Wanzhou; Kong, Xiangtu; Li, Haitao; Ouyang, Jian			NF-Kappa B Modulation Is Involved in Celastrol Induced Human Multiple Myeloma Cell Apoptosis	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; INFLAMMATORY PATHWAYS; TRANSCRIPTION FACTOR; CARCINOMA CELLS; DOWN-REGULATION; ANTICANCER; PROTEASOME; EXPRESSION; PROLIFERATION; THALIDOMIDE	Celastrol is an active compound extracted from the root bark of the traditional Chinese medicine Tripterygium wilfordii Hook F. To investigate the effect of celastrol on human multiple myeloma cell cycle arrest and apoptosis and explore its molecular mechanism of action. The activity of celastrol on LP-1 cell proliferation was detected by WST-8 assay. The celastrol-induced cell cycle arrest was analyzed by flow cytometry after propidium iodide staining. Nuclear translocation of the nuclear factor kappa B (NF-kappa B) was observed by fluorescence microscope. Celastrol inhibited cell proliferation of LP-1 myeloma cell in a dose-dependent manner with IC50 values of 0.8817 mu M, which was mediated through G1 cell cycle arrest and p27 induction. Celastrol induced apoptosis in LP-1 and RPMI 8226 myeloma cells in a time and dose dependent manner, and it involved Caspase-3 activation and NF-kB pathway. Celastrol down-modulated antiapoptotic proteins including Bcl-2 and survivin expression. The expression of NF-kB and IKKa were decreased after celastrol treatment. Celastrol effectively blocked the nuclear translocation of the p65 subunit and induced human multiple myeloma cell cycle arrest and apoptosis by p27 upregulation and NF-kB modulation. It has been demonstrated that the effect of celastrol on NF-kB was HO-1-independent by using zinc protoporphyrin-9 (ZnPPIX), a selective heme oxygenase inhibitor. From the results, it could be inferred that celastrol may be used as a NF-kB inhibitor to inhibit myeloma cell proliferation.	[Ni, Haiwen; Kong, Xiangtu] Nanjing Univ, TCM, Affiliated Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Wanzhou] Sino EU Biomed Innovat Ctr, Nanjing, Jiangsu, Peoples R China; [Li, Haitao] Nanjing Univ Chinese Med, Nanjing, Peoples R China; [Ouyang, Jian] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Hematol,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University	Ouyang, J (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp, Dept Hematol,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.	ouyangjiangulou@gmail.com						Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Allison AC, 2001, PROG NEURO-PSYCHOPH, V25, P1341, DOI 10.1016/S0278-5846(01)00192-0; Arumugam TV, 2011, MOL PHARMACOL, V80, P23, DOI 10.1124/mol.111.071076; Barrera LN, 2012, CELL CYCLE, V11, P2248, DOI 10.4161/cc.20343; Berda-Haddad Y, 2011, P NATL ACAD SCI USA, V108, P20684, DOI 10.1073/pnas.1116848108; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chen M, 2009, MOL CANCER RES, V7, P1946, DOI 10.1158/1541-7786.MCR-09-0243; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; Dai Y, 2009, AM J TRANSL RES, V1, P1; Feinman Rena, 2004, Clin Adv Hematol Oncol, V2, P162; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Gasparian AV, 2002, J CELL SCI, V115, P141; Glasmacher A, 2006, BRIT J HAEMATOL, V132, P584, DOI 10.1111/j.1365-2141.2005.05914.x; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; He D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-343; Hideshima T, 2000, BLOOD, V96, P2943, DOI 10.1182/blood.V96.9.2943; Huang SA, 2012, BIOCHEM BIOPH RES CO, V423, P467, DOI 10.1016/j.bbrc.2012.05.143; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Hubackova S, 2012, J BIOL CHEM, V287, P26702, DOI 10.1074/jbc.M111.316869; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kumar S, 2006, EUR J CANCER, V42, P1612, DOI 10.1016/j.ejca.2006.04.004; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Li F, 2010, BRIT J PHARMACOL, V161, P541, DOI 10.1111/j.1476-5381.2010.00874.x; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Liu JJ, 2002, CARCINOGENESIS, V23, P2087, DOI 10.1093/carcin/23.12.2087; Morita T, 2010, AM J HYPERTENS, V23, P821, DOI 10.1038/ajh.2010.87; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Ni H, 2001, BRIT J HAEMATOL, V115, P279, DOI 10.1046/j.1365-2141.2001.03102.x; Nishikori M, 2005, J CLIN EXP HEMATOP, V45, P15, DOI 10.3960/jslrt.45.15; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Wong KF, 2012, CLIN EXP PHARMACOL P, V39, P311, DOI 10.1111/j.1440-1681.2011.05586.x; Yadav VR, 2010, J MOL MED, V88, P1243, DOI 10.1007/s00109-010-0669-3; Yamai H, 2009, INT J CANCER, V125, P952, DOI 10.1002/ijc.24433; Yang S, 2011, FOOD CHEM TOXICOL, V49, P527, DOI 10.1016/j.fct.2010.11.044; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhao WZ, 2003, CANCER DETECT PREV, V27, P67, DOI 10.1016/S0361-090X(02)00170-8; Zorn JA, 2012, J BIOL CHEM, V287, P33781, DOI 10.1074/jbc.M112.386128	49	47	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95846	10.1371/journal.pone.0095846	http://dx.doi.org/10.1371/journal.pone.0095846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755677	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300105
J	Ousdal, OT; Andreassen, OA; Server, A; Jensen, J				Ousdal, Olga T.; Andreassen, Ole A.; Server, Andres; Jensen, Jimmy			Increased Amygdala and Visual Cortex Activity and Functional Connectivity towards Stimulus Novelty Is Associated with State Anxiety	PLOS ONE			English	Article							NEURAL MECHANISMS; SELECTIVE ATTENTION; RESPONSES; EMOTION; FACES; BRAIN; ORGANIZATION; PROJECTIONS; MODULATION; INTENSITY	Novel stimuli often require a rapid reallocation of sensory processing resources to determine the significance of the event, and the appropriate behavioral response. Both the amygdala and the visual cortex are central elements of the neural circuitry responding to novelty, demonstrating increased activity to new as compared to highly familiarized stimuli. Further, these brain areas are intimately connected, and thus the amygdala may be a key region for directing sensory processing resources to novel events. Although knowledge regarding the neurocircuit of novelty detection is gradually increasing, we still lack a basic understanding of the conditions that are necessary and sufficient for novelty-specific responses in human amygdala and the visual cortices, and if these brain areas interact during detection of novelty. In the present study, we investigated the response of amygdala and the visual cortex to novelty, by comparing functional MRI activity between 1st and 2nd time presentation of a series of emotional faces in an event-related task. We observed a significant decrease in amygdala and visual cortex activity already after a single stimulus exposure. Interestingly, this decrease in responsiveness was less for subjects with a high score on state anxiety. Further, novel faces stimuli were associated with a relative increase in the functional coupling between the amygdala and the inferior occipital gyrus (BA 18). Thus, we suggest that amygdala is involved in fast sensory boosting that may be important for attention reallocation to novel events, and that the strength of this response depends on individual state anxiety.	[Ousdal, Olga T.; Andreassen, Ole A.; Jensen, Jimmy] Univ Oslo, NORMENT, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict,Oslo Univ Hosp, Oslo, Norway; [Ousdal, Olga T.; Andreassen, Ole A.; Jensen, Jimmy] Univ Oslo, Inst Clin Med, Oslo, Norway; [Ousdal, Olga T.] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway; [Server, Andres] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway; [Jensen, Jimmy] Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden	University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Oslo; Kristianstad University	Ousdal, OT (corresponding author), Univ Oslo, NORMENT, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict,Oslo Univ Hosp, Oslo, Norway.	olgatherese.ousdal@gmail.com	Jensen, Jimmy/H-7517-2014; Andreassen, Ole A./AAY-7531-2020	Jensen, Jimmy/0000-0001-6841-1808; Andreassen, Ole A./0000-0002-4461-3568	University of Oslo; Research Council of Norway [167153/V50, 163070/V50]; South-Eastern Norway Regional Health Authority [39386/6051]	University of Oslo; Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	This work was supported by grants from the University of Oslo, the Research Council of Norway (#167153/V50, #163070/V50), and South-Eastern Norway Regional Health Authority (#39386/6051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annals.1280.015; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Amting JM, 2010, J NEUROSCI, V30, P10039, DOI 10.1523/JNEUROSCI.6434-09.2010; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Balderston NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063220; Balderston NL, 2011, NEUROIMAGE, V55, P1889, DOI 10.1016/j.neuroimage.2011.01.034; Beaton EA, 2008, BEHAV NEUROSCI, V122, P704, DOI 10.1037/0735-7044.122.3.704; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Bishop SJ, 2008, ANN NY ACAD SCI, V1129, P141, DOI 10.1196/annals.1417.016; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Blackford JU, 2013, SOC COGN AFFECT NEUR, V8, P143, DOI 10.1093/scan/nsr078; Blackford JU, 2010, NEUROIMAGE, V50, P1188, DOI 10.1016/j.neuroimage.2009.12.083; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Denny B.T., 2013, SOC COGN AFFECT NEUR; Driver J, 2001, BRIT J PSYCHOL, V92, P53, DOI 10.1348/000712601162103; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HIRSHFELD DR, 1992, J AM ACAD CHILD PSY, V31, P103, DOI 10.1097/00004583-199201000-00016; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kiehl KA, 2005, NEUROIMAGE, V25, P899, DOI 10.1016/j.neuroimage.2004.12.035; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Ousdal OT, 2008, NEUROSCIENCE, V156, P450, DOI 10.1016/j.neuroscience.2008.07.066; Ousdal OT, 2012, NEUROIMAGE; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Quigley L, 2012, COGNITION EMOTION, V26, P1390, DOI 10.1080/02699931.2012.662892; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Schwartz CE, 2003, BIOL PSYCHIAT, V53, P854, DOI 10.1016/S0006-3223(02)01906-6; Schwartz CE, 1999, J AM ACAD CHILD PSY, V38, P1008, DOI 10.1097/00004583-199908000-00017; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Toki S, 2013, NEUROPSYCHOBIOLOGY, V68, P156, DOI 10.1159/000353268; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2007, PHILOS T R SOC B, V362, P837, DOI 10.1098/rstb.2007.2092; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Wendt J, 2011, BIOL PSYCHOL, V86, P203, DOI 10.1016/j.biopsycho.2010.11.009; WILSON FAW, 1993, EXP BRAIN RES, V93, P367; Wright CI, 2008, NEUROIMAGE, V42, P956, DOI 10.1016/j.neuroimage.2008.05.015; Wright CI, 2003, NEUROIMAGE, V18, P660, DOI 10.1016/S1053-8119(02)00037-X; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zhen ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059886	60	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96146	10.1371/journal.pone.0096146	http://dx.doi.org/10.1371/journal.pone.0096146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755617	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300141
J	Westra, IM; Oosterhuis, D; Groothuis, GMM; Olinga, P				Westra, Inge M.; Oosterhuis, Dorenda; Groothuis, Geny M. M.; Olinga, Peter			The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; BILE-DUCT OBSTRUCTION; CIRRHOTIC RATS; VALPROIC ACID; IN-VITRO; FIBROSIS DEVELOPMENT; IMATINIB MESYLATE; NEW-MODEL; TGF-BETA; FIBROGENESIS	Two important signaling pathways in liver fibrosis are the PDGF-and TGF beta pathway and compounds inhibiting these pathways are currently developed as antifibrotic drugs. Testing antifibrotic drugs requires large numbers of animal experiments with high discomfort. Therefore, a method to study these drugs ex vivo was developed using precision-cut liver slices from fibrotic rat livers (fPCLS), representing an ex vivo model with a multicellular fibrotic environment. We characterized the fibrotic process in fPCLS from rat livers after 3 weeks of bile duct ligation (BDL) during incubation and tested compounds predominantly inhibiting the TGFb pathway (perindopril, valproic acid, rosmarinic acid, tetrandrine and pirfenidone) and PDGF pathway (imatinib, sorafenib and sunitinib). Gene expression of heat shock protein 47 (Hsp47), a smooth muscle actin (alpha Sma) and pro-collagen 1A1 (Pcol1A1) and protein expression of collagens were determined. During 48 hours of incubation, the fibrosis process continued in control fPCLS as judged by the increased gene expression of the three fibrosis markers, and the protein expression of collagen 1, mature fibrillar collagen and total collagen. Most PDGF-inhibitors and TGF beta-inhibitors significantly inhibited the increase in gene expression of Hsp47, aSma and Pcol1A1. Protein expression of collagen 1 was significantly reduced by all PDGF-inhibitors and TGFb-inhibitors, while total collagen was decreased by rosmarinic acid and tetrandrine only. However, fibrillar collagen expression was not changed by any of the drugs. In conclusion, rat fPCLS can be used as a functional ex vivo model of established liver fibrosis to test antifibrotic compounds inhibiting the PDGF-and TGFb signalling pathway.	[Westra, Inge M.; Oosterhuis, Dorenda; Groothuis, Geny M. M.; Olinga, Peter] Univ Groningen, Dept Pharm, Groningen, Netherlands	University of Groningen	Olinga, P (corresponding author), Univ Groningen, Dept Pharm, Groningen, Netherlands.	p.olinga@rug.nl	Olinga, Peter/J-2585-2015	Olinga, Peter/0000-0003-4855-8452	ZonMw [114000098]	ZonMw(Netherlands Organization for Health Research and Development)	This work was supported by ZonMw (Program: Dierproeven begrensd II, project 114000098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Castro V, 1996, J APPL TOXICOL, V16, P269, DOI 10.1002/(SICI)1099-1263(199605)16:3<269::AID-JAT346>3.0.CO;2-Y; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; Di Sario A, 2002, J HEPATOL, V37, P584, DOI 10.1016/S0168-8278(02)00245-3; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; EHRLICH HP, 1972, NATURE-NEW BIOL, V238, P257, DOI 10.1038/newbio238257a0; FISHER R, 1991, TOXICOL IN VITRO, V5, P201, DOI 10.1016/0887-2333(91)90018-9; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2013, J HEPATOL, V58, P1, DOI 10.1016/j.jhep.2012.10.014; Garcia L, 2002, J HEPATOL, V37, P797, DOI 10.1016/S0168-8278(02)00272-6; Hennenberg M, 2010, LAB INVEST; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hsu YC, 2007, J GASTROEN HEPATOL, V22, P99, DOI 10.1111/j.1440-1746.2006.04361.x; Hsu YC, 2006, CAN J PHYSIOL PHARM, V84, P967, DOI 10.1139/Y06-050; Ikura Y, 2010, HEPATOLOGY, V51, P2227, DOI 10.1002/hep.23688; Kinnman N, 2003, LAB INVEST, V83, P163, DOI 10.1097/01.LAB.0000054178.01162.E4; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Langrock T, 2012, METHODS MOL BIOL, V828, P271, DOI 10.1007/978-1-61779-445-2_21; Lee SJ, 2004, CHEM-BIOL INTERACT, V147, P9, DOI 10.1016/j.cbi.2003.10.005; Li GS, 2010, PHYTOMEDICINE, V17, P282, DOI 10.1016/j.phymed.2009.05.002; Liu YQ, 2009, LAB INVEST, V89, P209, DOI 10.1038/labinvest.2008.127; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Muriel P, 2003, LIVER INT, V23, P262, DOI 10.1034/j.1600-0676.2003.00837.x; Neef M, 2006, J HEPATOL, V44, P167, DOI 10.1016/j.jhep.2005.06.015; Olinga P, 2001, DRUG TARGETING ORGAN, P309; Olinga P, 2013, J HEPATOL, V58, P1252, DOI 10.1016/j.jhep.2013.01.009; Park PH, 2000, PHARMACOL TOXICOL, V87, P261, DOI 10.1034/j.1600-0773.2000.pto870604.x; POO JL, 1993, J HEPATOL, V19, P90, DOI 10.1016/S0168-8278(05)80181-3; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Salazar-Montes A, 2008, EUR J PHARMACOL, V595, P69, DOI 10.1016/j.ejphar.2008.06.110; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Ueki M, 2009, MOL MED REP, V2, P857, DOI 10.3892/mmr_00000184; van de Bovenkamp M, 2005, TOXICOL SCI, V85, P632, DOI 10.1093/toxsci/kfi127; van de Bovenkamp M, 2006, J HEPATOL, V45, P696, DOI 10.1016/j.jhep.2006.04.009; Wang Y, 2010, J HEPATOL; Westra IM, 2013, XENOBIOTICA, V43, P98, DOI 10.3109/00498254.2012.723151; Westra IM, 2014, TOXICOL APPL PHARM, V274, P328, DOI 10.1016/j.taap.2013.11.017; Yoshiji H, 2006, INT J MOL MED, V17, P899; Yoshiji H, 2005, AM J PHYSIOL-GASTR L, V288, pG907, DOI 10.1152/ajpgi.00420.2004; Yoshiji H, 2005, LIVER INT, V25, P153, DOI 10.1111/j.1478-3231.2005.01038.x	45	40	40	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95462	10.1371/journal.pone.0095462	http://dx.doi.org/10.1371/journal.pone.0095462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755660	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300044
J	Adam, J; Wuillemin, N; Watkins, S; Jamin, H; Eriksson, KK; Villiger, P; Fontana, S; Pichler, WJ; Yerly, D				Adam, Jacqueline; Wuillemin, Natascha; Watkins, Stephan; Jamin, Heidi; Eriksson, Klara K.; Villiger, Peter; Fontana, Stefano; Pichler, Werner J.; Yerly, Daniel			Abacavir Induced T Cell Reactivity from Drug Naive Individuals Shares Features of Allo-Immune Responses	PLOS ONE			English	Article							ALLERGIC CONTACT-DERMATITIS; VERSUS-HOST-DISEASE; PEPTIDE REPERTOIRE; IN-VITRO; HYPERSENSITIVITY; HLA; VIRUS; VIVO; ALLOREACTIVITY; ACTIVATION	Abacavir hypersensitivity is a severe hypersensitivity reaction which occurs exclusively in carriers of the HLA-B*57:01 allele. In vitro culture of PBMC with abacavir results in the outgrowth of abacavir-reacting CD8(+) T cells, which release IFN gamma and are cytotoxic. How this immune response is induced and what is recognized by these T cells is still a matter of debate. We analyzed the conditions required to develop an abacavir-dependent T cell response in vitro. The abacavir reactivity was independent of co-stimulatory signals, as neither DC maturation nor release of inflammatory cytokines were observed upon abacavir exposure. Abacavir induced T cells arose in the absence of professional APC and stemmed from naive and memory compartments. These features are reminiscent of allo-reactivity. Screening for allo-reactivity revealed that about 5% of generated T cell clones (n = 136) from three donors were allo-reactive exclusively to the related HLA-B*58:01. The addition of peptides which can bind to the HLA-B*57:01-abacavir complex and to HLA-B*58:01 during the induction phase increased the proportion of HLA-B*58:01 allo-reactive T cell clones from 5% to 42%. In conclusion, abacavir can alter the HLA-B*57:01-peptide complex in a way that mimics an allo-allele ('altered self-allele') and create the potential for robust T cell responses.	[Adam, Jacqueline; Wuillemin, Natascha; Watkins, Stephan; Jamin, Heidi; Eriksson, Klara K.; Villiger, Peter; Pichler, Werner J.; Yerly, Daniel] Univ Hosp Bern, Clin Rheumatol & Clin Immunol Allergol, CH-3010 Bern, Switzerland; [Fontana, Stefano] Swiss Red Cross, Reg Blood Transfus Serv, Bern, Switzerland	University of Bern; University Hospital of Bern	Pichler, WJ (corresponding author), Univ Hosp Bern, Clin Rheumatol & Clin Immunol Allergol, CH-3010 Bern, Switzerland.	werner.pichler@insel.ch	Villiger, Peter/AAV-8132-2021	Yerly, Daniel/0000-0003-2857-0737; Pichler, Werner J./0000-0002-8117-359X	Swiss National Science Foundation (SNF) [310030-129828-1]; Swiss Center for Applied Human Toxicology (SCAHT)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Center for Applied Human Toxicology (SCAHT)	This work was supported by the Swiss National Science Foundation (SNF grant Nr. 310030-129828-1) and by the Swiss Center for Applied Human Toxicology (SCAHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2012, EUR J IMMUNOL, V42, P1706, DOI 10.1002/eji.201142159; Adam J, 2011, BRIT J CLIN PHARMACO, V71, P701, DOI 10.1111/j.1365-2125.2010.03764.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; de Haan A, 2000, TRANSPLANTATION, V69, P1637; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hunziker IP, 2002, INT IMMUNOL, V14, P615, DOI 10.1093/intimm/dxf026; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Jeanmonod P, 2012, TRANSPL INFECT DIS, V14, P422, DOI 10.1111/j.1399-3062.2012.00746.x; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; Macedo C, 2009, AM J TRANSPLANT, V9, P2057, DOI 10.1111/j.1600-6143.2009.02742.x; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; MauriHellweg D, 1996, J IMMUNOL, V157, P1071; Norcross MA, 2012, AIDS, V26, pF21, DOI 10.1097/QAD.0b013e328355fe8f; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Pavlos R, 2012, PHARMACOGENOMICS, V13, P1285, DOI [10.2217/PGS.12.108, 10.2217/pgs.12.108]; Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Pichler WJ, 2005, TOXICOLOGY, V209, P95, DOI 10.1016/j.tox.2004.12.014; Rist M, 2005, EUR J IMMUNOL, V35, P996, DOI 10.1002/eji.200425746; Schulz John T 3rd, 2006, J Burns Wounds, V5, pe1; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; von Greyerz S, 2001, INT IMMUNOL, V13, P877, DOI 10.1093/intimm/13.7.877; Wuillemin N, 2013, J IMMUNOL, V190, P4956, DOI 10.4049/jimmunol.1202949; Yun J, 2012, ALLERGY	30	53	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95339	10.1371/journal.pone.0095339	http://dx.doi.org/10.1371/journal.pone.0095339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751900	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400051
J	Berard, E; Bongard, V; Dallongeville, J; Arveiler, D; Cottel, D; Wagner, A; Ruidavets, JB; Ferrieres, J				Berard, Emilie; Bongard, Vanina; Dallongeville, Jean; Arveiler, Dominique; Cottel, Dominique; Wagner, Aline; Ruidavets, Jean-Bernard; Ferrieres, Jean			14-Year Risk of All-Cause Mortality According to Hypoglycaemic Drug Exposure in a General Population	PLOS ONE			English	Article							DIABETES-MELLITUS; INSULIN ANALOGS; CANCER-RISK; TYPE-2; ASSOCIATION; COMMITTEE; DISEASE; FRANCE; RATES	Purpose: Guidelines for management of patients with type 2 diabetes mellitus recommend the use of hypoglycaemic drugs when lifestyle interventions remain insufficient for glycaemic control. Recent trials have provided worrying safety data on certain hypoglycaemic drugs. The aim of this study was to assess 14-year risk of all-cause mortality according to hypoglycaemic drug exposure at baseline, in a general population. Methods: Our analysis was based on the observational Third French MONICA survey on cardiovascular risk factors (19951997). Vital status was obtained 14 years after inclusion, and assessment of determinants of mortality was based on multivariable Cox modelling. Results: There were 3336 participants and 248 deaths over the 14-year period. At baseline, there were 3162 (95%) nondiabetic, 46 (1%) untreated type 2 diabetic and 128 (4%) type 2 diabetic subjects with hypoglycaemic drug treatment (metformin alone (31%), sulfonylureas alone or in combination (49%), insulin alone or in combination (10%), or other treatments (9%)). After adjustment for duration of diabetes, history of diabetes complications, area of residence (centre), age, gender, educational level, alcohol consumption, smoking, blood pressure, LDL and HDL cholesterol, which all were significant and independent determinants of mortality, the hazard ratio for all-cause mortality was 3.22 [95% confidence interval: 0.87-11.9] for untreated diabetic subjects, 2.28 [0.98-5.26] for diabetics treated with metformin alone, 1.70 [0.923.16] for diabetics with sulfonylureas and 4.92 [1.70-14.3] for diabetic with insulin versus non-diabetic subjects. Conclusions: Our results support the conclusion that until more evidence is provided from randomized trials, a prudent approach should be to restrain use of insulin to situations in which combinations of non-insulin agents have failed to appropriately achieve glycemic control, as it is recommended in the current guidelines for the management of type 2 diabetes.	[Berard, Emilie; Bongard, Vanina; Ruidavets, Jean-Bernard; Ferrieres, Jean] Toulouse Univ, Sch Med, Toulouse Univ Hosp, UMR 1027,INSERM,Dept Epidemiol Hlth Econ & Publ H, Toulouse, France; [Dallongeville, Jean; Cottel, Dominique] Univ Lille Nord France, Dept Epidemiol & Publ Hlth, Inst Pasteur Lille, INSERM U744, Lille, France; [Arveiler, Dominique; Wagner, Aline] Univ Strasbourg, Dept Epidemiol & Publ Hlth, EA 3430, Fac Med, Strasbourg, France; [Ferrieres, Jean] Toulouse Univ Hosp, Dept Cardiol B, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse	Ferrieres, J (corresponding author), Toulouse Univ, Sch Med, Toulouse Univ Hosp, UMR 1027,INSERM,Dept Epidemiol Hlth Econ & Publ H, Toulouse, France.	jean.ferrieres@univ-tlse3.fr	; Ferrieres, Jean/S-7993-2016	Bongard, Vanina/0000-0001-5789-0815; Ferrieres, Jean/0000-0001-6144-1297	Institut National de la Sante et de la Recherche Medicale'' (INSERM); Direction Generale de la Sante (DGS); Institut Pasteur de Lille; University Hospital of Lille; Fonds d'intervention en Sante Publique; Mutuelle Generale de I'Education Nationale; ONIVINS; Fondation de France; CPAM of Selestat; Federation Francaise de Cardiologie; Conseil Regional du Nord-Pas de Calais; Parke-Davis and Bayer pharmaceuticals; CERIN	Institut National de la Sante et de la Recherche Medicale'' (INSERM); Direction Generale de la Sante (DGS); Institut Pasteur de Lille; University Hospital of Lille; Fonds d'intervention en Sante Publique; Mutuelle Generale de I'Education Nationale; ONIVINS; Fondation de France(Fondation de France); CPAM of Selestat; Federation Francaise de Cardiologie; Conseil Regional du Nord-Pas de Calais(Region Hauts-de-FranceRegion Ile-de-France); Parke-Davis and Bayer pharmaceuticals; CERIN	The authors would like to thank the "Institut National de la Sante et de la Recherche Medicale'' (INSERM), the "Direction Generale de la Sante (DGS),'' the "Institut Pasteur de Lille,'' the " University Hospital of Lille,'' the "Fonds d'intervention en Sante Publique,'' the "Mutuelle Generale de I'Education Nationale,'' "ONIVINS,'' the "Fondation de France,'' the "CPAM of Selestat,'' the "Federation Francaise de Cardiologie,'' the "Conseil Regional du Nord-Pas de Calais,'' Parke-Davis and Bayer pharmaceuticals, and CERIN for their financial support enabling this work. The sponsors did not take part or interfere in data analysis or editing of the manuscript.	Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Cottel D, 2000, EUR J EPIDEMIOL, V16, P317, DOI 10.1023/A:1007678526840; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gamble JM, 2010, DIABETES OBES METAB, V12, P47, DOI 10.1111/j.1463-1326.2009.01125.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Machin D, 2009, SAMPLE SIZE TABLES C, P101; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; Marques-Vidal P, 2004, EUR J EPIDEMIOL, V19, P25, DOI 10.1023/B:EJEP.0000013393.11132.e8; Muis MJ, 2005, DIABETIC MED, V22, P118, DOI 10.1111/j.1464-5491.2004.01416.x; Saurel-Cubizolles MJ, 2009, J EPIDEMIOL COMMUN H, V63, P197, DOI 10.1136/jech.2008.078923; Shukla A, 2009, ENDOCR-RELAT CANCER, V16, P429, DOI 10.1677/ERC-08-0240; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011	19	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95671	10.1371/journal.pone.0095671	http://dx.doi.org/10.1371/journal.pone.0095671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752580	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400099
J	Fox, DT; Schmidt, EN; Tian, H; Dhungana, S; Valentine, MC; Warrington, NV; Phillips, PD; Finney, KB; Cope, EK; Leid, JG; Testa, CA; Koppisch, AT				Fox, David T.; Schmidt, Emily N.; Tian, Hongzhao; Dhungana, Suraj; Valentine, Michael C.; Warrington, Nicole V.; Phillips, Paul D.; Finney, Kellan B.; Cope, Emily K.; Leid, Jeff G.; Testa, Charles A.; Koppisch, Andrew T.			Sub-Inhibitory Fosmidomycin Exposures Elicits Oxidative Stress in Salmonella enterica Serovar typhimurium LT2	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; GLOBAL GENE-EXPRESSION; ESCHERICHIA-COLI; IN-VITRO; BACTERICIDAL ANTIBIOTICS; ISOPRENOID BIOSYNTHESIS; NONMEVALONATE PATHWAY; HYDROGEN-PEROXIDE; HEAT-SHOCK; RESISTANCE	Fosmidomycin is a time-dependent nanomolar inhibitor of methylerythritol phosphate (MEP) synthase, which is the enzyme that catalyzes the first committed step in the MEP pathway to isoprenoids. Importantly, fosmidomycin is one of only a few MEP pathway-specific inhibitors that exhibits antimicrobial activity. Most inhibitors identified to date only exhibit activity against isolated pathway enzymes. The MEP pathway is the sole route to isoprenoids in many bacteria, yet has no human homologs. The development of inhibitors of this pathway holds promise as novel antimicrobial agents. Similarly, analyses of the bacterial response toward MEP pathway inhibitors provides valuable information toward the understanding of how emergent resistance may ultimately develop to this class of antibiotics. We have examined the transcriptional response of Salmonella enterica serovar typhimurium LT2 to sub-inhibitory concentrations of fosmidomycin via cDNA microarray and RTPCR. Within the regulated genes identified by microarray were a number of genes encoding enzymes associated with the mediation of reactive oxygen species (ROS). Regulation of a panel of genes implicated in the response of cells to oxidative stress (including genes for catalases, superoxide dismutases, and alkylhydrogen peroxide reductases) was investigated and mild upregulation in some members was observed as a function of fosmidomycin exposure over time. The extent of regulation of these genes was similar to that observed for comparable exposures to kanamycin, but differed significantly from tetracycline. Furthermore, S. typhimurium exposed to sub-inhibitory concentrations of fosmidomycin displayed an increased sensitivity to exogenous H2O2 relative to either untreated controls or kanamycin-treated cells. Our results suggest that endogenous oxidative stress is one consequence of exposures to fosmidomycin, likely through the temporal depletion of intracellular isoprenoids themselves, rather than other mechanisms that have been proposed to facilitate ROS accumulation in bacteria (e.g. cell death processes or the ability of the antibiotic to redox cycle).	[Fox, David T.; Schmidt, Emily N.; Tian, Hongzhao; Dhungana, Suraj] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Warrington, Nicole V.; Phillips, Paul D.; Finney, Kellan B.; Koppisch, Andrew T.] No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA; [Valentine, Michael C.; Cope, Emily K.; Leid, Jeff G.] No Arizona Univ, Dept Biol, Flagstaff, AZ 86011 USA; [Testa, Charles A.] Echelon Biosci Inc, Salt Lake City, UT USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Northern Arizona University; Northern Arizona University	Fox, DT (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	dfox@lanl.gov; andy.koppisch@nau.edu			U.S. Defense Threat Reduction Agency Transformational Medical Technologies [IACRO B094738I, B064098I]; Northern Arizona University Faculty Development Program	U.S. Defense Threat Reduction Agency Transformational Medical Technologies; Northern Arizona University Faculty Development Program	This work was supported by the U.S. Defense Threat Reduction Agency Transformational Medical Technologies program under contract number IACRO B094738I and B064098I, and with support from the Northern Arizona University Faculty Development Program (A.T.K.). Echelon Biosciences provided support in the form of salaries for author C.A.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; ALLISON C, 1992, MOL MICROBIOL, V6, P1583; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Barnes AI, 2005, INT J ANTIMICROB AG, V26, P146, DOI 10.1016/j.ijantimicag.2005.04.014; Becerra MC, 2003, LUMINESCENCE, V18, P334, DOI 10.1002/bio.742; Becerra MC, 2002, BIOCHEM BIOPH RES CO, V297, P1003, DOI 10.1016/S0006-291X(02)02331-8; Betts JC, 2003, ANTIMICROB AGENTS CH, V47, P2903, DOI 10.1128/AAC.47.9.2903-2913.2003; Borrmann S, 2004, J INFECT DIS, V190, P1534, DOI 10.1086/424603; Borrmann S, 2006, ANTIMICROB AGENTS CH, V50, P2713, DOI 10.1128/AAC.00392-06; Botteldoorn N, 2006, J MICROBIOL METH, V66, P125, DOI 10.1016/j.mimet.2005.11.003; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Carretero-Paulet L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-180; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; Clinical and Laboratory Standards Institute, 2012, M07 A9 METH DIL ANT; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Fox DT, 2005, BIOCHEMISTRY-US, V44, P8360, DOI 10.1021/bi047312p; Fox DT, 2005, J ORG CHEM, V70, P1978, DOI 10.1021/jo048022h; Fujisaki S, 1996, GENE, V175, P83, DOI 10.1016/0378-1119(96)00128-X; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Hassett DJ, 2007, ACS CHEM BIOL, V2, P708, DOI 10.1021/cb700232k; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim Wook, 2003, Biological Procedures Online, V5, P189, DOI 10.1251/bpo61; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Koppisch AT, 2002, BIOCHEMISTRY-US, V41, P236, DOI 10.1021/bi0118207; Lai S, 2009, ENVIRON MICROBIOL, V11, P126, DOI 10.1111/j.1462-2920.2008.01747.x; Leid JG, 2012, J ANTIMICROB CHEMOTH, V67, P138, DOI 10.1093/jac/dkr408; Leon A, 2006, J MED CHEM, V49, P7331, DOI 10.1021/jm060492b; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Mackie Ryan S, 2012, Front Microbiol, V3, P226, DOI 10.3389/fmicb.2012.00226; Messiaen AS, 2011, INT J ANTIMICROB AG, V38, P261, DOI 10.1016/j.ijantimicag.2011.04.020; MORGAN RW, 1986, P NATL ACAD SCI USA, V83, P8059, DOI 10.1073/pnas.83.21.8059; Odom AR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002323; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; Proteau PJ, 2004, BIOORG CHEM, V32, P483, DOI 10.1016/j.bioorg.2004.08.004; Radhi IJ, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P461; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Sakamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2030, DOI 10.1271/bbb.67.2030; Salvetti S, 2011, APPL ENVIRON MICROB, V77, P5149, DOI 10.1128/AEM.00245-11; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Testa C. A., 2003, Current Pharmaceutical Biotechnology, V4, P248, DOI 10.2174/1389201033489784; Testa CA, 2004, J BACTERIOL, V186, P473, DOI 10.1128/JB.186.2.473-480.2004; Turnbull AL, 2010, RES MICROBIOL, V161, P643, DOI [10.1016/J.resmic.2010.06.004, 10.1016/j.resmic.2010.06.004]; Turnbull AL, 2008, MICROBIOL-SGM, V154, P3410, DOI 10.1099/mic.0.2008/020347-0; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wiesner J, 2002, ANTIMICROB AGENTS CH, V46, P2889, DOI 10.1128/AAC.46.9.2889-2894.2002; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12; Yim G, 2006, J BACTERIOL, V188, P7988, DOI 10.1128/JB.00791-06; Yim G, 2011, J ANTIBIOT, V64, P73, DOI 10.1038/ja.2010.137; Zhang BC, 2011, BIOCHEMISTRY-US, V50, P3570, DOI 10.1021/bi200113y	64	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95271	10.1371/journal.pone.0095271	http://dx.doi.org/10.1371/journal.pone.0095271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751777	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400048
J	Gulraiz, F; Bellinghausen, C; Dentener, MA; Reynaert, NL; Gaajetaan, GR; Beuken, EV; Rohde, GG; Bruggeman, CA; Stassen, FR				Gulraiz, Fahad; Bellinghausen, Carla; Dentener, Mieke A.; Reynaert, Niki L.; Gaajetaan, Giel R.; Beuken, Erik V.; Rohde, Gernot G.; Bruggeman, Cathrien A.; Stassen, Frank R.			Efficacy of IFN-lambda 1 to Protect Human Airway Epithelial Cells against Human Rhinovirus 1B Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; VIRUS TYPE-1 INFECTION; IFN-LAMBDA; ANTIVIRAL RESPONSES; RESPIRATORY VIRUSES; IN-VIVO; ASTHMA EXACERBATIONS; INTERFERON RESPONSE; III INTERFERON; BETA	Impaired interferon (IFN) production has been observed in various obstructive respiratory diseases. This contributes to enhanced sensitivity towards viral infections triggering acute exacerbations. To compensate for this impaired host IFN response, there is need to explore new therapeutic strategies, like exogenous administration of IFNs as prophylactic treatment. In the present study, we examined the protective potential of IFN-lambda 1 and compared it with the previously established protecting effect of IFN-beta. A549 cells and human primary bronchial epithelial cells were first treated with either IFN-beta (500 IU/ml) or IFN-lambda 1 (500 ng/ml) for 18 h. For infection, two approaches were adopted: i) Continuous scenario: after pre-treatment, cells were infected immediately for 24 h with human rhinovirus 1B (HRV1B) in IFN-containing medium, or were cultured for another 72 h in IFN-containing medium, and then infected for 24 h with HRV1B, ii) Pre-treatment scenario: IFN-containing medium was replaced after 18 h and cells were infected for 4 h either immediately after pre-treatment or after additional culturing for 72 h in IFN-free medium. The protective effect was evaluated in terms of reduction in the number of viral copies/infectious progeny, and enhanced expression of IFN-stimulated genes (ISGs). In both cell types and in both approaches, IFN-lambda 1 and IFN-beta treatment resulted in pronounced and long-lasting antiviral effects exemplified by significantly reduced viral copy numbers and diminished infectious progeny. This was associated with strong up-regulation of multiple ISGs. However, in contrast to the IFN-beta induced expression of ISGs, which decreased over time, expression of ISGs induced by IFN-lambda 1 was sustained or even increased over time. Here we demonstrate that the protective potential of IFN-lambda 1 is comparable to IFN-beta. Yet, the long-lasting induction of ISGs by IFN-lambda 1 and most likely less incitement of side effects due to more localized expression of its receptors could make it an even more promising candidate for prophylactic treatment than IFN-beta.	[Gulraiz, Fahad; Bellinghausen, Carla; Gaajetaan, Giel R.; Beuken, Erik V.; Bruggeman, Cathrien A.; Stassen, Frank R.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [Bellinghausen, Carla; Dentener, Mieke A.; Reynaert, Niki L.; Rohde, Gernot G.] Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands	Maastricht University; Maastricht University	Stassen, FR (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.	f.stassen@maastrichtuniversity.nl	Rohde, Gernot GU/F-3060-2013; Reynaert, Niki L/C-5491-2014	Rohde, Gernot GU/0000-0002-5193-7755; Reynaert, Niki/0000-0002-8577-8094	School for Nutrition; Toxicology and Metabolism of Maastricht University (NUTRIM); NUFFIC-HEC	School for Nutrition; Toxicology and Metabolism of Maastricht University (NUTRIM); NUFFIC-HEC	This work was supported by School for Nutrition, Toxicology and Metabolism of Maastricht University (NUTRIM). FG is a recipient of a NUFFIC-HEC Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINBAMI LJ, 2011, NATL HLTH STAT REPOR, V32, P1; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Baines KJ, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-15; Boncristiani HF, 2009, J VIROL METHODS, V161, P147, DOI 10.1016/j.jviromet.2009.06.006; Chattoraj SS, 2011, INFECT IMMUN, V79, P4131, DOI 10.1128/IAI.05120-11; Cheng JC, 2012, J VIRAL HEPATITIS, V19, pE154, DOI 10.1111/j.1365-2893.2011.01538.x; Colonne PM, 2011, INFECT IMMUN, V79, P3733, DOI 10.1128/IAI.05008-11; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Costa-Pereira AP, 2002, J VIROL, V76, P9060, DOI 10.1128/JVI.76.18.9060-9068.2002; Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Gaajetaan GR, 2013, J INFECTION, V66, P163, DOI 10.1016/j.jinf.2012.11.008; Gaajetaan GR, 2012, ANTIVIR RES, V93, P39, DOI 10.1016/j.antiviral.2011.10.015; Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Jewell NA, 2007, J VIROL, V81, P9790, DOI 10.1128/JVI.00530-07; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kotla S, 2008, VIROLOGY, V374, P399, DOI 10.1016/j.virol.2008.01.022; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stoltz M, 2010, J VIROL, V84, P9140, DOI 10.1128/JVI.00717-10; Traves SL, 2007, CURR OPIN PHARMACOL, V7, P252, DOI 10.1016/j.coph.2006.11.010; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51, DOI 10.1152/ajplung.2000.278.1.L51; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Venkatesh D, 2013, IMMUNITY, V38, P1025, DOI 10.1016/j.immuni.2013.01.012; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200	46	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95134	10.1371/journal.pone.0095134	http://dx.doi.org/10.1371/journal.pone.0095134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751942	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400034
J	Martinelli, NC; Cohen, CR; Santos, KG; Castro, MA; Biolo, A; Frick, L; Silvello, D; Lopes, A; Schneider, S; Andrades, ME; Clausell, N; Matte, U; Rohde, LE				Martinelli, Nidiane C.; Cohen, Carolina R.; Santos, Katia G.; Castro, Mauro A.; Biolo, Andreia; Frick, Luzia; Silvello, Daiane; Lopes, Amanda; Schneider, Stefanie; Andrades, Michael E.; Clausell, Nadine; Matte, Ursula; Rohde, Luis E.			An Analysis of the Global Expression of MicroRNAs in an Experimental Model of Physiological Left Ventricular Hypertrophy	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; CARDIOMYOCYTE HYPERTROPHY; HEART-FAILURE; GENE; MICE; APOPTOSIS; RECEPTOR; GROWTH; BIOINFORMATICS; PROLIFERATION	Background: MicroRNAs (miRs) are a class of small non-coding RNAs that regulate gene expression. Studies of transgenic mouse models have indicated that deregulation of a single miR can induce pathological cardiac hypertrophy and cardiac failure. The roles of miRs in the genesis of physiological left ventricular hypertrophy (LVH), however, are not well understood. Objective: To evaluate the global miR expression in an experimental model of exercise-induced LVH. Methods: Male Balb/c mice were divided into sedentary (SED) and exercise (EXE) groups. Voluntary exercise was performed on an odometer-monitored metal wheels for 35 days. Various tests were performed after 7 and 35 days of training, including a transthoracic echocardiography, a maximal exercise test, a miR microarray (miRBase v.16) and qRT-PCR analysis. Results: The ratio between the left ventricular weight and body weight was increased by 7% in the EXE group at day 7 (p < 0.01) and by 11% at day 35 of training (p < 0.001). After 7 days of training, the microarray identified 35 miRs that were differentially expressed between the two groups: 20 were up-regulated and 15 were down-regulated in the EXE group compared with the SED group (p = 0.01). At day 35 of training, 25 miRs were differentially expressed: 15 were up-regulated and 10 were decreased in the EXE animals compared with the SED animals (p < 0.01). The qRT-PCR analysis demonstrated an increase in miR-150 levels after 35 days and a decrease in miR-26b, miR-27a and miR-143 after 7 days of voluntary exercise. Conclusions: We have identified new miRs that can modulate physiological cardiac hypertrophy, particularly miR-26b, -150, -27a and -143. Our data also indicate that previously established regulatory gene pathways involved in pathological LVH are not changed in physiological LVH.	[Martinelli, Nidiane C.; Cohen, Carolina R.; Santos, Katia G.; Castro, Mauro A.; Biolo, Andreia; Frick, Luzia; Silvello, Daiane; Lopes, Amanda; Schneider, Stefanie; Andrades, Michael E.; Clausell, Nadine; Rohde, Luis E.] Hosp Clin Porto Alegre, Div Cardiol, Expt & Mol Cardiovasc Lab, Porto Alegre, RS, Brazil; [Martinelli, Nidiane C.; Cohen, Carolina R.; Santos, Katia G.; Castro, Mauro A.; Biolo, Andreia; Frick, Luzia; Silvello, Daiane; Lopes, Amanda; Schneider, Stefanie; Andrades, Michael E.; Clausell, Nadine; Rohde, Luis E.] Hosp Clin Porto Alegre, Div Cardiol, Heart Failure & Cardiac Transplant Unit, Porto Alegre, RS, Brazil; [Martinelli, Nidiane C.; Cohen, Carolina R.; Santos, Katia G.; Biolo, Andreia; Silvello, Daiane; Schneider, Stefanie; Andrades, Michael E.; Clausell, Nadine; Matte, Ursula; Rohde, Luis E.] Postgrad Program Cardiol & Cardiovasc Sci, Porto Alegre, RS, Brazil; [Martinelli, Nidiane C.; Cohen, Carolina R.; Matte, Ursula] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Rohde, LE (corresponding author), Hosp Clin Porto Alegre, Div Cardiol, Expt & Mol Cardiovasc Lab, Porto Alegre, RS, Brazil.	rohde.le@gmail.com	Gonçalves dos Santos, Kátia/GPT-4900-2022; Castro, Mauro A. A./A-5467-2008; Andrades, Michael/S-5394-2019; Silvello, Daiane/U-5515-2019; Da Silveira Matte umatte, Ursula/U-3912-2019; dos Santos, Kátia Gonçalves/D-2683-2014; Matte, Ursula/J-4589-2012; Biolo, Andreia/E-9860-2013; Clausell, Nadine Oliveira/C-7813-2016; Rohde, Luis Eduardo/I-4216-2013	Castro, Mauro A. A./0000-0003-4942-8131; Andrades, Michael/0000-0003-0337-9661; Da Silveira Matte umatte, Ursula/0000-0003-4977-6662; dos Santos, Kátia Gonçalves/0000-0001-5231-2071; Clausell, Nadine Oliveira/0000-0003-4207-3809; Biolo, Andreia/0000-0002-8579-4158; Lopes, Amanda/0000-0002-8390-2821	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasilia, Brazil; Fundo de Incentivo a Pesquisa (FIPE-HCPA), Porto Alegre, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa (FIPE-HCPA), Porto Alegre, Brazil	Funding was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasilia, Brazil, and Fundo de Incentivo a Pesquisa (FIPE-HCPA), Porto Alegre, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barauna VG, 2008, AM J PHYSIOL-REG I, V295, pR381, DOI 10.1152/ajpregu.00933.2007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Castro MAA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r29; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Duan X, 2012, CARDIOLOGY, V122, P36, DOI 10.1159/000338149; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Foppa Murilo, 2005, Cardiovasc Ultrasound, V3, P17, DOI 10.1186/1476-7120-3-17; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Han MY, 2012, CARDIOVASC RES, V93, P645, DOI 10.1093/cvr/cvs001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LaPier TLK, 2001, AM J HYPERTENS, V14, P708; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XB, 2013, ACTA BIOCH BIOPH SIN, V45, P734, DOI 10.1093/abbs/gmt067; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Natali AJ, 2001, J EXP BIOL, V204, P1191; Oliveira EM, 2009, J RENIN-ANGIO-ALDO S, V10, P15, DOI 10.1177/1470320309102304; Oliveira RSF, 2009, J PHYSIOL-LONDON, V587, P3899, DOI 10.1113/jphysiol.2009.173948; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Sourvinou IS, 2013, J MOL DIAGN, V15, P827, DOI 10.1016/j.jmoldx.2013.07.005; Sysa-Shah P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042805; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Ying HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032892; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034688; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200; Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145	50	45	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e93271	10.1371/journal.pone.0093271	http://dx.doi.org/10.1371/journal.pone.0093271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751578	Green Published, gold			2022-12-25	WOS:000335227400003
J	Xie, XF; Chen, ZW; Cao, JL; Guan, HZ; Lin, DG; Li, CL; Lan, T; Duan, YL; Mao, DM; Wu, WR				Xie, Xiaofang; Chen, Zhiwei; Cao, Jinliang; Guan, Huazhong; Lin, Degong; Li, Chunlan; Lan, Tao; Duan, Yuanlin; Mao, Damei; Wu, Weiren			Toward the Positional Cloning of qBlsr5a, a QTL Underlying Resistance to Bacterial Leaf Streak, Using Overlapping Sub-CSSLs in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; DISEASE RESISTANCE; BLIGHT-RESISTANCE; NUCLEOTIDE-BINDING; MAJOR QTL; GENE XA5; BLAST; EXPRESSION; ENCODES; WEIGHT	Bacterial leaf steak (BLS) is one of the most destructive diseases in rice. Studies have shown that BLS resistance in rice is quantitatively inherited, controlled by multiple quantitative trait loci (QTLs). A QTL with relatively large effect, qBlsr5a, was previously mapped in a region of similar to 380 kb on chromosome 5. To fine map qBlsr5a further, a set of overlapping sub-chromosome segment substitution lines (sub-CSSLs) were developed from a large secondary F-2 population (containing more than 7000 plants), in which only the chromosomal region harboring qBlsr5a was segregated. By genotyping the sub-CSSLs with molecular markers covering the target region and phenotyping the sub-CSSLs with artificial inoculation, qBlsr5a was delimited to a 30.0-kb interval, in which only three genes were predicted. qRT-PCR analysis indicated that the three putative genes did not show significant response to the infection of BLS pathogen in both resistant and susceptible parental lines. However, two nucleotide substitutions were found in the coding sequence of gene LOC_ Os05g01710, which encodes the gamma chain of transcription initiation factor IIA (TFIIA gamma). The nucleotide substitutions resulted in a change of the 39th amino acid from valine (in the susceptible parent) to glutamic acid (in the resistant parent). Interestingly, the resistant parent allele of LOC_ Os05g01710 is identical to xa5, a major gene resistant to bacterial leaf blight (another bacterial disease of rice). These results suggest that LOC_ Os05g01710 is very possibly the candidate gene of qBlsr5a.	[Xie, Xiaofang; Chen, Zhiwei; Cao, Jinliang; Guan, Huazhong; Lan, Tao; Duan, Yuanlin; Mao, Damei; Wu, Weiren] Fujian Agr & Forestry Univ, Key Lab Minist Educ Genet Breeding & Multiple Uti, Fuzhou, Peoples R China; [Xie, Xiaofang; Chen, Zhiwei; Guan, Huazhong; Lin, Degong; Li, Chunlan; Lan, Tao; Duan, Yuanlin; Mao, Damei; Wu, Weiren] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Crop Breeding Design, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Chen, ZW (corresponding author), Fujian Agr & Forestry Univ, Key Lab Minist Educ Genet Breeding & Multiple Uti, Fuzhou, Peoples R China.	czw9216@sina.com; wuwr@fafu.edu.cn			National Natural Science Foundation of China [30971762]; Natural Science Foundation of Fujian Province [2011J01089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by National Natural Science Foundation of China (No. 30971762) and the Natural Science Foundation of Fujian Province (No. 2011J01089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouwer DJ, 2004, THEOR APPL GENET, V108, P628, DOI 10.1007/s00122-003-1469-8; Chen C. H., 2006, AGR SCI CHINA, V5, P101; Chen ZhiWei, 2006, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V35, P619; Duan YL, 2003, SCI CHINA SER C, V46, P328, DOI 10.1360/03yc9035; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2001, THEOR APPL GENET, V103, P185, DOI 10.1007/s001220100611; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Han QingDian, 2008, Acta Agronomica Sinica, V34, P587, DOI 10.3724/SP.J.1006.2008.00587; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; Jiang GH, 2006, MOL GENET GENOMICS, V275, P354, DOI 10.1007/s00438-005-0091-7; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Kliebenstein DJ, 2009, SCIENCE, V323, P1301, DOI 10.1126/science.1171410; Kou YJ, 2010, CURR OPIN PLANT BIOL, V13, P181, DOI 10.1016/j.pbi.2009.12.010; Krattinger SG, 2011, PLANT J, V65, P392, DOI 10.1111/j.1365-313X.2010.04430.x; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Liu TM, 2009, THEOR APPL GENET, V118, P1509, DOI 10.1007/s00122-009-0999-0; Liu XQ, 2007, GENETICS, V176, P2541, DOI 10.1534/genetics.107.075465; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Obara M, 2010, THEOR APPL GENET, V121, P535, DOI 10.1007/s00122-010-1328-3; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Pink DAC, 2002, EUPHYTICA, V124, P227, DOI 10.1023/A:1015638718242; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Shen B, 2012, EUPHYTICA, V184, P57, DOI 10.1007/s10681-011-0539-2; Tang D, 2000, THEOR APPL GENET, V101, P286, DOI 10.1007/s001220051481; Tang DingZhong, 1998, Journal of Fujian Agricultural University, V27, P133; TANG DZ, 2000, J FUJIAN AGR U, V29, P134; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Wisser RJ, 2005, GENETICS, V169, P2277, DOI 10.1534/genetics.104.036327; Yang Q, 2010, THEOR APPL GENET, V121, P673, DOI 10.1007/s00122-010-1339-0; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Zhang DF, 2012, THEOR APPL GENET, V124, P585, DOI 10.1007/s00122-011-1731-4; Zheng JingSheng, 2005, Scientia Agricultura Sinica, V38, P1923; Zhu JY, 2011, MOL BREEDING, V27, P171, DOI 10.1007/s11032-010-9420-6	38	27	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95751	10.1371/journal.pone.0095751	http://dx.doi.org/10.1371/journal.pone.0095751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752581	gold, Green Submitted, Green Published			2022-12-25	WOS:000335227400116
J	Mansoor, JK; Schelegle, ES; Davis, CE; Walby, WF; Zhao, WX; Aksenov, AA; Pasamontes, A; Figueroa, J; Allen, R				Mansoor, J. K.; Schelegle, Edward S.; Davis, Cristina E.; Walby, William F.; Zhao, Weixiang; Aksenov, Alexander A.; Pasamontes, Alberto; Figueroa, Jennifer; Allen, Roblee			Analysis of Volatile Compounds in Exhaled Breath Condensate in Patients with Severe Pulmonary Arterial Hypertension	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; NITRIC-OXIDE; BIOMARKERS; DYSFUNCTION; PREDICTION; MARKERS; CANCER	Background: An important challenge to pulmonary arterial hypertension (PAH) diagnosis and treatment is early detection of occult pulmonary vascular pathology. Symptoms are frequently confused with other disease entities that lead to inappropriate interventions and allow for progression to advanced states of disease. There is a significant need to develop new markers for early disease detection and management of PAH. Methodolgy and Findings: Exhaled breath condensate (EBC) samples were compared from 30 age-matched normal healthy individuals and 27 New York Heart Association functional class III and IV idiopathic pulmonary arterial hypertenion (IPAH) patients, a subgroup of PAH. Volatile organic compounds (VOC) in EBC samples were analyzed using gas chromatography/mass spectrometry (GC/MS). Individual peaks in GC profiles were identified in both groups and correlated with pulmonary hemodynamic and clinical endpoints in the IPAH group. Additionally, GC/MS data were analyzed using autoregression followed by partial least squares regression (AR/PLSR) analysis to discriminate between the IPAH and control groups. After correcting for medicaitons, there were 62 unique compounds in the control group, 32 unique compounds in the IPAH group, and 14 in-common compounds between groups. Peak-by-peak analysis of GC profiles of IPAH group EBC samples identified 6 compounds significantly correlated with pulmonary hemodynamic variables important in IPAH diagnosis. AR/PLSR analysis of GC/MS data resulted in a distinct and identifiable metabolic signature for IPAH patients. Conclusions: These findings indicate the utility of EBC VOC analysis to discriminate between severe IPAH and a healthy population; additionally, we identified potential novel biomarkers that correlated with IPAH pulmonary hemodynamic variables that may be important in screening for less severe forms IPAH.	[Mansoor, J. K.] Univ Pacific, Dept Phys Therapy, Stockton, CA 95211 USA; [Schelegle, Edward S.; Walby, William F.; Figueroa, Jennifer] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Davis, Cristina E.; Zhao, Weixiang; Aksenov, Alexander A.; Pasamontes, Alberto] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA; [Allen, Roblee] Univ Calif Davis, Med Ctr, Dept Med, Sacramento, CA 95817 USA	University of the Pacific; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Schelegle, ES (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	esschelegle@ucdavis.edu	Funez, Alberto Pasamontes/M-8515-2016; Davis, Cristina E/C-4437-2008	Funez, Alberto Pasamontes/0000-0002-4142-6337; 	Gilead Sciences, Inc.	Gilead Sciences, Inc.(Gilead Sciences)	Research supported by contracts from Gilead Sciences, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MF, 2007, EXP LUNG RES, V33, P115, DOI 10.1080/01902140701364367; Andrade L, 2003, J VLSI SIG PROC SYST, V35, P229, DOI 10.1023/B:VLSI.0000003022.86639.1f; Archer SL, 1998, AM J RESP CRIT CARE, V158, P1061, DOI 10.1164/ajrccm.158.4.9802113; Carpagnano GE, 2007, AM J RHINOL, V21, P542, DOI 10.2500/ajr.2007.21.3066; Cikach F, 2013, CHEST; Conrad DH, 2008, J GEN INTERN MED, V23, P78, DOI 10.1007/s11606-007-0411-1; CREMONA G, 1994, Q J MED, V87, P547; Droste AS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-129; Fijalkowska A, 2006, CHEST, V129, P1313, DOI 10.1378/chest.129.5.1313; Girgis RE, 2005, AM J RESP CRIT CARE, V172, P352, DOI 10.1164/rccm.200412-1684OC; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Kaneko FT, 1998, AM J RESP CRIT CARE, V158, P917, DOI 10.1164/ajrccm.158.3.9802066; Kwak J, 2011, CURR PHARM BIOTECHNO, V12, P1067, DOI 10.2174/138920111795909050; Leuchte HH, 2004, J AM COLL CARDIOL, V43, P764, DOI 10.1016/j.jacc.2003.09.051; Mansoor JK, 2005, HIGH ALT MED BIOL, V6, P289, DOI 10.1089/ham.2005.6.289; Molina MA, 2008, ANAL CHIM ACTA, V628, P155, DOI 10.1016/j.aca.2008.09.010; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; Nagaya N, 2000, CIRCULATION, V102, P865; O'Reilly Philip, 2007, Int J Chron Obstruct Pulmon Dis, V2, P403; Phillips M, 2004, AM J CARDIOL, V94, P1593, DOI 10.1016/j.amjcard.2004.08.052; Phillips M, 2004, CLIN CHIM ACTA, V344, P189, DOI 10.1016/j.cccn.2004.02.025; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Phillips M, 2006, BREAST CANCER RES TR, V99, P19, DOI 10.1007/s10549-006-9176-1; Phillips Michael, 2003, Heart Dis, V5, P95, DOI 10.1097/01.hdx.0000061701.99611.e8; Riley MS, 1997, CHEST, V111, P44, DOI 10.1378/chest.111.1.44; Slutsky AS, 1999, AM J RESP CRIT CARE, V160, P2104; Smith D, 2011, ANALYST, V136, P2009, DOI 10.1039/c1an15082k; Van Muylem A, 2007, AM J RESP CRIT CARE, V175, P731, DOI 10.1164/rccm.200609-1301OC; Windey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052387; Zhao W, 2008, J SENSORS; Zhao WX, 2009, CHEMOMETR INTELL LAB, V96, P252, DOI 10.1016/j.chemolab.2009.02.010	32	30	31	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95331	10.1371/journal.pone.0095331	http://dx.doi.org/10.1371/journal.pone.0095331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748102	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500085
J	Nie, L; Yang, X; Adcock, I; Xu, ZW; Guo, YK				Nie, Lei; Yang, Xian; Adcock, Ian; Xu, Zhiwei; Guo, Yike			Inferring Cell-Scale Signalling Networks via Compressive Sensing	PLOS ONE			English	Article							PHOSPHATASE-MEDIATED CROSSTALK; STATE-SPACE MODELS; BIOCHEMICAL NETWORKS; MASS-SPECTROMETRY; PATHWAYS; SYSTEMS; PROTEIN; IDENTIFICATION; EXPRESSION; PARAMETERS	Signalling network inference is a central problem in system biology. Previous studies investigate this problem by independently inferring local signalling networks and then linking them together via crosstalk. Since a cellular signalling system is in fact indivisible, this reductionistic approach may have an impact on the accuracy of the inference results. Preferably, a cell-scale signalling network should be inferred as a whole. However, the holistic approach suffers from three practical issues: scalability, measurement and overfitting. Here we make this approach feasible based on two key observations: 1) variations of concentrations are sparse due to separations of timescales; 2) several species can be measured together using cross-reactivity. We propose a method, CCELL, for cell-scale signalling network inference from time series generated by immunoprecipitation using Bayesian compressive sensing. A set of benchmark networks with varying numbers of time-variant species is used to demonstrate the effectiveness of our method. Instead of exhaustively measuring all individual species, high accuracy is achieved from relatively few measurements.	[Nie, Lei; Yang, Xian; Guo, Yike] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Nie, Lei; Xu, Zhiwei] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China; [Nie, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Adcock, Ian] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Imperial College London; Chinese Academy of Sciences; Institute of Computing Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Imperial College London	Guo, YK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England.	y.guo@imperial.ac.uk	郭, 伊可/GYD-3212-2022; Adcock, Ian/L-3217-2019	Adcock, Ian/0000-0003-2101-8843; Yang, Xian/0000-0002-1496-8923	Strategic Priority Program of Chinese Academy of Sciences [XDA06010400]; Innovative R&D Team Support Program of Guangdong Province [201001D0104726115]; Medical Research Council [G1000758] Funding Source: researchfish	Strategic Priority Program of Chinese Academy of Sciences; Innovative R&D Team Support Program of Guangdong Province; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research is partially supported by the Strategic Priority Program of Chinese Academy of Sciences (No. XDA06010400) and the Innovative R&D Team Support Program of Guangdong Province (No. 201001D0104726115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	August E, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-25; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bishop C. M., 2000, P 16 C UNC ART INT, P46; Bonifacino JS, 2001, CURR PROTOC IMMUNOL, V41; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Dunn JD, 2010, MASS SPECTROM REV, V29, P29, DOI 10.1002/mas.20219; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; GALLAGER RG, 1962, IRE T INFORM THEOR, V8, P21, DOI 10.1109/tit.1962.1057683; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hendriks BS, 2008, BIOTECHNOL PROGR, V24, P96, DOI 10.1021/bp070084g; Ji SH, 2008, IEEE T SIGNAL PROCES, V56, P2346, DOI 10.1109/TSP.2007.914345; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Papin JA, 2004, BIOPHYS J, V87, P37, DOI 10.1529/biophysj.103.029884; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Schmidt H, 2005, FEBS J, V272, P2141, DOI 10.1111/j.1742-4658.2005.04605.x; Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200; Sontag E, 2004, BIOINFORMATICS, V20, P1877, DOI 10.1093/bioinformatics/bth173; Sun XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003758; Swameye I, 2003, P NATL ACAD SCI USA, V100, P1028, DOI 10.1073/pnas.0237333100; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Wang Z, 2006, INVEST OPHTH VIS SCI, V47, P5267, DOI 10.1167/iovs.06-0642; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Xiong H, 2008, BIOINFORMATICS, V24, P553, DOI 10.1093/bioinformatics/btm623; Yang X, 2013, CONCURRENCY COMPUTAT; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199	36	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95326	10.1371/journal.pone.0095326	http://dx.doi.org/10.1371/journal.pone.0095326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748057	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500084
J	Lang, MJ; Martinez-Marquez, JY; Prosser, DC; Ganser, LR; Buelto, D; Wendland, B; Duncan, MC				Lang, Michael J.; Martinez-Marquez, Jorge Y.; Prosser, Derek C.; Ganser, Laura R.; Buelto, Destiney; Wendland, Beverly; Duncan, Mara C.			Glucose Starvation Inhibits Autophagy via Vacuolar Hydrolysis and Induces Plasma Membrane Internalization by Down-regulating Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE COMPLEX; CLATHRIN ADAPTER; TRANSLATION INITIATION; GENE ENCODES; H+-ATPASE; PEP4 GENE; V-ATPASE; IN-VIVO	Cellular energy influences all aspects of cellular function. Although cells can adapt to a gradual reduction in energy, acute energy depletion poses a unique challenge. Because acute depletion hampers the transport of new energy sources into the cell, the cell must use endogenous substrates to replenish energy after acute depletion. In the yeast Saccharomyces cerevisiae, glucose starvation causes an acute depletion of intracellular energy that recovers during continued glucose starvation. However, how the cell replenishes energy during the early phase of glucose starvation is unknown. In this study, we investigated the role of pathways that deliver proteins and lipids to the vacuole during glucose starvation. We report that in response to glucose starvation, plasma membrane proteins are directed to the vacuole through reduced recycling at the endosomes. Furthermore, we found that vacuolar hydrolysis inhibits macroautophagy in a target of rapamycin complex 1-dependent manner. Accordingly, we found that endocytosis and hydrolysis are required for survival in glucose starvation, whereas macroautophagy is dispensable. Together, these results suggest that hydrolysis of components delivered to the vacuole independent of autophagy is the cell survival mechanism used by S. cerevisiae in response to glucose starvation.	[Lang, Michael J.; Martinez-Marquez, Jorge Y.; Duncan, Mara C.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Ganser, Laura R.; Duncan, Mara C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Prosser, Derek C.; Wendland, Beverly] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Buelto, Destiney; Duncan, Mara C.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Duncan, MC (corresponding author), Univ Michigan, Dept Cell & Dev Biol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	mcduncan@umich.edu	Duncan, Mara/Z-6236-2019	Duncan, Mara/0000-0002-2383-0109; Martinez-Marquez, Jorge/0000-0003-1485-4800; Prosser, Derek/0000-0002-6738-2758; Ganser, Laura/0000-0002-7357-4588; lang, michael/0000-0003-3544-5221	National Institutes of Health through NIGMS [GM092741, GM60979]; National Institutes of Health [T32 709237]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060979, R01GM092741] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM092741 (to M. C. D.) and GM60979 (to B. W.) through the NIGMS.; Supported by National Institutes of Health Grant T32 709237.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Aoh QL, 2013, MOL BIOL CELL, V24, P832, DOI 10.1091/mbc.E12-10-0750; Aoh QL, 2011, MOL BIOL CELL, V22, P3671, DOI 10.1091/mbc.E11-04-0309; Aravamudhan P, 2013, CURR BIOL, V23, P770, DOI 10.1016/j.cub.2013.03.042; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; CLARKE BL, 1985, J BIOL CHEM, V260, P128; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; INDGE KJ, 1968, J GEN MICROBIOL, V51, P447, DOI 10.1099/00221287-51-3-447; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; Juhasz G, 2012, AUTOPHAGY, V8, P1875, DOI 10.4161/auto.21544; Kama R, 2007, MOL CELL BIOL, V27, P605, DOI 10.1128/MCB.00699-06; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2011, AUTOPHAGY, V7, P1093, DOI 10.4161/auto.7.10.15492; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; LIAO JF, 1993, MOL PHARMACOL, V44, P364; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Loewith R, 2011, BIOCHEM SOC T, V39, P437, DOI 10.1042/BST0390437; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maldonado-Baez L, 2008, MOL BIOL CELL, V19, P2936, DOI 10.1091/mbc.E07-10-1019; MANOLSON MF, 1992, J EXP BIOL, V172, P105; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Perzov N, 2002, J EXP BIOL, V205, P1209; PODBILEWICZ B, 1990, EMBO J, V9, P3477, DOI 10.1002/j.1460-2075.1990.tb07556.x; Prosser DC, 2011, J CELL BIOL, V195, P657, DOI 10.1083/jcb.201104045; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Stephan JS, 2006, AUTOPHAGY, V2, P146, DOI 10.4161/auto.2.2.2485; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Uesono Y, 2004, MOL BIOL CELL, V15, P1544, DOI 10.1091/mbc.E03-12-0877; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	67	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16736	16747		10.1074/jbc.M113.525782	http://dx.doi.org/10.1074/jbc.M113.525782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24753258	Green Published, hybrid			2022-12-25	WOS:000338016200013
J	Podobnik, M; Siddiqui, N; Rebolj, K; Nambi, S; Merzel, F; Visweswariah, SS				Podobnik, Marjetka; Siddiqui, Nida; Rebolj, Katja; Nambi, Subhalaxmi; Merzel, Franci; Visweswariah, Sandhya S.			Allostery and Conformational Dynamics in cAMP-binding Acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GNAT SUPERFAMILY; PROTEIN; ACETYLTRANSFERASE; EVOLUTION	Mycobacteria harbor unique proteins that regulate protein lysine acylation in a cAMP-regulated manner. These lysine acyltransferases from Mycobacterium smegmatis (KATms) and Mycobacterium tuberculosis (KATmt) show distinctive biochemical properties in terms of cAMP binding affinity to the N-terminal cyclic nucleotide binding domain and allosteric activation of the C-terminal acyltransferase domain. Here we provide evidence for structural features in KATms that account for high affinity cAMP binding and elevated acyltransferase activity in the absence of cAMP. Structure-guided mutational analysis converted KATms from a cAMP-regulated to a cAMP-dependent acyltransferase and identified a unique asparagine residue in the acyltransferase domain of KATms that assists in the enzymatic reaction in the absence of a highly conserved glutamate residue seen in Gcn5-related N-acetyltransferase-like acyltransferases. Thus, we have identified mechanisms by which properties of similar proteins have diverged in two species of mycobacteria by modifications in amino acid sequence, which can dramatically alter the abundance of conformational states adopted by a protein.	[Podobnik, Marjetka; Rebolj, Katja] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana 1000, Slovenia; [Merzel, Franci] Natl Inst Chem, Lab Biomol Struct, Ljubljana 1000, Slovenia; [Siddiqui, Nida; Nambi, Subhalaxmi; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	National Institute of Chemistry - Slovenia; National Institute of Chemistry - Slovenia; Indian Institute of Science (IISC) - Bangalore	Podobnik, M (corresponding author), Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Hajdrihova 19, Ljubljana 1000, Slovenia.	marjetka.podobnik@ki.si; sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Merzel, Franci/0000-0002-2748-4901; Siddiqui, Nida/0000-0002-5416-8533; Nambi, Subhalaxmi/0000-0001-7104-659X	Slovenian Research Agency; Department of Science and Technology Indo-Slovene Joint Science and Technology Program; Intensification of Research in High Priority Area proposal	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Department of Science and Technology Indo-Slovene Joint Science and Technology Program; Intensification of Research in High Priority Area proposal	This work was supported by the Slovenian Research Agency (to M. P., K. R., and F. M.), the Department of Science and Technology Indo-Slovene Joint Science and Technology Program (to M. P. and S. S. V), and an Intensification of Research in High Priority Area proposal (to S. S. V).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Majorek KA, 2013, J BIOL CHEM, V288, P30223, DOI 10.1074/jbc.M113.501353; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Nasuno R, 2013, P NATL ACAD SCI USA, V110, P11821, DOI 10.1073/pnas.1300558110; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020	26	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16588	16600		10.1074/jbc.M114.560086	http://dx.doi.org/10.1074/jbc.M114.560086			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24748621	Green Published, hybrid			2022-12-25	WOS:000337965700059
J	Yeatman, HR; Lane, JR; Choy, KHC; Lambert, NA; Sexton, PM; Christopoulos, A; Canals, M				Yeatman, Holly R.; Lane, J. Robert; Choy, Kwok Ho Christopher; Lambert, Nevin A.; Sexton, Patrick M.; Christopoulos, Arthur; Canals, Meritxell			Allosteric Modulation of M-1 Muscarinic Acetylcholine Receptor Internalization and Subcellular Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Arrestin; G Protein-coupled Receptor (GPCR); Receptor Endocytosis; Trafficking; GPCR Regulation; Allosteric Modulator	PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN; KINASE 2; PHOSPHORYLATION; ENDOCYTOSIS; LIGANDS; SEQUESTRATION; PHARMACOLOGY; SELECTIVITY; MECHANISMS	Allosteric modulators are an attractive approach to achieve receptor subtype-selective targeting of G protein-coupled receptors. Benzyl quinolone carboxylic acid (BQCA) is an unprecedented example of a highly selective positive allosteric modulator of the M-1 muscarinic acetylcholine receptor (mAChR). However, despite favorable pharmacological characteristics of BQCA in vitro and in vivo, there is limited evidence of the impact of allosteric modulation on receptor regulatory mechanisms such as -arrestin recruitment or receptor internalization and endocytic trafficking. In the present study we investigated the impact of BQCA on M-1 mAChR regulation. We show that BQCA potentiates agonist-induced -arrestin recruitment to M-1 mAChRs. Using a bioluminescence resonance energy transfer approach to monitor intracellular trafficking of M-1 mAChRs, we show that once internalized, M-1 mAChRs traffic to early endosomes, recycling endosomes and late endosomes. We also show that BQCA potentiates agonist-induced subcellular trafficking. M-1 mAChR internalization is both -arrestin and G protein-dependent, with the third intracellular loop playing an important role in the dynamics of -arrestin recruitment. As the global effect of receptor activation ultimately depends on the levels of receptor expression at the cell surface, these results illustrate the need to extend the characterization of novel allosteric modulators of G protein-coupled receptors to encapsulate the consequences of chronic exposure to this family of ligands.	[Yeatman, Holly R.; Lane, J. Robert; Choy, Kwok Ho Christopher; Sexton, Patrick M.; Christopoulos, Arthur; Canals, Meritxell] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Melbourne, Vic 3052, Australia; [Lambert, Nevin A.] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	Monash University; University System of Georgia; Augusta University	Christopoulos, A (corresponding author), Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Melbourne, Vic 3052, Australia.	arthur.christopoulos@monash.edu; meri.canals@monash.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Choy, Kwok Ho Christopher/AAA-6128-2021	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Lane, J. Robert/0000-0002-7361-7875; Canals, Meritxell/0000-0002-7942-5006; Choy, K.H. Christopher/0000-0002-4650-2220; Yeatman, Holly/0000-0002-3963-4540	National Health and Medical Research Council [519461, APP1011796]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Health and Medical Research Council Program Grant 519461 (to A. C. and P. M. S.) and Project Grant APP1011796 (to M.C.).	Abdul-Ridha A, 2013, MOL PHARMACOL, V83, P521, DOI 10.1124/mol.112.083006; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Davie BJ, 2013, ACS CHEM NEUROSCI, V4, P1026, DOI 10.1021/cn400086m; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Haga K, 1996, J BIOL CHEM, V271, P2776, DOI 10.1074/jbc.271.5.2776; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Keov P, 2013, MOL PHARMACOL, V84, P425, DOI 10.1124/mol.113.087320; Kocan M, 2011, METHODS MOL BIOL, V746, P357, DOI 10.1007/978-1-61779-126-0_20; LAMEH J, 1992, J BIOL CHEM, V267, P13406; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; Lane JR, 2013, ACS CHEM NEUROSCI, V4, P527, DOI 10.1021/cn400005t; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; May LT, 2005, J PHARMACOL EXP THER, V312, P382, DOI 10.1124/jpet.104.073767; Messer WS, 2002, J MOL NEUROSCI, V19, P187, DOI 10.1007/s12031-002-0031-5; Nakajima K, 2012, MOL PHARMACOL, V82, P575, DOI 10.1124/mol.112.080358; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Raote I, 2013, MOL PHARMACOL, V83, P42, DOI 10.1124/mol.112.078626; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Willets JM, 2005, J BIOL CHEM, V280, P18950, DOI 10.1074/jbc.M412682200; Wu DF, 2008, J NEUROCHEM, V104, P1132, DOI 10.1111/j.1471-4159.2007.05063.x; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	41	22	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15856	15866		10.1074/jbc.M113.536672	http://dx.doi.org/10.1074/jbc.M113.536672			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753247	Green Published, hybrid			2022-12-25	WOS:000337465400064
J	Flachs, P; Bhattacharyya, T; Mihola, O; Pialek, J; Forejt, J; Trachtulec, Z				Flachs, Petr; Bhattacharyya, Tanmoy; Mihola, Ondrej; Pialek, Jaroslav; Forejt, Jiri; Trachtulec, Zdenek			Prdm9 Incompatibility Controls Oligospermia and Delayed Fertility but No Selfish Transmission in Mouse Intersubspecific Hybrids	PLOS ONE			English	Article							IN-HOUSE MICE; HISTONE H3 METHYLTRANSFERASE; MALE-STERILITY; X-CHROMOSOME; RECOMBINATION HOTSPOTS; REPRODUCTIVE ISOLATION; UNISEXUAL STERILITY; GENETIC-ANALYSIS; WILD MOUSE; SEX-RATIO	PR-domain 9 (Prdm9) is the first hybrid sterility gene identified in mammals. The incompatibility between Prdm9 from Mus musculus domesticus (Mmd; the B6 strain) and the Hstx2 region of chromosome (Chr) X from M. m. musculus (Mmm; the PWD strain) participates in the complete meiotic arrest of mouse intersubspecific (PWDxB6) F1 hybrid males. Other studies suggest that also semisterile intersubspecific hybrids are relevant for mouse speciation, but the genes responsible remain unknown. To investigate the causes of this semisterility, we analyzed the role of Prdm9 and Chr X in hybrids resulting from the crosses of PWK, another Mmm-derived inbred strain. We demonstrate that Prdm9 and Chr X control the partial meiotic arrest and reduced sperm count in (PWKxB6) F1 males. Asynapsis of heterosubspecific chromosomes and semisterility were partially suppressed by removal of the B6 allele of Prdm9. Polymorphisms between PWK and PWD on Chr X but not in the Prdm9 region were responsible for the modification of the outcome of Prdm9 - Chr X F1 hybrid incompatibility. Furthermore, (PWKxB6) F1 hybrid males displayed delayed fertility dependent on the Prdm9 incompatibility. While the Drosophila hybrid sterility gene Overdrive causes both delayed fertility and increased transmission of its own chromosome to the offspring, the segregation of Chr X and the Prdm9 region from the mouse (PWKxB6) F1 males was normal. Our results indicate extended functional consequences of Prdm9 - Chr X intersubspecific incompatibility on the fertility of hybrids and should influence the design of fertility analyses in hybrid zones and of laboratory crosses between Mmm and Mmd strains.	[Flachs, Petr; Bhattacharyya, Tanmoy; Mihola, Ondrej; Forejt, Jiri; Trachtulec, Zdenek] Acad Sci Czech Republic, Inst Mol Genet, Dept Mouse Mol Genet, Vvi, Prague, Czech Republic; [Pialek, Jaroslav] Acad Sci Czech Republic, Inst Vertebrate Biol, Res Facil Studenec, Brno, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Trachtulec, Z (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Dept Mouse Mol Genet, Vvi, Prague, Czech Republic.	Zdenek.Trachtulec@img.cas.cz	Trachtulec, Zdenek/G-3449-2014; Forejt, Jiri/AAF-5276-2019; Pialek, Jaroslav/B-1237-2008; Mihola, Ondrej/G-6362-2014; Mihola, Ondrej/AAM-7009-2020; Piálek, Jaroslav/AAP-8636-2020; Forejt, Jiri/G-7719-2012	Trachtulec, Zdenek/0000-0001-5772-9394; Forejt, Jiri/0000-0002-2793-3623; Forejt, Jiri/0000-0002-2793-3623; Mihola, Ondrej/0000-0003-3243-0825; Pialek, Jaroslav/0000-0002-0829-7481; Bhattacharyya, Tanmoy/0000-0002-8355-4417	Faculty of Science, Charles University, Prague; Czech Science Foundation [P305/10/1931, 13-08078S, P305/11/P605, 206/08/0640]; Academy of Sciences of the Czech Republic [RVO 68378050]	Faculty of Science, Charles University, Prague; Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	PhD studies of PF and TB were supported in part by the Faculty of Science, Charles University, Prague. This work was also supported by the Czech Science Foundation grants nos. P305/10/1931 (ZT), 13-08078S (JF), P305/11/P605 (OM), and 206/08/0640 (JP), and by the Academy of Sciences of the Czech Republic (RVO 68378050; Premium Academiae to JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtova J, 2012, P ROY SOC B-BIOL SCI, V279, P4803, DOI 10.1098/rspb.2012.1802; Anderson LK, 1999, GENETICS, V151, P1569; Baird SJE, 2012, EVOLUTION HOUSE MOUS, P334; Bateson W., 1909, DOI 10.1017/CBO9780511693953.007; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bhattacharyya T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004088; Bhattacharyya T, 2013, P NATL ACAD SCI USA, V110, pE468, DOI 10.1073/pnas.1219126110; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Britton-Davidian J, 2005, BIOL J LINN SOC, V84, P379, DOI 10.1111/j.1095-8312.2005.00441.x; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Dobzhansky T., 1937; Dufkova P, 2011, EVOLUTION, V65, P993, DOI 10.1111/j.1558-5646.2011.01222.x; Dzur-Gejdosova M, 2012, EVOLUTION, V66, P3321, DOI 10.1111/j.1558-5646.2012.01684.x; Flachs P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003044; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Forejt J, 1999, MAMM GENOME, V10, P958, DOI 10.1007/s003359901136; Forejt J, 2012, EVOLUTION HOUSE MOUS, P482; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Gregorova S, 1996, MAMM GENOME, V7, P107, DOI 10.1007/s003359900029; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HURST LD, 1991, GENETICS, V128, P841; Janousek V, 2012, MOL ECOL, V21, P3032, DOI 10.1111/j.1365-294X.2012.05583.x; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Mihola O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-20; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Muller HJ, 1942, BIOL S, V6, P71; Oka A, 2004, GENETICS, V166, P913, DOI 10.1534/genetics.166.2.913; Oka A, 2007, GENETICS, V175, P185, DOI 10.1534/genetics.106.062976; Oka A, 2010, GENETICS, V186, P339, DOI 10.1534/genetics.110.118976; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Payseur BA, 2004, EVOLUTION, V58, P2064; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Pialek J, 2008, J HERED, V99, P34, DOI 10.1093/jhered/esm083; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TRACHTULEC Z, 1994, GENOMICS, V23, P132, DOI 10.1006/geno.1994.1468; Trachtulec Z, 2008, GENETICS, V178, P1777, DOI 10.1534/genetics.107.082404; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner LM, 2012, EVOLUTION, V66, P443, DOI 10.1111/j.1558-5646.2011.01445.x; Vyskocilova M, 2005, BIOL J LINN SOC, V84, P663, DOI 10.1111/j.1095-8312.2005.00463.x; Vyskocilova M, 2009, MAMM GENOME, V20, P83, DOI 10.1007/s00335-008-9164-3; White MA, 2011, GENETICS, V189, P289, DOI 10.1534/genetics.111.129171; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; YOSHIKI A, 1993, DEV GROWTH DIFFER, V35, P271, DOI 10.1111/j.1440-169X.1993.00271.x	50	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95806	10.1371/journal.pone.0095806	http://dx.doi.org/10.1371/journal.pone.0095806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756080	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300098
J	Liu, DM; Wang, P; Zhang, XY; Xu, XL; Wu, H; Li, L				Liu, Dong-mei; Wang, Pan; Zhang, Xin-yue; Xu, Xi-lin; Wu, Hui; Li, Li			Characterization of Nitrite Degradation by Lactobacillus casei subsp rhamnosus LCR 6013	PLOS ONE			English	Article							REDUCTASE; OXIDE	Nitrites are potential carcinogens. Therefore, limiting nitrites in food is critically important for food safety. The nitrite degradation capacity of Lactobacillus casei subsp. rhamnosus LCR 6013 was investigated in pickle fermentation. After LCR 6013 fermentation for 120 h at 37 degrees C, the nitrite concentration in the fermentation system was significantly lower than that in the control sample without the LCR 6013 strain. The effects of NaCl and Vc on nitrite degradation by LCR 6013 in the De Man, Rogosa and Sharpe (MRS) medium were also investigated. The highest nitrite degradations, 9.29 mg/L and 9.89 mg/L, were observed when NaCl and Vc concentrations were 0.75% and 0.02%, respectively in the MRS medium, which was significantly higher than the control group (p <= 0.01). Electron capture/gas chromatography and indophenol blue staining were used to study the nitrite degradation pathway of LCR 6013. The nitrite degradation products contained N2O, but no NH4+. The LCR 6013 strain completely degraded all NaNO2 (50.00 mg/L) after 16 h of fermentation. The enzyme activity of NiR in the periplasmic space was 2.5 times of that in the cytoplasm. Our results demonstrated that L. casei subsp. rhamnosus LCR 6013 can effectively degrade nitrites in both the pickle fermentation system and in MRS medium by NiR. Nitrites are degraded by the LCR 6013 strain, likely via the nitrate respiration pathway (NO2->NO->N2O->N-2), rather than the aammonium formation pathway (dissimilatory nitrate reduction to ammonium, DNRA), because the degradation products contain N2O, but not NH4+.	[Liu, Dong-mei; Wang, Pan; Zhang, Xin-yue; Xu, Xi-lin; Wu, Hui; Li, Li] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Liu, DM (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	liudm@scut.edu.cn			National Natural Science Foundation of China [31101254]; Natural Science Foundation of the Guangdong Province [S2011010005679]; Foundation of SCUT [D2116760]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Guangdong Province(National Natural Science Foundation of Guangdong Province); Foundation of SCUT	This study was financially supported by the National Natural Science Foundation of China (No. 31101254), the Natural Science Foundation of the Guangdong Province ( No. S2011010005679) and the Foundation of SCUT (D2116760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2005, APPL ENVIRON MICROB, V71, P4427, DOI 10.1128/AEM.71.8.4427-4436.2005; COYNE MS, 1990, J BACTERIOL, V172, P2558, DOI 10.1128/jb.172.5.2558-2562.1990; GRANT MA, 1984, ARCH MICROBIOL, V137, P79, DOI 10.1007/BF00425812; Han M, 2011, J SHENYANG AGR U, V42, P4; Hashimoto T., 2001, J JAPANESE SOC FOOD, V48, P7; Hugo AA, 2006, INT J FOOD MICROBIOL, V111, P191, DOI 10.1016/j.ijfoodmicro.2006.04.024; Ji S-j, 2000, FOOD FERMENTATION IN, V27, P5; Le PTT, 2012, J WORLD AQUACULTURE, V43, P5; Liu D-m, 2008, J S CHINA U TECHNOLO, V36, P5; Lv Y-t, 2010, RES OPTIMIZATION FER; MANCINELLI RL, 1986, ARCH MICROBIOL, V145, P202, DOI 10.1007/BF00446781; Poock SR, 2002, J BIOL CHEM, V277, P23664, DOI 10.1074/jbc.M200731200; Qi H-p, 2010, J FOOD RES DEV, V31, P4; Santamaria P, 2006, J SCI FOOD AGR, V86, P10, DOI 10.1002/jsfa.2351; Schmidt I, 2002, FEMS MICROBIOL ECOL, V39, P175, DOI 10.1111/j.1574-6941.2002.tb00920.x; Sen NP, 2001, J AGR FOOD CHEM, V49, P2096, DOI 10.1021/jf0011384; Spencer JPE, 2000, FREE RADICAL BIO MED, V28, P1039, DOI 10.1016/S0891-5849(00)00190-8; Wang H, 2007, MODERN FOOD SCI TECH, V23, P4	18	14	16	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e93308	10.1371/journal.pone.0093308	http://dx.doi.org/10.1371/journal.pone.0093308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755671	gold, Green Submitted, Green Published			2022-12-25	WOS:000335240300006
J	Manzano, RM; Mascaretti, RS; Carrer, V; Haddad, LB; Fernandes, AR; Reyes, AMA; Rebello, CM				Manzano, Roberta Munhoz; Mascaretti, Renata Suman; Carrer, Valeria; Haddad, Luciana Branco; Fernandes, Aline Rabelo; Reyes, Ana M. A.; Rebello, Celso Moura			A Hyperoxic Lung Injury Model in Premature Rabbits: The Influence of Different Gestational Ages and Oxygen Concentrations	PLOS ONE			English	Article							PRETERM LAMBS; BRONCHOPULMONARY DYSPLASIA; ALVEOLAR DEVELOPMENT; BABOON; TOXICITY; EXPOSURE; ELASTIN; PATHOGENESIS; COLLAGEN; NEWBORN	Background: Many animal models have been developed to study bronchopulmonary dysplasia (BPD). The preterm rabbit is a low-cost, easy-to-handle model, but it has a high mortality rate in response to the high oxygen concentrations used to induce lung injury. The aim of this study was to compare the mortality rates of two models of hyperoxia-induced lung injury in preterm rabbits. Methods: Pregnant New Zealand white rabbits were subjected to caesarean section on gestational day 28 or 29 (full term = 31 days). The premature rabbits in the 28-day gestation group were exposed to room air or FiO(2) >= 95%, and the rabbits in the 29-day gestation group were exposed to room air or FiO(2) = 80% for 11 days. The mean linear intercept (Lm), internal surface area ( ISA), number of alveoli, septal thickness and proportion of elastic and collagen fibers were quantified. Results: The survival rates in the 29-day groups were improved compared with the 28-day groups. Hyperoxia impaired the normal development of the lung, as demonstrated by an increase in the Lm, the septal thickness and the proportion of elastic fibers. Hyperoxia also decreased the ISA, the number of alveoli and the proportion of collagen fibers in the 28-day oxygen-exposed group compared with the control 28-day group. A reduced number of alveoli was found in the 29-day oxygen exposed animals compared with the control 29-day group. Conclusions: The 29-day preterm rabbits had a reduced mortality rate compared with the 28-day preterm rabbits and maintained a reduction in the alveoli number, which is comparable to BPD in humans.	[Manzano, Roberta Munhoz] Integrated Coll Bauru, Bauru, SP, Brazil; [Mascaretti, Renata Suman] Pro Matre Paulista Hosp, Sao Paulo, Brazil; [Carrer, Valeria; Haddad, Luciana Branco; Fernandes, Aline Rabelo; Rebello, Celso Moura] Albert Einstein Jewish Hosp, Sao Paulo, Brazil; [Reyes, Ana M. A.] St Isabel Hosp, Aracaju, Sergipe, Brazil; [Rebello, Celso Moura] Clin Hosp Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Hospital Israelita Albert Einstein	Manzano, RM (corresponding author), Integrated Coll Bauru, Bauru, SP, Brazil.	roberta_m_m@hotmail.com	Rebello, Celso M/E-9400-2013; Manzano, Roberta/ABD-9950-2020	Rebello, Celso/0000-0002-4637-6295				Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945, DOI 10.1164/ajrccm.159.3.9804027; Albertine KH, 2013, SEMIN PERINATOL, V37, P60, DOI 10.1053/j.semperi.2013.01.001; Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6; Bland RD, 2005, AM J RESP CRIT CARE, V172, P899, DOI 10.1164/rccm.200503-384OC; Bland RD, 2003, AM J PHYSIOL-LUNG C, V285, pL76, DOI 10.1152/ajplung.00395.2002; Bland RD, 2003, BIOL NEONATE, V84, P101, DOI 10.1159/000071012; BONIKOS DS, 1975, LAB INVEST, V32, P619; Bremer F, 2012, PLOS ONE, V7; Chang M, 2013, AM J TRANSL RES, V5, P594; Chen YW, 1997, J PEDIATR-US, V130, P409, DOI 10.1016/S0022-3476(97)70202-6; Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; COALSON JJ, 1995, AM J RESP CRIT CARE, V152, P640, DOI 10.1164/ajrccm.152.2.7633720; COALSON JJ, 1992, AM REV RESPIR DIS, V145, P872, DOI 10.1164/ajrccm/145.4_Pt_1.872; Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333, DOI 10.1164/ajrccm.160.4.9810071; COALSON JJ, 1982, EXP MOL PATHOL, V37, P335, DOI 10.1016/0014-4800(82)90046-6; CRAPO JD, 1980, AM REV RESPIR DIS, V122, P123; Deakins KM, 2009, RESP CARE, V54, P1252; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; FRANK L, 1991, PEDIATR RES, V29, P292, DOI 10.1203/00006450-199103000-00014; Gras-Le Guen C, 2008, Eur Respir J, V32, P1520, DOI 10.1183/09031936.00023708; Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC; Johnson BH, 2009, PEDIATR RES, V66, P260, DOI 10.1203/PDR.0b013e3181b1bcd2; Karnak I, 1999, RES EXP MED, V198, P277, DOI 10.1007/s004330050111; KIKKAWA Y, 1971, AM J PATHOL, V64, P423; Kovar J, 2002, J APPL PHYSIOL, V93, P629, DOI 10.1152/japplphysiol.01044.2001; Lim K, 2014, J PEDIATR-US, V164, P730, DOI 10.1016/j.jpeds.2013.11.072; LUM H, 1987, J APPL PHYSIOL, V62, P1865, DOI 10.1152/jappl.1987.62.5.1865; MacRitchie AN, 2001, AM J PHYSIOL-LUNG C, V281, pL1011, DOI 10.1152/ajplung.2001.281.4.L1011; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; Mascaretti RS, 2009, CLINICS, V64, P1099, DOI 10.1590/S1807-59322009001100010; Mataloun MMGB, 2009, BRAZ J MED BIOL RES, V42, P606, DOI 10.1590/S0100-879X2009000700004; Mataloun Marta M. G. B., 2006, J. Pediatr. (Rio J.), V82, P179, DOI [10.2223/JPED.1471, 10.1590/S0021-75572006000300005]; Moore S, 2011, JCCC HONORS J, V11; NILSSON R, 1982, ACTA ANAESTH SCAND, V26, P89, DOI 10.1111/j.1399-6576.1982.tb01733.x; Okamoto Cristina Terumy, 2009, J. Bras. Patol. Med. Lab., V45, P155, DOI 10.1590/S1676-24442009000200011; Parker Thomas A, 2003, Semin Neonatol, V8, P51, DOI 10.1016/S1084-2756(02)00191-4; Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452, DOI 10.1152/ajplung.1997.272.3.L452; RANDELL SH, 1990, AM J PATHOL, V136, P1259; Saugstad OD, 2010, J PERINAT MED, V38, P571, DOI [10.1515/JPM.2010.108, 10.1515/jpm.2010.108]; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Speer Christian P, 2003, Semin Neonatol, V8, P29, DOI 10.1016/S1084-2756(02)00190-2; Thibeault DW, 2003, PEDIATRICS, V111, P766, DOI 10.1542/peds.111.4.766; Thomson MA, 2004, AM J RESP CRIT CARE, V169, P1054, DOI 10.1164/rccm.200309-1276OC; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P765; Walsh MC, 2006, PEDIATRICS, V118, pE1328, DOI 10.1542/peds.2006-0359; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Weinberger B, 2002, TOXICOL APPL PHARM, V181, P60, DOI 10.1006/taap.2002.9387	49	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95844	10.1371/journal.pone.0095844	http://dx.doi.org/10.1371/journal.pone.0095844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755658	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300104
J	Morton, SK; Chaston, DJ; Baillie, BK; Hill, CE; Matthaei, KI				Morton, Susan K.; Chaston, Daniel J.; Baillie, Brett K.; Hill, Caryl E.; Matthaei, Klaus I.			Regulation of Endothelial-Specific Transgene Expression by the Lacl Repressor Protein In Vivo	PLOS ONE			English	Article							GENE-EXPRESSION; MOUSE; MICE; CONNEXIN40; LINE	Genetically modified mice have played an important part in elucidating gene function in vivo. However, conclusions from transgenic studies may be compromised by complications arising from the site of transgene integration into the genome and, in inducible systems, the non-innocuous nature of inducer molecules. The aim of the present study was to use the vascular system to validate a technique based on the bacterial lac operon system, in which transgene expression can be repressed and de-repressed by an innocuous lactose analogue, IPTG. We have modified an endothelium specific promoter (TIE2) with synthetic LacO sequences and made transgenic mouse lines with this modified promoter driving expression of mutant forms of connexin40 and an independently translated reporter, EGFP. We show that tissue specificity of this modified promoter is retained in the vasculature of transgenic mice in spite of the presence of LacO sequences, and that transgene expression is uniform throughout the endothelium of a range of adult systemic and cerebral arteries and arterioles. Moreover, transgene expression can be consistently down-regulated by crossing the transgenic mice with mice expressing an inhibitor protein Lacl(R), and in one transgenic line, transgene expression could be de-repressed rapidly by the innocuous inducer, IPTG. We conclude that the modified bacterial lac operon system can be used successfully to validate transgenic phenotypes through a simple breeding schedule with mice homozygous for the Lacl(R) protein.	[Morton, Susan K.; Chaston, Daniel J.; Baillie, Brett K.; Hill, Caryl E.] Australian Natl Univ, John Curtin Sch Med Res, Blood Vessel Lab, Canberra, ACT 2601, Australia; [Morton, Susan K.; Chaston, Daniel J.; Matthaei, Klaus I.] Australian Natl Univ, John Curtin Sch Med Res, Stem Cell & Gene Targeting Lab, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research	Matthaei, KI (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Stem Cell & Gene Targeting Lab, Canberra, ACT 2601, Australia.	klaus.matthaei@anu.edu.au	Baillie, Brett K/H-2326-2013	Baillie, Brett K/0000-0002-4492-5844	NHMRC Project [#471421]	NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia)	CEH and KIM acknowledge funding support from NH&MRC Project Grant #471421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], OBES RES, V13, P1146; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Chaston DJ, 2013, ARTERIOSCL THROM VAS, V33, P962, DOI 10.1161/ATVBAHA.112.300957; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Cronin CA, 2003, J NEUROSCI, V23, P11692; Cronin CA, 2001, GENE DEV, V15, P1506, DOI 10.1101/gad.892001; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Grespi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018051; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hill CE, 2001, MED RES REV, V21, P1; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Matthaei KI, 2004, HDB STEM CELLS, P589; Matthaei KI, 2007, J PHYSIOL-LONDON, V582, P481, DOI 10.1113/jphysiol.2007.134908; Meyer MR, 2011, VASC PHARMACOL, V55, P17, DOI 10.1016/j.vph.2011.06.003; Nakamasu K, 2001, EUR J BIOCHEM, V268, P1468, DOI 10.1046/j.1432-1327.2001.02017.x; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Ryan Amy, 2004, Mol Imaging, V3, P33, DOI 10.1162/153535004773861705; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Scrable H, 2002, SEMIN CELL DEV BIOL, V13, P109, DOI 10.1016/S1084-9521(02)00017-4; Simon AM, 2003, J CELL SCI, V116, P2223, DOI 10.1242/jcs.00429	21	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95980	10.1371/journal.pone.0095980	http://dx.doi.org/10.1371/journal.pone.0095980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755679	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300126
J	Rohde, JF; Hessner, MV; Lous, J; Muller, P; Holund, U; Heitmann, BL				Rohde, Jeanett Friis; Hessner, Marie Vik; Lous, Jorgen; Muller, Pia; Holund, Ulla; Heitmann, Berit Lilienthal			The Importance of Gender of Patients and General Practitioners in Relation to Treatment Practices for Overweight	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; ADIPOSE-TISSUE; WEIGHT-GAIN; RISK; WOMEN; MEN; OBESITY; PARTICIPANTS; FOLLOW	Background: Several studies suggest that men and women are treated differently for similar disease including diabetes and cardiovascular disease. Differences in attitudes and treatment practices towards men and women with obesity are not well recognized. Objective: To investigate the attitudes and treatment practices among Danish general practitioners (GPs), in relation to treatment of overweight, while taking gender of both the patients and practitioners into account. Design: Questionnaire inventory covertly examining attitudes and practices among Danish general practitioners towards treatment of overweight. All 3.637 general practitioners from the Danish Medical Association register were invited to participate in the survey. In total 1.136 participated. Results: The GPs found weight loss to be more important for overweight male than overweight female patients. They also treated complications to overweight more rigorously among male than female patients, and recommended lipid lowering medicine more often to male than female overweight patients. In addition, the younger female GPs and older male GPs more often said that they would treat an overweight patient with lipid lowering medicine. Conclusion: Among general practitioners in Denmark, treatment for weight loss is more often practiced for overweight male than overweight female patients presenting with same symptoms. In addition, hyperlipidemia among overweight males is also more often treated with lipid lowering medicine than hyperlipidemia among overweight females.	[Rohde, Jeanett Friis; Hessner, Marie Vik; Heitmann, Berit Lilienthal] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Lous, Jorgen] Univ Southern Denmark, Inst Publ Hlth, Res Unit Gen Practice, Odense, Denmark; [Muller, Pia] Univ Copenhagen, Inst Publ Hlth, Sect Gen Practice, Copenhagen, Denmark; [Holund, Ulla] Danish Hlth & Med Author, Copenhagen, Denmark; [Heitmann, Berit Lilienthal] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Heitmann, Berit Lilienthal] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Copenhagen; University of Sydney; University of Southern Denmark	Heitmann, BL (corresponding author), Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark.	Berit.Lilienthal.Heitmann@regionh.dk		Rohde, Jeanett Friis/0000-0002-9300-9009; Heitmann, Berit Lilienthal/0000-0002-6809-4504	Danish College of General Practitioners (DSAM)	Danish College of General Practitioners (DSAM)	The Danish College of General Practitioners (DSAM) has funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2001, OBES RES, V9, P257, DOI 10.1038/oby.2001.30; Barrett-Connor E, 2004, ARCH INTERN MED, V164, P934, DOI 10.1001/archinte.164.9.934; Budd GM, 2011, APPL NURS RES, V24, P127, DOI 10.1016/j.apnr.2009.05.001; Campell L, 2010, CARDIOL GEN PRACTICE, P30; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chou AF, 2007, WOMEN HEALTH ISS, V17, P139, DOI 10.1016/j.whi.2007.03.004; Christensen AL, 2009, KRAM UNDERSOGELSE TA; Chrostowska M, 2011, BLOOD PRESSURE, V20, P145, DOI 10.3109/08037051.2010.538996; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Holund U, 1999, Ugeskr Laeger, V161, P40; Holund U, 1999, Ugeskr Laeger, V161, P44; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Mosca L, 2006, CIRCULATION, V113, P525, DOI 10.1161/CIRCULATIONAHA.105.588103; Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874; Puhl R., 2010, CLIN OBESITY ADULTS, P25; Shepherd J, 2004, ATHEROSCLEROSIS SUPP, V5, P91, DOI 10.1016/j.atherosclerosissup.2004.08.029	18	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95706	10.1371/journal.pone.0095706	http://dx.doi.org/10.1371/journal.pone.0095706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2IS	24756104	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300077
J	Sijmons, S; Thys, K; Corthout, M; Van Damme, E; Van Loock, M; Bollen, S; Baguet, S; Aerssens, J; Van Ranst, M; Maes, P				Sijmons, Steven; Thys, Kim; Corthout, Michael; Van Damme, Ellen; Van Loock, Marnix; Bollen, Stefanie; Baguet, Sylvie; Aerssens, Jeroen; Van Ranst, Marc; Maes, Piet			A Method Enabling High-Throughput Sequencing of Human Cytomegalovirus Complete Genomes from Clinical Isolates	PLOS ONE			English	Article							SINGLE-CELL; STRAINS; DNA; TRANSCRIPTION; VARIABILITY; ALGORITHMS; ASSEMBLER; GENES	Human cytomegalovirus (HCMV) is a ubiquitous virus that can cause serious sequelae in immunocompromised patients and in the developing fetus. The coding capacity of the 235 kbp genome is still incompletely understood, and there is a pressing need to characterize genomic contents in clinical isolates. In this study, a procedure for the high-throughput generation of full genome consensus sequences from clinical HCMV isolates is presented. This method relies on low number passaging of clinical isolates on human fibroblasts, followed by digestion of cellular DNA and purification of viral DNA. After multiple displacement amplification, highly pure viral DNA is generated. These extracts are suitable for high-throughput next-generation sequencing and assembly of consensus sequences. Throughout a series of validation experiments, we showed that the workflow reproducibly generated consensus sequences representative for the virus population present in the original clinical material. Additionally, the performance of 454 GS FLX and/or Illumina Genome Analyzer datasets in consensus sequence deduction was evaluated. Based on assembly performance data, the Illumina Genome Analyzer was the platform of choice in the presented workflow. Analysis of the consensus sequences derived in this study confirmed the presence of gene-disrupting mutations in clinical HCMV isolates independent from in vitro passaging. These mutations were identified in genes RL5A, UL1, UL9, UL111A and UL150. In conclusion, the presented workflow provides opportunities for high-throughput characterization of complete HCMV genomes that could deliver new insights into HCMV coding capacity and genetic determinants of viral tropism and pathogenicity.	[Sijmons, Steven; Corthout, Michael; Bollen, Stefanie; Baguet, Sylvie; Van Ranst, Marc; Maes, Piet] Katholieke Univ Leuven, Rega Inst Med Res, Lab Clin Virol, Louvain, Belgium; [Thys, Kim; Van Damme, Ellen; Van Loock, Marnix; Aerssens, Jeroen] Janssen Infect Dis BVBA, Beerse, Belgium	KU Leuven	Sijmons, S (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Lab Clin Virol, Louvain, Belgium.	steven.sijmons@uzleuven.be	Van Ranst, Marc/P-7522-2017; Maes, Piet/P-7782-2017	Van Ranst, Marc/0000-0002-1674-4157; Maes, Piet/0000-0002-4571-5232; Aerssens, Jeroen/0000-0002-9254-4800; Sijmons, Steven/0000-0003-3520-636X	Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen')	Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen')(FWO)	SS and PM are supported by the Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-47; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bankier A T, 1991, DNA Seq, V2, P1, DOI 10.3109/10425179109008433; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Bradley AJ, 2009, J GEN VIROL, V90, P2375, DOI 10.1099/vir.0.013250-0; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Cunningham C, 2010, J GEN VIROL, V91, P605, DOI 10.1099/vir.0.015891-0; Dargan DJ, 2010, J GEN VIROL, V91, P1535, DOI 10.1099/vir.0.018994-0; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; Direito SOL, 2014, ENVIRON MICROBIOL, V16, P643, DOI 10.1111/1462-2920.12365; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Garrigue I, 2007, J CLIN VIROL, V40, P120, DOI 10.1016/j.jcv.2007.06.015; Gatherer D, 2011, P NATL ACAD SCI USA, V108, P19755, DOI 10.1073/pnas.1115861108; Gorzer I, 2010, J VIROL, V84, P7195, DOI 10.1128/JVI.00475-10; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jung GS, 2011, VIRUS RES, V156, P113, DOI 10.1016/j.virusres.2011.01.005; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lasken RS, 2009, BIOCHEM SOC T, V37, P450, DOI 10.1042/BST0370450; Li ZY, 2012, BRIEF FUNCT GENOMICS, V11, P25, DOI 10.1093/bfgp/elr035; Machado Moara, 2011, Investig Genet, V2, P3, DOI 10.1186/2041-2223-2-3; Magoc T, 2013, BIOINFORMATICS, V29, P1718, DOI 10.1093/bioinformatics/btt273; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Milne I., 2012, BRIEF BIOINFORM; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pignatelli S, 2004, REV MED VIROL, V14, P383, DOI 10.1002/rmv.438; Prichard MN, 2001, REV MED VIROL, V11, P191, DOI 10.1002/rmv.315; Puchhammer-Stockl E, 2006, J CLIN VIROL, V36, P239, DOI 10.1016/j.jcv.2006.03.004; Puchhammer-Stockl E, 2011, FUTURE VIROL, V6, P259, DOI 10.2217/FVL.10.87; Renzette N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001344; Sekulin K, 2007, VIRUS GENES, V35, P577, DOI 10.1007/s11262-007-0158-0; Shikhagaie M, 2012, J VIROL, V86, P4091, DOI 10.1128/JVI.06291-11; Sinzger C, 1999, J VIROL METHODS, V81, P115, DOI 10.1016/S0166-0934(99)00058-0; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WEILAND KL, 1994, VIRUS RES, V34, P191, DOI 10.1016/0168-1702(94)90124-4; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GJ, 2007, J VIROL, V81, P11267, DOI 10.1128/JVI.00007-07	52	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95501	10.1371/journal.pone.0095501	http://dx.doi.org/10.1371/journal.pone.0095501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755734	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300048
J	Wang, MJ; Mykletun, A; Moyner, EI; Overland, S; Henderson, M; Stansfeld, S; Hotopf, M; Harvey, SB				Wang, Min-Jung; Mykletun, Arnstein; Moyner, Ellen Ihlen; Overland, Simon; Henderson, Max; Stansfeld, Stephen; Hotopf, Matthew; Harvey, Samuel B.			Job Strain, Health and Sickness Absence: Results from the Hordaland Health Study	PLOS ONE			English	Article							PSYCHOSOCIAL WORK-ENVIRONMENT; DISABILITY PENSION; DECISION LATITUDE; MENTAL-HEALTH; DEMANDS; CONSTRUCTION; PREDICTORS; EMPLOYEES; STRESS; IMPACT	Objectives: While it is generally accepted that high job strain is associated with adverse occupational outcomes, the nature of this relationship and the causal pathways involved are not well elucidated. We aimed to assess the association between job strain and long-term sickness absence (LTSA), and investigate whether any associations could be explained by validated health measures. Methods: Data from participants (n = 7346) of the Hordaland Health Study (HUSK), aged 40-47 at baseline, were analyzed using multivariate Cox regression to evaluate the association between job strain and LTSA over one year. Further analyses examined whether mental and physical health mediated any association between job strain and sickness absence. Results: A positive association was found between job strain and risk of a LTSA episode, even controlling for confounding factors (HR = 1.64 (1.36-1.98); high job strain exposure accounted for a small proportion of LTSA episodes (population attributable risk 0.068). Further adjustments for physical health and mental health individually attenuated, but could not fully explain the association. In the fully adjusted model, the association between high job strain and LTSA remained significant (HR = 1.30 (1.07-1.59)). Conclusion: High job strain increases the risk of LTSA. While our results suggest that one in 15 cases of LTSA could be avoided if high job strain were eliminated, we also provide evidence against simplistic causal models. The impact of job strain on future LTSA could not be fully explained by impaired health at baseline, which suggests that factors besides ill health are important in explaining the link between job strain and sickness absence.	[Wang, Min-Jung; Harvey, Samuel B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Mykletun, Arnstein; Moyner, Ellen Ihlen; Overland, Simon] Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway; [Mykletun, Arnstein] Norwegian Inst Publ Hlth, Div Mental Hlth, Dept Publ Mental Hlth, Bergen, Norway; [Henderson, Max; Hotopf, Matthew; Harvey, Samuel B.] Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England; [Stansfeld, Stephen] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Psychiat, London, England; [Harvey, Samuel B.] Black Dog Inst, Sydney, NSW, Australia	University of New South Wales Sydney; University of Bergen; Norwegian Institute of Public Health (NIPH); University of London; King's College London; University of London; Queen Mary University London; Black Dog Institute	Wang, MJ (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	min-jung.wang@unsw.edu.au	Hotopf, Matthew/E-4971-2010; Mykletun, Arnstein/L-5004-2015; Øverland, Simon/ABF-1289-2020	Mykletun, Arnstein/0000-0002-3878-0079; Øverland, Simon/0000-0001-6967-9355; Harvey, Samuel/0000-0001-9580-3743; Hotopf, Matthew/0000-0002-3980-4466; Stansfeld, Stephen/0000-0001-8716-3897	NSW Health; NIHR Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; Norwegian Research Council; MRC [G106/1252] Funding Source: UKRI; Medical Research Council [G106/1252] Funding Source: researchfish	NSW Health; NIHR Biomedical Research Centre for Mental Health at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; Norwegian Research Council(Research Council of NorwayEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MW and SBH are funded by NSW Health. M. Henderson and M. Hotopf were supported by the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. AM and SO were funded by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavinia SM, 2009, SCAND J WORK ENV HEA, V35, P325, DOI 10.5271/sjweh.1340; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P36, DOI 10.1080/14034950410021835; Andrea H, 2003, OCCUP ENVIRON MED, V60, P295, DOI 10.1136/oem.60.4.295; Bourbonnais R, 2001, AM J IND MED, V39, P194, DOI 10.1002/1097-0274(200102)39:2<194::AID-AJIM1006>3.0.CO;2-K; Harvey SB, 2010, OCCUP MED-OXFORD, V60, P362, DOI 10.1093/occmed/kqq031; Harvey S.B., 2009, PSYCHIATRY, V8, P174, DOI [10.1016/j.mppsy.2009.03.011, DOI 10.1016/J.MPPSY.2009.03.011, DOI 10.1016/j.mppsy.2009.03.011]; Health and Safety Executive, 2012, STRESS PSYCH DIS; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Henderson M, 2011, J ROY SOC MED, V104, P198, DOI 10.1258/jrsm.2011.100231; Henderson M., 2012, P IEEE PES GEN M, P1; Henderson M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000777; Henderson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036645; Henderson M, 2009, BRIT J PSYCHIAT, V194, P220, DOI 10.1192/bjp.bp.107.044271; Hensing G, 1998, SCAND J SOC MED, V26, P133, DOI 10.1177/14034948980260020201; Higgins A, 2012, J OCCUP REHABIL, V22, P322, DOI 10.1007/s10926-012-9362-4; Hystad SW, 2011, J OCCUP HEALTH PSYCH, V16, P265, DOI 10.1037/a0022904; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Knudsen SAK, 2010, EUR J PUBLIC HEALTH, V20, P25; Kondo K, 2006, INT ARCH OCC ENV HEA, V79, P213, DOI 10.1007/s00420-005-0027-x; KRISTENSEN TS, 1991, SOC SCI MED, V32, P15, DOI 10.1016/0277-9536(91)90122-S; Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147; Laine S, 2009, J EPIDEMIOL COMMUN H, V63, P24, DOI 10.1136/jech.2007.071407; LANDSBERGIS PA, 1988, J ORGAN BEHAV, V9, P217, DOI 10.1002/job.4030090303; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; Melchior M, 2005, AM J PUBLIC HEALTH, V95, P1206, DOI 10.2105/AJPH.2004.048835; Melchior M, 2003, J EPIDEMIOL COMMUN H, V57, P285, DOI 10.1136/jech.57.4.285; Melchior M, 2007, SOC PSYCH PSYCH EPID, V42, P573, DOI 10.1007/s00127-007-0203-2; NAV, 2013, PHYS CERT SICKN AB; Nielsen ML, 2006, J OCCUP ENVIRON MED, V48, P591, DOI 10.1097/01.jom.0000201567.70084.3a; Nielsen ML, 2004, WORK STRESS, V18, P323, DOI 10.1080/02678370412331324806; NORTH F, 1993, BRIT MED J, V306, P361, DOI 10.1136/bmj.306.6874.361; North FM, 1996, AM J PUBLIC HEALTH, V86, P332, DOI 10.2105/AJPH.86.3.332; Ostby KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-12; Ostry AS, 2004, SCAND J PUBLIC HEALT, V32, P456, DOI 10.1080/14034940410028190; Overland S, 2008, OCCUP ENVIRON MED, V65, P769, DOI 10.1136/oem.2007.037861; Peter R, 1997, SOC SCI MED, V45, P1111, DOI 10.1016/S0277-9536(97)00039-7; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; Smulders PGW, 1999, WORK STRESS, V13, P115, DOI 10.1080/026783799296093; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; StataCorp, 2011, STAT STAT SOFTW REL; Taimela S, 2010, J OCCUP REHABIL, V20, P14, DOI 10.1007/s10926-009-9221-0; THEORELL T, 1988, SCAND J WORK ENV HEA, V14, P189, DOI 10.5271/sjweh.1932; Vahtera J, 1996, WORK STRESS, V10, P286, DOI 10.1080/02678379608256809; Virtanen M, 2007, AM J PREV MED, V33, P182, DOI 10.1016/j.amepre.2007.05.003; Wainwright D., 2002, WORK STRESS MAKING M; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; WHO, 2012, ICD 10 CLASS MENT BE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96025	10.1371/journal.pone.0096025	http://dx.doi.org/10.1371/journal.pone.0096025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2IS	24755878	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300132
J	Chakraborty, M; Goel, M; Chinnadayyala, SR; Dahiya, UR; Ghosh, SS; Goswami, P				Chakraborty, Mitun; Goel, Manish; Chinnadayyala, Somasekhar R.; Dahiya, Ujjwal Ranjan; Ghosh, Siddhartha Sankar; Goswami, Pranab			Molecular Characterization and Expression of a Novel Alcohol Oxidase from Aspergillus terreus MTCC6324	PLOS ONE			English	Article							SECONDARY STRUCTURE ANALYSES; CANDIDA-TROPICALIS; N-ALKANE; CLONING; OXIDATION; PROTEINS; LIGNIN; CRYSTALLIZATION; OXIDOREDUCTASES; PURIFICATION	The alcohol oxidase (AOx) cDNA from Aspergillus terreus MTCC6324 with an open reading frame (ORF) of 2001 bp was constructed from n-hexadecane induced cells and expressed in Escherichia coli with a yield of similar to 4.2 mg protein g(-1) wet cell. The deduced amino acid sequences of recombinant rAOx showed maximum structural homology with the chain B of aryl AOx from Pleurotus eryngii. A functionally active AOx was achieved by incubating the apo-AOx with flavin adenine dinucleotide (FAD) for similar to 80 h at 16 degrees C and pH 9.0. The isoelectric point and mass of the apo-AOx were found to be 6.5 +/- 0.1 and similar to 74 kDa, respectively. Circular dichroism data of the rAOx confirmed its ordered structure. Docking studies with an ab-initio protein model demonstrated the presence of a conserved FAD binding domain with an active substrate binding site. The rAOx was specific for aryl alcohols and the order of its substrate preference was 4-methoxybenzyl alcohol >3-methoxybenzyl alcohol>3, 4-dimethoxybenzyl alcohol > benzyl alcohol. A significantly high aggregation to similar to 1000 nm (diameter) and catalytic efficiency (k(cat)/K-m) of 7829.5 min(-1) mM(-1) for 4-methoxybenzyl alcohol was also demonstrated for rAOx. The results infer the novelty of the AOx and its potential biocatalytic application.	[Chakraborty, Mitun; Goel, Manish; Chinnadayyala, Somasekhar R.; Dahiya, Ujjwal Ranjan; Ghosh, Siddhartha Sankar; Goswami, Pranab] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Ghosh, SS (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	sghosh@iitg.ernet.in; pgoswami@iitg.ernet.in		goel, manish/0000-0002-6087-6990				ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Benen JAE, 1998, J BIOL CHEM, V273, P7865, DOI 10.1074/jbc.273.14.7865; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Das M, 2013, BIOELECTROCHEMISTRY, V89, P19, DOI 10.1016/j.bioelechem.2012.08.007; DICKINSON FM, 1992, BIOCHEM J, V282, P325, DOI 10.1042/bj2820325; Eirich LD, 2004, APPL ENVIRON MICROB, V70, P4872, DOI 10.1128/AEM.70.8.4872-4879.2004; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Ferreira P, 2009, J BIOL CHEM, V284, P24840, DOI 10.1074/jbc.M109.011593; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Goswami P, 1999, APPL MICROBIOL BIOT, V51, P860, DOI 10.1007/s002530051474; Goswami P, 2013, APPL MICROBIOL BIOT, V97, P4259, DOI 10.1007/s00253-013-4842-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUILLEN F, 1992, EUR J BIOCHEM, V209, P603, DOI 10.1111/j.1432-1033.1992.tb17326.x; Hernandez-Ortega A, 2011, J BIOL CHEM, V286, P41105, DOI 10.1074/jbc.M111.282467; Hernandez-Ortega A, 2011, BIOCHEM J, V436, P341, DOI 10.1042/BJ20102090; HOMMEL R, 1990, FEMS MICROBIOL LETT, V70, P183, DOI 10.1016/S0378-1097(05)80036-9; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kakoti A, 2012, J MOL CATAL B-ENZYM, V78, P98, DOI 10.1016/j.molcatb.2012.03.013; KEMP GD, 1990, APPL MICROBIOL BIOT, V32, P461, DOI 10.1007/BF00903783; Kumar AK, 2006, APPL MICROBIOL BIOT, V72, P906, DOI 10.1007/s00253-006-0381-y; Kumar AK, 2008, BBA-PROTEINS PROTEOM, V1784, P1552, DOI 10.1016/j.bbapap.2008.06.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Y, 2010, APPL BIOCHEM BIOTECH, V160, P322, DOI 10.1007/s12010-008-8289-x; Maniatis T., 1982, MOL CLONING LAB MANU; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mattevi A, 1997, PROTEINS, V27, P601, DOI 10.1002/(SICI)1097-0134(199704)27:4<601::AID-PROT12>3.0.CO;2-O; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Ozimek P, 2005, FEMS YEAST RES, V5, P975, DOI 10.1016/j.femsyr.2005.06.005; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Robelo CR, 2004, APPL BIOCHEM BIOTECH, V113, P161, DOI 10.1385/ABAB:113:1-3:161; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruiz-Duenas FJ, 2006, PROTEIN EXPRES PURIF, V45, P191, DOI 10.1016/j.pep.2005.06.003; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SAVITHA J, 1991, FEMS MICROBIOL LETT, V80, P221, DOI 10.1111/j.1574-6968.1991.tb04665.x; Schwanke RC, 2009, INT J BIOL MACROMOL, V45, P97, DOI 10.1016/j.ijbiomac.2009.04.005; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Vanhanen S, 2000, J BIOL CHEM, V275, P4445, DOI 10.1074/jbc.275.6.4445; Varela E, 2000, BBA-PROTEIN STRUCT M, V1476, P129, DOI 10.1016/S0167-4838(99)00227-7; Varela E, 1999, BIOCHEM J, V341, P113, DOI 10.1042/0264-6021:3410113; Vatsyayan P, 2008, BIORESOURCE TECHNOL, V99, P68, DOI 10.1016/j.biortech.2006.11.055; WERNER W, 1970, Z ANAL CHEM FRESENIU, V252, P224; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	48	5	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95368	10.1371/journal.pone.0095368	http://dx.doi.org/10.1371/journal.pone.0095368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752075	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400056
J	Nguyen, H; Lamb, D; Herbohn, J; Firn, J				Huong Nguyen; Lamb, David; Herbohn, John; Firn, Jennifer			Designing Mixed Species Tree Plantations for the Tropics: Balancing Ecological Attributes of Species with Landholder Preferences in the Philippines	PLOS ONE			English	Article							COSTA-RICA; FOREST; PRODUCTIVITY; GROWTH; STANDS; YIELD; BIODIVERSITY; RESTORATION; SMALLHOLDER; PURE	A mixed species reforestation program known as the Rainforestation Farming system was undertaken in the Philippines to develop forms of farm forestry more suitable for smallholders than the simple monocultural plantations commonly used then. In this study, we describe the subsequent changes in stand structure and floristic composition of these plantations in order to learn from the experience and develop improved prescriptions for reforestation systems likely to be attractive to smallholders. We investigated stands aged from 6 to 11 years old on three successive occasions over a 6 year period. We found the number of species originally present in the plots as trees.5 cm dbh decreased from an initial total of 76 species to 65 species at the end of study period. But, at the same time, some new species reached the size class threshold and were recruited into the canopy layer. There was a substantial decline in tree density from an estimated stocking of about 5000 trees per ha at the time of planting to 1380 trees per ha at the time of the first measurement; the density declined by a further 4.9% per year. Changes in composition and stand structure were indicated by a marked shift in the Importance Value Index of species. Over six years, shade-intolerant species became less important and the native shade-tolerant species (often Dipterocarps) increased in importance. Based on how the Rainforestation Farming plantations developed in these early years, we suggest that mixed-species plantations elsewhere in the humid tropics should be around 1000 trees per ha or less, that the proportion of fast growing (and hence early maturing) trees should be about 30-40% of this initial density and that any fruit tree component should only be planted on the plantation margin where more light and space are available for crowns to develop.	[Huong Nguyen; Lamb, David; Herbohn, John] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Huong Nguyen; Herbohn, John] Univ Sunshine Coast, Forest Ind Res Ctr, Sippy Downs, Qld 4556, Australia; [Lamb, David] Univ Queensland, Ctr Mined Land Res, St Lucia, Qld, Australia; [Firn, Jennifer] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Fac Sci & Technol, Brisbane, Qld 4001, Australia	University of Queensland; University of the Sunshine Coast; University of Queensland; Queensland University of Technology (QUT)	Nguyen, H (corresponding author), Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia.	h.nguyen22@uq.edu.au	; Herbohn, John/B-3038-2008	Firn, Jennifer/0000-0001-6026-8912; Herbohn, John/0000-0001-5701-4882	ACIAR Smallholer Forest [ASEM/2003/052, ASEM/2006/091]	ACIAR Smallholer Forest(Australian Ctr Intl Agr Res)	The study was funded from ACIAR Smallholer Forest projects ASEM/2003/052 and ASEM/2006/091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2006, BIODIVERS CONSERV, V15, P4159, DOI 10.1007/s10531-005-3374-8; BARBOUR M., 1999, TERRESTRIAL PLANT EC, V3rd; Barbour M.G., 1980, TERRESTRIAL PLANT EC; Bullock BP, 2005, FOREST SCI, V51, P102; Crane JH, 2004, ACTA HORTIC, P179, DOI 10.17660/ActaHortic.2004.632.22; Dangol D. R., 2001, NEPAL J SCI TECHNOLO, V3, P69; DeBell DS, 1997, FOREST SCI, V43, P286; Ferguson L, 2002, ACTA HORTIC, P281, DOI 10.17660/ActaHortic.2002.586.54; Grant JC, 2006, FOREST ECOL MANAG, V233, P309, DOI 10.1016/j.foreco.2006.05.027; Guariguata MR, 1997, PLANT ECOL, V132, P107, DOI 10.1023/A:1009726421352; Haggar JP, 1997, ECOLOGY, V78, P1211, DOI 10.1890/0012-9658(1997)078[1211:PPARPI]2.0.CO;2; Le HD, 2014, GLOBAL ENVIRON CHANG, V24, P334, DOI 10.1016/j.gloenvcha.2013.09.010; Herbohn JL, 2014, SMALL-SCALE FOR, V13, P79, DOI 10.1007/s11842-013-9242-6; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Nguyen H, 2012, FOREST ECOL MANAG, V274, P81, DOI 10.1016/j.foreco.2012.02.022; Hussain I, 2008, PLANT PHYSL; Jahn R, 2001, CLIMATE GEOLOGY GEOM, P25; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; KELTY MJ, 1992, FOR SCI, V40, P125; Kolb M, 2003, THESIS U GOTTINGEN D; Kooyman R.M., 1996, RAINFOREST RESTORATI; Lamb D, 2011, WORLD FORESTS, V8, P1, DOI 10.1007/978-90-481-9870-2; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lamprecht H., 1989, SILVICULTURE TROPICS; Le HD, 2012, J RURAL STUD, V28, P5, DOI 10.1016/j.jrurstud.2011.07.006; Margraf J., 1996, DIPTEROCARP FOREST E, P124, DOI 10.1142/9789814261043_0006; Marohn C, 2007, THESIS U HOHENHEIM S; Medina-Urrutia VM, 1997, ACTA HORTIC, P305, DOI 10.17660/ActaHortic.1997.455.40; Milan PP, 1997, STRATEGY COMMUNITY I, V336; Milan PP, 1997, APPRAISAL MISSION RA; Milan PP, 2004, EVALUATION SILVICULT; Montagnini F., 1995, Commonwealth Forestry Review, V74, P306; Nebel G, 2001, FOREST ECOL MANAG, V150, P27, DOI 10.1016/S0378-1127(00)00680-0; Nguyen H.T.T., 2011, THESIS U QUEENSLAND; Oliver C.D., 1996, FOREST STAND DYNAMIC; Piotto D, 2004, FOREST ECOL MANAG, V190, P359, DOI 10.1016/j.foreco.2003.11.005; Schulte A, 2002, RAINFORESTATION FARM; Schulte A, 1998, COMMUNITY BASED RAIN; Schupp JR, 2008, HORTTECHNOLOGY, V18, P660, DOI 10.21273/HORTTECH.18.4.660; Shrestha R., 2000, Tropical Ecology, V41, P111; Tolentino EL, 2008, ADV AGROFOR, V5, P319; Wormald T. J., 1992, MIXED PURE FOREST PL	42	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95267	10.1371/journal.pone.0095267	http://dx.doi.org/10.1371/journal.pone.0095267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751720	gold, Green Published			2022-12-25	WOS:000335227400047
J	Thauerer, B; Voegele, P; Hermann-Kleiter, N; Thuille, N; de Araujo, MEG; Offterdinger, M; Baier, G; Huber, LA; Baier-Bitterlich, G				Thauerer, Bettina; Voegele, Paul; Hermann-Kleiter, Natascha; Thuille, Nikolaus; de Araujo, Mariana E. G.; Offterdinger, Martin; Baier, Gottfried; Huber, Lukas A.; Baier-Bitterlich, Gabriele			LAMTOR2-Mediated Modulation of NGF/MAPK Activation Kinetics during Differentiation of PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NUCLEOSIDE-MEDIATED NEUROPROTECTION; CEREBELLAR GRANULE NEURONS; SIGNAL-TRANSDUCTION; LATE ENDOSOMES; NEUROTROPHIN RECEPTOR; ESSENTIAL EFFECTOR; P42/44 MAPK; NGF; HYPOXIA	LAMTOR2 (p14), a part of the larger LAMTOR/Ragulator complex, plays a crucial role in EGF-dependent activation of p42/44 mitogen-activated protein kinases (MAPK, ERK1/2). In this study, we investigated the role of LAMTOR2 in nerve growth factor (NGF)-mediated neuronal differentiation. Stimulation of PC12 (rat adrenal pheochromocytoma) cells with NGF is known to activate the MAPK. Pharmacological inhibition of MEK1 as well as siRNA-mediated knockdown of both p42 and p44 MAPK resulted in inhibition of neurite outgrowth. Contrary to expectations, siRNA-mediated knockdown of LAMTOR2 effectively augmented neurite formation and neurite length of PC12 cells. Ectopic expression of a siRNA-resistant LAMTOR2 ortholog reversed this phenotype back to wildtype levels, ruling out nonspecific off-target effects of this LAMTOR2 siRNA approach. Mechanistically, LAMTOR2 siRNA treatment significantly enhanced NGF-dependent MAPK activity, and this effect again was reversed upon expression of the siRNA-resistant LAMTOR2 ortholog. Studies of intracellular trafficking of the NGF receptor TrkA revealed a rapid colocalization with early endosomes, which was modulated by LAMTOR2 siRNA. Inhibition of LAMTOR2 and concomitant destabilization of the remaining members of the LAMTOR complex apparently leads to a faster release of the TrkA/MAPK signaling module and nuclear increase of activated MAPK. These results suggest a modulatory role of the MEK1 adapter protein LAMTOR2 in NGF-mediated MAPK activation required for induction of neurite outgrowth in PC12 cells.	[Thauerer, Bettina; Voegele, Paul; Offterdinger, Martin; Baier-Bitterlich, Gabriele] Med Univ Innsbruck, CCB Bioctr, Div Neurobiochem, A-6020 Innsbruck, Austria; [Voegele, Paul; Hermann-Kleiter, Natascha; Thuille, Nikolaus; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Div Cell Genet, A-6020 Innsbruck, Austria; [de Araujo, Mariana E. G.; Huber, Lukas A.] Med Univ Innsbruck, CCB Bioctr, Div Cell Biol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Baier-Bitterlich, G (corresponding author), Med Univ Innsbruck, CCB Bioctr, Div Neurobiochem, A-6020 Innsbruck, Austria.	gabriele.baier-bitterlich@i-med.ac.at	Kleiter, Natascha/I-5101-2018; Huber, Lukas Alfons/AAM-3499-2021	Kleiter, Natascha/0000-0003-4389-9813; Thauerer, Bettina/0000-0001-8357-4082; Baier, Gottfried/0000-0002-2085-8325; Thuille, Nikolaus/0000-0002-2253-3946; Huber, Lukas Alfons/0000-0003-1116-2120; Eca Guimaraes de Araujo, Mariana/0000-0003-0576-2680	Austrian Science Fund (FWF): Hertha Firnberg fellowship "Cell proliferation and cell death in humans" [T421-B18, P19578-B05, P26002-B24, SFB021]; Tyrolean Science Fund (TWF); Austrian Science Fund (FWF) [P 25044, T 421] Funding Source: researchfish	Austrian Science Fund (FWF): Hertha Firnberg fellowship "Cell proliferation and cell death in humans"; Tyrolean Science Fund (TWF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF): Hertha Firnberg fellowship T421-B18, P19578-B05 and P26002-B24, and SFB021 "Cell proliferation and cell death in humans" and the Tyrolean Science Fund (TWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bocklinger K, 2004, EUR J CELL BIOL, V83, P51, DOI 10.1078/0171-9335-00362; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Cao GF, 2011, BIOCHEM BIOPH RES CO, V414, P499, DOI 10.1016/j.bbrc.2011.09.094; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; D'Alessio A, 2007, CELL SIGNAL, V19, P1193, DOI 10.1016/j.cellsig.2006.12.011; de Araujo MEG, 2013, J BIOL CHEM, V288, P18228, DOI 10.1074/jbc.M112.349480; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Dekkers MPJ, 2013, J CELL BIOL, V203, P385, DOI 10.1083/jcb.201306136; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; HEFTBERGER V, 2005, PURINE NUCLEOSIDE ME; KAHLE P, 1994, J NEUROSCI RES, V38, P599, DOI 10.1002/jnr.490380512; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; Kristiansen M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-551; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Magee J, 2011, BIOCHEMISTRY-US, V50, P3696, DOI 10.1021/bi101972y; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pullikuth A, 2005, MOL CELL BIOL, V25, P5119, DOI 10.1128/MCB.25.12.5119-5133.2005; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Teis D, 2003, CELL MOL LIFE SCI, V60, P2020, DOI 10.1007/s00018-003-3010-2; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tomaselli B, 2005, NEUROCHEM INT, V46, P513, DOI 10.1016/j.neuint.2005.02.003; Tomaselli B, 2008, MOL CELL NEUROSCI, V38, P559, DOI 10.1016/j.mcn.2008.05.004; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zeng M, 2008, CELL SIGNAL, V20, P659, DOI 10.1016/j.cellsig.2007.11.015; zur Nedden S, 2008, J NEUROCHEM, V105, P1901, DOI 10.1111/j.1471-4159.2008.05275.x	41	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95863	10.1371/journal.pone.0095863	http://dx.doi.org/10.1371/journal.pone.0095863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752675	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400142
J	Phan, TV; Ke, K; Sul, OJ; Park, YK; Kim, KK; Cho, YS; Chung, HT; Choi, HS				Tien Van Phan; Ke, Ke; Sul, Ok-Joo; Park, Yun-Kyung; Kim, Kack-Kyun; Cho, Yeon-Soo; Chung, Hun-Taeg; Choi, Hye-Seon			Protection against Ovariectomy-Induced Bone Loss by Tranilast	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION; ESTROGEN DEFICIENCY; IN-VIVO; EXPRESSION; NFATC1; ACTIVATION; REGULATOR; RECEPTOR; PATHWAY; PROTEIN	Background: Tranilast (N-(3 ',4 '-dimethoxycinnamonyl) anthranilic acid) has been shown to be therapeutically effective, exerting anti-inflammatory and anti-oxidative effects via acting on macrophage. We hypothesized that Tranilast may protect against oxidative stress-induced bone loss via action in osteoclasts (OCs) that shares precursors with macrophage. Methodology and Principal Findings: To elucidate the role of Tranilast, ovariectomy (OVX)-induced bone loss in vivo and OC differentiation in vitro were evaluated by mu CT and tartrate-resistant acid phosphatase staining, respectively. Oral administration of Tranilast protected against OVX-induced bone loss with decreased serum level of reactive oxygen species (ROS) in mice. Tranilast inhibited OC formation in vitro. Decreased osteoclastogenesis by Tranilast was due to a defect of receptor activator of nuclear factor-kappa B ligand (RANKL) signaling, at least partly via decreased activation of nuclear factor-kB and reduced induction and nuclear translocation of nuclear factor of activated T cells, cytoplasmic 1 (or NFAT2). Tranilast also decreased RANKL-induced a long lasting ROS level as well as TGF-beta to inhibit osteoclastogenesis. Reduced ROS caused by Tranilast was due to the induction of ROS scavenging enzymes (peroxiredoxin 1, heme oxygenase-1, and glutathione peroxidase 1) as well as impaired ROS generation. Conclusions/Significance: Our data suggests the therapeutic potential of Tranilast for amelioration of bone loss and oxidative stress due to loss of ovarian function.	[Tien Van Phan; Ke, Ke; Sul, Ok-Joo; Park, Yun-Kyung; Cho, Yeon-Soo; Chung, Hun-Taeg; Choi, Hye-Seon] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Kim, Kack-Kyun] Seoul Natl Univ, Dept Dent, Seoul, South Korea	University of Ulsan; Seoul National University (SNU)	Choi, HS (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	hschoi@mail.ulsan.ac.kr	Phan, Tien/GRN-9075-2022	Choi, Hye-Seon/0000-0003-2992-2677; Ok Joo, Sul/0000-0002-8517-0898	Bio & Medical Technology Development Program of NRF [2012M3A9C3048683]; Korean government	Bio & Medical Technology Development Program of NRF; Korean government(Korean Government)	This work was supported by the Bio & Medical Technology Development Program of NRF (2012M3A9C3048683) funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chikaraishi A, 2001, EUR J PHARMACOL, V427, P151, DOI 10.1016/S0014-2999(01)01215-8; Fox SW, 2008, BIOCHEM BIOPH RES CO, V366, P123, DOI 10.1016/j.bbrc.2007.11.120; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Jimi E, 1999, J IMMUNOL, V163, P434; Kim HJ, 2006, J CLIN INVEST, V116, P2152, DOI 10.1172/JCI28084; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; KOMATSU H, 1988, JPN J PHARMACOL, V46, P43, DOI 10.1254/jjp.46.43; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lee JE, 2007, EXP HEMATOL, V35, P1100, DOI 10.1016/j.exphem.2007.04.006; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SK, 2006, J BONE MINER RES, V21, P695, DOI 10.1359/JBMR.060117; Lee SK, 2006, J BONE MINER RES, V21, P1704, DOI 10.1359/JBMR.060726; Li JY, 2011, P NATL ACAD SCI USA, V108, P768, DOI 10.1073/pnas.1013492108; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; MIYACHI Y, 1987, J PHARMACOBIO-DYNAM, V10, P255, DOI 10.1248/bpb1978.10.255; Pae HO, 2008, BIOCHEM BIOPH RES CO, V371, P361, DOI 10.1016/j.bbrc.2008.04.054; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Platten M, 2001, BRIT J PHARMACOL, V134, P1279, DOI 10.1038/sj.bjp.0704373; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sato S, 2010, PROSTATE, V70, P229, DOI 10.1002/pros.21056; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Shiota N, 2010, BRIT J PHARMACOL, V159, P626, DOI 10.1111/j.1476-5381.2009.00561.x; Spiecker M, 2002, MOL PHARMACOL, V62, P856, DOI 10.1124/mol.62.4.856; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tan SM, 2011, NEPHROL DIAL TRANSPL, V26, P100, DOI 10.1093/ndt/gfq355; Uno M, 2008, HEPATOLOGY, V48, P109, DOI 10.1002/hep.22338; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95585	10.1371/journal.pone.0095585	http://dx.doi.org/10.1371/journal.pone.0095585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751945	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400083
J	Zhang, M; Xu, MX; Zhou, Z; Zhang, K; Zhou, J; Zhao, Y; Wang, Z; Lu, MJ				Zhang, Ming; Xu, Ming-xi; Zhou, Zhe; Zhang, Ke; Zhou, Juan; Zhao, Yang; Wang, Zhong; Lu, Mu-jun			The Differentiation of Human Adipose-Derived Stem Cells towards a Urothelium-Like Phenotype In Vitro and the Dynamic Temporal Changes of Related Cytokines by Both Paracrine and Autocrine Signal Regulation	PLOS ONE			English	Article							TISSUE	Purpose: To investigate the differentiation ability of human adipose-derived stem cells (ASCs) towards urothelium-like cells in vitro and the dynamic changes of related cytokines and cytokine receptors in the culture medium. Materials and Methods: The ASCs were induced using both conditioned media (CM) and the transwell co-culture system with an immortalized urothelium cell line (SV-HUC-1, HUC) for 21 days. Protein and mRNA expression of the mature urothelium specific markers uroplakin-IA (UP-1A) and uroplakin-II (UP-II) were detected by immunofluorescence and quantitative real-time PCR, respectively. Array detection was used to screen 41 cytokines and receptors in the upper medium of urothelium, non-induced ASCs and urothelium-induced ASCs at three time points, early (12 hours), intermediate (7 days) and late (21 days). Results: After induction for 7 days, the ASCs grown in both CM and transwell co-culture system expressed uroplakin-IA (13.54 +/- 2.00%; 17.28 +/- 1.84%) and uroplakin-II (19.49 +/- 1.73%; 13.98 +/- 1.47%). After induction for 21 days, ASCs grown in coculture had significantly increased expression of uroplakin-IA (48.03 +/- 1.25%; 49.57 +/- 2.85%) and uroplakin-II (45.38 +/- 2.50%; 46.58 +/- 1.95%). In the upper medium of urothelium, 28 cytokines and 8 cytokine receptors had significantly higher expression than the counterpart of non-induced ASCs. After 7 days induction, the expression of 22 cytokines and 8 cytokine receptors was significantly elevated in the upper medium of induced ASCs compared to non-induced ASCs. At the early and intermediate time points, ASCs secreted high levels of relative cytokines and soluble receptors, but their expressions decreased significantly at the late time point. Conclusion: The adipose-derived stem cells have the potential to be differentiated into urothelium-like cells in vitro by both CM and transwell co-culture system with mature urothelium. Numerous cytokines and receptors were involved in the differentiation process with dynamic temporal changes by both paracrine and autocrine signal regulation. Further studies should be carried out to determine the detailed mechanism of cytokines and receptors and to enhance the urothelium differentiation efficiency of ASCs.	[Zhang, Ming; Xu, Ming-xi; Zhou, Zhe; Zhang, Ke; Zhou, Juan; Zhao, Yang; Wang, Zhong; Lu, Mu-jun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Urol, Shanghai 200030, Peoples R China.	zhongwang2010@sina.com; lumujun@163.com	Lu, Mujun/AFV-7941-2022	Lu, Mujun/0000-0002-3404-1260	National Natural Science Foundation of China [81070605, 81370860]; Biomedical Engineering Research Fund of Shanghai Jiao Tong University [YG2011MS14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biomedical Engineering Research Fund of Shanghai Jiao Tong University	This work was supported by the General Programs of the National Natural Science Foundation of China ( No. 81070605 & No. 81370860) and the Biomedical Engineering Research Fund of Shanghai Jiao Tong University ( No. YG2011MS14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anumanthan G, 2008, J UROLOGY, V180, P1778, DOI 10.1016/j.juro.2008.04.076; Fernandes TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073266; Hemmingsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063638; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Kim YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040820; Liu J, 2009, BIOCHEM BIOPH RES CO, V390, P931, DOI 10.1016/j.bbrc.2009.10.080; Lu MJ, 2010, UROLOGY, V75, DOI 10.1016/j.urology.2009.12.060; Ma LM, 2012, P NATL ACAD SCI USA, V109, P2090, DOI 10.1073/pnas.1113810109; Maroni P, 2012, BIOCHEM BIOPH RES CO, V428, P271, DOI 10.1016/j.bbrc.2012.10.044; Mihaila SM, 2013, TISSUE ENG PT A, V19, P235, DOI [10.1089/ten.tea.2012.0092, 10.1089/ten.TEA.2012.0092]; Ning HX, 2009, J SEX MED, V6, P967, DOI 10.1111/j.1743-6109.2008.01172.x; Ning JW, 2011, CYTOTECHNOLOGY, V63, P531, DOI 10.1007/s10616-011-9376-3; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Shi JG, 2012, CELL TISSUE RES; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Titmarsh DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052405; Wu Rongpei, 2013, Methods Mol Biol, V1001, P65, DOI 10.1007/978-1-62703-363-3_7; Zhang M, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.10.030; Zhang R, 2012, STEM CELLS, V30, P481, DOI 10.1002/stem.1023; Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	25	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95583	10.1371/journal.pone.0095583	http://dx.doi.org/10.1371/journal.pone.0095583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752317	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400081
J	Huang, JX; Zhang, J; Shen, Y; Lian, JY; Cao, HL; Ye, WH; Wu, LF; Bin, Y				Huang, Jian-Xiong; Zhang, Jian; Shen, Yong; Lian, Ju-yu; Cao, Hong-lin; Ye, Wan-hui; Wu, Lin-fang; Bin, Yue			Different Relationships between Temporal Phylogenetic Turnover and Phylogenetic Similarity and in Two Forests Were Detected by a New Null Model	PLOS ONE			English	Article							RAOS QUADRATIC ENTROPY; BETA-DIVERSITY; TROPICAL FOREST; RAIN-FOREST; SPATIAL DISTRIBUTIONS; NEOTROPICAL FOREST; SEEDLING MORTALITY; COMMUNITY ECOLOGY; GLOBAL-NETWORK; TREE	Background: Ecologists have been monitoring community dynamics with the purpose of understanding the rates and causes of community change. However, there is a lack of monitoring of community dynamics from the perspective of phylogeny. Methods/Principle Findings: We attempted to understand temporal phylogenetic turnover in a 50 ha tropical forest (Barro Colorado Island, BCI) and a 20 ha subtropical forest (Dinghushan in southern China, DHS). To obtain temporal phylogenetic turnover under random conditions, two null models were used. The first shuffled names of species that are widely used in community phylogenetic analyses. The second simulated demographic processes with careful consideration on the variation in dispersal ability among species and the variations in mortality both among species and among size classes. With the two models, we tested the relationships between temporal phylogenetic turnover and phylogenetic similarity at different spatial scales in the two forests. Results were more consistent with previous findings using the second null model suggesting that the second null model is more appropriate for our purposes. With the second null model, a significantly positive relationship was detected between phylogenetic turnover and phylogenetic similarity in BCI at a 10 m x 10 m scale, potentially indicating phylogenetic density dependence. This relationship in DHS was significantly negative at three of five spatial scales. This could indicate abiotic filtering processes for community assembly. Using variation partitioning, we found phylogenetic similarity contributed to variation in temporal phylogenetic turnover in the DHS plot but not in BCI plot. Conclusions/Significance: The mechanisms for community assembly in BCI and DHS vary from phylogenetic perspective. Only the second null model detected this difference indicating the importance of choosing a proper null model.	[Huang, Jian-Xiong; Shen, Yong; Lian, Ju-yu; Cao, Hong-lin; Ye, Wan-hui; Wu, Lin-fang; Bin, Yue] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Huang, Jian-Xiong; Shen, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Jian] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Alberta	Bin, Y (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	binyue@scbg.ac.cn	Zhang, Jian/A-7878-2008	Zhang, Jian/0000-0003-0589-6267; , YONG/0000-0003-4614-2357	National Natural Science Foundation of China [31100312, 41371078]; Chinese Academy of Sciences [KSCX2-EW-Z]; Foreign Exchange Program National Founder [31011120470]; Chinese Forest Biodiversity Monitoring Network; Division Of Environmental Biology [1354741] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Foreign Exchange Program National Founder; Chinese Forest Biodiversity Monitoring Network; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by the National Natural Science Foundation of China (31100312, 41371078), URL is http://www.nsfc.gov.cn/Portal0/default166.htm, Knowledge Innovation Project of The Chinese Academy of Sciences (KSCX2-EW-Z), Foreign Exchange Program National Founder (31011120470) and Chinese Forest Biodiversity Monitoring Network, URL is http://www.cfbiodiv.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bivand R., 2020, SPDEP SPATIAL DEPEND; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bloor JMG, 2003, J ECOL, V91, P77, DOI 10.1046/j.1365-2745.2003.00743.x; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; Cliff A. D., 1981, SPATIAL PROCESSES MO; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; CONDIT R, 1992, BIOSCIENCE, V42, P822, DOI 10.2307/1312081; Condit R, 1998, TROPICAL FOREST CENS; Connor E.F., 2001, ENCY BIODIVERSITY EL, P397; COOK RE, 1980, OECOLOGIA, V47, P115, DOI 10.1007/BF00541785; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; De Caceres M, 2012, GLOBAL ECOL BIOGEOGR, V21, P1191, DOI 10.1111/j.1466-8238.2012.00770.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harper J. L., 1974, Annual Review of Ecology and Systematics, V5, P419, DOI 10.1146/annurev.es.05.110174.002223; Harper J. L, 1977, POPULATION BIOL PLAN; Hopkins B, 1957, J ECOL, P441; Hubbell S, 1984, SPEC PUBL BR ECOL SO; Hubbell Stephen P., 2001, V32, pi; Jakobsson A, 2003, EVOL ECOL, V17, P233, DOI 10.1023/A:1025526903281; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Lin GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056171; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999; Nipperess DA, 2010, J VEG SCI, V21, P809, DOI 10.1111/j.1654-1103.2010.01192.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Paine CET, 2012, ECOL LETT, V15, P34, DOI 10.1111/j.1461-0248.2011.01705.x; Pavoine S, 2005, THEOR POPUL BIOL, V67, P231, DOI 10.1016/j.tpb.2005.01.004; Pei NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021273; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; R Core Team, 2012, LANG ENV STAT COMP; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Ricotta C, 2007, DIVERS DISTRIB, V13, P237, DOI 10.1111/j.1472-4642.2007.00316.x; Ricotta C, 2006, THEOR POPUL BIOL, V70, P237, DOI 10.1016/j.tpb.2006.06.003; Shen Y, 2013, J TROP ECOL, V29, P131, DOI 10.1017/S0266467413000059; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEBB CO, 2008, PHYLOCOM SOFTWARE AN; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	61	2	9	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95703	10.1371/journal.pone.0095703	http://dx.doi.org/10.1371/journal.pone.0095703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748022	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500141
J	Machin, A; Telleria, J; Brizard, JP; Demettre, E; Seveno, M; Ayala, FJ; Tibayrenc, M				Machin, Alexandre; Telleria, Jenny; Brizard, Jean-Paul; Demettre, Edith; Seveno, Martial; Ayala, Francisco Jose; Tibayrenc, Michel			Trypanosoma cruzi: Gene Expression Surveyed by Proteomic Analysis Reveals Interaction between Different Genotypes in Mixed In Vitro Cultures	PLOS ONE			English	Article							PARASITIC PROTOZOA; CLONAL EVOLUTION; CHAGAS-DISEASE; IMPACT; PLASMODIUM; DIVERSITY; PROTEINS; AGENT	We have analyzed the comportment in in vitro culture of 2 different genotypes of Trypanosoma cruzi, the agent of Chagas disease, pertaining to 2 major genetic subdivisions (near-clades) of this parasite. One of the stocks was a fast-growing one, highly virulent in mice, while the other one was slow-growing, mildly virulent in mice. The working hypothesis was that mixtures of genotypes interact, a pattern that has been observed by us in empirical experimental studies. Genotype mixtures were followed every 7 days and characterized by the DIGE technology of proteomic analysis. Proteic spots of interest were characterized by the SAMESPOT software. Patterns were compared to those of pure genotypes that were also evaluated every 7 days. One hundred and three spots exhibited changes in time by comparison with T = 0. The major part of these spots (58%) exhibited an under-expression pattern by comparison with the pure genotypes. 32% of the spots wereover-expressed; 10% of spots were not different from those of pure genotypes. Interestingly, interaction started a few minutes after the mixtures were performed. We have retained 43 different proteins that clearly exhibited either under-or over-expression. Proteins showing interaction were characterized by mass spectrometry (MALDI-TOF). Close to 50% of them were either tubulins or heat shock proteins. This study confirms that mixed genotypes of T. cruzi interact at the molecular level. This is of great interest because mixtures of genotypes are very frequent in Chagas natural cycles, both in insect vectors and in mammalian hosts, and may play an important role in the transmission and severity of Chagas disease. The methodology proposed here is potentially applicable to any micropathogen, including fungi, bacteria and viruses. It should be of great interest in the case of bacteria, for which the epidemiological and clinical consequences of mixed infections could be underestimated.	[Machin, Alexandre; Telleria, Jenny; Tibayrenc, Michel] Univ Montpellier I, CNRS, Inst Rech Dev, Unite Mixte Rech Genet & Evolut Malad Infect 5290, Montpellier, France; [Machin, Alexandre; Telleria, Jenny; Tibayrenc, Michel] Univ Montpellier 2, CNRS, Inst Rech Dev, Unite Mixte Rech Genet & Evolut Malad Infect 5290, Montpellier, France; [Brizard, Jean-Paul] CNRS, Inst Rech Dev, UMR 5096, Ctr Inst Rech Dev, Montpellier, France; [Demettre, Edith; Seveno, Martial] Univ Montpellier I & II, CNRS, Plate Forme Prote Fonct, INSERM,UMR 5203,Unite 661, Montpellier, France; [Ayala, Francisco Jose] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of California System; University of California Irvine	Tibayrenc, M (corresponding author), Univ Montpellier I, CNRS, Inst Rech Dev, Unite Mixte Rech Genet & Evolut Malad Infect 5290, Montpellier, France.	michel.tibayrenc@ird.fr	Tibayrenc, Michel/AAY-7494-2021	SEVENO, Martial/0000-0002-5000-8735	European Commission [223034]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission Framework Programme Project "Comparative epidemiology of genetic lineages of Trypanosoma cruzi'' ChagasEpiNet, Contract No. 223034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; BRENIERE SF, 1985, CR ACAD SCI III-VIE, V300, P555; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Laurent JP, 1997, PARASITOLOGY, V114, P213, DOI 10.1017/S0031182096008414; Lopez-Villavicencio M, 2007, PLOS PATHOG, V3, P1710, DOI 10.1371/journal.ppat.0030176; Macedo AM, 2010, ELSEV INSIGHT, P489, DOI 10.1016/B978-0-12-384876-5.00020-4; Martins HR, 2006, EXP PARASITOL, V112, P237, DOI 10.1016/j.exppara.2005.11.006; McKean PG, 2001, J CELL SCI, V114, P2723; Moncayo A, 2010, AM TRYPANOSOMIASIS C; Pinto AD, 1998, PARASITOL RES, V84, P348, DOI 10.1007/s004360050409; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Revollo S, 1998, EXP PARASITOL, V89, P30, DOI 10.1006/expr.1998.4216; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Telleria J, 2010, P NATL ACAD SCI USA, V107, P20411, DOI 10.1073/pnas.1015496107; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; TIBAYRENC M, 1985, GENETICA, V67, P223, DOI 10.1007/BF02424493; Tibayrenc M, 1999, ANNU REV GENET, V33, P449, DOI 10.1146/annurev.genet.33.1.449; Tibayrenc M, 2013, TRENDS PARASITOL, V29, P264, DOI 10.1016/j.pt.2013.03.007; Tibayrenc M, 2012, P NATL ACAD SCI USA, V109, pE3305, DOI 10.1073/pnas.1212452109; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	21	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95442	10.1371/journal.pone.0095442	http://dx.doi.org/10.1371/journal.pone.0095442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748035	gold, Green Published			2022-12-25	WOS:000335226500102
J	Real, LM; Neukam, K; Herrero, R; Guardiola, JM; Reiberger, T; Rivero-Juarez, A; Salazar, J; Mandorfer, M; Merino, D; Soriano, V; Rivero, A; Macias, J; Pineda, JA; Caruz, A				Real, Luis M.; Neukam, Karin; Herrero, Rocio; Guardiola, Josep M.; Reiberger, Thomas; Rivero-Juarez, Antonio; Salazar, Juliana; Mandorfer, Mattias; Merino, Dolores; Soriano, Vicente; Rivero, Antonio; Macias, Juan; Pineda, Juan A.; Caruz, Antonio			IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians	PLOS ONE			English	Article							PEGYLATED INTERFERON; GENETIC-VARIATION; IL28B; LAMBDA; THERAPY; POLYMORPHISM; HIV; ASSOCIATION; EXPRESSION; CLEARANCE	Objectives: The rs12979860 variant, linked to IL28B gene, predicts sustained viral response (SVR) to pegylated-interferon/ribavirin (pegIFN/RBV) therapy in Hepatitis C Virus genotype 1 or 4 (HCV-1/4)-infected patients. Recently, a functional variant, ss469415590, in linkage disequilibrium (LD) with rs12979860, has been discovered. Our objective was to assess the value of ss469415590 to predict SVR to pegIFN/RBV in Caucasian HCV-1/4-infected individuals and to compare its performance with that of rs12979860. Methods: 272 Caucasian HCV-1/4-infected patients who completed a course of pegIFN/RBV were genotyped for both rs12979860 and ss469415590 markers. Logistic regression models including factors with univariate association with SVR and each genetic marker were elaborated. The area under the receiver operating-characteristic curve (AUROC) was calculated for each model and both were compared. Results: Both markers were in LD (r(2) = 0.82). For rs12979860, 66 (64.0%) CC versus 56 (33.1%) T allele carriers achieved SVR (Adjusted OR = 4.156, 95%CI = 2.388-7.232, p = 4.647 x 10(-7)). For ss469415590, 66 (66.0%) TT/TT versus 56 (32.5%) -G allele carriers (Adjusted OR = 4.783, 95%CI = 2.714-8.428, p = 6.153 x 10(-8)) achieved SVR. The AUROC of the model including rs12979860 was 0.742 (95%CI = 0.672-0.813) and of that based on ss469415590 was 0.756 (95%CI = 0.687-0.826) (p = 0.780). Conclusions: The ss469415590 variant shows an equivalent performance to predict SVR to pegIFN/RBV than the rs2979860 in Caucasian HCV-1/4-infected patients.	[Real, Luis M.; Neukam, Karin; Macias, Juan; Pineda, Juan A.] Hosp Univ Valme, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain; [Real, Luis M.; Neukam, Karin; Macias, Juan; Pineda, Juan A.] Inst Biomed Sevilla IBIS, Seville, Spain; [Herrero, Rocio; Caruz, Antonio] Univ Jaen, Unidad Inmunogenet, Jaen, Spain; [Guardiola, Josep M.; Salazar, Juliana] Hosp Santa Creu & Sant Pau, Med Interna Serv, Barcelona, Spain; [Reiberger, Thomas; Mandorfer, Mattias] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Reiberger, Thomas; Mandorfer, Mattias] Vienna HIV & Liver Study Grp, Vienna, Austria; [Rivero-Juarez, Antonio; Rivero, Antonio] Hosp Univ Reina Sofia, Unidad Enfermedades Infecciosas, Cordoba, Spain; [Rivero-Juarez, Antonio; Rivero, Antonio] IMIBC, Cordoba, Spain; [Merino, Dolores] Hosp Juan Ramon Jimenez, Unidad Enfermedades Infecciosas, Huelva, Spain; [Soriano, Vicente] Hosp Carlos III, Dept Enfermedades Infecciosas, Madrid, Spain	Hospital Valme; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Universidad de Jaen; Hospital of Santa Creu i Sant Pau; Medical University of Vienna; Hospital Universitario Reina Sofia - Cordoba; Hospital Juan Ramon Jimenez; Hospital Carlos III	Caruz, A (corresponding author), Univ Jaen, Unidad Inmunogenet, Jaen, Spain.	caruz@ujaen.es	Macias, Juan/I-9133-2019; Real, Luis M/K-9646-2014; Rivero, Antonio/ABE-5294-2020; Caruz, Antonio/N-5557-2014; Reiberger, Thomas/H-7613-2019; Soriano, Vicente/O-5730-2018; Neukam, Karin/D-9415-2018; Pineda, Juan A./AAO-9312-2021; Rivero-Juarez, Antonio/E-4528-2019; Mandorfer, Mattias/H-7603-2019; Guardiola Tey, Jose Maria/G-5306-2016	Macias, Juan/0000-0002-4778-790X; Real, Luis M/0000-0003-4932-7429; Caruz, Antonio/0000-0002-5788-7840; Reiberger, Thomas/0000-0002-4590-3583; Soriano, Vicente/0000-0002-4624-5199; Neukam, Karin/0000-0003-3875-1013; Pineda, Juan A./0000-0002-3751-0296; Rivero-Juarez, Antonio/0000-0002-5813-6889; Mandorfer, Mattias/0000-0003-2330-0017; Guardiola Tey, Jose Maria/0000-0001-5537-2600; Rivero Roman, Antonio/0000-0002-8643-4250; Herrero del Rio/0000-0002-9678-0309; Rivero, Antonio/0000-0001-5005-8268	Red de Investigacion en SIDA [ISCIII-RETIC RD12/0017]; Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia [PI-0247-2010, PI-0157/2011, PI-0430/2012]; Fondo de Investigaciones Sanitarias [PI10/01664]; Ministerio de Sanidad y Servicios Sociales [EC11-304]; Fundacion para la Investigacion y la Prevencion del Sida en Espana [121004/10]; Sara Borrell postdoctoral perfection grant from the Instituto de Salud Carlos III [SCO/523/2008]; Human resources grant from the Servicio de Salud de la Junta de Andalucia [B-0037]; Intensification grant from the Instituto de Salud Carlos III [Programa-I3SNS]	Red de Investigacion en SIDA; Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Sanidad y Servicios Sociales; Fundacion para la Investigacion y la Prevencion del Sida en Espana; Sara Borrell postdoctoral perfection grant from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); Human resources grant from the Servicio de Salud de la Junta de Andalucia(Junta de Andalucia); Intensification grant from the Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported in part by the Red de Investigacion en SIDA (ISCIII-RETIC RD12/ 0017), the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (grant numbers PI-0247-2010, PI-0157/2011, PI-0430/2012), the Fondo de Investigaciones Sanitarias (grant numbers PI10/01664), the Ministerio de Sanidad y Servicios Sociales (EC11-304) and the Fundacion para la Investigacion y la Prevencion del Sida en Espana (grant number 121004/10). Sara Borrell postdoctoral perfection grant from the Instituto de Salud Carlos III (grant number SCO/523/2008 to K.N.). Human resources grant from the Servicio de Salud de la Junta de Andalucia (grant number B-0037 to JMS). Intensification grant from the Instituto de Salud Carlos III (grant number Programa-I3SNS to J.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bota S, 2013, CLIN DRUG INVEST, V33, P325, DOI 10.1007/s40261-013-0074-0; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Franco S, 2013, AIDS, V28, P133; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kramer B, 2013, AIDS, V27, P2817, DOI 10.1097/01.aids.0000433234.78807.54; Mandorfer M, 2013, AIDS, V27, P2707, DOI 10.1097/01.aids.0000432460.44593.ef; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Mira JA, 2012, AIDS, V26, P1721, DOI 10.1097/QAD.0b013e3283568884; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shindo H, 2013, J VIRAL HEPATITIS, V20, P281, DOI 10.1111/j.1365-2893.2012.01649.x; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P104, DOI 10.1111/apt.12547; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019	26	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95515	10.1371/journal.pone.0095515	http://dx.doi.org/10.1371/journal.pone.0095515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748394	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500118
J	Suga, A; Sadamoto, K; Fujii, M; Mandai, M; Takahashi, M				Suga, Akiko; Sadamoto, Kazuyo; Fujii, Momo; Mandai, Michiko; Takahashi, Masayo			Proliferation Potential of Muller Glia after Retinal Damage Varies between Mouse Strains	PLOS ONE			English	Article							CYCLIN D1; NEURAL REGENERATION; ADULT NEUROGENESIS; CELL-PROLIFERATION; PROGENITOR CELLS; PHOTORECEPTOR DEGENERATION; SIGNALING PATHWAY; MAMMALIAN RETINA; ZEBRAFISH RETINA; PRECURSOR CELLS	Retinal Muller glia can serve as a source for regeneration of damaged retinal neurons in fish, birds and mammals. However, the proliferation rate of Muller glia has been reported to below in the mammalian retina. To overcome this problem, growth factors and morphogens have been studied as potent promoters of Muller glial proliferation, but the molecular mechanisms that limit the proliferation of Muller glia in the mammalian retina remain unknown. In the present study, we found that the degree of damage-induced Muller glia proliferation varies across mouse strains. In mouse line 129 x 1/SvJ (129), there was a significantly larger proliferative response compared with that observed in C57BL/6 (B6) after photoreceptor cell death. Treatment with a Glycogen synthase kinase 3 (GSK3) inhibitor enhanced the proliferation of Muller glia in 129 but not in B6 mouse retinas. We therefore focused on the different gene expression patterns during retinal degeneration between B6 and 129. Expression levels of Cyclin D1 and Nestin correlated with the degree of Muller glial proliferation. A comparison of genome-wide gene expression between B6 and 129 showed that distinct sets of genes were upregulated in the retinas after damage, including immune response genes and chromatin remodeling factors.	[Suga, Akiko; Sadamoto, Kazuyo; Fujii, Momo; Mandai, Michiko; Takahashi, Masayo] RIKEN, Lab Retinal Regenerat, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan	RIKEN	Takahashi, M (corresponding author), RIKEN, Lab Retinal Regenerat, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan.	mretina@cdb.riken.jp		Suga, Akiko/0000-0001-6609-2647; Fujii, Momo/0000-0002-1679-7056	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Arvelo G, 1989, Bol Asoc Med P R, V81, P351; BeleckyAdams T, 1997, INVEST OPHTH VIS SCI, V38, P1293; BELIN D, 1989, EMBO J, V8, P3287, DOI 10.1002/j.1460-2075.1989.tb08489.x; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Birkenmeier G, 1996, NEUROREPORT, V8, P149, DOI 10.1097/00001756-199612200-00030; Bramall AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058023; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; CHEN ST, 1994, NEUROSCI LETT, V172, P11, DOI 10.1016/0304-3940(94)90650-5; Claudepierre T, 2000, J CELL SCI, V113, P3409; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; Das G, 2012, DEV DYNAM, V241, P941, DOI 10.1002/dvdy.23782; Das G, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-15; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Del Debbio CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012425; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Goritz C, 2007, GLIA, V55, P1108, DOI 10.1002/glia.20531; Hatakeyama J, 2002, METHODS, V28, P387, DOI 10.1016/S1046-2023(02)00257-8; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jadhav AP, 2009, PROG RETIN EYE RES, V28, P249, DOI 10.1016/j.preteyeres.2009.05.002; Jin HK, 1999, J VIROL, V73, P4925, DOI 10.1128/JVI.73.6.4925-4930.1999; Joly S, 2011, GLIA, V59, P1033, DOI 10.1002/glia.21174; Ju WK, 2002, J COMP NEUROL, V452, P392, DOI 10.1002/cne.10400; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Koso H, 2007, DEV BIOL, V301, P141, DOI 10.1016/j.ydbio.2006.09.027; Kozlova EN, 1999, GLIA, V27, P249, DOI 10.1002/(SICI)1098-1136(199909)27:3<249::AID-GLIA6>3.3.CO;2-5; Kutty RK, 2006, NEUROSCI LETT, V404, P294, DOI 10.1016/j.neulet.2006.06.006; LAFUSE WP, 1995, J LEUKOCYTE BIOL, V57, P477, DOI 10.1002/jlb.57.3.477; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; LINSER P, 1981, P NATL ACAD SCI-BIOL, V78, P7190, DOI 10.1073/pnas.78.11.7190; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Lord-Grignon J, 2006, GENE EXPR PATTERNS, V6, P992, DOI 10.1016/j.modgep.2006.04.003; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; Miyake K, 1998, J IMMUNOL, V161, P1348; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; ORLOFSKY A, 1991, CELL REGUL, V2, P403, DOI 10.1091/mbc.2.5.403; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Powell C, 2013, P NATL ACAD SCI USA, V110, P19814, DOI 10.1073/pnas.1312009110; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Roesch Karin, 2012, Mol Vis, V18, P1197; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Teijido O, 2007, NEUROBIOL DIS, V26, P532, DOI 10.1016/j.nbd.2007.01.016; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; Trimarchi JM, 2009, DEV DYNAM, V238, P2327, DOI 10.1002/dvdy.21973; Ueki Y, 2012, GLIA, V60, P1579, DOI 10.1002/glia.22377; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Vogt SD, 2006, EXP EYE RES, V83, P834, DOI 10.1016/j.exer.2006.04.002; Wan J, 2007, BIOCHEM BIOPH RES CO, V363, P347, DOI 10.1016/j.bbrc.2007.08.178; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Wang L, 2012, HUM MOL GENET, V21, P692, DOI 10.1093/hmg/ddr503; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Weber JD, 1997, J BIOL CHEM, V272, P17320, DOI 10.1074/jbc.272.28.17320; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Wohl SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022408; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; YEATES RA, 1978, ACTA TROP, V35, P195; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zhu YA, 2010, INVEST OPHTH VIS SCI, V51, P4821, DOI 10.1167/iovs.09-5050	89	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94556	10.1371/journal.pone.0094556	http://dx.doi.org/10.1371/journal.pone.0094556			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747725	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500033
J	Wang, B; Nevins, JE; Nadler, Z; Wollstein, G; Ishikawa, H; Bilonick, RA; Kagemann, L; Sigal, IA; Grulkowski, I; Liu, JJ; Kraus, M; Lu, CD; Hornegger, J; Fujimoto, JG; Schuman, JS				Wang, Bo; Nevins, Jessica E.; Nadler, Zach; Wollstein, Gadi; Ishikawa, Hiroshi; Bilonick, Richard A.; Kagemann, Larry; Sigal, Ian A.; Grulkowski, Ireneusz; Liu, Jonathan J.; Kraus, Martin; Lu, Chen D.; Hornegger, Joachim; Fujimoto, James G.; Schuman, Joel S.			Reproducibility of In-Vivo OCT Measured Three-Dimensional Human Lamina Cribrosa Microarchitecture	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE HEAD; GLAUCOMA; PARADIGM; HEALTHY; DAMAGE	Purpose: To determine the reproducibility of automated segmentation of the three-dimensional (3D) lamina cribrosa (LC) microarchitecture scanned in-vivo using optical coherence tomography (OCT). Methods: Thirty-nine eyes (8 healthy, 19 glaucoma suspects and 12 glaucoma) from 49 subjects were scanned twice using swept-source (SS-) OCT in a 3.5x3.5x3.64 mm (400x400x896 pixels) volume centered on the optic nerve head, with the focus readjusted after each scan. The LC was automatically segmented and analyzed for microarchitectural parameters, including pore diameter, pore diameter standard deviation (SD), pore aspect ratio, pore area, beam thickness, beam thickness SD, and beam thickness to pore diameter ratio. Reproducibility of the parameters was assessed by computing the imprecision of the parameters between the scans. Results: The automated segmentation demonstrated excellent reproducibility. All LC microarchitecture parameters had an imprecision of less or equal to 4.2%. There was little variability in imprecision with respect to diagnostic category, although the method tends to show higher imprecision amongst healthy subjects. Conclusion: The proposed automated segmentation of the LC demonstrated high reproducibility for 3D LC parameters. This segmentation analysis tool will be useful for in-vivo studies of the LC.	[Wang, Bo; Nevins, Jessica E.; Nadler, Zach; Wollstein, Gadi; Ishikawa, Hiroshi; Bilonick, Richard A.; Kagemann, Larry; Sigal, Ian A.; Schuman, Joel S.] Univ Pittsburgh, Sch Med, Dept Ophthalmol,Ophthalmol & Visual Sci Res Ctr, Univ Pittsburgh Med Ctr UPMC Eye Ctr,Eye & Ear In, Pittsburgh, PA 15261 USA; [Wang, Bo; Ishikawa, Hiroshi; Kagemann, Larry; Sigal, Ian A.; Schuman, Joel S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA; [Bilonick, Richard A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Grulkowski, Ireneusz; Liu, Jonathan J.; Kraus, Martin; Lu, Chen D.; Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Kraus, Martin; Hornegger, Joachim] Univ Erlangen Nurnberg, Dept Comp Sci, Nurnberg, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT); University of Erlangen Nuremberg	Wollstein, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol,Ophthalmol & Visual Sci Res Ctr, Univ Pittsburgh Med Ctr UPMC Eye Ctr,Eye & Ear In, Pittsburgh, PA 15261 USA.	wollsteing@upmc.edu	Schuman, Joel S/K-7304-2012; Grulkowski, Ireneusz/N-9655-2013; Schuman, Joel S/M-2389-2019; Hornegger, Joachim/H-2465-2017; Ishikawa, Hiroshi/ABC-6293-2020	Schuman, Joel S/0000-0002-8885-3766; Grulkowski, Ireneusz/0000-0001-7688-1826; Schuman, Joel S/0000-0002-8885-3766; Hornegger, Joachim/0000-0002-1834-8844; Ishikawa, Hiroshi/0000-0001-6310-5748; Wang, Bo/0000-0003-4785-3361; Kagemann, Larry/0000-0001-8961-0187	National Institutes of Health (Bethesda, MD) [R01-EY013178, R01-EY011289, P30-EY008098]; Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE [R01EY013178, P30EY008098, R01EY011289] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health contracts R01-EY013178, R01-EY011289, P30-EY008098 (Bethesda, MD); Eye and Ear Foundation (Pittsburgh, PA) http://www.eyeandear.org; Research to Prevent Blindness (New York, NY) https://www.rpbusa.org/rpb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2012, INVEST OPHTH VIS SCI, V53, P4111, DOI 10.1167/iovs.11-7536; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; DANDONA L, 1990, ARCH OPHTHALMOL-CHIC, V108, P393, DOI 10.1001/archopht.1990.01070050091039; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Ivers KM, 2011, INVEST OPHTH VIS SCI, V52, P5473, DOI 10.1167/iovs.11-7347; Jaech J.L, 1985, STAT ANAL MEASUREMEN; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; Kiumehr S, 2012, ARCH OPHTHALMOL-CHIC, V130, P552, DOI 10.1001/archopthalmol.2011.1309; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P198, DOI 10.1167/iovs.11-7848; Nadler Z, 2013, BIOMED OPT EXPRESS, V4, P2596, DOI 10.1364/BOE.4.002596; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135, DOI 10.1001/archopht.1982.01030030137016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Team RDC, 2019, R LANG ENV STAT COMP	20	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95526	10.1371/journal.pone.0095526	http://dx.doi.org/10.1371/journal.pone.0095526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747957	Green Published, Green Accepted, gold			2022-12-25	WOS:000335226500120
J	Chaubey, S; Grover, M; Tatu, U				Chaubey, Shweta; Grover, Manish; Tatu, Utpal			Endoplasmic Reticulum Stress Triggers Gametocytogenesis in the Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; PLASMODIUM-FALCIPARUM MALARIA; KAR2 BIP GENE; TRANSCRIPTION FACTORS; HUMAN ERYTHROCYTES; GLUTATHIONE; SIGNAL; INDUCTION; PATHWAY; VIRULENCE	The malaria parasite experiences a significant amount of redox stress during its growth in human erythrocytes and heavily relies on secretory functions for pathogenesis. Most certainly, the parasite is equipped with machinery to tackle perturbations in the secretory pathway, like the unfolded protein response pathway in higher eukaryotes. Our bioinformatics analysis revealed the complete absence of genes involved in the canonical unfolded protein response pathway in Plasmodium falciparum. Accordingly, the parasite was unable to up-regulate endoplasmic reticulum (ER) chaperones or ER-associated degradation in response to DTT-mediated ER stress. Global profiling of gene expression upon DTT treatment revealed a network of AP2 transcription factors and their targets being activated. The overall outcome was up-regulation of genes involved in protein export and the sexual stage of the parasite life cycle culminating in gametocytogenesis. Our results suggest that the malaria parasite uses ER stress as a cue to switch to the transmissible sexual stages.	[Chaubey, Shweta; Grover, Manish; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Tatu, U (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in		GROVER, MANISH/0000-0002-1625-7930; Tatu, Utpal/0000-0003-0404-8872	Council for Scientific and Industrial Research, Delhi, India (CSIR); Department of Biotechnology, India; Department of Science and Technology, India; MALSIG Indo-EU grant; Roche through University of Bern, Switzerland	Council for Scientific and Industrial Research, Delhi, India (CSIR); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology, India(Department of Science & Technology (India)); MALSIG Indo-EU grant; Roche through University of Bern, Switzerland	Recipients of senior research fellowships from Council for Scientific and Industrial Research, Delhi, India (CSIR).; Recipient of funding from Department of Biotechnology, India, Department of Science and Technology, India, a MALSIG Indo-EU grant, and a Roche grant facilitated through University of Bern, Switzerland. To whom correspondence should be addressed. E-mail: tatu@biochem.iisc.ernet.in.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atamna H, 1997, EUR J BIOCHEM, V250, P670, DOI 10.1111/j.1432-1033.1997.00670.x; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Barrand MA, 2012, BIOCHEM J, V448, P389, DOI 10.1042/BJ20121050; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berhe S, 2000, EXP PARASITOL, V94, P194, DOI 10.1006/expr.1999.4481; Bozdech Z, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-23; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Chillemi R, 2004, CLIN CHIM ACTA, V348, P113, DOI 10.1016/j.cccn.2004.05.007; Dixon SE, 2010, MOL BIOCHEM PARASIT, V173, P1, DOI 10.1016/j.molbiopara.2010.05.001; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Gosline SJC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019118; Harbut MB, 2012, P NATL ACAD SCI USA, V109, P21486, DOI 10.1073/pnas.1216016110; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Joyce BR, 2013, EUKARYOT CELL, V12, P979, DOI 10.1128/EC.00021-13; Kangwanrangsan N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-129; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Kehr S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001242; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li FW, 2004, J BIOL CHEM, V279, P26635, DOI 10.1074/jbc.M401385200; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Patzewitz EM, 2012, MOL MICROBIOL, V83, P304, DOI 10.1111/j.1365-2958.2011.07933.x; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sheikh MS, 1999, J BIOL CHEM, V274, P16487, DOI 10.1074/jbc.274.23.16487; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Spycher C, 2013, MOL MICROBIOL, V88, P754, DOI 10.1111/mmi.12218; Talman AM, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-24; Tiburcio M, 2013, CELL MICROBIOL, V15, P647, DOI 10.1111/cmi.12062; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang M, 2012, P NATL ACAD SCI USA, V109, P3956, DOI 10.1073/pnas.1121567109	47	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16662	16674		10.1074/jbc.M114.551549	http://dx.doi.org/10.1074/jbc.M114.551549			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24755215	hybrid, Green Published			2022-12-25	WOS:000338016200007
J	Kumar, S; Sharma, P; Arora, K; Raje, M; Guptasarma, P				Kumar, Sukhdeep; Sharma, Prerna; Arora, Kanika; Raje, Manoj; Guptasarma, Purnananda			Calcium Binding to Beta-2-Microglobulin at Physiological Ph Drives the Occurrence of Conformational Changes Which Cause the Protein to Precipitate into Amorphous Forms That Subsequently Transform into Amyloid Aggregates	PLOS ONE			English	Article							FIBRIL FORMATION; BETA(2)-MICROGLOBULIN; MECHANISM; EXTENSION; INDUCE; MOUSE; MOTIF	Using spectroscopic, calorimetric and microscopic methods, we demonstrate that calcium binds to beta-2-microglobulin (beta 2m) under physiological conditions of pH and ionic strength, in biological buffers, causing a conformational change associated with the binding of up to four calcium atoms per beta 2m molecule, with a marked transformation of some random coil structure into beta sheet structure, and culminating in the aggregation of the protein at physiological (serum) concentrations of calcium and beta 2m. We draw attention to the fact that the sequence of beta 2m contains several potential calcium-binding motifs of the DXD and DXDXD (or DXEXD) varieties. We establish (a) that the microscopic aggregation seen at physiological concentrations of b2m and calcium turns into actual turbidity and visible precipitation at higher concentrations of protein and beta 2m, (b) that this initial aggregation/precipitation leads to the formation of amorphous aggregates, (c) that the formation of the amorphous aggregates can be partially reversed through the addition of the divalent ion chelating agent, EDTA, and (d) that upon incubation for a few weeks, the amorphous aggregates appear to support the formation of amyloid aggregates that bind to the dye, thioflavin T (ThT), resulting in increase in the dye's fluorescence. We speculate that beta 2m exists in the form of microscopic aggregates in vivo and that these don't progress to form larger amyloid aggregates because protein concentrations remain low under normal conditions of kidney function and beta 2m degradation. However, when kidney function is compromised and especially when dialysis is performed, beta 2m concentrations probably transiently rise to yield large aggregates that deposit in bone joints and transform into amyloids during dialysis related amyloidosis.	[Kumar, Sukhdeep; Sharma, Prerna; Arora, Kanika; Guptasarma, Purnananda] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sas Nagar, Punjab, India; [Sharma, Prerna; Raje, Manoj] CSIR, IMTECH, Inst Microbial Technol, Chandigarh, India	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Guptasarma, P (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sas Nagar, Punjab, India.	guptasarma@iisermohali.ac.in	Kumar, Sukhdeep/HHD-3410-2022; Kumar, Sukhdeep/AGZ-5792-2022; Guptasarma, Purnananda/C-3976-2009	Guptasarma, Purnananda/0000-0002-4801-3180; Kumar, Sukhdeep/0000-0001-5223-1466	intramural research funds of IISER(Indian Institute of Science Education and Research) Mohali	intramural research funds of IISER(Indian Institute of Science Education and Research) Mohali	The study was funded through intramural research funds of IISER(Indian Institute of Science Education and Research) Mohali and not through any particular grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeggeman E, 2002, GLYCOBIOLOGY, V12, P395, DOI 10.1093/glycob/cwf045; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Drueke TB, 1998, NEPHROL DIAL TRANSPL, V13, P58, DOI 10.1093/ndt/13.suppl_1.58; Eakin CM, 2005, BBA-PROTEINS PROTEOM, V1753, P92, DOI 10.1016/j.bbapap.2005.09.002; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hodkinson JP, 2012, RAPID COMMUN MASS SP, V26, P1783, DOI 10.1002/rcm.6282; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; Mendoza VL, 2010, BIOCHEMISTRY-US, V49, P1522, DOI 10.1021/bi901748h; Li JG, 2001, GLYCOBIOLOGY, V11, P217, DOI 10.1093/glycob/11.3.217; Long XF, 2008, SPECTROCHIM ACTA A, V69, P71, DOI 10.1016/j.saa.2007.03.011; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Miyata T, 1998, J AM SOC NEPHROL, V9, P1723; MOE SM, 1992, AM J PHYSIOL, V263, pF540, DOI 10.1152/ajprenal.1992.263.3.F540; Morgan CJ, 2001, J MOL BIOL, V309, P339, DOI 10.1006/jmbi.2001.4661; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nielsen MM, 2011, J BIOL CHEM, V286, P15155, DOI 10.1074/jbc.M110.199844; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; Pal-Gabor H, 2009, BIOCHEMISTRY-US, V48, P5689, DOI 10.1021/bi900356r; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Quesada JM, 1998, MECH AGEING DEV, V102, P293; Radford SE, 2005, BBA-PROTEINS PROTEOM, V1753, P51, DOI 10.1016/j.bbapap.2005.07.006; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Sharma M, 2009, BBA-GEN SUBJECTS, V1790, P1282, DOI 10.1016/j.bbagen.2009.06.010; Shukla A, 2008, BIOCHEMISTRY-MOSCOW+, V73, P681, DOI 10.1134/S0006297908060084; Srikanth R, 2009, BIOCHEMISTRY-US, V48, P9871, DOI 10.1021/bi901172y; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zhang PY, 2010, AMYLOID, V17, P50, DOI 10.3109/13506129.2010.483116; Zhang YN, 2001, J BIOL CHEM, V276, P11567, DOI 10.1074/jbc.M006530200	42	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95725	10.1371/journal.pone.0095725	http://dx.doi.org/10.1371/journal.pone.0095725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755626	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300081
J	Macierzanka, A; Mackie, AR; Bajka, BH; Rigby, NM; Nau, F; Dupont, D				Macierzanka, Adam; Mackie, Alan R.; Bajka, Balazs H.; Rigby, Neil M.; Nau, Francoise; Dupont, Didier			Transport of Particles in Intestinal Mucus under Simulated Infant and Adult Physiological Conditions: Impact of Mucus Structure and Extracellular DNA	PLOS ONE			English	Article							MOUSE SMALL-INTESTINE; EPITHELIAL-CELL MIGRATION; RECOMBINANT HUMAN DNASE; CYSTIC-FIBROSIS; GASTROINTESTINAL MUCUS; STEM-CELLS; TRACHEOBRONCHIAL SECRETIONS; NEONATAL MOUSE; GEL LAYER; IN-VIVO	The final boundary between digested food and the cells that take up nutrients in the small intestine is a protective layer of mucus. In this work, the microstructural organization and permeability of the intestinal mucus have been determined under conditions simulating those of infant and adult human small intestines. As a model, we used the mucus from the proximal (jejunal) small intestines of piglets and adult pigs. Confocal microscopy of both unfixed and fixed mucosal tissue showed mucus lining the entire jejunal epithelium. The mucus contained DNA from shed epithelial cells at different stages of degradation, with higher amounts of DNA found in the adult pig. The pig mucus comprised a coherent network of mucin and DNA with higher viscosity than the more heterogeneous piglet mucus, which resulted in increased permeability of the latter to 500-nm and 1-mu m latex beads. Multiple-particle tracking experiments revealed that diffusion of the probe particles was considerably enhanced after treating mucus with DNase. The fraction of diffusive 500-nm probe particles increased in the pig mucus from 0.6% to 64% and in the piglet mucus from ca. 30% to 77% after the treatment. This suggests that extracellular DNA can significantly contribute to the microrheology and barrier properties of the intestinal mucus layer. To our knowledge, this is the first time that the structure and permeability of the small intestinal mucus have been compared between different age groups and the contribution of extracellular DNA highlighted. The results help to define rules governing colloidal transport in the developing small intestine. These are required for engineering orally administered pharmaceutical preparations with improved delivery, as well as for fabricating novel foods with enhanced nutritional quality or for controlled calorie uptake.	[Macierzanka, Adam; Mackie, Alan R.; Bajka, Balazs H.; Rigby, Neil M.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Macierzanka, Adam; Nau, Francoise; Dupont, Didier] Agrocampus Ouest, UMR 1253, Rennes, France; [Macierzanka, Adam; Nau, Francoise; Dupont, Didier] INRA, STLO, UMR 1253, F-35042 Rennes, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Institut Agro; Agrocampus Ouest; INRAE	Macierzanka, A (corresponding author), Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	Adam.Macierzanka@ifr.ac.uk	Dupont, Didier/ABA-8197-2020; Mackie, Alan/N-7780-2018; Mackie, Alan/B-3753-2015; Dupont, Didier/N-8095-2017	Dupont, Didier/0000-0001-5304-6561; Mackie, Alan/0000-0002-5681-0593; Mackie, Alan/0000-0002-5681-0593; Dupont, Didier/0000-0001-5304-6561; Bajka, Balazs/0000-0002-1803-3340; Macierzanka, Adam/0000-0002-7403-4698	European Commission through the Universite Europeenne de Bretagne, France; BBSRC through an Institute Strategic Programme [BB/J004545/1]; BBSRC [BBS/E/F/00044420] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044420] Funding Source: researchfish	European Commission through the Universite Europeenne de Bretagne, France; BBSRC through an Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Adam Macierzanka is receiving the Research Based University Chair of Excellence - West France ( RBUCE WEST) grant, co-funded by the European Commission through the Universite Europeenne de Bretagne, France. The work at the Institute of Food Research was funded by the BBSRC through an Institute Strategic Programme Grant ( research grant BB/J004545/1). The authors are participants of the EU funded COST action INFOGEST (COST FA 1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALNAFUSSI AI, 1982, VIRCHOWS ARCH B, V40, P51, DOI 10.1007/BF02932850; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bourlieu C, 2014, CRIT REV FOOD SCI, V54, P1427, DOI 10.1080/10408398.2011.640757; Brunsgaard G, 1997, DIGEST DIS SCI, V42, P2384, DOI 10.1023/A:1018899625022; CHERNICK WS, 1959, PEDIATRICS, V24, P739; CHERNICK WS, 1961, PEDIATRICS, V27, P589; CLARKE RM, 1972, J ANAT, V112, P27; CLARKE RM, 1971, J ANAT, V108, P63; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Crater JS, 2010, MACROMOL BIOSCI, V10, P1473, DOI 10.1002/mabi.201000137; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Deplancke B, 2000, APPL ENVIRON MICROB, V66, P2166, DOI 10.1128/AEM.66.5.2166-2174.2000; DUNSFORD BR, 1991, AM J VET RES, V52, P1743; Forstner Janet F., 1995, P71; Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372; GREY RD, 1968, DEV BIOL, V18, P501, DOI 10.1016/0012-1606(68)90054-7; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; HALL PA, 1994, J CELL SCI, V107, P3569; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; HILL RRH, 1990, HISTOCHEM J, V22, P102, DOI 10.1007/BF01885788; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kues T, 2001, BIOPHYS J, V80, P2954, DOI 10.1016/S0006-3495(01)76261-3; Leedham SJ, 2005, J CELL MOL MED, V9, P11, DOI 10.1111/j.1582-4934.2005.tb00333.x; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Macierzanka A, 2012, LANGMUIR, V28, P17349, DOI 10.1021/la302194q; Macierzanka A, 2011, SOFT MATTER, V7, P8077, DOI 10.1039/c1sm05888f; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; MOON HW, 1971, P SOC EXP BIOL MED, V137, P151, DOI 10.3181/00379727-137-35533; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POTTER J, 1960, AM J DIS CHILD, V100, P493; RUNDELL JO, 1972, BIOL NEONATE, V20, P51, DOI 10.1159/000240445; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; Suh J, 2005, ADV DRUG DELIVER REV, V57, P1551, DOI 10.1016/j.addr.2005.05.003; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P227, DOI 10.1016/j.cis.2003.10.025; TURCK D, 1993, PEDIATR RES, V33, P564, DOI 10.1203/00006450-199306000-00005; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Watson AJ, 2003, GASTROENTEROLOGY, V124, pA27, DOI 10.1016/S0016-5085(03)80134-8; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P595, DOI 10.1111/j.1365-2184.1982.tb01066.x; ZAHM JM, 1995, EUR RESPIR J, V8, P381, DOI 10.1183/09031936.95.08030381	44	59	59	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95274	10.1371/journal.pone.0095274	http://dx.doi.org/10.1371/journal.pone.0095274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755941	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300035
J	van der Hoorn, A; Renken, RJ; Leenders, KL; de Jong, BM				van der Hoorn, Anouk; Renken, Remco J.; Leenders, Klaus L.; de Jong, Bauke M.			Parkinson-Related Changes of Activation in Visuomotor Brain Regions during Perceived Forward Self-Motion	PLOS ONE			English	Article							EXTERNALLY TRIGGERED MOVEMENTS; POSTERIOR PARIETAL CORTEX; SUPPLEMENTARY MOTOR AREA; COVERT SPATIAL ATTENTION; MEDIAL FRONTAL-CORTEX; OPTIC FLOW; SELECTIVE ATTENTION; REACHING MOVEMENTS; VISUAL-SYSTEM; BASAL GANGLIA	Radial expanding optic flow is a visual consequence of forward locomotion. Presented on screen, it generates illusionary forward self-motion, pointing at a close vision-gait interrelation. As particularly parkinsonian gait is vulnerable to external stimuli, effects of optic flow on motor-related cerebral circuitry were explored with functional magnetic resonance imaging in healthy controls (HC) and patients with Parkinson's disease (PD). Fifteen HC and 22 PD patients, of which 7 experienced freezing of gait (FOG), watched wide-field flow, interruptions by narrowing or deceleration and equivalent control conditions with static dots. Statistical parametric mapping revealed that wide-field flow interruption evoked activation of the (pre-) supplementary motor area (SMA) in HC, which was decreased in PD. During wide-field flow, dorsal occipito-parietal activations were reduced in PD relative to HC, with stronger functional connectivity between right visual motion area V5, pre-SMA and cerebellum (in PD without FOG). Non-specific 'changes' in stimulus patterns activated dorsolateral frontoparietal regions and the fusiform gyrus. This attention-associated network was stronger activated in HC than in PD. PD patients thus appeared compromised in recruiting medial frontal regions facilitating internally generated virtual locomotion when visual motion support falls away. Reduced dorsal visual and parietal activations during wide-field optic flow in PD were explained by impaired feedforward visual and visuomotor processing within a magnocellular (visual motion) functional chain. Compensation of impaired feedforward processing by distant fronto-cerebellar circuitry in PD is consistent with motor responses to visual motion stimuli being either too strong or too weak. The 'change'-related activations pointed at covert (stimulus-driven) attention.	[van der Hoorn, Anouk; Leenders, Klaus L.; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [van der Hoorn, Anouk; Renken, Remco J.; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	van der Hoorn, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	b.m.de.jong@umcg.nl	van der Hoon, Anouk/AAX-8298-2021	Norton, Daniel/0000-0002-7787-3294; Renken, Remco Jan/0000-0002-7777-9484; van der Hoorn, Anouk/0000-0003-4649-327X; de Jong, Bauke M./0000-0002-6568-5739	University of Groningen	University of Groningen	This work was supported by a Junior Scientific Masterclass grant of the University of Groningen to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Azulay JP, 1999, BRAIN, V122, P111, DOI 10.1093/brain/122.1.111; Bartels AL, 2006, MOVEMENT DISORD, V21, P1326, DOI 10.1002/mds.20952; Bengtsson SL, 2009, CEREB CORTEX, V19, P1929, DOI 10.1093/cercor/bhn222; Beudel M, 2009, NEUROIMAGE, V44, P1032, DOI 10.1016/j.neuroimage.2008.09.028; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Cohen RG, 2012, MOVEMENT DISORD, V27, P470, DOI 10.1002/mds.24934; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cowie D, 2010, NEUROPSYCHOLOGIA, V48, P2750, DOI 10.1016/j.neuropsychologia.2010.05.022; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Davidsdottir S, 2008, BRAIN, V131, P2882, DOI 10.1093/brain/awn237; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; DEJONG BM, 1994, BRAIN, V117, P1039; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Dirnberger G, 2005, NEUROIMAGE, V25, P588, DOI 10.1016/j.neuroimage.2004.11.023; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Fahn S, 1987, RECENT DEV PARKINSON; ffytche DH, 1995, BRAIN, V118, P1375, DOI 10.1093/brain/118.6.1375; FISCHER B, 1985, BRAIN RES, V345, P111, DOI 10.1016/0006-8993(85)90841-8; Fischer J, 2011, J COGNITIVE NEUROSCI, V23, P119, DOI 10.1162/jocn.2010.21417; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREEMAN JS, 1993, J NEUROL NEUROSUR PS, V56, P1078, DOI 10.1136/jnnp.56.10.1078; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Griffin HJ, 2011, J NEUROL, V258, P991, DOI 10.1007/s00415-010-5866-z; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Hallett M, 2008, MOVEMENT DISORD, V23, pS439, DOI 10.1002/mds.21836; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Imamizu H, 2008, J NEUROSCI, V28, P10751, DOI 10.1523/JNEUROSCI.1106-08.2008; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Lord S, 2010, GAIT POSTURE, V31, P169, DOI 10.1016/j.gaitpost.2009.09.019; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; Nakajima T, 2009, J NEUROPHYSIOL, V101, P1883, DOI 10.1152/jn.90636.2008; Nantel J, 2012, NEUROSCIENCE, V221, P151, DOI 10.1016/j.neuroscience.2012.07.007; Nieuwboer A, 2008, MOVEMENT DISORD, V23, pS475, DOI 10.1002/mds.21978; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Okuma Y, 2006, J NEUROL, V253, P27, DOI 10.1007/s00415-006-7007-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Praamstra P, 1998, BRAIN, V121, P167, DOI 10.1093/brain/121.1.167; Praamstra P, 2001, J COGNITIVE NEUROSCI, V13, P31, DOI 10.1162/089892901564153; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Riecke BE, 2007, PSYCHOL RES-PSYCH FO, V71, P298, DOI 10.1007/s00426-006-0085-z; Roiz RD, 2011, INT J REHABIL RES, V34, P343, DOI 10.1097/MRR.0b013e32834d32f0; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Rushworth MFS, 2008, ANN NY ACAD SCI, V1124, P181, DOI 10.1196/annals.1440.014; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; SCHELL GR, 1984, J NEUROSCI, V4, P539; Schindler I, 2004, NAT NEUROSCI, V7, P779, DOI 10.1038/nn1273; Schubert M, 2005, MOVEMENT DISORD, V20, P141, DOI 10.1002/mds.20281; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Silva MF, 2005, BRAIN, V128, P2260, DOI 10.1093/brain/awh581; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Sinjders AH, 2010, MOVEMENT DISORD, V25, P57, DOI 10.1002/mds.22894; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Stadler W, 2011, HUM BRAIN MAPP, V32, P677, DOI 10.1002/hbm.20949; Sultan F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1912; Suteerawattananon M, 2004, J NEUROL SCI, V219, P63, DOI 10.1016/j.jns.2003.12.007; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; van der Hoorn A, 2010, BRAIN RES, V1358, P160, DOI 10.1016/j.brainres.2010.08.050; van der Hoorn A, 2012, MOVEMENT DISORD, V27, P580, DOI 10.1002/mds.24011; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Verhage GJ, 1964, INTELLIGENCE AGE INV; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Wechsler D., 2005, WECHSLER ADULT INTEL; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Woolley DG, 2010, NEUROIMAGE, V50, P1566, DOI 10.1016/j.neuroimage.2010.01.012; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	106	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95861	10.1371/journal.pone.0095861	http://dx.doi.org/10.1371/journal.pone.0095861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755754	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300108
J	Han, SJ; Lee, BC; Yim, SH; Gladyshev, VN; Lee, SR				Han, Seong-Jeong; Lee, Byung Cheon; Yim, Sun Hee; Gladyshev, Vadim N.; Lee, Seung-Rock			Characterization of Mammalian Selenoprotein O: A Redox-Active Mitochondrial Protein	PLOS ONE			English	Article							SELENOCYSTEINE; SELENIUM; IDENTIFICATION; REDUCTASE; FORMS; CODON	Selenoproteins exhibit diverse biological functions, most of which are associated with redox control. However, the functions of approximately half of mammalian selenoproteins are not known. One such protein is Selenoprotein O (SelO), the largest mammalian selenoprotein with orthologs found in a wide range of organisms, including bacteria and yeast. Here, we report characterization of mammalian SelO. Expression of this protein could be verified in HEK 293T cells by metabolic labeling of cells with Se-75, and it was abolished when selenocysteine was replaced with serine. A CxxU motif was identified in the C-terminal region of SelO. This protein was reversibly oxidized in a time-and concentration-dependent manner in HEK 293T cells when cells were treated with hydrogen peroxide. This treatment led to the formation of a transient 88 kDa SelO-containing complex. The formation of this complex was enhanced by replacing the CxxU motif with SxxC, but abolished when it was replaced with SxxS, suggesting a redox interaction of SelO with another protein through its Sec residue. SelO was localized to mitochondria and expressed across mouse tissues. Its expression was little affected by selenium deficiency, suggesting it has a high priority for selenium supply. Taken together, these results show that SelO is a redox-active mitochondrial selenoprotein.	[Han, Seong-Jeong; Lee, Seung-Rock] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biochem,Res Ctr Aging & Geriatr, Kwangju, South Korea; [Han, Seong-Jeong] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju, South Korea; [Han, Seong-Jeong; Lee, Byung Cheon; Yim, Sun Hee; Gladyshev, Vadim N.; Lee, Seung-Rock] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Han, Seong-Jeong; Lee, Byung Cheon; Yim, Sun Hee; Gladyshev, Vadim N.; Lee, Seung-Rock] Harvard Univ, Sch Med, Boston, MA USA	Chonnam National University; Chonnam National University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, SR (corresponding author), Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biochem,Res Ctr Aging & Geriatr, Kwangju, South Korea.	leesr@chonnam.ac.kr		Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	National Research Foundation of Korea [NRF-2012R1A1B6003909]; NIH [GM061603]; Research Institute of Medical Sciences,Chonnam National University; Korea Healthcare Technology R D Project; Ministry of Health & Welfare, Republic of Korea [A103017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute of Medical Sciences,Chonnam National University; Korea Healthcare Technology R D Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Research Foundation of Korea Grant NRF-2012R1A1B6003909 and NIH GM061603. S.- R.Lee was supported by the Research Institute of Medical Sciences, Chonnam National University. S.- J.H. was partly supported by a grant of the Korea Healthcare Technology R& D Project, Ministry of Health & Welfare, Republic of Korea (Grant No.: A103017). The funders had no role in the preparation of the manuscript.	Arciuch VGA, 2009, ADV DRUG DELIVER REV, V61, P1234, DOI 10.1016/j.addr.2009.04.025; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Dudkiewicz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032138; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hawkes WC, 2010, BIOL TRACE ELEM RES, V134, P235, DOI 10.1007/s12011-010-8656-7; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Lee BC, 2011, J BIOL CHEM, V286, P18747, DOI 10.1074/jbc.M111.229807; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Lenart A, 2013, BBA-PROTEINS PROTEOM, V1834, P1279, DOI 10.1016/j.bbapap.2013.03.019; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528	26	33	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95518	10.1371/journal.pone.0095518	http://dx.doi.org/10.1371/journal.pone.0095518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751718	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400067
J	Kiedrowski, MR; Crosby, HA; Hernandez, FJ; Malone, CL; McNamara, JO; Horswill, AR				Kiedrowski, Megan R.; Crosby, Heidi A.; Hernandez, Frank J.; Malone, Cheryl L.; McNamara, James O., II; Horswill, Alexander R.			Staphylococcus aureus Nuc2 Is a Functional, Surface-Attached Extracellular Nuclease	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONTEMPORARY ENZYMOLOGY; GENE-EXPRESSION; CELL-DIVISION; IN-VITRO; VIRULENCE; DEGRADATION; PROTEINS; SEQUENCE; EPIDEMIC	Staphylococcus aureus is a prominent bacterial pathogen that causes a diverse range of acute and chronic infections. Recently, it has been demonstrated that the secreted nuclease (Nuc) enzyme is a virulence factor in multiple models of infection, and in vivo expression of nuc has facilitated the development of an infection imaging approach based on Nuc-activatable probes. Interestingly, S. aureus strains encode a second nuclease (Nuc2) that has received limited attention. With the growing interest in bacterial nucleases, we sought to characterize Nuc2 in more detail through localization, expression, and biochemical studies. Fluorescence microscopy and alkaline phosphatase localization approaches using Nuc2-GFP and Nuc2-PhoA fusions, respectively, demonstrated that Nuc2 is membrane bound with the C-terminus facing the extracellular environment, indicating it is a signal-anchored Type II membrane protein. Nuc2 enzyme activity was detectable on the S. aureus cell surface using a fluorescence resonance energy transfer (FRET) assay, and in time courses, both nuc2 transcription and enzyme activity peaked in early logarithmic growth and declined in stationary phase. Using a mouse model of S. aureus pyomyositis, Nuc2 activity was detected with activatable probes in vivo in nuc mutant strains, demonstrating that Nuc2 is produced during infections. To assess Nuc2 biochemical properties, the protein was purified and found to cleave both single-and double-stranded DNA, and it exhibited thermostability and calcium dependence, paralleling the properties of Nuc. Purified Nuc2 prevented biofilm formation in vitro and modestly decreased biomass in dispersal experiments. Altogether, our findings confirm that S. aureus encodes a second, surface-attached and functional DNase that is expressed during infections and displays similar biochemical properties to the secreted Nuc enzyme.	[Kiedrowski, Megan R.; Crosby, Heidi A.; Malone, Cheryl L.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Hernandez, Frank J.; McNamara, James O., II] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Horswill, AR (corresponding author), Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	alex-horswill@uiowa.edu	Hernandez, Frank J./G-5583-2017; Hernandez, Frank J./AAR-9031-2021	Hernandez, Frank J./0000-0001-6308-8087; Hernandez, Frank J./0000-0001-6308-8087; Crosby, Heidi/0000-0002-0360-0779; McNamara, James/0000-0003-4091-618X; Kiedrowski, Megan/0000-0003-4610-182X	NIH [AI083211, AI101391]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101391, T32AI007511, R01AI106738, P01AI083211] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH AI083211; NIH AI101391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends SJR, 2009, J BACTERIOL, V191, P3772, DOI 10.1128/JB.00179-09; Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chen JM, 2000, J MOL BIOL, V303, P125, DOI 10.1006/jmbi.2000.4140; CUATRECA.P, 1967, J BIOL CHEM, V242, P3063; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; Cuatrecasas P, 1968, Brookhaven Symp Biol, V21, P172; CUNNINGHAM L, 1956, J AM CHEM SOC, V78, P4642, DOI 10.1021/ja01599a031; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DAVIS A, 1977, J BIOL CHEM, V252, P6544; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hernandez FJ, 2014, NAT MED, V20, P301, DOI 10.1038/nm.3460; Hernandez FJ, 2012, NUCLEIC ACID THER, V22, P58, DOI 10.1089/nat.2011.0316; Heun M, 2012, APPL ENVIRON MICROB, V78, P4400, DOI 10.1128/AEM.07895-11; Hu Y, 2013, MICROBIOL RES, V168, P174, DOI 10.1016/j.micres.2012.09.003; Hu Y, 2012, FOODBORNE PATHOG DIS, V9, P265, DOI 10.1089/fpd.2011.1033; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; Kavanaugh JS, 2007, MOL MICROBIOL, V65, P780, DOI 10.1111/j.1365-2958.2007.05830.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; MANOIL C, 1991, METHOD CELL BIOL, V34, P61; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Morikawa K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003003; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; Olson ME, 2013, INFECT IMMUN, V81, P1316, DOI 10.1128/IAI.01242-12; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; PUYET A, 1990, J MOL BIOL, V213, P727, DOI 10.1016/S0022-2836(05)80259-1; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sterba KM, 2003, J BACTERIOL, V185, P4410, DOI 10.1128/JB.185.15.4410-4417.2003; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Tang JN, 2008, FEMS MICROBIOL LETT, V284, P176, DOI 10.1111/j.1574-6968.2008.01194.x; Tarry M, 2009, J MOL BIOL, V386, P504, DOI 10.1016/j.jmb.2008.12.043; Tsuji BT, 2007, DIAGN MICR INFEC DIS, V58, P41, DOI 10.1016/j.diagmicrobio.2006.10.021; TUCKER PW, 1978, MOL CELL BIOCHEM, V22, P67, DOI 10.1007/BF00496235; TUCKER PW, 1979, MOL CELL BIOCHEM, V23, P131; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; White MJ, 2014, INFECT IMMUN, V82, P1559, DOI 10.1128/IAI.01168-13; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	60	44	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95574	10.1371/journal.pone.0095574	http://dx.doi.org/10.1371/journal.pone.0095574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752186	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400078
J	Lim, SH; Delaney, GP; Descallar, J; Sayaloune, P; Papadatos, G; de Souza, P				Lim, Stephanie H.; Delaney, Geoff P.; Descallar, Joseph; Phan Sayaloune; Papadatos, George; de Souza, Paul			Outcomes of Ethnic Minority Groups with Node-Positive, Non-Metastatic Breast Cancer in Two Tertiary Referral Canters in Sydney, Australia	PLOS ONE			English	Article							ASIAN-AMERICAN WOMEN; DUCTAL CARCINOMA; CHEMOTHERAPY; DISPARITIES; SURVIVAL; RECEIPT; STAGE	Purpose: There is a lack of information in ethnic minority groups with regard to presentation and treatment of early node-positive breast cancer. We carried out a retrospective study of patients referred to two tertiary cancer centers in South Western Sydney, both of which serve a high proportion of this ethnic minority population. Patients and methods: Women who had pathologically node-positive non-metastatic breast cancer (T1-3, N1-3, M0) diagnosed between 2003 and 2006 were studied, with variables of interest being tumor size, number of positive nodes, histological grade, hormone receptor status, age at diagnosis, country of birth and treatment. We compared the Asian and Western subgroups with regard to tumor characteristics, treatment and clinical outcomes. Results: A total of 652 eligible patients were identified, with a median follow-up of 6.1 years. Women with Asian backgrounds (n = 125, 20%) were significantly younger at presentation (48 years versus 55 years, p-value<0.0001) and more likely to undergo mastectomy (53% versus 39%, p-value 0.0009) and chemotherapy (86% versus 72%, p-value 0.0063) than their non-Asian counterparts. Tumor stage, grade and receptor status were not statistically different between these two groups. There were also no differences in disease-free survival and overall survival, with medians of 12.7 and 14.8 years respectively. Conclusion: Women of Asian background are younger at diagnosis, which may reflect population epidemiology and likely results in higher uptake of chemotherapy. Higher mastectomy rates may be influenced by cultural factors. Future research is warranted to investigate potential differences in tumor biology, psychosocial, economic and cultural factors.	[Lim, Stephanie H.; de Souza, Paul] Liverpool Hosp, Dept Med Oncol, Liverpool, NSW, Australia; [Lim, Stephanie H.; de Souza, Paul] Campbelltown Hosp, Campbelltown, NSW, Australia; [Lim, Stephanie H.; Delaney, Geoff P.; Descallar, Joseph; de Souza, Paul] Ingham Inst Appl Med Res, Sydney, NSW, Australia; [Lim, Stephanie H.; Delaney, Geoff P.; de Souza, Paul] Univ New S Wales, Sch Med, Sydney, NSW 2052, Australia; [Delaney, Geoff P.; Phan Sayaloune; Papadatos, George; de Souza, Paul] South Western Sydney Local Hlth Dist, Canc Serv, Sydney, NSW, Australia; [Delaney, Geoff P.; de Souza, Paul] Univ Western Sydney, Mol Med Res Grp, Sch Med, Penrith, NSW 1797, Australia	Liverpool Hospital; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; Western Sydney University	Lim, SH (corresponding author), Liverpool Hosp, Dept Med Oncol, Liverpool, NSW, Australia.	stephanie.lim@sswahs.nsw.gov.au	de Souza, Paul/P-5069-2019	Lim, Stephanie Hui-Su/0000-0001-5940-7137; Papadatos, George/0000-0001-9460-3045; Delaney, Geoff/0000-0002-1829-396X				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ashing-Giwa KT, 2004, PSYCHO-ONCOLOGY, V13, P408, DOI 10.1002/pon.750; Australian Bureau of Statistics, 2012, AUSTR DEM STAT; Australian Institute of Health and Welfare Cancer Australia, 2012, AUSTR I HLTH WELF CA, V71; Bhoo-Pathy N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030995; Chen ZJ, 2004, AM J EPIDEMIOL, V159, P140, DOI 10.1093/aje/kwh028; GARNE JP, 1994, CANCER, V73, P1438, DOI 10.1002/1097-0142(19940301)73:5<1438::AID-CNCR2820730519>3.0.CO;2-Y; Hasebe T, 2011, AM J SURG PATHOL, V35, P1484, DOI 10.1097/PAS.0b013e318224ca28; Health Service Planning SSWAHS, 2005, HLTH PROF SYDN S W; Hedeen AN, 1999, AM J PUBLIC HEALTH, V89, P1248, DOI 10.2105/AJPH.89.8.1248; Kagawa-Singer M, 1997, CULT MED PSYCHIAT, V21, P449, DOI 10.1023/A:1005314602587; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Maskarinec G, 2001, INT J EPIDEMIOL, V30, P959, DOI 10.1093/ije/30.5.959; Mouridsen H, 2009, NEW ENGL J MED, V361, P766, DOI 10.1056/NEJMoa0810818; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Pham JT, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-246; Razum O, 2000, INT J EPIDEMIOL, V29, P191, DOI 10.1093/ije/29.1.191; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Schleinitz MD, 2006, J GEN INTERN MED, V21, P1253, DOI 10.1111/j.1525-1497.2006.00609.x; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Sheppard VB, 2013, BREAST CANCER RES TR, V139, P207, DOI 10.1007/s10549-013-2520-3; Silva ID, 2003, BRIT J CANCER, V89, P508, DOI 10.1038/sj.bjc.6601097; Van Belle V, 2009, J CLIN ONCOL, V27, pE150, DOI 10.1200/JCO.2009.24.0044; Velikova G, 2004, BRIT J CANCER, V90, P1926, DOI 10.1038/sj.bjc.6601795; Zhang Y, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-286	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95852	10.1371/journal.pone.0095852	http://dx.doi.org/10.1371/journal.pone.0095852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2DX	24752636	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400141
J	Pang, Z; Li, A; Li, JD; Qu, J; He, CC; Zhang, S; Li, C; Zhang, QF; Liang, MF; Li, DX				Pang, Zheng; Li, Aqian; Li, Jiandong; Qu, Jing; He, Chengcheng; Zhang, Shuo; Li, Chuan; Zhang, Quanfu; Liang, Mifang; Li, Dexin			Comprehensive Multiplex One-Step Real-Time TaqMan qRT-PCR Assays for Detection and Quantification of Hemorrhagic Fever Viruses	PLOS ONE			English	Article							RAPID DETECTION; IDENTIFICATION	Background: Viral hemorrhagic fevers (VHFs) are a group of animal and human illnesses that are mostly caused by several distinct families of viruses including bunyaviruses, flaviviruses, filoviruses and arenaviruses. Although specific signs and symptoms vary by the type of VHF, initial signs and symptoms are very similar. Therefore rapid immunologic and molecular tools for differential diagnosis of hemorrhagic fever viruses (HFVs) are important for effective case management and control of the spread of VHFs. Real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) assay is one of the reliable and desirable methods for specific detection and quantification of virus load. Multiplex PCR assay has the potential to produce considerable savings in time and resources in the laboratory detection. Results: Primers/probe sets were designed based on appropriate specific genes for each of 28 HFVs which nearly covered all the HFVs, and identified with good specificity and sensitivity using monoplex assays. Seven groups of multiplex one-step real-time qRT-PCR assays in a universal experimental system were then developed by combining all primers/probe sets into 4-plex reactions and evaluated with serial dilutions of synthesized viral RNAs. For all the multiplex assays, no cross-reactivity with other HFVs was observed, and the limits of detection were mainly between 45 and 150 copies/PCR. The reproducibility was satisfactory, since the coefficient of variation of Ct values were all less than 5% in each dilution of synthesized viral RNAs for both intra-assays and inter-assays. Evaluation of the method with available clinical serum samples collected from HFRS patients, SFTS patients and Dengue fever patients showed high sensitivity and specificity of the related multiplex assays on the clinical specimens. Conclusions: Overall, the comprehensive multiplex one-step real-time qRT-PCR assays were established in this study, and proved to be specific, sensitive, stable and easy to serve as a useful tool for rapid detection of HFVs.	[Pang, Zheng; Li, Aqian; Li, Jiandong; Qu, Jing; He, Chengcheng; Zhang, Shuo; Li, Chuan; Zhang, Quanfu; Liang, Mifang; Li, Dexin] China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, NHFPC, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Li, DX (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, NHFPC, Beijing, Peoples R China.	lidx@chinacdc.cn			National Science and Technology Major Project of China [2011ZX10004-001, 2013ZX10004-101]	National Science and Technology Major Project of China	This work was supported by the National Science and Technology Major Project of China (2011ZX10004-001) and (2013ZX10004-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitichou M, 2005, J VIROL METHODS, V124, P21, DOI 10.1016/j.jviromet.2004.10.004; Anderson Peter D, 2012, J Pharm Pract, V25, P521; Bossi Philippe, 2004, Euro Surveill, V9, pE11, DOI 10.2807/esm.09.12.00504-en; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Bray M, 2009, CLIN VIROLOGY; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P73; Charrel R N, 2003, Med Trop (Mars), V63, P296; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; Drosten C, 2003, ANTIVIR RES, V57, P61, DOI 10.1016/S0166-3542(02)00201-2; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Khan AS, 1997, AM J TROP MED HYG, V57, P519, DOI 10.4269/ajtmh.1997.57.519; LEGUENNO B, 1995, SCI AM, V273, P56, DOI 10.1038/scientificamerican1095-56; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001	23	52	66	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95635	10.1371/journal.pone.0095635	http://dx.doi.org/10.1371/journal.pone.0095635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752452	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400095
J	Shi, F; Long, XC; Hendershot, A; Miano, JM; Sottile, J				Shi, Feng; Long, Xiaochun; Hendershot, Allison; Miano, Joseph M.; Sottile, Jane			Fibronectin Matrix Polymerization Regulates Smooth Muscle Cell Phenotype through a Rac1 Dependent Mechanism	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SERUM RESPONSE FACTOR; ADAPTER PROTEIN SHC; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CYCLE PROGRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTIONAL ACTIVATION; RHO-FAMILY; STEM-CELLS	Smooth muscle cells are maintained in a differentiated state in the vessel wall, but can be modulated to a synthetic phenotype following injury. Smooth muscle phenotypic modulation is thought to play an important role in the pathology of vascular occlusive diseases. Phenotypically modulated smooth muscle cells exhibit increased proliferative and migratory properties that accompany the downregulation of smooth muscle cell marker proteins. Extracellular matrix proteins, including fibronectin, can regulate the smooth muscle phenotype when used as adhesive substrates. However, cells produce and organize a 3-dimensional fibrillar extracellular matrix, which can affect cell behavior in distinct ways from the protomeric 2-dimensional matrix proteins that are used as adhesive substrates. We previously showed that the deposition/polymerization of fibronectin into the extracellular matrix can regulate the deposition and organization of other extracellular matrix molecules in vitro. Further, our published data show that the presence of a fibronectin polymerization inhibitor results in increased expression of smooth muscle cell differentiation proteins and inhibits vascular remodeling in vivo. In this manuscript, we used an in vitro cell culture system to determine the mechanism by which fibronectin polymerization affects smooth muscle phenotypic modulation. Our data show that fibronectin polymerization decreases the mRNA levels of multiple smooth muscle differentiation genes, and downregulates the levels of smooth muscle alpha-actin and calponin proteins by a Rac1-dependent mechanism. The expression of smooth muscle genes is transcriptionally regulated by fibronectin polymerization, as evidenced by the increased activity of luciferase reporter constructs in the presence of a fibronectin polymerization inhibitor. Fibronectin polymerization also promotes smooth muscle cell growth, and decreases the levels of actin stress fibers. These data define a Rac1-dependent pathway wherein fibronectin polymerization promotes the SMC synthetic phenotype by modulating the expression of smooth muscle cell differentiation proteins.	[Shi, Feng; Long, Xiaochun; Hendershot, Allison; Miano, Joseph M.; Sottile, Jane] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA	University of Rochester	Sottile, J (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.	jane_sottile@urmc.rochester.edu	Miano, Joseph/L-5634-2018	Miano, Joseph/0000-0001-7522-3207; Long, Xiaochun/0000-0001-9714-0023	National Institutes of Health [GM097347, HL112793, HL117907]; American Heart Association [5640000, 10SDG3670036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117907, R01HL112793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Institutes of Health (GM097347 to JS, HL112793 and HL117907 to JMM) (http://www.nih.gov) and American Heart Association (GRNT5640000 to JS and 10SDG3670036 to XL) (http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Astrof S, 2007, DEV BIOL, V311, P11, DOI 10.1016/j.ydbio.2007.07.005; Barberis L, 2000, J BIOL CHEM, V275, P36532, DOI 10.1074/jbc.M002487200; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Chung J, 2004, CANCER RES, V64, P4711, DOI 10.1158/0008-5472.CAN-04-0347; Clark RAF, 1997, J CELL PHYSIOL, V170, P69; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; DELCOMMENNE M, 1995, J BIOL CHEM, V270, P26794, DOI 10.1074/jbc.270.45.26794; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ferguson JE, 2005, ARTERIOSCL THROM VAS, V25, P2246, DOI 10.1161/01.ATV.0000183609.55154.44; FOGERTY FJ, 1990, CELL DIFFER DEV, V32, P439, DOI 10.1016/0922-3371(90)90061-Z; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; HEDIN U, 1988, J CELL BIOL, V107, P307, DOI 10.1083/jcb.107.1.307; HEDIN U, 1987, DIFFERENTIATION, V33, P239, DOI 10.1111/j.1432-0436.1987.tb01563.x; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Jinguji Y., 1994, ENDOTHELIUM, V2, P35, DOI [10.2108/zsj.20.1359, DOI 10.2108/ZSJ.20.1359]; Long XC, 2013, ARTERIOSCL THROM VAS, V33, P378, DOI 10.1161/ATVBAHA.112.300645; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Mercurius KO, 1998, CIRC RES, V82, P548, DOI 10.1161/01.RES.82.5.548; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Morla AO, 2000, BIOCHEM BIOPH RES CO, V272, P298, DOI 10.1006/bbrc.2000.2769; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Owens G. K., 1995, PHYSIOL REV, V3, P75; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pasqualini R, 1996, NAT MED, V2, P1197, DOI 10.1038/nm1196-1197; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Sechler JL, 1998, J BIOL CHEM, V273, P25533, DOI 10.1074/jbc.273.40.25533; Sechler JL, 1996, CELL ADHES COMMUN, V4, P413, DOI 10.3109/15419069709004458; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; SINGER II, 1982, J CELL BIOL, V92, P398, DOI 10.1083/jcb.92.2.398; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sottile J, 1998, J CELL SCI, V111, P2933; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Yamada H, 2008, ANTICANCER RES, V28, P261; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	71	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94988	10.1371/journal.pone.0094988	http://dx.doi.org/10.1371/journal.pone.0094988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752318	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400022
J	Zhao, XH; Zhan, Q; Xiang, L; Wang, YD; Wang, XF; Li, AM; Liu, SD				Zhao, Xinhua; Zhan, Qiang; Xiang, Li; Wang, Yadong; Wang, Xianfei; Li, Aimin; Liu, Side			Clinicopathological Characteristics of Laterally Spreading Colorectal Tumor	PLOS ONE			English	Article							ENDOSCOPIC SUBMUCOSAL DISSECTION; MUCOSAL RESECTION; CANCER; NEOPLASIA; FLAT; PREVALENCE; FEATURES; SUBTYPES; ADENOMA; PATTERN	Background and Aims: Laterally spreading tumor (LST) is a colorectal pre-cancerous lesion. Previous studies have demonstrated distinct LST clinicopathological characteristics in different populations. This study evaluated clinicopathological characteristics of LST in a Chinese population. Methods: A total of 259 Chinese LST patients with 289 lesions were recruited for endoscopic and clinicopathological analyses. Results: Among these 289 lesions, 185 were granular type (LST-G), whereas 104 were non-granular type (LST-NG). LST-G lesions were further classified into homogeneous G-type and nodular mixed G-type, while LST-NG lesions were further classified into flat elevated NG-type and pseudo-depressed NG-type. Clinically, these four LST subtypes showed distinct clinicopathological characteristics, e.g., lesion size, location, or histopathological features (high-grade intraepithelial neoplasia and submucosal carcinoma). The nodular mixed G-type showed larger tumor size and higher incidence of high-grade intraepithelial neoplasia compared to the other three subtypes, while pseudo-depressed NG-type lesions showed the highest incidence of submucosal carcinoma. Noticeably, no diffidence was detected between the lesions of homogeneous G-type and flat elevated NG-type with regard to the histopathological features. Histology of the malignancy potential was associated with nodular mixed G-type [OR = 2.41, 95% CI (1.09-5.29); P = 0.029], flat elevated NG-type [OR = 3.49, 95% CI (1.41-8.22); P = 0.007], Diameter >= 30 mm [OR = 2.56, 95% CI (1.20-5.20); P = 0.009], Villous adenoma [OR = 2.76, 95% CI (1.01-7.58); P = 0.048] and serrated adenoma [OR = 6.99, 95% CI (1.81-26.98); P = 0.005]. Conclusion: Chinese LSTs can be divided into four different subtypes, which show distinct clinicopathological characteristics. Morphology, size and pathological characteristics are all independent predictors of advanced histology.	[Zhao, Xinhua; Zhan, Qiang; Xiang, Li; Wang, Yadong; Wang, Xianfei; Li, Aimin; Liu, Side] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Zhao, Xinhua] Mianyang Cent Hosp, Dept Gastroenterol, Mianyang, Peoples R China; [Zhan, Qiang] Nanjing Med Univ, Wuxi City Peoples Hosp, Dept Gastroenterol, Wuxi City, Peoples R China	Southern Medical University - China; Nanjing Medical University	Liu, SD (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China.	liuside2011@163.com			Guangdong Higher Education Talents special fund project (Guangdong Cai Jiao Zi) [431]	Guangdong Higher Education Talents special fund project (Guangdong Cai Jiao Zi)	This work was supported by Guangdong Higher Education Talents special fund project (Guangdong Cai Jiao Zi [2011] No. 431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen LA, 2000, PATHOLOGY GENETICS T; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Bianco MA, 2010, ENDOSCOPY, V42, P279, DOI 10.1055/s-0029-1244020; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Hiraoka S, 2006, GASTROENTEROLOGY, V131, P379, DOI 10.1053/j.gastro.2006.04.027; Hurlstone DP, 2004, GUT, V53, P1334, DOI 10.1136/gut.2003.036913; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaku E, 2011, CLIN GASTROENTEROL H, V9, P503, DOI 10.1016/j.cgh.2011.03.018; Kim BC, 2011, ENDOSCOPY, V43, P100, DOI 10.1055/s-0030-1256027; Klochan C, 2012, AM J GASTROENTEROL, V107, pS26, DOI 10.14309/00000434-201210001-00060; Kudo S, 2001, ENDOSCOPY, V33, P367; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Kudo S, 2000, WORLD J SURG, V24, P1081, DOI 10.1007/s002680010154; Kudo SE, 2008, GASTROINTEST ENDOSC, V68, pS3, DOI 10.1016/j.gie.2008.07.052; Kudo Shin-ei, 2008, Gastrointest Endosc Clin N Am, V18, P581, DOI 10.1016/j.giec.2008.05.013; Kurahashi T, 2002, J GASTROENTEROL, V37, P354, DOI 10.1007/s005350200049; Lambert R, 2012, EUR J GASTROEN HEPAT, V24, P1123, DOI 10.1097/MEG.0b013e328355e2d9; Lambert R, 2009, GASTROINTEST ENDOSC, V70, P1182, DOI 10.1016/j.gie.2009.09.015; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Miyamoto H, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-129; Oka S, 2004, GASTROINTEST ENDOSC, V59, P213, DOI 10.1016/S0016-5107(03)02693-2; Oka S, 2009, DIGEST ENDOSC, V21, pS43, DOI 10.1111/j.1443-1661.2009.00869.x; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rotondano G, 2011, ENDOSCOPY, V43, P856, DOI 10.1055/s-0030-1256639; Saito Y, 2009, DIGEST ENDOSC, V21, pS7, DOI 10.1111/j.1443-1661.2009.00870.x; Soetikno R, 2006, GASTROENTEROLOGY, V130, P566, DOI 10.1053/j.gastro.2005.12.006; Sugimoto T, 2010, INT J CANCER, V127, P1562, DOI 10.1002/ijc.25180; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Tanaka S, 2007, GASTROINTEST ENDOSC, V66, P100, DOI 10.1016/j.gie.2007.02.032; Uraoka T, 2006, GUT, V55, P1592, DOI 10.1136/gut.2005.087452; Xu MD, 2013, INT J COLORECTAL DIS, V28, P63, DOI 10.1007/s00384-012-1543-2	32	21	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94552	10.1371/journal.pone.0094552	http://dx.doi.org/10.1371/journal.pone.0094552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751926	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400013
J	Li, Q; Bian, LJ; Zhao, XF; Gao, XK; Zheng, JB; Li, ZJ; Zhang, YY; Jiang, R; Zheng, XH				Li, Qian; Bian, Liujiao; Zhao, Xinfeng; Gao, Xiaokang; Zheng, Jianbin; Li, Zijian; Zhang, Youyi; Jiang, Ru; Zheng, Xiaohui			Immobilised Histidine Tagged beta(2)-Adrenoceptor Oriented by a Diazonium Salt Reaction and Its Application in Exploring Drug-Protein Interaction Using Ephedrine and Pseudoephedrine as Probes	PLOS ONE			English	Article							PERFORMANCE AFFINITY-CHROMATOGRAPHY; HUMAN SERUM-ALBUMIN; RECEPTOR; BINDING; IDENTIFICATION	A new oriented method using a diazonium salt reaction was developed for linking beta(2)-adrenoceptor (beta(2)-AR) on the surface of macroporous silica gel. Stationary phase containing the immobilised receptor was used to investigate the interaction between beta(2)-AR and ephedrine plus pseudoephedrine by zonal elution. The isotherms of the two drugs best fit the Langmuir model. Only one type of binding site was found for ephedrine and pseudoephedrine targeting beta(2)-AR. At 37 degrees C, the association constants during the binding were (5.94+/-0.05) x10(3)/M for ephedrine and (3.80+/-0.02) x10(3)/M for pseudoephedrine, with the binding sites of (8.92+/-0.06) x10(-4) M. Thermodynamic studies showed that the binding of the two compounds to beta(2)-AR was a spontaneous reaction with exothermal processes. The Delta G(theta), Delta H-theta and Delta S-theta for the interaction between ephedrine and beta(2)-AR were -(22.33+/-0.04) kJ/mol, -(6.51+/-0.69) kJ/mol and 50.94+/-0.31 J/mol.K, respectively. For the binding of pseudoephedrine to the receptor, these values were -(21.17+/-0.02) kJ/mol, -(7.48+/-0.56) kJ/mol and 44.13+/-0.01 J/mol.K. Electrostatic interaction proved to be the driving force during the binding of the two drugs to beta(2)-AR. The proposed immobilised method will have great potential for attaching protein to solid substrates and realizing the interactions between proteins and drugs.	[Li, Qian; Bian, Liujiao; Zhao, Xinfeng; Gao, Xiaokang; Zheng, Xiaohui] NW Univ Xian, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China; [Zheng, Jianbin] NW Univ Xian, Inst Analyt Sci, Xian 710069, Shaanxi, Peoples R China; [Li, Zijian; Zhang, Youyi] Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100871, Peoples R China; [Li, Zijian; Zhang, Youyi] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Jiang, Ru] Fourth Mil Med Univ, Sch Pharm, Xian 710032, Shaanxi, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; Peking University; Air Force Military Medical University	Zhang, YY (corresponding author), Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100871, Peoples R China.	zhangyy@bjmu.edu.cn; zhengxh@nwu.edu.cn			National Nature Science Foundation of China [21075097, 21005060]; Innovative Research Team of Shaanxi Province [2013KCT-24]; Ministry of Science and Technology of the People's Republic of China [2013YQ170525, 2013YQ17052509]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of Shaanxi Province; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by National Nature Science Foundation of China (Nos. 21075097, 21005060), Innovative Research Team of Shaanxi Province (No. 2013KCT-24) and the Ministry of Science and Technology of the People's Republic of China (No. 2013YQ170525; subproject: 2013YQ17052509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Bender CF, 2005, J AM CHEM SOC, V127, P1070, DOI 10.1021/ja043278q; Bertucci C, 2010, J BIOTECHNOL, V150, pS30, DOI 10.1016/j.jbiotec.2010.08.088; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; D'Souza SF, 2002, J BIOCHEM BIOPH METH, V52, P59, DOI 10.1016/S0165-022X(02)00032-5; Dolan PL, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.21.e107; HAGE DS, 1995, J CHROMATOGR A, V693, P23, DOI 10.1016/0021-9673(94)01009-4; HALE JE, 1995, ANAL BIOCHEM, V231, P46, DOI 10.1006/abio.1995.1501; Hubbard RE, 2011, NEUROPHARMACOLOGY, V60, P7, DOI 10.1016/j.neuropharm.2010.07.016; Johnson M., 2005, J ALLERGY CLIN IMMUN, V117, P292, DOI [10.1513/pats.200504-027SR., DOI 10.1513/PATS.200504-027SR]; Kang JH, 2007, J CHROMATOGR A, V1161, P9, DOI 10.1016/j.chroma.2007.05.023; [李敏艳 LI Min-yan], 2009, [生物技术, Biotechnology], V19, P4; Mallik R, 2010, J CHROMATOGR A, V1217, P2796, DOI 10.1016/j.chroma.2010.02.026; PAEK SH, 1993, ANAL BIOCHEM, V210, P145, DOI 10.1006/abio.1993.1165; Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sassolas A, 2012, BIOTECHNOL ADV, V30, P489, DOI 10.1016/j.biotechadv.2011.09.003; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Sousa FFO, 2012, INT J PHARMACEUT, V439, P41, DOI 10.1016/j.ijpharm.2012.09.046; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Tong ZH, 2011, J CHROMATOGR A, V1218, P2065, DOI 10.1016/j.chroma.2010.10.070; Turkova J, 1999, J CHROMATOGR B, V722, P11, DOI 10.1016/S0378-4347(98)00434-4; Vansal SS, 1999, BIOCHEM PHARMACOL, V58, P807, DOI 10.1016/S0006-2952(99)00152-5; Verburg-van Kemenade BML, 2013, GEN COMP ENDOCR, V188, P94, DOI 10.1016/j.ygcen.2012.11.010; WALDECK B, 1985, CLIN EXP PHARMACOL P, V12, P439, DOI 10.1111/j.1440-1681.1985.tb00891.x; Wang CG, 2013, J PHARMACEUT BIOMED, V75, P112, DOI 10.1016/j.jpba.2012.11.018; Wang CIA, 2013, BIOCHEM PHARMACOL, V85, P153, DOI 10.1016/j.bcp.2012.09.001; Wang Xiang, 2012, Drug Discov Today Dis Models, V9, pe103; Wang ZH, 2003, J BIOCHEM BIOPH METH, V57, P203, DOI 10.1016/S0165-022X(03)00109-X; Werner T, 2012, ADV DRUG DELIVER REV, V64, P323, DOI 10.1016/j.addr.2011.11.011; Xu LH, 2010, CHIN J CHROMATOGR, V28, P374, DOI 10.3724/SP.J.1123.2010.00374; Zencir S, 2011, BIOCHEM BIOPH RES CO, V411, P792, DOI 10.1016/j.bbrc.2011.07.029; Zhang WS, 1999, MED CHEM; Zhao XF, 2012, J PHARMACEUT BIOMED, V70, P549, DOI 10.1016/j.jpba.2012.05.004; Zhaoa XF, 2009, J CHROMATOGR B, V877, P911, DOI 10.1016/j.jchromb.2009.02.031; Zheng XH, 2008, CHINESE SCI BULL, V53, P842, DOI 10.1007/s11434-007-0510-8; Zhu LL, 2008, J STRUCT BIOL, V162, P40, DOI 10.1016/j.jsb.2007.12.004; Zinn N, 2012, METHODS, V57, P430, DOI 10.1016/j.ymeth.2012.05.008	40	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94955	10.1371/journal.pone.0094955	http://dx.doi.org/10.1371/journal.pone.0094955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747442	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500046
J	Li, X; Liu, Y; Granberg, KJ; Wang, Q; Moore, LM; Ji, P; Gumin, J; Sulman, EP; Calin, GA; Haapasalo, H; Nykter, M; Shmulevich, I; Fuller, GN; Lang, FF; Zhang, W				Li, X.; Liu, Y.; Granberg, K. J.; Wang, Q.; Moore, L. M.; Ji, P.; Gumin, J.; Sulman, E. P.; Calin, G. A.; Haapasalo, H.; Nykter, M.; Shmulevich, I.; Fuller, G. N.; Lang, F. F.; Zhang, W.			Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma	ONCOGENE			English	Article							CHROMOSOME 9P21 DELETIONS; TUMOR STEM-CELLS; MOLECULAR PROCESSES; GROWTH; IDENTIFICATION; EXPRESSION; MICRORNA; IGFBP2; GENE; PATHWAY	MIR-491 is commonly co-deleted with its adjacent CDKN2A on chromosome 9p21.3 in glioblastoma multiforme (GBM). However, it is not known whether deletion of MIR-491 is only a passenger event or has an important role. Small-RNA sequencing of samples from GBM patients demonstrated that both mature products of MIR-491 (miR-491-5p and -3p) are downregulated in tumors compared with the normal brain. The integration of GBM data from The Cancer Genome Atlas (TCGA), miRNA target prediction and reporter assays showed that miR-491-5p directly targets EGFR, CDK6 and Bcl-xL, whereas miR-491-3p targets IGFBP2 and CDK6. Functionally, miR-491-3p inhibited glioma cell invasion; overexpression of both miR-491-5p and -3p inhibited proliferation of glioma cell lines and impaired the propagation of glioma stem cells (GSCs), thereby prolonging survival of xenograft mice. Moreover, knockdown of miR-491-5p in primary Ink4a-Arf-null mouse glial progenitor cells exacerbated cell proliferation and invasion. Therefore, MIR-491 is a tumor suppressor gene that, by utilizing both mature forms, coordinately controls the key cancer hallmarks: proliferation, invasion and stem cell propagation.	[Li, X.; Liu, Y.; Granberg, K. J.; Moore, L. M.; Ji, P.; Fuller, G. N.; Zhang, W.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Li, X.; Wang, Q.] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Granberg, K. J.; Nykter, M.] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Granberg, K. J.; Haapasalo, H.] Fimlab Labs, Dept Pathol, Tampere, Finland; [Granberg, K. J.; Haapasalo, H.] Univ Tampere, FIN-33101 Tampere, Finland; [Gumin, J.; Lang, F. F.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Sulman, E. P.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Calin, G. A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, G. A.; Zhang, W.] Univ Texas MD Anderson Canc Ctr, Noncoding RNA Ctr, Houston, TX 77030 USA; [Nykter, M.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Shmulevich, I.] Inst Syst Biol, Seattle, WA USA	University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University; Tampere University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tampere University; Institute for Systems Biology (ISB)	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, 1515 Holcombe Blvd Unit 85, Houston, TX 77030 USA.	wzhang@mdanderson.org	Calin, George/E-9390-2011	Sulman, Erik/0000-0003-4933-9120; Rautajoki, Kirsi Johanna/0000-0001-6549-7810; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615; Fuller, Gregory/0000-0001-9447-2647; Nykter, Matti/0000-0001-6956-2843	National Institutes of Health [CA098503, CA141432, CA143835, CA115729, CA127001]; Broach Foundation; Gene Pennebaker Brain Cancer Fund; Academy of Finland [259038]; Fourth Military Medical University [4138C4IA1Z]; American Cancer Society; IVY Foundation; Elias Foundation; NATIONAL CANCER INSTITUTE [R56CA098503, R01CA141432, R01CA098503, U24CA143835, P30CA016672, R01CA115729, P50CA127001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broach Foundation; Gene Pennebaker Brain Cancer Fund; Academy of Finland(Academy of Finland); Fourth Military Medical University; American Cancer Society(American Cancer Society); IVY Foundation; Elias Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate Xinna Zhang at the MicroRNA Core Facility for help with miRNA hybridization experiments, Zhimin Lu at the Department of Neuro-Oncology-Research for helpful comments, and Kathryn L Hale at the Department of Scientific Publications at MD Anderson Cancer Center for manuscript editing. This work was supported by grants from the National Institutes of Health (CA098503 to WZ and IS, CA141432 and CA143835 to WZ and CA115729 and CA127001 to FFL), IVY, Elias and Broach Foundations, the Gene Pennebaker Brain Cancer Fund, and the Academy of Finland (grant 259038 to KG); Xia Li was supported by a fellowship from The Fourth Military Medical University (4138C4IA1Z). Lynette Moore was supported by a fellowship from the American Cancer Society.	Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beukelaers P, 2011, STEM CELLS, V29, P713, DOI 10.1002/stem.616; Bexell D, 2013, CANCER TREAT REV, V39, P358, DOI 10.1016/j.ctrv.2012.06.006; Brockschmidt A, 2012, BRAIN, V135, P1027, DOI 10.1093/brain/aws045; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Das S, 2008, NAT CLIN PRACT NEURO, V4, P427, DOI 10.1038/ncpneuro0862; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; Feng JJ, 2012, CANCER-AM CANCER SOC, V118, P232, DOI 10.1002/cncr.26250; Fukushima T, 2007, J BIOL CHEM, V282, P18634, DOI 10.1074/jbc.M609567200; Fuxe J, 2000, CELL GROWTH DIFFER, V11, P373; Griffero F, 2009, J BIOL CHEM, V284, P7138, DOI 10.1074/jbc.M807111200; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Gursky S, 2001, CANCER GENET CYTOGEN, V129, P93, DOI 10.1016/S0165-4608(01)00444-7; Hai C, 2012, CHIN J CANCER, V31, P233, DOI 10.5732/cjc.011.10367; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He H, 2010, J PROTEOME RES, V9, P2098, DOI 10.1021/pr900793a; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Holmes KM, 2012, P NATL ACAD SCI USA, V109, P3475, DOI 10.1073/pnas.1120375109; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Hwang DW, 2011, BIOMATERIALS, V32, P4968, DOI 10.1016/j.biomaterials.2011.03.047; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Jin X, 2011, CANCER RES, V71, P7125, DOI 10.1158/0008-5472.CAN-11-1330; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim BN, 2005, INT J ONCOL, V26, P1217; Kohno T, 2006, DNA REPAIR, V5, P1273, DOI 10.1016/j.dnarep.2006.05.021; Lee EJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-7; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Mirimanoff RO, 2014, CHIN J CANCER, V33, P1, DOI 10.5732/cjc.013.10215; Moore LM, 2013, J PATHOL, V229, P449, DOI 10.1002/path.4109; Moore LM, 2009, P NATL ACAD SCI USA, V106, P16675, DOI 10.1073/pnas.0900807106; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sasaki S, 2003, ONCOGENE, V22, P3792, DOI 10.1038/sj.onc.1206589; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Testa JR, 1997, CANCER GENET CYTOGEN, V95, P20, DOI 10.1016/S0165-4608(96)00337-8; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200; Wang H, 2003, CANCER RES, V63, P4315; Yan W, 2011, BRAIN RES, V1411, P108, DOI 10.1016/j.brainres.2011.07.002; Yin J, 2011, MOL THER, V19, P1161, DOI 10.1038/mt.2011.28; Zhang W, 2007, CANCER BIOL THER, V6, P995; Zhou ZM, 2011, CANCER BIOTHER RADIO, V26, P77, DOI 10.1089/cbr.2010.0857	55	69	72	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1619	1628		10.1038/onc.2014.98	http://dx.doi.org/10.1038/onc.2014.98			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24747968	Green Accepted			2022-12-25	WOS:000351848400002
J	Feng, Q; Langereis, MA; Olagnier, D; Chiang, C; van de Winkel, R; van Essen, P; Zoll, J; Hiscott, J; van Kuppeveld, FJM				Feng, Qian; Langereis, Martijn A.; Olagnier, David; Chiang, Cindy; van de Winkel, Roel; van Essen, Peter; Zoll, Jan; Hiscott, John; van Kuppeveld, Frank J. M.			Coxsackievirus Cloverleaf RNA Containing a 5 ' Triphosphate Triggers an Antiviral Response via RIG-I Activation	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; 5'-TRIPHOSPHATE RNA; INNATE IMMUNITY; INFECTED CELLS; VIRUS; RECOGNITION; RECEPTORS; PANHANDLE; SENSORS; LIGAND	Upon viral infections, pattern recognition receptors (PRRs) recognize pathogen-associated molecular patterns (PAMPs) and stimulate an antiviral state associated with the production of type I interferons (IFNs) and inflammatory markers. Type I IFNs play crucial roles in innate antiviral responses by inducing expression of interferon-stimulated genes and by activating components of the adaptive immune system. Although pegylated IFNs have been used to treat hepatitis B and C virus infections for decades, they exert substantial side effects that limit their use. Current efforts are directed toward the use of PRR agonists as an alternative approach to elicit host antiviral responses in a manner similar to that achieved in a natural infection. RIG-I is a cytosolic PRR that recognizes 5' triphosphate (5'ppp)-containing RNA ligands. Due to its ubiquitous expression profile, induction of the RIG-I pathway provides a promising platform for the development of novel antiviral agents and vaccine adjuvants. In this study, we investigated whether structured RNA elements in the genome of coxsackievirus B3 (CVB3), a picornavirus that is recognized by MDA5 during infection, could activate RIG-I when supplied with 5'ppp. We show here that a 5'ppp-containing cloverleaf (CL) RNA structure is a potent RIG-I inducer that elicits an extensive antiviral response that includes induction of classical interferon-stimulated genes, as well as type III IFNs and proinflammatory cytokines and chemokines. In addition, we show that prophylactic treatment with CVB3 CL provides protection against various viral infections including dengue virus, vesicular stomatitis virus and enterovirus 71, demonstrating the antiviral efficacy of this RNA ligand.	[Feng, Qian; Langereis, Martijn A.; van Kuppeveld, Frank J. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands; [Olagnier, David; Chiang, Cindy; Hiscott, John] Vaccine & Gene Therapy Inst Florida, Div Infect Dis, Port St Lucie, FL USA; [van de Winkel, Roel; van Essen, Peter; Zoll, Jan] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Vaccine & Gene Therapy Institute of Florida; Radboud University Nijmegen	van Kuppeveld, FJM (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands.	F.J.M.vanKuppeveld@uu.nl	Zoll, G.J./L-4776-2015; Feng, Qian/AAL-4323-2020; van Essen, Peter/E-8659-2018	Zoll, G.J./0000-0003-2155-7935; Olagnier, David/0000-0001-6912-0674; van Kuppeveld, Frank/0000-0001-5800-749X	Mosaic grants [NWO-017.006.043]; Rubicon grant [NWO-825.11.022]; ECHO grant [NWO-CW-700.59.007]; Netherlands Organisation for Scientific Research (NWO)	Mosaic grants; Rubicon grant; ECHO grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Q.F. is supported by Mosaic grants (NWO-017.006.043), M. A. L. by a Rubicon grant (NWO-825.11.022), and F. V. K. by an ECHO grant (NWO-CW-700.59.007), all from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Chen YL, 2013, J EXP MED, V210, P2515, DOI 10.1084/jem.20130536; Cheong HK, 1996, NUCLEIC ACIDS RES, V24, P4197, DOI 10.1093/nar/24.21.4197; Dogan UB, 2013, EUR J GASTROEN HEPAT, V25, P1312, DOI 10.1097/MEG.0b013e328362389a; Feng Q, 2012, CELL REP, V2, P1187, DOI 10.1016/j.celrep.2012.10.005; GLICKMAN JN, 1988, J VIROL, V62, P902, DOI 10.1128/JVI.62.3.902-911.1988; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; KLUMP WM, 1990, J VIROL, V64, P1573, DOI 10.1128/JVI.64.4.1573-1583.1990; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Martinez-Gil L, 2013, J VIROL, V87, P1290, DOI 10.1128/JVI.02338-12; McCaskill JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064360; Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13; Ploss A, 2012, GUT, V61, P25, DOI 10.1136/gutjnl-2012-302048; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Rodriguez-Pulido M, 2011, J VIROL, V85, P6492, DOI 10.1128/JVI.00599-11; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Sleijfer S, 2005, PHARM WORLD SCI, V27, P423, DOI 10.1007/s11096-005-1319-7; Stackaruk ML, 2013, EXPERT REV VACCINES, V12, P875, DOI 10.1586/14760584.2013.814871; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Witwer C, 2001, NUCLEIC ACIDS RES, V29, P5079, DOI 10.1093/nar/29.24.5079; Zhao TS, 2012, INT IMMUNOPHARMACOL, V14, P665, DOI 10.1016/j.intimp.2012.09.018	30	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95927	10.1371/journal.pone.0095927	http://dx.doi.org/10.1371/journal.pone.0095927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759703	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200109
J	Jung, CC; Liang, HH; Lee, HL; Hsu, NY; Su, HJ				Jung, Chien-Cheng; Liang, Hsiu-Hao; Lee, Hui-Ling; Hsu, Nai-Yun; Su, Huey-Jen			Allostatic Load Model Associated with Indoor Environmental Quality and Sick Building Syndrome among Office Workers	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; URINARY 8-HYDROXYDEOXYGUANOSINE; SOCIOECONOMIC-STATUS; PSYCHOSOCIAL FACTORS; BLOOD-PRESSURE; AIR-POLLUTION; LUNG-FUNCTION; STRESS; SYMPTOMS; EXPOSURE	This study investigates whether indoor environmental quality (IEQ) influences allostatic load (AL) and whether AL can be a predictor for sick building syndrome (SBS). We also assessed and compared the associations between AL and SBS versus 8-hydroxydeoxyguanosine (8-OHdG) and SBS. A total of 115 office workers from 21 offices completed self-reported SBS questionnaires, and provided 11 biomarkers for their AL. Multiple linear regressions and logistic regression analysis were applied to examine the correlations between IEQ and AL or 8-OHdG and between AL or 8-OHdG and SBS, respectively. Our data revealed that the neuroendocrine system was correlated with CO2, the difference between indoor and outdoor CO2 levels (dCO(2)), and the indoor-outdoor ratio of CO2 (CO2 I/O). Metabolic system effects were associated with illumination. The relationships between illumination, CO2, dCO(2), CO2 I/O and 8-OHdG were consistent with those and AL in specific systems. Furthermore, we found that risks for SBS syndromes were related with neuroendocrine and metabolic system of the AL. 8-OHdG was associated with eye dryness or irritation, eye tiredness and vomiting. We conclude that IEQ significantly influences AL and that AL can be a predictor for reporting SBS with information on system-specific effects.	[Jung, Chien-Cheng; Liang, Hsiu-Hao; Hsu, Nai-Yun; Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Lee, Hui-Ling] Fu Jen Catholic Univ, Coll Sci & Engn, Dept Chem, New Taipei City, Taiwan	National Cheng Kung University; Fu Jen Catholic University	Su, HJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw	; Hsu, Nai-Yun/H-3318-2014	Su, Huey-Jen/0000-0003-3589-9987; Hsu, Nai-Yun/0000-0003-3321-6388	Taiwan Environmental Protection Administration [EPA-100-FA11-03-A018, EPA-101-FA11-03-D059]	Taiwan Environmental Protection Administration	The project is funded by Taiwan Environmental Protection Administration (EPA-100-FA11-03-A018, EPA-101-FA11-03-D059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraza-Villarreal A, 2011, EUR RESPIR J, V38, P548, DOI 10.1183/09031936.00111410; Bellingrath S, 2009, STRESS, V12, P37, DOI 10.1080/10253890802042041; Chuang CY, 2003, CHEMOSPHERE, V52, P1163, DOI 10.1016/S0045-6535(03)00307-2; Chuang KJ, 2010, J OCCUP ENVIRON MED, V52, P258, DOI 10.1097/JOM.0b013e3181ceff7a; Clark Michael S, 2007, Psychol Health Med, V12, P18, DOI 10.1080/13548500500429338; Crews DE, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-18; Rios JLD, 2009, ENVIRON INT, V35, P1136, DOI 10.1016/j.envint.2009.07.005; Doan SN, 2011, DEV PSYCHOPATHOL, V23, P873, DOI 10.1017/S0954579411000368; Dowd JB, 2009, INT J EPIDEMIOL, V38, P1297, DOI 10.1093/ije/dyp277; Fisk WJ, 2009, INDOOR AIR, V19, P159, DOI 10.1111/j.1600-0668.2008.00575.x; Flouris AD, 2009, AM J RESP CRIT CARE, V179, P1029, DOI 10.1164/rccm.200812-1920OC; FLOYD RA, 1990, FREE RADICAL BIO MED, V8, P327, DOI 10.1016/0891-5849(90)90097-3; Gallo LC, 2011, ANN BEHAV MED, V41, P21, DOI 10.1007/s12160-010-9233-1; Goldstein DS, 2012, CELL MOL NEUROBIOL; Gomzi M, 2007, ARCH ENVIRON OCCUP H, V62, P147, DOI 10.3200/AEOH.62.3.147-155; Groes L, 1995, STAT ANAL INDOOR ENV; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gustafsson PE, 2011, J EPIDEMIOL COMMUN H, V65, P986, DOI 10.1136/jech.2010.108332; Hansen AM, 2008, INDOOR AIR, V18, P440, DOI 10.1111/j.1600-0668.2008.00571.x; Hasson D, 2009, J HEALTH PSYCHOL, V14, P568, DOI 10.1177/1359105309103576; Hoffmann B, 2012, ENVIRON HEALTH PERSP, V120, P241, DOI 10.1289/ehp.1103647; Hu PF, 2007, J BIOSOC SCI, V39, P545, DOI 10.1017/S0021932006001556; Huang YP, 2004, J PHYS CHEM B, V108, P7263, DOI 10.1021/jp036054n; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kinman G, 2008, STRESS HEALTH, V24, P165, DOI 10.1002/smi.1175; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Kuo HW, 2003, OCCUP ENVIRON MED, V60, P590, DOI 10.1136/oem.60.8.590; LAGORIO S, 1994, OCCUP ENVIRON MED, V51, P739, DOI 10.1136/oem.51.11.739; Lai CH, 2005, OCCUP ENVIRON MED, V62, P216, DOI 10.1136/oem.2004.015107; Lester SR, 2010, ANAT SCI EDUC, V3, P160, DOI 10.1002/ase.161; Lin LY, 2011, ATMOS ENVIRON, V45, P5540, DOI 10.1016/j.atmosenv.2011.05.014; Liu JY, 2012, ORAL ONCOL, V48, P569, DOI 10.1016/j.oraloncology.2012.01.021; Lodovici M, 2000, FREE RADICAL BIO MED, V28, P13, DOI 10.1016/S0891-5849(99)00194-X; Lopez-Duran NL, 2009, PSYCHONEUROENDOCRINO, V34, P1272, DOI 10.1016/j.psyneuen.2009.03.016; Lu CY, 2007, ENVIRON RES, V103, P331, DOI 10.1016/j.envres.2006.08.009; Lu CY, 2007, INHAL TOXICOL, V19, P57, DOI 10.1080/08958370600985859; Ma CM, 2010, OCCUP MED-OXFORD, V60, P624, DOI 10.1093/occmed/kqq128; Mair CA, 2011, HEALTH PLACE, V17, P978, DOI 10.1016/j.healthplace.2011.03.009; Mattei J, 2010, SOC SCI MED, V70, P1988, DOI 10.1016/j.socscimed.2010.02.024; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Nilsson R, 2004, OCCUP ENVIRON MED, V61, P692, DOI 10.1136/oem.2003.007435; Norback D, 2008, INT ARCH OCC ENV HEA, V82, P21, DOI 10.1007/s00420-008-0301-9; Peek MK, 2010, AM J PUBLIC HEALTH, V100, P940, DOI 10.2105/AJPH.2007.129312; PERRY B, 1979, CLIN CHEM, V25, P625; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Rogosch FA, 2011, DEV PSYCHOPATHOL, V23, P1107, DOI 10.1017/S0954579411000587; Runeson R, 2006, INDOOR AIR, V16, P445, DOI 10.1111/j.1600-0668.2006.00438.x; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Sjogren E, 2006, BRAIN BEHAV IMMUN, V20, P270, DOI 10.1016/j.bbi.2005.08.001; Staessen JA, 2001, LANCET, V357, P1660, DOI 10.1016/S0140-6736(00)04822-4; Suglia SF, 2010, J EPIDEMIOL COMMUN H, V64, P636, DOI 10.1136/jech.2008.082842; Sun J, 2007, WORK STRESS, V21, P333, DOI 10.1080/02678370701742748; Sundblad BM, 2009, EUR RESPIR J, V34, P80, DOI 10.1183/09031936.00105308; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Takeda M, 2009, INT ARCH OCC ENV HEA, V82, P583, DOI 10.1007/s00420-009-0395-8; Tsai DH, 2012, J OCCUP ENVIRON HYG, V9, P345, DOI 10.1080/15459624.2012.675291; Von Korff M, 2009, PAIN, V143, P76, DOI 10.1016/j.pain.2009.01.034; Wahlstedt K, 2010, AM J IND MED, V53, P716, DOI 10.1002/ajim.20822; Wang BL, 2008, INT J HYG ENVIR HEAL, V211, P114, DOI 10.1016/j.ijheh.2007.03.004; Wang XX, 2012, CHINESE SCI BULL, V57, P1504, DOI 10.1007/s11434-012-5042-1; World Health Organization, 1986, ENV HLTH CRIT, P1; Zhang YY, 2008, CYTOKINE, V41, P144, DOI 10.1016/j.cyto.2007.11.004	63	20	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95791	10.1371/journal.pone.0095791	http://dx.doi.org/10.1371/journal.pone.0095791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3EI	24759685	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200089
J	Lee, CC; Lee, MTG; Chang, SS; Lee, SH; Huang, YC; Yo, CH; Lee, SH; Chen, SC				Lee, Chien-Chang; Lee, Meng-Tse Gabriel; Chang, Shy-Shin; Lee, Si-Huei; Huang, Yu-Chi; Yo, Chia-Hung; Lee, Shih-Hao; Chen, Shyr-Chyr			A Comparison of Vasopressin, Terlipressin, and Lactated Ringers for Resuscitation of Uncontrolled Hemorrhagic Shock in an Animal Model	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; DELAYED FLUID RESUSCITATION; MASSIVE SPLENIC INJURY; CYTOKINE RESPONSE; LIVER TRAUMA; SEPSIS; RATS; INFLAMMATION; EPINEPHRINE; MECHANISMS	Aim: The aim of this study is to compare the effect of lactated ringer (LR), vasopressin (Vaso) or terlipressin (Terli) on uncontrolled hemorrhagic shock (UHS) in rats. Methods: 48 rats were divided into four treatment groups for UHS study. Vaso group was given bolus vasopressin (0.8 U/kg); the Terli group was given bolus terlipressin (15 mcg/ kg); LR group was given LR and the sham group was not given anything. Mean arterial pressure (MAP), serum lactate level, plasma cytokine levels, lung injury and mortality are investigated for these different treatment groups. Results: Compared with LR group, vasopressin and terlipressin-treated groups were associated with higher MAP, lowered mortality rates, less lung injury, lowered serum lactate level, less proinflammatory and more anti-inflammatory cytokine production at certain time points. Comparing between vasopressin and terlipressin treated groups, there is no statistical difference in mortality rates, lung injury, serum lactate level and cytokine level. However, there is a difference in the length of time in maintaining a restored level of MAP (80 to 110 mmHg). The terlipressin treated rats can maintain this restored level of MAP for 45 minutes, but the vasopressin treated rats can only maintain this restored level of MAP for 5 minutes before decreasing gradually to the MAP observed in LR group (40 mmHg). Conclusion: Early optimization of hemodynamics with terlipressin or vasopressin in an animal model of UHS was associated with improved hemodynamics and inflammatory cytokine profile than the LR control. Compared with vasopressin, terlipressin has the advantage of ease of use and sustained effects.	[Lee, Chien-Chang; Lee, Meng-Tse Gabriel; Huang, Yu-Chi; Lee, Shih-Hao; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Chang, Shy-Shin] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Shy-Shin] Chang Gung Mem Hosp, Dept Family Med & Emergency Med, Taoyuan, Taiwan; [Lee, Si-Huei] Natl Yang Ming Univ, Dept Phys Med & Rehabil, Taipei 112, Taiwan; [Lee, Si-Huei] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Lee, Si-Huei] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei 112, Taiwan; [Yo, Chia-Hung] Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Far Eastern Memorial Hospital	Chen, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.	scchen@ntu.edu.tw	Lee, Chien-Chang/HHM-5986-2022	LEE, CHIEN-CHANG/0000-0002-1243-2463; CHEN, SHYR-CHYR/0000-0002-5858-3013	National Science Council [NSC 96-2314-B-002-042]; National Taiwan University Hospital Grant [NTUH96N01]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital Grant(National Taiwan University)	This study was supported by the National Science Council Grant NSC 96-2314-B-002-042 and National Taiwan University Hospital Grant NTUH96N01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asfar P, 2003, CRIT CARE MED, V31, P215, DOI 10.1097/00003246-200301000-00033; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Boyd JH, 2008, RESUSCITATION, V79, P325, DOI 10.1016/j.resuscitation.2008.07.006; Burris D, 1999, J TRAUMA, V46, P216, DOI 10.1097/00005373-199902000-00003; CAPONE A, 1995, RESUSCITATION, V29, P143, DOI 10.1016/0300-9572(95)00829-I; Dib N, 2006, CAN MED ASSOC J, V174, P1433, DOI 10.1503/cmaj.051700; Fink MP, 2002, CURR OPIN CLIN NUTR, V5, P167, DOI 10.1097/00075197-200203000-00009; Haas T, 2004, J TRAUMA, V57, P177, DOI 10.1097/01.TA.0000044357.25191.1B; Ioannou G, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002147]; Jarrar D, 1999, INT J MOL MED, V4, P575; Kalkan E, 2006, TURKISH J TRAUMA EME, V12, P263; Kaszaki J, 2006, TRANSPLANT P, V38, P826, DOI 10.1016/j.transproceed.2006.02.152; Kolarova J, 2005, CHEST, V127, P1327, DOI 10.1378/chest.127.4.1327; Krausz MM, 2001, SHOCK, V16, P383, DOI 10.1097/00024382-200116050-00011; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15; Lee CC, 2007, ANN EMERG MED, V49, P37, DOI 10.1016/j.annemergmed.2006.05.031; Leppaniemi A, 1996, J SURG RES, V63, P413, DOI 10.1006/jsre.1996.0285; Lienhart HG, 2008, CURR OPIN CRIT CARE, V14, P247, DOI 10.1097/MCC.0b013e3282fce62a; Meybohm P, 2007, J TRAUMA, V62, P640, DOI 10.1097/01.ta.0000240962.62319.c8; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Mzezewa S, 2004, BURNS, V30, P236, DOI 10.1016/j.burns.2003.11.004; Perl M, 2005, AM J PATHOL, V167, P1545, DOI 10.1016/S0002-9440(10)61240-0; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; REDL H, 1993, BRIT MED BULL, V49, P556, DOI 10.1093/oxfordjournals.bmb.a072630; Rocha JA, 2009, CLINICS, V64, P591, DOI 10.1590/S1807-59322009000600016; Rostron AJ, 2008, TRANSPLANTATION, V85, P597, DOI 10.1097/TP.0b013e31816398dd; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Rozenfeld V, 2000, ANN PHARMACOTHER, V34, P250; Schummer W, 2005, ANAESTHESIST, V54, P707, DOI 10.1007/s00101-005-0854-x; Sharma RM, 2005, ANESTH ANALG, V101, P833, DOI 10.1213/01.ANE.0000175209.61051.7F; Shires GT, 2005, AM J SURG, V189, P85, DOI 10.1016/j.amjsurg.2004.06.040; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; Stadlbauer KH, 2003, ANESTHESIOLOGY, V98, P699, DOI 10.1097/00000542-200303000-00018; Tamion F, 1997, AM J PHYSIOL-GASTR L, V273, pG314, DOI 10.1152/ajpgi.1997.273.2.G314; Tsuneyoshi Isao, 2005, J Anesth, V19, P170, DOI 10.1007/s00540-004-0299-4; Watters JM, 2006, J TRAUMA, V61, P300, DOI 10.1097/01.ta.0000224211.36154.44; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Yang GM, 2010, EUR J PHARMACOL, V628, P148, DOI 10.1016/j.ejphar.2009.11.040	39	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95821	10.1371/journal.pone.0095821	http://dx.doi.org/10.1371/journal.pone.0095821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759799	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200093
J	Di Santo, S; Seiler, S; Fuchs, AL; Staudigl, J; Widmer, HR				Di Santo, Stefano; Seiler, Stefanie; Fuchs, Anna-Lena; Staudigl, Jennifer; Widmer, Hans Rudolf			The Secretome of Endothelial Progenitor Cells Promotes Brain Endothelial Cell Activity through PI3-Kinase and MAP-Kinase	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INHIBIT APOPTOSIS; CONDITIONED MEDIUM; STROMAL CELLS; IN-VITRO; ANGIOGENESIS; SURVIVAL; AKT; TRANSPORT; ACTIVATE	Background: Angiogenesis and vascular remodelling are crucial events in tissue repair mechanisms promoted by cell transplantation. Current evidence underscores the importance of the soluble factors secreted by stem cells in tissue regeneration. In the present study we investigated the effects of paracrine factors derived from cultured endothelial progenitor cells (EPC) on rat brain endothelial cell properties and addressed the signaling pathways involved. Methods: Endothelial cells derived from rat brain (rBCEC4) were incubated with EPC-derived conditioned medium (EPC-CM). The angiogenic response of rBCEC4 to EPC-CM was assessed as effect on cell number, migration and tubular network formation. In addition, we have compared the outcome of the in vitro experiments with the effects on capillary sprouting from rat aortic rings. The specific PI3K/AKT inhibitor LY294002 and the MEK/ERK inhibitor PD98059 were used to study the involvement of these two signaling pathways in the transduction of the angiogenic effects of EPC-CM. Results: Viable cell number, migration and tubule network formation were significantly augmented upon incubation with EPC-CM. Similar findings were observed for aortic ring outgrowth with significantly longer sprouts. The EPC-CM-induced activities were significantly reduced by the blockage of the PI3K/AKT and MEK/ERK signaling pathways. Similarly to the outcome of the rBCEC4 experiments, inhibition of the PI3K/AKT and MEK/ERK pathways significantly interfered with capillary sprouting induced by EPC-CM. Conclusion: The present study demonstrates that EPC-derived paracrine factors substantially promote the angiogenic response of brain microvascular endothelial cells. In addition, our findings identified the PI3K/AKT and MEK/ERK pathways to play a central role in mediating these effects.	[Widmer, Hans Rudolf] Univ Bern, Inselspital, Dept Neurosurg, Neuroctr, CH-3010 Bern, Switzerland; Univ Bern, Inselspital, Regenerat Neurosci Cluster, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Widmer, HR (corresponding author), Univ Bern, Inselspital, Dept Neurosurg, Neuroctr, CH-3010 Bern, Switzerland.	hanswi@insel.ch	Di Santo, Stefano/K-5739-2014; Di Santo, Stefano/P-2433-2019; Widmer, Hans R./AAC-8948-2022; Widmer, Hans Rudolf/O-5172-2017	Di Santo, Stefano/0000-0002-4032-999X; Di Santo, Stefano/0000-0002-4032-999X; Widmer, Hans Rudolf/0000-0003-3378-8765	Swiss National Science Foundation; National Research Program [63(406340_ 128124)]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Research Program	This study was supported by the Swiss National Science Foundation, National Research Program 63(406340_ 128124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Binu S, 2013, J PHYSIOL BIOCHEM, V69, P383, DOI 10.1007/s13105-012-0220-9; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Blasig IE, 2001, MICROVASC RES, V62, P114, DOI 10.1006/mvre.2001.2318; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bronckaers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071104; Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Chen L, 2014, J PHARMACOL EXP THER, V348, P442, DOI 10.1124/jpet.113.210120; Dao M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-81; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Eliopoulos N, 2010, AM J PHYSIOL-RENAL, V299, pF1288, DOI 10.1152/ajprenal.00671.2009; Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Font MA, 2010, CURR CARDIOL REV, V6, P238, DOI 10.2174/157340310791658802; Gerasimovskaya EV, 2008, ANGIOGENESIS, V11, P169, DOI 10.1007/s10456-007-9087-8; Guan J, 2013, BRAIN PATHOL, V23, P154, DOI 10.1111/j.1750-3639.2012.00628.x; Hemmen K, 2011, ANGIOGENESIS, V14, P163, DOI 10.1007/s10456-011-9200-x; Henning RJ, 2012, TRANSL RES, V159, P497, DOI 10.1016/j.trsl.2012.02.004; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Jin H, 2013, CELL TRANSPLANTATION; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kelleher RJ, 2013, AM J CARDIOVASC DIS, V3, P197; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kolbe M, 2011, TISSUE ENG PT A, V17, P2199, DOI [10.1089/ten.TEA.2010.0474, 10.1089/ten.tea.2010.0474]; Krenning G, 2009, TRENDS MOL MED, V15, P180, DOI 10.1016/j.molmed.2009.02.001; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Lichtenauer M, 2011, BASIC RES CARDIOL, V106, P1283, DOI 10.1007/s00395-011-0224-6; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; O'Neill CL, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt122; Park KJ, 2013, J CEREB BLOOD FLOW M; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Ratajczak J, 2013, STEM CELLS DEV, V22, P422, DOI 10.1089/scd.2012.0268; Rosell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073244; Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9; Singla DK, 2008, AM J PHYSIOL-HEART C, V295, pH907, DOI 10.1152/ajpheart.00279.2008; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tecilazich F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083314; Thirant C, 2012, STEM CELLS, V30, P845, DOI 10.1002/stem.1062; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Urbich C, 2011, J MOL CELL CARDIOL, V50, P333, DOI 10.1016/j.yjmcc.2010.11.022; von Ballmoos MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014107; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Xia L, 2009, CYTOTHERAPY, V11, P492, DOI 10.1080/14653240902960460; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Zacchigna S, 2008, CURR TOP DEV BIOL, V80, P1, DOI 10.1016/S0070-2153(07)80001-9	52	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95731	10.1371/journal.pone.0095731	http://dx.doi.org/10.1371/journal.pone.0095731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755675	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300084
J	Shiura, H; Okamoto, A; Sasaki, H; Abe, K				Shiura, Hirosuke; Okamoto, Akimitsu; Sasaki, Hiroyuki; Abe, Kuniya			Whole-Mount MeFISH: A Novel Technique for Simultaneous Visualization of Specific DNA Methylation and Protein/RNA Expression	PLOS ONE			English	Article							CATALYZED REPORTER DEPOSITION; PRIMORDIAL GERM-CELLS; IN-SITU HYBRIDIZATION; SIGNAL AMPLIFICATION; SATELLITE REPEATS; X-CHROMOSOME; MOUSE; GENOME; MICE; RNA	To understand the spatiotemporal changes in cellular status that occur during embryonic development, it is desirable to detect simultaneously the expression of genes, proteins, and epigenetic modifications in individual embryonic cells. A technique termed methylation-specific fluorescence in situ hybridization (MeFISH) was developed recently that can visualize the methylation status of specific DNA sequences in cells fixed on a glass slide. Here, we adapted this glass slide-based MeFISH to the study of intact embryos, and established a method called whole-mount MeFISH. This method can be applied to any DNA sequences in theory and, as a proof-of-concept experiment, we examined the DNA methylation status of satellite repeats in developing mouse primordial germ cells, in which global DNA demethylation is known to take place, and obtained a result that was consistent with previous findings, thus validating the MeFISH method. We also succeeded in combining whole-mount MeFISH with immunostaining or RNA fluorescence in situ hybridization (RNA-FISH) techniques by adopting steps to retain signals of RNA-FISH or immunostaining after harsh denaturation step of MeFISH. The combined methods enabled the simultaneous visualization of DNA methylation and protein or RNA expression at single-cell resolution without destroying embryonic and nuclear structures. This whole-mount MeFISH technique should facilitate the study of the dynamics of DNA methylation status during embryonic development with unprecedented resolution.	[Shiura, Hirosuke; Abe, Kuniya] RIKEN, BioResource Ctr, Technol & Dev Team Mammalian Genome Dynam, Ibaraki, Japan; [Okamoto, Akimitsu] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [Sasaki, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Div Epigen & Dev, Fukuoka 812, Japan; [Sasaki, Hiroyuki] Kyushu Univ, Epigenome Network Res Ctr, Fukuoka 812, Japan; [Abe, Kuniya] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan	RIKEN; University of Tokyo; Kyushu University; Kyushu University; University of Tsukuba	Abe, K (corresponding author), RIKEN, BioResource Ctr, Technol & Dev Team Mammalian Genome Dynam, Ibaraki, Japan.	abe@rtc.riken.jp	Okamoto, Akimitsu/K-8965-2018	Okamoto, Akimitsu/0000-0002-7418-6237; Shiura, Hirosuke/0000-0003-2553-6971	Ministry of Education,Culture,Sports,Science and Technology of Japan; Grants-in-Aid for Scientific Research [25112001, 25112010, 13F03342] Funding Source: KAKEN	Ministry of Education,Culture,Sports,Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant to KA from the Ministry of Education, Culture,Sports,Science and Technology of Japan. The funder had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.No additional external funding received for this study.	BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hunyady B, J HISTOCHEM CYTOCHEM, V44, P1353; Ichiyanagi K, 2011, GENOME RES, V21, P2058, DOI 10.1101/gr.123679.111; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Komissarov AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-531; Li YY, 2011, METHODS MOL BIOL, V791, P11, DOI 10.1007/978-1-61779-316-5_2; Li YF, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt766; Lindhout BI, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm618; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Namekawa SH, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.195; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Sugizaki K, 2011, ORG BIOMOL CHEM, V9, P4176, DOI 10.1039/c1ob05247k; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Tanaka K, 2007, J AM CHEM SOC, V129, P14511, DOI 10.1021/ja076140r; vanGijlswijk RPM, 1997, J HISTOCHEM CYTOCHEM, V45, P375, DOI 10.1177/002215549704500305; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041	29	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95750	10.1371/journal.pone.0095750	http://dx.doi.org/10.1371/journal.pone.0095750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755742	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300087
J	Dong, TT; Chen, GP; Tian, SB; Xie, QL; Yin, WC; Zhang, YJ; Hu, ZL				Dong, Tingting; Chen, Guoping; Tian, Shibing; Xie, Qiaoli; Yin, Wencheng; Zhang, Yanjie; Hu, Zongli			A Non-Climacteric Fruit Gene CaMADS-RIN Regulates Fruit Ripening and Ethylene Biosynthesis in Climacteric Fruit	PLOS ONE			English	Article							MADS BOX GENES; CAROTENOID BIOSYNTHESIS; LIPOXYGENASE GENES; DOWN-REGULATION; ANTISENSE GENE; TOMATO; EXPRESSION; IDENTIFICATION; PHYTOENE; CLONING	MADS-box genes have been reported to play a major role in the molecular circuit of developmental regulation. Especially, SEPALLATA (SEP) group genes play a central role in the developmental regulation of ripening in both climacteric and non-climacteric fruits. However, the mechanisms underlying the regulation of SEP genes to non-climacteric fruits ripening are still unclear. Here a SEP gene of pepper, CaMADS-RIN, has been cloned and exhibited elevated expression at the onset of ripening of pepper. To further explore the function of CaMADS-RIN, an overexpressed construct was created and transformed into ripening inhibitor (rin) mutant tomato plants. Broad ripening phenotypes were observed in CaMADS-RIN overexpressed rin fruits. The accumulation of carotenoid and expression of PDS and ZDS were enhanced in overexpressed fruits compared with rin mutant. The transcripts of cell wall metabolism genes (PG, EXP1 and TBG4) and lipoxygenase genes (TomloxB and TomloxC) accumulated more abundant compared to rin mutant. Besides, both ethylene-dependent genes including ACS2, ACO1, E4 and E8 and ethylene-independent genes such as HDC and Nor were also up-regulated in transgenic fruits at different levels. Moreover, transgenic fruits showed approximately 1-3 times increase in ethylene production compared with rin mutant fruits. Yeast two-hybrid screen results indicated that CaMADS-RIN could interact with TAGL1, FUL1 and itself respectively as SlMADS-RIN did in vitro. These results suggest that CaMADS-RIN affects fruit ripening of tomato both in ethylene-dependent and ethylene-independent aspects, which will provide a set of significant data to explore the role of SEP genes in ripening of non-climacteric fruits.	[Dong, Tingting; Chen, Guoping; Xie, Qiaoli; Yin, Wencheng; Zhang, Yanjie; Hu, Zongli] Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China; [Tian, Shibing] Chongqing Acad Agr Sci, Inst Vegetable Res, Chongqing, Peoples R China	Chongqing University	Hu, ZL (corresponding author), Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China.	huzongli@cqu.edu.cn	Xie, Qiaoli/AAH-1705-2019		National Natural Science Foundation of China [30771463, 31171968, 30871709]; Natural Science Foundation of Chongqing of China [cstc, 2011BB1068]; Fundamental Research Funds for the Central Universities [CDJRC10230007]; Technology System of NationalBulk Vegetable Industry-Eggplant Breeding Position [CARS-25-A-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing of China(Natural Science Foundation of Chongqing); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Technology System of NationalBulk Vegetable Industry-Eggplant Breeding Position	This work was supported by National Natural Science Foundation of China (nos. 30771463, 31171968, 30871709), Natural Science Foundation of Chongqing of China (No. cstc, 2011BB1068), the Fundamental Research Funds for the Central Universities (no. CDJRC10230007), and Technology System of NationalBulk Vegetable Industry-Eggplant Breeding Position (CARS-25-A-06). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; BIRD CR, 1991, BIO-TECHNOL, V9, P635, DOI 10.1038/nbt0791-635; Blume B, 1997, PLANT J, V12, P731, DOI 10.1046/j.1365-313X.1997.12040731.x; Bramley P. M., 1993, CAROTENOIDS PHOTOSYN, P127, DOI DOI 10.1007/978-94-011-2124-8_5; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Cazzonelli CI, 1998, AUST J PLANT PHYSIOL, V25, P513, DOI 10.1071/PP98013; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; Dong TT, 2013, PLANT PHYSIOL, V163, P1026, DOI 10.1104/pp.113.224436; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; FERRIE BJ, 1994, PLANT PHYSIOL, V106, P109, DOI 10.1104/pp.106.1.109; Forth D, 2006, J EXP BOT, V57, P1971, DOI 10.1093/jxb/erj144; FRASER PD, 1994, PLANT PHYSIOL, V105, P405, DOI 10.1104/pp.105.1.405; FRAY RG, 1993, PLANT MOL BIOL, V22, P589, DOI 10.1007/BF00047400; Fujisawa M, 2012, PLANTA, V235, P1107, DOI 10.1007/s00425-011-1561-2; Fujisawa M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-26; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Griffiths A, 1999, J EXP BOT, V50, P793, DOI 10.1093/jexbot/50.335.793; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Hiwasa K, 2003, J EXP BOT, V54, P771, DOI 10.1093/jxb/erg073; Ireland HS, 2013, PLANT J, V73, P1044, DOI 10.1111/tpj.12094; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; Kesanakurti D, 2012, PHYSIOL PLANTARUM, V146, P136, DOI 10.1111/j.1399-3054.2012.01626.x; Kneissl ML, 1996, PLANT PHYSIOL, V112, P537, DOI 10.1104/pp.112.2.537; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Krasnyanski SF, 2001, IN VITRO CELL DEV-PL, V37, P427, DOI 10.1007/s11627-001-0075-1; Kumar R, 2012, MOL GENET GENOMICS, V287, P189, DOI 10.1007/s00438-011-0671-7; Lee S, 2010, FUNCT INTEGR GENOMIC, V10, P135, DOI 10.1007/s10142-009-0136-9; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; LINCOLN JE, 1987, P NATL ACAD SCI USA, V84, P2793, DOI 10.1073/pnas.84.9.2793; MANN V, 1994, PLANT MOL BIOL, V24, P429, DOI 10.1007/BF00024111; Mellway RD, 2013, J PLANT PHYSIOL, V170, P1424, DOI 10.1016/j.jplph.2013.05.010; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; PECKER I, 1992, P NATL ACAD SCI USA, V89, P4962, DOI 10.1073/pnas.89.11.4962; PENARRUBIA L, 1992, PLANT CELL, V4, P681, DOI 10.1105/tpc.4.6.681; PICTON S, 1993, PLANT MOL BIOL, V23, P627, DOI 10.1007/BF00019310; Rose JKC, 2000, PLANT PHYSIOL, V123, P1583, DOI 10.1104/pp.123.4.1583; Sandhu JS, 2000, TRANSGENIC RES, V9, P127, DOI 10.1023/A:1008979525909; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; SMITH CJS, 1990, PLANT MOL BIOL, V14, P369, DOI 10.1007/BF00028773; Smith DL, 2002, PLANT PHYSIOL, V129, P1755, DOI 10.1104/pp.011025; Sung SK, 2001, MOL CELLS, V11, P352; Tigchelaar E., 1973, REP TOMATO GENET COO, V23, P33; Trainotti L, 2005, J EXP BOT, V56, P2037, DOI 10.1093/jxb/eri202; Victoria BM, 2003, PLANT MOL BIOL, V52, P801, DOI 10.1023/A:1025001402838; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936	54	18	22	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95559	10.1371/journal.pone.0095559	http://dx.doi.org/10.1371/journal.pone.0095559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751940	gold, Green Submitted, Green Published			2022-12-25	WOS:000335227400074
J	Faria, TD; Costa, GP; Almenara, CCP; Angeli, JK; Vassallo, DV; Stefanon, I; Vassallo, PF				Faria, Thais de Oliveira; Costa, Gustavo Pinto; Pereira Almenara, Camila Cruz; Angeli, Jhuli Keli; Vassallo, Dalton Valentim; Stefanon, Ivanita; Vassallo, Paula Frizera			Chronic Exposure to Low Doses of HgCl2 Avoids Calcium Handling Impairment in the Right Ventricle after Myocardial Infarction in Rats	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; HEART-FAILURE; MERCURY; RISK; HYPERTENSION; CORONARY; BLOOD; CONTRACTILITY; PERFORMANCE	Right ventricle systolic dysfunction is a major risk factor for death and heart failure after myocardial infarction (MI). Heavy metal exposure has been associated with the development of several cardiovascular diseases, such as MI. The aim of this study was to investigate whether chronic exposure to low doses of mercury chloride (HgCl2) enhances the functional deterioration of right ventricle strips after MI. Male Wistar rats were divided into four groups: Control (vehicle); HgCl2 (exposure during 4 weeks-1st dose 4.6 mu g/kg, subsequent dose 0.07 mu g/kg/day, i.m. to cover daily loss); MI surgery induced and HgCl2-MI groups. One week after MI, the morphological and hemodynamic measurements and isometric tension of right ventricle strips were investigated. The chronic HgCl2 exposure did not worsen the injury compared with MI alone in the morphological or hemodynamic parameters evaluated. At basal conditions, despite similar maximum isometric force at L-max, relaxation time was increased in the MI group but unaffected in the HgCl2-MI compared to the Control group. Impairment of the sarcoplasmic reticulum (SR) function and reduction in the sarcolemmal calcium influx were observed in MI group associated with SERCA2a reduction and increased PLB protein expression. Induction of MI in chronic HgCl2 exposed rats did not cause any alteration in the developed force at L-max, lusitropic function or -dF/dt except for a tendency of a reduction SR function. These findings could be partially explained by the normalization in the sarcolemmal calcium influx and the increase in NCX protein expression observed only in this group. These results suggest that chronic exposure to low doses of HgCl2 prevents the impaired SR function and the reduced sarcolemmal calcium influx observed in MI likely by acting on NCX, PLB and SERCA2a protein expression.	[Faria, Thais de Oliveira; Costa, Gustavo Pinto; Pereira Almenara, Camila Cruz; Angeli, Jhuli Keli; Vassallo, Dalton Valentim; Stefanon, Ivanita; Vassallo, Paula Frizera] Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Brazil; [Vassallo, Dalton Valentim] EMESCAM, Escola Ensino Super Santa Casa de Misericordia Vi, Vitoria, Brazil	Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria	Vassallo, PF (corresponding author), Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Brazil.	paula.frizera@terra.com.br	Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Stefanon, Ivanita/0000-0003-2638-5183; Vassallo, Dalton/0000-0002-4463-4174	FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo) [54685435/2011]; PRONEX FAPES/CNPq (FAPES/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [48511935/2009]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo); PRONEX FAPES/CNPq (FAPES/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from No. 54685435/2011-FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo), No. 48511935/2009 PRONEX FAPES/CNPq (FAPES/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Anavekar NS, 2008, AM J CARDIOL, V101, P607, DOI 10.1016/j.amjcard.2007.09.115; Bauersachs J, 2008, PHARMACOL REP, V60, P119; Bers DM, 2013, ANNU REV PHYSIOL; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Booth FW, 2008, BRIT J SPORT MED, V42, P950, DOI 10.1136/bjsm.2008.052589; Chen CY, 2005, CLIN CHEM, V51, P759, DOI 10.1373/clinchem.2004.042093; CLARKSON TW, 1987, ENVIRON HEALTH PERSP, V75, P59, DOI 10.2307/3430577; Dangas G, 1998, J AM COLL CARDIOL, V32, P2035, DOI 10.1016/S0735-1097(98)00469-0; Faria Tde O, 2010, ARCH MED RES, V42, P274; Fioresi M, 2013, BRAZ J MED BIOL RES, V46, P178, DOI 10.1590/1414-431X20122190; Furieri LB, 2011, BRIT J PHARMACOL, V162, P1819, DOI 10.1111/j.1476-5381.2011.01203.x; Furieri LB, 2011, TOXICOL APPL PHARM, V255, P193, DOI 10.1016/j.taap.2011.06.015; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Gupta M, 1996, IND HEALTH, V34, P421, DOI 10.2486/indhealth.34.421; Hashimoto M, 2001, CLIN RADIOL, V56, P17, DOI 10.1053/crad.2000.0601; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Houston MC, 2011, J CLIN HYPERTENS, V13, P621, DOI 10.1111/j.1751-7176.2011.00489.x; Jasmin JF, 2003, CARDIOVASC RES, V58, P621, DOI 10.1016/S0008-6363(03)00290-6; KANLUEN S, 1991, ARCH PATHOL LAB MED, V115, P56; Mill JG, 2011, BRAZ J MED BIOL RES, V44, P890, DOI 10.1590/S0100-879X2011000900010; MILL JG, 1990, CARDIOVASC RES, V24, P748, DOI 10.1093/cvr/24.9.748; Moreira CM, 2003, COMP BIOCHEM PHYS C, V135, P269, DOI 10.1016/S1532-0456(03)00110-8; Mozaffarian D, 2011, NEW ENGL J MED, V364, P1116, DOI 10.1056/NEJMoa1006876; ORCHARD CH, 1983, NATURE, V304, P735, DOI 10.1038/304735a0; Park SK, 2013, ENVIRON RES, V123, P25, DOI 10.1016/j.envres.2013.02.003; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Rossoni LV, 2006, LIFE SCI, V79, P1537, DOI 10.1016/j.lfs.2006.04.017; Rossoni LV, 1999, BRAZ J MED BIOL RES, V32, P989, DOI 10.1590/S0100-879X1999000800009; Ryden L, 2012, DIABETES VASC DIS RE, V9, P170, DOI 10.1177/1479164112451581; SALONEN JT, 1995, CIRCULATION, V91, P645, DOI 10.1161/01.CIR.91.3.645; Stefanon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064986; Vassallo DV, 2011, BRAZ J MED BIOL RES, V44, P939, DOI 10.1590/S0100-879X2011000900016; Vassallo DV, 1999, TOXICOL APPL PHARM, V156, P113, DOI 10.1006/taap.1999.8636; Walker LA, 2013, CURR CARDIOL REV, V9, P73, DOI 10.2174/1573403X11309010009; Wiggers GA, 2008, COMP BIOCHEM PHYS C, V147, P252, DOI 10.1016/j.cbpc.2007.10.003; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Zornoff LAM, 2002, J AM COLL CARDIOL, V39, P1450, DOI 10.1016/S0735-1097(02)01804-1	40	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95639	10.1371/journal.pone.0095639	http://dx.doi.org/10.1371/journal.pone.0095639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748367	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500132
J	Vieira, LM; Jones, MES; Winston, JE; Migotto, AE; Marques, AC				Vieira, Leandro M.; Jones, Mary E. Spencer; Winston, Judith E.; Migotto, Alvaro E.; Marques, Antonio C.			Evidence for Polyphyly of the Genus Scrupocellaria (Bryozoa: Candidae) Based on a Phylogenetic Analysis of Morphological Characters	PLOS ONE			English	Article							1ST RECORD; SEA; BIODIVERSITY; FAUNA	The bryozoan genus Scrupocellaria comprises about 80 species in the family Candidae. We propose a hypothesis for the phylogenetic relationships among species assigned to Scrupocellaria to serve as framework for a phylogenetic classification using 35 morphological characters. Our results suggest that the genus Scrupocellaria is polyphyletic. Scrupocellaria s. str. is redefined according to four morphological features: vibracular chamber with a curved setal groove, ooecium with a single ectooecial fenestra, two axillary vibracula, and a membranous operculum with a distinct distal rim. Thus, the genus includes only 11 species: Scrupocellaria aegeensis, Scrupocellaria delilii, Scrupocellaria harmeri, Scrupocellaria incurvata, Scrupocellaria inermis, Scrupocellaria intermedia, Scrupocellaria jullieni, Scrupocellaria minuta, Scrupocellaria puelcha, Scrupocellaria scrupea, and Scrupocellaria scruposa. The monophyly of Cradoscrupocellaria is supported and five new genera are erected: Aquiloniella n. gen., Aspiscellaria n. gen., Paralicornia n. gen., Pomocellaria n. gen. and Scrupocaberea n. gen. Two other new genera, Bathycellaria n. gen. and Sinocellaria n. gen., are erected to accommodate two poorly known species, Scrupocellaria profundis Osburn and Scrupocellaria uniseriata Liu, respectively. Scrupocellaria congesta is tentatively assigned to Tricellaria. Fifteen species are reassigned to Licornia: Licornia cookie n. comb., Licornia micheli n. comb., Licornia milneri n. comb., Licornia curvata n. comb., Licornia diegensis n. comb., Licornia drachi n. comb., Licornia mexicana n. comb., Licornia pugnax n. comb., Licornia raigadensis n. comb., Licornia regularis n. comb., Licornia resseri n. comb., Licornia securifera n. comb., Licornia spinigera n. comb., Licornia tridentata n. comb., and Licornia wasinensis n. comb. Notoplites americanus n. name is proposed as a replacement name for Scrupocellaria clausa Canu & Bassler. Three fossil species are reassigned to Canda: Canda rathbuni n. comb., Canda triangulata n. comb. and Canda williardi n. comb. A species is reassigned to Notoplites, Notoplites elegantissima n. comb. The generic assignment of eleven species of Scrupocellaria, including Scrupocellaria macandrei, remains uncertain.	[Vieira, Leandro M.; Migotto, Alvaro E.; Marques, Antonio C.] Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil; [Jones, Mary E. Spencer] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Winston, Judith E.] Virginia Museum Nat Hist, Martinsville, VA USA; [Marques, Antonio C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidade de Sao Paulo; Natural History Museum London; Universidade de Sao Paulo	Vieira, LM (corresponding author), Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil.	leandromanzoni@hotmail.com	Migotto, Alvaro E/D-3748-2011; Vieira, Leandro/B-7712-2011; Fapesp, Biota/F-8655-2017; Marques, Antonio Carlos/E-8049-2011	Migotto, Alvaro E/0000-0003-3887-1947; Vieira, Leandro/0000-0001-8661-8861; Fapesp, Biota/0000-0002-9887-8449; Marques, Antonio Carlos/0000-0002-2884-0541	Sao Paulo Research Foundation - FAPESP through the Graduate Program in Zoology of the Departamento de Zoologia - IBUSP [Proc. 2008/10619-0]; FAPESP [Proc. 2012/24285-1, Proc. 2010/52324-6, 2011/50242-5, 2013/50484-4]; International Bryozoology Association; CAPES; CNPq [Proc. 304720/2009-7, 562143/2010-6, 563106/2010-7, 458555/2013-4]; PROEX-CAPES (IBUSP)	Sao Paulo Research Foundation - FAPESP through the Graduate Program in Zoology of the Departamento de Zoologia - IBUSP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Bryozoology Association; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROEX-CAPES (IBUSP)	This study is part of the L. M. Vieira's PhD thesis supported by Sao Paulo Research Foundation - FAPESP (Proc. 2008/10619-0) through the Graduate Program in Zoology of the Departamento de Zoologia - IBUSP, and supported by FAPESP (Proc. 2012/24285-1) and International Bryozoology Association. A. C. Marques was supported by CAPES, CNPq (Proc. 304720/2009-7, 562143/2010-6, 563106/2010-7, 458555/2013-4) and FAPESP (Proc. 2010/52324-6, 2011/50242-5, 2013/50484-4). Publication charges were supported by the PROEX-CAPES (IBUSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audouin J.V., 1826, DESCRIPTION EGYPTE H, P225; Badve R.M., 1997, Journal of the Palaeontological Society of India, V42, P35; Bizzarini F., 1999, ANN MUSEO CIVICO ROV, V13, P91; Bizzarini Fabrizio, 2001, Bollettino della Societa Paleontologica Italiana, V40, P445; Bock P., 2013, RECENT FOSSIL BRYOZO; BREMER K, 1990, CLADISTICS, V6, P369, DOI 10.1111/j.1096-0031.1990.tb00551.x; Brock B.J., 1985, P45; Busk G., 1884, ZOOLOGY, V10, P1; Busk G., 1851, ANN MAG NAT HIST, V2, P81; Busk G., 1852, CATALOGUE MARINE POL; Busk G, 1860, Q J MICROSCOPICAL SC, V8, P280, DOI [10.1242/jcs.s1-8.32.280, DOI 10.1242/JCS.S1-8.32.280]; Canning-Clode J, 2013, AQUAT INVASIONS, V8, P261, DOI 10.3391/ai.2013.8.3.02; Canu F., 1927, Bulletin Soc Sci Seine-et-Oise Ser 2, V8, P1; Canu F., 1920, B US NATL MUSEUM, V106, P1, DOI [DOI 10.5479/SI.03629236.106.I, 10.5962/bhl.title.1142]; Carter MC, 2010, MAR ECOL PROG SER, V399, P117, DOI 10.3354/meps08348; d'Orbigny A., 1841, VOYAGE AMERIQUE MERI, V5, P7; d'Orbigny A., 1851, PALEONTOLOGIE FRANCA; DAVID L, 1986, ANN I OCEANOGR PARIS, V62, P141; Denisenko Nina V., 2008, P35; Ellis J., 1755, ESSAY NATURAL HIST C; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fransen C. H. J. M., 1986, STUD FAUNA CURACAO C, V68, P1; Galil Bella S., 2007, Aquatic Invasions, V2, P281, DOI 10.3391/ai.2007.2.4.2; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GORDON D P, 1986, New Zealand Oceanographic Institute Memoir, P1; Gordon D.P., 1984, New Zealand Oceanographic Institute Memoir, P1; Grischenko AV, 2013, DEEP-SEA RES PT II, V86-87, P172, DOI 10.1016/j.dsr2.2012.08.003; Hao JS, 2005, CHINESE SCI BULL, V50, P1205, DOI 10.1360/982004-755; Harmelin J.-G., 1969, B MUS NAT HIST NAT 2, V40, P1179; Harmer S. F., 1923, Journal of the Linnean Society London Zoology, V35, P293; Harmer S.F., 1926, SIBOGA EXPEDITIE, V28b, P181; Hastings A. B., 1943, Discovery Reports Cambridge, V22, P301; Haswell A. W., 1880, Proceedings of the Linnean Society of New South Wales, Vv, P33; Hayward P.J., 1981, Galathea Report, V15, P21; Hayward P.J., 1998, SYNOPSES BRIT FAUNA, V10, P1; HAYWARD PJ, 1978, J ZOOL, V184, P207; Hayward PJ, 2002, B AM MUS NAT HIST, P1; HAYWARD PJ, 1988, J ZOOL, V215, P269, DOI 10.1111/j.1469-7998.1988.tb04900.x; Hincks T.H, 1882, ANN MAGAZINE NATUR 5, V10, P459, DOI [10.1080/00222938209459751, DOI 10.1080/00222938209459751]; Jullien JL, 1903, RESULTATS CAMPAGNES, V23, P1; Kirkpatrick R., 1888, Annals of Natural History, V(6), P72; Kirkpatrick R, 1890, J LINN SOC LOND, V20, P504; Kluge G.A., 1915, FAUNA KOLSKY GULF CO, V8, P376; Kluge G.A., 1955, ATLAS INVERTEBRATES, P99; Kluge GA, 1962, 76 AK NAUK SSSR, V76; Knight S, 2011, MOL PHYLOGENET EVOL, V61, P351, DOI 10.1016/j.ympev.2011.07.005; Linnaeus C, 1758, SYSTEMA NATURAE PER; Liu X., 1984, Studia Marina Sinica, P257; Liu X, 1980, STUD MAR SIN, V17, P179; Lodola Alice, 2012, Marine Biodiversity Records, V5, pe41, DOI 10.1017/S1755267212000309; Lopez Gappa J.J., 1982, Physis Secciones A B y C (Buenos Aires), V40, P59; MacGillivray PH, 1895, P R SOC VIC, V4, P1, DOI DOI 10.5962/BHL.TITLE.6076; Maddison WP, 2011, MESQUITE MODULAR SYS; MALECKI J, 1979, B POL ACAD SCI-EARTH, V27, P159; Maplestone CM, 1909, P ROYAL SOC VICTORIA, V21, P410; Marcus E., 1955, Arquivos do Museu Nacional Rio de Janeiro, V42, P273; Marques AC, 2013, LAT AM J AQUAT RES, V41, P265, DOI 10.3856/vol41-issue2-fulltext-6; Norman A. M., 1867, Report British Association, P193; Norman A.M., 1903, ANN MAG NAT HIST, V7, P567, DOI [10.1080/00222930308678818, DOI 10.1080/00222930308678818]; Norman AM, 1893, ANN MAG NAT HIST, V12, P446; O'Donoghue C. H., 1926, CONTRIBUTIONS CANADI, V3, P47, DOI DOI 10.1139/F26-003; Osburn R. C., 1950, Allan Hancock Pacific Expedition, V14, P1; Osburn Raymond C., 1947, REPT ALLAN HANCOCK ATLANTIC EXPED, V5, P1; Packard AS., 1863, CANADIAN NATURALIST, V8, P401; Pourtales L. F. De., 1868, Bulletin of the Museum of Comparative Zoology at Harvard College, VNo. 6, P103; Reuss A.E., 1848, HAIDINGERS NATURWISS, V2, P1; Reuss A.E., 1869, MATH NATURWISSENSCHA, V59, P446; Robertson A, 1905, U CALIF PUBL ZOOL, V2, P235; Farrapeira CMR, 2011, MAR POLLUT BULL, V62, P832, DOI 10.1016/j.marpolbul.2010.12.014; Rocha RM, 2013, MAR POLLUT BULL, V67, P241, DOI 10.1016/j.marpolbul.2012.12.009; Ryland JS, 1970, BRYOZOANS; SAVIGNY J. C., 1817, DESCRIPTION EGYPTE R, V2; Silun L., 1977, BIOL BRYOZOANS, P184, DOI DOI 10.1016/B978-0-12-763150-9.50012-X; Smitt F.A., 1872, KONGLIGA SVENSKA VET, V10, P1; TAYLOR P. D., 2008, VIRGINIA MUSEUM NATU, V15, P101; Thomson C.W., 1858, P DUBLIN U ZOOLOGICA, V1, P77; Tilbrook K. J., 2006, SANTA BARBARA MUSEUM, V3, P1; Tilbrook KJ, 2012, ZOOTAXA, P29; Trask J, 1857, P CAL ACAD SCI, V1-2, P11; van Beneden P.J., 1845, NOUVELLE MEMOIRES LA, V18, P1; Van Beneden P.-J., 1850, B ACAD ROYALE BELGIQ, V16, P644; Van Beneden PJ., 1848, B ACAD ROY SCI BELG, V15, P67; Vieira LM, 2008, ZOOTAXA, P1; Vieira LM, 2012, ZOOTAXA, P26; Vieira LM, 2013, J MAR BIOL ASSOC UK, V93, P1911, DOI 10.1017/S0025315413000301; Vieira LM, 2013, ZOOTAXA, V3707, P1, DOI 10.11646/zootaxa.3707.1.1; Vieira LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040492; Vieira LM, 2012, CAH BIOL MAR, V53, P159; Waters Arthur Wm., 1909, Journal of the Linnean Society London Zoology, V31; Waters AW, 1913, P ZOOL SOC LOND, V1913, P458; Waters AW, 1897, ZOOL J LINN SOC-LOND, V26, P1, DOI [10.1111/j.1096-3642.1897.tb00241.x, DOI 10.1111/J.1096-3642.1897.TB00241.X]; Waters AW, 1891, Q J GEOL SOC LOND, V47, P1, DOI DOI 10.1144/GSL.JGS.1891.047.01-04.03; Winston J.E., 1984, American Museum Novitates, P1; Winston J.E., 2005, VIRGINIA MUSEUM NATU, V7, P1; Yanagi Naokatsu, 1918, Annotationes Zoologicae Japonenses, V9; Zintzen V, 2010, BELG J ZOOL, V140, P20	96	23	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95296	10.1371/journal.pone.0095296	http://dx.doi.org/10.1371/journal.pone.0095296			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747915	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500080
J	Castellone, MD; Laukkanen, MO; Teramoto, H; Bellelli, R; Ali, G; Fontanini, G; Santoro, M; Gutkind, JS				Castellone, M. D.; Laukkanen, M. O.; Teramoto, H.; Bellelli, R.; Ali, G.; Fontanini, G.; Santoro, M.; Gutkind, J. S.			Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma	ONCOGENE			English	Article							GASTRIN-RELEASING-PEPTIDE; NF-KAPPA-B; AUTOCRINE GROWTH; CANCER; ACTIVATION; RHO; BINDING; REQUIREMENT; INHIBITION; GTPASES	Small cell lung carcinoma (SCLC) often features the upregulation of the Sonic hedgehog (Shh) pathway leading to activation of Gli transcription factors. SCLC cells secrete bombesin (BBS)-like neuropeptides that act as autocrine growth factors. Here, we show that SCLC tumor samples feature co-expression of Shh and BBS-cognate receptor (gastrin-releasing peptide receptor (GRPR)). We also demonstrate that BBS activates Gli in SCLC cells, which is crucial for BBS-mediated SCLC proliferation, because cyclopamine, an inhibitor of the Shh pathway, hampered the BBS-mediated effects. BBS binding to GRPR stimulated Gli through its downstream G alpha(q) and G alpha(12/13) GTPases, and consistently, other G alpha(q) and G alpha(13) coupled receptors (such as muscarinic receptor, m1, and thrombin receptor, PAR-1) and constitutively active G alpha(q)QL and G alpha(12/13)QL mutants stimulated Gli. By using cells null for G alpha(q) and G alpha(12/13), we demonstrate that these G proteins are strictly necessary for Gli activation by BBS. Moreover, by using constitutively active Rho small G-protein (Rho QL) as well as its inhibitor, C3 toxin, we show that Rho mediates G-protein-coupled receptor (GPCR)-, G alpha(q)- and G alpha(12/13)-dependent Gli stimulation. At the molecular level, BBS caused a significant increase in Shh gene transcription and protein secretion that was dependent on BBS-induced GPCR/G alpha(q)-(12/13)/Rho mediated activation of nuclear factor kappa B (NF kappa B), which can stimulate a NF-kappa B response element in the Shh gene promoter. Our data identify a novel molecular network acting in SCLC linking autocrine BBS and Shh circuitries and suggest Shh inhibitors as novel therapeutic strategies against this aggressive cancer type.	[Castellone, M. D.; Teramoto, H.; Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Castellone, M. D.; Bellelli, R.; Santoro, M.] Univ Naples Federico II, Ist Endocrinol Oncol Sperimentale G Salvatore IEO, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Laukkanen, M. O.] SDN Fdn, Naples, Italy; [Teramoto, H.] Kojin Hosp, Dept Internal Med, Nagoya, Aichi, Japan; [Ali, G.; Fontanini, G.] Univ Pisa, Dept Surg, Div Anat Pathol, Pisa, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Pisa	Castellone, MD (corresponding author), Univ Naples Federico II, Ist Endocrinol Oncol Sperimentale G Salvatore IEO, Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	mcastell@unina.it	Alì, Greta/J-9642-2016; Fontanini, Gabriella/O-7636-2015; Gutkind, J. Silvio/J-1201-2016; Laukkanen, Mikko/K-5868-2016	Alì, Greta/0000-0001-9258-3466; Fontanini, Gabriella/0000-0003-1957-2052; Gutkind, J. Silvio/0000-0002-5150-4482; Laukkanen, Mikko/0000-0002-1004-7131; CASTELLONE, MARIADOMENICA/0000-0003-0507-8037	Associazione Italiana per la Ricerca sul Cancro (AIRC); Intramural Research Program of NIH, National Institute of Dental and Craniofacial Research [Z01DE00551]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Intramural Research Program of NIH, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was in part supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) and by the Intramural Research Program of NIH, National Institute of Dental and Craniofacial Research, Z01DE00551.	ALEXANDER RW, 1988, CANCER RES, V48, P1439; BRENNAN J, 1991, CANCER RES, V51, P1708; Bruzzese F, 2009, MOL CANCER THER, V8, P3075, DOI 10.1158/1535-7163.MCT-09-0254; CARNEY DN, 1987, CANCER RES, V47, P821; CARNEY DN, 1985, CANCER RES, V45, P2913; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; CORJAY MH, 1991, J BIOL CHEM, V266, P18771; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Douglas AE, 2011, J BIOL CHEM, V286, P30714, DOI 10.1074/jbc.M111.219279; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kasperczyk H, 2009, FASEB J, V23, P21, DOI 10.1096/fj.08-111096; Kiaris H, 1999, ONCOGENE, V18, P7168, DOI 10.1038/sj.onc.1203213; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kim S, 2002, ANN SURG, V235, P621, DOI 10.1097/00000658-200205000-00003; Lango MN, 2002, J NATL CANCER I, V94, P375; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Mulshine JL, 2005, NEW ENGL J MED, V352, P2714, DOI 10.1056/NEJMcp042630; Offermanns S, 1998, ONCOGENE, V17, P1375, DOI 10.1038/sj.onc.1202173; Pacifico F, 2004, J BIOL CHEM, V279, P54610, DOI 10.1074/jbc.M403492200; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Ruiz I, 2002, NAT REV CANCER, V2, P361, DOI DOI 10.1038/NRC796; Saurin JC, 2002, CANCER RES, V62, P4829; Schally AV, 2004, CELL MOL LIFE SCI, V61, P1042, DOI 10.1007/s00018-004-3434-3; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; THOMAS F, 1992, CANCER RES, V52, P4872; ToiScott M, 1996, LUNG CANCER-J IASLC, V15, P341, DOI 10.1016/0169-5002(95)00597-8; Travis W, 2004, WHO CLASSIFICATION T; Watkins DN, 2003, CELL CYCLE, V2, P196, DOI 10.4161/cc.2.3.378; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839; Zakowski MF, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50015; Zhou JH, 2004, ANTI-CANCER DRUG, V15, P921, DOI 10.1097/00001813-200411000-00001	46	29	30	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1679	1687		10.1038/onc.2014.104	http://dx.doi.org/10.1038/onc.2014.104			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24747971	Green Accepted			2022-12-25	WOS:000351848400008
J	Shaik, MM; Maccagni, A; Tourcier, G; Di Guilmi, AM; Dessen, A				Shaik, Md Munan; Maccagni, Amandine; Tourcier, Guillaume; Di Guilmi, Anne Marie; Dessen, Andrea			Structural Basis of Pilus Anchoring by the Ancillary Pilin RrgC of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SURFACE; SORTASE; PROTEINS; VIRULENCE; STABILIZE; MECHANISM; ALIGNMENT; PYOGENES; SUBUNITS	Pili are surface-attached, fibrous virulence factors that play key roles in the pathogenesis process of a number of bacterial agents. Streptococcus pneumoniae is a causative agent of pneumonia and meningitis, and the appearance of drug-resistance organisms has made its treatment challenging, especially in developing countries. Pneumococcus-expressed pili are composed of three structural proteins: RrgB, which forms the polymerized backbone, RrgA, the tip-associated adhesin, and RrgC, which presumably associates the pilus with the bacterial cell wall. Despite the fact that the structures of both RrgA and RrgB were known previously, structural information for RrgC was still lacking, impeding the analysis of a complete model of pilus architecture. Here, we report the structure of RrgC to 1.85 and reveal that it is a three-domain molecule stabilized by two intradomain isopeptide bonds. RrgC does not depend on pilus-specific sortases to become attached to the cell wall; instead, it binds the preformed pilus to the peptidoglycan by employing the catalytic activity of SrtA. A comprehensive model of the type 1 pilus from S. pneumoniae is also presented.	[Shaik, Md Munan; Maccagni, Amandine; Tourcier, Guillaume; Di Guilmi, Anne Marie; Dessen, Andrea] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Shaik, Md Munan; Maccagni, Amandine; Tourcier, Guillaume; Di Guilmi, Anne Marie; Dessen, Andrea] CEA, F-38000 Grenoble, France; [Shaik, Md Munan; Maccagni, Amandine; Tourcier, Guillaume; Di Guilmi, Anne Marie; Dessen, Andrea] CNRS, UMR 5075, Grenoble, France; [Dessen, Andrea] Brazilian Natl Lab Biosci LNBio, CNPEM, BR-13083100 Campinas, SP, Brazil	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Dessen, A (corresponding author), Inst Biol Struct, Bacterial Pathogenesis Grp, 41 Ave Martyrs, F-38044 Grenoble, France.	andrea.dessen@ibs.fr		Dessen, Andrea/0000-0001-6487-4020; Di Guilmi, Anne Marie/0000-0001-7335-3470	FRISBI [ANR-10-INBS-05-02]; GRAL [ANR-10-LABX-49-01];  [ANR-11-BSV8-005-02]	FRISBI; GRAL; 	This work was supported by ANR-11-BSV8-005-02, including a postdoctoral fellowship (to M. M. S.) and used the platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INBS-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen WJ, 2012, CURR OPIN STRUC BIOL, V22, P500, DOI 10.1016/j.sbi.2012.02.001; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; El Mortaji L, 2012, BIOCHEMISTRY-US, V51, P342, DOI 10.1021/bi201591n; El Mortaji L, 2012, BIOCHEM J, V441, P833, DOI 10.1042/BJ20111397; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Kwon H, 2014, P NATL ACAD SCI USA, V111, P1367, DOI 10.1073/pnas.1316855111; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Paterson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022095; Persson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048364; Prabakaran P, 2008, ACTA CRYSTALLOGR D, V64, P1062, DOI 10.1107/S0907444908025274; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; SHOCKMAN GD, 1967, J BACTERIOL, V94, P1525, DOI 10.1128/JB.94.5.1525-1530.1967; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vengadesan K, 2011, PROTEIN SCI, V20, P759, DOI 10.1002/pro.613	60	33	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16988	16997		10.1074/jbc.M114.555854	http://dx.doi.org/10.1074/jbc.M114.555854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24755220	hybrid, Green Published			2022-12-25	WOS:000338016200033
J	Liu, CY; Wen, ZM; Li, Y; Peng, LP				Liu, Chaoying; Wen, Zhongmei; Li, Yang; Peng, Liping			Application of ThinPrep Bronchial Brushing Cytology in the Early Diagnosis of Lung Cancer: A Retrospective Study	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; RESPIRATORY CYTOLOGY; SPUTUM CYTOLOGY; SMALL BIOPSIES; CELL BLOCK; CLASSIFICATION; EPIDEMIOLOGY; PREVENTION; SPECIMENS; PITFALLS	The majority of lung cancer patients are diagnosed at advanced stages of disease. This study evaluated the diagnostic value of ThinPrep (TP) bronchial brushing cytology in lung cancer. A total of 595 patients with suspicious lung cancer were enrolled in this study. The bronchial brushing samples were prepared by TP. The data were then compared to histology of lung tissue samples. Histologically, 479 of these 595 patients were diagnosed with lung cancer, including 223 cases of lung squamous cell carcinoma (SCC), 77 cases of lung adenocarcinoma (ADC), and 152 cases of small cell lung carcinoma (SCLC). The TP cytology revealed a total of 460 cases of lung cancer (including 232 SCCs, 91 ADCs, and 108 SCLCs). The TP cytological technique had 87.06% sensitivity and 62.93% specificity in the diagnosis of lung cancer. Specifically, TP cytology confirmed 195 of 223 SCCs, 47 of 77 ADCs, and 94 of 152 SCLCs. The TP cytology showed 87.44% sensitivity and 90.05% specificity for the diagnosis of SCC, with a Matthew's correlation coefficient (MCC) of 0.820; while the sensitivity was reduced to 61.04% and the specificity was 90.93% for the diagnosis of ADC, with a MCC of 0.464. For the diagnosis of SCLC, the sensitivity was 61.84% and the specificity was 96.84%, with a MCC of 0.648. Thus, this study demonstrated the usefulness of TP bronchial brushing cytology in the early diagnosis of lung cancer, especially the early stage of lung SCC. A prospective clinical trial will verify these data before being translated into the clinic.	[Liu, Chaoying; Wen, Zhongmei; Li, Yang; Peng, Liping] Jilin Univ, Hosp 1, Dept Resp Med, Changchun 130023, Peoples R China	Jilin University	Peng, LP (corresponding author), Jilin Univ, Hosp 1, Dept Resp Med, Changchun 130023, Peoples R China.	plp640317@163.com						[Anonymous], 1982, Am J Clin Pathol, V77, P123; Cao Jian, 2006, Zhonghua Zhongliu Zazhi, V28, P536; Chi Qiong, 2010, Zhonghua Zhong Liu Za Zhi, V32, P221; Choi YD, 2008, DIAGN CYTOPATHOL, V36, P167, DOI 10.1002/dc.20761; Collins GR, 2012, CANCER CYTOPATHOL, V120, P134, DOI 10.1002/cncy.20181; D'Urso V, 2013, J CELL PHYSIOL, V228, P945, DOI 10.1002/jcp.24263; de Groot P, 2012, RADIOL CLIN N AM, V50, P863, DOI 10.1016/j.rcl.2012.06.006; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Dutt N, 2012, LUNG INDIA, V29, P199, DOI 10.4103/0970-2113.95352; Elsheikh TM, 2006, CANCER CYTOPATHOL, V108, P144, DOI 10.1002/cncr.21841; Erkilic S, 2003, ACTA CYTOL, V47, P1023, DOI 10.1159/000326639; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2000, INT J CANCER, V127, P2893; FRAIRE AE, 1991, ACTA CYTOL, V35, P385; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043441; Huang T, 2012, PROTEIN CELL, V3, P38, DOI 10.1007/s13238-011-1130-2; HUTCHINSON ML, 1991, AM J CLIN PATHOL, V96, P300, DOI 10.1093/ajcp/96.3.300; Idowu MO, 2010, INT J CLIN EXP PATHO, V3, P367; Kim S, 2009, CANCER CYTOPATHOL, V117, P51, DOI 10.1002/cncy.20007; Konofaos P, 2006, SURG ONCOL, V15, P173, DOI 10.1016/j.suronc.2006.12.001; Leung CS, 1997, DIAGN CYTOPATHOL, V16, P368, DOI 10.1002/(SICI)1097-0339(199704)16:4<368::AID-DC14>3.3.CO;2-H; Michael CW, 2000, DIAGN CYTOPATHOL, V23, P6, DOI 10.1002/1097-0339(200007)23:1<6::AID-DC2>3.3.CO;2-6; Rana DN, 2001, CYTOPATHOLOGY, V12, P390, DOI 10.1046/j.1365-2303.2001.00351.x; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA; Travis WD, 2010, J THORAC ONCOL, V5, P411, DOI 10.1097/JTO.0b013e3181d57f6e; Wallace WAH, 2007, J CLIN PATHOL, V60, P388, DOI 10.1136/jcp.2006.038901; Wright PK, 2012, CYTOPATHOLOGY, V23, P133, DOI 10.1111/j.1365-2303.2011.00919.x; Yadav Rohtas K, 2010, J Indian Med Assoc, V108, P571; Yang Yan, 2008, Zhonghua Zhongliu Zazhi, V30, P616; Ylagan LR, 2005, DIAGN CYTOPATHOL, V32, P137, DOI 10.1002/dc.20200	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e90163	10.1371/journal.pone.0090163	http://dx.doi.org/10.1371/journal.pone.0090163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759600	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200002
J	Ma, MM; Zhang, ZW; Du, EG; Zheng, WJ; Gu, Q; Xu, X; Ke, BL				Ma, Mingming; Zhang, Zhengwei; Du, Ergang; Zheng, Wenjing; Gu, Qing; Xu, Xun; Ke, Bilian			Wnt Signaling in Form Deprivation Myopia of the Mice Retina	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; GENOME-WIDE ASSOCIATION; EYE GROWTH; REFRACTIVE STATUS; OCULAR GROWTH; AXIAL MYOPIA; RISK-FACTORS; FACTOR BFGF; EXPRESSION; CHICK	Background: The canonical Wnt signaling pathway plays important roles in cellular proliferation and differentiation, axonal outgrowth, cellular maintenance in retinas. Here we test the hypothesis that elements of the Wnt signaling pathway are involved in the regulation of eye growth and prevention of myopia, in the mouse form-deprivation myopia model. Methodology/Principal Findings: (1) One hundred twenty-five C57BL/6 mice were randomly distributed into form deprivation myopia and control groups. Form-deprivation myopia (FDM) was induced by suturing the right eyelid, while the control group received no treatment. After 1, 2, and 4 weeks of treatment, eyes were assessed in vivo by cycloplegic retinoscopic refraction and axial length measurement by photography or A-scan ultrasonography. Levels of retinal Wnt2b, Fzd5 and beta-catenin mRNA and protein were evaluated using RT-PCR and western blotting, respectively. (2) Another 96 mice were divided into three groups: control, drugs-only, and drugs+FDM (by diffuser). Experimentally treated eyes in the last two groups received intravitreal injections of vehicle or the proteins, DKK-1 (Wnt-pathway antagonist) or Norrin (Wnt-pathway agonist), once every three days, for 4 injections total. Axial length and retinoscopic refraction were measured on the 14th day of form deprivation. Following form-deprivation for 1, 2, and 4 weeks, FDM eyes had a relatively myopic refractive error, compared with contralateral eyes. There were no significant differences in refractive error between right and left eye in control group. The amounts of Wnt2b, Fzd5 and b-catenin mRNA and protein were significantly greater in form-deprived myopia eyes than in control eyes. DKK-1 (antagonist) reduced the myopic shift in refractive error and increase in axial elongation, whereas Norrin had the opposite effect in FDM eyes. Conclusions/Significance: Our studies provide the first evidence that the Wnt2b signaling pathway may play a role in the development and progression of form-deprivation myopia, in a mammalian model.	[Ma, Mingming; Zhang, Zhengwei; Zheng, Wenjing; Gu, Qing; Xu, Xun; Ke, Bilian] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Ma, Mingming; Zhang, Zhengwei; Zheng, Wenjing; Gu, Qing; Xu, Xun; Ke, Bilian] Shanghai Key Lab Fundus Dis, Shanghai, Peoples R China; [Du, Ergang] Jinhua Eye Hosp, Jinhua, Zhejiang, Peoples R China	Shanghai Jiao Tong University	Xu, X (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China.	drxuxun@sjtu.edu.cn; kebilian@126.com			National Natural Science Foundation of China [81200713, 81170862, 81273424]; Hospital Training Plan of Medical Talent [12RC06]; foundation of Interdisciplinary Research of "Medical and Engineering or Science'' of Shanghai Jiaotong University [YG2011MS62]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hospital Training Plan of Medical Talent; foundation of Interdisciplinary Research of "Medical and Engineering or Science'' of Shanghai Jiaotong University	This work was sponsored by the National Natural Science Foundation of China (grant number 81200713); the Hospital Training Plan of Medical Talent in 2012 (grant number 12RC06); the foundation of Interdisciplinary Research of "Medical and Engineering or Science'' of Shanghai Jiaotong University (grant number YG2011MS62); the National Natural Science Foundation of China (grant number 81170862); and the National Natural Science Foundation of China (grant number 81273424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borello U, 1999, MECH DEVELOP, V89, P173, DOI 10.1016/S0925-4773(99)00205-1; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Chalupa LM, 2008, EYE RETINA VISUAL SY, Vxii, P754; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; de Iongh RU, 2006, FRONT BIOSCI-LANDMRK, V11, P2442, DOI 10.2741/1982; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Feldkaemper MP, 2009, INVEST OPHTH VIS SCI, V50, P13, DOI 10.1167/iovs.08-1702; George A, 2005, EXP EYE RES, V81, P616, DOI 10.1016/j.exer.2005.03.021; HODOS W, 1990, VISION RES, V30, P653, DOI 10.1016/0042-6989(90)90091-X; Hoffmann M, 1996, NEUROCHEM INT, V28, P95, DOI 10.1016/0197-0186(95)00050-I; Hu JM, 2008, MOL VIS, V14, P2373; HUNG LF, 1995, NAT MED, V1, P761, DOI 10.1038/nm0895-761; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; KHAMAR BM, 1990, OPTOMETRY VISION SCI, V67, P908, DOI 10.1097/00006324-199012000-00007; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Lad EM, 2009, STEM CELLS DEV, V18, P7, DOI 10.1089/scd.2008.0169; Lam CSY, 2004, OPTOMETRY VISION SCI, V81, P317, DOI 10.1097/01.opx.0000134905.98403.18; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Liu CQ, 2012, HUM MOL GENET, V21, P1848, DOI 10.1093/hmg/ddr616; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu F, 2006, EXP EYE RES, V82, P628, DOI 10.1016/j.exer.2005.09.001; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Mao JF, 2006, CURR EYE RES, V31, P983, DOI 10.1080/02713680600910510; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; Nakagawa S, 2004, SEIKAGAKU, V76, P1573; OSOL G, 1986, INVEST OPHTH VIS SCI, V27, P255; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Parodi MB, 2010, DEV OPHTHALMOL, V46, P73, DOI 10.1159/000320010; Penha AM, 2011, MOL VIS, V17, P1436; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Qian YS, 2009, CURR EYE RES, V34, P623, DOI 10.1080/02713680903003492; Rasmussen JT, 2001, P NATL ACAD SCI USA, V98, P3861, DOI 10.1073/pnas.071586298; REH TA, 1993, J NEUROBIOL, V24, P949, DOI 10.1002/neu.480240708; ROHRER B, 1994, EXP EYE RES, V58, P553, DOI 10.1006/exer.1994.1049; ROHRER B, 1995, BRAIN RES, V686, P169, DOI 10.1016/0006-8993(95)00370-6; Rohrer B, 1997, NEUROSCIENCE, V79, P775, DOI 10.1016/S0306-4522(97)00042-0; ROTHBLAT LA, 1979, BRAIN RES, V161, P156, DOI 10.1016/0006-8993(79)90203-8; Schaeffel F, 2004, OPTOMETRY VISION SCI, V81, P99, DOI 10.1097/00006324-200402000-00008; Schroer U, 2007, EUR J NEUROSCI, V26, P2169, DOI 10.1111/j.1460-9568.2007.05849.x; Seko Y, 1998, OPHTHALMIC RES, V30, P361, DOI 10.1159/000055496; SELTNER RLP, 1995, VISION RES, V35, P1265, DOI 10.1016/0042-6989(94)00244-G; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; STONE RA, 1988, P NATL ACAD SCI USA, V85, P257, DOI 10.1073/pnas.85.1.257; THORN F, 1982, CURR EYE RES, V1, P727, DOI 10.3109/02713688108998372; Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P2043; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Wang Q, 2011, MOL VIS, V17, P647; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Worley A, 2011, AUST J PRIM HEALTH, V17, P233, DOI 10.1071/PY10042; Zhou XT, 2008, INVEST OPHTH VIS SCI, V49, P5208, DOI 10.1167/iovs.07-1545	57	33	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e91086	10.1371/journal.pone.0091086	http://dx.doi.org/10.1371/journal.pone.0091086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755605	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300001
J	van de Looij, Y; Chatagner, A; Quairiaux, C; Gruetter, R; Huppi, PS; Sizonenko, SV				van de Looij, Yohan; Chatagner, Alexandra; Quairiaux, Charles; Gruetter, Rolf; Hueppi, Petra S.; Sizonenko, Stephane V.			Multi-Modal Assessment of Long-Term Erythropoietin Treatment after Neonatal Hypoxic-Ischemic Injury in Rat Brain	PLOS ONE			English	Article							DIFFUSION TENSOR; WHITE-MATTER; IN-VITRO; RECOVERY; RECEPTOR; TIME; MECHANISMS; PROTECTION; RESPONSES; NEURONS	Erythropoietin (EPO) has been recognized as a neuroprotective agent. In animal models of neonatal brain injury, exogenous EPO has been shown to reduce lesion size, improve structure and function. Experimental studies have focused on short course treatment after injury. Timing, dose and length of treatment in preterm brain damage remain to be defined. We have evaluated the effects of high dose and long-term EPO treatment in hypoxic-ischemic (HI) injury in 3 days old (P3) rat pups using histopathology, magnetic resonance imaging (MRI) and spectroscopy (MRS) as well as functional assessment with somatosensory-evoked potentials (SEP). After HI, rat pups were assessed by MRI for initial damage and were randomized to receive EPO or vehicle. At the end of treatment period (P25) the size of resulting cortical damage and white matter (WM) microstructure integrity were assessed by MRI and cortical metabolism by MRS. Whisker elicited SEP were recorded to evaluate somatosensory function. Brains were collected for neuropathological assessment. The EPO treated animals did not show significant decrease of the HI induced cortical loss at P25. WM microstructure measured by diffusion tensor imaging was improved and SEP response in the injured cortex was recovered in the EPO treated animals compared to vehicle treated animals. In addition, the metabolic profile was less altered in the EPO group. Long-term treatment with high dose EPO after HI injury in the very immature rat brain induced recovery of WM microstructure and connectivity as well as somatosensory cortical function despite no effects on volume of cortical damage. This indicates that long-term high-dose EPO induces recovery of structural and functional connectivity despite persisting gross anatomical cortical alteration resulting from HI.	[van de Looij, Yohan; Chatagner, Alexandra; Hueppi, Petra S.; Sizonenko, Stephane V.] Univ Geneva, Sch Med, Dept Paediat, Div Child Dev & Growth, CH-1211 Geneva, Switzerland; [van de Looij, Yohan; Chatagner, Alexandra; Hueppi, Petra S.; Sizonenko, Stephane V.] Univ Hosp Geneva, Geneva, Switzerland; [van de Looij, Yohan; Gruetter, Rolf] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging LIFMET, Lausanne, Switzerland; [Quairiaux, Charles] Univ Geneva, Sch Med, Dept Fundamental Neurosci, CH-1211 Geneva, Switzerland; [Gruetter, Rolf] Univ Lausanne, Dept Radiol, Lausanne, Switzerland; [Gruetter, Rolf] Univ Geneva, Dept Radiol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Lausanne; University of Geneva	van de Looij, Y (corresponding author), Univ Geneva, Sch Med, Dept Paediat, Div Child Dev & Growth, CH-1211 Geneva, Switzerland.	yohan.vandelooij@epfl.ch	Sizonenko, Stephane/GXV-9222-2022; Huppi, Petra S/A-4079-2009; Gruetter, Rolf/H-6260-2011; Huppi, Petra/A-4079-2009	Huppi, Petra S/0000-0002-7383-6648; Gruetter, Rolf/0000-0003-1870-4025; Quairiaux, Charles/0000-0003-3770-8232; Huppi, Petra/0000-0002-7063-4215; van de Looij, Yohan/0000-0003-2830-5482; Sizonenko, Stephane/0000-0003-0093-8747	Swiss National Fund [31003A-112233, 33CM30-124101]; ELA Foundation-France [ELA 2006-049I5]	Swiss National Fund(Swiss National Science Foundation (SNSF)); ELA Foundation-France	This work was funded by the Swiss National Fund (No 31003A-112233 and No 33CM30-124101) and by the ELA Foundation-France ( No ELA 2006-049I5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin A, 2003, BRAIN DEV-JPN, V25, P494, DOI 10.1016/S0387-7604(03)00039-1; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Buemi M, 2003, J NEUROPATH EXP NEUR, V62, P228, DOI 10.1093/jnen/62.3.228; Castillo-Melendez M, 2005, DEV NEUROSCI-BASEL, V27, P220, DOI 10.1159/000085995; Cerri G, 2012, NEUROSCIENCE, V219, P290, DOI 10.1016/j.neuroscience.2012.05.041; Chan KC, 2009, INT J DEV NEUROSCI, V27, P607, DOI 10.1016/j.ijdevneu.2009.05.012; Chin K, 2000, MOL BRAIN RES, V81, P29, DOI 10.1016/S0169-328X(00)00157-1; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Fan XY, 2011, PEDIATR RES, V69, P56, DOI 10.1203/PDR.0b013e3181fcbef3; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Juul S, 2012, J MATERN-FETAL NEO M, V25, P105, DOI 10.3109/14767058.2012.715025; Kim Moon Sun, 2010, Korean J Pediatr, V53, P898, DOI 10.3345/kjp.2010.53.10.898; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Kumral A, 2003, BIOL NEONATE, V83, P224, DOI 10.1159/000068926; Kunz N, 2013, NMR BIOMED, V26, P1251, DOI 10.1002/nbm.2945; Matsushita H, 2003, NEUROREPORT, V14, P1757, DOI 10.1097/00001756-200309150-00020; McPherson RJ, 2008, INT J DEV NEUROSCI, V26, P103, DOI 10.1016/j.ijdevneu.2007.08.012; Mlynarik V, 2006, MAGN RESON MED, V56, P965, DOI 10.1002/mrm.21043; Molnar Z, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005379; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Quairiaux C, 2010, CEREB CORTEX, V20, P2080, DOI 10.1093/cercor/bhp281; Riviere D., 2003, NEUROIMAGE, V19, P934; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Sizonenko SV, 2007, SEMIN FETAL NEONAT M, V12, P241, DOI 10.1016/j.siny.2007.01.007; Sizonenko SV, 2005, PEDIATR RES, V57, P865, DOI 10.1203/01.PDR.0000157673.36848.67; Sizonenko SV, 2003, PEDIATR RES, V54, P263, DOI 10.1203/01.PDR.0000072517.01207.87; Sola A, 2005, PEDIATR RES, V57, p110R, DOI 10.1203/01.PDR.0000159571.50758.39; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; Towfighi J, 1997, DEV BRAIN RES, V100, P149, DOI 10.1016/S0165-3806(97)00036-9; Traudt Christopher M, 2013, Methods Mol Biol, V982, P113, DOI 10.1007/978-1-62703-308-4_7; Troncoso E, 2000, J NEUROSCI METH, V97, P51, DOI 10.1016/S0165-0270(00)00164-3; van de Looij Y, 2012, PEDIATR RES, V72, P285, DOI 10.1038/pr.2012.72; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; van de Looij Y, 2011, MAGN RESON MED, V65, P732, DOI 10.1002/mrm.22656; van de Looij Y, 2011, MAGN RESON MED, V65, P305, DOI 10.1002/mrm.22617; van der Kooij MA, 2008, BRAIN RES REV, V59, P22, DOI 10.1016/j.brainresrev.2008.04.007; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wen TC, 2004, NEUROSCI LETT, V355, P165, DOI 10.1016/j.neulet.2003.10.078; Zhong YS, 2007, GRAEF ARCH CLIN EXP, V245, P1859, DOI 10.1007/s00417-007-0671-9	48	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95643	10.1371/journal.pone.0095643	http://dx.doi.org/10.1371/journal.pone.0095643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755676	Green Published, gold			2022-12-25	WOS:000335240300065
J	Wang, TH; Yang, ZH; Yang, F; Zhang, MY; Zhao, JL; Chen, JW; Li, YM				Wang, Tianhu; Yang, Zhenhua; Yang, Fang; Zhang, Mingye; Zhao, Jinlong; Chen, Jinwu; Li, Yongming			A Three Dimensional Study of Upper Airway in Adult Skeletal Class II Patients with Different Vertical Growth Patterns	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; COMPUTED-TOMOGRAPHY; DIMENSIONS; GENDER; RESISTANCE; MORPHOLOGY; DEPTH; SIZE; AGE	Objective: The study was performed to compare the 3D pharyngeal airway dimensions in adult skeletal Class II patients with different vertical growth patterns (low, normal, and high angle) and to investigate whether the upper airway dimensions of untreated skeletal Class II adults were affected by vertical skeletal variables. Methods: Cone-beam computed tomography (CBCT) records of 64 untreated adult skeletal Class II patients (34 male and 30 female) were collected to evaluate the pharyngeal airway dimensions. Subjects were divided into three subgroups according to the GoGn-SN angle (low angle, normal angle or high angle). All subgroups were matched for sex. ANOVA and SNK - q tests were used to identify differences within and among groups (p<0.05). Coefficient of product-moment correlation (Pearson correlation coefficient) was used to analyze the association between pharyngeal airway dimensions and vertical growth patterns. Results: The results showed that pharyngeal airway measurements were statistically significantly less (p<0.05) in high angle group as compared to normal angle or low angle group. Conclusions: Adult skeletal Class II subjects with vertical growth patterns have significantly narrower pharyngeal airways than those with normal or horizontal growth patterns, confirming an association between pharyngeal airway measurements and a vertical skeletal pattern.	[Wang, Tianhu; Yang, Zhenhua; Yang, Fang; Zhang, Mingye; Li, Yongming] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China; [Zhao, Jinlong] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China; [Chen, Jinwu] Fourth Mil Med Univ, Sch Stomatol, Dept Radiol & Intervent Therapy, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Li, YM (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China.	liyongming@fmmu.edu.cn	li, yong/HDN-3885-2022					Aboudara C, 2009, AM J ORTHOD DENTOFAC, V135, P468, DOI 10.1016/j.ajodo.2007.04.043; Abramson Z, 2009, J CRANIOFAC SURG, V20, P657, DOI 10.1097/SCS.0b013e318193d521; Alsufyani NA, 2013, SLEEP BREATH, V17, P911, DOI 10.1007/s11325-012-0799-7; BACON WH, 1988, CLEFT PALATE J, V25, P374; Bock JJ, 2007, J OROFAC ORTHOP, V68, P210, DOI 10.1007/s00056-007-0646-9; CEYLAN I, 1995, AM J ORTHOD DENTOFAC, V108, P69, DOI 10.1016/S0889-5406(95)70068-4; Daniel MM, 2007, CLINICS, V62, P5, DOI 10.1590/S1807-59322007000100002; de Freitas MR, 2006, AM J ORTHOD DENTOFAC, V130, P742, DOI 10.1016/j.ajodo.2005.01.033; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Endo Satoshi, 2003, Journal of Medical and Dental Sciences, V50, P109; Freudenthaler J, 2012, EUR J ORTHODONT, V34, P114, DOI 10.1093/ejo/cjq177; Ghoneima A, 2013, EUR J ORTHODONT, V35, P256, DOI 10.1093/ejo/cjr099; Gregorio Marcelo Gervilla, 2007, Braz J Otorhinolaryngol, V73, P618; Jena AK, 2010, ANGLE ORTHOD, V80, P1061, DOI 10.2319/030210-125.1; Johnson PL, 2005, SLEEP, V28, P85, DOI 10.1093/sleep/28.1.85; Joseph AA, 1998, J ORAL MAXIL SURG, V56, P135, DOI 10.1016/S0278-2391(98)90850-3; KERR WJS, 1985, ANGLE ORTHOD, V55, P31; Kim YJ, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.10.025; Kirjavainen M, 2007, ANGLE ORTHOD, V77, P1046, DOI 10.2319/081406-332; LAINE T, 1991, EUR J ORTHODONT, V13, P311, DOI 10.1093/ejo/13.4.311; Lam B, 2004, RESP MED, V98, P301, DOI 10.1016/j.rmed.2003.10.009; Lenza MG, 2010, ORTHOD CRANIOFAC RES, V13, P96, DOI 10.1111/j.1601-6343.2010.01482.x; Major MP, 2006, AM J ORTHOD DENTOFAC, V130, P700, DOI 10.1016/j.ajodo.2005.05.050; Martin O, 2006, AM J ORTHOD DENTOFAC, V130, pe431; MIRALLES R, 1991, ANGLE ORTHOD, V61, P277; Mohsenin V, 2003, SLEEP MED, V4, P523, DOI 10.1016/S1389-9457(03)00168-0; Oh KM, 2011, ANGLE ORTHOD, V81, P1075, DOI 10.2319/010711-8.1; Oz U, 2013, J OROFAC ORTHOP, V74, P18, DOI 10.1007/s00056-012-0121-0; Park JW, 2010, AM J ORTHOD DENTOFAC, V138, P292, DOI 10.1016/j.ajodo.2009.10.036; Samman N., 2003, Hong Kong Medical Journal, V9, P25; Sheng CM, 2009, ANGLE ORTHOD, V79, P484, DOI 10.2319/062308-328.1; Tangugsorn V, 2000, Int J Adult Orthodon Orthognath Surg, V15, P179; Tangugsorn V, 2000, Int J Adult Orthodon Orthognath Surg, V15, P139; TOURNE LPM, 1991, AM J ORTHOD DENTOFAC, V99, P129, DOI 10.1016/0889-5406(91)70115-D; TOURNE LPM, 1990, ANGLE ORTHOD, V60, P167; Ucar FI, 2011, ANGLE ORTHOD, V81, P460, DOI 10.2319/091910-545.1; Vig KWL, 1998, AM J ORTHOD DENTOFAC, V113, P603, DOI 10.1016/S0889-5406(98)70219-7; Ye LC, 2009, J CLIN SLEEP MED, V5, P512; Zeng B, 2008, SLEEP, V31, P543, DOI 10.1093/sleep/31.4.543	39	20	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95544	10.1371/journal.pone.0095544	http://dx.doi.org/10.1371/journal.pone.0095544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755893	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300053
J	Zurfluh, K; Abgottspon, H; Hachler, H; Nuesch-Inderbinen, M; Stephan, R				Zurfluh, Katrin; Abgottspon, Helga; Haechler, Herbert; Nueesch-Inderbinen, Magdalena; Stephan, Roger			Quinolone Resistance Mechanisms among Extended-Spectrum Beta-Lactamase (ESBL) Producing Escherichia coli Isolated from Rivers and Lakes in Switzerland	PLOS ONE			English	Article							FLUOROQUINOLONE RESISTANCE; TRANSFERABLE PLASMID; MODIFYING ENZYME; CLINICAL ISOLATE; UNITED-STATES; 1ST DETECTION; EFFLUX PUMP; GENE; STRAINS; ENTEROBACTERIACEAE	Sixty extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from rivers and lakes in Switzerland were screened for individual strains additionally exhibiting a reduced quinolone susceptibility phenotype. Totally, 42 such isolates were found and further characterized for their molecular (fluoro) quinolone resistance mechanisms. PCR and sequence analysis were performed to identify chromosomal mutations in the quinolone resistance-determining regions (QRDR) of gyrA, gyrB, parC and parE and to describe the occurrence of the following plasmid-mediated quinolone resistance genes: qepA, aac-6 '-Ib-cr, qnrA, qnrB, qnrC, qnrD and qnrS. The contribution of efflux pumps to the resistance phenotype of selected strains was further determined by the broth microdilution method in the presence and absence of the efflux pump inhibitor phe-arg-beta-naphthylamide (PA beta N). Almost all strains, except two isolates, showed at least one mutation in the QRDR of gyrA. Ten strains showed only one mutation in gyrA, whereas thirty isolates exhibited up to four mutations in the QRDR of gyrA, parC and/or parE. No mutations were detected in gyrB. Most frequently the amino-acid substitution Ser83 -> Leu was detected in GyrA followed by Asp87 -> Asn in GyrA, Ser80 -> Ile in ParC, Glu84 -> Val in ParC and Ser458 -> Ala in ParE. Plasmid-mediated quinolone resistance mechanisms were found in twenty isolates bearing QnrS1 (4/20), AAC-6 '-Ib-cr (15/20) and QepA (1/20) determinants, respectively. No qnrA, qnrB, qnrC and qnrD were found. In the presence of PAbN, the MICs of nalidixic acid were decreased 4-to 32-fold. (Fluoro) quinolone resistance is due to various mechanisms frequently associated with ESBL-production in E. coli from surface waters in Switzerland.	[Zurfluh, Katrin; Abgottspon, Helga; Haechler, Herbert; Nueesch-Inderbinen, Magdalena; Stephan, Roger] Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland	University of Zurich	Stephan, R (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland.	stephanr@fsafety.uzh.ch	Stephan, Roger/AAP-8501-2020; Nüesch-Inderbinen, Magdalena/B-8597-2018	Nüesch-Inderbinen, Magdalena/0000-0002-3242-9739; Zurfluh, Katrin/0000-0002-8760-4768	Swiss Federal Office for Public Health, Division Communicable Diseases	Swiss Federal Office for Public Health, Division Communicable Diseases	The authors thank the Swiss Federal Office for Public Health, Division Communicable Diseases, for partial financial support. No additional funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briales A, 2011, ANTIMICROB AGENTS CH, V55, P1266, DOI 10.1128/AAC.00927-10; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Cattoir V, 2007, ANTIMICROB AGENTS CH, V51, P2650, DOI 10.1128/AAC.00070-07; Cavaco LM, 2007, J ANTIMICROB CHEMOTH, V59, P804, DOI 10.1093/jac/dkl554; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Colomer-Lluch M, 2013, J ANTIMICROB CHEMOTH, V68, P758, DOI 10.1093/jac/dks477; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P512, DOI 10.1093/jac/dkq472; Fendukly F, 2003, APMIS, V111, P857, DOI 10.1034/j.1600-0463.2003.1110904.x; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Friedman SM, 2001, ANTIMICROB AGENTS CH, V45, P2378, DOI 10.1128/AAC.45.8.2378-2380.2001; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Heisig P, 1996, ANTIMICROB AGENTS CH, V40, P879, DOI 10.1128/AAC.40.4.879; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Karczmarczyk M, 2011, APPL ENVIRON MICROB, V77, P7113, DOI 10.1128/AEM.00600-11; Karczmarczyk M, 2010, FEMS MICROBIOL LETT, V313, P10, DOI 10.1111/j.1574-6968.2010.02119.x; KAYSER FH, 1982, ANTIMICROB AGENTS CH, V22, P15, DOI 10.1128/AAC.22.1.15; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P639, DOI 10.1128/AAC.01051-08; Liassine N, 2008, J ANTIMICROB CHEMOTH, V62, P1151, DOI 10.1093/jac/dkn295; Lupo A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00018; Rodriguez-Martinez JM, 2011, J INFECT CHEMOTHER, V17, P149, DOI 10.1007/s10156-010-0120-2; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Pico RC, 2008, J ANTIMICROB CHEMOTH, V62, P948, DOI 10.1093/jac/dkn341; Pitout JDD, 2008, J ANTIMICROB CHEMOTH, V61, P999, DOI 10.1093/jac/dkn068; Poirel L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00024; Rizzo L, 2012, SCI TOTAL ENVIRON, V427, P263, DOI 10.1016/j.scitotenv.2012.03.062; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, ANTIMICROB AGENTS CH, V50, P2872, DOI 10.1128/AAC.01647-05; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Saenz Y, 2004, J ANTIMICROB CHEMOTH, V53, P544, DOI 10.1093/jac/dkh117; Saenz Y, 2003, J ANTIMICROB CHEMOTH, V51, P1001, DOI 10.1093/jac/dkg168; Sato T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00125; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Sun JX, 2012, CHEMOSPHERE, V87, P37, DOI 10.1016/j.chemosphere.2011.11.050; VILA J, 1994, ANTIMICROB AGENTS CH, V38, P2477, DOI 10.1128/AAC.38.10.2477; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	44	47	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95864	10.1371/journal.pone.0095864	http://dx.doi.org/10.1371/journal.pone.0095864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755830	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000335240300110
J	Camargo, R; Faria, LO; Kloss, A; Favali, CBF; Kuckelkorn, U; Kloetzel, PM; de Sa, CM; Lima, BD				Camargo, Ricardo; Faria, Liliam O.; Kloss, Alexander; Favali, Cecilia B. F.; Kuckelkorn, Ulrike; Kloetzel, Peter-Michael; de Sa, Cezar Martins; Lima, Beatriz D.			Trypanosoma cruzi Infection Down-Modulates the Immunoproteasome Biosynthesis and the MHC Class I Cell Surface Expression in HeLa Cells	PLOS ONE			English	Article							COMPLEX CLASS-I; HIGHLY ONCOGENIC ADENOVIRUS-12; IFN-GAMMA; MAMMALIAN-CELLS; CHAGAS-DISEASE; T-CELLS; POLYACRYLAMIDE-GELS; ACTIVATOR PA28; 20S PROTEASOME; BETA-SUBUNITS	Generally, Trypanosoma cruzi infection in human is persistent and tends to chronicity, suggesting that the parasite evade the immune surveillance by down regulating the intracellular antigen processing routes. Within the MHC class I pathway, the majority of antigenic peptides are generated by the proteasome. However, upon IFN-gamma stimulation, the catalytic constitutive subunits of the proteasome are replaced by the subunits beta 1i/LMP2, beta 2i/MECL-1 and beta 5i/LMP7 to form the immunoproteasome. In this scenario, we analyzed whether the expression and activity of the constitutive and the immunoproteasome as well as the expression of other components of the MHC class I pathway are altered during the infection of HeLa cells with T. cruzi. By RT-PCR and two-dimensional gel electrophoresis analysis, we showed that the expression and composition of the constitutive proteasome is not affected by the parasite. In contrast, the biosynthesis of the beta 1i, beta 2i, beta 5i immunosubunits, PA28 beta, TAP1 and the MHC class I molecule as well as the proteasomal proteolytic activities were down-regulated in infected-IFN-gamma-treated cell cultures. Taken together, our results provide evidence that the protozoan T. cruzi specifically modulates its infection through an unknown posttranscriptional mechanism that inhibits the expression of the MHC class I pathway components.	[Camargo, Ricardo; Faria, Liliam O.; Favali, Cecilia B. F.; de Sa, Cezar Martins; Lima, Beatriz D.] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [Kloss, Alexander; Kuckelkorn, Ulrike; Kloetzel, Peter-Michael] Charite, Inst Biochim, D-13353 Berlin, Germany	Universidade de Brasilia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lima, BD (corresponding author), Univ Brasilia, Dept Biol Celular, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil.	bdlima@unb.br	Favali, Cecilia B F/C-1028-2009	Favali, Cecilia B F/0000-0003-0343-8393; Kuckelkorn, Ulrike/0000-0002-3085-9161; Camargo, Ricardo/0000-0003-0592-8396	Conselho Nacional de DesenvolvimentoCientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF)	Conselho Nacional de DesenvolvimentoCientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; ANDREWS NW, 1982, J PROTOZOOL, V29, P264, DOI 10.1111/j.1550-7408.1982.tb04024.x; Bergeron M, 2008, PARASITE IMMUNOL, V30, P280, DOI 10.1111/j.1365-3024.2008.01022.x; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; BURLEIGH BA, 1995, ANNU REV MICROBIOL, V49, P175, DOI 10.1146/annurev.mi.49.100195.001135; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Chou B, 2008, MICROBES INFECT, V10, P241, DOI 10.1016/j.micinf.2007.11.010; Claverol S, 2002, MOL CELL PROTEOMICS, V1, P567, DOI 10.1074/mcp.M200030-MCP200; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; de Graaf N, 2011, EUR J IMMUNOL, V41, P926, DOI 10.1002/eji.201041040; DESA MFG, 1988, J CELL SCI, V89, P151; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Dutra WO, 2008, CURR OPIN INFECT DIS, V21, P287, DOI 10.1097/QCO.0b013e3282f88b80; Faria LO, 2008, EXP PARASITOL, V120, P261, DOI 10.1016/j.exppara.2008.08.003; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Garg N, 1997, J IMMUNOL, V158, P3293; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; HENDIL KB, 1988, BIOCHEM INT, V17, P471; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JENNINGS SR, 1985, J VIROL, V56, P757, DOI 10.1128/JVI.56.3.757-766.1985; Khan S, 2004, J VIROL, V78, P1831, DOI 10.1128/JVI.78.4.1831-1842.2004; King NJC, 2003, ADV VIRUS RES, V60, P121, DOI 10.1016/S0065-3527(03)60004-7; KING NJC, 1988, J GEN VIROL, V69, P2535, DOI 10.1099/0022-1317-69-10-2535; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; KOHONENCORISH MRJ, 1989, J IMMUNOL, V143, P623; KRAUS E, 1992, EUR J IMMUNOL, V22, P175, DOI 10.1002/eji.1830220126; Kuehn L, 1996, ARCH BIOCHEM BIOPHYS, V329, P87, DOI 10.1006/abbi.1996.0195; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEY V, 1990, J EXP MED, V171, P401, DOI 10.1084/jem.171.2.401; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA CP, 1992, J BIOL CHEM, V267, P10515; Marinho CRF, 1999, INFECT IMMUN, V67, P308, DOI 10.1128/IAI.67.1.308-318.1999; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; MULLBACHER A, 1992, IMMUNOL CELL BIOL, V70, P59, DOI 10.1038/icb.1992.9; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; NICKELL SP, 1993, J IMMUNOL, V150, P1446; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; Proffitt JA, 1997, FEBS LETT, V400, P141, DOI 10.1016/S0014-5793(96)01375-0; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Rodrigues AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001598; RotemYehudar R, 1996, J EXP MED, V183, P499, DOI 10.1084/jem.183.2.499; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; Schwarz K, 2000, J IMMUNOL, V165, P768, DOI 10.4049/jimmunol.165.2.768; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Silva LHP, 1953, FOLIA CLIN BIOL, V20, P191; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V159, P1309, DOI 10.1016/0006-291X(89)92253-5; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; Tarleton RL, 1996, INT IMMUNOL, V8, P13, DOI 10.1093/intimm/8.1.13; Tarleton RL, 1999, PARASITOL TODAY, V15, P94, DOI 10.1016/S0169-4758(99)01398-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Hall T, 2000, J EXP MED, V192, P483, DOI 10.1084/jem.192.4.483; Van Overtvelt L, 2002, INT IMMUNOL, V14, P1135, DOI 10.1093/intimm/dxf077; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WHO - World Health Organization, 2014, FACT SHEET NU340 CHA	70	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95977	10.1371/journal.pone.0095977	http://dx.doi.org/10.1371/journal.pone.0095977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752321	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400148
J	Hong, HL; Hong, SB; Ko, GB; Huh, JW; Sung, H; Do, KH; Kim, SH; Lee, SO; Kim, MN; Jeong, JY; Lim, CM; Kim, YS; Woo, JH; Koh, Y; Choi, SH				Hong, Hyo-Lim; Hong, Sang-Bum; Ko, Gwang-Beom; Huh, Jin Won; Sung, Heungsup; Do, Kyung-Hyun; Kim, Sung-Han; Lee, Sang-Oh; Kim, Mi-Na; Jeong, Jin-Yong; Lim, Chae-Man; Kim, Yang Soo; Woo, Jun Hee; Koh, Younsuck; Choi, Sang-Ho			Viral Infection Is Not Uncommon in Adult Patients with Severe Hospital-Acquired Pneumonia	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANT; RESPIRATORY VIRUS-INFECTIONS; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; IMMUNOCOMPROMISED PATIENTS; NOSOCOMIAL PNEUMONIA; SYNCYTIAL VIRUS; SINGLE-CENTER; RECIPIENTS; EPIDEMIOLOGY	Background: Viral pathogens have not generally been regarded as important causes of severe hospital-acquired pneumonia (HAP), except in patients with hematologic malignancy or transplant recipients. We investigated the role and distribution of viruses in adult with severe HAP who required intensive care. Methods: From March 2010 to February 2012, adult patients with severe HAP required admission to the intensive care unit (ICU), 28-bed medical ICU in a tertiary care hospital, were prospectively enrolled. Respiratory viruses were detected using multiplex reverse-transcription polymerase chain reaction and/or shell vial culture. Results: A total of 262 patients were enrolled and 107 patients (40.8%) underwent bronchoscopic BAL for etiologic diagnosis. One hundred and fifty-six patients (59.5%) had bacterial infections and 59 patients (22.5%) had viral infections. Viruses were detected in BAL fluid specimens of 37 patients (62.7%, 37/59). The most commonly identified viruses were respiratory syncytial virus and parainfluenza virus (both 27.1%, 16/59), followed by rhinovirus (25.4%, 15/59), and influenza virus (16.9%, 10/59). Twenty-one patients (8.0%, 21/262) had bacterial-viral coinfections and Staphylococcus aureus was the most commonly coexisting bacteria (n = 10). Viral infection in non-immunocompromised patients was not uncommon (11.1%, 16/143), although it was not as frequent as that in immunocompromised patients (36.4%, 43/119). Non-immunocompromised patients were significantly older than immunocompromised patients and had significantly higher rates of underlying chronic obstructive pulmonary disease, tuberculous destroyed lung and chronic kidney disease. The 28 day mortalities of patients with bacterial infections, viral infections and bacterial-viral coinfections were not significantly different (29.5%, 35.6% and 19.0%, respectively; p=0.321). Conclusions: Viral pathogens are not uncommon in adult patients with severe HAP who required ICU admission. Since viral pathogens may cause severe HAP and could be a potential source of viral transmission, further investigation is required to delineate the role of viral pathogens in severe HAP.	[Hong, Hyo-Lim; Ko, Gwang-Beom; Kim, Sung-Han; Lee, Sang-Oh; Jeong, Jin-Yong; Kim, Yang Soo; Woo, Jun Hee; Choi, Sang-Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Hong, Sang-Bum; Huh, Jin Won; Lim, Chae-Man; Koh, Younsuck] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Sung, Heungsup; Kim, Mi-Na] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea; [Do, Kyung-Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Jeong, Jin-Yong] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Choi, SH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.	sangho@amc.seoul.kr	Lee, Sang-Oh/AGV-5413-2022	Lee, Sang-Oh/0000-0003-1381-8787; Hong, Hyo-Lim/0000-0003-2147-1381; Choi, Sang-Ho/0000-0002-4972-4531	Asan Institute of Life Sciences [2013-389]	Asan Institute of Life Sciences	The study was supported by a grant from Asan Institute of Life Sciences (grant 2013-389). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arens MQ, 2010, J CLIN MICROBIOL, V48, P2387, DOI 10.1128/JCM.00220-10; Bibby DF, 2011, J MED VIROL, V83, P1469, DOI 10.1002/jmv.22125; Boeckh M, 2008, BRIT J HAEMATOL, V143, P455, DOI 10.1111/j.1365-2141.2008.07295.x; CELIS R, 1988, CHEST, V93, P318, DOI 10.1378/chest.93.2.318; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Cilloniz C, 2012, J INFECTION, V65, P223, DOI 10.1016/j.jinf.2012.04.009; Cilloniz C, 2011, CRIT CARE, V15, DOI 10.1186/cc10444; Gastmeier P, 2009, ANTIMICROB AGENTS CH, V53, P2714, DOI 10.1128/AAC.01070-08; Gharabaghi F, 2011, CLIN MICROBIOL INFEC, V17, P1900, DOI 10.1111/j.1469-0691.2011.03529.x; Graman P S, 1989, Infect Dis Clin North Am, V3, P815; Ison MG, 2009, AM J TRANSPLANT, V9, pS166, DOI 10.1111/j.1600-6143.2009.02908.x; Ison MG, 2002, CURR OPIN INFECT DIS, V15, P355, DOI 10.1097/00001432-200208000-00002; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Khanna N, 2008, CLIN INFECT DIS, V46, P402, DOI 10.1086/525263; Kim S, 2009, J CLIN MICROBIOL, V47, P1221, DOI 10.1128/JCM.01959-08; Kim YJ, 2007, SEMIN RESP CRIT CARE, V28, P222, DOI 10.1055/s-2007-976494; Kuster SP, 2013, EMERG INFECT DIS, V19, P606, DOI 10.3201/eid1904.111812; Ljungman P, 2001, BONE MARROW TRANSPL, V28, P479, DOI 10.1038/sj.bmt.1703139; LJUNGMAN P, 1989, BONE MARROW TRANSPL, V4, P35; Machado CM, 2003, BONE MARROW TRANSPL, V31, P695, DOI 10.1038/sj.bmt.1703900; Malavaud S, 2001, TRANSPLANTATION, V72, P535, DOI 10.1097/00007890-200108150-00032; Mandell LA, 1998, CHEST, V113, p188S, DOI 10.1378/chest.113.3_Supplement.188S; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MCCABE WR, 1962, ARCH INTERN MED, V110, P845; Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07; Milano F, 2010, BLOOD, V115, P2088, DOI 10.1182/blood-2009-09-244152; PINGLETON SK, 1992, CHEST, V102, pS553, DOI 10.1378/chest.102.5_Supplement_1.553S; Raboud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010717; Renaud C, 2011, CURR OPIN INFECT DIS, V24, P333, DOI 10.1097/QCO.0b013e3283480440; ROSENBAUM MJ, 1971, AM J EPIDEMIOL, V93, P183, DOI 10.1093/oxfordjournals.aje.a121245; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Seki M, 2007, INTERNAL MED, V46, P953, DOI 10.2169/internalmedicine.46.6364; Shah JN, 2011, PULMONARY INVOLVEMENT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, P301, DOI 10.1007/978-3-642-15742-4_24; Taylor GS, 2001, J CLIN MICROBIOL, V39, P801, DOI 10.1128/JCM.39.2.801-803.2001; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Weigt SS, 2011, SEMIN RESP CRIT CARE, V32, P471, DOI 10.1055/s-0031-1283286	38	59	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95865	10.1371/journal.pone.0095865	http://dx.doi.org/10.1371/journal.pone.0095865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752070	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400143
J	Prager, R; Lang, C; Aurass, P; Fruth, A; Tietze, E; Flieger, A				Prager, Rita; Lang, Christina; Aurass, Philipp; Fruth, Angelika; Tietze, Erhard; Flieger, Antje			Two Novel EHEC/EAEC Hybrid Strains Isolated from Human Infections	PLOS ONE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; HEMOLYTIC-UREMIC SYNDROME; AGGREGATIVE ADHERENCE; AGGR REGULON; TOXIN; VIRULENCE; OUTBREAK; IDENTIFICATION; O157-H7; SEQUENCE	The so far highest number of life-threatening hemolytic uremic syndrome was associated with a food-borne outbreak in 2011 in Germany which was caused by an enterohemorrhagic Escherichia coli (EHEC) of the rare serotype O104:H4. Most importantly, the outbreak strain harbored genes characteristic of both EHEC and enteroaggregative E. coli (EAEC). Such strains have been described seldom but due to the combination of virulence genes show a high pathogenicity potential. To evaluate the importance of EHEC/EAEC hybrid strains in human disease, we analyzed the EHEC strain collection of the German National Reference Centre for Salmonella and other Bacterial Enteric Pathogens (NRC). After exclusion of O104:H4 EHEC/EAEC strains, out of about 2400 EHEC strains sent to NRC between 2008 and 2012, two strains exhibited both EHEC and EAEC marker genes, specifically were stx2 and aatA positive. Like the 2011 outbreak strain, one of the novel EHEC/EAEC harbored the Shiga toxin gene type stx2a. The strain was isolated from a patient with bloody diarrhea in 2010, was serotyped as O59:H-, belonged to MLST ST1136, and exhibited genes for type IV aggregative adherence fimbriae (AAF). The second strain was isolated from a patient with diarrhea in 2012, harbored stx2b, was typed as Orough:H-, and belonged to MLST ST26. Although the strain conferred the aggregative adherence phenotype, no known AAF genes corresponding to fimbrial types I to V were detected. In summary, EHEC/EAEC hybrid strains are currently rarely isolated from human disease cases in Germany and two novel EHEC/EAEC of rare serovars/MLST sequence types were characterized.	[Prager, Rita; Lang, Christina; Aurass, Philipp; Fruth, Angelika; Tietze, Erhard; Flieger, Antje] Robert Koch Inst, Natl Reference Ctr Salmonella & Other Bacterial E, Div Enteropathogen Bacteria & Legionella, Wernigerode, Germany	Robert Koch Institute	Flieger, A (corresponding author), Robert Koch Inst, Natl Reference Ctr Salmonella & Other Bacterial E, Div Enteropathogen Bacteria & Legionella, Wernigerode, Germany.	fliegera@rki.de		Flieger, Antje/0000-0003-3819-2979	Robert Koch Institute	Robert Koch Institute	This work was supported by the Robert Koch Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DWK, 1998, INFECT IMMUN, V66, P4496; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; Bielaszewska M, 2014, EMBO MOL MED, V6, P347, DOI 10.1002/emmm.201303133; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Boudailliez B, 1997, PEDIATR NEPHROL, V11, P36, DOI 10.1007/s004670050229; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Dallman T, 2012, J CLIN MICROBIOL, V50, P4116, DOI 10.1128/JCM.02047-12; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Elias WP, 1999, J MED MICROBIOL, V48, P597, DOI 10.1099/00222615-48-6-597; Elias WP, 2002, EPIDEMIOL INFECT, V129, P49, DOI 10.1017/S0950268802007136; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gervilla R, 1997, J DAIRY SCI, V80, P2297, DOI 10.3168/jds.S0022-0302(97)76179-4; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Guo HJ, 2005, FEMS MICROBIOL LETT, V248, P153, DOI 10.1016/j.femsle.2005.05.036; Harrington SM, 2006, FEMS MICROBIOL LETT, V254, P12, DOI 10.1111/j.1574-6968.2005.00005.x; Iyoda S, 2000, FEMS MICROBIOL LETT, V191, P7, DOI 10.1016/S0378-1097(00)00360-8; Jandhyala DM, 2013, INFECT DIS CLIN N AM, V27, P631, DOI 10.1016/j.idc.2013.05.002; Jourdan-da Silva N, 2012, EUROSURVEILLANCE, P17; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Monecke S, 2011, APPL ENVIRON MICROB, V77, P8784, DOI 10.1128/AEM.06524-11; Morabito S, 1999, J MED MICROBIOL, V48, P891, DOI 10.1099/00222615-48-10-891; Morabito S, 1998, J CLIN MICROBIOL, V36, P840, DOI 10.1128/JCM.36.3.840-842.1998; Morin N, 2013, INFECT IMMUN, V81, P122, DOI 10.1128/IAI.00676-12; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; OBRIEN AD, 1983, LANCET, V2, P573; Prager R, 2005, INT J MED MICROBIOL, V295, P29, DOI 10.1016/j.ijmm.2004.12.009; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Prager R, 2011, INT J MED MICROBIOL, V301, P181, DOI 10.1016/j.ijmm.2010.06.003; Prager R, 2009, INT J MED MICROBIOL, V299, P343, DOI 10.1016/j.ijmm.2008.10.008; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Robert Koch Institute, 2011, FIN PRES EV EP FIND; Robert-Koch-Institut, 2013, INF JB MELD KRANKH 2; Roberts PH, 2001, J MICROBIOL METH, V43, P171, DOI 10.1016/S0167-7012(00)00222-0; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Sau A, 2012, BEILSTEIN J ORG CHEM, V8, P2053, DOI 10.3762/bjoc.8.230; Scaletsky ICA, 2005, INFECT IMMUN, V73, P4753, DOI 10.1128/IAI.73.8.4753-4765.2005; SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; SCHMIDT H, 1995, J CLIN MICROBIOL, V33, P701, DOI 10.1128/JCM.33.3.701-705.1995; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Shringi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051572; Thomas S, 2013, BIOCHIM BIOPHYS ACTA; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Toval F, 2014, J CLIN MICROBIOL, V52, P407, DOI 10.1128/JCM.02069-13; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; Vila J, 2000, J INFECT DIS, V182, P1780, DOI 10.1086/317617; WELLS JG, 1983, J CLIN MICROBIOL, V18, P512, DOI 10.1128/JCM.18.3.512-520.1983; Wilson A, 2001, EUR J EPIDEMIOL, V17, P1125, DOI 10.1023/A:1021224915322; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066717; Zhao G, 2007, CARBOHYD RES, V342, P1275, DOI 10.1016/j.carres.2007.03.005	63	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95379	10.1371/journal.pone.0095379	http://dx.doi.org/10.1371/journal.pone.0095379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752200	Green Published, gold			2022-12-25	WOS:000335227400058
J	Yesuf, EA; Kerie, MW; Calderon-Margalit, R				Yesuf, Elias Ali; Kerie, Mirkuzie Woldie; Calderon-Margalit, Ronit			Birth in a Health Facility -Inequalities among the Ethiopian Women: Results from Repeated National Surveys	PLOS ONE			English	Article							DELIVERY SERVICE UTILIZATION; INSTITUTIONAL DELIVERY; MATERNAL MORTALITY; STRATEGIES; DISTRICT; WOREDA; CARE	Background: Uptake of health facilities for delivery care in Ethiopia has not been examined in the light of equality. We investigated differences in institutional deliveries by urbanity, administrative region, economic status and maternal education. Methods: This study was based on nation-wide repeated surveys undertaken in the years 2000, 2005, and 2011. The surveys used a cluster sampling design. Women of reproductive age were interviewed on the place of their last delivery. Data was analyzed using logistic regressions to estimate the weighted association between birth in a health facility and study's predictors. Results: Utilization of health institutions for deliveries has improved throughout the study period, however, rates remain low (5.4%, 2000 and 11.8%, 2011). Compared with women from rural places, women from urban areas had independent OR of a health facility delivery of 4.9 (95% CI: 3.4, 7.0), 5.0 (95% CI: 3.6, 6.9), and 4.6 (95% CI: 3.5, 6.0) in 2000, 2005, and 2011, respectively. Women with secondary/higher education had more deliveries in a healthcare facility than women with no education, and these gaps widened over the years (OR: 35.1, 45.0 and 53.6 in 2000, 2005, and 2011, respectively). Women of the upper economic quintile had 3.0-7.2 times the odds of healthcare facility deliveries, compared with the lowest quintile, with no clear trend over the years. While Addis-Ababa and Dire Dawa remained with the highest OR for deliveries in a health facility compared with Amhara, other regions displayed shifts in their relative ranking with Oromiya, SNNPR, Afar, Harari, and Somali getting relatively worse over time. Conclusions: The disparity related to urbanity or education in the use of health facility for birth in Ethiopia is staggering. There is a small inequality between most regions except Addis Ababa/Dire Dawa and sign of abating inequity between economic strata except for the richest households.	[Yesuf, Elias Ali; Kerie, Mirkuzie Woldie] Jimma Univ, Dept Hlth Serv Management, Jimma, Ethiopia; [Calderon-Margalit, Ronit] Hebrew Univ Jerusalem, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel	Jimma University; Hebrew University of Jerusalem	Yesuf, EA (corresponding author), Jimma Univ, Dept Hlth Serv Management, Jimma, Ethiopia.	eliasaliyesuf@yahoo.com	Woldie, Mirkuzie/S-4086-2017	Woldie, Mirkuzie/0000-0002-1777-0816; Yesuf, Elias Ali/0000-0003-0281-5564	Braun School of Public Health; Hebrew University, Jerusalem, Israel; Pears Foundation, Jerusalem, Israel	Braun School of Public Health; Hebrew University, Jerusalem, Israel; Pears Foundation, Jerusalem, Israel	We would like to acknowledge the support stretched by the Braun School of Public Health, Hebrew University, Jerusalem, Israel and Pears Foundation, Jerusalem, Israel for providing computer, access to international peer-reviewed journals and internet during data analysis. We also thank Department of Health Services Management, Jimma University, Jimma, Ethiopia for providing internet and access to HINARI, WHO database of peer-reviewed Journals and Books, during manuscript preparation. Also we would like to acknowledge Professor Orly Manor and Dr. Maureen Malowany, both from Hebrew University, for their constructive comments; and Jessica Koval, USA for reviewing the manuscript. Last but not least, we extend our gratitude for ICF International and CSA Ethiopia for grating access to the datasets used in this study.	Abebe Fantu, 2012, BMC Res Notes, V5, P653, DOI 10.1186/1756-0500-5-653; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carvalho N, 2013, HEALTH POLICY PLANN, V28, P62, DOI 10.1093/heapol/czs026; Central Statistical Agency [Ethiopia], 2008, 2007 POP HOUS CENS E; Central Statistical Agency [Ethiopia], 1998, 1994 POP HOUS CENS E, V1; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20; Central Statistical Authority [Ethiopia] ORC Macro, 2001, ETH DEM HLTH SURV 20; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Countdown to 2015, 2012, BUILD FUT WOM CHILDR; Fikre AA, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-33; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Greenaway ES, 2012, J BIOSOC SCI, V44, P733, DOI 10.1017/S0021932012000041; HOTCHKISS DR, 2003, ROLE USER CHARGES ST; Kitaw Y, 2005, EVOLUTION HLTH FACIL; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Ministry of Health [Ethiopia], 2010, HLTH SECT DEV PROGR; Mrisho M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-10; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Pearson L, 2011, INT J GYNECOL OBSTET, V115, P310, DOI 10.1016/j.ijgo.2011.09.007; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; Wagle Rajendra Raj, 2004, BMC Pregnancy Childbirth, V4, P8, DOI 10.1186/1471-2393-4-8; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Yesuf EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-131	26	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95439	10.1371/journal.pone.0095439	http://dx.doi.org/10.1371/journal.pone.0095439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2DX	24751600	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400063
J	Zhu, C; Luo, NN; He, M; Chen, GX; Zhu, JT; Yin, GJ; Li, XH; Hu, YK; Li, JR; Yan, YM				Zhu, Chong; Luo, Nana; He, Miao; Chen, Guanxing; Zhu, Jiantang; Yin, Guangjun; Li, Xiaohui; Hu, Yingkao; Li, Jiarui; Yan, Yueming			Molecular Characterization and Expression Profiling of the Protein Disulfide Isomerase Gene Family in Brachypodium distachyon L.	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ENDOPLASMIC-RETICULUM; SALT-STRESS; IDENTIFICATION; LOCALIZATION; CLONING; MUTANT; DOMAIN; PLANT; CHLOROPLAST	Protein disulfide isomerases (PDI) are involved in catalyzing protein disulfide bonding and isomerization in the endoplasmic reticulum and functions as a chaperone to inhibit the aggregation of misfolded proteins. Brachypodium distachyon is a widely used model plant for temperate grass species such as wheat and barley. In this work, we report the first molecular characterization, phylogenies, and expression profiles of PDI and PDI-like (PDIL) genes in B. distachyon in different tissues under various abiotic stresses. Eleven PDI and PDIL genes in the B. distachyon genome by in silico identification were evenly distributed across all five chromosomes. The plant PDI family has three conserved motifs that are involved in catalyzing protein disulfide bonding and isomerization, but a different exon/intron structural organization showed a high degree of structural differentiation. Two pairs of genes (BdPDIL4-1 and BdPDIL4-2; BdPDIL7-1 and BdPDIL7-2) contained segmental duplications, indicating each pair originated from one progenitor. Promoter analysis showed that Brachypodium PDI family members contained important cis-acting regulatory elements involved in seed storage protein synthesis and diverse stress response. All Brachypodium PDI genes investigated were ubiquitously expressed in different organs, but differentiation in expression levels among different genes and organs was clear. BdPDIL1-1 and BdPDIL5-1 were expressed abundantly in developing grains, suggesting that they have important roles in synthesis and accumulation of seed storage proteins. Diverse treatments (drought, salt, ABA, and H2O2) induced up-and down-regulated expression of Brachypodium PDI genes in seedling leaves. Interestingly, BdPDIL1-1 displayed significantly up-regulated expression following all abiotic stress treatments, indicating that it could be involved in multiple stress responses. Our results provide new insights into the structural and functional characteristics of the plant PDI gene family.	[Zhu, Chong; Luo, Nana; He, Miao; Chen, Guanxing; Zhu, Jiantang; Yin, Guangjun; Li, Xiaohui; Hu, Yingkao; Yan, Yueming] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Li, Jiarui] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	Capital Normal University; Kansas State University	Hu, YK (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	yingkaohu@sohu.com; yanym@cnu.edu.cn		Hu, Yingkao/0000-0003-1848-7374	National Natural Science Foundation of China [31271703, 31101145]; Chinese Ministry of Science and Technology [2013DFG30530]; National Key Project for Transgenic Crops in China [2011ZX08009-003-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Key Project for Transgenic Crops in China	This research was financially supported by grants from the National Natural Science Foundation of China (31271703, 31101145), the China-Australia Cooperation Project from the Chinese Ministry of Science and Technology (2013DFG30530), and the National Key Project for Transgenic Crops in China (2011ZX08009-003-004). This is contribution number 14-198-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200; Chauhan H, 2011, PLANT MOL BIOL, V75, P35, DOI 10.1007/s11103-010-9702-8; Clissold PM, 2003, BIOESSAYS, V25, P603, DOI 10.1002/bies.10287; d'Aloisio E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-101; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Desikan R, 1998, BIOCHEM J, V330, P115, DOI 10.1042/bj3300115; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; GOLDBERG RB, 1989, CELL, V56, P149, DOI 10.1016/0092-8674(89)90888-X; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P8; Guillon F, 2012, J EXP BOT, V63, P739, DOI 10.1093/jxb/err298; Han XH, 2012, J EXP BOT, V63, P121, DOI 10.1093/jxb/err262; Hayano T, 1995, FEBS LETT, V377, P505, DOI 10.1016/0014-5793(95)01410-1; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Houston NL, 2005, PLANT PHYSIOL, V137, P762, DOI 10.1104/pp.104.056507; Iwasaki K, 2009, FEBS J, V276, P4130, DOI 10.1111/j.1742-4658.2009.07123.x; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jacquot JP, 2002, BIOCHEM PHARMACOL, V64, P1065, DOI 10.1016/S0006-2952(02)01177-2; Kamauchi S, 2008, FEBS J, V275, P2644, DOI 10.1111/j.1742-4658.2008.06412.x; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Kim DY, 2012, GENES GENOM, V34, P475, DOI 10.1007/s13258-012-0067-z; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Larre C, 2010, J EXP BOT, V61, P1771, DOI 10.1093/jxb/erq050; Laudencia-Chingcuanco DL, 2008, THEOR APPL GENET, V117, P555, DOI 10.1007/s00122-008-0799-y; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Levitan A, 2005, P NATL ACAD SCI USA, V102, P6225, DOI 10.1073/pnas.0500676102; Li CP, 1996, PLANT MOL BIOL, V30, P873, DOI 10.1007/BF00020800; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DP, 2008, MOL GENET GENOMICS, V280, P199, DOI 10.1007/s00438-008-0356-z; Lu DP, 2006, INT J PLANT SCI, V167, P1, DOI 10.1086/498071; Lucero HA, 1999, J BIOL CHEM, V274, P3243, DOI 10.1074/jbc.274.5.3243; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Monnat J, 2000, MOL BIOL CELL, V11, P3469, DOI 10.1091/mbc.11.10.3469; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; QUAN H, 1995, J BIOL CHEM, V270, P17078, DOI 10.1074/jbc.270.29.17078; Ravel C, 2009, PLANT PHYSIOL, V151, P2133, DOI 10.1104/pp.109.146076; Sakamoto H, 2008, PLANT J, V56, P411, DOI 10.1111/j.1365-313X.2008.03614.x; SHIMONI Y, 1995, PLANT PHYSIOL, V107, P281, DOI 10.1104/pp.107.1.281; SHIMONI Y, 1995, PLANT PHYSIOL, V108, P327, DOI 10.1104/pp.108.1.327; Somanchi A, 1999, CURR OPIN PLANT BIOL, V2, P404, DOI 10.1016/S1369-5266(99)00013-8; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Verelst W, 2013, MOL PLANT, V6, P311, DOI 10.1093/mp/sss098; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wadahama H, 2007, FEBS J, V274, P687, DOI 10.1111/j.1742-4658.2006.05613.x; Wang HZ, 2008, PLANT CELL, V20, P3300, DOI 10.1105/tpc.108.062919; Wang K, 2010, J CEREAL SCI, V52, P177, DOI 10.1016/j.jcs.2010.05.001; Wang SL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-221; Wang SL, 2012, PLOS ONE, V8, P58947; Welsh LM, 2006, J CELL SCI, V119, P4730, DOI 10.1242/jcs.03250; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wu HM, 2009, PLANT SCI, V176, P420, DOI 10.1016/j.plantsci.2008.12.009; Yamamoto MP, 2006, PLANT PHYSIOL, V141, P1694, DOI 10.1104/pp.106.082826; Ying-Hui Liu, 2009, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V25, P229; Yousefi M., 2012, International Journal of Agriculture and Crop Sciences (IJACS), V4, P1240	68	25	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94704	10.1371/journal.pone.0094704	http://dx.doi.org/10.1371/journal.pone.0094704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747843	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500036
J	Gao, C; Liu, Y; Zhang, HT; Zhang, YB; Fukuda, MN; Palma, AS; Kozak, RP; Childs, RA; Nonaka, M; Li, Z; Siegel, DL; Hanfland, P; Peehl, DM; Chai, WG; Greene, MI; Ten, FZ				Gao, Chao; Liu, Yan; Zhang, Hongtao; Zhang, Yibing; Fukuda, Michiko N.; Palma, Angelina S.; Kozak, Radoslaw P.; Childs, Robert A.; Nonaka, Motohiro; Li, Zhen; Siegel, Don L.; Hanfland, Peter; Peehl, Donna M.; Chai, Wengang; Greene, Mark I.; Ten Feizi			Carbohydrate Sequence of the Prostate Cancer-associated Antigen F77 Assigned by a Mucin O-Glycome Designer Array	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT ERYTHROCYTE-MEMBRANES; MILD PERIODATE-OXIDATION; BLOOD-GROUP ANTIGENS; GROUP-B; MASS-SPECTROMETRY; GROUP-A; GROUP-I; GROUP-H; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODIES	Monoclonal antibody F77 was previously raised against human prostate cancer cells and has been shown to recognize a carbohydrate antigen, but the carbohydrate sequence of the antigen was elusive. Here, we make multifaceted approaches to characterize F77 antigen, including binding analyses with the glycolipid extract of the prostate cancer cell line PC3, microarrays with sequence-defined glycan probes, and designer arrays from the O-glycome of an antigen-positive mucin, in conjunction with mass spectrometry. Our results reveal F77 antigen to be expressed on blood group H on a 6-linked branch of a poly-N-acetyllactosamine backbone. We show that mAb F77 can also bind to blood group A and B analogs but with lower intensities. We propose that the close association of F77 antigen with prostate cancers is a consequence of increased blood group H expression together with up-regulated branching enzymes. This is in contrast to other epithelial cancers that have up-regulated branching enzymes but diminished expression of H antigen. With knowledge of the structure and prevalence of F77 antigen in prostate cancer, the way is open to explore rationally its application as a biomarker to detect F77-positive circulating prostate cancer-derived glycoproteins and tumor cells.	[Gao, Chao; Liu, Yan; Zhang, Yibing; Palma, Angelina S.; Childs, Robert A.; Li, Zhen; Chai, Wengang; Ten Feizi] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England; [Zhang, Hongtao; Siegel, Don L.; Greene, Mark I.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fukuda, Michiko N.; Nonaka, Motohiro] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Glycobiol Unit, La Jolla, CA 92037 USA; [Palma, Angelina S.] New Univ, Dept Chem, P-2829516 Lisbon, Portugal; [Kozak, Radoslaw P.] Ludger Ltd, Culham Sci Ctr, Abingdon OX14 3EB, Oxon, England; [Hanfland, Peter] Univ Bonn, Fdn Haemotherapy Res, Inst Expt Haematol & Transfus Med, D-53127 Bonn, Germany; [Peehl, Donna M.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA	Imperial College London; University of Pennsylvania; Sanford Burnham Prebys Medical Discovery Institute; Universidade Nova de Lisboa; Culham Science Centre; UK Atomic Energy Authority; University of Bonn; Stanford University	Liu, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, Hammersmith Campus,Burlington Danes Bldg, London W12 0NN, England.	yan.liu2@imperial.ac.uk; w.chai@imperial.ac.uk; t.feizi@imperial.ac.uk	Liu, Yan/D-9117-2013; Palma, Angelina S/D-2052-2013	Palma, Angelina S/0000-0001-5797-6555; Liu, Yan/0000-0002-2566-6867; Gao, Chao/0000-0003-3489-3989; Li, Zhen/0000-0002-8853-4941; Feizi, Ten/0000-0001-6495-0329; Zhang, Hongtao/0000-0001-9173-0049	National Institutes of Health [U01 CA128416, U01 CA168925]; NCI Alliance of Glycobiologists; Wellcome Trust [WT093378MA, WT099197MA]; United Kingdom Research Council Basic Technology Initiative "Glycoarrays" Grant [GRS/79268]; UK Engineering and Physical Sciences Research Council [EP/G037604/1]; China Scholarship Council; Fundacao para a Ciencia e Tecnologia Portugal Grant [BPD SFRH/26515/2006]; Engineering and Physical Sciences Research Council [EP/G037604/1, GR/S79268/02] Funding Source: researchfish; EPSRC [EP/G037604/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA030199, U01CA128416, P30CA016520, U01CA168925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Alliance of Glycobiologists(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Research Council Basic Technology Initiative "Glycoarrays" Grant; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); China Scholarship Council(China Scholarship Council); Fundacao para a Ciencia e Tecnologia Portugal Grant; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 CA128416 and U01 CA168925, NCI Alliance of Glycobiologists. This work was also supported by Wellcome Trust Grants WT093378MA and WT099197MA, United Kingdom Research Council Basic Technology Initiative "Glycoarrays" Grant GRS/79268, and UK Engineering and Physical Sciences Research Council Grant EP/G037604/1.; Recipients of fellowships from China Scholarship Council.; Supported by Fundacao para a Ciencia e Tecnologia Portugal Grant BPD SFRH/26515/2006.	ABEL PD, 1987, BRIT J UROL, V59, P430, DOI 10.1111/j.1464-410X.1987.tb04841.x; BENDICH A, 1947, J AM CHEM SOC, V69, P2163, DOI 10.1021/ja01201a031; CARROLL AM, 1984, CLIN IMMUNOL IMMUNOP, V33, P268, DOI 10.1016/0090-1229(84)90081-3; Chai WG, 2003, METHOD ENZYMOL, V362, P160; Chai WG, 1997, GLYCOBIOLOGY, V7, P861, DOI 10.1093/glycob/7.6.861; CHAI WG, 1993, CARBOHYD RES, V239, P107, DOI 10.1016/0008-6215(93)84207-M; CHAI WG, 1992, EUR J BIOCHEM, V203, P257, DOI 10.1111/j.1432-1033.1992.tb19855.x; Cheng PF, 2013, ANAL BIOANAL CHEM, V405, P6683, DOI 10.1007/s00216-013-7128-2; Dean L., 2005, BLOOD GROUPS RED CEL; EGGE H, 1985, J BIOL CHEM, V260, P4927; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; FEIZI T, 1981, IMMUNOL COMMUN, V10, P127, DOI 10.3109/08820138109050693; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FEIZI T, 1971, J EXP MED, V133, P39, DOI 10.1084/jem.133.1.39; FEIZI T, 1979, J EXP MED, V149, P975, DOI 10.1084/jem.149.4.975; FEIZI T, 1985, CANCER SURV, V4, P245; FUKUDA MN, 1983, BIOCHEMISTRY-US, V22, P5034, DOI 10.1021/bi00290a024; FUKUDA MN, 1982, J BIOL CHEM, V257, P446; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Hagisawa S, 2005, GLYCOBIOLOGY, V15, P1016, DOI 10.1093/glycob/cwi086; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HANFLAND P, 1981, BIOCHEMISTRY-US, V20, P5310, DOI 10.1021/bi00521a034; HANFLAND P, 1988, CARBOHYD RES, V178, P1, DOI 10.1016/0008-6215(88)80098-3; HANFLAND P, 1984, EUR J BIOCHEM, V145, P531, DOI 10.1111/j.1432-1033.1984.tb08589.x; Hatakeyama S, 2010, INT J CANCER, V127, P1052, DOI 10.1002/ijc.25117; HOUNSELL EF, 1985, EUR J BIOCHEM, V148, P367, DOI 10.1111/j.1432-1033.1985.tb08848.x; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; IYER RN, 1971, ARCH BIOCHEM BIOPHYS, V142, P101, DOI 10.1016/0003-9861(71)90263-3; KABAT EA, 1982, AM J CLIN PATHOL, V78, P281, DOI 10.1093/ajcp/78.3.281; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Klein H, 2005, MOLLISONS BLOOD TRAN, P114; Kozak RP, 2012, ANAL BIOCHEM, V423, P119, DOI 10.1016/j.ab.2012.01.002; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; Le Pendu J, 2001, APMIS, V109, P9; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Liu Y, 2012, METHODS MOL BIOL, V808, P117, DOI 10.1007/978-1-61779-373-8_8; Machida E, 2001, CANCER RES, V61, P2226; Miyamoto T, 2013, HISTOPATHOLOGY, V62, P986, DOI 10.1111/his.12107; NISHI K, 1992, INT J LEGAL MED, V105, P75, DOI 10.1007/BF02340827; Nonaka M, 2014, J BIOL CHEM, V289, P16478, DOI 10.1074/jbc.M114.559047; Palma AS, 2014, CURR OPIN CHEM BIOL, V18, P87, DOI 10.1016/j.cbpa.2014.01.007; Palma AS, 2011, BIOCHEM BIOPH RES CO, V408, P548, DOI 10.1016/j.bbrc.2011.04.055; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; PERLMAN EJ, 1990, AM J SURG PATHOL, V14, P810, DOI 10.1097/00000478-199009000-00002; Rabu C, 2012, FUTURE ONCOL, V8, P943, DOI [10.2217/FON.12.88, 10.2217/fon.12.88]; Shimodaira K, 1997, CANCER RES, V57, P5201; Stoll M. S., 2009, P BEILST S GLYC BIOI, P123; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; STOLL MS, 1990, EUR J BIOCHEM, V189, P499, DOI 10.1111/j.1432-1033.1990.tb15515.x; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; VOWDEN P, 1986, BRIT J CANCER, V53, P307, DOI 10.1038/bjc.1986.53; Wang LZ, 2005, BIOCHEM BIOPH RES CO, V331, P958, DOI 10.1016/j.bbrc.2005.04.022; Watkins W M, 1980, Adv Hum Genet, V10, P1; WOOD E, 1979, FEBS LETT, V104, P135, DOI 10.1016/0014-5793(79)81100-X; Zhang G, 2010, P NATL ACAD SCI USA, V107, P732, DOI 10.1073/pnas.0911397107; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414	57	36	36	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16462	16477		10.1074/jbc.M114.558932	http://dx.doi.org/10.1074/jbc.M114.558932			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24753245	hybrid, Green Published			2022-12-25	WOS:000337965700048
J	Paul, A; Garcia, YA; Zierer, B; Patwardhan, C; Gutierrez, O; Hildenbrand, Z; Harris, DC; Balsiger, HA; Sivils, JC; Johnson, JL; Buchner, J; Chadli, A; Cox, MB				Paul, Atanu; Garcia, Yenni A.; Zierer, Bettina; Patwardhan, Chaitanya; Gutierrez, Omar; Hildenbrand, Zacariah; Harris, Diondra C.; Balsiger, Heather A.; Sivils, Jeffrey C.; Johnson, Jill L.; Buchner, Johannes; Chadli, Ahmed; Cox, Marc B.			The Cochaperone SGTA (Small Glutamine-rich Tetratricopeptide Repeat-containing Protein Alpha) Demonstrates Regulatory Specificity for the Androgen, Glucocorticoid, and Progesterone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen Receptor; Glucocorticoid Receptor; Heat Shock Protein 90 (Hsp90); Progesterone; Prostate Cancer; Steroid Hormone Receptor; FKBP52; Hsp70; SGTA; Cochaperone	PROSTATE-CANCER; BINDING-PROTEIN; IDENTIFICATION; DOMAIN; HOP; INTERACTS; COMPLEX	Background: Cochaperones are important for the folding and activation of steroid hormone receptors. Results: The androgen receptor-associated cochaperone SGTA binds both Hsp70 and Hsp90 and regulates progesterone and glucocorticoid receptors. Conclusion: SGTA is a receptor-specific cochaperone that regulates distinct steps in the receptor chaperoning cycle. Significance: SGTA is a relevant factor in diseases that depend on androgens, progestins and/or glucocorticoids. Steroid hormone receptors are ligand-dependent transcription factors that require the ordered assembly of multichaperone complexes for transcriptional activity. Although heat shock protein (Hsp) 90 and Hsp70 are key players in this process, multiple Hsp70- and Hsp90-associated cochaperones associate with receptor-chaperone complexes to regulate receptor folding and activation. Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) was recently characterized as an Hsp70 and Hsp90-associated cochaperone that specifically regulates androgen receptor activity. However, the specificity of SGTA for additional members of the steroid hormone receptor superfamily and the mechanism by which SGTA regulates receptor activity remain unclear. Here we report that SGTA associates with and specifically regulates the androgen, glucocorticoid, and progesterone receptors and has no effect on the mineralocorticoid and estrogen receptors in both yeast and mammalian cell-based reporter assays. In both systems, SGTA knockdown/deletion enhances receptor activity, whereas SGTA overexpression suppresses receptor activity. We demonstrate that SGTA binds directly to Hsp70 and Hsp90 in vitro with similar affinities yet predominately precipitates with Hsp70 from cell lysates, suggesting a role for SGTA in early, Hsp70-mediated folding. Furthermore, SGTA expression completely abrogates the regulation of receptor function by FKBP52 (52-kDa FK506-binding protein), which acts at a later stage of the chaperone cycle. Taken together, our data suggest a role for SGTA at distinct steps in the chaperone-dependent modulation of androgen, glucocorticoid, and progesterone receptor activity.	[Paul, Atanu; Garcia, Yenni A.; Gutierrez, Omar; Harris, Diondra C.; Balsiger, Heather A.; Sivils, Jeffrey C.; Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Paul, Atanu; Garcia, Yenni A.; Gutierrez, Omar; Harris, Diondra C.; Balsiger, Heather A.; Sivils, Jeffrey C.; Cox, Marc B.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Hildenbrand, Zacariah] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Zierer, Bettina; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Garching, Germany; [Patwardhan, Chaitanya; Chadli, Ahmed] Georgia Regents Univ, Canc Res Ctr, Augusta, GA 30912 USA; [Johnson, Jill L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Technical University of Munich; University System of Georgia; Augusta University; Idaho; University of Idaho	Cox, MB (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	mbcox@utep.edu	Paul, Atanu/J-5720-2019; Buchner, Johannes/A-2651-2010	Paul, Atanu/0000-0002-9967-6005; Gutierrez-Ruiz, Omar/0000-0002-9561-7067; Cox, Marc/0000-0001-7854-2676; Buchner, Johannes/0000-0003-1282-7737	National Institutes of Health [5 G12 RR008124, 8 G12 MD007592, SC1GM084863, R01 GM102443-01]; Direct For Biological Sciences [0744522] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102443, SC1GM084863] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 G12 RR008124, 8 G12 MD007592, SC1GM084863 (to M. B. C.), and R01 GM102443-01 (to A. C.).	Angeletti PC, 2002, CELL STRESS CHAPERON, V7, P258, DOI 10.1379/1466-1268(2002)007<0258:SGRPVP>2.0.CO;2; Balsiger Heather A., 2009, V505, P141, DOI 10.1007/978-1-60327-575-0_8; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; Butler MS, 2013, FERTIL STERIL, V99, P2076, DOI 10.1016/j.fertnstert.2013.01.140; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cox MB, 2007, MOL ENDOCRINOL, V21, P2956, DOI 10.1210/me.2006-0547; Cziepluch C, 1998, J VIROL, V72, P4149, DOI 10.1128/JVI.72.5.4149-4156.1998; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Goodarzi MO, 2008, HUM REPROD, V23, P1214, DOI 10.1093/humrep/den065; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Kordes E, 1998, GENOMICS, V52, P90, DOI 10.1006/geno.1998.5385; Laschober GT, 2010, AGING CELL, V9, P1084, DOI 10.1111/j.1474-9726.2010.00637.x; Leznicki P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059590; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Liu JW, 1998, FEMS MICROBIOL LETT, V159, P167, DOI 10.1111/j.1574-6968.1998.tb12856.x; McKeen HD, 2008, ENDOCRINOLOGY, V149, P5724, DOI 10.1210/en.2008-0168; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Ommen G, 2010, CELL STRESS CHAPERON, V15, P443, DOI 10.1007/s12192-009-0160-7; Patwardhan CA, 2013, J BIOL CHEM, V288, P7313, DOI 10.1074/jbc.M112.427328; Philp LK, 2013, HORM CANCER-US, V4, P343, DOI 10.1007/s12672-013-0151-0; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Trotta AP, 2013, INT J CANCER, V133, P2812, DOI 10.1002/ijc.28310; Trotta AP, 2012, J MOL ENDOCRINOL, V49, P57, DOI 10.1530/JME-11-0152; Worrall LJ, 2008, BBA-PROTEINS PROTEOM, V1784, P496, DOI 10.1016/j.bbapap.2007.12.003; Wu SJ, 2001, BIOCHEM J, V359, P419, DOI 10.1042/0264-6021:3590419; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	45	25	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15297	15308		10.1074/jbc.M113.535229	http://dx.doi.org/10.1074/jbc.M113.535229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753260	Green Published, hybrid			2022-12-25	WOS:000337465400014
J	Blosser, W; Vakana, E; Wyss, LV; Swearingen, ML; Stewart, J; Stancato, L; Tate, CM				Blosser, Wayne; Vakana, Eliza; Wyss, Lisa V.; Swearingen, Michelle L.; Stewart, Julie; Stancato, Louis; Tate, Courtney M.			A Method to Assess Target Gene Involvement in Angiogenesis In Vitro and In Vivo Using Lentiviral Vectors Expressing shRNA	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; CELL LUNG-CANCER; STEM-LIKE CELLS; TUMOR ANGIOGENESIS; VEGF EXPRESSION; SP1; KINASE; MODEL; DIFFERENTIATION; ADENOCARCINOMA	Current methods to study angiogenesis in cancer growth and development can be difficult and costly, requiring extensive use of in vivo methodologies. Here, we utilized an in vitro adipocyte derived stem cell and endothelial colony forming cell (ADSC/ECFC) co-culture system to investigate the effect of lentiviral-driven shRNA knockdown of target genes compared to a non-targeting shRNA control on cord formation using High Content Imaging. Cord formation was significantly reduced following knockdown of the VEGF receptor VEGFR2 in VEGF-driven cord formation and the FGF receptor FGFR1 in basic FGF (bFGF)-driven cord formation. In addition, cord formation was signifcantly reduced following knockdown of the transcription factor forkhead box protein O1 (FOXO1), a protein with known positive effects on angiogenesis and blood vessel stabilization in VEGF-and bFGF-driven cord formation. Lentiviral shRNA also demonstrated utility for stable knockdown of VEGFR2 and FOXO1 in ECFCs, allowing for interrogation of protein knockdown effects on in vivo neoangiogenesis in a Matrigel plug assay. In addition to interrogating the effect of gene knockdown in endothelial cells, we utilized lentiviral shRNA to knockdown specificity protein 1 (SP1), a transcription factor involved in the expression of VEGF, in U-87 MG tumor cells to demonstrate the ability to analyze angiogenesis in vitro in a tumor-driven transwell cord formation system and in tumor angiogenesis in vivo. A significant reduction in tumor-driven cord formation, VEGF secretion, and in vivo tumor angiogenesis was observed upon SP1 knockdown. Therefore, evaluation of target gene knockdown effects in the in vitro co-culture cord formation assay in the ADSC/ECFC co-culture, ECFCs alone, and in tumor cells translated directly to in vivo results, indicating the in vitro method as a robust, cost-effective and efficient in vitro surrogate assay to investigate target gene involvement in endothelial or tumor cell function in angiogenesis.	[Blosser, Wayne; Vakana, Eliza; Swearingen, Michelle L.; Stewart, Julie; Stancato, Louis; Tate, Courtney M.] Eli Lilly & Co, Oncol Res, Indianapolis, IN 46285 USA; [Wyss, Lisa V.] Adv Testing Labs, Cincinnati, OH USA	Eli Lilly	Tate, CM (corresponding author), Eli Lilly & Co, Oncol Res, Indianapolis, IN 46285 USA.	tateco@lilly.com						Bagri A, 2010, TRENDS MOL MED, V16, P122, DOI 10.1016/j.molmed.2010.01.004; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Chen YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-264; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Deacon K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397042; Falcon BL, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-31; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gyanchandani R, 2013, CLIN CANC RES; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang C, 2012, CYTOKINE GROWTH F R, V23, P25, DOI 10.1016/j.cytogfr.2012.01.003; Jih Yng-Jyh, 2001, Angiogenesis, V4, P313, DOI 10.1023/A:1016080321956; Kebers F, 1998, EXP CELL RES, V240, P197, DOI 10.1006/excr.1998.3935; Klagsbrun M, 1999, CHEM BIOL, V6, pR217, DOI 10.1016/S1074-5521(99)80081-7; KLAGSBRUN M, 1991, J CELL BIOCHEM, V47, P199, DOI 10.1002/jcb.240470302; Low J, 2012, J BIOMOL SCREEN, V17, P152, DOI 10.1177/1087057111422565; Majeti BK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-213; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Meier T, 2011, MOL CANCER THER, V10, P2168, DOI 10.1158/1535-7163.MCT-11-0323; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Oellerich MF, 2012, CIRC RES, V110, P1238, DOI 10.1161/CIRCRESAHA.111.246488; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Riely G, 2007, CLIN CANCER RES, V13, p4623S, DOI 10.1158/1078-0432.CCR-07-0544; Roskoski R, 2007, BIOCHEM BIOPH RES CO, V356, P323, DOI 10.1016/j.bbrc.2007.02.156; Shi Q, 2001, CANCER RES, V61, P4143; STACHOWIAK MK, 1994, J CELL BIOL, V127, P203, DOI 10.1083/jcb.127.1.203; Tate C, 2013, J BIOL CHEM; Tiong KH, 2013, APOPTOSIS; Wang LW, 2005, CLIN EXP METASTAS, V22, P205, DOI 10.1007/s10585-005-5684-3; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Willard MD, 2012, MOL CANCER RES, V10, P739, DOI 10.1158/1541-7786.MCR-11-0483; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068	38	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96036	10.1371/journal.pone.0096036	http://dx.doi.org/10.1371/journal.pone.0096036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759702	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200128
J	Skiold, B; Wu, QZ; Hooper, SB; Davis, PG; McIntyre, R; Tolcos, M; Pearson, J; Vreys, R; Egan, GF; Barton, SK; Cheong, JLY; Polglase, GR				Skiold, Beatrice; Wu, Qizhu; Hooper, Stuart B.; Davis, Peter G.; McIntyre, Richard; Tolcos, Mary; Pearson, James; Vreys, Ruth; Egan, Gary F.; Barton, Samantha K.; Cheong, Jeanie L. Y.; Polglase, Graeme R.			Early Detection of Ventilation-Induced Brain Injury Using Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging: An In Vivo Study in Preterm Lambs	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; PROTON MR SPECTROSCOPY; INTRAVENTRICULAR HEMORRHAGE; PERINATAL ASPHYXIA; RELAXATION-TIMES; RETINAL ISCHEMIA; TIDAL VOLUME; INFANTS; H-1; NEWBORNS	Background and Aim: High tidal volume (V-T) ventilation during resuscitation of preterm lambs results in brain injury evident histologically within hours after birth. We aimed to investigate whether magnetic resonance spectroscopy (MRS) and/or diffusion tensor imaging (DTI) can be used for early in vivo detection of ventilation-induced brain injury in preterm lambs. Methods: Newborn lambs (0.85 gestation) were stabilized with a ``protective ventilation'' strategy (PROT, n = 7: prophylactic Curosurf, sustained inflation, V-T 7 mL/kg, positive end expiratory pressure (PEEP) 5 cmH(2)O) or an initial 15 minutes of ``injurious ventilation'' (INJ, n = 10: V-T 12 mL/kg, no PEEP, late Curosurf) followed by PROT ventilation for the remainder of the experiment. At 1 hour, lambs underwent structural magnetic resonance imaging (Siemens, 3 Tesla). For measures of mean/axial/radial diffusivity (MD, AD, RD) and fractional anisotropy (FA), 30 direction DTI was performed. Regions of interests encompassed the thalamus, internal capsule, periventricular white matter and the cerebellar vermis. MRS was performed using a localized single-voxel (15 x 15 x 20 mm(3), echo time 270 ms) encompassing suptratentorial deep nuclear grey matter and central white matter. Peak-area ratios for lactate (Lac) relative to N-acetylaspartate (NAA), choline (Cho) and creatine (Cr) were calculated. Groups were compared using 2-way RM-ANOVA, Mann-Whitney U-test and Spearman's correlations. Results: No cerebral injury was seen on structural MR images. Lambs in the INJ group had higher mean FA and lower mean RD in the thalamus compared to PROT lambs, but not in the other regions of interest. Peak-area lactate ratios.1.0 was only seen in INJ lambs. A trend of higher mean peak-area ratios for Lac/Cr and Lac/Cho was seen, which correlated with lower pH in both groups. Conclusion: Acute changes in brain diffusion measures and metabolite peak-area ratios were observed after injurious ventilation. Early MRS/DTI is able to detect the initiation of ventilation-induced brain injury.	[Skiold, Beatrice; Davis, Peter G.; Cheong, Jeanie L. Y.] Royal Hosp Women, Neonatal Serv, Melbourne, Vic, Australia; [Wu, Qizhu; McIntyre, Richard; Pearson, James; Vreys, Ruth; Egan, Gary F.] Monash Univ, Monash Biomed Imaging, Clayton, Vic, Australia; [Wu, Qizhu] CSIRO Mat Sci & Engn, Clayton, Vic, Australia; [Hooper, Stuart B.; Tolcos, Mary; Barton, Samantha K.; Polglase, Graeme R.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Hooper, Stuart B.; Polglase, Graeme R.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Cheong, Jeanie L. Y.] Murdoch Childrens Res Inst, Victorian Infant Brain Studies, Melbourne, Vic, Australia; [Cheong, Jeanie L. Y.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia	Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Monash University; Murdoch Children's Research Institute; University of Melbourne	Skiold, B (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	beatrice.skiold@outlook.com	Pearson, James T/B-4631-2012; Egan, Gary F./A-1381-2013	Pearson, James T/0000-0002-3318-5406; Egan, Gary/0000-0002-3186-4026; Barton, Samantha/0000-0001-7601-0238; Polglase, Graeme/0000-0002-8906-614X; Cheong, Jeanie/0000-0001-5901-0455; Tolcos, Mary/0000-0001-6105-4553; Hooper, Stuart/0000-0003-1676-4825	Swedish Medical Society; Swedish Brain Foundation; Sallskapet Barnavard; Rebecca L. Cooper Medical Research Foundation; Monash University; Monash Biomedical Imaging; NH&MRC Research Fellowship [1026890]; NHMRC [1053787]; Victorian Government	Swedish Medical Society; Swedish Brain Foundation; Sallskapet Barnavard; Rebecca L. Cooper Medical Research Foundation; Monash University(Monash University); Monash Biomedical Imaging; NH&MRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This research was supported by the Swedish Medical Society, the Swedish Brain Foundation, Sallskapet Barnavard, the Rebecca L. Cooper Medical Research Foundation, Monash University Researcher Accelerator Grant, Monash Biomedical Imaging, NH&MRC Research Fellowship (GRP: 1026890), NHMRC Early Career Fellowship (ID 1053787 to JC) and the Victorian Government's Operational Infrastructure Support Program. Chiesi Farmaceutici S. p. A. generously donated the surfactant used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN DG, 1981, ANAT REC, V201, P655, DOI 10.1002/ar.1092010410; Alderliesten T, 2011, RADIOLOGY, V261, P235, DOI 10.1148/radiol.11110213; Ancora G, 2013, NEURORADIOLOGY, V55, P1017, DOI 10.1007/s00234-013-1202-5; Arzoumanian Y, 2003, AM J NEURORADIOL, V24, P1646; Back SA, 2012, NEUROTHERAPEUTICS; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Boichot C, 2006, RADIOLOGY, V239, P839, DOI 10.1148/radiol.2393050027; Card D, 2013, PEDIATR RES, V74, P75, DOI 10.1038/pr.2013.62; Chau V, 2009, PEDIATR NEUROL, V40, P181, DOI 10.1016/j.pediatrneurol.2008.09.012; Cheong JLY, 2006, AM J NEURORADIOL, V27, P1546; Cheong JLY, 2012, J PAEDIATR CHILD H, V48, P784, DOI 10.1111/j.1440-1754.2012.02536.x; Dudink J, 2012, ARCH DIS CHILD-FETAL, V97, pF362, DOI 10.1136/archdischild-2011-300121; Duerden EG, 2013, NEURORADIOLOGY; Gancia P, 2012, J MATERN-FETAL NEO M, V25, P94, DOI 10.3109/14767058.2012.715023; Gano D, 2013, PEDIATR RES, V74, P82, DOI 10.1038/pr.2013.69; GROENENDAAL F, 1995, NEUROPEDIATRICS, V26, P243, DOI 10.1055/s-2007-979764; Hanrahan JD, 1999, DEV MED CHILD NEUROL, V41, P76, DOI 10.1017/S0012162299000171; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LETH H, 1995, ACTA PAEDIATR, V84, P495, DOI 10.1111/j.1651-2227.1995.tb13681.x; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Panigrahy A, 2010, SEMIN PERINATOL, V34, P3, DOI 10.1053/j.semperi.2009.10.001; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Polglase GR, 2012, J APPL PHYSIOL, V112, P481, DOI 10.1152/japplphysiol.00995.2011; Pouwels PJW, 1998, NEUROPEDIATRICS, V29, P254, DOI 10.1055/s-2007-973571; Righini A, 2010, NEURORADIOLOGY, V52, P1025, DOI 10.1007/s00234-010-0745-y; Robertson NJ, 2000, J CEREBR BLOOD F MET, V20, P1446, DOI 10.1097/00004647-200010000-00006; Sarkar S, 2009, AM J PERINAT, V26, P419, DOI 10.1055/s-0029-1214237; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF393, DOI 10.1136/adc.2009.174003; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Skiold B, 2010, ACTA PAEDIATR, V99, P842, DOI 10.1111/j.1651-2227.2009.01634.x; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spittle AJ, 2011, DEV MED CHILD NEUROL, V53, P1000, DOI 10.1111/j.1469-8749.2011.04095.x; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; Ward P, 2006, PEDIATRICS, V117, pE619, DOI 10.1542/peds.2005-0545; WELLS JT, 1995, EARLY HUM DEV, V42, P209, DOI 10.1016/0378-3782(95)01651-I; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Xu D, 2013, PEDIATR RADIOL, V43, P55, DOI 10.1007/s00247-012-2481-4; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739	51	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95804	10.1371/journal.pone.0095804	http://dx.doi.org/10.1371/journal.pone.0095804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759765	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200092
J	El Mendili, MM; Cohen-Adad, J; Pelegrini-Issac, M; Rossignol, S; Morizot-Koutlidis, R; Marchand-Pauvert, V; Iglesias, C; Sangari, S; Katz, R; Lehericy, S; Benali, H; Pradat, PF				El Mendili, Mohamed-Mounir; Cohen-Adad, Julien; Pelegrini-Issac, Melanie; Rossignol, Serge; Morizot-Koutlidis, Regine; Marchand-Pauvert, Veronique; Iglesias, Caroline; Sangari, Sina; Katz, Rose; Lehericy, Stephane; Benali, Habib; Pradat, Pierre-Francois			Multi-Parametric Spinal Cord MRI as Potential Progression Marker in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							DIFFUSION TENSOR MRI; MAGNETIC-RESONANCE SPECTROSCOPY; CORTICOSPINAL TRACT; CERVICAL CORD; BRAIN; MOTOR; ALS; ATROPHY; DEGENERATION; DISABILITY	Objective: To evaluate multimodal MRI of the spinal cord in predicting disease progression and one-year clinical status in amyotrophic lateral sclerosis (ALS) patients. Materials and Methods: After a first MRI (MRI1), 29 ALS patients were clinically followed during 12 months; 14/29 patients underwent a second MRI (MRI2) at 1163 months. Cross-sectional area (CSA) that has been shown to be a marker of lower motor neuron degeneration was measured in cervical and upper thoracic spinal cord from T2-weighted images. Fractional anisotropy (FA), axial/radial/mean diffusivities (lambda(1), lambda(H1), MD) and magnetization transfer ratio (MTR) were measured within the lateral corticospinal tract in the cervical region. Imaging metrics were compared with clinical scales: Revised ALS Functional Rating Scale (ALSFRS-R) and manual muscle testing (MMT) score. Results: At MRI1, CSA correlated significantly (P < 0.05) with MMT and arm ALSFRS-R scores. FA correlated significantly with leg ALFSRS-R scores. One year after MRI1, CSA predicted (P < 0.01) arm ALSFSR-R subscore and FA predicted (P, 0.01) leg ALSFRS-R subscore. From MRI1 to MRI2, significant changes (P < 0.01) were detected for CSA and MTR. CSA rate of change (i.e. atrophy) highly correlated (P < 0.01) with arm ALSFRS-R and arm MMT subscores rate of change. Conclusion: Atrophy and DTI metrics predicted ALS disease progression. Cord atrophy was a better biomarker of disease progression than diffusion and MTR. Our study suggests that multimodal MRI could provide surrogate markers of ALS that may help monitoring the effect of disease- modifying drugs.	[El Mendili, Mohamed-Mounir; Pelegrini-Issac, Melanie; Marchand-Pauvert, Veronique; Iglesias, Caroline; Sangari, Sina; Katz, Rose; Benali, Habib; Pradat, Pierre-Francois] Univ Paris 06, Univ Sorbonne, UM CR 2, Lab Imagerie Biomed, Paris, Ile De France, France; [El Mendili, Mohamed-Mounir; Pelegrini-Issac, Melanie; Marchand-Pauvert, Veronique; Iglesias, Caroline; Sangari, Sina; Katz, Rose; Benali, Habib; Pradat, Pierre-Francois] CNRS, UMR 7371, Lab Imagerie Biomed, Paris, Ile De France, France; [El Mendili, Mohamed-Mounir; Pelegrini-Issac, Melanie; Marchand-Pauvert, Veronique; Iglesias, Caroline; Sangari, Sina; Katz, Rose; Benali, Habib; Pradat, Pierre-Francois] INSERM, U 1146, Lab Imagerie Biomed, Paris, Ile De France, France; [Cohen-Adad, Julien] Ecole Polytech Montreal, Dept Genie Elect, Montreal, PQ, Canada; [Rossignol, Serge] Univ Montreal, GRSNC, Fac Med, Montreal, PQ, Canada; [Morizot-Koutlidis, Regine] Grp Hosp Pitie Salpetriere, AP HP, Dept Explorat Fonct Neurol, F-75634 Paris, Ile De France, France; [Lehericy, Stephane] Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, Ctr Neuroimagerie Rech CENIR, CNRS,Inserm U975,UMR S975,UMR7225, Paris, Ile De France, France; [Lehericy, Stephane] Grp Hosp Pitie Salpetriere, AP HP, Serv Neuroradiol, F-75634 Paris, Ile De France, France; [Pradat, Pierre-Francois] Grp Hosp Pitie Salpetriere, AP HP, Dept Malad Syst Nerveux, F-75634 Paris, Ile De France, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Pradat, PF (corresponding author), Univ Paris 06, Univ Sorbonne, UM CR 2, Lab Imagerie Biomed, Paris, Ile De France, France.	pierre-francois.pradat@psl.aphp.fr	Marchand-Pauvert, Veronique/E-5001-2017	Marchand-Pauvert, Veronique/0000-0002-0226-7169; Sangari, Sina/0000-0002-7800-9959; Pelegrini-Issac, Melanie/0000-0003-3260-5795	Association Francaise contre les Myopathies (AFM); Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME); Investissements d'avenir [ANR-10-IAIHU-06]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME); Investissements d'avenir(French National Research Agency (ANR))	This study was supported by the Association Francaise contre les Myopathies (AFM) and the Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME). The research leading to these results has also received funding from the program "Investissements d'avenir'' ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2009, J NEUROL NEUROSUR PS, V80, P53, DOI 10.1136/jnnp.2008.154252; Andre Jalal B, 2010, Top Magn Reson Imaging, V21, P367, DOI 10.1097/RMR.0b013e31823e65a1; Bede P, 2012, AMYOTROPH LATERAL SC, V13, P407, DOI 10.3109/17482968.2011.649760; Bensimon G, 2002, J NEUROL, V249, P609, DOI 10.1007/s004150200071; Blain CRV, 2007, AMYOTROPH LATERAL SC, V8, P348, DOI 10.1080/17482960701548139; Block W, 1998, ARCH NEUROL-CHICAGO, V55, P931, DOI 10.1001/archneur.55.7.931; Branco LM, 2013, AMYOTROPH L IN PRESS; Carrara G, 2012, AM J NEURORADIOL, V33, P733, DOI 10.3174/ajnr.A2855; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Charil A, 2009, AMYOTROPH LATERAL SC, V10, P269, DOI 10.3109/17482960902777339; Chio A, 2002, NEUROLOGY, V59, P99, DOI 10.1212/WNL.59.1.99; Ciccarelli O, 2007, BRAIN, V130, P2220, DOI 10.1093/brain/awm152; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cohen-Adad J, 2007, P ANN INT IEEE EMBS, P323, DOI 10.1109/IEMBS.2007.4352289; Cohen-Adad J, 2013, AMYOTROPH LAT SCL FR, V14, P30, DOI 10.3109/17482968.2012.701308; da Rocha AJ, 2004, AM J NEURORADIOL, V25, P1509; El Mendili MM, 2014, J MAGN RESO IN PRESS; Gordon PH, 2012, J NEUROL, V259, P1788, DOI 10.1007/s00415-011-6403-4; Hong YH, 2004, J NEUROL SCI, V227, P73, DOI 10.1016/j.jns.2004.08.014; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Keil C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-141; Leary SM, 1999, MAGN RESON IMAGING, V17, P773, DOI 10.1016/S0730-725X(99)00005-3; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; Mills KR, 1997, MUSCLE NERVE, V20, P1137, DOI 10.1002/(SICI)1097-4598(199709)20:9<1137::AID-MUS7>3.0.CO;2-9; Mitsumoto H, 2007, NEUROLOGY, V68, P1402, DOI 10.1212/01.wnl.0000260065.57832.87; Nair G, 2010, NEUROIMAGE, V53, P576, DOI 10.1016/j.neuroimage.2010.06.060; Pradat PF, 2010, REV NEUROL-FRANCE, V166, P683, DOI 10.1016/j.neurol.2010.03.006; Pradat PF, 2009, MOVEMENT DISORD, V24, P2143, DOI 10.1002/mds.22762; Rajagopalan Venkateswaran, 2011, J Aging Res, V2011, P481745, DOI 10.4061/2011/481745; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rule RR, 2004, AMYOTROPH LATERAL SC, V5, P141, DOI 10.1080/14660820410017109; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Sorenson EJ, 2003, NEUROLOGY, V61, P1503; Suhy J, 2002, NEUROLOGY, V58, P773, DOI 10.1212/WNL.58.5.773; Turner RT, 2010, EXPERT OPIN MED DIAG, V4, P483; Unrath A, 2007, J NEUROL, V254, P1099, DOI 10.1007/s00415-006-0495-2; Valsasina P, 2007, J NEUROL NEUROSUR PS, V78, P480, DOI 10.1136/jnnp.2006.100032; Xu JQ, 2013, NEUROIMAGE, V67, P64, DOI 10.1016/j.neuroimage.2012.11.014; Yin H, 2008, ANN ACAD MED SINGAP, V37, P411; Zhang Y, 2011, AMYOTROPH LATERAL SC, V12, P421, DOI 10.3109/17482968.2011.593036	41	74	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95516	10.1371/journal.pone.0095516	http://dx.doi.org/10.1371/journal.pone.0095516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755826	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000335240300050
J	Elcadi, GH; Forsman, M; Hallman, DM; Aasa, U; Fahlstrom, M; Crenshaw, AG				Elcadi, Guilherme H.; Forsman, Mikael; Hallman, David M.; Aasa, Ulrika; Fahlstrom, Martin; Crenshaw, Albert G.			Oxygenation and Hemodynamics Do Not Underlie Early Muscle Fatigue for Patients with Work-Related Muscle Pain	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; FOREARM BLOOD-FLOW; TRAPEZIUS MUSCLE; FEMALE CLEANERS; HEALTHY; CONSUMPTION; SHOULDER; CONTRACTIONS; MYALGIA; FORCE	Patients suffering from work-related muscle pain (WRMP) fatigue earlier during exercise than healthy controls. Inadequate oxygen consumption and/ or inadequate blood supply can influence the ability of the muscles to withstand fatigue. However, it remains unknown if oxygenation and hemodynamics are associated with early fatigue in muscles of WRMP patients. In the present study we applied near-infrared spectroscopy (NIRS) on the extensor carpi radialis (ECR) and trapezius (TD) muscles of patients with WRMP (n = 18) and healthy controls (n = 17). Our objective was to determine if there were group differences in endurance times for a low-level contraction of 15% maximal voluntary contraction (MVC) -sustained for 12-13 min, and to see if these differences were associated with differences in muscle oxygenation and hemodynamics. At baseline, oxygen saturation (StO(2)%) was similar between groups for the ECR, but StO2% was significantly lower for TD for the WRMP patients (76%) compared to controls (85%) (P < 0.01). Also, baseline ECR blood flow was similar in the two groups. For both muscles there were a larger number of patients, compared to controls, that did not maintain the 15% MVC for the allotted time. Consequently, the endurance times were significantly shorter for the WRMP patients than controls (medians, ECR: 347 s vs. 582 s; TD: 430 s vs. 723 s respectively). Responses in StO(2)% during the contractions were not significantly different between groups for either muscle, i.e. no apparent difference in oxygen consumption. Overall, we interpret our findings to indicate that the early fatigue for our WRMP patients was not associated with muscle oxygenation and hemodynamics.	[Elcadi, Guilherme H.; Forsman, Mikael; Hallman, David M.; Crenshaw, Albert G.] Univ Gavle, Ctr Musculoskeletal Res, Gavle, Sweden; [Forsman, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Elcadi, Guilherme H.; Aasa, Ulrika; Fahlstrom, Martin] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Fahlstrom, Martin] Umea Univ, Dept Clin Sci, Umea, Sweden	University of Gavle; Karolinska Institutet; Umea University; Umea University	Elcadi, GH (corresponding author), Univ Gavle, Ctr Musculoskeletal Res, Gavle, Sweden.	guilherme.elcadi@hig.se	Forsman, Mikael/AAE-5119-2020	Forsman, Mikael/0000-0001-5777-4232; Elcadi, Guilherme H./0000-0001-5005-9957; Aasa, Ulrika/0000-0002-3383-0540	University of Gavle	University of Gavle	Funded by internal funds from the University of Gavle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIDYA KN, 1988, ERGONOMICS, V31, P227, DOI 10.1080/00140138808966664; Beneck GJ, 2013, J ELECTROMYOGR KINES, V23, P70, DOI 10.1016/j.jelekin.2012.07.001; Blangsted AK, 2005, J ELECTROMYOGR KINES, V15, P138, DOI 10.1016/j.jelekin.2004.10.004; Borg G., 1982, PSYCHOPHYSICAL JUDGM, p25?34, DOI DOI 10.1016/J.ERGON.2009.11.006; Boushel R, 2000, ACTA PHYSIOL SCAND, V168, P615, DOI 10.1046/j.1365-201x.2000.00713.x; Brunnekreef JJ, 2012, INT J SPORTS MED, V33, P835, DOI 10.1055/s-0032-1306281; Brunnekreef JJ, 2006, CLIN PHYSIOL FUNCT I, V26, P178, DOI 10.1111/j.1475-097X.2006.00671.x; BYSTROM S, 1994, HUM FACTORS, V36, P158, DOI 10.1177/001872089403600110; Camm AJ, 1996, EUR HEART J, V17, P354; Crenshaw AG, 2010, INT J IND ERGONOM, V40, P153, DOI 10.1016/j.ergon.2009.06.002; Crenshaw AG, 2012, EUR J APPL PHYSIOL, V112, P2703, DOI 10.1007/s00421-011-2244-1; CUI WJ, 1991, P SOC PHOTO-OPT INS, V1431, P180, DOI 10.1117/12.44189; DEBLASI RA, 1994, J APPL PHYSIOL, V76, P1388, DOI 10.1152/jappl.1994.76.3.1388; Dedering A, 1999, CLIN BIOMECH, V14, P103, DOI 10.1016/S0268-0033(98)00053-9; DUNCAN W, 1985, J ROY SOC MED, V78, P1; Elcadi GH, 2013, EUR J APPL PHYSIOL, V113, P1103, DOI 10.1007/s00421-012-2530-6; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Flodgren G, 2010, J BIOMED BIOTECHNOL, V2010, P9; HAGBERG M, 1984, ARCH PHYS MED REHAB, V65, P522; Hallman DM, 2011, EUR J APPL PHYSIOL, V111, P1725, DOI 10.1007/s00421-010-1813-z; HOGAN MC, 1994, J APPL PHYSIOL, V77, P2380, DOI 10.1152/jappl.1994.77.5.2380; Homma S, 1996, J APPL PHYSIOL, V80, P1279, DOI 10.1152/jappl.1996.80.4.1279; Johnson PW, 2013, APPL ERGON, V44, P35, DOI 10.1016/j.apergo.2012.04.007; Johnson PW, 1998, THESIS U BERKELEY SA; Kallenberg LAC, 2007, J ELECTROMYOGR KINES, V17, P264, DOI 10.1016/j.jelekin.2006.04.004; Katayama K, 2007, AM J PHYSIOL-REG I, V292, pR1279, DOI 10.1152/ajpregu.00554.2006; Kell RT, 2006, EUR J APPL PHYSIOL, V96, P241, DOI 10.1007/s00421-005-0072-x; Larsson B, 2000, PAIN, V84, P379, DOI 10.1016/S0304-3959(99)00237-7; Larsson B, 2000, EUR J APPL PHYSIOL, V83, P257, DOI 10.1007/s004210000292; Maluf KS, 2005, J APPL PHYSIOL, V99, P389, DOI 10.1152/japplphysiol.00207.2005; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; Mathiassen SE, 1999, INT J IND ERGONOM, V24, P315; Mense S, 2001, MUSCLE PAIN UNDERSTA, P1; Myers DE, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1925250; O'Leary S, 2009, J ORTHOP SPORT PHYS, V39, P324, DOI 10.2519/jospt.2009.2872; Oskarsson E, 2007, SCAND J MED SCI SPOR, V17, P211, DOI 10.1111/j.1600-0838.2006.00567.x; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Schulte E, 2006, EUR J APPL PHYSIOL, V96, P185, DOI 10.1007/s00421-004-1291-2; Shiro Y, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-146; Sjogaard G, 2010, EUR J APPL PHYSIOL, V108, P657, DOI 10.1007/s00421-009-1268-2; Troiano A, 2008, GAIT POSTURE, V28, P179, DOI 10.1016/j.gaitpost.2008.04.002; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; Wolf U, 2007, J VASC INTERV RADIOL, V18, P1094, DOI 10.1016/j.jvir.2007.06.004	45	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95582	10.1371/journal.pone.0095582	http://dx.doi.org/10.1371/journal.pone.0095582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755957	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300056
J	Hedback, N; Jensen, DH; Specht, L; Fiehn, AMK; Therkildsen, MH; Friis-Hansen, L; Dabelsteen, E; von Buchwald, C				Hedback, Nora; Jensen, David H.; Specht, Lena; Fiehn, Anne-Marie K.; Therkildsen, Marianne H.; Friis-Hansen, Lennart; Dabelsteen, Erik; von Buchwald, Christian			MiR-21 Expression in the Tumor Stroma of Oral Squamous Cell Carcinoma: An Independent Biomarker of Disease Free Survival	PLOS ONE			English	Article							PROGNOSTIC VALUE; MICRORNA-21 TARGETS; CANCER; MYOFIBROBLASTS; PROLIFERATION; FIBROBLASTS; ACTIN; PDCD4	Oral squamous cell carcinoma (OSCC) patients have a high mortality rate; thus, new clinical biomarkers and therapeutic options are needed. MicroRNAs (miRNAs) are short noncoding RNAs that regulate posttranscriptional gene expression and are commonly deregulated in OSCC and other cancers. MicroRNA-21 (miR-21) is the most consistently overexpressed miRNA in several types of cancer, and it might be a useful clinical biomarker and therapeutic target. To better understand the role of miR-21 in OSCC, paraffin-embedded tumor tissue samples from 86 patients with primary OSCC were analyzed by in situ hybridization. We found that miR-21 was primarily expressed in the tumor stroma and in some tumor-associated blood vessels with no expression in the adjacent normal epithelia or stroma. Using image analysis, we quantitatively estimated miR-21 expression levels specifically in the stroma of a cohort of OSCC samples. These miR-21 levels significantly correlated with disease free survival with the highest levels being located in the stroma. Stromal miR-21 expression was independently associated with a poorer prognosis, even after adjusting for clinical parameters (perineural invasion and N-stage) in a multivariate analysis. In summary, we have shown that miR-21 is located in the carcinoma cells, stroma and blood vessels of tumors, and its expression specifically in the stromal compartment has a negative prognostic value in OSCC.	[Hedback, Nora; Jensen, David H.; von Buchwald, Christian] Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark; [Specht, Lena] Univ Copenhagen, Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Fiehn, Anne-Marie K.; Therkildsen, Marianne H.] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Friis-Hansen, Lennart] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Dabelsteen, Erik] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Dept Oral Hlth Sci, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	von Buchwald, C (corresponding author), Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark.	Christian.Buchwald@regionh.dk	Specht, Lena/J-6422-2019; von Buchwald, Christian/D-5336-2016	Specht, Lena/0000-0002-6902-2190; von Buchwald, Christian/0000-0001-6753-8129; Friis-Hansen, Lennart/0000-0002-7222-0163; Fiehn, Anne-Marie Kanstrup/0000-0003-1741-1140	Candys Foundation; Fredheim Stiftung	Candys Foundation; Fredheim Stiftung	David H. Jensen is supported by a grant from the non-profit foundation Candys Foundation. Erik Dabelsteen is supported by a grant from the Fredheim Stiftung. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L., 2005, PATHOLOGY GENETICS H; Bullock MD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.213; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; DABELSTEEN E, 1978, PLAST RECONSTR SURG, V62, P429, DOI 10.1097/00006534-197809000-00015; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Fassan M, 2012, DIS ESOPHAGUS, V25, P263, DOI 10.1111/j.1442-2050.2011.01236.x; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; HASE K, 1993, DIS COLON RECTUM, V36, P627, DOI 10.1007/BF02238588; Hermansen SK, 2013, J NEURO-ONCOL, V111, P71, DOI 10.1007/s11060-012-0992-3; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kellermann MG, 2007, HISTOPATHOLOGY, V51, P849, DOI 10.1111/j.1365-2559.2007.02873.x; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Rask L, 2011, APMIS, V119, P663, DOI 10.1111/j.1600-0463.2011.02782.x; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sempere LF, 2010, CLIN CANCER RES, V16, P4246, DOI 10.1158/1078-0432.CCR-10-1152; Thode C, 2011, J ORAL PATHOL MED, V40, P201, DOI 10.1111/j.1600-0714.2010.00999.x; van Beurden HE, 2005, J DENT RES, V84, P871, DOI 10.1177/154405910508401002; Vered M, 2010, CANCER SCI, V101, P274, DOI 10.1111/j.1349-7006.2009.01357.x; Wang Y, 2013, JPN J CLIN ONCOL, V43, P813, DOI 10.1093/jjco/hyt084; Wikberg ML, 2013, TUMOR BIOL, P1; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	31	67	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95193	10.1371/journal.pone.0095193	http://dx.doi.org/10.1371/journal.pone.0095193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755828	gold, Green Submitted, Green Published			2022-12-25	WOS:000335240300031
J	Kacprzyk, J; Devine, A; McCabe, PF				Kacprzyk, Joanna; Devine, Aoife; McCabe, Paul F.			The Root Hair Assay Facilitates the Use of Genetic and Pharmacological Tools in Order to Dissect Multiple Signalling Pathways That Lead to Programmed Cell Death	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PHENYLALANINE AMMONIA-LYASE; SALICYLIC-ACID; ISOCHORISMATE SYNTHASE; ARABIDOPSIS; AUTOPHAGY; TOBACCO; BIOSYNTHESIS; SENESCENCE; INDUCTION	The activation of programmed cell death (PCD) is often a result of complex signalling pathways whose relationship and intersection are not well understood. We recently described a PCD root hair assay and proposed that it could be used to rapidly screen genetic or pharmacological modulators of PCD. To further assess the applicability of the root hair assay for studying multiple signalling pathways leading to PCD activation we have investigated the crosstalk between salicylic acid, autophagy and apoptosis-like PCD (AL-PCD) in Arabidopsis thaliana. The root hair assay was used to determine rates of AL-PCD induced by a panel of cell death inducing treatments in wild type plants treated with chemical modulators of salicylic acid synthesis or autophagy, and in genetic lines defective in autophagy or salicylic acid signalling. The assay demonstrated that PCD induced by exogenous salicylic acid or fumonisin B1 displayed a requirement for salicylic acid signalling and was partially dependent on the salicylic acid signal transducer NPR1. Autophagy deficiency resulted in an increase in the rates of AL-PCD induced by salicylic acid and fumonisin B1, but not by gibberellic acid or abiotic stress. The phenylalanine ammonia lyase-dependent salicylic acid synthesis pathway contributed only to death induced by salicylic acid and fumonisin B1. 3-Methyladenine, which is commonly used as an inhibitor of autophagy, appeared to influence PCD induction in all treatments suggesting a possible secondary, non-autophagic, effect on a core component of the plant PCD pathway. The results suggest that salicylic acid signalling is negatively regulated by autophagy during salicylic acid and mycotoxininduced AL-PCD. However, this crosstalk does not appear to be directly involved in PCD induced by gibberellic acid or abiotic stress. This study demonstrates that the root hair assay is an effective tool for relatively rapid investigation of complex signalling pathways leading to the activation of PCD.	[Kacprzyk, Joanna; Devine, Aoife; McCabe, Paul F.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University College Dublin	McCabe, PF (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	paul.mccabe@ucd.ie	Kacprzyk, Janusz A./M-9574-2014; Kacprzyk, Janusz/AAX-3998-2020	Kacprzyk, Janusz A./0000-0003-4187-5877; Kacprzyk, Janusz/0000-0003-4187-5877; Kacprzyk, Joanna/0000-0003-1054-2367; McCabe, Paul/0000-0002-6146-8307	UCD; Government of Ireland Postgraduate Scholarship from the Irish Research Council	UCD; Government of Ireland Postgraduate Scholarship from the Irish Research Council	This work was supported by a UCD seed funding grant. JK was supported by a Government of Ireland Postgraduate Scholarship from the Irish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS HK, 1994, PLANT PHYSIOL, V106, P1085, DOI 10.1104/pp.106.3.1085; Abreu ME, 2009, J EXP BOT, V60, P1261, DOI 10.1093/jxb/ern363; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Bassham DC, 2006, AUTOPHAGY, V2, P2, DOI 10.4161/auto.2092; Bassham DC, 2007, CURR OPIN PLANT BIOL, V10, P587, DOI 10.1016/j.pbi.2007.06.006; Bezier A, 2002, EUR J PLANT PATHOL, V108, P111, DOI 10.1023/A:1015061108045; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Brodersen P, 2005, PLANT PHYSIOL, V138, P1037, DOI 10.1104/pp.105.059303; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Coquoz JL, 1998, PLANT PHYSIOL, V117, P1095, DOI 10.1104/pp.117.3.1095; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; de la Torre-Hernandez ME, 2010, PHYSIOL MOL PLANT P, V74, P337, DOI 10.1016/j.pmpp.2010.05.004; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gao CJ, 2008, PLANTA, V227, P755, DOI 10.1007/s00425-007-0654-4; Garcia-Heredia JM, 2008, PLANTA, V228, P89, DOI 10.1007/s00425-008-0721-5; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Hogg BV, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-45; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P471, DOI 10.1093/pcp/pcj013; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P1641, DOI 10.1093/pcp/pcl031; Kacprzyk J, 2011, ADV BOT RES, V60, P169, DOI 10.1016/B978-0-12-385851-1.00004-4; Kadono T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013373; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; KANGASJARVI J, 1994, PLANT CELL ENVIRON, V17, P783, DOI 10.1111/j.1365-3040.1994.tb00173.x; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Lenz HD, 2011, PLANT J, V66, P818, DOI 10.1111/j.1365-313X.2011.04546.x; Lieberherr D, 2005, PLANT PHYSIOL, V138, P1644, DOI 10.1104/pp.104.057414; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Liu YM, 2009, AUTOPHAGY, V5, P954, DOI 10.4161/auto.5.7.9290; Lu H, 2009, PLANT J, V58, P401, DOI 10.1111/j.1365-313X.2009.03791.x; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; Mazel A, 2001, FREE RADICAL BIO MED, V30, P98, DOI 10.1016/S0891-5849(00)00452-4; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mur LAJ, 1997, PLANT J, V12, P1113, DOI 10.1046/j.1365-313X.1997.12051113.x; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Norman C, 2004, PLANT PHYSIOL, V134, P492, DOI 10.1104/pp.103.031039; Overmyer K, 2005, PLANT PHYSIOL, V137, P1092, DOI 10.1104/pp.104.055681; Pallas JA, 1996, PLANT J, V10, P281, DOI 10.1046/j.1365-313X.1996.10020281.x; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; Poor P, 2012, PROTOPLASMA, V250, P1; Reape TJ, 2013, PLANT SCI, V207, P135, DOI 10.1016/j.plantsci.2013.03.001; Sanchez G, 2010, MOL PLANT MICROBE IN, V23, P394, DOI 10.1094/MPMI-23-4-0394; Sanchez-Rangel D, 2012, PLANTA, V235, P965, DOI 10.1007/s00425-011-1555-0; Scott I, 2008, NEW PHYTOL, V177, P90, DOI 10.1111/j.1469-8137.2007.02255.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shepherd PR, 1996, TRENDS CELL BIOL, V6, P92, DOI 10.1016/0962-8924(96)80998-6; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Takatsuka C, 2004, PLANT CELL PHYSIOL, V45, P265, DOI 10.1093/pcp/pch031; Tanaka N, 2003, MOL PLANT MICROBE IN, V16, P422, DOI 10.1094/MPMI.2003.16.5.422; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; VERNOOIJ B, 1994, PLANT CELL, V6, P959, DOI 10.1105/tpc.6.7.959; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; WANG E, 1991, J BIOL CHEM, V266, P14486; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xiao SY, 2003, PLANT CELL, V15, P33, DOI 10.1105/tpc.006940; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Xue LZ, 2002, BIOCHEM PHARMACOL, V64, P441, DOI 10.1016/S0006-2952(02)01181-4; YALPANI N, 1991, PLANT CELL, V3, P809, DOI 10.1105/tpc.3.8.809; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zottini M, 2006, NEW PHYTOL, V172, P239, DOI 10.1111/j.1469-8137.2006.01830.x	73	11	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94898	10.1371/journal.pone.0094898	http://dx.doi.org/10.1371/journal.pone.0094898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755572	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300020
J	Ladinig, A; Wilkinson, J; Ashley, C; Detmer, SE; Lunney, JK; Plastow, G; Harding, JCS				Ladinig, Andrea; Wilkinson, Jamie; Ashley, Carolyn; Detmer, Susan E.; Lunney, Joan K.; Plastow, Graham; Harding, John C. S.			Variation in Fetal Outcome, Viral Load and ORF5 Sequence Mutations in a Large Scale Study of Phenotypic Responses to Late Gestation Exposure to Type 2 Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							TRANSPLACENTAL INFECTION; EXPERIMENTAL INOCULATION; MICROSCOPIC LESIONS; IMPLANTATION SITES; FETUSES; PIGS; PATHOGENESIS; GILTS; SWINE; PRRSV	In spite of extensive research, the mechanisms of reproductive disease associated with Porcine Reproductive and Respiratory Syndrome virus (PRRSv) are still poorly understood. The objectives of this large scale study were to evaluate associations between viral load and fetal preservation, determine the impact of type 2 PRRSv on fetal weights, and investigate changes in ORF5 PRRSv genome in dams and fetuses during a 21-day period following challenge. At gestation day 85 (+/- 1), 114 gilts were experimentally infected with type 2 PRRSv, while 19 gilts served as reference controls. At necropsy, fetuses were categorized according to their preservation status and tissue samples were collected. PRRSv RNA concentrations were measured in gilt serum collected on days 0, 2, 6, and 21 post-infection, as well as in gilt and fetal tissues collected at termination. Fetal mortality was 41 +/- 22.8% in PRRS infected litters. Dead fetuses appeared to cluster in some litters but appeared solitary or random in others. Nine percent of surviving piglets were meconium-stained. PRRSv RNA concentration in fetal thymus, fetal serum and endometrium differed significantly across preservation category and was greatest in tissues of meconium-stained fetuses. This, together with the virtual absence of meconium staining in noninfected litters indicates it is an early pathological condition of reproductive PRRS. Viral load in fetal thymus and in fetal serum was positively associated with viral load in endometrium, suggesting the virus exploits dynamic linkages between individual maternal-fetal compartments. Point mutations in ORF5 sequences from gilts and fetuses were randomly located in 20 positions in ORF5, but neither nucleotide nor amino acid substitutions were associated with fetal preservation. PRRSv infection decreased the weights of viable fetuses by approximately 17%. The considerable variation in gilt and fetal outcomes provides tremendous opportunity for more detailed investigations of potential mechanisms and single nucleotide polymorphisms associated with fetal death.	[Ladinig, Andrea; Ashley, Carolyn; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [Wilkinson, Jamie; Plastow, Graham] Univ Alberta, Fac Agr Life & Environm Sci, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Detmer, Susan E.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK S7N 0W0, Canada; [Lunney, Joan K.] ARS, Anim Parasit Dis Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA	University of Saskatchewan; University of Alberta; University of Saskatchewan; United States Department of Agriculture (USDA)	Ladinig, A (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada.	andrea.ladinig@usask.ca		Ladinig, Andrea/0000-0001-5037-7269; Detmer, Susan/0000-0002-4064-3460; Plastow, Graham/0000-0002-3774-3110	Genome Canada; Genome Alberta; Genome Prairie [2209-F]	Genome Canada(Genome Canada); Genome Alberta; Genome Prairie	Funding for the project was generously provided by grants from Genome Canada, Genome Alberta and Genome Prairie (grant number 2209-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; Andreyev VG, 1997, ARCH VIROL, V142, P993, DOI 10.1007/s007050050134; Benfield D., 2000, Veterinary Research (Paris), V31, P71, DOI 10.1051/vetres:2000007; Boddicker N, 2012, J ANIM SCI, V90, P1733, DOI 10.2527/jas.2011-4464; Cano JP, 2009, CAN J VET RES, V73, P303; Chang CC, 2002, J VIROL, V76, P4750, DOI 10.1128/JVI.76.10.4750-4763.2002; Chang CC, 2009, J SWINE HEALTH PROD, V17, P318; Cheon DS, 2001, J COMP PATHOL, V124, P231, DOI 10.1053/jcpa.2000.0457; CHRISTIANSON WT, 1993, CAN J VET RES, V57, P262; Gagnon CA, 2008, J VET DIAGN INVEST, V20, P545, DOI 10.1177/104063870802000503; Han K, 2013, J COMP PATHOL, V148, P396, DOI 10.1016/j.jcpa.2012.09.004; Karniychuk UU, 2012, THERIOGENOLOGY, V78, P1527, DOI 10.1016/j.theriogenology.2012.06.015; Karniychuk UU, 2009, PLACENTA, V30, P497, DOI 10.1016/j.placenta.2009.03.016; Karniychuk UU, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-95; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; Kekarainen T, 2006, J GEN VIROL, V87, P833, DOI 10.1099/vir.0.81586-0; Kim WI, 2008, J CLIN MICROBIOL, V46, P1758, DOI 10.1128/JCM.01927-07; Kleiboeker SB, 2005, J VET DIAGN INVEST, V17, P165, DOI 10.1177/104063870501700211; Kranker S, 1998, VET MICROBIOL, V61, P21, DOI 10.1016/S0378-1135(98)00176-X; Lager KM, 1996, J VET DIAGN INVEST, V8, P275, DOI 10.1177/104063879600800301; LAGER KM, 1995, CAN J VET RES, V59, P187; MENGELING WL, 1994, AM J VET RES, V55, P1391; Osorio FA, 2002, VIROLOGY, V302, P9, DOI 10.1006/viro.2002.1612; Pirzadeh B, 1998, CAN J VET RES, V62, P170; Prieto C, 1996, VET REC, V138, P536, DOI 10.1136/vr.138.22.536; Prieto C, 1997, VET MICROBIOL, V57, P301, DOI 10.1016/S0378-1135(97)00112-0; Rossow KD, 1996, VET PATHOL, V33, P95, DOI 10.1177/030098589603300115; Rowland RRR, 2010, VIRUS RES, V154, P114, DOI 10.1016/j.virusres.2010.09.001; Rowland RRR, 1999, VIROLOGY, V259, P262, DOI 10.1006/viro.1999.9789; Staden R, 2000, Methods Mol Biol, V132, P115; TERPSTRA C, 1991, VET QUART, V13, P131, DOI 10.1080/01652176.1991.9694297; Wilhelm S, 2006, J VIROL METHODS, V134, P257, DOI 10.1016/j.jviromet.2006.01.004	32	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96104	10.1371/journal.pone.0096104	http://dx.doi.org/10.1371/journal.pone.0096104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756023	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300137
J	Lai, CH; Chang, LL; Lin, JN; Tsai, KH; Hung, YC; Kuo, LL; Lin, HH; Chen, YH				Lai, Chung-Hsu; Chang, Lin-Li; Lin, Jiun-Nong; Tsai, Kun-Hsien; Hung, Ya-Chien; Kuo, Li-Li; Lin, Hsi-Hsun; Chen, Yen-Hsu			Human Spotted Fever Group Rickettsioses Are Underappreciated in Southern Taiwan, Particularly for the Species Closely-Related to Rickettsia felis	PLOS ONE			English	Article							MURINE TYPHUS; TICK-BORNE; CLINICAL CHARACTERISTICS; FLEAS SIPHONAPTERA; COXIELLA-BURNETII; FEBRILE ILLNESS; SCRUB TYPHUS; INFECTION; DISEASES; IDENTIFICATION	Background: Despite increased identification of spotted fever group rickettsioses (SFGR) in animals and arthropods, human SFGR are poorly characterized in Taiwan. Methods: Patients with suspected Q fever, scrub typhus, murine typhus, leptospirosis, and dengue fever from April 2004 to December 2009 were retrospectively investigated for SFGR antibodies (Abs). Sera were screened for Rickettsia rickettsii Abs by indirect immunofluorescence antibody assay (IFA), and those with positive results were further examined for Abs against R. rickettsii, R. typhi, R. felis, R. conorii, and R. japonica using micro-immunofluorescence (MIF) tests. Polymerase chain reaction (PCR) for detection of SFGR DNA was applied in those indicated acute infections. Case geographic distribution was made by the geographic information system software. Results: A total of 413 cases with paired serum, including 90 cases of Q fever, 47 cases of scrub typhus, 12 cases of murine typhus, 6 cases of leptospirosis, 3 cases of dengue fever, and 255 cases of unknown febrile diseases were investigated. Using IFA tests, a total of 49 cases with 47 (11.4%) and 4 (1.0%) cases had sera potentially positive for R. rickettsii IgG and IgM, respectively. In the 49 cases screened from IFA, MIF tests revealed that there were 5 cases of acute infections (3 possible R. felis and 2 undetermined SFGR) and 13 cases of past infections (3 possible R. felis and 10 undetermined SFGR). None of the 5 cases of acute infection had detectable SFGR DNA in the blood specimen by PCR. Possible acute infection of R. felis was identified in both one case of Q fever and scrub typhus. The geographic distribution of SFGR cases is similar with that of scrub typhus. Conclusions: Human SFGR exist and are neglected diseases in southern Taiwan, particularly for the species closely-related to R. felis.	[Lai, Chung-Hsu; Chang, Lin-Li; Lin, Jiun-Nong; Chen, Yen-Hsu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lai, Chung-Hsu; Lin, Jiun-Nong; Lin, Hsi-Hsun] I Shou Univ, E Da Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lai, Chung-Hsu; Hung, Ya-Chien] I Shou Univ, E Da Hosp, Div Infect Control Lab, Kaohsiung, Taiwan; [Chang, Lin-Li] Kaohsiung Med Univ, Coll Med, Dept Microbiol, Fac Med, Kaohsiung, Taiwan; [Tsai, Kun-Hsien] Natl Taiwan Univ, Inst Environm Hlth, Coll Publ, Taipei 10764, Taiwan; [Tsai, Kun-Hsien] Minist Hlth & Welf, Infect Dis Res & Educ Ctr, Taipei, Taiwan; [Tsai, Kun-Hsien] Natl Taiwan Univ, Taipei 10764, Taiwan; [Kuo, Li-Li] Ctr Dis Control, Res & Diagnost Ctr, Dept Hlth, Taipei, Taiwan; [Lin, Hsi-Hsun] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Dept Internal Med, Div Infect Dis, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Kaohsiung Medical University; National Taiwan University; National Taiwan University; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.	infchen@gmail.com		TSAI, KUN-HSIEN/0000-0002-6154-113X; Chen, Yen-hsu/0000-0002-8667-4844	National Science Council [NSC 98-2745-B-650-001, NSC100-2314-B-037-001-MY3]; E-Da Hospital [EDAHP98008]	National Science Council(Ministry of Science and Technology, Taiwan); E-Da Hospital	This work was supported by research grants from the National Science Council [NSC 98-2745-B-650-001 and NSC100-2314-B-037-001-MY3] and E-Da Hospital [EDAHP98008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang K, 2012, AM J TROP MED HYG, V87, P141, DOI 10.4269/ajtmh.2012.11-0465; Chen H L, 1997, Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi, V30, P115; Chen NY, 2008, J MICROBIOL IMMUNOL, V41, P362; Choi YJ, 2005, EMERG INFECT DIS, V11, P237, DOI 10.3201/eid1102.040603; Chung MH, 2006, EMERG INFECT DIS, V12, P1122, DOI 10.3201/eid1207.051372; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Hsu YM, 2011, COMP IMMUNOL MICROB, V34, P513, DOI 10.1016/j.cimid.2011.09.005; JANBON F, 1989, J INFECT DIS, V160, P354, DOI 10.1093/infdis/160.2.354; Jensenius M, 2004, CLIN INFECT DIS, V39, P1493, DOI 10.1086/425365; Kuo CC, 2012, MED VET ENTOMOL, V26, P341, DOI 10.1111/j.1365-2915.2012.01009.x; Kuo CC, 2011, MED VET ENTOMOL, V25, P169, DOI 10.1111/j.1365-2915.2010.00941.x; Lai CH, 2008, AM J TROP MED HYG, V79, P441, DOI 10.4269/ajtmh.2008.79.441; Lai CH, 2008, SCAND J INFECT DIS, V40, P105, DOI 10.1080/00365540701558722; Lai CH, 2009, EMERG INFECT DIS, V15, P1659, DOI 10.3201/eid1510.090007; Lai CH, 2009, J FORMOS MED ASSOC, V108, P367, DOI 10.1016/S0929-6646(09)60080-2; Lai CH, 2009, INT J INFECT DIS, V13, P387, DOI 10.1016/j.ijid.2008.07.020; LaScola B, 1997, J CLIN MICROBIOL, V35, P2715, DOI 10.1128/JCM.35.11.2715-2727.1997; Lee HC, 2002, J FORMOS MED ASSOC, V101, P385; LIU QH, 1995, EPIDEMIOL INFECT, V115, P177, DOI 10.1017/S0950268800058246; Mahara F, 1997, EMERG INFECT DIS, V3, P105, DOI 10.3201/eid0302.970203; Mahara F, 2006, ANN NY ACAD SCI, V1078, P60, DOI 10.1196/annals.1374.007; Maina AN, 2012, EMERG INFECT DIS, V18, P328, DOI 10.3201/eid1802.111372; Mediannikov O, 2010, PLOS NEGL TROP DIS, V4; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2005, VET RES, V36, P469, DOI 10.1051/vetres:2005004; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Parola P, 2003, EMERG INFECT DIS, V9, P592, DOI 10.3201/eid0905.020511; Perez-Arellano JL, 2005, EMERG INFECT DIS, V11, P1961, DOI 10.3201/eid1112.050711; Perez-Osorio CE, 2008, EMERG INFECT DIS, V14, P1019, DOI 10.3201/eid1407.071656; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Qi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070440; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Renvoise A, 2009, EMERG INFECT DIS, V15, P1126, DOI 10.3201/eid1507.090029; Rolain JM, 2005, CLIN INFECT DIS, V40, P82, DOI 10.1086/426440; Socolovschi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048254; Takada Nobuhiro, 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P354; Tsai KH, 2008, AM J TROP MED HYG, V79, P256, DOI 10.4269/ajtmh.2008.79.256; Tsai KH, 2011, J MED ENTOMOL, V48, P445, DOI 10.1603/ME10022; Tsai KH, 2009, AM J TROP MED HYG, V81, P735, DOI 10.4269/ajtmh.2009.09-0101; Tsai KH, 2009, VECTOR-BORNE ZOONOT, V9, P561, DOI 10.1089/vbz.2008.0076; Tsai KH, 2008, EMERG INFECT DIS, V14, P1970, DOI [10.3201/eid1412.080525, 10.3201/eid1412.080515]; Tsui PY, 2007, AM J TROP MED HYG, V77, P883, DOI 10.4269/ajtmh.2007.77.883; UCHIDA T, 1992, INT J SYST BACTERIOL, V42, P303, DOI 10.1099/00207713-42-2-303; Vardi M, 2011, EUR J CLIN MICROBIOL, V30, P1527, DOI 10.1007/s10096-011-1255-5; Wu XB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-119	46	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95810	10.1371/journal.pone.0095810	http://dx.doi.org/10.1371/journal.pone.0095810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755560	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300099
J	Zhang, GB; Jin, GS; Nie, XT; Mi, RF; Zhu, GD; Jia, W; Liu, FS				Zhang, Guobin; Jin, Guishan; Nie, Xiutao; Mi, Ruifang; Zhu, Guidong; Jia, William; Liu, Fusheng			Enhanced Antitumor Efficacy of an Oncolytic Herpes Simplex Virus Expressing an Endostatin-Angiostatin Fusion Gene in Human Glioblastoma Stem Cell Xenografts	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; MALIGNANT GLIOMA; THERAPEUTIC TARGET; CANCER; NICHE; ANGIOGENESIS; GROWTH; TRIAL; MICROENVIRONMENT; VASCULATURE	Viruses have demonstrated strong potential for the therapeutic targeting of glioblastoma stem cells (GSCs). In this study, the use of a herpes simplex virus carrying endostatin-angiostatin (VAE) as a novel therapeutic targeting strategy for glioblastoma-derived cancer stem cells was investigated. We isolated six stable GSC-enriched cultures from 36 human glioblastoma specimens and selected one of the stable GSCs lines for establishing GSC-carrying orthotopic nude mouse models. The following results were obtained: (a) VAE rapidly proliferated in GSCs and expressed endo-angio in vitro and in vivo 48 h and 10 d after infection, respectively; (b) compared with the control gliomas treated with rHSV or Endostar, the subcutaneous gliomas derived from the GSCs showed a significant reduction in microvessel density after VAE treatment; (c) compared with the control, a significant improvement was observed in the length of the survival of mice with intracranial and subcutaneous gliomas treated with VAE; (d) MRI analysis showed that the tumor volumes of the intracranial gliomas generated by GSCs remarkably decreased after 10 d of VAE treatment compared with the controls. In conclusion, VAE demonstrated oncolytic therapeutic efficacy in animal models of human GSCs and expressed an endostatin-angiostatin fusion gene, which enhanced antitumor efficacy most likely by restricting tumor microvasculature development.	[Zhang, Guobin] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Jin, Guishan; Mi, Ruifang; Zhu, Guidong; Liu, Fusheng] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Brain Tumor Res Ctr, Beijing, Peoples R China; [Nie, Xiutao] Rizhao City Peoples Hosp, Dept Neurosurg, Rizhao City, Shandong, Peoples R China; [Jia, William] Univ British Columbia, Fac Med, Dept Surg, Brain Res Ctr, Vancouver, BC, Canada	Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University; University of British Columbia	Liu, FS (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Brain Tumor Res Ctr, Beijing, Peoples R China.	liufushengs@hotmail.com	JIA, WILLIAM/AAE-4322-2020	, Fusheng/0000-0002-9974-6069	National Natural Science Foundation of China [81071776, 81372354, 81302186]; Beijing Natural Science Foundation [7132034]; Beijing Health System High-level Personnel Building Foundation [2013-2-018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Health System High-level Personnel Building Foundation	This work was supported by a grant from National Natural Science Foundation of China (No. 81071776, 81372354, 81302186), Beijing Natural Science Foundation (No. 7132034) and Beijing Health System High-level Personnel Building Foundation (No. 2013-2-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The	Aghi M, 2007, CANCER RES, V67, P440, DOI 10.1158/0008-5472.CAN-06-3145; Angarita FA, 2013, TRENDS MOL MED, V19, P378, DOI 10.1016/j.molmed.2013.02.008; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Breitbach CJ, 2011, MOL THER, V19, P886, DOI 10.1038/mt.2011.26; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Dey M, 2010, CANCER LETT, V289, P1, DOI 10.1016/j.canlet.2009.04.045; Diabira S, 2008, MED HYPOTHESES, V70, P96, DOI 10.1016/j.mehy.2007.04.024; Ezhilarasan R, 2007, INT J ONCOL, V30, P701; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hardcastle J, 2010, MOL THER, V18, P285, DOI 10.1038/mt.2009.232; Huszthy PC, 2008, CLIN CANCER RES, V14, P1571, DOI 10.1158/1078-0432.CCR-07-2000; Kurozumi K, 2008, MOL THER, V16, P1382, DOI 10.1038/mt.2008.112; Kurozumi K, 2007, JNCI-J NATL CANCER I, V99, P1768, DOI 10.1093/jnci/djm229; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Liu JM, 2008, ADV THER, V25, P389, DOI 10.1007/s12325-008-0050-x; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Manservigi Roberto, 2010, Open Virol J, V4, P123, DOI 10.2174/1874357901004030123; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Parker JN, 2009, NEUROTHERAPEUTICS, V6, P558, DOI 10.1016/j.nurt.2009.04.011; Pinto A, 2010, ANTI-CANCER DRUG, V21, P890, DOI 10.1097/CAD.0b013e32833e83b2; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Selznick LA, 2008, NEUROSURG REV, V31, P141, DOI 10.1007/s10143-008-0121-0; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Yang CT, 2005, ANTICANCER RES, V25, P2049; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhan Q, 2011, PHOTODIAGN PHOTODYN, V8, P314, DOI 10.1016/j.pdpdt.2011.04.002; Zhang X, 2013, CURR MED CHEM, V20, P1974, DOI 10.2174/0929867311320150004; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhu GD, 2011, BRAIN RES, V1390, P59, DOI 10.1016/j.brainres.2011.03.050	42	20	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95872	10.1371/journal.pone.0095872	http://dx.doi.org/10.1371/journal.pone.0095872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755877	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300112
J	An, JZ; Liu, JB; Liu, L; Liu, Y; Pan, Y; Huang, MD; Qi, FZ; Wen, J; Xie, KP; Ma, HX; Shen, HB; Hu, ZB				An, Jiaze; Liu, Jibin; Liu, Li; Liu, Yao; Pan, Yun; Huang, Mingde; Qi, Fuzhen; Wen, Juan; Xie, Kaipeng; Ma, Hongxia; Shen, Hongbing; Hu, Zhibin			A Genetic Variant in Primary miR-378 Is Associated with Risk and Prognosis of Hepatocellular Carcinoma in a Chinese Population	PLOS ONE			English	Article							POTENTIALLY FUNCTIONAL POLYMORPHISM; LUNG-CANCER SURVIVAL; HUMAN GASTRIC-CANCER; PROMOTER REGION; EXPRESSION; LIVER; CELLS; EPIDEMIOLOGY; ANGIOGENESIS; PROGRESSION	Background: MiR-378 has been reported to be related to cell survival, tumor growth and angiogenesis and may participate in hepatocellular carcinoma (HCC) development and prognosis. Genetic variants in primary miR-378 (pri-miR-378) may impact miR-378 expression and contribute to HCC risk and survival. This study aimed to assess the associations between a genetic variant in primary miR-378 and HCC susceptibility and prognosis. Methods: We conducted a case-control study to analyze the association of rs1076064 in pri-miR-378 with hepatocellular carcinoma risk in 1300 HCC patients with positive hepatitis B virus (HBV) and 1344 HBV carriers. Then, we evaluated the correlation between the polymorphism and hepatocellular carcinoma prognosis in 331 HCC patients at either intermediate or advanced stage without surgical treatment. Results: The variant genotypes of rs1076064 were associated with a decreased HCC risk in HBV carriers [Adjusted odds ratio (OR) = 0.90, 95% confidence intervals (CI) = 0.81-1.00, P = 0.047]. Moreover, HCC patients with the variant genotypes were associated with a better survival [Adjusted hazard ratio (HR) = 0.70, 95% CIs = 0.59-0.83, P<0.0001 in an additive genetic model]. The reporter gene assay showed that the variant G allele of rs1076064 exerted higher promoter activity than the A allele. Conclusions: These findings indicate that rs1076064 may be a biomarker for HCC susceptibility and prognosis through altering pri-miR-378 transcription.	[An, Jiaze] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China; [Liu, Jibin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Jiangsu, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 1, Digest Endoscopy Ctr, Nanjing, Jiangsu, Peoples R China; [Liu, Yao] Soochow Univ, Pathol Ctr, Suzhou, Jiangsu, Peoples R China; [Liu, Yao] Soochow Univ, Dept Pathol, Suzhou, Jiangsu, Peoples R China; [Pan, Yun; Wen, Juan; Xie, Kaipeng; Ma, Hongxia; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat,Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Huang, Mingde] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Oncol, Huaian, Jiangsu, Peoples R China; [Qi, Fuzhen] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Hepatopancreatobiliary Surg, Huaian, Jiangsu, Peoples R China; [Ma, Hongxia; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Air Force Military Medical University; Nanjing Medical University; Soochow University - China; Soochow University - China; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Hu, ZB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat,Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn			National Natural Science Foundation of China [81372606, 81072344]; National Key Basic Research Program Grant [2013CB911400]; National Science Foundation for Distinguished Young Scholars of China [81225020]; Foundation of Jiangsu Province for Distinguished Young Scholars [BK2012042]; Foundation for the Program for New Century Excellent Talents in University [NCET-10-0178]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions [122031]; Organization Department of the CPC Central Committee; Author of National Excellent Doctoral Dissertation [201081]; Jiangsu Province Clinical Science and Technology Projects [BL2012008]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program Grant(National Basic Research Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Foundation of Jiangsu Province for Distinguished Young Scholars; Foundation for the Program for New Century Excellent Talents in University; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions; Organization Department of the CPC Central Committee; Author of National Excellent Doctoral Dissertation; Jiangsu Province Clinical Science and Technology Projects; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This work was supported by the National Natural Science Foundation of China (81372606 and 81072344), Project supported by the National Key Basic Research Program Grant (2013CB911400), the project supported by the National Science Foundation for Distinguished Young Scholars of China (81225020), Foundation of Jiangsu Province for Distinguished Young Scholars (BK2012042), Foundation for the Program for New Century Excellent Talents in University (NCET-10-0178), the Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions (122031), Young tip-top talents support program by the Organization Department of the CPC Central Committee, the Author of National Excellent Doctoral Dissertation (201081), Jiangsu Province Clinical Science and Technology Projects (BL2012008) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Choi SJ, 2003, BLOOD, V101, P3778, DOI 10.1182/blood-2002-08-2641; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Rodriguez RG, 2012, REV ESP ENFERM DIG, V104, P298, DOI 10.4321/s1130-01082012000600003; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2011, AM J RESP CRIT CARE, V183, P641, DOI 10.1164/rccm.201005-0717OC; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Kuper H, 2000, INT J CANCER, V85, P498, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;498::AID-IJC9&gt;3.0.CO;2-F; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li Q, 2012, GASTROENTEROLOGY, V143, P799, DOI 10.1053/j.gastro.2012.05.043; MAKELA TP, 1992, SCIENCE, V256, P373, DOI 10.1126/science.256.5055.373; Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413; McCarver DG, 1998, TOXICOL APPL PHARM, V152, P276, DOI 10.1006/taap.1998.8532; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Ramaiah SK, 2001, DRUG METAB DISPOS, V29, P1088; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Testoni B, 2011, ONCOGENE, V30, P2670, DOI 10.1038/onc.2010.635; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Wang Ping, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P535; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Xie KP, 2013, CANCER EPIDEMIOL, V37, P998, DOI 10.1016/j.canep.2013.09.005; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhu Zhong-zheng, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P574	42	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e93707	10.1371/journal.pone.0093707	http://dx.doi.org/10.1371/journal.pone.0093707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751683	Green Submitted, gold, Green Published			2022-12-25	WOS:000335227400006
J	Doughton, G; Wei, J; Tapon, N; Welham, MJ; Chalmers, AD				Doughton, Gail; Wei, Jun; Tapon, Nicolas; Welham, Melanie J.; Chalmers, Andrew D.			Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr/Erk Signalling	PLOS ONE			English	Article							EPITHELIAL-CELL POLARITY; MOUSE BLASTOCYST; STEM-CELLS; VISCERAL ENDODERM; BASEMENT-MEMBRANES; FATE DECISIONS; BODY FORMATION; IN-VITRO; DIFFERENTIATION; EXPRESSION	The primitive endoderm arises from the inner cell mass during mammalian pre-implantation development. It faces the blastocoel cavity and later gives rise to the extraembryonic parietal and visceral endoderm. Here, we investigate a key step in primitive endoderm development, the acquisition of apico-basolateral polarity and epithelial characteristics by the non-epithelial inner cell mass cells. Embryoid bodies, formed from mouse embryonic stem cells, were used as a model to study this transition. The outer cells of these embryoid bodies were found to gradually acquire the hallmarks of polarised epithelial cells and express markers of primitive endoderm cell fate. Fgf receptor/Erk signalling is known to be required for specification of the primitive endoderm, but its role in polarisation of this tissue is less well understood. To investigate the function of this pathway in the primitive endoderm, embryoid bodies were cultured in the presence of a small molecule inhibitor of Mek. This inhibitor caused a loss of expression of markers of primitive endoderm cell fate and maintenance of the pluripotency marker Nanog. In addition, a mislocalisation of apico-basolateral markers and disruption of the epithelial barrier, which normally blocks free diffusion across the epithelial cell layer, occurred. Two inhibitors of the Fgf receptor elicited similar phenotypes, suggesting that Fgf receptor signalling promotes Erk-mediated polarisation. This data shows that primitive endoderm cells of the outer layer of embryoid bodies gradually polarise, and formation of a polarised primitive endoderm layer requires the Fgf receptor/Erk signalling pathway.	[Doughton, Gail; Wei, Jun; Chalmers, Andrew D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Doughton, Gail; Wei, Jun; Welham, Melanie J.; Chalmers, Andrew D.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Doughton, Gail; Welham, Melanie J.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Tapon, Nicolas] London Res Inst, Canc Res UK, Apoptosis & Proliferat Control Lab, London, England	University of Bath; University of Bath; University of Bath; Cancer Research UK	Chalmers, AD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	ac270@bath.ac.uk	Chalmers, Andrew/D-4103-2009	Chalmers, Andrew/0000-0003-4182-6717; Tapon, Nicolas/0000-0001-5267-6510	Medical Research Council Doctoral Training Grant PhD studentship; Cancer Research UK; Cancer Research UK [17064] Funding Source: researchfish; Medical Research Council [1220757] Funding Source: researchfish	Medical Research Council Doctoral Training Grant PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GD is supported by an Medical Research Council Doctoral Training Grant PhD studentship. Work in the lab of NT is supported by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Bergstralh DT, 2012, ESSAYS BIOCHEM, V53, P129, DOI [10.1042/BSE0530129, 10.1042/bse0530129]; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Chalmers AD, 2006, MECH DEVELOP, V123, P702, DOI 10.1016/j.mod.2006.04.006; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Dolgin E, 2011, NATURE, V474, P262, DOI 10.1038/474262a; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gerbe F, 2008, DEV BIOL, V313, P594, DOI 10.1016/j.ydbio.2007.10.048; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Kang MJ, 2013, DEVELOPMENT, V140, P267, DOI 10.1242/dev.084996; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811; Liu J, 2009, J CELL SCI, V122, P233, DOI 10.1242/jcs.037663; MARTIN GR, 1977, DEV BIOL, V61, P230, DOI 10.1016/0012-1606(77)90294-9; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Minsuk SB, 1997, DEV GENES EVOL, V207, P389, DOI 10.1007/s004270050128; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Moore R, 2009, GENESIS, V47, P579, DOI 10.1002/dvg.20536; Morrisey EE, 2000, J BIOL CHEM, V275, P19949, DOI 10.1074/jbc.M001331200; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Murray P, 2001, J CELL SCI, V114, P931; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259; Rula ME, 2007, GENESIS, V45, P327, DOI 10.1002/dvg.20298; Saiz N, 2013, DEVELOPMENT, V140, P4311, DOI 10.1242/dev.093922; Saiz N, 2013, REPRODUCTION, V145, pR65, DOI 10.1530/REP-12-0381; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Schrode N, 2013, GENESIS, V51, P219, DOI 10.1002/dvg.22368; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang Y, 2011, DEV DYNAM, V240, P566, DOI 10.1002/dvdy.22447; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138	48	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95434	10.1371/journal.pone.0095434	http://dx.doi.org/10.1371/journal.pone.0095434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752320	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400061
J	Kim, BG; Kim, JY; Kim, HN; Bok, J; Namkung, W; Choi, JY; Kim, SH				Kim, Bo Gyung; Kim, Jin Young; Kim, Hee Nam; Bok, Jinwoong; Namkung, Wan; Choi, Jae Young; Kim, Sung Huhn			Developmental Changes of ENaC Expression and Function in the Inner Ear of Pendrin Knock-Out Mice as a Perspective on the Development of Endolymphatic Hydrops	PLOS ONE			English	Article							VESTIBULAR AQUEDUCT SYNDROME; EPITHELIAL NA+ CHANNEL; REISSNERS MEMBRANE; SODIUM-TRANSPORT; SELF-INHIBITION; SYNDROME GENE; HEARING-LOSS; HOMEOSTASIS; ACTIVATION; SECRETION	Pendrin mutations cause enlarged vestibular aqueducts and various degrees of sensorineural hearing loss. The selective abolition of pendrin causes dilation of the membranous labyrinth known as endolymphatic hydrops, loss of the endocochlear potential, and consequently loss of hearing function. Because Na+ transport is one of the most important driving forces for fluid transport, the epithelial Na+ channel (ENaC) is believed to play an important role in fluid volume regulation in the inner ear. Therefore, the dysfunction of Na+ transport through ENaC by the acidification of endolymph in Pendred syndrome is one of the potential causes of endolymphatic hydrops. We investigated the changes of ENaC expression and function during the development of the pendrin knock-out mouse. In the cochlea, the expression of beta and gamma ENaC was significantly increased at P56 in Pds(-/-) mice compared with Pds(+/+) mice. In the vestibule, the expression of beta ENaC was significantly increased at P56, and gamma ENaC expression significantly increased from P6 to P56 in Pds(-/-) mice. The ENaC-dependent trans-epithelial current was not significantly different between Pds(+/+) and Pds(-/-) mice in Reissner's membrane or the saccular extramacular roof epithelium at P0, but the current was significantly increased in Pds(-/-) mice at P56 compared with Pds(+/+) mice. These findings indicate that the expression and function of ENaC were enhanced in Pds(-/-) mice after the development of endolymphatic hydrops as a compensatory mechanism. This result provides insight into the role of Na+ transport in the development and regulation of endolymphatic hydrops due to pendrin mutations.	[Kim, Bo Gyung; Choi, Jae Young; Kim, Sung Huhn] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Kim, Jin Young; Choi, Jae Young] Yonsei Univ, Coll Med, Res Ctr Nat Human Def Syst, Seoul, South Korea; [Kim, Hee Nam] Hana ENT Hosp, Div Otol, Seoul, South Korea; [Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Namkung, Wan] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	jychoi@yuhs.ac; fledermaus@yuhs.ac	Bok, Jinwoong/M-2834-2019	Bok, Jinwoong/0000-0003-1958-1872; choi, jae young/0000-0001-9493-3458; Kim, Sung Huhn/0000-0003-4408-3066	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2011-0028066]; Ministry of Education, Science and Technology [2010-0011806]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP)(https://ernd.nrf.re.kr) (No. 2011-0028066) to JYC and a grant from the Basic Science Research Program through the NRF funded by the Ministry of Education, Science and Technology (https://ernd.nrf.re.kr) (2010-0011806) to SHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki I, 2004, UROLOGY, V64, P1255, DOI 10.1016/j.urology.2004.06.064; Benos DJ, 2004, HYPERTENSION, V44, P616, DOI 10.1161/01.HYP.0000144467.43205.ed; Chen JX, 2012, J BIOL CHEM, V287, P35589, DOI 10.1074/jbc.M112.394734; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Colvin IB, 2006, LARYNGOSCOPE, V116, P2027, DOI 10.1097/01.mlg.0000240908.88759.fe; Du S, 2007, UROLOGY, V69, P590; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Grimmer JF, 2008, INT J PEDIATR OTORHI, V72, P1711, DOI 10.1016/j.ijporl.2008.08.009; Grunder S, 2001, EUR J NEUROSCI, V13, P641, DOI 10.1046/j.1460-9568.2001.01426.x; Kim BG, 2013, INT J PEDIATR OTORHI, V77, P833, DOI 10.1016/j.ijporl.2013.02.023; Kim CH, 2009, NEUROREPORT, V20, P1275, DOI 10.1097/WNR.0b013e32833017eb; Kim HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017949; Kim HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014041; Kim SH, 2011, HEARING RES, V280, P21, DOI 10.1016/j.heares.2011.05.003; Kim SH, 2009, J NEUROSCI, V29, P15851, DOI 10.1523/JNEUROSCI.3044-09.2009; Kim SH, 2009, AM J PHYSIOL-CELL PH, V296, pC544, DOI 10.1152/ajpcell.00338.2008; Kopp UC, 1998, AM J PHYSIOL-REG I, V275, pR1780, DOI 10.1152/ajpregu.1998.275.6.R1780; Lee JH, 2003, NEUROSCIENCE, V119, P3, DOI 10.1016/S0306-4522(03)00104-0; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065977; Lin CY, 2005, AURIS NASUS LARYNX, V32, P99, DOI 10.1016/j.anl.2004.11.001; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Marcus DC, 2009, OXFORD HDB AUDITORY, P213; Pondugula SR, 2006, PHYSIOL GENOMICS, V24, P114, DOI 10.1152/physiolgenomics.00006.2005; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; VALVASSORI GE, 1978, LARYNGOSCOPE, V88, P723; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wangemann P, 2011, CELL PHYSIOL BIOCHEM, V28, P527, DOI 10.1159/000335113; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009	33	10	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95730	10.1371/journal.pone.0095730	http://dx.doi.org/10.1371/journal.pone.0095730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752462	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400112
J	Tertipis, N; Haeggblom, L; Nordfors, C; Grun, N; Nasman, A; Vlastos, A; Dalianis, T; Ramqvist, T				Tertipis, Nikolaos; Haeggblom, Linnea; Nordfors, Cecilia; Grun, Nathalie; Nasman, Anders; Vlastos, Andrea; Dalianis, Tina; Ramqvist, Torbjorn			Correlation of LMP10 Expression and Clinical Outcome in Human Papillomavirus (HPV) Positive and HPV-Negative Tonsillar and Base of Tongue Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ANTIGEN-PROCESSING MACHINERY; HLA CLASS-I; FAVORABLE PROGNOSTIC-FACTOR; OROPHARYNGEAL CANCER; HEAVY-CHAIN; ASSOCIATION; EPIDEMIC; DEFECTS; TRENDS	Aim: To examine LMP10 expression and its possible impact on clinical outcome in human papillomavirus (HPV) positive and HPV-negative tonsillar and base of tongue squamous cell carcinoma (TSCC and BOTSCC). Background: Outcome is better in HPV-positive TSCC and BOTSCC compared to matching HPV-negative tumours, with roughly 80% vs. 40% 5-year disease free survival (DFS) with less aggressive treatment than today's chemoradiotherapy. Since current treatment often results in harmful side effects, less intensive therapy, with sustained patient survival would be an attractive alternative. However, other markers together with HPV status are necessary to select patients and for this purpose LMP10 expression is investigated here in parallel to HPV status and clinical outcome. Materials and Methods: From 385 patients diagnosed between 2000 and 2007 at the Karolinska University Hospital, 278 formalin fixed paraffin embedded TSCC and BOTSCC biopsies, with known HPV DNA status, were tested for LMP10 nuclear and cytoplasmic expression (fraction of positive cells and staining intensity). The data was then correlated to clinical outcome. Results: An absent/low compared to a moderate/high LMP10 nuclear fraction of positive cells was correlated to a better 3-year DFS in the HPV-positive group of patients (log-rank p = 0.005), but not in the HPV-negative group. In the HPV-negative group of patients, in contrast to the HPV-positive group, moderate/high LMP10 cytoplasmic fraction and weak/moderate/high LMP10 cytoplasmic intensity correlated to a better 3-year DFS (p = 0.003 and p = 0.001) and 3-year overall survival (p = 0.001 and 0.009). Conclusion: LMP10 nuclear expression in the HPV-positive group and LMP10 cytoplasmic expression in the HPV-negative group of patients correlated to better clinical outcome.	[Tertipis, Nikolaos; Haeggblom, Linnea; Nordfors, Cecilia; Grun, Nathalie; Nasman, Anders; Vlastos, Andrea; Dalianis, Tina; Ramqvist, Torbjorn] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Tertipis, N (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Nikolaos.Tertipis@ki.se		Nasman, Anders/0000-0003-4602-4297; Dalianis, Tina/0000-0001-7022-2424	Swedish Cancer Foundation [120417]; Swedish Medical Research Council [K2011-56X-15282-07-06]; Stockholm Cancer Foundation [121043]; Henning and Ida Perssons Foundation; Karolinska Institutet [2013fobi37387]; Stockholm County Council [520007]; King Gustaf V Jubilee Fund; Cancer and Allergy Foundation	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Cancer Foundation; Henning and Ida Perssons Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); King Gustaf V Jubilee Fund; Cancer and Allergy Foundation	The Swedish Cancer Foundation 120417; The Swedish Medical Research Council K2011-56X-15282-07-06; The Stockholm Cancer Foundation 121043; Henning and Ida Perssons Foundation; Karolinska Institutet 2013fobi37387; The Stockholm County Council 520007; The King Gustaf V Jubilee Fund; The Cancer and Allergy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2010, N ENGL J MED; Attner P, 2011, INT J CANCER, V128, P2892, DOI 10.1002/ijc.25625; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Braakhuis BJM, 2009, ORAL ONCOL, V45, pE85, DOI 10.1016/j.oraloncology.2009.03.010; Campo MS, 2010, VIROLOGY, V407, P137, DOI 10.1016/j.virol.2010.07.044; Cathro HP, 2010, CANCER IMMUNOL IMMUN, V59, P465, DOI 10.1007/s00262-009-0765-9; Conway DI, 2006, ORAL ONCOL, V42, P586, DOI 10.1016/j.oraloncology.2005.10.018; Dahlgren L, 2004, INT J CANCER, V112, P1015, DOI 10.1002/ijc.20490; Dahlgren L, 2003, INT J CANCER, V107, P244, DOI 10.1002/ijc.11371; Dahstrand HM, 2005, ADV CANCER RES, V93, P59, DOI 10.1016/S0065-230X(05)93002-9; Favole A, 2012, TRANSL ONCOL, V5, P48, DOI 10.1593/tlo.11247; Friesland S, 2001, ANTICANCER RES, V21, P529; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hammarstedt L, 2007, ACTA OTO-LARYNGOL, V127, P988, DOI 10.1080/00016480601110170; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; IARC, 2007, HUM PAP; Licitra L, 2002, CRIT REV ONCOL HEMAT, V41, P107, DOI 10.1016/S1040-8428(01)00129-9; Lindquist D, 2007, MOL ONCOL, V1, P350, DOI 10.1016/j.molonc.2007.08.005; Lindquist D, 2012, ANTICANCER RES, V32, P153; Marur S, 2010, LANCET ONCOL; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Mellin H, 2002, INT J CANCER, V102, P152, DOI 10.1002/ijc.10669; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Mellin H, 2003, ANTICANCER RES, V23, P2821; Muller M, 2013, HISTOPATHOLOGY, V62, P847, DOI 10.1111/his.12086; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Nasman A, 2009, INT J CANCER, V124, P150, DOI [DOI 10.1002/IJC.23920, 10.1002/ijc.2392018839427]; Nasman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077025; Nasman A, 2013, CANCER MED-US, V2, P507, DOI 10.1002/cam4.90; Nasman A, 2013, INT J CANCER, V132, P72, DOI 10.1002/ijc.27635; Nasman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038711; Nordfors C, 2013, EUR J CANC; Ramqvist T, 2011, ANTICANCER RES, V31, P1515; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Rietbergen MM, 2012, INT J CANC; Robinson KL, 2003, ORAL ONCOL, V39, P31, DOI 10.1016/S1368-8375(02)00014-3; Romanitan M, 2008, ANTICANCER RES, V28, P2077; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Tanaka K, 2012, INT J ONCOL, V40, P965, DOI 10.3892/ijo.2011.1274	41	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95624	10.1371/journal.pone.0095624	http://dx.doi.org/10.1371/journal.pone.0095624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752327	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400091
J	Tsunoda, T; Cuong, TC; Dong, TD; Yen, NT; Le, NH; Phong, TV; Minakawa, N				Tsunoda, Takashi; Tran Chi Cuong; Tran Duc Dong; Nguyen Thi Yen; Nguyen Hoang Le; Tran Vu Phong; Minakawa, Noboru			Winter Refuge for Aedes aegypti and Ae. albopictus Mosquitoes in Hanoi during Winter	PLOS ONE			English	Article							DIPTERA-CULICIDAE; DENGUE VECTORS; DISPERSAL; URBANIZATION; SURVIVAL	Dengue occurs throughout the year in Hanoi, Vietnam, despite winter low temperatures < 10 degrees C. During July 2010 to March 2012, we surveyed monthly for Aedes larvae and pupae in 120 houses in 8 Hanoi districts. Aedes albopictus preferred discarded containers in summer and pupal density drastically decreased in winter. Aedes aegypti preferred concrete tanks and this preference increased in winter. Even in winter, the lowest water temperature found in concrete tanks was > 14 degrees C, exceeding the developmental zero point of Ae. aegypti. Although jars, drums and concrete tanks were the dominant containers previously (1994-97) in Hanoi, currently the percentage of residences with concrete tanks was still high while jars and drums were quite low. Our study showed that concrete tanks with broken lids allowing mosquitoes access were important winter refuge for Ae. aegypti. We also indicate a concern about concrete tanks serving as foci for Ae. aegypti to expand their distribution in cooler regions.	[Tsunoda, Takashi; Minakawa, Noboru] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Vector Ecol & Environm, Nagasaki 852, Japan; [Tran Chi Cuong; Tran Duc Dong; Nguyen Thi Yen; Nguyen Hoang Le; Tran Vu Phong] Natl Inst Hyg & Epidemiol, Dept Med Entomol & Zool, Hanoi, Vietnam	Nagasaki University; National Institute of Hygiene & Epidemiology (NIHE)	Tsunoda, T (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Vector Ecol & Environm, Nagasaki 852, Japan.	tsunoda@nagasaki.u-ac.jp		, Noboru/0000-0003-3664-9605	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) granted by Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499; Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Chen C. S., 1988, YUSHANIA, V5, P1; Christophers S., 1960, YELLOW FEVER MOSQUIT; GOULD DJ, 1970, J MED ENTOMOL, V7, P499, DOI 10.1093/jmedent/7.4.499; HANSON SM, 1995, J MED ENTOMOL, V32, P599, DOI 10.1093/jmedent/32.5.599; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322; Khatchikian CE, 2010, EVOL ECOL, V24, P1159, DOI 10.1007/s10682-010-9359-4; Knox TB, 2007, J MED ENTOMOL, V44, P192, DOI 10.1603/0022-2585(2007)44[192:CEOQSM]2.0.CO;2; KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; Leather S.R., 1995, ECOLOGY INSECT OVERW; Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2; MCDONALD PT, 1977, J MED ENTOMOL, V14, P49, DOI 10.1093/jmedent/14.1.49; MING JG, 1993, MED VET ENTOMOL, V7, P323, DOI 10.1111/j.1365-2915.1993.tb00699.x; Ministry of Health, 2009, AN COMM DIS DAT VIET; Ministry of Health, 2010, AN COMM DIS DAT VIET; Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277; National Hydro-Meteorological Service, 2012, MET DAT 2010 2012; OFUJI K., 1963, Endemic Diseases Bulletin of Nagasaki University, V5, P209; REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177; Rodhain Francois, 1997, P45; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Tran Vu Phong, 1999, Dengue Bulletin, V23, P67; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Weatherbase, 2012, HAN VIETN TRAV WEATH; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101	32	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95606	10.1371/journal.pone.0095606	http://dx.doi.org/10.1371/journal.pone.0095606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752230	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400088
J	Fujimura, K; Wakino, S; Minakuchi, H; Hasegawa, K; Hosoya, K; Komatsu, M; Kaneko, Y; Shinozuka, K; Washida, N; Kanda, T; Tokuyama, H; Hayashi, K; Itoh, H				Fujimura, Keiko; Wakino, Shu; Minakuchi, Hitoshi; Hasegawa, Kazuhiro; Hosoya, Koji; Komatsu, Motoaki; Kaneko, Yuka; Shinozuka, Keisuke; Washida, Naoki; Kanda, Takeshi; Tokuyama, Hirobumi; Hayashi, Koichi; Itoh, Hiroshi			Ghrelin Protects against Renal Damages Induced by Angiotensin-II via an Antioxidative Stress Mechanism in Mice	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; MITOCHONDRIAL BIOGENESIS; UNCOUPLING PROTEIN-2; ACYLATED PEPTIDE; SKELETAL-MUSCLE; BLOOD-VESSELS; GROWTH; SENESCENCE; EXPRESSION; OVEREXPRESSION	We explored the renal protective effects by a gut peptide, Ghrelin. Daily peritoneal injection with Ghrelin ameliorated renal damages in continuously angiotensin II (AngII)-infused C57BL/6 mice as assessed by urinary excretion of protein and renal tubular markers. AngII-induced increase in reactive oxygen species (ROS) levels and senescent changes were attenuated by Ghrelin. Ghrelin also inhibited AngII-induced upregulations of transforming growth factor-beta (TGF-beta) and plasminogen activator inhibitor-1 (PAI-1), ameliorating renal fibrotic changes. These effects were accompanied by concomitant increase in mitochondria uncoupling protein, UCP2 as well as in a key regulator of mitochondria biosynthesis, PGC1 alpha. In renal proximal cell line, HK-2 cells, Ghrelin reduced mitochondria membrane potential and mitochondria-derived ROS. The transfection of UCP2 siRNA abolished the decrease in mitochondria-derived ROS by Ghrelin. Ghrelin ameliorated AngII-induced renal tubular cell senescent changes and AngII-induced TGF-beta and PAI-1 expressions. Finally, Ghrelin receptor, growth hormone secretagogue receptor (GHSR)-null mice exhibited an increase in tubular damages, renal ROS levels, renal senescent changes and fibrosis complicated with renal dysfunction. GHSR-null mice harbored elongated mitochondria in the proximal tubules. In conclusion, Ghrelin suppressed AngII-induced renal damages through its UCP2 dependent anti-oxidative stress effect and mitochondria maintenance. Ghrelin/GHSR pathway played an important role in the maintenance of ROS levels in the kidney.	[Fujimura, Keiko; Wakino, Shu; Minakuchi, Hitoshi; Hasegawa, Kazuhiro; Hosoya, Koji; Komatsu, Motoaki; Kaneko, Yuka; Shinozuka, Keisuke; Washida, Naoki; Kanda, Takeshi; Tokuyama, Hirobumi; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan	Keio University	Wakino, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	shuwakino@z8.keio.jp			Japanese Ministry of Health, Labor, Welfare	Japanese Ministry of Health, Labor, Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was funded by the grant from Japanese Ministry of Health, Labor, Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews Zane B, 2010, Curr Aging Sci, V3, P102; Andrews ZB, 2010, ENDOCRINOLOGY, V151, P2078, DOI 10.1210/en.2009-0850; Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; de Cavanagh EMV, 2003, FASEB J, V17, P1096, DOI 10.1096/fj.02-0063fje; Diep QN, 2002, CIRCULATION, V105, P2296, DOI 10.1161/01.CIR.0000016049.86468.23; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Feldkamp T, 2004, AM J PHYSIOL-RENAL, V286, pF749, DOI 10.1152/ajprenal.00276.2003; Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039739; Kimura S, 2005, HYPERTENSION, V45, P860, DOI 10.1161/01.HYP.0000163462.98381.7f; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Krause KH, 2007, EXP GERONTOL, V42, P256, DOI 10.1016/j.exger.2006.10.011; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Melk A, 2003, NEPHROL DIAL TRANSPL, V18, P2474, DOI 10.1093/ndt/gfg322; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Mitsuishi M, 2009, DIABETES, V58, P710, DOI 10.2337/db08-0949; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Park JY, 2005, DIABETOLOGIA, V48, P1022, DOI 10.1007/s00125-005-1712-8; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rizk DEE, 2005, UROLOGY, V66, P1343, DOI 10.1016/j.urology.2005.06.113; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Satriano J, 2010, AM J PHYSIOL-CELL PH, V299, pC374, DOI 10.1152/ajpcell.00096.2010; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Takeda R, 2006, J AM SOC NEPHROL, V17, P113, DOI 10.1681/ASN.2004080626; Thompson MP, 2004, FEBS LETT, V568, P4, DOI 10.1016/j.febslet.2004.05.011; Verhulst PJ, 2012, REGUL PEPTIDES, V173, P27, DOI 10.1016/j.regpep.2011.09.001; Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008; Wang W, 2009, AM J PHYSIOL-RENAL, V297, pF1032, DOI 10.1152/ajprenal.00044.2009; Yang HC, 2010, J AM SOC NEPHROL, V21, P1436, DOI 10.1681/ASN.2010020205; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	44	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94373	10.1371/journal.pone.0094373	http://dx.doi.org/10.1371/journal.pone.0094373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747517	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500029
J	Roberts, BA; Deary, IJ; Dykiert, D; Der, G; Batty, GD				Roberts, Beverly A.; Deary, Ian J.; Dykiert, Dominika; Der, Geoff; Batty, G. David			Reaction Time and Incident Cancer: 25 Years of Follow-Up of Study Members in the UK Health and Lifestyle Survey	PLOS ONE			English	Article							NATIONAL CHILD-DEVELOPMENT; CORONARY-HEART-DISEASE; DANISH BIRTH COHORT; MILLION SWEDISH MEN; 1970 BRITISH COHORT; COGNITIVE-ABILITY; EARLY ADULTHOOD; MIDDLE-AGE; SOCIOECONOMIC POSITION; PREMATURE MORTALITY	Objectives: To investigate the association of reaction time with cancer incidence. Methods: 6900 individuals aged 18 to 94 years who participated in the UK Health and Lifestyle Survey in 1984/1985 and were followed for a cancer registration for 25 years. Results: Disease surveillance gave rise to 1015 cancer events from all sites. In general, there was essentially no clear pattern of association for either simple or choice reaction time with cancer of all sites combined, nor specific malignancies. However, selected associations were found for lung cancer, colorectal cancer and skin cancer. Conclusions: In the present study, reaction time and its components were not generally related to cancer risk.	[Roberts, Beverly A.; Deary, Ian J.; Dykiert, Dominika; Der, Geoff; Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Der, Geoff] Univ Glasgow, Med Res Council Publ & Hlth Sci Unit, Glasgow, Lanark, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Edinburgh; University of Glasgow; University of London; University College London	Roberts, BA (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	beverly.roberts@ed.ac.uk	Deary, Ian J/C-6297-2009; Batty, GD/Y-4401-2018	Deary, Ian J/0000-0002-1733-263X; Batty, GD/0000-0003-1822-5753; Dykiert, Dominika/0000-0002-6050-8223; Der, Geoff/0000-0002-8677-073X	Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); Economic and Social Research Council (ESRC); Medical Research Council (MRC); Medical Research Council [MR/K026992/1, MC_UU_12017/5, G0700704] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [G0700704, MC_UU_12017/5] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC) and Medical Research Council (MRC) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty GD, 2008, DIABETOLOGIA, V51, P436, DOI 10.1007/s00125-007-0908-5; Batty GD, 2007, ANN ONCOL, V18, P21, DOI 10.1093/annonc/mdl473; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P997, DOI 10.1136/jech.2006.054494; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P241, DOI 10.1136/jech.2006.048215; Batty GD, 2007, PEDIATRICS, V119, pE38, DOI 10.1542/peds.2006-1831; Batty GD, 2006, J EPIDEMIOL COMMUN H, V60, P872, DOI 10.1136/jech.2005.045039; Batty GD, 2009, PSYCHO-ONCOLOGY, V18, P1122, DOI 10.1002/pon.1521; Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381; Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x; Batty GD, 2005, BRIT J PSYCHIAT, V187, P180, DOI 10.1192/bjp.187.2.180; Calvin CM, 2011, HEALTH PSYCHOL, V30, P710, DOI 10.1037/a0023940; Chandola T, 2006, INT J OBESITY, V30, P1422, DOI 10.1038/sj.ijo.0803279; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Gale CR, 2008, ARCH GEN PSYCHIAT, V65, P1410, DOI 10.1001/archpsyc.65.12.1410; Gore, 1987, HLTH LIFESTYLE SURVE; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Hemmingsson T, 2007, SOC SCI MED, V65, P1410, DOI 10.1016/j.socscimed.2007.05.006; SAS Institute Inc, 1999, SAS STAT US GUID 8; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Shipley BA, 2006, PSYCHOSOM MED, V68, P17, DOI 10.1097/01.psy.0000195867.66643.0f; Shipley BA, 2008, J PSYCHOSOM RES, V65, P143, DOI 10.1016/j.jpsychores.2008.02.017; Walker NP, 2002, INTELLIGENCE, V30, P233, DOI 10.1016/S0160-2896(01)00098-8; Whitley E, 2010, J EPIDEMIOL COMMUN H, V64, P419, DOI 10.1136/jech.2009.100669	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95054	10.1371/journal.pone.0095054	http://dx.doi.org/10.1371/journal.pone.0095054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2DP	24747801	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000335226500053
J	Tanigaki, Y; Ito, K; Obuchi, Y; Kosaka, A; Yamato, KT; Okanami, M; Lehtonen, MT; Valkonen, JPT; Akita, M				Tanigaki, Yusuke; Ito, Kenji; Obuchi, Yoshiyuki; Kosaka, Akiko; Yamato, Katsuyuki T.; Okanami, Masahiro; Lehtonen, Mikko T.; Valkonen, Jari P. T.; Akita, Motomu			Physcomitrella patens Has Kinase-LRR R Gene Homologs and Interacting Proteins	PLOS ONE			English	Article							DISEASE RESISTANCE; RECEPTOR KINASE; MOSS; DEFENSE; PEROXIDASE; PATHOGEN	Plant disease resistance gene (R gene)-like sequences were screened from the Physcomitrella patens genome. We found 603 kinase-like, 475 Nucleotide Binding Site (NBS)-like and 8594 Leucine Rich Repeat (LRR)-like sequences by homology searching using the respective domains of PpC24 (Accession No. BAD38895), which is a candidate kinase-NBS-LRR (kinase-NL) type R-like gene, as a reference. The positions of these domains in the genome were compared and 17 kinase-NLs were predicted. We also found four TIR-NBS-LRR (TIR-NL) sequences with homology to Arabidopsis TIR-NL (NM_001125847), but three out of the four TIR-NLs had tetratricopeptide repeats or a zinc finger domain in their predicted C-terminus. We also searched for kinase-LRR (KLR) type sequences by homology with rice OsXa21 and Arabidopsis thaliana FLS2. As a result, 16 KLRs with similarity to OsXa21 were found. In phylogenetic analysis of these 16 KLRs, PpKLR36, PpKLR39, PpKLR40, and PpKLR43 formed a cluster with OsXa21. These four PpKLRs had deduced transmembrane domain sequences and expression of all four was confirmed. We also found 14 homologs of rice OsXB3, which is known to interact with OsXa21 and is involved in signal transduction. Protein-protein interaction was observed between the four PpKLRs and at least two of the XB3 homologs in Y2H analysis.	[Tanigaki, Yusuke; Ito, Kenji; Obuchi, Yoshiyuki; Kosaka, Akiko; Yamato, Katsuyuki T.; Okanami, Masahiro; Akita, Motomu] Kinki Univ, Dept Biotechnol Sci, Wakayama, Japan; [Lehtonen, Mikko T.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland	Kindai University (Kinki University); University of Helsinki	Akita, M (corresponding author), Kinki Univ, Dept Biotechnol Sci, Wakayama, Japan.	akita@waka.kindai.ac.jp	YAMATO, Katsuyuki T/Q-7263-2016	YAMATO, Katsuyuki T/0000-0002-7130-0911; Lehtonen, Mikko/0000-0002-8279-3598; Valkonen, Jari/0000-0002-3704-9911				Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Akita M, 2002, J MOL EVOL, V55, P595, DOI 10.1007/s00239-002-2355-8; Akita M, 2011, SCI TOTAL ENVIRON, V409, P3166, DOI 10.1016/j.scitotenv.2011.05.009; Andersson Robert A., 2005, Journal of General Plant Pathology, V71, P23, DOI 10.1007/s10327-004-0154-3; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Cao YR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003313; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Danna CH, 2011, P NATL ACAD SCI USA, V108, P9286, DOI 10.1073/pnas.1106366108; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; Davey ML, 2009, AM J BOT, V96, P1281, DOI 10.3732/ajb.0900010; de Leon IP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-52; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Kim J, 2012, MOL CELLS, V33, P385, DOI 10.1007/s10059-012-0003-8; Kosuta S, 2011, PLANT J, V67, P929, DOI 10.1111/j.1365-313X.2011.04645.x; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lehtonen MT, 2012, MOL PLANT MICROBE IN, V25, P363, DOI 10.1094/MPMI-10-11-0265; Lehtonen MT, 2009, NEW PHYTOL, V183, P432, DOI 10.1111/j.1469-8137.2009.02864.x; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Xue JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036700; Yoshida S, 2005, J BIOL CHEM, V280, P9203, DOI 10.1074/jbc.M411665200	32	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95118	10.1371/journal.pone.0095118	http://dx.doi.org/10.1371/journal.pone.0095118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748046	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500059
J	Divekar, SD; Burrell, TC; Lee, JE; Weeber, EJ; Rebeck, GW				Divekar, Shailaja D.; Burrell, Teal C.; Lee, Jennifer E.; Weeber, Edwin J.; Rebeck, G. William			Ligand-induced Homotypic and Heterotypic Clustering of Apolipoprotein E Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; DENSITY-LIPOPROTEIN RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; F-SPONDIN; VLDL RECEPTOR; SYNAPTIC PLASTICITY; TAU PHOSPHORYLATION; SIGNAL-TRANSDUCTION; NEURONAL MIGRATION; BRAIN-DEVELOPMENT	ApoE Receptor 2 (ApoER2) and the very low density lipoprotein receptor (VLDLR) are type I transmembrane proteins belonging to the LDLR family of receptors. They are neuronal proteins found in synaptic compartments that play an important role in neuronal migration during development. ApoER2 and VLDLR bind to extracellular glycoproteins, such as Reelin and F-spondin, which leads to phosphorylation of adaptor proteins and subsequent activation of downstream signaling pathways. It is thought that ApoER2 and VLDLR undergo clustering upon binding to their ligands, but no direct evidence of clustering has been shown. Here we show strong clustering of ApoER2 induced by the dimeric ligands Fc-RAP, F-spondin, and Reelin but relatively weak clustering with the ligand apoE in the absence of lipoproteins. This clustering involves numerous proteins besides ApoER2, including amyloid precursor protein and the synaptic adaptor protein PSD-95. Interestingly, we did not observe strong clustering of ApoER2 with VLDLR. Clustering was modulated by both extracellular and intracellular domains of ApoER2. Together, our data demonstrate that several multivalent ligands for ApoER2 induce clustering in transfected cells and primary neurons and that these complexes included other synaptic molecules, such as APP and PSD-95.	[Divekar, Shailaja D.; Burrell, Teal C.; Lee, Jennifer E.; Rebeck, G. William] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Weeber, Edwin J.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33613 USA	Georgetown University; State University System of Florida; University of South Florida	Rebeck, GW (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20007 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012; Weeber, Edwin J/A-5396-2012	Rebeck, George William/0000-0001-6276-248X; 	National Institutes of Health [P01 AG030128, R01 AG035379]; NATIONAL INSTITUTE ON AGING [R01AG035379, P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG030128 and R01 AG035379.	Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Arneja A, 2014, J IMMUNOL, V192, P123, DOI 10.4049/jimmunol.1302291; Ballif BA, 2003, MOL BRAIN RES, V117, P152, DOI 10.1016/S0169-328X(03)00295-X; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Bouche E, 2013, CELL RES, V23, P473, DOI 10.1038/cr.2013.7; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Bustos FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094037; Care BR, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012720; Chadwick W., 2010, INT J ALZHEIMERS DIS, V2010, DOI [10.4061/2010/604792, DOI 10.4061/2010/604792]; Cheng YC, 2012, MOL NEUROBIOL, V45, P536, DOI 10.1007/s12035-012-8275-8; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Dumanis SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017203; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Feinstein Y, 2004, INT J BIOCHEM CELL B, V36, P975, DOI 10.1016/j.biocel.2004.01.002; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Hoe HS, 2008, MOL NEUROBIOL, V37, P64, DOI 10.1007/s12035-008-8017-0; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, BRAIN RES, V1112, P70, DOI 10.1016/j.brainres.2006.07.035; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Hsu CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032398; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Ketchum C, 2014, BIOPHYS J, V106, P26, DOI 10.1016/j.bpj.2013.10.043; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kozer N, 2014, BIOCHEMISTRY-US, V53, P2594, DOI 10.1021/bi500182x; Kozer N, 2013, MOL BIOSYST, V9, P1849, DOI 10.1039/c3mb70073a; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Laffont I, 2002, BIOCHEM BIOPH RES CO, V292, P83, DOI 10.1006/bbrc.2002.6586; Levenson JM, 2008, BBA-GENE REGUL MECH, V1779, P422, DOI 10.1016/j.bbagrm.2008.01.001; Li XP, 2003, BIOCHEMISTRY-US, V42, P10406, DOI 10.1021/bi027093c; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Lohmuller T, 2013, NANO LETT, V13, P3059, DOI 10.1021/nl400874v; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Reddy SS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-30; Rice HC, 2013, BIOCHEMISTRY-US, V52, P3264, DOI 10.1021/bi400165f; Rice HC, 2012, DEVELOPMENT, V139, P3986, DOI 10.1242/dev.082909; Rogers JT, 2011, LEARN MEMORY, V18, P558, DOI 10.1101/lm.2153511; Rogers JT, 2008, NEURON GLIA BIOL, V4, P259, DOI 10.1017/S1740925X09990184; Royaux I, 1997, GENOMICS, V46, P240, DOI 10.1006/geno.1997.4983; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Schamel WWA, 2013, IMMUNOL REV, V251, P13, DOI 10.1111/imr.12019; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tamboli IY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093120; Tanaka T, 2000, ALZ DIS ASSOC DIS, V14, pS18, DOI 10.1097/00002093-200000001-00004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Yasui N, 2011, J BIOL CHEM, V286, P35247, DOI 10.1074/jbc.M111.242719; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	85	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15894	15903		10.1074/jbc.M113.537548	http://dx.doi.org/10.1074/jbc.M113.537548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755222	Green Published, hybrid			2022-12-25	WOS:000337965700001
J	Chan, YGY; Kim, HK; Schneewind, O; Missiakas, D				Chan, Yvonne Gar-Yun; Kim, Hwan Keun; Schneewind, Olaf; Missiakas, Dominique			The Capsular Polysaccharide of Staphylococcus aureus Is Attached to Peptidoglycan by the LytR-CpsA-Psr (LCP) Family of Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Cell Wall; Peptidoglycan; Staphylococcus aureus (S; aureus); Teichoic Acid; LytR-CpsA-Psr; Capsular Polysaccharide; Hydrolase; Undecaprenol	GRAM-POSITIVE BACTERIA; GROUP-B STREPTOCOCCUS; WALL TEICHOIC-ACIDS; CELL-WALL; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; FUNCTIONAL-ANALYSIS; SURFACE-PROTEINS; O-ACETYLATION	Envelope biogenesis in bacteria involves synthesis of intermediates that are tethered to the lipid carrier undecaprenol-phosphate. LytR-CpsA-Psr (LCP) enzymes have been proposed to catalyze the transfer of undecaprenol-linked intermediates onto the C6-hydroxyl of MurNAc in peptidoglycan, thereby promoting attachment of wall teichoic acid (WTA) in bacilli and staphylococci and capsular polysaccharides (CPS) in streptococci. S. aureus encodes three lcp enzymes, and a variant lacking all three genes (lcp) releases WTA from the bacterial envelope and displays a growth defect. Here, we report that the type 5 capsular polysaccharide (CP5) of Staphylococcus aureus Newman is covalently attached to the glycan strands of peptidoglycan. Cell wall attachment of CP5 is abrogated in the lcp variant, a defect that is best complemented via expression of lcpC in trans. CP5 synthesis and peptidoglycan attachment are not impaired in the tagO mutant, suggesting that CP5 synthesis does not involve the GlcNAc-ManNAc linkage unit of WTA and may instead utilize another Wzy-type ligase to assemble undecaprenyl-phosphate intermediates. Thus, LCP enzymes of S. aureus are promiscuous enzymes that attach secondary cell wall polymers with discrete linkage units to peptidoglycan.	[Chan, Yvonne Gar-Yun; Kim, Hwan Keun; Schneewind, Olaf; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Schneewind, Olaf; Missiakas, Dominique] Argonne Natl Lab, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, 920 East 58th Str, Chicago, IL 60637 USA.	dmissiak@bsd.uchicago.edu		Kim, Hwan Keun/0000-0003-2095-9705	National Institutes of Health from the NIAID [AI38897]; Novartis Vaccines and Diagnostics (Siena, Italy); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE); National Institutes of Health NIAID [1-U54-AI-057153]; American Heart Association [13POST16980091]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI038897] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Novartis Vaccines and Diagnostics (Siena, Italy); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI38897 from the NIAID and Novartis Vaccines and Diagnostics (Siena, Italy). The authors acknowledge membership within and support from the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE) supported by National Institutes of Health NIAID Award 1-U54-AI-057153.; Supported by American Heart Association Award 13POST16980091.	ARBEIT RD, 1984, DIAGN MICR INFEC DIS, V2, P85, DOI 10.1016/0732-8893(84)90002-6; ARMSTRONG JJ, 1959, NATURE, V184, P248, DOI 10.1038/184248a0; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bhasin N, 1998, MOL MICROBIOL, V27, P9, DOI 10.1046/j.1365-2958.1998.00646.x; BRAY D, 1967, BIOCHEM BIOPH RES CO, V28, P334, DOI 10.1016/0006-291X(67)90314-2; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Caliot E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002756; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Cartee RT, 2005, J BACTERIOL, V187, P7425, DOI 10.1128/JB.187.21.7425-7433.2005; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; Chen C, 2013, J BIOL CHEM, V288, P29440, DOI 10.1074/jbc.M113.502039; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; CRATER DL, 1995, J BIOL CHEM, V270, P18452, DOI 10.1074/jbc.270.31.18452; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Deng LY, 2000, J BIOL CHEM, V275, P7497, DOI 10.1074/jbc.275.11.7497; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; FATTOM A, 1990, INFECT IMMUN, V58, P2367, DOI 10.1128/IAI.58.7.2367-2374.1990; Fattom AI, 1998, INFECT IMMUN, V66, P4588, DOI 10.1128/IAI.66.10.4588-4592.1998; FOURNIER JM, 1984, INFECT IMMUN, V45, P87, DOI 10.1128/IAI.45.1.87-93.1984; Gilbert I, 1931, J BACTERIOL, V21, P157, DOI 10.1128/JB.21.3.157-160.1931; Hanson BR, 2012, J BACTERIOL, V194, P1668, DOI 10.1128/JB.06373-11; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jones C, 2005, CARBOHYD RES, V340, P1097, DOI 10.1016/j.carres.2005.02.001; KARAKAWA WW, 1985, J CLIN MICROBIOL, V22, P445, DOI 10.1128/JCM.22.3.445-447.1985; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; KOJIMA N, 1983, J BIOL CHEM, V258, P9043; KOJIMA N, 1985, J BACTERIOL, V161, P299, DOI 10.1128/JB.161.1.299-306.1985; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; MCGRATH BC, 1991, J BACTERIOL, V173, P649, DOI 10.1128/jb.173.2.649-654.1991; Melchiorre S, 2012, MICROBIOL-SGM, V158, P338, DOI 10.1099/mic.0.054270-0; Morona JK, 1997, MOL MICROBIOL, V23, P751, DOI 10.1046/j.1365-2958.1997.2551624.x; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Over B, 2011, FEMS MICROBIOL LETT, V320, P142, DOI 10.1111/j.1574-6968.2011.02303.x; Pelosi L, 2005, BIOCHEM BIOPH RES CO, V327, P857, DOI 10.1016/j.bbrc.2004.12.082; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Portoles M, 2001, INFECT IMMUN, V69, P917, DOI 10.1128/IAI.69.2.917-923.2001; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Richter S, 2009, MOL MICROBIOL, V71, P404, DOI 10.1111/j.1365-2958.2008.06533.x; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Sau S, 1997, J BACTERIOL, V179, P1614, DOI 10.1128/jb.179.5.1614-1621.1997; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; SORENSEN UBS, 1990, MICROB PATHOGENESIS, V8, P325, DOI 10.1016/0882-4010(90)90091-4; von Eiff C, 2007, DIAGN MICR INFEC DIS, V58, P297, DOI 10.1016/j.diagmicrobio.2007.01.016; Wacker M, 2014, J INFECT DIS, V209, P1551, DOI 10.1093/infdis/jit800; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WYKE AW, 1977, J BACTERIOL, V130, P1055, DOI 10.1128/JB.130.3.1055-1063.1977; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yamamoto S, 1999, J BACTERIOL, V181, P5176, DOI 10.1128/JB.181.17.5176-5184.1999; YOKOYAMA K, 1986, EUR J BIOCHEM, V161, P479, DOI 10.1111/j.1432-1033.1986.tb10469.x; Yother J, 1997, MOL MICROBIOL, V25, P201, DOI 10.1046/j.1365-2958.1997.4361798.x; Yother J, 1999, GENETICS OF BACTERIALS POLYSACCHARIDES, P161; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	72	68	70	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15680	15690		10.1074/jbc.M114.567669	http://dx.doi.org/10.1074/jbc.M114.567669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753256	Green Published, hybrid			2022-12-25	WOS:000337465400049
J	Chen, W; Fan, SY; Xie, XN; Xue, NN; Jin, XY; Wang, LL				Chen, Wei; Fan, Shiyong; Xie, Xinni; Xue, Nina; Jin, Xueyuan; Wang, Lili			Novel PPAR Pan Agonist, ZBH Ameliorates Hyperlipidemia and Insulin Resistance in High Fat Diet Induced Hyperlipidemic Hamster	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; RESVERATROL SUPPLEMENTATION; DIABETIC-RATS; SIRTUIN 1; BEZAFIBRATE; FENOFIBRATE; METABOLISM; DYSLIPIDEMIA; EXPRESSION; PROTECTS	Effective and safe pharmacological interventions for hyperlipidemia remains badly needed. By incorporating the key pharmacophore of fibrates into the natural scaffold of resveratrol, a novel structural compound ZBH was constructed. In present study, we found ZBH reserved approximately one third of the sirtuin 1 (SIRT1) activation produced by resveratrol at in-vitro enzyme activity assay, directly bound to and activated all three peroxisome proliferator-activated receptor (PPAR) subtypes respectively in PPAR binding and transactivation assays. Moreover, ZBH (EC50, 1.75 mu M) activate PPAR alpha 21 fold more efficiently than the well-known PPAR pan agonist bezafibrate (EC50, 37.37 mM) in the cellular transactivation assays. In the high fat diet induced hyperlipidemic hamsters, 5-week treatment with ZBH significantly lowered serum triglyceride, total cholesterol, LDL-C, FFA, hyperinsulinemia, and improved insulin sensitivity more potently than bezafibrate. Meanwhile, serum transaminases, creatine phosphokinase and CREA levels were found not altered by ZBH intervention. Mechanism study indicated ZBH promoted the expression of PPAR alpha target genes and SIRT1 mRNA. Hepatic lipogenesis was markedly decreased via down-regulation of lipogenic genes, and fatty acid uptake and oxidation was simultaneously increased in the liver and skeletal muscle via up-regulation of lipolysis genes. Glucose uptake and utilization was also significantly promoted in skeletal muscle. These results suggested that ZBH significantly lowered hyperlipidemia and ameliorated insulin resistance more efficiently than bezafibrate in the hyperlipidemic hamsters primarily by activating of PPAR alpha, and SIRT1 promotion and activation. ZBH thus presents a potential new agent to combat hyperlipidemia.	[Chen, Wei; Fan, Shiyong; Xie, Xinni; Xue, Nina; Wang, Lili] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Jin, Xueyuan] Beijing 302 Hosp, Int Ctr Liver Dis Treatment, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Fifth Medical Center of Chinese PLA General Hospital	Jin, XY (corresponding author), Beijing 302 Hosp, Int Ctr Liver Dis Treatment, Beijing, Peoples R China.	xueyuanjin@yahoo.com; wangll63@126.com			Ministry of Science and Technology of China [2012ZX09301003-001, 2012ZX09301003-003]; National Natural Science Foundation of China [81102308]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge grant support from the National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2012ZX09301003-001 and 2012ZX09301003-003; www.most.gov.cn/), and the National Natural Science Foundation of China (No. 81102308; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Z, 2005, HYPERTENSION, V45, P1012, DOI 10.1161/01.HYP.0000164570.20420.67; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beaudoin MS, 2013, AM J PHYSIOL-REG I, V305, pR542, DOI 10.1152/ajpregu.00200.2013; Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Chen W, 2009, BRIT J PHARMACOL, V157, P724, DOI 10.1111/j.1476-5381.2009.00231.x; Chen YJ, 2008, J PHARMACOL EXP THER, V324, P658, DOI 10.1124/jpet.107.129197; Chiha M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/697240; Dong X Charlie, 2012, Diabetes Manag (Lond), V2, P243; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Guo Q, 2001, BBA-MOL CELL BIOL L, V1533, P220, DOI 10.1016/S1388-1981(01)00156-1; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; Kemper JK, 2013, VITAM HORM, V91, P385, DOI 10.1016/B978-0-12-407766-9.00016-X; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li W, 2012, J ENZYM INHIB MED CH, V27, P311, DOI 10.3109/14756366.2011.589840; Li W, 2010, CHEMMEDCHEM, V5, P1977, DOI 10.1002/cmdc.201000360; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lu WQ, 2011, J STEROID BIOCHEM, V124, P112, DOI 10.1016/j.jsbmb.2011.01.019; Maronpot RR, 2010, TOXICOL PATHOL, V38, P776, DOI 10.1177/0192623310373778; Matsui HR, 1997, DIABETES, V46, P348, DOI 10.2337/diabetes.46.3.348; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mori Y, 2004, ENDOCRINE, V25, P247, DOI 10.1385/ENDO:25:3:247; Nakajima T, 2009, MOL PHARMACOL, V75, P782, DOI 10.1124/mol.108.052928; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; PILL J, 1992, ARCH TOXICOL, V66, P327, DOI 10.1007/BF01973627; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Schirmer H, 2012, MOL BIOL REP, V39, P3281, DOI 10.1007/s11033-011-1096-4; Shearer BG, 2003, CURR MED CHEM, V10, P267, DOI 10.2174/0929867033368295; Srivastava RAK, 2010, MOL CELL BIOCHEM, V345, P197, DOI 10.1007/s11010-010-0573-8; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Tenenbaum A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-140; Tenenbaum A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-125; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Tsukamoto T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-46; Wang PR, 2001, EUR J PHARMACOL, V427, P285, DOI 10.1016/S0014-2999(01)01249-3; WATANABE T, 1989, BIOCHEM PHARMACOL, V38, P367; Yu CY, 2004, EUR J BIOCHEM, V271, P386, DOI 10.1046/j.1432-1033.2003.03937.x; Zhang ZS, 2009, MOL NUTR FOOD RES, V53, P921, DOI 10.1002/mnfr.200800517	45	26	26	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96056	10.1371/journal.pone.0096056	http://dx.doi.org/10.1371/journal.pone.0096056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759758	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200130
J	Lei, PG; Gu, F; Hong, LR; Sun, YL; Li, MR; Wang, HL; Zhong, BH; Chen, MH; Cui, Y; Zhang, SH				Lei, Pingguang; Gu, Fang; Hong, Liru; Sun, Yuli; Li, Minrui; Wang, Huiling; Zhong, Bihui; Chen, Minhu; Cui, Yi; Zhang, Shenghong			Pediatric Colonoscopy in South China: A 12-Year Experience in a Tertiary Center	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; JUVENILE POLYPS; COLORECTAL POLYPS; CHILDREN; ENDOSCOPY; EPIDEMIOLOGY	Objective: To investigate: 1) the demographics and clinical characteristics, 2) the findings, and 3) the safety and effectiveness in a cohort of Chinese pediatric patients undergoing colonoscopy. Methods: The study participants were consecutive patients aged <= 14 years old that underwent their first colonoscopy in the endoscopy center at the First Affiliated Hospital, Sun Yat-sen University between Jan. 1, 2001 and Dec. 31, 2012. Demographic, clinical, endoscopic, and pathological findings were collected. Results: The cohort consisted of 322 patients, including 218 boys (67.7%) and 104 girls (32.3%). The median age was 8.0 years old and ranged from 9 months to 14 years old. Hematochezia (48.8%) and abdominal pain/discomfort (41.3%) were the most common presentations preceding pediatric colonoscopy. The caecal intubation success rate was 96.3%. No serious complications occurred during the procedures. A total of 227 patients (70.5%) received a positive diagnosis under endoscopy, including 138 patients with polyps and 53 patients with inflammatory bowel disease (IBD). Among the patients with polyps, 71.0% were juvenile polyps. Comparisons between years 2001-2006 and 2007-2012 showed that the IBD detection rate increased significantly (4.6% vs. 22.4%, P<0.001), while the opposite occurred for the polyp detection rate (73.1% vs. 27.6%, P<0.001). Conclusion: Colonoscopy in pediatric patients is a safe and effective procedure. Polyps are the primary finding during colonoscopy. In South China there has been an increase in pediatric patients diagnosed with IBD over the past decade. However, a large epidemiological study is needed to confirm our findings.	[Lei, Pingguang] Shenzhen Baoan Dist Songgang Peoples Hosp, Div Gastroenterol, Shenzhen, Peoples R China; [Lei, Pingguang; Hong, Liru; Sun, Yuli; Li, Minrui; Wang, Huiling; Zhong, Bihui; Chen, Minhu; Cui, Yi; Zhang, Shenghong] Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Gu, Fang] Sun Yat Sen Univ, Affiliated Hosp 1, Div Reprod Med, Guangzhou 510275, Guangdong, Peoples R China; [Hong, Liru] Sun Yat Sen Univ, Affiliated Shantou Hosp, Div Gastroenterol, Shantou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Cui, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	gzcuiyi@163.com; shenghongzhang@163.com			Natural Science Grant of Guangdong Province [S2012040007685]; Specialized Research Fund for the Doctoral Program of Higher Education [20120171120090]; NSFC [81301769]	Natural Science Grant of Guangdong Province; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NSFC(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Grant of Guangdong Province (S2012040007685 to Shenghong Zhang), Specialized Research Fund for the Doctoral Program of Higher Education (20120171120090 to Shenghong Zhang), and NSFC (81301769 to Shenghong Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtiani MTH, 2009, MED PRIN PRACT, V18, P53, DOI 10.1159/000163047; Barth BA, 2012, GASTROINTEST ENDOSC, V76, P8, DOI 10.1016/j.gie.2012.02.023; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Braegger CP, 2011, J PEDIATR GASTR NUTR, V53, P141, DOI 10.1097/MPG.0b013e318218be35; Chen W, 2012, J PEDIATR SURG, V47, P1853, DOI 10.1016/j.jpedsurg.2012.05.024; Fox VL, 2010, CLIN GASTROENTEROL H, V8, P795, DOI 10.1016/j.cgh.2010.05.010; Friedt M, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-24; Hood B, 2011, CLIN PEDIATR, V50, P910, DOI 10.1177/0009922811407177; Kim BJ, 2010, DIGEST DIS SCI, V55, P1989, DOI 10.1007/s10620-009-0963-5; Lee BG, 2012, PEDIATR GASTROENTERO, V15, P250, DOI 10.5223/pghn.2012.15.4.250; Lee HJ, 2010, GUT LIVER, V4, P326, DOI 10.5009/gnl.2010.4.3.326; Lev-Tzion R, 2012, Minerva Gastroenterol Dietol, V58, P137; MESTRE JR, 1986, AM J GASTROENTEROL, V81, P312; Mudawi H. M. Y., 2009, Eastern Mediterranean Health Journal, V15, P1027; Ng SC, 2013, GASTROENTEROLOGY, V145, P158, DOI 10.1053/j.gastro.2013.04.007; Park Jae Hong, 2010, Korean J Pediatr, V53, P824, DOI 10.3345/kjp.2010.53.9.824; Park KH, 2007, PEDIATR GASTROENTERO, V10, P20, DOI 10.5223/kjpgn.2007.10.1.20; Poddar U, 1998, AM J GASTROENTEROL, V93, P619; Tam YH, 2010, WORLD J GASTROENTERO, V16, P1119, DOI 10.3748/wjg.v16.i9.1119; Thakkar K, 2008, CLIN GASTROENTEROL H, V6, P515, DOI 10.1016/j.cgh.2008.01.007; Thakkar K, 2012, CURR OPIN PEDIATR, V24, P632, DOI 10.1097/MOP.0b013e328357419f; Thakkar K, 2012, DIGEST DIS SCI, V57, P1050, DOI 10.1007/s10620-011-1972-8; Ukarapol N, 2007, WORLD J SURG, V31, P395, DOI 10.1007/s00268-005-0686-5; Victor LF, 1996, PEDIAT GASTROINTESTI, V2nd, P1533; Waitayakul Satawan, 2004, Journal of the Medical Association of Thailand, V87, P41; Wang XQ, 2013, INFLAMM BOWEL DIS, V19, P423, DOI 10.1097/MIB.0b013e318286f9f2; Zeng ZR, 2013, J GASTROEN HEPATOL, V28, P1148, DOI 10.1111/jgh.12164; Zhang SH, 2009, INT J COLORECTAL DIS, V24, P943, DOI 10.1007/s00384-009-0726-y	28	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95933	10.1371/journal.pone.0095933	http://dx.doi.org/10.1371/journal.pone.0095933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759776	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200111
J	Collette, JR; Zhou, HJ; Lorenz, MC				Collette, John R.; Zhou, Huaijin; Lorenz, Michael C.			Candida albicans Suppresses Nitric Oxide Generation from Macrophages via a Secreted Molecule	PLOS ONE			English	Article							TRANSCRIPTIONAL RESPONSE; INTERFERON-GAMMA; GENE; SYNTHASE; STRAINS; DECARBOXYLASE; DISRUPTION; EXPRESSION; ORNITHINE; DELETION	Macrophages and neutrophils generate a potent burst of reactive oxygen and nitrogen species as a key aspect of the antimicrobial response. While most successful pathogens, including the fungus Candida albicans, encode enzymes for the detoxification of these compounds and repair of the resulting cellular damage, some species actively modulate immune function to suppress the generation of these toxic compounds. We report here that C. albicans actively inhibits macrophage production of nitric oxide (NO). NO production was blocked in a dose-dependent manner when live C. albicans were incubated with either cultured or bone marrow-derived mouse macrophages. While filamentous growth is a key virulence trait, yeast-locked fungal cells were still capable of dose-dependent NO suppression. C. albicans suppresses NO production from macrophages stimulated by exposure to IFN-gamma and LPS or cells of the non-pathogenic Saccharomyces cerevisiae. The NO inhibitory activity was produced only when the fungal cells were in direct contact with macrophages, but the compound itself was secreted into the culture media. LPS/IFN gamma stimulated macrophages cultured in cell-free conditioned media from co-cultures showed reduced levels of iNOS enzymatic activity and lower amounts of iNOS protein. Initial biochemical characterization of this activity indicates that the inhibitor is a small, aqueous, heat-stable compound. In summary, C. albicans actively blocks NO production by macrophages via a secreted mediator; these findings expand our understanding of phagocyte modulation by this important fungal pathogen and represent a potential target for intervention to enhance antifungal immune responses.	[Collette, John R.; Zhou, Huaijin; Lorenz, Michael C.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Lorenz, MC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Michael.Lorenz@uth.tmc.edu		Lorenz, Michael/0000-0002-7881-8027	U.S. Public Health Service [NIH R01AI075091, NIH R21AI071134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075091, R21AI071134] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. Public Health Service awards NIH R01AI075091 and NIH R21AI071134 to MCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baydoun AR, 1998, BRIT J PHARMACOL, V125, P1511, DOI 10.1038/sj.bjp.0702231; Brachmann CB, 1998, YEAST, V14, P115; Chinen T, 1999, CLIN EXP IMMUNOL, V115, P491; Fernandez-Arenas E, 2009, CELL MICROBIOL, V11, P560, DOI 10.1111/j.1462-5822.2008.01274.x; Fickling SA, 1999, ACTA PHYSIOL SCAND, V167, P145; FONZI WA, 1993, GENETICS, V134, P717; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gonzalez A, 2011, MICROB PATHOGENESIS, V50, P100, DOI 10.1016/j.micpath.2010.11.006; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Jimenez-Lopez C, 2013, EUKARYOT CELL, V12, P91, DOI 10.1128/EC.00290-12; Kawakami K, 1997, CELL IMMUNOL, V180, P47, DOI 10.1006/cimm.1997.1166; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; LYONS CR, 1992, J BIOL CHEM, V267, P6370; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; MORTIMER RK, 1986, GENETICS, V113, P35; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Newman SL, 2001, INFECT IMMUN, V69, P6813, DOI 10.1128/IAI.69.11.6813-6822.2001; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Rocco NM, 2011, INFECT IMMUN, V79, P2385, DOI 10.1128/IAI.01249-10; Schroppel K, 2001, INT J MED MICROBIOL, V290, P659, DOI 10.1016/S1438-4221(01)80003-5; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; STAHL P, 1982, J CELL BIOL, V93, P49, DOI 10.1083/jcb.93.1.49; Ullmann BD, 2004, EUKARYOT CELL, V3, P715, DOI 10.1128/EC.3.3.715-723.2004; VAZQUEZTORRES A, 1995, INFECT IMMUN, V63, P1142, DOI 10.1128/IAI.63.3.1142-1144.1995; VAZQUEZTORRES A, 1995, J INFECT DIS, V172, P192, DOI 10.1093/infdis/172.1.192; Vylkova S, 2014, PLOS PATHOG IN PRESS; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11	32	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96203	10.1371/journal.pone.0096203	http://dx.doi.org/10.1371/journal.pone.0096203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755669	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300145
J	Costa, PS; Scholte, LLS; Reis, MP; Chaves, AV; Oliveira, PL; Itabayana, LB; Suhadolnik, MLS; Barbosa, FAR; Chartone-Souza, E; Nascimento, AMA				Costa, Patricia S.; Scholte, Larissa L. S.; Reis, Mariana P.; Chaves, Anderson V.; Oliveira, Pollyanna L.; Itabayana, Luiza B.; Suhadolnik, Maria Luiza S.; Barbosa, Francisco A. R.; Chartone-Souza, Edmar; Nascimento, Andrea M. A.			Bacteria and Genes Involved in Arsenic Speciation in Sediment Impacted by Long-Term Gold Mining	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; OXIDIZING BACTERIA; SP NOV.; OXIDATION; OXIDASE; DIVERSITY; REDUCTASE; MINE; ENVIRONMENT; PERFORMANCE	The bacterial community and genes involved in geobiocycling of arsenic (As) from sediment impacted by long-term gold mining were characterized through culture-based analysis of As-transforming bacteria and metagenomic studies of the arsC, arrA, and aioA genes. Sediment was collected from the historically gold mining impacted Mina stream, located in one of the world's largest mining regions known as the "Iron Quadrangle". A total of 123 As-resistant bacteria were recovered from the enrichment cultures, which were phenotypically and genotypically characterized for As-transformation. A diverse As-resistant bacteria community was found through phylogenetic analyses of the 16S rRNA gene. Bacterial isolates were affiliated with Proteobacteria, Firmicutes, and Actinobacteria and were represented by 20 genera. Most were AsV-reducing (72%), whereas AsIII-oxidizing accounted for 20%. Bacteria harboring the arsC gene predominated (85%), followed by aioA (20%) and arrA (7%). Additionally, we identified two novel As-transforming genera, Thermomonas and Pannonibacter. Metagenomic analysis of arsC, aioA, and arrA sequences confirmed the presence of these genes, with arrA sequences being more closely related to uncultured organisms. Evolutionary analyses revealed high genetic similarity between some arsC and aioA sequences obtained from isolates and clone libraries, suggesting that those isolates may represent environmentally important bacteria acting in As speciation. In addition, our findings show that the diversity of arrA genes is wider than earlier described, once none arrA-OTUs were affiliated with known reference strains. Therefore, the molecular diversity of arrA genes is far from being fully explored deserving further attention.	[Costa, Patricia S.; Reis, Mariana P.; Chaves, Anderson V.; Oliveira, Pollyanna L.; Itabayana, Luiza B.; Suhadolnik, Maria Luiza S.; Barbosa, Francisco A. R.; Chartone-Souza, Edmar; Nascimento, Andrea M. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Scholte, Larissa L. S.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou CPqRR, Grp Genom & Biol Computac, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Nascimento, AMA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	amaral@ufmg.br	Nascimento, Andréa/ABD-9042-2020; Barbosa, Francisco A. R./C-9730-2016; Barbosa, Francisco/M-6225-2019; Chaves, Anderson Vieira/AAB-2717-2019	Nascimento, Andréa/0000-0002-0447-3505; Chaves, Anderson Vieira/0000-0002-0934-1763; Barbosa, Francisco Antonio/0000-0002-2026-6936; Costa, Patricia/0000-0002-2166-9497	FAPEMIG [APQ 00801/12]; CNPq [472411/2012-8]; CNPq/INCT [15206-7]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/INCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Sources of funding: FAPEMIG APQ 00801/12, CNPq no472411/2012-8, CNPq/INCT no 15206-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Anderson CR, 2004, CURR MICROBIOL, V48, P341, DOI 10.1007/s00284-003-4205-3; Andres J, 2013, GENOME BIOL EVOL, V5, P934, DOI 10.1093/gbe/evt061; Bandyopadhyay S, 2013, ARCH MICROBIOL, V195, P1, DOI 10.1007/s00203-012-0840-z; Basu P., 2010, MICROBE MAG, V5, P53, DOI DOI 10.1128/MICR0BE.5.53.1; Bhattacharya P, 2007, SCI TOTAL ENVIRON, V379, P109, DOI 10.1016/j.scitotenv.2007.02.037; Borba RP, 2000, REV BRASIL GEOCIENC, V30, P554; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Cavalca L, 2010, SYST APPL MICROBIOL, V33, P154, DOI 10.1016/j.syapm.2010.02.004; CCME, CAN ENV QUAL GUID; Chang JS, 2008, ENVIRON GEOCHEM HLTH, V32, P95; Chang YC, 2012, J IND MICROBIOL BIOT, V39, P37, DOI 10.1007/s10295-011-0996-6; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dowdle PR, 1996, APPL ENVIRON MICROB, V62, P1664, DOI 10.1128/AEM.62.5.1664-1669.1996; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Duval S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-206; Freitas DB, 2008, LETT APPL MICROBIOL, V47, P241, DOI 10.1111/j.1472-765X.2008.02415.x; Golterman H. L., 1978, METHODS CHEM ANAL FR; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gootz TD, 2009, ANTIMICROB AGENTS CH, V53, P1998, DOI 10.1128/AAC.01355-08; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamamura N, 2009, ENVIRON MICROBIOL, V11, P421, DOI 10.1111/j.1462-2920.2008.01781.x; Heinrich-Salmeron A, 2011, APPL ENVIRON MICROB, V77, P4685, DOI 10.1128/AEM.02884-10; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Instituto Mineiro de Gestao das Aguas (IGAM), 2004, CAM LMM PLAN DIR REC; Jackson CR, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-18; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaur S, 2009, CURR MICROBIOL, V59, P288, DOI 10.1007/s00284-009-9432-9; 장진수, 2010, Environmental Engineering Research, V15, P15; Kruger MC, 2013, APPL MICROBIOL BIOT, V97, P3827, DOI 10.1007/s00253-013-4838-5; Kulp TR, 2008, SCIENCE, V321, P967, DOI 10.1126/science.1160799; Lane D.J., 1991, 16S 23S RRNA SEQUENC; Lett MC, 2012, J BACTERIOL, V194, P207, DOI 10.1128/JB.06391-11; Liao VHC, 2011, J CONTAM HYDROL, V123, P20, DOI 10.1016/j.jconhyd.2010.12.003; Lievremont D, 2009, BIOCHIMIE, V91, P1229, DOI 10.1016/j.biochi.2009.06.016; Mackereth F.J.H., 1978, WATER ANAL SOME REVI; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Marchand C, 2011, J SOIL SEDIMENT, V11, P529, DOI 10.1007/s11368-010-0330-3; McClintock TR, 2012, SCI TOTAL ENVIRON, V429, P76, DOI 10.1016/j.scitotenv.2011.08.051; Muller D, 2003, J BACTERIOL, V185, P135, DOI 10.1128/JB.185.1.135-141.2003; NEUBAUER O, 1947, BRIT J CANCER, V1, P192, DOI 10.1038/bjc.1947.22; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Oliveira A, 2009, WATER AIR SOIL POLL, V200, P237, DOI 10.1007/s11270-008-9907-5; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Oremland RS, 2009, GEOMICROBIOL J, V26, P522, DOI 10.1080/01490450903102525; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Quemeneur M, 2008, APPL ENVIRON MICROB, V74, P4567, DOI 10.1128/AEM.02851-07; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; Reis MP, 2013, EXTREMOPHILES, V17, P301, DOI 10.1007/s00792-013-0517-9; SALAS HJ, 1991, WATER RES, V25, P341, DOI 10.1016/0043-1354(91)90015-I; Salmassi TM, 2002, GEOMICROBIOL J, V19, P53, DOI 10.1080/014904502317246165; SALOMONS W, 1987, HYDROBIOLOGIA, V149, P13, DOI 10.1007/BF00048643; Santini JM, 2004, J BACTERIOL, V186, P1614, DOI 10.1128/JB.186.6.1614-1619.2004; Santini JM, 2002, GEOMICROBIOL J, V19, P67, DOI 10.1080/014904502317246174; Santini JM, 2000, APPL ENVIRON MICROB, V66, P92, DOI 10.1128/AEM.66.1.92-97.2000; Sarkar A, 2013, ECOTOXICOLOGY, V22, P363, DOI 10.1007/s10646-012-1031-z; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Slyemi D, 2012, ENV MICROBIOL REP, V4, P571, DOI 10.1111/j.1758-2229.2011.00300.x; Sun WJ, 2010, APPL ENVIRON MICROB, V76, P6804, DOI 10.1128/AEM.00734-10; Sun YM, 2004, J MICROBIOL METH, V58, P335, DOI 10.1016/j.mimet.2004.04.015; Sunita MSL, 2012, ECOTOXICOLOGY, V21, P202, DOI 10.1007/s10646-011-0779-x; Tsai SL, 2009, CURR OPIN BIOTECH, V20, P659, DOI 10.1016/j.copbio.2009.09.013; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamamura S, 2003, J BIOSCI BIOENG, V96, P454, DOI 10.1016/S1389-1723(03)70131-5; Zargar K, 2012, ENVIRON MICROBIOL, V14, P1635, DOI 10.1111/j.1462-2920.2012.02722.x	68	22	24	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95655	10.1371/journal.pone.0095655	http://dx.doi.org/10.1371/journal.pone.0095655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755825	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300069
J	Li, XQ; Zhao, HY; Lu, Y				Li, Xiaoqing; Zhao, Haiyan; Lu, Yong			The Relation between Thematic Role Computing and Semantic Relatedness Processing during On-Line Sentence Comprehension	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; WORLD KNOWLEDGE; WORKING-MEMORY; LANGUAGE; RETRIEVAL; ANIMACY; ENGLISH; SYSTEM; VERBS; POWER	Sentence comprehension involves timely computing different types of relations between its verbs and noun arguments, such as morphosyntactic, semantic, and thematic relations. Here, we used EEG technique to investigate the potential differences in thematic role computing and lexical-sematic relatedness processing during on-line sentence comprehension , and the intraction between these two types of processes. Mandarin Chinese sentences were used as materials. The basic structure of those sentences is "Noun+Verb+'le'+a two-character word", with the Noun being the initial argument. The verb disambiguates the initial argument as an agent or a patient, Meanwhile, the initial argument and the verb are highly or lowly semantically related. The ERPs at the verbs revealed that: relative to the agent condition, the patient condition evoked a larger N400 only when the argument and verb were lowly semantically related; however, relative to the high-relatedness condition, the low-relatedness condition elicited a larger N400 regardless of the thematic relation; although both thematic role variation and sematic relatedness variation elicited N400 effects, the N400 effect elicited by the former was broadly distributed and reached maximun over the frontal electrodes, and the N400 effect elicited by the latter had a posterior distribution. In addition, the brain oscillations results showed that, although thematic role variation (patient vs. agent) induced power decreases around the beta frequency band (15-30 Hz), semantic relatedness variation (low-relatedness vs. high-relatedness) induced power increases in the theta frequency band (4-7 Hz). These results suggested that, in the sentence context, thematic role computing is modulated by the sematic relatedness between the verb and its argument; semantic relatedness processing, however, is in some degree independent from the thematic relations. Moreover, our results indicated that, during on-line sentence comprehension, thematic role computing and sematic relatedness processing are mediated by distinct neural systems.	[Li, Xiaoqing; Zhao, Haiyan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zhao, Haiyan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Yong] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tianjin Normal University	Li, XQ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	lixq@psych.ac.cn			National Natural Science Foundation of China [31271091]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Grants from the National Natural Science Foundation of China (31271091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Balconi M, 2011, NEUROSCIENCE, V197, P191, DOI 10.1016/j.neuroscience.2011.09.026; Bastiaansen M, 2010, J COGNITIVE NEUROSCI, V22, P1333, DOI 10.1162/jocn.2009.21283; Bastiaansen MCM, 2008, BRAIN LANG, V106, P15, DOI 10.1016/j.bandl.2007.10.006; Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bornkessel I, 2004, J MEM LANG, V51, P495, DOI 10.1016/j.jml.2004.06.011; Chen Q, 2010, PLOS ONE, V7; Crutch SJ, 2010, COGN NEUROPSYCHOL, V27, P46, DOI 10.1080/02643294.2010.491359; DEMIRAL SB, 2008, EVIDENCE TURKISH COG, V106, P484; Erdocia K, 2009, BRAIN LANG, V109, P1, DOI 10.1016/j.bandl.2008.12.003; Estes Z, 2011, PSYCHOL LEARN MOTIV, V54, P249, DOI 10.1016/B978-0-12-385527-5.00008-5; Ferretti TR, 2001, J MEM LANG, V44, P516, DOI 10.1006/jmla.2000.2728; Fisher AE, 2008, INT J PSYCHOPHYSIOL, V68, P111, DOI 10.1016/j.ijpsycho.2007.12.005; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gennari S, 2003, COGNITION, V89, pB27, DOI 10.1016/S0010-0277(03)00069-6; GOUPILLAUD P, 1984, GEOEXPLORATION, V23, P85, DOI 10.1016/0016-7142(84)90025-5; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hampton JA, 2006, ENCY COGNITIVE SCI; JACKENDOFF R, 1985, NAT LANG LINGUIST TH, V3, P271, DOI 10.1007/BF00154264; JACKENDOFF R, 1987, LINGUIST INQ, V18, P369; Jia LP, 2007, THESIS S CENTRAL U C; Kalenine S, 2009, NEUROIMAGE, V44, P1152, DOI 10.1016/j.neuroimage.2008.09.043; Kuperberg GR, 2008, NEUROIMAGE, V40, P367, DOI 10.1016/j.neuroimage.2007.10.009; Kuperberg GR, 2007, BRAIN LANG, V100, P223, DOI 10.1016/j.bandl.2005.12.006; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Li Charles N, 1976, SUBJECT TOPIC; Liu SX, 1994, ACAD J NANKAI U, P61; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; MACWHINNEY B, 1984, J VERB LEARN VERB BE, V23, P127, DOI 10.1016/S0022-5371(84)90093-8; Maguire MJ, 2010, BRAIN LANG, V114, P16, DOI 10.1016/j.bandl.2010.03.005; Markman AB, 1997, J EXP PSYCHOL LEARN, V23, P54, DOI 10.1037/0278-7393.23.1.54; McRae K, 1997, LANG COGNITIVE PROC, V12, P137, DOI 10.1080/016909697386835; Mirman D, 2012, J EXP PSYCHOL GEN, V141, P601, DOI 10.1037/a0026451; Nakano H, 2010, J COGNITIVE NEUROSCI, V22, P2886, DOI 10.1162/jocn.2009.21400; Palolahti M, 2005, NEUROSCI LETT, V384, P222, DOI 10.1016/j.neulet.2005.04.076; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Qiu X, 2009, THESIS HUNAN U CHANG; Schwartz MF, 2011, P NATL ACAD SCI USA, V108, P8520, DOI 10.1073/pnas.1014935108; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; van Elk M, 2010, NEUROIMAGE, V50, P665, DOI 10.1016/j.neuroimage.2009.12.123; Wang LM, 2009, LANG COGNITIVE PROC, V24, P1180, DOI 10.1080/01690960802159937; Weiss S., 2001, BRAIN TOPOGRAPHY, V13, P317; Weiss S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00201; Wolff S, 2008, BRAIN LANG, V107, P133, DOI 10.1016/j.bandl.2008.06.003; Yang CL, 2010, BRAIN LANG, V112, P85, DOI 10.1016/j.bandl.2009.10.005	50	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95834	10.1371/journal.pone.0095834	http://dx.doi.org/10.1371/journal.pone.0095834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2IS	24755643	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300103
J	Siletsky, SA; Zaspa, AA; Poole, RK; Borisov, VB				Siletsky, Sergey A.; Zaspa, Andrey A.; Poole, Robert K.; Borisov, Vitaliy B.			Microsecond Time-Resolved Absorption Spectroscopy Used to Study CO Compounds of Cytochrome bd from Escherichia coli	PLOS ONE			English	Article							HEME B(558) COMPONENT; QUINOL OXIDASE BD; CARBON-MONOXIDE; NITRIC-OXIDE; DI-HEME; TERMINAL OXIDASES; CATALYTIC INTERMEDIATE; AZOTOBACTER-VINELANDII; CHARGE TRANSLOCATION; UBIQUINOL OXIDASE	Cytochrome bd is a tri-heme (b(558), b(595), d) respiratory oxygen reductase that is found in many bacteria including pathogenic species. It couples the electron transfer from quinol to O-2 with generation of an electrochemical proton gradient. We examined photolysis and subsequent recombination of CO with isolated cytochrome bd from Escherichia coli in oneelectron reduced (MV) and fully reduced (R) states by microsecond time-resolved absorption spectroscopy at 532-nm excitation. Both Soret and visible band regions were examined. CO photodissociation from MV enzyme possibly causes fast (t<1.5 mu s) electron transfer from heme d to heme b595 in a small fraction of the protein, not reported earlier. Then the electron migrates to heme b558 (tau similar to 16 mu s). It returns from the b-hemes to heme d with tau similar to 180 ms. Unlike cytochrome bd in the R state, in MV enzyme the apparent contribution of absorbance changes associated with CO dissociation from heme d is small, if any. Photodissociation of CO from heme d in MV enzyme is suggested to be accompanied by the binding of an internal ligand (L) at the opposite side of the heme. CO recombines with heme d (tau similar to 16 mu s) yielding a transient hexacoordinate state (CO-Fe2+-L). Then the ligand slowly (tau similar to 30 mu s) dissociates from heme d. Recombination of CO with a reduced heme b in a fraction of the MV sample may also contribute to the 30-ms phase. In R enzyme, CO recombines to heme d (tau similar to 20 mu s), some heme b558 (tau similar to 0.2-3 mu s), and finally migrates from heme d to heme b595 (t, 24 ms) in,5% of the enzyme population. Data are consistent with the recent nanosecond study of Rappaport et al. conducted on the membranes at 640-nm excitation but limited to the Soret band. The additional phases were revealed due to differences in excitation and other experimental conditions.	[Siletsky, Sergey A.; Zaspa, Andrey A.; Borisov, Vitaliy B.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	Lomonosov Moscow State University; University of Sheffield	Siletsky, SA (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	siletsky@belozersky.msu.su; r.poole@sheffield.ac.uk; bor@genebee.msu.su	Borisov, Vitaliy B/C-9504-2012; Siletsky, Sergey A./D-8076-2012; Zaspa, Andrey/AAO-3821-2020	Borisov, Vitaliy B/0000-0002-3400-9068; 	UK Biotechnology and Biological Sciences Research Council [BB/I004122]; Russian Foundation for Basic Research [12-04-01000-a, 14-04-00153-a]	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported in part by Research Grant BB/I004122 from the UK Biotechnology and Biological Sciences Research Council ( to RKP), and the Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng), grants 12-04-01000-a (to SAS) and 14-04-00153-a (to VBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arutyunyan AM, 2012, BBA-BIOENERGETICS, V1817, P2087, DOI 10.1016/j.bbabio.2012.06.009; Arutyunyan AM, 2008, BIOCHEMISTRY; Azarkina N, 1999, J BIOL CHEM, V274, P32810, DOI 10.1074/jbc.274.46.32810; Azarkina N, 1997, FEBS LETT, V416, P171, DOI 10.1016/S0014-5793(97)01196-4; Belevich I, 2005, P NATL ACAD SCI USA, V102, P3657, DOI 10.1073/pnas.0405683102; Belevich I, 2005, FEBS LETT, V579, P4567, DOI 10.1016/j.febslet.2005.07.011; Belevich I, 2007, BIOCHEMISTRY-US, V46, P11177, DOI 10.1021/bi700862u; Belevich I, 2007, J BIOL CHEM, V282, P28514, DOI 10.1074/jbc.M705562200; Bloch DA, 2009, BBA-BIOENERGETICS, V1787, P1246, DOI 10.1016/j.bbabio.2009.05.003; Borisov V, 1999, BIOCHEMISTRY-US, V38, P740, DOI 10.1021/bi981908t; Borisov V, 1995, BIOCHEM MOL BIOL INT, V37, P975; Borisov VB, 2008, BIOCHEMISTRY-MOSCOW+, V73, P14, DOI 10.1134/S0006297908010021; Borisov VB, 2010, BIOCHEMISTRY-MOSCOW+, V75, P428, DOI 10.1134/S000629791004005X; Borisov VB, 2002, BIOCHEMISTRY-US, V41, P1654, DOI 10.1021/bi0158019; BORISOV VB, 1994, BIOCHEMISTRY-MOSCOW+, V59, P437; Borisov VB, 2004, FEBS LETT, V576, P201, DOI 10.1016/j.febslet.2004.09.013; Borisov VB, 2001, J BIOL CHEM, V276, P22095, DOI 10.1074/jbc.M011542200; BORISOV VB, 1995, BIOCHEMISTRY-MOSCOW+, V60, P231; Borisov VB, 1996, BIOCHEMISTRY-MOSCOW+, V61, P565; Borisov VB, 2008, BIOCHEMISTRY-US, V47, P7907, DOI 10.1021/bi800435a; Borisov VB, 2007, BIOCHEM BIOPH RES CO, V355, P97, DOI 10.1016/j.bbrc.2007.01.118; Borisov VB, 2006, FEBS LETT, V580, P4823, DOI 10.1016/j.febslet.2006.07.072; Borisov VB, 2013, FEBS LETT, V587, P2214, DOI 10.1016/j.febslet.2013.05.047; Borisov VB, 2013, J INORG BIOCHEM, V118, P65, DOI 10.1016/j.jinorgbio.2012.09.016; Borisov VB, 2011, P NATL ACAD SCI USA, V108, P17320, DOI 10.1073/pnas.1108217108; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P503, DOI 10.1016/j.bbabio.2011.02.007; Borisov VB, 2009, J INORG BIOCHEM, V103, P1185, DOI 10.1016/j.jinorgbio.2009.06.002; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; Forte E, 2013, MBIO, V4, DOI 10.1128/mBio.01006-13; Forte Elena, 2007, Ital J Biochem, V56, P265; Giuffre A, 2014, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbabio.2014.1001.1016, DOI 10.1016/J.BBABI0.2014.1001.1016]; Giuffre A, 2012, FEBS LETT, V586, P622, DOI 10.1016/j.febslet.2011.07.035; HILL BC, 1994, BIOCHEMISTRY-US, V33, P15110, DOI 10.1021/bi00254a021; HILL JJ, 1993, P NATL ACAD SCI USA, V90, P5863, DOI 10.1073/pnas.90.12.5863; Jasaitis A, 2000, BIOCHEMISTRY-US, V39, P13800, DOI 10.1021/bi001165n; Jasaitis A, 2007, P NATL ACAD SCI USA, V104, P20811, DOI 10.1073/pnas.0709876105; Jesse HE, 2013, BBA-PROTEINS PROTEOM, V1834, P1693, DOI 10.1016/j.bbapap.2013.04.019; JUNEMANN S, 1995, J BIOL CHEM, V270, P16213, DOI 10.1074/jbc.270.27.16213; JUNEMANN S, 1995, BIOCHEM SOC T, V23, pS157; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; KAYSSER TM, 1995, BIOCHEMISTRY-US, V34, P13491, DOI 10.1021/bi00041a029; Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379; LORENCE RM, 1986, BIOCHEMISTRY-US, V25, P2314, DOI 10.1021/bi00357a003; Mason MG, 2009, NAT CHEM BIOL, V5, P94, DOI 10.1038/nchembio.135; MILLER MJ, 1986, METHOD ENZYMOL, V126, P87; Mogi T, 2006, BIOCHEMISTRY-US, V45, P15785, DOI 10.1021/bi0615792; MUNTYAN MS, 1993, FEBS LETT, V327, P347, DOI 10.1016/0014-5793(93)81018-U; Paulus A, 2012, J BIOL CHEM, V287, P8830, DOI 10.1074/jbc.M111.333542; Pilet E, 2004, P NATL ACAD SCI USA, V101, P16198, DOI 10.1073/pnas.0405032101; POOLE RK, 1987, FEBS LETT, V217, P49, DOI 10.1016/0014-5793(87)81240-1; POOLE RK, 1983, J GEN MICROBIOL, V129, P1335; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Rappaport F, 2010, BBA-BIOENERGETICS, V1797, P1657, DOI 10.1016/j.bbabio.2010.05.010; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; Siletsky SA, 2004, J BIOL CHEM, V279, P52558, DOI 10.1074/jbc.M407549200; Siletsky SA, 2013, FRONT BIOSCI-LANDMRK, V18, P36, DOI 10.2741/4086; Siletsky SA, 2012, BBA-BIOENERGETICS, V1817, P476, DOI 10.1016/j.bbabio.2011.08.003; Siletsky SA, 2010, BIOCHEMISTRY-US, V49, P3060, DOI 10.1021/bi901719e; SPINNER F, 1995, BIOCHEM J, V308, P641, DOI 10.1042/bj3080641; Sun J, 1996, BIOCHEMISTRY-US, V35, P2403, DOI 10.1021/bi9518252; Vos MH, 2000, P NATL ACAD SCI USA, V97, P1554, DOI 10.1073/pnas.030528197; WOOD PM, 1984, BIOCHIM BIOPHYS ACTA, V768, P293, DOI 10.1016/0304-4173(84)90020-X	65	16	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95617	10.1371/journal.pone.0095617	http://dx.doi.org/10.1371/journal.pone.0095617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755641	Green Accepted, Green Published, gold			2022-12-25	WOS:000335240300063
J	Zhou, YG; Lu, JM; Liu, XM; Zhang, PC; Chen, WY				Zhou, Yangen; Lu, Jiamei; Liu, Xianmin; Zhang, Pengcheng; Chen, Wuying			Effects of Core Self-Evaluations on the Job Burnout of Nurses: The Mediator of Organizational Commitment	PLOS ONE			English	Article							SATISFACTION; PERFORMANCE; INVENTORY; SCALE	Objective: To explore the impact of Core self- evaluations on job burnout of nurses, and especially to test and verify the mediator role of organizational commitment between the two variables. Method: (R)andom cluster sampling was used to pick up participants sample, which consisted of 445 nurses of a hospital in Shanghai. Core self-evaluations questionnaire, job burnout scale and organizational commitment scale were administrated to the study participants. Results: There are significant relationships between Core self-evaluations and dimensions of job burnout and organizational commitment. There is a significant mediation effect of organizational commitment between Core self-evaluations and job burnout. Conclusions: To enhance nurses' Core self-evaluations can reduce the incidence of job burnout.	[Zhou, Yangen; Lu, Jiamei; Zhang, Pengcheng; Chen, Wuying] Shanghai Normal Univ, Educ Sci Coll, Shanghai, Peoples R China; [Zhou, Yangen; Liu, Xianmin] Nanjing Normal Univ, Taizhou Coll, Dept Educ, Taizhou, Peoples R China	Shanghai Normal University; Nanjing Normal University; Taizhou University	Lu, JM (corresponding author), Shanghai Normal Univ, Educ Sci Coll, Shanghai, Peoples R China.	1933056616@qq.com						Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Allen NJ, 1996, J VOCAT BEHAV, V49, P252, DOI 10.1006/jvbe.1996.0043; Bakker AB, 2002, ANXIETY STRESS COPIN, V15, P245, DOI 10.1080/1061580021000020716; Chun JS, 2013, J MANAGE, V39, P853, DOI 10.1177/0149206311419662; Federici RA, 2012, SOC PSYCHOL EDUC, V15, P295, DOI 10.1007/s11218-012-9183-5; Fu W, 2013, J BUS ETHICS, P1; Judge TA, 1999, PERS PSYCHOL, V52, P621, DOI 10.1111/j.1744-6570.1999.tb00174.x; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Judge TA, 2012, ORGAN BEHAV HUM DEC, V117, P208, DOI 10.1016/j.obhdp.2011.08.005; Judge TA, 2010, J VOCAT BEHAV, V77, P157, DOI 10.1016/j.jvb.2010.04.002; LEITER MP, 1988, J ORGAN BEHAV, V9, P297, DOI 10.1002/job.4030090402; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 2006, STRESS AND QUALITY OF WORKING LIFE, P37; Peng J, 2014, J HEALTH PSYCHOL; Peng JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084193, 10.1371/journal.pone.0082465]; Riketta M, 2002, J ORGAN BEHAV, V23, P257, DOI 10.1002/job.141; Skaalvik EM, 2010, TEACH TEACH EDUC, V26, P1059, DOI 10.1016/j.tate.2009.11.001; Tsaousis I, 2007, PERS INDIV DIFFER, V42, P1441, DOI 10.1016/j.paid.2006.10.025; Xiao W, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-8; Zhang J., 2013, REGIONAL GEOCHEMICAL, P1, DOI DOI 10.1680/WAMA.12.00071	21	9	10	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95975	10.1371/journal.pone.0095975	http://dx.doi.org/10.1371/journal.pone.0095975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2IS	24755670	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300125
J	Agarwal, SR; Yang, PC; Rice, M; Singer, CA; Nikolaev, VO; Lohse, MJ; Clancy, CE; Harvey, RD				Agarwal, Shailesh R.; Yang, Pei-Chi; Rice, Monica; Singer, Cherie A.; Nikolaev, Viacheslav O.; Lohse, Martin J.; Clancy, Colleen E.; Harvey, Robert D.			Role of Membrane Microdomains in Compartmentation of cAMP Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; ADENYLYL-CYCLASE ISOFORMS; ADULT CARDIAC MYOCYTES; PLASMA-MEMBRANE; LIPID RAFTS; CHOLESTEROL DEPLETION; BETA(2)-ADRENERGIC RECEPTOR; LIVING CELLS; CYCLIC-AMP; DOMAINS	Spatially restricting cAMP production to discrete subcellular locations permits selective regulation of specific functional responses. But exactly where and how cAMP signaling is confined is not fully understood. Different receptors and adenylyl cyclase isoforms responsible for cAMP production are not uniformly distributed between lipid raft and non-lipid raft domains of the plasma membrane. We sought to determine the role that these membrane domains play in organizing cAMP responses in HEK293 cells. The freely diffusible FRET-based biosensor Epac2-camps was used to measure global cAMP responses, while versions of the probe targeted to lipid raft (Epac2-MyrPalm) and non-raft (Epac2-CAAX) domains were used to monitor local cAMP production near the plasma membrane. Disruption of lipid rafts by cholesterol depletion selectively altered cAMP responses produced by raft-associated receptors. The results indicate that receptors associated with lipid raft as well as non-lipid raft domains can contribute to global cAMP responses. In addition, basal cAMP activity was found to be significantly higher in non-raft domains. This was supported by the fact that pharmacologic inhibition of adenylyl cyclase activity reduced basal cAMP activity detected by Epac2-CAAX but not Epac2-MyrPalm or Epac2-camps. Responses detected by Epac2-CAAX were also more sensitive to direct stimulation of adenylyl cyclase activity, but less sensitive to inhibition of phosphodiesterase activity. Quantitative modeling was used to demonstrate that differences in adenylyl cyclase and phosphodiesterase activities are necessary but not sufficient to explain compartmentation of cAMP associated with different microdomains of the plasma membrane.	[Agarwal, Shailesh R.; Rice, Monica; Singer, Cherie A.; Harvey, Robert D.] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA; [Yang, Pei-Chi; Clancy, Colleen E.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Nikolaev, Viacheslav O.] Univ Gottingen, European Heart Res Inst Gottingen, D-37073 Gottingen, Germany; [Lohse, Martin J.] Univ Wurzburg, Dept Pharmacol, D-97070 Wurzburg, Germany	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Davis; University of Gottingen; University of Wurzburg	Harvey, RD (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA.	rdharvey@medicine.nevada.edu	Lohse, Martin J/A-7160-2012; Harvey, Robert D/L-8496-2016; Nikolaev, Vyacheslav/AAT-7746-2020	Lohse, Martin J/0000-0002-0599-3510; Harvey, Robert D/0000-0002-8499-8765; 	National Institutes of Health [R01 GM101928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, grant R01 GM101928 (RDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Berrera M., 2008, V186, P285, DOI 10.1007/978-3-540-72843-6_12; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Bogard AS, 2011, J PHARMACOL EXP THER, V337, P209, DOI 10.1124/jpet.110.177923; Bolger GB, 1997, BIOCHEM J, V328, P539; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; BRUNTON LL, 1981, ADV CYCL NUCL RES<D>, V14, P391; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Day CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034923; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; HAYES JS, 1982, J CYCLIC NUCL PROT, V8, P1; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Iancu RV, 2008, AM J PHYSIOL-CELL PH, V295, pC414, DOI 10.1152/ajpcell.00038.2008; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Karpen Jeffrey W., 2005, V307, P15; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lebreton S, 2008, J BIOL CHEM, V283, P29545, DOI 10.1074/jbc.M803819200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu XQ, 2008, N-S ARCH PHARMACOL, V377, P359, DOI 10.1007/s00210-007-0196-0; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Matthiesen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024392; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mika D, 2012, J MOL CELL CARDIOL, V52, P323, DOI 10.1016/j.yjmcc.2011.08.016; Nikolaev VO, 2006, PHYSIOLOGY, V21, P86, DOI 10.1152/physiol.00057.2005; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Oliveira RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011725; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; PIERONI JP, 1995, J BIOL CHEM, V270, P21368, DOI 10.1074/jbc.270.36.21368; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pinto C, 2008, J PHARMACOL EXP THER, V325, P27, DOI 10.1124/jpet.107.131904; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stoclet J.C., 1995, EXPERT OPIN INV DRUG, V4, P1081; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Thangavel M, 2009, CELL SIGNAL, V21, P301, DOI 10.1016/j.cellsig.2008.10.017; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Voit E. O., 2000, COMPUTATIONAL ANAL B; Vrljic M, 2005, BIOPHYS J, V88, P334, DOI 10.1529/biophsj.104.045989; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Warrier S, 2005, AM J PHYSIOL-CELL PH, V289, pC455, DOI 10.1152/ajpcell.00058.2005; Warrier S, 2007, J PHYSIOL-LONDON, V580, P765, DOI 10.1113/jphysiol.2006.124891; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	66	59	59	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95835	10.1371/journal.pone.0095835	http://dx.doi.org/10.1371/journal.pone.0095835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752595	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400139
J	Chen, Y; Ray, WK; Helm, RF; Melville, SB; Popham, DL				Chen, Yan; Ray, W. Keith; Helm, Richard F.; Melville, Stephen B.; Popham, David L.			Levels of Germination Proteins in Bacillus subtilis Dormant, Superdormant, and Germinating Spores	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS SPORES; DIPICOLINIC ACID UPTAKE; INNER MEMBRANE; SPOVA PROTEINS; CONTRAST MICROSCOPY; NUTRIENT RECEPTORS; LOCALIZATION; RESISTANCE; OPERON; GERD	Bacterial endospores exhibit extreme resistance to most conditions that rapidly kill other life forms, remaining viable in this dormant state for centuries or longer. While the majority of Bacillus subtilis dormant spores germinate rapidly in response to nutrient germinants, a small subpopulation termed superdormant spores are resistant to germination, potentially evading antibiotic and/or decontamination strategies. In an effort to better understand the underlying mechanisms of superdormancy, membrane-associated proteins were isolated from populations of B. subtilis dormant, superdormant, and germinated spores, and the relative abundance of 11 germination-related proteins was determined using multiple-reaction-monitoring liquid chromatography-mass spectrometryassays. GerAC, GerKC, and GerD were significantly less abundant in the membrane fractions obtained from superdormant spores than those derived from dormant spores. The amounts of YpeB, GerD, PrkC, GerAC, and GerKC recovered in membrane fractions decreased significantly during germination. Lipoproteins, as a protein class, decreased during spore germination, while YpeB appeared to be specifically degraded. Some protein abundance differences between membrane fractions of dormant and superdormant spores resemble protein changes that take place during germination, suggesting that the superdormant spore isolation procedure may have resulted in early, non-committal germination-associated changes. In addition to low levels of germinant receptor proteins, a deficiency in the GerD lipoprotein may contribute to heterogeneity of spore germination rates. Understanding the reasons for superdormancy may allow for better spore decontamination procedures.	[Chen, Yan; Melville, Stephen B.; Popham, David L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Ray, W. Keith; Helm, Richard F.] Virginia Tech, Dept Biochem, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Popham, DL (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	dpopham@vt.edu	Chen, Yan/M-9814-2018; Helm, Richard/N-6249-2018; Melville, Steve/D-4763-2016; Popham, David L/F-8066-2015	Chen, Yan/0000-0002-1125-313X; Helm, Richard/0000-0001-5317-0925; Melville, Steve/0000-0002-0116-4280; Popham, David L/0000-0002-2614-143X	National Institute of Allergy and Infectious Disease of the National Institutes of Health [R21AI088298]; Fralin Life Science Institute at Virginia Tech; Agricultural Experiment Station Hatch Program at Virginia Tech (CRIS) [VA-135981]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088298] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1057871] Funding Source: National Science Foundation	National Institute of Allergy and Infectious Disease of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fralin Life Science Institute at Virginia Tech; Agricultural Experiment Station Hatch Program at Virginia Tech (CRIS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Disease of the National Institutes of Health under award number R21AI088298. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The mass spectrometry resources used in this work are maintained in part through funding by the Fralin Life Science Institute at Virginia Tech and the Agricultural Experiment Station Hatch Program at Virginia Tech (CRIS Project Number: VA-135981). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atluri S, 2006, J BACTERIOL, V188, P28, DOI 10.1128/JB.188.1.28-36.2006; Boland FM, 2000, MICROBIOL-UK, V146, P57, DOI 10.1099/00221287-146-1-57; Cabrera-Martinez RM, 2003, J BACTERIOL, V185, P2457, DOI 10.1128/JB.185.8.2457-2464.2003; Chirakkal H, 2002, MICROBIOL-SGM, V148, P2383, DOI 10.1099/00221287-148-8-2383; CORFE BM, 1994, MICROBIOL-UK, V140, P471, DOI 10.1099/00221287-140-3-471; Cowan AE, 2004, P NATL ACAD SCI USA, V101, P7733, DOI 10.1073/pnas.0306859101; Forouhar F, 2010, NORTHEAST STRUCTURAL; FORT P, 1985, J GEN MICROBIOL, V131, P1091; Fusaro VA, 2009, NAT BIOTECHNOL, V27, P190, DOI 10.1038/nbt.1524; Ghosh S, 2012, J BACTERIOL, V194, P2221, DOI 10.1128/JB.00151-12; Ghosh S, 2009, J BACTERIOL, V191, P1787, DOI 10.1128/JB.01668-08; GonzalezCastro MJ, 1997, J CHROMATOGR SCI, V35, P181, DOI 10.1093/chromsci/35.4.181; Griffiths KK, 2011, MOL MICROBIOL, V81, P1061, DOI 10.1111/j.1365-2958.2011.07753.x; Hahne H, 2008, PROTEOMICS, V8, P4123, DOI 10.1002/pmic.200800258; Igarashi T, 2004, J BACTERIOL, V186, P2984, DOI 10.1128/JB.186.10.2984-2991.2004; Ishikawa S, 1998, J BACTERIOL, V180, P1375, DOI 10.1128/JB.180.6.1375-1380.1998; Kong LB, 2010, ANAL CHEM, V82, P3840, DOI 10.1021/ac1003322; Korza G, 2013, J BACTERIOL, V195, P1484, DOI 10.1128/JB.02262-12; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; LEIGHTON TJ, 1971, J BIOL CHEM, V246, P3189; Li YF, 2012, J BACTERIOL, V194, P1875, DOI 10.1128/JB.00062-12; Mallozzi M, 2010, FUTURE MICROBIOL, V5, P1109, DOI 10.2217/FMB.10.60; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; Moir A, 1994, J APPL BACTERIOL, V77, p9S; Nicholson WL, 1990, SPORULATION GERMINAT, P391; Paidhungat M, 2001, J BACTERIOL, V183, P4886, DOI 10.1128/JB.183.16.4886-4893.2001; Paidhungat M, 2001, J BACTERIOL, V183, P3982, DOI 10.1128/JB.183.13.3982-3990.2001; Paredes-Sabja D, 2008, J BACTERIOL, V190, P4648, DOI 10.1128/JB.00325-08; Pelczar PL, 2008, J BACTERIOL, V190, P5635, DOI 10.1128/JB.00670-08; Pelczar PL, 2007, J BACTERIOL, V189, P1090, DOI 10.1128/JB.01606-06; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Popham DL, 1996, P NATL ACAD SCI USA, V93, P15405, DOI 10.1073/pnas.93.26.15405; Ramirez-Peralta A, 2013, J BACTERIOL, V195, P3009, DOI 10.1128/JB.00257-13; Riesenman PJ, 2000, APPL ENVIRON MICROB, V66, P620, DOI 10.1128/AEM.66.2.620-626.2000; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Stewart KAV, 2013, J BACTERIOL, V195, P3575, DOI 10.1128/JB.00377-13; Stewart KAV, 2012, J BACTERIOL, V194, P3156, DOI 10.1128/JB.00405-12; Tovar-Rojo F, 2002, J BACTERIOL, V184, P584, DOI 10.1128/JB.184.2.584-587.2002; Vepachedu VR, 2007, FEMS MICROBIOL LETT, V274, P42, DOI 10.1111/j.1574-6968.2007.00807.x; Vepachedu VR, 2007, J BACTERIOL, V189, P1565, DOI 10.1128/JB.01613-06; Vepachedu VR, 2005, J BACTERIOL, V187, P5677, DOI 10.1128/JB.187.16.5677-5682.2005; Wang G, 2011, J APPL MICROBIOL, V111, P1212, DOI 10.1111/j.1365-2672.2011.05135.x; Wang GW, 2011, J BACTERIOL, V193, P2301, DOI 10.1128/JB.00122-11; Zhang P, 2012, J APPL MICROBIOL, V112, P526, DOI 10.1111/j.1365-2672.2011.05230.x; ZUBERI AR, 1985, J BACTERIOL, V162, P756, DOI 10.1128/JB.162.2.756-762.1985	46	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95781	10.1371/journal.pone.0095781	http://dx.doi.org/10.1371/journal.pone.0095781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752279	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400127
J	Houssaye, A; Scheyer, TM; Kolb, C; Fischer, V; Sander, M				Houssaye, Alexandra; Scheyer, Torsten M.; Kolb, Christian; Fischer, Valentin; Sander, Martin			A New Look at Ichthyosaur Long Bone Microanatomy and Histology: Implications for Their Adaptation to an Aquatic Life	PLOS ONE			English	Article							PALEOHISTOLOGY; OMPHALOSAURUS; PHYLOGENY; AMNIOTES; DENSITY; STYLE	Background: Ichthyosaurs are Mesozoic reptiles considered as active swimmers highly adapted to a fully open-marine life. They display a wide range of morphologies illustrating diverse ecological grades. Data concerning their bone microanatomical and histological features are rather limited and suggest that ichthyosaurs display a spongious, "osteoporotic-like'' bone inner structure, like extant cetaceans. However, some taxa exhibit peculiar features, suggesting that the analysis of the microanatomical and histological characteristics of various ichthyosaur long bones should match the anatomical diversity and provide information about their diverse locomotor abilities and physiology. Methodology/Principal Findings: The material analyzed for this study essentially consists of mid-diaphyseal transverse sections from stylopod bones of various ichthyosaurs and of a few microtomographic (both conventional and synchrotron) data. The present contribution discusses the histological and microanatomical variation observed within ichthyosaurs and the peculiarities of some taxa (Mixosaurus, Pessopteryx). Four microanatomical types are described. If Mixosaurus sections differ from those of the other taxa analyzed, the other microanatomical types, characterized by the relative proportion of compact and loose spongiosa of periosteal and endochondral origin respectively, seem to rather especially illustrate variation along the diaphysis in taxa with similar microanatomical features. Our analysis also reveals that primary bone in all the ichthyosaur taxa sampled (to the possible exception of Mixosaurus) is spongy in origin, that cyclical growth is a common pattern among ichthyosaurs, and confirms the previous assumptions of high growth rates in ichthyosaurs. Conclusions/Significance: The occurrence of two types of remodelling patterns along the diaphysis, characterized by bone mass decrease and increase respectively is described for the first time. It raises questions about the definition of the osseous microanatomical specializations bone mass increase and osteoporosis, notably based on the processes involved, and reveals the difficulty in determining the true occurrence of these osseous specializations in ichthyosaurs.	[Houssaye, Alexandra; Sander, Martin] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Scheyer, Torsten M.; Kolb, Christian] Palaontol Inst, Zurich, Switzerland; [Scheyer, Torsten M.; Kolb, Christian] Museum Univ Zurich, Zurich, Switzerland; [Fischer, Valentin] Univ Liege, Dept Geol, Liege, Belgium	University of Bonn; University of Liege	Houssaye, A (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	houssaye@mnhn.fr	Houssaye, Alexandra/J-5631-2015	Fischer, Valentin/0000-0002-8808-6747; Scheyer, Torsten M./0000-0002-6301-8983	Alexander von Humboldt Foundation; Swiss National Science Foundation [31003A146440]; DAAD [D/09/46969]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	AH acknowledges financial support from the Alexander von Humboldt Foundation, TMS from the Swiss National Science Foundation (grant no. 31003A146440), and CK from the DAAD (D/09/46969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Buchholtz EA, 2001, J VERTEBR PALEONTOL, V21, P61, DOI 10.1671/0272-4634(2001)021[0061:SSIJI]2.0.CO;2; Buffrenil Vd, 1987, ANN PALEONTOL, V73, P195; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003; de Ricqles Armand, 2001, P289; DEBUFFRENIL V, 1988, J MORPHOL, V198, P149, DOI 10.1002/jmor.1051980203; DEBUFFRENIL V, 1990, PALEOBIOLOGY, V16, P435, DOI 10.1017/S0094837300010174; Dumont M, 2013, J MORPHOL, V274, P570, DOI 10.1002/jmor.20122; Fernandez MS, 2014, GEOL MAG, V151, P49, DOI 10.1017/S0016756813000058; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fraas E, 1891, ICHTHYOSAURIER SUDDE, P1; Francillon-Vieillot H., 1990, P471; GROSS WALTER, 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P731, DOI 10.1007/BF02118752; Hayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059146; Houssaye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076741; Houssaye A, 2013, BIOL J LINN SOC, V108, P3, DOI 10.1111/j.1095-8312.2012.02002.x; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Huiskes R, 2000, J ANAT, V197, P145, DOI 10.1046/j.1469-7580.2000.19720145.x; Kiprijanoff AV, 1881, MEMOIRES ACAD IMPERI, V7, P1; Kolb C, 2011, CR PALEVOL, V10, P403, DOI 10.1016/j.crpv.2010.10.008; Liebe L, 2012, NORW J GEOL, V92, P285; Lingham-Soliar Theagarten, 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V207, P171; Liu XS, 2009, J BIOMECH, V42, P249, DOI 10.1016/j.jbiomech.2008.10.035; Madar SI, 1998, ADV VERT PALEOBIOL, P353; Maisch Michael W., 2010, Palaeodiversity, P151; Maxwell EE, 2014, GEOL MAG, V151, P29, DOI 10.1017/S0016756812001070; Maxwell EE, 2013, GFF, V135, P85, DOI 10.1080/11035897.2012.759145; McGowan C, 2003, HDB PALEOHERPETOLO 8; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1996, NATURE, V382, P347, DOI 10.1038/382347a0; Motani R, 2000, J VERTEBR PALEONTOL, V20, P295, DOI 10.1671/0272-4634(2000)020[0295:IOIAPP]2.0.CO;2; Motani Ryosuke, 2008, Paleontological Society Papers, V14, P147; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Nakajima J, 2014, ACTA PALAEO IN PRESS, DOI [10.4202/app.2012.0045, DOI 10.4202/APP.2012.0045]; Quemeneur S, 2013, BIOL J LINN SOC, V109, P644, DOI 10.1111/bij.12066; Ruimerman R, 2005, ANN BIOMED ENG, V33, P71, DOI 10.1007/s10439-005-8964-9; Ruimerman R, 2005, J BIOMECH, V38, P931, DOI 10.1016/j.jbiomech.2004.03.037; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Sander P. Martin, 1998, Palaeontologische Zeitschrift, V72, P149; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Sander PM, 2003, J VERTEBR PALEONTOL, V23, P799, DOI 10.1671/6; Seitz ALL, 1907, NOVA ACTA ABHANDLUNG, V87, P230; STEIN BR, 1989, J MAMMAL, V70, P467, DOI 10.2307/1381418; Talevi M, 2012, AMEGHINIANA, V49, P38, DOI 10.5710/AMGH.v49i1(403); Talevi M, 2012, NATURWISSENSCHAFTEN, V99, P241, DOI 10.1007/s00114-012-0886-4; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Vd Buffrenil, 1995, ANN SCI NAT ZOOL, V16, P21; WALL WP, 1983, J PALEONTOL, V57, P197; Wiman C, 1910, B GEOLOGICAL I U UPS, V10, P124	50	39	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95637	10.1371/journal.pone.0095637	http://dx.doi.org/10.1371/journal.pone.0095637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752508	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400096
J	Shin, EY; Lee, CS; Yun, CY; Won, SY; Kim, HK; Lee, YH; Kwak, SJ; Kim, EG				Shin, Eun-Young; Lee, Chan-Soo; Yun, Cheong-Yong; Won, So-Yoon; Kim, Hyong-Kyu; Lee, Yong Hee; Kwak, Sahng-June; Kim, Eung-Gook			Non-Muscle Myosin II Regulates Neuronal Actin Dynamics by Interacting with Guanine Nucleotide Exchange Factors	PLOS ONE			English	Article							INDUCED NEURITE OUTGROWTH; NERVE GROWTH-FACTOR; RHO-GTPASES; BETA-PIX; HEAVY-CHAIN; BARRIER DYSFUNCTION; B PHOSPHORYLATION; ADHESION DYNAMICS; KINASE; CONES	Background: Non-muscle myosin II (NM II) regulates a wide range of cellular functions, including neuronal differentiation, which requires precise spatio-temporal activation of Rho GTPases. The molecular mechanism underlying the NM II-mediated activation of Rho GTPases is poorly understood. The present study explored the possibility that NM II regulates neuronal differentiation, particularly morphological changes in growth cones and the distal axon, through guanine nucleotide exchange factors (GEFs) of the Dbl family. Principal Findings: NM II colocalized with GEFs, such as beta PIX, kalirin and intersectin, in growth cones. Inactivation of NM II by blebbistatin (BBS) led to the increased formation of short and thick filopodial actin structures at the periphery of growth cones. In line with these observations, FRET analysis revealed enhanced Cdc42 activity in BBS-treated growth cones. BBS treatment also induced aberrant targeting of various GEFs to the distal axon where GEFs were seldom observed under physiological conditions. As a result, numerous protrusions and branches were generated on the shaft of the distal axon. The disruption of the NM II-GEF interactions by overexpression of the DH domains of bPIX or Tiam1, or by bPIX depletion with specific siRNAs inhibited growth cone formation and induced slender axons concomitant with multiple branches in cultured hippocampal neurons. Finally, stimulation with nerve growth factor induced transient dissociation of the NM II-GEF complex, which was closely correlated with the kinetics of Cdc42 and Rac1 activation. Conclusion: Our results suggest that NM II maintains proper morphology of neuronal growth cones and the distal axon by regulating actin dynamics through the GEF-Rho GTPase signaling pathway.	[Shin, Eun-Young; Yun, Cheong-Yong; Won, So-Yoon; Lee, Yong Hee; Kim, Eung-Gook] Chungbuk Natl Univ, Coll Med, Dept Biochem, Cheongju, Chungbuk, South Korea; [Shin, Eun-Young; Yun, Cheong-Yong; Won, So-Yoon; Kim, Hyong-Kyu; Lee, Yong Hee; Kim, Eung-Gook] Chungbuk Natl Univ, Med Res Inst, Cheongju, Chungbuk, South Korea; [Lee, Chan-Soo] Daejeon Reg Food & Drug Adm, Div Hazardous Subst Anal, Taejon, Chungnam, South Korea; [Kim, Hyong-Kyu] Chungbuk Natl Univ, Coll Med, Dept Microbiol, Cheongju, Chungbuk, South Korea; [Kwak, Sahng-June] Dankook Univ, Coll Med, Dept Biochem, Cheonan, Chungnam, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University; Dankook University	Kim, EG (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Biochem, Cheongju, Chungbuk, South Korea.	egkim@chungbuk.ac.kr			National Research Foundation of Korea [NRF-2010-0021813, NRF-2007-0054943]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF-2010-0021813 and NRF-2007-0054943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; Buxton DB, 2000, J BIOL CHEM, V275, P34772, DOI 10.1074/jbc.M004996200; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Even-Faitelson L, 2005, CELL SIGNAL, V17, P1137, DOI 10.1016/j.cellsig.2004.12.015; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gallo G, 2002, J CELL BIOL, V158, P1219, DOI 10.1083/jcb.200204140; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kornack DR, 2005, CURR OPIN NEUROBIOL, V15, P58, DOI 10.1016/j.conb.2005.01.009; Lee CS, 2010, J CELL BIOL, V190, P663, DOI 10.1083/jcb.201003057; Lee CS, 2004, EXP MOL MED, V36, P582, DOI 10.1038/emm.2004.75; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Moon MS, 2010, MOL CELL NEUROSCI, V44, P118, DOI 10.1016/j.mcn.2010.03.001; Nakamura T, 2005, MOL BRAIN RES, V139, P277, DOI 10.1016/j.molbrainres.2005.05.030; OKABE S, 1991, J NEUROSCI, V11, P1918; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606; Redowicz MJ, 2001, J MUSCLE RES CELL M, V22, P163; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Santiago-Medina M, 2013, J CELL SCI, V126, P1122, DOI 10.1242/jcs.112607; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Straussman R, 2001, J CELL SCI, V114, P3047; Sutton TA, 2001, AM J PHYSIOL-RENAL, V281, pF810, DOI 10.1152/ajprenal.2001.281.5.F810; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Trapp T, 2001, MOL CELL NEUROSCI, V17, P883, DOI 10.1006/mcne.2001.0971; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4	51	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95212	10.1371/journal.pone.0095212	http://dx.doi.org/10.1371/journal.pone.0095212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752242	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400040
J	Yang, X; He, L; Qin, S; Tao, GH; Huang, M; Lv, Y				Yang, Xiao; He, Ling; Qin, Song; Tao, Guo-Hong; Huang, Ming; Lv, Yi			Electrochemical and Thermodynamic Properties of Ln(III) (Ln = Eu, Sm, Dy, Nd) in 1-Butyl-3-Methylimidazolium Bromide Ionic Liquid	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; CARBON-DIOXIDE; BEHAVIOR; SOLVENTS; EUROPIUM; ELECTROLYTES; COEFFICIENTS; VOLTAMMETRY; EXTRACTION; URANIUM	The electrochemical behavior and thermodynamic properties of Ln(III) (Ln = Eu, Sm, Dy, Nd) were studied in 1-butyl-3-methylimidazolium bromide ionic liquid (BmimBr) at a glassy carbon (GC) electrode in the range of 293-338 K. The electrode reaction of Eu(III) was found to be quasi-reversible by the cyclic voltammetry, the reactions of the other three lanthanide ions were regarded as irreversible systems. An increase of the current intensity was obtained with the temperature increase. At 293 K, the cathodic peak potentials of -0.893 V (Eu(III)), -0.596 V (Sm(III)), -0.637 V (Dy(III)) and -0.641 V (Nd(III)) were found, respectively, to be assigned to the reduction of Ln(III) to Ln(II). The diffusion coefficients (Do), the transfer coefficients (a) of Ln(III) (Ln = Eu, Sm, Dy, Nd) and the charge transfer rate constants (k(s)) of Eu(III) were estimated. The apparent standard potential (E-0*) and the thermodynamic properties of the reduction of Eu(III) to Eu(II) were also investigated.	[Yang, Xiao; He, Ling; Qin, Song; Tao, Guo-Hong; Lv, Yi] Sichuan Univ, Coll Chem, Chengdu 610064, Sichuan, Peoples R China; [Huang, Ming] China Acad Engn Phys, Inst Chem Mat, Mianyang, Sichuan, Peoples R China	Sichuan University; Chinese Academy of Engineering Physics	Tao, GH (corresponding author), Sichuan Univ, Coll Chem, Chengdu 610064, Sichuan, Peoples R China.	taogh@scu.edu.cn; lvy@scu.edu.cn	Tao, Guo-Hong/I-6871-2019; Lv, Yi/E-3343-2010	Tao, Guo-Hong/0000-0002-1152-7460; Lv, Yi/0000-0002-7104-2414	National Natural Science Foundation of China [21103116, J1210004]; Specialized Research Fund for Doctoral Program of Higher Education [20100181120042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	G.H.T. gratefully acknowledges the financial support of the National Natural Science Foundation of China (No. 21103116 and J1210004), and the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20100181120042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/NMAT2448, 10.1038/nmat2448]; Backer T, 2011, CRYST GROWTH DES, V11, P2564, DOI 10.1021/cg200326n; Bard A. J., 1980, ELECTROCHEMICAL METH; Barrosse-Antle LE, 2010, CHEM-ASIAN J, V5, P202, DOI 10.1002/asia.200900191; Berthod A, 2008, J CHROMATOGR A, V1184, P6, DOI 10.1016/j.chroma.2007.11.109; Bhatt AI, 2006, INORG CHEM, V45, P1677, DOI 10.1021/ic051750i; Bhatt AI, 2005, INORG CHEM, V44, P4934, DOI 10.1021/ic048199u; Bhatt AI, 2002, J CHEM SOC DALTON, P4532, DOI 10.1039/b208968h; Brown ER, 1986, PHYS METHODS CHEM EL, V2; Carneiro AP, 2012, J CHEM THERMODYN, V55, P184, DOI 10.1016/j.jct.2012.05.020; Del Sesto RE, 2008, CHEM COMMUN, P447, DOI 10.1039/b711189d; Dong LL, 2013, RSC ADV, V3, P4806, DOI 10.1039/c3ra23034a; Dong LL, 2013, EUR J INORG CHEM, P5009; Dupont J, 2010, CHEM SOC REV, V39, P1780, DOI 10.1039/b822551f; Earle MJ, 2007, ANAL CHEM, V79, P758, DOI 10.1021/ac061481t; El Abedin SZ, 2007, ACCOUNTS CHEM RES, V40, P1106, DOI 10.1021/ar700049w; Hallett JP, 2011, CHEM REV, V111, P3508, DOI 10.1021/cr1003248; Hapiot P, 2008, CHEM REV, V108, P2238, DOI 10.1021/cr0680686; Hayashi S, 2006, IEEE T MAGN, V42, P12, DOI 10.1109/TMAG.2005.854875; He L, 2011, INORG CHEM, V50, P679, DOI 10.1021/ic101959r; He L, 2010, CHEM-EUR J, V16, P5736, DOI 10.1002/chem.200902651; Jayakumar M, 2007, ELECTROCHIM ACTA, V52, P7121, DOI 10.1016/j.electacta.2007.05.049; Ji SP, 2013, CHEM-EUR J, V19, P4452, DOI 10.1002/chem.201300092; Jiang T, 2009, CURR ORG CHEM, V13, P1278, DOI 10.2174/138527209789055117; Kazemi S, 2013, J CHEM ENG DATA, V58, P1597, DOI 10.1021/je301303u; Kou Y, 2008, PROG CHEM, V20, P6; Kuznetsov SA, 2006, ELECTROCHIM ACTA, V51, P2463, DOI 10.1016/j.electacta.2005.07.028; Lewandowski A, 2009, J POWER SOURCES, V194, P601, DOI 10.1016/j.jpowsour.2009.06.089; Lunstroot K, 2006, CHEM MATER, V18, P5711, DOI 10.1021/cm061704w; Mallick B, 2008, ANGEW CHEM INT EDIT, V47, P7635, DOI 10.1002/anie.200802390; Matsumiya M, 2008, J ELECTROANAL CHEM, V622, P129, DOI 10.1016/j.jelechem.2008.04.021; Paduszynski K, 2013, J CHEM THERMODYN, V60, P169, DOI 10.1016/j.jct.2013.01.005; Park HJ, 2010, IND ENG CHEM RES, V49, P12567, DOI 10.1021/ie100403b; Quinn BM, 2002, LANGMUIR, V18, P1734, DOI 10.1021/la011458x; Ramenskaya LM, 2008, RUSS J PHYS CHEM A+, V82, P1098, DOI 10.1134/S003602440807008X; Rao CJ, 2009, ELECTROCHIM ACTA, V54, P4718, DOI 10.1016/j.electacta.2009.03.074; Sato T, 2004, J POWER SOURCES, V138, P253, DOI 10.1016/j.jpowsour.2004.06.027; Sun XQ, 2012, CHEM REV, V112, P2100, DOI 10.1021/cr200193x; Tao GH, 2005, AUST J CHEM, V58, P327, DOI 10.1071/CH05025; Tao GH, 2008, J MATER CHEM, V18, P5524, DOI 10.1039/b811506k; Tao GH, 2006, GREEN CHEM, V8, P639, DOI 10.1039/b600813e; Tao GH, 2012, EUR J INORG CHEM, P3070, DOI 10.1002/ejic.201200065; Vasantha T, 2013, J CHEM THERMODYN, V56, P21, DOI 10.1016/j.jct.2012.07.009; Visser AE, 2001, CHEM COMMUN, P135, DOI 10.1039/b008041l; Wang JS, 2009, CHEM-EUR J, V15, P4458, DOI 10.1002/chem.200801415; Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; Wasserscheid P., 2002, IONIC LIQUIDS SYNTHE; Wei D, 2008, ANAL CHIM ACTA, V607, P126, DOI 10.1016/j.aca.2007.12.011; Wilkes JS, 2004, J MOL CATAL A-CHEM, V214, P11, DOI 10.1016/j.molcata.2003.11.029; Yamagata M, 2006, J ELECTROCHEM SOC, V153, pE5, DOI 10.1149/1.2136088; Ye CF, 2001, CHEM COMMUN, P2244, DOI 10.1039/b106935g; Zhao F, 2004, ANAL CHEM, V76, P4960, DOI 10.1021/ac0494026	53	14	14	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95832	10.1371/journal.pone.0095832	http://dx.doi.org/10.1371/journal.pone.0095832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752584	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400138
J	Guissouma, H; Ghaddab-Zroud, R; Seugnet, I; Decherf, S; Demeneix, B; Clerget-Froidevaux, MS				Guissouma, Hajer; Ghaddab-Zroud, Rym; Seugnet, Isabelle; Decherf, Stephanie; Demeneix, Barbara; Clerget-Froidevaux, Marie-Stephanie			TR Alpha 2 Exerts Dominant Negative Effects on Hypothalamic Trh Transcription In Vivo	PLOS ONE			English	Article							THYROID-HORMONE-RECEPTOR; THYROTROPIN-RELEASING-HORMONE; VARIANT ALPHA-2; PARAVENTRICULAR NUCLEUS; MESSENGER-RNA; EXPRESSION; BINDING; ISOFORMS; NEURONS; GENES	Mammalian thyroid hormone receptors (TRs) have multiple isoforms, including the bona fide receptors that bind T3 (TR alpha 1, TR beta 1 and TR beta 2) and a non-hormone-binding variant, TR alpha 2. Intriguingly, TR alpha 2 is strongly expressed in the brain, where its mRNA levels exceed those of functional TRs. Ablation of TR alpha 2 in mice results in over-expression of TR alpha 1, and a complex phenotype with low levels of free T-3 and T-4, without elevated TSH levels, suggesting an alteration in the negative feedback at the hypothalamic-pituitary level. As the hypothesis of a potential TRH response defect has never been tested, we explored the functional role of TR alpha 2 in negative feedback on transcription of hypothalamic thyrotropin, Trh. The in vivo transcriptional effects of TR alpha 2 on hypothalamic Trh were analysed using an in vivo reporter gene approach. Effects on Trhluc expression were examined to that of two, T-3 positively regulated genes used as controls. Applying in vivo gene transfer showed that TR alpha 2 over-expression in the mouse hypothalamus abrogates T-3-dependent repression of Trh and T-3 activation of positively regulated promoters, blocking their physiological regulation. Surprisingly, loss of function studies carried out by introducing a shTR alpha 2 construct in the hypothalamus also blocked physiological T-3 dependent regulation. Thus, modulating hypothalamic TR alpha 2 expression by either gain or loss of function abrogated T-3 dependent regulation of Trh transcription, producing constant transcriptional levels insensitive to feedback. This loss of physiological regulation was reflected at the level of the endogenous Trh gene, were gain or loss of function held mRNA levels constant. These results reveal the as yet undescribed dominant negative role of TR alpha 2 over TR alpha 1 effect on hypothalamic Trh transcription.	[Guissouma, Hajer] Univ Tunis El Manar, Lab Genet Immunol & Pathol Humaines, Fac Sci Tunis, Dept Biol,CAMPUS, Tunis, Tunisia; [Guissouma, Hajer; Ghaddab-Zroud, Rym; Seugnet, Isabelle; Decherf, Stephanie; Demeneix, Barbara; Clerget-Froidevaux, Marie-Stephanie] Museum Natl Hist Nat, CNRS, Dept Regulat Dev & Diversite Mol, UMR 7221, Paris, France	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN)	Clerget-Froidevaux, MS (corresponding author), Museum Natl Hist Nat, CNRS, Dept Regulat Dev & Diversite Mol, UMR 7221, Paris, France.	clerget@mnhn.fr	Clerget-Froidevaux, Marie-Stéphanie/B-7569-2012; Clerget-Froidevaux/P-4252-2019; Decherf, Stephanie/GYU-1222-2022	Clerget-Froidevaux, Marie-Stéphanie/0000-0003-1192-0243; Clerget-Froidevaux/0000-0003-1192-0243; 	European Union CRESCENDO [LSHM-CT-2005-018652]	European Union CRESCENDO	This work was supported by European Union CRESCENDO contract (LSHM-CT-2005-018652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P904, DOI 10.1210/jc.2004-0474; Becker N, 2001, ENDOCRINOLOGY, V142, P5321, DOI 10.1210/en.142.12.5321; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Burgos-Trinidad M, 1999, MOL CELL ENDOCRINOL, V149, P107, DOI 10.1016/S0303-7207(98)00253-6; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clerget-Froidevaux MS, 2004, FEBS LETT, V569, P341, DOI 10.1016/j.febslet.2004.05.076; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; DRATMAN MB, 1987, J COMP NEUROL, V260, P392, DOI 10.1002/cne.902600306; Dupre SM, 2004, ENDOCRINOLOGY, V145, P2337, DOI 10.1210/en.2003-1209; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; Guissouma H, 2002, MOL ENDOCRINOL, V16, P1652, DOI 10.1210/me.16.7.1652; Guissouma H, 1998, FASEB J, V12, P1755, DOI 10.1096/fasebj.12.15.1755; Hadj-Sahraoui N, 2000, NEUROSCI LETT, V280, P79, DOI 10.1016/S0304-3940(00)00768-0; KATZ D, 1993, J BIOL CHEM, V268, P20904; KOLLER KJ, 1987, P NATL ACAD SCI USA, V84, P7329, DOI 10.1073/pnas.84.20.7329; Lazar AL, 1993, ENDOCR REV, V14, P184; LAZAR MA, 1988, MOL ENDOCRINOL, V2, P893, DOI 10.1210/mend-2-10-893; Lebel JM, 1994, CURR OPIN ENDOCRINOL, V1, P167; LECHAN RM, 1994, ENDOCRINOLOGY, V135, P92, DOI 10.1210/en.135.1.92; LEZOUALCH F, 1992, MOL ENDOCRINOL, V6, P1797, DOI 10.1210/me.6.11.1797; LIU RT, 1995, MOL ENDOCRINOL, V9, P86, DOI 10.1210/me.9.1.86; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; Mittag J, 2005, ENDOCRINOLOGY, V146, P3179, DOI 10.1210/en.2005-0114; RENTOUMIS A, 1990, MOL ENDOCRINOL, V4, P1522, DOI 10.1210/mend-4-10-1522; Robert JJ, 1997, J NEUROCHEM, V68, P2152; Salto C, 2001, MOL ENDOCRINOL, V15, P2115, DOI 10.1210/me.15.12.2115; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SEGERSON TP, 1987, SCIENCE, V238, P78, DOI 10.1126/science.3116669; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; Tagami T, 1998, ENDOCRINOLOGY, V139, P2535, DOI 10.1210/en.139.5.2535; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Yang YZ, 1996, J BIOL CHEM, V271, P28235, DOI 10.1074/jbc.271.45.28235; Zhang JS, 1997, MOL CELL BIOL, V17, P6887, DOI 10.1128/MCB.17.12.6887	34	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95064	10.1371/journal.pone.0095064	http://dx.doi.org/10.1371/journal.pone.0095064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747825	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500054
J	Pedersen, SW; Hultqvist, G; Stromgaard, K; Jemth, P				Pedersen, Soren W.; Hultqvist, Greta; Stromgaard, Kristian; Jemth, Per			The Role of Backbone Hydrogen Bonds in the Transition State for Protein Folding of a PDZ Domain	PLOS ONE			English	Article							PHI-VALUE ANALYSIS; CHYMOTRYPSIN INHIBITOR-2; MECHANISM; RECOGNITION; INTERMEDIATE; BINDING; LANDSCAPE; DYNAMICS; VIEW	Backbone hydrogen bonds are important for the structure and stability of proteins. However, since conventional site-directed mutagenesis cannot be applied to perturb the backbone, the contribution of these hydrogen bonds in protein folding and stability has been assessed only for a very limited set of small proteins. We have here investigated effects of five amide-to-ester mutations in the backbone of a PDZ domain, a 90-residue globular protein domain, to probe the influence of hydrogen bonds in a b-sheet for folding and stability. The amide-to-ester mutation removes NH-mediated hydrogen bonds and destabilizes hydrogen bonds formed by the carbonyl oxygen. The overall stability of the PDZ domain generally decreased for all amide-to-ester mutants due to an increase in the unfolding rate constant. For this particular region of the PDZ domain, it is therefore clear that native hydrogen bonds are formed after crossing of the rate-limiting barrier for folding. Moreover, three of the five amide-to-ester mutants displayed an increase in the folding rate constant suggesting that the hydrogen bonds are involved in non-native interactions in the transition state for folding.	[Pedersen, Soren W.; Hultqvist, Greta; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Uppsala, Sweden; [Pedersen, Soren W.; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark	Uppsala University; University of Copenhagen	Stromgaard, K (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	kristian.stromgaard@sund.ku.dk; Per.Jemth@imbim.uu.se		Stromgaard, Kristian/0000-0003-2206-4737; Hultqvist, Greta/0000-0002-4136-6792	Swedish Research Council [2012-5096]; Danish Council for Independent Research Medical Sciences; Lundbeck Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Swedish Research Council (grant 2012-5096, PJ)(http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), the Danish Council for Independent Research Medical Sciences (KS)(http://fivu.dk/en/research-and-innovation/funding-programmes-for-research-and-innovation/find-danish-funding-programmes/dff-the-danish-council-for-independent-research), and the Lundbeck Foundation (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; Chapman E, 1997, J AM CHEM SOC, V119, P7151, DOI 10.1021/ja970826+; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13008, DOI 10.1073/pnas.221467398; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FERSHT AR, 1987, TRENDS BIOCHEM SCI, V12, P301, DOI 10.1016/0968-0004(87)90146-0; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Gao JM, 2009, NAT STRUCT MOL BIOL, V16, P684, DOI 10.1038/nsmb.1610; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956; Haq SR, 2010, J BIOL CHEM, V285, P18051, DOI 10.1074/jbc.M110.110833; Hultqvist G, 2012, BIOCHEM BIOPH RES CO, V421, P550, DOI 10.1016/j.bbrc.2012.04.042; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Ivarsson Y, 2008, J BIOL CHEM, V283, P8954, DOI 10.1074/jbc.M707424200; Ivarsson Y, 2007, J BIOL CHEM, V282, P8568, DOI 10.1074/jbc.M611026200; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kaneko T, 2011, TRENDS BIOCHEM SCI, V36, P183, DOI 10.1016/j.tibs.2010.12.001; Li L, 2000, NAT STRUCT BIOL, V7, P336; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nickson AA, 2013, CURR OPIN STRUC BIOL, V23, P66, DOI 10.1016/j.sbi.2012.11.009; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Pedersen SW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4215; Powers ET, 2005, ADV PROTEIN CHEM, V72, P39, DOI 10.1016/S0065-3233(05)72002-7; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Sakarya O, 2010, MOL BIOL EVOL, V27, P1058, DOI 10.1093/molbev/msp311; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	38	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95619	10.1371/journal.pone.0095619	http://dx.doi.org/10.1371/journal.pone.0095619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748272	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500130
J	Rasmussen, MA; Maslova, E; Halldorsson, TI; Olsen, SF				Rasmussen, Morten Arendt; Maslova, Ekaterina; Halldorsson, Thorhallur Ingi; Olsen, Sjurdur Frodi			Characterization of Dietary Patterns in the Danish National Birth Cohort in Relation to Preterm Birth	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MEDITERRANEAN-TYPE DIET; CHILD HEALTH; REDUCED RISK; PREGNANCY; WOMEN; INFANTS; SUPPLEMENTATION; ASSOCIATION; POSTPARTUM	Background: Dietary patterns better reflect eating habits as opposed to single dietary components. However, the use of dietary pattern analysis in nutritional epidemiology has been hampered by the complexity of interpreting and presenting multidimensional dietary data. Methods: This study extracts and visualizes dietary patterns from self-reported dietary data collected in mid-pregnancy (25th week of gestation) from nearly 60,000 mother-child pairs part of a prospective, longitudinal cohort (Danish National Birth Cohort) and further examines their associations with spontaneous and induced preterm birth (gestational age<259 days (<37 weeks)). Results: A total of seven dietary patterns were extracted by principal component analysis, characterized and visualized by color-coded spider plots, and referred to as: Vegetables/Prudent, Alcohol, Western, Nordic, Seafood, Candy and Rice/Pasta/Poultry. A consistent dose-response association with preterm birth was only observed for Western diet with an odds ratio of 1.30 (95% CI: 1.13, 1.49) comparing the highest to the lowest quintile. This association was primarily driven by induced preterm deliveries (odds ratio = 1.66, 95% CI: 1.30, 2.11, comparing the highest to the lowest quintile) while the corresponding odds ratio for spontaneous preterm deliveries was more modest (odds ratio = 1.18, 95% CI: 0.99, 1.39). All based on adjusted analyses. Conclusions: In conclusion, this study presented a simple and novel framework for visualizing correlation structures between overall consumption of foods group and their relation to nutrient intake and maternal characteristics. Our results suggest that Western-type diet, high in meat and fats and low in fruits and vegetables, is associated with increased odds of induced preterm birth.	[Rasmussen, Morten Arendt] Univ Copenhagen, Fac Sci, Frederiksberg, Denmark; [Maslova, Ekaterina; Halldorsson, Thorhallur Ingi; Olsen, Sjurdur Frodi] Statens Serum Inst, Ctr Fetal Programming, Div Epidemiol, DK-2300 Copenhagen, Denmark; [Halldorsson, Thorhallur Ingi] Univ Iceland, Fac Food Sci & Nutr, Unit Nutr Res, Sch Hlth Sci, Reykjavik, Iceland; [Olsen, Sjurdur Frodi] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	University of Copenhagen; Statens Serum Institut; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health	Rasmussen, MA (corresponding author), Univ Copenhagen, Fac Sci, Frederiksberg, Denmark.	mortenr@food.ku.dk	Halldorsson, Tohrhallur/M-1823-2015; Rasmussen, Morten/AAE-9517-2020; Arendt, Morten/S-8843-2017	Halldorsson, Tohrhallur/0000-0001-5115-0162; Rasmussen, Morten/0000-0001-7431-5206; Arendt, Morten/0000-0001-7431-5206; Olsen, Sjurdur/0000-0003-3017-7096; Halldorsson, Thorhallur/0000-0002-3488-0777	Danish Council for Strategic Research [09-067124]; Danish Council for Independent Research \ Medical Sciences, Danish Agency for Science, Technology and Innovation [09-063410]; Lundbeck foundation [R13-A907]; European Union (EU) Integrated Research Project EARNEST [FOOD-CT-2005-007036]; Commission of the European Communities under the FP 6 priority 5: food quality and safety; March of Dimes Birth Defects Foundation; Danish Heart Association; Danish Medical Research Council; Sygekassernes Helsefond; Danish National Research Foundation; Danish Pharmaceutical Association; Ministry of Health, National Board of Health, Statens Serum Institut	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research \ Medical Sciences, Danish Agency for Science, Technology and Innovation; Lundbeck foundation(Lundbeckfonden); European Union (EU) Integrated Research Project EARNEST; Commission of the European Communities under the FP 6 priority 5: food quality and safety; March of Dimes Birth Defects Foundation(March of Dimes); Danish Heart Association; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sygekassernes Helsefond; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Pharmaceutical Association; Ministry of Health, National Board of Health, Statens Serum Institut	This study was supported by the Danish Council for Strategic Research (09-067124); the Danish Council for Independent Research vertical bar Medical Sciences, Danish Agency for Science, Technology and Innovation (09-063410); the Lundbeck foundation (R13-A907); and the European Union (EU) Integrated Research Project EARNEST (FOOD-CT-2005-007036). The EU project EARNEST (http://www.metabolic-programming.org) receives financial support from the Commission of the European Communities under the FP 6 priority 5: food quality and safety. The Danish National Birth Cohort has been financed by the March of Dimes Birth Defects Foundation, the Danish Heart Association, the Danish Medical Research Council, and the Sygekassernes Helsefond, Danish National Research Foundation, Danish Pharmaceutical Association, Ministry of Health, National Board of Health, Statens Serum Institut. The supporting bodies for this project had no role in the design, analysis or writing of this article.	Berkowitz GS, 1998, EPIDEMIOLOGY, V9, P279, DOI 10.1097/00001648-199805000-00011; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Chatzi L, 2007, THORAX, V62, P677, DOI 10.1136/thx.2006.069419; Cole ZA, 2009, J BONE MINER RES, V24, P663, DOI 10.1359/JBMR.081212; Cuco G, 2006, EUR J CLIN NUTR, V60, P364, DOI 10.1038/sj.ejcn.1602324; Haugen M, 2008, ACTA OBSTET GYN SCAN, V87, P319, DOI 10.1080/00016340801899123; Hauner H, 2012, AM J CLIN NUTR, V95, P383, DOI 10.3945/ajcn.111.022590; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Khoury J, 2005, AM J OBSTET GYNECOL, V193, P1292, DOI 10.1016/j.ajog.2005.05.016; Lange NE, 2010, J ALLERGY CLIN IMMUN, V126, P250, DOI 10.1016/j.jaci.2010.05.009; Makrides M, 2009, JAMA-J AM MED ASSOC, V301, P175, DOI 10.1001/jama.2008.945; Mikkelsen TB, 2008, ACTA OBSTET GYN SCAN, V87, P325, DOI 10.1080/00016340801899347; Miyake Y, 2011, PEDIAT ALLERG IMM-UK, V22, P734, DOI 10.1111/j.1399-3038.2011.01176.x; Musselman JRB, 2011, AM J EPIDEMIOL, V173, P282, DOI 10.1093/aje/kwq365; Northstone K, 2008, BRIT J NUTR, V99, P1099, DOI 10.1017/S0007114507842802; Okubo H, 2012, BRIT J NUTR, V107, P1526, DOI 10.1017/S0007114511004636; Okubo H, 2011, PUBLIC HEALTH NUTR, V14, P611, DOI 10.1017/S1368980010002521; OLSEN SF, 1992, LANCET, V339, P1003, DOI 10.1016/0140-6736(92)90533-9; OLSEN SF, 1986, LANCET, V2, P367; Olsen SF, 2007, PAEDIATR PERINAT EP, V21, P76, DOI 10.1111/j.1365-3016.2007.00777.x; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Thompson JMD, 2010, BRIT J NUTR, V103, P1665, DOI 10.1017/S0007114509993606; Torjusen H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-612; Vujkovic M, 2009, BJOG-INT J OBSTET GY, V116, P408, DOI 10.1111/j.1471-0528.2008.01963.x; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Wolff Cindy Brattan, 1995, Nutrition and Health (Bicester), V10, P121; Zhang C, 2006, DIABETOLOGIA, V49, P2604, DOI 10.1007/s00125-006-0422-1	29	47	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93644	10.1371/journal.pone.0093644	http://dx.doi.org/10.1371/journal.pone.0093644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747715	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500011
J	Shi, GX; Liu, YJ; Mao, L; Jiang, SJ; Zhang, Q; Cheng, G; An, LZ; Du, GZ; Feng, HY				Shi, Guoxi; Liu, Yongjun; Mao, Lin; Jiang, Shengjing; Zhang, Qi; Cheng, Gang; An, Lizhe; Du, Guozhen; Feng, Huyuan			Relative Importance of Deterministic and Stochastic Processes in Driving Arbuscular Mycorrhizal Fungal Assemblage during the Spreading of a Toxic Plant	PLOS ONE			English	Article							WEED LIGULARIA-VIRGAUREA; PHYLOGENETIC STRUCTURE; COMMUNITY COMPOSITION; BETA DIVERSITY; ALPINE; NICHE; ROOTS; FERTILIZATION; AMPLIFICATION; SUPPRESSES	Both deterministic and stochastic processes are expected to drive the assemblages of arbuscular mycorrhizal (AM) fungi, but little is known about the relative importance of these processes during the spreading of toxic plants. Here, the species composition and phylogenetic structure of AM fungal communities colonizing the roots of a toxic plant, Ligularia virgaurea, and its neighborhood plants, were analyzed in patches with different individual densities of L. virgaurea (represents the spreading degree). Community compositions of AM fungi in both root systems were changed significantly by the L. virgaurea spreading, and also these communities fitted the neutral model very well. AM fungal communities in patches with absence and presence of L. virgaurea were phylogenetically random and clustered, respectively, suggesting that the principal ecological process determining AM fungal assemblage shifted from stochastic process to environmental filtering when this toxic plant was present. Our results indicate that deterministic and stochastic processes together determine the assemblage of AM fungi, but the dominant process would be changed by the spreading of toxic plants, and suggest that the spreading of toxic plants in alpine meadow ecosystems might be involving the mycorrhizal symbionts.	[Shi, Guoxi; Liu, Yongjun; Mao, Lin; Jiang, Shengjing; Zhang, Qi; Cheng, Gang; An, Lizhe; Du, Guozhen; Feng, Huyuan] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China	Lanzhou University	Feng, HY (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	fenghy@lzu.edu.cn	Liu, Yongjun/D-6970-2013; Yang, Xiaoming/GRJ-9483-2022	Liu, Yongjun/0000-0001-7654-2955; Yang, Xiaoming/0000-0002-1792-6921; Liu, Yongjun/0000-0002-2909-1730	Key Program of the National Natural Science Foundation of China [40930533]; National Basic Research Program [2012CB026105]; National Natural Science Foundation [31170482, 31300445, 31370450]; PhD Programs Foundation of Ministry of Education [2010021111002, 20110211110021]; Fundamental Research Funds for the Central Universities in China [LZUJBKY-2013-92]	Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); PhD Programs Foundation of Ministry of Education; Fundamental Research Funds for the Central Universities in China	This research was supported by the Key Program of the National Natural Science Foundation of China (40930533), National Basic Research Program (2012CB026105), National Natural Science Foundation (31170482, 31300445, 31370450), PhD Programs Foundation of Ministry of Education (2010021111002, 20110211110021) and the Fundamental Research Funds for the Central Universities (LZUJBKY-2013-92) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LABDSV ORDINATION MU; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Caruso T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035942; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chagnon PL, 2012, NEW PHYTOL, V194, P307, DOI 10.1111/j.1469-8137.2011.04044.x; Chu CJ, 2007, ANN BOT-LONDON, V100, P807, DOI 10.1093/aob/mcm166; COLWELL R. K., 2007, ESTIMATES 8 0 STAT E; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; DRAY S, 2005, PACKFOR FORWARD SELE; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; Egerton-Warburton LM, 2007, ECOL MONOGR, V77, P527, DOI 10.1890/06-1772.1; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Hankin RKS, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i12; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Hazard C, 2013, ISME J, V7, P498, DOI 10.1038/ismej.2012.127; Heinemeyer A, 2004, GLOBAL CHANGE BIOL, V10, P52, DOI 10.1111/j.1365-2486.2003.00713.x; Hodge A, 2000, FEMS MICROBIOL ECOL, V32, P91, DOI 10.1111/j.1574-6941.2000.tb00702.x; Hubbell Stephen P., 2001, V32, pi; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2013, ISME J, V7, P1424, DOI 10.1038/ismej.2013.41; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Liu YJ, 2011, FEMS MICROBIOL ECOL, V78, P355, DOI 10.1111/j.1574-6941.2011.01163.x; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Lu R.K., 2000, SOIL AGRO CHEM ANAL; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Maherali H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036695; Maire V, 2012, NEW PHYTOL, V196, P497, DOI 10.1111/j.1469-8137.2012.04287.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Oehl F, 2005, NEW PHYTOL, V165, P273, DOI 10.1111/j.1469-8137.2004.01235.x; Oksanen J., 2011, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Roberts KJ, 2001, AM MIDL NAT, V146, P146, DOI 10.1674/0003-0031(2001)146[0146:EOGMAP]2.0.CO;2; Rominger AJ, 2009, OECOLOGIA, V161, P791, DOI 10.1007/s00442-009-1420-z; Saks U, 2013, BOTANY, V92, P1; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarzott D, 2001, MYCORRHIZA, V10, P203, DOI 10.1007/PL00009996; Shi XM, 2011, PLANT SOIL, V347, P65, DOI 10.1007/s11104-011-0818-7; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wu GL, 2011, PLANT ECOL EVOL, V144, P275, DOI 10.5091/plecevo.2011.459; Wu GL, 2010, POL J ECOL, V58, P81; Yang ZL, 2013, OECOLOGIA, V171, P495, DOI 10.1007/s00442-012-2433-6; Zhang Q, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012380, 10.1371/journal.pone.0011063]	70	10	15	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95672	10.1371/journal.pone.0095672	http://dx.doi.org/10.1371/journal.pone.0095672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748393	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500136
J	Spitaels, F; Wieme, AD; Janssens, M; Aerts, M; Daniel, HM; Van Landschoot, A; De Vuyst, L; Vandamme, P				Spitaels, Freek; Wieme, Anneleen D.; Janssens, Maarten; Aerts, Maarten; Daniel, Heide-Marie; Van Landschoot, Anita; De Vuyst, Luc; Vandamme, Peter			The Microbial Diversity of Traditional Spontaneously Fermented Lambic Beer	PLOS ONE			English	Article							ACETIC-ACID BACTERIA; SP-NOV; SEQUENCE-ANALYSIS; MICROBIOLOGICAL ASPECTS; POLYPHASIC TAXONOMY; HOUSEKEEPING GENES; ESCHERICHIA-COLI; AMPHOTERICIN-B; RIBOSOMAL-RNA; IDENTIFICATION	Lambic sour beers are the products of a spontaneous fermentation that lasts for one to three years before bottling. The present study determined the microbiota involved in the fermentation of lambic beers by sampling two fermentation batches during two years in the most traditional lambic brewery of Belgium, using culture-dependent and culture-independent methods. From 14 samples per fermentation, over 2000 bacterial and yeast isolates were obtained and identified. Although minor variations in the microbiota between casks and batches and a considerable species diversity were found, a characteristic microbial succession was identified. This succession started with a dominance of Enterobacteriaceae in the first month, which were replaced at 2 months by Pediococcus damnosus and Saccharomyces spp., the latter being replaced by Dekkera bruxellensis at 6 months fermentation duration.	[Spitaels, Freek; Wieme, Anneleen D.; Aerts, Maarten; Vandamme, Peter] Univ Ghent, Microbiol Lab, Fac Sci, B-9000 Ghent, Belgium; [Wieme, Anneleen D.; Van Landschoot, Anita] Univ Ghent, Lab Biochem & Brewing, Fac Biosci Engn, B-9000 Ghent, Belgium; [Janssens, Maarten; De Vuyst, Luc] Vrije Univ Brussel, Res Grp Ind Microbiol & Food Biotechnol IMDO, Fac Sci & Bioengn Sci, Brussels, Belgium; [Daniel, Heide-Marie] Catholic Univ Louvain, MUCL, Belgian Coordinated Collect Microorganisms BCCM E, B-1348 Louvain, Belgium	Ghent University; Ghent University; Vrije Universiteit Brussel; Universite Catholique Louvain	Vandamme, P (corresponding author), Univ Ghent, Microbiol Lab, Fac Sci, B-9000 Ghent, Belgium.	Peter.Vandamme@UGent.be	Vandamme, Peter AR/B-7967-2009; Aerts, Maarten/O-6194-2014; Vandamme, Peter/ABG-3431-2021	Vandamme, Peter AR/0000-0002-5581-7937; Aerts, Maarten/0000-0003-0125-6721; Vandamme, Peter/0000-0002-5581-7937; De Vuyst, Luc/0000-0002-7534-7186; Wieme, Anneleen/0000-0003-4503-4063	Agency for Innovation by Science and Technology (IWT); Research Foundation Flanders (FWO-Vlaanderen); University College Ghent; Vrije Universiteit Brussel; Belgian Federal Science Policy [BCCM C4/10/017]	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO-Vlaanderen)(FWO); University College Ghent(Ghent University); Vrije Universiteit Brussel; Belgian Federal Science Policy(Belgian Federal Science Policy Office)	This research was funded by a Ph.D. grant (FS) of the Agency for Innovation by Science and Technology (IWT) and by the Research Foundation Flanders (FWO-Vlaanderen). The authors further acknowledge their finances from the research fund of the University College Ghent (AW) and the Vrije Universiteit Brussel (HOA, SRP, IRP, and IOF projects; MJ and LDV) and from the Belgian Federal Science Policy (BCCM C4/10/017) (HMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DA, 2005, APPL MICROBIOL BIOT, V66, P641, DOI 10.1007/s00253-004-1769-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035507; Camu N, 2007, APPL ENVIRON MICROB, V73, P1809, DOI 10.1128/AEM.02189-06; CHEUNG SC, 1975, ANTIMICROB AGENTS CH, V8, P426, DOI 10.1128/AAC.8.4.426; Cleenwerck I, 2002, INT J SYST EVOL MICR, V52, P1551, DOI 10.1099/00207713-52-5-1551; Cleenwerck I, 2008, INT J SYST EVOL MICR, V58, P2180, DOI 10.1099/ijs.0.65778-0; Cleenwerck I, 2008, INT J FOOD MICROBIOL, V125, P2, DOI 10.1016/j.ijfoodmicro.2007.04.017; Cleenwerck I, 2010, INT J SYST EVOL MICR, V60, P2277, DOI 10.1099/ijs.0.018465-0; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; Daniel HM, 2003, INT J FOOD MICROBIOL, V86, P61, DOI 10.1016/S0168-1605(03)00248-4; De Bruyne K, 2008, INT J SYST EVOL MICR, V58, P2909, DOI 10.1099/ijs.0.65833-0; De Bruyne K, 2007, INT J SYST EVOL MICR, V57, P2952, DOI 10.1099/ijs.0.65292-0; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; DeKeersmaecker J, 1996, SCI AM, V275, P74; Dieckmann R, 2005, APPL MICROBIOL BIOT, V67, P539, DOI 10.1007/s00253-004-1812-2; Duytschaever G, 2011, APPL ENVIRON MICROB, V77, P8015, DOI 10.1128/AEM.05933-11; FARROW JAE, 1988, FEMS MICROBIOL LETT, V55, P163, DOI 10.1111/j.1574-6968.1988.tb13927.x; GARVIE EI, 1974, INT J SYST BACTERIOL, V24, P301, DOI 10.1099/00207713-24-2-301; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Hutzler M., 2013, Brauwelt International, V31, P23; JOYEUX A, 1984, APPL ENVIRON MICROB, V48, P153, DOI 10.1128/AEM.48.1.153-156.1984; Judicial Commission of the International Committee on Systematic Bacteriology, 1976, INT J SYSTEMATIC BAC, V26, P292; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Latouche GN, 1997, J CLIN MICROBIOL, V35, P3171, DOI 10.1128/JCM.35.12.3171-3180.1997; Licker J, 1998, WHAT IS BRETT BRETTA, P96; Lisdiyanti P., 2003, MICROBIOL CULT COLLE, V19, P91; Martens H, 1997, J I BREWING, V103, P85, DOI 10.1002/j.2050-0416.1997.tb00939.x; MARTENS H, 1991, J I BREWING, V97, P435, DOI 10.1002/j.2050-0416.1991.tb01082.x; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Medina K, 2013, FOOD CHEM, V141, P2513, DOI 10.1016/j.foodchem.2013.04.056; MEYER SA, 1978, A VAN LEEUW J MICROB, V44, P79, DOI 10.1007/BF00400078; Millet V, 2000, LETT APPL MICROBIOL, V30, P136, DOI 10.1046/j.1472-765X.2000.00684.x; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Mossel D. A. A., 1978, Laboratory Practice, V27, P1049; MOSSEL DAA, 1962, J BACTERIOL, V84, P381, DOI 10.1128/JB.84.2.381-381.1962; Naser SM, 2007, INT J SYST EVOL MICR, V57, P2777, DOI 10.1099/ijs.0.64711-0; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; Nguyen HV, 2005, FEMS YEAST RES, V5, P471, DOI 10.1016/j.femsyr.2004.12.004; Nhung PH, 2007, DIAGN MICR INFEC DIS, V58, P153, DOI 10.1016/j.diagmicrobio.2006.12.019; Niemann S, 1997, J APPL MICROBIOL, V82, P477, DOI 10.1046/j.1365-2672.1997.00141.x; Papalexandratou Z, 2011, FOOD MICROBIOL, V28, P1326, DOI 10.1016/j.fm.2011.06.003; Papalexandratou Z, 2011, FOOD MICROBIOL, V28, P964, DOI 10.1016/j.fm.2011.01.010; Priest F.G., 2006, HDB BREWING, P607; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Ribereau-Gayon P, 2006, HDB ENOLOGY CHEM WIN, V2, P387; Scheirlinck I, 2008, APPL ENVIRON MICROB, V74, P2414, DOI 10.1128/AEM.02771-07; SMITH MT, 1990, YEAST, V6, P299, DOI 10.1002/yea.320060403; Snauwaert I, 2013, INT J SYST EVOL MICR, V63, P1709, DOI 10.1099/ijs.0.040311-0; Spitaels F, 2013, INT J SYST EVOL MICR, DOI [2010.1099/ijs.2010.059311-059310, DOI 10.1099/IJS.2010.059311-059310]; Spitaels F, 2013, INT J SYST EVOL MICR, DOI [2010.1099/ijs.2010.057315-057310, DOI 10.1099/IJS.2010.057315-057310]; Suarez R, 2007, FOOD CHEM, V102, P10, DOI 10.1016/j.foodchem.2006.03.030; Swaffield CH, 1997, FOOD MICROBIOL, V14, P353, DOI 10.1006/fmic.1997.0105; SWAFFIELD CH, 1995, J AM SOC BREW CHEM, V53, P117; te Dorsthorst DTA, 2005, ANTIMICROB AGENTS CH, V49, P3341, DOI 10.1128/AAC.49.8.3341-3346.2005; Van der Meulen R, 2007, APPL ENVIRON MICROB, V73, P4741, DOI 10.1128/AEM.00315-07; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; VANDERWALT JP, 1964, ANTON VAN LEE J M S, V30, P273, DOI 10.1007/BF02046733; VANOEVELEN D, 1977, J I BREWING, V83, P356, DOI 10.1002/j.2050-0416.1977.tb03825.x; Verachtert H., 1995, CEREVISIA BELG J BRE, V20, P37; Wieme A, 2012, INT J SYST EVOL MICR, V62, P3105, DOI 10.1099/ijs.0.046201-0	65	152	154	4	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95384	10.1371/journal.pone.0095384	http://dx.doi.org/10.1371/journal.pone.0095384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748344	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500094
J	Patra, A; Nagy, LD; Zhang, QQ; Su, Y; Muller, L; Guengerich, FP; Egli, M				Patra, Amritraj; Nagy, Leslie D.; Zhang, Qianqian; Su, Yan; Mueller, Livia; Guengerich, F. Peter; Egli, Martin			Kinetics, Structure, and Mechanism of 8-Oxo-7,8-dihydro-2 '-deoxyguanosine Bypass by Human DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERROR-FREE BYPASS; LESION-BYPASS; TRANSLESION SYNTHESIS; SACCHAROMYCES-CEREVISIAE; 8-OXO-GUANINE BYPASS; ESCHERICHIA-COLI; FINGER DOMAIN; THYMINE DIMER; REPLICATION; EFFICIENT	DNA damage incurred by a multitude of endogenous and exogenous factors constitutes an inevitable challenge for the replication machinery. Cells rely on various mechanisms to either remove lesions or bypass them in a more or less error-prone fashion. The latter pathway involves the Y-family polymerases that catalyze trans-lesion synthesis across sites of damaged DNA. 7,8-Dihydro-8-oxo-2'-deoxyguanosine (8-oxoG) is a major lesion that is a consequence of oxidative stress and is associated with cancer, aging, hepatitis, and infertility. We have used steady-state and transient-state kinetics in conjunction with mass spectrometry to analyze in vitro bypass of 8-oxoG by human DNA polymerase eta (hpol eta). Unlike the high fidelity polymerases that show preferential insertion of A opposite 8-oxoG, hpol eta is capable of bypassing 8-oxoG in a mostly error-free fashion, thus preventing GC -> AT transversion mutations. Crystal structures of ternary hpol eta-DNA complexes and incoming dCTP, dATP, or dGTP opposite 8-oxoG reveal that an arginine from the finger domain assumes a key role in avoiding formation of the nascent 8-oxoG: A pair. That hpol eta discriminates against dATP exclusively at the insertion stage is confirmed by structures of ternary complexes that allow visualization of the extension step. These structures with G: dCTP following either 8-oxoG: C or 8-oxoG: A pairs exhibit virtually identical active site conformations. Our combined data provide a detailed understanding of hpol eta bypass of the most common oxidative DNA lesion.	[Patra, Amritraj; Nagy, Leslie D.; Zhang, Qianqian; Su, Yan; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Patra, Amritraj; Nagy, Leslie D.; Zhang, Qianqian; Su, Yan; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Mueller, Livia] Eidgenoss Tech Hsch Zentrum, Lab Food & Nutr Toxicol, CH-8092 Zurich, Switzerland	Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 868A Robinson Res Bldg, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA068485, P01CA160032, R01CA055678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to Dr. L. Lei for help with protein expression and purification, Dr. Z. Wawrzak for assistance with x-ray diffraction data collection at the Advanced Photon Source, Dr. W. Yang for helpful discussions, and K. Trisler for assistance in preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at sector 21 of the Advanced Photon Source, Argonne, IL. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Avkin S, 2002, MUTAT RES-FUND MOL M, V510, P81, DOI 10.1016/S0027-5107(02)00254-3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Bridges BA, 2005, DNA REPAIR, V4, P725, DOI 10.1016/j.dnarep.2004.12.009; Carlson KD, 2005, MOL CELL BIOL, V25, P2169, DOI 10.1128/MCB.25.6.2169-2176.2005; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Chowdhury G., 2011, CURRENT PROTOCOLS NU; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; DEGAN P, 1991, CARCINOGENESIS, V12, P865, DOI 10.1093/carcin/12.5.865; Earley MC, 1998, P NATL ACAD SCI USA, V95, P15487, DOI 10.1073/pnas.95.26.15487; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.11003; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Guengerich F. P, 2010, CHEM BIOL DNA DAMAGE, P299; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Hogg M, 2005, CURR OPIN STRUC BIOL, V15, P86, DOI 10.1016/j.sbi.2005.01.014; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Jaloszynski P, 2003, NUCLEIC ACIDS RES, V31, P6085, DOI 10.1093/nar/gkg829; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kamiya H, 2004, BIOL PHARM BULL, V27, P475, DOI 10.1248/bpb.27.475; Lamoureux JS, 2004, J MOL BIOL, V335, P399, DOI 10.1016/j.jmb.2003.10.071; Lee DH, 2008, MUTAT RES-FUND MOL M, V641, P19, DOI 10.1016/j.mrfmmm.2008.02.006; Lehmann AR, 2006, MOL CELL, V24, P493, DOI 10.1016/j.molcel.2006.10.021; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Lowe LG, 1996, BIOCHEMISTRY-US, V35, P9840, DOI 10.1021/bi960485x; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; MALINS DC, 1991, CANCER RES, V51, P5430; Markkanen E, 2012, P NATL ACAD SCI USA, V109, P20401, DOI 10.1073/pnas.1211532109; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rodriguez GP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003682; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SHIMODA R, 1994, CANCER RES, V54, P3171; Silverstein TD, 2010, STRUCTURE, V18, P1463, DOI 10.1016/j.str.2010.08.019; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Suarez SC, 2013, MUTAT RES-FUND MOL M, V745, P46, DOI 10.1016/j.mrfmmm.2013.03.001; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yuan FH, 2000, J BIOL CHEM, V275, P8233, DOI 10.1074/jbc.275.11.8233; Yung Chinwei, 2007, Nucleic Acids Symp Ser (Oxf), P49; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhao Y, 2013, P NATL ACAD SCI USA, V110, P8146, DOI 10.1073/pnas.1303126110; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	71	65	67	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16867	16882		10.1074/jbc.M114.551820	http://dx.doi.org/10.1074/jbc.M114.551820			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24759104	Green Published, hybrid			2022-12-25	WOS:000338016200024
J	Cuadrado, A; Martin-Moldes, Z; Ye, JP; Lastres-Becker, I				Cuadrado, Antonio; Martin-Moldes, Zaira; Ye, Jianping; Lastres-Becker, Isabel			Transcription Factors NRF2 and NF-kappa B Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Lipopolysaccharide (LPS); Microglia; NF- B (NF-KB); Nuclear Factor 2 (Erythroid-derived 2-like Factor) (NFE2L2) (Nrf2); Oxidative Stress; Ras-related C3 Botulinum Toxin Substrate 1 (Rac1); Rho GTPases	SIGNALING CASCADE; PARKINSONS-DISEASE; HEME OXYGENASE-1; IKK-BETA; EXPRESSION; ACTIVATION; INHIBITION; PATHWAY; PHAGOCYTOSIS; REDOX	Background: RAC1 is a small G-protein of the Rho family that activates the transcription factor NF-B to elicit an inflammatory response. Results: We have found that RAC1 also induces the NRF2/ARE pathway, which in term blocks RAC1-dependent NF-B activation. Conclusion: RAC1 modulates inflammation by coordinating the activity of pro-inflammatory NF-B and anti-oxidant NRF2 transcription factors. Significance: Therapeutic intervention on RAC1 could help modulate pro- and anti-inflammatory processes. The small GTPase protein RAC1 participates in innate immunity by activating a complex program that includes cytoskeleton remodeling, chemotaxis, activation of NADPH oxidase, and modulation of gene expression. However, its role in regulating the transcriptional signatures that in term control the cellular inflammatory profiles are not well defined. Here we investigated the functional and mechanistic connection between RAC1 and the transcription factor NRF2 (nuclear factor erythroid 2-related factor 2), master regulator of the anti-oxidant response. Lipopolysaccharide and constitutively active RAC1(Q61L) mutant induced the anti-oxidant enzyme heme-oxygenase-1 (HO-1) through activation of NRF2. The use of KEAP1-insensitive NRF2 mutants indicated that RAC1 regulation of NRF2 is KEAP1-independent. Interestingly, NRF2 overexpression inhibited, whereas a dominant-negative mutant of NRF2 exacerbated RAC1-dependent activation of nuclear factor-B (NF-B), suggesting that NRF2 has an antagonistic effect on the NF-B pathway. Moreover, we found that RAC1 acts through NF-B to induce NRF2 because either expression of a dominant negative mutant of IB that leads to NF-B degradation or the use of p65-NF-B-deficient cells demonstrated lower NRF2 protein levels and basally impaired NRF2 signature compared with control cells. In contrast, NRF2-deficient cells showed increased p65-NF-B protein levels, although the mRNA levels remain unchanged, indicating post-translational alterations. Our results demonstrate a new mechanism of modulation of RAC1 inflammatory pathway through a cross-talk between NF-B and NRF2.	[Cuadrado, Antonio; Martin-Moldes, Zaira; Lastres-Becker, Isabel] Univ Autonoma Madrid, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Invest Sanitaria La Paz IdiPAZ, Dept Bioquim, Madrid 28029, Spain; [Cuadrado, Antonio; Martin-Moldes, Zaira; Lastres-Becker, Isabel] Univ Autonoma Madrid, Fac Med, Inst Invest Biomed Alberto Sols CSIC UAM, Madrid 28029, Spain; [Martin-Moldes, Zaira] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain; [Ye, Jianping] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Autonomous University of Madrid; CIBERNED; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Lastres-Becker, I (corresponding author), Inst Invest Biomed Alberto Sols UAM CSIC, C Arturo Duperier 4, Madrid 28029, Spain.	ilbecker@iib.uam.es	Lastres-Becker, Isabel/R-3403-2018; Ye, Jianping/N-1998-2017; Becker, Isabel Lastres/AAB-6788-2019	Lastres-Becker, Isabel/0000-0002-4968-2175; Ye, Jianping/0000-0003-3875-365X; Becker, Isabel Lastres/0000-0002-4968-2175; Cuadrado, Antonio/0000-0002-3444-9012; Cuadrado, Antonio/0000-0002-4039-7140	Spanish Ministerio de Ciencia e Innovacion [SAF2010-17822]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068036, P30DK072476, R56DK068036, R01DK085495] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grant SAF2010-17822.	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Atreya R, 2006, ANN NY ACAD SCI, V1072, P98, DOI 10.1196/annals.1326.001; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bongmba OYN, 2011, BRAIN RES, V1399, P79, DOI 10.1016/j.brainres.2011.05.020; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brandenburg LO, 2010, INFLAMM RES, V59, P443, DOI 10.1007/s00011-009-0116-5; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Espada S, 2009, J NEUROCHEM, V110, P1107, DOI 10.1111/j.1471-4159.2009.06208.x; Gao ZG, 2009, J BIOL CHEM, V284, P18368, DOI 10.1074/jbc.M109.007260; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634; Hong HY, 2008, FEBS LETT, V582, P861, DOI 10.1016/j.febslet.2008.02.012; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Innamorato NG, 2009, CURR OPIN NEUROL, V22, P308, DOI 10.1097/WCO.0b013e32832a3225; Jazwa A, 2011, ANTIOXID REDOX SIGN, V14, P2347, DOI 10.1089/ars.2010.3731; Jazwa A, 2010, CURR DRUG TARGETS, V11, P1517, DOI 10.2174/1389450111009011517; Jiang Z. Y., 2013, PLOS ONE, V8; Joshi Gururaj, 2012, Recent Pat CNS Drug Discov, V7, P218; Kim NH, 2010, J PHARMACOL SCI, V113, P246, DOI 10.1254/jphs.09330FP; Kitamura Y, 2003, J PHARMACOL SCI, V92, P115; Kusano Y, 2008, BIOCHEMISTRY-US, V47, P6169, DOI 10.1021/bi800199z; Lastres-Becker I, 2014, BRAIN, V137, P78, DOI 10.1093/brain/awt323; Lastres-Becker I, 2012, HUM MOL GENET, V21, P3173, DOI 10.1093/hmg/dds143; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Masters TA, 2013, P NATL ACAD SCI USA, V110, P11875, DOI 10.1073/pnas.1301766110; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Ohsawa K, 2000, J CELL SCI, V113, P3073; Pan QT, 2003, MOL CANCER RES, V1, P701; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Suganuma H, 2011, BIOCHEM BIOPH RES CO, V405, P146, DOI 10.1016/j.bbrc.2011.01.025; Tanaka T, 2010, BIOCHEM BIOPH RES CO, V399, P677, DOI 10.1016/j.bbrc.2010.07.141; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Utsugi M, 2006, J IMMUNOL, V177, P4550, DOI 10.4049/jimmunol.177.7.4550; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang PL, 2009, J NEUROSCI RES, V87, P2105, DOI 10.1002/jnr.22039; Wang XF, 2011, J IMMUNOL, V186, P5791, DOI 10.4049/jimmunol.1002127	49	205	209	4	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15244	15258		10.1074/jbc.M113.540633	http://dx.doi.org/10.1074/jbc.M113.540633			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24759106	Green Published, hybrid			2022-12-25	WOS:000337465400010
J	Jiang, SF; Su, J; Yao, SQ; Zhang, YS; Cao, FY; Wang, F; Wang, HH; Li, J; Xi, SH				Jiang, Shoufang; Su, Jing; Yao, Sanqiao; Zhang, Yanshu; Cao, Fuyuan; Wang, Fei; Wang, Huihui; Li, Jun; Xi, Shuhua			Fluoride and Arsenic Exposure Impairs Learning and Memory and Decreases mGluR5 Expression in the Hippocampus and Cortex in Rats	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; DRINKING-WATER; OXIDATIVE STRESS; SODIUM ARSENITE; INTELLECTUAL FUNCTION; NERVOUS-SYSTEM; SPATIAL MEMORY; DNA-DAMAGE; BRAIN	Fluoride and arsenic are two common inorganic contaminants in drinking water that are associated with impairment in child development and retarded intelligence. The present study was conducted to explore the effects on spatial learning, memory, glutamate levels, and group I metabotropic glutamate receptors (mGluRs) expression in the hippocampus and cortex after subchronic exposure to fluoride, arsenic, and a fluoride and arsenic combination in rats. Weaned male Sprague-Dawley rats were assigned to four groups. The control rats drank tap water. Rats in the three exposure groups drank water with sodium fluoride (120 mg/L), sodium arsenite (70 mg/L), and a sodium fluoride (120 mg/L) and sodium arsenite (70 mg/L) combination for 3 months. Spatial learning and memory was measured in Morris water maze. mGluR1 and mGluR5 mRNA and protein expression in the hippocampus and cortex was detected using RT-PCR and Western blot, respectively. Compared with controls, learning and memory ability declined in rats that were exposed to fluoride and arsenic both alone and combined. Combined fluoride and arsenic exposure did not have a more pronounced effect on spatial learning and memory compared with arsenic and fluoride exposure alone. Compared with controls, glutamate levels decreased in the hippocampus and cortex of rats exposed to fluoride and combined fluoride and arsenic, and in cortex of arsenic-exposed rats. mGluR5 mRNA and protein expressions in the hippocampus and mGluR5 protein expression in the cortex decreased in rats exposed to arsenic alone. Interestingly, compared with fluoride and arsenic exposure alone, fluoride and arsenic combination decreased mGluR5 mRNA expression in the cortex and protein expression in the hippocampus, suggesting a synergistic effect of fluoride and arsenic. These data indicate that fluoride and arsenic, either alone or combined, can decrease learning and memory ability in rats. The mechanism may be associated with changes of glutamate level and mGluR5 expression in cortex and hippocampus.	[Jiang, Shoufang; Wang, Fei; Wang, Huihui; Xi, Shuhua] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Liaoning Prov Key Lab Arsen Biol Effect & Poisoni, Shenyang, Liaoning, Peoples R China; [Jiang, Shoufang; Su, Jing; Yao, Sanqiao; Zhang, Yanshu; Li, Jun] Hebei United Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Hebei Prov Key Lab Occupat Hlth & Safety Coal Ind, Tangshan, Hebei, Peoples R China; [Cao, Fuyuan] Hebei United Univ, Lab Anim Ctr, Tangshan, Hebei, Peoples R China	China Medical University; North China University of Science & Technology; North China University of Science & Technology	Xi, SH (corresponding author), China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Liaoning Prov Key Lab Arsen Biol Effect & Poisoni, Shenyang, Liaoning, Peoples R China.	shxi@mail.cmu.edu.cn	Wang, Huihui/AAS-4039-2020	Wang, Huihui/0000-0001-5545-1982	National Natural Science Foundation of China [81102083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China: #81102083, URL: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balschun D, 1999, LEARN MEMORY, V6, P138; Balschun D, 2006, NEUROSCIENCE, V142, P691, DOI 10.1016/j.neuroscience.2006.06.043; Balschun D, 2002, PHARMACOL BIOCHEM BE, V73, P375, DOI 10.1016/S0091-3057(02)00847-X; Bhatnagar M, 2006, FLUORIDE, V39, P280; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; Bortolotto ZA, 1999, CURR OPIN NEUROBIOL, V9, P299, DOI 10.1016/S0959-4388(99)80044-0; Bortolotto ZA, 2005, NEUROPHARMACOLOGY, V49, P13, DOI 10.1016/j.neuropharm.2005.05.020; Chioca LR, 2008, EUR J PHARMACOL, V579, P196, DOI 10.1016/j.ejphar.2007.10.019; Chirumari K, 2007, FLUORIDE, V40, P101; Choi KY, 2011, J NEUROSCI, V31, P5921, DOI 10.1523/JNEUROSCI.6253-10.2011; Chouhan S, 2010, INDIAN J EXP BIOL, V48, P666; Cinque C, 2003, NEUROSCIENCE, V122, P277, DOI 10.1016/S0306-4522(03)00442-1; Ding YP, 2011, J HAZARD MATER, V186, P1942, DOI 10.1016/j.jhazmat.2010.12.097; Duker AA, 2005, ENVIRON INT, V31, P631, DOI 10.1016/j.envint.2004.10.020; Fan GQ, 2010, TOXICOLOGY, V272, P23, DOI 10.1016/j.tox.2010.03.018; Flora SJS, 2011, BIOMETALS, V24, P615, DOI 10.1007/s10534-011-9412-y; Flora SJS, 2009, J NEUROL SCI, V285, P198, DOI 10.1016/j.jns.2009.07.001; Flora SJS, 2012, METALLOMICS, V4, P78, DOI 10.1039/c1mt00118c; Gao Q, 2009, FLUORIDE, V42, P277; Gui CZ, 2010, NEUROTOXICOL TERATOL, V32, P536, DOI 10.1016/j.ntt.2010.03.010; Hamadani JD, 2011, INT J EPIDEMIOL, V40, P1593, DOI 10.1093/ije/dyr176; Hong Feng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P794; HUANG YZ, 1992, CHINESE MED J-PEKING, V105, P586; Jha SK, 2013, J TOXICOL ENV HEAL B, V16, P52, DOI 10.1080/10937404.2013.769420; Jia ZP, 1998, LEARN MEMORY, V5, P331; Jin YP, 2006, ENVIRON RES, V101, P349, DOI 10.1016/j.envres.2005.11.006; Jing JF, 2012, NEUROTOXICOLOGY, V33, P1230, DOI 10.1016/j.neuro.2012.07.003; Kang Jiaqi, 2007, Wei Sheng Yan Jiu, V36, P347; Kim Kyoung-Woong, 2011, Front Med, V5, P420, DOI 10.1007/s11684-011-0158-2; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Liu XH, 2013, ADV EXP MED BIOL, V776, P277, DOI 10.1007/978-1-4614-6093-0_26; Long YG, 2002, NEUROTOXICOL TERATOL, V24, P751, DOI 10.1016/S0892-0362(02)00273-8; Lu YM, 1997, J NEUROSCI, V17, P5196; Luo JH, 2009, TOXICOL LETT, V184, P121, DOI 10.1016/j.toxlet.2008.10.029; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Rodriguez VM, 2010, NEUROTOXICOL TERATOL, V32, P640, DOI 10.1016/j.ntt.2010.07.005; Mittal M, 2006, CHEM-BIOL INTERACT, V162, P128, DOI 10.1016/j.cbi.2006.05.018; Mukherjee S, 2013, NEUROPHARMACOLOGY, V66, P65, DOI 10.1016/j.neuropharm.2012.06.005; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Neyman S, 2008, EUR J NEUROSCI, V27, P1345, DOI 10.1111/j.1460-9568.2008.06109.x; Niu RY, 2009, ENVIRON TOXICOL PHAR, V28, P254, DOI 10.1016/j.etap.2009.04.012; PETRES J, 1977, ENVIRON HEALTH PERSP, V19, P223, DOI 10.2307/3428480; Rios R, 2009, TOXICOLOGY, V261, P68, DOI 10.1016/j.tox.2009.04.055; Rocha-Amador D, 2007, CAD SAUDE PUBLICA, V23, pS579, DOI 10.1590/S0102-311X2007001600018; Rodriguez VM, 2003, TOXICOL LETT, V145, P1, DOI 10.1016/S0378-4274(03)00262-5; Rodriguez VM, 2001, BRAIN RES BULL, V55, P301, DOI 10.1016/S0361-9230(01)00477-4; Rodriguez VM, 2002, NEUROTOXICOL TERATOL, V24, P743, DOI 10.1016/S0892-0362(02)00313-6; Romano C, 1996, J COMP NEUROL, V367, P403, DOI 10.1002/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9; Salgado-Bustamante M, 2010, SCI TOTAL ENVIRON, V408, P760, DOI 10.1016/j.scitotenv.2009.11.016; Saxena S, 2012, J NEUROSCI RURAL PRA, V3, P144, DOI 10.4103/0976-3147.98213; Seraj B, 2012, J Dent (Tehran), V9, P221; Tsai SY, 2003, NEUROTOXICOLOGY, V24, P747, DOI 10.1016/S0161-813X(03)00029-9; Valdez-Jimenez L, 2011, NEUROLOGIA, V26, P297, DOI 10.1016/j.nrl.2010.10.008; Wang SX, 2007, ENVIRON HEALTH PERSP, V115, P643, DOI 10.1289/ehp.9270; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wasserman GA, 2007, ENVIRON HEALTH PERSP, V115, P285, DOI 10.1289/ehp.9501; Wu CX, 2006, FLUORIDE, V39, P274; Xi SH, 2010, J BIOCHEM MOL TOXIC, V24, P368, DOI 10.1002/jbt.20349; Xi SH, 2010, BIOL TRACE ELEM RES, V134, P84, DOI 10.1007/s12011-009-8455-1; Xi SH, 2009, ARCH TOXICOL, V83, P549, DOI 10.1007/s00204-009-0403-5; Xu J, 2009, TOXICOL LETT, V191, P223, DOI 10.1016/j.toxlet.2009.09.001; Yadav RS, 2009, TOXICOL APPL PHARM, V240, P367, DOI 10.1016/j.taap.2009.07.017; Zhang C, 1999, Wei Sheng Yan Jiu, V28, P337; [张志瑜 Zhang Zhiyu], 2011, [中国公共卫生, China Public Health], V27, P255	66	68	72	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96041	10.1371/journal.pone.0096041	http://dx.doi.org/10.1371/journal.pone.0096041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759735	Green Published, gold			2022-12-25	WOS:000335298200129
J	Scott-Phillips, TC; Gurney, J; Ivens, A; Diggle, SP; Popat, R				Scott-Phillips, Thomas C.; Gurney, James; Ivens, Alasdair; Diggle, Stephen P.; Popat, Roman			Combinatorial Communication in Bacteria: Implications for the Origins of Linguistic Generativity	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA-LAS; QUORUM-SENSING HIERARCHY; SYSTEMS; SIGNAL; GENES; IDENTIFICATION; COMBINATIONS; SPECIFICITY; NETWORK; PHASE	Combinatorial communication, in which two signals are used together to achieve an effect that is different to the sum of the effects of the component parts, is apparently rare in nature: it is ubiquitous in human language, appears to exist in a simple form in some non-human primates, but has not been demonstrated in other species. This observed distribution has led to the pair of related suggestions, that (i) these differences in the complexity of observed communication systems reflect cognitive differences between species; and (ii) that the combinations we see in non-human primates may be evolutionary pre-cursors of human language. Here we replicate the landmark experiments on combinatorial communication in non-human primates, but in an entirely different species, unrelated to humans, and with no higher cognition: the bacterium Pseudomonas aeruginosa. Using the same general methods as the primate studies, we find the same general pattern of results: the effect of the combined signal differs from the composite effect of the two individual signals. This suggests that advanced cognitive abilities and large brains do not necessarily explain why some species have combinatorial communication systems and others do not. We thus argue that it is premature to conclude that the systems observed in non-human primates are evolutionarily related to language. Our results illustrate the value of an extremely broad approach to comparative research.	[Scott-Phillips, Thomas C.] Univ Durham, Dept Anthropol, Durham, England; [Gurney, James; Diggle, Stephen P.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Ivens, Alasdair; Popat, Roman] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland	Durham University; University of Nottingham; University of Edinburgh	Scott-Phillips, TC (corresponding author), Univ Durham, Dept Anthropol, Durham, England.	t.c.scott-phillips@durham.ac.uk		Ivens, Al/0000-0002-0112-3876	Leverhulme Early Career Fellowship [ECG/2009/0442]; Royal Society University Research Fellowship; Natural Environment Research Council grant [NE/J007064/1]; Wellcome Trust CIIE fellowship [095831]; Human Science Frontiers Program [RGY0081/2012]; Economic and Social Research Council [ES/K001647/1] Funding Source: researchfish; Natural Environment Research Council [NE/J007064/1] Funding Source: researchfish; ESRC [ES/K001647/1] Funding Source: UKRI; NERC [NE/J007064/1] Funding Source: UKRI	Leverhulme Early Career Fellowship(Leverhulme Trust); Royal Society University Research Fellowship(Royal Society of London); Natural Environment Research Council grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust CIIE fellowship(Wellcome Trust); Human Science Frontiers Program; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Leverhulme Early Career Fellowship to TSP, no. ECG/2009/0442. Royal Society University Research Fellowship to SD. Natural Environment Research Council grant to SD, no. NE/J007064/1. Wellcome Trust CIIE fellowship to RP, no. 095831. Human Science Frontiers Program to SD, no. RGY0081/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Cornforth DM, P NAT ACAD IN PRESS; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; de Kievit TR, 2002, FEMS MICROBIOL LETT, V212, P101, DOI 10.1016/S0378-1097(02)00735-8; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, PHILOS T R SOC B, V362, P1241, DOI 10.1098/rstb.2007.2049; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; HOLM S, 1979, SCAND J STAT, V6, P65; Hurford J. R., 2011, ORIGINS GRAMMAR; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Moore R, DEV SCI IN PRESS; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pesci EC, 1997, TRENDS MICROBIOL, V5, P132, DOI 10.1016/S0966-842X(97)01008-1; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Schuster M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-287; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Scott-Phillips TC, SPEAKING OU IN PRESS; Scott-Phillips TC, CURR ANTH IN PRESS; Scott-Phillips TC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0520; Scott-Phillips TC, 2012, P ROY SOC B-BIOL SCI, V279, P1943, DOI 10.1098/rspb.2011.2181; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Sperber Dan, 2010, EVOLUTION HUMAN LANG, P124; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tomasello M, 2008, JEAN NICOD LECT, P1; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Whiteley M, 2001, J BACTERIOL, V183, P5529, DOI 10.1128/JB.183.19.5529-5534.2001; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Zuberbuhler K, 2002, ANIM BEHAV, V63, P293, DOI 10.1006/anbe.2001.1914	39	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95929	10.1371/journal.pone.0095929	http://dx.doi.org/10.1371/journal.pone.0095929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759740	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000335298200110
J	Zhang, R; Ran, HH; Peng, L; Xu, F; Sun, JF; Zhang, LN; Fan, YY; Peng, L; Cui, G				Zhang, Ran; Ran, Hai-hong; Peng, Liang; Xu, Fei; Sun, Jun-fang; Zhang, Lan-ning; Fan, Yong-yan; Peng, Li; Cui, Geng			Mitochondrial Regulation of NADPH Oxidase in Hindlimb Unweighting Rat Cerebral Arteries	PLOS ONE			English	Article							OXIDATIVE STRESS; ANGIOTENSIN-II; SIMULATED MICROGRAVITY; CAROTID ARTERIES; CROSS-TALK; NOX4; SUPEROXIDE; DYSFUNCTION; ADAPTATION; DEFICIENCY	Exposure to microgravity results in post-flight cardiovascular deconditioning and orthostatic intolerance in astronauts. Vascular oxidative stress injury and mitochondrial dysfunction have been indicated in this process. To elucidate the mechanism for this condition, we investigated whether mitochondria regulated NADPH oxidase in hindlimb unweighting (HU) rat cerebral and mesenteric arteries. Four-week HU was used to simulate microgravity in rats. Vascular superoxide generation, protein and mRNA levels of Nox2/Nox4, and the activity of NADPH oxidase were examined in the present study. Compared with control rats, the levels of superoxide increased in cerebral (P, 0.001) but not in mesenteric vascular smooth muscle cells. The protein and mRNA levels of Nox2 and Nox4 were upregulated significantly (P<0.001 and P<0.001 for Nox2, respectively; P<0.001 and P<0.001 for Nox4, respectively) in HU rat cerebral arteries but not in mesenteric arteries. NADPH oxidases were activated significantly by HU (P<0.001) in cerebral arteries but not in mesenteric arteries. Chronic treatment with mitochondria-targeted antioxidant mitoTEMPO attenuated superoxide levels (P<0.001), decreased the protein and mRNA expression levels of Nox2/Nox4 (P<0.01 and P<0.05 for Nox2, respectively; P<0.001 and P<0.001 for Nox4, respectively) and the activity of NADPH oxidase (P<0.001) in HU rat cerebral arteries, but exerted no effects on HU rat mesenteric arteries. Therefore, mitochondria regulated the expression and activity of NADPH oxidases during simulated microgravity. Both mitochondria and NADPH oxidase participated in vascular redox status regulation.	[Zhang, Ran; Peng, Liang; Sun, Jun-fang; Zhang, Lan-ning; Fan, Yong-yan; Peng, Li] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr Cardiol, Beijing, Peoples R China; [Ran, Hai-hong] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Hematol, Beijing, Peoples R China; [Xu, Fei] Chinese Peoples Liberat Army 302 Hosp, Dept Radiotherapy, Beijing, Peoples R China; [Cui, Geng] Chinese Peoples Liberat Army Gen Hosp, Dept Osteol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Cui, G (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Osteol, Beijing, Peoples R China.	bjzhangran@126.com	Zhang, Ran/ABB-5587-2021		National Natural Science Foundation of China [81101468, 81030002/H02]; Beijing NOVO Program [XX2013105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVO Program	This work was supported by the National Natural Science Foundation of China (Grant No. 81101468 and Grant No. 81030002/H02) and Beijing NOVO Program (Grant No. XX2013105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2012, BIOCHEM J, V441, P719, DOI 10.1042/BJ20111130; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Chan SL, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/793630; Chan SL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00133; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P281, DOI 10.1089/ars.2012.4918; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Elnakish MT, 2013, J PATHOL, V231, P290, DOI 10.1002/path.4255; Fu ZJ, 2004, AM J PHYSIOL-HEART C, V287, pH1505, DOI 10.1152/ajpheart.00143.2004; Haddad P, 2011, ATHEROSCLEROSIS, V217, P340, DOI 10.1016/j.atherosclerosis.2011.03.038; Hargens AR, 1996, MED SCI SPORT EXER, V28, P977, DOI 10.1097/00005768-199608000-00007; Jayroe J, 2012, ANN CLIN LAB SCI, V42, P140; Kimura S, 2005, HYPERTENSION, V45, P438, DOI 10.1161/01.HYP.0000157169.27818.ae; Konior A, 2013, ANTIOXID RE IN PRESS; Kroller-Schon S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee DY, 2013, J BIOL CHEM, V288, P28668, DOI 10.1074/jbc.M113.470971; Li GB, 2004, ACTA ASTRONAUT, V55, P953, DOI 10.1016/j.actaastro.2004.04.014; Loukogeorgakis SP, 2010, CIRCULATION, V121, P2310, DOI 10.1161/CIRCULATIONAHA.108.814731; Oelze M, 2014, HYPERTENSION, V63, P390, DOI 10.1161/HYPERTENSIONAHA.113.01602; Rai B, 2011, J PERIODONTOL, V82, P1478, DOI 10.1902/jop.2011.100711; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Ray R, 2011, ARTERIOSCL THROM VAS, V31, P1368, DOI 10.1161/ATVBAHA.110.219238; Ren XL, 2011, CLIN EXP PHARMACOL P, V38, P683, DOI 10.1111/j.1440-1681.2011.05565.x; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Schulz E, 2014, ANTIOXID REDOX SIGN, V20, P308, DOI 10.1089/ars.2012.4609; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; Song P, 2012, FREE RADICAL BIO MED, V52, P1607, DOI 10.1016/j.freeradbiomed.2012.01.025; Stein TP, 2002, NUTRITION, V18, P867, DOI 10.1016/S0899-9007(02)00938-3; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takac I, 2012, CURR HYPERTENS REP, V14, P70, DOI 10.1007/s11906-011-0238-3; Taverne YJHJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/862423; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Violi F, 2009, CIRCULATION, V120, P1616, DOI 10.1161/CIRCULATIONAHA.109.877191; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Xue JH, 2007, AM J PHYSIOL-HEART C, V293, pH691, DOI 10.1152/ajpheart.01229.2006; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang LF, 2013, EUR J APPL PHYSIOL, V113, P2873, DOI 10.1007/s00421-013-2597-8; Zhang R, 2014, FASEB J IN PRESS; Zhang R, 2008, J PHYSIOL SCI, V58, P67, DOI 10.2170/physiolsci.RP010707; Zhang R, 2012, J PHYSIOL BIOCHEM, V68, P99, DOI 10.1007/s13105-011-0123-1; Zhang R, 2009, J APPL PHYSIOL, V106, P251, DOI 10.1152/japplphysiol.01278.2007; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95916	10.1371/journal.pone.0095916	http://dx.doi.org/10.1371/journal.pone.0095916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759683	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200108
J	Ade, S; Harries, AD; Trebucq, A; Ade, G; Agodokpessi, G; Adjonou, C; Azon, S; Anagonou, S				Ade, Serge; Harries, Anthony D.; Trebucq, Arnaud; Ade, Gabriel; Agodokpessi, Gildas; Adjonou, Christine; Azon, Sophie; Anagonou, Severin			National Profile and Treatment Outcomes of Patients with Extrapulmonary Tuberculosis in Benin	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; RISK-FACTORS; DIAGNOSIS; MTB/RIF; HIV	Background: In sub-Saharan Africa, there is a dearth of published literature on extrapulmonary tuberculosis (EPTB). Objective: To describe demographic, diagnostic and HIV-status characteristics of patients with EPTB in Benin, their treatment outcomes, and among those who completed their treatment in the Centre National Hospitalier de PneumoPhtisiologie (CNHP-P), the proportion whose bodyweight increased during treatment. Material and Findings: This was a retrospective cohort study with comparisons made between EPTB and new smearpositive pulmonary tuberculosis (NPTB) patients diagnosed in the country from January to December 2011. There were 383 EPTB patients (9% of all TB cases) with a mean age of 35 years, male/female ratio of 1.3 and important regional variation. There were significantly more females (p = 0.001), children < 15years (p < 0.001) and HIV-positive patients (p = 0.005) with EPTB compared with NPTB. Pleural effusion, spinal and lymph node tuberculosis accounted for 66% of all EPTB. Children, 15 years represented 16% of cases, with lymph node disease being most common among them (p < 0.001). Of 130 EPTB patients registered in CNHP-P, 7% had a confirmed bacteriological/histological diagnosis. There were 331 (86%) patients who successfully completed treatment. More patients with EPTB were lost-to-follow-up compared with NPTB (p, 0.001) with all these patients from one region. The best treatment completion rates were in children,15 years (OR: 3.5, 95% CI: 1.014.8) while patients with pleural effusion and ascites had the worst outcomes. Of 72 HIV-coinfected patients, 88% were on antiretroviral therapy (ART). HIV-positive status was associated with poor outcomes while those on ART fared better. In the CNHP-P, more than 80% who completed their treatment showed an increase in bodyweight and this was more evident in HIV-positive compared with HIV-negative patients (p = 0.03). Conclusion: Patients with EPTB generally do well in Benin, although the TB Programme would benefit through more attention to accurate diagnosis and earlier start of ART in HIV-infected patients.	[Ade, Serge; Ade, Gabriel; Agodokpessi, Gildas; Adjonou, Christine; Azon, Sophie; Anagonou, Severin] Natl TB Programme, Cotonou, Benin; [Harries, Anthony D.; Trebucq, Arnaud] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Ade, S (corresponding author), Natl TB Programme, Cotonou, Benin.	adeserg@yahoo.fr			International Union Against Tuberculosis and Lung Disease ( The Union), Paris, France through a Union Operational Research Fellowship; Department for International Development, UK; Service de la sante publique; Lausanne de l'Etat de Vaud, Switzerland	International Union Against Tuberculosis and Lung Disease ( The Union), Paris, France through a Union Operational Research Fellowship; Department for International Development, UK; Service de la sante publique; Lausanne de l'Etat de Vaud, Switzerland	The International Union Against Tuberculosis and Lung Disease ( The Union), Paris, France, financially supports Serge Ade through a Union Operational Research Fellowship. Funding was from an anonymous donor and the Department for International Development, UK. Additional financial support for this study was provided by the <INF></INF>Service de la sante publique, Lausanne de l'Etat de Vaud, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade S, 2013, T ROY SOC TROP MED H, V107, P783, DOI 10.1093/trstmh/trt092; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Gonzalez OY, 2003, INT J TUBERC LUNG D, V7, P1178; Gunal S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-154; Harries AD, 2003, TROP DOCT, V33, P7, DOI 10.1177/004947550303300106; Jamtsho T, 2013, PUBLIC HEALTH ACTION, V3, P38, DOI 10.5588/pha.12.0085; Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013; Kourbatova EV, 2006, EUR J EPIDEMIOL, V21, P715, DOI 10.1007/s10654-006-9060-7; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Kruyt ML, 1999, B WORLD HEALTH ORGAN, V77, P386; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2012, EXPERT REV ANTI-INFE, V10, P631, DOI [10.1586/ERI.12.43, 10.1586/eri.12.43]; Leeds IL, 2012, CLIN INFECT DIS, V55, P75, DOI 10.1093/cid/cis303; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Mazza-Stalder J, 2012, REV MAL RESPIR, V29, P566, DOI 10.1016/j.rmr.2011.05.021; Ministere de la Sante, 2012, ANN STAT SANITAIRES; National Tuberculosis Control Programme, 2009, NAT TUB GUID; Ozbay B, 2002, CLIN CHEST MED, V23, P351, DOI 10.1016/S0272-5231(02)00002-3; Ozvaran Mustafa Kursat, 2007, Ann Thorac Med, V2, P118, DOI 10.4103/1817-1737.33700; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Rock RB, 2006, EMERG INFECT DIS, V12, P1434, DOI 10.3201/eid1209.050295; Sandgren A, 2013, EURO SURVEILL, V18; Savina T A, 2007, Probl Tuberk Bolezn Legk, P12; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; UNAIDS, 2013, GLOBAL REP UNAIDS RE; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; WHO, 2010, ANT THER HIV INF AD; World Health Organization (WHO), 2009, WHOHTMTB2009420; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	33	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95603	10.1371/journal.pone.0095603	http://dx.doi.org/10.1371/journal.pone.0095603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755603	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300060
J	Banis, S; Geerligs, L; Lorist, MM				Banis, Stella; Geerligs, Linda; Lorist, Monicque M.			Acute Stress Modulates Feedback Processing in Men and Women: Differential Effects on the Feedback-Related Negativity and Theta and Beta Power	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; DECISION-MAKING; OSCILLATORY ACTIVITY; ANTICIPATORY STRESS; COGNITIVE CONTROL; BRAIN POTENTIALS; PHASE SYNCHRONY; GAMBLING TASK; REWARD; DEPRESSION	Sex-specific prevalence rates in mental and physical disorders may be partly explained by sex differences in physiological stress responses. Neural networks that might be involved are those underlying feedback processing. Aim of the present EEG study was to investigate whether acute stress alters feedback processing, and whether stress effects differ between men and women. Male and female participants performed a gambling task, in a control and a stress condition. Stress was induced by exposing participants to a noise stressor. Brain activity was analyzed using both event-related potential and time-frequency analyses, measuring the feedback-related negativity (FRN) and feedback-related changes in theta and beta oscillatory power, respectively. While the FRN and feedback-related theta power were similarly affected by stress induction in both sexes, feedback-related beta power depended on the combination of stress induction condition and sex. FRN amplitude and theta power increases were smaller in the stress relative to the control condition in both sexes, demonstrating that acute noise stress impairs performance monitoring irrespective of sex. However, in the stress but not in the control condition, early lower beta-band power increases were larger for men than women, indicating that stress effects on feedback processing are partly sex-dependent. Our findings suggest that sex-specific effects on feedback processing may comprise a factor underlying sex-specific stress responses.	[Banis, Stella; Geerligs, Linda; Lorist, Monicque M.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Geerligs, Linda; Lorist, Monicque M.] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Lorist, MM (corresponding author), Univ Groningen, Dept Expt Psychol, Groningen, Netherlands.	m.m.lorist@rug.nl	Geerligs, Linda/D-5212-2013	Geerligs, Linda/0000-0002-1624-8380; Lorist, Monicque M./0000-0002-7361-093X	NWO grant [400-07-001]	NWO grant	This research was supported by an NWO grant (400-07-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SEX DIFFERENCES BRAI; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Babisch W, 2003, Noise Health, V5, P1; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Banis S, 2012, BIOL PSYCHOL, V91, P163, DOI 10.1016/j.biopsycho.2012.06.009; Bogdan R, 2006, BIOL PSYCHIAT, V60, P1147, DOI 10.1016/j.biopsych.2006.03.037; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cavanagh JF, 2011, SOC COGN AFFECT NEUR, V6, P311, DOI 10.1093/scan/nsq041; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Cohen MX, 2011, TRENDS COGN SCI, V15, P558, DOI 10.1016/j.tics.2011.10.004; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Dedovic K, 2009, CAN J PSYCHIAT, V54, P6, DOI 10.1177/070674370905400104; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Forbes EE, 2007, BIOL PSYCHIAT, V61, P633, DOI 10.1016/j.biopsych.2006.05.026; Foti D, 2009, BIOL PSYCHOL, V81, P1, DOI 10.1016/j.biopsycho.2008.12.004; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Gratton G., 1983, ELECTROENCEPHALOGRAP, V5, P468, DOI DOI 10.1016/0013-4694(83)90135-9; HajiHosseini A, 2012, NEUROIMAGE, V60, P1678, DOI 10.1016/j.neuroimage.2012.01.125; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lighthall NR, 2012, SOC COGN AFFECT NEUR, V7, P476, DOI 10.1093/scan/nsr026; Lighthall NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006002; Luck S.J., 2005, INTRO EVENT RELATED; Luft CD, 2013, J NEUROSCI, V33, P2029, DOI 10.1523/JNEUROSCI.2565-12.2013; Luque D, 2012, J COGNITIVE NEUROSCI, V24, P794, DOI 10.1162/jocn_a_00145; Marco-Pallares J, 2008, NEUROPSYCHOLOGIA, V46, P241, DOI 10.1016/j.neuropsychologia.2007.07.016; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ossewaarde L, 2011, SOC COGN AFFECT NEUR, V6, P612, DOI 10.1093/scan/nsq071; Ossewaarde L, 2011, NEUROIMAGE, V55, P345, DOI 10.1016/j.neuroimage.2010.11.068; Ossewaarde L, 2010, PSYCHONEUROENDOCRINO, V35, P47, DOI 10.1016/j.psyneuen.2009.08.011; Petzold A, 2010, BEHAV NEUROSCI, V124, P248, DOI 10.1037/a0018930; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Porcelli AJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00157; Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x; Preston SD, 2007, BEHAV NEUROSCI, V121, P257, DOI 10.1037/0735-7044.121.2.257; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Starcke K, 2012, NEUROSCI BIOBEHAV R, V36, P1228, DOI 10.1016/j.neubiorev.2012.02.003; Starcke K, 2008, BEHAV NEUROSCI, V122, P1352, DOI 10.1037/a0013281; Steele JD, 2007, BRAIN, V130, P2367, DOI 10.1093/brain/awm150; Szalma JL, 2011, PSYCHOL BULL, V137, P682, DOI 10.1037/a0023987; Tucker DM, 2003, J ABNORM PSYCHOL, V112, P667, DOI 10.1037/0021-843X.112.4.667; van de Vijver I, 2011, J COGNITIVE NEUROSCI, V23, P4106, DOI 10.1162/jocn_a_00110; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016; Wald FDM., 1990, NEDERLANDS TIJDSCHRI, V45, P86; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	62	21	21	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95690	10.1371/journal.pone.0095690	http://dx.doi.org/10.1371/journal.pone.0095690			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2IS	24755943	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300073
J	Choi, UY; Hur, JY; Lee, MS; Zhang, QR; Choi, WY; Kim, LK; Lee, WB; Oh, GT; Kim, YJ				Choi, Un Yung; Hur, Ji Yeon; Lee, Myeong Sup; Zhang, Quanri; Choi, Won Young; Kim, Lark Kyun; Lee, Wook-Bin; Oh, Goo Taeg; Kim, Young-Joon			Tripartite Motif-Containing Protein 30 Modulates TCR-Activated Proliferation and Effector Functions in CD4(+) T Cells	PLOS ONE			English	Article							EXPRESSION; TAB2; TRIM30-ALPHA; TRIM5-ALPHA; EXPANSION	To avoid excessive activation, immune signals are tightly controlled by diverse inhibitory proteins. TRIM30, a tripartite motif (TRIM)-containing protein is one of such inhibitors known to function in macrophages. To define the roles of TRIM30, we generated Trim30 knockout (Trim30(-/-)) mice. Trim30 deletion caused no major developmental defects in any organs, nor showed any discernable defect in the activation of macrophages. But, Trim30(-/-) mice showed increased CD4/CD8 ratio when aged and Trim30(-/-) CD4(+) T cells exhibited an abnormal response upon TCR activation, in particular in the absence of a costimulatory signal. Adoptive transfer of wild-type and Trim30(-/-) CD4(+) T cells together into lymphopenic hosts confirmed higher proliferation of the Trim30(-/-) CD4(+) T cells in vivo. Despite the enhanced proliferation, Trim30(-/-) T cells showed decreased levels of NF-kappa B activation and IL-2 production compared to wild-type cells. These results indicate a distinct requirement for TRIM30 in modulation of NF-kappa B activation and cell proliferation induced by TCR stimulation.	[Choi, Un Yung; Lee, Myeong Sup; Choi, Won Young; Kim, Lark Kyun; Lee, Wook-Bin; Kim, Young-Joon] Yonsei Univ, Dept Biochem, Coll Life Sci & Technol, Seoul 120749, South Korea; [Hur, Ji Yeon; Zhang, Quanri; Kim, Young-Joon] Yonsei Univ, Grad Sch, Dept Integrated Om Biomed Sci, WCU Program, Seoul 120749, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea	Yonsei University; Yonsei University; Ewha Womans University	Kim, YJ (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Technol, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr	Oh, Goo Taeg/AAQ-9995-2021; Choi, Un Yung/GWZ-5421-2022	Kim, Lark Kyun/0000-0001-5983-4470	Global Research Laboratory Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MEST) [K20705000006-12A0500-00610]; Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MEST) [2012028272]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI13C08470200]	Global Research Laboratory Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MEST); Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MEST); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea	This research was supported by the Global Research Laboratory Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (MEST; K20705000006-12A0500-00610 to Y.-J.K.), the Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (MEST; 2012028272 to Y.-J.K.), the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI13C08470200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Barrat F, 1997, CLIN EXP IMMUNOL, V107, P593, DOI 10.1046/j.1365-2249.1997.3021199.x; Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Colombetti S, 2006, J IMMUNOL, V176, P2730, DOI 10.4049/jimmunol.176.5.2730; Datta S, 2009, TRENDS IMMUNOL, V30, P430, DOI 10.1016/j.it.2009.06.002; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; LAING TJ, 1988, J IMMUNOL, V140, P1056; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Paolino M, 2009, EUR J IMMUNOL, V39, P2337, DOI 10.1002/eji.200939662; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Rizvi MA, 2006, BLOOD, V107, P1255, DOI 10.1182/blood-2005-03-1306; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tareen SU, 2011, VIROLOGY, V409, P113, DOI 10.1016/j.virol.2010.09.018; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Wimmer N, 2013, MOL IMMUNOL, V54, P40, DOI 10.1016/j.molimm.2012.10.036	28	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95805	10.1371/journal.pone.0095805	http://dx.doi.org/10.1371/journal.pone.0095805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24756037	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300097
J	David, MZ; Cadilla, A; Boyle-Vavra, S; Daum, RS				David, Michael Z.; Cadilla, Adriana; Boyle-Vavra, Susan; Daum, Robert S.			Replacement of HA-MRSA by CA-MRSA Infections at an Academic Medical Center in the Midwestern United States, 2004-5 to 2008	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; METHICILLIN-RESISTANT; EMERGENCY-DEPARTMENT; CHANGING EPIDEMIOLOGY; SKIN INFECTIONS; TRENDS; VETERANS; SYSTEM; USA	We noted anecdotally that infections designated as health care-associated (HA-) MRSA by epidemiologic criteria seemed to be decreasing in incidence at the University of Chicago Medical Center (UCMC) after 2004. We compared MRSA patients seen at any site of clinical care at UCMC and the isolates that caused their infections in 2004-5 (n = 545) with those in 2008 (n = 135). The percent of patients with MRSA infections cultured. 2 days after hospital admission decreased from 19.5% in 2004-5 to 7.4% in 2008 (p = 0.001). The percent in 2004-5 compared with 2008 who had a hospitalization (49.1% to 26.7%, p = 0.001) or surgery (43.0% to 14.1%, p, 0.001) in the previous year decreased. In 2008 a greater percent of patients was seen in the emergency department (23.1% vs. 39.3%) and a smaller percent both in intensive care units (15.6% vs. 6.7%) and in other inpatient units (40.7% vs. 32.6%) (p< 0.001). The percent of patients with CA-MRSA infections by the CDC epidemiologic criteria increased from 36.5% in 2004-5 to 62.2% in 2008 (p, 0.001). The percent of MRSA isolates sharing genetic characteristics of USA100 decreased from 27.9% (152/545) to 12.6% (17/135), while the percent with CA-MRSA (USA300) characteristics increased from 53.2% (290/545) to 66.7% (90/135). The percent of infections that were invasive did not change significantly. Our data suggest that HA-MRSA infections, both by epidemiologic and microbiologic criteria, relative to CA-MRSA, decreased between 2004-5 and 2008 at UCMC.	[David, Michael Z.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [David, Michael Z.; Cadilla, Adriana; Boyle-Vavra, Susan; Daum, Robert S.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	David, MZ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mdavid@medicine.bsd.uchicago.edu	David, Michael Z./X-6737-2019	David, Michael Z./0000-0002-1926-7800	National Institutes of Health [R01 A140481-01A1, 2R56AI040481-08A1, 1 U01 GM087729-01/B270JA, 1K23 AI095361-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040481, K23AI095361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01 A140481-01A1 and 2R56AI040481-08A1 to RSD and SBV; 1 U01 GM087729-01/B270JA to RSD; and 1K23 AI095361-01 to MZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Caffrey AR, 2012, INFECTION, V40, P291, DOI 10.1007/s15010-011-0232-3; Chua T, 2008, J CLIN MICROBIOL, V46, P2345, DOI 10.1128/JCM.00154-08; Como-Sabetti K, 2009, PUBLIC HEALTH REP, V124, P427, DOI 10.1177/003335490912400312; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; David MZ, 2012, EMERG INFECT DIS, V18, P105, DOI 10.3201/eid1801.110746; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Farr AM, 2012, INFECT CONT HOSP EP, V33, P725, DOI 10.1086/666329; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kennedy LA, 2010, INFECT CONT HOSP EP, V31, P983, DOI 10.1086/655837; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; NCCLS, 2004, M100S14 NCCLS; Qualls ML, 2012, CLIN INFECT DIS, V55, P103, DOI 10.1093/cid/cis342; Ray GT, 2012, J CLIN MICROBIOL, V50, P1950, DOI 10.1128/JCM.00134-12; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11; Tracy LA, 2011, EMERG INFECT DIS, V17, P441, DOI 10.3201/eid1703.100502	23	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e92760	10.1371/journal.pone.0092760	http://dx.doi.org/10.1371/journal.pone.0092760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755631	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300004
J	Kirov, I; Van Laere, K; De Riek, J; De Keyser, E; Van Roy, N; Khrustaleva, L				Kirov, Ilya; Van Laere, Katrijn; De Riek, Jan; De Keyser, Ellen; Van Roy, Nadine; Khrustaleva, Ludmila			Anchoring Linkage Groups of the Rosa Genetic Map to Physical Chromosomes with Tyramide-FISH and EST-SNP Markers	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; SINGLE-COPY GENE; CATALYZED REPORTER DEPOSITION; RESOLUTION MELTING ANALYSIS; POWDERY MILDEW RESISTANCE; ULTRA-SENSITIVE FISH; NUCLEAR-DNA AMOUNTS; SIGNAL AMPLIFICATION; RIBOSOMAL DNA; MESSENGER-RNA	In order to anchor Rosa linkage groups to physical chromosomes, a combination of the Tyramide-FISH technology and the modern molecular marker system based on High Resolution Melting (HRM) is an efficient approach. Although, Tyramide-FISH is a very promising technique for the visualization of short DNA probes, it is very challenging for plant species with small chromosomes such as Rosa. In this study, we successfully applied the Tyramide-FISH technique for Rosa and compared different detection systems. An indirect detection system exploiting biotinylated tyramides was shown to be the most suitable technique for reliable signal detection. Three gene fragments with a size of 1100 pb-1700 bp (Phenylalanine Ammonia Lyase, Pyrroline-5-Carboxylate Synthase and Orcinol O-Methyl Transferase) have been physically mapped on chromosomes 7, 4 and 1, respectively, of Rosa wichurana. The signal frequency was between 25% and 40%. HRM markers of these 3 gene fragments were used to include the gene fragments on the existing genetic linkage map of Rosa wichurana. As a result, three linkage groups could be anchored to their physical chromosomes. The information was used to check for synteny between the Rosa chromosomes and Fragaria.	[Kirov, Ilya; Khrustaleva, Ludmila] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia; [Kirov, Ilya; Khrustaleva, Ludmila] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Dept Genet & Biotechnol, Moscow, Russia; [Kirov, Ilya; Van Laere, Katrijn; De Riek, Jan; De Keyser, Ellen] Inst Agr & Fisheries Res ILVO, Plant Sci Unit, Melle, Belgium; [Van Roy, Nadine] Univ Ghent, Fac Med & Hlth Sci, Ctr Med Genet, B-9000 Ghent, Belgium	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; Institute For Agricultural & Fisheries Research; Ghent University	Van Laere, K (corresponding author), Inst Agr & Fisheries Res ILVO, Plant Sci Unit, Melle, Belgium.	katrijn.vanlaere@ilvo.vlaanderen.be	Киров, Илья/G-2570-2019; Khrustaleva, Ludmila/J-9508-2013	Киров, Илья/0000-0003-3885-3837; Khrustaleva, Ludmila/0000-0002-0614-4641; Van Laere, Katrijn/0000-0001-5398-5489				Akasaka M, 2003, BREEDING SCI, V53, P177, DOI 10.1270/jsbbs.53.177; Akasaka Maiko, 2002, Chromosome Science, V6, P17; Alberts B, 1989, MOL BIOL CELL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON LK, 1985, EXP CELL RES, V156, P367, DOI 10.1016/0014-4827(85)90544-0; [Anonymous], FOLIA BIOL, V54, P121; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; Channeliere S, 2002, FEBS LETT, V515, P35, DOI 10.1016/S0014-5793(02)02413-4; Cheng CH, 2005, MOL GENET GENOMICS, V274, P337, DOI 10.1007/s00438-005-0039-y; Choi HK, 2004, GENETICS, V166, P1463, DOI 10.1534/genetics.166.3.1463; Crespel L, 2002, THEOR APPL GENET, V105, P1207, DOI 10.1007/s00122-002-1102-2; Danilova TV, 2012, CHROMOSOMA, V121, P597, DOI 10.1007/s00412-012-0384-7; Darlington C. D., 1955, CHROMOSOME ATLAS FLO; De Keyser E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-1; Debener T, 1999, THEOR APPL GENET, V99, P891, DOI 10.1007/s001220051310; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Deryckere D, 2013, PLANT MOL BIOL REP, V31, P731, DOI 10.1007/s11105-012-0547-y; Dubois A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028455; Dugo ML, 2005, THEOR APPL GENET, V111, P511, DOI 10.1007/s00122-005-2042-4; Fernandez-Romero MD, 2001, THEOR APPL GENET, V103, P835, DOI 10.1007/s001220100709; Figueroa DM, 2010, BRIEF FUNCT GENOMICS, V9, P95, DOI 10.1093/bfgp/elp058; Gar O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020463; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Gudin S., 2000, Plant Breeding Reviews, V17, P159; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Han YH, 2012, MOL BREEDING, V29, P489, DOI 10.1007/s11032-011-9566-x; HART GE, 1976, GENETICS, V83, P49; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Hurst C.C., 1925, EXPT GENETICS, V37, P534; Hurst CC, 1927, INT K VER, P867; Illa E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-9; Islam-Faridi MN, 2009, CYTOGENET GENOME RES, V125, P74, DOI 10.1159/000218749; Jian HY, 2013, GENET RESOUR CROP EV, V60, P115, DOI 10.1007/s10722-012-9820-z; Jian HY, 2010, CARYOLOGIA, V63, P162, DOI 10.1080/00087114.2010.10589722; [蹇洪英 Jian Hongying], 2010, [植物遗传资源学报, Journal of Plant Genetic Resources], V11, P457; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Jung S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-129; Kato A, 2006, BIOTECH HISTOCHEM, V81, P71, DOI 10.1080/10520290600643677; Kato A, 2011, GENOME, V54, P151, DOI 10.1139/G10-098; Khrustaleva L, 2012, ACTA HORTIC, V969, P43; Khrustaleva LI, 2001, PLANT J, V25, P699, DOI 10.1046/j.1365-313X.2001.00995.x; Kim JS, 2005, GENETICS, V169, P1169, DOI 10.1534/genetics.104.035980; Kirov I, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-21; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Komulainen P, 2003, THEOR APPL GENET, V107, P667, DOI 10.1007/s00122-003-1312-2; Koumbaris GL, 2003, PLANT J, V35, P647, DOI 10.1046/j.1365-313X.2003.01829.x; Krylov V, 2007, CYTOGENET GENOME RES, V116, P110, DOI 10.1159/000097427; Kubota K, 2006, J MICROBIOL METH, V66, P521, DOI 10.1016/j.mimet.2006.02.002; Lamb JC, 2007, GENETICS, V175, P1047, DOI 10.1534/genetics.106.065573; Lehmensiek A, 2008, THEOR APPL GENET, V117, P721, DOI 10.1007/s00122-008-0813-4; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Linde M, 2006, THEOR APPL GENET, V113, P1081, DOI 10.1007/s00122-006-0367-2; Liu ChengYuan, 2008, Journal of Jiangsu Forestry Science & Technology, V35, P5; Liu D.H., 1985, J WUHAN BOT RES, V3, P403; Ma Y, 1997, CARYOLOGIA, V50, P317, DOI 10.1080/00087114.1997.10797405; Ma Y, 1997, J HERED, V88, P158, DOI 10.1093/oxfordjournals.jhered.a023078; Ma Y, 1996, HORTSCIENCE, V31, P855, DOI 10.21273/HORTSCI.31.5.855; Ma Y., 1991, J FUJIAN COLL FOREST, V11, P215; MA Y, 1992, GUIHAIA, V12, P333; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; Moghaddam HH, 2012, EUPHYTICA, V184, P413, DOI 10.1007/s10681-011-0616-6; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Oyant LHS, 2008, TREE GENET GENOMES, V4, P11, DOI 10.1007/s11295-007-0084-2; Paesold S, 2012, PLANT J, V72, P600, DOI 10.1111/j.1365-313X.2012.05102.x; Perez R, 2009, CYTOGENET GENOME RES, V125, P321, DOI 10.1159/000235938; Peters SA, 2012, PLANT J, V71, P602, DOI 10.1111/j.1365-313X.2012.05012.x; PIJNACKER LP, 1984, CAN J GENET CYTOL, V26, P415, DOI 10.1139/g84-067; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; PRICE L, 1981, CARYOLOGIA, V34, P69, DOI 10.1080/00087114.1981.10796873; Raap AK, 1998, MUTAT RES-FUND MOL M, V400, P287, DOI 10.1016/S0027-5107(98)00029-3; RAAP AK, 1995, HUM MOL GENET, V4, P529, DOI 10.1093/hmg/4.4.529; Raina SN, 2005, J HERED, V96, P424, DOI 10.1093/jhered/esi041; Rajapakse S, 2001, THEOR APPL GENET, V103, P575, DOI 10.1007/PL00002912; Razavi F, 2011, EUPHYTICA, V180, P385, DOI 10.1007/s10681-011-0398-x; Reardon CL, 2007, MOL IMMUNOL, V44, P906, DOI 10.1016/j.molimm.2006.03.024; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Roberts AV, 2009, PLANT CELL REP, V28, P61, DOI 10.1007/s00299-008-0615-9; Rousseau-Gueutin M, 2011, PLANT BREEDING, V130, P248, DOI 10.1111/j.1439-0523.2010.01785.x; Sanz MJ, 2012, CYTOGENET GENOME RES, V136, P145, DOI 10.1159/000335641; Schmidlin L, 2008, PLANT PHYSIOL, V148, P1630, DOI 10.1104/pp.108.126003; Schriml LM, 1999, BIOTECHNIQUES, V27, P608, DOI 10.2144/99273pf01; SEARS ER, 1953, AM NAT, V87, P245, DOI 10.1086/281780; SHIGYO M, 1994, JPN J GENET, V69, P417, DOI 10.1266/jjg.69.417; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Speel EJM, 1997, J HISTOCHEM CYTOCHEM, V45, P1439, DOI 10.1177/002215549704501013; Spiller M, 2010, THEOR APPL GENET, V120, P1461, DOI 10.1007/s00122-010-1268-y; Spiller M, 2011, THEOR APPL GENET, V122, P489, DOI 10.1007/s00122-010-1463-x; Stanarius A, 1999, J NEUROSCI METH, V88, P55, DOI 10.1016/S0165-0270(99)00012-6; Stephens JL, 2004, GENOME, V47, P179, DOI [10.1139/g03-084, 10.1139/G03-084]; Studer B, 2009, MOL BREEDING, V24, P191, DOI 10.1007/s11032-009-9291-x; SUBRAMANIAN D, 1987, CYTOLOGIA, V52, P395, DOI 10.1508/cytologia.52.395; Szinay D, 2008, PLANT J, V56, P627, DOI 10.1111/j.1365-313X.2008.03626.x; van de Corput MPC, 1998, J HISTOCHEM CYTOCHEM, V46, P1249, DOI 10.1177/002215549804601105; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; Van Ooijen JW, 2004, JOINMAP 4 0 SOFTWARE; vanGijlswijk RPM, 1997, J HISTOCHEM CYTOCHEM, V45, P375, DOI 10.1177/002215549704500305; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; WYLIE ANN P., 1954, JOUR ROYAL HORT SOC, V79, P555; Yan Z, 2005, THEOR APPL GENET, V110, P766, DOI 10.1007/s00122-004-1903-6; Yokoya K, 2000, ANN BOT-LONDON, V85, P557, DOI 10.1006/anbo.1999.1102	105	24	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95793	10.1371/journal.pone.0095793	http://dx.doi.org/10.1371/journal.pone.0095793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755945	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300094
J	Sato, T; Okubo, T; Usui, M; Yokota, S; Izumiyama, S; Tamura, Y				Sato, Toyotaka; Okubo, Torahiko; Usui, Masaru; Yokota, Shin-ichi; Izumiyama, Satoshi; Tamura, Yutaka			Association of Veterinary Third-Generation Cephalosporin Use with the Risk of Emergence of Extended-Spectrum-Cephalosporin Resistance in Escherichia coli from Dairy Cattle in Japan	PLOS ONE			English	Article							FOOD-PRODUCING ANIMALS; BETA-LACTAMASE; SALMONELLA-ENTERICA; CTX-M; ANTIMICROBIAL RESISTANCE; MULTIPLEX PCR; CEFTIOFUR; PLASMIDS; GENES; SELECTION	The use of extended-spectrum cephalosporins in food animals has been suggested to increase the risk of spread of Enterobacteriaceae carrying extended-spectrum b-lactamases to humans. However, evidence that selection of extended-spectrum cephalosporin-resistant bacteria owing to the actual veterinary use of these drugs according to criteria established in cattle has not been demonstrated. In this study, we investigated the natural occurrence of cephalosporin-resistant Escherichia coli in dairy cattle following clinical application of ceftiofur. E. coli isolates were obtained from rectal samples of treated and untreated cattle (n = 20/group) cultured on deoxycholate-hydrogen sulfide-lactose agar in the presence or absence of ceftiofur. Eleven cefazoline-resistant isolates were obtained from two of the ceftiofur-treated cattle; no cefazoline-resistant isolates were found in untreated cattle. The cefazoline-resistant isolates had mutations in the chromosomal ampC promoter region and remained susceptible to ceftiofur. Eighteen extended-spectrum cephalosporin-resistant isolates from two ceftiofur-treated cows were obtained on ceftiofur-supplemented agar; no extended-spectrum cephalosporin-resistant isolates were obtained from untreated cattle. These extended-spectrum cephalosporin-resistant isolates possessed plasmid-mediated beta-lactamase genes, including blaC(TX-M-2) (9 isolates), bla(CTX-M-14) (8 isolates), or bla(CMY-2) (1 isolate); isolates possessing bla(CTX-M-2) and bla(CTX-M-14) were clonally related. These genes were located on self-transmissible plasmids. Our results suggest that appropriate veterinary use of ceftiofur did not trigger growth extended-spectrum cephalosporin-resistant E. coli in the bovine rectal flora; however, ceftiofur selection in vitro suggested that additional ceftiofur exposure enhanced selection for specific extended-spectrum cephalosporin-resistant beta-lactamase-expressing E. coli clones	[Sato, Toyotaka; Okubo, Torahiko; Usui, Masaru; Tamura, Yutaka] Rakuno Gakuen Univ, Sch Vet Med, Dept Hlth & Environm Sci, Lab Food Microbiol & Food Safety, Ebetsu, Hokkaido 069, Japan; [Yokota, Shin-ichi] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan; [Izumiyama, Satoshi] Nemuro Dist Agr Mutual Aid Assoc, Nakashibetsu, Hokkaido, Japan	Rakuno Gakuen University; Sapporo Medical University	Tamura, Y (corresponding author), Rakuno Gakuen Univ, Sch Vet Med, Dept Hlth & Environm Sci, Lab Food Microbiol & Food Safety, Ebetsu, Hokkaido 069, Japan.	tamuray@rakuno.ac.jp	Yokota, Shin-ichi/K-8139-2019; Okubo, Torahiko/Q-1707-2019; Sato, Toyotaka/J-4685-2019	Yokota, Shin-ichi/0000-0002-0831-3429; Okubo, Torahiko/0000-0002-3194-5862; 	Japanese Ministry of Agriculture, Forestry, and Fisheries; Program for Developing the Supporting System for Upgrading Education and Research from the Japan Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Agriculture, Forestry, and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Program for Developing the Supporting System for Upgrading Education and Research from the Japan Ministry of Education, Culture, Sports, Science, and Technology	This study was supported in part by a Grant-in-Aid from the Japanese Ministry of Agriculture, Forestry, and Fisheries and a grant from the Program for Developing the Supporting System for Upgrading Education and Research from the Japan Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander TW, 2010, INT J FOOD MICROBIOL, V137, P40, DOI 10.1016/j.ijfoodmicro.2009.11.008; Asai T, 2005, JPN J INFECT DIS, V58, P369; Bergman M, 2009, ANTIMICROB AGENTS CH, V53, P912, DOI 10.1128/AAC.00856-08; Bertrand S, 2006, J CLIN MICROBIOL, V44, P2897, DOI 10.1128/JCM.02549-05; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Cavaco LM, 2008, ANTIMICROB AGENTS CH, V52, P3612, DOI 10.1128/AAC.00354-08; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Chong Y, 2011, EUR J CLIN MICROBIOL, V30, P83, DOI 10.1007/s10096-010-1057-1; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; CLSI, 2020, PERFORMANCE STANDARD, V5th ed.; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Donaldson SC, 2006, APPL ENVIRON MICROB, V72, P3940, DOI 10.1128/AEM.02770-05; FAO/WHO/OIE, 2007, JOINT FAO WHO OIE EX; Jouini A, 2007, J ANTIMICROB CHEMOTH, V60, P1137, DOI 10.1093/jac/dkm316; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005; Liebana E, 2006, J CLIN MICROBIOL, V44, P1630, DOI 10.1128/JCM.44.5.1630-1634.2006; Ma L, 1998, ANTIMICROB AGENTS CH, V42, P1181, DOI 10.1128/AAC.42.5.1181; Matsumoto Y, 2007, JPN J INFECT DIS, V60, P236; NURU S, 1972, CORNELL VET, V62, P242; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Shiraki Y, 2004, EMERG INFECT DIS, V10, P69, DOI 10.3201/eid1001.030219; Singer RS, 2008, APPL ENVIRON MICROB, V74, P6956, DOI 10.1128/AEM.01241-08; Sugawara M, 2011, J VET MED SCI, V73, P345, DOI 10.1292/jvms.10-0156; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Uchida Y, 2010, INT J ANTIMICROB AG, V35, P444, DOI 10.1016/j.ijantimicag.2009.12.012; Winokur PL, 2001, ANTIMICROB AGENTS CH, V45, P2716, DOI 10.1128/AAC.45.10.2716-2722.2001; World Health Organization, 2007, P 2 WHO EXP M COP DE; Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0	33	24	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96101	10.1371/journal.pone.0096101	http://dx.doi.org/10.1371/journal.pone.0096101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755996	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300136
J	Cong, RH; Wang, XJ; Xu, MG; Ogle, SM; Parton, WJ				Cong, Rihuan; Wang, Xiujun; Xu, Minggang; Ogle, Stephen M.; Parton, William J.			Evaluation of the CENTURY Model Using Long-Term Fertilization Trials under Corn-Wheat Cropping Systems in the Typical Croplands of China	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; SIMULATING SOC CHANGES; NORTHERN CHINA; CLIMATE-CHANGE; FOOD SECURITY; DNDC MODEL; NO-TILLAGE; SEQUESTRATION; NITROGEN; DYNAMICS	Soil organic matter models are widely used to study soil organic carbon (SOC) dynamics. Here, we used the CENTURY model to simulate SOC in wheat-corn cropping systems at three long-term fertilization trials. Our study indicates that CENTURY can simulate fertilization effects on SOC dynamics under different climate and soil conditions. The normalized root mean square error is less than 15% for all the treatments. Soil carbon presents various changes under different fertilization management. Treatment with straw return would enhance SOC to a relatively stable level whereas chemical fertilization affects SOC differently across the three sites. After running CENTURY over the period of 1990-2050, the SOC levels are predicted to increase from 31.8 to 52.1 Mg ha(-1) across the three sites. We estimate that the carbon sequestration potential between 1990 and 2050 would be 9.4-35.7 Mg ha(-1) under the current high manure application at the three sites. Analysis of SOC in each carbon pool indicates that long-term fertilization enhances the slow pool proportion but decreases the passive pool proportion. Model results suggest that change in the slow carbon pool is the major driver of the overall trends in SOC stocks under long-term fertilization.	[Cong, Rihuan; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Crop Nutr & Fertilizat, Beijing 100193, Peoples R China; [Cong, Rihuan] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China; [Wang, Xiujun] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Wang, Xiujun] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Ogle, Stephen M.; Parton, William J.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; University System of Maryland; University of Maryland College Park; Colorado State University	Xu, MG (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Crop Nutr & Fertilizat, Beijing 100193, Peoples R China.	mgxu@caas.ac.cn	Wang, Xiujun/F-2641-2010	Wang, Xiujun/0000-0002-2859-8011; Ogle, Stephen/0000-0003-1899-7446	National Science Foundation of China [41171239]; National Basic Research Program [2011CB100501]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	Financial supports are from the National Science Foundation of China (41171239) and the National Basic Research Program (2011CB100501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro-Fuentes J, 2009, AGR ECOSYST ENVIRON, V134, P211, DOI 10.1016/j.agee.2009.07.001; [Anonymous], 1993, CENTURY SOIL ORGANIC; Bhattacharyya T, 2010, AGR ECOSYST ENVIRON, V139, P264, DOI 10.1016/j.agee.2010.08.012; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Bruun S, 2003, SOIL BIOL BIOCHEM, V35, P67, DOI 10.1016/S0038-0717(02)00237-7; Cerri CEP, 2007, AGR ECOSYST ENVIRON, V122, P46, DOI 10.1016/j.agee.2007.01.007; Cheng WX, 1996, SOIL BIOL BIOCHEM, V28, P1283, DOI 10.1016/S0038-0717(96)00138-1; Chilcott CR, 2007, AUST J SOIL RES, V45, P206, DOI 10.1071/SR06105; Cong RH, 2012, EUR J SOIL SCI, V63, P341, DOI 10.1111/j.1365-2389.2012.01448.x; Cong RH, 2012, NUTR CYCL AGROECOSYS, V93, P201, DOI 10.1007/s10705-012-9510-4; Denef K, 2004, SOIL SCI SOC AM J, V68, P1935, DOI 10.2136/sssaj2004.1935; Domke GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059949; Dumanski J, 1998, CLIMATIC CHANGE, V40, P81, DOI 10.1023/A:1005390815340; Edmeades DC, 2003, NUTR CYCL AGROECOSYS, V66, P165, DOI 10.1023/A:1023999816690; Falloon P, 2003, SOIL USE MANAGE, V19, P265, DOI [10.1079/SUM2003201, 10.1111/j.1475-2743.2003.tb00313.x]; Falloon P, 2002, SOIL USE MANAGE, V18, P101, DOI [10.1079/SUM2001108, 10.1111/j.1475-2743.2002.tb00227.x]; Fang Dong-ming, 2012, Yingyong Shengtai Xuebao, V23, P2411; Feng XM, 2011, ECOL INDIC, V11, P175, DOI 10.1016/j.ecolind.2009.07.002; Halvorson AD, 1999, SOIL SCI SOC AM J, V63, P912, DOI 10.2136/sssaj1999.634912x; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Kelly RH, 1997, GEODERMA, V81, P75, DOI 10.1016/S0016-7061(97)00082-7; Kong AYY, 2005, SOIL SCI SOC AM J, V69, P1078, DOI 10.2136/sssaj2004.0215; Korschens M., 2006, Plant, Soil and Environment, V52, P1; Lal R, 2007, SOIL SCI, V172, P943, DOI 10.1097/ss.0b013e31815cc498; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li CS, 2003, ECOL APPL, V13, P327, DOI 10.1890/1051-0761(2003)013[0327:MSOCCI]2.0.CO;2; Lu F, 2009, GLOBAL CHANGE BIOL, V15, P281, DOI 10.1111/j.1365-2486.2008.01743.x; Manzoni S, 2009, SOIL BIOL BIOCHEM, V41, P1355, DOI 10.1016/j.soilbio.2009.02.031; Metherell AK, 1993, PLANT PRODUCTION SUB; Ogle SM, 2007, ECOL MODEL, V205, P453, DOI 10.1016/j.ecolmodel.2007.03.007; PARTON WJ, 1994, SOIL SCI SOC AM J, V58, P530, DOI 10.2136/sssaj1994.03615995005800020040x; PAUSTIAN K, 1992, SOIL SCI SOC AM J, V56, P476, DOI 10.2136/sssaj1992.03615995005600020023x; R.F F, 2001, SOIL TILLAGE RES, V61, P77; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Schuman GE, 2002, ENVIRON POLLUT, V116, P391, DOI 10.1016/S0269-7491(01)00215-9; Shirato Y, 2005, SOIL SCI PLANT NUTR, V51, P405, DOI 10.1111/j.1747-0765.2005.tb00046.x; Smith JU, 1996, NATO ASI SER 1, V38, P181; Smith P, 1997, GEODERMA, V81, P153, DOI 10.1016/S0016-7061(97)00087-6; Tang HJ, 2006, GEODERMA, V134, P200, DOI 10.1016/j.geoderma.2005.10.005; Thomsen IK, 2004, SOIL USE MANAGE, V20, P432, DOI 10.1079/SUM2004281; Tonitto C, 2007, NUTR CYCL AGROECOSYS, V78, P51, DOI 10.1007/s10705-006-9076-0; Van Heemst H.D.J., 1986, MODELLING AGR PRODUC, V1st ed., P13; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang SH, 2011, PEDOSPHERE, V21, P277, DOI 10.1016/S1002-0160(11)60128-8; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Yan HM, 2007, AGR ECOSYST ENVIRON, V121, P325, DOI 10.1016/j.agee.2006.11.008; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Zhang HM, 2008, COMMUN SOIL SCI PLAN, V39, P1583, DOI 10.1080/00103620802071721; Zhang W., 2012, J NANOMATER, V2012, P1; Zhang WJ, 2010, BIOGEOSCIENCES, V7, P409, DOI 10.5194/bg-7-409-2010; Zhao BQ, 2010, AGRON J, V102, P216, DOI 10.2134/agronj2009.0182	51	17	20	12	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95142	10.1371/journal.pone.0095142	http://dx.doi.org/10.1371/journal.pone.0095142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751981	gold, Green Submitted, Green Published			2022-12-25	WOS:000335227400035
J	Paspaliari, DK; Mollerup, MS; Kallipolitis, BH; Ingmer, H; Larsen, MH				Paspaliari, Dafni Katerina; Mollerup, Maria Storm; Kallipolitis, Birgitte H.; Ingmer, Hanne; Larsen, Marianne Halberg			Chitinase Expression in Listeria monocytogenes Is Positively Regulated by the Agr System	PLOS ONE			English	Article							QUORUM SENSING SYSTEMS; CHITINOLYTIC ACTIVITY; SERRATIA-MARCESCENS; EGD-E; VIRULENCE; BINDING; DIFFUSION; DEGRADATION; PROTEINS; DYNAMICS	The food-borne pathogen Listeria monocytogenes encodes two chitinases, ChiA and ChiB, which allow the bacterium to hydrolyze chitin, the second most abundant polysaccharide in nature. Intriguingly, despite the absence of chitin in human and mammalian hosts, both of the chitinases have been deemed important for infection, through a mechanism that, at least in the case of ChiA, involves modulation of host immune responses. In this study, we show that the expression of the two chitinases is subject to regulation by the listerial agr system, a homologue of the agr quorum-sensing system of Staphylococcus aureus, that has so far been implicated in virulence and biofilm formation. We demonstrate that in addition to these roles, the listerial agr system is required for efficient chitin hydrolysis, as deletion of agrD, encoding the putative precursor of the agr autoinducer, dramatically decreased chitinolytic activity on agar plates. Agr was specifically induced in response to chitin addition in stationary phase and agrD was found to regulate the amount of chiA, but not chiB, transcripts. Although the transcript levels of chiB did not depend on agrD, the extracellular protein levels of both chitinases were reduced in the Delta agrD mutant. The regulatory effect of agr on chiA is potentially mediated through the small RNA LhrA, which we show here to be negatively regulated by agr. LhrA is in turn known to repress chiA translation by binding to the chiA transcript and interfering with ribosome recruitment. Our results highlight a previously unrecognized role of the agr system and suggest that autoinducer-based regulation of chitinolytic systems may be more commonplace than previously thought.	[Paspaliari, Dafni Katerina; Ingmer, Hanne; Larsen, Marianne Halberg] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Mollerup, Maria Storm; Kallipolitis, Birgitte H.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Copenhagen; University of Southern Denmark	Larsen, MH (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	mhl@sund.ku.dk		Kallipolitis, Birgitte H./0000-0003-1233-9776; Ingmer, Hanne/0000-0002-8350-5631; Mollerup, Maria Storm/0000-0002-8042-1977; Larsen, Marianne Halberg/0000-0001-6242-6937	Danish Council for Independent Research - Technology and Production Sciences [09-067081]; Danish AgriFish Agency [3304-FVFP-09-F-013-1]; Danish Dairy foundation and The Danish Council for Independent Research - Natural Sciences [12-1247735]	Danish Council for Independent Research - Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Danish AgriFish Agency; Danish Dairy foundation and The Danish Council for Independent Research - Natural Sciences	This work was supported by grants from The Danish Council for Independent Research - Technology and Production Sciences (09-067081), the Danish AgriFish Agency (3304-FVFP-09-F-013-1), the Danish Dairy foundation and The Danish Council for Independent Research - Natural Sciences (12-1247735, to B. H. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Alden L, 2001, APPL ENVIRON MICROB, V67, P1830, DOI 10.1128/AEM.67.4.1830-1838.2001; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Aluwihare LI, 2005, SCIENCE, V308, P1007, DOI 10.1126/science.1108925; Autret N, 2003, INFECT IMMUN, V71, P4463, DOI 10.1128/IAI.71.8.4463-4471.2003; Beier S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00149; Bou-m'handi N, 2007, FOODBORNE PATHOG DIS, V4, P409, DOI 10.1089/fpd.2007.0019; Chaudhuri S, 2013, MBIO, V4, DOI 10.1128/mBio.00617-12; Chaudhuri S, 2010, APPL ENVIRON MICROB, V76, P7302, DOI 10.1128/AEM.01338-10; Chernin LS, 1998, J BACTERIOL, V180, P4435, DOI 10.1128/JB.180.17.4435-4441.1998; Christensen AB, 2003, MICROBIOL-SGM, V149, P471, DOI 10.1099/mic.0.25575-0; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Cooksley CM, 2010, APPL ENVIRON MICROB, V76, P4448, DOI 10.1128/AEM.03038-09; Coulthurst SJ, 2006, MICROBIOL-SGM, V152, P1899, DOI 10.1099/mic.0.28803-0; DeAngelis KM, 2008, FEMS MICROBIOL ECOL, V66, P197, DOI 10.1111/j.1574-6941.2008.00550.x; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Defoirdt T, 2010, ENV MICROBIOL REP, V2, P44, DOI 10.1111/j.1758-2229.2009.00043.x; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Garmyn D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043154; Garmyn D, 2011, APPL ENVIRON MICROB, V77, P6286, DOI 10.1128/AEM.02891-10; Garmyn Dominique, 2009, Commun Integr Biol, V2, P371; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gooday GW, 1990, BIODEGRADATION, V1, P177, DOI 10.1007/BF00058835; Gray B, 2013, SENSORS-BASEL, V13, P5130, DOI 10.3390/s130405130; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Larsen MH, 2010, APPL ENVIRON MICROB, V76, P6470, DOI 10.1128/AEM.00297-10; Leisner JJ, 2008, APPL ENVIRON MICROB, V74, P3823, DOI 10.1128/AEM.02701-07; Leisner JJ, 2009, J APPL MICROBIOL, V107, P2080, DOI 10.1111/j.1365-2672.2009.04420.x; Locatelli A, 2013, J MICROBIOL METH, V93, P242, DOI 10.1016/j.mimet.2013.03.017; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; Nielsen JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019019; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Piveteau P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024881; Platt TG, 2010, TRENDS MICROBIOL, V18, P383, DOI 10.1016/j.tim.2010.05.003; Raghupathi PK, 2013, CHITINASES LIS UNPUB; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Rieu A, 2007, APPL ENVIRON MICROB, V73, P6125, DOI 10.1128/AEM.00608-07; Rieu A, 2008, APPL ENVIRON MICROB, V74, P4491, DOI 10.1128/AEM.00255-08; Schauer K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-573; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Waidmann MS, 2012, THESIS U ULM; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Wuster A, 2008, J BACTERIOL, V190, P743, DOI 10.1128/JB.01135-07	53	19	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95385	10.1371/journal.pone.0095385	http://dx.doi.org/10.1371/journal.pone.0095385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752234	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400059
J	Gao, ZQ; Wang, M; Blair, D; Zheng, YD; Dou, YX				Gao, Zeqian; Wang, Miao; Blair, David; Zheng, Yadong; Dou, Yongxi			Phylogenetic Analysis of the Endoribonuclease Dicer Family	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA; EVOLUTION; RIBONUCLEASE; RECOGNITION; MICRORNAS; SELECTION; MECHANISM; CLEAVAGE; ORIGINS	Dicers are proteins of the ribonuclease III family with the ability to process dsRNA, involved in regulation of gene expression at the post-transcriptional level. Dicers are conserved from basal metazoans to higher metazoans and contain a number of functional domains that interact with dsRNA. The completed genome sequences of over 34 invertebrate species allowed us to systematically investigate Dicer genes over a diverse range of phyla. The majority of invertebrate Dicers clearly fell into the Dicer1 or Dicer2 subfamilies. Most nematodes possessed only one Dicer gene, a member of the Dicer1 subfamily, whereas two Dicer genes (Dicer1 and Dicer2) were present in all platyhelminths surveyed. Analysis of the key domains showed that a 5' pocket was conserved across members of the Dicer1 subfamily, with the exception of the nematode Bursaphelenchus xylophilus. Interestingly, Nematostella vectensis DicerB grouped into Dicer2 subfamily harbored a 5' pocket, which is commonly present in Dicer1. Similarly, the 3' pocket was also found to be conserved in all Dicer proteins with the exceptions of Schmidtea mediterranea Dicer2 and Trichoplax adherens Dicer A. The loss of catalytic residues in the RNase III domain was noted in platyhelminths and cnidarians, and the 'ball' and 'socket' junction between two RNase III domains in platyhelminth Dicers was different from the canonical junction, suggesting the possibility of different conformations. The present data suggest that Dicers might have duplicated and diversified independently, and have evolved for various functions in invertebrates.	[Gao, Zeqian; Wang, Miao; Zheng, Yadong; Dou, Yongxi] CAAS, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China; [Blair, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; James Cook University	Zheng, YD (corresponding author), CAAS, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China.	zhengyadong@caas.cn; douyongxi@caas.cn	Blair, David/O-2786-2019; YD, Zh/HGA-5541-2022	Blair, David/0000-0002-4658-3251; YD, Zh/0000-0001-6795-9978	Gansu Natural Science Foundation [0710RJZA081]; State Public-interest Institution Basal Research Fund; Special Fund for Agro-scientific Research in the Public Interest [201103008]	Gansu Natural Science Foundation; State Public-interest Institution Basal Research Fund; Special Fund for Agro-scientific Research in the Public Interest	This work was financially sponsored by Gansu Natural Science Foundation (0710RJZA081), State Public-interest Institution Basal Research Fund and by Special Fund for Agro-scientific Research in the Public Interest (201103008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Jong D, 2009, MOL BIOL EVOL, V26, P1333, DOI 10.1093/molbev/msp042; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; HE L, 2004, NAT REV GENET, V5, P522; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Ji XH, 2006, ACTA CRYSTALLOGR D, V62, P933, DOI 10.1107/S090744490601153X; Krishna S, 2013, NUCLEIC ACIDS RES, V41, P599, DOI 10.1093/nar/gks1020; Kurimoto K, 2005, J STRUCT BIOL, V150, P58, DOI 10.1016/j.jsb.2005.01.006; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Moran Y, 2013, MOL BIOL EVOL, V30, P2541, DOI 10.1093/molbev/mst159; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	27	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95350	10.1371/journal.pone.0095350	http://dx.doi.org/10.1371/journal.pone.0095350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748168	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000335226500089
J	Li, YF; Zhao, SH; Wang, YL; Chen, YL; Lin, Y; Zhu, NH; Zheng, HD; Wu, M; Cheng, DX; Li, YD; Bai, L; Fan, JL; Liu, EQ				Li, Yafeng; Zhao, Sihai; Wang, Yanli; Chen, Yulong; Lin, Yan; Zhu, Ninghong; Zheng, Huadong; Wu, Min; Cheng, Daxing; Li, Yandong; Bai, Liang; Fan, Jianglin; Liu, Enqi			Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits	PLOS ONE			English	Article							CYSTEINE PROTEASE CATHEPSINS; MUSCLE-CELL-PROLIFERATION; CAROTID ATHEROSCLEROSIS; PLASMA UROTENSIN; IMMUNOREACTIVITY; MACROPHAGES; DISEASE	Urotensin II (UII) is a vasoactive peptide composed of 11 amino acids that has been implicated to contribute to the development of cardiovascular disease. The purpose of this study was to investigate whether UII affects the development of atherosclerosis in cholesterol-fed rabbits. UII was infused for 16 weeks through an osmotic mini-pump into male Japanese White rabbits fed on a high-cholesterol diet. Plasma lipids and body weight were measured every 4 weeks. Aortic atherosclerotic lesions along with cellular components, collagen fibers, matrix metalloproteinase-1 and -9 were examined. Moreover, vulnerability index of atherosclerotic plaques was evaluated. UII infusion significantly increased atherosclerotic lesions within the entire aorta by 21% over the control (P = 0.013). Atherosclerotic lesions were increased by 24% in the aortic arch (P = 0.005), 11% in the thoracic aorta (P = 0.054) and 18% in the abdominal aorta (P = 0.035). These increases occurred without changes in plasma levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides or body weight. Immunohistochemical staining revealed that macrophages and matrix metalloproteinase-9 were significantly enhanced by 2.2-fold and 1.6-fold in UII group. In vitro studies demonstrated that UII up-regulated the expression of vascular cell adhesion protein-1 and intercellular adhesion molecule-1 in human umbilical vein endothelial cells, which was inhibited by the UII receptor antagonist urantide. In conclusion, our results showed that UII promotes the development of atherosclerotic lesions and destabilizes atherosclerotic plaques in cholesterol-fed rabbits.	[Li, Yafeng; Zhao, Sihai; Wang, Yanli; Chen, Yulong; Lin, Yan; Zhu, Ninghong; Zheng, Huadong; Wu, Min; Cheng, Daxing; Li, Yandong; Bai, Liang; Liu, Enqi] Xi An Jiao Tong Univ, Lab Lipid Metab & Atherosclerosis, Cardiovasc Res Ctr, Xian 710049, Shaanxi, Peoples R China; [Li, Yafeng; Zhao, Sihai; Wang, Yanli; Chen, Yulong; Lin, Yan; Zhu, Ninghong; Li, Yandong; Bai, Liang; Liu, Enqi] Xi An Jiao Tong Univ, Lab Anim Ctr, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Yamanashi	Zhao, SH (corresponding author), Xi An Jiao Tong Univ, Lab Lipid Metab & Atherosclerosis, Cardiovasc Res Ctr, Xian 710049, Shaanxi, Peoples R China.	sihaizhao@mail.xjtu.edu.cn; liuenqi@mail.xjtu.edu.cn	liu, enqi/S-7771-2019	Fan, Jianglin/0000-0002-1737-6130; Zhao, Sihai/0000-0002-5845-6639; Liu, Enqi/0000-0002-2092-3158	National Natural Science Foundation of China [81070250, 30900526]; Public Service Platform Grant from Shaanxi Province [2012FWPT-03]; Grants-in-Aid for Scientific Research [25670190] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Platform Grant from Shaanxi Province; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the National Natural Science Foundation of China(81070250, 30900526), by a Public Service Platform Grant from Shaanxi Province (2012FWPT-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Chen YL, 2013, THROMB RES, V132, P565, DOI 10.1016/j.thromres.2013.09.007; Cheng XW, 2012, CIRCULATION, V125, P1551, DOI 10.1161/CIRCULATIONAHA.111.066712; Cheng XW, 2011, HYPERTENSION, V58, P978, DOI 10.1161/HYPERTENSIONAHA.111.180935; Cheung BMY, 2004, J HYPERTENS, V22, P1341, DOI 10.1097/01.hjh.0000125452.28861.f1; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Douglas SA, 2000, TRENDS CARDIOVAS MED, V10, P229, DOI 10.1016/S1050-1738(00)00069-4; Heringlake M, 2004, REGUL PEPTIDES, V121, P129, DOI 10.1016/j.regpep.2004.04.012; Lapp H, 2004, INT J CARDIOL, V94, P93, DOI 10.1016/j.ijcard.2003.05.008; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Loirand G, 2008, PEPTIDES, V29, P778, DOI 10.1016/j.peptides.2007.08.024; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Ng LL, 2002, CIRCULATION, V106, P2877, DOI 10.1161/01.CIR.0000044388.19119.02; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Rodriguez-Moyano M, 2013, CARDIOVASC RES, V100, P297, DOI 10.1093/cvr/cvt196; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; Shiomi M, 2005, ATHEROSCLEROSIS, V178, P287, DOI 10.1016/j.atherosclerosis.2004.10.024; Shiraishi Y, 2008, J HYPERTENS, V26, P1955, DOI 10.1097/HJH.0b013e32830b61d8; Suguro T, 2007, AM J HYPERTENS, V20, P211, DOI 10.1016/j.amjhyper.2006.08.001; Suguro T, 2008, CLIN SCI, V115, P327, DOI 10.1042/CS20080014; Tamura K, 2003, LIFE SCI, V72, P1049, DOI 10.1016/S0024-3205(02)02346-9; Totsune K, 2001, LANCET, V358, P810, DOI 10.1016/S0140-6736(01)06002-0; Tran L, 2010, AM J PHYSIOL-HEART C, V298, pH608, DOI 10.1152/ajpheart.00942.2009; Watanabe T, 2005, HYPERTENSION, V46, P738, DOI 10.1161/01.HYP.0000184226.99196.b5; Zhang C, 2010, J COMP PATHOL, V142, P122, DOI 10.1016/j.jcpa.2009.08.159	25	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95089	10.1371/journal.pone.0095089	http://dx.doi.org/10.1371/journal.pone.0095089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747943	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500057
J	Jin, SX; Bartolome, C; Arai, JA; Hoffman, L; Uzturk, BG; Kumar-Singh, R; Waxham, MN; Feig, LA				Jin, Shan-Xue; Bartolome, Christopher; Arai, Junko A.; Hoffman, Laurel; Uzturk, B. Gizem; Kumar-Singh, Rajendra; Waxham, M. Neal; Feig, Larry A.			Domain Contributions to Signaling Specificity Differences Between Ras-Guanine Nucleotide Releasing Factor (Ras-GRF) 1 and Ras-GRF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE CASCADE; SYNAPTIC PLASTICITY; MAP KINASE; COMPLEX-FORMATION; NMDA RECEPTOR; ERK PATHWAY; CALMODULIN; ACTIVATION; CALCIUM	Ras-GRF1 (GRF1) and Ras-GRF2 (GRF2) constitute a family of similar calcium sensors that regulate synaptic plasticity. They are both guanine exchange factors that contain a very similar set of functional domains, including N-terminal pleckstrin homology, coiled-coil, and calmodulin-binding IQ domains and C-terminal Dbl homology Rac-activating domains, Ras-exchange motifs, and CDC25 Ras-activating domains. Nevertheless, they regulate different forms of synaptic plasticity. Although both GRF proteins transduce calcium signals emanating from NMDA-type glutamate receptors in the CA1 region of the hippocampus, GRF1 promotes LTD, whereas GRF2 promotes theta-burst stimulation-induced LTP (TBS-LTP). GRF1 can also mediate high frequency stimulation-induced LTP (HFS-LTP) in mice over 2-months of age, which involves calcium-permeable AMPA-type glutamate receptors. To add to our understanding of how proteins with similar domains can have different functions, WT and various chimeras between GRF1 and GRF2 proteins were tested for their abilities to reconstitute defective LTP and/or LTD in the CA1 hippocampus of Grf1/Grf2 double knock-out mice. These studies revealed a critical role for the GRF2 CDC25 domain in the induction of TBS-LTP by GRF proteins. In contrast, the N-terminal pleckstrin homology and/or coiled-coil domains of GRF1 are key to the induction of HFS-LTP by GRF proteins. Finally, the IQ motif of GRF1 determines whether a GRF protein can induce LTD. Overall, these findings show that for the three forms of synaptic plasticity that are regulated by GRF proteins in the CA1 hippocampus, specificity is encoded in only one or two domains, and a different set of domains for each form of synaptic plasticity.	[Jin, Shan-Xue; Bartolome, Christopher; Arai, Junko A.; Uzturk, B. Gizem; Kumar-Singh, Rajendra; Feig, Larry A.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Hoffman, Laurel; Waxham, M. Neal] Univ Texas Houston, Dept Neurobiol & Anat, Houston, TX 77225 USA	Tufts University; University of Texas System; University of Texas Health Science Center Houston	Feig, LA (corresponding author), 136 Harrison Ave, Boston, MA 02111 USA.	larry.feig@tufts.edu		Waxham, M. Neal/0000-0003-4801-1190; Kumar-Singh, Rajendra/0000-0002-7754-0713	National Institutes of Health through the Tufts Center for Neuroscience Research [RO1 MH083324, RO1 GM097553, P30 NS047243]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097553, R25GM066567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health through the Tufts Center for Neuroscience Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 MH083324 (to L. A. F.) and RO1 GM097553 (to M. N. W.) and Grant P30 NS047243 through the Tufts Center for Neuroscience Research.	Akyol Z, 2004, J BIOL CHEM, V279, P2166, DOI 10.1074/jbc.M302542200; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Buchsbaum R, 1996, MOL CELL BIOL, V16, P4888; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; d'Isa R, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00078; Darcy MJ, 2014, HIPPOCAMPUS, V24, P315, DOI 10.1002/hipo.22225; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Feig Larry A, 2011, Genes Cancer, V2, P306, DOI 10.1177/1947601911408077; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Hoffman L, 2014, J BIOL CHEM, V289, P14644, DOI 10.1074/jbc.M114.560656; Jin SX, 2013, J BIOL CHEM, V288, P21703, DOI 10.1074/jbc.M113.471904; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kumar V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01392; Li SM, 2006, CURR BIOL, V16, P2303, DOI 10.1016/j.cub.2006.10.028; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Quintana AR, 2005, BIOCHEM BIOPH RES CO, V334, P674, DOI 10.1016/j.bbrc.2005.06.152; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Silingardi D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00084; Stacey D, 2012, P NATL ACAD SCI USA, V109, P21128, DOI 10.1073/pnas.1211844110; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zippel R, 1997, MOL BRAIN RES, V48, P140	36	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16551	16564		10.1074/jbc.M114.557959	http://dx.doi.org/10.1074/jbc.M114.557959			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755227	Green Published, hybrid			2022-12-25	WOS:000337965700056
J	Body, G; Weladji, RB; Holand, O; Nieminen, M				Body, Guillaume; Weladji, Robert B.; Holand, Oystein; Nieminen, Mauri			Highly Competitive Reindeer Males Control Female Behavior during the Rut	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; MALE PHENOTYPIC QUALITY; MATE CHOICE; RED DEER; RANGIFER-TARANDUS; GROUP-SIZE; SOCIAL COHESION; SEX-RATIO; REPRODUCTIVE EFFORT; ANTLER SIZE	During the rut, female ungulates move among harems or territories, either to sample mates or to avoid harassment. Females may be herded by a male, may stay with a preferred male, or aggregate near a dominant male to avoid harassment from other males. In fission-fusion group dynamics, female movement is best described by the group's fission probability, instead of inter-harem movement. In this study, we tested whether male herding ability, female mate choice or harassment avoidance influence fission probability. We recorded group dynamics in a herd of reindeer Rangifer tarandus equipped with GPS collars with activity sensors. We found no evidence that the harassment level in the group affected fission probability, or that females sought high rank (i.e. highly competitive and hence successful) males. However, the behavior of high ranked males decreased fission probability. Male herding activity was synchronous with the decrease of fission probability observed during the rut. We concluded that male herding behavior stabilized groups, thereby increasing average group size and consequently the opportunity for sexual selection.	[Body, Guillaume; Weladji, Robert B.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Holand, Oystein] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Nieminen, Mauri] Finnish Game & Fisheries Res Inst, Reindeer Res Stn, Kaamanen, Finland	Concordia University - Canada; Norwegian University of Life Sciences; Natural Resources Institute Finland (Luke)	Weladji, RB (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	robert.weladji@concordia.ca			Natural Sciences and Engineering Research Council of Canada; Research Council of Norway; Quebec Centre for Biodiversity Sciences	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research Council of Norway(Research Council of Norway); Quebec Centre for Biodiversity Sciences	The authors also acknowledge the financial support of the Natural Sciences and Engineering Research Council of Canada (to RBW), the Research Council of Norway to OH and of the Quebec Centre for Biodiversity Sciences to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung M, 2001, J MAMMAL, V82, P836, DOI 10.1644/1545-1542(2001)082<0836:EASOOA>2.0.CO;2; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2012, BEHAV ECOL, V23, P1308, DOI 10.1093/beheco/ars122; Body G, 2012, BEHAV ECOL SOCIOBIOL, V66, P1531, DOI 10.1007/s00265-012-1414-4; Bowyer RT, 2011, BEHAV ECOL SOCIOBIOL, V65, P2251, DOI 10.1007/s00265-011-1234-y; Bro-Jorgensen J, 2011, EVOL BIOL, V38, P28, DOI 10.1007/s11692-010-9105-4; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Byers JA, 2005, AM NAT, V166, P661, DOI 10.1086/497401; BYERS JA, 1994, ANIM BEHAV, V47, P33, DOI 10.1006/anbe.1994.1005; Carranza J, 1999, BEHAV ECOL, V10, P525, DOI 10.1093/beheco/10.5.525; CARRANZA J, 1995, ANIM BEHAV, V50, P445, DOI 10.1006/anbe.1995.0258; Carter AJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P237, DOI 10.1007/s00265-009-0840-4; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; CLUTTONBROCK T, 1993, BEHAV ECOL, V4, P191, DOI 10.1093/beheco/4.3.191; CLUTTONBROCK TH, 1992, BEHAV ECOL, V3, P234, DOI 10.1093/beheco/3.3.234; Conradt L, 2000, P ROY SOC B-BIOL SCI, V267, P2213, DOI 10.1098/rspb.2000.1271; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; Crawley MJ., 2007, R BOOK; Danchin E., 2008, BEHAV ECOLOGY; Darwin, 1871, DESCENT MAN SELECTIO; Djakovic N, 2012, ACTA ETHOL, V15, P165, DOI 10.1007/s10211-011-0121-x; ESPMARK Y, 1964, ANIM BEHAV, V12, P159, DOI 10.1016/0003-3472(64)90117-4; Ezenwa VO, 2008, ANIM BEHAV, V75, P2013, DOI 10.1016/j.anbehav.2007.12.013; Focardi S, 2005, BEHAV ECOL SOCIOBIOL, V59, P84, DOI 10.1007/s00265-005-0012-0; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Geist V., 1999, DEER WORLD THEIR EVO; Gerard JF, 2002, BIOL BULL, V202, P275, DOI 10.2307/1543479; HIROTANI A, 1989, APPL ANIM BEHAV SCI, V24, P183, DOI 10.1016/0168-1591(89)90066-X; Holand O, 2006, BEHAV ECOL SOCIOBIOL, V59, P682, DOI 10.1007/s00265-005-0097-5; Holand O., 2012, Rangifer, V32, P65; Isvaran K, 2005, CURR SCI INDIA, V89, P1192; Jedrzejewski W, 2006, J WILDLIFE MANAGE, V70, P1054, DOI 10.2193/0022-541X(2006)70[1054:GSDORD]2.0.CO;2; Kojola I., 1986, RANGIFER, V1, P173, DOI 10.7557/2.6.2.643; L'Italien L, 2012, ETHOLOGY, V118, P783, DOI 10.1111/j.1439-0310.2012.02073.x; Maher CR, 1997, SOUTHWEST NAT, V42, P25; Mainguy J, 2008, J MAMMAL, V89, P626, DOI 10.1644/07-MAMM-A-234R.1; Marshall HH, 2012, ANIM BEHAV, V84, P1295, DOI 10.1016/j.anbehav.2012.09.030; MCCOMB K, 1994, P ROY SOC B-BIOL SCI, V255, P13, DOI 10.1098/rspb.1994.0003; Melnycky NA, 2013, J MAMMAL, V94, P1371, DOI 10.1644/12-MAMM-A-282.1; Michelena P, 2008, APPL ANIM BEHAV SCI, V112, P81, DOI 10.1016/j.applanim.2007.06.020; Muller MN, 2011, BEHAV ECOL SOCIOBIOL, V65, P921, DOI 10.1007/s00265-010-1093-y; Mysterud A, 2003, J ZOOL, V261, P341, DOI 10.1017/S0952836903004114; Naulty F, 2013, FOLIA ZOOL, V62, P143; Nefdt RJC, 1997, BEHAV ECOL, V8, P1, DOI 10.1093/beheco/8.1.1; OZOGA JJ, 1975, J WILDLIFE MANAGE, V39, P679, DOI 10.2307/3800227; Pays O, 2007, ANIM BEHAV, V74, P1429, DOI 10.1016/j.anbehav.2007.02.012; Pays O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034678; REALE D, 1996, CAN J ZOOL, V74, P1812; Richard E, 2008, BEHAV PROCESS, V79, P28, DOI 10.1016/j.beproc.2008.04.008; Roed KH, 2002, MOL ECOL, V11, P1239, DOI 10.1046/j.1365-294X.2002.01509.x; Roed KH, 2007, P ROY SOC B-BIOL SCI, V274, P727, DOI 10.1098/rspb.2006.0214; Sanchez-Prieto CB, 2004, J MAMMAL, V85, P761, DOI 10.1644/BJK-122; Stopher KV, 2011, BEHAV ECOL, V22, P808, DOI 10.1093/beheco/arr052; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tennenhouse EM, 2012, ANN ZOOL FENN, V49, P152, DOI 10.5735/086.049.0303; Tennenhouse EM, 2011, BEHAV ECOL SOCIOBIOL, V65, P287, DOI 10.1007/s00265-010-1043-8; Vanpe C, 2007, AM NAT, V169, P481, DOI 10.1086/512046; Wade MJ, 2004, AM NAT, V164, pE83, DOI 10.1086/424531; Wiegmann DD, 2013, CURR ZOOL, V59, P184, DOI 10.1093/czoolo/59.2.184	64	12	12	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95618	10.1371/journal.pone.0095618	http://dx.doi.org/10.1371/journal.pone.0095618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759701	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000335298200070
J	Townroe, S; Callaghan, A				Townroe, Susannah; Callaghan, Amanda			British Container Breeding Mosquitoes: The Impact of Urbanisation and Climate Change on Community Composition and Phenology	PLOS ONE			English	Article							WEST-NILE-VIRUS; CULEX-PIPIENS; ABUNDANCE; DIPTERA; URBAN; TEMPERATURE	The proliferation of artificial container habitats in urban areas has benefitted urban adaptable mosquito species globally. In areas where mosquitoes transmit viruses and parasites, it can promote vector population productivity and fuel mosquito-borne disease outbreaks. In Britain, storage of water in garden water butts is increasing, potentially expanding mosquito larval habitats and influencing population dynamics and mosquito-human contact. Here we show that the community composition, abundance and phenology of mosquitoes breeding in experimental water butt containers were influenced by urbanisation. Mosquitoes in urban containers were less species-rich but present in significantly higher densities (100.4 +/- 21.3) per container than those in rural containers (77.7 +/- 15.1). Urban containers were dominated by Culex pipiens (a potential vector of West Nile Virus [WNV]) and appear to be increasingly exploited by Anopheles plumbeus (a human-biting potential WNV and malaria vector). Culex phenology was influenced by urban land use type, with peaks in larval abundances occurring earlier in urban than rural containers. Among other factors, this was associated with an urban heat island effect which raised urban air and water temperatures by 0.9 degrees C and 1.2 degrees C respectively. Further increases in domestic water storage, particularly in urban areas, in combination with climate changes will likely alter mosquito population dynamics in the UK.	[Townroe, Susannah; Callaghan, Amanda] Univ Reading, Sch Biol Sci, Reading, Berks, England	University of Reading	Callaghan, A (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	a.callaghan@reading.ac.uk		Callaghan, Amanda/0000-0002-2731-3352	NERC studentship [DTG 2010-14]	NERC studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Susannah Townroe was supported by a NERC studentship number DTG 2010-14 (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis TG, 2010, J AM MOSQUITO CONTR, V26, P257, DOI 10.2987/10-6004.1; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Burkett-Cadena ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017681; Ciota AT, 2011, J AM MOSQUITO CONTR, V27, P21, DOI 10.2987/8756-971X-27.1.21; Clements AN., 1992, BIOL MOSQUITOES DEV; Cranston PS, 1987, ADULTS LARAVE PUPAE, P1; Crawley M. J., 2009, R BOOK; Derraik Jose G.B., 2005, Entomotropica, V20, P89; GILLIES M T, 1982, Mosquito Systematics, V14, P127; Kolokotroni M, 2008, SOL ENERGY, V82, P986, DOI 10.1016/j.solener.2008.05.004; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Loetti V., 2011, Journal of Natural History, V45, P2203, DOI 10.1080/00222933.2011.590946; Marshall J. F., 1938, BRIT MOSQUITOES; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Medlock JM, 2007, EPIDEMIOL INFECT, V135, P466, DOI 10.1017/S0950268806007047; Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Onyeka JA, 1980, THESIS U LONDON; Papworth J, 2012, THREATENED HOSEPIPE; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Paz S, 2008, ECOHEALTH, V5, P40, DOI 10.1007/s10393-007-0150-0; Pecoraro HL, 2007, J VECTOR ECOL, V32, P22, DOI 10.3376/1081-1710(2007)32[22:CALCFP]2.0.CO;2; R Core Team, 2012, R LANG ENV STAT COMP; Reisen WK, 2008, J VECTOR ECOL, V33, P89, DOI 10.3376/1081-1710(2008)33[89:IOCVOM]2.0.CO;2; Reisen WK, 2010, J MED ENTOMOL, V47, P230, DOI 10.1603/ME09207; Reiskind MH, 2009, ECOL ENTOMOL, V34, P447, DOI 10.1111/j.1365-2311.2008.01067.x; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaffner F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-393; SERVICE MW, 1968, J ZOOL, V156, P313; Smith RM, 2005, LANDSCAPE ECOL, V20, P235, DOI 10.1007/s10980-004-3160-0; Snow K., 2008, European Mosquito Bulletin, P9; Snow Keith, 2006, European Mosquito Bulletin, V21, P1; Snow Keith, 1998, European Mosquito Bulletin, V1, P9; Statistics OfN, 2011, TABL H01 2011 CENS N; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; Yee DA, 2007, J MED ENTOMOL, V44, P580, DOI 10.1603/0022-2585(2007)44[580:DAIEOA]2.0.CO;2	39	68	70	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95325	10.1371/journal.pone.0095325	http://dx.doi.org/10.1371/journal.pone.0095325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759617	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000335298200048
J	Aguilar-Guzman, L; Lobos-Gonzalez, L; Rosas, C; Vallejos, G; Falcon, C; Sosoniuk, E; Coddou, F; Leyton, L; Lemus, D; Quest, AFG; Ferreira, A				Aguilar-Guzman, Lorena; Lobos-Gonzalez, Lorena; Rosas, Carlos; Vallejos, Gerardo; Falcon, Cristian; Sosoniuk, Eduardo; Coddou, Francisca; Leyton, Lisette; Lemus, David; Quest, Andrew F. G.; Ferreira, Arturo			Human Survivin and Trypanosoma cruzi Calreticulin Act in Synergy against a Murine Melanoma In Vivo	PLOS ONE			English	Article							ANTI-APOPTOSIS GENE; PROGNOSTIC-SIGNIFICANCE; TARGETING SURVIVIN; HUMAN-COMPLEMENT; 1ST COMPONENT; CELL-DIVISION; BINDING-SITE; CANCER; ANGIOGENESIS; EXPRESSION	Immune-based anti-tumor or anti-angiogenic therapies hold considerable promise for the treatment of cancer. The first approach seeks to activate tumor antigen-specific T lymphocytes while, the second, delays tumor growth by interfering with blood supply. Tumor Associated Antigens are often employed to target tumors with therapeutic drugs, but some are also essential for tumor viability. Survivin (Surv) is a member of the inhibitor of apoptosis protein family that is considered a Tumor Associated Antigen important for cancer cell viability and proliferation. On the other hand, Trypanosoma cruzi (the agent of Chagas' disease) calreticulin (TcCRT) displays remarkable anti-angiogenic properties. Because these molecules are associated with different tumor targets, we reasoned that immunization with a Surv-encoding plasmid (pSurv) and concomitant TcCRT administration should generate a stronger anti-tumor response than application of either treatment separately. To evaluate this possibility, C57BL/6 mice were immunized with pSurv and challenged with an isogenic melanoma cell line that had been pre-incubated with recombinant TcCRT (rTcCRT). Following tumor cell inoculation, mice were injected with additional doses of rTcCRT. For the combined regimen we observed in mice that: i). Tumor growth was impaired, ii). Humoral anti-rTcCRT immunity was induced and, iii). In vitro rTcCRT bound to melanocytes, thereby promoting the incorporation of human C1q and subsequent macrophage phagocytosis of tumor cells. These observations are interpreted to reflect the consequence of the following sequence of events: rTcCRT anti-angiogenic activity leads to stress in tumor cells. Murine CRT is then translocated to the external membrane where, together with rTcCRT, complement C1 is captured, thus promoting tumor phagocytosis. Presentation of the Tumor Associated Antigen Surv induces the adaptive anti-tumor immunity and, independently, mediates anti-endothelial cell immunity leading to an important delay in tumor growth.	[Aguilar-Guzman, Lorena; Rosas, Carlos; Vallejos, Gerardo; Falcon, Cristian; Sosoniuk, Eduardo; Coddou, Francisca; Ferreira, Arturo] Univ Chile, Fac Med, Inst Biomed Sci, Program Immunol, Santiago 7, Chile; [Lobos-Gonzalez, Lorena; Leyton, Lisette; Quest, Andrew F. G.] Univ Chile, Fac Med, Lab Cellular Commun, Ctr Mol Studies Cell,Program Cell & Mol Biol,Inst, Santiago 7, Chile; [Rosas, Carlos; Lemus, David] Univ Chile, Fac Med, Inst Biomed Sci, Program Anat & Dev Biol, Santiago 7, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Quest, AFG (corresponding author), Univ Chile, Fac Med, Lab Cellular Commun, Ctr Mol Studies Cell,Program Cell & Mol Biol,Inst, Santiago 7, Chile.	aquest@med.uchile.cl; aferreir@med.uchile.cl	Aguilar, Lorena/I-5867-2014; Rosas, Carlos/AAM-6774-2021; Rosas, Carlos/AAE-7385-2019; Ferreira, Arturo/I-1581-2013	Aguilar, Lorena/0000-0001-5540-8255; Rosas, Carlos/0000-0003-1787-9931; Lobos-Gonzalez, Lorena/0000-0002-4957-9864	National Fund for Scientific and Technological Development FONDECYT [1090071, 1130099]; FONDECYT-FONDAP [15010006]; Associative Research Project; CONICYT/PIA; ACT112	National Fund for Scientific and Technological Development FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); Associative Research Project; CONICYT/PIA; ACT112	This work was supported by grants from the National Fund for Scientific and Technological Development FONDECYT 1090071(AFGQ) and 1130099 (AF), FONDECYT-FONDAP 15010006 (AFGQ) and Associative Research Project, CONICYT/PIA, ACT112 (AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 2000, BRIT J HAEMATOL, V111, P196, DOI 10.1046/j.1365-2141.2000.02328.x; Adida C, 1998, AM J PATHOL, V152, P43; Adida C, 2000, BLOOD, V96, P1921; Aguilar L, 2005, BIOL RES, V38, P187, DOI 10.4067/S0716-97602005000200008; Aguilera R, 2011, CLIN CANCER RES, V17, P2474, DOI 10.1158/1078-0432.CCR-10-2384; Aguillon JC, 1997, ACTA TROP, V63, P159, DOI 10.1016/S0001-706X(96)00619-5; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2006, MOL CANCER THER, V5, P478, DOI 10.1158/1535-7163.MCT-05-0436; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Castillo C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002376; Eggleton P, 2000, CLIN EXP IMMUNOL, V120, P406, DOI 10.1046/j.1365-2249.2000.01218.x; Ferreira V, 2004, J IMMUNOL, V172, P3042, DOI 10.4049/jimmunol.172.5.3042; Ferreira V, 2004, MOL IMMUNOL, V40, P1279, DOI 10.1016/j.molimm.2003.11.018; Gabri MR, 2006, CLIN CANCER RES, V12, P7092, DOI 10.1158/1078-0432.CCR-06-1075; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Griffioen AW, 2000, PHARMACOL REV, V52, P237; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Liu XM, 2013, FISH SHELLFISH IMMUN, V35, P776, DOI 10.1016/j.fsi.2013.06.013; Lladser A, 2006, IMMUNOBIOLOGY, V211, P11, DOI 10.1016/j.imbio.2005.08.002; Lladser A, 2010, CANCER IMMUNOL IMMUN, V59, P81, DOI 10.1007/s00262-009-0725-4; Lopez NC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000730; Mahotka C, 1999, CANCER RES, V59, P6097; Marcelain K, 2000, ACTA TROP, V75, P291, DOI 10.1016/S0001-706X(00)00062-0; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Molina MC, 2005, MOL BIOCHEM PARASIT, V140, P133, DOI 10.1016/j.molbiopara.2004.12.014; Morley BJ, 2000, COMPLEMENT FACTSBOOK; National Research Council, 1996, GUIDE CARE USE LAB A; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; Pike SE, 1999, BLOOD, V94, P2461, DOI 10.1182/blood.V94.7.2461.419a26_2461_2468; Pike SE, 1998, J EXP MED, V188, P2349, DOI 10.1084/jem.188.12.2349; Ramirez G, 2012, MOL IMMUNOL, V52, P133, DOI 10.1016/j.molimm.2012.05.006; Ramirez G, 2011, IMMUNOBIOLOGY, V216, P265, DOI 10.1016/j.imbio.2010.04.001; RAMOS R, 1991, AM J TROP MED HYG, V44, P314, DOI 10.4269/ajtmh.1991.44.314; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Reed JC, 2000, CELL, V102, P545, DOI 10.1016/S0092-8674(00)00076-3; Valdez FJS, 2013, MOL IMMUNOL, V53, P198, DOI 10.1016/j.molimm.2012.08.001; Sosoniuk E, 2014, MOL IMMUNOL, V60, P80, DOI 10.1016/j.molimm.2014.03.014; Stuart GR, 1996, FEBS LETT, V397, P245, DOI 10.1016/S0014-5793(96)01156-8; Stuart GR, 1997, IMMUNOPHARMACOLOGY, V38, P73, DOI 10.1016/S0162-3109(97)00076-3; Toledo V, 2010, BIOL RES, V43, P287, DOI [10.4067/S0716-97602010000300004, /S0716-97602010000300004]; Valck C, 2010, MOL IMMUNOL, V47, P1516, DOI 10.1016/j.molimm.2010.01.019; WHITE TK, 1995, J BIOL CHEM, V270, P15926, DOI 10.1074/jbc.270.27.15926; World Health Organization, 2022, CANCER; Xiang R, 2005, CANCER RES, V65, P553; Yao L, 2002, J LEUKOCYTE BIOL, V71, P47; Yokoyama M, 2005, CIRC RES, V97, P961, DOI 10.1161/01.RES.0000193564.46466.2a; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	53	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95457	10.1371/journal.pone.0095457	http://dx.doi.org/10.1371/journal.pone.0095457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755644	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300043
J	Guimaraes, M; Munguia-Steyer, R; Doherty, PF; Martins, M; Sawaya, RJ				Guimaraes, Murilo; Munguia-Steyer, Roberto; Doherty, Paul F., Jr.; Martins, Marcio; Sawaya, Ricardo J.			Population Dynamics of the Critically Endangered Golden Lancehead Pitviper, Bothrops insularis: Stability or Decline?	PLOS ONE			English	Article							WINTER WEATHER; SURVIVAL; RECAPTURE; GROWTH; ISLAND; REPRODUCTION; PROBABILITY; PARAMETERS; SERPENTES; PYTHONS	Little is known about vital rates of snakes generally because of the difficulty in collecting data. Here we used a robust design mark-recapture model to estimate survival, behavioral effects on capture probability, temporary emigration, abundance and test the hypothesis of population decline in the golden lancehead pitviper, Bothrops insularis, an endemic and critically endangered species from southeastern Brazil. We collected data at irregular intervals over ten occasions from 2002 to 2010. Survival was slightly higher in the wet season than in the dry season. Temporal emigration was high, indicating the importance of accounting for this parameter both in the sampling design and modeling. No behavioral effects were detected on capture probability. We detected an average annual population decrease (lambda = 0.93, CI = 0.47- 1.38) during the study period, but estimates included high uncertainty, and caution in interpretation is needed. We discuss the potential effects of the illegal removal of individuals and the implications of the vital rates obtained for the future persistence and conservation of this endemic, endangered species.	[Guimaraes, Murilo] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Munguia-Steyer, Roberto] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, FES Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Martins, Marcio] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Sawaya, Ricardo J.] Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidad Nacional Autonoma de Mexico; Colorado State University; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Guimaraes, M (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil.	mu.guima@gmail.com	Sawaya, Ricardo J/F-9209-2012; Munguía-Steyer, Roberto/U-3935-2019; Martins, Marcio/C-1150-2011	Sawaya, Ricardo J/0000-0003-1897-1836; Munguía-Steyer, Roberto/0000-0002-2951-4684; Martins, Marcio/0000-0001-8108-6309	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao Grupo Boticario de Protecao a Natureza; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundo de Auxilio aos Docentes e Alunos (FADA-UNIFESP); Instituto Nacional de Cienca e Tecnologia em Toxinas (INCTTOX)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Grupo Boticario de Protecao a Natureza; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundo de Auxilio aos Docentes e Alunos (FADA-UNIFESP); Instituto Nacional de Cienca e Tecnologia em Toxinas (INCTTOX)	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao Grupo Boticario de Protecao a Natureza, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundo de Auxilio aos Docentes e Alunos (FADA-UNIFESP), and Instituto Nacional de Cienca e Tecnologia em Toxinas (INCTTOX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Altwegg R, 2005, OIKOS, V110, P55, DOI 10.1111/j.0030-1299.2001.13723.x; Altwegg R, 2006, OECOLOGIA, V149, P44, DOI 10.1007/s00442-006-0430-3; [Anonymous], 2013, VERS 3 1; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Beaupre Steven J., 2009, P244; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bonnet X, 2002, AUSTRAL ECOL, V27, P442, DOI 10.1046/j.1442-9993.2002.01198.x; Breininger DR, 2012, ANIM CONSERV, V15, P361, DOI 10.1111/j.1469-1795.2012.00524.x; Brown GP, 1997, CAN J ZOOL, V75, P424, DOI 10.1139/z97-052; Brown WS, 2007, COPEIA, V2007, P973; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Christy MT, 2010, J APPL ECOL, V47, P106, DOI 10.1111/j.1365-2664.2009.01753.x; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Dorcas Michael E., 2009, P5; Durso AM, 2011, BIOL CONSERV, V144, P1508, DOI 10.1016/j.biocon.2011.01.020; FOLEY P, 1994, CONSERV BIOL, V8, P124, DOI 10.1046/j.1523-1739.1994.08010124.x; GIBBONS J W, 1987, P396; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Greene H. W., 1997, SNAKES EVOLUTION MYS; Guimaraes M, 2014, S AM J HERP IN PRESS; Guimaraes M, 2014, ECOL EVOL IN PRESS; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Hyslop NL, 2012, POPUL ECOL, V54, P145, DOI 10.1007/s10144-011-0292-3; Kendall WL, 1997, ECOLOGY, V78, P563; Koons DN, 2009, HERPETOL CONSERV BIO, V4, P221; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lillywhite H.B., 1987, P422; Lind AJ, 2005, ECOL APPL, V15, P294, DOI 10.1890/03-5322; Lyons JA, 2011, BIOL CONSERV, V144, P3073, DOI 10.1016/j.biocon.2011.10.002; Madsen T, 2006, AUSTRAL ECOL, V31, P30, DOI 10.1111/j.1442-9993.2006.01540.x; Maritz B, 2012, HERPETOLOGICA, V68, P195; Marques O.A.V., 2002, CIENCIA HOJE, V31, P56; Marques OAV, 2013, J HERPETOL, V47, P393, DOI 10.1670/11-267; Marques OAV, 2012, J NAT HIST, V46, P885, DOI 10.1080/00222933.2011.654278; Martins Marcio, 2008, South American Journal of Herpetology, V3, P168, DOI 10.2994/1808-9798(2008)3[168:AFEOTP]2.0.CO;2; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; MUSHINSKY H R, 1987, P302; Nada Mohamad A., 2001, Zoology in the Middle East, V24, P109; NICHOLS JD, 1984, J WILDLIFE MANAGE, V48, P289, DOI 10.2307/3808491; PARKER W S, 1987, P253; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Prival DB, 2012, HERPETOL MONOGR, V26, P1; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Sazima Ivan, 1992, P199; Schmidt BR, 2003, CR BIOL, V326, pS119, DOI 10.1016/S1631-0691(03)00048-9; Schmutz JA, 2009, ENVIRON ECOL STAT SE, V3, P441, DOI 10.1007/978-0-387-78151-8_19; SEIGEL R A, 1987, P210; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Turner F.B., 1977, P157; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM	57	20	23	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95203	10.1371/journal.pone.0095203	http://dx.doi.org/10.1371/journal.pone.0095203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755842	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300032
J	Makarev, E; Gorivodsky, M				Makarev, Evgeny; Gorivodsky, Marat			Islet1 and Its Co-Factor Ldb1 Are Expressed in Quiescent Cells of Mouse Intestinal Epithelium	PLOS ONE			English	Article							LIM-HOMEODOMAIN PROTEINS; STEM-CELL; PROGENITOR CELLS; HOMEOBOX GENES; DIFFERENTIATION; LGR5; MARKERS; ISL1; IDENTIFICATION; REQUIREMENT	Islet1 belongs to Lim homeobox (Lhx) gene family which encodes transcription factors that have been conserved in evolution. They form complexes with other transcriptional regulators, among them obligatory co-factors encoded by Ldb genes. Isl1 (Islet1), Lhx and Ldb1 genes play a crucial role in organ patterning, cell fate determination and cell differentiation in both embryonic and adult tissues. In this study we analyzed expression pattern of Isl1 and its co-factor Ldb1 in small intestine. We also studied the biological role of Ldb1 in gut endoderm. Quantitative PCR analysis revealed a relatively high level of expression of Lhx1, Isl1, Isl2, Lmx1a, Ldb1 and Ldb2 mRNAs in the gut tissue as compared to the level of less abundant detectable Lmx1b mRNA. Immunohistochemical studies demonstrated a unique pattern of Ldb1 and Islet1 proteins in the crypt compartment. Ldb1 is produced at a low level in majority of crypt cells; but, its abundant expression was demonstrated for some single cells. Islet1 is also expressed in single cells of the crypt. Double staining experiments with Ldb1 and Isl1 antibodies showed that both genes are co-expressed in certain cells of the crypt. Further analysis revealed the Ldb1-expressing cells in the gut are both of endodermal and mesodermal origin. Proliferation studies using antibodies to phospho-histone H3 and Ki-67 antigens, as well as long-term BrdU labeling, showed that cells prominently expressing Ldb1/Islet1 are quiescent but do not belong to any known terminally differentiated cell lineages. They may represent a group of stem-like cells in the crypt. Further experiments by cell lineage tracing should be performed to better characterize this cell population. Functional studies of mice with Ldb1 gene ablated in gut endoderm revealed no specific role of Ldb1 in that tissue.	[Makarev, Evgeny; Gorivodsky, Marat] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mammalian Mol Genet, Lab Mammalian Genes & Dev, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Gorivodsky, M (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mammalian Mol Genet, Lab Mammalian Genes & Dev, Bethesda, MD 20892 USA.	lvmarat@yahoo.com			Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; CETIN Y, 1989, HISTOCHEMISTRY, V92, P265, DOI 10.1007/BF00500540; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; Dey-Guha I, 2009, INT J BIOL SCI, V5, P686; GONG ZY, 1995, J BIOL CHEM, V270, P3335, DOI 10.1074/jbc.270.7.3335; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Li LQ, 2011, NAT IMMUNOL, V12, P129, DOI 10.1038/ni.1978; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Montgomery RK, 2008, J ANAT, V213, P52, DOI 10.1111/j.1469-7580.2008.00925.x; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mukhopadhyay M, 2003, DEVELOPMENT, V130, P495, DOI 10.1242/dev.00225; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Suleiman H, 2007, DEV BIOL, V304, P701, DOI 10.1016/j.ydbio.2007.01.020; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tam PPL, 2004, DEV BIOL, V274, P171, DOI 10.1016/j.ydbio.2004.07.005; Teufel A, 2010, J HEPATOL, V53, P1078, DOI 10.1016/j.jhep.2010.05.027; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	41	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95256	10.1371/journal.pone.0095256	http://dx.doi.org/10.1371/journal.pone.0095256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755910	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300034
J	Ohl, M; Lohrmann, V; Breitkreuz, L; Kirschey, L; Krause, S				Ohl, Michael; Lohrmann, Volker; Breitkreuz, Laura; Kirschey, Lukas; Krause, Stefanie			The Soul-Sucking Wasp by Popular Acclaim - Museum Visitor Participation in Biodiversity Discovery and Taxonomy	PLOS ONE			English	Article							COLLECTIONS; VENOM	Taxonomy, the science of describing and naming of the living world, is recognized as an important and relevant field in modern biological science. While there is wide agreement on the importance of a complete inventory of all organisms on Earth, the public is partly unaware of the amount of known and unknown biodiversity. Out of the enormous number of undescribed (but already recognized) species in natural history museum collections, we selected an attractive example of a wasp, which was presented to museum visitors at a special museum event. We asked 300 visitors to vote on a name for the new species and out of four preselected options, Ampulex dementor Ohl n. sp. was selected. The name, derived from the `soul sucking' dementors from the popular Harry Potter books is an allusion to the wasps' behavior to selectively paralyze its cockroach prey. In this example, public voting on a scientific name has been shown to be an appropriate way to link museum visitors emotionally to biodiversity and its discovery.	[Ohl, Michael; Lohrmann, Volker; Breitkreuz, Laura; Kirschey, Lukas; Krause, Stefanie] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung	Ohl, M (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany.	michael.ohl@mfn-berlin.de	Lohrmann, Volker/AAB-4489-2020	Lohrmann, Volker/0000-0003-0476-7041				Aguiar AP, 2013, ZOOTAXA, V3703, P51; [Anonymous], 2010, GUARDIAN; Behrer P, 2009, STUDENT ESSAY 2009 C; BIOPAT, 2013, BIOPAT PATR BIOD; Bowker GC., 2005, MEMORY PRACTICES SCI; Boxshall G., 2011, UK TAXONOMY SYSTEMAT; Causey D, 2004, SCIENCE, V305, P1106; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Evans EM, 2010, J RES SCI TEACH, V47, P326, DOI 10.1002/tea.20337; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fontaine B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036881; Haspel G, 2003, J NEUROBIOL, V56, P287, DOI 10.1002/neu.10238; Libersat F, 2003, J COMP PHYSIOL A, V189, P497, DOI 10.1007/s00359-003-0432-0; Lohrmann V, 2012, TAXONOMISCHE FORSCHU; Lohrmann V, 2012, MITT DEUT GES ALLGEM, V18, P31; Lovejoy T, 2010, CANADIAN TAXONOMY EX; Mayr E., 1982, GROWTH BIOL THOUGHT; Monbiot G., 2010, GUARDIAN; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; [NatSCA] Natural Sciences Collections Association, 2005, MATT LIF DEATH NAT S; Ohl Michael, 2007, P141, DOI 10.1007/978-3-540-33761-4_4; Ohl M, 2010, CLADISTICS, V26, P49, DOI 10.1111/j.1096-0031.2009.00275.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pulawski WJ, 2014, SPHECIDAE NUMBER SPE; Shaffer HB, 1998, TRENDS ECOL EVOL, V13, P27, DOI 10.1016/S0169-5347(97)01177-4; Simon N., 2010, PARTICIPATORY MUSEUM; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Sluys R, 2013, BIODIVERS CONSERV, V22, P1095, DOI 10.1007/s10531-013-0472-x; Thompson F. C., 1996, BIODIVERSITY, P199; VELTMAN J, 1991, International Zoo Yearbook, V30, P118; Wheeler QD, 2012, SYST BIODIVERS, V10, P1, DOI 10.1080/14772000.2012.665095; Wheeler Q. D., 2008, SYSTEMATICS ASS SPEC, V76; Winston JE, 1999, DESCRIBING SPECIES P; Yoon C.K., 2009, NAMING NATURE CLASH	37	2	2	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95068	10.1371/journal.pone.0095068	http://dx.doi.org/10.1371/journal.pone.0095068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755672	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300026
J	Tabernero, J; Artal, P				Tabernero, Juan; Artal, Pablo			Lens Oscillations in the Human Eye. Implications for Post-Saccadic Suppression of Vision	PLOS ONE			English	Article							BINOCULAR COORDINATION; RETINAL IMAGE; MOVEMENTS; DISPLACEMENT	The eye changes gaze continuously from one visual stimulus to another. Using a high speed camera to record eye and lens movements we demonstrate how the crystalline lens sustains an inertial oscillatory decay movement immediately after every change of gaze. This behavior fit precisely with the movement of a classical damped harmonic oscillator. The time course of the oscillations range from 50 to 60 msec with an oscillation frequency of around 20 Hz. That has dramatic implications on the image quality at the retina on the very short times (similar to 50 msec) that follow the movement. However, it is well known that our vision is nearly suppressed on those periods (post-saccadic suppression). Both phenomenon follow similar time courses and therefore might be synchronized to avoid the visual impairment.	[Tabernero, Juan; Artal, Pablo] Univ Murcia, Inst Univ Invest Opt & Nanofis, Lab Opt, Murcia, Spain	University of Murcia	Artal, P (corresponding author), Univ Murcia, Inst Univ Invest Opt & Nanofis, Lab Opt, Murcia, Spain.	pablo@um.es	Artal, Pablo/AAG-4485-2020; Tabernero, Juan/AAO-9855-2020; Artal, Pablo/AGV-7547-2022; Tabernero, Juan/D-1120-2014	Artal, Pablo/0000-0003-1284-6591; Artal, Pablo/0000-0003-1284-6591; Tabernero, Juan/0000-0002-5149-8350	Ministerio de Ciencia e Innovacio'n,Spain [FIS2010-14926, CSD2007-00013]; Fundacio'n Se'neca (Region de Murcia,Spain) [4524/GERM/06]	Ministerio de Ciencia e Innovacio'n,Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio'n Se'neca (Region de Murcia,Spain)(Fundacion Seneca)	This work was supported by the Ministerio de Ciencia e Innovacio'n,Spain (grants FIS2010-14926 and CSD2007-00013) and Fundacio'n Se'neca (Region de Murcia, Spain), grant 4524/GERM/06. The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	BARTHOLOMEW RS, 1970, BRIT J OPHTHALMOL, V54, P663, DOI 10.1136/bjo.54.10.663; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P183, DOI 10.1113/jphysiol.1988.sp017285; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; CRANE HD, 1985, APPL OPTICS, V24, P527, DOI 10.1364/AO.24.000527; Crnej A, 2011, J CATARACT REFR SURG, V37, P1768, DOI 10.1016/j.jcrs.2011.04.028; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; DEUBEL H, 1995, VISION RES, V35, P529, DOI 10.1016/0042-6989(94)00146-D; Deubel H, 1995, VISION RES, V35, P2987; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; He L, 2010, J VISION, V10, DOI 10.1167/10.4.14; JACOBI KW, 1981, A GRAEF ARCH KLIN EX, V216, P49, DOI 10.1007/BF00407776; Kimmel DL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00049; MACKAY DM, 1970, NATURE, V225, P90, DOI 10.1038/225872a0; MILLER D, 1984, AM J OPHTHALMOL, V97, P752, DOI 10.1016/0002-9394(84)90508-7; Nystrom M, 2013, VISION RES, V92, P59, DOI 10.1016/j.visres.2013.09.009; Tabernero J, 2006, OPT EXPRESS, V14, P10945, DOI 10.1364/OE.14.010945; Tabernero J, 2006, INVEST OPHTH VIS SCI, V47, P4651, DOI 10.1167/iovs.06-0444	18	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95764	10.1371/journal.pone.0095764	http://dx.doi.org/10.1371/journal.pone.0095764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755771	Green Published, gold			2022-12-25	WOS:000335240300088
J	Harbaum, L; Hennigs, JK; Baumann, HJ; Luneburg, N; Griesch, E; Bokemeyer, C; Grunig, E; Klose, H				Harbaum, Lars; Hennigs, Jan K.; Baumann, Hans J.; Lueneburg, Nicole; Griesch, Elisabeth; Bokemeyer, Carsten; Gruenig, Ekkehard; Klose, Hans			N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; 6-MINUTE WALK TEST; ARTERIAL-HYPERTENSION; DISEASE SEVERITY; DYSFUNCTION; GUIDELINES; STRATIFICATION; PREDICTORS; BIOMARKERS; OUTCOMES	N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in patients with pre-capillary pulmonary hypertension (PH). As it accumulates in the presence of impaired renal function, the clinical utility of NT-proBNP in PH patients with concomitant renal insufficiency remains unclear. In a retrospective approach, patients with pre-capillary PH (group I or IV) and concomitant renal insufficiency at time of right heart catheterization (glomerular filtration rate (GFR) <= 60 ml/min/1.73 m(2)) were identified out of all prevalent pre-capillary PH patients treated at a single center. Forty patients with renal insufficiency (25.8%) were identified and matched regarding hemodynamic parameters with a control group of 56 PH patients with normal renal function (GFR>60 ml/min/1.73 m(2)). Correlations of NT-proBNP levels with hemodynamic and prognostic parameters (time to clinical worsening and overall survival) were assessed. Overall, GFR correlated inversely with NT-proBNP and had the strongest influence on NT-proBNP levels in a stepwise multiple linear regression model including hemodynamic parameters and age (r(2) = 0.167). PH patients with renal insufficiency had significant higher levels of NT-proBNP (median: 1935 ng/l vs. 573 ng/l, p = 0.001). Nevertheless, NT-proBNP correlated with invasive hemodynamic parameters in these patients. Using higher cut-off values than in patients with preserved renal function, NT-proBNP levels were significantly associated with time to clinical worsening (>1660 ng/l, p = 0.001) and survival (>2212 ng/l, p = 0.047) in patients with renal insufficiency. Multivariate Cox's proportional hazards analysis including established prognostic parameters, age and GFR confirmed NT-proBNP as an independent risk factor for clinical worsening in PH patients with renal insufficiency (hazard ratio 4.8, p = 0.007). Thus, in a retrospective analysis we showed that NT-proBNP levels correlated with hemodynamic parameters and outcome regardless of renal function. By using higher cut-off values, NT-proBNP seems to represent a valid clinical marker even in PH patients with renal insufficiency.	[Harbaum, Lars; Hennigs, Jan K.; Baumann, Hans J.; Griesch, Elisabeth; Bokemeyer, Carsten; Klose, Hans] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med Oncol, BMT Sect Pneumol, Hamburg, Germany; [Hennigs, Jan K.] Stanford Univ, Sch Med, Vera Moulton Wall Pulm Vasc Res Labs, Stanford, CA 94305 USA; [Lueneburg, Nicole] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Gruenig, Ekkehard] Heidelberg Univ, Ctr Pulm Hypertens, Thoraxclin Heidelberg, Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	Klose, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Internal Med Oncol, BMT Sect Pneumol, Hamburg, Germany.	klose@uke.de		Hennigs, Jan K./0000-0002-7784-8267	University Medical Center Hamburg-Eppendorf; Deutsche Forschungsgemeinschaft [He 6855/1-1]	University Medical Center Hamburg-Eppendorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded by the University Medical Center Hamburg-Eppendorf. Furthermore, this work was supported by a grant from the Deutsche Forschungsgemeinschaft to JKH (He 6855/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen AK, 2006, AM J CARDIOL, V98, P525, DOI 10.1016/j.amjcard.2006.02.061; Anwaruddin S, 2006, J AM COLL CARDIOL, V47, P91, DOI 10.1016/j.jacc.2005.08.051; Battistoni A, 2012, INT J CARDIOL, V157, P160, DOI 10.1016/j.ijcard.2011.06.066; Benza RL, 2012, CHEST, V141, P354, DOI 10.1378/chest.11-0676; Bernal V, 2009, TRANSPL P, V41, P987, DOI 10.1016/j.transproceed.2009.02.025; Blyth KG, 2007, EUR RESPIR J, V29, P737, DOI 10.1183/09031936.00095606; Cracowski JL, 2012, AM J CARDIOL, V110, p32S, DOI 10.1016/j.amjcard.2012.06.014; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Fijalkowska A, 2006, CHEST, V129, P1313, DOI 10.1378/chest.129.5.1313; Frantz RP, 2012, J HEART LUNG TRANSPL, V31, P811, DOI 10.1016/j.healun.2012.04.005; Galasko GIW, 2005, EUR HEART J, V26, P2269, DOI 10.1093/eurheartj/ehi410; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gan CT, 2006, EUR RESPIR J, V28, P1190, DOI 10.1183/09031936.00016006; Haddad F, 2011, J CARD FAIL, V17, P533, DOI 10.1016/j.cardfail.2011.03.003; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Horii M, 2013, J CARDIOL, V61, P410, DOI 10.1016/j.jjcc.2013.01.015; Humbert M, 2010, EUR RESPIR REV, V19, P59, DOI 10.1183/09059180.00007309; Leuchte HH, 2007, CHEST, V131, P402, DOI 10.1378/chest.06-1758; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Martinez-Rumayor A, 2008, AM J CARDIOL, V101, p3A, DOI 10.1016/j.amjcard.2007.11.012; Mathai SC, 2010, EUR RESPIR J, V35, P95, DOI 10.1183/09031936.00074309; Mauritz GJ, 2011, AM J CARDIOL, V108, P1645, DOI 10.1016/j.amjcard.2011.07.025; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; McLaughlin VV, 2013, J AM COLL CARDIOL, V62, pD73, DOI 10.1016/j.jacc.2013.10.034; Mielniczuk Lisa M, 2012, Congest Heart Fail, V18, P151, DOI 10.1111/j.1751-7133.2011.00275.x; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Nickel N, 2012, EUR RESPIR J, V39, P589, DOI 10.1183/09031936.00092311; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Raymond RJ, 2002, J AM COLL CARDIOL, V39, P1214, DOI 10.1016/S0735-1097(02)01744-8; Sato Y, 2013, J CARDIOL, V61, P446, DOI 10.1016/j.jjcc.2013.01.013; Souza R, 2005, EUR RESPIR J, V25, P509, DOI 10.1183/09031936.05.00100504; Souza R, 2007, RESP MED, V101, P69, DOI 10.1016/j.rmed.2006.04.014; Srisawasdi P, 2010, AM J CLIN PATHOL, V133, P14, DOI 10.1309/AJCP60HTPGIGFCNK; Suntharalingam J, 2007, RESP MED, V101, P2254, DOI 10.1016/j.rmed.2007.06.027; van Kimmenade RRJ, 2006, J AM COLL CARDIOL, V48, P1621, DOI 10.1016/j.jacc.2006.06.056; Wu AHB, 2003, AM J CARDIOL, V92, P628, DOI 10.1016/S0002-9149(03)00741-0; Yeager ME, 2012, EUR RESPIR J, V39, P104, DOI 10.1183/09031936.00072311	37	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94263	10.1371/journal.pone.0094263	http://dx.doi.org/10.1371/journal.pone.0094263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751887	Green Submitted, gold, Green Published			2022-12-25	WOS:000335227400011
J	Hodd, RL; Bourke, D; Skeffington, MS				Hodd, Rory L.; Bourke, David; Skeffington, Micheline Sheehy			Projected Range Contractions of European Protected Oceanic Montane Plant Communities: Focus on Climate Change Impacts Is Essential for Their Future Conservation	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; VASCULAR PLANTS; MOUNTAIN PLANTS; BRYOPHYTES; DIVERSITY; DISTRIBUTIONS; SCALE; DISPERSAL; ELEVATION; RICHNESS	Global climate is rapidly changing and while many studies have investigated the potential impacts of this on the distribution of montane plant species and communities, few have focused on those with oceanic montane affinities. In Europe, highly sensitive bryophyte species reach their optimum occurrence, highest diversity and abundance in the northwest hyperoceanic regions, while a number of montane vascular plant species occur here at the edge of their range. This study evaluates the potential impact of climate change on the distribution of these species and assesses the implications for EU Habitats Directive-protected oceanic montane plant communities. We applied an ensemble of species distribution modelling techniques, using atlas data of 30 vascular plant and bryophyte species, to calculate range changes under projected future climate change. The future effectiveness of the protected area network to conserve these species was evaluated using gap analysis. We found that the majority of these montane species are projected to lose suitable climate space, primarily at lower altitudes, or that areas of suitable climate will principally shift northwards. In particular, rare oceanic montane bryophytes have poor dispersal capacity and are likely to be especially vulnerable to contractions in their current climate space. Significantly different projected range change responses were found between 1) oceanic montane bryophytes and vascular plants; 2) species belonging to different montane plant communities; 3) species categorised according to different biomes and eastern limit classifications. The inclusion of topographical variables in addition to climate, significantly improved the statistical and spatial performance of models. The current protected area network is projected to become less effective, especially for specialised arctic-montane species, posing a challenge to conserving oceanic montane plant communities. Conservation management plans need significantly greater focus on potential climate change impacts, including models with higher-resolution species distribution and environmental data, to aid these communities' long-term survival.	[Hodd, Rory L.; Skeffington, Micheline Sheehy] Natl Univ Ireland Univ Coll Galway, Plant Ecol Res Unit, Galway, Ireland; [Bourke, David] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Bot, Dublin 2, Ireland; [Bourke, David] Univ Dublin Trinity Coll, Sch Nat Sci, Trinity Ctr Biodivers Res, Dublin 2, Ireland	Ollscoil na Gaillimhe-University of Galway; Trinity College Dublin; Trinity College Dublin	Hodd, RL (corresponding author), Natl Univ Ireland Univ Coll Galway, Plant Ecol Res Unit, Galway, Ireland.	rlhodd@gmail.com	Bourke, David/AAK-8211-2020; Bourke, David O/C-1119-2011	Bourke, David/0000-0002-0137-4448	Irish Research Council; Irish National Parks and Wildlife Service; NUIG Thomas Crawford Hayes Fund; Science, Technology, Research and Innovation for the Environment (STRIVE) Programme - Irish Government under the National Development Plan, Department of the Environment, Heritage and Local Government by the Irish Environmental Protection Agency [2007-633 CCRP-2.26]; Royal Irish Academy Mobility Grant	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Irish National Parks and Wildlife Service; NUIG Thomas Crawford Hayes Fund; Science, Technology, Research and Innovation for the Environment (STRIVE) Programme - Irish Government under the National Development Plan, Department of the Environment, Heritage and Local Government by the Irish Environmental Protection Agency; Royal Irish Academy Mobility Grant	Research for this paper was funded by the Irish Research Council, the Irish National Parks and Wildlife Service and NUIG Thomas Crawford Hayes Fund. DB was funded by the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme, financed by the Irish Government under the National Development Plan 2007-2013, administered on behalf of the Department of the Environment, Heritage and Local Government by the Irish Environmental Protection Agency, under grant 2007-633 CCRP-2.26 and a Royal Irish Academy Mobility Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RJ, 1995, MOL ECOL, V4, P199, DOI 10.1111/j.1365-294X.1995.tb00209.x; Alagador D, 2011, BIOL CONSERV, V144, P811, DOI 10.1016/j.biocon.2010.11.011; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Averis A., 2004, ILLUSTRATED GUIDE BR; Averis AM, 1994, THESIS U EDINBURGH; Baczkiewicz A, 2012, BIODIVERSITY RES CON, V27, P55, DOI DOI 10.2478/V10119-012-0023-4; Bassler C, 2010, ECOL INDIC, V10, P341, DOI 10.1016/j.ecolind.2009.06.014; Bates JW., 2011, BRYOPHYTE ECOLOGY CL, P371; Bergamini A, 2009, DIVERS DISTRIB, V15, P871, DOI 10.1111/j.1472-4642.2009.00595.x; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Britton AJ, 2009, BIOL CONSERV, V142, P1728, DOI 10.1016/j.biocon.2009.03.010; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Bruun HH, 2006, J VEG SCI, V17, P37, DOI 10.1111/j.1654-1103.2006.tb02421.x; Burt TP, 2010, CLIM RES, V45, P57, DOI 10.3354/cr00910; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Coll J, 2010, CLIM RES, V45, P71, DOI 10.3354/cr00958; Crabtree D, 2010, J VEG SCI, V21, P744, DOI 10.1111/j.1654-1103.2010.01184.x; Crawford R. M. M., 2001, Botanical Journal of Scotland, V53, P77; Crawford R.M.M., 2008, ECOLOGICAL LIMITS CL; Crawford RMM, 2000, NEW PHYTOL, V147, P257, DOI 10.1046/j.1469-8137.2000.00705.x; Crawford RMM, 2013, TUNDR BIOL HUM; Curtis T.G.F., 1988, IRISH RED DATA BOOK; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; de Witte LC, 2012, MOL ECOL, V21, P1081, DOI 10.1111/j.1365-294X.2011.05326.x; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Eireann Met, 2011, IR MET SERV ONL; Ellis NE, 2005, MOUNTAINS NO EUROPE, P99; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; European Union,, 1992, OFFICIAL J EUROPEA L; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Fosaa AM, 2004, GLOBAL ECOL BIOGEOGR, V13, P427, DOI 10.1111/j.1466-822X.2004.00113.x; Frahm JP, 2008, BIODIVERS CONSERV, V17, P277, DOI 10.1007/s10531-007-9251-x; Frahm Jan-Peter, 2001, Lindbergia, V26, P97; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Geml J, 2010, J BIOGEOGR, V37, P1529, DOI 10.1111/j.1365-2699.2010.02287.x; Gignac LD, 2001, BRYOLOGIST, V104, P410, DOI 10.1639/0007-2745(2001)104[0410:BAIOCC]2.0.CO;2; Gignac LD., 2011, BRYOPHYTE ECOLOGY CL, P461, DOI [10.1017/CBO9780511779701.024, DOI 10.1017/CBO9780511779701.024]; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Guisan A, 2000, INTEGRATED ASSESSMEN, V1, P307, DOI [DOI 10.1023/A:1018912114948, 10.1023/A:1018912114948]; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; Harrison PA, 2006, ENVIRON SCI POLICY, V9, P116, DOI 10.1016/j.envsci.2005.11.003; Hill MO, 2004, CTR ECOLOGY HYDROLOG; Hill MO, 2007, CTR ECOLOGY HYDROLOG; Hodd R, 2011, FIELD BRYOLOGY, V104, P2; Hodd R.L., 2011, CLIMATE CHANGE ECOLO, P490; Hodd RL, 2012, THESIS NUI GALWAY IR; Holden J, 2007, EARTH-SCI REV, V82, P75, DOI 10.1016/j.earscirev.2007.01.003; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kingston N, 2012, CHECKLIST PROT UNPUB; Klanderud K, 2003, HOLOCENE, V13, P1, DOI 10.1191/0959683603hl589ft; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lockhart N., 2012, RARE THREATENED BRYO; Lockhart ND, 2012, IRELAND RED LIST 8 B; McGrath R, 2008, IRELAND WARMER WORLD; NPWS, 2013, STAT EU PROT HAB SPE; NPWS, 2010, DRAFT DAT RED LIST B; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Paton Jean A., 1999, P1; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pocs T, 2011, BRYOPHYTE ECOLOGY CL, P359; Preston C, 2002, NEW ATLAS BRIT IRISH; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; RATCLIFFE DA, 1968, NEW PHYTOL, V67, P365, DOI 10.1111/j.1469-8137.1968.tb06392.x; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Rohan PK, 1986, CLIMATE IRELAND; Rothero Gordon, 2003, Botanical Journal of Scotland, V55, P17; Saetersdal M, 1997, J BIOGEOGR, V24, P127, DOI 10.1046/j.1365-2699.1997.00096.x; SCOTT JM, 1991, LANDSCAPE LINKAGES AND BIODIVERSITY, P15; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Smith A.J.E., 2004, MOSS FLORA BRITAIN I, DOI [10.1017/cbo9780511541858, DOI 10.1017/CBO9780511541858]; Sweeney J, 2003, 15 ER TRI; Sweeney John, 2002, Biology and Environment, V102B, P121, DOI 10.3318/BIOE.2002.102.3.121; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W., 2012, BIOMOD2 ENSEMBLE PLA; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Trivedi MR, 2008, BIOL CONSERV, V141, P1665, DOI 10.1016/j.biocon.2008.04.008; U.S. Geological Survey, 2008, GTOPO30 GLOB DIG EL; Virkkala R, 2010, ACTA OECOL, V36, P269, DOI 10.1016/j.actao.2010.01.006; Walmsley C., 2005, DEV CONCEPTUAL METHO; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	94	26	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95147	10.1371/journal.pone.0095147	http://dx.doi.org/10.1371/journal.pone.0095147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752011	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000335227400036
J	Iwai, S; Huang, D; Fong, S; Jarlsberg, LG; Worodria, W; Yoo, S; Cattamanchi, A; Davis, JL; Kaswabuli, S; Segal, M; Huang, L; Lynch, SV				Iwai, Shoko; Huang, Delphine; Fong, Serena; Jarlsberg, Leah G.; Worodria, William; Yoo, Samuel; Cattamanchi, Adithya; Davis, J. Lucian; Kaswabuli, Sylvia; Segal, Mark; Huang, Laurence; Lynch, Susan V.			The Lung Microbiome of Ugandan HIV-Infected Pneumonia Patients Is Compositionally and Functionally Distinct from That of San Franciscan Patients	PLOS ONE			English	Article							ANTIBIOTIC-TREATMENT; AIRWAY MICROBIOTA; INDUCTION; IDENTIFICATION; DISEASE; CELLS	Sub-Saharan Africa represents 69% of the total number of individuals living with HIV infection worldwide and 72% of AIDS deaths globally. Pulmonary infection is a common and frequently fatal complication, though little is known regarding the lower airway microbiome composition of this population. Our objectives were to characterize the lower airway microbiome of Ugandan HIV-infected patients with pneumonia, to determine relationships with demographic, clinical, immunological, and microbiological variables and to compare the composition and predicted metagenome of these communities to a comparable cohort of patients in the US (San Francisco). Bronchoalveolar lavage samples from a cohort of 60 Ugandan HIV-infected patients with acute pneumonia were collected. Amplified 16S ribosomal RNA was profiled and aforementioned relationships examined. Ugandan airway microbiome composition and predicted metagenomic function were compared to US HIV-infected pneumonia patients. Among the most common bacterial pulmonary pathogens, Pseudomonas aeruginosa was most prevalent in the Ugandan cohort. Patients with a richer and more diverse airway microbiome exhibited lower bacterial burden, enrichment of members of the Lachnospiraceae and sulfur-reducing bacteria and reduced expression of TNF-alpha and matrix metalloproteinase-9. Compared to San Franciscan patients, Ugandan airway microbiome was significantly richer, and compositionally distinct with predicted metagenomes that encoded a multitude of distinct pathogenic pathways e. g secretion systems. Ugandan pneumonia-associated airway microbiome is compositionally and functionally distinct from those detected in comparable patients in developed countries, a feature which may contribute to adverse outcomes in this population.	[Iwai, Shoko; Huang, Delphine; Lynch, Susan V.] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; [Huang, Delphine] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Fong, Serena; Huang, Laurence] Univ Calif San Francisco, Div HIV AIDS, San Francisco, CA 94143 USA; [Jarlsberg, Leah G.; Cattamanchi, Adithya; Davis, J. Lucian; Huang, Laurence] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Worodria, William; Yoo, Samuel; Kaswabuli, Sylvia] Makerere Univ, Mulago Hosp, Dept Med, Kampala, Uganda; [Segal, Mark] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University; Mulago National Referral Hospital; University of California System; University of California San Francisco	Lynch, SV (corresponding author), Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu	Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAE-1590-2019; Huang, Laurence/AAZ-7120-2021	Davis, J. Lucian/0000-0002-8629-9992; Huang, Laurence/0000-0003-3888-2195; Jarlsberg, Leah/0000-0001-6548-6337	National Institutes of Health [HL087713, HL090335-02S109, HL098964, AI075410]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098964, K24HL087713, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075410, P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health grants HL087713, HL090335-02S109, HL098964, and AI075410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Aslami H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063497; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; BARON AD, 1993, AM REV RESPIR DIS, V148, P992, DOI 10.1164/ajrccm/148.4_Pt_1.992; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Hall JC, 2011, HIV AIDS POSTHAART E; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Iwai S, 2012, J CLIN MICROBIOL, V50, P2995, DOI 10.1128/JCM.00278-12; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lane D.J., 1991, 16S 23S RRNA SEQUENC; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lozupone C, 2013, AM J RESP CRIT CARE, V187, P1110, DOI 10.1164/rccm.201211-2145OC; Meynard JL, 1999, J INFECTION, V38, P176, DOI 10.1016/S0163-4453(99)90247-5; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nagano Y, 2012, CURR OPIN IMMUNOL, V24, P392, DOI 10.1016/j.coi.2012.05.007; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	28	45	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95726	10.1371/journal.pone.0095726	http://dx.doi.org/10.1371/journal.pone.0095726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752365	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400110
J	Maciejczyk, M; Wiecek, M; Szymura, J; Szygula, Z; Wiecha, S; Cempla, J				Maciejczyk, Marcin; Wiecek, Magdalena; Szymura, Jadwiga; Szygula, Zbigniew; Wiecha, Szczepan; Cempla, Jerzy			The Influence of Increased Body Fat or Lean Body Mass on Aerobic Performance	PLOS ONE			English	Article							SUBMAXIMAL OXYGEN-UPTAKE; ALLOMETRIC SCALE; PEAK; OBESE; EXERCISE; CAPACITY; WEIGHT; VO(2); RATIO; SIZE	Purpose: The purpose of this study was to determine aerobic performance in men with an increased body mass due to (a) high body fat (> 21.5%) but with a average (59.0- 64.3 kg) lean body mass (HBF group) and (b) high lean body mass (> 66.3 kg), but with average body fat (14.0- 18.5%) (HLBM group). Methods: The men in the HBF and HLBM had similar absolute body mass and body mass index (BMI). The aerobic performance was also determined in control group. Methods: Study participants comprised 39 men aged 21.3 +/- 1.9 years who did not participate in competitive sports but were recreationally physically active. Participants were divided into three groups. Each group comprised 13 persons. The study involved anthropometric measurements, assessing aerobic performance (VO(2)max) using an incremental test on a mechanical treadmill. VO(2)max was expressed in absolute values, relative to body mass (VO(2)max center dot BM-1), relative to lean body mass (VO(2)max center dot LBM-1), and relative to BM raised by the exponents of 0.75 and 0.67. Body composition was measured using bioelectrical impedance analysis. Results: No statistically significant differences in relative values of VO2max were found between the HBF and HLBM groups, in VO(2)max BM-1 (50.24 +/- 4.56 vs. 53.11 +/- 5.45 mL center dot kg(-1)), VO(2)max center dot LBM-1 (65.33 +/- 5.63 vs. 63.86 +/- 7.13 mL center dot kgLBM(-1)), and VO(2)max center dot BM-0.75 (150.29 +/- 13.5 vs. 160.39 +/- 16.15 mL center dot kg(-0.75)). Values of VO(2)max center dot BM-1 were significantly lower in the HBF and HLBM groups than in the control group (58.23 +/- 5.84 mL center dot kg(-1)). Conclusion: High body mass, regardless of the cause decreases VO(2)max center dot BM-1.	[Maciejczyk, Marcin; Wiecek, Magdalena; Wiecha, Szczepan; Cempla, Jerzy] Univ Sch Phys Educ, Dept Physiol & Biochem, Inst Biomed Sci, Krakow, Poland; [Szymura, Jadwiga] Univ Sch Phys Educ, Dept Clin Rehabil, Krakow, Poland; [Szygula, Zbigniew] Univ Sch Phys Educ, Dept Sport Med & Human Nutr, Inst Biomed Sci, Krakow, Poland		Maciejczyk, M (corresponding author), Univ Sch Phys Educ, Dept Physiol & Biochem, Inst Biomed Sci, Krakow, Poland.	marcin.maciejczyk@awf.krakow.pl	Maciejczyk, Marcin/E-1211-2017; Więcek, Magdalena/P-8276-2018; Magdalena, Wiecek/U-2339-2019; Szymura, Jadwiga/V-6413-2018; Wiecha, Szczepan/S-1199-2016	Maciejczyk, Marcin/0000-0002-9505-4081; Więcek, Magdalena/0000-0002-5390-3049; Magdalena, Wiecek/0000-0002-5390-3049; Szymura, Jadwiga/0000-0003-4594-7954; Szygula, Zbigniew/0000-0002-6685-6579; Wiecha, Szczepan/0000-0001-9458-557X	National Science Centre (Poland) [N N404 071240]	National Science Centre (Poland)	The study has been carried out within the grant No. N N404 071240, funded by the National Science Centre (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MED SCI SPORT EXER S, V29, P89, DOI DOI 10.1097/00005768-199706001-00018; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; DEHGHAN M, 2008, NUTR J, V7, DOI DOI 10.1186/1475-2891-7-26; Eisenmann JC, 2001, J APPL PHYSIOL, V90, P2172, DOI 10.1152/jappl.2001.90.6.2172; Ekelund U, 2004, OBES RES, V12, P513, DOI 10.1038/oby.2004.58; Goran M, 2000, INT J OBESITY, V24, P841, DOI 10.1038/sj.ijo.0801241; GROSS LD, 1990, RES Q EXERCISE SPORT, V61, P321, DOI 10.1080/02701367.1990.10607494; Heil DP, 1997, MED SCI SPORT EXER, V29, P1602, DOI 10.1097/00005768-199712000-00009; Hulens M, 2001, SCAND J MED SCI SPOR, V11, P305, DOI 10.1034/j.1600-0838.2001.110509.x; Janz KF, 1998, MED SCI SPORT EXER, V30, P1436, DOI 10.1097/00005768-199809000-00014; Jensen K, 2001, EUR J APPL PHYSIOL, V84, P201, DOI 10.1007/s004210170005; KATCH VL, 1973, MED SCI SPORT EXER, V5, P253; Loftin M, 2001, OBES RES, V9, P290, DOI 10.1038/oby.2001.36; McInnis KJ, 1999, RES Q EXERCISE SPORT, V70, P150, DOI 10.1080/02701367.1999.10608032; Nevill AM, 2003, MED SCI SPORT EXER, V35, P488, DOI 10.1249/01.MSS.0000053728.12929.5D; NEVILL AM, 1994, J APPL PHYSIOL, V77, P2870, DOI 10.1152/jappl.1994.77.6.2870; NEVILL AM, 1992, EUR J APPL PHYSIOL, V65, P110, DOI 10.1007/BF00705066; SALVADORI A, 1992, CHEST, V101, P674, DOI 10.1378/chest.101.3.674; Sterkowicz S, 2011, BIOL SPORT, V28, P271, DOI 10.5604/965486; Sun G, 2005, AM J CLIN NUTR, V81, P74; Svedenhag J., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P175; Tartaruga MP, 2010, BIOL SPORT, V27, P297; Tartaruga MP, 2009, BIOL SPORT, V26, P263, DOI 10.5604/20831862.894791; TOTH MJ, 1993, J APPL PHYSIOL, V75, P2288, DOI 10.1152/jappl.1993.75.5.2288; Vanderburgh PM, 1996, MED SCI SPORT EXER, V28, P1204, DOI 10.1097/00005768-199609000-00019; Venkata Y., 2004, J EXERC PHYSL, V7, P34; Vogel JA, 1992, ARMY DATA BODY COMPO, P89; Welsman JR, 1996, MED SCI SPORT EXER, V28, P259, DOI 10.1097/00005768-199602000-00016; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	30	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95797	10.1371/journal.pone.0095797	http://dx.doi.org/10.1371/journal.pone.0095797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752377	Green Submitted, Green Published, gold			2022-12-25	WOS:000335227400131
J	Nenadovic, V; Velazquez, JLP; Hutchison, JS				Nenadovic, Vera; Velazquez, Jose Luis Perez; Hutchison, James Saunders			Phase Synchronization in Electroencephalographic Recordings Prognosticates Outcome in Paediatric Coma	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SOMATOSENSORY-EVOKED POTENTIALS; INTENSIVE-CARE-UNIT; VOLUME CONDUCTION; SPLINE-LAPLACIAN; EEG COHERENCE; CHILDREN; VARIABILITY; COMPLEXITY; MORTALITY	Brain injury from trauma, cardiac arrest or stroke is the most important cause of death and acquired disability in the paediatric population. Due to the lifetime impact of brain injury, there is a need for methods to stratify patient risk and ultimately predict outcome. Early prognosis is fundamental to the implementation of interventions to improve recovery, but no clinical model as yet exists. Healthy physiology is associated with a relative high variability of physiologic signals in organ systems. This was first evaluated in heart rate variability research. Brain variability can be quantified through electroencephalographic (EEG) phase synchrony. We hypothesised that variability in brain signals from EEG recordings would correlate with patient outcome after brain injury. Lower variability in EEG phase synchronization, would be associated with poor patient prognosis. A retrospective study, spanning 10 years (2000-2010) analysed the scalp EEGs of children aged 1 month to 17 years in coma (Glasgow Coma Scale, GCS, < 8) admitted to the paediatric critical care unit (PCCU) following brain injury from TBI, cardiac arrest or stroke. Phase synchrony of the EEGs was evaluated using the Hilbert transform and the variability of the phase synchrony calculated. Outcome was evaluated using the 6 point Paediatric Performance Category Score (PCPC) based on chart review at the time of hospital discharge. Outcome was dichotomized to good outcome (PCPC score 1 to 3) and poor outcome (PCPC score 4 to 6). Children who had a poor outcome following brain injury secondary to cardiac arrest, TBI or stroke, had a higher magnitude of synchrony (R index), a lower spatial complexity of the synchrony patterns and a lower temporal variability of the synchrony index values at 15 Hz when compared to those patients with a good outcome.	[Nenadovic, Vera; Hutchison, James Saunders] Div Neurol Sick Kids, Toronto, ON, Canada; [Hutchison, James Saunders] Dept Crit Care Med Sick Kids, Toronto, ON, Canada; [Velazquez, Jose Luis Perez; Hutchison, James Saunders] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Nenadovic, V (corresponding author), Div Neurol Sick Kids, Toronto, ON, Canada.	Vera.nenadovic@sickkids.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Dr. Nenadovic's CIHR Banting and Best Doctoral Fellowship to, and by Dr. Perez Velazquez's Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Avner JR, 2006, PEDIATR REV, V27, P331, DOI 10.1542/pir.27-9-331; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Babiloni F, 1996, ELECTROEN CLIN NEURO, V98, P363, DOI 10.1016/0013-4694(96)00284-2; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Bricolo A, 1990, HDB CLIN NEUROLOGY, V13, P181; Buchman TG, 1996, J TRAUMA, V41, P599, DOI 10.1097/00005373-199610000-00002; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Catroppa C, 2009, FUTUR NEUROL, V4, P811, DOI 10.2217/FNL.09.52; Cimponeriu L, 2002, P ANN INT IEEE EMBS, P2029, DOI 10.1109/IEMBS.2002.1053151; Daubin C, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-35; Davey MP, 2000, CLIN NEUROPHYSIOL, V111, P1949, DOI 10.1016/S1388-2457(00)00435-1; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Dominguez LG, 2008, INT J BIFURCAT CHAOS, V18, P429; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Farrell CA, 2013, PAED CHILD HEALT-CAN, V18, P253, DOI 10.1093/pch/18.5.253; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; Fischer J, 2001, Crit Care Nurs Q, V23, P52; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Flohr H, 1995, BEHAV BRAIN RES, V71, P157, DOI 10.1016/0166-4328(95)00033-X; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P554, DOI 10.1136/adc.2009.161083; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Jones KE, 2009, LEVETIRACETAM VERSUS; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kirton A, 2007, NEUROREHABILITATION, V22, P371; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Van Quyen M, 2007, TRENDS NEUROSCI, V30, P365, DOI 10.1016/j.tins.2007.05.006; Lerma C, 2008, MED BIOL ENG COMPUT, V46, P715, DOI 10.1007/s11517-008-0326-y; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Mandel R, 2002, J PEDIATR-US, V141, P45, DOI 10.1067/mpd.2002.125005; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mewasingh LD, 2003, PEDIATR NEUROL, V28, P178, DOI 10.1016/S0887-8994(02)00509-X; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Noirhomme A, 2010, FRONTIERS SYS NEUROS, V4, P1; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Peliowski-Davidovich A, 2012, PAED CHILD HEALT-CAN, V17, P41, DOI 10.1093/pch/17.1.41; Perez Velazquez JL, 2011, BRAIN BEHAV CONTINUU; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Scheuer ML, 2004, J CLIN NEUROPHYSIOL, V21, P353; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff Nicholas D, 2010, Cleve Clin J Med, V77 Suppl 3, pS27, DOI 10.3949/ccjm.77.s3.05; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shields DC, 2007, SURG NEUROL, V67, P354, DOI 10.1016/j.surneu.2006.09.036; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; Turgeon AF, 2012, CRIT CARE ROUNDS, V8; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Van CA, 2003, CURRENT PRACTICE CLI, P463; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Velazquez JLP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00098; Vet NJ, 2013, INTENS CARE MED, V39, P1524, DOI 10.1007/s00134-013-2971-3; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; Winter WR, 2007, STAT MED, V26, P3946, DOI 10.1002/sim.2978; Wittman JJ, 2005, NEUROCRIT CARE, V2, P330, DOI 10.1385/NCC:2:3:330; Wu WQ, 2011, CLIN NEUROPHYSIOL, V122, P21, DOI 10.1016/j.clinph.2010.06.003; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077325; Young GB, 2009, CAN J NEUROL SCI, V36, pS9; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH	92	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94942	10.1371/journal.pone.0094942	http://dx.doi.org/10.1371/journal.pone.0094942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752289	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400021
J	Salameh, A; Haunschild, J; Braauchle, P; Peim, O; Seidel, T; Reitmann, M; Kostelka, M; Bakhtiary, F; Dhein, S; Dahnert, I				Salameh, Aida; Haunschild, Josphina; Braeuchle, Paul; Peim, Oliver; Seidel, Thomas; Reitmann, Marko; Kostelka, Martin; Bakhtiary, Farhad; Dhein, Stefan; Daehnert, Ingo			On the Role of the Gap Junction Protein Cx43 (GJA1) in Human Cardiac Malformations with Fallot-Pathology. A Study on Paediatric Cardiac Specimen	PLOS ONE			English	Article							VENTRICULAR MYOCARDIUM; CONNEXIN EXPRESSION; HUMAN FETAL; HEART; AGE; PATTERNS; MUSCLE; GROWTH; DISTRIBUTIONS; HYPERTROPHY	Introduction: Gap junction channels are involved in growth and differentiation. Therefore, we wanted to elucidate if the main cardiac gap junction protein connexin43 (GJA1) is altered in patients with Tetralogy of Fallot or double-outlet right ventricle of Fallot-type (62 patients referred to as Fallot) compared to other cardiac anomalies (21 patients referred to as non-Fallot). Patients were divided into three age groups: 0-2years, 2-12years and >12years. Myocardial tissue samples were collected during corrective surgery and analysis of cell morphology, GJA1- and N-cadherin (CDH2)-distribution, as well as GJA1 protein-and mRNA-expression was carried out. Moreover, GJA1-gene analysis of 16 patients and 20 healthy subjects was performed. Results: Myocardial cell length and width were significantly increased in the oldest age group compared to the younger ones. GJA1 distribution changed significantly during maturation with the ratio of polar/lateral GJA1 increasing from 2.93 +/- 0.68 to 8.52 +/- 1.41. While in 0-2years old patients similar to 6% of the lateral GJA1 was co-localised with CDH2 this decreased with age. Furthermore, the changes in cell morphology and GJA1-distribution were not due to the heart defect itself but were significantly dependent on age. Total GJA1 protein expression decreased during growing-up, whereas GJA1-mRNA remained unchanged. Sequencing of the GJA1-gene revealed only few heterozygous single nucleotide polymorphisms within the Fallot and the healthy control group. Conclusion: During maturation significant changes in gap junction remodelling occur which might be necessary for the growing and developing heart. In our study point mutations within the Cx43-gene could not be identified as a cause of the development of TOF.	[Salameh, Aida; Braeuchle, Paul; Peim, Oliver; Reitmann, Marko; Daehnert, Ingo] Univ Leipzig, Ctr Heart, Clin Paediat Cardiol, D-04109 Leipzig, Germany; [Haunschild, Josphina; Kostelka, Martin; Bakhtiary, Farhad; Dhein, Stefan] Univ Leipzig, Ctr Heart, Clin Cardiac Surg, D-04109 Leipzig, Germany; [Seidel, Thomas] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT USA	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Utah System of Higher Education; University of Utah	Salameh, A (corresponding author), Univ Leipzig, Ctr Heart, Clin Paediat Cardiol, D-04109 Leipzig, Germany.	aida.salameh@med.uni-leipzig.de		Seidel, Thomas/0000-0002-3127-1693				Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; CHEN SC, 1994, PEDIATR RES, V36, P561, DOI 10.1203/00006450-199411000-00002; COLAN SD, 1992, J AM COLL CARDIOL, V19, P619, DOI 10.1016/S0735-1097(10)80282-7; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Coppen SR, 2003, MOL CELL BIOCHEM, V242, P121, DOI 10.1023/A:1021150014764; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; GOURDIE RG, 1992, ANAT EMBRYOL, V185, P363; HORT W, 1953, VIRCHOWS ARCH A, V323, P223, DOI 10.1007/BF00957500; Huang Guo-Ying, 2011, J Cardiovasc Dis Res, V2, P206, DOI 10.4103/0975-3583.89804; Kostin S, 2004, CARDIOVASC RES, V62, P426, DOI 10.1016/j.cardiores.2003.12.010; Lackey DP, 2011, ANN BIOMED ENG, V39, P2683, DOI 10.1007/s10439-011-0369-3; LEGATO MJ, 1979, CIRC RES, V44, P250, DOI 10.1161/01.RES.44.2.250; LI C, 1989, CIRC RES, V64, P501, DOI 10.1161/01.RES.64.3.501; Li JF, 2008, J MOL CELL CARDIOL, V44, P597, DOI 10.1016/j.yjmcc.2007.11.013; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; NEEDLMAN RD, 2000, NELSON TXB PEDIAT, P23; Nishikawa T, 1990, AM J CARDIOVASC PATH, V3, P11; PETERS NS, 1994, CIRCULATION, V90, P713, DOI 10.1161/01.CIR.90.2.713; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; Salameh A, 2009, BRIT J PHARMACOL, V158, P198, DOI 10.1111/j.1476-5381.2009.00344.x; Salameh A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00070; Salameh A, 2012, CIRCULATION, V125, P2578, DOI 10.1161/CIRCULATIONAHA.111.079087; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; SAWADA K-I, 1991, Heart and Vessels, V6, P129, DOI 10.1007/BF02058278; Seidel T, 2013, MAGN RESON MED, V69, DOI 10.1002/mrm.24408; Seidel T, 2010, BIOPHYS J, V99, P2821, DOI 10.1016/j.bpj.2010.09.010; SEKIGUCHI M, 1986, JPN CIRC J, V50, P1023, DOI 10.1253/jcj.50.1023; Sepp R, 1996, HEART, V76, P412, DOI 10.1136/hrt.76.5.412; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; SPACH MS, 1988, CIRC RES, V62, P811, DOI 10.1161/01.RES.62.4.811; SPACH MS, 1994, J CARDIOVASC ELECTR, V5, P182, DOI 10.1111/j.1540-8167.1994.tb01157.x; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Walters H L 3rd, 2000, Ann Thorac Surg, V69, pS249, DOI 10.1016/S0003-4975(99)01247-3; ZAK R, 1974, CIRC RES, V35, P17	38	13	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95344	10.1371/journal.pone.0095344	http://dx.doi.org/10.1371/journal.pone.0095344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751918	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400052
J	Yan, JM; Campbell, JH; Glick, BR; Smith, MD; Liang, Y				Yan, Jianmin; Campbell, James H.; Glick, Bernard R.; Smith, Matthew D.; Liang, Yan			Molecular Characterization and Expression Analysis of Chloroplast Protein Import Components in Tomato (Solanum lycopersicum)	PLOS ONE			English	Article							DISTINCT PATHWAYS; RECEPTOR FAMILY; GENOME SEQUENCE; OUTER ENVELOPE; ARABIDOPSIS; APPARATUS; TRANSLOCON; PLASTIDS; MACHINERY; MEMBRANE	The translocon at the outer envelope membrane of chloroplasts (Toc) mediates the recognition and initial import into the organelle of thousands of nucleus-encoded proteins. These proteins are translated in the cytosol as precursor proteins with cleavable amino-terminal targeting sequences called transit peptides. The majority of the known Toc components that mediate chloroplast protein import were originally identified in pea, and more recently have been studied most extensively in Arabidopsis. With the completion of the tomato genome sequencing project, it is now possible to identify putative homologues of the chloroplast import components in tomato. In the work reported here, the Toc GTPase cDNAs from tomato were identified, cloned and analyzed. The analysis revealed that there are four Toc159 homologues (slToc159-1, -2, 3 and -4) and two Toc34 homologues (slToc34-1 and -2) in tomato, and it was shown that tomato Toc159 and Toc34 homologues share high sequence similarity with the comparable import apparatus components from Arabidopsis and pea. Thus, tomato is a valid model for further study of this system. The expression level of Toc complex components was also investigated in different tissues during tomato development. The two tomato Toc34 homologues are expressed at higher levels in non-photosynthetic tissues, whereas, the expression of two tomato Toc159 homologues, slToc159-1 and slToc159-4, were higher in photosynthetic tissues, and the expression patterns of slToc159-2 was not significantly different in photosynthetic and non-photosynthetic tissues, and slToc159-3 expression was limited to a few select tissues.	[Yan, Jianmin; Liang, Yan] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Yan, Jianmin; Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Campbell, James H.; Smith, Matthew D.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada	Northwest A&F University - China; University of Waterloo; Wilfrid Laurier University	Smith, MD (corresponding author), Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada.	msmith@wlu.ca; liangyan@nwsuaf.edu.cn	Smith, Matthew/M-4726-2014	Smith, Matthew/0000-0002-2855-5126	Natural Sciences and Engineering Research Council Discovery Grant [312143-2010]; NSERC Discovery Accelerator Supplement [396033-2010]	Natural Sciences and Engineering Research Council Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Accelerator Supplement(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council Discovery Grant (grant number 312143-2010). NSERC Discovery Accelerator Supplement (grant number 396033-2010). The website address for NSERC is: http://www. nserc-crsng. gc. ca/index_ eng. asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Becker T, 2004, MOL BIOL CELL, V15, P5130, DOI 10.1091/mbc.E04-05-0405; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chen KH, 2000, PLANT PHYSIOL, V122, P813, DOI 10.1104/pp.122.3.813; Cline K, 1996, ANNU REV CELL DEV BI, V12, P1, DOI 10.1146/annurev.cellbio.12.1.1; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Dhanoa PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010098; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gnanasambandam A, 2007, PLANT BIOTECHNOL J, V5, P290, DOI 10.1111/j.1467-7652.2007.00241.x; Gutensohn M, 2000, PLANT J, V23, P771, DOI 10.1046/j.1365-313x.2000.00849.x; Hiltbrunner A, 2001, BIOCHEM CELL BIOL, V79, P629, DOI 10.1139/bcb-79-5-629; HIRSCH S, 1994, SCIENCE, V266, P1989, DOI 10.1126/science.7801125; Inoue H, 2010, PLANT CELL, V22, P1947, DOI 10.1105/tpc.110.074328; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jackson-Constan D, 2001, PLANT PHYSIOL, V125, P1567, DOI 10.1104/pp.125.4.1567; Jarvis P, 2004, CURR BIOL, V14, pR317, DOI 10.1016/j.cub.2004.03.054; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Jelic M, 2003, BIOCHEMISTRY-US, V42, P5906, DOI 10.1021/bi034001q; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Ko K, 1999, BBA-BIOMEMBRANES, V1421, P198, DOI 10.1016/S0005-2736(99)00126-1; Kubis S, 2004, PLANT CELL, V16, P2059, DOI 10.1105/tpc.104.023309; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lopez-Juez E, 2007, J EXP BOT, V58, P11, DOI 10.1093/jxb/erl196; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mueller LA, 2009, PLANT GENOME-US, V2, P78, DOI 10.3835/plantgenome2008.08.0005; Richardson LGL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-35; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; SEEDORF M, 1995, PLANT J, V7, P401, DOI 10.1046/j.1365-313X.1995.7030401.x; Smith MD, 2006, CAN J BOT, V84, P531, DOI 10.1139/B06-050; Smith MD, 2004, J CELL BIOL, V165, P323, DOI 10.1083/jcb.200311074; Sohrt K, 2000, J CELL BIOL, V148, P1213, DOI 10.1083/jcb.148.6.1213; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Soll J, 1998, PLANT MOL BIOL, V38, P191, DOI 10.1023/A:1006034020192; Sommer M, 2013, PLANT CELL ENVIRON, V36, P970, DOI 10.1111/pce.12030; Stengel A, 2007, BIOL CHEM, V388, P765, DOI 10.1515/BC.2007.099; Summer EJ, 1999, PLANT PHYSIOL, V119, P575, DOI 10.1104/pp.119.3.1147; Voigt A, 2005, FEBS LETT, V579, P1343, DOI 10.1016/j.febslet.2004.12.096	45	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95088	10.1371/journal.pone.0095088	http://dx.doi.org/10.1371/journal.pone.0095088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751891	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400031
J	Boender, GJ; van den Hengel, R; van Roermund, HJW; Hagenaars, TJ				Boender, Gert Jan; van den Hengel, Rob; van Roermund, Herman J. W.; Hagenaars, Thomas J.			The Influence of Between-Farm Distance and Farm Size on the Spread of Classical Swine Fever during the 1997-1998 Epidemic in The Netherlands	PLOS ONE			English	Article							VIRUS; TRANSMISSION; STRATEGIES	As the size of livestock farms in The Netherlands is on the increase for economic reasons, an important question is how disease introduction risks and risks of onward transmission scale with farm size (i.e. with the number of animals on the farm). Here we use the epidemic data of the 1997-1998 epidemic of Classical Swine Fever (CSF) Virus in The Netherlands to address this question for CSF risks. This dataset is one of the most powerful ones statistically as in this epidemic a total of 428 pig farms where infected, with the majority of farm sizes ranging between 27 and 1750 pigs, including piglets. We have extended the earlier models for the transmission risk as a function of between-farm distance, by adding two factors. These factors describe the effect of farm size on the susceptibility of a 'receiving' farm and on the infectivity of a 'sending' farm (or 'source' farm), respectively. Using the best-fitting model, we show that the size of a farm has a significant influence on both farm-level susceptibility and infectivity for CSF. Although larger farms are both more susceptible to CSF and, when infected, more infectious to other farms than smaller farms, the increase is less than linear. The higher the farm size, the smaller the effect of increments of farm size on the susceptibility and infectivity of a farm. Because of changes in the Dutch pig farming characteristics, a straightforward extrapolation of the observed farm size dependencies from 1997/1998 to present times would not be justified. However, based on our results one may expect that also for the current pig farming characteristics in The Netherlands, farm susceptibility and infectivity depend non-linearly on farm size, with some saturation effect for relatively large farm sizes.	[Boender, Gert Jan; van den Hengel, Rob; van Roermund, Herman J. W.; Hagenaars, Thomas J.] Cent Vet Inst CVI Wageningen, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands	Wageningen University & Research	Boender, GJ (corresponding author), Cent Vet Inst CVI Wageningen, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands.	gertjan.boender@wur.nl			BO-Project Maatschappelijk aanvaardbare dierziektebestrijding [BO-08-010-011]; Netherlands Ministry for Economic Affairs, Agriculture and Innovation (ELI)	BO-Project Maatschappelijk aanvaardbare dierziektebestrijding; Netherlands Ministry for Economic Affairs, Agriculture and Innovation (ELI)	This work is part of BO-Project Maatschappelijk aanvaardbare dierziektebestrijding (BO-08-010-011) and was funded by the Netherlands Ministry for Economic Affairs, Agriculture and Innovation (EL&I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Backer JA, 2009, J R SOC INTERFACE, V6, P849, DOI 10.1098/rsif.2008.0408; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Benard HJ, 1999, PREV VET MED, V42, P235, DOI 10.1016/S0167-5877(99)00078-1; Boender GJ, 2007, PREV VET MED, V82, P90, DOI 10.1016/j.prevetmed.2007.05.016; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Boender GJ, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-9; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Hennecken M, 2000, VET QUART, V22, P228, DOI 10.1080/01652176.2000.9695064; Jalvingh AW, 1999, PREV VET MED, V42, P271, DOI 10.1016/S0167-5877(99)00080-X; Klinkenberg D, 2003, MATH BIOSCI, V186, P145, DOI 10.1016/j.mbs.2003.08.005; Mintiens K, 2003, PREV VET MED, V60, P27, DOI 10.1016/S0167-5877(03)00080-1; Pluimers FH, 1999, PREV VET MED, V42, P139, DOI 10.1016/S0167-5877(99)00085-9; Stegeman A, 2000, VET MICROBIOL, V73, P183, DOI 10.1016/S0378-1135(00)00144-9; Stegeman A, 1999, PREV VET MED, V42, P219, DOI 10.1016/S0167-5877(99)00077-X; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699	19	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95278	10.1371/journal.pone.0095278	http://dx.doi.org/10.1371/journal.pone.0095278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748233	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500073
J	Jung, IL				Jung, Il Lae			Soluble Extract from Moringa oleifera Leaves with a New Anticancer Activity	PLOS ONE			English	Article							MEDICINAL-PLANT EXTRACTS; BREAST-CANCER CELLS; PHARMACOLOGICAL PROPERTIES; ANTIOXIDANT PROPERTIES; LAM. LEAVES; IN-VITRO; VIRUS; VIVO; CARCINOGENESIS; THIOCARBAMATE	Moringa oleifera has been regarded as a food substance since ancient times and has also been used as a treatment for many diseases. Recently, various therapeutic effects of M. oleifera such as antimicrobial, anticancer, anti-inflammatory, antidiabetic, and antioxidant effects have been investigated; however, most of these studies described only simple biological phenomena and their chemical compositions. Due to the increasing attention on natural products, such as those from plants, and the advantages of oral administration of anticancer drugs, soluble extracts from M. oleifera leaves (MOL) have been prepared and their potential as new anticancer drug candidates has been assessed in this study. Here, the soluble cold Distilled Water extract (4 degrees C; concentration, 300 mu g/mL) from MOL greatly induced apoptosis, inhibited tumor cell growth, and lowered the level of internal reactive oxygen species (ROS) in human lung cancer cells as well as other several types of cancer cells, suggesting that the treatment of cancer cells with MOL significantly reduced cancer cell proliferation and invasion. Moreover, over 90% of the genes tested were unexpectedly downregulated more than 2-fold, while just below 1% of the genes were upregulated more than 2-fold in MOL extract-treated cells, when compared with nontreated cells. Since severe dose-dependent rRNA degradation was observed, the abnormal downregulation of numerous genes was considered to be attributable to abnormal RNA formation caused by treatment with MOL extracts. Additionally, the MOL extract showed greater cytotoxicity for tumor cells than for normal cells, strongly suggesting that it could potentially be an ideal anticancer therapeutic candidate specific to cancer cells. These results suggest the potential therapeutic implications of the soluble extract from MOL in the treatment of various types of cancers.	Korea Atom Energy Res Inst, Dept Radiat Biol, Environm Radiat Res Grp, Taejon, South Korea	Korea Atomic Energy Research Institute (KAERI)	Jung, IL (corresponding author), Korea Atom Energy Res Inst, Dept Radiat Biol, Environm Radiat Res Grp, Taejon, South Korea.	ex-jil7147@kaeri.re.kr			Korea Atomic Energy Research Institute [527240-14]	Korea Atomic Energy Research Institute	Funding for this study was provided by the Korea Atomic Energy Research Institute (grant number 527240-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; Bharali Rupjyoti, 2003, Asian Pac J Cancer Prev, V4, P131; Brunelli D, 2010, BIOCHEM PHARMACOL, V79, P1141, DOI 10.1016/j.bcp.2009.12.008; Budda S, 2011, ASIAN PAC J CANCER P, V12, P3221; CACERES A, 1992, J ETHNOPHARMACOL, V36, P233, DOI 10.1016/0378-8741(92)90049-W; CACERES A, 1991, J ETHNOPHARMACOL, V33, P213, DOI 10.1016/0378-8741(91)90078-R; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Chumark P, 2008, J ETHNOPHARMACOL, V116, P439, DOI 10.1016/j.jep.2007.12.010; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Dahiru D, 2006, AFR J TRADIT COMPLEM, V3, P70; Dahot MU, 1985, J PHARM, V3, P75; Fahey J. W., 2005, TREES LIFE J, V1, P1, DOI DOI 10.1201/9781420039078.CH12; FAIZI S, 1994, J NAT PROD, V57, P1256, DOI 10.1021/np50111a011; FAIZI S, 1995, PHYTOCHEMISTRY, V38, P957, DOI 10.1016/0031-9422(94)00729-D; Fakurazi S, 2008, FOOD CHEM TOXICOL, V46, P2611, DOI 10.1016/j.fct.2008.04.018; Fuglie LJ, 1999, MIRACLE TREE MORINGA, V68, P172; Ghasi S, 2000, J ETHNOPHARMACOL, V69, P21, DOI 10.1016/S0378-8741(99)00106-3; Guevara AP, 1999, MUTAT RES-GEN TOX EN, V440, P181, DOI 10.1016/S1383-5718(99)00025-X; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Iqbal S, 2006, J FOOD COMPOS ANAL, V19, P544, DOI 10.1016/j.jfca.2005.05.001; Kampa M, 2004, BREAST CANCER RES, V6, pR63, DOI 10.1186/bcr752; Katoh M, 2007, INT J ONCOL, V30, P247; Khalafalla MM, 2010, AFR J BIOTECHNOL, V9, P8467; Khan HA, 2011, J APPL TOXICOL, V31, P707, DOI 10.1002/jat.1716; Kumar Gupta S, 2012, J OCUL PHAR IN PRESS; Kumar N. Ashok, 2003, Journal of Medicinal Food, V6, P255; Kumar V., 2012, INT J PHARMA SCI REV, V12, P89; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Li HT, 2010, BRIT J PHARMACOL, V160, P1352, DOI 10.1111/j.1476-5381.2010.00785.x; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Lipipun V, 2003, ANTIVIR RES, V60, P175, DOI 10.1016/S0166-3542(03)00152-9; Lotito SB, 2000, P SOC EXP BIOL MED, V225, P32, DOI 10.1046/j.1525-1373.2000.22504.x; Mahajan SG, 2007, J IMMUNOTOXICOL, V4, P39, DOI 10.1080/15476910601115184; Mahmood K.T., 2010, J PHARM SCI RES, V2, P775, DOI DOI 10.1371/JOURNAL.PONE.0095492; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miyoshi N, 2004, CARCINOGENESIS, V25, P567, DOI 10.1093/carcin/bgh051; Mukunzi D., 2011, Pakistan Journal of Nutrition, V10, P602; Murakami A, 1998, PLANTA MED, V64, P319, DOI 10.1055/s-2006-957442; Oliveira JTA, 1999, J SCI FOOD AGR, V79, P815, DOI [10.1002/(SICI)1097-0010(19990501)79:6&lt;815::AID-JSFA290&gt;3.0.CO;2-P, 10.1002/(SICI)1097-0010(19990501)79:6<815::AID-JSFA290>3.0.CO;2-P]; Pari L., 2002, Journal of Medicinal Food, V5, P171, DOI 10.1089/10966200260398206; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Siddhuraju P, 2003, J AGR FOOD CHEM, V51, P2144, DOI 10.1021/jf020444+; Sultana B, 2009, MOLECULES, V14, P2167, DOI 10.3390/molecules14062167; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Teicher B.A., 2004, ANTICANCER DRUG DEV; Thangapazham RL, 2007, CANCER BIOL THER, V6, P1938, DOI 10.4161/cbt.6.12.4974; Tiloke C, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-226; Tsaknis J, 1999, J AGR FOOD CHEM, V47, P4495, DOI 10.1021/jf9904214; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Velayutham P, 2008, CURR MED CHEM, V15, P1840; Waiyaput W, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-246; Welstead G Grant, 2008, J Vis Exp, DOI 10.3791/734; WOOD M, 1997, BOOK HERBAL WISDOM U, P374	55	114	123	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95492	10.1371/journal.pone.0095492	http://dx.doi.org/10.1371/journal.pone.0095492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748376	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500114
J	Li, P; Wu, DF; Liu, KY; Suolang, SZ; He, T; Liu, X; Wu, CM; Wang, Y; Lin, DG				Li, Peng; Wu, Dongfang; Liu, Kunyao; Suolang, Sizhu; He, Tao; Liu, Xuan; Wu, Congming; Wang, Yang; Lin, Degui			Investigation of Antimicrobial Resistance in Escherichia coli and Enterococci Isolated from Tibetan Pigs	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; GENES; ANIMALS; DIVERSITY; STRAINS; TURKEY; PERIOD; RIVER	Objectives: This study investigated the antimicrobial resistance of Escherichia coli and enterococci isolated from free-ranging Tibetan pigs in Tibet, China, and analyzed the influence of free-ranging husbandry on antimicrobial resistance. Methods: A total of 232 fecal samples were collected from Tibetan pigs, and the disk diffusion method was used to examine their antimicrobial resistance. Broth microdilution and agar dilution methods were used to determine minimum inhibitory concentrations for antimicrobial agents for which disks were not commercially available. Results: A total of 129 E. coli isolates and 84 Enterococcus isolates were recovered from the fecal samples. All E. coli isolates were susceptible to amoxicillin/clavulanic acid, and 40.4% were resistant to tetracycline. A small number of isolates were resistant to florfenicol (27.9%), ampicillin (27.9%), sulfamethoxazole/trimethoprim (19.4%), nalidixic acid (19.4%), streptomycin (16.2%) and ceftiofur (10.9%), and very low resistance rates to ciprofloxacin (7.8%), gentamicin (6.9%), and spectinomycin (2.3%) were observed in E. coli. All Enterococcus isolates, including E. faecium, E. faecalis, E. hirae, and E. mundtii, were susceptible to amoxicillin/clavulanic acid and vancomycin, but showed high frequencies of resistance to oxacillin (92.8%), clindamycin (82.1%), tetracycline (64.3%), and erythromycin (48.8%). Resistance rates to florfenicol (17.9%), penicillin (6.0%), ciprofloxacin (3.6%), levofloxacin (1.2%), and ampicillin (1.2%) were low. Only one high-level streptomycin resistant E. faecium isolate and one high-level gentamicin resistant E. faecium isolate were observed. Approximately 20% and 70% of E. coli and Enterococcus isolates, respectively, were defined as multidrug-resistant. Conclusions: In this study, E. coli and Enterococcus isolated from free-ranging Tibetan pigs showed relatively lower resistance rates than those in other areas of China, where more intensive farming practices are used. These results also revealed that free-range husbandry and absence of antibiotic use could decrease the occurrence of antimicrobial resistance to some extent.	[Li, Peng; Lin, Degui] China Agr Univ, Coll Vet Med, Dept Small Anim Clin Sci, Beijing 100094, Peoples R China; [Wu, Dongfang; He, Tao; Liu, Xuan; Wu, Congming; Wang, Yang] China Agr Univ, Coll Vet Med, Natl Ctr Vet Drug Safety Evaluat, Beijing 100094, Peoples R China; [Liu, Kunyao] China Inst Vet Drugs Control, Dept Pharmaceut, Beijing, Peoples R China; [Suolang, Sizhu] Tibet Univ, Coll Agr & Anim Husb, Linzhi, Peoples R China	China Agricultural University; China Agricultural University; Tibet University	Lin, DG (corresponding author), China Agr Univ, Coll Vet Med, Dept Small Anim Clin Sci, Beijing 100094, Peoples R China.	csama@sina.com	Wang, Yang/ABD-5983-2021	Wang, Yang/0000-0002-5928-9377	Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAK01B02]; Tibet Regional Natural Science Foundation; Special Fund for Agro-scientific Research in the Public Interest [201203040]	Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; Tibet Regional Natural Science Foundation; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAK01B02), the Tibet Regional Natural Science Foundation, and the Special Fund for Agro-scientific Research in the Public Interest (201203040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; da Costa PM, 2010, PREV VET MED, V93, P71, DOI 10.1016/j.prevetmed.2009.09.012; Dai L, 2008, FEMS MICROBIOL LETT, V286, P178, DOI 10.1111/j.1574-6968.2008.01272.x; Diarra MS, 2007, APPL ENVIRON MICROB, V73, P6566, DOI 10.1128/AEM.01086-07; Franz CMAP, 1999, INT J FOOD MICROBIOL, V47, P1, DOI 10.1016/S0168-1605(99)00007-0; Guerra B, 2003, J ANTIMICROB CHEMOTH, V52, P489, DOI 10.1093/jac/dkg362; Han D, 2011, INT J FOOD MICROBIOL, V144, P387, DOI 10.1016/j.ijfoodmicro.2010.10.024; Hu JY, 2008, ENVIRON SCI TECHNOL, V42, P3415, DOI 10.1021/es7026746; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Hwang IY, 2009, J VET DIAGN INVEST, V21, P858, DOI 10.1177/104063870902100616; Jahan M, 2013, INT J FOOD MICROBIOL, V163, P89, DOI 10.1016/j.ijfoodmicro.2013.02.017; Kak V, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P355; Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005; Korten V, 2007, DIAGN MICR INFEC DIS, V59, P453, DOI 10.1016/j.diagmicrobio.2007.06.016; Li H, 2005, VET RES COMMUN, V29, P395, DOI 10.1007/s11259-005-9141-1; Liassine N, 1998, J CLIN MICROBIOL, V36, P1853, DOI 10.1128/JCM.36.7.1853-1858.1998; Liu Y, 2013, J APPL MICROBIOL, V114, P555, DOI 10.1111/jam.12054; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Luppi A, 2015, TRANSBOUND EMERG DIS, V62, P67, DOI 10.1111/tbed.12081; Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003; McDonald LC, 1997, EMERG INFEC DIS, V3, P261; Navarro-Gonzalez N, 2013, APPL ENVIRON MICROB, V79, P6184, DOI 10.1128/AEM.01745-13; Oudhuis GJ, 2008, INT J ANTIMICROB AG, V31, P58, DOI 10.1016/j.ijantimicag.2007.08.009; Pan X, 2011, CHEMOSPHERE, V84, P695, DOI 10.1016/j.chemosphere.2011.03.022; Rice LB, 2001, EMERG INFECT DIS, V7, P183, DOI 10.3201/eid0702.010205; Rodrigues J, 2002, J VET MED B, V49, P278, DOI 10.1046/j.1439-0450.2002.00561.x; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Tao R, 2010, ENVIRON POLLUT, V158, P2101, DOI 10.1016/j.envpol.2010.03.004; Tremblay CL, 2011, J FOOD PROTECT, V74, P1639, DOI 10.4315/0362-028X.JFP-10-451; von Baum H, 2005, INT J MED MICROBIOL, V295, P503, DOI 10.1016/j.ijmm.2005.07.002; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Wasyl D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00221; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802	34	25	25	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95623	10.1371/journal.pone.0095623	http://dx.doi.org/10.1371/journal.pone.0095623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748326	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500131
J	Pielstrom, S; Roces, F				Pielstroem, Steffen; Roces, Flavio			Soil Moisture and Excavation Behaviour in the Chaco Leaf-Cutting Ant (Atta vollenweideri): Digging Performance and Prevention of Water Inflow into the Nest	PLOS ONE			English	Article							INTERNAL STRUCTURE; HYMENOPTERA-FORMICIDAE; 1893 HYM; FOREL; COMMUNICATION; ARCHITECTURE; VENTILATION; PREFERENCE; WORKERS; GROWTH	The Chaco leaf-cutting ant Atta vollenweideri is native to the clay-heavy soils of the Gran Chaco region in South America. Because of seasonal floods, colonies are regularly exposed to varying moisture across the soil profile, a factor that not only strongly influences workers' digging performance during nest building, but also determines the suitability of the soil for the rearing of the colony's symbiotic fungus. In this study, we investigated the effects of varying soil moisture on behaviours associated with underground nest building in A. vollenweideri. This was done in a series of laboratory experiments using standardised, plastic clay-water mixtures with gravimetric water contents ranging from relatively brittle material to mixtures close to the liquid limit. Our experiments showed that preference and group-level digging rate increased with increasing water content, but then dropped considerably for extremely moist materials. The production of vibrational recruitment signals during digging showed, on the contrary, a slightly negative linear correlation with soil moisture. Workers formed and carried clay pellets at higher rates in moist clay, even at the highest water content tested. Hence, their weak preference and low group-level excavation rate observed for that mixture cannot be explained by any inability to work with the material. More likely, extremely high moistures may indicate locations unsuitable for nest building. To test this hypothesis, we simulated a situation in which workers excavated an upward tunnel below accumulated surface water. The ants stopped digging about 12 mm below the interface soil/water, a behaviour representing a possible adaptation to the threat of water inflow field colonies are exposed to while digging under seasonally flooded soils. Possible roles of soil water in the temporal and spatial pattern of nest growth are discussed.	[Pielstroem, Steffen; Roces, Flavio] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Pielstrom, S (corresponding author), Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany.	steffen.pielstroem@gmx.com		Roces, Flavio/0000-0001-9258-3079	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG) [SFB 554/TP E1]; German Research Foundation (DFG); University of Wuerzburg	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	S.P. was supported by a Ph.D. grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. The research was partially supported by funds from the German Research Foundation (DFG, grant SFB 554/TP E1). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade A.P.P., 2005, 17 S MIRM CAMP GRAND, P490; Autuori M., 1942, ARQ INST BIOL [SAO PAULO], V13, P137; Belt T., 1874, NATURALIST NICARAGUA; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2007, ANIM BEHAV, V74, P1349, DOI 10.1016/j.anbehav.2007.02.021; Bollazzi M, 2010, J ETHOL, V28, P399, DOI 10.1007/s10164-010-0207-3; BRIAN MV, 1966, J ANIM ECOL, V35, P281, DOI 10.2307/2395; Chen J, 2009, J ECON ENTOMOL, V102, P1393, DOI 10.1603/029.102.0369; Cosarinsky MI, 2007, GEODERMA, V141, P224, DOI 10.1016/j.geoderma.2007.06.006; Cosarinsky MI, 2012, J INSECT BEHAV, V25, P222, DOI 10.1007/s10905-011-9290-8; DELYE G, 1971, INSECT SOC, V18, P15, DOI 10.1007/BF02223160; Delye G., 1957, Insectes Sociaux Paris, V4, P77, DOI 10.1007/BF02224144; Elahi R, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.34; EMERSON ALFRED E., 1938, ECOL MONOGR, V8, P247, DOI 10.2307/1943251; Espinoza DN, 2010, GRANUL MATTER, V12, P607, DOI 10.1007/s10035-010-0202-y; Frohle K, 2009, THESIS; Frohle K., 2009, INSECT NEST HUMAN AR, P95; Gorleri M.C., 2005, TEMAS DE NAT Y CONSE, V4, P13; Jacoby M., 1955, Zeitschrift fuer Angewandte Entomologie, V37, P129; Jacoby M, 1953, Z ANGEW ENTOMOL, V34, P145; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P158; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; JONKMAN JCM, 1976, Z ANGEW ENTOMOL, V81, P140; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; MARKL H, 1970, Z VERGL PHYSIOL, V69, P6, DOI 10.1007/BF00340908; Marshall T.J., 1996, SOIL PHYS, DOI [10.1017/CBO9781139170673, DOI 10.1017/CBO9781139170673]; Mikheyev AS, 2004, INSECT SOC, V51, P30, DOI 10.1007/s00040-003-0703-3; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; Pielstrom S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057040; Pielstrom S, 2012, ANIM BEHAV, V84, P743, DOI 10.1016/j.anbehav.2012.07.008; Rasse P, 2001, J INSECT BEHAV, V14, P433, DOI 10.1023/A:1011163804217; Roces F, 2000, INSECT SOC, V47, P348, DOI 10.1007/PL00001728; SPANGLER H G, 1973, Journal of the Kansas Entomological Society, V46, P157; STAHEL GEROLD, 1941, REV ENT [RIO DE JANEIRO], V12, P243; Stahel Gerold, 1939, REV ENT [RIO DE JANEIRO], V10, P27; Sudd J. H., 1969, Zeitschrift fuer Tierpsychologie, V26, P257; TOHME G, 1972, INSECT SOC, V19, P95, DOI 10.1007/BF02224727; van Gils HAJA, 2010, INSECT SOC, V57, P487, DOI 10.1007/s00040-010-0108-z; Weyrauch W, 1942, B DIRECCION AGR GANA, V13, P204; Wild AL, 2007, ZOOTAXA, P1; Xu YJ, 2009, INSECT SOC, V56, P367, DOI 10.1007/s00040-009-0032-2	46	21	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95658	10.1371/journal.pone.0095658	http://dx.doi.org/10.1371/journal.pone.0095658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748382	gold, Green Published			2022-12-25	WOS:000335226500134
J	Akiyama, T; Miyamoto, Y; Yoshimura, K; Yamada, A; Takami, M; Suzawa, T; Hoshino, M; Imamura, T; Akiyama, C; Yasuhara, R; Mishima, K; Maruyama, T; Kohda, C; Tanaka, K; Potempa, J; Yasuda, H; Baba, K; Kamijo, R				Akiyama, Tomohito; Miyamoto, Yoichi; Yoshimura, Kentaro; Yamada, Atsushi; Takami, Masamichi; Suzawa, Tetsuo; Hoshino, Marie; Imamura, Takahisa; Akiyama, Chie; Yasuhara, Rika; Mishima, Kenji; Maruyama, Toshifumi; Kohda, Chikara; Tanaka, Kazuo; Potempa, Jan; Yasuda, Hisataka; Baba, Kazuyoshi; Kamijo, Ryutaro			Porphyromonas gingivalis-derived Lysine Gingipain Enhances Osteoclast Differentiation Induced by Tumor Necrosis Factor-alpha and Interleukin-1 beta but Suppresses That by Interleukin-17A IMPORTANCE OF PROTEOLYTIC DEGRADATION OF OSTEOPROTEGERIN BY LYSINE GINGIPAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cytokine; Inflammation; Osteoclast; Proteolytic Enzyme; Gingipain; Osteoprotegerin	ARGININE-SPECIFIC PROTEINASES; ALVEOLAR BONE LOSS; CYSTEINE PROTEINASES; RECEPTOR ACTIVATOR; PROSTAGLANDIN E-2; INHIBITORY FACTOR; VITAMIN-D; LIGAND; EXPRESSION; CYTOKINE	Periodontitis is a chronic inflammatory disease accompanied by alveolar bone resorption by osteoclasts. Porphyromonas gingivalis, an etiological agent for periodontitis, produces cysteine proteases called gingipains, which are classified based on their cleavage site specificity (i.e. arginine (Rgps) and lysine (Kgps) gingipains). We previously reported that Kgp degraded osteoprotegerin (OPG), an osteoclastogenesis inhibitory factor secreted by osteoblasts, and enhanced osteoclastogenesis induced by various Toll-like receptor (TLR) ligands (Yasuhara, R., Miyamoto, Y., Takami, M., Imamura, T., Potempa, J., Yoshimura, K., and Kamijo, R. (2009) Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D-3-induced osteoclast differentiation by degrading osteoprotegerin. Biochem. J. 419, 159-166). Osteoclastogenesis is induced not only by TLR ligands but also by proinflammatory cytokines, including tumor necrosis factor- (TNF-), interleukin (IL)-1, and IL-17A, in inflammatory conditions, such as periodontitis. Although Kgp augmented osteoclastogenesis induced by TNF- and IL-1 in co-cultures of mouse osteoblasts and bone marrow cells, it suppressed that induced by IL-17A. In a comparison of proteolytic degradation of these cytokines by Kgp in a cell-free system with that of OPG, TNF- and IL-1 were less susceptible, whereas IL-17A and OPG were equally susceptible to degradation by Kgp. These results indicate that the enhancing effect of Kgp on cytokine-induced osteoclastogenesis is dependent on the difference in degradation efficiency between each cytokine and OPG. In addition, elucidation of the N-terminal amino acid sequences of OPG fragments revealed that Kgp primarily cleaved OPG in its death domain homologous region, which might prevent dimer formation of OPG required for inhibition of receptor activator of nuclear factor B ligand. Collectively, our results suggest that degradation of OPG by Kgp is a crucial event in the development of osteoclastogenesis and bone loss in periodontitis.	[Akiyama, Tomohito; Miyamoto, Yoichi; Yoshimura, Kentaro; Yamada, Atsushi; Takami, Masamichi; Suzawa, Tetsuo; Hoshino, Marie; Maruyama, Toshifumi; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan; [Hoshino, Marie; Maruyama, Toshifumi; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo 1428555, Japan; [Imamura, Takahisa; Mishima, Kenji] Showa Univ, Sch Dent, Div Pathol, Dept Oral Diagnost Sci, Tokyo 1428555, Japan; [Akiyama, Chie; Yasuhara, Rika] Kumamoto Univ, Fac Iife Sci, Dept Mol Pathol, Kumamoto 8608556, Japan; [Kohda, Chikara; Tanaka, Kazuo] Showa Univ, Sch Med, Dept Microbiol, Tokyo 1428555, Japan; [Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Oral Hlth & System Dis Grp, Louisville, KY 40202 USA; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Tokyo 1748505, Japan	Showa University; Showa University; Showa University; Kumamoto University; Showa University; Jagiellonian University; University of Louisville; Oriental Yeast Co., Ltd.	Miyamoto, Y (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	yoichim@dent.showa-u.ac.jp	Potempa, Jan/AAA-6850-2021; Baba, Kazuyoshi/AAY-2304-2021	Baba, Kazuyoshi/0000-0001-8025-2168; Takami, Masamichi/0000-0002-4506-3975; Potempa, Jan/0000-0002-3600-7461; Yasuhara, Rika/0000-0003-2282-6295	National Institutes of Health, NIDCR [DE22597]; Japan Society for the Promotion of Sciences; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23591876, 24592813] Funding Source: KAKEN; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health, NIDCR, Grant DE22597 (to J. P.). This work was also supported in part by the Japan Society for the Promotion of Sciences and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Banbula A, 1999, BIOCHEM BIOPH RES CO, V261, P598, DOI 10.1006/bbrc.1999.1075; BROMER WW, 1967, BIOCHEMISTRY-US, V6, P2378, DOI 10.1021/bi00860a013; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Fitzpatrick RE, 2009, J PERIODONTAL RES, V44, P565, DOI 10.1111/j.1600-0765.2008.01151.x; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Graves DT, 2001, J DENT RES, V80, P1875, DOI 10.1177/00220345010800100301; Gron H, 1997, J PERIODONTAL RES, V32, P61, DOI 10.1111/j.1600-0765.1997.tb01383.x; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hans Mayank, 2011, J Oral Sci, V53, P263; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hernandez M, 2011, J DENT RES, V90, P1164, DOI 10.1177/0022034511401405; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Kontani M, 1997, MOL MICROBIOL, V24, P1179, DOI 10.1046/j.1365-2958.1997.4321788.x; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Liu XH, 2006, ANN NY ACAD SCI, V1068, P225, DOI 10.1196/annals.1346.047; Miyachi K, 2007, J DENT RES, V86, P446, DOI 10.1177/154405910708600511; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Pathirana RD, 2007, INFECT IMMUN, V75, P1436, DOI 10.1128/IAI.01627-06; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Rajapakse PS, 2002, INFECT IMMUN, V70, P2480, DOI 10.1128/IAI.70.5.2480-2486.2002; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Suda K, 2004, J IMMUNOL, V172, P2504, DOI 10.4049/jimmunol.172.4.2504; Suda T, 1997, METHOD ENZYMOL, V282, P223; Suda T, 2003, J CELL BIOCHEM, V88, P259, DOI 10.1002/jcb.10331; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2005, IMMUNOL REV, V208, P181, DOI 10.1111/j.0105-2896.2005.00337.x; Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Yamaguchi K, 1998, J BIOL CHEM, V273, P5117, DOI 10.1074/jbc.273.9.5117; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yasuhara R, 2011, J ORAL BIOSCI, V53, P197, DOI 10.2330/joralbiosci.53.197; Yasuhara R, 2009, BIOCHEM J, V419, P159, DOI 10.1042/BJ20081469; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487	44	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15621	15630		10.1074/jbc.M113.520510	http://dx.doi.org/10.1074/jbc.M113.520510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24755218	Green Published, hybrid			2022-12-25	WOS:000337465400044
J	Athinarayanan, S; Wei, RR; Zhang, M; Bai, SC; Traber, MG; Yates, K; Cummings, OW; Molleston, J; Liu, WQ; Chalasani, N				Athinarayanan, Shaminie; Wei, Rongrong; Zhang, Min; Bai, Shaochun; Traber, Maret G.; Yates, Katherine; Cummings, Oscar W.; Molleston, Jean; Liu, Wanqing; Chalasani, Naga			Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials	PLOS ONE			English	Article							OMEGA-HYDROXYLASE PATHWAY; TYPE-1 DIABETES-MELLITUS; METABOLIC SYNDROME; OXIDATIVE STRESS; ALPHA-TOCOPHEROL; COMMON VARIANTS; BLOOD-PRESSURE; V433M VARIANT; CYP4F2; 20-HETE	Vitamin E improved liver histology in children and adults with NAFLD who participated in TONIC and PIVENS clinical trials, but with significant inter-individual variability in its efficacy. Cytochrome P450 4F2 (CYP4F2) is the major enzyme metabolizing Vit E, with two common genetic variants (V433M, rs2108622 and W12G, rs3093105) found to alter its activity. We investigated the relationship between CYP4F2 genotypes, alpha-tocopherol levels and histological improvement in these two trials. V433M and W12G variants were genotyped in TONIC (n = 155) and PIVENS (n = 213) DNA samples. The relationships between CYP4F2 genotypes, plasma alpha-tocopherol levels at baseline and weeks 48 (w48) and 96 (w96) and histological end points (overall improvement in liver histology and resolution of NASH) were investigated. As a result, the V433M genotype was significantly associated with baseline plasma alpha-tocopherol in the TONIC trial (p = 0.004), but not in PIVENS. Among those receiving Vit E treatment, CYP4F2 V433M genotype was associated with significantly decreased plasma alpha-tocopherol levels at w48 (p = 0.003 for PIVENS and p = 0.026 for TONIC) but not at w96. The w96 alpha-tocopherol level was significantly associated with resolution of NASH (p = 0.006) and overall histology improvement (p = 0.021) in the PIVENS, but not in the TONIC trial. There was no significant association between CYP4F2 genotypes and histological end points in either trial. Our study suggested the a moderate role of CYP4F2 polymorphisms in affecting the pharmacokinetics of Vit E as a therapeutic agent. In addition, there may be age-dependent relationship between CYP4F2 genetic variability and Vit E pharmacokinetics in NAFLD.	[Athinarayanan, Shaminie; Wei, Rongrong; Liu, Wanqing] Purdue Univ, Dept Med Chem & Mol Med, W Lafayette, IN 47907 USA; [Zhang, Min] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Bai, Shaochun] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Traber, Maret G.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Yates, Katherine] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MA USA; [Cummings, Oscar W.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Molleston, Jean] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Liu, Wanqing; Chalasani, Naga] Indiana Univ Sch Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA; [Liu, Wanqing; Chalasani, Naga] Indiana Univ Sch Med, Indiana Fatty Liver Dis Res Grp, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Oregon State University; Johns Hopkins University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Liu, WQ (corresponding author), Purdue Univ, Dept Med Chem & Mol Med, W Lafayette, IN 47907 USA.	liu781@purdue.edu; nchalasa@iu.edu	Athinarayanan, Shaminie/ABH-3703-2020; Traber, Maret G./ABI-2511-2020	Traber, Maret G./0000-0002-2892-4024	NIH/NIDDK [R21 DK090437]; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University; NIH [U01DK061737, U01DK061730]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061737, R21DK090437, U01DK061730] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by the NIH/NIDDK grant (R21 DK090437) (WL) and the start-up fund (WL) by the Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University. The NASH CRN Clinical Center at Indiana University is supported by the NIH grant U01DK061737, and the data coordinating center at Johns Hopkins School of Public Health is supported by the NIH grant U01DK061730. The authors would like to thank Dr. Rohit Loomba for his participation in the discussion and suggestions on data interpretation. The authors thank authors, coordinators, and participants of the PIVENS and TONIC clinical trials and a full list of authors is available from references 4 and 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardowel SA, 2010, J NUTR, V140, P1901, DOI 10.3945/jn.110.128579; Brigelius-Flohe R, 2002, AM J CLIN NUTR, V76, P703, DOI 10.1093/ajcn/76.4.703; Brigelius-Flohe R, 2003, BIOCHEM BIOPH RES CO, V305, P737, DOI 10.1016/S0006-291X(03)00811-8; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Costea I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015672; Curley CR, 2006, EUR J HUM GENET, V14, P1215, DOI 10.1038/sj.ejhg.5201687; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Fava C, 2008, HYPERTENSION, V52, P373, DOI 10.1161/HYPERTENSIONAHA.108.114199; Fava C, 2012, PROSTAG OTH LIPID M, V98, P31, DOI 10.1016/j.prostaglandins.2012.03.001; Fer M, 2008, CYTOCHROMES P450 FAM; Gupta S, 2011, CLIN LAB, V57, P379; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Hernandez-Marco R, 2009, PEDIATR NEPHROL, V24, P121, DOI 10.1007/s00467-008-0961-4; Hsu E, 2012, CLIN LIVER DIS, V16, P587, DOI 10.1016/j.cld.2012.05.004; KAYDEN HJ, 1993, J LIPID RES, V34, P343; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Lai GR, 2012, MOL ENDOCRINOL, V26, P1907, DOI 10.1210/me.2012-1139; Landes N, 2003, MOL ASPECTS MED, V24, P337, DOI 10.1016/S0098-2997(03)00029-3; Lavine JE, 2000, J PEDIATR-US, V136, P734, DOI 10.1016/S0022-3476(00)05040-X; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Liu H, 2008, J AM SOC NEPHROL, V19, P714, DOI 10.1681/ASN.2007060713; Lodge JK, 2005, J PLANT PHYSIOL, V162, P790, DOI 10.1016/j.jplph.2005.04.012; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Munshi A, 2012, MOL BIOL REP, V39, P1677, DOI 10.1007/s11033-011-0907-y; Mustacich DJ, 2007, VITAM HORM, V76, P1, DOI 10.1016/S0083-6729(07)76001-6; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Parker RS, 2004, ANN NY ACAD SCI, V1031, P13, DOI 10.1196/annals.1331.002; Parks E, 2000, ANTIOXID REDOX SIGN, V2, P405, DOI 10.1089/15230860050192189; Patel K, 2010, PRACT GASTROENTEROL, V34, P20; Powell PK, 1998, J PHARMACOL EXP THER, V285, P1327; Sanders RJ, 2008, FASEB J, V22, P2064, DOI 10.1096/fj.07-099150; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Sookoian S, 2012, CLIN LIVER DIS, V16, P467, DOI 10.1016/j.cld.2012.05.011; Stec DE, 2007, PHYSIOL GENOMICS, V30, P74, DOI 10.1152/physiolgenomics.00003.2007; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287; Traber MG, 2013, J LIPID RES, V54, P2295, DOI 10.1194/jlr.R032946; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Traber MG, 1998, AM J CLIN NUTR, V68, P847, DOI 10.1093/ajcn/68.4.847; Ulatowski L, 2012, FREE RADICAL BIO MED, V53, P2318, DOI 10.1016/j.freeradbiomed.2012.10.528; Ward NC, 2008, HYPERTENSION, V51, P1393, DOI 10.1161/HYPERTENSIONAHA.107.104463; Yu Andy S, 2002, Rev Gastroenterol Disord, V2, P11; Zordoky BNM, 2010, PHARMACOL THERAPEUT, V125, P446, DOI 10.1016/j.pharmthera.2009.12.002	46	26	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95366	10.1371/journal.pone.0095366	http://dx.doi.org/10.1371/journal.pone.0095366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759732	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200050
J	Kim, N; Park, J; Gadhe, CG; Cho, SJ; Oh, Y; Kim, D; Song, K				Kim, Namil; Park, Jeongyeon; Gadhe, Changdev G.; Cho, Seung Joo; Oh, Youngjin; Kim, Donghyun; Song, Kiwon			A Protoberberine Derivative HWY336 Selectively Inhibits MKK4 and MKK7 in Mammalian Cells: The Importance of Activation Loop on Selectivity	PLOS ONE			English	Article							PROTEIN-KINASES; SENSITIVITY; BERBERINE; CASCADE; MAPKS	A protoberberine derivative library was used to search for selective inhibitors against kinases of the mitogen-activated protein kinase (MAPK) cascades in mammalian cells. Among kinases in mammalian MAPK pathways, we identified a compound (HWY336) that selectively inhibits kinase activity of mitogen-activated protein kinase kinase 4 and 7 (MKK4 and MKK7). The IC50 of HWY336 was 6 mu M for MKK4 and 10 mu M for MKK7 in vitro. HWY336 bound to both kinases reversibly via noncovalent interactions, and inhibited their activity by interfering with access of a protein substrate to its binding site. The binding affinity of HWY336 to MKK4 was measured by surface plasmon resonance to determine a dissociation constant (K-d) of 3.2 mu M. When mammalian cells were treated with HWY336, MKK4 and MKK7 were selectively inhibited, resulting in inhibition of c-Jun NH2-terminal protein kinases in vivo. The structural model of HWY336 bound to either MKK4 or MKK7 predicted that HWY336 was docked to the activation loop, which is adjacent to the substrate binding site. This model suggested the importance of the activation loop of MKKs in HWY336 selectivity. We verified this model by mutating three critical residues within this loop of MKK4 to the corresponding residues in MKK3. The mutant MKK4 displayed similar kinase activity as wild-type kinase, but its activity was not inhibited by HWY336 compared to wild-type MKK4. We propose that the specific association of HWY336 to the activation loop of MKK4/MKK7 is responsible for its selective inhibition.	[Kim, Namil; Park, Jeongyeon; Song, Kiwon] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Gadhe, Changdev G.; Cho, Seung Joo] Chosun Univ, Coll Med, Dept Bionew Drug Dev, Kwangju, South Korea; [Cho, Seung Joo] Chosun Univ, Coll Med, Dept Cellular Mol Med, Kwangju, South Korea; [Cho, Seung Joo] Chosun Univ, Coll Med, Res Ctr Resistant Cells, Kwangju, South Korea; [Oh, Youngjin; Kim, Donghyun] Yonsei Univ, Coll Engn, Sch Elect & Elect Engn, Seoul 120749, South Korea	Yonsei University; Chosun University; Chosun University; Chosun University; Yonsei University	Song, K (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	bc5012@yonsei.ac.kr	Kim, Donghyun/A-2682-2011; Gorakshnath, Gadhe Changdev/AAR-5175-2020	Kim, Donghyun/0000-0003-1960-0527	National R&D Program for Cancer Control in Korea [NCCR-0920300]; KRICT [SI-1105]; Ministry of Knowledge Economy, Korea	National R&D Program for Cancer Control in Korea; KRICT; Ministry of Knowledge Economy, Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control (NCCR-0920300, 2009) in Korea. The authors also thank to KRICT (SI-1105) and Ministry of Knowledge Economy, Korea for financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Goto H, 2012, CANCER SCI, V103, P775, DOI 10.1111/j.1349-7006.2012.02212.x; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Jang MJ, 2002, J BIOL CHEM, V277, P12388, DOI 10.1074/jbc.M111018200; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Lisnock JM, 1998, BIOCHEMISTRY-US, V37, P16573, DOI 10.1021/bi981591x; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ruppert J, 1997, PROTEIN SCI, V6, P524; Rusconi P, 2012, CURR MED CHEM, V19, P1164; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Sheth PR, 2011, BIOCHEMISTRY-US, V50, P7964, DOI 10.1021/bi200542r; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang J, 2007, CURR TOP MED CHEM, V7, P1364; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	19	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e91037	10.1371/journal.pone.0091037	http://dx.doi.org/10.1371/journal.pone.0091037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759688	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200004
J	Duffy, KJ; Johnson, SD; Peter, CI				Duffy, Karl J.; Johnson, Steven D.; Peter, Craig I.			A Temporal Dimension to the Influence of Pollen Rewards on Bee Behaviour and Fecundity in Aloe tenuior	PLOS ONE			English	Article							NECTAR PRODUCTION; FLORAL TRAITS; POLLINATION; FLOWER; LIMITATION; PATTERNS; QUALITY; PLANT	The net effect of pollen production on fecundity in plants can range from negative - when self-pollen interferes with fecundity due to incompatibility mechanisms, to positive -when pollen availability is associated with increased pollinator visitation and fecundity due to its utilization as a reward. We investigated the responses of bees to pollen and nectar rewards, and the effects of these rewards on pollen deposition and fecundity in the hermaphroditic succulent shrub Aloe tenuior. Self-pollinated plants failed to set fruit, but their ovules were regularly penetrated by self-pollen tubes, which uniformly failed to develop into seeds as expected from ovarian self-incompatibility (or strong early inbreeding depression). Bees consistently foraged for pollen during the morning and early afternoon, but switched to nectar in the late afternoon. As a consequence of this differential foraging, we were able to test the relative contribution to fecundity of pollen-versus nectar-collecting flower visitors. We exposed emasculated and intact flowers in either the morning or late afternoon to foraging bees and showed that emasculation reduced pollen deposition by insects in the morning, but had little effect in the afternoon. Despite the potential for self-pollination to result in ovule discounting due to late-acting self-sterility, fecundity was severely reduced in artificially emasculated plants. Although there were temporal fluctuations in reward preference, most bee visits were for pollen rewards. Therefore the benefit of providing pollen that is accessible to bee foragers outweighs any potential costs to fitness in terms of gender interference in this species.	[Duffy, Karl J.; Johnson, Steven D.] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa; [Peter, Craig I.] Rhodes Univ, Dept Bot, ZA-6140 Grahamstown, South Africa	University of Kwazulu Natal; Rhodes University	Duffy, KJ (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa.	duffyk@tcd.ie	Johnson, Steven D/F-1146-2010; Peter, Craig/B-6564-2008; Johnson, Steven/P-2104-2019; Duffy, Karl J./ABC-2797-2021	Johnson, Steven D/0000-0002-5114-5862; Peter, Craig/0000-0002-9741-6533; Johnson, Steven/0000-0002-5114-5862; Duffy, Karl J./0000-0002-1190-6145	Postdoctoral Fellowship from the Claude Leon Foundation; Rhodes University; South African Research Chair; National Research Foundation	Postdoctoral Fellowship from the Claude Leon Foundation; Rhodes University; South African Research Chair; National Research Foundation	This work was funded by a Postdoctoral Fellowship from the Claude Leon Foundation (K.J.D.), Rhodes University and the National Research Foundation (C.I.P.), and a South African Research Chair (S.D.J.), which the authors gratefully acknowledge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Botes C, 2009, S AFR J BOT, V75, P675, DOI 10.1016/j.sajb.2009.07.010; Botes C, 2008, OIKOS, V117, P875, DOI 10.1111/j.0030-1299.2008.16391.x; BUCHMANN SL, 1989, OECOLOGIA, V81, P289, DOI 10.1007/BF00377073; CRESSWELL JE, 1994, OIKOS, V69, P304, DOI 10.2307/3546151; DELPH LF, 1992, OIKOS, V63, P161, DOI 10.2307/3545374; Dobson HEM, 1996, AM J BOT, V83, P877, DOI 10.2307/2446264; DOBSON HEM, 1988, AM J BOT, V75, P170, DOI 10.2307/2443884; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; Duffy KJ, 2011, PLANT BIOLOGY, V13, P556, DOI 10.1111/j.1438-8677.2011.00445.x; Duffy KJ, 2013, J ECOL, V101, P953, DOI 10.1111/1365-2745.12104; Duffy KJ, 2013, AM J BOT, V100, P622, DOI 10.3732/ajb.1200531; Fewell JH, 1996, BEHAV ECOL, V7, P286, DOI 10.1093/beheco/7.3.286; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; Giraudoux P, 2011, PGIRMESS PACKAGE R; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; Hargreaves AL, 2008, S AFR J BOT, V74, P606, DOI 10.1016/j.sajb.2008.02.009; Hargreaves AL, 2012, ANN BOT-LONDON, V109, P761, DOI 10.1093/aob/mcr324; Hargreaves AL, 2010, ECOLOGY, V91, P1693, DOI 10.1890/09-0792.1; HEINRICH B, 1975, ANNU REV ECOL SYST, V6, P139, DOI 10.1146/annurev.es.06.110175.001035; HERRERA CM, 1990, OIKOS, V58, P277, DOI 10.2307/3545218; Herrera CM, 2000, ECOLOGY, V81, P15, DOI 10.1890/0012-9658(2000)081[0015:FTSCOD]2.0.CO;2; KAY QON, 1984, NEW PHYTOL, V98, P515, DOI 10.1111/j.1469-8137.1984.tb04145.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McCullagh P, 1989, GEN LINEAR MODELS; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robertson AW, 1999, ECOLOGY, V80, P2594, DOI 10.1890/0012-9658(1999)080[2594:BBSOMG]2.0.CO;2; Simpson B.B., 1983, P142; Stone GN, 1999, ECOL ENTOMOL, V24, P208, DOI 10.1046/j.1365-2311.1999.00181.x; THOMSON JD, 1989, ECOLOGY, V70, P1061, DOI 10.2307/1941375; Vaughton G, 2010, ANN BOT-LONDON, V106, P547, DOI 10.1093/aob/mcq149; Vaughton G, 2010, AM J BOT, V97, P174, DOI 10.3732/ajb.0900183; [No title captured]; [No title captured]; [No title captured]	35	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94908	10.1371/journal.pone.0094908	http://dx.doi.org/10.1371/journal.pone.0094908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755611	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300021
J	Valenzuela, O; Gonzalez-Diaz, M; Garibay-Escobar, A; Burgara-Estrella, A; Cano, M; Durazo, M; Bernal, RM; Hernandez, J; Xiao, LH				Valenzuela, Olivia; Gonzalez-Diaz, Mariana; Garibay-Escobar, Adriana; Burgara-Estrella, Alexel; Cano, Manuel; Durazo, Maria; Bernal, Rosa M.; Hernandez, Jesus; Xiao, Lihua			Molecular Characterization of Cryptosporidium spp. in Children from Mexico	PLOS ONE			English	Article							GIARDIA-DUODENALIS; GENETIC DIVERSITY; PARVUM INFECTION; DAIRY CALVES; HUMANS; EPIDEMIOLOGY; TRANSMISSION; PARASITES; DIARRHEA; ANIMALS	Cryptosporidiosis is a parasitic disease caused by Cryptosporidium spp. In immunocompetent individuals, it usually causes an acute and self-limited diarrhea; in infants, infection with Cryptosporidium spp. can cause malnutrition and growth retardation, and declined cognitive ability. In this study, we described for the first time the distribution of C. parvum and C. hominis subtypes in 12 children in Mexico by sequence characterization of the 60-kDa glycoprotein (GP60) gene of Cryptosporidium. Altogether, 7 subtypes belonging to 4 subtype families of C. hominis ( Ia, Ib, Id and Ie) and 1 subtype family of C. parvum ( IIa) were detected, including IaA14R3, IaA15R3, IbA10G2, IdA17, IeA11G3T3, IIaA15G2R1 and IIaA16G1R1. The frequency of the subtype families and subtypes in the samples analyzed in this study differed from what was observed in other countries.	[Valenzuela, Olivia; Gonzalez-Diaz, Mariana; Garibay-Escobar, Adriana; Burgara-Estrella, Alexel] Univ Sonora, Dept Ciencias Quim Biol, Hermosillo 83000, Sonora, Mexico; [Cano, Manuel; Durazo, Maria] Hosp Infantil Estado Sonora, Serv Infectol, Hermosillo, Sonora, Mexico; [Bernal, Rosa M.] Hosp Infantil Mexico Dr Federico Gomez, Lab Parasitol & Micol, Mexico City, DF, Mexico; [Hernandez, Jesus] Ctr Invest Alimentac & Desarrollo AC, Lab Inmunol, Hermosillo, Sonora, Mexico; [Xiao, Lihua] Ctr Dis Control & Prevent, Atlanta, GA USA	Universidad de Sonora; Hospital Infantil de Mexico Federico Gomez; CIAD - Centro de Investigacion en Alimentacion y Desarrollo; Centers for Disease Control & Prevention - USA	Valenzuela, O (corresponding author), Univ Sonora, Dept Ciencias Quim Biol, Hermosillo 83000, Sonora, Mexico.	o_valenzuela@guayacan.uson.mx	Hernandez, Jesus/G-2984-2012; Xiao, Lihua/B-1704-2013; Valenzuela, Olivia/C-6062-2014; Burgara-Estrella, Alexel J./J-3679-2014	Hernandez, Jesus/0000-0002-5131-3600; Xiao, Lihua/0000-0001-8532-2727; Valenzuela, Olivia/0000-0002-4456-2107; Gonzalez-Diaz, Mariana/0000-0002-1675-9164; Burgara-Estrella, Alexel J./0000-0003-3461-0029	University of Sonora funds	University of Sonora funds	This work has been funded by University of Sonora funds and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena H, 2012, INFECT GENET EVOL, V12, P1984, DOI 10.1016/j.meegid.2012.08.004; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Alves M, 2006, J EUKARYOT MICROBIOL, V53, pS24, DOI 10.1111/j.1550-7408.2006.00162.x; Asma L, 2011, TROP BIOMED, V28, P400; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Berrilli F, 2012, T ROY SOC TROP MED H, V106, P191, DOI 10.1016/j.trstmh.2011.12.005; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Cama VA, 2007, J INFECT DIS, V196, P684, DOI 10.1086/519842; Chalmers RM, 2008, EMERG INFECT DIS, V14, P496, DOI 10.3201/eid1403.071320; Chalmers RM, 2005, INT J PARASITOL, V35, P397, DOI 10.1016/j.ijpara.2005.01.001; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Clarke SC, 2001, BRIT J BIOMED SCI, V58, P7; Diaz E, 2003, AM J TROP MED HYG, V68, P384, DOI 10.4269/ajtmh.2003.68.384; Domenech C, 2011, J PEDIAT HEMATOL ONC, V33, P570, DOI 10.1097/MPH.0b013e31820e2d3a; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; Gatei W, 2006, AM J TROP MED HYG, V75, P78, DOI 10.4269/ajtmh.2006.75.78; Gonçalves Elenice Messias do Nascimento, 2006, Clinics, V61, P119, DOI 10.1590/S1807-59322006000200006; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Herges GR, 2012, APPL ENVIRON MICROB, V78, P8096, DOI 10.1128/AEM.02105-12; Huang David B, 2004, Semin Pediatr Infect Dis, V15, P253, DOI 10.1053/j.spid.2004.07.006; Iqbal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031139; Jex AR, 2008, J CLIN MICROBIOL, V46, P2252, DOI 10.1128/JCM.00116-08; Jex AR, 2010, BIOTECHNOL ADV, V28, P17, DOI 10.1016/j.biotechadv.2009.08.003; Jex AR, 2008, ELECTROPHORESIS, V29, P4119, DOI 10.1002/elps.200800422; Karanis P, 2010, VET PARASITOL, V169, P387, DOI 10.1016/j.vetpar.2010.01.014; Kato S, 2003, VET PARASITOL, V111, P153, DOI 10.1016/S0304-4017(02)00353-9; Kurniawan A, 2013, ANN EPIDEMIOL; Larrosa-Haro A, 2002, SALUD PUBLICA MEXICO, V44, P328, DOI 10.1590/S0036-36342002000400006; Leav BA, 2002, INFECT IMMUN, V70, P3881, DOI 10.1128/IAI.70.7.3881-3890.2002; MA P, 1983, J INFECT DIS, V147, P824, DOI 10.1093/infdis/147.5.824; Magi B, 2006, PARASITOL RES, V98, P150, DOI 10.1007/s00436-005-0050-6; Misic Z, 2007, PARASITOLOGY, V134, P351, DOI 10.1017/S0031182006001508; Ng JSY, 2010, EXP PARASITOL, V125, P325, DOI 10.1016/j.exppara.2010.02.012; Nuchjangreed C, 2008, PARASITOL RES, V103, P1347, DOI 10.1007/s00436-008-1139-5; O'Brien E, 2008, EXP PARASITOL, V118, P118, DOI 10.1016/j.exppara.2007.05.012; Ochoa Theresa J, 2004, Semin Pediatr Infect Dis, V15, P229, DOI 10.1053/j.spid.2004.07.003; Pedraza-Diaz S, 2001, EMERG INFECT DIS, V7, P49, DOI 10.3201/eid0701.010109; Peng MM, 2001, J EUKARYOT MICROBIOL, p28S; Peng MM, 1997, EMERG INFECT DIS, V3, P567, DOI 10.3201/eid0304.970423; Pereira MDC, 2010, APPL ENVIRON MICROB, V76, P8269, DOI 10.1128/AEM.00687-10; Siwila J, 2011, T ROY SOC TROP MED H, V105, P102, DOI 10.1016/j.trstmh.2010.10.004; Smith HV, 2006, TRENDS PARASITOL, V22, P160, DOI 10.1016/j.pt.2006.02.009; Snelling WJ, 2007, J INFECT DEV COUNTR, V1, P242, DOI 10.3855/jidc.360; Soba B, 2008, PARASITOLOGY, V135, P1263, DOI 10.1017/S0031182008004800; Solorzano-Santos F, 2000, REV INVEST CLIN, V52, P625; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Sulaiman IM, 1998, EMERG INFECT DIS, V4, P681, DOI 10.3201/eid0404.980424; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Trotz-Williams LA, 2005, VET PARASITOL, V134, P15, DOI 10.1016/j.vetpar.2005.06.023; Waldron LS, 2009, EXP PARASITOL, V122, P124, DOI 10.1016/j.exppara.2009.02.006; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Widmer G, 2010, APPL ENVIRON MICROB, V76, P6639, DOI 10.1128/AEM.01268-10; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xiao LH, 2004, CURR OPIN INFECT DIS, V17, P483, DOI 10.1097/00001432-200410000-00014; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	64	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96128	10.1371/journal.pone.0096128	http://dx.doi.org/10.1371/journal.pone.0096128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755606	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300140
J	Basu, R; Chen, YD; Quann, EJ; Huse, M				Basu, Roshni; Chen, Yuedan; Quann, Emily J.; Huse, Morgan			The Variable Hinge Region of Novel PKCs Determines Localization to Distinct Regions of the Immunological Synapse	PLOS ONE			English	Article							KINASE-C-THETA; T-CELLS; DIACYLGLYCEROL; ACTIVATION; MICROCLUSTERS; POLARIZATION	The immunological synapse (IS) formed between a T cell and its cognate antigen-presenting cell (APC) enables the directional secretion of cytolytic and inflammatory molecules. Synaptic architecture is established in part by a two-step cascade of novel protein kinase C (nPKC) isozymes. PKC epsilon and PKC eta arrive at the IS first, and occupy the entire synaptic membrane. Then, PKC theta accumulates in a smaller zone at the center of the contact. We investigated the molecular basis for this differential recruitment behavior using chimeric nPKC constructs and total internal reflection fluorescence microscopy. Our studies revealed that the V3 linker just N-terminal to the kinase domain plays a crucial role in specifying nPKC localization. Substitution of this linker switched the scope and the kinetics of PKC theta accumulation to that of PKC epsilon and PKC eta, and vice versa. Although the V3 was necessary for synaptic compartmentalization, it was not sufficient, as the tandem C1 domains were also required to mediate membrane association. Together, these results suggest a model whereby the V3 linker controls nPKC sub-compartmentalization after initial C1 domain-mediated accumulation at the IS.	[Basu, Roshni; Chen, Yuedan; Quann, Emily J.; Huse, Morgan] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Huse, M (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	husem@mskcc.org			US National Institutes of Health [R01-AI087644]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087644] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US National Institutes of Health (R01-AI087644, to M.H.). URL: http://www.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Beemiller P, 2012, NAT IMMUNOL, V13, P787, DOI 10.1038/ni.2364; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Cartwright NG, 2011, MOL BIOL CELL, V22, P3491, DOI 10.1091/mbc.E10-11-0916; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Huse M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00235; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Le Floc'h A, 2013, J EXP MED IN PRESS; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Merino E, 2012, J IMMUNOL, V189, P4859, DOI 10.4049/jimmunol.1200825; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	20	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95531	10.1371/journal.pone.0095531	http://dx.doi.org/10.1371/journal.pone.0095531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751783	gold, Green Submitted, Green Published			2022-12-25	WOS:000335227400069
J	Tsangaras, K; Siracusa, MC; Nikolaidis, N; Ishida, Y; Cui, P; Vielgrader, H; Helgen, KM; Roca, AL; Greenwood, AD				Tsangaras, Kyriakos; Siracusa, Matthew C.; Nikolaidis, Nikolas; Ishida, Yasuko; Cui, Pin; Vielgrader, Hanna; Helgen, Kristofer M.; Roca, Alfred L.; Greenwood, Alex D.			Hybridization Capture Reveals Evolution and Conservation across the Entire Koala Retrovirus Genome	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; SEQUENCE; ESCAPE; SELECTION; INVASION; SUBGROUP; DYNAMICS; PATTERNS; PCR	The koala retrovirus (KoRV) is the only retrovirus known to be in the midst of invading the germ line of its host species. Hybridization capture and next generation sequencing were used on modern and museum DNA samples of koala (Phascolarctos cinereus) to examine ca. 130 years of evolution across the full KoRV genome. Overall, the entire proviral genome appeared to be conserved across time in sequence, protein structure and transcriptional binding sites. A total of 138 polymorphisms were detected, of which 72 were found in more than one individual. At every polymorphic site in the museum koalas, one of the character states matched that of modern KoRV. Among non-synonymous polymorphisms, radical substitutions involving large physiochemical differences between amino acids were elevated in env, potentially reflecting anti-viral immune pressure or avoidance of receptor interference. Polymorphisms were not detected within two functional regions believed to affect infectivity. Host sequences flanking proviral integration sites were also captured; with few proviral loci shared among koalas. Recently described variants of KoRV, designated KoRV-B and KoRV-J, were not detected in museum samples, suggesting that these variants may be of recent origin.	[Tsangaras, Kyriakos] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany; [Siracusa, Matthew C.; Nikolaidis, Nikolas; Cui, Pin; Greenwood, Alex D.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA; [Siracusa, Matthew C.; Nikolaidis, Nikolas; Cui, Pin; Greenwood, Alex D.] Calif State Univ Fullerton, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA; [Ishida, Yasuko; Roca, Alfred L.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Vielgrader, Hanna] Zoo Vienna, Vienna, Austria; [Helgen, Kristofer M.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Leibniz Institut fur Zoo und Wildtierforschung; California State University System; California State University Fullerton; California State University System; California State University Fullerton; University of Illinois System; University of Illinois Urbana-Champaign; Smithsonian Institution; Smithsonian National Museum of Natural History	Greenwood, AD (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA.	greenwood@izw-berlin.de	Helgen, Kristofer M./AAB-8348-2019; Greenwood, Alex/GWU-8292-2022	Helgen, Kristofer M./0000-0002-8776-4040; Roca, Alfred/0000-0001-9217-5593	California State University, Fullerton; HHMI; Smithsonian Institution; National Institute of General Medical Sciences (NIGMS) [R01GM092706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092706] Funding Source: NIH RePORTER	California State University, Fullerton; HHMI(Howard Hughes Medical Institute); Smithsonian Institution(Smithsonian Institution); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NN was supported by start-up funds and a state-mini grant from California State University, Fullerton and a Faculty-Student research Grant from California State University, Fullerton. MS was supported by an HHMI scholarship. KH was supported by the Smithsonian Institution. The project described was supported by Grant Number R01GM092706 from the National Institute of General Medical Sciences (NIGMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Vienna Zoo is a public entity, e.g. a state funded zoo.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avila-Arcos MC, 2013, MOL BIOL EVOL, V30, P299, DOI 10.1093/molbev/mss223; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Capelli C, 2003, FORENSIC SCI INT, V131, P59, DOI 10.1016/S0379-0738(02)00396-1; Cornelis G, 2013, P NATL ACAD SCI USA, V110, pE828, DOI 10.1073/pnas.1215787110; De Feo CJ, 2012, VIRUSES-BASEL, V4, P3859, DOI 10.3390/v4123859; Duncavage EJ, 2011, J MOL DIAGN, V13, P325, DOI 10.1016/j.jmoldx.2011.01.006; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Han JY, 1998, J VIROL, V72, P9101, DOI 10.1128/JVI.72.11.9101-9108.1998; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; HANKE M, 1994, BIOTECHNIQUES, V17, P858; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Horn S, 2012, METHODS MOL BIOL, V840, P189, DOI 10.1007/978-1-61779-516-9_22; Hu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059994; Hunter P, 2010, EMBO REP, V11, P28, DOI 10.1038/embor.2009.267; Kewitz S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00179; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Melder DC, 2003, J VIROL, V77, P10504, DOI 10.1128/JVI.77.19.10504-10514.2003; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oliveira NM, 2007, P NATL ACAD SCI USA, V104, P17506, DOI 10.1073/pnas.0704313104; Ortiz M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-11; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Shimode S, 2014, FEBS LETT, V588, P41, DOI 10.1016/j.febslet.2013.10.046; Shojima T, 2013, J VIROL, V87, P9943, DOI 10.1128/JVI.01385-13; Shojima T, 2013, J VIROL, V87, P5081, DOI 10.1128/JVI.01584-12; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Stoye JP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-241; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarlinton R, 2008, CELL MOL LIFE SCI, V65, P3413, DOI 10.1007/s00018-008-8499-y; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; Tsangaras K, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-92; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Xu WQ, 2013, P NATL ACAD SCI USA, V110, P11547, DOI 10.1073/pnas.1304704110; Yan Y, 2009, P NATL ACAD SCI USA, V106, P3259, DOI 10.1073/pnas.0900181106	50	31	31	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95633	10.1371/journal.pone.0095633	http://dx.doi.org/10.1371/journal.pone.0095633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752422	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400094
J	Yan, H; Wang, XB; Niu, JF; Wang, YQ; Wang, P; Liu, QH				Yan, Han; Wang, Xiaobing; Niu, Junfeng; Wang, Yaqin; Wang, Pan; Liu, Quanhong			Anti-Cancer Effect and the Underlying Mechanisms of Gypenosides on Human Colorectal Cancer SW-480 Cells	PLOS ONE			English	Article							ANOECTOCHILUS-FORMOSANUS; INDUCED APOPTOSIS; CYCLE ARREST; IN-VITRO; ANTIOXIDANT; ACTIVATION; MIGRATION; EXTRACT; BREAST; DEATH	Background: Gypenosides (Gyp), the main components from Gynostemma pentaphyllum Makino, are widely used in traditional Chinese medicine. The present study aimed to investigate the anti-cancer effect and the underlying mechanisms of Gyp on human colorectal cancer cells SW-480. Materials and Methods: The inhibitory effect of Gyp on SW-480 cells was evaluated by MTT assay. Apoptotic cell death was detected by nuclear Hoechst 33342 staining and DNA fragmentation analysis. Apoptosis was analyzed using Annexin V-PE/ 7-amino-actinomycin D staining. Cell membrane integrity was evaluated with flow cytometry following PI staining. Changes of mitochondrial membrane potential (Delta Psi(m)) were detected through flow cytometry analysis of rhodamine 123 (Rh123). The role of reactive oxygen species (ROS) in Gyp induced cell death was investigated by intracellular ROS generation and general ROS scavenger. Wound-healing assay was carried out to investigate Gyp-inhibited migration of SW-480 cells in vitro. Additionally, the alterations in F-actin microfilaments were analyzed by FITC-labeled phalloidin toxin staining and the morphological changes were evaluated under scanning electron microscope (SEM). Results: After the Gyp treatment, the plasma membrane permeability of SW-480 cell was increased, Delta Psi(m) was decreased significantly, the level of intracellular ROS level was increased, DNA fragmentation and apoptotic morphology were observed. Cells treated with Gyp exert serious microfilament network collapse as well as the significant decrease in the number of microvilli. Gyp induced the changes of cell viability, cell migration, intracellular ROS generation and nuclear morphology were alleviated obviously by NAC. Conclusion: The results in this study implied that ROS play an important role in Gyp induced cell toxicity and apoptosis, and the mitochondria damage may be upstream of ROS generation post Gyp treatment. The findings of the present study provide new evidences for anti-tumor mechanisms by which Gyp induces apoptosis in vitro.	[Yan, Han; Wang, Xiaobing; Niu, Junfeng; Wang, Yaqin; Wang, Pan; Liu, Quanhong] Shaanxi Normal Univ, Coll Life Sci, Minist Educ,Natl Engn Lab Resource Dev Endangered, Key Lab Med Resources & Nat Pharmaceut Chem, Xian, Shaanxi, Peoples R China	Shaanxi Normal University	Wang, P (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Minist Educ,Natl Engn Lab Resource Dev Endangered, Key Lab Med Resources & Nat Pharmaceut Chem, Xian, Shaanxi, Peoples R China.	wangpan@snnu.edu.cn; lshaof@snnu.edu.cn		Junfeng, Niu/0000-0003-4617-1211	National "Twelfth Five-Year'' Plan for Science and Technology [2011BAI06B05]	National "Twelfth Five-Year'' Plan for Science and Technology	This work was supported by National "Twelfth Five-Year'' Plan for Science and Technology Support (2011BAI06B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; Antosiewicz J, 2006, CANCER RES, V66, P5379, DOI 10.1158/0008-5472.CAN-06-0356; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Cheng XX, 2012, J ETHNOPHARMACOL, V143, P49, DOI 10.1016/j.jep.2012.05.054; COOPER JA, 1991, ANNU REV PHYSIOL, V53, P585, DOI 10.1146/annurev.ph.53.030191.003101; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Engel N, 2011, J ETHNOPHARMACOL, V137, P1003, DOI 10.1016/j.jep.2011.07.023; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Gerber M, 2009, ANN NUTR METAB, V55, P140, DOI 10.1159/000229000; Hsu HY, 2011, INTEGR CANCER THER, V10, P101, DOI 10.1177/1534735410377198; Kekre N, 2005, CANCER CHEMOTH PHARM, V56, P29, DOI 10.1007/s00280-004-0941-8; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; LACOUR B, 1995, J ETHNOPHARMACOL, V46, P125, DOI 10.1016/0378-8741(95)01234-5; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li HX, 2012, J ETHNOPHARMACOL, V144, P322, DOI 10.1016/j.jep.2012.09.015; LI L, 1993, CANCER BIOTHERAPY, V8, P263, DOI 10.1089/cbr.1993.8.263; Lin CC, 2000, AM J CHINESE MED, V28, P87, DOI 10.1142/S0192415X00000118; LIN JM, 1993, AM J CHINESE MED, V21, P59, DOI 10.1142/S0192415X9300008X; Lipponen P, 1999, ENDOCR-RELAT CANCER, V6, P13, DOI 10.1677/erc.0.0060013; Liu YL, 2010, J ETHNOPHARMACOL, V131, P1, DOI 10.1016/j.jep.2010.04.008; Lu KW, 2011, HUM EXP TOXICOL, V30, P406, DOI 10.1177/0960327110372405; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Purmova J, 1995, Ceska Slov Farm, V44, P246; Qian XH, 1998, J CHINA PHARM U, V30, P51; Razmovski-Naumovsld V., 2005, PHYTOCHEMISTRY, V14, P197, DOI DOI 10.1007/S11101-005-3754-4; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; Sanchez M, 2006, CANCER LETT, V233, P28, DOI 10.1016/j.canlet.2005.02.036; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Tan H, 1993, Zhongguo Zhong Xi Yi Jie He Za Zhi, V13, P278; Tanner MA, 1999, NITRIC OXIDE-BIOL CH, V3, P359, DOI 10.1006/niox.1999.0245; van Duijnhoven FJB, 2009, AM J CLIN NUTR, V89, P1441, DOI 10.3945/ajcn.2008.27120; Verma M, 2008, CHEM-BIOL INTERACT, V171, P45, DOI 10.1016/j.cbi.2007.08.010; Wang QF, 2002, CANCER LETT, V183, P169, DOI 10.1016/S0304-3835(01)00828-X; Wang ZB, 2007, CELL BIOL INT, V31, P1353, DOI 10.1016/j.cellbi.2007.05.009; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Yan H, 2014, HUM EXP TOXICOL, V33, P522, DOI 10.1177/0960327113497771	40	43	48	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95609	10.1371/journal.pone.0095609	http://dx.doi.org/10.1371/journal.pone.0095609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752286	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400089
J	Azami, Y; Hattori, A; Nishimura, H; Kawaide, H; Yoshimura, T; Hemmi, H				Azami, Yasuhiro; Hattori, Ai; Nishimura, Hiroto; Kawaide, Hiroshi; Yoshimura, Tohru; Hemmi, Hisashi			(R)-Mevalonate 3-Phosphate Is an Intermediate of the Mevalonate Pathway in Thermoplasma acidophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENTENYL PHOSPHATE KINASE; ARCHAEON SULFOLOBUS-SOLFATARICUS; DIPHOSPHATE DECARBOXYLASE; ISOPRENOID BIOSYNTHESIS; IDENTIFICATION; JANNASCHII; SYNTHASE; CLONING	The lack of a few conserved enzymes in the classical mevalonate pathway and the widespread existence of isopentenyl phosphate kinase suggest the presence of a partly modified mevalonate pathway in most archaea and in some bacteria. In the pathway, (R)-mevalonate 5-phosphate is thought to be metabolized to isopentenyl diphosphate via isopentenyl phosphate. The long anticipated enzyme that catalyzes the reaction from (R)-mevalonate 5-phosphate to isopentenyl phosphate was recently identified in a Cloroflexi bacterium, Roseiflexus casten-holzii, and in a halophilic archaeon, Haloferax volcanii. However, our trial to convert the intermediates of the classical and modified mevalonate pathways into isopentenyl diphosphate using cell-free extract from a thermophilic archaeon Thermoplasma acidophilum implied that the branch point intermediate of these known pathways, i.e. (R)-mevalonate 5-phosphate, is unlikely to be the precursor of isoprenoid. Through the process of characterizing the recombinant homologs of mevalonate pathway-related enzymes from the archaeon, a distant homolog of diphosphomevalonate decarboxylase was found to catalyze the phosphorylation of (R)-mevalonate to yield (R)-mevalonate 3-phosphate. The product could be converted into isopentenyl phosphate, probably through (R)-mevalonate 3,5-bisphosphate, by the action of unidentified T. acidophilum enzymes fractionated by anion-exchange chromatography. These findings demonstrate the presence of a third alternative "Thermoplasmatype" mevalonate pathway, which involves (R)-mevalonate 3-phosphotransferase and probably both (R)-mevalonate 3-phosphate 5-phosphotransferase and (R)-mevalonate 3,5-bisphosphate decarboxylase, in addition to isopentenyl phosphate kinase.	[Azami, Yasuhiro; Hattori, Ai; Nishimura, Hiroto; Yoshimura, Tohru; Hemmi, Hisashi] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagricultural Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kawaide, Hiroshi] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan	Nagoya University; Tokyo University of Agriculture & Technology	Hemmi, H (corresponding author), Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagricultural Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hhemmi@agr.nagoya-u.ac.jp	Kawaide, Hiroshi/F-9243-2013; Hemmi, Hisashi/I-6868-2014	Kawaide, Hiroshi/0000-0001-6693-1332; Hemmi, Hisashi/0000-0002-9538-809X	Japan Society for the Promotion of Science KAKENHI [23580111, 23108531, 25108712]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23580111, 23108531, and 25108712 (to H. H.).	Barta ML, 2012, BIOCHEMISTRY-US, V51, P5611, DOI 10.1021/bi300591x; Chen M, 2010, BIOCHEMISTRY-US, V49, P207, DOI 10.1021/bi9017957; Delcourt M., 2013, International Patent Application, Patent No. [PCT/EP2013/057108, 2013057108]; Dellas N, 2013, ELIFE, V2, DOI 10.7554/eLife.00672; Dellas N, 2010, ACS CHEM BIOL, V5, P589, DOI 10.1021/cb1000313; FUJII H, 1982, BIOCHIM BIOPHYS ACTA, V712, P716; Grochowski LL, 2006, J BACTERIOL, V188, P3192, DOI 10.1128/JB.188.9.3192-3198.2006; Hemmi H, 2004, J BIOL CHEM, V279, P50197, DOI 10.1074/jbc.M409207200; Huang KX, 1999, PROTEIN EXPRES PURIF, V17, P33, DOI 10.1006/prep.1999.1106; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Kuzuyama T, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P493; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Mabanglo MF, 2010, ACS CHEM BIOL, V5, P517, DOI 10.1021/cb100032g; Matsumi R, 2011, RES MICROBIOL, V162, P39, DOI 10.1016/j.resmic.2010.10.003; Nishimura H, 2013, J BIOCHEM, V153, P415, DOI 10.1093/jb/mvt006; OHNUMA S, 1994, J BIOL CHEM, V269, P14792; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; Sambrook J., 2002, MOL CLONING LAB MANU; Smit A, 2000, GENOME RES, V10, P1468, DOI 10.1101/gr.145600; Sugai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P128, DOI 10.1271/bbb.100733; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; VanNice JC, 2014, J BACTERIOL, V196, P1055, DOI 10.1128/JB.01230-13	23	29	31	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15957	15967		10.1074/jbc.M114.562686	http://dx.doi.org/10.1074/jbc.M114.562686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755225	Green Published, hybrid			2022-12-25	WOS:000337965700007
J	Zhou, JH; Nagarkatti, P; Zhong, Y; Ginsberg, JP; Singh, NP; Zhang, JJ; Nagarkatti, M				Zhou, Juhua; Nagarkatti, Prakash; Zhong, Yin; Ginsberg, Jay P.; Singh, Narendra P.; Zhang, Jiajia; Nagarkatti, Mitzi			Dysregulation in microRNA Expression Is Associated with Alterations in Immune Functions in Combat Veterans with Post-Traumatic Stress Disorder	PLOS ONE			English	Article							BECK-DEPRESSION-INVENTORY; MAJOR DEPRESSION; PTSD; DISTURBANCE; DIAGNOSES; CELLS; TH1	While the immunological dysfunction in combat Veterans with post-traumatic stress disorder (PTSD) has been well documented, the precise mechanisms remain unclear. The current study evaluated the role of microRNA (miR) in immunological dysfunction associated with PTSD. The presence of peripheral blood mononuclear cells (PBMC) and various lymphocyte subsets in blood collected from PTSD patients were analyzed. Our studies demonstrated that the numbers of both PBMC and various lymphocyte subsets increased significantly in PTSD patients. When T cells were further analyzed, the percentage of Th1 cells and Th17 cells increased, regulatory T cells(Tregs) decreased, while Th2 cells remained unaltered in PTSD patients. These data correlated with increased plasma levels of IFN-gamma and IL-17 while IL-4 showed no significant change. The increase in PBMC counts, Th1 and Th17 cells seen in PTSD patients correlated with the clinical scores. High-throughput analysis of PBMCs for 1163 miRs showed that the expression of a significant number of miRs was altered in PTSD patients. Pathway analysis of dysregulated miRs seen in PTSD patients revealed relationship between selected miRNAs and genes that showed direct/indirect role in immunological signaling pathways consistent with the immunological changes seen in these patients. Of interest was the down-regulation of miR-125a in PTSD, which specifically targeted IFN-gamma production. Together, the current study demonstrates for the first time that PTSD was associated with significant alterations in miRNAs, which may promote pro-inflammatory cytokine profile. Such epigenetic events may provide useful tools to identify potential biomarkers for diagnosis, and facilitate therapy of PTSD.	[Zhou, Juhua; Nagarkatti, Prakash; Zhong, Yin; Singh, Narendra P.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Ginsberg, Jay P.; Nagarkatti, Mitzi] William Jennings Bryan Dorn Vet Med Ctr, Columbia, SC USA; [Zhang, Jiajia] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Mitzi.Nagarkatti@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Nagarkatti, Mitzi/0000-0002-5977-5615; Ginsberg, JP (Jack)/0000-0002-8375-2288	National Institutes of Health (NIH) [R01MH094755, P01AT003961, P20 GM103641, R01AT006888, R01ES019313]; VA Merit Award [BX001357]; National Center for Complementary & Integrative Health [R01AT006888, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) R01MH094755, P01AT003961, P20 GM103641, R01AT006888, R01ES019313, and VA Merit Award BX001357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Boscarino JA, 1999, PSYCHOSOM MED, V61, P378, DOI 10.1097/00006842-199905000-00019; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Childress JE, 2013, J NEUROPSYCH CLIN N, V25, P12, DOI 10.1176/appi.neuropsych.12010003; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Crane IJ, 2005, CRIT REV IMMUNOL, V25, P75, DOI 10.1615/CritRevImmunol.v25.i2.10; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; De Berardis D, 2010, INT J IMMUNOPATH PH, V23, P417, DOI 10.1177/039463201002300204; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2708; Elhai JD, 2003, J CLIN PSYCHOL, V59, P385, DOI 10.1002/jclp.10135; Fojtikova M, 2010, Vnitr Lek, V56, P402; Gill JM, 2009, PERSPECT PSYCHIATR C, V45, P262, DOI 10.1111/j.1744-6163.2009.00229.x; Glaesmer H, 2011, PSYCHOSOM MED, V73, P401, DOI 10.1097/PSY.0b013e31821b47e8; Glynn S M, 1995, J Psychother Pract Res, V4, P214; Gray MJ, 2004, PSYCHIAT QUART, V75, P321, DOI 10.1023/B:PSAQ.0000043508.52428.6e; Guo M, 2012, ASIAN PAC J TROP MED, V5, P323, DOI 10.1016/S1995-7645(12)60048-0; Inoue-Sakurai C, 2000, PREV MED, V31, P467, DOI 10.1006/pmed.2000.0744; Leskin GA, 2002, J PSYCHIAT RES, V36, P449, DOI 10.1016/S0022-3956(02)00025-0; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Luo Y, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/728930; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Ribeiro S, 2012, CLIN CHEM LAB MED, V50, P399, DOI 10.1515/CCLM.2011.782; Shurin MR, 1999, SPRINGER SEMIN IMMUN, V21, P339, DOI 10.1007/BF00812261; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Spelman K, 2006, ALTERN MED REV, V11, P128; Steer RA, 1999, J CLIN PSYCHOL, V55, P117, DOI 10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A; STEER RA, 1993, J PERS ASSESS, V60, P532, DOI 10.1207/s15327752jpa6003_10; Sutherland AG, 2003, CYTOKINE, V24, P219, DOI 10.1016/j.cyto.2003.09.004; Vidovic A, 2007, CROAT MED J, V48, P198; Weathers FW, 1996, J TRAUMA STRESS, V9, P111, DOI 10.1007/BF02116837; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Woods AB, 2005, AM J COMMUN PSYCHOL, V36, P159, DOI 10.1007/s10464-005-6240-7; Woods SJ, 2005, ADV NURS SCI, V28, P306, DOI 10.1097/00012272-200510000-00003; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 2009, J TRAUMA STRESS, V22, P427, DOI 10.1002/jts.20448	45	62	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94075	10.1371/journal.pone.0094075	http://dx.doi.org/10.1371/journal.pone.0094075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759737	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200011
J	Anthony, K; More, A; Zhang, XL				Anthony, Kim; More, Abhijit; Zhang, Xiaoliu			Activation of Silenced Cytokine Gene Promoters by the Synergistic Effect of TBP-TALE and VP64-TALE Activators	PLOS ONE			English	Article							T-CELL-ACTIVATION; TATA-BINDING PROTEIN; IL-2 MESSENGER-RNA; TRANSCRIPTION FACTORS; GM-CSF; ARTIFICIAL RECRUITMENT; DNA-BINDING; TNF-ALPHA; EXPRESSION; SEQUENCES	Recent work has shown that the combinatorial use of multiple TALE activators can selectively activate certain cellular genes in inaccessible chromatin regions. In this study, we aimed to interrogate the activation potential of TALEs upon transcriptionally silenced immune genes in the context of non-immune cells. We designed a unique strategy, in which a single TALE fused to the TATA-box binding protein (TBP-TALE) is coupled with multiple VP64-TALE activators. We found that our strategy is significantly more potent than multiple TALE activators alone in activating expression of IL-2 and GM-CSF in diverse cell origins in which both genes are otherwise completely silenced. Chromatin analysis revealed that the gene activation was due in part to displacement of a distinctly positioned nucleosome. These studies provide a novel epigenetic mechanism for artificial gene induction and have important implications for targeted cancer immunotherapy, DNA vaccine development, as well as rational design of TALE activators.	[Anthony, Kim; More, Abhijit; Zhang, Xiaoliu] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Anthony, Kim; Zhang, Xiaoliu] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Zhang, XL (corresponding author), Univ Houston, Sci & Engn Res Ctr, Houston, TX 77004 USA.	xzhang5@central.uh.edu		Zhang, Shaun/0000-0002-2085-3997	NIH [R01CA132792]; William and Ella Owens Medical Research Foundation; NATIONAL CANCER INSTITUTE [R01CA132792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William and Ella Owens Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partly supported by NIH supplemental grant #R01CA132792 and William and Ella Owens Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attema JL, 2002, J IMMUNOL, V169, P2466, DOI 10.4049/jimmunol.169.5.2466; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Burg J, 2002, AM J PHYSIOL-LUNG C, V283, pL460, DOI 10.1152/ajplung.00249.2001; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chapdelaine P, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.41; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Coleman RA, 1997, P NATL ACAD SCI USA, V94, P7221, DOI 10.1073/pnas.94.14.7221; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Dorris DR, 2000, MOL CELL BIOL, V20, P4350, DOI 10.1128/MCB.20.12.4350-4358.2000; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Fitzgerald SM, 2003, J INTERF CYTOK RES, V23, P57, DOI 10.1089/107999003321455453; Gaudreau L, 1999, P NATL ACAD SCI USA, V96, P2668, DOI 10.1073/pnas.96.6.2668; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Hirai H, 2010, INT J DEV BIOL, V54, P1589, DOI 10.1387/ijdb.103194hh; Holloway AF, 2003, J EXP MED, V197, P413, DOI 10.1084/jem.20021039; Ishihara S, 2011, J IMMUNOL, V187, P3292, DOI 10.4049/jimmunol.1003173; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Kim JM, 2000, BIOCHEM BIOPH RES CO, V269, P302, DOI 10.1006/bbrc.2000.2298; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Maeder ML, 2013, NAT BIOTECHNOL; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; Majello B, 1998, J BIOL CHEM, V273, P16509, DOI 10.1074/jbc.273.26.16509; McKarns SC, 2008, J IMMUNOL, V181, P1272, DOI 10.4049/jimmunol.181.2.1272; Mendenhall EM, 2013, NAT BIOTECHNOL; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mishra AK, 2003, J BIOSCIENCES, V28, P423, DOI 10.1007/BF02705117; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Owens JB, 2013, NUCL ACIDS RES; PATIL RR, 1995, BLOOD, V85, P80, DOI 10.1182/blood.V85.1.80.bloodjournal85180; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Poke FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041734; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Ragheb JA, 1999, J IMMUNOL, V163, P120; Ragheb JA, 1999, J IMMUNOL, V163, P3321; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; SHANNON MF, 1995, J LEUKOCYTE BIOL, V57, P767, DOI 10.1002/jlb.57.5.767; Stoecklin G, 2001, RNA, V7, P1578; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Tremblay JP, 2012, HUM GENE THER, V23, P883, DOI 10.1089/hum.2012.034; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	54	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95790	10.1371/journal.pone.0095790	http://dx.doi.org/10.1371/journal.pone.0095790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755922	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300093
J	Olarte-Lozano, M; Mendoza-Nunez, MA; Pastor, N; Segovia, L; Folch-Mallol, J; Martinez-Anaya, C				Olarte-Lozano, Miguel; Mendoza-Nunez, Mario A.; Pastor, Nina; Segovia, Lorenzo; Folch-Mallol, Jorge; Martinez-Anaya, Claudia			PcExl1 a Novel Acid Expansin-Like Protein from the Plant Pathogen Pectobacterium carotovorum, Binds Cell Walls Differently to BsEXLX1	PLOS ONE			English	Article							BACTERIAL EXPANSIN; DISEASE RESISTANCE; BACILLUS-SUBTILIS; CELLULOSE; ELECTROSTATICS; HYDROLYSIS; PREDICTION; EXLX1; PH	Microbial expansins act on plant cell walls similarly to plant expansins, albeit their loosening activity levels are tenfold lesser compared to plant expansins. We report the characterization of an expansin-like gene from the plant pathogen Pectobacterium carotovorum, named exl1. PcExl1 is an acidic protein that binds cellulose ( Avicel), and weakens filter paper. The acidic nature of PcExl1 confers different binding properties when compared to Bacillus subtilis BsEXLX1, which is a basic protein. PcExl1 binding to wheat cell wall increased when acidic components were depleted, reaching a similar level to the binding to Avicel, indicating that cellulose is the target of PcExl1.	[Olarte-Lozano, Miguel; Mendoza-Nunez, Mario A.; Segovia, Lorenzo; Martinez-Anaya, Claudia] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico; [Olarte-Lozano, Miguel; Folch-Mallol, Jorge] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico; [Pastor, Nina] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos	Martinez-Anaya, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	cma@ibt.unam.mx	Pastor, Nina/W-4452-2019; Segovia, Lorenzo/A-5206-2008	Pastor, Nina/0000-0001-7755-2936; Segovia, Lorenzo/0000-0002-4291-4711; Martinez-Anaya, Claudia/0000-0002-2483-6115; Folch-Mallol, Jorge/0000-0002-1860-8175	SEP-CONACYT (Mexico) for Basic Science Research [166050]; CONACYT (Mexico)	SEP-CONACYT (Mexico) for Basic Science Research; CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by a grant from SEP-CONACYT (Mexico) for Basic Science Research to CMA (166050). MOL and MAMN were supported by scholarships from CONACYT (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adney B, 1996, NRELTP51042628; Baccelli I, 2014, APPL MICROBIOL BIOT, V98, P175, DOI 10.1007/s00253-013-4822-0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Durachko Daniel M, 2009, J Vis Exp, P1263, DOI 10.3791/1263; Georgelis N, 2014, CARBOHYD POLYM, V100, P17, DOI 10.1016/j.carbpol.2013.04.094; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; Gonzalez-Rodriguez Miguel Angel, 2005, Revista Mexicana de Fitopatologia, V23, P176; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Kim IJ, 2013, BIOTECHNOL BIOENG, V110, P401, DOI 10.1002/bit.24719; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Lee HJ, 2013, BIORESOURCE TECHNOL, V149, P516, DOI 10.1016/j.biortech.2013.09.086; Lee HJ, 2010, MOL CELLS, V29, P379, DOI 10.1007/s10059-010-0033-z; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Marquez-Villavicencio MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022974; Nikolaidis N, 2014, MOL BIOL EVOL, V31, P376, DOI 10.1093/molbev/mst206; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Quiroz-Castaneda RE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-8; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Wang T, 2013, P NATL ACAD SCI USA, V110, P16444, DOI 10.1073/pnas.1316290110; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	30	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95638	10.1371/journal.pone.0095638	http://dx.doi.org/10.1371/journal.pone.0095638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755657	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300064
J	Pelletier, EB; Emond, M; Lauzier, F; Savard, M; Turgeon, AF				Pelletier, Elyse Berger; Emond, Marcel; Lauzier, Francois; Savard, Martin; Turgeon, Alexis F.			Hyperosmolar Therapy in Severe Traumatic Brain Injury: A Survey of Emergency Physicians from a Large Canadian Province	PLOS ONE			English	Article							INCREASED INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; HEAD-INJURY; MANAGEMENT; MANNITOL; HYPOTENSION; INFUSION; CARE	Introduction: Worldwide, severe traumatic brain injury is a frequent pathology and is associated with high morbidity and mortality. Mannitol and hypertonic saline are therapeutic options for intracranial hypertension occurring in the acute phase of care. However, current practices of emergency physicians are unknown. Methods: We conducted a self-administered survey of emergency physicians in the province of Quebec, Canada, to understand their attitudes surrounding the use of hyperosmolar solutions in patients with severe traumatic brain injury. Using information from a systematic review of hypertonic saline solutions and experts' opinion, we developed a questionnaire following a systematic approach (items generation and reduction). We tested the questionnaire for face and content validity, and test-retest reliability. Physicians were identified through the department head of each eligible level I and II trauma centers. We administered the survey using a web-based interface and planned email reminders. Results: We received 210 questionnaires out of 429 potentials respondents (response rate 49%). Most respondents worked in level II trauma centers (69%). Fifty-three percent (53%) of emergency physicians stated using hypertonic saline to treat severe traumatic brain injury. Most reported using hyperosmolar therapy in the presence of severe traumatic brain injury and unilateral reactive mydriasis, midline shift or cistern compression on brain computed tomography. Conclusion: Hyperosmolar therapy is believed being broadly used by emergency physicians in Quebec following severe traumatic brain injury. Despite the absence of clinical practice guidelines promoting the use of hypertonic saline, a majority of them said to use these solutions in specific clinical situations.	[Pelletier, Elyse Berger; Emond, Marcel; Lauzier, Francois; Savard, Martin; Turgeon, Alexis F.] Univ Laval, Hop Enfant Jesus, Ctr Hosp Univ Quebec,Res Ctr, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada; [Pelletier, Elyse Berger; Emond, Marcel] Univ Laval, Dept Family & Emergency Med, Quebec City, PQ, Canada; [Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol, Div Crit Care, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Savard, Martin] Univ Laval, Dept Neurol Sci, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Turgeon, AF (corresponding author), Univ Laval, Hop Enfant Jesus, Ctr Hosp Univ Quebec,Res Ctr, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada.	alexis.turgeon@fmed.ulaval.ca	Savard, Martin/O-2549-2019; Lauzier, Francois/B-9237-2015; Emond, Marcel/G-5804-2014	Lauzier, Francois/0000-0002-6530-5513; Emond, Marcel/0000-0001-7158-8110	Association des medecins d'urgence du Quebec (AMUQ)	Association des medecins d'urgence du Quebec (AMUQ)	The Association des medecins d'urgence du Quebec (AMUQ) partly funded this project. The AMUQ had no influence on the design, conduct, analysis, or decision to submit the manuscript for publication. No additional external funding was received for this study.	AAPOR, 2016, STAND DEF FIN DISP C; [American College of Surgeons committee on trauma American College of Surgeons], 2008, ADV TRAUM LIF SUPP, P131; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Behnia R, 1996, ANESTH ANALG, V82, P902, DOI 10.1097/00000539-199605000-00002; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; BROWN FD, 1979, J NEUROSURG, V50, P423, DOI 10.3171/jns.1979.50.4.0423; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; COTE CJ, 1979, ANESTHESIOLOGY, V50, P30, DOI 10.1097/00000542-197901000-00007; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Dillman D.A., 2008, INTERNET PHONE MAIL, V3rd ed.; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; Marko NF, 2012, CRIT CARE, V16, DOI 10.1186/cc11182; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Papangelou A, 2009, CURR TREAT OPTION NE, V11, P64, DOI 10.1007/s11940-009-0009-5; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Turgeon A, 2009, CRIT CARE MED, V37, pA435; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Wenham TN, 2008, ANAESTHESIA, V63, P558, DOI 10.1111/j.1365-2044.2008.05532.x	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95778	10.1371/journal.pone.0095778	http://dx.doi.org/10.1371/journal.pone.0095778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755863	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300091
J	Peterson, SH; Hassrick, JL; Lafontaine, A; Thome, JP; Crocker, DE; Debier, C; Costa, DP				Peterson, Sarah H.; Hassrick, Jason L.; Lafontaine, Anne; Thome, Jean-Pierre; Crocker, Daniel E.; Debier, Cathy; Costa, Daniel P.			Effects of Age, Adipose Percent, and Reproduction on PCB Concentrations and Profiles in an Extreme Fasting North Pacific Marine Mammal	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; POLYBROMINATED DIPHENYL ETHERS; SEALS PHOCA-VITULINA; ELEPHANT SEAL; POLYCHLORINATED-BIPHENYLS; HARBOR SEALS; ORGANOCHLORINE CONTAMINATION; BLUBBER; WHALES; CALIFORNIA	Persistent organic pollutants, including polychlorinated biphenyls (PCBs), are widely distributed and detectable far from anthropogenic sources. Northern elephant seals (Mirounga angustirostris) biannually travel thousands of kilometers to forage in coastal and open-ocean regions of the northeast Pacific Ocean and then return to land where they fast while breeding and molting. Our study examined potential effects of age, adipose percent, and the difference between the breeding and molting fasts on PCB concentrations and congener profiles in blubber and serum of northern elephant seal females. Between 2005 and 2007, we sampled blubber and blood from 58 seals before and after a foraging trip, which were then analyzed for PCBs. Age did not significantly affect total PCB concentrations; however, the proportion of PCB congeners with different numbers of chlorine atoms was significantly affected by age, especially in the outer blubber. Younger adult females had a significantly greater proportion of low-chlorinated PCBs (tri-, tetra-, and penta-CBs) than older females, with the opposite trend observed for hepta-CBs, indicating that an age-associated process such as parity (birth) may significantly affect congener profiles. The percent of adipose tissue had a significant relationship with inner blubber PCB concentrations, with the highest mean concentrations observed at the end of the molting fast. These results highlight the importance of sampling across the entire blubber layer when assessing contaminant levels in phocid seals and taking into account the adipose stores and reproductive status of an animal when conducting contaminant research.	[Peterson, Sarah H.; Hassrick, Jason L.; Costa, Daniel P.] Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA; [Lafontaine, Anne; Thome, Jean-Pierre] Univ Liege, Lab Ecol Anim & Ecotoxicol, Liege, Belgium; [Crocker, Daniel E.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA; [Debier, Cathy] Catholic Univ Louvain, Inst Sci Vie, B-3000 Louvain, Belgium	University of California System; University of California Santa Cruz; University of Liege; California State University System; Sonoma State University; Universite Catholique Louvain	Peterson, SH (corresponding author), Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA.	sarahpeterson23@gmail.com	Hassrick, Jason/AAE-4905-2020; Costa, Daniel/E-2616-2013	Costa, Daniel/0000-0002-0233-5782	National Ocean Partnership Program [N00014-02-1-1012]; Office of Naval Research [N00014-00-10880, N00014-03-1-0651, N00014-08-1-1195, N00014-10-1-0356]; E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers [JIP2207-23]; Moore Foundation; Packard Foundation; Sloan Foundation; Ida Benson Lynn Endowed Chair in Ocean Health; University of California; Santa Cruz Open Access Fund	National Ocean Partnership Program; Office of Naval Research(Office of Naval Research); E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers; Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); Sloan Foundation(Alfred P. Sloan Foundation); Ida Benson Lynn Endowed Chair in Ocean Health; University of California(University of California System); Santa Cruz Open Access Fund	This research was conducted as part of the Tagging of Pacific Predators (TOPP) program and was supported in part by the National Ocean Partnership Program (N00014-02-1-1012); the Office of Naval Research (N00014-00-10880, N00014-03-1-0651, N00014-08-1-1195, and N00014-10-1-0356); the E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers (JIP2207-23); the Moore, Packard, and Sloan Foundations; the Ida Benson Lynn Endowed Chair in Ocean Health; Steve Blank. Full funding for Open Access provided by the University of California, Santa Cruz Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISON RF, 1986, ENVIRON SCI TECHNOL, V20, P253, DOI 10.1021/es00145a005; ADDISON RF, 1987, CAN J FISH AQUAT SCI, V44, P782, DOI 10.1139/f87-095; AGUILAR A, 1994, ARCH ENVIRON CON TOX, V27, P546; ANTONELIS GA, 1987, MAR MAMMAL SCI, V3, P308, DOI 10.1111/j.1748-7692.1987.tb00318.x; Barron MG, 2003, SCI TOTAL ENVIRON, V311, P111, DOI 10.1016/S0048-9697(03)00140-2; Blasius ME, 2008, MAR POLLUT BULL, V56, P1973, DOI 10.1016/j.marpolbul.2008.08.011; BORRELL A, 1995, ENVIRON POLLUT, V88, P283, DOI 10.1016/0269-7491(95)93441-2; Braune BM, 2005, SCI TOTAL ENVIRON, V351, P4, DOI 10.1016/j.scitotenv.2004.10.034; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P181, DOI 10.1016/S0048-9697(01)01075-0; Cameron ME, 1997, MAR ENVIRON RES, V43, P99, DOI 10.1016/0141-1136(96)00005-0; COSTA DP, 1986, J ZOOL, V209, P21, DOI 10.1111/j.1469-7998.1986.tb03563.x; Crocker DE, 2014, ADV NUTR, V5, P57, DOI 10.3945/an.113.004663; Das K, 2003, N P TOX ENV, P135; Debier C, 2005, ENVIRON TOXICOL CHEM, V24, P629, DOI 10.1897/04-033R.1; Debier C, 2003, MAR ECOL PROG SER, V247, P237, DOI 10.3354/meps247237; Debier C, 2006, AQUAT TOXICOL, V80, P149, DOI 10.1016/j.aquatox.2006.08.002; Debier C, 2012, COMP BIOCHEM PHYS A, V162, P323, DOI 10.1016/j.cbpa.2012.04.001; Desforges JPW, 2012, ENVIRON TOXICOL CHEM, V31, P296, DOI 10.1002/etc.750; DESWART RL, 1995, CLIN EXP IMMUNOL, V101, P480; Elfes CT, 2010, ENVIRON TOXICOL CHEM, V29, P824, DOI 10.1002/etc.110; Finkelstein M, 2006, ECOL APPL, V16, P678, DOI 10.1890/1051-0761(2006)016[0678:ASDRDI]2.0.CO;2; Fowler MA, 2014, J COMP PHYSIOL B, V184, P125, DOI 10.1007/s00360-013-0787-7; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; Gauger KJ, 2004, ENVIRON HEALTH PERSP, V112, P516, DOI 10.1289/ehp.6672; Greig DJ, 2011, SCI TOTAL ENVIRON, V409, P3537, DOI 10.1016/j.scitotenv.2011.05.047; Kajiwara N, 2001, ARCH ENVIRON CON TOX, V41, P90, DOI 10.1007/s002440010224; Le Boeuf B.J., 1994, ELEPHANT SEALS POPUL; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; LOGANATHAN BG, 1994, AMBIO, V23, P187; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lopez J, 2012, MAR POLLUT BULL, V64, P2588, DOI 10.1016/j.marpolbul.2012.07.012; Loughlin TR, 2002, MAR POLLUT BULL, V44, P1024, DOI 10.1016/S0025-326X(02)00149-2; Muir D, 1999, SCI TOTAL ENVIRON, V230, P83, DOI 10.1016/S0048-9697(99)00037-6; Myers MJ, 2012, MAR MAMMAL SCI, V28, P105, DOI 10.1111/j.1748-7692.2011.00466.x; Naito Y, 2013, FUNCTIONAL ECOLOGY; Nash SMB, 2013, ENVIRON SCI TECHNOL, V47, P9404, DOI 10.1021/es401441n; Nisbet I C, 1972, Environ Health Perspect, V1, P21; POLISCHUK SC, 1995, SCI TOTAL ENVIRON, V160-61, P465, DOI 10.1016/0048-9697(95)04380-J; Polischuk SC, 2002, ENVIRON POLLUT, V118, P29, DOI 10.1016/S0269-7491(01)00278-0; Pomeroy PP, 1996, CAN J FISH AQUAT SCI, V53, P1526, DOI 10.1139/cjfas-53-7-1526; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036728; Ross P, 1996, TOXICOLOGY, V112, P157, DOI 10.1016/0300-483X(96)03396-3; Ross PS, 2004, ENVIRON TOXICOL CHEM, V23, P157, DOI 10.1897/03-85; Ross PS, 2000, MAR POLLUT BULL, V40, P504, DOI 10.1016/S0025-326X(99)00233-7; Sarkar D., 2019, NLME LINEAR NONLINEA; Schwacke LH, 2012, P ROY SOC B-BIOL SCI, V279, P48, DOI 10.1098/rspb.2011.0665; Simmons Samantha E., 2010, Endangered Species Research, V10, P233, DOI 10.3354/esr00254; Sormo EG, 2003, SCI TOTAL ENVIRON, V302, P145, DOI 10.1016/S0048-9697(02)00300-5; Springer AM, 1999, PROG OCEANOGR, V43, P443, DOI 10.1016/S0079-6611(99)00014-2; Strandberg U, 2008, PHYSIOL BIOCHEM ZOOL, V81, P473, DOI 10.1086/589108; SUBRAMANIAN A, 1988, MAR ENVIRON RES, V25, P161, DOI 10.1016/0141-1136(88)90001-3; TANABE S, 1987, MAR POLLUT BULL, V18, P561, DOI 10.1016/0025-326X(87)90541-8; Vanden Berghe M, 2012, ENVIRON INT, V46, P6, DOI 10.1016/j.envint.2012.04.011; Vos JG, 2003, PURE APPL CHEM, V75, P2039, DOI 10.1351/pac200375112039; VOS JG, 1972, TOXICOL APPL PHARM, V21, P549, DOI 10.1016/0041-008X(72)90011-7; Wang DL, 2007, ENVIRON POLLUT, V146, P268, DOI 10.1016/j.envpol.2006.01.050; Webb PM, 1998, J EXP BIOL, V201, P2349; Weijs L, 2009, ENVIRON POLLUT, V157, P437, DOI 10.1016/j.envpol.2008.09.024; Wolkers H, 2004, SCI TOTAL ENVIRON, V319, P137, DOI 10.1016/S0048-9697(03)00449-2; WORTHY GAJ, 1992, J ZOOL, V227, P257, DOI 10.1111/j.1469-7998.1992.tb04821.x; Ylitalo GM, 2005, MAR POLLUT BULL, V50, P30, DOI 10.1016/j.marpolbul.2004.08.005; Yordy JE, 2010, ENVIRON TOXICOL CHEM, V29, P1263, DOI 10.1002/etc.152; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	65	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96191	10.1371/journal.pone.0096191	http://dx.doi.org/10.1371/journal.pone.0096191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755635	Green Submitted, gold, Green Published			2022-12-25	WOS:000335240300143
J	Bagchi, S; Baomar, HA; Al-Walai, S; Al-Sadi, S; Fredriksson, R				Bagchi, Sonchita; Baomar, Hajar Ali; Al-Walai, Somar; Al-Sadi, Saifaddin; Fredriksson, Robert			Histological Analysis of SLC38A6 (SNAT6) Expression in Mouse Brain Shows Selective Expression in Excitatory Neurons with High Expression in the Synapses	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; FAMILIES SLC32; SYSTEM N; IN-SITU; GLUTAMINE; PROTEIN; IDENTIFICATION; CLONING; LOCALIZATION; SUGGESTS	SLC38A6 is one of the newly found members of the solute carrier 38 family consisting of total 11 members, of which only 6 have been characterized so far. Being the only glutamine transporter family expressed in the brain, this family of proteins are most probably involved in the regulation of the glutamate-glutamine cycle, responsible for preventing excitotoxicity. We used immunohistochemistry to show that SLC38A6 is primarily expressed in excitatory neurons and is not expressed in the astrocytes. Using proximity ligation assay, we have quantified the interactions of this SLC38 family protein with other proteins with known localization in the cells, showing that this transporter is expressed at the synapses. Moreover, this study has enabled us to come up with a model suggesting sub-cellular localization of SLC38A6 at the synaptic membrane of the excitatory neurons.	[Bagchi, Sonchita; Baomar, Hajar Ali; Al-Walai, Somar; Al-Sadi, Saifaddin; Fredriksson, Robert] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Fredriksson, R (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Robert.Fredriksson@neuro.uu.se		Fredriksson, Robert/0000-0002-2810-3226	Swedish Research Council; Swedish Society for Medical Research; Novo Nordisk foundation; Ahlens foundation; Engkvist Foundation; Thurings Foundation for metabolic research; Gunvor and Josef Aners foundation; Novo Nordisk Fonden [NNF12OC1016287, NNF13OC0005723] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Ahlens foundation; Engkvist Foundation; Thurings Foundation for metabolic research; Gunvor and Josef Aners foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council, The Swedish Society for Medical Research, The Novo Nordisk foundation, Ahlens foundation, Engkvist Foundation, Thurings Foundation for metabolic research, Gunvor and Josef Aners foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Boulland JL, 2002, EUR J NEUROSCI, V15, P1615, DOI 10.1046/j.1460-9568.2002.01995.x; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Gonzalez-Gonzalez IM, 2005, NEUROSCIENCE, V130, P61, DOI 10.1016/j.neuroscience.2004.09.023; Gu SM, 2000, P NATL ACAD SCI USA, V97, P3230, DOI 10.1073/pnas.050318197; Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; Manns ID, 2001, NEUROSCIENCE, V107, P249, DOI 10.1016/S0306-4522(01)00302-5; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Van der Gucht E, 2003, BRAIN RES, V988, P29, DOI 10.1016/S0006-8993(03)03332-8; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Yao D, 2000, J BIOL CHEM, V275, P22790	34	18	19	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95438	10.1371/journal.pone.0095438	http://dx.doi.org/10.1371/journal.pone.0095438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752331	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400062
J	Basavarajappa, HD; Lee, B; Fei, X; Lim, D; Callaghan, B; Mund, JA; Case, J; Rajashekhar, G; Seo, SY; Corson, TW				Basavarajappa, Halesha D.; Lee, Bit; Fei, Xiang; Lim, Daesung; Callaghan, Breedge; Mund, Julie A.; Case, Jamie; Rajashekhar, Gangaraju; Seo, Seung-Yong; Corson, Timothy W.			Synthesis and Mechanistic Studies of a Novel Homoisoflavanone Inhibitor of Endothelial Cell Growth	PLOS ONE			English	Article							NF-KAPPA-B; RETINAL NEOVASCULARIZATION; PROTEIN-KINASE; GENE-TRANSCRIPTION; ANGIOGENESIS; ACTIVATION; EXPRESSION; THERAPY; INTERLEUKIN-8; RANIBIZUMAB	Preventing pathological ocular angiogenesis is key to treating retinopathy of prematurity, diabetic retinopathy and age-related macular degeneration. At present there is no small molecule drug on the market to target this process and hence there is a pressing need for developing novel small molecules that can replace or complement the present surgical and biologic therapies for these neovascular eye diseases. Previously, an antiangiogenic homoisoflavanone was isolated from the bulb of a medicinal orchid, Cremastra appendiculata. In this study, we present the synthesis of a novel homoisoflavanone isomer of this compound. Our compound, SH-11052, has antiproliferative activity against human umbilical vein endothelial cells, and also against more ocular disease-relevant human retinal microvascular endothelial cells ( HRECs). Tube formation and cell cycle progression of HRECs were inhibited by SH-11052, but the compound did not induce apoptosis at effective concentrations. SH-11052 also decreased TNF-alpha induced p38 MAPK phosphorylation in these cells. Intriguingly, SH-11052 blocked TNF-a induced IkB-a degradation, and therefore decreased NF-kappa B nuclear translocation. It decreased the expression of NF-kappa B target genes and the pro-angiogenic or pro-inflammatory markers VCAM-1, CCL2, IL8, and PTGS2. In addition SH-11052 inhibited VEGF induced activation of Akt but not VEGF receptor autophosphorylation. Based on these results we propose that SH-11052 inhibits inflammation induced angiogenesis by blocking both TNF-alpha and VEGF mediated pathways, two major pathways involved in pathological angiogenesis. Synthesis of this novel homoisoflavanone opens the door to structure-activity relationship studies of this class of compound and further evaluation of its mechanism and potential to complement existing antiangiogenic drugs.	[Basavarajappa, Halesha D.; Callaghan, Breedge; Rajashekhar, Gangaraju; Corson, Timothy W.] Indiana Univ Sch Med, Dept Ophthalmol, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Basavarajappa, Halesha D.; Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Lee, Bit; Fei, Xiang; Lim, Daesung; Seo, Seung-Yong] Gachon Univ, Coll Pharm, Inchon, South Korea; [Mund, Julie A.; Case, Jamie] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Mund, Julie A.; Case, Jamie; Corson, Timothy W.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Rajashekhar, Gangaraju] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Gachon University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Seo, SY (corresponding author), Gachon Univ, Coll Pharm, Inchon, South Korea.	syseo@gachon.ac.kr; tcorson@iupui.edu	Gangaraju, Rajashekhar/I-7852-2019; Basavarajappa, Halesha Dhurvigere/V-2038-2019; Corson, Timothy W./B-6851-2009; Fei, Xiang/D-6670-2014	Gangaraju, Rajashekhar/0000-0002-6664-8286; Basavarajappa, Halesha Dhurvigere/0000-0002-2840-5937; Corson, Timothy W./0000-0002-1402-7875; Case, Jamie/0000-0002-6721-0307; Fei, Xiang/0000-0001-9637-1989	International Retinal Research Foundation; Carl Marshall and Mildred Almen Reeves Foundation; Ralph W. and Grace M. Showalter Research Trust; Retina Research Foundation; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2007151]; Cryptic Masons Medical Research Foundation; Ausich Graduate Scholarship from Kemin Health; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [KL2 TR000163]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000163, UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	International Retinal Research Foundation; Carl Marshall and Mildred Almen Reeves Foundation; Ralph W. and Grace M. Showalter Research Trust; Retina Research Foundation; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Cryptic Masons Medical Research Foundation; Ausich Graduate Scholarship from Kemin Health; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the International Retinal Research Foundation, Carl Marshall and Mildred Almen Reeves Foundation, Ralph W. and Grace M. Showalter Research Trust, and Retina Research Foundation to TWC, a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2007151) to S-YS, a grant from the Cryptic Masons Medical Research Foundation to GR, and the Ausich Graduate Scholarship from Kemin Health to HDB. This publication was also made possible in part by grant number KL2 TR000163 (A. Shekhar, PI) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award to TWC and GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Bid HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035513; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen DZ, 2010, J ASIAN NAT PROD RES, V12, P124, DOI 10.1080/10286020903508416; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Crouch NR, 1999, PHYTOCHEMISTRY, V51, P943, DOI 10.1016/S0031-9422(99)00154-5; du Toit K, 2005, BIOORGAN MED CHEM, V13, P2561, DOI 10.1016/j.bmc.2005.01.036; Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889; Faia Lisa J, 2011, Int Ophthalmol Clin, V51, P1, DOI 10.1097/IIO.0b013e3182011033; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Folk JC, 2010, NEW ENGL J MED, V363, P1648, DOI 10.1056/NEJMct1000495; Friedlander M, 2009, RETINA-J RET VIT DIS, V29, pS27, DOI 10.1097/IAE.0b013e3181ad2673; Fujii M, 2009, HETEROCYCLES, V78, P2061, DOI 10.3987/COM-09-11684; Gilbert C, 1997, LANCET, V350, P12, DOI 10.1016/S0140-6736(97)01107-0; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hodge W, 2010, CAN J OPHTHALMOL, V45, P223, DOI 10.3129/i10-047; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hur S, 2010, J DERMATOL SCI, V59, P163, DOI 10.1016/j.jdermsci.2010.07.001; Ikeda Y, 2005, J NAT PROD, V68, P572, DOI 10.1021/np049650x; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kawasaki M, 2005, HETEROCYCLES, V65, P761, DOI 10.3987/COM-05-10347; Kim JH, 2008, MOL VIS, V14, P556; Kim JH, 2007, BIOCHEM BIOPH RES CO, V362, P848, DOI 10.1016/j.bbrc.2007.08.100; Kim JH, 2009, MOL VIS, V15, P1868; Klein S, 2002, MOL CELL BIOL, V22, P5912, DOI 10.1128/MCB.22.16.5912-5922.2002; Lai SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038103; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Liu RY, 2000, J BIOL CHEM, V275, P21086, DOI 10.1074/jbc.M001281200; Lux A, 2007, BRIT J OPHTHALMOL, V91, P1318, DOI 10.1136/bjo.2006.113902; Maehara K, 2000, J CELL BIOCHEM, V77, P474, DOI 10.1002/(SICI)1097-4644(20000601)77:3<474::AID-JCB12>3.0.CO;2-H; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Mitchell P, 2011, PHARMACOECONOMICS, V29, P107, DOI 10.2165/11585520-000000000-00000; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Omar HA, 2013, TOXICOL APPL PHARM, V272, P616, DOI 10.1016/j.taap.2013.07.014; Ozes ON, 1999, NATURE, V401, P82; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Poisson T, 2010, J ORG CHEM, V75, P7704, DOI 10.1021/jo101585t; Ponce ML, 2001, METH MOLEC MED, V46, P205, DOI 10.1385/1-59259-143-4:205; Raffioni S, 1999, P NATL ACAD SCI USA, V96, P7178, DOI 10.1073/pnas.96.13.7178; Rajashekhar G, 2006, J VASC RES, V43, P193, DOI 10.1159/000090949; Rajashekhar G, 2007, PHYSIOL GENOMICS, V31, P104, DOI 10.1152/physiolgenomics.00157.2006; Rajashekhar G, 2011, J CELL PHYSIOL, V226, P800, DOI 10.1002/jcp.22404; Rao VM, 2008, ARKIVOC, P285; Ratner M, 2004, NAT BIOTECHNOL, V22, P1198, DOI 10.1038/nbt1004-1198; Roskoski R, 2007, BIOCHEM BIOPH RES CO, V356, P323, DOI 10.1016/j.bbrc.2007.02.156; Royds JA, 1998, J CLIN PATHOL-MOL PA, V51, P55; Sagar S M, 2006, Curr Oncol, V13, P99; Sagar S M, 2006, Curr Oncol, V13, P14; Shim JS, 2004, PLANTA MED, V70, P171, DOI 10.1055/s-2004-815496; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tomita K, 1999, N-S ARCH PHARMACOL, V359, P249, DOI 10.1007/PL00005349; Vanderslice P, 1998, Angiogenesis, V2, P265, DOI 10.1023/A:1009296700991; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Yang HT, 2012, MOL CELL BIOL, V32, P3438, DOI 10.1128/MCB.00564-12; Yoshida A, 1999, INVEST OPHTH VIS SCI, V40, P1624; Yoshida A, 1998, INVEST OPHTH VIS SCI, V39, P1097; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zhang F, 2002, ATHEROSCLEROSIS, V161, P381, DOI 10.1016/S0021-9150(01)00672-4; Zhang L, 2008, J ASIAN NAT PROD RES, V10, P909, DOI 10.1080/10286020802217499; Zhang MS, 2010, J MED PLANTS RES, V4, P1837	65	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95694	10.1371/journal.pone.0095694	http://dx.doi.org/10.1371/journal.pone.0095694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752613	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400102
J	Craig, PM; Trudeau, VL; Moon, TW				Craig, Paul M.; Trudeau, Vance L.; Moon, Thomas W.			Profiling Hepatic microRNAs in Zebrafish: Fluoxetine Exposure Mimics a Fasting Response That Targets AMP-Activated Protein Kinase (AMPK)	PLOS ONE			English	Article							EXPRESSION; SEROTONIN; PHARMACEUTICALS; FISH; ECOTOXICOLOGY; CONTAMINANTS; INHIBITOR; HORMONES; BRAIN; DRUGS	This study examined the similarities in microRNA profiles between fasted and fluoxetine (FLX) exposed zebrafish and downstream target transcripts and biological pathways. Using a custom designed microarray targeting 270 zebrafish miRNAs, we identified 9 differentially expressed miRNAs targeting transcripts in biological pathways associated with anabolic metabolism, such as adipogenesis, cholesterol biosynthesis, triacylglycerol synthesis, and insulin signaling. Exposure of female zebrafish to 540 ng/L FLX, an environmentally relevant concentration and a known metabolic repressor, increased specific miRNAs indicating greater inhibition of these pathways in spite of continued feeding. Further examination revealed two specific miRNAs, dre-let-7d and dre-miR-140-5p, were predicted in silico to bind to a primary regulator of metabolism, adenosine monophosphate-activated protein kinase (AMPK), and more specifically the two isoforms of the catalytic subunit, AMPK alpha 1 and alpha 2, respectively. Real-time analysis of the relative transcript abundance of the alpha 1 and alpha 2 mRNAs indicated a significant inverse relationship between specific miRNA and target transcript. This suggests that AMPK-related pathways may be compromised during FLX exposure as a result of increased miRNA abundance. The mechanism by which FLX regulates miRNA abundance is unknown but may be direct at the liver. The serotonin transporter, slc6a4, is the target of FLX and other selective serotonin reuptake inhibitors (SSRI) and it was found to be expressed in the liver, although treatment did not alter expression of this transporter. Exposure to FLX disrupts key hepatic metabolic pathways, which may be indicative of reduced overall fitness and these effects may be linked to specific miRNA abundance. This has important implications for the heath of fish because concentrations of SSRIs in aquatic ecosystems are continually increasing.	[Craig, Paul M.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Craig, PM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	pcraig@uottawa.ca	Trudeau, Vance L./P-5542-2019; Craig, Paul/J-4058-2015	Trudeau, Vance L./0000-0002-0845-9444; 	NSERC Discovery Grants	NSERC Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NSERC Discovery Grants to both TWM and VLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brooks BW, 2009, ENVIRON TOXICOL CHEM, V28, P2469, DOI 10.1897/09-325.1; Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Choudhuri S, 2010, J BIOCHEM MOL TOXIC, V24, P195, DOI 10.1002/jbt.20325; Chu S, 2007, J CHROMATOGR A, V1163, P112, DOI 10.1016/j.chroma.2007.06.014; Cohen A, 2013, ZEBRAFISH IN PRESS; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Craig PM, 2011, ZEBRAFISH, V8, P109, DOI 10.1089/zeb.2011.0702; Cunningham KA, 2012, CELL METAB, V16, P113, DOI 10.1016/j.cmet.2012.05.014; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Gaworecki KM, 2008, AQUAT TOXICOL, V88, P207, DOI 10.1016/j.aquatox.2008.04.011; Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004; Hardie DG, 2007, SCIENCE, V315, P1671, DOI 10.1126/science.1140737; Hou LF, 2011, MUTAT RES-FUND MOL M, V714, P105, DOI 10.1016/j.mrfmmm.2011.05.004; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lam Daniel D., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000245; Lesurtel M, 2012, SURG-J R COLL SURG E, V10, P107, DOI 10.1016/j.surge.2011.11.002; Li XY, 2013, TOXICON, V73, P17, DOI 10.1016/j.toxicon.2013.07.002; Lister A, 2009, AQUAT TOXICOL, V95, P320, DOI 10.1016/j.aquatox.2009.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann JJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0537; Martyniuk CJ, 2006, PHYSIOL GENOMICS, V27, P328, DOI 10.1152/physiolgenomics.00090.2006; McBride RS, 2013, FISH FISHER IN PRESS; Mennigen JA, 2013, J EXP BIOL, V216, P1597, DOI 10.1242/jeb.082248; Mennigen JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038604; Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559; Mennigen JA, 2010, AQUAT TOXICOL, V100, P354, DOI 10.1016/j.aquatox.2010.08.016; Mennigen JA, 2010, AQUAT TOXICOL, V100, P128, DOI 10.1016/j.aquatox.2010.07.022; Mennigen JA, 2009, REGUL PEPTIDES, V155, P99, DOI 10.1016/j.regpep.2009.01.001; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Nakamura Y, 2008, CHEMOSPHERE, V70, P865, DOI 10.1016/j.chemosphere.2007.06.089; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Oakes Ken D., 2010, Integrated Environmental Assessment and Management, V6, P524, DOI 10.1002/ieam.77; Paterson G, 2008, CHEMOSPHERE, V74, P125, DOI 10.1016/j.chemosphere.2008.08.022; Ruddell RG, 2008, J HEPATOL, V48, P666, DOI 10.1016/j.jhep.2008.01.006; Stanley JK, 2007, CHEMOSPHERE, V69, P9, DOI 10.1016/j.chemosphere.2007.04.080; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Waye A, 2011, J TOXICOL ENV HEAL B, V14, P270, DOI 10.1080/10937404.2011.578273; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Wu CW, 2013, GENE, V529, P269, DOI 10.1016/j.gene.2013.07.064; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Zhang DP, 2009, PHYSIOL GENOMICS, V38, P351, DOI 10.1152/physiolgenomics.00051.2009	48	28	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95351	10.1371/journal.pone.0095351	http://dx.doi.org/10.1371/journal.pone.0095351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751937	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400053
J	Rogers, N; McAninch, D; Thomas, P				Rogers, Nicholas; McAninch, Dale; Thomas, Paul			Dbx1 Is a Direct Target of SOX3 in the Spinal Cord	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX3; GENES; NEUROGENESIS; EXPRESSION; MICE; SPECIFICATION; GASTRULATION; DEFICIENCY; BRAIN; FATE	SoxB1 sub-family of transcriptional regulators are expressed in progenitor (NP) cells throughout the neuroaxis and are generally downregulated during neuronal differentiation. Gain-and loss-of-function studies indicate that Sox1, Sox2 and Sox3 are key regulators of NP differentiation and that their roles in CNS development are largely redundant. Nevertheless, mutation of each SoxB1 individually results in a different array of CNS defects, raising the possibility that SoxB1 proteins have subtly different functions in NP cells. To explore the mechanism of SOXB1 functional redundancy, and to identify genes that are most sensitive to loss of the Sox3 gene, we performed genome wide expression profiling of Sox3 null NP cells. Nineteen genes with abnormal expression were identified, including the homeobox gene Dbx1. Analysis of Sox3 null embryos revealed that Dbx1 was significantly reduced in the neural tube and developing brain and that SOX3 bound directly to conserved elements associated with this gene in cultured NP cells and in vivo. These data define Dbx1 as a direct SOX3 target gene whose expression, intriguingly, is not fully rescued by other SOXB1 transcription factors, suggesting that there are inherent differences in SOXB1 protein activity.	[Rogers, Nicholas; McAninch, Dale; Thomas, Paul] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Biochem, Adelaide, SA, Australia	University of Adelaide	Thomas, P (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Discipline Biochem, Adelaide, SA, Australia.	paul.thomas@adelaide.edu.au	Thomas, Paul Q/K-4497-2012	McAninch, Dale/0000-0001-9735-6553; Rogers, Nicholas/0000-0002-0012-9360				Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; Amaniti EM, 2013, DEV BIOL, V376, P113, DOI 10.1016/j.ydbio.2013.02.001; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Collignon J, 1996, DEVELOPMENT, V122, P509; Ekonomou A, 2005, PLOS BIOL, V3, P1111, DOI 10.1371/journal.pbio.0030186; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Hirata T, 2006, DEVELOPMENT, V133, P3993, DOI 10.1242/dev.02585; Hughes J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003290; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Malas S, 2003, NEUROSCIENCE, V119, P421, DOI 10.1016/S0306-4522(03)00158-1; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Oosterveen T, 2013, P NATL ACAD SCI USA, V110, P7330, DOI 10.1073/pnas.1220010110; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Rizzoti K, 2007, DEVELOPMENT, V134, P3437, DOI 10.1242/dev.007906; Rogers N, 2013, GENE EXPR PATTERNS, V13, P240, DOI 10.1016/j.gep.2013.04.004; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Uchikawa M, 2011, DEV GROWTH DIFFER, V53, P761, DOI 10.1111/j.1440-169X.2011.01286.x; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wolf A, 2013, DEVELOPMENT, V140, P1762, DOI 10.1242/dev.085357; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang C, 2013, NEURON, V78, P986, DOI 10.1016/j.neuron.2013.04.021	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95356	10.1371/journal.pone.0095356	http://dx.doi.org/10.1371/journal.pone.0095356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751947	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400054
J	Salamon, J; Hoffmann, T; Elies, E; Peldschus, K; Johansen, JS; Luers, G; Schumacher, U; Wicklein, D				Salamon, Johannes; Hoffmann, Tatjana; Elies, Eva; Peldschus, Kersten; Johansen, Julia S.; Lueers, Georg; Schumacher, Udo; Wicklein, Daniel			Antibody Directed against Human YKL-40 Increases Tumor Volume in a Human Melanoma Xenograft Model in Scid Mice	PLOS ONE			English	Article							HUMAN CARTILAGE GLYCOPROTEIN-39; CHITINASE PROTEIN FAMILY; SMOOTH-MUSCLE-CELLS; MAMMALIAN MEMBER; POOR SURVIVAL; SERUM YKL-40; CANCER; EXPRESSION; RESPONSES; GP38K	Induced overexpression of the secretory protein YKL-40 promotes tumor growth in xenograft experiments. We investigated if targeting YKL-40 with a monoclonal antibody could inhibit tumor growth. YKL-40 expressing human melanoma cells (LOX) were injected subcutenously in Balb/c scid mice. Animals were treated with intraperitoneal injections of anti-YKL-40, isoptype control or PBS. Non-YKL-40 expressing human pancreatic carcinoma cell line PaCa 5061 served as additional control. MR imaging was used for evaluation of tumor growth. Two days after the first injections of anti-YKL-40, tumor volume had increased significantly compared with controls, whereas no effects were observed for control tumors from PaCa 5061 cells lacking YKL-40 expression. After 18 days, mean tumor size of the mice receiving repeated anti-YKL-40 injections was 1.82 g, > 4 times higher than mean tumor size of the controls (0.42 g). The effect of anti-YKL-40 on the increase of tumor volume started within hours after injection and was dose dependent. Intratumoral hemorrhage was observed in the treated animals. The strong effect on tumor size indicates important roles for YKL-40 in melanoma growth and argues for a careful evaluation of antibody therapy directed against YKL-40.	[Salamon, Johannes; Elies, Eva; Lueers, Georg; Schumacher, Udo; Wicklein, Daniel] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany; [Salamon, Johannes; Peldschus, Kersten] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Dept Radiol, Hamburg, Germany; [Hoffmann, Tatjana] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Dept Interdisciplinary Endoscopy, Hamburg, Germany; [Johansen, Julia S.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Copenhagen, Denmark	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Copenhagen; Herlev & Gentofte Hospital	Wicklein, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany.	d.wicklein@uke.de						Bigg HF, 2006, J BIOL CHEM, V281, P21082, DOI 10.1074/jbc.M601153200; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; FODSTAD O, 1988, INT J CANCER, V41, P442, DOI 10.1002/ijc.2910410322; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Fredriksson S, 2008, CLIN CHEM, V54, P582, DOI 10.1373/clinchem.2007.093195; Fukushima N, 2005, MODERN PATHOL, V18, P779, DOI 10.1038/modpathol.3800337; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Harvey S, 1998, CLIN CHEM, V44, P509; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Johansen JS, 2007, J HISTOCHEM CYTOCHEM, V55, P1213, DOI 10.1369/jhc.7A7245.2007; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Junker N, 2005, LUNG CANCER, V48, P223, DOI 10.1016/j.lungcan.2004.11.011; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Lee CG, 2010, ALLERGY ASTHMA IMMUN, V2, P20, DOI 10.4168/aair.2010.2.1.20; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Nishikawa KC, 2003, EXP CELL RES, V287, P79, DOI 10.1016/S0014-4827(03)00069-7; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Romeis B, 2010, ROMEIS MIKROSKOPISCH, Vxii; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Schmidt H, 2006, CANCER-AM CANCER SOC, V106, P1130, DOI 10.1002/cncr.21678; Schmidt H, 2006, J CLIN ONCOL, V24, P798, DOI 10.1200/JCO.2005.03.7960; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shao R, 2009, ONCOGENE; Thies A, 2007, BRIT J CANCER, V96, P609, DOI 10.1038/sj.bjc.6603594; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	33	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95822	10.1371/journal.pone.0095822	http://dx.doi.org/10.1371/journal.pone.0095822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752554	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400136
J	Tricotel, A; Raguideau, F; Collin, C; Zureik, M				Tricotel, Aurore; Raguideau, Fanny; Collin, Cedric; Zureik, Mahmoud			Estimate of Venous Thromboembolism and Related-Deaths Attributable to the Use of Combined Oral Contraceptives in France	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; HORMONAL CONTRACEPTION; PULMONARY-EMBOLISM; RISK	Purpose: To estimate the number of venous thromboembolic events and related-premature mortality (including immediate in-hospital lethality) attributable to the use of combined oral contraceptives in women aged 15 to 49 years-old between 2000 and 2011 in France. Methods: French data on sales of combined oral contraceptives and on contraception behaviours from two national surveys conducted in 2000 and 2010 were combined to estimate the number of exposed women according to contraceptives generation and age. Absolute risk of first time venous thromboembolism in non-users of hormonal contraception and increased risk of thromboembolism in users vs. non-users of hormonal contraception were estimated on the basis of literature data. Finally, immediate in-hospital lethality due to pulmonary embolism and premature mortality due to recurrent venous thromboembolism were estimated from the French national database of hospitalisation and literature data. Results: In France, more than four million women are daily exposed to combined oral contraceptives. The mean annual number of venous thromboembolic events attributable to their use was 2,529 (778 associated to the use of first- and second-generation contraceptives and 1,751 to the use of third-and fourth-generation contraceptives), corresponding to 20 premature deaths (six with first-and second-generation contraceptives and fourteen with third-and fourth-generation contraceptives), of which there were eight to nine immediate in-hospital deaths. As compared to the use of first-and second-generation contraceptives, exposure to third- and fourth-generation contraceptives led to a mean annual excess of 1,167 venous thromboembolic events and nine premature deaths (including three immediate in-hospital deaths). Conclusions: Corrective actions should be considered to limit exposure to third-and fourth-generation contraceptives, and thus optimise the benefit-risk ratio of combined oral contraception.	[Tricotel, Aurore; Raguideau, Fanny; Collin, Cedric; Zureik, Mahmoud] French Natl Agcy Med & Hlth Prod Safety ANSM, Dept Epidemiol Hlth Prod, St Denis, France		Zureik, M (corresponding author), French Natl Agcy Med & Hlth Prod Safety ANSM, Dept Epidemiol Hlth Prod, St Denis, France.	mahmoud.zureik@ansm.sante.fr	Zureik, Mahmoud/F-7855-2018	Zureik, Mahmoud/0000-0002-8393-4217				ANAND JK, 1961, LANCET, V2, P1146; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Baillargeon JP, 2005, J CLIN ENDOCR METAB, V90, P3863, DOI 10.1210/jc.2004-1958; Bajos N, 2003, HUM REPROD, V18, P994, DOI 10.1093/humrep/deg215; Bajos N, 2012, POPUL SOC; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; BOYCE J, 1963, LANCET, V1, P111, DOI 10.1016/S0140-6736(63)91117-6; Dinger JC, 2007, CONTRACEPTION, V75, P344, DOI 10.1016/j.contraception.2006.12.019; FARLEY TMM, 1995, LANCET, V346, P1582; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Helmerhorst FM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1464; Hoffmann B, 2010, THROMB RES, V125, P303, DOI 10.1016/j.thromres.2009.06.015; IMS-Health, MS MIDAS MARK SEGM; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lidegaard O, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2990; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; National Institute of Statistics and Economic Studies (Insee), POP SEX 5 YEAR AG GR; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Spitzer WO, 1996, BRIT MED J, V312, P83; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; White RH, 2008, THROMB HAEMOSTASIS, V99, P683, DOI 10.1160/TH07-09-0557	28	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e93792	10.1371/journal.pone.0093792	http://dx.doi.org/10.1371/journal.pone.0093792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751717	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400007
J	Bankamp, B; Liu, CY; Rivailler, P; Bera, J; Shrivastava, S; Kirkness, EF; Bellini, WJ; Rota, PA				Bankamp, Bettina; Liu, Chunyu; Rivailler, Pierre; Bera, Jayati; Shrivastava, Susmita; Kirkness, Ewen F.; Bellini, William J.; Rota, Paul A.			Wild-Type Measles Viruses with Non-Standard Genome Lengths	PLOS ONE			English	Article							SUBACUTE SCLEROSING-PANENCEPHALITIS; CANINE-DISTEMPER VIRUS; PCR PRIMER DESIGN; FUSION PROTEIN; MESSENGER-RNA; UNTRANSLATED REGIONS; NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION; REPLICATION; MUTATIONS	The length of the single stranded, negative sense RNA genome of measles virus (MeV) is highly conserved at 15,894 nucleotides (nt). MeVs can be grouped into 24 genotypes based on the highly variable 450 nucleotides coding for the carboxyl-terminus of the nucleocapsid protein (N-450). Here, we report the genomic sequences of 2 wild-type viral isolates of genotype D4 with genome lengths of 15,900 nt. Both genomes had a 7 nt insertion in the 39 untranslated region (UTR) of the matrix (M) gene and a 1 nt deletion in the 5' UTR of the fusion (F) gene. The net gain of 6 nt complies with the rule-of-six required for replication competency of the genomes of morbilliviruses. The insertions and deletion (indels) were confirmed in a patient sample that was the source of one of the viral isolates. The positions of the indels were identical in both viral isolates, even though epidemiological data and the 3 nt differences in N-450 between the two genomes suggested that the viruses represented separate chains of transmission. Identical indels were found in the M-F intergenic regions of 14 additional genotype D4 viral isolates that were imported into the US during 2007-2010. Viral isolates with and without indels produced plaques of similar size and replicated efficiently in A549/hSLAM and Vero/hSLAM cells. This is the first report of wild-type MeVs with genome lengths other than 15,894 nt and demonstrates that the length of the M-F UTR of wild-type MeVs is flexible.	[Bankamp, Bettina; Liu, Chunyu; Rivailler, Pierre; Bellini, William J.; Rota, Paul A.] Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpes Virus Lab Branch, Atlanta, GA 30333 USA; [Liu, Chunyu] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Liu, Chunyu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Bera, Jayati; Shrivastava, Susmita; Kirkness, Ewen F.] J Craig Venter Inst, Rockville, MD USA	Centers for Disease Control & Prevention - USA; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; J. Craig Venter Institute	Bankamp, B (corresponding author), Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpes Virus Lab Branch, Atlanta, GA 30333 USA.	bbankamp@cdc.gov			National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2008, J VIROL, V82, P10510, DOI 10.1128/JVI.01419-08; Anderson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031561; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P242; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P73; BACZKO K, 1988, J INFECT DIS, V158, P144, DOI 10.1093/infdis/158.1.144; Baricevic M, 2007, VIRUS GENES, V35, P17, DOI 10.1007/s11262-006-0035-2; Barikamp B, 2008, VIROLOGY, V373, P39, DOI 10.1016/j.virol.2007.11.025; BELLINI WJ, 1986, J VIROL, V58, P408, DOI 10.1128/JVI.58.2.408-416.1986; Brandler S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000096; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Cathomen T, 1995, VIROLOGY, V214, P628, DOI 10.1006/viro.1995.0075; CATTANEO R, 1993, J VIROL, V67, P1493, DOI 10.1128/JVI.67.3.1493-1502.1993; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; CATTANEO R, 1988, J VIROL, V62, P1388, DOI 10.1128/JVI.62.4.1388-1397.1988; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; Denver DR, 2004, J MOL EVOL, V58, P584, DOI 10.1007/s00239-004-2580-4; Dong J, 2009, VIRUS GENES, V39, P330, DOI 10.1007/s11262-009-0408-4; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; Hashimoto K, 2002, J VIROL, V76, P6743, DOI 10.1128/JVI.76.13.6743-6749.2002; Heider A, 1997, ARCH VIROL, V142, P2521, DOI 10.1007/s007050050259; Hierholzer J, 1996, VIROLOGY METHODS MAN, P24; Iankov ID, 2013, VACCINE, V31, P4795, DOI 10.1016/j.vaccine.2013.07.085; Kessler JR, 2011, J CLIN MICROBIOL, V49, P677, DOI 10.1128/JCM.01703-10; Knol MJ, 2013, EUROSURVEILLANCE, V18; Kremer JR, 2008, EMERG INFECT DIS, V14, P107, DOI 10.3201/eid1401.070778; Li K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-261; Li K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-191; LIEBERT UG, 1986, J GEN VIROL, V67, P2435, DOI 10.1099/0022-1317-67-11-2435; Liu X, 2006, VIRUS RES, V122, P78, DOI 10.1016/j.virusres.2006.06.014; Mankertz A, 2011, EMERG INFECT DIS, V17, P1396, DOI 10.3201/eid1708.101994; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; RICHARDSON C, 1986, VIROLOGY, V155, P508, DOI 10.1016/0042-6822(86)90212-6; Rima BK, 2009, CURR TOP MICROBIOL, V329, P77; Roberts A.R.G.D.P., 2013, FIELDS VIROLOGY, V6th, P957; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Rota PA, 2011, J INFECT DIS, V204, pS506, DOI 10.1093/infdis/jir117; SCHMID A, 1992, VIROLOGY, V188, P910, DOI 10.1016/0042-6822(92)90552-Z; Schrag SJ, 1999, J VIROL, V73, P51, DOI 10.1128/JVI.73.1.51-54.1999; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Takeda M, 1998, J VIROL, V72, P8690, DOI 10.1128/JVI.72.11.8690-8696.1998; Takeuchi K, 2000, VIRUS GENES, V20, P253, DOI 10.1023/A:1008196729676; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Valsamakis A, 1998, J VIROL, V72, P7754, DOI 10.1128/JVI.72.10.7754-7761.1998; VIDAL S, 1990, EMBO J, V9, P2017, DOI 10.1002/j.1460-2075.1990.tb08330.x; Wairagkar N, 2011, J INFECT DIS, V204, pS403, DOI 10.1093/infdis/jir150; Wang SL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-451; Wernegreen JJ, 2010, MOL BIOL EVOL, V27, P833, DOI 10.1093/molbev/msp290; Zhang XM, 2013, J VIROL, V87, P2686, DOI 10.1128/JVI.02146-12	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95470	10.1371/journal.pone.0095470	http://dx.doi.org/10.1371/journal.pone.0095470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748123	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500105
J	Lyksborg, M; Siebner, HR; Sorensen, PS; Blinkenberg, M; Parker, GJM; Dogonowski, AM; Garde, E; Larsen, R; Dyrby, TB				Lyksborg, Mark; Siebner, Hartwig R.; Sorensen, Per S.; Blinkenberg, Morten; Parker, Geoff J. M.; Dogonowski, Anne-Marie; Garde, Ellen; Larsen, Rasmus; Dyrby, Tim B.			Secondary Progressive and Relapsing Remitting Multiple Sclerosis Leads to Motor-Related Decreased Anatomical Connectivity	PLOS ONE			English	Article							APPEARING WHITE-MATTER; DISABILITY STATUS SCALE; LESION LOAD; DIFFUSION; MRI; DAMAGE; TRACTOGRAPHY; ASSOCIATION; DISTORTION; FEATURES	Multiple sclerosis (MS) damages central white matter pathways which has considerable impact on disease-related disability. To identify disease-related alterations in anatomical connectivity, 34 patients (19 with relapsing remitting MS (RR-MS), 15 with secondary progressive MS (SP-MS) and 20 healthy subjects underwent diffusion magnetic resonance imaging (dMRI) of the brain. Based on the dMRI, anatomical connectivity mapping (ACM) yielded a voxel-based metric reflecting the connectivity shared between each individual voxel and all other brain voxels. To avoid biases caused by inter-individual brain-shape differences, they were estimated in a spatially normalized space. Voxel-based statistical analyses using ACM were compared with analyses based on the localized microstructural indices of fractional anisotropy (FA). In both RR-MS and SP-MS patients, considerable portions of the motor-related white matter revealed decreases in ACM and FA when compared with healthy subjects. Patients with SP-MS exhibited reduced ACM values relative to RR-MS in the motor-related tracts, whereas there were no consistent decreases in FA between SP-MS and RR-MS patients. Regional ACM statistics exhibited moderate correlation with clinical disability as reflected by the expanded disability status scale (EDSS). The correlation between these statistics and EDSS was either similar to or stronger than the correlation between FA statistics and the EDSS. Together, the results reveal an improved relationship between ACM, the clinical phenotype, and impairment. This highlights the potential of the ACM connectivity indices to be used as a marker which can identify disease related-alterations due to MS which may not be seen using localized microstructural indices.	[Lyksborg, Mark; Siebner, Hartwig R.; Dogonowski, Anne-Marie; Garde, Ellen; Dyrby, Tim B.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Lyksborg, Mark; Larsen, Rasmus] Tech Univ Denmark, Dept Appl Math & Comp Sci, DTU Compute, DK-2800 Lyngby, Denmark; [Sorensen, Per S.; Blinkenberg, Morten] Rigshosp, Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark; [Parker, Geoff J. M.] Univ Manchester, Ctr Imaging Sci, Biomed Imaging Inst, Manchester M13 9PL, Lancs, England; [Parker, Geoff J. M.] Bioxydyn Ltd, Manchester, Lancs, England	University of Copenhagen; Technical University of Denmark; Rigshospitalet; University of Copenhagen; University of Manchester	Lyksborg, M (corresponding author), Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark.	markl@drcmr.dk	Siebner, Hartwig R/G-4052-2016; Dyrby, Tim Bjørn/M-4823-2015; Parker, Geoff/Y-6269-2019	Dyrby, Tim Bjørn/0000-0003-3361-9734; Parker, Geoff/0000-0003-2934-2234; Sorensen, Per Soelberg/0000-0002-2818-3780; Larsen, Rasmus/0000-0001-8507-0523; Garde, Ellen/0000-0002-9906-6880	Danish Council for Strategic Research [2142-08-0039]; Danish Multiple Sclerosis Society [R266-A14682]; Lundbeck Foundation [R59-A5399]; Lundbeck Foundation [R59-2010-5399] Funding Source: researchfish	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Multiple Sclerosis Society; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	The project work was supported by the Danish Council for Strategic Research (grant-nr. 2142-08-0039), the Danish Multiple Sclerosis Society (grant-nr. R266-A14682), and the Lundbeck Foundation (Grant of Excellence: Mapping, Modulation & Modelling the Control of Actions, grant-no. R59-A5399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BINGHAM C, 1974, ANN STAT, V2, P1201, DOI 10.1214/aos/1176342874; Bozzali M, 2013, MULT SCLER; Bozzali M, 2011, NEUROIMAGE, V54, P2045, DOI 10.1016/j.neuroimage.2010.08.069; Cercignani M, 2012, NMR BIOMED, V25, P1224, DOI 10.1002/nbm.2793; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Ciccarelli O, 2003, J NEUROL, V250, P287, DOI 10.1007/s00415-003-0992-5; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Cook PA, 2006, P INT SOC MAG RESON, V14; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Dyrby TB, 2008, NEUROIMAGE, V41, P335, DOI 10.1016/j.neuroimage.2008.02.024; Embleton KV, 2007, P INT SOC MAG RESON, V15; FILIPPI M, 1994, NEUROLOGY, V44, P635, DOI 10.1212/WNL.44.4.635; Filippi M, 2007, J NEUROIMAGING, V17, p3S, DOI 10.1111/j.1552-6569.2007.00129.x; Filippi M, 2011, ARCH NEUROL-CHICAGO, V68, P1514, DOI 10.1001/archneurol.2011.914; Gallo A, 2005, ARCH NEUROL-CHICAGO, V62, P803, DOI 10.1001/archneur.62.5.803; Holodny AI, 2005, ANN NY ACAD SCI, V1064, P88, DOI 10.1196/annals.1340.016; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Logan BR, 2008, HUM BRAIN MAPP, V29, P1379, DOI 10.1002/hbm.20471; MILLER RG, 1977, J AM STAT ASSOC, V72, P779, DOI 10.2307/2286459; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Ozturk A, 2010, MULT SCLER J, V16, P166, DOI 10.1177/1352458509353649; Parker GJM, 2003, LECT NOTES COMPUT SC, V2732, P684; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Preziosa P, 2011, RADIOLOGY, V260, P541, DOI 10.1148/radiol.11110315; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reich DS, 2008, AM J NEURORADIOL, V29, P333, DOI 10.3174/ajnr.A0788; Riahi F, 1998, BRAIN, V121, P1305, DOI 10.1093/brain/121.7.1305; Rocca MA, 2013, J NEUROL, V260, P929, DOI 10.1007/s00415-012-6788-8; ROSENFELD A, 1982, DIGITAL PICTURE PROC, V2; Seunarine KK, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P55, DOI 10.1016/B978-0-12-374709-9.00004-3; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van Hecke W, 2010, J MAGN RESON IMAGING, V31, P1492, DOI 10.1002/jmri.22198; Vry MS, 2012, EXP BRAIN RES, V219, P203, DOI 10.1007/s00221-012-3079-7; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	49	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95540	10.1371/journal.pone.0095540	http://dx.doi.org/10.1371/journal.pone.0095540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748023	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500122
J	Majhi, SK; Hattori, RS; Rahman, SM; Strussmann, CA				Majhi, Sullip Kumar; Hattori, Ricardo Shohei; Rahman, Sheikh Mustafizur; Struessmann, Carlos Augusto			Surrogate Production of Eggs and Sperm by Intrapapillary Transplantation of Germ Cells in Cytoablated Adult Fish	PLOS ONE			English	Article							ODONTESTHES-BONARIENSIS; TESTICULAR CELLS; SPERMATOGENESIS; GENERATION; FERTILITY; CRYOPRESERVATION; DIFFERENTIATION; CONSERVATION; MANIPULATION; RESTORATION	Germ cell transplantation (GCT) is a promising assisted reproductive technology for the conservation and propagation of endangered and valuable genetic resources. In teleost fish, GCT in adult gonads has been achieved only in male recipients, limiting greatly the usefulness of this technique in situations where both sexes need equal and timely attention for conservation and/or propagation. Here we describe a simplified GCT approach that ultimately leads to production of donor-derived eggs and sperm in considerably short time. Donor germ cells isolated from young pejerrey Odontesthes bonariensis (Atherinopsidae) were transplanted non-surgically through the genital papilla into the sexually mature gonads of Patagonian pejerrey O. hatcheri recipients whose gonads have been depleted of endogenous GCs by heat (26 degrees C) and chemical treatment (four doses of Busulfan at 30 mg/kg and 40 mg/kg for females and males, respectively). Transplanted spermatogonial and oogonial cells were able to recolonize the recipients' gonads and produce functional donor origin eggs and sperm within 7 months from the GCT. We confirmed the presence of donor-derived gametes by PCR in 17% and 5% of the surrogate O. hatcheri fathers and mothers, respectively. The crosses between surrogate fathers and O. bonariensis mothers yielded 12.6-39.7% pure O. bonariensis and that between a surrogate mother and an O. bonariensis father yielded 52.2% pure O. bonariensis offspring. Our findings confirm that transplantation of germ cells into sexually competent adult fish by non-surgical methods allows the production of functional donor-derived eggs and sperm in a considerably short time. The methods described here could play a vital role in conservation and rapid propagation of endangered fish genetic resources.	[Majhi, Sullip Kumar; Hattori, Ricardo Shohei; Rahman, Sheikh Mustafizur; Struessmann, Carlos Augusto] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo, Japan; [Majhi, Sullip Kumar] Natl Bur Fish Genet Resources, Div Mol Biol & Biotechnol, Lucknow, Uttar Pradesh, India	Tokyo University of Marine Science & Technology; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Fish Genetic Resources	Majhi, SK (corresponding author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo, Japan.	sullipkm@gmail.com	Hattori, Ricardo S/K-2870-2012; Strussmann, Carlos A/O-1932-2014	Majhi, Dr. Sullip Kumar/0000-0001-9389-7467	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Department of Biotechnology (DBT), Government of India; MEXT; Interuniversity Bio-Backup Project for Basic Biology (IBBP); Grants-in-Aid for Scientific Research [12F02092] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Interuniversity Bio-Backup Project for Basic Biology (IBBP); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Fellowships from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Department of Biotechnology (DBT), Government of India to SKM and a grant from the MEXT and the Interuniversity Bio-Backup Project for Basic Biology (IBBP) to CAS are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2001, AQUACULTURE, V197, P205, DOI 10.1016/S0044-8486(01)00588-9; BILLARD R, 1982, GEN COMP ENDOCR, V48, P33, DOI 10.1016/0016-6480(82)90035-1; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Herrid M, 2006, REPRODUCTION, V132, P617, DOI 10.1530/rep.1.01125; Honaramooz A, 2005, J ANDROL, V26, P698, DOI 10.2164/jandrol.05032; Ito LS, 2003, FISH PHYSIOL BIOCHEM, V28, P421, DOI 10.1023/B:FISH.0000030613.33121.95; Kapuscinski AR, 2005, MINNESOTA SEA GRANT, V20; Lacerda S. M. S. N., 2006, Animal Reproduction, V3, P146; Lacerda SMSN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010740; Lee S, 2013, P NATL ACAD SCI USA, V110, P1640, DOI 10.1073/pnas.1218468110; Ma WZ, 2011, BIOL REPROD, V85, P670, DOI 10.1095/biolreprod.110.089623; Maclean N, 2002, GENE, V295, P265, DOI 10.1016/S0378-1119(02)00735-7; Majhi SK, 2009, THERIOGENOLOGY, V71, P1162, DOI 10.1016/j.theriogenology.2008.12.008; Majhi SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006132; Morita T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097873; Ogawa T, 1999, TISSUE CELL, V31, P461, DOI 10.1054/tice.1999.0060; Okutsu T, 2007, SCIENCE, V317, P1517, DOI 10.1126/science.1145626; Okutsu T, 2006, J REPROD DEVELOP, V52, P685, DOI 10.1262/jrd.18096; Pukazhenthi B, 2006, REPROD FERT DEVELOP, V18, P77, DOI 10.1071/RD05117; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Rodriguez-Sosa JR, 2006, THERIOGENOLOGY, V66, P2091, DOI 10.1016/j.theriogenology.2006.03.039; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Saito T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024460; Shinohara T, 2002, HUM REPROD, V17, P3039, DOI 10.1093/humrep/17.12.3039; Shinomiya A, 2001, J EXP ZOOL, V290, P402, DOI 10.1002/jez.1081; Strussmann CA, 1998, COMP BIOCHEM PHYS A, V119, P637, DOI 10.1016/S1095-6433(97)00477-7; Swanson WR, 2006, THERIOGENOLOGY, V66, P49, DOI 10.1016/j.theriogenology.2006.03.024; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Trefil P, 2006, BIOL REPROD, V75, P575, DOI 10.1095/biolreprod.105.050278; VANDENAARDWEG GJMJ, 1983, RADIAT RES, V94, P447, DOI 10.2307/3575904; Wong TT, 2011, BIOL REPROD, V84, P1190, DOI 10.1095/biolreprod.110.088427; Yazawa R, 2010, BIOL REPROD, V82, P896, DOI 10.1095/biolreprod.109.081281; Yong GP, 1988, ENDOCRINOLOGY, V122, P1047	37	35	39	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95294	10.1371/journal.pone.0095294	http://dx.doi.org/10.1371/journal.pone.0095294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748387	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500079
J	Richard, GF; Viterbo, D; Khanna, V; Mosbach, V; Castelain, L; Dujon, B				Richard, Guy-Franck; Viterbo, David; Khanna, Varun; Mosbach, Valentine; Castelain, Lauriane; Dujon, Bernard			Highly Specific Contractions of a Single CAG/CTG Trinucleotide Repeat by TALEN in Yeast	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; HOMING ENDONUCLEASES; EFFECTOR NUCLEASES; DYNAMIC MUTATIONS; TRIPLET REPEATS; CLEAVAGE DOMAIN; CHROMOSOME-XI	Trinucleotide repeat expansions are responsible for more than two dozens severe neurological disorders in humans. A double-strand break between two short CAG/CTG trinucleotide repeats was formerly shown to induce a high frequency of repeat contractions in yeast. Here, using a dedicated TALEN, we show that induction of a double-strand break into a CAG/CTG trinucleotide repeat in heterozygous yeast diploid cells results in gene conversion of the repeat tract with near 100% efficacy, deleting the repeat tract. Induction of the same TALEN in homozygous yeast diploids leads to contractions of both repeats to a final length of 3-13 triplets, with 100% efficacy in cells that survived the double-strand breaks. Whole-genome sequencing of surviving yeast cells shows that the TALEN does not increase mutation rate. No other CAG/CTG repeat of the yeast genome showed any length alteration or mutation. No large genomic rearrangement such as aneuploidy, segmental duplication or translocation was detected. It is the first demonstration that induction of a TALEN in an eukaryotic cell leads to shortening of trinucleotide repeat tracts to lengths below pathological thresholds in humans, with 100% efficacy and very high specificity.	[Richard, Guy-Franck; Viterbo, David; Khanna, Varun; Mosbach, Valentine; Castelain, Lauriane; Dujon, Bernard] Inst Pasteur, Unite Genet Mol Levures, Dept Genomes & Genet, Paris, France; [Richard, Guy-Franck; Viterbo, David; Khanna, Varun; Mosbach, Valentine; Castelain, Lauriane; Dujon, Bernard] Univ Paris 06, Sorbonne Univ, IFD, Paris, France; [Richard, Guy-Franck; Viterbo, David; Khanna, Varun; Mosbach, Valentine; Castelain, Lauriane; Dujon, Bernard] CNRS, UMR3525, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Richard, GF (corresponding author), Inst Pasteur, Unite Genet Mol Levures, Dept Genomes & Genet, Paris, France.	gfrichar@pasteur.fr	Dujon, Bernard A/F-4971-2010; Richard, Guy-Franck/ABB-9185-2021	Richard, Guy-Franck/0000-0002-8233-3532; Mosbach, Valentine/0000-0002-5538-1061	Association pour la Recherche contre le Cancer (ARC) [SFI20111203641]; ANR blanc; Fondation pour la Recherche Medicale (FRM) [PLP20131028794]	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); ANR blanc(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Association pour la Recherche contre le Cancer (ARC) to G.-F. Richard (grant number: SFI20111203641) and by ANR blanc 2011 (DYGEVO) to B. Dujon. V. Mosbach is the recipient of a doctoral fellowship from the Fondation pour la Recherche Medicale (FRM) (grant number: PLP20131028794). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P1717, DOI 10.1534/g3.113.007260; Beurdeley M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2782; Bhattacharyya S, 2004, MOL CELL BIOL, V24, P7324, DOI 10.1128/MCB.24.17.7324-7330.2004; Blackwood JK, 2010, P NATL ACAD SCI USA, V107, P22582, DOI 10.1073/pnas.1012906108; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Castel AL, 2011, HUM MOL GENET, V20, P1, DOI 10.1093/hmg/ddq427; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Claassen DA, 2007, HUM MOL GENET, V16, P3088, DOI 10.1093/hmg/ddm270; Cleary JD, 2005, TRENDS GENET, V21, P272, DOI 10.1016/j.tig.2005.03.008; Cleary JD, 2010, NAT STRUCT MOL BIOL, V17, P1079, DOI 10.1038/nsmb.1876; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Daboussi F, 2012, NUCLEIC ACIDS RES, V40, P6367, DOI 10.1093/nar/gks268; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dion V, 2008, HUM MOL GENET, V17, P1306, DOI 10.1093/hmg/ddn019; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; FAIRHEAD C, 1994, YEAST, V10, P1403, DOI 10.1002/yea.320101103; FAIRHEAD C, 1993, MOL GEN GENET, V240, P170, DOI 10.1007/BF00277054; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Gomes-Pereira M, 2004, NUCLEIC ACIDS RES, V32, P2865, DOI 10.1093/nar/gkh612; Gorbunova V, 2003, MOL CELL BIOL, V23, P4485, DOI 10.1128/MCB.23.13.4485-4493.2003; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; Huang WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084176; Jung J, 2011, GENETICS, V187, P61, DOI 10.1534/genetics.110.121418; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Kerrest A, 2009, NAT STRUCT MOL BIOL, V16, P159, DOI 10.1038/nsmb.1544; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; KOSTRIKEN R, 1983, CELL, V35, P167, DOI 10.1016/0092-8674(83)90219-2; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lenzmeier BA, 2003, CYTOGENET GENOME RES, V100, P7, DOI 10.1159/000072836; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Mittelman D, 2009, P NATL ACAD SCI USA, V106, P9607, DOI 10.1073/pnas.0902420106; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; OHOY KL, 1993, SCIENCE, V259, P809, DOI 10.1126/science.8094260; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Pinheiro P, 2002, J BIOL CHEM, V277, P35183, DOI 10.1074/jbc.M202235200; Qiu Z, 2013, NUCL ACIDS RES; Redding S., 2014, NATURE; Richard GF, 2000, EMBO REP, V1, P122, DOI 10.1093/embo-reports/kvd031; Richard GF, 1997, RES MICROBIOL, V148, P731, DOI 10.1016/S0923-2508(97)82449-7; Richard GF, 1999, MOL GEN GENET, V261, P871, DOI 10.1007/s004380050031; Richard GF, 2000, EMBO J, V19, P2381, DOI 10.1093/emboj/19.10.2381; Richard GF, 2003, J MOL BIOL, V326, P769, DOI 10.1016/S0022-2836(02)01405-5; Richard GF, 1997, J MOL BIOL, V268, P303, DOI 10.1006/jmbi.1997.0973; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773	74	41	42	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95611	10.1371/journal.pone.0095611	http://dx.doi.org/10.1371/journal.pone.0095611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748175	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500128
J	Nam, TS; Park, KH; Shawl, AI; Kim, BJ; Han, MK; Kim, Y; Moss, J; Kim, UH				Nam, Tae-Sik; Park, Kwang-Hyun; Shawl, Asif Iqbal; Kim, Byung-Ju; Han, Myung-Kwan; Kim, Youngho; Moss, Joel; Kim, Uh-Hyun			Critical Role for NAD Glycohydrolase in Regulation of Erythropoiesis by Hematopoietic Stem Cells through Control of Intracellular NAD Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; MOLECULAR CHARACTERIZATION; NICOTINAMIDE RIBOSIDE; RABBIT ERYTHROCYTES; SKELETAL-MUSCLE; RIBOSYLTRANSFERASE; MEMBRANE; RAT; MOUSE; METABOLISM	NAD glycohydrolases (NADases) catalyze the hydrolysis of NAD to ADP-ribose and nicotinamide. Although many members of the NADase family, including ADP-ribosyltransferases, have been cloned and characterized, the structure and function of NADases with pure hydrolytic activity remain to be elucidated. Here, we report the structural and functional characterization of a novel NADase from rabbit reticulocytes. The novel NADase is a glycosylated, glycosylphosphatidylinositol-anchored cell surface protein exclusively expressed in reticulocytes. shRNA-mediated knockdown of the NADase in bone marrow cells resulted in a reduction of erythroid colony formation and an increase in NAD level. Furthermore, treatment of bone marrow cells with NAD, nicotinamide, or nicotinamide riboside, which induce an increase in NAD content, resulted in a significant decrease in erythroid progenitors. These results indicate that the novel NADase may play a critical role in regulating erythropoiesis of hematopoietic stem cells by modulating intracellular NAD.	[Nam, Tae-Sik; Park, Kwang-Hyun; Shawl, Asif Iqbal; Kim, Byung-Ju; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea; [Nam, Tae-Sik; Park, Kwang-Hyun; Shawl, Asif Iqbal; Kim, Byung-Ju; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju 561182, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561182, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Jeonju 561182, South Korea; [Kim, Youngho] Wonkwang Univ, Sch Med, Dept Biochem, Iksan 570749, South Korea; [Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Wonkwang University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Keumam Dong 561182, Jeonju, South Korea.	uhkim@chonbuk.ac.kr		Han, Myung-Kwan/0000-0003-1931-8898; Kim, Uh-Hyun/0000-0003-3304-7190	National Institutes of Health Intramural Research Program, NHLBI; National Research Foundation - Korean government [2012R1A3A2026453]; Chonbuk National University for the International Collaborative Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NHLBI; National Research Foundation - Korean government(Korean Government); Chonbuk National University for the International Collaborative Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NHLBI (to J. M.). This work was also supported by National Research Foundation Grant 2012R1A3A2026453 funded by the Korean government (to U.-H. K.) and the Chonbuk National University for the International Collaborative Research (2009) (to U.-H. K.).	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Aslesen R, 1998, AM J PHYSIOL-ENDOC M, V275, pE448, DOI 10.1152/ajpendo.1998.275.3.E448; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bortell R, 1999, MOL CELL BIOCHEM, V193, P61, DOI 10.1023/A:1006951809531; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cho YS, 1998, COMP BIOCHEM PHYS B, V120, P175, DOI 10.1016/S0305-0491(98)10006-8; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; FERGUSON MAJ, 1992, BIOCHEM SOC T, V20, P243, DOI 10.1042/bst0200243; Ghosh J, 2010, J BIOL CHEM, V285, P5683, DOI 10.1074/jbc.M109.070300; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hara N, 1996, J BIOL CHEM, V271, P29552, DOI 10.1074/jbc.271.47.29552; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; ISSAAD C, 1993, BLOOD, V81, P2916; KIM UH, 1993, ARCH BIOCHEM BIOPHYS, V305, P147, DOI 10.1006/abbi.1993.1404; KIM UH, 1988, BIOCHIM BIOPHYS ACTA, V965, P76, DOI 10.1016/0304-4165(88)90153-5; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lutton JD, 1997, P NATL ACAD SCI USA, V94, P1432, DOI 10.1073/pnas.94.4.1432; Maehama T, 1996, FEBS LETT, V388, P189, DOI 10.1016/0014-5793(96)00568-6; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; Okazaki IJ, 1996, J BIOL CHEM, V271, P22052, DOI 10.1074/jbc.271.36.22052; Okazaki IJ, 1996, BLOOD, V88, P915; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; OKAZAKI IJ, 1994, BIOCHEMISTRY-US, V33, P12828, DOI 10.1021/bi00209a014; TAKADA T, 1994, J BIOL CHEM, V269, P9420; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; UDENFRIEND S, 1992, CELL MOL BIOL, V38, P11; Weng BY, 1999, J BIOL CHEM, V274, P31797, DOI 10.1074/jbc.274.45.31797; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Ziegler M, 1996, BIOCHEMISTRY-US, V35, P5207, DOI 10.1021/bi9527698; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352	34	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16362	16373		10.1074/jbc.M114.560359	http://dx.doi.org/10.1074/jbc.M114.560359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24759100	hybrid, Green Published			2022-12-25	WOS:000337965700039
J	Kim, MJ; Frausto, RF; Rosenwasser, GOD; Bui, T; Le, DJ; Stone, EM; Aldave, AJ				Kim, Michelle J.; Frausto, Ricardo F.; Rosenwasser, George O. D.; Bui, Tina; Le, Derek J.; Stone, Edwin M.; Aldave, Anthony J.			Posterior Amorphous Corneal Dystrophy Is Associated with a Deletion of Small Leucine-rich Proteoglycans on Chromosome 12	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; KERATAN SULFATE; SKIN FRAGILITY; PLANA; KERATOCAN; MUTATION; LUMICAN; DECORIN; FAMILY; GENE	Posterior amorphous corneal dystrophy (PACD) is a rare, autosomal dominant disorder affecting the cornea and iris. Next-generation sequencing of the previously identified PACD linkage interval on chromosome 12q21.33 failed to yield a pathogenic mutation. However, array-based copy number analysis and qPCR were used to detect a hemizygous deletion in the PACD linkage interval containing 4 genes encoding small leucine-rich proteoglycans (SLRPs): KERA, LUM, DCN, and EPYC. Two other unrelated families with PACD also demonstrated deletion of these SLRPs, which play important roles in collagen fibrillogenesis and matrix assembly. Given that these genes are essential to the maintenance of corneal clarity and the observation that knockout murine models display corneal phenotypic similarities to PACD, we provide convincing evidence that PACD is associated with haploinsufficiency of these SLRPs.	[Kim, Michelle J.; Frausto, Ricardo F.; Bui, Tina; Le, Derek J.; Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA; [Rosenwasser, George O. D.] Cent Penn Eye Inst, Hershey, PA USA; [Stone, Edwin M.] Univ Iowa Hosp & Clin, Dept Ophthalmol, Iowa City, IA 52242 USA; [Stone, Edwin M.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Iowa; Howard Hughes Medical Institute	Aldave, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.	aldave@jsei.ucla.edu	Frausto, Ricardo/AAE-3146-2021	Frausto, Ricardo/0000-0003-3064-6745; Stone, Edwin M./0000-0003-3343-4414	Research to Prevent Blindness (RPB); NATIONAL EYE INSTITUTE [R01EY022082] Funding Source: NIH RePORTER	Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This was funded by an unrestricted grant from Research to Prevent Blindness (RPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2007, OPHTHALMIC GENET, V28, P57, DOI 10.1080/13816810701351321; Aldave AJ, 2010, INVEST OPHTH VIS SCI, V51, P4006, DOI 10.1167/iovs.09-4067; Branco BC, 2002, CORNEA, V21, P220, DOI 10.1097/00003226-200203000-00020; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Bredrup C, 2010, INVEST OPHTH VIS SCI, V51, P5578, DOI 10.1167/iovs.09-4933; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; CARPEL EF, 1977, AM J OPHTHALMOL, V83, P629, DOI 10.1016/0002-9394(77)90127-1; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868; Conrad AH, 2003, MATRIX BIOL, V22, P323, DOI 10.1016/S0945-053X(03)00039-8; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Day-Williams AG, 2011, GENET EPIDEMIOL, V35, P360, DOI 10.1002/gepi.20584; Deere M, 1999, GENOME RES, V9, P449; DUNN SP, 1984, ARCH OPHTHALMOL-CHIC, V102, P236; Ebenezer ND, 2005, ARCH OPHTHALMOL-CHIC, V123, P1248, DOI 10.1001/archopht.123.9.1248; Erdem U, 2007, CLIN EXP OPHTHALMOL, V35, P99, DOI 10.1111/j.1442-9071.2007.01426.x; GRIMM BB, 1995, AM J OPHTHALMOL, V120, P448, DOI 10.1016/S0002-9394(14)72658-3; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; JOHNSON AT, 1990, OPHTHALMOLOGY, V97, P104; Johnson J, 1999, DEV DYNAM, V216, P499, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<499::AID-DVDY18>3.0.CO;2-S; Khan AO, 2005, BRIT J OPHTHALMOL, V89, P1538, DOI 10.1136/bjo.2005.073510; Khan Arif, 2004, Ophthalmic Genet, V25, P147, DOI 10.1080/13816810490514397; Khan AO, 2006, OPHTHALMOLOGY, V113, P1773, DOI 10.1016/j.ophtha.2006.04.026; Khan AO, 2009, OPHTHALMIC GENET, V30, P142, DOI 10.1080/13816810902937084; Lehmann OJ, 2001, INVEST OPHTH VIS SCI, V42, P3118; Liskova P, 2007, MOL VIS, V13, P1339; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Moshegov CN, 1996, OPHTHALMOLOGY, V103, P474; Nuka S, 2010, OSTEOARTHR CARTILAGE, V18, P88, DOI 10.1016/j.joca.2009.11.006; Oliveira Lauro Augusto de, 2006, Arq Bras Oftalmol, V69, P945; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; Rodahl E, 2006, AM J OPHTHALMOL, V142, P520, DOI 10.1016/j.ajo.2006.03.064; ROTH SI, 1992, CORNEA, V11, P165, DOI 10.1097/00003226-199203000-00013; Saika S, 2003, INVEST OPHTH VIS SCI, V44, P2094, DOI 10.1167/iovs.02-1059; SiglerVillanueva A, 1997, OPHTHALMIC GENET, V18, P55, DOI 10.3109/13816819709057116; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Tocyap ML, 2006, AM J OPHTHALMOL, V141, P566, DOI 10.1016/j.ajo.2005.09.024; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhang YT, 2005, INVEST OPHTH VIS SCI, V46, P1604, DOI 10.1167/iovs.04-1453	47	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95037	10.1371/journal.pone.0095037	http://dx.doi.org/10.1371/journal.pone.0095037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759697	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200030
J	Ye, F; Cheng, Q; Shen, JJ; Zhou, CY; Chen, HZ				Ye, Feng; Cheng, Qi; Shen, Jiajie; Zhou, Caiyun; Chen, Huaizeng			Mismatch Repair Gene MLH3 Pro844Leu and Thr942Ile Polymorphisms and the Susceptibility to Cervical Carcinoma and HPV Infection: A Case-Control Study in a Chinese Population	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS; LYNCH SYNDROME; ASSOCIATION; VARIANTS; RISK; MUTATIONS	To investigate the association between MLH3 Pro844Leu, Thr942Ile polymorphisms and potential linkage with the risk of cervical carcinoma and potential effect on protein function, we carried out a case-control study with 400 cervical squamous cell carcinoma, 400 CIN3 and 1200 normal controls in a Chinese population. The results showed that there was an increased risk of cervical carcinoma and CIN3 associated with the genotype 844CT [OR 2.17 (1.61-2.94); P<0.001; OR 1.49 (1.08-2.07), P 0.017, respectively] and a decreased risk with the 942CT genotype [OR 0.56 (0.38-0.82); P<0.001; OR 0.37 (0.24-0.58), P<0.001, respectively]. Most 844CT genotypes were linkage CT(844)-CC(942), which increased the risk of cervical carcinoma and CIN3 [77/83, OR 2.04 (1.48-2.80), P<0.001; 55/61, OR 1.46 (1.03-2.06), P 0.035, respectively]. Most 942CT were linkage CC(844)-CT(942), which decreased the risk of cervical carcinoma [29/35, OR 0.60 (0.40-0.91); P 0.017; 18/24, OR 0.33 (0.20-0.55), P<0.001, respectively]. In some grouping, the 844CT and 942CT were further enriched; especially HR-HPV-positive subjects both in the CIN3 and the cervical carcinoma, the 844CT had greater enrichment. These results included that CT(844)-CC(942) was associated with a high risk of cervical carcinoma and CIN3, and the CC(844)-CT(942) decreased the risk. The 844CT had a higher level of enrichment in HR-HPV positive individuals, which is probably related to HR-HPV susceptibility. There was no significant difference of the MLH3 mRNA expression and these two amino acid substitutions did not impact on the protein function.	[Ye, Feng; Cheng, Qi; Shen, Jiajie; Chen, Huaizeng] Zhejiang Univ, Sch Med, Womens Reprod Hlth Key Lab Zhejiang Prov, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Caiyun] Zhejiang Univ, Sch Med, Womens Hosp, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, HZ (corresponding author), Zhejiang Univ, Sch Med, Womens Reprod Hlth Key Lab Zhejiang Prov, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	chenhz@zju.edu.cn			Zhejiang Natural Science Foundation of China [Y2110200]; National Nature Science foundation of China [30973380]	Zhejiang Natural Science Foundation of China; National Nature Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Zhejiang Natural Science Foundation of China (Y2110200, http://www.zjnsf.gov.cn/), and from National Nature Science foundation of China (No. 30973380, http:// www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Chen PC, 2005, CANCER RES, V65, P8662, DOI 10.1158/0008-5472.CAN-05-0742; Chen PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000092; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; de Jong MM, 2004, CANCER GENET CYTOGEN, V152, P70, DOI 10.1016/j.cancergencyto.2003.10.008; Fishel R, 2001, CANCER RES, V61, P7369; Giarnieri E, 2000, CLIN CANCER RES, V6, P3600; He XH, 2008, PATHOBIOLOGY, V75, P356, DOI 10.1159/000164220; Hienonen T, 2003, INT J CANCER, V106, P292, DOI 10.1002/ijc.11218; Kisseljov F, 2008, INT REV CEL MOL BIO, V271, P35, DOI 10.1016/S1937-6448(08)01202-1; Korhonen MK, 2008, GENE CHROMOSOME CANC, V47, P803, DOI 10.1002/gcc.20581; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Liu HX, 2006, WORLD J GASTROENTERO, V12, P5281, DOI 10.3748/wjg.v12.i33.5281; Liu HX, 2003, CANCER RES, V63, P1894; Muller A, 2003, IN VIVO, V17, P55; Ou JH, 2009, GENE CHROMOSOME CANC, V48, P340, DOI 10.1002/gcc.20644; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Rodriguez JA, 1998, DIAGN MOL PATHOL, V7, P276, DOI 10.1097/00019606-199810000-00007; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Taylor NP, 2006, CANCER RES, V66, P7502, DOI 10.1158/0008-5472.CAN-06-0248; Thomison J, 2008, HUM PATHOL, V39, P154, DOI 10.1016/j.humpath.2007.11.002; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037446	27	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96224	10.1371/journal.pone.0096224	http://dx.doi.org/10.1371/journal.pone.0096224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759751	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200148
J	Finley, BJ; Kilkki, K				Finley, Benjamin J.; Kilkki, Kalevi			Exploring Empirical Rank-Frequency Distributions Longitudinally through a Simple Stochastic Process	PLOS ONE			English	Article							MODEL	The frequent appearance of empirical rank-frequency laws, such as Zipf's law, in a wide range of domains reinforces the importance of understanding and modeling these laws and rank-frequency distributions in general. In this spirit, we utilize a simple stochastic cascade process to simulate several empirical rank-frequency distributions longitudinally. We focus especially on limiting the process's complexity to increase accessibility for non-experts in mathematics. The process provides a good fit for many empirical distributions because the stochastic multiplicative nature of the process leads to an often observed concave rank-frequency distribution (on a log-log scale) and the finiteness of the cascade replicates realworld finite size effects. Furthermore, we show that repeated trials of the process can roughly simulate the longitudinal variation of empirical ranks. However, we find that the empirical variation is often less that the average simulated process variation, likely due to longitudinal dependencies in the empirical datasets. Finally, we discuss the process limitations and practical applications.	[Finley, Benjamin J.; Kilkki, Kalevi] Aalto Univ, Dept Commun & Networking, Espoo, Finland	Aalto University	Finley, BJ (corresponding author), Aalto Univ, Dept Commun & Networking, Espoo, Finland.	benjamin.finley@aalto.fi			general department funding at Aalto University	general department funding at Aalto University	The funding was derived from general department funding at Aalto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DIG LIB MATH FUNCT; Bergstra J, AUDIOSCROBBLER DATA; Bertoin J., 2006, RANDOM FRAGMENTATION; Borgos H. G., 2000, STOCHASTIC MODELING; Box Office Mojo, YEARL BOX OFF IMDB; Box Office Mojo, 2013, BOX OFF TRACK TIM; Capocci A., 2006, PHYS REV E, V74; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dettmann CP, 2009, STAT PROBABIL LETT, V79, P2501, DOI 10.1016/j.spl.2009.09.004; Dwyer S, 2010, PANDORAS BOX OFFICE; Egghe L, 2011, INFORM PROCESS MANAG, V47, P238, DOI 10.1016/j.ipm.2010.03.009; Frisch U, 1997, J PHYS I, V7, P1155, DOI 10.1051/jp1:1997114; Glen A. G., 1997, INFORMS Journal on Computing, V9, P288, DOI 10.1287/ijoc.9.3.288; Glen AG, 2004, COMPUT STAT DATA AN, V44, P451, DOI 10.1016/S0167-9473(02)00234-7; Goel S, 2010, P 3 ACM INT C WEB SE; Hernandez G, 2003, PHYSICA A, V323, P1, DOI 10.1016/S0378-4371(03)00032-3; Herrada OC, 2008, MUSIC RECOMMENDATION; Judge G, 2012, SHAPE INTERPRETATION; Kilkki K, 2007, 1 MONDAY, P12; Kolmogorov A.N., 1941, REP ACAD SCI USSR, V31, P99; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Li WT, 2010, ENTROPY-SWITZ, V12, P1743, DOI 10.3390/e12071743; LLOYD CJ, 1988, STOCH PROC APPL, V28, P111, DOI 10.1016/0304-4149(88)90069-5; Martinez-Mekler G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004791; Mathworks, 2013, INV INC GAMM FUNCT; Naumis GG, 2008, PHYSICA A, V387, P84, DOI 10.1016/j.physa.2007.08.002; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Peltier S, 2010, P 16 ACEI INT C; Rose C, 2006, P 17 INT C COMP STAT; Saichev A., 2009, THEORY ZIPFS LAW; SIEGEL AF, 1983, J APPL PROBAB, V20, P158, DOI 10.2307/3213730; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; The Association of Magazine Media, CIRC TRENDS DAT; Toivonen R, 2006, PHYSICA A, V371, P851, DOI 10.1016/j.physa.2006.03.050; University of Massachusetts Amherst, UMASS TRAC REP; US Census Bureau, 2000, GEN DAT FREQ OCC SUM; Van der Veert AW, 1998, ASYMPTOTIC STAT; Wolfram, 2013, INVERSEGAMMAREGULARI; Zink M, 2008, P SPIE, V6818; Zipf G. K., 1935, PSYCHOBIOLOGY LANGUA	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e94920	10.1371/journal.pone.0094920	http://dx.doi.org/10.1371/journal.pone.0094920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755621	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300022
J	Kumar, P; Rathi, P; Schottner, M; Baldwin, IT; Pandit, S				Kumar, Pavan; Rathi, Preeti; Schoettner, Matthias; Baldwin, Ian T.; Pandit, Sagar			Differences in Nicotine Metabolism of Two Nicotiana attenuata Herbivores Render Them Differentially Susceptible to a Common Native Predator	PLOS ONE			English	Article							TOBACCO HORNWORM; DIETARY NICOTINE; PYRROLIZIDINE ALKALOIDS; HOST-SPECIFICITY; INSECT HERBIVORE; MANDUCA-SEXTA; PLANT; GENERALIST; LEPIDOPTERA; SPECIALIST	Background: Nicotiana attenuata is attacked by larvae of both specialist (Manduca sexta) and generalist (Spodoptera exigua) lepidopteran herbivores in its native habitat. Nicotine is one of N. attenuata's important defenses. M. sexta is highly nicotine tolerant; whether cytochrome P450 (CYP)-mediated oxidative detoxification and/or rapid excretion is responsible for its exceptional tolerance remains unknown despite five decades of study. Recently, we demonstrated that M. sexta uses its nicotine-induced CYP6B46 to efflux midgut-nicotine into the hemolymph, facilitating nicotine exhalation that deters predatory wolf spiders (Camptocosa parallela). S. exigua's nicotine metabolism is uninvestigated. Methodology/Principal Findings: We compared the ability of these two herbivores to metabolize, tolerate and co-opt ingested nicotine for defense against the wolf spider. In addition, we analyzed the spider's excretion to gain insights into its nicotine metabolism. Contrary to previous reports, we found that M. sexta larvae neither accumulate the common nicotine oxides (cotinine, cotinine N-oxide and nicotine N-oxide) nor excrete them faster than nicotine. In M. sexta larvae, ingestion of nicotine as well as its oxides increases the accumulation of CYP6B46 transcripts. In contrast, S. exigua accumulates nicotine oxides and exhales less (66%) nicotine than does M. sexta. Spiders prefer nicotine-fed S. exigua over M. sexta, a preference reversed by topical or headspace nicotine supplementation, but not ingested or topically-coated nicotine oxides, suggesting that externalized nicotine but not the nicotine detoxification products deter spider predation. The spiders also do not accumulate nicotine oxides. Conclusions: Nicotine oxidation reduces S. exigua's headspace-nicotine and renders it more susceptible to predation by spiders than M. sexta, which exhales unmetabolized nicotine. These results are consistent with the hypothesis that generalist herbivores incur costs of detoxification, which include the ecological costs of greater predation risks, in addition to the previously demonstrated energetic, physiological and metabolic costs.	[Kumar, Pavan; Rathi, Preeti; Schoettner, Matthias; Baldwin, Ian T.; Pandit, Sagar] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Pandit, S (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	spandit@ice.mpg.de	Baldwin, Ian T/K-1809-2013	Baldwin, Ian/0000-0001-5371-2974; kumar, Pavan/0000-0003-4718-3601	Max Plank Society; European Research Council [293926]; National Research Foundation of Korea [2012055546]; DAAD	Max Plank Society(Max Planck Society); European Research Council(European Research Council (ERC)European Commission); National Research Foundation of Korea(National Research Foundation of Korea); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	PK acknowledges the DAAD for doctoral fellowship. The authors acknowledge the financial support from the Max Plank Society, the European Research Council advanced grant ClockworkGreen (No. 293926) to ITB and the Global Research Lab program (2012055546) from the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL HM, 1992, ECOLOGY, V73, P216, DOI 10.2307/1938733; Bass C, 2013, P NATL ACAD SCI USA, V110, P19460, DOI 10.1073/pnas.1314122110; BENTZ JA, 1990, ENTOMOL EXP APPL, V57, P1, DOI 10.1007/BF00349589; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bowers M.D., 1992, P216; Cianfrogna JA, 2002, J CHEM ECOL, V28, P1349, DOI 10.1023/A:1016292317948; CORNELIUS ML, 1995, J INSECT BEHAV, V8, P579, DOI 10.1007/BF01997232; CRAIG JC, 1970, J ORG CHEM, V35, P1721, DOI 10.1021/jo00830a121; CRESSWELL JE, 1992, OECOLOGIA, V89, P449, DOI 10.1007/BF00317425; DAGNE E, 1972, J MED CHEM, V15, P840, DOI 10.1021/jm00278a011; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; DYER LA, 1995, ECOLOGY, V76, P1483, DOI 10.2307/1938150; EISNER T, 1981, SCIENCE, V213, P476, DOI 10.1126/science.7244647; EISNER T, 1991, Psyche (Cambridge), V98, P111, DOI 10.1155/1991/95350; Garcia-Robledo C, 2012, J EVOLUTION BIOL, V25, P38, DOI 10.1111/j.1420-9101.2011.02401.x; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Greenberg SM, 2001, ANN ENTOMOL SOC AM, V94, P566, DOI 10.1603/0013-8746(2001)094[0566:FALHOS]2.0.CO;2; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Hartmann T, 2004, PLANTA, V219, P1, DOI 10.1007/s00425-004-1249-y; Hartmann T, 2004, J CHEM ECOL, V30, P229, DOI 10.1023/B:JOEC.0000017975.16399.c3; Hartmann Thomas, 2008, P213, DOI 10.1007/978-1-4020-8182-8_10; Harvey JA, 2007, ECOL ENTOMOL, V32, P15, DOI 10.1111/j.1365-2311.2006.00838.x; Hodgson E, 1985, COMPREHENSIVE INSECT, P225; Johnson KS, 1999, J CHEM ECOL, V25, P253, DOI 10.1023/A:1020890628279; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Kumar P, 2014, P NATL ACAD SCI USA, V111, P1245, DOI 10.1073/pnas.1314848111; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; MADDRELL SHP, 1976, J EXP BIOL, V64, P267; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; MORRIS CE, 1983, J INSECT PHYSIOL, V29, P807, DOI 10.1016/0022-1910(83)90146-4; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; Pentzold S, 2013, BIOL REV; Rayapuram C, 2006, PLANT CELL ENVIRON, V29, P1585, DOI 10.1111/j.1365-3040.2006.01534.x; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072678, 10.1371/journal.pone.0058568]; Schramm K, 2012, INSECT BIOCHEM MOLEC, V42, P174, DOI 10.1016/j.ibmb.2011.12.002; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; SELF LS, 1964, NATURE, V204, P300, DOI 10.1038/204300a0; SELF LS, 1964, J INSECT PHYSIOL, V10, P907, DOI 10.1016/0022-1910(64)90081-2; Singer MS, 2003, OIKOS, V100, P554, DOI 10.1034/j.1600-0706.2003.11720.x; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; SNYDER MJ, 1993, J CHEM ECOL, V19, P2903, DOI 10.1007/BF00980591; SNYDER MJ, 1994, INSECT BIOCHEM MOLEC, V24, P837, DOI 10.1016/0965-1748(94)90112-0; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Tautz J, 2008, CURR BIOL, V18, pR1125, DOI 10.1016/j.cub.2008.10.038; Trigo JR, 2011, PHYTOCHEM REV, V10, P83, DOI 10.1007/s11101-010-9191-z; Voelckel C, 2001, CHEMOECOLOGY, V11, P121, DOI 10.1007/PL00001841; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; WHITTAKER RH, 1971, SCIENCE, V171, P757, DOI 10.1126/science.171.3973.757; Winde I, 2011, PHYTOCHEMISTRY, V72, P1566, DOI 10.1016/j.phytochem.2011.01.016; Wink M, 2002, CHEMOECOLOGY, V12, P29, DOI 10.1007/s00049-002-8324-2; Winz RA, 2001, PLANT PHYSIOL, V125, P2189, DOI 10.1104/pp.125.4.2189	55	15	15	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95982	10.1371/journal.pone.0095982	http://dx.doi.org/10.1371/journal.pone.0095982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755743	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300128
J	Riccio, E; Cataldi, M; Minco, M; Argentino, G; Russo, R; Brancaccio, S; Memoli, A; Grumetto, L; Postiglione, L; Guida, B; Memoli, B				Riccio, Eleonora; Cataldi, Mauro; Minco, Maristella; Argentino, Gennaro; Russo, Roberta; Brancaccio, Stefania; Memoli, Andrea; Grumetto, Lucia; Postiglione, Loredana; Guida, Bruna; Memoli, Bruno			Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients?	PLOS ONE			English	Article							UREMIC TOXINS; CARDIOVASCULAR MORTALITY; PLASMA INTERLEUKIN-6; RETENTION SOLUTE; TNF-ALPHA; HEMODIALYSIS; REMOVAL; HEMODIAFILTRATION; HEMOFILTRATION; CLEARANCE	Introduction: Hemodialysis (HD) and hemodiafiltration clear only with a low efficiency the plasma from interleukin-6 and p-cresol, two protein-bound uremic toxins associated with high cardiovascular risk in end stage renal disease. HFR Supra is a double-chamber hemodiafiltration system in which the ultrafiltrate returns to the patient after its regeneration through a resin cartridge that binds hydrophobic and protein-bound solutes. In the present study, we evaluated whether the HFR cartridge can also bind total p-cresol and IL-6 and remove them from the ultrafiltrate. Methods: We compared the levels of IL-6 and p-cresol in ultrafiltrate samples collected at the inlet (UFin) and at the outlet (UFout) of the cartridge at the start or at the end of a 240 min HFR session in 12 inflamed chronic HD patients. The pro-inflammatory activity of the ultrafiltrate samples was also determined by evaluating the changes that they induced in IL-6 mRNA expression and protein release in peripheral blood mononuclear cells from 12 healthy volunteers. IL-6 and p-cresol circulating levels were also assessed in peripheral plasma blood samples collected before and after HFR and, for comparison, a control HD. Results: p-Cresol and IL-6 were lower in UFout than in UFin both at the start and at the end of the HFR session, suggesting that they were retained by the cartridge. IL-6 mRNA expression and release were lower in PBMC incubated with UFout collected at the end than with UFin collected at the start of HFR, suggesting that passage through the cartridge reduced UF pro-inflammatory activity. Plasma total p-cresol decreased by about 53% after HFR, and 37% after HD. IL-6 circulating values were unmodified by either these dialysis procedures. Conclusions: This study shows that the HFR-Supra cartridge retains total p-cresol and IL-6 in the ultrafiltrate and lowers plasma total p-cresol but not IL-6 levels.	[Riccio, Eleonora; Minco, Maristella; Argentino, Gennaro; Russo, Roberta; Brancaccio, Stefania; Memoli, Andrea; Memoli, Bruno] Univ Naples Federico II, Nephrol Sect, Dept Publ Hlth, Naples, Italy; [Cataldi, Mauro] Univ Naples Federico II, Pharmacol Sect, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Grumetto, Lucia] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Naples, Italy; [Postiglione, Loredana] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Guida, Bruna] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Memoli, B (corresponding author), Univ Naples Federico II, Nephrol Sect, Dept Publ Hlth, Naples, Italy.	memoli@unina.it	Cataldi, Mauro/AAB-3642-2019	Cataldi, Mauro/0000-0001-7787-3406; Grumetto, Lucia/0000-0002-3529-1819				Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Bologa RM, 1998, AM J KIDNEY DIS, V32, P107, DOI 10.1053/ajkd.1998.v32.pm9669431; Calaf R, 2011, J CHROMATOGR B, V879, P2281, DOI 10.1016/j.jchromb.2011.06.014; Calo LA, 2007, NEPHROL DIAL TRANSPL, V22, P1413, DOI 10.1093/ndt/gfl783; Cerini C, 2004, THROMB HAEMOSTASIS, V92, P140, DOI 10.1160/th03-07-0491; Cozzolino M, 2005, KIDNEY INT, V68, P429, DOI 10.1111/j.1523-1755.2005.00421.x; CUMMINGS JH, 1983, LANCET, V1, P1206; de Francisco ALM, 2000, KIDNEY INT, V58, pS66, DOI 10.1046/j.1523-1755.2000.07608.x; De Nitti C, 2001, INT J ARTIF ORGANS, V24, P765, DOI 10.1177/039139880102401102; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Ghezzi P M, 1992, ASAIO J, V38, P61, DOI 10.1097/00002480-199201000-00015; Guida B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073558; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Krieter DH, 2010, NEPHROL DIAL TRANSPL, V25, P212, DOI 10.1093/ndt/gfp437; Lesaffer G, 2000, NEPHROL DIAL TRANSPL, V15, P50, DOI 10.1093/ndt/15.1.50; Levin A, 2002, KIDNEY INT, V61, pS35, DOI 10.1046/j.1523-1755.61.s80.7.x; Martinez AW, 2005, J AM SOC NEPHROL, V16, P3430, DOI 10.1681/ASN.2005030310; Meert N, 2011, NEPHROL DIAL TRANSPL, V26, P2624, DOI 10.1093/ndt/gfq803; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BK, 2008, ARTIF ORGANS, V32, P214, DOI 10.1111/j.1525-1594.2007.00525.x; Meijers BKI, 2009, CLIN J AM SOC NEPHRO, V4, P1932, DOI 10.2215/CJN.02940509; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Memoli B, 2005, J AM SOC NEPHROL, V16, P1099, DOI 10.1681/ASN.2004080628; Memoli B, 2003, CONTRIB NEPHROL, V138, P80; Memoli B, 2000, KIDNEY INT, V58, P417, DOI 10.1046/j.1523-1755.2000.00181.x; Memoli B, 2010, CLIN SCI, V119, P163, DOI 10.1042/CS20090634; Meyer TW, 2007, J AM SOC NEPHROL, V18, P868, DOI 10.1681/ASN.2006080863; Overbergh L, 2003, J Biomol Tech, V14, P33; Panichi V, 2008, NEPHROL DIAL TRANSPL, V23, P2337, DOI 10.1093/ndt/gfm951; Rao M, 2005, AM J KIDNEY DIS, V45, P324, DOI 10.1053/j.ajkd.2004.09.018; Samak MJ, 2002, CLIN NEPHROL, V57, P327; Sander A, 1997, INTENS CARE MED, V23, P878, DOI 10.1007/s001340050425; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Tarakcioglu M, 2003, MEDIAT INFLAMM, V12, P15, DOI 10.1080/0962935031000096935; Tetta C, 2002, CONTRIB NEPHROL, V137, P212; vanBommel EFH, 1997, RENAL FAILURE, V19, P443, DOI 10.3109/08860229709047730; Vanholder R, 2003, NEPHROL DIAL TRANSPL, V18, P463, DOI 10.1093/ndt/18.3.463; Vanholder R, 2011, NEPHROL DIAL TRANSPL, V26, P1464, DOI 10.1093/ndt/gfr056; Wratten M L, 2004, G Ital Nefrol, V21 Suppl 30, pS67; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Ying Y, 2011, CIRC J, V75, P2252, DOI 10.1253/circj.CJ-11-0046; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	50	18	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95811	10.1371/journal.pone.0095811	http://dx.doi.org/10.1371/journal.pone.0095811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755610	Green Published, Green Submitted, gold			2022-12-25	WOS:000335240300100
J	Breitenkamp, AFS; Matthes, J; Nass, RD; Sinzig, J; Lehmkuhl, G; Nurnberg, P; Herzig, S				Breitenkamp, Alexandra F. S.; Matthes, Jan; Nass, Robert Daniel; Sinzig, Judith; Lehmkuhl, Gerd; Nuernberg, Peter; Herzig, Stefan			Rare Mutations of CACNB2 Found in Autism Spectrum Disease-Affected Families Alter Calcium Channel Function	PLOS ONE			English	Article							BETA-SUBUNITS; TIMOTHY-SYNDROME; CA2+ CHANNEL; EXPRESSION; GENETICS; INACTIVATION; HETEROGENEITY; LOCALIZATION; MODULATION; ARRHYTHMIA	Autism Spectrum Disorders (ASD) are complex neurodevelopmental diseases clinically defined by dysfunction of social interaction. Dysregulation of cellular calcium homeostasis might be involved in ASD pathogenesis, and genes coding for the L-type calcium channel subunits Ca(V)1.2 (CACNA1C) and Ca-V beta 2 (CACNB2) were recently identified as risk loci for psychiatric diseases. Here, we present three rare missense mutations of CACNB2 (G167S, S197F, and F240L) found in ASD-affected families, two of them described here for the first time (G167S and F240L). All these mutations affect highly conserved regions while being absent in a sample of ethnically matched controls. We suggest the mutations to be of physiological relevance since they modulate whole-cell Ba2+ currents through calcium channels when expressed in a recombinant system (HEK-293 cells). Two mutations displayed significantly decelerated time-dependent inactivation as well as increased sensitivity of voltage-dependent inactivation. In contrast, the third mutation (F240L) showed significantly accelerated time-dependent inactivation. By altering the kinetic parameters, the mutations are reminiscent of the CACNA1C mutation causing Timothy Syndrome, a Mendelian disease presenting with ASD. In conclusion, the results of our first-time biophysical characterization of these three rare CACNB2 missense mutations identified in ASD patients support the hypothesis that calcium channel dysfunction may contribute to autism.	[Breitenkamp, Alexandra F. S.; Matthes, Jan; Nass, Robert Daniel; Herzig, Stefan] Univ Cologne, Dept Pharmacol, D-50931 Cologne, Germany; [Sinzig, Judith] LVR Klin Bonn, Dept Child & Adolescent Psychiat & Psychotherapy, Bonn, Germany; [Sinzig, Judith; Lehmkuhl, Gerd] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Herzig, Stefan] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Herzig, S (corresponding author), Univ Cologne, Dept Pharmacol, D-50931 Cologne, Germany.	stefan.herzig@uni-koeln.de	Matthes, Jan/AAF-1229-2020	Matthes, Jan/0000-0003-2754-1555; Nass, Robert Daniel/0000-0003-4446-8898; Sinzig, Judith/0000-0002-3693-3318; Herzig, Stefan/0000-0001-8107-5204	"Koeln Fortune'' program and DFG [KF 20/2006, KF 93/2007]; German Research Foundation [He 1578 15-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	"Koeln Fortune'' program and DFG; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the "Koeln Fortune'' program (KF 20/2006 and KF 93/2007) and DFG, the German Research Foundation, (He 1578 15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bader PL, 2011, P NATL ACAD SCI USA, V108, P15432, DOI 10.1073/pnas.1112667108; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Ben-David E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002556; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Cens T, 1996, FEBS LETT, V391, P232, DOI 10.1016/0014-5793(96)00704-1; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Jangsangthong W, 2009, PFLUGERS ARCH, V459, P399; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Karmazinova M, 2010, PHYSIOL RES, V59, pS1, DOI 10.33549/physiolres.932000; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Leineweber K, 2007, N-S ARCH PHARMACOL, V375, P303, DOI 10.1007/s00210-007-0166-6; Liao P, 2010, PFLUG ARCH EUR J PHY, V460, P353, DOI 10.1007/s00424-009-0753-0; Limpitikul W, 2013, BIOPHYS J, V104, p459A, DOI 10.1016/j.bpj.2012.11.2538; Lintas C, 2010, J NEUROVIROL, V16, P141, DOI 10.3109/13550281003685839; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Ludwig A, 1997, J NEUROSCI, V17, P1339; McEnery MW, 1998, J BIOENERG BIOMEMBR, V30, P409, DOI 10.1023/A:1021997924473; Miranda-Laferte E, 2012, J BIOL CHEM, V287, P32588, DOI 10.1074/jbc.M112.362509; Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Schleithoff L, 1999, GENOMICS, V61, P201, DOI 10.1006/geno.1999.5941; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; Skafidas E, 2012, MOL PSYCHIATR, DOI [10.1038/mp.2012.1126, DOI 10.1038/MP.2012.1126]; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Strom SP, 2010, MOL PSYCHIATR, V15, P996, DOI 10.1038/mp.2009.41; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Trikalinos TA, 2006, MOL PSYCHIATR, V11, P29, DOI 10.1038/sj.mp.4001750; Volsen SG, 1997, NEUROSCIENCE, V80, P161, DOI 10.1016/S0306-4522(97)00115-2	47	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95579	10.1371/journal.pone.0095579	http://dx.doi.org/10.1371/journal.pone.0095579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752249	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400080
J	Visser, M; van der Walt, AP; Maree, HJ; Rees, DJG; Burger, JT				Visser, Marike; van der Walt, Anelda P.; Maree, Hans J.; Rees, D. Jasper G.; Burger, Johan T.			Extending the sRNAome of Apple by Next-Generation Sequencing	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; TRANS-ACTING SIRNAS; MALUS-X-DOMESTICA; SMALL RNAS; GENOME-WIDE; INTERFERING RNA; ARABIDOPSIS; BIOGENESIS; MICRORNAS; EXPRESSION	The global importance of apple as a fruit crop necessitates investigations into molecular aspects of the processes that influence fruit quality and yield, including plant development, fruit ripening and disease resistance. In order to study and understand biological processes it is essential to recognise the range of molecules, which influence these processes. Small non-coding RNAs are regulatory agents involved in diverse plant activities, ranging from development to stress response. The occurrence of these molecules in apple leaves was studied by means of next-generation sequencing. 85 novel microRNA (miRNA) gene loci were predicted and characterized along with known miRNA loci. Both cis- and trans-natural antisense transcript pairs were identified. Although the trans-overlapping regions were enriched in small RNA (sRNA) production, cis-overlaps did not seem to agree. More than 150 phased regions were also identified, and for a small subset of these, potential miRNAs that could initiate phasing, were revealed. Repeat-associated siRNAs, which are generated from repetitive genomic regions such as transposons, were also analysed. For this group almost all available repeat sequences, associated with the apple genome and present in Repbase, were found to produce siRNAs. Results from this study extend our current knowledge on apple sRNAs and their precursors significantly. A rich molecular resource has been created and is available to the research community to serve as a baseline for future studies.	[Visser, Marike; Rees, D. Jasper G.] Agr Res Council, Biotechnol Platform, Pretoria, Gauteng, South Africa; [Visser, Marike; Maree, Hans J.; Burger, Johan T.] Univ Stellenbosch, Dept Genet, ZA-7600 Stellenbosch, Western Cape, South Africa; [van der Walt, Anelda P.] Univ Stellenbosch, Cent Analyt Facil, ZA-7600 Stellenbosch, Western Cape, South Africa; [Maree, Hans J.] Agr Res Council, Infruitec Nietvoorbij, Stellenbosch, Western Cape, South Africa	Agricultural Research Council of South Africa; Stellenbosch University; Stellenbosch University; Agricultural Research Council of South Africa	Burger, JT (corresponding author), Univ Stellenbosch, Dept Genet, ZA-7600 Stellenbosch, Western Cape, South Africa.	jtb@sun.ac.za	Rees, David Jasper Gilbert/AAZ-8073-2020; Maree, Hans J/F-5846-2012	Rees, David Jasper Gilbert/0000-0003-3321-1325; Maree, Hans J/0000-0001-9639-4558; van der Walt, Anelda/0000-0003-4245-8119; Visser, Marike/0000-0001-7087-6073	National Research Foundation (NRF)	National Research Foundation (NRF)	The financial assistance of the National Research Foundation (NRF) towards this research is hereby acknowledged. Opinions expressed and conclusions arrived at, are those of the author and are not necessarily to be attributed to the NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, RNA, V19, P740, DOI 10.1261/rna.035279.112; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen DJ, 2012, NUCLEIC ACIDS RES, V40, pD1187, DOI 10.1093/nar/gkr823; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Henz SR, 2007, PLANT PHYSIOL, V144, P1247, DOI 10.1104/pp.107.100396; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Hu Z, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-280; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kallman T, 2013, PLANT PHYSIOL, V162, P741, DOI 10.1104/pp.113.214643; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krost C, 2013, PLANT MOL BIOL, V81, P211, DOI 10.1007/s11103-012-9992-0; Krost C, 2012, GENE, V498, P223, DOI 10.1016/j.gene.2012.01.078; Kume K, 2010, BIOSCI BIOTECH BIOCH, V74, P1435, DOI 10.1271/bbb.100111; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li Y, 2008, NUCLEIC ACIDS RES, V36, P6048, DOI 10.1093/nar/gkn596; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; Lu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-721; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moldovan D, 2010, J EXP BOT, V61, P165, DOI 10.1093/jxb/erp296; Pedrosa A, 2001, CHROMOSOMA, V110, P203, DOI 10.1007/s004120000125; Quintero Andres, 2013, Genomics Proteomics & Bioinformatics, V11, P172, DOI 10.1016/j.gpb.2013.03.001; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P6241, DOI 10.1093/nar/gks242; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rock CD, 2013, TRENDS PLANT SCI, V18, P601, DOI 10.1016/j.tplants.2013.07.006; Romanel E, 2012, PLANT MOL BIOL, V80, P443, DOI 10.1007/s11103-012-9959-1; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Wei HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056842; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xia R, 2013, PLANT CELL, V25, P1555, DOI 10.1105/tpc.113.110957; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zakrzewski F, 2011, CHROMOSOMA, V120, P409, DOI 10.1007/s00412-011-0325-x; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhan SH, 2013, PLANT PHYSIOL, V161, P2171, DOI 10.1104/pp.112.212100; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zhang RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057233; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zubko E, 2007, PLANT J, V52, P1131, DOI 10.1111/j.1365-313X.2007.03309.x	78	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95782	10.1371/journal.pone.0095782	http://dx.doi.org/10.1371/journal.pone.0095782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752316	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400128
J	Kong, YY; Mullangi, A; Kokkinakis, K				Kong, Ying-Yee; Mullangi, Ala; Kokkinakis, Kostas			Classification of Fricative Consonants for Speech Enhancement in Hearing Devices	PLOS ONE			English	Article							ACOUSTIC CHARACTERISTICS; VOICELESS FRICATIVES; ENGLISH; PERCEPTION; IDENTIFICATION; TRANSPOSITION; LISTENERS; CHILDREN	Objective: To investigate a set of acoustic features and classification methods for the classification of three groups of fricative consonants differing in place of articulation. Method: A support vector machine (SVM) algorithm was used to classify the fricatives extracted from the TIMIT database in quiet and also in speech babble noise at various signal-to-noise ratios (SNRs). Spectral features including four spectral moments, peak, slope, Mel-frequency cepstral coefficients (MFCC), Gammatone filters outputs, and magnitudes of fast Fourier Transform (FFT) spectrum were used for the classification. The analysis frame was restricted to only 8 msec. In addition, commonly-used linear and nonlinear principal component analysis dimensionality reduction techniques that project a high-dimensional feature vector onto a lower dimensional space were examined. Results: With 13 MFCC coefficients, 14 or 24 Gammatone filter outputs, classification performance was greater than or equal to 85% in quiet and at +10 dB SNR. Using 14 Gammatone filter outputs above 1 kHz, classification accuracy remained high (greater than 80%) for a wide range of SNRs from +20 to +5 dB SNR. Conclusions: High levels of classification accuracy for fricative consonants in quiet and in noise could be achieved using only spectral features extracted from a short time window. Results of this work have a direct impact on the development of speech enhancement algorithms for hearing devices.	[Kong, Ying-Yee] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [Kong, Ying-Yee; Mullangi, Ala] Northeastern Univ, Bioengn Program, Boston, MA 02115 USA; [Kokkinakis, Kostas] Univ Kansas, Dept Speech Language Hearing, Lawrence, KS 66045 USA	Northeastern University; Northeastern University; University of Kansas	Kong, YY (corresponding author), Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA.	yykong@neu.edu			NIH/NIDCD [R01-DC-012300]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005803, R01DC012300] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH/NIDCD R01-DC-012300 to Y-YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AMA, 2001, J ACOUST SOC AM, V109, P2217, DOI 10.1121/1.1357814; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Brookes M., 1997, VOICEBOX SPEECH PROC, V47; BYRNE D, 1994, J ACOUST SOC AM, V96, P2108, DOI 10.1121/1.410152; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dillon H., 2001, HEARING AIDS, V1st; Erdogmus D, 2008, STUD COMPUT INTELL, V83, P1, DOI 10.1007/978-3-540-75398-8_1; FORREST K, 1988, J ACOUST SOC AM, V84, P115, DOI 10.1121/1.396977; Fox RA, 2005, J SPEECH LANG HEAR R, V48, P753, DOI 10.1044/1092-4388(2005/052); Frid A., 2010, 2010 IEEE 26th Convention of Electrical & Electronics Engineers in Israel (IEEEI 2010), P751, DOI 10.1109/EEEI.2010.5662110; Garofolo J. S., 1993, DARPA TIMIT ACOUSTIC, V93, DOI DOI 10.6028/NIST.IR.4930; Genussov M, 2010, 12 INT WORKSH AC ECH; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Joder C, 2012, IEEE P 10 ITG C SPEE; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Jongman A, 2000, J ACOUST SOC AM, V108, P1252, DOI 10.1121/1.1288413; Kong YY, 2013, EAR HEARING, V34, P300, DOI 10.1097/AUD.0b013e31826fe77a; Kong YY, 2012, SPEECH COMMUN, V54, P147, DOI 10.1016/j.specom.2011.07.008; Kuk F, 2009, J AM ACAD AUDIOL, V20, P465, DOI 10.3766/jaaa.20.8.2; LAWRENCE DL, 1969, J SPEECH HEAR RES, V12, P426, DOI 10.1044/jshr.1202.426; Maniwa K, 2009, J ACOUST SOC AM, V125, P3962, DOI 10.1121/1.2990715; Nittrouer S, 2000, PERCEPT PSYCHOPHYS, V62, P266, DOI 10.3758/BF03205548; Onaka A, 2000, 8 AUSTR INT C SPEECH; POSEN MP, 1993, J REHABIL RES DEV, V30, P26; Robinson JD, 2007, INT J AUDIOL, V46, P293, DOI 10.1080/14992020601188591; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Shannon RV, 1999, J ACOUST SOC AM, V106, pL71, DOI 10.1121/1.428150; Simpson A, 2006, INT J AUDIOL, V45, P619, DOI 10.1080/14992020600825508; Stelmachowicz PG, 2001, J ACOUST SOC AM, V110, P2183, DOI 10.1121/1.1400757; Stone MA, 1999, EAR HEARING, V20, P182, DOI 10.1097/00003446-199906000-00002; WHALEN DH, 1981, J ACOUST SOC AM, V69, P275, DOI 10.1121/1.385348; ZENG FG, 1990, J SPEECH HEAR RES, V33, P440, DOI 10.1044/jshr.3303.440	32	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95001	10.1371/journal.pone.0095001	http://dx.doi.org/10.1371/journal.pone.0095001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747721	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500051
J	Martinez, VR; Attal, N; Vanzo, B; Vicaut, E; Gautier, JM; Bouhassira, D; Lanteri-Minet, M				Martinez, Valeria; Attal, Nadine; Vanzo, Bertrand; Vicaut, Eric; Gautier, Jean Michel; Bouhassira, Didier; Lanteri-Minet, Michel			Adherence of French GPs to Chronic Neuropathic Pain Clinical Guidelines: Results of a Cross-Sectional, Randomized, "e" Case-Vignette Survey	PLOS ONE			English	Article							EVIDENCE-BASED RECOMMENDATIONS; PERSISTENT POSTSURGICAL PAIN; PHYSICIAN PRACTICE; PHARMACOLOGICAL-TREATMENT; STANDARDIZED PATIENTS; GENERAL-POPULATION; QUALITY; CARE; ETIOLOGY; QUESTIONNAIRE	Background and aims: The French Pain Society published guidelines for neuropathic pain management in 2010. Our aim was to evaluate the compliance of GPs with these guidelines three years later. Methods: We used "e" case vignette methodology for this non interventional study. A national panel of randomly selected GPs was included. We used eight "e" case-vignettes relating to chronic pain, differing in terms of the type of pain (neuropathic/non neuropathic), etiology (cancer, postoperative pain, low back pain with or without radicular pain, diabetes) and symptoms. GPs received two randomly selected consecutive "e" case vignettes (with/without neuropathic pain). We analyzed their ability to recognize neuropathic pain and to prescribe appropriate first-line treatment. Results: From the 1265 GPs in the database, we recruited 443 (35.0%), 334 of whom logged onto the web site (26.4%) and 319 (25.2%) of whom completed the survey. Among these GPs, 170 (53.3%) were aware of the guidelines, 136 (42.6%) were able to follow them, and 110 (34.5%) used the DN4 diagnostic tool. Sensitivity for neuropathic pain recognition was 87.8% (CI: 84.2%; 91.4%). However, postoperative neuropathic pain was less well diagnosed (77.9%; CI: 69.6%; 86.2%) than diabetic pain (95.2%; CI: 90.0%; 100.0%), cancer pain (90.6%; CI: 83.5%; 97.8%) and typical radicular pain (90.7%; CI: 84.9%; 96.5%). When neuropathic pain was correctly recognized, the likelihood of appropriate first-line treatment prescription was 90.6% (CI: 87.4%; 93.8%). The treatments proposed were pregabaline (71.8%), gabapentine (43.9%), amiptriptylline (23.2%) and duloxetine (18.2%). However, ibuprofen (11%), acetaminophen-codeine (29.5%) and clonazepam (10%) were still prescribed. Conclusions: The compliance of GPs with clinical practice guidelines appeared to be satisfactory, but differed between etiologies.	[Martinez, Valeria] Hop Raymond Poincare, Garches, France; [Martinez, Valeria; Attal, Nadine; Bouhassira, Didier] INSERM U 987, Ctr Evaluat & Traitement Douleur, CHU Ambroise Pare, Boulogne, France; [Attal, Nadine; Bouhassira, Didier] Univ Versailles St Quentin, Versailles, France; [Vanzo, Bertrand] Gen Practitioner, Athis Mons, France; [Vicaut, Eric] Hop Fernand Widal, Unite Rech Clin, Paris, France; [Gautier, Jean Michel] CHRU Montpellier, Reseau InterCLUD Languedoc Roussillon, Montpellier, France; [Lanteri-Minet, Michel] CHU Nice, Ctr Evaluat & Traitement Douleur, F-06202 Nice, France; [Lanteri-Minet, Michel] Univ Clermont Ferrand, INSERM, UdA, U1107, Clermont Ferrand, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm)	Martinez, VR (corresponding author), Hop Raymond Poincare, Garches, France.	valeria.martinez.aphp@gmail.com	Bouhassira, Didier/Y-8403-2018	Bouhassira, Didier/0000-0001-6446-8719; LANTERI-MINET, Michel/0000-0001-6717-9234	Pfizer; independent clinical research organization (ITEC, Bordeaux, France)	Pfizer(Pfizer); independent clinical research organization (ITEC, Bordeaux, France)	This study was supported by Pfizer. The sponsor financed the data collection and statistical analysis of the data, which was performed by an independent clinical research organization (ITEC, Bordeaux, France). The funders had no role in the study design and analysis, decision to publish or preparation of the manuscript.	AFFSAPS, 2011, MOD MOD PRESCR DEL R; Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Attal N, 2011, PAIN, V152, P2836, DOI 10.1016/j.pain.2011.09.014; Bachmann LM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-50; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; Bennett MI, 2012, PAIN, V153, P359, DOI 10.1016/j.pain.2011.10.028; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bouhassira D, 2012, DOULEURS NEUROPATHIQ; Bouhassira D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074195; Bouhassira D, 2011, PAIN, V152, pS74, DOI 10.1016/j.pain.2010.11.027; Centre for Clinical Practice at NICE (UK)-National Institute for Health and Care Excellence: Clinical Guidelines, 2010, NEUR PAIN PHARM MAN; Clerc I, 2011, MED CARE RES REV, V68, P504, DOI 10.1177/1077558710397761; Dresselhaus TR, 2000, J GEN INTERN MED, V15, P782, DOI 10.1046/j.1525-1497.2000.91007.x; Dumesnil H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052429; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Dworkin RH, 2012, PAIN, V153, P869, DOI 10.1016/j.pain.2012.01.015; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Haanpaa ML, 2009, AM J MED, V122, pS13, DOI 10.1016/j.amjmed.2009.04.006; Hall GC, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-28; Johansen A, 2012, PAIN, V153, P1390, DOI 10.1016/j.pain.2012.02.018; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Martinez V, 2013, ANN FR ANESTH, V32, P422, DOI 10.1016/j.annfar.2013.04.012; Martinez V, 2010, DOULEUR ANALG, V23, P51, DOI 10.1007/s11724-010-0180-1; Norcini J, 2004, ANN INTERN MED, V141, P813, DOI 10.7326/0003-4819-141-10-200411160-00014; Parsons B, 2013, J PAIN RES, V6, P459, DOI 10.2147/JPR.S44939; Peabody JW, 2007, HEALTH POLICY PLANN, V22, P294, DOI 10.1093/heapol/czm020; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, HEALTH SERV RES, V39, P1951, DOI 10.1111/j.1475-6773.2004.00327.x; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Perkins FM, 2000, ANESTHESIOLOGY, V93, P1123, DOI 10.1097/00000542-200010000-00038; Pham T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-128; Radat F, 2013, EUR J PAIN, V17, P1547, DOI 10.1002/j.1532-2149.2013.00334.x; Torrance N, 2013, PAIN, V154, P690, DOI 10.1016/j.pain.2012.12.022; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520; Veloski JJ, 2005, ACAD MED, V80, P366, DOI 10.1097/00001888-200504000-00014; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	40	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93855	10.1371/journal.pone.0093855	http://dx.doi.org/10.1371/journal.pone.0093855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747826	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500015
J	Mendonca, LM; Poeys, SC; Abreu, CM; Tanuri, A; Costa, LJ				Mendonca, Luiza M.; Poeys, Sandro C.; Abreu, Celina M.; Tanuri, Amilcar; Costa, Luciana J.			HIV-1 Nef Inhibits Protease Activity and Its Absence Alters Protein Content of Mature Viral Particles	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 DOWN-REGULATION; REVERSE TRANSCRIPTION; GAGPOL PRECURSOR; CLEAVAGE SITES; IN-VITRO; CELL; INFECTIVITY; SUSCEPTIBILITY; RECOMBINANT	Nef is an important player for viral infectivity and AIDS progression, but the mechanisms involved are not completely understood. It was previously demonstrated that Nef interacts with GagPol through p6*-Protease region. Because p6* and Protease are involved in processing, we explored the effect of Nef on viral Protease activity and virion assembly. Using in vitro assays, we observed that Nef is highly capable of inhibiting Protease activity. The IC50 for nef-deficient viruses in drug susceptibility assays were 1.7- to 3.5-fold higher than the wild-type counterpart varying with the type of the Protease inhibitor used. Indicating that, in the absence of Nef, Protease is less sensitive to Protease inhibitors. We compared the protein content between wild-type and nef-deficient mature viral particles by gradient sedimentation and observed up to 2.7-fold reduction in the Integrase levels in nef-deficient mature particles. This difference in levels of Integrase correlated with the difference in infectivity levels of wild type and nef-deficient viral progeny. In addition, an overall decrease in the production of mature particles was detected in nef-deficient viruses. Collectively, our data support the hypothesis that the decreased infectivity typical of nef-deficient viruses is due to an abnormal function of the viral Protease, which is in turn associated with less mature particles being produced and the loss of Integrase content in these particles, and these results may characterize Nef as a regulator of viral Protease activity.	[Mendonca, Luiza M.; Poeys, Sandro C.; Costa, Luciana J.] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil; [Abreu, Celina M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Costa, LJ (corresponding author), Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.	ljcosta@micro.ufrj.br	Abreu, Celina Monteiro/AAT-7447-2020; Tanuri, Amilcar/AAM-8601-2021; Costa, Luciana J/B-7878-2013		CAPES (ProEx); CNPq; FAPERJ	CAPES (ProEx)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study has been supported with funding from CAPES (ProEx), CNPq and FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Adamson CS, 2009, EXPERT OPIN THER TAR, V13, P895, DOI 10.1517/14728220903039714; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Chiu HC, 2006, J GEN VIROL, V87, P2041, DOI 10.1099/vir.0.81601-0; CHOWERS MY, 1995, VIROLOGY, V212, P451, DOI 10.1006/viro.1995.1502; Costa LJ, 2004, J VIROL, V78, P5311, DOI 10.1128/JVI.78.10.5311-5323.2004; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Covens K, 2009, J CLIN MICROBIOL, V47, P2232, DOI 10.1128/JCM.01739-08; de Marco A, 2012, J VIROL, V86, P13708, DOI 10.1128/JVI.01704-12; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Dobard CW, 2007, J VIROL, V81, P10037, DOI 10.1128/JVI.00519-07; Dyer WB, 1999, J VIROL, V73, P436, DOI 10.1128/JVI.73.1.436-443.1999; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Forshey BM, 2003, J VIROL, V77, P4409, DOI 10.1128/JVI.77.7.4409-4414.2003; FREUND J, 1994, EUR J BIOCHEM, V223, P589, DOI 10.1111/j.1432-1033.1994.tb19029.x; FREUND J, 1994, EUR J BIOCHEM, V221, P811, DOI 10.1111/j.1432-1033.1994.tb18795.x; GAEDIGKNITSCHKO K, 1995, FEBS LETT, V357, P275, DOI 10.1016/0014-5793(94)01370-G; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Garcia-Perez J, 2007, J MED VIROL, V79, P127, DOI 10.1002/jmv.20770; Gatlin J, 1998, J BIOMED SCI, V5, P305; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995; GRANDGENETT DP, 1994, PROTEIN SCI, V3, P888; Ishima R, 2010, PROTEINS, V78, P1015, DOI 10.1002/prot.22625; Janvier K, 2001, J VIROL, V75, P3971, DOI 10.1128/JVI.75.8.3971-3976.2001; KAPLAN AH, 1994, J VIROL, V68, P6782, DOI 10.1128/JVI.68.10.6782-6786.1994; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Khan M, 2001, J VIROL, V75, P12081, DOI 10.1128/JVI.75.24.12081-12087.2001; KIKUKAWA R, 1986, J VIROL, V57, P1159, DOI 10.1128/JVI.57.3.1159-1162.1986; Kotler M, 1997, J VIROL, V71, P5774, DOI 10.1128/JVI.71.8.5774-5781.1997; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Ludwig M, 1998, ANDROLOGIA, V30, P41; LUUKKONEN BGM, 1995, VIROLOGY, V206, P854, DOI 10.1006/viro.1995.1008; Mahalingam B, 2001, PROTEINS, V43, P455, DOI 10.1002/prot.1057; Malbec M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-80; Miller MD, 1997, VIROLOGY, V234, P215, DOI 10.1006/viro.1997.8641; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; NAVIA MA, 1990, ANN NY ACAD SCI, V616, P73; Pandori M, 1998, VIROLOGY, V251, P302, DOI 10.1006/viro.1998.9407; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Sanches M, 2004, ACTA CRYSTALLOGR D, V60, P1625, DOI 10.1107/S0907444904015276; Schindler M, 2004, J VIROL, V78, P10588, DOI 10.1128/JVI.78.19.10588-10597.2004; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schorr J, 1996, J VIROL, V70, P9051, DOI 10.1128/JVI.70.12.9051-9054.1996; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Stolp B, 2010, J VIROL, V84, P3935, DOI 10.1128/JVI.02467-09; Westerman KA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-96; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; WYCKOFF EE, 1992, J VIROL, V66, P2943, DOI 10.1128/JVI.66.5.2943-2951.1992	57	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95352	10.1371/journal.pone.0095352	http://dx.doi.org/10.1371/journal.pone.0095352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748174	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500090
J	Moreland, KT; Hong, MN; Lu, WF; Rowley, CW; Ornitz, DM; De Yoreo, JJ; Thalmann, R				Moreland, K. Trent; Hong, Mina; Lu, Wenfu; Rowley, Christopher W.; Ornitz, David M.; De Yoreo, James J.; Thalmann, Ruediger			In Vitro Calcite Crystal Morphology Is Modulated by Otoconial Proteins Otolin-1 and Otoconin-90	PLOS ONE			English	Article							BENIGN POSITIONAL VERTIGO; ATOMIC-FORCE MICROSCOPY; GROWTH; CRYSTALLIZATION; KINETICS; MINERALIZATION; ACCELERATION; OSTEOPOROSIS; MECHANISMS; OSTEOPENIA	Otoconia are formed embryonically and are instrumental in detecting linear acceleration and gravity. Degeneration and fragmentation of otoconia in elderly patients leads to imbalance resulting in higher frequency of falls that are positively correlated with the incidence of bone fractures and death. In this work we investigate the roles otoconial proteins Otolin-1 and Otoconin 90 (OC90) perform in the formation of otoconia. We demonstrate by rotary shadowing and atomic force microscopy (AFM) experiments that Otolin-1 forms homomeric protein complexes and self-assembled networks supporting the hypothesis that Otolin-1 serves as a scaffold protein of otoconia. Our calcium carbonate crystal growth data demonstrate that Otolin-1 and OC90 modulate in vitro calcite crystal morphology but neither protein is sufficient to produce the shape of otoconia. Coadministration of these proteins produces synergistic effects on crystal morphology that contribute to morphology resembling otoconia.	[Moreland, K. Trent; Lu, Wenfu; Rowley, Christopher W.; Thalmann, Ruediger] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Ornitz, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [De Yoreo, James J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Hong, Mina] George Washington Univ, Dept Chem, Washington, DC 20052 USA	Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; George Washington University	Thalmann, R (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA.	thalmannr@ent.wustl.edu	Moreland, Trent/I-5497-2013	Moreland, Trent/0000-0002-8996-832X; Ornitz, David/0000-0003-1592-7629	NIH/NIDCD [R01 DC011614, R21 DC009320]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009320, R01DC011614] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This publication was funded by Grant Numbers R01 DC011614 and R21 DC009320 from the NIH/NIDCD (www.nidcd.nih.gov). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH/NIDCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005; Andrade LR, 2012, HEARING RES, V292, P14, DOI 10.1016/j.heares.2012.07.003; ANNIKO M, 1984, ACTA OTO-LARYNGOL, V97, P283, DOI 10.3109/00016488409130990; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Chen CL, 2011, J AM CHEM SOC, V133, P5214, DOI 10.1021/ja200595f; Cho KR, 2013, CRYSTENGCOMM, V15, P54, DOI 10.1039/c2ce25936b; De Yoreo JJ, 2009, CRYST GROWTH DES, V9, P5135, DOI 10.1021/cg900543g; De Yoreo JJ, 2007, CRYSTENGCOMM, V9, P1144, DOI 10.1039/b713006f; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; Friddle RW, 2010, P NATL ACAD SCI USA, V107, P11, DOI 10.1073/pnas.0908205107; Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547; Fu G, 2005, ADV MATER, V17, P2678, DOI 10.1002/adma.200500633; Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+; Huss D, 2003, J NEUROSCI METH, V125, P129, DOI 10.1016/S0165-0270(03)00048-7; Jeong SH, 2009, NEUROLOGY, V72, P1069, DOI 10.1212/01.wnl.0000345016.33983.e0; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; LIM DJ, 1984, ANN OTO RHINOL LARYN, V93, P17, DOI 10.1177/00034894840930S404; Lins U, 2000, J STRUCT BIOL, V131, P67, DOI 10.1006/jsbi.2000.4260; Lu WF, 2010, HEARING RES, V268, P172, DOI 10.1016/j.heares.2010.05.019; Maruyama M, 2009, CRYST GROWTH DES, V9, P127, DOI 10.1021/cg701219h; Murayama E, 2002, EUR J BIOCHEM, V269, P688, DOI 10.1046/j.0014-2956.2001.02701.x; Narayanan B, 2014, LANGMUIR, V30, P1343, DOI 10.1021/la4043364; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Parkhurst D.L., 1999, USER GUIDE PHREEQC V; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; ROSS MD, 1976, ANN OTO RHINOL LARYN, V85, P310, DOI 10.1177/000348947608500302; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Teng HH, 2000, GEOCHIM COSMOCHIM AC, V64, P2255, DOI 10.1016/S0016-7037(00)00341-0; Thalmann I, 2006, ELECTROPHORESIS, V27, P1598, DOI 10.1002/elps.200500768; Vibert D, 2003, ANN OTO RHINOL LARYN, V112, P885, DOI 10.1177/000348940311201010; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Welgampola MS, 2011, MED J AUSTRALIA, V195, P518, DOI 10.5694/mja11.11001; Yang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020498; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013	36	23	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95333	10.1371/journal.pone.0095333	http://dx.doi.org/10.1371/journal.pone.0095333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748133	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500086
J	Wang, X; Liu, TZ; Bai, YF; Liao, HZ; Qiu, SC; Chang, ZH; Liu, YT; Yan, XH; Guo, HB				Wang, Xin; Liu, Tianzhu; Bai, Yifeng; Liao, Hongzhan; Qiu, Shengcong; Chang, Zhenhua; Liu, Yanting; Yan, Xiaohui; Guo, Hongbo			Polymerase I and Transcript Release Factor Acts As an Essential Modulator of Glioblastoma Chemoresistance	PLOS ONE			English	Article							CAVEOLIN-1 EXPRESSION; MALIGNANT GLIOMA; UP-REGULATION; EXPERIMENTAL-DESIGN; CELL-GROWTH; RESISTANCE; TEMOZOLOMIDE; PROTEOME; PTRF; EGFR	Objectives: This study is to investigate if polymerase I and transcript release factor (PTRF) acts as a modulator in glioblastoma (GBM) chemoresistance. Methods: Multidrug resistant (MDR) GBM cell line U251AR was established by exposing the U251 cell line to imatinib. The 2D-DIGE and MALDI-TOF/TOF-MS were performed on U251 and U251AR cell lines to screen MDR-related proteins. The expression of PTRF was determined by Western blot and quantitative RT-PCR analyses. Results: When compared with the parental U251 cells, expression of 21 proteins was significantly altered in U251AR cells. Among the 21 differentially expressed proteins, the expression of PTRF was up-regulated by 2.14 folds in U251AR cells when compared with that in the parental U251 cells. Knockdown of PTRF in GBM cell lines significantly increased chemosensitivity of cells to various chemical drugs and decreased the expression levels of caveolin1, a major structural component of caveolae. Expression levels of PTRF and caveolin1 were significantly up-regulated in the relapsed GBM patients. The mRNA level of PTRF and caveolin1 showed a positive correlation in the same GBM specimens. Conclusions: Our results indicate that PTRF acts as a modulator in GBM chemoresistance.	[Wang, Xin; Liu, Tianzhu; Liao, Hongzhan; Qiu, Shengcong; Liu, Yanting; Guo, Hongbo] Southern Med Univ, Natl Key Clin Specialty Neurosurg Inst Guangdong, Guangdong Prov Key Lab Brain Funct Repair & Regen, Dept Neurosurg,Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Xin] Fourth Mil Med Univ, Dept Neurosurg & Inst Funct Brain Disorders, Tangdu Hosp, Xian 710032, Peoples R China; [Bai, Yifeng] Sichuan Acad Med Sci, Dept Oncol, Chengdu, Peoples R China; [Bai, Yifeng] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Chang, Zhenhua] Tongchuan Peoples Hosp, Dept Lab Med, Tongchuan, Peoples R China; [Yan, Xiaohui] Southern Med Univ, Clin Res Ctr, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Air Force Military Medical University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Southern Medical University - China	Guo, HB (corresponding author), Southern Med Univ, Natl Key Clin Specialty Neurosurg Inst Guangdong, Guangdong Prov Key Lab Brain Funct Repair & Regen, Dept Neurosurg,Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China.	nfykwx@sina.com	Guo, Hongbo/U-6168-2018; liu, yan/HGV-1365-2022	Guo, Hongbo/0000-0003-3671-0445; 	National Nature Science Foundation of China [81041068, 30971183, 81372691]; Funds for Key Sci-Tech Research Projects of Guangdong [2009B030801230]; Nature Science Foundation of Guangdong Province, China [S2011010004065]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for Key Sci-Tech Research Projects of Guangdong; Nature Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by National Nature Science Foundation of China (81041068, 30971183, 81372691), the Funds for Key Sci-Tech Research Projects of Guangdong (2009B030801230), Nature Science Foundation of Guangdong Province, China (S2011010004065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911; Akhavan D, 2013, CANCER DISCOV, V3, P534, DOI 10.1158/2159-8290.CD-12-0502; Bai L, 2011, CELL RES, V21, P1088, DOI 10.1038/cr.2011.56; Bai YF, 2013, EUR J CANCER, V49, P710, DOI 10.1016/j.ejca.2012.08.020; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Belanger MM, 2004, CANCER BIOL THER, V3, P954, DOI 10.4161/cbt.3.10.1112; Bruyere C, 2011, TRANSL ONCOL, V4, P92, DOI 10.1593/tlo.10205; Cai CX, 2004, BIOCHEM BIOPH RES CO, V320, P868, DOI 10.1016/j.bbrc.2004.06.030; Camp ER, 2005, CLIN CANCER RES, V11, P397; Cassoni P, 2007, AM J SURG PATHOL, V31, P760, DOI 10.1097/01.pas.0000213433.14740.5d; Cecconi D, 2011, PROTEOMICS, V11, P816, DOI 10.1002/pmic.201000401; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Engelen K, 2010, J PROTEOME RES, V9, P4919, DOI 10.1021/pr100010u; Gamez-Pozo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033752; Gould ML, 2010, PROSTATE, V70, P1609, DOI 10.1002/pros.21195; Hamoudane M, 2013, J ENDOCRINOL INVEST, V36, P204, DOI 10.3275/8848; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hehlgans S, 2011, AM J CANCER RES, V1, P521; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Kilic T, 2000, CANCER RES, V60, P5143; Kim BW, 2010, EXPERT REV PROTEOMIC, V7, P849, DOI 10.1586/EPR.10.87; Kumar DM, 2013, PROTEOMICS, V13, P2113, DOI 10.1002/pmic.201200261; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Meng Q, 2013, J CANCER RES CLIN, V139, P509, DOI 10.1007/s00432-012-1350-8; Moon H, 2014, ONCOGENE, V33, P3561, DOI 10.1038/onc.2013.315; Parker JJ, 2013, NEURO-ONCOLOGY, V15, P1048, DOI 10.1093/neuonc/not053; Quann K, 2013, CELL CYCLE, V12, P1510, DOI 10.4161/cc.24497; Reardon DA, 2006, J CLIN ONCOL, V24, P1253, DOI 10.1200/JCO.2005.04.5302; Shatz M, 2008, INT J RADIAT BIOL, V84, P177, DOI 10.1080/09553000701745293; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun S, 2012, J NEURO-ONCOL, V107, P89, DOI 10.1007/s11060-011-0729-8; Trog D, 2008, AMINO ACIDS, V34, P539, DOI 10.1007/s00726-007-0007-4; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wu CC, 2002, CURR OPIN MOL THER, V4, P242; Yang CPH, 1998, FEBS LETT, V439, P368, DOI 10.1016/S0014-5793(98)01354-4; Yi JS, 2013, J PROTEOME RES, V12, P605, DOI 10.1021/pr300651m; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Zeiser JJ, 2011, J PROTEOMICS, V75, P469, DOI 10.1016/j.jprot.2011.08.012	47	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93439	10.1371/journal.pone.0093439	http://dx.doi.org/10.1371/journal.pone.0093439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747515	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500007
J	West, J; Aalto, A; Tisell, A; Leinhard, OD; Landtblom, AM; Smedby, O; Lundberg, P				West, Janne; Aalto, Anne; Tisell, Anders; Leinhard, Olof Dahlqvist; Landtblom, Anne-Marie; Smedby, Orjan; Lundberg, Peter			Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR	PLOS ONE			English	Article							BRAIN PARENCHYMAL FRACTION; MAGNETIC-RESONANCE; AXONAL LOSS; IN-VIVO; INVIVO DETERMINATION; DIAGNOSTIC-CRITERIA; LESION LOAD; MS; T1; DEMYELINATION	Introduction: Magnetic Resonance Imaging is a sensitive technique for detecting white matter (WM) MS lesions, but the relation with clinical disability is low. Because of this, changes in both 'normal appearing white matter' (NAWM) and 'diffusely abnormal white matter' (DAWM) have been of interest in recent years. MR techniques, including quantitative magnetic resonance imaging (qMRI) and quantitative magnetic resonance spectroscopy (qMRS), have been developed in order to detect and quantify such changes. In this study, qMRI and qMRS were used to investigate NAWM and DAWM in typical MS patients and in MS patients with low number of WM lesions. Patient data were compared to 'normal white matter' (NWM) in healthy controls. Methods: QMRI and qMRS measurements were performed on a 1.5 T Philips MR-scanner. 35 patients with clinically definite MS and 20 healthy controls were included. Twenty of the patients fulfilled the 'Barkhof-Tintore criteria' for MS, ('MRIpos'), whereas 15 showed radiologically atypical findings with few WM lesions ('MRIneg'). QMRI properties were determined in ROIs of NAWM, DAWM and lesions in the MS groups and of NWM in controls. Descriptive statistical analysis and comparisons were performed. Correlations were calculated between qMRI measurements and (1) clinical parameters and (2) WM metabolite concentrations. Regression analyses were performed with brain parenchyma fraction and MSSS. Results: NAWM in the MRIneg group was significantly different from NAWM in the MRIpos group and NWM. In addition, R1 and R2 of NAWM in the MRIpos group correlated negatively with EDSS and MSSS. DAWM was significantly different from NWM, but similar in the MS groups. N-acetyl aspartate correlated negatively with R1 and R2 in MRIneg. R2 of DAWM was associated with BPF. Conclusions: Changes in NAWM and DAWM are independent pathological entities in the disease. The correlation between qMRI and clinical status may shed new light on the clinicoradiological paradox.	[West, Janne; Tisell, Anders; Leinhard, Olof Dahlqvist; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth, Linkoping, Sweden; [West, Janne; Aalto, Anne; Tisell, Anders; Leinhard, Olof Dahlqvist; Landtblom, Anne-Marie; Smedby, Orjan; Lundberg, Peter] Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Neurol, Linkoping, Sweden; [Landtblom, Anne-Marie] UHL & LiM Cty Council Ostergotland, Linkoping, Sweden; [Aalto, Anne; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth, Dept Radiat Phys, UHL Cty Council Ostergotland, Linkoping, Sweden; [Smedby, Orjan] Linkoping Univ, Dept Med & Hlth, Dept Radiol, UHL Cty Council Ostergotland, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; City Council Ostergotland; City Council Ostergotland; Linkoping University; City Council Ostergotland; Linkoping University	West, J (corresponding author), Linkoping Univ, Dept Med & Hlth, Linkoping, Sweden.	janne.west@liu.se	West, Janne/H-3681-2019; Lundberg, Peter/AGD-9679-2022	West, Janne/0000-0001-8369-0075; Smedby, Orjan/0000-0002-7750-1917; Landtblom, Anne-Marie/0000-0001-9567-470X	National Research Council (VR/NT); County Council of Ostergotland (ALF)	National Research Council (VR/NT)(Swedish Research Council); County Council of Ostergotland (ALF)	This study was supported by grants from The National Research Council (VR/NT) and the County Council of Ostergotland (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IV, 2001, NEUROL SCI, V22, P141, DOI 10.1007/s100720170012; Audoin B, 2007, NEUROIMAGE, V36, P1324, DOI 10.1016/j.neuroimage.2007.04.038; BARBOSA S, 1994, MAGN RESON IMAGING, V12, P33, DOI 10.1016/0730-725X(94)92350-7; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Bjartmar C, 2002, ANN NEUROL, V51, P51, DOI 10.1002/ana.10052; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; Chen SCY, 2003, AM J NEURORADIOL, V24, P1929; Davies GR, 2007, MULT SCLER J, V13, P169, DOI 10.1177/1352458506070726; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Ge YL, 2003, AM J NEURORADIOL, V24, P1935; Graaf RA, 2007, IN VIVO NMR SPECTROS, V2nd ed.; Gustafsson MC, 2007, AM J NEURORADIOL, V28, P1306, DOI 10.3174/ajnr.A0580; Harirchian MH, 2010, J CLIN NEUROSCI, V17, P736, DOI 10.1016/j.jocn.2009.10.010; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Labadie C, 2013, MAGN RESON MED; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; LARSSON HBW, 1988, MAGN RESON MED, V7, P43, DOI 10.1002/mrm.1910070106; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; Moore GRW, 2008, J NEUROL, V255, P1802, DOI 10.1007/s00415-008-0002-z; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Seewann A, 2009, ARCH NEUROL-CHICAGO, V66, P601, DOI 10.1001/archneurol.2009.57; Stevenson VL, 2000, J NEUROL SCI, V178, P81, DOI 10.1016/S0022-510X(00)00339-7; Thorpe JW, 1996, BRAIN, V119, P709, DOI 10.1093/brain/119.3.709; Tisell A, 2012, MAGN RESON MED; Tisell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061817; Vagberg M, 2013, AM J NEURORADIOL, V34, P498, DOI 10.3174/ajnr.A3262; van Walderveen MAA, 1999, ANN NEUROL, V46, P79, DOI 10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.3.CO;2-0; Vavasour IM, 2007, J NEUROL, V254, P1653, DOI 10.1007/s00415-007-0604-x; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Vrenken H, 2006, AM J NEURORADIOL, V27, P2005; Vrenken H, 2010, AM J NEURORADIOL, V31, P541, DOI 10.3174/ajnr.A1839; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; West J, 2012, EUR RADIOL, V22, P998, DOI 10.1007/s00330-011-2336-7	46	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95161	10.1371/journal.pone.0095161	http://dx.doi.org/10.1371/journal.pone.0095161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747946	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500062
J	Wolfs, E; Holvoet, B; Gijsbers, R; Casteels, C; Roberts, SJ; Struys, T; Maris, M; Ibrahimi, A; Debyser, Z; Van Laere, K; Verfaillie, CM; Deroose, CM				Wolfs, Esther; Holvoet, Bryan; Gijsbers, Rik; Casteels, Cindy; Roberts, Scott J.; Struys, Tom; Maris, Michael; Ibrahimi, Abdelilah; Debyser, Zeger; Van Laere, Koen; Verfaillie, Catherine M.; Deroose, Christophe M.			Optimization of Multimodal Imaging of Mesenchymal Stem Cells Using the Human Sodium Iodide Symporter for PET and Cerenkov Luminescence Imaging	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; HUMAN HEMATOPOIETIC-CELLS; LENTIVIRAL VECTORS; GENE-THERAPY; EXPRESSION; PROMOTER; DIFFERENTIATION; TRANSPLANTATION; RESISTANT; VIVO	Purpose: The use of stably integrated reporter gene imaging provides a manner to monitor the in vivo fate of engrafted cells over time in a non-invasive manner. Here, we optimized multimodal imaging (small-animal PET, Cerenkov luminescence imaging (CLI) and bioluminescence imaging (BLI)) of mesenchymal stem cells (MSCs), by means of the human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) as reporters. Methods: First, two multicistronic lentiviral vectors (LV) were generated for multimodal imaging: BLI, I-124 PET/SPECT and CLI. Expression of the imaging reporter genes was validated in vitro using (TcO4-)-Tc-99m radioligand uptake experiments and BLI. Uptake kinetics, specificity and tracer elution were determined as well as the effect of the transduction process on the cell's differentiation capacity. MSCs expressing the LV were injected intravenously or subcutaneously and imaged using small-animal PET, CLI and BLI. Results: The expression of both imaging reporter genes was functional and specific. An elution of (TcO4-)-Tc-99m from the cells was observed, with 31% retention after 3 h. After labeling cells with I-124 in vitro, a significantly higher CLI signal was noted in hNIS expressing murine MSCs. Furthermore, it was possible to visualize cells injected intravenously using BLI or subcutaneously in mice, using I-124 small-animal PET, CLI and BLI. Conclusions: This study identifies hNIS as a suitable reporter gene for molecular imaging with PET and CLI, as confirmed with BLI through the expression of Fluc. It supports the potential for a wider application of hNIS reporter gene imaging and future clinical applications.	[Wolfs, Esther; Holvoet, Bryan; Casteels, Cindy; Van Laere, Koen; Deroose, Christophe M.] Katholieke Univ Leuven, Dept Imaging & Pathol, Louvain, Belgium; [Gijsbers, Rik; Maris, Michael; Ibrahimi, Abdelilah; Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Dept Pharmaceut & Pharmacol Sci, Louvain, Belgium; [Gijsbers, Rik; Maris, Michael; Ibrahimi, Abdelilah; Debyser, Zeger] Katholieke Univ Leuven, Leuven Viral Vector Core, Louvain, Belgium; [Roberts, Scott J.] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Dept Dev & Regenerat, Louvain, Belgium; [Struys, Tom] Univ Hasselt, Biomed Res Inst, Dept Morphol, Histol Lab, Hasselt, Belgium; [Verfaillie, Catherine M.] Katholieke Univ Leuven, Stem Cell Inst Leuven, Dept Dev & Regenerat, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Hasselt University; KU Leuven	Deroose, CM (corresponding author), Katholieke Univ Leuven, Dept Imaging & Pathol, Louvain, Belgium.	christophe.deroose@uzleuven.be	Wolfs, Esther/H-1862-2017; Deroose, Christophe/AAG-7385-2020; Verfaillie, Catherine/H-5148-2013; debyser, zeger/H-1310-2013	Deroose, Christophe/0000-0002-6080-1577; Verfaillie, Catherine/0000-0001-7564-4079; debyser, zeger/0000-0002-3982-1565; Wolfs, Esther/0000-0001-9277-6524	University hospitals Leuven	University hospitals Leuven	CMD is a post-doctoral fellow of the Clinical Research Fund of the University hospitals Leuven (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bernardo ME, 2011, BONE MARROW TRANSPL, V46, P200, DOI 10.1038/bmt.2010.87; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cho Je-Yoel, 2002, Current Gene Therapy, V2, P393, DOI 10.2174/1566523023347599; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dupuy FP, 2005, J GENE MED, V7, P1158, DOI 10.1002/jgm.769; Dwyer RM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt25; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hu S, 2011, MOL IMAGING, V10, P227, DOI 10.2310/7290.2010.00051; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Kebriaei P, 2009, BIOL BLOOD MARROW TR, V15, P804, DOI 10.1016/j.bbmt.2008.03.012; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Petkov S, 2013, CELL REPROGRAM, V15, P1, DOI 10.1089/cell.2012.0053; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; Thorek DLJ, 2012, AM J NUCL MED MOLEC, V2, P163; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Van Sande J, 2003, ENDOCRINOLOGY, V144, P247, DOI 10.1210/en.2002-220744; Varma NRS, 2011, J STEM CELLS REGEN, V7, P41; Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084; Xu Y, 2009, J NUCL MED, V52, P2009	33	29	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94833	10.1371/journal.pone.0094833	http://dx.doi.org/10.1371/journal.pone.0094833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747914	gold, Green Published			2022-12-25	WOS:000335226500037
J	Zhang, N; Yang, JW; Wang, ZM; Wen, YK; Wang, J; He, WH; Liu, BL; Si, HJ; Wang, D				Zhang, Ning; Yang, Jiangwei; Wang, Zemin; Wen, Yikai; Wang, Jie; He, Wenhui; Liu, Bailin; Si, Huaijun; Wang, Di			Identification of Novel and Conserved MicroRNAs Related to Drought Stress in Potato by Deep Sequencing	PLOS ONE			English	Article							ABSCISIC-ACID; RESPONSIVE MICRORNAS; EXPRESSION PROFILES; PLANT MICRORNA; SALT STRESS; GENES; TOLERANCE; TARGETS; MICROARRAY; PREDICTION	MicroRNAs (miRNAs) are a group of small, non-coding RNAs that play important roles in plant growth, development and stress response. There have been an increasing number of investigations aimed at discovering miRNAs and analyzing their functions in model plants (such as Arabidopsis thaliana and rice). In this research, we constructed small RNA libraries from both polyethylene glycol (PEG 6,000) treated and control potato samples, and a large number of known and novel miRNAs were identified. Differential expression analysis showed that 100 of the known miRNAs were down-regulated and 99 were up-regulated as a result of PEG stress, while 119 of the novel miRNAs were up-regulated and 151 were down-regulated. Based on target prediction, annotation and expression analysis of the miRNAs and their putative target genes, 4 miRNAs were identified as regulating drought-related genes (miR811, miR814, miR835, miR4398). Their target genes were MYB transcription factor (CV431094), hydroxyproline-rich glycoprotein (TC225721), quaporin (TC223412) and WRKY transcription factor (TC199112), respectively. Relative expression trends of those miRNAs were the same as that predicted by Solexa sequencing and they showed a negative correlation with the expression of the target genes. The results provide molecular evidence for the possible involvement of miRNAs in the process of drought response and/or tolerance in the potato plant.	[Zhang, Ning; Yang, Jiangwei; Wang, Zemin; Wang, Jie; He, Wenhui; Liu, Bailin; Si, Huaijun; Wang, Di] Gansu Agr Univ, Gansu Prov Key Lab Aridland Crop Sci, Gansu Key Lab Crop Genet & Germplasm Enhancement, Lanzhou, Peoples R China; [Zhang, Ning; Wang, Zemin; Wen, Yikai; Wang, Jie; He, Wenhui; Si, Huaijun] Gansu Agr Univ, Coll Life Sci & Technol, Lanzhou, Peoples R China	Gansu Agricultural University; Gansu Agricultural University	Si, HJ (corresponding author), Gansu Agr Univ, Gansu Prov Key Lab Aridland Crop Sci, Gansu Key Lab Crop Genet & Germplasm Enhancement, Lanzhou, Peoples R China.	hjsi@gsau.edu.cn; wangd@gsau.edu.cn		Wang, Zemin/0000-0001-7936-5229	Specialized Research Fund for the Doctoral Program of Higher Education of China [20106202120003]; Gansu Key Laboratory of Arid land Crop Science of Gansu Agricultural University [GSCS-2010-01]; Fund for Creative Research Groups of Gansu Province [130RJIA005]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Gansu Key Laboratory of Arid land Crop Science of Gansu Agricultural University; Fund for Creative Research Groups of Gansu Province	This work was sponsored by the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20106202120003), the Gansu Key Laboratory of Arid land Crop Science of Gansu Agricultural University (No. GSCS-2010-01), and the Fund for Creative Research Groups of Gansu Province (No. 130RJIA005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Gerbens-Leenes W, 2009, P NATL ACAD SCI USA, V106, P10219, DOI 10.1073/pnas.0812619106; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kim HJ, 2011, GENOME, V54, P91, DOI 10.1139/G10-104; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ricardi MM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-29; Sahi Chandan, 2006, Functional & Integrative Genomics, V6, P263, DOI 10.1007/s10142-006-0032-5; Song Y, 2009, CHINESE SCI BULL, V54, P4671, DOI 10.1007/s11434-009-0710-5; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yang WZ, 2010, MOL BIOL REP, V37, P3081, DOI 10.1007/s11033-009-9881-z; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057233; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	48	53	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95489	10.1371/journal.pone.0095489	http://dx.doi.org/10.1371/journal.pone.0095489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748226	gold, Green Submitted, Green Published			2022-12-25	WOS:000335226500111
J	Khan, YM; Kirkham, P; Barnes, PJ; Adcock, IM				Khan, Younis M.; Kirkham, Paul; Barnes, Peter J.; Adcock, Ian M.			Brd4 Is Essential for IL-1 beta-Induced Inflammation in Human Airway Epithelial Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; BET BROMODOMAIN INHIBITION; EXPIRED BREATH CONDENSATE; RNA-POLYMERASE-II; OXIDATIVE STRESS; HISTONE ACETYLATION; GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL ELONGATION	Background: Chronic inflammation and oxidative stress are key features of chronic obstructive pulmonary disease (COPD). Oxidative stress enhances COPD inflammation under the control of the pro-inflammatory redox-sensitive transcription factor nuclear factor-kappaB (NF-kappa B). Histone acetylation plays a critical role in chronic inflammation and bromodomain and extra terminal (BET) proteins act as "readers'' of acetylated histones. Therefore, we examined the role of BET proteins in particular Brd2 and Brd4 and their inhibitors (JQ1 and PFI-1) in oxidative stress-enhanced inflammation in human bronchial epithelial cells. Methods: Human primary epithelial (NHBE) cells and BEAS-2B cell lines were stimulated with IL-1 beta (inflammatory stimulus) in the presence or absence of H2O2 (oxidative stress) and the effect of pre-treatment with bromodomain inhibitors (JQ1 and PFI-1) was investigated. Pro-inflammatory mediators (CXCL8 and IL-6) were measured by ELISA and transcripts by RT-PCR. H3 and H4 acetylation and recruitment of p65 and Brd4 to the native IL-8 and IL-6 promoters was investigated using chromatin immunoprecipitation (ChIP). The impact of Brd2 and Brd4 siRNA knockdown on inflammatory mediators was also investigated. Result: H2O2 enhanced IL1 beta-induced IL-6 and CXCL8 expression in NHBE and BEAS-2B cells whereas H2O2 alone did not have any affect. H3 acetylation at the IL-6 and IL-8 promoters was associated with recruitment of p65 and Brd4 proteins. Although p65 acetylation was increased this was not directly targeted by Brd4. The BET inhibitors JQ1 and PFI-1 significantly reduced IL-6 and CXCL8 expression whereas no effect was seen with the inactive enantiomer JQ1(-). Brd4, but not Brd2, knockdown markedly reduced IL-6 and CXCL8 release. JQ1 also inhibited p65 and Brd4 recruitment to the IL-6 and IL-8 promoters. Conclusion: Oxidative stress enhanced IL1 beta-induced IL-6 and CXCL8 expression was significantly reduced by Brd4 inhibition. Brd4 plays an important role in the regulation of inflammatory genes and provides a potential novel anti-inflammatory target.	[Khan, Younis M.; Barnes, Peter J.; Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis Sect, London, England; [Kirkham, Paul] Wolverhampton Univ, Sch Appl Sci, Wolverhampton WV1 1DJ, W Midlands, England	Imperial College London; University of Wolverhampton	Adcock, IM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis Sect, London, England.	ian.adcock@imperial.ac.uk	Adcock, Ian/L-3217-2019	Adcock, Ian/0000-0003-2101-8843; Barnes, Peter/0000-0002-5122-4018	NHLI studentship; Wellcome Trust [IMA 093080/Z/10/Z]; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10148] Funding Source: researchfish	NHLI studentship; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	YMK supported by NHLI studentship and by Wellcome Trust grant IMA 093080/Z/10/Z awarded to IMA and PJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock I M, 1997, Monaldi Arch Chest Dis, V52, P178; Adcock IM, 2009, BIOCHEM SOC T, V37, P824, DOI 10.1042/BST0370824; Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Adcock IM, 2005, ANTIOXID REDOX SIGN, V7, P144, DOI 10.1089/ars.2005.7.144; Alsarraj J, 2011, CANCER RES, V71, P3121, DOI 10.1158/0008-5472.CAN-10-4417; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Barnes PJ, 2011, AM J RESP CRIT CARE, V184, P866, DOI 10.1164/rccm.201108-1436ED; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Barnes PJ, 2012, CURR MED CHEM; Bartling TR, 2009, AM J RESP CELL MOL, V40, P58, DOI 10.1165/rcmb.2007-0464OC; Belkina AC, 2013, J IMMUNOL, DOI 104049/jimmunol1202838; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Chan KH, 2010, INT J TUBERC LUNG D, V14, P1193; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chiang Cheng-Ming, 2009, F1000 Biol Rep, V1, P98, DOI 10.3410/B1-98; Chung KF, ANN N Y ACAD SCI, V1203, P85; Consortium SG, 2012, PFI 1 SEL CHEM PROB; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Dekhuijzen PNR, 1996, AM J RESP CRIT CARE, V154, P813, DOI 10.1164/ajrccm.154.3.8810624; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Durham AL, 2013, FASEB J; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Hacievliyagil SS, 2013, NIGER J CLIN PRACT, V16, P76, DOI 10.4103/1119-3077.106771; Ho SC, 2009, J IMMUNOL, V183, P411, DOI 10.4049/jimmunol.0803729; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Joppa P, 2006, CHEST, V130, P326, DOI 10.1378/chest.130.2.326; Kim JW, 2012, J BIOL CHEM, V287, P7780, DOI 10.1074/jbc.M111.278465; Koch A, 2004, AM J RESP CELL MOL, V30, P342, DOI 10.1165/rcmb.2003-0122OC; Kostikas K, 2003, CHEST, V124, P1373, DOI 10.1378/chest.124.4.1373; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Loukides S, 2002, CHEST, V121, P338, DOI 10.1378/chest.121.2.338; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Picaud S, 2013, P NATL ACAD SCI US; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rodriguez RM, 2012, J MOL MED, V90, P587, DOI 10.1007/s00109-011-0837-0; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Shorter K, 2008, FASEB J, V22, P1725, DOI 10.1096/fj.07-099424; Sin DD, 2008, CHEST, V133, P4, DOI 10.1378/chest.07-2085; Sin DD, 2007, CAN J PHYSIOL PHARM, V85, P141, DOI 10.1139/Y06-093; Sinden NJ, 2010, THER ADV CHRONIC DIS, V1, P43, DOI 10.1177/2040622310370631; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Tsaprouni LG, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-1; Tsuchiya A, 2010, J PHARMACOL EXP THER, V333, P236, DOI 10.1124/jpet.109.158899; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yellepeddi VK, 2011, ANTICANCER RES, V31, P897; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047	75	72	80	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95051	10.1371/journal.pone.0095051	http://dx.doi.org/10.1371/journal.pone.0095051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759736	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200031
J	Schilbach, L; Muller, VI; Hoffstaedter, F; Clos, M; Goya-Maldonado, R; Gruber, O; Eickhoff, SB				Schilbach, Leonhard; Mueller, Veronika I.; Hoffstaedter, Felix; Clos, Mareike; Goya-Maldonado, Roberto; Gruber, Oliver; Eickhoff, Simon B.			Meta-Analytically Informed Network Analysis of Resting State fMRI Reveals Hyperconnectivity in an Introspective Socio-Affective Network in Depression	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; DEEP BRAIN-STIMULATION; FUNCTIONAL CONNECTIVITY; DISORDER; AMYGDALA	Alterations of social cognition and dysfunctional interpersonal expectations are thought to play an important role in the etiology of depression and have, thus, become a key target of psychotherapeutic interventions. The underlying neurobiology, however, remains elusive. Based upon the idea of a close link between affective and introspective processes relevant for social interactions and alterations thereof in states of depression, we used a meta-analytically informed network analysis to investigate resting-state functional connectivity in an introspective socio-affective (ISA) network in individuals with and without depression. Results of our analysis demonstrate significant differences between the groups with depressed individuals showing hyperconnectivity of the ISA network. These findings demonstrate that neurofunctional alterations exist in individuals with depression in a neural network relevant for introspection and socio-affective processing, which may contribute to the interpersonal difficulties that are linked to depressive symptomatology.	[Schilbach, Leonhard] Univ Hosp Cologne, Dept Psychiat, Cologne, Germany; [Mueller, Veronika I.; Hoffstaedter, Felix; Clos, Mareike; Eickhoff, Simon B.] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Mueller, Veronika I.; Hoffstaedter, Felix; Eickhoff, Simon B.] Univ Dusseldorf, Cognit Neurosci Grp, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Goya-Maldonado, Roberto; Gruber, Oliver] Univ Gottingen, Dept Psychiat & Psychotherapy, Ctr Translat Res Syst Neurosci & Psychiat, D-37073 Gottingen, Germany	University of Cologne; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; University of Gottingen	Schilbach, L (corresponding author), Univ Hosp Cologne, Dept Psychiat, Cologne, Germany.	leonhard.schilbach@uk-koeln.de	Schilbach, Leonhard/G-5832-2010; Goya, Roberto/N-7976-2019; Gruber, Oliver/AAY-5563-2020; Eickhoff, Simon B./K-2061-2013	Schilbach, Leonhard/0000-0001-5547-8309; Eickhoff, Simon B./0000-0001-6363-2759; Clos, Mareike/0000-0002-1611-9474; Muller, Veronika/0000-0003-4382-3181; Hoffstaedter, Felix/0000-0001-7163-3110	Koeln Fortune Program of the Medical Faculty at the University of Cologne; Volkswagen Foundation; Human Brain Project [R01-MH074457-01A1]; DFG [IRTG 1328]; Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER	Koeln Fortune Program of the Medical Faculty at the University of Cologne; Volkswagen Foundation(Volkswagen); Human Brain Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DFG(German Research Foundation (DFG)); Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	L.S. was supported by the Koeln Fortune Program of the Medical Faculty at the University of Cologne and by the Volkswagen Foundation. S.B.E. was funded by the Human Brain Project (R01-MH074457-01A1), the DFG (IRTG 1328) and the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Cisler JM, 2012, PSYCHOL MED, P1; Clos M, 2012, HUM BRAIN MAPP; Cremers HR, 2010, NEUROIMAGE, V49, P963, DOI 10.1016/j.neuroimage.2009.08.023; Cusi AM, 2011, PSYCHIAT RES, V188, P231, DOI 10.1016/j.psychres.2011.04.013; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Fox MD, 2012, BIOL PSYCHIAT; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goulden N, 2012, BIOL PSYCHIAT; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hautzinger M., 2006, BECK DEPRESSIONS INV; Jacobs RH, 2012, NEUROSCI BIOBEHAV RE; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Kashdan TB, 2007, J ANXIETY DISORD, V21, P284, DOI 10.1016/j.janxdis.2006.05.009; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Lanzenberger R, 2012, MOL PSYCHIAT; Lu Q, 2012, NEUROSCI LETT; Marchetti I, 2014, FRONT HUM NEUROSCI; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McCabe C, 2011, NEUROIMAGE, V57, P1317, DOI 10.1016/j.neuroimage.2011.05.051; McCullough James P Jr, 2011, Am J Psychother, V65, P225; Nichols TE, 2003, HUMAN BRAIN FUNCTION; O'Nions EJP, 2011, J COGNITIVE NEUROSCI, V23, P3681, DOI 10.1162/jocn_a_00055; Perrin JS, 2012, P NATL ACAD SCI USA, V109, P5464, DOI 10.1073/pnas.1117206109; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Poldrack RA, 2011, NEURON, V72, P692, DOI 10.1016/j.neuron.2011.11.001; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schilbach L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030920; Schilbach L, 2011, SOC COGN AFFECT NEUR, V6, P393, DOI 10.1093/scan/nsq067; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; Servaas MN, 2014, HUM BRAIN MAPP; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sommer IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043516; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Zahn R, 2009, NEUROSCI LETT, V457, P107, DOI 10.1016/j.neulet.2009.03.090; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	38	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94973	10.1371/journal.pone.0094973	http://dx.doi.org/10.1371/journal.pone.0094973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759619	Green Published, gold			2022-12-25	WOS:000335298200028
J	Lin, CH; Shen, ML; Zhou, N; Lee, CC; Kao, ST; Wu, DC				Lin, Ching-Huei; Shen, Mei-Lin; Zhou, Ning; Lee, Chen-Chen; Kao, Shung-Te; Wu, Dong Chuan			Protective Effects of the Polyphenol Sesamin on Allergen-Induced T(H)2 Responses and Airway Inflammation in Mice	PLOS ONE			English	Article							NF-KAPPA-B; IN-VITRO; ASTHMA; INTERLEUKIN-5; EOSINOPHILS; SUPPRESSION; MECHANISMS; INHIBITION; IMMUNOLOGY; DEFICIENT	Allergic asthma is a lifelong airway condition that affects people of all ages. In recent decades, asthma prevalence continues to increase globally, with an estimated number of 250,000 annual deaths attributed to the disease. Although inhaled corticosteroids and beta-adrenergic receptor agonists are the primary therapeutic avenues that effectively reduce asthma symptoms, profound side effects may occur in patients with long-term treatments. Therefore, development of new therapeutic strategies is needed as alternative or supplement to current asthma treatments. Sesamin is a natural polyphenolic compound with strong anti-oxidative effects. Several studies have reported that sesamin is effective in preventing hypertension, thrombotic tendency, and neuroinflammation. However, it is still unknown whether sesamin can reduce asthma-induced allergic inflammation and airway hyperresponsiveness (AHR). Our study has revealed that sesamin exhibited significant anti-inflammatory effects in ovalbumin (OVA)-induced murine asthma model. We found that treatments with sesamin after OVA sensitization and challenge significantly decreased expression levels of interleukin-4 (IL-4), IL-5, IL-13, and serum IgE. The numbers of total inflammatory cells and eosinophils in BALF were also reduced in the sesamin-treated animals. Histological results demonstrated that sesamin attenuated OVA-induced eosinophil infiltration, airway goblet cell hyperplasia, mucus occlusion, and MUC5AC expression in the lung tissue. Mice administered with sesamin showed limited increases in AHR compared with mice receiving vehicle after OVA challenge. OVA increased phosphorylation levels of I kappa B-alpha and nuclear expression levels of NF-kappa B, both of which were reversed by sesamin treatments. These data indicate that sesamin is effective in treating allergic asthma responses induced by OVA in mice.	[Lin, Ching-Huei; Shen, Mei-Lin; Zhou, Ning; Wu, Dong Chuan] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Lin, Ching-Huei; Shen, Mei-Lin; Kao, Shung-Te] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan; [Zhou, Ning; Wu, Dong Chuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lee, Chen-Chen] China Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Kao, ST (corresponding author), China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.	stkao@mail.cmu.edu.tw; dongchuanwu@gmail.com	Lee, Chen-Chen/H-4267-2014; Wu, Dong Chuan/O-3909-2015	WU, DONG CHUAN/0000-0002-9539-5935	Taiwan National Science Council [NSC 101-2320-B-039-057, NSC 100-2632-B-039-001-MY3, NSC 102-2320-B-039-038-MY3, NSC 102-2320-B-039-035]; China Medical University Hospital [DMR-102-114]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This work was supported by grants from Taiwan National Science Council (NSC 101-2320-B-039-057, NSC 100-2632-B-039-001-MY3, NSC 102-2320-B-039-038-MY3, and NSC 102-2320-B-039-035) and grants from China Medical University Hospital (DMR-102-114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Aich J, 2012, INT IMMUNOPHARMACOL, V14, P438, DOI 10.1016/j.intimp.2012.08.017; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; AKIMOTO K, 1993, ANN NUTR METAB, V37, P218, DOI 10.1159/000177771; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; BARGATZE RF, 1980, J IMMUNOL, V125, P2306; Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P451, DOI 10.1016/j.iac.2005.05.003; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Baroffio Michele, 2009, Ther Adv Respir Dis, V3, P163, DOI 10.1177/1753465809343595; Bournival J, 2012, OXID MED CELL LONGEV, V2012, P921, DOI DOI 10.1155/2012/921941; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cazzola M, 2013, AM J RESP CRIT CARE, V187, P690, DOI 10.1164/rccm.201209-1739PP; CHAPMAN ID, 1993, CLIN EXP ALLERGY, V23, P168, DOI 10.1111/j.1365-2222.1993.tb00877.x; Chavali SR, 2001, CRIT CARE MED, V29, P140, DOI 10.1097/00003246-200101000-00028; Christman JW, 2000, CHEST, V117, P1482, DOI 10.1378/chest.117.5.1482; Ci XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034634; Cui YH, 2010, J NUTR, V140, P377, DOI 10.3945/jn.109.117804; Dar AA, 2013, BIOORG CHEM, V50, P1, DOI 10.1016/j.bioorg.2013.06.009; Di Carlo G, 1999, LIFE SCI, V65, P337, DOI 10.1016/S0024-3205(99)00120-4; Diamant Z, 2013, CURR ALLERGY ASTHM R, V13, P477, DOI 10.1007/s11882-013-0376-6; Dimitrios B, 2006, TRENDS FOOD SCI TECH, V17, P505, DOI 10.1016/j.tifs.2006.04.004; Fujisawa T, 2011, AM J RESP CELL MOL, V45, P246, DOI 10.1165/rcmb.2009-0313OC; FUKUDA Y, 1986, AGR BIOL CHEM TOKYO, V50, P857, DOI 10.1080/00021369.1986.10867500; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gould HJ, 2008, NAT REV IMMUNOL; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Han AR, 2008, CHEM BIODIVERS, V5, P346, DOI 10.1002/cbdv.200890033; Harikumar KB, 2010, MOL CANCER RES, V8, P751, DOI 10.1158/1541-7786.MCR-09-0565; Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; HIROSE N, 1992, ANTICANCER RES, V12, P1259; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; HOLT PG, 1981, IMMUNOLOGY, V42, P409; Hsieh PF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-57; Hsu WH, 2012, FREE RADICAL BIO MED, V53, P1643, DOI 10.1016/j.freeradbiomed.2012.08.587; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Jarnicki AG, 2003, CURR OPIN PHARMACOL, V3, P449, DOI 10.1016/S1471-4892(03)00077-8; Jeng KCG, 2005, IMMUNOL LETT, V97, P101, DOI 10.1016/j.imlet.2004.10.004; Kay AB, 2006, CHEM IMMUNOL ALLERGY, V91, P59; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee CC, 2004, J HYPERTENS, V22, P2329, DOI 10.1097/00004872-200412000-00015; Lee CC, 2011, INFLAMMATION, V34, P209, DOI 10.1007/s10753-010-9226-z; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lee WJ, 2009, J AGR FOOD CHEM, V57, P11406, DOI 10.1021/jf902876p; Lee W, 2013, TOXICOL APPL PHARM, V267, P201, DOI 10.1016/j.taap.2013.01.008; Liu CJ, 2008, MOL CELL BIOCHEM, V313, P167, DOI 10.1007/s11010-008-9754-0; LUNDGREN R, 1988, EUR RESPIR J, V1, P883; Mabalirajan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062916; MATSUMURA Y, 1995, BIOL PHARM BULL, V18, P1016, DOI 10.1248/bpb.18.1016; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; Menzies-Gow A, 2002, CURR OPIN PULM MED, V8, P33, DOI 10.1097/00063198-200201000-00006; Noguchi Takanori, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS24, DOI 10.1111/j.1440-1681.2004.04103.x; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Perez-Berezo T, 2009, MOL NUTR FOOD RES, V53, P389, DOI 10.1002/mnfr.200700396; Pichavant Muriel, 2007, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1518s79; Pignatti PF, 2004, PHARMACOL RES, V49, P343, DOI 10.1016/j.phrs.2003.04.002; Rogers DF, 2007, RESP CARE, V52, P1134; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Saura-Calixto F, 2007, FOOD CHEM, V101, P492, DOI 10.1016/j.foodchem.2006.02.006; Seyoum A, 2006, PHYTOCHEMISTRY, V67, P2058, DOI 10.1016/j.phytochem.2006.07.002; Singh A, 2011, CLIN EXP ALLERGY, V41, P1346, DOI 10.1111/j.1365-2222.2011.03773.x; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Voynow JA, 2004, AM J PHYSIOL-LUNG C, V287, pL1293, DOI 10.1152/ajplung.00140.2004; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; World Health Organization, 2007, GLOB SURV PREV CONTR; Wu WH, 2010, MOL NUTR FOOD RES, V54, P1340, DOI 10.1002/mnfr.200900271; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	69	29	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e96091	10.1371/journal.pone.0096091	http://dx.doi.org/10.1371/journal.pone.0096091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755955	Green Published, gold, Green Submitted			2022-12-25	WOS:000335240300135
J	Liu, HM; Chen, YC; Tsao, FM				Liu, Huei-Mei; Chen, Yuchun; Tsao, Feng-Ming			Developmental Changes in Mismatch Responses to Mandarin Consonants and Lexical Tones from Early to Middle Childhood	PLOS ONE			English	Article							SPEECH-PERCEPTION; LANGUAGE-DEVELOPMENT; CHILDREN; NEGATIVITY; DISCRIMINATION; VOWEL; MATURATION; ADULTS; IMPAIRMENT; 3-YEAR-OLD	The purpose of this study was to use mismatch responses (MMRs) to explore the dynamic changes of Mandarin speech perception abilities from early to middle childhood. Twenty preschoolers, 18 school-aged children, and 26 adults participated in this study. Two sets of synthesized speech stimuli varying in Mandarin consonant (alveolo-palatal affricate vs. fricative) and lexical tone features (rising vs. contour tone) were used to examine the developmental course of speech perception abilities. The results indicated that only the adult group demonstrated typical early mismatch negativity (MMN) responses, suggesting that the ability to discriminate specific speech cues in Mandarin consonant and lexical tone is a continuing process in preschool-and school-aged children. Additionally, distinct MMR patterns provided evidence indicating diverse developmental courses to different speech characteristics. By incorporating data from the two speech conditions, we propose using MMR profiles consisting of mismatch negativity (MMN), positive mismatch response (p-MMR), and late discriminative negativity (LDN) as possible brain indices to investigate speech perception development.	[Liu, Huei-Mei; Chen, Yuchun] Natl Taiwan Normal Univ, Dept Special Educ, Taipei, Taiwan; [Tsao, Feng-Ming] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan	National Taiwan Normal University; National Taiwan University	Chen, YC (corresponding author), Natl Taiwan Normal Univ, Dept Special Educ, Taipei, Taiwan.	yuchun.m.chen@gmail.com		TSAO, FENG-MING/0000-0003-1597-7589	National Science Council [NSC 100-2628-H-003-160-MY3-]; Ministry of Education, Taiwan, R.O.C.; "International Research-Intensive Center of Excellence Program'' of NTNU; National Science Council, Taiwan, R.O.C. [NSC 103-2911-I-003-301]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); "International Research-Intensive Center of Excellence Program'' of NTNU; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research is partially supported by National Science Council ( grant No. NSC 100-2628-H-003-160-MY3-) and the "Aim for the Top University Project'' of National Taiwan Normal University (NTNU), sponsored by the Ministry of Education, Taiwan, R.O.C. and the "International Research-Intensive Center of Excellence Program'' of NTNU and National Science Council, Taiwan, R.O.C. under Grant no. NSC 103-2911-I-003-301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmmed AU, 2008, DEV MED CHILD NEUROL, V50, P938, DOI 10.1111/j.1469-8749.2008.03093.x; Arai T, 2008, ACOUST SCI TECHNOL, V29, P106, DOI 10.1250/ast.29.106; Archibald LMD, 2008, Z PSYCHOL, V216, P161, DOI 10.1027/0044-3409.216.3.161; Benasich AA, 2002, BEHAV BRAIN RES, V136, P31, DOI 10.1016/S0166-4328(02)00098-0; Boersma P., 2021, PRAAT DOING PHONETIC; BOUNTRESS NG, 1984, J COMMUN DISORD, V17, P349, DOI 10.1016/0021-9924(84)90036-4; Bradlow AR, 1999, J ACOUST SOC AM, V106, P2086, DOI 10.1121/1.427953; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Ceponiene R, 2004, PSYCHOPHYSIOLOGY, V41, P130, DOI 10.1111/j.1469-8986.2003.00138.x; Ceponiene R, 2003, CLIN NEUROPHYSIOL, V114, P652, DOI 10.1016/S1388-2457(02)00436-4; Ceponiene R, 2002, INT J PSYCHOPHYSIOL, V43, P199, DOI 10.1016/S0167-8760(01)00172-6; Chandrasekaran B, 2007, BRAIN RES, V1128, P148, DOI 10.1016/j.brainres.2006.10.064; Cheng YY, 2013, DEV NEUROPSYCHOL, V38, P281, DOI 10.1080/87565641.2013.799672; Cheour M, 2002, NEUROSCI LETT, V325, P187, DOI 10.1016/S0304-3940(02)00269-0; Concanon J, 1996, THESIS U COLL LONDON; CSEPE V, 1995, EAR HEARING, V16, P91, DOI 10.1097/00003446-199502000-00007; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Hazan V, 2000, J PHONETICS, V28, P377, DOI 10.1006/jpho.2000.0121; Howie J. M., 1976, ACOUSTICAL STUDIES M; Hua Z, 2000, J CHILD LANG, V27, P3, DOI 10.1017/S030500099900402X; Ip VWK, 2006, PERC PROD LEX TON YO; Jeng JY, 2011, B SPECIAL ED, V36, P27; Korpilahti P, 1995, ELECTROENCEPHALOGR C, V95, p96P; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Kraus N, 1993, J Am Acad Audiol, V4, P238; KRAUS N, 1995, J COGNITIVE NEUROSCI, V7, P25, DOI 10.1162/jocn.1995.7.1.25; Kushnerenko E, 2002, NEUROREPORT, V13, P1843, DOI 10.1097/00001756-200210280-00002; Lee CY, 2012, NEUROPSYCHOLOGIA, V50, P3228, DOI 10.1016/j.neuropsychologia.2012.08.025; Lin BG., 2008, CHILD LANGUAGE DISOR; Liu HM, 2013, B ED PSYCHOL, V45, P224; Lu L., 1998, XIUDING BIBAODE TUHU; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Maurer U, 2003, NEUROREPORT, V14, P2245, DOI 10.1097/00001756-200312020-00022; McGee TJ, 2001, PSYCHOPHYSIOLOGY, V38, P653, DOI 10.1017/S0048577201990973; Medina V, 2010, J PHONETICS, V38, P493, DOI 10.1016/j.wocn.2010.06.002; Meng XZ, 2005, DYSLEXIA, V11, P292, DOI 10.1002/dys.309; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; NITTROUER S, 1987, J SPEECH HEAR RES, V30, P319, DOI 10.1044/jshr.3003.319; OHDE RN, 1995, J ACOUST SOC AM, V97, P3800, DOI 10.1121/1.412395; Putkinen V, 2012, DEV NEUROPSYCHOL, V37, P51, DOI 10.1080/87565641.2011.615873; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shafer VL, 2010, EAR HEARING, V31, P735, DOI 10.1097/AUD.0b013e3181e5d1a7; Shafer VL, 2000, EAR HEARING, V21, P242, DOI 10.1097/00003446-200006000-00008; Shestakova A, 2003, CLIN NEUROPHYSIOL, V114, P1507, DOI 10.1016/S1388-2457(03)00134-2; Sussman JE, 2001, J ACOUST SOC AM, V109, P1173, DOI 10.1121/1.1349428; Tsao F. M., 2008, CHINESE J PSYCHOL, V50, P111, DOI DOI 10.6129/CJP.2008.5002.01; Tsao FM, 2006, J ACOUST SOC AM, V120, P2285, DOI 10.1121/1.2338290; Tsao FM, 2004, CHILD DEV, V75, P1067, DOI 10.1111/j.1467-8624.2004.00726.x; Vance M, 2009, INT J AUDIOL, V48, P708, DOI 10.1080/14992020902930550; Wong AMY, 2009, J SPEECH LANG HEAR R, V52, P1493, DOI 10.1044/1092-4388(2009/08-0170); Wong PS, 2005, J SPEECH LANG HEAR R, V48, P1065, DOI 10.1044/1092-4388(2005/074); Xu Y, 1997, J PHONETICS, V25, P61, DOI 10.1006/jpho.1996.0034; Zachau S, 2005, NEUROREPORT, V16, P2015, DOI 10.1097/00001756-200512190-00009; Zhang YJ, 2012, J CHILD PSYCHOL PSYC, V53, P874, DOI 10.1111/j.1469-7610.2012.02528.x	58	22	24	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95587	10.1371/journal.pone.0095587	http://dx.doi.org/10.1371/journal.pone.0095587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2IS	24755999	gold, Green Published, Green Submitted			2022-12-25	WOS:000335240300057
J	Ahlin, S; Olsson, M; Wilhelmson, AS; Skalen, K; Boren, J; Carlsson, LMS; Svensson, PA; Sjoholm, K				Ahlin, Sofie; Olsson, Maja; Wilhelmson, Anna S.; Skalen, Kristina; Boren, Jan; Carlsson, Lena M. S.; Svensson, Per-Arne; Sjoholm, Kajsa			Adipose Tissue-Derived Human Serum Amyloid A Does Not Affect Atherosclerotic Lesion Area in hSAA(+/) (-/)ApoE(-/-) Mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; REVERSE CHOLESTEROL TRANSPORT; HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; ACUTE-PHASE PROTEIN; MACROPHAGE CHOLESTEROL; INFLAMMATION; EFFLUX; PREDICTOR; INDUCTION	Chronically elevated serum levels of serum amyloid A (SAA) are linked to increased risk of cardiovascular disease. However, whether SAA is directly involved in atherosclerosis development is still not known. The aim of this study was to investigate the effects of adipose tissue-derived human SAA on atherosclerosis in mice. hSAA1(+/-) transgenic mice (hSAA1 mice) with a specific expression of human SAA1 in adipose tissue were bred with ApoE-deficient mice. The hSAA1 mice and their wild type (wt) littermates were fed normal chow for 35 weeks. At the end of the experiment, the mice were euthanized and blood, gonadal adipose tissue and aortas were collected. Plasma levels of SAA, cholesterol and triglycerides were measured. Atherosclerotic lesion areas were analyzed in the aortic arch, the thoracic aorta and the abdominal aorta in en face preparations of aorta stained with Sudan IV. The human SAA protein was present in plasma from hSAA1 mice but undetectable in wt mice. Similar plasma levels of cholesterol and triglycerides were observed in hSAA1 mice and their wt controls. There were no differences in atherosclerotic lesion areas in any sections of the aorta in hSAA1 mice compared to wt mice. In conclusion, our data suggest that adipose tissue-derived human SAA does not influence atherosclerosis development in mice.	[Ahlin, Sofie; Olsson, Maja; Skalen, Kristina; Boren, Jan; Carlsson, Lena M. S.; Svensson, Per-Arne; Sjoholm, Kajsa] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Wilhelmson, Anna S.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Sjoholm, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.	kajsa.sjoholm@medic.gu.se	Carlsson, Lena/F-7570-2018; Wilhelmson, Anna S/HCI-9867-2022; Svensson, Per-Arne/R-4626-2019	Carlsson, Lena/0000-0003-4145-6242; Wilhelmson, Anna S/0000-0003-0640-0251; Ahlin, Sofie/0000-0003-0619-2683; Svensson, Per-Arne/0000-0002-6731-806X; Sjoholm, Kajsa/0000-0003-0146-8193	Swedish Research Council [K2008-65X-20753-01-4]; Swedish federal government under LUA/ALF; Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research; Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics; Karolinska Institutet; Jeansson Foundations; Magnus Bergvall Foundation; Royal Physiographic Society (Nilsson-Ehle Foundation); Tore Nilsson Foundation; VINNOVA-VINNMER program; Sahlgrenska University Hospital Foundation; Langmanska Foundation; Wilhelm and Martina Lundgren Foundation; Novo Nordisk Fonden [NNF13OC0004973] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish federal government under LUA/ALF; Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research(Swedish Foundation for Strategic Research); Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics; Karolinska Institutet(Karolinska Institutet); Jeansson Foundations; Magnus Bergvall Foundation; Royal Physiographic Society (Nilsson-Ehle Foundation); Tore Nilsson Foundation; VINNOVA-VINNMER program(Vinnova); Sahlgrenska University Hospital Foundation; Langmanska Foundation; Wilhelm and Martina Lundgren Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The work was funded by the Swedish Research Council (K2008-65X-20753-01-4), the Swedish federal government under the LUA/ALF agreement, the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, the Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at Corporate Alliances, Karolinska Institutet, the Jeansson Foundations, the Magnus Bergvall Foundation, the Royal Physiographic Society (Nilsson-Ehle Foundation), the Tore Nilsson Foundation, the VINNOVA-VINNMER program, the Sahlgrenska University Hospital Foundation, the Langmanska Foundation, and the Wilhelm and Martina Lundgren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072204; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Chiba T, 2011, ARTERIOSCL THROM VAS, V31, P1326, DOI 10.1161/ATVBAHA.111.226159; de Beer MC, 2013, J LIPIDS, V2013, DOI 10.1155/2013/283486; De Beer MC, 2013, ARTERIOSCLER THROMB; Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; JIANG SL, 1995, J IMMUNOL, V154, P825; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; King VL, 2009, OBESITY SILVER SPRIN; Kisilevsky R, 2003, J LIPID RES, V44, P2257, DOI 10.1194/jlr.M300133-JLR200; KISILEVSKY R, 1992, LAB INVEST, V66, P778; Kisilevsky R, 2008, CURR OPIN INVEST DR, V9, P265; Kosuge M, 2007, CIRC J, V71, P186, DOI 10.1253/circj.71.186; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; Lee HY, 2013, BIOCHEM BIOPH RES CO, V433, P18, DOI 10.1016/j.bbrc.2013.02.077; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; MCADAM KPWJ, 1978, J CLIN INVEST, V61, P390, DOI 10.1172/JCI108949; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; O'Brien Kevin D, 2006, Curr Atheroscler Rep, V8, P62, DOI 10.1007/s11883-006-0066-0; Olsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019609; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shainkin-Kestenbaum R, 1996, Biomed Pept Proteins Nucleic Acids, V2, P79; Shainkin-Kestenbaum R, 1996, Biomed Pept Proteins Nucleic Acids, V2, P101; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Tam SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003867; Tam SP, 2005, J LIPID RES, V46, P2091, DOI 10.1194/jlr.M500191-JLR200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; Wilson PG, 2008, AM J PATHOL, V173, P1902, DOI 10.2353/ajpath.2008.080201; Witting PK, 2011, FREE RADICAL BIO MED, V51, P1390, DOI 10.1016/j.freeradbiomed.2011.06.031	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95468	10.1371/journal.pone.0095468	http://dx.doi.org/10.1371/journal.pone.0095468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751653	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400064
J	Chalasani, MLS; Kumari, A; Radha, V; Swarup, G				Chalasani, Madhavi Latha Somaraju; Kumari, Asha; Radha, Vegesna; Swarup, Ghanshyam			E50K-OPTN-Induced Retinal Cell Death Involves the Rab GTPase-Activating Protein, TBC1D17 Mediated Block in Autophagy	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NF-KAPPA-B; TRANSFERRIN RECEPTOR; FUNCTIONAL DAMAGE; OPTINEURIN GENE; GANGLION-CELLS; MUTANT; PHOSPHORYLATION; DEGRADATION; EXPRESSION	The protein optineurin coded by OPTN gene is involved in several functions including regulation of endocytic trafficking, autophagy and signal transduction. Certain missense mutations in the gene OPTN cause normal tension glaucoma. A glaucoma-causing mutant of optineurin, E50K, induces death selectively in retinal cells. This mutant induces defective endocytic recycling of transferrin receptor by causing inactivation of Rab8 mediated by the GTPase-activating protein, TBC1D17. Here, we have explored the mechanism of E50K-induced cell death. E50K-OPTN-induced cell death was inhibited by co-expression of a catalytically inactive mutant of TBC1D17 and also by shRNA mediated knockdown of TBC1D17. Endogenous TBC1D17 colocalized with E50K-OPTN in vesicular structures. Co-expression of transferrin receptor partially protected against E50K-induced cell death. Overexpression of the E50K-OPTN but not WT-OPTN inhibited autophagy flux. Treatment of cells with rapamycin, an inducer of autophagy, reduced E50K-OPTN-induced cell death. An LC3-binding-defective mutant of E50K-OPTN showed reduced cell death, further suggesting the involvement of autophagy. TBC1D17 localized to autophagosomes and inhibited autophagy flux dependent on its catalytic activity. Knockdown of TBC1D17 rescued cells from E50K-mediated inhibition of autophagy flux. Overall, our results suggest that E50K mutant induced death of retinal cells involves impaired autophagy as well as impaired transferrin receptor function. TBC1D17, a GTPase-activating protein for Rab GTPases, plays a crucial role in E50K-induced impaired autophagy and cell death.	[Chalasani, Madhavi Latha Somaraju; Kumari, Asha; Radha, Vegesna; Swarup, Ghanshyam] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Swarup, G (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	gshyam@ccmb.res.in	Somaraju, Madhavi Latha/AAG-8890-2020	Somaraju, Madhavi Latha/0000-0001-9968-8770; Swarup, Ghanshyam/0000-0002-8098-0509	Department of Biotechnology, Government of India [BT/PR10130/BRB/10/614/2008]; Department of Science and Technology, Government of India [SR/WOS-A/LS-28/2010]; Department of Science and Technology [SR/WOS-A/LS-28/2010]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Science and Technology(Department of Science & Technology (India))	This work was supported by a grant to GS from the Department of Biotechnology, Government of India [grant number BT/PR10130/BRB/10/614/2008]. GS gratefully acknowledges the Department of Science and Technology, Government of India for J C Bose National Fellowship. MLC gratefully acknowledges Department of Science and Technology for funding under the Women Scientist Scheme (SR/WOS-A/LS-28/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo-Barriuso M, 2013, CURR OPIN PHARMACOL, V13, P5, DOI 10.1016/j.coph.2012.09.006; Ayala-Lugo RM, 2007, MOL VIS, V13, P151; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Choi SS, 2011, BRIT J OPHTHALMOL, V95, P131, DOI 10.1136/bjo.2010.183756; Chua CEL, 2011, CELL MOL LIFE SCI, V68, P3349, DOI 10.1007/s00018-011-0748-9; Cuenca N, 2010, EXP EYE RES, V91, P273, DOI 10.1016/j.exer.2010.05.020; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Fuse N, 2004, J GLAUCOMA, V13, P299, DOI 10.1097/00061198-200408000-00007; Fuse N, 2010, TOHOKU J EXP MED, V221, P1, DOI 10.1620/tjem.221.1; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000521; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kachaner D, 2012, MOL CELL, V45, P553, DOI 10.1016/j.molcel.2011.12.030; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Leung YF, 2003, INVEST OPHTH VIS SCI, V44, P3880, DOI 10.1167/iovs.02-0693; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Minegishi Y, 2013, HUM MOL GENET, V22, P3559, DOI 10.1093/hmg/ddt210; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Pelzel HR, 2006, MOL VIS, V12, P1272; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Raz D, 2003, INVEST OPHTH VIS SCI, V44, P3675, DOI 10.1167/iovs.02-1236; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Shen XA, 2011, J BIOL CHEM, V286, P3618, DOI 10.1074/jbc.M110.175810; Shivakrupa R, 2003, J BIOL CHEM, V278, P52188, DOI 10.1074/jbc.M310656200; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Swarup G, 2004, J BIOSCIENCES, V29, P129, DOI 10.1007/BF02703408; Swarup G, 2013, GLAUCOMA BASIC CLIN; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Willoughby CE, 2004, INVEST OPHTH VIS SCI, V45, P3122, DOI 10.1167/iovs.04-0107; Xiao Z, 2009, MOL VIS, V15, P1649; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	53	42	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95758	10.1371/journal.pone.0095758	http://dx.doi.org/10.1371/journal.pone.0095758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752605	gold, Green Published, Green Submitted			2022-12-25	WOS:000335227400119
J	Choi, JY; Kim, SK; Chang, KH; Kim, MC; La, GH; Joo, GJ; Jeong, KS				Choi, Jong-Yun; Kim, Seong-Ki; Chang, Kwang-Hyeon; Kim, Myoung-Chul; La, Geung-Hwan; Joo, Gea-Jae; Jeong, Kwang-Seuk			Population Growth of the Cladoceran, Daphnia magna: A Quantitative Analysis of the Effects of Different Algal Food	PLOS ONE			English	Article							FATTY-ACID CONTENT; STEPHANODISCUS-HANTZSCHII; PHENOTYPIC PLASTICITY; PHYTOPLANKTON CONTROL; LIPID-COMPOSITION; REGULATED RIVER; SIZE; REPRODUCTION; ASSIMILATION; MICROALGAE	In this study, we examined the effects of two phytoplankton species, Chlorella vulgaris and Stephanodiscus hantzschii, on growth of the zooplankton Daphnia magna. Our experimental approach utilized stable isotopes to determine the contribution of food algae to offspring characteristics and to the size of adult D. magna individuals. When equal amounts of food algae were provided (in terms of carbon content), the size of individuals, adult zooplankton, and their offspring increased significantly following the provision of S. hantzschii, but not after the provision of C. vulgaris or of a combination of the two species. Offspring size was unaffected when C. vulgaris or a mixture of the two algal species was delivered, whereas providing only S. hantzschii increased the production of larger-sized offspring. Stable isotope analysis revealed significant assimilation of diatom-derived materials that was important for the growth of D. magna populations. Our results confirm the applicability of stable isotope approaches for clarifying the contribution of different food algae and elucidate the importance of food quality for growth of D. magna individuals and populations. Furthermore, we expect that stable isotope analysis will help to further precisely examine the contribution of prey to predators or grazers in controlled experiments.	[Choi, Jong-Yun; Kim, Seong-Ki; Joo, Gea-Jae; Jeong, Kwang-Seuk] Pusan Natl Univ, Dept Biol Sci, Pusan, South Korea; [Chang, Kwang-Hyeon] Kyung Hee Univ, Dept Environm Sci, Yongin, South Korea; [Chang, Kwang-Hyeon] Kyung Hee Univ, Dept Engn, Yongin, South Korea; [Kim, Myoung-Chul] Chemtopia Co Ltd, Inst Environm Ecol, Seoul, South Korea; [La, Geung-Hwan] Suncheon Natl Univ, Dept Environm Educ, Sunchon, South Korea; [Jeong, Kwang-Seuk] Pusan Natl Univ, Inst Environm Sci & Technol, Pusan, South Korea	Pusan National University; Kyung Hee University; Kyung Hee University; Sunchon National University; Pusan National University	Jeong, KS (corresponding author), Pusan Natl Univ, Dept Biol Sci, Pusan, South Korea.	kknd.ecoinfo@gmail.com	CHOI, Jong-Yun/AAT-6338-2020	CHOI, Jong-Yun/0000-0003-3237-8334; chang, Kwang-Hyeon/0000-0002-7952-4047	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2012-R1A6A3A04040793]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was fully supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: NRF-2012-R1A6A3A04040793; http:// www. nrf. re. kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLGREN G, 1990, J PLANKTON RES, V12, P809, DOI 10.1093/plankt/12.4.809; AHLGREN G, 1992, J PHYCOL, V28, P37, DOI 10.1111/j.0022-3646.1992.00037.x; Bohrer RN, 1988, FUNCT ECOL, V2, P463, DOI 10.2307/2389389; BOURDIER GG, 1989, J PLANKTON RES, V11, P1201, DOI 10.1093/plankt/11.6.1201; BRANSTRATOR DK, 1991, LIMNOL OCEANOGR, V36, P483, DOI 10.4319/lo.1991.36.3.0483; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; CHANT DA, 1961, CAN J ZOOLOG, V39, P311, DOI 10.1139/z61-035; DAWIDOWICZ P, 1990, HYDROBIOLOGIA, V200, P43, DOI 10.1007/BF02530327; DRENNER RW, 1986, CAN J FISH AQUAT SCI, V43, P1935, DOI 10.1139/f86-239; DUNSTAN GA, 1993, J APPL PHYCOL, V5, P71, DOI 10.1007/BF02182424; Dutz J, 2008, LIMNOL OCEANOGR, V53, P225, DOI 10.4319/lo.2008.53.1.0225; ELENDT BP, 1990, PROTOPLASMA, V154, P25, DOI 10.1007/BF01349532; GELLER W, 1981, OECOLOGIA, V49, P316, DOI 10.1007/BF00347591; GLIWICZ ZM, 1990, ECOLOGY, V71, P691, DOI 10.2307/1940323; HART RC, 1993, J PLANKTON RES, V15, P295, DOI 10.1093/plankt/15.3.295; HERZIG A, 1989, HYDROBIOLOGIA, V186, P129, DOI 10.1007/BF00048904; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jeong KS, 2007, WATER RES, V41, P1269, DOI 10.1016/j.watres.2006.11.054; Jo H, 2014, ECOL EVOL, V4, P219, DOI 10.1002/ece3.921; Jung SW, 2010, J APPL PHYCOL, V22, P409, DOI 10.1007/s10811-009-9473-2; KILHAM P, 1986, LIMNOL OCEANOGR, V31, P1169, DOI 10.4319/lo.1986.31.6.1169; Kim DK, 2007, FRESHWATER BIOL, V52, P2021, DOI 10.1111/j.1365-2427.2007.01804.x; KIMBALL DC, 1971, T AM FISH SOC, V100, P572, DOI 10.1577/1548-8659(1971)100<572:AMOEFS>2.0.CO;2; LAMPERT W, 1993, ECOLOGY, V74, P1455, DOI 10.2307/1940074; LAMPERT W, 1986, LIMNOL OCEANOGR, V31, P478, DOI 10.4319/lo.1986.31.3.0478; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MullerNavarra D, 1996, J PLANKTON RES, V18, P1137, DOI 10.1093/plankt/18.7.1137; MullerNavarra DC, 1995, LIMNOL OCEANOGR, V40, P1209; MURTAUGH PA, 1985, J PLANKTON RES, V7, P415, DOI 10.1093/plankt/7.3.415; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; REEDE T, 1995, J PLANKTON RES, V17, P1661, DOI 10.1093/plankt/17.8.1661; RENAUD SM, 1994, J APPL PHYCOL, V6, P337, DOI 10.1007/BF02181948; Scheiner SM, 1998, EVOLUTION, V52, P368, DOI 10.1111/j.1558-5646.1998.tb01638.x; SICKOGOAD L, 1991, J PHYCOL, V27, P710, DOI 10.1111/j.0022-3646.1991.00710.x; SPITZE K, 1991, EVOLUTION, V45, P82, DOI [10.2307/2409484, 10.1111/j.1558-5646.1991.tb05268.x]; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; Toft S, 1999, OECOLOGIA, V119, P191, DOI 10.1007/s004420050776; Urabe J, 2009, GLOBAL CHANGE BIOL, V15, P523, DOI 10.1111/j.1365-2486.2008.01720.x; VANDONK E, 1990, J PHYCOL, V26, P40; VanDonk E, 1997, LIMNOL OCEANOGR, V42, P357; Wetzel RG, 2001, LIMNOLOGY, Vthird, P331; Yu RQ, 2002, LIMNOL OCEANOGR, V47, P495, DOI 10.4319/lo.2002.47.2.0495	45	15	15	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95591	10.1371/journal.pone.0095591	http://dx.doi.org/10.1371/journal.pone.0095591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752042	Green Published, gold, Green Submitted			2022-12-25	WOS:000335227400085
J	South, T; Holmes, NM; Martire, SI; Westbrook, RF; Morris, MJ				South, Timothy; Holmes, Nathan M.; Martire, Sarah I.; Westbrook, R. Frederick; Morris, Margaret J.			Rats Eat a Cafeteria-Style Diet to Excess but Eat Smaller Amounts and Less Frequently when Tested with Chow	PLOS ONE			English	Article							PROTEIN LEVERAGE HYPOTHESIS; HIGH-FAT; MEAL PATTERNS; BODY-WEIGHT; FOOD-INTAKE; OBESE RATS; SELECTION; BEHAVIOR; GHRELIN; SIZE	Background: Obesity is associated with excessive consumption of palatable, energy dense foods. The present study used an animal model to examine feeding patterns during exposure to and withdrawal from these foods. Methods: Male Sprague Dawley rats were exposed to standard lab chow only (Chow rats) or a range of cafeteria-style foods eaten by people (Caf rats). After 1, 4, 7 and 10 weeks of diet in their home cage, rats were subjected to 24-hour test sessions in a Comprehensive Lab Animal Monitoring System (CLAMS). In the first two test sessions, Chow rats were exposed to standard lab chow only while Caf rats were exposed to a biscuit and high-fat chow diet. In the final two test sessions, half the rats in each group were switched to the opposing diet. In each session we recorded numbers of bouts, energy consumed per bout, and intervals between bouts across the entire 24 hours. Results: Relative to Chow rats, Caf rats initiated fewer bouts but consumed more energy per bout; however, their motivation to feed in the CLAMS declined over time, which was attributed to reduced variety of foods relative to their home cage diet. This decline in motivation was especially pronounced among Caf rats switched from the palatable CLAMS diet to standard lab chow only: the reduced energy intake in this group was due to a modest decline in bout frequency and a dramatic decline in bout size. Conclusions: Exposure to a cafeteria-diet, rich in variety, altered feeding patterns, reduced rats' motivation to consume palatable foods in the absence of variety, and further diminished motivation to feed when palatable foods were withdrawn and replaced with chow. Hence, variety is a key factor in driving excessive consumption of energy dense foods, and therefore, excessive weight gain.	[South, Timothy; Morris, Margaret J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Holmes, Nathan M.; Martire, Sarah I.; Westbrook, R. Frederick] Univ New S Wales, Dept Psychol, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Morris, MJ (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.	m.morris@unsw.edu.au	Morris, Margaret J/J-4285-2013	Westbrook, Fred/0000-0002-6880-9274; Morris, Margaret/0000-0003-2285-5117; Holmes, Nathan/0000-0002-0592-2026	National Health and Medical Research Council of Australia [568728]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a project grant (568728) from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campfield LA, 1997, APPETITE, V29, P135, DOI 10.1006/appe.1997.0122; DAVIS JD, 1989, ANN NY ACAD SCI, V575, P106, DOI DOI 10.1111/J.1749-6632.1989.TB53236.X; Epstein LH, 2011, AM J CLIN NUTR, V94, P12, DOI 10.3945/ajcn.110.010314; Erdmann J, 2004, J CLIN ENDOCR METAB, V89, P3048, DOI 10.1210/jc.2003-031610; Goularte JF, 2012, BRIT J NUTR, V108, P1511, DOI 10.1017/S0007114511006933; Green SM, 2000, BRIT J NUTR, V84, P521; Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Koletzko B, 2010, CRIT REV FOOD SCI, V50, P100, DOI 10.1080/10408390903467431; LARUEACHAGIOTIS C, 1992, PHYSIOL BEHAV, V51, P995, DOI 10.1016/0031-9384(92)90083-E; Lindberg MA, 2011, J ADDICT MED, V5, P272, DOI 10.1097/ADM.0b013e3182118d41; Lucas F, 1999, PHYSIOL BEHAV, V66, P381, DOI 10.1016/S0031-9384(98)00275-3; Maniam J, 2010, PSYCHONEUROENDOCRINO, V35, P717, DOI 10.1016/j.psyneuen.2009.10.013; Martinez-Cordero C, 2012, APPETITE, V59, P312, DOI 10.1016/j.appet.2012.05.013; Martire SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060407; Melhorn SJ, 2010, PHYSIOL BEHAV, V99, P33, DOI 10.1016/j.physbeh.2009.10.004; ROGERS PJ, 1985, PHYSIOL BEHAV, V35, P493, DOI 10.1016/0031-9384(85)90129-5; ROGERS PJ, 1984, NEUROSCI BIOBEHAV R, V8, P441, DOI 10.1016/0149-7634(84)90003-4; ROLLS BJ, 1983, PHYSIOL BEHAV, V31, P21, DOI 10.1016/0031-9384(83)90091-4; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Synowski SJ, 2005, APPETITE, V45, P191, DOI 10.1016/j.appet.2005.02.004; Warwick ZS, 2003, PHYSIOL BEHAV, V80, P253, DOI 10.1016/j.physbeh.2003.07.007; Zhang SY, 2013, MOL MED REP, V7, P223, DOI 10.3892/mmr.2012.1154; Zizza C, 2001, PREV MED, V32, P303, DOI 10.1006/pmed.2000.0817	26	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e93506	10.1371/journal.pone.0093506	http://dx.doi.org/10.1371/journal.pone.0093506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751610	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400004
J	Fletcher, PA; Clement, F; Vidal, A; Tabak, J; Bertram, R				Fletcher, Patrick A.; Clement, Frederique; Vidal, Alexandre; Tabak, Joel; Bertram, Richard			Interpreting Frequency Responses to Dose-Conserved Pulsatile Input Signals in Simple Cell Signaling Motifs	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GNRH PULSE FREQUENCY; GENE-EXPRESSION; RHESUS-MONKEY; DELIVERY; STIMULATION; SECRETION; SENSITIVITY; DYNAMICS; INCREASE	Many hormones are released in pulsatile patterns. This pattern can be modified, for instance by changing pulse frequency, to encode relevant physiological information. Often other properties of the pulse pattern will also change with frequency. How do signaling pathways of cells targeted by these hormones respond to different input patterns? In this study, we examine how a given dose of hormone can induce different outputs from the target system, depending on how this dose is distributed in time. We use simple mathematical models of feedforward signaling motifs to understand how the properties of the target system give rise to preferences in input pulse pattern. We frame these problems in terms of frequency responses to pulsatile inputs, where the amplitude or duration of the pulses is varied along with frequency to conserve input dose. We find that the form of the nonlinearity in the steady state input-output function of the system predicts the optimal input pattern. It does so by selecting an optimal input signal amplitude. Our results predict the behavior of common signaling motifs such as receptor binding with dimerization, and protein phosphorylation. The findings have implications for experiments aimed at studying the frequency response to pulsatile inputs, as well as for understanding how pulsatile patterns drive biological responses via feedforward signaling pathways.	[Fletcher, Patrick A.; Tabak, Joel; Bertram, Richard] Florida State Univ, Dept Math, Tallahassee, FL 32306 USA; [Clement, Frederique; Vidal, Alexandre] Inria Paris Rocquencourt Res Ctr, Project Team MYCENAE, Le Chesnay, France; [Vidal, Alexandre] Univ Evry Val dEssonne, Lab Anal & Probabil EA 2172, Evry, France; [Tabak, Joel] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Bertram, Richard] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Bertram, Richard] Florida State Univ, Program Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; UDICE-French Research Universities; Universite Paris Saclay; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bertram, R (corresponding author), Florida State Univ, Dept Math, Tallahassee, FL 32306 USA.	bertram@zeno.math.fsu.edu	Bertram, Richard/ABI-5859-2020; Fletcher, Patrick/AAC-6848-2019	Fletcher, Patrick/0000-0003-0227-5895; /0000-0002-0588-957X	National Science Foundation [DMS-1220063]; large-scale action REGATE (REgulation of the GonAdoTropE axis); Direct For Mathematical & Physical Scien [1220063] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); large-scale action REGATE (REgulation of the GonAdoTropE axis); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by the National Science Foundation grant DMS-1220063 to R. Bertram and J. Tabak (http://www.nsf.gov) and by the large-scale action REGATE (REgulation of the GonAdoTropE axis) to F. Clement and A. Vidal (https://www.rocq.inria.fr/sisyphe/reglo/regate.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; BICKNELL RJ, 1988, J EXP BIOL, V139, P51; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; EVANS NP, 1995, ENDOCRINOLOGY, V136, P1603, DOI 10.1210/en.136.4.1603; FUCHS AR, 1991, AM J OBSTET GYNECOL, V165, P1515; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; KNOBIL E, 1980, SCIENCE, V207, P1371, DOI 10.1126/science.6766566; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; MATTHEWS DR, 1983, DIABETES, V32, P617, DOI 10.2337/diabetes.32.7.617; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; Tsaneva-Atanasova K, 2012, J R SOC INTERFACE, V9, P170, DOI 10.1098/rsif.2011.0215; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; WEIGLE DS, 1984, AM J PHYSIOL, V247, pE564, DOI 10.1152/ajpendo.1984.247.4.E564; WILDT L, 1981, ENDOCRINOLOGY, V109, P376, DOI 10.1210/endo-109-2-376	25	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95613	10.1371/journal.pone.0095613	http://dx.doi.org/10.1371/journal.pone.0095613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748217	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500129
J	Mendoza, Y; Martinez, AA; Mewa, JC; Gonzalez, C; Garcia-Morales, C; Avila-Rios, S; Reyes-Teran, G; Armien, B; Pascale, JM; Bello, G				Mendoza, Yaxelis; Martinez, Alexander A.; Castillo Mewa, Juan; Gonzalez, Claudia; Garcia-Morales, Claudia; Avila-Rios, Santiago; Reyes-Teran, Gustavo; Armien, Blas; Pascale, Juan M.; Bello, Gonzalo			Human Immunodeficiency Virus Type 1 (HIV-1) Subtype B Epidemic in Panama Is Mainly Driven by Dissemination of Country-Specific Clades	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; POPULATION-DYNAMICS; MAXIMUM-LIKELIHOOD; CENTRAL-AMERICA; SEQUENCES; PREVALENCE; MUTATIONS; INFERENCE; HIV/AIDS; HONDURAS	The Human immunodeficiency virus type-1 (HIV-1) subtype B is the most predominant clade in Central America; but information about the evolutionary history of this virus in this geographic region is scarce. In this study, we reconstructed the spatiotemporal and population dynamics of the HIV-1 subtype B epidemic in Panama. A total of 761 HIV-1 subtype B pol sequences obtained in Panama between 2004 and 2013 were combined with subtype B pol sequences from the Americas and Europe. Maximum Likelihood phylogenetic analyses revealed that HIV-1 subtype B infections in Panama derived from the dissemination of multiple founder viruses. Most Panamanian subtype B viruses (94.5%) belong to the pandemic viral strain proposed as originated in the US, whereas others (5.5%) were intermixed among non-pandemic Caribbean strains. The bulk (76.6%) of subtype B sequences from Panama grouped within 12 country-specific clades that were not detected in other Central American countries. Bayesian coalescent-based analyses suggest that most Panamanian clades probably originated between the early 1970s and the early 1980s. The root location of major Panamanian clades was traced to the most densely populated districts of Panama province. Major Panamanian clades appear to have experienced one or two periods of exponential growth of variable duration between the 1970s and the 2000s, with median growth rates from 0.2 to 0.4 year(-1). Thus, the HIV-1 subtype B epidemic in Panama is driven by the expansion of local viral strains that were introduced from the Caribbean and other American countries at an early stage of the AIDS pandemic.	[Mendoza, Yaxelis; Martinez, Alexander A.; Castillo Mewa, Juan; Gonzalez, Claudia; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, Andhra Pradesh, India; [Mendoza, Yaxelis] Univ Panama, Dept Genet & Mol Biol, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] City Knowledge, INDICASAT AIP, Panama City, Panama; [Garcia-Morales, Claudia; Avila-Rios, Santiago; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Armien, Blas] Gorgas Mem Inst Hlth Studies, Dept Emerging & Zoonot Infect Dis, Panama City, Panama	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de Panama; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Fundacao Oswaldo Cruz; Instituto Conmemorativo Gorgas de Estudios de la Salud	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	Bentancor, Gonzalo Jose Bello/N-7377-2019; Avila-Rios, Santiago/AAB-4383-2020; Martínez, Alexander/HHC-2101-2022; Martinez, Alexander A/F-9601-2012; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Martinez, Alexander A/0000-0002-7816-3040; Reyes-Teran, Gustavo/0000-0002-4115-4888; Gonzalez, Claudia/0000-0002-0055-9758	Department of Genomics and Proteomics (ICGES); Ministry of Health (Panama); International Atomic Energy Agency (IAEA) [PAN-6011]; Instituto para la Formacion de Recursos Humanos (IFARHU); Secretaria Nacional de Ciencia y Tecnologia (SENACYT)	Department of Genomics and Proteomics (ICGES); Ministry of Health (Panama); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Instituto para la Formacion de Recursos Humanos (IFARHU); Secretaria Nacional de Ciencia y Tecnologia (SENACYT)	The project was supported in part by the Department of Genomics and Proteomics (ICGES) and the Ministry of Health (Panama) and Project PAN-6011 from the International Atomic Energy Agency (IAEA). YM was funded by a fellowship from Instituto para la Formacion de Recursos Humanos (IFARHU) and Secretaria Nacional de Ciencia y Tecnologia (SENACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 1981, MORBIDITY MORTALITY, V30, P250; Avila-Rios S, 2011, REV PANAM SALUD PUBL, V30, P641, DOI 10.1590/S1020-49892011001200024; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Castillo J, 2011, REV PANAM SALUD PUBL, V30, P649, DOI 10.1590/S1020-49892011001200025; Centers for Disease Control (CDC), 1981, MMWR-MORBID MORTAL W, V30, P305; Chen J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026827, 10.1371/journal.pone.0025286]; Cleghorn FR, 2000, P NATL ACAD SCI USA, V97, P10532, DOI 10.1073/pnas.97.19.10532; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Ycaza M M, 1985, Rev Med Panama, V10, P66; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holguin A, 2013, CLIN MICROBIOL INFEC, V17, P1469; Holguin A, 2011, PEDIATR INFECT DIS J, V30, pE82, DOI 10.1097/INF.0b013e3182117289; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; Lara C, 1997, J CLIN MICROBIOL, V35, P783, DOI 10.1128/JCM.35.3.783-784.1997; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lloyd B, 2008, AIDS RES HUM RETROV, V24, P529, DOI 10.1089/aid.2007.0172; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085153; Murillo W, 2010, HIV MED, V11, P95, DOI 10.1111/j.1468-1293.2009.00747.x; Murillo W, 2013, J VIROL, V87, P7463, DOI 10.1128/JVI.01602-12; Murillo W, 2012, J MED VIROL, V84, P1514, DOI 10.1002/jmv.23381; Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Pagan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069218; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, TRACER V1 6; Rambaut A., 2014, FIGTREE V14 TREE FIG; Renjifo B, 1999, VIRUS RES, V60, P191, DOI 10.1016/S0168-1702(99)00014-3; Republica de Panama: Ministerio de Salud, 2012, B EST AN 2011; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; StatsDirect, 2013, STATSDIRECT STAT SOF; Taylor-Castillo L, 2010, REV PANAM SALUD PUBL, V27, P23, DOI 10.1590/S1020-49892010000100004; Teva I, 2012, REV MED CHILE, V140, P50, DOI /S0034-98872012000100007; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson MM, 2005, AIDS REV, V7, P210; UNAIDS, 2013, GLOB FACT SHEET; UNAIDS, 2013, GLOB REP REP GLOB AI; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95360	10.1371/journal.pone.0095360	http://dx.doi.org/10.1371/journal.pone.0095360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748274	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500092
J	Pawar, SA; Shao, LJ; Chang, JH; Wang, WZ; Pathak, R; Zhu, XY; Wang, JR; Hendrickson, H; Boerma, M; Sterneck, E; Zhou, DH; Hauer-Jensen, M				Pawar, Snehalata A.; Shao, Lijian; Chang, Jianhui; Wang, Wenze; Pathak, Rupak; Zhu, Xiaoyan; Wang, Junru; Hendrickson, Howard; Boerma, Marjan; Sterneck, Esta; Zhou, Daohong; Hauer-Jensen, Martin			C/EBP delta Deficiency Sensitizes Mice to Ionizing Radiation-Induced Hematopoietic and Intestinal Injury	PLOS ONE			English	Article							BINDING-PROTEIN-DELTA; TOTAL-BODY IRRADIATION; DNA-DAMAGE RESPONSE; IN-VIVO; GASTROINTESTINAL-SYNDROME; SELECTIVELY PROTECTS; CELLULAR-RESPONSE; GROWTH ARREST; STEM; EXPRESSION	Knowledge of the mechanisms involved in the radiation response is critical for developing interventions to mitigate radiation-induced injury to normal tissues. Exposure to radiation leads to increased oxidative stress, DNA-damage, genomic instability and inflammation. The transcription factor CCAAT/enhancer binding protein delta (Cebpd; C/EBP delta is implicated in regulation of these same processes, but its role in radiation response is not known. We investigated the role of C/EBP delta in radiation-induced hematopoietic and intestinal injury using a Cebpd knockout mouse model. Cebpd-/- mice showed increased lethality at 7.4 and 8.5 Gy total-body irradiation (TBI), compared to Cebpd+/+ mice. Two weeks after a 6 Gy dose of TBI, Cebpd-/- mice showed decreased recovery of white blood cells, neutrophils, platelets, myeloid cells and bone marrow mononuclear cells, decreased colony-forming ability of bone marrow progenitor cells, and increased apoptosis of hematopoietic progenitor and stem cells compared to Cebpd+/+ controls. Cebpd-/- mice exhibited a significant dose-dependent decrease in intestinal crypt survival and in plasma citrulline levels compared to Cebpd+/+ mice after exposure to radiation. This was accompanied by significantly decreased expression of gamma-H2AX in Cebpd-/- intestinal crypts and villi at 1 h post-TBI, increased mitotic index at 24 h post-TBI, and increase in apoptosis in intestinal crypts and stromal cells of Cebpd-/- compared to Cebpd+/+ mice at 4 h post-irradiation. This study uncovers a novel biological function for C/EBP delta in promoting the response to radiation-induced DNA-damage and in protecting hematopoietic and intestinal tissues from radiation-induced injury.	[Pawar, Snehalata A.; Shao, Lijian; Chang, Jianhui; Wang, Wenze; Pathak, Rupak; Zhu, Xiaoyan; Wang, Junru; Boerma, Marjan; Zhou, Daohong; Hauer-Jensen, Martin] Univ Arkansas Med Sci, Div Radiat Hlth, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Hendrickson, Howard] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Sterneck, Esta] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Surg Serv, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Pawar, SA (corresponding author), Univ Arkansas Med Sci, Div Radiat Hlth, Dept Pharmaceut Sci, Little Rock, AR 72205 USA.	SAPawar@uams.edu	Shao, Lijian/AAA-1074-2020; Pawar, Snehalata/ABD-4557-2020	Pawar, Snehalata/0000-0003-3992-2494; Sterneck, Esta/0000-0001-7716-8766	Arkansas Bioscience Institute; UAMS Medical Research Endowment Funds; Center for Microbial Pathogenesis and Host Inflammatory Responses COBRE Grant [1P20GM103625]; Edward P. Evan's Foundation; NIH, National Cancer Institute; Veterans Administration; NATIONAL CANCER INSTITUTE [ZIABC010307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103625] Funding Source: NIH RePORTER	Arkansas Bioscience Institute; UAMS Medical Research Endowment Funds; Center for Microbial Pathogenesis and Host Inflammatory Responses COBRE Grant; Edward P. Evan's Foundation; NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant support by Arkansas Bioscience Institute (SAP), UAMS Medical Research Endowment Funds (SAP), Center for Microbial Pathogenesis and Host Inflammatory Responses COBRE Grant 1P20GM103625 (SAP) and the Edward P. Evan's Foundation (DZ, MHJ), Veterans Administration (MHJ) is gratefully acknowledged. ES is supported by the Intramural Research Program of the NIH, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen CN, 2009, RADIOTHER ONCOL, V92, P299, DOI 10.1016/j.radonc.2009.06.015; Apostolov EO, 2009, RADIAT RES, V172, P481, DOI 10.1667/RR1647.1; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chua HL, 2012, HEALTH PHYS, V103, P356, DOI 10.1097/HP.0b013e3182666d6f; Ejarque-Ortiz A, 2010, J NEUROSCI RES, V88, P1113, DOI 10.1002/jnr.22272; Fu Q, 2009, RADIAT RES, V171, P698, DOI 10.1667/RR1685.1; Gabai VL, 2010, ONCOGENE, V29, P1952, DOI 10.1038/onc.2009.480; GALE RP, 1988, HEMATOPOIESIS LONG T, P63; Garg S, 2010, RADIAT RES, V173, P469, DOI 10.1667/RR1742.1; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Gery S, 2005, ONCOGENE, V24, P1589, DOI 10.1038/sj.onc.1208393; Gupta PK, 2011, ANAL METHODS-UK, V3, P1759, DOI 10.1039/c1ay05213f; HENDRY JH, 1983, RADIAT RES, V96, P100, DOI 10.2307/3576169; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hour TC, 2010, BIOCHEM PHARMACOL, V80, P325, DOI 10.1016/j.bcp.2010.04.007; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Lee JH, 2010, ONCOGENE, V29, P1431, DOI 10.1038/onc.2009.438; Li DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062921; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.161; LOHRMANN HPE, 1988, HEMATOPOIESIS LONG T, P325; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Lutgens L, 2007, WORLD J GASTROENTERO, V13, P3033, DOI 10.3748/wjg.v13.i22.3033; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Moding EJ, 2013, NAT REV DRUG DISCOV, V12, P526, DOI 10.1038/nrd4003; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; O'Rourke JP, 1999, J BIOL CHEM, V274, P16582, DOI 10.1074/jbc.274.23.16582; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Pawar SA, 2010, P NATL ACAD SCI USA, V107, P9210, DOI 10.1073/pnas.0913813107; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; Plett PA, 2014, HEALTH PHYS, V106, P7, DOI 10.1097/HP.0b013e3182a4dd4e; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Prasanna PGS, 2012, TRANSL CANCER RES, V1, P35, DOI 10.3978/j.issn.2218-676X.2012.05.05; Pritchard DM, 1999, ONCOGENE, V18, P7287, DOI 10.1038/sj.onc.1203150; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; SCOTT LM, 1992, BLOOD, V80, P1725; Shao LJ, 2010, BLOOD, V115, P4707, DOI 10.1182/blood-2009-10-248872; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Takata Y, 2002, CIRC RES, V91, P427, DOI 10.1161/01.RES.0000031271.20771.4F; TESTA NG, 1985, ANTICANCER RES, V5, P101; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Wang J, 2010, P NATL ACAD SCI USA, V107, P16131, DOI 10.1073/pnas.1002603107; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang Y, 2006, CELL CYCLE, V5, P35, DOI 10.4161/cc.5.1.2280; Wang Y, 2004, CANCER RES, V64, P6240, DOI 10.1158/0008-5472.CAN-04-0591; Wang Y, 2011, RADIAT RES, V176, P743, DOI 10.1667/RR2727.1; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Watson AJM, 2000, AM J PHYSIOL-GASTR L, V278, pG1, DOI 10.1152/ajpgi.2000.278.1.G1; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122	61	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94967	10.1371/journal.pone.0094967	http://dx.doi.org/10.1371/journal.pone.0094967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747529	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500047
J	Reichenheim, M; Souza, W; Coutinho, ESF; Figueira, I; Quintana, MI; de Mello, MF; Bressan, RA; Mari, JD; Andreoli, SB				Reichenheim, Michael; Souza, Wanderson; Freire Coutinho, Evandro Silva; Figueira, Ivan; Quintana, Maria Ines; de Mello, Marcelo Feijo; Bressan, Rodrigo Affonseca; Mari, Jair de Jesus; Andreoli, Sergio Baxter			Structural Validity of the Tonic Immobility Scale in a Population Exposed to Trauma: Evidence from Two Large Brazilian Samples	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD SEXUAL-ABUSE; RAPE; SURVIVORS; VIOLENCE; ASSAULT; FREEZE; FLIGHT; DEATH; FIGHT	Background: Tonic Immobility is a temporary state of motor inhibition in situations involving extreme fear. The first scale developed for its assessment was the 10-item Tonic Immobility Scale (TIS). However, there are still few studies on its structural (dimensional) validity. The objective of this study was to reassess the factor structure of the TIS applied to representative samples exposed to general trauma of two Brazilian mega-cities. Methods: The sample comprised 3,223 participants reporting at least one traumatic experience. In Sao Paulo (n = 2,148), a Confirmatory Factor Analysis (CFA) first tested the originally proposed two-dimensional structure. This was followed by sequential Exploratory Structural Equation Models to identify the best fitting model, and subsequently tested in Rio de Janeiro (n = 1,075) via CFA. Alternative reduced versions were further explored using the aggregate sample. Model-based Item Response Theory (IRT) location parameters were also investigated. Results: An absence of factor-based convergent and discriminant validity rejected the original proposition. However, the one-dimensional structure still held several residual correlations. Further exploration indicated the sustainability of reduced versions with seven (alternative A) and six (alternative B) items. Both presented excellent fit and no relevant residual item correlation. According to the IRT location parameters, items in alternative B covered a wider range of the latent trait. The Loevinger's H scalability coefficients underscored this pattern. Conclusions: The original model did not hold. A one-factor solution was the most tenable in both large samples, but with significant item residual correlations, indicating that content redundancies persisted. Further reduced and simplified versions of the TIS proved promising. Although studies are yet to be carried out in other settings, it is the authors' impression that the restricted versions of the TIS are already apt for use in epidemiologic studies since the pros tend to outweigh the cons (as outlined in the Discussion section).	[Reichenheim, Michael] State Univ Rio de Janeiro UERJ, Dept Epidemiol, Inst Social Med IMS, Rio De Janeiro, RJ, Brazil; [Souza, Wanderson] Fed Rural Univ Rio de Janeiro UFRRJ, Dept Psychol, Inst Educ, Seropedica, RJ, Brazil; [Freire Coutinho, Evandro Silva] Fiocruz MS, Dept Epidemiol, Natl Sch Publ Hlth ENSP, Rio De Janeiro, RJ, Brazil; [Figueira, Ivan] Fed Univ Rio de Janeiro UFRJ, Inst Psychiat IPUB, Rio De Janeiro, RJ, Brazil; [Quintana, Maria Ines; de Mello, Marcelo Feijo; Bressan, Rodrigo Affonseca; Mari, Jair de Jesus; Andreoli, Sergio Baxter] Fed Univ Sao Paulo UNIFESP, Dept Psychiat, Sao Paulo, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP)	Reichenheim, M (corresponding author), State Univ Rio de Janeiro UERJ, Dept Epidemiol, Inst Social Med IMS, Rio De Janeiro, RJ, Brazil.	michael@ims.uerj.br	Mello, Marcelo/D-9565-2011; Andreoli, Sergio Baxter/M-7112-2019; Bressan, Rodrigo A/E-9178-2010; de Jesus Mari, Jair/A-7309-2008; Andreoli, Sergio Baxter/D-9568-2012; Quintana, Maria Ines/F-6320-2012	Mello, Marcelo/0000-0002-0475-4729; Andreoli, Sergio Baxter/0000-0002-1976-0881; Bressan, Rodrigo A/0000-0002-0868-4449; de Jesus Mari, Jair/0000-0002-5403-0112; Andreoli, Sergio Baxter/0000-0002-1976-0881; Quintana, Maria Ines/0000-0002-3808-8189; Souza, Wanderson/0000-0002-9389-6234; Coutinho, Evandro/0000-0002-4649-7353	State of Sao Paulo Funding Agency (FAPESP) [2004/15039-0]; National Research and Technology Development Council (CNPq) [420122/2005-2]; CNPq [301221/2009-0, 06575/2011 6]	State of Sao Paulo Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research and Technology Development Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the State of Sao Paulo Funding Agency (FAPESP) by the Grant: 2004/15039-0, and the National Research and Technology Development Council (CNPq) by the Grant: 420122/2005-2. CNPq partially supported Michael Reichenheim (Grant: 301221/2009-0) and Evandro S. F. Coutinho (Grant: 06575/2011 6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MP, 2012, PSYCHOL TRAUMA-US, V4, P278, DOI 10.1037/a0023272; Abrams MP, 2009, DEPRESS ANXIETY, V26, P550, DOI 10.1002/da.20462; Andreoli SB, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-34; [Anonymous], 1997, COMP INT DIAGN INT C; Bracha HS, 2004, CNS SPECTRUMS, V9, P679, DOI 10.1017/S1092852900001954; Bracha HS, 2004, PSYCHOSOMATICS, V45, P448, DOI 10.1176/appi.psy.45.5.448; Brown T. A., 2015, CONFIRMATORY FACTOR, VSecond; Cassill DL, 2008, NATURWISSENSCHAFTEN, V95, P617, DOI 10.1007/s00114-008-0362-3; Embretson S, 2000, MULTIVARIATE APPL BO; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Fiszman A, 2008, J AFFECT DISORDERS, V107, P193, DOI 10.1016/j.jad.2007.07.015; Forsyth JP, 2000, TONIC IMMOBILI UNPUB; Fuse T, 2007, J ANXIETY DISORD, V21, P265, DOI 10.1016/j.janxdis.2006.05.004; GALLIANO G, 1993, J INTERPERS VIOLENCE, V8, P109, DOI 10.1177/088626093008001008; GALLUP GG, 1977, PSYCHOL REC, V27, P41, DOI 10.1007/BF03394432; Gallup GG, 1996, MOTOR ACTIVITY MOVEM, P57, DOI DOI 10.1007/978-1-59259-469-6_; Gorsuch R., 1983, FACTOR ANAL; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hardouin JB, 2011, STATA J, V11, P30, DOI 10.1177/1536867X1101100102; Heidt JM, 2005, BEHAV RES THER, V43, P1157, DOI 10.1016/j.brat.2004.08.005; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Humphreys KL, 2010, J INTERPERS VIOLENCE, V25, P358, DOI 10.1177/0886260509334412; Korn E. L., 1999, ANAL HLTH SURVEYS; Leach J, 2004, AVIAT SPACE ENVIR MD, V75, P539; Lima AA, 2010, J PSYCHIATR RES, V44, P224, DOI 10.1016/j.jpsychires.2009.08.005; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; Miyatake T, 2004, P ROY SOC B-BIOL SCI, V271, P2293, DOI 10.1098/rspb.2004.2858; Molenaar IW, 2000, MSP5 WINDOWS USERS M; Muthen BO, 2002, LATENT VARIABLE ANAL; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Portugal LCL, 2012, REV BRAS PSIQUIATR, V34, P60, DOI 10.1590/S1516-44462012000100011; Quintana MI, 2012, CAD SAUDE PUBLICA, V28, P1312, DOI 10.1590/S0102-311X2012000700009; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; Sijtsma K., 2002, INTRO NONPARAMETRIC, VVol. 5; SUAREZ SD, 1979, PSYCHOL REC, V29, P315, DOI 10.1007/BF03394619	36	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94367	10.1371/journal.pone.0094367	http://dx.doi.org/10.1371/journal.pone.0094367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG2DP	24747437	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500028
J	Wutka, A; Palagani, V; Barat, S; Chen, X; El Khatib, M; Gotze, J; Belahmer, H; Zender, S; Bozko, P; Malek, NP; Plentz, RR				Wutka, Annika; Palagani, Vindhya; Barat, Samarpita; Chen, Xi; El Khatib, Mona; Goetze, Julian; Belahmer, Hanane; Zender, Steffen; Bozko, Przemyslaw; Malek, Nisar P.; Plentz, Ruben R.			Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO; INDUCED APOPTOSIS; CYCLE ARREST; CANCER CELLS; HEDGEHOG; MUTATIONS; CARCINOMA; CHEMOTHERAPY; GALLBLADDER	Capsaicin, the most abundant pungent molecule produced by pepper plants, represents an important ingredient in spicy foods consumed throughout the world. Studies have shown that capsaicin can relieve inflammation and has antiproliferative effects on various human malignancies. Cholangiocarcinoma (CC) is a cancer disease with rising incidence. The prognosis remains dismal with little advance in treatment. The aim of the present study is to explore the anti-tumor activity of capsaicin in cultured human CC cell lines. Capsaicin effectively impaired cell proliferation, migration, invasion, epithelial to mesenchymal transition and growth of softagar colonies. Further, we show that capsaicin treatment of CC cells regulates the Hedgehog signaling pathway. Conclusion: Our results provide a basis for capsaicin to improve the prognosis of CCs in vivo and present new insights into the effectiveness and mode of action of capsaicin.	[Wutka, Annika; Palagani, Vindhya; Barat, Samarpita; Chen, Xi; El Khatib, Mona; Goetze, Julian; Belahmer, Hanane; Bozko, Przemyslaw; Malek, Nisar P.; Plentz, Ruben R.] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Zender, Steffen] Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Plentz, RR (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	Ruben.Plentz@med.uni-tuebingen.de	Udhane, Vindhya/Z-5947-2019					Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Bai H, 2011, CARCINOGENESIS, V32, P1689, DOI 10.1093/carcin/bgr191; BERGER A, 1995, J PAIN SYMPTOM MANAG, V10, P243, DOI 10.1016/0885-3924(94)00130-D; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bley K, 2012, TOXICOL PATHOL, V40, P847, DOI 10.1177/0192623312444471; Brown KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010243; CARRIAGA MT, 1995, CANCER-AM CANCER SOC, V75, P171, DOI 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2; Chen D, 2012, INT J UROL, V19, P662, DOI 10.1111/j.1442-2042.2012.02981.x; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; Deshpande V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-60; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; El Khatib M, 2013, HEPATOLOGY, V57, P1035, DOI 10.1002/hep.26147; FALKSON G, 1984, CANCER, V54, P965, DOI 10.1002/1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X; Fendrich V, 2011, ANN SURG, V253, P546, DOI 10.1097/SLA.0b013e31820a5bbe; Fingas CD, 2011, HEPATOLOGY, V54, P2076, DOI 10.1002/hep.24588; Gatto M, 2010, WORLD J GASTRO ONCOL, V2, P136, DOI 10.4251/wjgo.v2.i3.136; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; Hayman M., 2008, CURR ANAESTH CRIT CA, V19, P338, DOI [10.1016/j.cacc.2008.07.003, DOI 10.1016/J.CACC.2008.07.003]; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; HOLZER P, 1991, PHARMACOL REV, V43, P143; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huang SP, 2009, ANTICANCER RES, V29, P165; Jinawath A, 2007, J CANCER RES CLIN, V133, P271, DOI 10.1007/s00432-006-0166-9; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Jung MY, 2001, CANCER LETT, V165, P139, DOI 10.1016/S0304-3835(01)00426-8; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Khan SA, 2005, LIVER INT, V25, P704, DOI 10.1111/j.1478-3231.2005.01106.x; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Kiesslich T, 2009, PHOTOCH PHOTOBIO SCI, V8, P23, DOI 10.1039/b813183j; Kim CS, 2004, J MED FOOD, V7, P267, DOI 10.1089/jmf.2004.7.267; Kim JD, 1997, CANCER LETT, V120, P235, DOI 10.1016/S0304-3835(97)00321-2; Lee QW, 2006, AM J CLIN ONCOL-CANC, V29, P127, DOI 10.1097/01.coc.0000203742.22828.bb; Lin CH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-46; Lu HF, 2010, J AGR FOOD CHEM, V58, P12999, DOI 10.1021/jf103335w; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Pramanik KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020151; Sancho R, 2002, EUR J IMMUNOL, V32, P1753, DOI 10.1002/1521-4141(200206)32:6<1753::AID-IMMU1753>3.0.CO;2-2; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Sicklick JK, 2006, CARCINOGENESIS, V27, P748, DOI 10.1093/carcin/bgi292; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tang L, 2013, CLIN CANCER RES, V19, P2014, DOI 10.1158/1078-0432.CCR-12-0349; Tannapfel A, 2000, DIGEST DIS SCI, V45, P317, DOI 10.1023/A:1005412626515; Tannapfel A, 2000, GUT, V47, P721, DOI 10.1136/gut.47.5.721; Tannapfel A, 2003, GUT, V52, P706, DOI 10.1136/gut.52.5.706; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thongprasert S, 2005, ANN ONCOL, V16, P279, DOI 10.1093/annonc/mdi046; Tripathi YB, 2005, FRONT BIOSCI-LANDMRK, V10, P1607, DOI 10.2741/1644; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; von Hahn T, 2011, SCAND J GASTROENTERO, V46, P1092, DOI 10.3109/00365521.2011.589472; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Welzel TM, 2006, J NATL CANCER I, V98, P873, DOI 10.1093/jnci/djj234; Wu CC, 2006, MUTAT RES-FUND MOL M, V601, P71, DOI 10.1016/j.mrfmmm.2006.06.015; Yang J, 2013, NEOPLASMA, V60, P364, DOI 10.4149/neo_2013_048; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zhang R, 2008, APOPTOSIS, V13, P1465, DOI 10.1007/s10495-008-0278-6	58	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95605	10.1371/journal.pone.0095605	http://dx.doi.org/10.1371/journal.pone.0095605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748170	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500127
J	Kouro, H; Kon, S; Matsumoto, N; Miyashita, T; Kakuchi, A; Ashitomi, D; Saitoh, K; Nakatsuru, T; Togi, S; Muromoto, R; Matsuda, T				Kouro, Hitomi; Kon, Shigeyuki; Matsumoto, Naoki; Miyashita, Tomoe; Kakuchi, Ayaka; Ashitomi, Dai; Saitoh, Kodai; Nakatsuru, Takuya; Togi, Sumihito; Muromoto, Ryuta; Matsuda, Tadashi			The Novel alpha 4B Murine alpha 4 Integrin Protein Splicing Variant Inhibits alpha 4 Protein-dependent Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CYTOPLASMIC DOMAINS; CONFORMATIONAL-CHANGES; TUMOR-METASTASIS; KINASE; LIGAND; OSTEOPONTIN; EXPRESSION; PAXILLIN; ALPHA(4)BETA(1)	Integrins affect the motility of multiple cell types to control cell survival, growth, or differentiation, which are mediated by cell-cell and cell-extracellular matrix interactions. We reported previously that the alpha 9 integrin splicing variant, SF alpha 9, promotes WT alpha 9 integrin-dependent adhesion. In this study, we introduced a new murine alpha 4 integrin splicing variant, alpha 4B, which has a novel short cytoplasmic tail. In inflamed tissues, the expression of alpha 4B, as well as WT alpha 4 integrin, was up-regulated. Cells expressing alpha 4B specifically bound to VCAM-1 but not other alpha 4 integrin ligands, such as fibronectin CS1 or osteopontin. The binding of cells expressing WT alpha 4 integrin to alpha 4 integrin ligands is inhibited by coexpression of alpha 4B. Knockdown of alpha 4B in metastatic melanoma cell lines results in a significant increase in lung metastasis. Expression levels of WT alpha 4 integrin are unaltered by alpha 4B, with alpha 4B acting as a regulatory subunit for WT alpha 4 integrin by a dominant-negative effect or inhibiting alpha 4 integrin activation.	[Kouro, Hitomi; Kon, Shigeyuki; Matsumoto, Naoki; Miyashita, Tomoe; Kakuchi, Ayaka; Ashitomi, Dai; Saitoh, Kodai; Nakatsuru, Takuya; Togi, Sumihito; Muromoto, Ryuta; Matsuda, Tadashi] Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Kon, S (corresponding author), Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	kon@pharm.hokudai.ac.jp; tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Togi, Sumihito/ABH-6734-2020; Muromoto, Ryuta/E-4203-2012	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X; Togi, Sumihito/0000-0002-3189-8111	JSPS KAKENHI [24590072]; Akiyama Life Science Foundation; Suzuken Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Akiyama Life Science Foundation; Suzuken Memorial Foundation	This study was supported in part by JSPS KAKENHI Grant 24590072, by the Akiyama Life Science Foundation, and by the Suzuken Memorial Foundation.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557; Bayless KJ, 1998, J CELL SCI, V111, P1165; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Belkin AM, 1996, J CELL BIOL, V132, P211, DOI 10.1083/jcb.132.1.211; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; de Melker AA, 1999, BIOESSAYS, V21, P499, DOI 10.1002/(SICI)1521-1878(199906)21:6<499::AID-BIES6>3.0.CO;2-D; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; ELICES MJ, 1994, J CLIN INVEST, V93, P405, DOI 10.1172/JCI116975; Fornaro M, 1997, MATRIX BIOL, V16, P185, DOI 10.1016/S0945-053X(97)90007-X; Foster CA, 1996, J ALLERGY CLIN IMMUN, V98, pS270, DOI 10.1016/S0091-6749(96)70075-1; Garmy-Susini B, 2010, CANCER RES, V70, P3042, DOI 10.1158/0008-5472.CAN-09-3761; HEMLER ME, 1992, COLD SPRING HARB SYM, V57, P213, DOI 10.1101/SQB.1992.057.01.026; Holzmann B, 1998, CURR TOP MICROBIOL, V231, P125; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1994, CURR OPIN GENET DEV, V4, P569, DOI 10.1016/0959-437X(94)90074-D; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Isobe T, 1997, J BIOL CHEM, V272, P8447, DOI 10.1074/jbc.272.13.8447; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Kanayama M, 2009, J IMMUNOL, V182, P8015, DOI 10.4049/jimmunol.0900725; KENT SJ, 1995, J NEUROIMMUNOL, V58, P1, DOI 10.1016/0165-5728(94)00165-K; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kon S, 2000, J CELL BIOCHEM, V77, P487; Kon S, 2011, EXP CELL RES, V317, P1774, DOI 10.1016/j.yexcr.2011.04.005; Liu SC, 2000, J CELL SCI, V113, P3563; Newham P, 1998, J IMMUNOL, V160, P4508; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	37	4	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16389	16398		10.1074/jbc.M114.553610	http://dx.doi.org/10.1074/jbc.M114.553610			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755217	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000337965700041
J	Fugier, E; Marche, H; Thelu, MA; Jilkova, ZM; Van Campenhout, N; Dufeu-Duchesne, T; Leroy, V; Zarski, JP; Sturm, N; Marche, PN; Jouvin-Marche, E				Fugier, Emilie; Marche, Helene; Thelu, Marie-Ange; Jilkova, Zuzana Macek; Van Campenhout, Nicolas; Dufeu-Duchesne, Tania; Leroy, Vincent; Zarski, Jean-Pierre; Sturm, Nathalie; Marche, Patrice N.; Jouvin-Marche, Evelyne			Functions of Liver Natural Killer Cells Are Dependent on the Severity of Liver Inflammation and Fibrosis in Chronic Hepatitis C	PLOS ONE			English	Article							VIRUS-INFECTION; NK CELLS; T-CELLS; EXPRESSION; RESPONSES; DISEASE; INNATE; SUSCEPTIBILITY; DEGRANULATION; CAPACITY	During chronic hepatitis C virus (HCV) infection, the role of intra-hepatic (IH) natural killer (NK) cells is still controversial. To clarify their functions, we investigated anti-viral and cytotoxic activity of NK cells in human fresh liver biopsies. We compared the functions of IH-NK cells in HCV-infected and NASH patients in physiological conditions as well as after stimulation using flow cytometric and immunohistochemical analyses. Interestingly, few IH-NK cells produced anti-viral cytokine IFN-gamma in HCV-infected patients similarly as in non-infected individuals. Spontaneous degranulation activity was extremely low in peripheral NK cells compared to IH-NK cells, and was significantly higher in IH-NK cells from HCV-infected patients compared to non-infected individuals. Immunohistochemical analysis revealed that perforin granules were polarized at the apical pole of IH-NK cells. The presence of CD107a and perforin in IH-NK cells demonstrated that NK cells exerted a cytolytic activity at the site of infection. Importantly, IH-NK cell functions from HCV-infected patients were inducible by specific exogenous stimulations. Upon ex vivo K562 target cell stimulations, the number of degranulating NK cells was significantly increased in the pool of IH-NK cells compared to circulating NK cells. Interestingly, after stimulation, the frequency of IFN-gamma-producing IH-NK cells in HCV-infected patients was significantly higher at early stage of inflammation whereas the spontaneous IH-NK cell degranulation activity was significantly impaired in patients with highest inflammation and fibrosis Metavir scores. Our study highlights that some IH-NK cells in HCV-infected patients are able to produce INF-gamma and degranulate and that those two activities depend on liver environment including the severity of liver injury. Thus, we conclude that critical roles of IH-NK cells have to be taken into account in the course of the liver pathogenesis associated to chronic HCV infection.	[Fugier, Emilie; Marche, Helene; Thelu, Marie-Ange; Jilkova, Zuzana Macek; Van Campenhout, Nicolas; Dufeu-Duchesne, Tania; Leroy, Vincent; Zarski, Jean-Pierre; Sturm, Nathalie; Marche, Patrice N.; Jouvin-Marche, Evelyne] INSERM, U823, Grenoble, France; [Fugier, Emilie; Marche, Helene; Thelu, Marie-Ange; Jilkova, Zuzana Macek; Van Campenhout, Nicolas; Dufeu-Duchesne, Tania; Leroy, Vincent; Zarski, Jean-Pierre; Sturm, Nathalie; Marche, Patrice N.; Jouvin-Marche, Evelyne] Univ Grenoble 1, UMR S823, Grenoble, France; [Thelu, Marie-Ange; Dufeu-Duchesne, Tania; Leroy, Vincent; Zarski, Jean-Pierre; Marche, Patrice N.] CHU Grenoble, Clin Univ Hepatogastroenterol, F-38043 Grenoble, France; [Sturm, Nathalie] CHU Grenoble, Dept Anat & Cytol Pathol, F-38043 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Marche, PN (corresponding author), INSERM, U823, Grenoble, France.	patrice.marche@ujf-grenoble.fr	Macek Jílková, Zuzana/N-4051-2014; JOUVIN MARCHE, Evelyne/L-8648-2013; Marche, Patrice N/K-5060-2013	Macek Jílková, Zuzana/0000-0002-2553-5971; JOUVIN MARCHE, Evelyne/0000-0001-8616-138X; Marche, Patrice N/0000-0002-8930-9340	Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale pour la Recherche sur le Sida (ANRS) [AO 2009 - 2, CSS7]; Centre National de la Recherche Scientifique (CNRS); Fundation Finovi; ALPHA VAC of the "Pole de Competitivite Lyon Biopole''; Rhone- Alpes Region Cluster 10 "Infectiologie''	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale pour la Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fundation Finovi; ALPHA VAC of the "Pole de Competitivite Lyon Biopole''; Rhone- Alpes Region Cluster 10 "Infectiologie''(Region Auvergne-Rhone-Alpes)	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), the Agence Nationale pour la Recherche sur le Sida (ANRS) no AO 2009 - 2, CSS7. EF and ZMJ received financial support from Centre National de la Recherche Scientifique (CNRS) and Fundation Finovi; AD from ALPHA VAC of the "Pole de Competitivite Lyon Biopole'', and NVC was the recipient of a grant from the Rhone- Alpes Region Cluster 10 "Infectiologie''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bozzano F, 2012, EXPERT REV CLIN IMMU, V8, P775, DOI [10.1586/ECI.12.71, 10.1586/eci.12.71]; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Howell J, 2013, ANTIVIR THER, V18, P853, DOI 10.3851/IMP2565; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Kawarabayashi N, 2000, HEPATOLOGY, V32, P962, DOI 10.1053/jhep.2000.19362; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Lunemann S, 2012, DIGEST DIS, V30, P48, DOI 10.1159/000341680; Mondelli MU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00351; Mondelli MU, 2010, EUR J CLIN INVEST, V40, P851, DOI 10.1111/j.1365-2362.2010.02332.x; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Pelletier S, 2010, J HEPATOL, V53, P805, DOI 10.1016/j.jhep.2010.05.013; Pernollet M, 2002, CLIN EXP IMMUNOL, V130, P518, DOI 10.1046/j.1365-2249.2002.01996.x; Ryan EJ, 2011, J VIRAL HEPATITIS, V18, P840, DOI 10.1111/j.1365-2893.2010.01384.x; Saez-Borderias A, 2009, J IMMUNOL, V182, P829, DOI 10.4049/jimmunol.182.2.829; Sene D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001184; Sturm N, 2010, J HEPATOL, V53, P25, DOI 10.1016/j.jhep.2010.02.024; Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115; Varchetta S, 2012, HEPATOLOGY, V56, P841, DOI 10.1002/hep.25723; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang FS, 2013, NAT REV GASTRO HEPAT, V10, P390, DOI 10.1038/nrgastro.2013.72; Yoon JC, 2011, J VIROL, V85, P12557, DOI 10.1128/JVI.00838-11	33	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95614	10.1371/journal.pone.0095614	http://dx.doi.org/10.1371/journal.pone.0095614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759660	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200069
J	Pandey, R; Joshi, G; Bhardwaj, AR; Agarwal, M; Katiyar-Agarwal, S				Pandey, Ritu; Joshi, Gopal; Bhardwaj, Ankur R.; Agarwal, Manu; Katiyar-Agarwal, Surekha			A Comprehensive Genome-Wide Study on Tissue-Specific and Abiotic Stress-Specific miRNAs in Triticum aestivum	PLOS ONE			English	Article							AUXIN RESPONSE FACTORS; SMALL RNAS; PLANT MICRORNAS; HEAT-STRESS; COMPUTATIONAL IDENTIFICATION; POLYETHYLENE GLYCOL-6000; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; REGULATED MICRORNAS; GENE-EXPRESSION	Productivity of wheat crop is largely dependent on its growth and development that, in turn, is mainly regulated by environmental conditions, including abiotic stress factors. miRNAs are key regulators of gene expression networks involved in diverse aspects of development and stress responses in plants. Using high-throughput sequencing of eight small RNA libraries prepared from diverse abiotic stresses and tissues, we identified 47 known miRNAs belonging to 20 families, 49 true novel and 1030 candidate novel miRNAs. Digital gene expression analysis revealed that 257 miRNAs exhibited tissue-specific expression and 74 were associated with abiotic stresses. Putative target genes were predicted for miRNAs identified in this study and their grouping into functional categories indicated that the putative targets were involved in diverse biological processes. RLM-RACE of predicted targets of three known miRNAs (miR156, miR160 and miR164) confirmed their mRNA cleavage, thus indicating their regulation at post-transcriptional level by the corresponding miRNAs. Mapping of the sequenced data onto the wheat progenitors and closely related monocots revealed a large number of evolutionary conserved miRNAs. Additional expression profiling of some of these miRNAs in other abiotic stresses underline their involvement in multiple stresses. Our findings provide valuable resource for an improved understanding of the role of miRNAs in stress tolerance as well as plant development.	[Pandey, Ritu; Katiyar-Agarwal, Surekha] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Joshi, Gopal; Bhardwaj, Ankur R.; Agarwal, Manu] Univ Delhi, Dept Bot, Delhi 110007, India	University of Delhi; University of Delhi	Agarwal, M (corresponding author), Univ Delhi, Dept Bot, Delhi 110007, India.	agarwalm71@gmail.com; katiyars@south.du.ac.in		AGARWAL, MANU/0000-0003-4241-5055; Joshi, Gopal/0000-0002-6238-9926	Department of Biotechnology (DBT), Govt. of India, New Delhi, India; University of Delhi, India; CSIR, India; DBT, India; DBT	Department of Biotechnology (DBT), Govt. of India, New Delhi, India; University of Delhi, India(University of Delhi); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); DBT, India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India)	This work was supported by research grants from Department of Biotechnology (DBT), Govt. of India, New Delhi, India and University of Delhi, India. RP acknowledges a research fellowship provided by CSIR, India. RP, GJ and ARB thank DBT, India for their fellowships. DBT-funded High-throughput Sequencing Facility at University of Delhi South Campus provided small RNA sequencing services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam H, 2011, MOL BIOL EVOL, V28, P1439, DOI 10.1093/molbev/msq328; Agarwal PK, 2008, PLANT CELL REP, V27, P105, DOI 10.1007/s00299-007-0446-0; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Chellappan P, 2010, NUCLEIC ACIDS RES, V38, P6883, DOI 10.1093/nar/gkq590; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chorostecki U, 2012, NUCLEIC ACIDS RES, V40, P8893, DOI 10.1093/nar/gks625; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Feng H, 2013, MOL PLANT PATHOL; Golldack D, 2013, PLANT CELL REP, V32, P1007, DOI 10.1007/s00299-013-1409-2; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Han YS, 2009, SCI CHINA SER C, V52, P1091, DOI 10.1007/s11427-009-0144-y; HOHL M, 1991, PLANT PHYSIOL, V95, P716, DOI 10.1104/pp.95.3.716; Huerta C, 2013, PLANT CELL REP, V32, P293, DOI 10.1007/s00299-012-1363-4; JACOMINI E, 1988, CAN J BOT, V66, P970, DOI 10.1139/b88-140; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Katiyar-Agarwal S, 2007, METHOD ENZYMOL, V427, P215, DOI 10.1016/S0076-6879(07)27012-0; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057359; Liu Q, 2009, BIOCHEM BIOPH RES CO, V384, P1, DOI 10.1016/j.bbrc.2009.04.028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040859; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mallory AC, 2004, CURR OPIN PLANT BIOL, V7, P120, DOI 10.1016/j.pbi.2004.01.006; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meng FR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-140; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Mutum RD, 2013, FEBS J, V280, P1717, DOI 10.1111/febs.12186; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054148; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rahaie M, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P367, DOI 10.5772/54795; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Rubio-Somoza I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003374; Sanan-Mishra N, 2009, MOL GENET GENOMICS, V282, P463, DOI 10.1007/s00438-009-0478-y; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Tester M, 2005, PLANT PHYSIOL, V137, P791, DOI 10.1104/pp.104.900138; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Vargas WA, 2007, PLANTA, V226, P1535, DOI 10.1007/s00425-007-0590-3; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Wang H, 2011, PLANT J, V67, P292, DOI 10.1111/j.1365-313X.2011.04594.x; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang ZG, 2010, MICRORNA EXPRESSION DETECTION METHODS, P147, DOI 10.1007/978-3-642-04928-6_7; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yan L., 2013, ADV J FOOD SCI TECHN, V5; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yang YH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-53; Yao YY, 2010, FUNCT INTEGR GENOMIC, V10, P187, DOI 10.1007/s10142-010-0163-6; Yin ZJ, 2010, GENET MOL RES, V9, P1186, DOI 10.4238/vol9-2gmr805; Yucebilgili K, 2013, PLOS ONE, V8; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	85	50	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95800	10.1371/journal.pone.0095800	http://dx.doi.org/10.1371/journal.pone.0095800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759739	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200091
J	Xu, SS; Li, Y; Wang, GX				Xu, Shanshan; Li, Yan; Wang, Genxuan			Scaling Relationships between Leaf Mass and Total Plant Mass across Chinese Forests	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; DENSITY RELATIONSHIPS; METABOLIC THEORY; GENERAL-MODEL; BIOMASS; SIZE; RESPIRATION; UNIVERSAL; ALLOMETRY; SEEDLINGS	Biomass partitioning is important for illustrating terrestrial ecosystem carbon flux. West, Brown and Enquist (WBE) model predicts that an optimal 3/4 allometric scaling of leaf mass and total biomass of individual plants will be applied in diverse communities. However, amount of scientific evidence suggests an involvement of some biological and environmental factors in interpreting the variation of scaling exponent observed in empirical studies. In this paper, biomass information of 1175 forested communities in China was collected and categorized into groups in terms of leaf form and function, as well as their locations to test whether the allocation pattern was conserved or variable with internal and/or environmental variations. Model Type II regression protocol was adopted to perform all the regressions. The results empirically showed that the slopes varied significantly across diverse forested biomes, between conifer and broadleaved forests, and between evergreen and deciduous forests. Based on the results, leaf form and function and their relations to environments play a significant role in the modification of the WBE model to explore more accurate laws in nature.	[Xu, Shanshan; Li, Yan; Wang, Genxuan] Zhejiang Univ, Coll Life Sci, Inst Ecol, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, GX (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Ecol, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	fzstsys2@zju.edu.cn			National High-Tech R & D Program (863 Program) [2011AA100503]; Natural Science Fund of China [31330010]; Zhejiang Provincial Natural Science Foundation of China [LZ13C030002]	National High-Tech R & D Program (863 Program)(National High Technology Research and Development Program of China); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National High-Tech R & D Program (863 Program) for the 12th Five-Year Plan (2011AA100503), Natural Science Fund of China (31330010), and Zhejiang Provincial Natural Science Foundation of China (LZ13C030002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond-Lamberty B, 2002, TREE PHYSIOL, V22, P993, DOI 10.1093/treephys/22.14.993; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cannell MGR, 1982, WORLD FOREST BIOMASS; Castro-Diez P, 2000, OECOLOGIA, V124, P476, DOI 10.1007/PL00008873; Chen XW, 2003, ACTA OECOL, V24, P125, DOI 10.1016/S1146-609X(03)00062-6; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; Cheng DL, 2010, BIOL LETTERS, V6, P715, DOI 10.1098/rsbl.2010.0070; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Dai XF, 2009, BIOL LETTERS, V5, P571, DOI 10.1098/rsbl.2009.0228; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; Deng JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001799; Deng JM, 2012, P NATL ACAD SCI USA, V109, P8600, DOI 10.1073/pnas.1205663109; Denny M, 2012, ANNU REV ECOL EVOL S, V43, P1, DOI 10.1146/annurev-ecolsys-102710-145103; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Enquist BJ, 2003, MACROECOLOGY CONCEPT, P321; Enquist BJ, 2007, INT J PLANT SCI, V168, P729, DOI 10.1086/513479; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Falster D.S., 2006, USERS GUIDE SMATR ST; Finkel ZV, 2004, MAR ECOL PROG SER, V273, P269, DOI 10.3354/meps273269; Glazier DS, 2006, BIOSCIENCE, V56, P325, DOI 10.1641/0006-3568(2006)56[325:TPLINU]2.0.CO;2; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; Kozlowski J, 2005, FUNCT ECOL, V19, P739, DOI 10.1111/j.1365-2435.2005.01021.x; Kozlowski J, 2004, FUNCT ECOL, V18, P283, DOI 10.1111/j.0269-8463.2004.00830.x; Kozlowski Jan, 2003, P299; Li HT, 2005, J INTEGR PLANT BIOL, V47, P1173, DOI 10.1111/j.1744-7909.2005.00167.x; Lin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057612; Luo T. X., 1996, THESIS CHINESE ACAD; Luo TX, 2009, ECOGRAPHY, V32, P526, DOI 10.1111/j.1600-0587.2008.05735.x; Luo TX, 2002, ECOL APPL, V12, P980, DOI 10.1890/1051-0761(2002)012[0980:EBAPON]2.0.CO;2; Mori S, 2010, P NATL ACAD SCI USA, V107, P1447, DOI 10.1073/pnas.0902554107; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Ni J, 2001, ANN FOR SCI, V58, P351, DOI 10.1051/forest:2001131; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Pan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076872; Peng YH, 2010, FUNCT ECOL, V24, P502, DOI 10.1111/j.1365-2435.2009.01667.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Powers JS, 2010, FUNCT ECOL, V24, P927, DOI 10.1111/j.1365-2435.2010.01701.x; Pretzsch H, 2006, OECOLOGIA, V146, P572, DOI 10.1007/s00442-005-0126-0; Pretzsch H, 2008, TREES-STRUCT FUNCT, V22, P611, DOI 10.1007/s00468-008-0231-x; Pretzsch H, 2012, OECOLOGIA, V169, P637, DOI 10.1007/s00442-011-2240-5; Price CA, 2006, FUNCT ECOL, V20, P11, DOI 10.1111/j.1365-2435.2006.01078.x; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2012, ECOL LETT, V15, P1465, DOI 10.1111/j.1461-0248.2012.01860.x; Price CA, 2012, ECOL LETT, V15, P87, DOI 10.1111/j.1461-0248.2011.01712.x; Rahman MM, 2013, FORESTRY, V86, P441, DOI 10.1093/forestry/cpt015; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2004, PHYS TODAY, V57, P36, DOI 10.1063/1.1809090; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Zhang WP, 2011, ECOL RES, V26, P819, DOI 10.1007/s11284-011-0843-2	59	5	5	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95938	10.1371/journal.pone.0095938	http://dx.doi.org/10.1371/journal.pone.0095938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759801	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200112
J	Zhang, ZG; Wu, L; Wang, JL; Li, G; Feng, DY; Zhang, B; Li, LH; Yang, JD; Ma, LT; Qin, HZ				Zhang, Zhiguo; Wu, Lin; Wang, Julei; Li, Gang; Feng, Dayun; Zhang, Bin; Li, Lihong; Yang, Jiandong; Ma, Lianting; Qin, Huaizhou			Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell Apoptosis	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; MACROPHAGE INHIBITORY CYTOKINE-1; ACTIVATED GENE NAG-1/GDF15; MORPHOGENETIC PROTEIN; MEMBER; GROWTH; CANCER; EXPRESSION; GLIOMA; LINES	Nonsteroidal anti-inflammatory drug (NSAID) activated gene-1 (NAG-1) is a divergent member of the transforming growth factor-beta (TGF-beta) superfamily. NAG-1 plays remarkable multifunctional roles in controlling diverse physiological and pathological processes including cancer. Like other TGF-beta family members, NAG-1 can play dual roles during cancer development and progression by negatively or positively modulating cancer cell behaviors. In glioblastoma brain tumors, NAG-1 appears to act as a tumor suppressor gene; however, the precise underlying mechanisms have not been well elucidated. In the present study, we discovered that overexpression of NAG-1 induced apoptosis in U87 MG, U118 MG, U251 MG, and T98G cell lines via the intrinsic mitochondrial pathway, but not in A172 and LN-229 cell lines. NAG-1 could induce the phosphorylation of PI3K/Akt and Smad2/3 in all six tested glioblastoma cell lines, except Smad3 phosphorylation in A172 and LN-229 cell lines. In fact, Smad3 expression and its phosphorylation were almost undetectable in A172 and LN-229 cells. The PI3K inhibitors promoted NAG-1-induced glioblastoma cell apoptosis, while siRNAs to Smad2 and Smad3 decreased the apoptosis rate. NAG-1 also stimulated the direct interaction between Akt and Smad3 in glioblastoma cells. Elevating the level of Smad3 restored the sensitivity to NAG-1-induced apoptosis in A172 and LN-229 cells. In conclusion, our results suggest that PI3K/Akt and Smad-dependent signaling pathways display opposing effects in NAG-1-induced glioblastoma cell apoptosis.	[Zhang, Zhiguo; Wang, Julei; Li, Gang; Feng, Dayun; Zhang, Bin; Li, Lihong; Qin, Huaizhou] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Zhang, Zhiguo; Wang, Julei; Li, Gang; Feng, Dayun; Zhang, Bin; Li, Lihong; Qin, Huaizhou] Fourth Mil Med Univ, Tangdu Hosp, Inst Funct Brain Disorders, Xian 710032, Peoples R China; [Wu, Lin] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Yang, Jiandong] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China; [Zhang, Zhiguo; Ma, Lianting] PLA, Wuhan Gen Hosp Guangzhou Command, Postdoctoral Res Stn Neurosurg, Wuhan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Qin, HZ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China.	qinhuaizhou@hotmail.com			National Natural Science Foundation of China [81171086]; Natural Science Foundation of Shaanxi Province [2013JQ4035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was partially supported by the National Natural Science Foundation of China (No. 81171086) (http://isisn.nsfc.gov.cn/egrantweb/) and the Natural Science Foundation of Shaanxi Province (No. 2013JQ4035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bottner M, 1999, CELL TISSUE RES, V297, P103, DOI 10.1007/s004410051337; Brown DA, 2006, CLIN CANCER RES, V15, P6658; Eling TE, 2006, J BIOCHEM MOL BIOL, V39, P649; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Ganguly A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011253; Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Kadowaki M, 2012, INT J CANCER, V130, P267, DOI 10.1002/ijc.26082; Kim KK, 2008, CARCINOGENESIS, V29, P704, DOI 10.1093/carcin/bgn031; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Li HS, 2005, J CLIN ENDOCR METAB, V90, P3045, DOI 10.1210/jc.2004-0808; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065549; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Piek E, 1999, INT J CANCER, V80, P756, DOI 10.1002/(SICI)1097-0215(19990301)80:5<756::AID-IJC21>3.0.CO;2-N; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Sami A, 2013, TUMOR BIOL, V34, P1991, DOI 10.1007/s13277-013-0800-5; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shnaper S, 2009, INT J CANCER, V125, P2624, DOI 10.1002/ijc.24639; Strelau J, 2008, CANCER LETT, V270, P30, DOI 10.1016/j.canlet.2008.04.042; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; Wang X, 2012, BIOCHEM PHARMACOL, V85, P597; XUEJIAO S, 2013, PLOS ONE, V0008; Yoshioka H, 2008, J BIOL CHEM, V283, P33129, DOI 10.1074/jbc.M805248200; Zhang L, 2006, J NEUROSURG, V105, P119, DOI 10.3171/jns.2006.105.1.119	32	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96283	10.1371/journal.pone.0096283	http://dx.doi.org/10.1371/journal.pone.0096283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759784	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200149
J	Richmond, O; Ghotbaddini, M; Allen, C; Walker, A; Zahir, S; Powell, JB				Richmond, Oliver; Ghotbaddini, Maryam; Allen, Cidney; Walker, Alice; Zahir, Shokouh; Powell, Joann B.			The Aryl Hydrocarbon Receptor Is Constitutively Active in Advanced Prostate Cancer Cells	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AH RECEPTOR; BREAST-CANCER; ANDROGEN RECEPTOR; CYCLE PROGRESSION; GENE-EXPRESSION; CARCINOMA-CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; LNCAP; GROWTH	Background: Distant prostate cancers are commonly hormone refractory and exhibit increased growth no longer inhibited by androgen deprivation therapy. Understanding all molecular mechanisms contributing to uncontrolled growth is important to obtain effective treatment strategies for hormone refractory prostate cancers (HRPC). The aryl hydrocarbon receptor (AhR) affects a number of biological processes including cell growth and differentiation. Several studies have revealed that exogenous AhR ligands inhibit cellular proliferation but recent evidence suggests AhR may possess intrinsic functions that promote cellular proliferation in the absence of exogenous ligands. Methods/ Results: qRT-PCR and western blot analysis was used to determine AhR mRNA and protein expression in hormone sensitive LNCaP cells as well as hormone refractory DU145, PC3 and PC3M prostate cancer cell lines. LNCaP cells express AhR mRNA and protein at a much lower level than the hormone refractory cell models. Cellular fractionation and immunocytochemistry revealed nuclear localization of AhR in the established hormone refractory cell lines while LNCaP cells are devoid of nuclear AhR protein. qRT-PCR analysis used to assess basal CYP1B1 levels and a xenobiotic responsive element binding assay confirmed ligand independent transcriptional activity of AhR in DU145, PC3 and PC3M cells. Basal CYP1B1 levels were decreased by treatment with specific AhR inhibitor, CH223191. An in vitro growth assay revealed that CH223191 inhibited growth of DU145, PC3 and PC3M cells in an androgen depleted environment. Immunohistochemical staining of prostate cancer tissues revealed increased nuclear localization of AhR in grade 2 and grade 3 cancers compared to the well differentiated grade 1 cancers. Conclusions: Together, these results show that AhR is constitutively active in advanced prostate cancer cell lines that model hormone refractory prostate cancer. Chemical ablation of AhR signaling can reduce the growth of advanced prostate cancer cells, an effect not achieved with androgen receptor inhibitors or growth in androgen depleted media.	[Richmond, Oliver; Ghotbaddini, Maryam; Walker, Alice; Powell, Joann B.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Allen, Cidney; Powell, Joann B.] Clark Atlanta Univ, Dept Biol Sci, Atlanta, GA 30314 USA; [Zahir, Shokouh] Shahid Sadoughi Univ Med Sci & Hlth Serv, Yazd, Iran	Clark Atlanta University; Clark Atlanta University	Powell, JB (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.	jpowell@cau.edu			National Institutes of Health/National Institute on Minority Health and Health Disparities/Research Center in Minority Institutions [8 G12 MD007590]; National Institute on Minority Health and Health Disparities [G12MD007590] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Minority Health and Health Disparities/Research Center in Minority Institutions; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	These studies were supported by National Institutes of Health/National Institute on Minority Health and Health Disparities/Research Center in Minority Institutions Grant #8 G12 MD007590. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik IU, 2006, J CELL BIOCHEM, V99, P362, DOI 10.1002/jcb.20811; Alexander DL, 1997, CANCER RES, V57, P4498; Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; BACSI SG, 1995, MOL PHARMACOL, V47, P432; Barhoover MA, 2010, MOL PHARMACOL, V77, P195, DOI 10.1124/mol.109.059675; Barnes-Ellerbe S, 2004, MOL PHARMACOL, V66, P502, DOI 10.1124/mol.104.000356; Brooks J, 2011, CURR CANCER DRUG TAR, V11, P654, DOI 10.2174/156800911795655967; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; Chang JHT, 2007, CLIN CANCER RES, V13, P38, DOI 10.1158/1078-0432.CCR-06-1166; Tran C, 2013, BIOCHEM PHARMACOL, V85, P753, DOI 10.1016/j.bcp.2012.12.010; Dever DP, 2012, MOL PHARMACOL, V81, P669, DOI 10.1124/mol.111.077305; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; Endo F, 2003, REPROD TOXICOL, V17, P229, DOI 10.1016/S0890-6238(02)00126-0; GLEAVE M, 1991, CANCER RES, V51, P3753; Gluschnaider U, PLOS ONE, V5, pe9060; Goode GD, 2013, INT J CANCER, V133, P2769, DOI 10.1002/ijc.28297; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hruba E, 2011, TOXICOL LETT, V206, P178, DOI 10.1016/j.toxlet.2011.07.011; Ikuta T, 2000, J BIOCHEM, V127, P503, DOI 10.1093/oxfordjournals.jbchem.a022633; Jana NR, 1999, BIOCHEM BIOPH RES CO, V256, P462, DOI 10.1006/bbrc.1999.0367; Jung NK, 2010, ENDOCR J, V57, P863, DOI 10.1507/endocrj.K10E-220; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kashani M, 1998, PROSTATE, V37, P98; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kerzee JK, 2001, CIRC RES, V89, P573, DOI 10.1161/hh1901.097083; Kizu R, 2003, ARCH TOXICOL, V77, P335, DOI 10.1007/s00204-003-0454-y; Kollara A, 2010, J STEROID BIOCHEM, V118, P51, DOI 10.1016/j.jsbmb.2009.09.017; Kollara A, 2009, INT J BIOCHEM CELL B, V41, P1182, DOI 10.1016/j.biocel.2008.10.019; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Kurzawski M, PHARM REP, V64, P927; Lemm F, 2004, INT J HYG ENVIR HEAL, V207, P325, DOI 10.1078/1438-4639-00298; LIM DJ, 1993, PROSTATE, V22, P109, DOI 10.1002/pros.2990220203; Lin P, 2003, LUNG CANCER-J IASLC, V42, P255, DOI 10.1016/S0169-5002(03)00359-3; Mao HL, 2009, ASIAN J ANDROL, V11, P68, DOI 10.1038/aja.2008.14; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Morrow D, 2004, J STEROID BIOCHEM, V88, P27, DOI 10.1016/j.jsbmb.2003.10.005; Ohtake F, 2009, BIOCHEM PHARMACOL, V77, P474, DOI 10.1016/j.bcp.2008.08.034; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Pollenz RS, 1996, MOL PHARMACOL, V49, P391; PROKIPCAK RD, 1991, CAN J PHYSIOL PHARM, V69, P1204, DOI 10.1139/y91-176; Sanada N, 2009, J PHARMACOL SCI, V109, P380, DOI 10.1254/jphs.08328FP; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Seruga B, 2011, J CLIN ONCOL, V29, P3686, DOI 10.1200/JCO.2010.34.3996; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Society AC, 2012, CANC TREATM SURV FAC; Society AC, 2013, CANC PREV EARL DET F; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Wang T, 2011, TOXICOL SCI, V124, P291, DOI 10.1093/toxsci/kfr247; WHITLOCK JP, 1989, MOL BIOL MED, V6, P169; Yang XH, 2008, J CELL BIOCHEM, V104, P402, DOI 10.1002/jcb.21630	53	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95058	10.1371/journal.pone.0095058	http://dx.doi.org/10.1371/journal.pone.0095058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	24755659	Green Submitted, Green Published, gold			2022-12-25	WOS:000335240300025
J	Boissy, RJ; Romberger, DJ; Roughead, WA; Weissenburger-Moser, L; Poole, JA; LeVan, TD				Boissy, Robert J.; Romberger, Debra J.; Roughead, William A.; Weissenburger-Moser, Lisa; Poole, Jill A.; LeVan, Tricia D.			Shotgun Pyrosequencing Metagenomic Analyses of Dusts from Swine Confinement and Grain Facilities	PLOS ONE			English	Article							DOSE-RESPONSE RELATIONSHIPS; ENVIRONMENTAL EXPOSURES; RESPIRATORY HEALTH; PULMONARY-FUNCTION; AIRBORNE DUST; LUNG-FUNCTION; FARM-WORKERS; BUILDINGS; MICROORGANISMS; PIG	Inhalation of agricultural dusts causes inflammatory reactions and symptoms such as headache, fever, and malaise, which can progress to chronic airway inflammation and associated diseases, e. g. asthma, chronic bronchitis, chronic obstructive pulmonary disease, and hypersensitivity pneumonitis. Although in many agricultural environments feed particles are the major constituent of these dusts, the inflammatory responses that they provoke are likely attributable to particle-associated bacteria, archaebacteria, fungi, and viruses. In this study, we performed shotgun pyrosequencing metagenomic analyses of DNA from dusts from swine confinement facilities or grain elevators, with comparisons to dusts from pet-free households. DNA sequence alignment showed that 19% or 62% of shotgun pyrosequencing metagenomic DNA sequence reads from swine facility or household dusts, respectively, were of swine or human origin, respectively. In contrast only 2% of such reads from grain elevator dust were of mammalian origin. These metagenomic shotgun reads of mammalian origin were excluded from our analyses of agricultural dust microbiota. The ten most prevalent bacterial taxa identified in swine facility compared to grain elevator or household dust were comprised of 75%, 16%, and 42% gram-positive organisms, respectively. Four of the top five swine facility dust genera were assignable (Clostridium, Lactobacillus, Ruminococcus, and Eubacterium, ranging from 4% to 19% relative abundance). The relative abundances of these four genera were lower in dust from grain elevators or pet-free households. These analyses also highlighted the predominance in swine facility dust of Firmicutes (70%) at the phylum level, Clostridia (44%) at the Class level, and Clostridiales at the Order level (41%). In summary, shotgun pyrosequencing metagenomic analyses of agricultural dusts show that they differ qualitatively and quantitatively at the level of microbial taxa present, and that the bioinformatic analyses used for such studies must be carefully designed to avoid the potential contribution of non-microbial DNA, e.g. from resident mammals.	[Romberger, Debra J.; LeVan, Tricia D.] Vet Nebraska Western Iowa Healthcare Syst, Omaha, NE 68105 USA; [Romberger, Debra J.; Roughead, William A.; Weissenburger-Moser, Lisa; Poole, Jill A.; LeVan, Tricia D.] Univ Nebraska Med Ctr, Pulm Crit Care Sleep Med & Allergy Div, Omaha, NE USA; [Boissy, Robert J.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Weissenburger-Moser, Lisa; LeVan, Tricia D.] Univ Nebraska Med Ctr, Dept Epidemiol, Omaha, NE USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	LeVan, TD (corresponding author), Vet Nebraska Western Iowa Healthcare Syst, Omaha, NE 68105 USA.	tlevan@unmc.edu			National Institute of Environmental Health Sciences [R01: ES019325]; National Institute of Occupational Safety Health [1U54OH010162-01, 2RO1OH008539]; VA Merit Award [5 I01 CX000434 03]; Central States Center for Agricultural Safety and Health (CS-CASH); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008539, U54OH010162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019325] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Occupational Safety Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); VA Merit Award(US Department of Veterans Affairs); Central States Center for Agricultural Safety and Health (CS-CASH); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Study supported by grants from the National Institute of Environmental Health Sciences (R01: ES019325 to J.A.P.), National Institute of Occupational Safety Health (1U54OH010162-01 to J.A.P. and 2RO1OH008539 to DJR), and VA Merit Award (5 I01 CX000434 03 to T.D.L.). This work was supported in part by the Central States Center for Agricultural Safety and Health (CS-CASH; T.D.L., D.J.R., J.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey KL, 2008, AM J PHYSIOL-LUNG C, V294, pL1049, DOI 10.1152/ajplung.00526.2007; Bauer C, 2013, AM J RESP CELL MOL, V48, P781, DOI 10.1165/rcmb.2012-0479OC; Chang CW, 2001, APPL ENVIRON MICROB, V67, P155, DOI 10.1128/AEM.67.1.155-161.2001; CLARK S, 1983, AM IND HYG ASSOC J, V44, P537, DOI 10.1080/15298668391405265; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; CROOK B, 1991, AM IND HYG ASSOC J, V52, P271, DOI 10.1080/15298669191364721; DONHAM K, 1989, BRIT J IND MED, V46, P31; DONHAM KJ, 1984, AM J IND MED, V5, P367, DOI 10.1002/ajim.4700050505; DONHAM KJ, 1995, AM J IND MED, V27, P405, DOI 10.1002/ajim.4700270309; DONHAM KJ, 1986, AM J IND MED, V10, P294, DOI 10.1002/ajim.4700100318; Eduard W, 2009, CHEST, V136, P716, DOI 10.1378/chest.08-2192; Gao ZW, 2013, ANN ALLERG ASTHMA IM, V110, P44, DOI 10.1016/j.anai.2012.11.003; Halstensen AS, 2007, ANN OCCUP HYG, V51, P581, DOI [10.1093/annhyg/mem038, 10.1093/annhyg/rnem038]; Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Kristiansen A, 2012, FEMS MICROBIOL ECOL, V80, P390, DOI 10.1111/j.1574-6941.2012.01305.x; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; LARSSON KA, 1994, AM J RESP CRIT CARE, V150, P973, DOI 10.1164/ajrccm.150.4.7921472; Lee SA, 2006, J OCCUP ENVIRON HYG, V3, P118, DOI 10.1080/15459620500524607; Letourneau V, J OCCUP ENV HYG, V7, P94; Letourneau V, 2010, J OCCUP ENVIRON HYG, V7, P94, DOI 10.1080/15459620903425642; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; MALMBERG P, 1993, EUR RESPIR J, V6, P400; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Monso E, 2004, AM J IND MED, V46, P357, DOI 10.1002/ajim.20077; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Poole JA, AM J RESP CELL MOL B; Poole JA, J TOXICOL ENV HLTH A, V73, P684; Poole JA, 2008, J ALLERGY CLIN IMMUN, V122, P375, DOI 10.1016/j.jaci.2008.05.023; Poole JA, 2011, AM J PHYSIOL-LUNG C, V301, pL296, DOI 10.1152/ajplung.00086.2011; Radon K, 2002, ANN AGR ENV MED, V9, P41; Reynolds SJ, 1996, AM J IND MED, V29, P33, DOI 10.1002/(SICI)1097-0274(199601)29:1<33::AID-AJIM5>3.0.CO;2-#; SCHWARTZ DA, 1995, AM J RESP CRIT CARE, V151, P47, DOI 10.1164/ajrccm.151.1.7812571; THORNE PS, 1992, APPL ENVIRON MICROB, V58, P2543, DOI 10.1128/AEM.58.8.2543-2551.1992; Viegas C, 2013, J TOXICOL ENV HEAL A, V76, P272, DOI 10.1080/15287394.2013.757205; Von Essen S, 1999, OCCUP MED, V14, P337; ZEJDA JE, 1994, J OCCUP ENVIRON MED, V36, P49	39	44	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95578	10.1371/journal.pone.0095578	http://dx.doi.org/10.1371/journal.pone.0095578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748147	Green Published, gold			2022-12-25	WOS:000335226500125
J	Luo, ZJ; Zhao, Y; Azencott, R				Luo, Zijun; Zhao, Yi; Azencott, Robert			Impact of miRNA Sequence on miRNA Expression and Correlation between miRNA Expression and Cell Cycle Regulation in Breast Cancer Cells	PLOS ONE			English	Article							MICRORNAS; TARGETS; RNAS	The miRNAs regulate cell functions by inhibiting expression of proteins. Research on miRNAs had usually focused on identifying targets by base pairing between miRNAs and their targets. Instead of identifying targets, this paper proposed an innovative approach, namely impact significance analysis, to study the correlation between mature sequence, expression across patient samples or time and global function on cell cycle signaling of miRNAs. With three distinct types of data: The Cancer Genome Atlas miRNA expression data for 354 human breast cancer specimens, microarray of 266 miRNAs in mouse Embryonic Stem cells (ESCs), and Reverse Phase Protein Array (RPPA) transfected by 776 miRNAs in MDA-MB-231 cell line, we linked the expression and function of miRNAs by their mature sequence and discovered systematically that the similarity of miRNA expression enhances the similarity of miRNA function, which indicates the miRNA expression can be used as a supplementary factor to predict miRNA function. The results also show that both seed region and 3' portion are associated with miRNA expression levels across human breast cancer specimens and in ESCs; miRNAs with similar seed tend to have similar 3' portion. And we discussed that the impact of 3' portion, including nucleotides 13-16, is not significant for miRNA function. These results provide novel insights to understand the correlation between miRNA sequence, expression and function. They can be applied to improve the prediction algorithm and the impact significance analysis can also be implemented to similar analysis for other small RNAs such as siRNAs.	[Luo, Zijun; Zhao, Yi] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Azencott, Robert] Univ Houston, Houston, TX USA	Harbin Institute of Technology; University Town of Shenzhen; University of Houston System; University of Houston	Luo, ZJ (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen, Peoples R China.	boluomiduo1@gmail.com	Zhao, Yi/AAX-3232-2020					Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luo ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023263; Mourelatos Z, 2008, NATURE, V455, P44, DOI 10.1038/455044a; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Uhlmann S, 2011, NAT MOL SYSTEMS BIOL, V8, P570; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404	25	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95205	10.1371/journal.pone.0095205	http://dx.doi.org/10.1371/journal.pone.0095205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748078	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500066
J	Monge, ME; Dwivedi, P; Zhou, MS; Payne, M; Harris, C; House, B; Juggins, Y; Cizmarik, P; Newton, PN; Fernandez, FM; Jenkins, D				Monge, Maria Eugenia; Dwivedi, Prabha; Zhou, Manshui; Payne, Michael; Harris, Chris; House, Blaine; Juggins, Yvonne; Cizmarik, Peter; Newton, Paul N.; Fernandez, Facundo M.; Jenkins, David			A Tiered Analytical Approach for Investigating Poor Quality Emergency Contraceptives	PLOS ONE			English	Article							SUBSTANDARD MEDICINES; LEVONORGESTREL; PRIORITY; DRUGS	Reproductive health has been deleteriously affected by poor quality medicines. Emergency contraceptive pills (ECPs) are an important birth control method that women can use after unprotected coitus for reducing the risk of pregnancy. In response to the detection of poor quality ECPs commercially available in the Peruvian market we developed a tiered multi-platform analytical strategy. In a survey to assess ECP medicine quality in Peru, 7 out of 25 different batches showed inadequate release of levonorgestrel by dissolution testing or improper amounts of active ingredient. One batch was found to contain a wrong active ingredient, with no detectable levonorgestrel. By combining ultrahigh performance liquid chromatography-ion mobility spectrometry-mass spectrometry (UHPLC-IMS-MS) and direct analysis in real time MS (DART-MS) the unknown compound was identified as the antibiotic sulfamethoxazole. Quantitation by UHPLC-triple quadrupole tandem MS (QqQ-MS/MS) indicated that the wrong ingredient was present in the ECP sample at levels which could have significant physiological effects. Further chemical characterization of the poor quality ECP samples included the identification of the excipients by 2D Diffusion-Ordered Nuclear Magnetic Resonance Spectroscopy (DOSY H-1 NMR) indicating the presence of lactose and magnesium stearate.	[Monge, Maria Eugenia; Dwivedi, Prabha; Zhou, Manshui; Fernandez, Facundo M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Payne, Michael; Harris, Chris; House, Blaine; Juggins, Yvonne; Cizmarik, Peter; Jenkins, David] FHI 360, Prod Qual & Compliance, Durham, NC USA; [Newton, Paul N.] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Microbiol Lab, Viangchan, Laos; [Newton, Paul N.] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford, England; [Newton, Paul N.] Univ Oxford, Churchill Hosp, WorldWide Antimalarial Resistance Network, Oxford, England	University System of Georgia; Georgia Institute of Technology; FHI 360; University of Oxford; University of Oxford; Worldwide Antimalarial Resistance Network (WWARN)	Fernandez, FM (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	facundo.fernandez@chemistry.gatech.edu; djenkins@fhi360.org	Jenkins, David/K-8021-2019; Fernandez, Facundo Martin/B-7015-2008	Jenkins, David/0000-0001-6698-272X; Fernandez, Facundo Martin/0000-0002-0302-2534; Dwivedi, Prabha/0000-0002-6435-2166; Newton, Paul/0000-0002-4608-6431; Monge, Maria/0000-0001-6517-5301	Prosalud Inter Americana [FHI 360]; ACT Consortium; Bill & Melinda Gates Foundation; Wellcome Trust of Great Britain; Division Of Chemistry [1004570] Funding Source: National Science Foundation	Prosalud Inter Americana; ACT Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust of Great Britain(Wellcome Trust); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Sample collection, HPLC analysis, dissolution testing and TLC screening were funded through a contract between Prosalud Inter Americana (http://prosaludinteramericana.org/) to FHI 360. All drug purchasing was handled in-country by an independent organization subcontracted by FHI 360. PD was partially supported by the ACT Consortium (www.actconsortium.org), which is funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene & Tropical Medicine. The authors are also thankful for access to MS instrumentation acquired through the ACT Consortium and the NSF/NASA Center for Chemical Evolution. Paul Newton is supported by the Wellcome Trust of Great Britain (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, COUNT PROBL FALS SUB; [Anonymous], 2011, CONTRACEPTIVE TECHNO; Attaran A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7381; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; CDC, 2013, US EM CONTR WOM AG 1; Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j; Csillag C, 1998, LANCET, V352, P553, DOI 10.1016/S0140-6736(05)79267-9; Dorlo TPC, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7518; FDA, 2004, FDA JOHNS JOHNS WARN; FDA, 2011, UN EM BIRTH CONTR ME; Fernandez FM, 2011, ANALYST, V136, P3073, DOI 10.1039/c0an00627k; Holzgrabe U, 2008, NMR SPECTROSCOPY IN PHARMACEUTICAL ANALYSIS, P1; Kuczynski PP, 2006, CONSTITUYEN GRUPO TE; Ministerio de salud, 2006, EV SIT MED PER; Newton P, 2009, DEV COUNTRIES; Newton PN, 2008, PLOS MED, V5, P209, DOI 10.1371/journal.pmed.0050032; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Nishtar S, 2012, LANCET, V379, P1084, DOI 10.1016/S0140-6736(12)60277-3; Noe G, 2010, CONTRACEPTION, V81, P414, DOI 10.1016/j.contraception.2009.12.015; Novikova N, 2007, CONTRACEPTION, V75, P112, DOI 10.1016/j.contraception.2006.08.015; Nyadong L, 2009, ANAL CHEM, V81, P4803, DOI 10.1021/ac900384j; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Smith RM, 2012, NEW ENGL J MED; Trussell J, 2012, EMERGENCY CONTRACEPTION: THE STORY OF A GLOBAL REPRODUCTIVE HEALTH TECHNOLOGY, P19; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; Wanja J, 2009, DAILY NATION KENYA; WHO, 2015, PREQ PROGR; WHO, 2011, LEV TABL; World Health Organization IES, 2013, FALS BATCH POST 2 RE	31	10	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95353	10.1371/journal.pone.0095353	http://dx.doi.org/10.1371/journal.pone.0095353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748219	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500091
J	Prashad, RC; Charlton, MP				Prashad, Rene C.; Charlton, Milton P.			SNARE Zippering and Synaptic Strength	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BOTULINUM TYPE-B; MEMBRANE-PROTEIN; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; LIGHT-CHAIN; CLOSTRIDIAL NEUROTOXINS; NEUROMUSCULAR-JUNCTION; FUSION COMPLEX; VESICLE FUSION	Synapses vary widely in the probability of neurotransmitter release. We tested the hypothesis that the zippered state of the trans-SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex determines initial release probability. We tested this hypothesis at phasic and tonic synapses which differ by 100-1000-fold in neurotransmitter release probability. We injected, presynaptically, three Clostridial neurotoxins which bind and cleave at different sites on VAMP to determine whether these sites were occluded by the zippering of the SNARE complex or open to proteolytic attack. Under low stimulation conditions, the catalytic light-chain fragment of botulinum B (BoNT/B-LC) inhibited evoked release at both phasic and tonic synapses and cleaved VAMP; however, neither BoNT/D-LC nor tetanus neurotoxin (TeNT-LC) were effective in these conditions. The susceptibility of VAMP to only BoNT/B-LC indicated that SNARE complexes at both phasic and tonic synapses were partially zippered only at the N-terminal end to approximately the zero-layer with the C-terminal end exposed under resting state. Therefore, the existence of the same partially zippered state of the trans-SNARE complex at both phasic and tonic synapses indicates that release probability is not determined solely by the zippered state of the trans-SNARE complex at least to the zero-layer.	[Prashad, Rene C.; Charlton, Milton P.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto	Charlton, MP (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	milton.charlton@utoronto.ca			Canadian Institutes of Health Research [MOP-82827]; Margaret J. Santalo research fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Margaret J. Santalo research fellowship	This work was supported by a grant to M. P. C. from the Canadian Institutes of Health Research, MOP-82827, and the Margaret J. Santalo research fellowship to R. C. P., Department of Physiology, University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt JW, 2006, BIOCHEMISTRY-US, V45, P3255, DOI 10.1021/bi052518r; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; BOYD RS, 1995, J BIOL CHEM, V270, P18216, DOI 10.1074/jbc.270.31.18216; Bradacs H, 1997, J EXP BIOL, V200, P677; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Dittman JS, 2000, J NEUROSCI, V20, P1374; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Hua SY, 1998, J NEUROPHYSIOL, V80, P3233, DOI 10.1152/jn.1998.80.6.3233; King MJR, 1996, J COMP NEUROL, V372, P618, DOI 10.1002/(SICI)1096-9861(19960902)372:4<618::AID-CNE9>3.0.CO;2-7; Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072; LI Y, 1994, BIOCHEMISTRY-US, V33, P7014, DOI 10.1021/bi00188a034; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Matos MF, 2003, NEUROPHARMACOLOGY, V45, P777, DOI 10.1016/S0028-3908(03)00318-6; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Millar AG, 2005, J NEUROSCI, V25, P3113, DOI 10.1523/JNEUROSCI.4717-04.2005; Millar AG, 2002, J NEUROSCI, V22, P9661; Msghina M, 1998, J NEUROSCI, V18, P1374; Msghina M, 1999, J NEUROSCI, V19, P8419; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; PELLEGRINI LL, 1994, FEBS LETT, V353, P319, DOI 10.1016/0014-5793(94)01070-6; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; Pellizzari R, 1997, FEBS LETT, V409, P339, DOI 10.1016/S0014-5793(97)00482-1; Raciborska DA, 1998, EUR J NEUROSCI, V10, P2617, DOI 10.1046/j.1460-9568.1998.00270.x; Rossetto O, 1996, J CELL BIOL, V132, P167, DOI 10.1083/jcb.132.1.167; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SHONE CC, 1993, EUR J BIOCHEM, V217, P965, DOI 10.1111/j.1432-1033.1993.tb18327.x; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Su ZL, 2008, STRUCTURE, V16, P1138, DOI 10.1016/j.str.2008.03.018; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Vites O, 2008, BIOPHYS J, V95, P1295, DOI 10.1529/biophysj.108.129510; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003; Zamir O, 2006, J PHYSIOL-LONDON, V571, P83, DOI 10.1113/jphysiol.2005.098319	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95130	10.1371/journal.pone.0095130	http://dx.doi.org/10.1371/journal.pone.0095130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747882	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500060
J	Lee, HK; Song, HE; Lee, HB; Kim, CS; Koketsu, M; Ngan, LTM; Ahn, YJ				Lee, Hyun-Kyung; Song, Ha Eun; Lee, Haeng-Byung; Kim, Cheol-Soo; Koketsu, Mamoru; Luong Thi My Ngan; Ahn, Young-Joon			Growth Inhibitory, Bactericidal, and Morphostructural Effects of Dehydrocostus Lactone from Magnolia sieboldii Leaves on Antibiotic-Susceptible and -Resistant Strains of Helicobacter pylori	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; IN-VITRO; MEDICINAL-PLANTS; UREASE; OMEPRAZOLE; PHYTOCHEMICALS; CLARITHROMYCIN; METRONIDAZOLE; THERAPY; PH	Helicobacter pylori is associated with various diseases of the upper gastrointestinal tract, such as gastric inflammation and duodenal and gastric ulcers. The aim of the study was to assess anti-H. pylori effects of the sesquiterpene lactone dehydrocostus lactone (DCL) from Magnolia sieboldii leaves, compared to commercial pure DCL, two previously known sesquiterpene lactones (costunolide and parthenolide), (-)-epigallocatechin gallate, and four antibiotics. The antibacterial activity of natural DCL toward antibiotic-susceptible H. pylori ATCC 700392 and H. pylori ATCC 700824 strains (MIC, 4.9 and 4.4 mg/L) was similar to that of commercial DCL and was more effective than costunolide, parthenolide, and EGCG. The activity of DCL was slightly lower than that of metronidazole (MIC, 1.10 and 1.07 mg/L). The antibacterial activity of DCL was virtually identical toward susceptible and resistant strains, even though resistance to amoxicillin (MIC, 11.1 mg/L for PED 503G strain), clarithromycin (49.8 mg/L for PED 3582GA strain), metronidazole (21.6 mg/L for H. pylori ATCC 43504 strain; 71.1 mg/L for 221 strain), or tetracycline (14.2 mg/L for B strain) was observed. This finding indicates that DCL and the antibiotics do not share a common mode of action. The bactericidal activity of DCL toward H. pylori ATCC 43504 was not affected by pH values examined (4.0-7.0). DCL caused considerable conversion to coccoid form (94 versus 49% at 8 and 4 mg/L of DCL for 48 h). The Western blot analysis revealed that urease subunits (UreA and UreB) of H. pylori ATCC 43504 were not affected by 10 mM of DCL, whereas UreA monomer band completely disappeared at 0.1 mM of (-)-epigallocatechin gallate. Global efforts to reduce the level of antibiotics justify further studies on M. sieboldii leaf-derived materials containing DCL as potential antibacterial products or a lead molecule for the prevention or eradication of drug-resistant H. pylori.	[Lee, Hyun-Kyung; Lee, Haeng-Byung] Seoul Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Agr Biotechnol, Seoul, South Korea; [Song, Ha Eun; Ahn, Young-Joon] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Cheol-Soo] Halla Bot Garden, Jeju City, Jeju, South Korea; [Koketsu, Mamoru] Gifu Univ, Dept Chem & Biomol Sci, Gifu, Japan; [Luong Thi My Ngan] Vietnam Natl Univ, Ho Chi Minh City Univ Sci, Fac Biol, Dept Plant Biotechnol & Biotransformat, Ho Chi Minh City, Vietnam	Seoul National University (SNU); Seoul National University (SNU); Gifu University; Vietnam National University Hanoi; Vietnam National University Hochiminh City	Ngan, LTM (corresponding author), Vietnam Natl Univ, Ho Chi Minh City Univ Sci, Fac Biol, Dept Plant Biotechnol & Biotransformat, Ho Chi Minh City, Vietnam.	ltmngan@hcmus.edu.vn; yjahn@snu.ac.kr	Cho, Eunyoung/AAV-4469-2020; Kim, Cho-il/B-5961-2011	Cho, Eunyoung/0000-0001-6594-2582; Luong, Ngan/0000-0003-0500-007X	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	This work was carried out with the support by the Brain Korea 21 PLUS through the National Research Foundation of Korea funded by the Ministry of Education of the Korean Government to Y.-J. Ahn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsson I, 1999, J ANTIMICROB CHEMOTH, V44, P629, DOI 10.1093/jac/44.5.629; Buhling A, 2001, ALIMENT PHARM THER, V15, P1445, DOI 10.1046/j.1365-2036.2001.01033.x; Chaturvedi D., 2011, SESQUITERPENE LACTON, P313; Cho SH, 2003, J APPL MICROBIOL, V95, P7, DOI 10.1046/j.1365-2672.2003.01998.x; Cole SP, 1999, J INFECT DIS, V180, P1713, DOI 10.1086/315079; Cole SP, 1997, INFECT IMMUN, V65, P843, DOI 10.1128/IAI.65.2.843-846.1997; De Leo M, 2006, PHYTOCHEMISTRY, V67, P2623, DOI 10.1016/j.phytochem.2006.07.017; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Fabry W, 1996, CHEMOTHERAPY, V42, P315, DOI 10.1159/000239460; Francesco Vincenzo De, 2011, World J Gastrointest Pathophysiol, V2, P35, DOI 10.4291/wjgp.v2.i3.35; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Funatogawa K, 2004, MICROBIOL IMMUNOL, V48, P251, DOI 10.1111/j.1348-0421.2004.tb03521.x; Gerrits MM, 2006, LANCET INFECT DIS, V6, P699, DOI 10.1016/S1473-3099(06)70627-2; Graham DY, 2014, CLIN GASTROENTEROL H, V12, P177, DOI 10.1016/j.cgh.2013.05.028; Haristoy X, 2005, PLANTA MED, V71, P326, DOI 10.1055/s-2005-864098; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Icatlo FC, 1998, J BIOL CHEM, V273, P18130, DOI 10.1074/jbc.273.29.18130; ITOH T, 1987, MICROBIOL IMMUNOL, V31, P603, DOI 10.1111/j.1348-0421.1987.tb03121.x; Kim KW, 2007, MICRON, V38, P626, DOI 10.1016/j.micron.2006.09.006; Kusters JG, 1997, INFECT IMMUN, V65, P3672, DOI 10.1128/IAI.65.9.3672-3679.1997; Lee Hyun-Kyung, 2004, Journal of Applied Biological Chemistry, V47, P91; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Lin YT, 2005, APPL ENVIRON MICROB, V71, P8558, DOI 10.1128/AEM.71.12.8558-8564.2005; Luong TMN, 2012, J AGR FOOD CHEM, V60, P9062, DOI 10.1021/jf3035034; Mabe K, 1999, ANTIMICROB AGENTS CH, V43, P1788, DOI 10.1128/AAC.43.7.1788; MALANOSKI GJ, 1993, EUR J CLIN MICROBIOL, V12, P131, DOI 10.1007/BF01967591; Marshall BJ, 2005, MED CLIN N AM, V89, P313, DOI 10.1016/j.mcna.2004.09.001; Matsubara S, 2003, BIOCHEM BIOPH RES CO, V310, P715, DOI 10.1016/j.bbrc.2003.09.066; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Nakao M, 1998, HELICOBACTER, V3, P21, DOI 10.1046/j.1523-5378.1998.08024.x; Nascimento GGF, 2000, BRAZ J MICROBIOL, V31, P247; Ohno T, 2003, HELICOBACTER, V8, P207, DOI 10.1046/j.1523-5378.2003.00146.x; Park BS, 2006, J ETHNOPHARMACOL, V105, P255, DOI 10.1016/j.jep.2005.11.005; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Rimbara E, 2011, NAT REV GASTRO HEPAT, V8, P79, DOI 10.1038/nrgastro.2010.210; Saito N, 2003, J INFECTION, V46, P49, DOI 10.1053/jinf.2002.1047; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sekiguchi H, 2008, J CLIN BIOCHEM NUTR, V43, P109, DOI 10.3164/jcbn.2008054; SHIBATA K, 1995, ANTIMICROB AGENTS CH, V39, P1295, DOI 10.1128/AAC.39.6.1295; Sjostrom JE, 1996, J MED MICROBIOL, V44, P425; TANIGUCHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P2064, DOI 10.1271/bbb.59.2064; Taylor David N., 1995, P551; Wang YC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep147; Watt IM, 1997, PRICIPLES PRACTICE E; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Wink M, 2006, ADV PHYTOMED, V3, P251; Yoshikawa M, 2000, BIOORGAN MED CHEM, V8, P2071, DOI 10.1016/S0968-0896(00)00127-9; Zeyrek FY, 2005, ANN MICROBIOL, V55, P125	48	99	102	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95530	10.1371/journal.pone.0095530	http://dx.doi.org/10.1371/journal.pone.0095530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747984	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500121
J	Zheng, YL; Kwong, MT; MacCormick, IJC; Beare, NAV; Harding, SP				Zheng, Yalin; Kwong, Man Ting; MacCormick, Ian J. C.; Beare, Nicholas A. V.; Harding, Simon P.			A Comprehensive Texture Segmentation Framework for Segmentation of Capillary Non-Perfusion Regions in Fundus Fluorescein Angiograms	PLOS ONE			English	Article							CEREBRAL MALARIA; IMAGE-ANALYSIS; MINIMIZATION; RETINOPATHY; COMPETITION; CHILDREN; DENSITY; COLOR	Capillary non-perfusion (CNP) in the retina is a characteristic feature used in the management of a wide range of retinal diseases. There is no well-established computation tool for assessing the extent of CNP. We propose a novel texture segmentation framework to address this problem. This framework comprises three major steps: pre-processing, unsupervised total variation texture segmentation, and supervised segmentation. It employs a state-of-the-art multiphase total variation texture segmentation model which is enhanced by new kernel based region terms. The model can be applied to texture and intensity-based multiphase problems. A supervised segmentation step allows the framework to take expert knowledge into account, an AdaBoost classifier with weighted cost coefficient is chosen to tackle imbalanced data classification problems. To demonstrate its effectiveness, we applied this framework to 48 images from malarial retinopathy and 10 images from ischemic diabetic maculopathy. The performance of segmentation is satisfactory when compared to a reference standard of manual delineations: accuracy, sensitivity and specificity are 89.0%, 73.0%, and 90.8% respectively for the malarial retinopathy dataset and 80.8%, 70.6%, and 82.1% respectively for the diabetic maculopathy dataset. In terms of region-wise analysis, this method achieved an accuracy of 76.3% (45 out of 59 regions) for the malarial retinopathy dataset and 73.9% (17 out of 26 regions) for the diabetic maculopathy dataset. This comprehensive segmentation framework can quantify capillary non-perfusion in retinopathy from two distinct etiologies, and has the potential to be adopted for wider applications.	[Zheng, Yalin; Kwong, Man Ting; MacCormick, Ian J. C.; Beare, Nicholas A. V.; Harding, Simon P.] Univ Liverpool, Dept Eye & Vision Sci, Liverpool L69 3BX, Merseyside, England; [Zheng, Yalin; Kwong, Man Ting; Beare, Nicholas A. V.; Harding, Simon P.] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England; [MacCormick, Ian J. C.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Malawi	Zheng, YL (corresponding author), Univ Liverpool, Dept Eye & Vision Sci, Liverpool L69 3BX, Merseyside, England.	yalin.zheng@liverpool.ac.uk	Zheng, Yalin/N-6432-2017; MacCormick, Ian/GPW-8622-2022; Beare, Nicholas/AAG-4946-2019; MacCormick, Ian JC/AFW-1885-2022	Zheng, Yalin/0000-0002-7873-0922; MacCormick, Ian/0000-0002-8171-0332; MacCormick, Ian JC/0000-0002-8171-0332; Harding, Simon/0000-0003-4676-1158; Beare, Nicholas/0000-0001-8086-990X	Wellcome Trust [092668/Z/10/Z]; Foundation for the Prevention of Blindness	Wellcome Trust(Wellcome TrustEuropean Commission); Foundation for the Prevention of Blindness	This work was supported by the Wellcome Trust (grant number 092668/Z/10/Z) and the Foundation for the Prevention of Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON N, 1953, BRIT J OPHTHALMOL, V37, P282, DOI 10.1136/bjo.37.5.282; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Buchanan CR, 2008, IEEE ENG MED BIO, P5437, DOI 10.1109/IEMBS.2008.4650444; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan TF, 2005, IMAGE PROCESSING AND ANALYSIS, P1, DOI 10.1137/1.9780898717877; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Choy SK, 2011, IEEE T IMAGE PROCESS, V20, P1473, DOI 10.1109/TIP.2010.2095023; Cree MJ, 1999, PHYS MED BIOL, V44, P293, DOI 10.1088/0031-9155/44/1/021; Cremers D, 2007, INT J COMPUT VISION, V72, P195, DOI 10.1007/s11263-006-8711-1; Dithmar S., 2008, FLUORESCENCE ANGIOGR; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Garcia Sevilla P., 2006, IMAGE PROCESSING DEA; Gardiner TA, 2007, MICROCIRCULATION, V14, P25, DOI 10.1080/10739680601072123; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hijazi MHA, 2012, KNOWL-BASED SYST, V29, P83, DOI 10.1016/j.knosys.2011.07.002; JASIOBEDZKI P, 1993, IMAGE VISION COMPUT, V11, P139, DOI 10.1016/0262-8856(93)90052-I; JASIOBEDZKI P, 1991, COMPUTER-BASED MEDICA SYSTEMS, P162, DOI 10.1109/CBMS.1991.128960; Nguyen K, 2012, PATTERN RECOGN LETT, V33, P951, DOI 10.1016/j.patrec.2011.10.001; Kim JM, 2005, IEEE T IMAGE PROCESS, V14, P1486, DOI 10.1109/TIP.2005.854442; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li F, 2010, COMMUN COMPUT PHYS, V8, P623, DOI 10.4208/cicp.160609.311209a; Mabrouk M.S., 2006, ICGST INT J GRAPH VI, V6, P1; Maude RJ, 2009, T ROY SOC TROP MED H, V103, P661, DOI 10.1016/j.trstmh.2008.11.003; Mirmehdi M., 2008, HDB TEXTURE ANAL; Narasimha-Iyer H, 2006, IEEE T BIO-MED ENG, V53, P1084, DOI 10.1109/TBME.2005.863971; Ni K, 2009, INT J COMPUT VISION, V84, P97, DOI 10.1007/s11263-009-0234-0; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Rousson M, 2003, PROC CVPR IEEE, P699; Sandberg B, 2002, 0239 CAM UCLA DEP MA; Saxena Sandeep, 2007, Indian Journal of Ophthalmology, V55, P267; Sivaswamy J, 2008, COMM COM INF SC, V25, P176; Sonka M., 2006, IMAGE PROCESSING ANA; TALBOT JF, 1982, BRIT J OPHTHALMOL, V66, P149, DOI 10.1136/bjo.66.3.149; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Trucco E, 2007, P ANN INT IEEE EMBS, P6740; Winder RJ, 2009, COMPUT MED IMAG GRAP, V33, P608, DOI 10.1016/j.compmedimag.2009.06.003; WOLF S, 1994, HYPERTENSION, V23, P464, DOI 10.1161/01.HYP.23.4.464; Zheng Y., 2012, ISRN SIGNAL PROCESS, V2012, P1; Zheng YL, 2007, P ANN INT IEEE EMBS, P4433, DOI 10.1109/IEMBS.2007.4353322; Zheng YL, 2013, BIOMED SIGNAL PROCES, V8, P374, DOI 10.1016/j.bspc.2013.02.004; Zheng YL, 2013, AM J OPHTHALMOL, V155, P277, DOI 10.1016/j.ajo.2012.07.030; Zheng YL, 2010, INVEST OPHTH VIS SCI, V51, P3653, DOI 10.1167/iovs.09-4935; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343	45	73	78	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93624	10.1371/journal.pone.0093624	http://dx.doi.org/10.1371/journal.pone.0093624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	25314156	Green Published, gold			2022-12-25	WOS:000335226500010
J	Mishra, AM; Bai, XX; Sanganahalli, BG; Waxman, SG; Shatillo, O; Grohn, O; Hyder, F; Pitkanen, A; Blumenfeld, H				Mishra, Asht Mangal; Bai, Xiaoxiao; Sanganahalli, Basavaraju G.; Waxman, Stephen G.; Shatillo, Olena; Grohn, Olli; Hyder, Fahmeed; Pitkanen, Asla; Blumenfeld, Hal			Decreased Resting Functional Connectivity after Traumatic Brain Injury in the Rat	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; TONIC-CLONIC SEIZURES; POSTTRAUMATIC EPILEPSY; WAG/RIJ RATS; FMRI; EPILEPTOGENESIS; MODEL; MRI; FLUCTUATIONS; NETWORKS	Traumatic brain injury (TBI) contributes to about 10% of acquired epilepsy. Even though the mechanisms of post-traumatic epileptogenesis are poorly known, a disruption of neuronal networks predisposing to altered neuronal synchrony remains a viable candidate mechanism. We tested a hypothesis that resting state BOLD-fMRI functional connectivity can reveal network abnormalities in brain regions that are connected to the lesioned cortex, and that these changes associate with functional impairment, particularly epileptogenesis. TBI was induced using lateral fluid-percussion injury in seven adult male Sprague-Dawley rats followed by functional imaging at 9.4T 4 months later. As controls we used six sham-operated animals that underwent all surgical operations but were not injured. Electroencephalogram (EEG)-functional magnetic resonance imaging (fMRI) was performed to measure resting functional connectivity. A week after functional imaging, rats were implanted with bipolar skull electrodes. After recovery, rats underwent pentyleneterazol (PTZ) seizure-susceptibility test under EEG. For image analysis, four pairs of regions of interests were analyzed in each hemisphere: ipsilateral and contralateral frontal and parietal cortex, hippocampus, and thalamus. High-pass and low-pass filters were applied to functional imaging data. Group statistics comparing injured and sham-operated rats and correlations over time between each region were calculated. In the end, rats were perfused for histology. None of the rats had epileptiform discharges during functional imaging. PTZ-test, however revealed increased seizure susceptibility in injured rats as compared to controls. Group statistics revealed decreased connectivity between the ipsilateral and contralateral parietal cortex and between the parietal cortex and hippocampus on the side of injury as compared to sham-operated animals. Injured animals also had abnormal negative connectivity between the ipsilateral and contralateral parietal cortex and other regions. Our data provide the first evidence on abnormal functional connectivity after experimental TBI assessed with resting state BOLD-fMRI.	[Mishra, Asht Mangal; Bai, Xiaoxiao; Waxman, Stephen G.; Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Mishra, Asht Mangal; Sanganahalli, Basavaraju G.; Hyder, Fahmeed; Blumenfeld, Hal] Yale Univ, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA; [Waxman, Stephen G.] Ctr Neurosci & Regenerat Res, West Haven, CT USA; [Grohn, Olli] Univ Eastern Finland, Biomed NMR Res Grp, Biomed Imaging Unit, Kuopio, Finland; [Shatillo, Olena; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	Yale University; Yale University; Yale University; Yale University; Yale University; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Blumenfeld, H (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	hal.blumenfeld@yale.edu	khan, yusuf/E-6726-2015; Sanganahalli, Basavaraju G/C-3296-2008; Hyder, Fahmeed/A-2644-2015; Waxman, Stephen/Z-2507-2019; khan, yusuf/AAQ-9470-2021; Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017; MISHRA, AWDHESH/U-1920-2019	khan, yusuf/0000-0001-6986-4657; Sanganahalli, Basavaraju G/0000-0002-0851-6621; Hyder, Fahmeed/0000-0001-7822-4002; Waxman, Stephen/0000-0001-5718-7177; Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; /0000-0002-3312-3264	National Institutes of Health (NIH) [R01 NS049307]; NIH [R01 NS066974]; Epilepsy Foundation Postdoctoral Research and Training Award [123505]; Yale QNMR Pilot study; Betsy and Jonathan Blattmachr family; Academy of Finland; Sigrid Juselius Foundation;  [P30 NS052519]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation Postdoctoral Research and Training Award; Yale QNMR Pilot study; Betsy and Jonathan Blattmachr family; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); 	This work was supported by National Institutes of Health (NIH) R01 NS049307 (HB), NIH R01 NS066974 (HB), Epilepsy Foundation Postdoctoral Research and Training Award ID: 123505 (AMM), Yale QNMR Pilot study (AMM), P30 NS052519 (FH), the Betsy and Jonathan Blattmachr family (HB), the Academy of Finland (AP, OG), and by the Sigrid Juselius Foundation (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2011, NEUROLOGY, V76, P1960, DOI 10.1212/WNL.0b013e31821e54de; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Coggan JS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065002; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; El-Hassar L, 2007, EPILEPSIA, V48, P131, DOI 10.1111/j.1528-1167.2007.01301.x; Englot DJ, 2008, J NEUROSCI, V28, P9066, DOI 10.1523/JNEUROSCI.2014-08.2008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Franken ND, 2008, VET ANAESTH ANALG, V35, P424, DOI 10.1111/j.1467-2995.2008.00404.x; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hettinger PC, 2011, J NEUROSCI METH, V200, P106, DOI 10.1016/j.jneumeth.2011.06.018; Immonen R, 2013, J NEUROTRAUM, P1; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Karhunen H, 2007, NEUROSCIENCE, V148, P314, DOI 10.1016/j.neuroscience.2007.05.047; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Khubchandani M, 2003, MAGNET RESON MED, V49, P962, DOI 10.1002/mrm.10441; Killory BD, 2011, NEUROIMAGE, V56, P2209, DOI 10.1016/j.neuroimage.2011.03.036; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lemieux L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00012; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mishra AM, 2009, EPILEPSIA, V50, P362; Mishra AM, 2011, J NEUROSCI, V31, P15053, DOI 10.1523/JNEUROSCI.0101-11.2011; Nersesyan H, 2004, J CEREBR BLOOD F MET, V24, P589, DOI 10.1097/01.WCB.0000117688.98763.23; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Sachdev RNS, 2003, NEUROIMAGE, V19, P742, DOI 10.1016/S1053-8119(03)00093-4; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063	41	114	121	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95280	10.1371/journal.pone.0095280	http://dx.doi.org/10.1371/journal.pone.0095280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748279	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500074
J	Wu, CL; Qu, XH; Liu, FX; Li, HW; Mao, YQ; Zhu, ZN				Wu, Chuanlong; Qu, Xinhua; Liu, Fengxiang; Li, Huiwu; Mao, Yuanqing; Zhu, Zhenan			Risk Factors for Periprosthetic Joint Infection after Total Hip Arthroplasty and Total Knee Arthroplasty in Chinese Patients	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; DIABETES-MELLITUS; POSTOPERATIVE MORTALITY; BACTERIAL-INFECTION; MEDICARE PATIENTS; GLYCEMIC CONTROL; IMMUNE-RESPONSE; REPLACEMENT; VACCINATION; CIRRHOSIS	Purpose: The purpose of this hospital-based case-control study was to evaluate the risk factors for periprosthetic joint infection (PJI) of total hip arthroplasty (THA) and total knee arthroplasty (TKA) in Chinese patients. Method: From January 2000 to December 2012, 45 patients undergoing THA and TKA who developed PJI were recruited for case subjects; controls were 252 without PJI, matched by year of index for surgery and type of surgery. Conditional logistic regressions were run to compute odds ratios (ORs) and 95% confidence intervals (CIs). Results: Demographic factors and comorbid conditions associated with an increased adjusted risk of PJI (in decreasing order of significance) were diabetes (OR = 5.47, 95% CI: 1.77-16.97; p = 0.003), age (65-75 vs. 45-65 years) (OR = 3.36, 95% CI: 1.30-8.69; p = 0.013), BMI (>= 28 vs. 18.5-28 kg/m(2)) (OR = 2.77, 95% CI: 1.20-6.40; p = 0.017), place of residence (rural) (OR = 2.63, 95% CI: 1.13-6.10; p = 0.025) and alcohol abuse (OR = 2.95, 95% CI: 1.06-8.23; p = 0.039). Conclusion: Patients with diabetes, older age, BMI of >= 28 kg/m(2) and alcohol abuse or living in rural areas, had increased PJI risk. Additional systematic large-scale studies are needed to verify these results.	[Wu, Chuanlong; Qu, Xinhua; Liu, Fengxiang; Li, Huiwu; Mao, Yuanqing; Zhu, Zhenan] Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Mao, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	13761360486@163.com; zhenan_zhu@126.com	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890; Huang, Nicole/0000-0002-6629-1176	National Natural Science Foundation of China [81171729, 81301590]; Major Basic Research of Science and Technology Commission of Shanghai Municipality [11DJ1400303]; Fund for Key Disciplines of Shanghai Municipal Education Commission [J50206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Fund for Key Disciplines of Shanghai Municipal Education Commission	This work was supported by grants from the National Natural Science Foundation of China (No. 81171729 and No. 81301590), Major Basic Research of Science and Technology Commission of Shanghai Municipality (Grant No. 11DJ1400303), and Fund for Key Disciplines of Shanghai Municipal Education Commission (J50206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berbari EF, 2010, CLIN INFECT DIS, V50, P8, DOI 10.1086/648676; Bozic KJ, 2012, J BONE JOINT SURG AM, V94A, P794, DOI 10.2106/JBJS.K.00072; Bozic KJ, 2012, CLIN ORTHOP RELAT R, V470, P130, DOI 10.1007/s11999-011-2043-3; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Bozic KJ, 2013, J ARTHROPLASTY; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chesney D, 2008, J ARTHROPLASTY, V23, P355, DOI 10.1016/j.arth.2007.05.052; Dale H, 2012, ACTA ORTHOP, V83, P449, DOI 10.3109/17453674.2012.733918; Dowsey MM, 2008, CLIN ORTHOP RELAT R, V466, P153, DOI 10.1007/s11999-007-0016-3; Eibl N, 2002, CLIN IMMUNOL, V103, P249, DOI 10.1006/clim.2002.5220; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Everhart JS, 2013, CLIN ORTHOP RELAT RE; Gamble L, 2006, MED MALADIES INFECT, V36, P72, DOI 10.1016/j.medmal.2005.08.010; GOMEZ F, 1994, NEW ENGL J MED, V331, P1122, DOI 10.1056/NEJM199410273311704; Hegde V, 2013, CLIN MICROBIOL INFEC, V19, P314, DOI 10.1111/1469-0691.12157; Jamsen Esa, 2012, J Bone Joint Surg Am, V94, pe101, DOI 10.2106/JBJS.J.01935; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Lai K, 2007, J ARTHROPLASTY, V22, P651, DOI 10.1016/j.arth.2006.09.002; Malinzak RA, 2009, J ARTHROPLASTY, V24, P84, DOI 10.1016/j.arth.2009.05.016; Marchant MH, 2009, J BONE JOINT SURG AM, V91A, P1621, DOI 10.2106/JBJS.H.00116; Meding JB, 2003, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000093002.90435.56; MENDENHALL CL, 1991, HEPATOLOGY, V14, P581; Namba RS, 2012, J BONE JOINT SURG BR, V94B, P1330, DOI 10.1302/0301-620X.94B10.29184; Namba RS, 2013, J BONE JOINT SURG AM, V95A, P775, DOI 10.2106/JBJS.L.00211; Pedersen AB, 2010, J BONE JOINT SURG BR, V92B, P929, DOI 10.1302/0301-620X.92B7.24461; Poultsides LA, 2013, J ARTHROPLASTY, V28, P385, DOI 10.1016/j.arth.2012.06.027; POZZILLI P, 1986, DIABETOLOGIA, V29, P850, DOI 10.1007/BF00870139; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Ridgeway S, 2005, J BONE JOINT SURG BR, V87B, P844, DOI 10.1302/0301-620X.87B6.15121; Sculco T P, 1993, Instr Course Lect, V42, P349; van Kasteren MEE, 2007, CLIN INFECT DIS, V44, P921, DOI 10.1086/512192; Yurgin N, 2007, CLIN THER, V29, P316, DOI 10.1016/j.clinthera.2007.02.012; J AM ACAD ORTHOP SUR, V21, P195	33	113	124	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95300	10.1371/journal.pone.0095300	http://dx.doi.org/10.1371/journal.pone.0095300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	25014070	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500082
J	Liu, J; Huang, JS; Su, TX; Bertoldi, K; Clarke, DR				Liu, Jia; Huang, Jiangshui; Su, Tianxiang; Bertoldi, Katia; Clarke, David R.			Structural Transition from Helices to Hemihelices	PLOS ONE			English	Article							NONLINEAR DYNAMICS; TENDRIL PERVERSION; FILAMENTS; LEAVES; INSTABILITIES; KIRCHHOFF; MECHANICS; STRIPS; EDGES; RODS	Helices are amongst the most common structures in nature and in some cases, such as tethered plant tendrils, a more complex but related shape, the hemihelix forms. In its simplest form it consists of two helices of opposite chirality joined by a perversion. A recent, simple experiment using elastomer strips reveals that hemihelices with multiple reversals of chirality can also occur, a richness not anticipated by existing analyses. Here, we show through analysis and experiments that the transition from a helical to a hemihelical shape, as well as the number of perversions, depends on the height to width ratio of the strip's cross-section. Our findings provides the basis for the deterministic manufacture of a variety of complex three-dimensional shapes from flat strips.	[Liu, Jia; Huang, Jiangshui; Su, Tianxiang; Bertoldi, Katia; Clarke, David R.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Bertoldi, Katia; Clarke, David R.] Harvard Univ, Kavli Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University	Bertoldi, K (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	bertoldi@seas.harvard.edu; clarke@seas.harvard.edu	Huang, Jiangshui/G-5833-2010	Huang, Jiangshui/0000-0002-3523-2165; Liu, Jia/0000-0002-5628-8889; Liu, Jianfeng/0000-0003-1172-7080; Clarke, David/0000-0002-5902-7369	Materials Research Science and Engineering Center under NSF [DMR-0820484]; National Science Foundation [CMMI-1149456-CAREER, CMMI-1333835]; Wyss institute through the Seed Grant Program	Materials Research Science and Engineering Center under NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Wyss institute through the Seed Grant Program	This work was supported by the Materials Research Science and Engineering Center under NSF Award No. DMR-0820484. K.B. also acknowledges support from the National Science Foundation (CMMI-1149456-CAREER) and the Wyss institute through the Seed Grant Program. D.R. acknowledges funding from the National Science Foundation (CMMI-1333835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Audoly B, 2002, CR MECANIQUE, V330, P831, DOI 10.1016/S1631-0721(02)01545-0; Audoly B, 2010, ELASTICITY GEOMETRY; Ball P, 1999, SELF MADE TAPESTRY P; Balluffi RW, 2005, KINETICS OF MATERIALS, P1; Bower A.F., 2009, APPL MECH SOLIDS; Budynas R.G., 2002, ROARKS FORMULAS STRE; Chapman RE, 1965, BIOL SKIN HAIR GROWT; Chen Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530441; COLEMAN BD, 1993, ARCH RATION MECH AN, V121, P339, DOI 10.1007/BF00375625; Darwin C, 1888, MOVEMENTS HABITS CLI, P55; Forterre Y, 2011, SCIENCE, V333, P1715, DOI 10.1126/science.1210734; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; Gerbode SJ, 2012, SCIENCE, V337, P1087, DOI 10.1126/science.1223304; Goriely A, 1997, PHYSICA D, V105, P20, DOI 10.1016/S0167-2789(96)00290-4; Goriely A, 1997, PHYSICA D, V105, P45, DOI 10.1016/S0167-2789(97)83389-1; Goriely A, 2000, PHYS REV E, V61, P4508, DOI 10.1103/PhysRevE.61.4508; Goriely A, 2000, NONLINEAR DYNAM, V21, P101, DOI 10.1023/A:1008366526875; Goriely A, 1998, PHYS REV LETT, V80, P1564, DOI 10.1103/PhysRevLett.80.1564; Gray A, 1868, GRAYS LESSONS BOT VE, P38; Huang JS, 2012, SOFT MATTER, V8, P6291, DOI 10.1039/c2sm25278c; Kirchhoff G, 1859, J REINE ANGEW MATH, V56, P285, DOI DOI 10.1515/CRLL.1859.56.285; Kirchhoff G., 1876, MECHANIK, V28; Listing JB, 1847, VORSTUDIEN TOPOLOGIE, VI, P811; Marder M, 2003, EUROPHYS LETT, V62, P498, DOI 10.1209/epl/i2003-00334-5; Maxwell MC, 1873, TREATISE ELECT MAGNE, VII, P456; McMillen T, 2002, J NONLINEAR SCI, V12, P241, DOI 10.1007/s00332-002-0493-1; Patricio P, 1998, PHYSICA D, V124, P285, DOI 10.1016/S0167-2789(98)00203-6; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Sharon E, 2004, AM SCI, V92, P254, DOI 10.1511/2004.47.932; Sharon E, 2002, NATURE, V419, P579, DOI 10.1038/419579a; Sharon E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046211; Silverberg JL, 2012, P NATL ACAD SCI USA, V109, P16794, DOI 10.1073/pnas.1209287109; Thompson D. W., 1917, GROWTH FORM; Valverde J, 2010, J NONLINEAR SCI, V20, P309, DOI 10.1007/s00332-010-9059-9; Zhou HJ, 1999, J CHEM PHYS, V110, P1247, DOI 10.1063/1.478167	36	76	75	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e93183	10.1371/journal.pone.0093183	http://dx.doi.org/10.1371/journal.pone.0093183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24915574	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200007
J	Wu, CY; Chou, YC; Huang, N; Chou, YJ; Hu, HY; Li, CP				Wu, Chen-Yi; Chou, Yi-Chang; Huang, Nicole; Chou, Yiing-Jenq; Hu, Hsiao-Yun; Li, Chung-Pin			Association of Body Mass Index with All-Cause and Cardiovascular Disease Mortality in the Elderly	PLOS ONE			English	Article							OBESITY PARADOX; METABOLIC SYNDROME; PLASMA-LIPIDS; OVERWEIGHT; RISK; DEATHS; ADULTS; UNDERWEIGHT; PREVALENCE; AMERICAN	Objectives: To evaluate the associations of body mass index (BMI) with all-cause, cardiovascular disease (CVD), and expanded CVD mortality in the elderly. Design: Observational cohort study. Setting: Annual physical examination program for the elderly from 2006 to 2010. Participants: We included 77,541 Taipei residents aged >= 65 years (39,365 men and 38,176 women). Measurements: BMI was categorized as underweight (BMI<18.5), normal weight (18.5 <= BMI<25), overweight (25 <= BMI<30), grade 1 obesity (30 <= BMI<35), or grade 2-3 obesity (BMI >= 35). Mortality was ascertained by national death files. Results: Underweight (hazard ratios [HRs] of all-cause, CVD, and expanded CVD mortality: 1.92, 1.74, and 1.77, respectively), grade 2-3 obesity (HRs: 1.59, 2.36, and 2.22, respectively), older age, male sex, smoking, and high fasting blood sugar were significant predictors of mortality. Meanwhile, being married/cohabitating, higher education, alcohol consumption, more regular exercise, and high total cholesterol were inversely associated with mortality. Multivariate stratified subgroup analyses verified smokers (HRs of all-cause, CVD, and expanded CVD mortality: 3.25, 10.71, and 7.86, respectively, for grade 2-3 obesity), the high triglyceride group (HRs: 5.82, 10.99, and 14.22, respectively for underweight), and patients with 3-4 factors related to metabolic syndrome (HRs: 4.86, 12.72, and 11.42, respectively, for underweight) were associated with mortality. Conclusion: The associations of BMI with all-cause, CVD, expanded CVD mortality in the elderly are represented by U-shaped curves, suggesting unilateral promotions or interventions in weight reduction in the elderly may be inappropriate. Heterogeneous effects of grades 1 and 2-3 obesity on mortality were observed and should be treated as different levels of obesity.	[Wu, Chen-Yi; Chou, Yi-Chang; Chou, Yiing-Jenq; Hu, Hsiao-Yun] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wu, Chen-Yi] Taipei City Hosp, Heping Fuyou Branch, Dept Dermatol, Taipei, Taiwan; [Chou, Yi-Chang; Huang, Nicole; Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Li, Chung-Pin] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Li, Chung-Pin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Hu, HY (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	hyhu@ym.edu.tw; cpli@vghtpe.gov.tw	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890; Huang, Nicole/0000-0002-6629-1176	Taiwan Ministry of Education; Department of Health of the Taipei City Government [10301-62-001]; Taiwan's National Science Council [98-2314-B-010-015-MY2]	Taiwan Ministry of Education(Ministry of Education, Taiwan); Department of Health of the Taipei City Government; Taiwan's National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by the Taiwan Ministry of Education through its "Aim for the Top University Plan,'' by the Department of Health of the Taipei City Government (Grant 10301-62-001), and by Taiwan's National Science Council (Grant 98-2314-B-010-015-MY2). This study is based on data from the Taipei City Public Health Database provided by the Department of Health of the Taipei City Government and managed by the Databank for Public Health Analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom JL, 2008, AGE AGEING, V37, P207, DOI 10.1093/ageing/afn017; Artham SM, 2008, POSTGRAD MED, V120, P34, DOI 10.3810/pgm.2008.07.1788; Auyeung TW, 2010, J GERONTOL A-BIOL, V65, P99, DOI 10.1093/gerona/glp099; Doehner W, 2010, EUR HEART J, V31, P146, DOI 10.1093/eurheartj/ehp339; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2007, AM J EPIDEMIOL, V166, P975, DOI 10.1093/aje/kwm152; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Flegal KM, 2010, AM J CLIN NUTR, V91, P519, DOI 10.3945/ajcn.2009.28222; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Greenberg JA, 2013, AM J CLIN NUTR, V97, P1195, DOI 10.3945/ajcn.112.045815; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; He Y, 2007, DIABETES CARE, V30, P2128, DOI 10.2337/dc06-2402; Heymsfield SB, 2013, JAMA-J AM MED ASSOC, V309, P87, DOI 10.1001/jama.2012.185445; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lavie CJ, 2008, NAT CLIN PRACT CARD, V5, P428, DOI 10.1038/ncpcardio1257; Lin WY, 2010, J AM GERIATR SOC, V58, P2092, DOI 10.1111/j.1532-5415.2010.03148.x; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Nagai M, 2010, J EPIDEMIOL, V20, P398, DOI 10.2188/jea.JE20090204; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Schenkeveld L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000535; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Tsai SP, 2008, DIABETES RES CLIN PR, V82, P148, DOI 10.1016/j.diabres.2008.07.016; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071223; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007	32	113	124	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102589	10.1371/journal.pone.0102589	http://dx.doi.org/10.1371/journal.pone.0102589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014070	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400104
J	Liu, AQ; Yang, FK; Shen, YJ; Zhang, WZ; Wang, RJ; Zhao, W; Zhang, LX; Ling, H; Cao, JP				Liu, Aiqin; Yang, Fengkun; Shen, Yujuan; Zhang, Weizhe; Wang, Rongjun; Zhao, Wei; Zhang, Longxian; Ling, Hong; Cao, Jianping			Genetic Analysis of the Gdh and Bg Genes of Animal-Derived Giardia duodenalis Isolates in Northeastern China and Evaluation of Zoonotic Transmission Potential	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; DAIRY-CATTLE; IDENTIFICATION; GENOTYPES; CRYPTOSPORIDIUM; LAMBLIA; HUMANS; LOCUS; ASSEMBLAGES	Background: Giardia duodenalis is a common intestinal parasite that infects humans and many other mammals, mainly distributing in some areas with poor sanitation. The proportion of the human giardiasis burden attributable to G. duodenalis of animal origin differs in different geographical areas. In Mainland China, genetic data of the gdh and bg genes of G. duodenalis from animals are only limited in dogs and cats. The aim of the study was to provide information on the genetic characterizations of animal-derived G. duodenalis isolates (from rabbits, sheep and cattle) at both loci in Heilongjiang Province, Northeastern China, and to assess the potential for zoonotic transmission. Methodology/Principal Findings: 61 G. duodenalis isolates from animal feces (dairy and beef cattle, sheep and rabbits) in Heilongjiang Province were characterized at the gdh and bg loci in the present study. The gdh and bg gene sequences of sheep-derived G. duodenalis assemblage AI, and the gdh sequences of rabbit-derived G. duodenalis assemblage B had 100% similarity with those from humans, respectively. Novel subtypes of G. duodenalis were identified, with one and seven subtypes for assemblages A and E at the gdh locus, and two and three subtypes for assemblages B and E at the bg locus, respectively. Three pairs of the same bg sequences of assemblage E were observed in sheep and cattle. Conclusions/Significance: This is the first description of genetic characterizations of the gdh and bg genes of G. duodenalis from rabbits, sheep and cattle in Mainland China. Homology analysis of assemblages AI and B implied the possibility of zoonotic transmission. The novel subtypes of assemblages of G. duodenalis may represent the endemic genetic characteristics of G. duodenalis in Heilongjiang Province, China.	[Liu, Aiqin; Yang, Fengkun; Zhang, Weizhe; Zhao, Wei; Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Shen, Yujuan; Cao, Jianping] WHO Collaborating Ctr Malaria Schistosomiasis & F, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China; [Wang, Rongjun; Zhang, Longxian] Henan Agr Univ Zhengzhou, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Zhang, WZ (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	zhangweizhe526@163.com; caojp@yahoo.com	Cao, Jianping/AFL-5468-2022; Zhang, Longxian/I-9223-2019; Stojanovski, Kristefer/H-8291-2019; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/R-7799-2019	Cao, Jianping/0000-0002-1974-0047; Zhang, Longxian/0000-0002-5706-131X; Stojanovski, Kristefer/0000-0003-1239-5153; ling, hong/0000-0002-1886-1242; Grant, Robert/0000-0002-0851-7085	Natural Science Foundation of Heilongjiang Province [D200628]; National S & T Major Program for Infectious Disease of China [2012ZX10004-201, 2009ZX10004-201]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065233, U01AI084735, R01AI098472, P30AI027763, UM1AI069496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085598] Funding Source: NIH RePORTER	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); National S & T Major Program for Infectious Disease of China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by grants from the Natural Science Foundation of Heilongjiang Province No. D200628(AL) and the National S & T Major Program for Infectious Disease of China Nos. 2012ZX10004-201 and 2009ZX10004-201(JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2010, PARASITOL RES, V106, P733, DOI 10.1007/s00436-009-1703-7; Bertrand I, 2005, J CLIN MICROBIOL, V43, P5940, DOI 10.1128/JCM.43.12.5940-5944.2005; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Chen XiaoNing, 2001, Chinese Journal of Parasitic Disease Control, V14, P100; Di Giovanni GD, 2006, INT J ENVIRON HEAL R, V16, P405, DOI 10.1080/09603120601095100; Feng YY, 2008, PARASITOL RES, V103, P87, DOI 10.1007/s00436-008-0932-5; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Gomez-Couso H, 2012, VET PARASITOL, V187, P414, DOI 10.1016/j.vetpar.2012.01.025; Khan SM, 2011, VET PARASITOL, V178, P342, DOI 10.1016/j.vetpar.2011.01.029; Kosuwin R, 2010, GENE, V449, P1, DOI 10.1016/j.gene.2009.09.010; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lasek-Nesselquist E, 2009, J EUKARYOT MICROBIOL, V56, P504, DOI 10.1111/j.1550-7408.2009.00443.x; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Lebbad M, 2010, VET PARASITOL, V168, P231, DOI 10.1016/j.vetpar.2009.11.003; Li J, 2012, VET PARASITOL, V188, P368, DOI 10.1016/j.vetpar.2012.04.004; Liu AQ, 2012, PARASITOL RES, V111, P655, DOI 10.1007/s00436-012-2883-0; Lu SQ, 2002, B MED RES, V31, P19; Monis PT, 2009, TRENDS PARASITOL, V25, P93, DOI 10.1016/j.pt.2008.11.006; Mukherjee A. K., 2013, British Microbiology Research Journal, V3, P190; Silva FMPE, 2012, FOLIA PARASIT, V59, P15; PORTER JDH, 1990, AM J PUBLIC HEALTH, V80, P1259, DOI 10.2105/AJPH.80.10.1259; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Robertson LJ, 2007, J INFECTION, V55, P79, DOI 10.1016/j.jinf.2007.02.001; Robertson LJ, 2010, VET PARASITOL, V171, P140, DOI 10.1016/j.vetpar.2010.03.014; Robertson LJ, 2010, TRENDS PARASITOL, V26, P75, DOI 10.1016/j.pt.2009.11.010; Ruiz A, 2008, VET PARASITOL, V154, P137, DOI 10.1016/j.vetpar.2008.03.003; Scorza AV, 2012, VET PARASITOL, V189, P182, DOI 10.1016/j.vetpar.2012.04.032; Soares RM, 2011, VET PARASITOL, V180, P344, DOI 10.1016/j.vetpar.2011.03.049; Souza SLP, 2007, VET PARASITOL, V149, P258, DOI 10.1016/j.vetpar.2007.08.019; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Stuart JM, 2003, EMERG INFECT DIS, V9, P229; Teodorovic S, 2007, EUKARYOT CELL, V6, P1421, DOI 10.1128/EC.00138-07; Gomez-Munoz MT, 2012, RES VET SCI, V93, P836, DOI 10.1016/j.rvsc.2011.12.012; Gomez-Munoz MT, 2009, PARASITOL INT, V58, P297, DOI 10.1016/j.parint.2009.06.005; Trout JM, 2004, VET PARASITOL, V124, P179, DOI 10.1016/j.vetpar.2004.07.010; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Warburton A R, 1994, Commun Dis Rep CDR Rev, V4, pR32; Wen G, 1990, CHIN J PARASIT DIS C, V3, P79; Wielinga CM, 2007, PARASITOLOGY, V134, P1795, DOI 10.1017/S0031182007003071; Yang RC, 2010, INT J PARASITOL, V40, P293, DOI 10.1016/j.ijpara.2009.08.003; Yong TS, 2000, J PARASITOL, V86, P887, DOI 10.1645/0022-3395(2000)086[0887:GOGLIF]2.0.CO;2; Zhang WZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001826; Zhang WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031262	45	174	181	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95291	10.1371/journal.pone.0095291	http://dx.doi.org/10.1371/journal.pone.0095291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24421901	Green Published, gold			2022-12-25	WOS:000335226500077
J	Sun, XJ; Zhang, N; Liu, K; Li, W; Oksanen, T; Shi, LZ				Sun, Xiaojie; Zhang, Nan; Liu, Kun; Li, Wen; Oksanen, Tuula; Shi, Lizheng			Effects of a Randomized Intervention to Improve Workplace Social Capital in Community Health Centers in China	PLOS ONE			English	Article							SELF-RATED HEALTH; MULTILEVEL ANALYSIS; JOB-SATISFACTION; EMPLOYEES; PROFESSION; DEPRESSION; PREDICTOR; HOSPITALS; MORTALITY; SMOKING	Objective: To examine whether workplace social capital improved after implementing a workplace social capital intervention in community health centers in China. Methods: This study was conducted in 20 community health centers of similar size in Jinan of China during 2012-2013. Using the stratified site randomization, 10 centers were randomized into the intervention group; one center was excluded due to leadership change in final analyses. The baseline survey including 447 staff (response rate: 93.1%) was conducted in 2012, and followed by a six-month workplace social capital intervention, including team building courses for directors of community health centers, voluntarily public services, group psychological consultation, and outdoor training. The follow-up survey in July 2013 was responded to by 390 staff members (response rate: 86.9%). Workplace social capital was assessed with the translated and culturally adapted scale, divided into vertical and horizontal dimensions. The facility-level intervention effects were based on all baseline (n=427) and follow-up (n=377) respondents, except for Weibei respondents. We conducted a bivariate Difference-in-Difference analysis to estimate the facility-level intervention effects. Results: No statistically significant intervention effects were observed at the center level; the intervention increased the facility-level workplace social capital, and its horizontal and vertical dimensions by 1.0 (p=0.24), 0.4 (p=0.46) and 0.8 (p=0.16), respectively. Conclusions: The comprehensive intervention seemed to slightly improve workplace social capital in community health centers of urban China at the center level. High attrition rate limits any causal interpretation of the results. Further studies are warranted to test these findings.	[Sun, Xiaojie; Zhang, Nan; Liu, Kun] Shandong Univ, Ctr Hlth Management & Policy, Key Lab Hlth Econ & Policy, Natl Hlth & Planning Commiss, Jinan, Shandong, Peoples R China; [Li, Wen] Hlth Bur Jinan, Jinan, Shandong, Peoples R China; [Oksanen, Tuula] Finnish Inst Occupat Hlth, Helsinki, Finland; [Shi, Lizheng] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA	Shandong University; Finnish Institute of Occupational Health; Tulane University	Shi, LZ (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA.	lshi1@tulane.edu	Song, Weihong/O-7623-2017; Herculano, Bruno/N-4587-2019; Herculano, Bruno/F-8917-2018; Oksanen, Tuula/AAK-5599-2021	Song, Weihong/0000-0001-9928-889X; Herculano, Bruno/0000-0003-0095-3381; Herculano, Bruno/0000-0003-0095-3381; wu, yili/0000-0002-2369-6974	China Medical Board [CMB09-991]; Independent Innovation Foundation of Shandong University [IFYT1227]	China Medical Board; Independent Innovation Foundation of Shandong University	XS was supported by the China Medical Board (http://www.chinamedicalboard.org/) (projects #CMB09-991) and the Independent Innovation Foundation of Shandong University (http://en.sdu.edu.cn/) (project#IFYT1227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almedom A. M., 2008, SOCIAL CAPITAL HLTH, P191; Amos MA, 2005, J NURSES PROF DEV, V21, P10, DOI 10.1097/00124645-200501000-00003; [Anonymous], 2009, BEIJING YOUTH DAILY; Baum FE, 2003, J EPIDEMIOL COMMUN H, V57, P320, DOI 10.1136/jech.57.5.320; CAUDRON S, 1994, PERS J, V73, P38; Chen L, 2009, CHINESE J SOCIAL MED, V29, P200; Cominetti Laura, 2011, Prof Inferm, V64, P102; DiMeglio K, 2005, J NURS ADMIN, V35, P110; Dumville JC, 2006, BMJ-BRIT MED J, V332, P969, DOI 10.1136/bmj.332.7547.969; Engstrom K, 2008, SOC SCI MED, V66, P2268, DOI 10.1016/j.socscimed.2008.01.019; Ferrie JE, 2007, SCAND J PUBLIC HEALT, V35, P62, DOI 10.1080/14034940600813073; Finney MI, 1997, HRM MAGAZINE, P110; Gao J, 2012, CHINESE J HLTH ED, V28, P806, DOI DOI 10.16168/J.CNKI.ISSN.1002; Gao JL, 2013, PREV MED, V57, P831, DOI 10.1016/j.ypmed.2013.09.009; Hayes LJ, 2006, INT J NURS STUD, V43, P237, DOI 10.1016/j.ijnurstu.2005.02.007; Hess D, 2002, CALIF MANAGE REV, V44, P110, DOI 10.2307/41166125; Homans GC, 1995, HUMAN GROUP; Huang HT, 2012, SOC BEHAV PERSONAL, V40, P1201, DOI 10.2224/sbp.2012.40.7.1201; Kawachi I, 1999, ANN NY ACAD SCI, V896, P120, DOI 10.1111/j.1749-6632.1999.tb08110.x; Kennelly B, 2003, SOC SCI MED, V56, P2367, DOI 10.1016/S0277-9536(02)00241-1; Kim D., 2008, SOCIAL CAPITAL HLTH, P139, DOI DOI 10.1007/978-0-387-71311-3_8; Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Lindstrom M, 2008, AM J EPIDEMIOL, V167, P1152, DOI 10.1093/aje/kwn070; Ling W., 2001, SOC SCI CHINA, V128, P90; Ma L, 2007, RELATIONSHIPS ORG SO; Markuns JF, 2010, FAM MED, V42, P403; Murayama H, 2013, GLOBAL PERSPECTIVES, P205; Oksanen T., 2013, GLOBAL PERSPECTIVES, P23; Oksanen T, 2008, SOC SCI MED, V66, P637, DOI 10.1016/j.socscimed.2007.10.013; Oksanen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065846; Oksanen T, 2011, AM J PUBLIC HEALTH, V101, P1742, DOI 10.2105/AJPH.2011.300166; Oksanen T, 2010, J EPIDEMIOL COMMUN H, V64, P684, DOI 10.1136/jech.2008.086074; Olsen O, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-39; Ommen O, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-81; Parry J, 2008, J ADV NURS, V64, P157, DOI 10.1111/j.1365-2648.2008.04771.x; Peterson DK, 2004, PERS REV, V33, P615, DOI 10.1108/00483480410561510; Potts H, 2007, ROLE SOCIAL CAPITAL; Pronyk PM, 2008, SOC SCI MED, V67, P1559, DOI 10.1016/j.socscimed.2008.07.022; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Simon M, 2010, J ADV NURS, V66, P616, DOI 10.1111/j.1365-2648.2009.05204.x; Sundquist K, 2007, HEALTH PLACE, V13, P324, DOI 10.1016/j.healthplace.2006.02.002; Suzuki E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-489; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Vaananen A, 2009, OCCUP ENVIRON MED, V66, P432, DOI 10.1136/oem.2008.042044; Williams S. D., 2003, Journal of Management Development, V22, P45, DOI 10.1108/02621710310454851	47	75	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114924	10.1371/journal.pone.0114924	http://dx.doi.org/10.1371/journal.pone.0114924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25503627	Green Submitted, gold, Green Published			2022-12-25	WOS:000347146700073
J	Shen, Y; Honma, N; Kobayashi, K; Jia, LN; Hosono, T; Shindo, K; Ariga, T; Seki, T				Shen, Yan; Honma, Natsumi; Kobayashi, Katsuya; Jia, Liu Nan; Hosono, Takashi; Shindo, Kazutoshi; Ariga, Toyohiko; Seki, Taiichiro			Cinnamon Extract Enhances Glucose Uptake in 3T3-L1 Adipocytes and C2C12 Myocytes by Inducing LKB1-AMP-Activated Protein Kinase Signaling	PLOS ONE			English	Article							HUMAN HEPG2 CELLS; INSULIN SENSITIVITY; DIABETES-MELLITUS; MUSCLE-CELLS; IN-VIVO; ACTIVATION; TYPE-2; METFORMIN; LKB1; AMPK	We previously demonstrated that cinnamon extract (CE) ameliorates type 1 diabetes induced by streptozotocin in rats through the up-regulation of glucose transporter 4 (GLUT4) translocation in both muscle and adipose tissues. This present study was aimed at clarifying the detailed mechanism(s) with which CE increases the glucose uptake in vivo and in cell culture systems using 3T3-L1 adipocytes and C2C12 myotubes in vitro. Specific inhibitors of key enzymes in insulin signaling and AMP-activated protein kinase (AMPK) signaling pathways, as well as small interference RNA, were used to examine the role of these kinases in the CE-induced glucose uptake. The results showed that CE stimulated the phosphorylation of AMPK and acetyl-CoA carboxylase. An AMPK inhibitor and LKB1 siRNA blocked the CE-induced glucose uptake. We also found for the first time that insulin suppressed AMPK activation in the adipocyte. To investigate the effect of CE on type 2 diabetes in vivo, we further performed oral glucose tolerance tests and insulin tolerance tests in type 2 diabetes model rats administered with CE. The CE improved glucose tolerance in oral glucose tolerance tests, but not insulin sensitivity in insulin tolerance test. In summary, these results indicate that CE ameliorates type 2 diabetes by inducing GLUT4 translocation via the AMPK signaling pathway. We also found insulin antagonistically regulates the activation of AMPK.	[Shen, Yan; Honma, Natsumi; Kobayashi, Katsuya; Hosono, Takashi; Ariga, Toyohiko; Seki, Taiichiro] Nihon Univ, Coll Bioresource Sci, Grad Sch Bioresource Sci, Dept Chem & Life Sci, Fujisawa, Kanagawa, Japan; [Jia, Liu Nan] Nihon Univ, Sch Pharm, Chiba, Japan; [Shindo, Kazutoshi] Japan Womens Univ, Dept Food & Nutr, Tokyo 112, Japan	Nihon University; Nihon University; Japan Womens University	Hosono, T (corresponding author), Nihon Univ, Coll Bioresource Sci, Grad Sch Bioresource Sci, Dept Chem & Life Sci, Fujisawa, Kanagawa, Japan.	hosono.takashi@nihon-u.ac.jp			Nihon University; Japan Science and Technology Agency (JST) A-STEP program; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Nihon University; Japan Science and Technology Agency (JST) A-STEP program; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Nihon University individual research grant program (to T. S.). This work was also supported by grants from the Japan Science and Technology Agency (JST) A-STEP program (to T. H.). Y.S. is supported by a Fellowship from the Academic Frontier Project from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Amitani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053913; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; Babu PS, 2007, PHYTOMEDICINE, V14, P15, DOI 10.1016/j.phymed.2006.11.005; Beauloye C, 2001, FEBS LETT, V505, P348, DOI 10.1016/S0014-5793(01)02788-0; BERRIO LF, 1992, HORM RES, V37, P225, DOI 10.1159/000182317; Blevins SM, 2007, DIABETES CARE, V30, P2236, DOI 10.2337/dc07-0098; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheng BC., 1983, ZHONG CAO YAO, V14, P134; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gamble J, 1997, METABOLISM, V46, P1270, DOI 10.1016/S0026-0495(97)90229-8; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang YP, 2013, J NUTR BIOCHEM, V24, P1469, DOI 10.1016/j.jnutbio.2012.12.006; Hwang YP, 2013, MOL NUTR FOOD RES, V57, P471, DOI 10.1002/mnfr.201200529; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kannappan S., 2006, SMJ Singapore Medical Journal, V47, P858; Kim SH, 2006, J ETHNOPHARMACOL, V104, P119, DOI 10.1016/j.jep.2005.08.059; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Leverve XM, 2003, DIABETES METAB, V29, pS88; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mang B, 2006, EUR J CLIN INVEST, V36, P340, DOI 10.1111/j.1365-2362.2006.01629.x; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Onderoglu S, 1999, J PHARM PHARMACOL, V51, P1305, DOI 10.1211/0022357991776886; Pham AQ, 2007, PHARMACOTHERAPY, V27, P595, DOI 10.1592/phco.27.4.595; Qin B, 2004, HORM METAB RES, V36, P119, DOI 10.1055/s-2004-814223; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Ragolia L, 1997, ENDOCRINOLOGY, V138, P2398, DOI 10.1210/en.138.6.2398; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Riddle MC, 1999, AM FAM PHYSICIAN, V60, P2613; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Seki T, 2001, J CELL PHYSIOL, V189, P72, DOI 10.1002/jcp.1140; Sewter C, 2002, DIABETES OBES METAB, V4, P239, DOI 10.1046/j.1463-1326.2002.00187.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2418, DOI 10.1271/bbb.100453; Suppapitiporn S, 2006, J MED ASS THAI S3, V89, pS200; Vanschoonbeek K, 2006, J NUTR, V136, P977, DOI 10.1093/jn/136.4.977; Verspohl EJ, 2005, PHYTOTHER RES, V19, P203, DOI 10.1002/ptr.1643; Wang JG, 2007, FERTIL STERIL, V88, P240, DOI 10.1016/j.fertnstert.2006.11.082; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	50	82	86	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87894	10.1371/journal.pone.0087894	http://dx.doi.org/10.1371/journal.pone.0087894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24748132	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500023
J	Graversen, L; Sorensen, TIA; Petersen, L; Sovio, U; Kaakinen, M; Sandbaek, A; Laitinen, J; Taanila, A; Pouta, A; Jarvelin, MR; Obel, C				Graversen, Lise; Sorensen, Thorkild I. A.; Petersen, Liselotte; Sovio, Ulla; Kaakinen, Marika; Sandbaek, Annelli; Laitinen, Jaana; Taanila, Anja; Pouta, Anneli; Jarvelin, Marjo-Riitta; Obel, Carsten			Preschool Weight and Body Mass Index in Relation to Central Obesity and Metabolic Syndrome in Adulthood	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CORONARY-HEART-DISEASE; FINLAND BIRTH COHORT; AGE 31 YEARS; CHILDHOOD OBESITY; RISK-FACTORS; CARDIOVASCULAR RISK; ABERDEEN CHILDREN; LIFE; INFANCY	Background: If preschool measures of body size routinely collected at preventive health examinations are associated with adult central obesity and metabolic syndrome, a focused use of these data for the identification of high risk children is possible. The aim of this study was to test the associations between preschool weight and body mass index (BMI) and adult BMI, central obesity and metabolic alterations. Methods: The Northern Finland Birth Cohort 1966 (NFBC1966) (N = 4111) is a population-based cohort. Preschool weight (age 5 months and 1 year) and BMI (age 2-5 years) were studied in relation to metabolic syndrome as well as BMI, waist circumference, lipoproteins, blood pressure, and fasting glucose at the age of 31 years. Linear regression models and generalized linear regression models with log link were used. Results: Throughout preschool ages, weight and BMI were significantly linearly associated with adult BMI and waist circumference. Preschool BMI was inversely associated with high-density lipoprotein levels from the age of 3 years. Compared with children in the lower half of the BMI range, the group of children with the 5% highest BMI at the age of 5 years had a relative risk of adult obesity of 6.2(95% CI: 4.2-9.3), of adult central obesity of 2.4(95% CI:2.0-2.9), and of early onset adult metabolic syndrome of 2.5(95% CI:1.7-3.8). Conclusions: High preschool BMI is consistently associated with adult obesity, central obesity and early onset metabolic syndrome. Routinely collected measures of body size in preschool ages can help to identify children in need of focused prevention due to their increased risk of adverse metabolic alterations in adulthood.	[Graversen, Lise; Sandbaek, Annelli; Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Petersen, Liselotte] Aarhus Univ, Natl Ctr Register Based Res, Fac Social Sci, Aarhus, Denmark; [Sovio, Ulla] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Sovio, Ulla; Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Kaakinen, Marika; Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Hosp Oulu, Primary Hlth Care Unit, Oulu, Finland; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Pouta, Anneli] Univ Oulu, Dept Obstet & Gynecol, SF-90220 Oulu, Finland; [Pouta, Anneli] Oulu Univ Hosp, Oulu, Finland	Aarhus University; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen; Aarhus University; University of Cambridge; Imperial College London; University of Oulu; University of Oulu; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Graversen, L (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark.	lgra@alm.au.dk; m.jarvelin@imperial.ac.uk	Sovio, Ulla/H-8532-2019; Obel, Carsten/H-9605-2016	Sovio, Ulla/0000-0002-0799-1105; Obel, Carsten/0000-0001-5004-1933; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Kaakinen, Marika/0000-0002-9228-0462	Nordic Council of Ministers research program 'Longitudinal Epidemiology' [020056]; Academy of Finland; Oulu University Hospital; Biocenter Oulu, University of Oulu, Finland; The Finnish Ministry of Health and Social Affairs; European Commission Quality of Life and Management of Living Resources Programme [QLG1-CT-2000-01643]; Medical Research Council, UK [G0500539, G0600705, PrevMetSyn/SALVE, PS0476]; Danish Tryg Foundation, the Health Foundation, Denmark; Aarhus University, Denmark; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Nordic Council of Ministers research program 'Longitudinal Epidemiology'; Academy of Finland(Academy of Finland); Oulu University Hospital; Biocenter Oulu, University of Oulu, Finland; The Finnish Ministry of Health and Social Affairs; European Commission Quality of Life and Management of Living Resources Programme(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Tryg Foundation, the Health Foundation, Denmark; Aarhus University, Denmark; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by the Nordic Council of Ministers research program 'Longitudinal Epidemiology' (020056), the Academy of Finland, Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland, The Finnish Ministry of Health and Social Affairs, the European Commission Quality of Life and Management of Living Resources Programme Contract QLG1-CT-2000-01643, the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE, PS0476), the Danish Tryg Foundation, the Health Foundation, Denmark, and Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Carmienke S, 2013, EUR J CLIN NUTR; de Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013966; Fall CHD, 2008, DIABETES CARE, V31, P2349, DOI 10.2337/dc08-0911; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Gamborg M, 2009, AM J EPIDEMIOL, V169, P1167, DOI 10.1093/aje/kwp047; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Liddle K, 2012, J PAEDIATR CHILD H, V48, P424, DOI 10.1111/j.1440-1754.2011.02247.x; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sovio U, 2013, INT J OBES LOND; Sovio U, 2007, J HEALTH PSYCHOL, V12, P371, DOI 10.1177/1359105307074301; Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027; Zimmermann E, 2011, INT J OBESITY, V35, P1193, DOI 10.1038/ijo.2010.274	28	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89986	10.1371/journal.pone.0089986	http://dx.doi.org/10.1371/journal.pone.0089986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24748033	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900052
J	Apitzsch, JC; Westphal, S; Penzkofer, T; Kuhl, CK; Knuchel, R; Mahnken, AH				Apitzsch, Jonas Christoph; Westphal, Saskia; Penzkofer, Tobias; Kuhl, Christiane Katharina; Knuechel, Ruth; Mahnken, Andreas H.			The Use of Contrast-Enhanced Post Mortem CT in the Detection of Cardiovascular Deaths	PLOS ONE			English	Article							DECLINING AUTOPSY RATE; POSTMORTEM ANGIOGRAPHY; VIRTOPSY; RATES	Objectives: To evaluate the diagnostic value of contrast enhanced post mortem computed tomography (PMCT) in comparison to non-enhanced post mortem CT in the detection of cardiovascular causes of death (COD). Background: As autopsy rates decline, new methods to determine CODs are necessary. So contrast enhanced PMCT shall be evaluated in comparison to established non-enhanced PMCT in order to further improve the method. Methods: In a prospective study, 20 corpses were examined using a 64-row multisclice CT (MSCT) before and after intraarterial perfusion with a newly developed, barium-bearing contrast agent and ventilation of the lungs. The cause of death was determined in enhanced and unenhanced scans and a level of confidence (LOC) was given by three experienced radiologists on a scale between 0 and 4. Results were compared to autopsy results as gold standard. Autopsy was performed blinded to PMCT-findings. Results: The method allowed visualization of different types of cause of death. There was a significant improvement in LOC in enhanced scans compared to unenhanced scans as well as an improvement in the detection of COD. The cause of death could be determined in 19 out of 20 patients. Conclusions: PMCT is feasible and appears to be robust for diagnosing cardiovascular causes of death. When compared with unenhanced post-mortem CT intraarterial perfusion and pulmonary ventilation significantly improve visualization and diagnostic accuracy. These promising results warrant further studies.	[Apitzsch, Jonas Christoph] Philipps Univ Hosp Marburg, Dept Diagnost & Intervent Radiol, Marburg, Germany; [Westphal, Saskia; Knuechel, Ruth] RWTH Aachen Univ Hosp, Dept Pathol, Aachen, Germany; [Penzkofer, Tobias] Rhein Westfal TH Aachen, Helmholtz Inst, Aachen, Germany; [Penzkofer, Tobias; Kuhl, Christiane Katharina; Mahnken, Andreas H.] RWTH Aachen Univ Hosp, Dept Diagnost & Intervent Radiol, Aachen, Germany	Philipps University Marburg; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital	Apitzsch, JC (corresponding author), Philipps Univ Hosp Marburg, Dept Diagnost & Intervent Radiol, Marburg, Germany.	apitzsch@med.uni-marburg.de	Penzkofer, Tobias/AAW-8839-2020; Penzkofer, Tobias/AFN-1192-2022; Kuhl, Christiane K/H-3301-2013	Penzkofer, Tobias/0000-0001-9591-8575; Kuhl, Christiane K/0000-0001-8696-2363; Malvick, Dean/0000-0002-0131-8411; von Stillfried, Saskia/0000-0002-5260-8494; Mahnken, Andreas H./0000-0001-8077-9306				Brinkmann B, 2002, DEUT MED WOCHENSCHR, V127, P791, DOI 10.1055/s-2002-25021; Chariot P, 2000, ARCH PATHOL LAB MED, V124, P739; Davies DJ, 2004, MED J AUSTRALIA, V180, P281, DOI 10.5694/j.1326-5377.2004.tb05926.x; Ebert LC, 2012, J FORENSIC LEG MED, V19, P126, DOI 10.1016/j.jflm.2011.12.007; Grabherr S, 2008, AM J ROENTGENOL, V190, P345, DOI 10.2214/AJR.07.2261; Grabherr Silke, 2006, AJR Am J Roentgenol, V187, pW515, DOI 10.2214/AJR.05.1394; Grabherr S, 2007, AM J ROENTGENOL, V188, P832, DOI 10.2214/AJR.06.0787; Grabherr S, 2011, INT J LEGAL MED, V125, P791, DOI 10.1007/s00414-010-0526-5; Harrington DE, 2010, SOC SCI MED, V70, P191, DOI 10.1016/j.socscimed.2009.09.018; Ishiko T, 1989, Gan To Kagaku Ryoho, V16, P1920; Jackowski C, 2005, J FORENSIC SCI, V50, P1175; Jackowski C, 2006, J FORENSIC SCI, V51, P1134, DOI 10.1111/j.1556-4029.2006.00207.x; Lindstrom P, 1997, J INTERN MED, V242, P157, DOI 10.1046/j.1365-2796.1997.00178.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McNamara JJ, 1971, JAMA, V216, P1185; Michiue T, 2012, FORENSIC SCI INT, V220, P232, DOI 10.1016/j.forsciint.2012.03.007; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Ross S, 2008, AM J ROENTGENOL, V190, P1380, DOI 10.2214/AJR.07.3082; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Ruder TD, 2011, LEGAL MED, V13, P91, DOI 10.1016/j.legalmed.2010.11.005; Smith M, 1999, ARCH PATHOL LAB MED, V123, P885; START RD, 1993, J PATHOL, V171, P63, DOI 10.1002/path.1711710113; Thali MJ, 2005, J FORENSIC SCI, V50, P428; Westphal SE, 2012, VIRCHOWS ARCH; ZAPATA MG, 1989, Z RECHTSMED, V103, P27, DOI 10.1007/BF01255843	25	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e93101	10.1371/journal.pone.0093101	http://dx.doi.org/10.1371/journal.pone.0093101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759757	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200006
J	Sun, XL; Wu, YL; Herculano, B; Song, WH				Sun, Xiulian; Wu, Yili; Herculano, Bruno; Song, Weihong			RCAN1 Overexpression Exacerbates Calcium Overloading-Induced Neuronal Apoptosis	PLOS ONE			English	Article							CALCINEURIN-INTERACTING PROTEIN-1; DOWN-SYNDROME; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IN-VITRO; TRANSCRIPTION FACTORS; INHIBITS CALCINEURIN; CARDIAC-HYPERTROPHY; CELL-DEATH; DSCR1	Down Syndrome (DS) patients develop characteristic Alzheimer's Disease (AD) neuropathology after their middle age. Prominent neuronal loss has been observed in the cortical regions of AD brains. However, the underlying mechanism leading to this neuronal loss in both DS and AD remains to be elucidated. Calcium overloading and oxidative stress have been implicated in AD pathogenesis. Two major isoforms of regulator of calcineurin 1 (RCAN1), RCAN1.1 and RCAN1.4, are detected in human brains. In this report we defined the transcriptional regulation of RCAN1.1 and RCAN1.4 by two alternative promoters. Calcium overloading upregulated RCAN1.4 expression by activating RCAN1.4 promoter through calcineurin-NFAT signaling pathway, thus forming a negative feedback loop in isoform 4 regulation. Furthermore, RCAN1.4 overexpression exacerbated calcium overloading-induced neuronal apoptosis, which was mediated by caspase-3 apoptotic pathway. Our results suggest that downregulating RCAN1.4 expression in neurons could be beneficial to AD patients.	[Sun, Xiulian] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China; [Wu, Yili; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Chongqing City Key Lab Translat Med Res Cognit De, Chongqing, Peoples R China; [Wu, Yili; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Sun, Xiulian; Wu, Yili; Herculano, Bruno; Song, Weihong] Univ British Columbia, Grad Program Neurosci, Brain Res Ctr, Dept Psychiat,Townsend Family Labs, Vancouver, BC V5Z 1M9, Canada	Shandong University; Chongqing Medical University; Chongqing Medical University; University of British Columbia	Song, WH (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing City Key Lab Translat Med Res Cognit De, Chongqing, Peoples R China.	weihong@mail.ubc.ca	Song, Weihong/O-7623-2017; Herculano, Bruno/N-4587-2019; Herculano, Bruno/F-8917-2018; Oksanen, Tuula/AAK-5599-2021	Song, Weihong/0000-0001-9928-889X; Herculano, Bruno/0000-0003-0095-3381; Herculano, Bruno/0000-0003-0095-3381; wu, yili/0000-0002-2369-6974	Canadian Institutes of Health Research (CIHR) [TAD-117948]; National Natural Science Foundation of China (NSFC) Grant [30871387]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (NSFC) Grant(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant TAD-117948 (WS), and National Natural Science Foundation of China (NSFC) Grant 30871387 (XS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Arlt S, 2002, CURR OPIN LIPIDOL, V13, P289, DOI 10.1097/00041433-200206000-00009; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Baek KH, 2009, NATURE; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Bhoiwala DL, 2013, NEUROL RES, V35, P79, DOI 10.1179/1743132812Y.0000000117; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Cho KO, 2008, EXP NEUROL, V212, P85, DOI 10.1016/j.expneurol.2008.03.017; de Haan JB, 2003, J NEURAL TRANSM-SUPP, P67; Down J.L., 1866, OBSERVATION ETHNIC C, DOI DOI 10.1038/HDY.1966.69; Eckert A, 2003, ANN NY ACAD SCI, V1010, P604, DOI 10.1196/annals.1299.113; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2012, J BIOL CHEM, V287, P14088, DOI 10.1074/jbc.M111.305342; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Iannello RC, 1999, J NEURAL TRANSM-SUPP, P257; JACOBS PA, 1959, LANCET, V1, P710; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Ma H, 2004, J NEUROCHEM, V88, P1485, DOI 10.1046/j.1471-4159.2003.02294.x; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Peiris H, 2012, ENDOCRINOLOGY, V153, P5212, DOI 10.1210/en.2011-2149; Poppek D, 2006, BIOCHEM J, V400, P511, DOI 10.1042/BJ20060463; Porta S, 2007, HUM MOL GENET; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Sobrado M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-48; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wang W, 2012, EMBO J, V31, P3655, DOI 10.1038/emboj.2012.190; Wu YL, 2013, FASEB J, V27, P208, DOI 10.1096/fj.12-213124; Xing LZ, 2013, MAMM GENOME, V24, P30, DOI 10.1007/s00335-012-9436-9; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zanin MP, 2013, J NEUROCHEM, V124, P290, DOI 10.1111/jnc.12086	56	75	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95471	10.1371/journal.pone.0095471	http://dx.doi.org/10.1371/journal.pone.0095471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	25503627	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400065
J	Liu, AY; Yang, QY; Huang, Y; Bacchetti, P; Anderson, PL; Jin, CS; Goggin, K; Stojanovski, K; Grant, R; Buchbinder, SP; Greenblatt, RM; Gandhi, M				Liu, Albert Y.; Yang, Qiyun; Huang, Yong; Bacchetti, Peter; Anderson, Peter L.; Jin, Chengshi; Goggin, Kathy; Stojanovski, Kristefer; Grant, Robert; Buchbinder, Susan P.; Greenblatt, Ruth M.; Gandhi, Monica			Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; HIV-INFECTION; ANTIRETROVIRAL PROPHYLAXIS; INTERIM GUIDANCE; PREVENTION; PLASMA; NEVIRAPINE; EFAVIRENZ; AXILLARY; HEAD	Background: Pre-exposure prophylaxis (PrEP) trials using tenofovir-based regimens have demonstrated that high levels of adherence are required to evaluate efficacy; the incorporation of objective biomarkers of adherence in trial design has been essential to interpretation, given the inaccuracy of self-report. Antiretroviral measurements in scalp hair have been useful as a marker of long-term exposure in the HIV treatment setting, and hair samples are relatively easy and inexpensive to collect, transport, and store for analysis. To evaluate the relationship between dose and tenofovir concentrations in hair, we examined the dose proportionality of tenofovir in hair in healthy, HIV-uninfected adults. Methods: A phase I, crossover pharmacokinetic study was performed in 24 HIV-negative adults receiving directly-observed oral tenofovir tablets administered 2, 4, and 7 doses/week for 6 weeks, with a >= 3-week break between periods. Small samples of hair were collected after each six-week period and analyzed for tenofovir concentrations. Geometric-mean-ratios compared levels between each pair of dosing conditions. Intensive plasma pharmacokinetic studies were performed during the daily-dosing period to calculate areas-under-the-time-concentration curves (AUCs). Results: Over 90% of doses were observed per protocol. Median tenofovir concentrations in hair increased monotonically with dose. A log-linear relationship was seen between dose and hair levels, with an estimated 76% (95% CI 60-93%) increase in hair level per 2-fold dose increase. Tenofovir plasma AUCs modestly predicted drug concentrations in hair. Conclusions: This study found a strong linear relationship between frequency of dosing and tenofovir levels in scalp hair. The analysis of quantitative drug levels in hair has the potential to improve adherence measurement in the PrEP field and may be helpful in determining exposure thresholds for protection and explaining failures in PrEP trials. Hair measures for adherence monitoring may also facilitate adherence measurement in real-world settings and merit further investigation in upcoming PrEP implementation studies and programs.	[Liu, Albert Y.; Stojanovski, Kristefer; Buchbinder, Susan P.] Bridge HIV, San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Liu, Albert Y.; Buchbinder, Susan P.; Greenblatt, Ruth M.; Gandhi, Monica] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Yang, Qiyun; Huang, Yong] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Bacchetti, Peter; Jin, Chengshi; Buchbinder, Susan P.; Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Anderson, Peter L.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Goggin, Kathy] Univ Missouri, Childrens Mercy Hosp & Clin, Kansas City, MO 64110 USA; [Grant, Robert] Gladstone Inst, San Francisco, CA USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Liu, AY (corresponding author), Bridge HIV, San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA.	albert.liu@sfdph.org	Cao, Jianping/AFL-5468-2022; Zhang, Longxian/I-9223-2019; Stojanovski, Kristefer/H-8291-2019; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/R-7799-2019	Cao, Jianping/0000-0002-1974-0047; Zhang, Longxian/0000-0002-5706-131X; Stojanovski, Kristefer/0000-0003-1239-5153; ling, hong/0000-0002-1886-1242; Grant, Robert/0000-0002-0851-7085	National Institutes of Mental Health [R21MH085598]; National Institutes of Allergy and Infectious Diseases [U01 AI084735, RO1 AI065233, RO1AI098472]; Center for AIDS Research Center [P30 AI027763]; University of California San Francisco Clinical and Translational Science Institute Clinical Research Center Grant [UL1 RR024131, UL1 TR000004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065233, U01AI084735, R01AI098472, P30AI027763, UM1AI069496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085598] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Research Center; University of California San Francisco Clinical and Translational Science Institute Clinical Research Center Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Mental Health (grant number R21MH085598 to A. L.), National Institutes of Allergy and Infectious Diseases (grant numbers U01 AI084735 to P. A., RO1 AI065233 to R. G., RO1AI098472 to M. G.), Center for AIDS Research Center (grant number P30 AI027763), and University of California San Francisco Clinical and Translational Science Institute Clinical Research Center Grant (grant numbers UL1 RR024131 and UL1 TR000004). Study drug was supplied by Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli N., 2009, 16 C RETROVIRUSES OP; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bartelink IH, 2013, J CLIN PHARM; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Beumer JH, 2001, INT J CLIN PRACT, V55, P353; Blum MR, 2007, J CLIN PHARMACOL, V47, P751, DOI 10.1177/0091270007300951; Chi BH, 2006, HIV CLIN TRIALS, V7, P263, DOI 10.1310/hct0705-263; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cirimele V, 2000, FORENSIC SCI INT, V107, P289, DOI 10.1016/S0379-0738(99)00172-3; Clevenbergh P, 2002, AIDS, V16, P2311, DOI 10.1097/00002030-200211220-00011; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coetzee B, 2012, FUTURE VIROL, V7, P1135, DOI 10.2217/FVL.12.100; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; Delahunty T, 2006, J CHROMATOGR B, V830, P6, DOI 10.1016/j.jchromb.2005.10.015; Dubuisson JG, 2004, JAIDS-J ACQ IMM DEF, V35, P155, DOI 10.1097/00126334-200402010-00009; Gandhi M, 2013, AIDS RES HU IN PRESS; Gandhi M, 2013, JAIDS-J ACQ IMM DEF, V63, P578, DOI 10.1097/QAI.0b013e31829c48ad; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Gandhi M, 2011, CLIN INFECT DIS, V52, P1267, DOI 10.1093/cid/cir131; Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9; Goggin K, 2013, AIDS BEHAV; Goggin K, 2007, PUBLIC HEALTH REP, V122, P472, DOI 10.1177/003335490712200408; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Han EY, 2005, FORENSIC SCI INT, V147, P21, DOI 10.1016/j.forsciint.2004.03.035; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; HENDERSON GL, 1993, FORENSIC SCI INT, V63, P19, DOI 10.1016/0379-0738(93)90256-A; Hendrix CW, 2012, CURR OPIN HIV AIDS, V7, P498, DOI 10.1097/COH.0b013e32835847ae; Jackson A, 2013, JAIDS-J ACQ IMM DEF, V62, P275, DOI 10.1097/QAI.0b013e3182829bd0; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Koenig LJ, 2013, AM J PREV MED, V44, pS91, DOI 10.1016/j.amepre.2012.09.047; L'homme RFA, 2008, CLIN INFECT DIS, V47, P1339, DOI 10.1086/592694; Lagakos SW, 2008, METHODOLOGICAL CHALL; Liu A, 2011, 18 C RETR OPP INF CR; Liu A, 2010, 17 C RETR OPP INF CR; Macalino GE, 2004, CLIN INFECT DIS, V38, pS393, DOI 10.1086/421402; MANGIN P, 1993, FORENSIC SCI INT, V63, P77, DOI 10.1016/0379-0738(93)90261-8; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Nettles RE, 2006, CLIN INFECT DIS, V42, P1189, DOI 10.1086/501458; OFFIDANI C, 1993, FORENSIC SCI INT, V63, P105, DOI 10.1016/0379-0738(93)90264-B; PageShafer K, 1997, AM J EPIDEMIOL, V146, P531, DOI 10.1093/oxfordjournals.aje.a009311; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; PETERSON JL, 2000, AIDS PREVENT MENT H, P217; Podsadecki TJ, 2008, HIV CLIN TRIALS, V9, P238, DOI 10.1310/hct0904-238; Shen M, 2013, FORENSIC SCI INT, V227, P64, DOI 10.1016/j.forsciint.2012.10.028; Shen M, 2012, J FORENSIC SCI, V57, P669, DOI 10.1111/j.1556-4029.2012.02052.x; Smith D, 2011, MMWR, V60; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Wertheimer BZ, 2006, HIV CLIN TRIALS, V7, P59, DOI 10.1310/4CCJ-KT1T-H6PV-NLFC; Yang Q, 2010, AM ASS PHARM SCI AAP	57	174	181	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83736	10.1371/journal.pone.0083736	http://dx.doi.org/10.1371/journal.pone.0083736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421901	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500068
J	Lee, HJ; Cho, JI; Lee, HSH; Kim, CI; Cho, E				Lee, Hae-Jeung; Cho, Jang-ik; Lee, Hye-Seung H.; Kim, Cho-il; Cho, Eunyoung			Intakes of Dairy Products and Calcium and Obesity in Korean Adults: Korean National Health and Nutrition Examination Surveys (KNHANES) 2007-2009	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY CALCIUM; FAT OXIDATION; YOUNG-ADULTS; WEIGHT; CONSUMPTION; OVERWEIGHT; ADIPOSITY; WOMEN; FOODS	Background: The possible effects of dairy product intake against obesity have been suggested in animal studies; however, the association is still not well established in epidemiological studies. Few studies in Asian countries with relatively low intake of dairy products exist. Objective: We investigated the association between dairy products and calcium intake and obesity in Korean population with relatively low intake of dairy products. Subjects and Methods: Our study population consisted of adults (n = 7173) aged 19-64 among participants of the 2007, 2008 and 2009 Korean National Health and Nutrition Examination Survey who had not made any attempt of intentional weight loss. Dietary intake data from food frequency questionnaire (FFQ) and 24-hour recall were used. Dairy products included milk and yogurt in the FFQ. Obesity was defined as BMI >= 25 kg/m(2). Results: Higher frequency of dairy product intake was associated with a reduced prevalence of obesity (OR = 0.63; 95% CI = 0.45-0.89 for >= 2 times/day vs. <= 1 time/month; p for trend = 0.003) using the intake data from FFQ. Similarly, high frequency of milk or yogurt intake had an inverse association with obesity. The association between milk and yogurt intake and obesity was similar when the intake from 24-hour recall was examined. Higher calcium intake from dairy products as well as total dietary calcium intake was associated with a decreased prevalence of obesity (OR = 0.83; 95% CI = 0.71-0.98 for highest vs. lowest quintile of dairy calcium intake; p for trend = 0.02, OR = 0.78; 95% CI = 0.64-0.94 for highest vs. lowest quintile of total calcium intake; p for trend = 0.04). The associations appeared to be stronger in women than in men. Conclusion: These results suggest that high consumption of dairy products is associated with a lower prevalence of obesity and that calcium in dairy products may be one of the components contributing to the association. Further longitudinal studies are warranted to replicate our findings.	[Lee, Hae-Jeung] Eulji Univ, Dept Food & Nutr, Songnam, Gyeonggi Do, South Korea; [Cho, Jang-ik] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Lee, Hye-Seung H.; Cho, Eunyoung] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Lee, Hye-Seung H.; Cho, Eunyoung] Harvard Univ, Sch Med, Boston, MA USA; [Kim, Cho-il] Korea Hlth Ind Dev Inst, Dept Hlth Ind & Policy, Cheongwon Gun, Chungcheongbuk, South Korea; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA	Eulji University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University	Cho, E (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	eunyoung.cho@channing.harvard.edu	Cho, Eunyoung/AAV-4469-2020; Kim, Cho-il/B-5961-2011	Cho, Eunyoung/0000-0001-6594-2582; Luong, Ngan/0000-0003-0500-007X				Alonso A, 2009, J HUM NUTR DIET, V22, P336, DOI 10.1111/j.1365-277X.2009.00967.x; [Anonymous], 2009, KOR NAT HLTH NUTR EX; Bortolotti M, 2008, AM J CLIN NUTR, V88, P877, DOI 10.1093/ajcn/88.4.877; Brooks BM, 2006, J AM COLL NUTR, V25, P523, DOI 10.1080/07315724.2006.10719568; DENKE MA, 1993, J NUTR, V123, P1047; Dougkas A, 2011, NUTR RES REV, V24, P72, DOI 10.1017/S095442241000034X; Faghih S, 2011, NUTR METAB CARDIOVAS, V21, P499, DOI 10.1016/j.numecd.2009.11.013; Heaney RP, 2002, J AM COLL NUTR, V21, p152S, DOI 10.1080/07315724.2002.10719213; Jacobsen R, 2005, INT J OBESITY, V29, P292, DOI 10.1038/sj.ijo.0802785; Jacqmain M, 2003, AM J CLIN NUTR, V77, P1448, DOI 10.1093/ajcn/77.6.1448; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Loos RJF, 2004, J NUTR, V134, P1772, DOI 10.1093/jn/134.7.1772; Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x; Major GC, 2008, OBES REV, V9, P428, DOI 10.1111/j.1467-789X.2007.00465.x; Marques-Vidal P, 2006, INT J OBESITY, V30, P88, DOI 10.1038/sj.ijo.0803045; Ministry of Health and Welfare, 2005, KOR NAT HLTH NUTR EX; Ministry of Health and Welfare, 2008, KOR NAT HLTH NUTR EX; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Murakami K, 2006, NUTRITION, V22, P490, DOI 10.1016/j.nut.2005.12.003; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; Schrager S, 2005, J AM BOARD FAM PRACT, V18, P205, DOI 10.3122/jabfm.18.3.205; Shah NP, 2000, BRIT J NUTR, V84, pS3; St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467; Van Loan M, 2009, J AM COLL NUTR, V28, p120S, DOI 10.1080/07315724.2009.10719805; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; WELBERG JWM, 1994, ANN NUTR METAB, V38, P185, DOI 10.1159/000177810; *WHO W PAC REG OFF, 2000, AS PAC PERSP RED OB; 이계오, 2007, 조사연구, V8, P67; Zemel MB, 2005, J AM COLL NUTR, V24, p537S, DOI 10.1080/07315724.2005.10719502; Zemel MB, 2004, AM J CLIN NUTR, V79, P907; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67; Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212	35	99	102	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99085	10.1371/journal.pone.0099085	http://dx.doi.org/10.1371/journal.pone.0099085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24747984	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700062
J	Liu, Y; Zhang, JW; Qian, WY; Dong, Y; Yang, YB; Liu, ZQ; Feng, YJ; Ma, D; Zhang, ZB; Wu, SF				Liu, Yuan; Zhang, Jiawen; Qian, Wenyan; Dong, Yu; Yang, Yongbin; Liu, Zhiqiang; Feng, Youji; Ma, Ding; Zhang, Zhenbo; Wu, Sufang			Gankyrin Is Frequently Overexpressed in Cervical High Grade Disease and Is Associated with Cervical Carcinogenesis and Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-CELL PROLIFERATION; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; BREAST-CANCER; ONCOPROTEIN; PROMOTES; PATHWAY; PROGRESSION	Our previous studies have showed that Gankyrin expression is correlated with a malignant phenotype in endometrial carcinoma. Here, we investigated the possible role of Gankyrin in cervical disease. The increasing protein level of Gankyrin was observed in high-grade cervical intraepithelial neoplasia and carcinoma compared with benign cervical tissues and low-grade cervical intraepithelial neoplasia. In para-carcinoma tissues, it was found interestingly that there was no lymph node metastasis when nuclei Gankyrin was positively expressed, but lymph node metastasis rate was 30% (6/20) when nuclei Gankyrin was negatively expressed. In vitro, the transfection of Gankyrin resulted in markedly up-regulating of Vimentin, beta-catenin and Twist2, as well as down-regulating of E-cadherin in cervical carcinoma cells. Our results suggested that Gankyrin may be functional in cervical carcinogenesis and metastasis.	[Liu, Yuan; Dong, Yu; Yang, Yongbin; Feng, Youji; Zhang, Zhenbo; Wu, Sufang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhang, Jiawen] Shanghai Tongji Univ, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Qian, Wenyan] Nanjing Univ Chinese Med, Kunshan Hosp Tradit Chinese Med, Dept Gynecol & Obstet, Nanjing, Jiangsu, Peoples R China; [Liu, Zhiqiang] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Dept Lymphoma & Myeloma, Div Canc Med, Houston, TX 77030 USA; [Ma, Ding] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Canc Biol Med Ctr, Wuhan 430074, Peoples R China	Shanghai Jiao Tong University; Tongji University; Nanjing University of Chinese Medicine; University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology	Zhang, ZB (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	zxdzzb@gmail.com; wsf_sfph@163.com		Kang, Chaogui/0000-0002-0122-9419; Zhang, Jiawen/0000-0003-0489-776X	National Natural Science Foundation of China (NSFC) [81201541]; Shanghai Pujiang Talent Program [12PJD002]; Science and Research Foundation for Public Welfare Industry of Ministry of Health of China [201002013]; Shanghai Science and Technology Committee Foundation [09411962500]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talent Program; Science and Research Foundation for Public Welfare Industry of Ministry of Health of China; Shanghai Science and Technology Committee Foundation(Shanghai Science & Technology Committee)	The project was supported by grants from the National Natural Science Foundation of China (NSFC No. 81201541), Shanghai Pujiang Talent Program (12PJD002), Science and Research Foundation for Public Welfare Industry of Ministry of Health of China (201002013), Shanghai Science and Technology Committee Foundation(09411962500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZF, 2013, CANCER RES, V73, P4548, DOI 10.1158/0008-5472.CAN-12-4586; Cai Q, 2013, ARCH GYNECOL OBSTET, V287, P541, DOI 10.1007/s00404-012-2665-z; Chen Y, 2007, CELL RES, V17, P1020, DOI 10.1038/cr.2007.99; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Fu J, 2011, HEPATOLOGY, V53, P181, DOI 10.1002/hep.24015; Fu XY, 2002, WORLD J GASTROENTERO, V8, P638, DOI 10.3748/wjg.v8.i4.638; Kim YH, 2013, EXP MOL PATHOL, V94, P360, DOI 10.1016/j.yexmp.2012.12.002; Lee MY, 2012, AM J TRANSL RES, V4, P1; Levy L, 2002, ANN NY ACAD SCI, V963, P21; Li Y, 2012, GYNECOL ONCOL, V124, P112, DOI 10.1016/j.ygyno.2011.09.003; Mao YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078200; Meng Y, 2010, CANCER LETT, V297, P9, DOI 10.1016/j.canlet.2010.04.019; Ortiz CM, 2008, INT J CANCER, V122, P325, DOI 10.1002/ijc.23106; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-114; Wei YA, 2012, ONCOL REP, V27, P504, DOI 10.3892/or.2011.1536; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Wu Z, 2013, INT J GYNECOL CANCER, V23, P906, DOI 10.1097/IGC.0b013e318292da82; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Zhang JW, 2013, CANCER LETT, V339, P279, DOI 10.1016/j.canlet.2012.10.037; Zhang ZB, 2012, CANCER LETT, V319, P89, DOI 10.1016/j.canlet.2011.12.033; Zhen C, 2013, ONCOGENE, V32, P3452, DOI 10.1038/onc.2012.356; Zheng T, 2013, HEPATOLOGY; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	24	251	254	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95043	10.1371/journal.pone.0095043	http://dx.doi.org/10.1371/journal.pone.0095043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751719	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400027
J	Zhao, QH; Zhou, B; Ding, D; Teramukai, S; Guo, QH; Fukushima, M; Hong, Z				Zhao, Qianhua; Zhou, Bin; Ding, Ding; Teramukai, Satoshi; Guo, Qihao; Fukushima, Masanori; Hong, Zhen			Cognitive Decline in Patients with Alzheimer's Disease and Its Related Factors in a Memory Clinic Setting, Shanghai, China	PLOS ONE			English	Article							COMMUNITY POPULATION; OLDER PERSONS; COLOR-WORD; PROGRESSION; DEMENTIA; EDUCATION; PREDICT; AGE; TESTS; MODEL	Objectives: Progressive cognitive decline is a characteristic hallmark of AD. It is important to identify prognostic markers to improve patient care and long-term planning. We aimed to identify the characteristics of disease progression in AD patients, focusing on cognitive decline and its related factors. Methods: Clinically diagnosed AD patients in a memory clinic were followed. The mini-mental state examination (MMSE) and a battery of other neuropsychological tests were performed to assess the rate of cognitive decline and to analyze the related factors. Results: A total of 165 AD patients were analyzed for cognitive changes. The MMSE scores declined at a rate of 1.52 points per year. Most neuropsychological test scores deteriorated significantly over time. Younger and early-onset AD patients deteriorated more rapidly than older and late-onset patients in global cognition and executive function. Men declined faster in memory but slower in attention than women. Higher education was associated with more rapid deterioration in visuo-spatial ability. Family history, hypertension and cerebral vascular disease were also associated with disease progression. Conclusion: Attention, executive and visuo-spatial functions deteriorate at faster rates than other cognitive functions in AD patients. Age and age at onset were the main factors that associated with deterioration.	[Zhao, Qianhua; Guo, Qihao; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Zhou, Bin; Fukushima, Masanori] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Zhao, Qianhua; Ding, Ding; Guo, Qihao; Hong, Zhen] Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China; [Teramukai, Satoshi] Kyoto Univ Hosp, Translat Res Ctr, Dept Clin Trial Design & Management, Kyoto 606, Japan	Fudan University; Institute for Biomedical Research & Innovation (IBRI); Fudan University; Kyoto University	Zhou, B (corresponding author), Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan.	zhoubin@tri-kobe.org; profzhong@sina.com	Zhou, Bin/AAW-5985-2020; Teramukai, Satoshi/I-2249-2019	Teramukai, Satoshi/0000-0003-2184-0597	Natural Science Foundation of China [81200835]; National 973 Project [2013CB530900, 2013CB530904, 2011ZX09307-00103]; Eisai Co. Ltd.	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Project(National Basic Research Program of China); Eisai Co. Ltd.(Eisai Co Ltd)	The study was supported by Natural Science Foundation of China (81200835), National 973 Project (2013CB530900, 2013CB530904, 2011ZX09307-00103) and Eisai Co. Ltd. Eisai was not involved in the design and conduct of the study or in the data analysis and interpretation of the results.	Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bernick C, 2012, ARCH NEUROL; Bracco L., 1997, ALZ DIS ASSOC DIS, V12, P347; Buccione I, 2007, EUR J NEUROL, V14, P440, DOI 10.1111/j.1468-1331.2007.01693.x; Cao X, 2010, INT J GERIATR PSYCHI; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Clark CM, 1999, ARCH NEUROL-CHICAGO, V56, P857, DOI 10.1001/archneur.56.7.857; DEHOUWER J, 1994, PSYCHOL RES-PSYCH FO, V56, P293, DOI 10.1007/BF00419659; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; Guo Qihao LC, 2001, CHINESE J MENTAL HLT, V15, P13; Hall CB, 2007, NEUROLOGY, V69, P1657, DOI 10.1212/01.wnl.0000278163.82636.30; Helzner EP, 2007, ARCH NEUROL-CHICAGO, V64, P1749, DOI 10.1001/archneur.64.12.1749; Huan Yu QG, 2005, NEUROL DIS MENT HYGE, V5, P89; Junchao Lu QG, 2006, CHIN J CLIN PSYCHOL, V14, P118; Lin C GQ, 2011, CHINESE J BEHAV MED, V20, P11; Fernandez AL, 2009, CLIN NEUROPSYCHOL, V23, P501, DOI 10.1080/13854040802279675; Mangone CA, 2004, REV NEUROLOGIA, V38, P675, DOI 10.33588/rn.3807.2003542; Martins CAR, 2005, NEUROLOGY, V65, P1888, DOI 10.1212/01.wnl.0000188871.74093.12; Mielke MM, 2007, NEUROLOGY, V69, P1850, DOI 10.1212/01.wnl.0000279520.59792.fe; Mungas D, 2001, ARCH NEUROL-CHICAGO, V58, P1243, DOI 10.1001/archneur.58.8.1243; Musicco M, 2010, DEMENT GERIATR COGN, V30, P219, DOI 10.1159/000319533; Musicco M, 2009, J NEUROL, V256, P1288, DOI 10.1007/s00415-009-5116-4; Pavlik VN, 2006, DEMENT GERIATR COGN, V22, P367, DOI 10.1159/000095640; Qihao Guo CL, 2000, CHIN J CLIN PSYCHOL, V8, P205; Qihao Guo ZH, 2005, CHIN J NEUROMED, V4, P701; Qihao Guo ZH, 2006, CHIN MENT HLTH J, V20, P81; Regan C, 2006, NEUROLOGY, V67, P1357, DOI 10.1212/01.wnl.0000240129.46080.53; Roselli F, 2009, CLIN NEUROL NEUROSUR, V111, P327, DOI 10.1016/j.clineuro.2008.10.006; Sanz C, 2009, NEUROLOGY, V73, P1359, DOI 10.1212/WNL.0b013e3181bd80e9; Schmidt C, 2011, ARCH NEUROL-CHICAGO, V68, P1124, DOI 10.1001/archneurol.2011.189; Small BJ, 1997, J GERONTOL A-BIOL, V52, pM299, DOI 10.1093/gerona/52A.5.M299; Suh GH, 2004, INT J GERIATR PSYCH, V19, P817, DOI 10.1002/gps.1168; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Wilson RS, 1999, J GERONTOL B-PSYCHOL, V54, pP155, DOI 10.1093/geronb/54B.3.P155; Wilson RS, 2004, J NEUROL NEUROSUR PS, V75, P126; Wilson RS, 2004, NEUROLOGY, V63, P1198, DOI 10.1212/01.WNL.0000140488.65299.53; Wilson RS, 2003, NEUROLOGY, V61, P812, DOI 10.1212/01.WNL.0000083989.44027.05; [赵倩华 ZHAO Qianhua], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P233; Zhou B, 2010, J ALZHEIMERS DIS, V22, P673, DOI 10.3233/JAD-2010-100318	43	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95755	10.1371/journal.pone.0095755	http://dx.doi.org/10.1371/journal.pone.0095755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24870360	Green Submitted, gold, Green Published			2022-12-25	WOS:000335227400118
J	Mishra, AK; Muthamilarasan, M; Khan, Y; Parida, SK; Prasad, M				Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Khan, Yusuf; Parida, Swarup Kumar; Prasad, Manoj			Genome-Wide Investigation and Expression Analyses of WD40 Protein Family in the Model Plant Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENE-EXPRESSION; SEQUENCE; ARABIDOPSIS; STRESS; EVOLUTION; REPEAT; RICE; ARCHITECTURE; RECOGNITION	WD40 proteins play a crucial role in diverse protein-protein interactions by acting as scaffolding molecules and thus assisting in the proper activity of proteins. Hence, systematic characterization and expression profiling of these WD40 genes in foxtail millet would enable us to understand the networks of WD40 proteins and their biological processes and gene functions. In the present study, a genome-wide survey was conducted and 225 potential WD40 genes were identified. Phylogenetic analysis categorized the WD40 proteins into 5 distinct sub-families (I-V). Gene Ontology annotation revealed the biological roles of the WD40 proteins along with its cellular components and molecular functions. In silico comparative mapping with sorghum, maize and rice demonstrated the orthologous relationships and chromosomal rearrangements including duplication, inversion and deletion of WD40 genes. Estimation of synonymous and non-synonymous substitution rates revealed its evolutionary significance in terms of gene-duplication and divergence. Expression profiling against abiotic stresses provided novel insights into specific and/or overlapping expression patterns of SiWD40 genes. Homology modeling enabled three-dimensional structure prediction was performed to understand the molecular functions of WD40 proteins. Although, recent findings had shown the importance of WD40 domains in acting as hubs for cellular networks during many biological processes, it has invited a lesser research attention unlike other common domains. Being a most promiscuous interactors, WD40 domains are versatile in mediating critical cellular functions and hence this genome-wide study especially in the model crop foxtail millet would serve as a blue-print for functional characterization of WD40s in millets and bioenergy grass species. In addition, the present analyses would also assist the research community in choosing the candidate WD40s for comprehensive studies towards crop improvement of millets and biofuel grasses.	[Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Khan, Yusuf; Parida, Swarup Kumar; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	manoj_prasad@nipgr.ac.in	khan, yusuf/E-6726-2015; Sanganahalli, Basavaraju G/C-3296-2008; Hyder, Fahmeed/A-2644-2015; Waxman, Stephen/Z-2507-2019; khan, yusuf/AAQ-9470-2021; Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017; MISHRA, AWDHESH/U-1920-2019	khan, yusuf/0000-0001-6986-4657; Sanganahalli, Basavaraju G/0000-0002-0851-6621; Hyder, Fahmeed/0000-0001-7822-4002; Waxman, Stephen/0000-0001-5718-7177; Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; /0000-0002-3312-3264	NIPGR; Council of Scientific and Industrial Research; University Grants Commission, New Delhi, India	NIPGR; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi, India(University Grants Commission, India)	The authors work in this area was supported by the core grant of NIPGR. AKM and MM acknowledge the award of Senior Research Fellowship and Junior Research Fellowship from Council of Scientific and Industrial Research and University Grants Commission, New Delhi, India, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Cochrane G, 2013, NUCLEIC ACIDS RES, V41, pD30, DOI 10.1093/nar/gks1175; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Gupta S, 2013, PLANT BREEDING, V132, P367, DOI 10.1111/pbr.12070; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Gupta S, 2011, GENOME, V54, P586, DOI [10.1139/G11-020, 10.1139/g11-020]; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jayaraman A, 2008, MOL BIOTECHNOL, V40, P241, DOI 10.1007/s12033-008-9081-4; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2013, J PLANT BIOCHEM BIOT, V22, P257, DOI 10.1007/s13562-013-0216-8; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lata C, 2011, PROTOPLASMA, V248, P817, DOI 10.1007/s00709-010-0257-y; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mishra AK, 2012, J PLANT BIOCHEM BIOT, V21, pS32, DOI 10.1007/s13562-012-0134-1; Mishra AK, 2012, GENOMICS, V100, P252, DOI 10.1016/j.ygeno.2012.06.012; Muthamilarasan M, 2014, DNA RES, V21, P41, DOI 10.1093/dnares/dst039; Muthamilarasan M, 2013, CURR SCI INDIA, V105, P155; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Puranik S, 2011, PLANT SIGNAL BEHAV, V6, P1588, DOI 10.4161/psb.6.10.17130; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	64	114	121	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86852	10.1371/journal.pone.0086852	http://dx.doi.org/10.1371/journal.pone.0086852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24748279	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000158
J	Lopez, DC; Zhu-Salzman, K; Ek-Ramos, MJ; Sword, GA				Castillo Lopez, Diana; Zhu-Salzman, Keyan; Julissa Ek-Ramos, Maria; Sword, Gregory A.			The Entomopathogenic Fungal Endophytes Purpureocillium lilacinum (Formerly Paecilomyces lilacinus) and Beauveria bassiana Negatively Affect Cotton Aphid Reproduction under Both Greenhouse and Field Conditions	PLOS ONE			English	Article							VERTICILLIUM-LECANII; PERENNIAL RYEGRASS; THOM SAMSON; SEED; PLANT; ASCOMYCOTA; RESISTANCE; GRASSES; DISEASE; COLONIZATION	The effects of two entomopathogenic fungal endophytes, Beauveria bassiana and Purpureocillium lilacinum (formerly Paecilomyces lilacinus), were assessed on the reproduction of cotton aphid, Aphis gossypii Glover (Homoptera:Aphididae), through in planta feeding trials. In replicate greenhouse and field trials, cotton plants (Gossypium hirsutum) were inoculated as seed treatments with two concentrations of B. bassiana or P. lilacinum conidia. Positive colonization of cotton by the endophytes was confirmed through potato dextrose agar (PDA) media plating and PCR analysis. Inoculation and colonization of cotton by either B. bassiana or P. lilacinum negatively affected aphid reproduction over periods of seven and 14 days in a series of greenhouse trials. Field trials were conducted in the summers of 2012 and 2013 in which cotton plants inoculated as seed treatments with B. bassiana and P. lilacinum were exposed to cotton aphids for 14 days. There was a significant overall effect of endophyte treatment on the number of cotton aphids per plant. Plants inoculated with B. bassiana had significantly lower numbers of aphids across both years. The number of aphids on plants inoculated with P. lilacinum exhibited a similar, but non-significant, reduction in numbers relative to control plants. We also tested the pathogenicity of both P. lilacinum and B. bassiana strains used in the experiments against cotton aphids in a survival experiment where 60% and 57% of treated aphids, respectively, died from infection over seven days versus 10% mortality among control insects. Our results demonstrate (i) the successful establishment of P. lilacinum and B. bassiana as endophytes in cotton via seed inoculation, (ii) subsequent negative effects of the presence of both target endophytes on cotton aphid reproduction using whole plant assays, and (iii) that the P. lilacinum strain used is both endophytic and pathogenic to cotton aphids. Our results illustrate the potential of using these endophytes for the biological control of aphids and other herbivores under greenhouse and field conditions.	[Castillo Lopez, Diana; Zhu-Salzman, Keyan; Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Julissa Ek-Ramos, Maria] Autonomous Univ Nuevo Leon, Dept Immunol & Microbiol, San Nicolas De Los Garza, Nuevo Leon, Mexico	Texas A&M University System; Texas A&M University College Station; Universidad Autonoma de Nuevo Leon	Lopez, DC (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	dianacastillo8@tamu.edu	Ramos, Maria Julissa Ek/W-1017-2018; Potts, Brad M/C-6489-2013	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Potts, Brad M/0000-0001-6244-289X; Costa e Silva, Joao/0000-0003-1422-9554	Cotton Incorporated Grant; Good Neighbor Scholarship	Cotton Incorporated Grant; Good Neighbor Scholarship	The work was supported by Cotton Incorporated Grant and Good Neighbor Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello J, 2008, CROP PROT, V27, P1437, DOI 10.1016/j.cropro.2008.07.003; Akello J, 2012, BIOL CONTROL, V61, P215, DOI 10.1016/j.biocontrol.2012.02.007; Atkins SD, 2005, FEMS MICROBIOL ECOL, V51, P257, DOI 10.1016/j.femsec.2004.09.002; Ball OJP, 1997, J CHEM ECOL, V23, P1419, DOI 10.1023/B:JOEC.0000006473.26175.19; Ball OJP, 1997, J ECON ENTOMOL, V90, P1382, DOI 10.1093/jee/90.5.1382; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Biswas C, 2012, BIOCONTROL, V57, P565, DOI 10.1007/s10526-011-9424-0; Brownbridge M, 2012, BIOL CONTROL, V61, P194, DOI 10.1016/j.biocontrol.2012.01.002; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Carriere Y, 1998, J ECON ENTOMOL, V91, P324, DOI 10.1093/jee/91.1.324; Carrión Gloria, 2012, Rev. mex. fitopatol, V30, P86; Chaudhary KK, 2012, S ASIAN J EXP BIOL, V1, P36; CLAY K, 1993, ECOLOGY, V74, P1767, DOI 10.2307/1939935; Clay K, 1996, RES POPUL ECOL, V38, P191, DOI 10.1007/BF02515727; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dugassa-Gobena D., 1996, MITTEILUNGEN BIOL BU, V321, P299; Ek-Ramos MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066049; Fiedler Z, 2007, BIOCONTROL, V52, P547, DOI 10.1007/s10526-006-9052-2; Gange AC, 2012, OECOLOGIA, V168, P1023, DOI 10.1007/s00442-011-2151-5; Gassmann AJ, 2009, PEST MANAG SCI, V65, P1174, DOI 10.1002/ps.1844; GINDIN G, 1994, PHYTOPARASITICA, V22, P189, DOI 10.1007/BF02980318; Godfrey L. D., 1997, 1997 Proceedings Beltwide Cotton Conferences, New Orleans, LA, USA, January 6-10, 1997: Volume 2., P1048; Godfrey L.D., 2000, CALIF AGR, V54, P32, DOI [10.3733/ca.v054n06p26, DOI 10.3733/CA.V054N06P26]; Gould F, 1995, WEED TECHNOL, V9, P830, DOI 10.1017/S0890037X00024301; GRAFTONCARDWELL EE, 1991, J ECON ENTOMOL, V84, P741, DOI 10.1093/jee/84.3.741; Gurulingappa P, 2011, CROP PROT, V30, P349, DOI 10.1016/j.cropro.2010.11.017; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Imoulan A, 2011, WORLD J MICROB BIOT, V27, P2619, DOI 10.1007/s11274-011-0735-1; Jaber LR, 2010, ECOL ENTOMOL, V35, P25, DOI 10.1111/j.1365-2311.2009.01152.x; Jung H.S., 2006, KOREAN J MYCOL, V34, P112; KERNS DL, 1992, J ECON ENTOMOL, V85, P1, DOI 10.1093/jee/85.1.1; Khan MR, 2012, TURK J BIOL, V36, P161, DOI 10.3906/biy-1008-72; Kiewnick S, 2011, PHYTOPATHOLOGY, V101, P105, DOI 10.1094/PHYTO-03-10-0090; King EG, 1987, 40 ANN C REP COTT IN; LATCH GCM, 1993, AGR ECOSYST ENVIRON, V44, P143, DOI 10.1016/0167-8809(93)90043-O; Luangsa-Ard J, 2011, FEMS MICROBIOL LETT, V321, P141, DOI 10.1111/j.1574-6968.2011.02322.x; Marti GA, 2006, MYCOPATHOLOGIA, V162, P369, DOI 10.1007/s11046-006-0072-3; Martinuz A, 2012, BIOL CONTROL, V62, DOI 10.1016/j.biocontrol.2012.05.006; McGee PA, 2002, AUST J EXP AGR, V42, P995, DOI 10.1071/EA01124; Munawar Fazal, 2011, Annals of Plant Protection Sciences, V19, P168; O'Brien PJ, 1990, INSECT ACAR TESTS, V15, P254; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Ownley BH, 2008, J INVERTEBR PATHOL, V98, P267, DOI 10.1016/j.jip.2008.01.010; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Posada FJ, 2005, MYCOLOGIA, V97, P1208; Posada F, 2007, MYCOL RES, V111, P748, DOI 10.1016/j.mycres.2007.03.006; Powell WA, 2009, J ENTOMOL SCI, V44, P391, DOI 10.18474/0749-8004-44.4.391; Price PW, 2011, INSECT ECOLOGY, P121; Raja Kannan, 2012, Journal of Agricultural Science (Toronto), V4, P119; Rao N. B. V. C., 2012, Insect Environment, V17, P151; Raps A, 1998, OECOLOGIA, V114, P541, DOI 10.1007/s004420050478; Rasmussen S, 2008, PLANT PHYSIOL, V146, P1440, DOI 10.1104/pp.107.111898; Reddy Narasimha P., 2009, Journal of Asia-Pacific Entomology, V12, P221, DOI 10.1016/j.aspen.2009.06.001; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saari S, 2010, MICROB ECOL, V60, P928, DOI 10.1007/s00248-010-9749-8; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011395; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036810; Swati Sharma, 2012, Indian Journal of Nematology, V42, P1; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Vicari M, 2002, ECOLOGY, V83, P2452, DOI 10.1890/0012-9658(2002)083[2452:CEOFAM]2.0.CO;2; Wang LD, 2007, PEST MANAG SCI, V63, P381, DOI 10.1002/ps.1359; Waqas Wakil, 2012, African Journal of Biotechnology, V11, P821; Young C, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P660	69	130	135	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103891	10.1371/journal.pone.0103891	http://dx.doi.org/10.1371/journal.pone.0103891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093505	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200041
J	Silva, JCE; Potts, BM; Lopez, GA				Costa e Silva, Joao; Potts, Brad M.; Lopez, Gustavo A.			Heterosis May Result in Selection Favouring the Products of Long-Distance Pollen Dispersal in Eucalyptus	PLOS ONE			English	Article							GLOBULUS SSP GLOBULUS; SPATIAL GENETIC-STRUCTURE; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; LOCAL ADAPTATION; POPULATION DIFFERENTIATION; ENVIRONMENT INTERACTION; RECIPROCAL HYBRIDS; SEED DISPERSAL; WOOD DENSITY	Using native trees from near the northern and southern extremities of the relatively continuous eastern distribution of Eucalyptus globulus in Tasmania, we compared the progenies derived from natural open-pollination (OP) with those generated from within-region and long-distance outcrossing. Controlled outcrossing amongst eight parents - with four parents from each of the northern and southern regions - was undertaken using a diallel mating scheme. The progeny were planted in two field trials located within the species native range in southern Tasmania, and their survival and diameter growth were monitored over a 13-year-period. The survival and growth performances of all controlled cross types exceeded those of the OP progenies, consistent with inbreeding depression due to a combination of selfing and bi-parental inbreeding. The poorer survival of the northern regional (female(N)male(N)) outcrosses compared with the local southern regional outcrosses (female(S)male(S)) indicated differential selection against the former. Despite this mal-adaptation of the non-local female(N)male(N) crosses at both southern sites, the survival of the inter-regional hybrids (male(N)male(S) and female(S)male(N)) was never significantly different from that of the local female(S)male(S) crosses. Significant site-dependent heterosis was detected for the growth of the surviving long-distance hybrids. This was expressed as mid-parent heterosis, particularly at the more northern planting site. Heterosis increased with age, while the difference between the regional female(N)male(N) and female(S)male(S) crosses remained insignificant at any age at either site. Nevertheless, the results for growth suggest that the fitness of individuals derived from long-distance crossing may be better at the more northern of the planting sites. Our results demonstrate the potential for early-age assessments of pollen dispersal to underestimate realised gene flow, with local inbreeding under natural open-pollination resulting in selection favouring the products of longer-distance pollinations. Indeed, heterosis derived from long-distance pollinations may be sufficient to counter local mal-adaptation, at least in the first generation.	[Costa e Silva, Joao] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal; [Potts, Brad M.; Lopez, Gustavo A.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Potts, Brad M.; Lopez, Gustavo A.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas, Australia	Universidade de Lisboa; University of Tasmania; University of Tasmania	Silva, JCE (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal.	jces@isa.utl.pt	Ramos, Maria Julissa Ek/W-1017-2018; Potts, Brad M/C-6489-2013	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Potts, Brad M/0000-0001-6244-289X; Costa e Silva, Joao/0000-0003-1422-9554	University of Tasmania; Instituto Nacional de Tecnologia Agropecuaria; Argentina Government; Australian Research Council Linkage [LP0884001]; Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal) through the Ciencia initiative	University of Tasmania; Instituto Nacional de Tecnologia Agropecuaria; Argentina Government; Australian Research Council Linkage(Australian Research Council); Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal) through the Ciencia initiative	The trials studied were established as part of the genetic research undertaken by the CRC for Sustainable Production Forestry, and as part of the PhD studies of Gustavo Lopez. This PhD was supported by the University of Tasmania, the Instituto Nacional de Tecnologia Agropecuaria, and the Argentina Government. Trial measurements and data collation were supported by the CRC for Sustainable Production Forestry, as well as an Australian Research Council Linkage grant (LP0884001) partnered by the Southern Tree Breeding Association Inc. and SeedEnergy Pty. Ltd. The financial support given to Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal), through the Ciencia 2007 initiative, is gratefully acknowledged and provided the opportunity to complete this long-term study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, CATEGORICAL DATA ANA; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Barbour RC, 2003, AUST J BOT, V51, P429, DOI 10.1071/BT03016; Barlow R., 1981, Animal Breeding Abstracts, V49, P715; Barton NH, 2004, EVOLUTION, V58, P2111; Berens DG, 2013, OIKOS, V122, P1616, DOI 10.1111/j.1600-0706.2013.00515.x; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Breslow N, 2004, LECT NOTES STAT, V179, P1; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Buschbom J, 2011, J HERED, V102, P464, DOI 10.1093/jhered/esr023; Byrne M., 2008, PLANT GENOME BIODI E, V1, P303; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V305, P129, DOI 10.1016/j.foreco.2013.05.037; Campbell DR, 2010, AM J BOT, V97, P925, DOI 10.3732/ajb.0900387; Campbell DR, 2001, EVOLUTION, V55, P669, DOI 10.1554/0014-3820(2001)055[0669:GBEIAT]2.0.CO;2; Chybicki IJ, 2010, MOL ECOL, V19, P2137, DOI 10.1111/j.1365-294X.2010.04632.x; Silva JCE, 2011, HEREDITY, V107, P50, DOI 10.1038/hdy.2010.154; Silva JCE, 2006, TREE GENET GENOMES, V2, P61, DOI 10.1007/s11295-005-0025-x; Silva JCE, 2012, TREE GENET GENOMES, V8, P249, DOI 10.1007/s11295-011-0437-8; Silva JCE, 2009, TREE GENET GENOMES, V5, P291, DOI 10.1007/s11295-008-0174-9; Cox D.R., 1970, ANAL BINARY DATA, V2; Dungey HS, 2001, FOREST ECOL MANAG, V148, P243, DOI 10.1016/S0378-1127(00)00539-9; Dutkowski GW, 2012, TREE GENET GENOMES, V8, P757, DOI 10.1007/s11295-011-0461-8; Dutkowski GW, 1999, AUST J BOT, V47, P237, DOI 10.1071/BT97114; Dutkowski GW, 2002, CAN J FOREST RES, V32, P2201, DOI 10.1139/X02-111; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; ELLSTRAND NC, 1992, OIKOS, V63, P77, DOI 10.2307/3545517; Epperson B. K., 1992, New Forests, V6, P257, DOI 10.1007/BF00120648; Eyles A, 2013, FOREST ECOL MANAG, V304, P49, DOI 10.1016/j.foreco.2013.04.033; Fenster CB, 2000, EVOLUTION, V54, P1157, DOI 10.1111/j.0014-3820.2000.tb00551.x; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Fishman L, 2001, EVOLUTION, V55, P1932, DOI 10.1111/j.0014-3820.2001.tb01311.x; Forrest CN, 2011, ANN BOT-LONDON, V108, P185, DOI 10.1093/aob/mcr100; Freeman JS, 2007, ANN FOREST SCI, V64, P639, DOI 10.1051/forest:2007042; Fritz RS, 2006, EVOLUTION, V60, P1215, DOI 10.1111/j.0014-3820.2006.tb01200.x; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gilmour A.R., 2009, ASREML USER GUIDE RE; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goto S, 2011, RESTOR ECOL, V19, P243, DOI 10.1111/j.1526-100X.2009.00568.x; GOVINDARAJU DR, 1989, BIOL J LINN SOC, V37, P345, DOI 10.1111/j.1095-8312.1989.tb01910.x; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; HAASE P, 1993, J BIOGEOGR, V20, P79, DOI 10.2307/2845741; Hamilton MG, 2013, HEREDITY, V110, P372, DOI 10.1038/hdy.2012.106; Hamilton MG, 2011, AUST J BOT, V59, P170, DOI 10.1071/BT10313; Hampe A., 2013, P ROYAL SOC B, V280, P1764; Hamrick J. L., 2000, Forest conservation genetics: principles and practice, P81, DOI 10.1079/9780851995045.0081; Hansen TF, 2013, EVOLUTION, V67, P3501, DOI 10.1111/evo.12214; Hardner CM, 1997, EVOLUTION, V51, P103, DOI 10.1111/j.1558-5646.1997.tb02392.x; HARDNER CM, 1995, SILVAE GENET, V44, P46; Hardner CM, 1998, EVOLUTION, V52, P614, DOI [10.2307/2411096, 10.1111/j.1558-5646.1998.tb01660.x]; Harfouche A, 2000, CAN J FOREST RES, V30, P10, DOI 10.1139/cjfr-30-1-10; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hingston A. B., 1998, Tasforests, V10, P125; Hingston AB, 2005, AUSTRAL ECOL, V30, P319, DOI 10.1111/j.1442-9993.2005.01476.x; Hingston AB, 2004, AUSTRAL ECOL, V29, P624, DOI 10.1111/j.1442-9993.2004.01397.x; Hingston AB, 2004, AUST J BOT, V52, P371, DOI 10.1071/BT03018; Hingston AB, 2004, AUST J BOT, V52, P353, DOI 10.1071/BT03002; Hirao AS, 2010, ANN BOT-LONDON, V105, P637, DOI 10.1093/aob/mcq018; HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Igic B, 2006, EVOLUTION, V60, P1098, DOI 10.1111/j.0014-3820.2006.tb01186.x; Isagi Y, 2007, J ECOL, V95, P983, DOI 10.1111/j.1365-2745.2007.01272.x; Jones RC, 2013, ECOL EVOL, V3, P1, DOI 10.1002/ece3.421; Jones RC, 2011, TREE GENET GENOMES, V7, P1209, DOI 10.1007/s11295-011-0407-1; Jones TH, 2007, MOL ECOL, V16, P697, DOI 10.1111/j.1365-294X.2006.03180.x; Robledo-Arnuncio JJ, 2011, NEW PHYTOL, V190, P222, DOI 10.1111/j.1469-8137.2010.03588.x; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kimball S, 2008, J ECOL, V96, P1306, DOI 10.1111/j.1365-2745.2008.01432.x; KOMENDER P, 1989, LIVEST PROD SCI, V21, P101, DOI 10.1016/0301-6226(89)90042-0; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Larcombe MJ, 2013, BIOL INVASIONS, V15, P2763, DOI 10.1007/s10530-013-0492-1; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; LEVIN DA, 1981, ANN MO BOT GARD, V68, P233, DOI 10.2307/2398797; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lopez GA, 2000, HEREDITY, V85, P242, DOI 10.1046/j.1365-2540.2000.00739.x; Lopez GA, 2003, CAN J FOREST RES, V33, P2108, DOI [10.1139/x03-132, 10.1139/X03-132]; Lynch Michael, 1998; Martin B, 1989, P IUFRO C BREED TROP, P79; McKinnon GE, 2001, GENOME, V44, P831, DOI 10.1139/gen-44-5-831; Mehta CR, 1992, J COMPUTATIONAL GRAP, V1, P21, DOI DOI 10.2307/1390598; Mimura M, 2009, MOL ECOL, V18, P4180, DOI 10.1111/j.1365-294X.2009.04350.x; Nikles DG, 1992, ACIAR P, P101; O'Reilly-Wapstra JM, 2005, J CHEM ECOL, V31, P357, DOI 10.1007/s10886-005-1346-9; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; O'Reilly-Wapstra JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058416; O'Reilly-Wapstra JM, 2011, TREE GENET GENOMES, V7, P485, DOI 10.1007/s11295-010-0350-6; Ozawa H, 2013, J HERED, V104, P465, DOI 10.1093/jhered/est022; POTTS BM, 1988, EVOLUTION, V42, P1245, DOI 10.1111/j.1558-5646.1988.tb04184.x; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Robertson AW, 2011, INT J PLANT SCI, V172, P191, DOI 10.1086/657678; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Silva JCE, 2004, THEOR APPL GENET, V108, P1113, DOI 10.1007/s00122-003-1524-5; Silva JCE, 2001, CAN J FOREST RES, V31, P1887, DOI 10.1139/cjfr-31-11-1887; Silva JCE, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010018; Silva JCE, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010019; Skabo S, 1998, AUST J BOT, V46, P583, DOI 10.1071/BT97056; Slavov GT, 2002, ECOLOGICAL AGRONOMIC, P106; Stackpole DJ, 2011, G3-GENES GENOM GENET, V1, P151, DOI 10.1534/g3.111.000372; Stackpole DJ, 2010, TREE GENET GENOMES, V6, P179, DOI 10.1007/s11295-009-0239-4; Steane DA, 2006, TREE GENET GENOMES, V2, P30, DOI 10.1007/s11295-005-0028-7; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Stringer JK, 2006, THESIS U QUEENSLAND; Stringer JK, 2011, J AGR BIOL ENVIR ST, V16, P269, DOI 10.1007/s13253-010-0051-5; Su G, 2009, J DAIRY SCI, V92, P2204, DOI 10.3168/jds.2008-1499; Taylor SJ, 2009, EVOLUTION, V63, P2581, DOI 10.1111/j.1558-5646.2009.00742.x; Vaillancourt R. E., 1995, Forest Genetics, V2, P11; Volker PW, 2008, TREE GENET GENOMES, V4, P445, DOI 10.1007/s11295-007-0122-0; Volker PW, 2002, THEISI U TASMANIA; WADDINGTON KD, 1983, AM NAT, V122, P147, DOI 10.1086/284124; Wallis IR, 2011, PERSPECT PLANT ECOL, V13, P305, DOI 10.1016/j.ppees.2011.05.005; Waser N.M., 1983, P341; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; White T. L., 2007, FOREST GENETICS; Wolfinger RD, 1996, J AGR BIOL ENVIR ST, V1, P205, DOI [10.2307/1400366, DOI 10.2307/1400366]; Yeoh SH, 2012, TREE GENET GENOMES, V8, P695, DOI 10.1007/s11295-011-0457-4; Yu H, 2010, MOL ECOL, V19, P4441, DOI 10.1111/j.1365-294X.2010.04777.x	124	130	135	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e93811	10.1371/journal.pone.0093811	http://dx.doi.org/10.1371/journal.pone.0093811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	25093505	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400008
J	Liu, WQ; Zhang, SW; Zhao, D; Zou, HW; Sun, NY; Liang, X; Dard, M; Lanske, B; Yuan, Q				Liu, Weiqing; Zhang, Shiwen; Zhao, Dan; Zou, Huawei; Sun, Ningyuan; Liang, Xing; Dard, Michel; Lanske, Beate; Yuan, Quan			Vitamin D Supplementation Enhances the Fixation of Titanium Implants in Chronic Kidney Disease Mice	PLOS ONE			English	Article							POSITION STATEMENT; RENAL-FAILURE; OSSEOINTEGRATION; PREVALENCE; BONE; DEFICIENCY; ASSOCIATION; ADOLESCENTS; CHILDREN; PATIENT	Vitamin D (Vit D) deficiency is a common condition in chronic kidney disease (CKD) patients that negatively affects bone regeneration and fracture healing. Previous study has shown that timely healing of titanium implants is impaired in CKD. This study aimed to investigate the effect of Vit D supplementation on implant osseointegration in CKD mice. Uremia was induced by 5/6 nephrectomy in C57BL mice. Eight weeks after the second renal surgery, animals were given 1,25(OH)(2)D-3 three times a week intraperitoneally for four weeks. Experimental titanium implants were inserted into the distal end of femurs two weeks later. Serum measurements confirmed decreased 1,25(OH)(2)D levels in CKD mice, which could be successfully corrected by Vit D injections. Moreover, the hyperparathyroidism observed in CKD mice was also corrected. Xray examination and histological sections showed successful osseointegration in these mice. Histomorphometrical analysis revealed that the bone-implant contact (BIC) ratio and bone volume (BV/TV) around the implant were significantly increased in the Vit D-supplementation group. In addition, resistance of the implant, as measured by a push-in method, was significantly improved compared to that in the vehicle group. These results demonstrate that Vit D supplementation is an effective approach to improve the fixation of titanium implants in CKD.	[Liu, Weiqing; Zhang, Shiwen; Zhao, Dan; Zou, Huawei; Sun, Ningyuan; Liang, Xing; Yuan, Quan] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA; [Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Sichuan University; New York University; Harvard University; Harvard School of Dental Medicine	Yuan, Q (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.	yuanquan@scu.edu.cn	yuan, quan/GZM-5597-2022	Yuan, Quan/0000-0002-2836-1081; Lanske, Beate/0000-0003-4638-804X; zhao, dan/0000-0002-0037-1464	National Natural Science Foundation of China [NSFC 81371173]; New Century Excellent Talents in University [NCET-12-0379]; International Team of Implantology [ITI 717_2010]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-073944]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); International Team of Implantology; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81371173), New Century Excellent Talents in University (NCET-12-0379) and International Team of Implantology (ITI 717_2010) to Q.Y., and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, R01-073944) to B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan Ali, 2012, Dent Res J (Isfahan), V9, P582; Alvim-Pereira F, 2008, CLIN ORAL IMPLAN RES, V19, P786, DOI 10.1111/j.1600-0501.2008.01532.x; Andress DL, 2008, KIDNEY INT, V73, P1345, DOI 10.1038/ki.2008.60; Andress DL, 2005, SEMIN DIALYSIS, V18, P315, DOI 10.1111/j.1525-139X.2005.18408.x; Bayraktar G, 2007, ORAL DIS, V13, P393, DOI 10.1111/j.1601-0825.2006.01297.x; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Brinker MR, 2007, J ORTHOP TRAUMA, V21, P557, DOI 10.1097/BOT.0b013e31814d4dc6; Chandra Prakash, 2008, Endocr Pract, V14, P10; Cho YJ, 2011, INT J ORAL MAX IMPL, V26, P1225; Choukroun J, 2013, J ORAL IMPLANTOL; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Craig RG, 2007, NEPHROL DIAL TRANSPL, V22, P312, DOI 10.1093/ndt/gfl604; Davidovich E, 2005, PEDIATR DENT, V27, P98; Davidovich E, 2005, J CLIN PERIODONTOL, V32, P1076, DOI 10.1111/j.1600-051X.2005.00812.x; DeRossi SS, 1996, J AM DENT ASSOC, V127, P211, DOI 10.14219/jada.archive.1996.0171; Dijakiewicz M, 2007, NEPHROL DIAL TRANSPL, V22, P2722, DOI 10.1093/ndt/gfm317; Dvorak G, 2012, CLIN ORAL IMPLAN RES, V23, P1308, DOI 10.1111/j.1600-0501.2011.02346.x; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Ishimura E, 1999, KIDNEY INT, V55, P1019, DOI 10.1046/j.1523-1755.1999.0550031019.x; Jingushi S, 1998, ENDOCRINOLOGY, V139, P1467, DOI 10.1210/en.139.4.1467; Cervero AJ, 2008, MED ORAL PATOL ORAL, V13, pE419; Kandula P, 2011, CLIN J AM SOC NEPHRO, V6, P50, DOI 10.2215/CJN.03940510; Kelly J, 2009, J PROSTHODONT, V18, P473, DOI 10.1111/j.1532-849X.2009.00446.x; Kimura Genjiro, 2007, Clin Exp Nephrol, V11, P188, DOI 10.1007/s10157-007-0474-7; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Lee MM, 2010, J PERIODONTOL, V81, P300, DOI 10.1902/jop.2009.090379; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Mengatto CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015848; Messier MD, 2012, J PERIODONTOL, V83, P602, DOI 10.1902/jop.2011.110306; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Pillar R, 2013, HYPERTENS RES, V36, P428, DOI 10.1038/hr.2012.230; Rouached M, 2008, KIDNEY INT, V74, P389, DOI 10.1038/ki.2008.169; Ruospo M, 2013, NEPHROL DIAL TRANSPL; Saran R, 2010, ADV CHRONIC KIDNEY D, V17, P271, DOI 10.1053/j.ackd.2010.03.001; Stellingsma C, 2004, CRIT REV ORAL BIOL M, V15, P240, DOI 10.1177/154411130401500406; Wu YY, 2013, BONE, V52, P1, DOI 10.1016/j.bone.2012.09.005; Xu B, 2009, J DENT RES, V88, P1003, DOI 10.1177/0022034509346928; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhou CC, 2012, OR SURG OR MED OR PA, V114, pS174, DOI 10.1016/j.oooo.2011.09.030; Zou HW, 2013, BONE, V56, P410, DOI 10.1016/j.bone.2013.07.014	46	38	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95689	10.1371/journal.pone.0095689	http://dx.doi.org/10.1371/journal.pone.0095689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752599	Green Published, gold			2022-12-25	WOS:000335227400101
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
